PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wang, L; Kofler, M; Brosch, G; Melesina, J; Sippl, W; Martinez, ED; Easmon, J				Wang, Lei; Kofler, Marina; Brosch, Gerald; Melesina, Jelena; Sippl, Wolfgang; Martinez, Elisabeth D.; Easmon, Johnny			2-Benzazolyl-4-Piperazin-1-Ylsulfonylbenzenecarbohydroxamic Acids as Novel Selective Histone Deacetylase-6 Inhibitors with Antiproliferative Activity	PLOS ONE			English	Article							TRICHOSTATIN; DERIVATIVES; POTENT; R306465	We have screened our compound collection in an established cell based assay that measures the derepression of an epigenetically silenced transgene, the locus derepression assay. The screen led to the identification of 4-[4-(1-methylbenzimidazol-2-yl)piperazin-1-yl] sulfonylbenzenecarbohydroxamic acid (9b) as an active which was found to inhibit HDAC1. In initial structure activity relationships study, the 1-methylbenzimidazole ring was replaced by the isosteric heterocycles benzimidazole, benzoxazole, and benzothiazole and the position of the hydroxamic acid substituent on the phenyl ring was varied. Whereas compounds bearing a para substituted hydroxamic acid (9a-d) were active HDAC inhibitors, the meta substituted analogues (8a-d) were appreciably inactive. Compounds 9a-d selectively inhibited HDAC6 (IC50 = 0.1-1.0 mu M) over HDAC1 (IC50 = 0.9-6 mu M) and moreover, also selectively inhibited the growth of lung cancer cells vs. patient matched normal cells. The compounds induce a cell cycle arrest in the S-phase while induction of apoptosis is neglible as compared to controls. Molecular modeling studies uncovered that the MM-GBSA energy for interaction of 9a-d with HDAC6 was higher than for HDAC1 providing structural rationale for the HDAC6 selectivity.	[Wang, Lei; Martinez, Elisabeth D.] UT Southwestern Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Kofler, Marina; Easmon, Johnny] Univ Innsbruck, Ctr Chem & Biomed, Inst Pharm, Dept Pharmaceut Chem, A-6020 Innsbruck, Austria; [Brosch, Gerald] Med Univ Innsbruck, Ctr Chem & Biomed, Div Mol Biol, A-6020 Innsbruck, Austria; [Melesina, Jelena; Sippl, Wolfgang] Univ Halle Wittenberg, Dept Med Chem, Inst Pharm, D-06099 Halle, Germany; [Martinez, Elisabeth D.] UT Southwestern Med Ctr, Dept Pharmacol, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Innsbruck; Medical University of Innsbruck; Martin Luther University Halle Wittenberg; University of Texas System; University of Texas Southwestern Medical Center Dallas	Martinez, ED (corresponding author), UT Southwestern Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA.	elisabeth.martinez@utsouthwestern.edu; johnny.easmon@uibk.ac.at	Melesina, Jelena/AAI-1787-2019; Sippl, Wolfgang/P-5944-2014	Sippl, Wolfgang/0000-0002-5985-9261; Melesina, Jelena/0000-0001-7335-7041	NIH [R01CA12526901, 1R21AI11622201, P50-CA70907]; Doctor's Cancer Foundation (Nolan Miller Lung Cancer grant); Welch Foundation; National Cancer Institut [R01CA12526901]; CPRIT [RP120717]; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doctor's Cancer Foundation (Nolan Miller Lung Cancer grant); Welch Foundation(The Welch Foundation); National Cancer Institut(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was partly funded by the NIH (R01CA12526901 to E.D.M., 1R21AI11622201 to I.D./E.D.M. P50-CA70907 to J.D.M., subaward to E.D.M.) by the Doctor's Cancer Foundation (Nolan Miller Lung Cancer grant to E.D.M.), by the Friends of the Cancer Center, by the Welch Foundation (grants to E.D.M.), by the National Cancer Institut R01CA12526901 to E.D.M., and by CPRIT (RP120717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jianjun Chang for technical assistance with proliferation assays. This project was partly funded by the NIH (R01CA12526901 to E.D.M., 1R21AI11622201 to I.D./E.D.M. P50-CA70907 to J.D.M., subaward to E.D.M.) by the Doctor's Cancer Foundation (Nolan Miller Lung Cancer grant to E.D.M.), by the Friends of the Cancer Center, by the Welch Foundation (grants to E.D.M.) and by CPRIT (RP120717).	[Anonymous], 2012, ROTEIN PREPARATION W; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Arts J, 2007, BRIT J CANCER, V97, P1344, DOI 10.1038/sj.bjc.6604025; Best AM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/868095; Burli RW, 2013, J MED CHEM, V56, P9934, DOI 10.1021/jm4011884; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Chang J, 2012, BRIT J CANCER, V106, P116, DOI 10.1038/bjc.2011.532; Dallavalle S, 2012, BIOCHEM PHARMACOL, V84, P756, DOI 10.1016/j.bcp.2012.06.014; Fong PC, 2007, J CLIN ONCOL, V25; Furumai R, 2001, P NATL ACAD SCI USA, V98, P87, DOI 10.1073/pnas.011405598; Grassadonia Antonino, 2013, Cancers (Basel), V5, P919, DOI 10.3390/cancers5030919; Hofer S, 2013, BIOORG MED CHEM LETT, V23, P5397, DOI 10.1016/j.bmcl.2013.07.047; Johnson RL, 2008, ANAL BIOCHEM, V375, P237, DOI 10.1016/j.ab.2007.12.028; Lin HY, 2006, MED RES REV, V26, P397, DOI 10.1002/med.20056; Martinez ED, 2006, METHOD ENZYMOL, V414, P21, DOI 10.1016/S0076-6879(06)14002-1; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; Monga M, 2002, LEUKEMIA, V16, P520, DOI 10.1038/sj.leu.2402464; Ononye SN, 2012, PHARM PAT ANAL, V1, DOI [10.4144/ppa.12.21, DOI 10.4144/PPA.12.21]; Orjales A, 1997, J MED CHEM, V40, P586, DOI 10.1021/jm960442e; Paris M, 2008, J MED CHEM, V51, P1505, DOI 10.1021/jm7011408; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Reddy AS, 2000, TETRAHEDRON LETT, V41, P6285, DOI 10.1016/S0040-4039(00)01058-3; Sato Y, 1998, J MED CHEM, V41, P3015, DOI 10.1021/jm9801004; Schaefer S, 2009, CHEMMEDCHEM, V4, P283, DOI 10.1002/cmdc.200800196; SENDRA R, 1988, PLANT MOL BIOL, V11, P857, DOI 10.1007/BF00019525; Shafik RM, 2003, ALEX J PHARM SCI, V17, P137; Silvestri L, 2012, J CHEM INF MODEL, V52, P2215, DOI 10.1021/ci300160y; Ververis K, 2013, BIOL-TARGETS THER, V7, P47, DOI 10.2147/BTT.S29965; Walczynski K, 1999, FARMACO, V54, P684, DOI 10.1016/S0014-827X(99)00081-6; Wang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3035; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	32	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0134556	10.1371/journal.pone.0134556	http://dx.doi.org/10.1371/journal.pone.0134556			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698121	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600001
J	Drummond, AMA; Ferreira, EF; Gomes, VE; Marcenes, W				Araujo Drummond, Andreia Maria; Ferreira, Efigenia Ferreira; Gomes, Viviane Elisangela; Marcenes, Wagner			Inequality of Experience of Dental Caries between Different Ethnic Groups of Brazilians Aged 15 to 19 Years	PLOS ONE			English	Article							CHILD ORAL-HEALTH; SOCIOECONOMIC-STATUS; RACE; DISPARITIES; STATES	Introduction The aim of this study was to assess inequality of experience of dental caries, based on race/ethnicity, among Brazilian adolescents aged 15 to 19 years in 2010 and test whether socioeconomic indicators fully explain ethnic differences in dental caries. Methods Data from a National Oral Health Survey conducted in Brazil in 2010 was analysed. Race/ethnicity was self-assigned and modified to White, African descents, East Asian descents, Mixed Race and Indigenous descents. The prevalence of caries experience by race/ethnic group in 2010(n = 5,367) was calculated. Further analysis included conceptual hierarchical modelling and mediation analysis. Results Caries experience was 76.9% in 15 to 19 year old Brazilians in 2010. While African descents were 32% more likely to have caries experience than Whites, Mixed Race were 69% more likely to have caries experience than Whites. Hierarchical conceptual modelling analysis confirmed the highly significant association between caries and race/ethnicity. Mixed Race and East Asian descents were 1.44 (95% CI 1.24-1.67) and 1.81 (95% CI 1.02-3.20) times more likely to experience caries than Whites after adjusting for age, sex, education and income. The difference in the likelihood of experiencing caries between Whites and African descents was not statistically significant after adjusting for years of education and family income. The results of mediation analysis confirmed that inequality of caries experience between Whites and Mixed Race and East Asian descents was mediated through education and income. The likelihood that Mixed Race and East Asian descents would experience caries compared to Whites was attenuated, by 14.8% and by 9.5% respectively, after adjusting for years of education and income. Conclusions Data analysis demonstrated that Whites have benefited more from the significant reduction in dental caries experience in 15 to 19 year old Brazilians, as compared to African descents and Mixed Race. Education and income fully explained ethnic inequalities in experience of dental caries between Whites and African descents, and largely explained inequalities between Whites and Mixed Race.	[Araujo Drummond, Andreia Maria; Marcenes, Wagner] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England; [Araujo Drummond, Andreia Maria; Ferreira, Efigenia Ferreira; Gomes, Viviane Elisangela] Univ Fed Minas Gerais, Fac Dent, Belo Horizonte, MG, Brazil	University of London; Queen Mary University London; Universidade Federal de Minas Gerais	Drummond, AMA (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England.	andreia_drummond@hotmail.com	Ferreira, Efigenia/AAF-5226-2021; Gomes, Viviane Elisângela/S-5481-2019	Ferreira, Efigenia/0000-0002-0665-211X; Gomes, Viviane Elisângela/0000-0001-9637-1911	CAPES Foundation, Ministry of Education of Brazil, Brasilia - DF, Brazil [70.040-020]	CAPES Foundation, Ministry of Education of Brazil, Brasilia - DF, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by CAPES Foundation, Ministry of Education of Brazil, Brasilia - DF, 70.040-020, Brazil.	Altman DG, 1991, PPRATICAL STAT MED R; [Anonymous], BOLS FAM; [Anonymous], 2014, AUST DENT J, V59, P395, DOI [10.1111/adj.12205, DOI 10.1111/ADJ.12205]; Antunes JLF, 2006, COMMUNITY DENT ORAL, V34, P146, DOI 10.1111/j.1600-0528.2006.00274.x; Antunes JLF, 2003, INT DENT J, V53, P7, DOI 10.1111/j.1875-595X.2003.tb00649.x; Ayo-Yusuf O, 2007, J S AFRICAN DENT ASS, V62, P8; Bailey SR, 2013, SOC SCI RES, V42, P106, DOI 10.1016/j.ssresearch.2012.06.006; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Brasil, 2005, PROJ SB BRAS 2003 CO; Conway DI, 2007, COMMUNITY DENT HLTH, V24, P161; Dressler WW, 2005, ANNU REV ANTHROPOL, V34, P231, DOI 10.1146/annurev.anthro.34.081804.120505; Dye BA, 2010, INT J PAEDIATR DENT, V20, P132, DOI 10.1111/j.1365-263X.2009.01029.x; FLEISS JL, 1980, BIOMETRICS, V36, P343, DOI 10.2307/2529990; Francis AM, 2012, ECON EDUC REV, V31, P45, DOI 10.1016/j.econedurev.2011.08.005; Guiotoku SK, 2012, REV PANAM SALUD PUBL, V31, P135, DOI 10.1590/S1020-49892012000200007; Gushi Lívia Litsue, 2005, Cad. Saúde Pública, V21, P1383, DOI 10.1590/S0102-311X2005000500010; Jamieson LM, 2007, J PAEDIATR CHILD H, V43, P117, DOI 10.1111/j.1440-1754.2007.01029.x; Jamieson LM, 2007, ETHNIC HEALTH, V12, P89, DOI 10.1080/13557850601002197; Kaplan JB, 2003, JAMA-J AM MED ASSOC, V289, P2709, DOI 10.1001/jama.289.20.2709; Kawachi I, 2002, J EPIDEMIOL COMMUN H, V56, P647, DOI 10.1136/jech.56.9.647; Lawrence HP, 2009, COMMUNITY DENT ORAL, V37, P495, DOI 10.1111/j.1600-0528.2009.00497.x; Liang J, 2013, COMMUNITY DENT ORAL, V41, P517, DOI 10.1111/cdoe.12045; Liu Y, 2014, INT DENT J, V64, P52, DOI 10.1111/idj.12062; Marcenes W, 2013, BRIT DENT J, V215, DOI 10.1038/sj.bdj.2013.687; Marteleto LJ, 2012, DEMOGRAPHY, V49, P337, DOI 10.1007/s13524-011-0084-6; Medina Widman, 2008, Braz. Dent. J., V19, P83, DOI 10.1590/S0103-64402008000100015; Ministerio da Saude (Brasil), 2010, BANC DAD PESQ COND D; Ministerio da Saude (Brasil), 2001, GUIA PRAT PROGR SAUD; Mitchell DA, 2007, J HEALTH CARE POOR U, V18, P814; Piovesan C, 2010, J PUBLIC HEALTH DENT, V70, P319, DOI 10.1111/j.1752-7325.2010.00191.x; Psoter WJ, 2006, J PUBLIC HEALTH DENT, V66, P23, DOI 10.1111/j.1752-7325.2006.tb02547.x; Roncalli A, 2015, COMMUNITY DENT ORAL, V43, P516; Roncalli AG, 2012, CAD SAUDE PUBLICA, V28, pS40, DOI 10.1590/S0102-311X2012001300006; Sabbah W, 2009, J EPIDEMIOL COMMUN H, V63, P516, DOI 10.1136/jech.2008.082313; Schwendicke F, 2015, J DENT RES, V94, P10, DOI 10.1177/0022034514557546; Travassos Claudia, 2004, Cad. Saúde Pública, V20, P660, DOI 10.1590/S0102-311X2004000300003; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th; Wu B, 2011, J PUBLIC HEALTH DENT, V71, P308, DOI 10.1111/j.1752-7325.2011.00273.x	40	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145553	10.1371/journal.pone.0145553	http://dx.doi.org/10.1371/journal.pone.0145553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SH	26694321	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092500056
J	Herzog, S; Wemheuer, F; Wemheuer, B; Daniel, R				Herzog, Sarah; Wemheuer, Franziska; Wemheuer, Bernd; Daniel, Rolf			Effects of Fertilization and Sampling Time on Composition and Diversity of Entire and Active Bacterial Communities in German Grassland Soils	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; MICROBIAL COMMUNITIES; SEASONAL-CHANGES; PLANT DIVERSITY; NITROGEN; BACILLUS; PH; IDENTIFICATION; PREDOMINANT; ABUNDANCE	Soil bacteria are major players in driving and regulating ecosystem processes. Thus, the identification of factors shaping the diversity and structure of these communities is crucial for understanding bacterial-mediated processes such as nutrient transformation and cycling. As most studies only target the entire soil bacterial community, the response of active community members to environmental changes is still poorly understood. The objective of this study was to investigate the effect of fertilizer application and sampling time on structure and diversity of potentially active (RNA-based) and the entire (DNA-based) bacterial communities in German grassland soils. Analysis of more than 2.3 million 16S rRNA transcripts and gene sequences derived from amplicon-based sequencing of 16S rRNA genes revealed that fertilizer application and sampling time significantly altered the diversity and composition of entire and active bacterial communities. Although the composition of both the entire and the active bacterial community was correlated with environmental factors such as pH or C/N ratio, the active community showed a higher sensitivity to environmental changes than the entire community. In addition, functional analyses were performed based on predictions derived from 16S rRNA data. Genes encoding the uptake of nitrate/nitrite, nitrification, and denitrification were significantly more abundant in fertilized plots compared to non-fertilized plots. Hence, this study provided novel insights into changes in dynamics and functions of soil bacterial communities as response to season and fertilizer application.	[Herzog, Sarah; Wemheuer, Bernd; Daniel, Rolf] Univ Gottingen, Dept Genom & Appl Microbiol, D-37077 Gottingen, Germany; [Herzog, Sarah; Wemheuer, Bernd; Daniel, Rolf] Univ Gottingen, Inst Microbiol & Genet, Gottingen Genom Lab, D-37077 Gottingen, Germany; [Wemheuer, Franziska] Univ Gottingen, Dept Crop Sci, Sect Agr Entomol, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Daniel, R (corresponding author), Univ Gottingen, Dept Genom & Appl Microbiol, Grisebachstr 8, D-37077 Gottingen, Germany.	rdaniel@gwdg.de	Daniel, Rolf/AAQ-5933-2021	Daniel, Rolf/0000-0002-8646-7925	Ministry of Science and Culture of Lower Saxony (Germany); "Niedersachsisches Vorab" as part of the Cluster of Excellence "Functional Biodiversity Research" of Georg-August-University; DFG; Gottingen University; "Niedersachsisches Vorab" as part of the Cluster of Excellence "Functional Biodiversity Research"	Ministry of Science and Culture of Lower Saxony (Germany); "Niedersachsisches Vorab" as part of the Cluster of Excellence "Functional Biodiversity Research" of Georg-August-University; DFG(German Research Foundation (DFG)); Gottingen University; "Niedersachsisches Vorab" as part of the Cluster of Excellence "Functional Biodiversity Research"	This study was funded by the Ministry of Science and Culture of Lower Saxony (Germany) and the "Niedersachsisches Vorab" as part of the Cluster of Excellence "Functional Biodiversity Research" of Georg-August-University. Additionally, the authors acknowledge support by DFG and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all persons who were involved in the installation and maintenance of the GrassMan experiment in the Solling. We thank Klaus Schutzenmeister for providing assistance with the sampling. The data on soil properties were kindly provided by Till Heller (Department of Forest Botany and Tree Physiology at the Georg-August-University Gottingen). This study was funded by the Ministry of Science and Culture of Lower Saxony (Germany) and the "Niedersachsisches Vorab" as part of the Cluster of Excellence "Functional Biodiversity Research". Additionally, we acknowledge support by DFG and the Open Access Publication Funds of the Gottingen University.	Alexander M.J.S.S., 1978, SOIL SCI, V125, P331, DOI [10.1097/00010694-197805000-00012, DOI 10.1097/00010694-197805000-00012]; Anandham R, 2008, J BASIC MICROB, V48, P439, DOI 10.1002/jobm.200700380; Angel R, 2013, FEMS MICROBIOL ECOL, V86, P130, DOI 10.1111/1574-6941.12155; Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Barberan Albert, 2014, Front Microbiol, V5, P203, DOI 10.3389/fmicb.2014.00203; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1021, DOI 10.1016/S0038-0717(99)00016-4; Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Broszat M, 2014, APPL ENVIRON MICROB, V80, P5282, DOI 10.1128/AEM.01295-14; Campbell BJ, 2010, ENVIRON MICROBIOL, V12, P1842, DOI 10.1111/j.1462-2920.2010.02189.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cruz-Martinez K, 2009, ISME J, V3, P738, DOI 10.1038/ismej.2009.16; de Vries FT, 2012, ECOL LETT, V15, P1230, DOI 10.1111/j.1461-0248.2012.01844.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Garbeva P, 2003, MICROB ECOL, V45, P302, DOI 10.1007/s00248-002-2034-8; Gardener BBM, 2004, PHYTOPATHOLOGY, V94, P1252, DOI 10.1094/PHYTO.2004.94.11.1252; Griffiths RI, 2003, FEMS MICROBIOL ECOL, V43, P35, DOI 10.1111/j.1574-6941.2003.tb01043.x; Habekost M, 2008, SOIL BIOL BIOCHEM, V40, P2588, DOI 10.1016/j.soilbio.2008.06.019; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kennedy N, 2004, ENVIRON MICROBIOL, V6, P1070, DOI 10.1111/j.1462-2920.2004.00638.x; Kennedy NM, 2005, FEMS MICROBIOL ECOL, V53, P329, DOI 10.1016/j.femsec.2005.01.013; Keuter A, 2013, PLANT SOIL, V364, P193, DOI 10.1007/s11104-012-1344-y; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lueders T, 2006, APPL ENVIRON MICROB, V72, P5342, DOI 10.1128/AEM.00400-06; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mooshammer M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4694; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Petersen U, 2012, BASIC APPL ECOL, V13, P1, DOI 10.1016/j.baae.2011.10.003; Pfeiffer B, 2013, APPL SOIL ECOL, V72, P150, DOI 10.1016/j.apsoil.2013.06.008; POPHAM DL, 1995, APPL ENVIRON MICROB, V61, P3633, DOI 10.1128/AEM.61.10.3633-3638.1995; Poulsen PHB, 2013, SOIL BIOL BIOCHEM, V57, P784, DOI 10.1016/j.soilbio.2011.12.023; Prosser JI, 2012, FEMS MICROBIOL ECOL, V81, P507, DOI 10.1111/j.1574-6941.2012.01435.x; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Rampelotto PH, 2013, MICROB ECOL, V66, P593, DOI 10.1007/s00248-013-0235-y; Ruiz A, 2000, INT J SYST EVOL MICR, V50, P1981, DOI 10.1099/00207713-50-6-1981; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Schmalenberger A, 2001, APPL ENVIRON MICROB, V67, P3557, DOI 10.1128/AEM.67.8.3557-3563.2001; Schneider D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066662; Sengun IY, 2011, FOOD CONTROL, V22, P647, DOI 10.1016/j.foodcont.2010.11.008; Shange RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040338; Sievers M., 2005, BERGEYS MAN SYSTMATI, V2, P41; Smit E, 2001, APPL ENVIRON MICROB, V67, P2284, DOI 10.1128/AEM.67.5.2284-2291.2001; Stevens RJ, 1998, SOIL BIOL BIOCHEM, V30, P1119, DOI 10.1016/S0038-0717(97)00227-7; Team RDC, 2012, R LANG ENV STAT COM; Tripathi BM, 2012, MICROB ECOL, V64, P474, DOI 10.1007/s00248-012-0028-8; Udikovic-Kolic N, 2014, P NATL ACAD SCI USA, V111, P15202, DOI 10.1073/pnas.1409836111; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wemheuer B, 2014, FEMS MICROBIOL ECOL, V87, P378, DOI 10.1111/1574-6941.12230; Wemheuer B, 2012, ARCHAEA, V2012, DOI 10.1155/2012/695826; Wietz M, 2015, ENVIRON MICROBIOL, V17, P3822, DOI 10.1111/1462-2920.12842; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Zhou XW, 2014, ENV MICROBIOL REP, V6, P45, DOI 10.1111/1758-2229.12107	61	31	34	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145575	10.1371/journal.pone.0145575	http://dx.doi.org/10.1371/journal.pone.0145575			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694644	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092500058
J	Ngoh, SY; Tan, D; Shen, XY; Kathiresan, P; Jiang, JH; Liew, WC; Thevasagayam, NM; Kwan, HY; Saju, JM; Prakki, SRS; Goh, CH; Wong, HC; Chan, TT; Mezes, M; Orban, L				Ngoh, Si Yan; Tan, Daniel; Shen, Xueyan; Kathiresan, Purushothaman; Jiang, Junhui; Liew, Woei Chang; Thevasagayam, Natascha May; Kwan, Hsiao Yuen; Saju, Jolly M.; Prakki, Sridatta R. S.; Goh, Chin Heng; Wong, Hong Ching; Chan, Tai Teck; Mezes, Miklos; Orban, Laszlo			Nutrigenomic and Nutritional Analyses Reveal the Effects of Pelleted Feeds on Asian Seabass (Lates calcarifer)	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DIETARY FISH-OIL; VEGETABLE-OILS; GILTHEAD SEABREAM; GENE-EXPRESSION; SOYBEAN-MEAL; BARRAMUNDI; GROWTH; CHAIN; OMEGA-3-FATTY-ACIDS	As nutrition-related expenses constitute the majority of the costs for aquaculture farms, it is essential for them to use feeds that provide an ideal combination of nutrients for the species of choice. In this study, the relative effect of consuming three different pelleted feeds (B, C and D) in comparison to frozen baitfish (A; control) were compared on juvenile Asian sea-bass (77.3 +/- 22.4g) that were selected for increased growth rate over two generations. Our objectives were: 1) to evaluate the effects of different pelleted feeds based on overall physiological changes and nutritional quality of fillets; 2) improve our understanding of the underlying mechanisms with transcriptomic analysis; 3) if possible, identify the feed type that supports the growth of these fishes without substantially reducing the nutritional quality of fillet. The growth performance, fatty acid composition of fillet, hepatic histology and transcriptome of the fishes (Groups A-D) were analyzed. The majority of fatty acids of the fillets, except.-linolenic acid (GLA, C18:3n6), correlated significantly with the respective diets. Asian seabass fed Feed C showed highest specific growth rate (SGR) and feed conversion efficiency (FCE) with closest histology and transcriptomic profile to control, but their fillet contained the highest n6/n3 ratio. When the liver-based transcriptomes were analyzed, a complex set of differentially expressed genes were detected between groups fed pelleted feeds and controls as well as among the pellet-fed groups themselves. Significant enrichment of genes with growth-related function tallied with the morphological data measured. When compared with control (Group A), 'Biosynthesis of unsaturated fatty acids' and 'Steroid biosynthesis' pathways were significantly enriched in pellet-fed groups. Reduced goblet cell numbers were observed in the gut of pellet-fed fish compared to controls and fads6 was found to be a suitable candidate gene to separate wild-caught Asian seabass, from pelletfed ones. These results provide insights for researchers on the various effects of feeds on the biochemistry and global gene expression of the fish and potentially for seabass farms to make more informed feed choices.	[Ngoh, Si Yan; Tan, Daniel; Shen, Xueyan; Kathiresan, Purushothaman; Jiang, Junhui; Liew, Woei Chang; Thevasagayam, Natascha May; Kwan, Hsiao Yuen; Saju, Jolly M.; Prakki, Sridatta R. S.; Wong, Hong Ching; Chan, Tai Teck; Orban, Laszlo] Natl Univ Singapore, Reprod Genom Grp, Temasek Life Sci Lab, Singapore 117548, Singapore; [Ngoh, Si Yan] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Jiang, Junhui] Agri Food & Vet Author, Marine Aquaculture Ctr, St Johns Isl, Singapore; [Jiang, Junhui] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Goh, Chin Heng] Natl Univ Singapore, Temasek Life Sci Lab, Fish Facil, Singapore 117548, Singapore; [Mezes, Miklos] Szent Istvan Univ, Dept Nutr, Godollo, Hungary; [Orban, Laszlo] Univ Pannonia, Georgikon Fac, Dept Anim Sci & Breeding, Keszthely, Hungary; [Orban, Laszlo] Murdoch Univ, Ctr Comparat Genom, Murdoch, WA 6150, Australia; [Orban, Laszlo] Szent Istvan Univ, Dept Aquaculture, Godollo, Hungary	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Hungarian University of Agriculture & Life Sciences; University of Pannonia; Murdoch University; Hungarian University of Agriculture & Life Sciences	Orban, L (corresponding author), Natl Univ Singapore, Reprod Genom Grp, Temasek Life Sci Lab, 1 Res Link, Singapore 117548, Singapore.	Mezes.Miklos@mkk.szie.hu; laszlo@tll.org.sg	Orbán, László/A-3030-2009	Orbán, László/0000-0001-5435-5948; Liew, Woei Chang/0000-0001-9354-1647; Jiang, Junhui/0000-0003-1319-8813; Thevasagayam, Natascha May/0000-0003-2630-3600	National Research Foundation, Prime Minister's Office, Singapore [NRF-CRP7-2010-001]; Research Centre of Excellence - (Szent Istvan University) [8526-9878/2015/FEKUT]	National Research Foundation, Prime Minister's Office, Singapore(National Research Foundation, Singapore); Research Centre of Excellence - (Szent Istvan University)	This study was supported by the National Research Foundation, Prime Minister's Office, Singapore under its competitive Research Program (Award No: NRF-CRP7-2010-001) for LO and his team. During the course of this study, MM was supported by the Research Centre of Excellence -8526-9878/2015/FEKUT project (Szent Istvan University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adarme-Vega TC, 2014, CURR OPIN BIOTECH, V26, P14, DOI 10.1016/j.copbio.2013.08.003; Alhazzaa R, 2011, J AGR FOOD CHEM, V59, P8423, DOI 10.1021/jf201871w; [Anonymous], 2011, FAO YB FISH AQ STAT; Arslan M, 2012, TURK J FISH AQUAT SC, V12, P575, DOI 10.4194/1303-2712-v12_3_04; BOONYARATPALIN M, 1993, COLLOQ INRA, V61, P819; Boonyaratpalin M, 1988, 7 NAT I COAST AQ DEP; Bowyer JN, 2012, AQUACULTURE, V356, P211, DOI 10.1016/j.aquaculture.2012.05.014; Caballero MJ, 2002, AQUACULTURE, V214, P253, DOI 10.1016/S0044-8486(01)00852-3; Catacutan MR, 1997, AQUACULTURE, V149, P137, DOI 10.1016/S0044-8486(96)01432-9; CATACUTAN MR, 1995, AQUACULTURE, V131, P125, DOI 10.1016/0044-8486(94)00358-U; Chaimongkol A, 2001, AQUAC RES, V32, P53, DOI 10.1046/j.1355-557x.2001.00035_32_s1.x; Chen YB, 2012, J SURG ONCOL, V106, P286, DOI 10.1002/jso.22150; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; Dastani Z, 2006, ATHEROSCLEROSIS, V185, P127, DOI 10.1016/j.atherosclerosis.2005.05.028; Daviglus M., 2002, COMMENTS TOXICOL, V8, P345, DOI DOI 10.1080/08865140215064; de Mello H, 2013, PESQUI VET BRASIL, V33, P724, DOI 10.1590/S0100-736X2013000600006; Domingos JA, 2015, ANIM GENET, V46, P468, DOI 10.1111/age.12312; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; European Commission, 1998, OFF J EUR COMMUNITIE, V257, P14; FERNANDES G, 1993, NUTR RES, V13, pS19, DOI 10.1016/S0271-5317(05)80282-9; FOLCH J, 1957, J BIOL CHEM, V226, P497; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Gang J., 2006, FRONT BIOL CHINA, V1, P9, DOI DOI 10.1007/s11515-005-0002-7; Glencross B, 2006, AQUACULT NUTR, V12, P291, DOI 10.1111/j.1365-2095.2006.00410.x; Glencross B, 2012, AQUACULT NUTR, V18, P388, DOI 10.1111/j.1365-2095.2011.00903.x; Glencross B, 2011, AQUACULT NUTR, V17, pE536, DOI 10.1111/j.1365-2095.2010.00795.x; Glencross B, 2013, BIOL CULTURE ASIAN S, P179; Greenwood PH, 1976, REV FAMILY CENTROPOM; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; Harel M, 2002, AQUACULTURE, V213, P347, DOI 10.1016/S0044-8486(02)00047-9; HOFFMAN CJ, 1994, ARTERIOSCLER THROMB, V14, P1737, DOI 10.1161/01.ATV.14.11.1737; Horibe H, 2014, MOL MED REP, V9, P808, DOI 10.3892/mmr.2014.1902; Kim JJ, 2013, PATHOGENS, V2, P55, DOI 10.3390/pathogens2010055; Kris-Etherton PM, 2003, ARTERIOSCL THROM VAS, V23, pE20, DOI 10.1161/01.ATV.0000038493.65177.94; Kris-Etherton PM, 2000, AM J CLIN NUTR, V71, p179S, DOI 10.1093/ajcn/71.1.179S; Kunisawa J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09750; Leaver MJ, 2008, REV FISH SCI, V16, P73, DOI 10.1080/10641260802325278; Liu P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051142; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; MCCLEARY BV, 1994, J CEREAL SCI, V20, P51, DOI 10.1006/jcrs.1994.1044; MOORE R, 1982, AUST J MAR FRESH RES, V33, P671, DOI 10.1071/MF9820671; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Mourente G, 2006, COMP BIOCHEM PHYS B, V145, P389, DOI 10.1016/j.cbpb.2006.08.012; Mukaka MM, 2012, MALAWI MED J, V24, P69; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; O'Fallon JV, 2007, J ANIM SCI, V85, P1511, DOI 10.2527/jas.2006-491; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pethiyagoda R, 2012, ZOOTAXA, P1; Phromkunthong W, 1997, AQUACULTURE, V151, P225, DOI 10.1016/S0044-8486(96)01489-5; Raso S, 2003, AQUAC RES, V34, P813, DOI 10.1046/j.1365-2109.2003.00885.x; Ravi P, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-5; Rimmer M.A., 2014, LATES CALCARIFER CUL; Robaina L, 1998, AQUACULTURE, V161, P281, DOI 10.1016/S0044-8486(97)00276-7; Sahlmann C, 2013, FISH SHELLFISH IMMUN, V34, P599, DOI 10.1016/j.fsi.2012.11.031; Sargent JR, 1997, AQUACULTURE, V155, P117, DOI 10.1016/S0044-8486(97)00122-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silva SD., 1995, FISH NUTR AQUACULTUR, P103; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; SPECIAN RD, 1991, AM J PHYSIOL, V260, pC183, DOI 10.1152/ajpcell.1991.260.2.C183; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Thevasagayam NM, 2015, J MAR SCI ENG, V3, P382, DOI 10.3390/jmse3020382; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Torrecillas S, 2013, FISH SHELLFISH IMMUN, V34, P1485, DOI 10.1016/j.fsi.2013.03.351; Tu WC, 2013, COMP BIOCHEM PHYS B, V164, P29, DOI 10.1016/j.cbpb.2012.10.001; Tukey JW, 1977, EXPLORATORY DATA ANA; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vij S, 2015, GENOME ASIAN SEABASS; Vij S, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00030; Wang CM, 2008, AQUAC RES, V39, P1612, DOI 10.1111/j.1365-2109.2008.02034.x; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; Ward RD, 2008, J FISH BIOL, V72, P458, DOI 10.1111/j.1095-8649.2007.01703.x; Wassef EA, 2007, AQUAC RES, V38, P852, DOI 10.1111/j.1365-2109.2007.01738.x; Williams KC, 2003, AQUACULTURE, V225, P191, DOI 10.1016/S0044-8486(03)00278-3; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	83	11	12	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145456	10.1371/journal.pone.0145456	http://dx.doi.org/10.1371/journal.pone.0145456			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696533	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092500051
J	Leon, LAA; de Almeida, AJ; de Paula, VS; Tourinho, RS; Villela, DAM; Gaspar, AMC; Lewis-Ximenez, LL; Pinto, MA				Amado Leon, Luciane Almeida; de Almeida, Adilson Jose; de Paula, Vanessa Salete; Tourinho, Renata Santos; Maciel Villela, Daniel Antunes; Coimbra Gaspar, Ana Maria; Lewis-Ximenez, Lia Laura; Pinto, Marcelo Alves			Longitudinal Study of Hepatitis A Infection by Saliva Sampling: The Kinetics of HAV Markers in Saliva Revealed the Application of Saliva Tests for Hepatitis A Study	PLOS ONE			English	Article							TIME RT-PCR; ORAL FLUID; RAPID TEST; VIRUS; VIREMIA; QUANTIFICATION; ANTIBODIES; DURATION; BLOOD; SERUM	Despite the increasing numbers of studies investigating hepatitis A diagnostic through saliva, the frequency and the pattern of hepatitis A virus (HAV) markers in this fluid still remains unknown. To address this issue, we carried on a longitudinal study to examine the kinetics of HAV markers in saliva, in comparison with serum samples. The present study followed-up ten patients with acute hepatitis A infection during 180 days post diagnosis (dpd). Total anti-HAV was detected in paired serum and saliva samples until the end of the follow-up, showing a peak titer at 90th. However, total anti-HAV level was higher in serum than in saliva samples. This HAV marker showed a probability of 100% to be detected in both serum and saliva during 180 dpd. The IgM anti-HAV could be detected in saliva up to 150 dpd, showing the highest frequency at 30th, when it was detected in all individuals. During the first month of HAV infection, this acute HAV marker showed a detection probability of 100% in paired samples. The detection of IgM anti-HAV in saliva was not dependent on its level in serum, HAV-RNA detection and/or viral load, since no association was found between IgM anti-HAV positivity in saliva and any of these parameter (p > 0.05). Most of the patients (80%) were found to contain HAV-RNA in saliva, mainly at early acute phase (30th day). However, it was possible to demonstrate the HAV RNA presence in paired samples for more than 90 days, even after seroconversion. No significant relationship was observed between salivary HAV-RNA positivity and serum viral load, demonstrating that serum viral load is not predictive of HAV-RNA detection in saliva. Similar viral load was seen in paired samples (on average 104 copies/mL). These data demonstrate that the best diagnostic coverage can be achieved by salivary anti-HAV antibodies and HAV-RNA tests during 30-90 dpd. The long detection and high probability of specific-HAV antibodies positivity in saliva samples make the assessment of salivary antibodies a useful tool for diagnosis and epidemiological studies. The high frequency of HAV-RNA in saliva and the probability of detection of about 50%, during the first 30 dpd, demonstrate that saliva is also useful for molecular investigation of hepatitis A cases, mainly during the early course of infection. Therefore, the collection of saliva may provide a simple, cheap and non-invasive means of diagnosis, epidemiological surveys and monitoring of hepatitis A infection purposes.	[Amado Leon, Luciane Almeida; de Paula, Vanessa Salete; Tourinho, Renata Santos; Coimbra Gaspar, Ana Maria; Pinto, Marcelo Alves] Oswaldo Cruz Inst Fdn, Lab Technol Dev Virol, Rio De Janeiro, RJ, Brazil; [de Almeida, Adilson Jose; Lewis-Ximenez, Lia Laura] Oswaldo Cruz Inst Fdn, Lab Viral Hepatitis, Rio De Janeiro, RJ, Brazil; [Maciel Villela, Daniel Antunes] Oswaldo Cruz Inst Fdn, Sci Comp Program Dept, PROCC, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Leon, LAA (corresponding author), Oswaldo Cruz Inst Fdn, Lab Technol Dev Virol, Rio De Janeiro, RJ, Brazil.	l_amado@ioc.fiocruz	Amado, Luciane/AAI-9442-2021; de Paula, Vanessa S/I-8037-2016; Villela, Daniel/AAG-6445-2019; Pinto, Marcelo/G-7503-2012; Pinto, Marcelo Alves/ABA-3312-2020	de Paula, Vanessa S/0000-0002-6314-754X; Villela, Daniel/0000-0001-8371-2959; Pinto, Marcelo/0000-0003-3462-7277; Lewis-Ximenez, Lia Laura/0000-0002-3447-4621	Fundacao de Amparo a pesquisa do Estado do Rio de Janeiro [E-26/112.097/2013]	Fundacao de Amparo a pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Support was provided by the Fundacao de Amparo a pesquisa do Estado do Rio de Janeiro [www.faperj.br], grant number: E-26/112.097/2013 to author: LAAL.	Ahmed M, 2011, INDIAN J MED MICROBI, V29, P72, DOI 10.4103/0255-0857.76532; Amado LA, 2006, MEM I OSWALDO CRUZ, V101, P149, DOI 10.1590/S0074-02762006000200006; Amado LA, 2010, INT J EXP PATHOL, V91, P87, DOI 10.1111/j.1365-2613.2009.00699.x; Arnado LA, 2008, J VIROL METHODS, V148, P74, DOI 10.1016/j.jviromet.2007.10.020; Belza MJ, 2012, SEX TRANSM INFECT, V88, P218, DOI 10.1136/sextrans-2011-050131; Bower WA, 2000, J INFECT DIS, V182, P12, DOI 10.1086/315701; BRANDTZAEG P, 1970, SCAND J HAEMAT     S, V12, P1; Costa-Mattioli M, 2002, J VIRAL HEPATITIS, V9, P101, DOI 10.1046/j.1365-2893.2002.00336.x; Cruz HM, 2011, J CLIN LAB ANAL, V25, P134, DOI 10.1002/jcla.20447; Ximenes RAD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094622; De Paula VS, 2007, WATER RES, V41, P1169, DOI 10.1016/j.watres.2006.11.029; Donnell-Fink LA, 2012, JAIDS-J ACQ IMM DEF, V61, P588, DOI [10.1097/QAI.0b013e31826a6d67., 10.1097/QAI.0b013e31826a6d67]; Drobnik A, 2011, AM J PUBLIC HEALTH, V101, P2151, DOI 10.2105/AJPH.2011.300251; FitzSimons David, 2010, Vaccine, V28, P583, DOI 10.1016/j.vaccine.2009.10.136; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hussain Z, 2006, WORLD J GASTROENTERO, V12, P4683, DOI 10.3748/wjg.v12.i29.4683; Joshi MS, 2014, DIAGN MICR INFEC DIS, V78, P379, DOI 10.1016/j.diagmicrobio.2013.12.013; Kwon OS, 2000, J GASTROEN HEPATOL, V15, P1043, DOI 10.1046/j.1440-1746.2000.02291.x; Lackner A, 2010, J MED VIROL, V82, P1582, DOI 10.1002/jmv.21849; Lima LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102925; Menezes GBL, 2012, MEM I OSWALDO CRUZ, V107, P680, DOI 10.1590/S0074-02762012000500016; Mackiewicz V, 2004, J CLIN MICROBIOL, V42, P4329, DOI 10.1128/JCM.42.9.4329-4331.2004; Matheson K, 2010, VACCINE, V28, P8105, DOI 10.1016/j.vaccine.2010.09.107; Morris-Cunnington MC, 2004, AM J EPIDEMIOL, V159, P786, DOI 10.1093/aje/kwh107; Mortimer P P, 1994, Clin Diagn Virol, V2, P231, DOI 10.1016/0928-0197(94)90048-5; Normann A, 2004, J MED VIROL, V72, P10, DOI 10.1002/jmv.10532; Oba Isabel Takano, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P197, DOI 10.1590/S0036-46652000000400004; Ochnio JJ, 1997, J CLIN MICROBIOL, V35, P98, DOI 10.1128/JCM.35.1.98-101.1997; PARRY JV, 1989, J MED VIROL, V28, P255, DOI 10.1002/jmv.1890280410; Poovorawan Y, 2005, J CLIN VIROL, V32, P24, DOI 10.1016/j.jcv.2004.04.008; R Core Team, 2013, R LANG ENV STAT COMP; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tourinho RS, 2012, VACCINE, V30, P6421, DOI 10.1016/j.vaccine.2012.08.015; Tourinho RS, 2011, J VIROL METHODS, V173, P169, DOI 10.1016/j.jviromet.2011.01.014; Vitral CL, 2012, MEM I OSWALDO CRUZ, V107, P652, DOI 10.1590/S0074-02762012000500012; Wood S, 2013, GAMMA4 GEN ADDITIVE; [No title captured]	37	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145454	10.1371/journal.pone.0145454	http://dx.doi.org/10.1371/journal.pone.0145454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690904	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092300077
J	Arthur, GK; Duffy, SM; Roach, KM; Hirst, RA; Shikotra, A; Gaillard, EA; Bradding, P				Arthur, Greer K.; Duffy, S. Mark; Roach, Katy M.; Hirst, Rob A.; Shikotra, Aarti; Gaillard, Erol A.; Bradding, Peter			K(Ca)3.1 K+ Channel Expression and Function in Human Bronchial Epithelial Cells	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; CHLORIDE SECRETION; MAST-CELLS; IN-VITRO; AIRWAY; ASTHMA; FIBROSIS; ACTIVATION; MIGRATION; GROWTH	The K(Ca)3.1 K+ channel has been proposed as a novel target for pulmonary diseases such as asthma and pulmonary fibrosis. It is expressed in epithelia but its expression and function in primary human bronchial epithelial cells (HBECs) has not been described. Due to its proposed roles in the regulation of cell proliferation, migration, and epithelial fluid secretion, inhibiting this channel might have either beneficial or adverse effects on HBEC function. The aim of this study was to assess whether primary HBECs express the K(Ca)3.1 channel and its role in HBEC function. Primary HBECs from the airways of healthy and asthmatic subjects, SV-transformed BEAS-2B cells and the neoplastic H292 epithelial cell line were studied. Primary HBECs, BEAS-2B and H292 cells expressed K(Ca)3.1 mRNA and protein, and robust K(Ca)3.1 ion currents. K(Ca)3.1 protein expression was increased in asthmatic compared to healthy airway epithelium in situ, and K(Ca)3.1 currents were larger in asthmatic compared to healthy HBECs cultured in vitro. Selective K(Ca)3.1 blockers (TRAM-34, ICA-17043) had no effect on epithelial cell proliferation, wound closure, ciliary beat frequency, or mucus secretion. However, several features of TGF beta 1-dependent epithelial-mesenchymal transition (EMT) were inhibited by K(Ca)3.1 blockade. Treatment with K(Ca)3.1 blockers is likely to be safe with respect to airway epithelial biology, and may potentially inhibit airway remodelling through the inhibition of EMT.	[Arthur, Greer K.; Duffy, S. Mark; Roach, Katy M.; Hirst, Rob A.; Shikotra, Aarti; Gaillard, Erol A.; Bradding, Peter] Univ Leicester, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England	University of Leicester	Arthur, GK (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England.	gka12@le.ac.uk	Hirst, Robert/AAD-1649-2022	Roach, Katy M/0000-0002-4825-8719; Gaillard, Erol/0000-0003-0996-8133; Arthur, Greer/0000-0002-4849-4076; Bradding, Peter/0000-0001-8403-0319	Medical Research Council; Dunhill Medical Trust [R270/1112]; National Institute for Health Research Leicester Respiratory Biomedical Research Unit; The Dunhill Medical Trust [R270/1112] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dunhill Medical Trust(Dunhill Medical Trust); National Institute for Health Research Leicester Respiratory Biomedical Research Unit; The Dunhill Medical Trust(Dunhill Medical Trust)	This work was supported in part by a Medical Research Council PhD studentship for GKA, a project grant from The Dunhill Medical Trust (project grant R270/1112), and was also supported in part by the National Institute for Health Research Leicester Respiratory Biomedical Research Unit. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaqumi M, 2008, KIDNEY INT, V74, P740, DOI 10.1038/ki.2008.246; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Avasarala S, 2015, J BIOL CHEM; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2008, Thorax, V63 Suppl 4, piv1, DOI 10.1136/thx.2008.097741; BRADDING P, 1992, J EXP MED, V176, P1381, DOI 10.1084/jem.176.5.1381; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Brooks SA, 2000, HISTOL HISTOPATHOL, V15, P143, DOI 10.14670/HH-15.143; Cruse G, 2006, THORAX, V61, P880, DOI 10.1136/thx.2006.060319; Cruse G, 2011, J ALLERGY CLIN IMMUN, V128, P1303, DOI 10.1016/j.jaci.2011.07.047; Devor DC, 1999, J GEN PHYSIOL, V113, P743, DOI 10.1085/jgp.113.5.743; Duffy SM, 2005, FASEB J, V19, P1006, DOI 10.1096/fj.04-3439fje; Duffy SM, 2004, J ALLERGY CLIN IMMUN, V114, P66, DOI 10.1016/j.jaci.2004.04.005; Duffy SM, 2003, J ALLERGY CLIN IMMUN, V112, P965, DOI 10.1016/j.jaci.2003.07.004; Duffy SM, 2001, J IMMUNOL, V167, P4261, DOI 10.4049/jimmunol.167.8.4261; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; Fischer KD, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0146-6; Girodet PO, 2013, AM J RESP CELL MOL, V48, P212, DOI 10.1165/rcmb.2012-0103OC; Gras D, 2012, J ALLERGY CLIN IMMUN, V129, P1259, DOI 10.1016/j.jaci.2012.01.073; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harron SA, 2009, CAN J PHYSIOL PHARM, V87, P337, DOI [10.1139/Y09-009, 10.1139/y09-009]; Hewson CA, 2004, J MOL BIOL, V344, P683, DOI 10.1016/j.jmb.2004.09.059; Hirst RA, 2010, CHEST, V138, P1441, DOI 10.1378/chest.10-0175; Holgate ST, 1998, CLIN EXP ALLERGY, V28, P97; Holgate ST, 1999, CLIN EXP ALLERGY, V29, P90, DOI 10.1046/j.1365-2222.1999.00016.x; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Hollins F, 2008, J IMMUNOL, V181, P2772, DOI 10.4049/jimmunol.181.4.2772; Jensen BS, 1999, P NATL ACAD SCI USA, V96, P10917, DOI 10.1073/pnas.96.19.10917; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Klein H, 2009, AM J PHYSIOL-CELL PH, V296, pC285, DOI 10.1152/ajpcell.00418.2008; Latella G, 1996, INT J COLORECTAL DIS, V11, P76; Nowrin K, 2014, EXPERT REV RESP MED, V8, P547, DOI 10.1586/17476348.2014.948853; Ohya S, 2011, J BIOL CHEM, V286, P16940, DOI 10.1074/jbc.M110.184192; Okumura S, 2005, J ALLERGY CLIN IMMUN, V115, P272, DOI 10.1016/j.jaci.2004.10.004; Pedersen KA, 1999, BBA-BIOMEMBRANES, V1420, P231, DOI 10.1016/S0005-2736(99)00110-8; Roach KM, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0022-0; Roach KM, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0155-5; Roach KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085244; ROCHE WR, 1989, LANCET, V1, P520; Schilling T, 2004, EUR J NEUROSCI, V19, P1469, DOI 10.1111/j.1460-9568.2004.03265.x; Schilling T, 2009, PFLUG ARCH EUR J PHY, V459, P71, DOI 10.1007/s00424-009-0710-y; Schwab A, 1999, PFLUG ARCH EUR J PHY, V438, P330, DOI 10.1007/s004240050917; SCHWAB A, 1995, PFLUG ARCH EUR J PHY, V430, P802, DOI 10.1007/BF00386179; Schwab A, 1999, CELL PHYSIOL BIOCHEM, V9, P126, DOI 10.1159/000016309; Shepherd MC, 2007, AM J RESP CELL MOL, V37, P525, DOI 10.1165/rcmb.2006-0358OC; Shikotra A, 2012, J ALLERGY CLIN IMMUN, V129, P104, DOI 10.1016/j.jaci.2011.08.031; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Singh AK, 2000, J PHARMACOL EXP THER, V292, P778; Sohal Sukhwinder S, 2011, Respir Res, V12, P130, DOI 10.1186/1465-9921-12-130; Sohal SS, 2010, RESPIROLOGY, V15, P930, DOI 10.1111/j.1440-1843.2010.01808.x; Stewart CE, 2012, THORAX, V67, P477, DOI 10.1136/thoraxjnl-2011-200508; Stocker JW, 2003, BLOOD, V101, P2412, DOI 10.1182/blood-2002-05-1433; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Tharp DL, 2006, AM J PHYSIOL-HEART C, V291, pH2493, DOI 10.1152/ajpheart.01254.2005; Thomas B, 2009, EUR RESPIR J, V34, P401, DOI 10.1183/09031936.00153308; Trinh NTN, 2008, AM J PHYSIOL-LUNG C, V295, pL866, DOI 10.1152/ajplung.90224.2008; Van Der Velden J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066886; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151	62	13	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145259	10.1371/journal.pone.0145259	http://dx.doi.org/10.1371/journal.pone.0145259			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689552	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300049
J	Avau, B; Bauters, D; Steensels, S; Vancleef, L; Laermans, J; Lesuisse, J; Buyse, J; Lijnen, HR; Tack, J; Depoortere, I				Avau, Bert; Bauters, Dries; Steensels, Sandra; Vancleef, Laurien; Laermans, Jorien; Lesuisse, Jens; Buyse, Johan; Lijnen, H. Roger; Tack, Jan; Depoortere, Inge			The Gustatory Signaling Pathway and Bitter Taste Receptors Affect the Development of Obesity and Adipocyte Metabolism in Mice	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; NORMAL-WEIGHT; SECRETION; TOXICITY; GHRELIN; ABSORPTION; GUSTDUCIN; BENZOATE	Intestinal chemosensory signaling pathways involving the gustatory G-protein, gustducin, and bitter taste receptors (TAS2R) have been implicated in gut hormone release. Alterations in gut hormone profiles may contribute to the success of bariatric surgery. This study investigated the involvement of the gustatory signaling pathway in the development of diet-induced obesity and the therapeutic potential of targeting TAS2Rs to induce body weight loss. alpha-gustducin-deficient (alpha-gust(-/-)) mice became less obese than wild type (WT) mice when fed a highfat diet (HFD). White adipose tissue (WAT) mass was lower in alpha-gust(-/-) mice due to increased heat production as a result of increases in brown adipose tissue (BAT) thermogenic activity, involving increased protein expression of uncoupling protein 1. Intra-gastric treatment of obese WT and alpha-gust(-/-) mice with the bitter agonists denatonium benzoate (DB) or quinine (Q) during 4 weeks resulted in an alpha-gustducin-dependent decrease in body weight gain associated with a decrease in food intake (DB), but not involving major changes in gut peptide release. Both WAT and 3T3-F442A pre-adipocytes express TAS2Rs. Treatment of pre-adipocytes with DB or Q decreased differentiation into mature adipocytes. In conclusion, interfering with the gustatory signaling pathway protects against the development of HFD-induced obesity presumably through promoting BAT activity. Intra-gastric bitter treatment inhibits weight gain, possibly by directly affecting adipocyte metabolism.	[Avau, Bert; Steensels, Sandra; Vancleef, Laurien; Laermans, Jorien; Tack, Jan; Depoortere, Inge] Univ Leuven, Gut Peptide Res Lab, Translat Res Ctr Gastrointestinal Disorders, B-3000 Leuven, Belgium; [Bauters, Dries; Lijnen, H. Roger] Univ Leuven, Ctr Mol & Vasc Biol, B-3000 Leuven, Belgium; [Lesuisse, Jens; Buyse, Johan] Univ Leuven, Dept Biosyst, Lab Livestock Physiol, B-3001 Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven	Depoortere, I (corresponding author), Univ Leuven, Gut Peptide Res Lab, Translat Res Ctr Gastrointestinal Disorders, Gasthuisberg O&N1,Box 701, B-3000 Leuven, Belgium.	inge.depoortere@med.kuleuven.be	Lijnen, Roger/AAA-4085-2020; Depoortere, Inge/I-5019-2013	Tack, Jan/0000-0002-3206-6704; Steensels, Sandra/0000-0001-6544-1884; Depoortere, Inge/0000-0002-0289-2175; Laermans, Jorien/0000-0002-6695-6019	University of Leuven; Flemish Foundation for Scientific Research [FWO G073615N]	University of Leuven(KU Leuven); Flemish Foundation for Scientific Research(FWO)	This work was supported in part by a Methusalem grant from the University of Leuven (www.kuleuven.be) and by a grant from the Flemish Foundation for Scientific Research (http://www.fwo.be, FWO G073615N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avau B, 2015, ACTA PHYSL OXF; Avau B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15985; Barja-Fernandez S, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/560938; Bauters D, 2015, BBA-GEN SUBJECTS, V1850, P1449, DOI 10.1016/j.bbagen.2015.04.003; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Biere A, 2004, OECOLOGIA, V140, P430, DOI 10.1007/s00442-004-1603-6; BOTTGER WM, 1990, J PHARMACOKINET BIOP, V18, P1, DOI 10.1007/BF01063619; Buyse J, 1998, BRIT POULTRY SCI, V39, P264, DOI 10.1080/00071669889231; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cettour-Rose Philippe, 2013, BMC Physiology, V13, P5, DOI 10.1186/1472-6793-13-5; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; COLLEY JC, 1989, TOXICOLOGY, V54, P219, DOI 10.1016/0300-483X(89)90047-4; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Depoortere I, 2014, GUT, V63, P179, DOI 10.1136/gutjnl-2013-305112; DREWITT PN, 1993, FOOD CHEM TOXICOL, V31, P235, DOI 10.1016/0278-6915(93)90073-8; Fruhbeck G, 2015, NAT REV ENDOCRINOL, V11, P465, DOI 10.1038/nrendo.2015.84; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; HANSEN SR, 1993, VET HUM TOXICOL, V35, P234; Hass N, 2010, CELL TISSUE RES, V339, P493, DOI 10.1007/s00441-009-0907-6; HURWITZ A, 1971, J PHARMACOL EXP THER, V179, P485; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen P, 2011, ALIMENT PHARM THER, V33, P880, DOI 10.1111/j.1365-2036.2011.04609.x; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Janssen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040168; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Kakkar AK, 2015, EUR J INTERN MED, V26, P89, DOI 10.1016/j.ejim.2015.01.005; Kim KS, 2014, DIABETOLOGIA, V57, P2117, DOI 10.1007/s00125-014-3326-5; KLAUS S, 1991, INT J BIOCHEM, V23, P791, DOI 10.1016/0020-711X(91)90062-R; KREYMANN B, 1987, LANCET, V2, P1300; le Roux CW, 2005, J CLIN ENDOCR METAB, V90, P1068, DOI 10.1210/jc.2004-1216; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Li Y, 2013, AM J PHYSIOL-ENDOC M, V304, pE651, DOI 10.1152/ajpendo.00471.2012; Masubuchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054500; Meyer-Gerspach AC, 2014, PHYSIOL BEHAV, V129, P265, DOI 10.1016/j.physbeh.2014.02.043; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Poher AL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00004; Romijn CaL W, 1961, 2 S EN MET EUR ASS A, V10, P49; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; Sampath H, 2009, J BIOL CHEM, V284, P19961, DOI 10.1074/jbc.M109.014225; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Simon BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086454; Simon BR, 2013, J BIOL CHEM, V288, P32475, DOI 10.1074/jbc.M113.514034; Singh N, 2011, BIOCHEM BIOPH RES CO, V406, P146, DOI 10.1016/j.bbrc.2011.02.016; Steinert RE, 2011, CLIN NUTR, V30, P524, DOI 10.1016/j.clnu.2011.01.007; Sundberg JP, 2000, AM J PATHOL, V156, P2067, DOI 10.1016/S0002-9440(10)65078-X; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Talavera K, 2008, FASEB J, V22, P1343, DOI 10.1096/fj.07-9591com; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vegezzi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107732; Verhulst PJ, 2008, GASTROENTEROLOGY, V135, P1267, DOI 10.1053/j.gastro.2008.06.044; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; Widmayer P, 2012, INT J OBESITY, V36, P1353, DOI 10.1038/ijo.2011.216; Zagrobelny M, 2004, PHYTOCHEMISTRY, V65, P293, DOI 10.1016/j.phytochem.2003.10.016	56	41	42	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145538	10.1371/journal.pone.0145538	http://dx.doi.org/10.1371/journal.pone.0145538			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692363	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092300086
J	Chang, TH; Hsu, HH; Chou, YC; Yu, JC; Hsu, GC; Huang, GS; Liao, GS				Chang, Tsun-Hou; Hsu, Hsian-He; Chou, Yu-Ching; Yu, Jyh-Cherng; Hsu, Giu-Cheng; Huang, Guo-Shu; Liao, Guo-Shiou			The Values of Combined and Sub-Stratified Imaging Scores with Ultrasonography and Mammography in Breast Cancer Subtypes	PLOS ONE			English	Article							NEGATIVE MAMMOGRAPHY; MOLECULAR SUBTYPE; SCORING SYSTEM; ULTRASOUND; WOMEN; RECEPTOR; THERAPY; PERFORMANCE; SURVIVAL; FEATURES	Background and Objectives The Breast Imaging Reporting and Data System (BI-RADS) of Mammography (MG) and Ultrasonography (US) were equivalent to the "5-point score" and applied for combined and sub-stratified imaging assessments. This study evaluated the value of combined and sub-stratified imaging assessments with MG and US over breast cancer subtypes (BCS). Materials and Methods Medical records of 5,037 cases having imaging-guided core biopsy, performed from 2009 to 2012, were retrospectively reviewed. This study selected 1,995 cases (1,457 benign and 538 invasive cancer) having both MG and US before biopsy. These cases were categorized with the "5-point score" for their MG and US, and applied for combined and sub-stratified imaging assessments. Invasive cancers were classified on the basis of BCS, and correlated with combined and sub-stratified imaging assessments. Results These selected cases were evaluated by the "5-point score." MG, US, and combined and sub-stratified imaging assessments all revealed statistically significant (P < 0.001) incidence of malignancy. The sensitivity was increased in the combined imaging score (99.8%), and the specificity was increased in the sub-stratified combined score (75.4%). In the sub-stratified combined imaging assessment, all BCS can be classified with higher scores (abnormality hierarchy), and luminal B subtype showed the most salient result (hierarchy: higher, 95%; lower, 5%). Conclusions Combined and sub-stratified imaging assessments can increase sensitivity and specificity of breast cancer diagnosis, respectively, and Luminal B subtype shows the best identification by sub-stratified combined imaging scoring.	[Chang, Tsun-Hou] Tri Serv Gen Hosp, Dept Radiol, Taipei, Taiwan; [Hsu, Hsian-He; Huang, Guo-Shu] Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Yu, Jyh-Cherng; Liao, Guo-Shiou] Natl Def Med Ctr, Tri Serv Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Hsu, Giu-Cheng] Kang Ning Gen Hosp, Breast Med Ctr, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Liao, GS (corresponding author), Natl Def Med Ctr, Tri Serv Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan.	guoshiou@ndmctsgh.edu.tw			 [TSGH-C104-050];  [TSGH-C105-046];  [TSGH-C105-017]	; ; 	We would like to thank the sources of the funding, TSGH-C104-050, TSGH-C105-046, and TSGH-C105-017, which support our study.	Ben T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2904; Berg WA, 2012, JAMA-J AM MED ASSOC, V307, P1394, DOI 10.1001/jama.2012.388; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Chae EY, 2013, J ULTRAS MED, V32, P1573, DOI 10.7863/ultra.32.9.1573; Chan SWW, 2008, WORLD J SURG, V32, P2593, DOI 10.1007/s00268-007-9273-2; Crispo A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-15; Dogan BE, 2012, ANN ONCOL, V23, P23, DOI 10.1093/annonc/mds191; [EA S EB M EA M CJ DO], 2013, ACR BI RADS ATLAS BR; Fernandez-Morales LA, 2007, CLIN BREAST CANCER, V7, P559, DOI 10.3816/CBC.2007.n.012; Girardi V, 2013, BREAST, V22, P806, DOI 10.1016/j.breast.2013.02.010; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Grimm LJ, 2015, RADIOLOGY, V274, P352, DOI 10.1148/radiol.14140594; Ha R, 2015, AM J ROENTGENOL, V204, P1354, DOI 10.2214/AJR.14.13666; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Kelly KM, 2010, EUR RADIOL, V20, P2557, DOI 10.1007/s00330-010-1844-1; Kim MY, 2013, ACTA RADIOL, V54, P889, DOI 10.1177/0284185113488580; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Li B, 2014, ASIAN PAC J CANCER P, V15, P3555, DOI 10.7314/APJCP.2014.15.8.3555; Li CI, 2009, CANCER RES, V69, P6865, DOI 10.1158/0008-5472.CAN-09-1355; Li JG, 2014, BREAST CANCER RES TR, V144, P391, DOI 10.1007/s10549-014-2863-4; Maxwell AJ, 2009, CLIN RADIOL, V64, P624, DOI 10.1016/j.crad.2009.01.010; Minicozzi P, 2013, J CANCER RES CLIN, V139, P1569, DOI 10.1007/s00432-013-1478-1; Murphy IG, 2007, J SURG ONCOL, V96, P457, DOI 10.1002/jso.20801; Puig-Vives M, 2013, GYNECOL ONCOL, V130, P609, DOI 10.1016/j.ygyno.2013.05.039; Roche NA, 1998, BRIT J SURG, V85, P669; Skaane P, 2015, ACTA RADIOL, V56, P404, DOI 10.1177/0284185114528835; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Taylor K, 2011, BRIT J RADIOL, V84, P1005, DOI 10.1259/bjr/48490964; Wilkinson LS, 2011, BRIT J RADIOL, V84, P965, DOI 10.1259/bjr/51580547; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wong FY, 2011, ANN ACAD MED SINGAP, V40, P90; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11085	32	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145390	10.1371/journal.pone.0145390	http://dx.doi.org/10.1371/journal.pone.0145390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689198	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300067
J	Kilari, S; Cossette, S; Pooya, S; Bordas, M; Huang, YW; Ramchandran, R; Wilkinson, GA				Kilari, Sreenivasulu; Cossette, Stephanie; Pooya, Shabnam; Bordas, Michelle; Huang, Yi-Wen; Ramchandran, Ramani; Wilkinson, George A.			Endothelial Cell Surface Expressed Chemotaxis and Apoptosis Regulator (ECSCR) Regulates Lipolysis in White Adipocytes via the PTEN/AKT Signaling Pathway	PLOS ONE			English	Article							INSULIN; MECHANISMS; PROTEIN	Elevated plasma triglycerides are associated with increased susceptibility to heart disease and stroke, but the mechanisms behind this relationship are unclear. A clearer understanding of gene products which influence plasma triglycerides might help identify new therapeutic targets for these diseases. The Endothelial Cell Surface expressed Chemotaxis and apoptosis Regulator (ECSCR) was initially studied as an endothelial cell marker, but has recently been identified in white adipocytes, the primary storage cell type for triglycerides. Here we confirm ECSCR expression in white adipocytes and show that Ecscr knockout mice show elevated fasting plasma triglycerides. At a cellular level, cultured 3T3-L1 adipocytes silenced for Ecscr show a blunted Akt phosphorylation response. Additionally we show that the phosphatase and tensin homology containing (PTEN) lipid phosphatase association with ECSCR is increased by insulin stimulation. These data suggest a scenario by which ECSCR contributes to control of white adipocyte lipolysis. In this scenario, white adipocytes lacking Ecscr display elevated PTEN activity, thereby reducing AKT activation and impairing insulin-mediated suppression of lipolysis. Collectively, these results suggest that ECSCR plays a critical function in regulating lipolysis in white adipose tissue.	[Kilari, Sreenivasulu; Cossette, Stephanie; Pooya, Shabnam; Bordas, Michelle; Ramchandran, Ramani; Wilkinson, George A.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Kilari, Sreenivasulu; Cossette, Stephanie; Pooya, Shabnam; Bordas, Michelle; Ramchandran, Ramani; Wilkinson, George A.] Med Coll Wisconsin, Dev Vasc Biol Program, Milwaukee, WI 53226 USA; [Kilari, Sreenivasulu; Cossette, Stephanie; Pooya, Shabnam; Bordas, Michelle; Huang, Yi-Wen; Ramchandran, Ramani; Wilkinson, George A.] Childrens Res Inst, Milwaukee, WI USA; [Huang, Yi-Wen; Ramchandran, Ramani] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Ramchandran, R (corresponding author), Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	rramchan@mcw.edu; gwilkinson@cuw.edu		Kilari, Sreenivasulu/0000-0002-9149-7360	National Institutes of Health Heart, Lung and Blood Institute [1R01 HL09712, 1R01HL102745-01, 1R01HL112639-01]; NIH; Women's Health Research Fund; Concordia University of Wisconsin funds; Children's Research Institute of the Medical College of Wisconsin; American Heart Association Scientist Development [11SDG5310020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112639, R01HL102745] Funding Source: NIH RePORTER	National Institutes of Health Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Women's Health Research Fund; Concordia University of Wisconsin funds; Children's Research Institute of the Medical College of Wisconsin; American Heart Association Scientist Development(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from National Institutes of Health Heart, Lung and Blood Institute (1R01 HL09712, 1R01HL102745-01 & 1R01HL112639-01 to RR, http://www.nhlbi.nih.gov/). SC & SB are partially supported from NIH grants to RR. SK, MB, are supported by funds from Women's Health Research Fund. GAW was supported by Concordia University of Wisconsin funds, the Children's Research Institute of the Medical College of Wisconsin, and American Heart Association Scientist Development Grant 11SDG5310020 (http://research.americanheart.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2009, TRENDS ENDOCRIN MET, V20, P424, DOI 10.1016/j.tem.2009.06.002; Akakabe Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3389; Armstrong LJ, 2008, ARTERIOSCL THROM VAS, V28, P1640, DOI 10.1161/ATVBAHA.108.162511; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; BERHANU P, 1983, J CLIN INVEST, V72, P1958, DOI 10.1172/JCI111160; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Fang K, 2011, PHYSIOL GENOMICS, V43, P43, DOI 10.1152/physiolgenomics.00138.2010; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Herbert TP, 2000, J BIOL CHEM, V275, P11249, DOI 10.1074/jbc.275.15.11249; Jiang GQ, 2002, FRONT BIOSCI-LANDMRK, V7, pD904; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kilari S, 2013, J BIOL CHEM, V288, P10265, DOI 10.1074/jbc.M112.413542; Kim J, 2007, J BIOL CHEM, V282, P11038, DOI 10.1074/jbc.M606197200; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; Koide M, 2011, P NATL ACAD SCI USA, V108, P9472, DOI 10.1073/pnas.1101296108; Koren S, 2015, DIABETOLOGIA, V58, P1063, DOI 10.1007/s00125-015-3532-9; Lopez MJ, 2011, METHODS MOL BIOL, V702, P37, DOI 10.1007/978-1-61737-960-4_4; Lu J, 2012, COMPUT BIOL CHEM, V41, P41, DOI 10.1016/j.compbiolchem.2012.10.003; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Rask-Madsen C, 2012, ARTERIOSCL THROM VAS, V32, P2052, DOI 10.1161/ATVBAHA.111.241919; Rask-Madsen C, 2010, CELL METAB, V11, P379, DOI 10.1016/j.cmet.2010.03.013; Shi CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021482; Sierra-Filardi E, 2011, BLOOD, V117, P5092, DOI 10.1182/blood-2010-09-306993; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Verma A, 2010, BLOOD, V115, P4614, DOI 10.1182/blood-2009-10-248856	27	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144185	10.1371/journal.pone.0144185	http://dx.doi.org/10.1371/journal.pone.0144185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692198	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300005
J	Wang, ZW; Chen, ST; Nie, ZL; Zhang, JW; Zhou, Z; Deng, T; Sun, H				Wang, Zhi-Wei; Chen, Shao-Tian; Nie, Ze-Long; Zhang, Jian-Wen; Zhou, Zhuo; Deng, Tao; Sun, Hang			Climatic Factors Drive Population Divergence and Demography: Insights Based on the Phylogeography of a Riparian Plant Species Endemic to the Hengduan Mountains and Adjacent Regions	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; EAST-ASIAN MONSOON; SOUTH CHINA SEA; GENETIC CONSEQUENCES; CHLOROPLAST; EVOLUTION; FOREST; MITOCHONDRIAL; SEQUENCES; EXPANSION	Quaternary climatic factors have played a significant role in population divergence and demography. Here we investigated the phylogeography of Osteomeles schwerinae, a dominant riparian plant species of the hot/warm-dry river valleys of the Hengduan Mountains (HDM), Qinling Mountains (QLM) and Yunnan-Guizhou Plateau (YGP). Three chloroplast DNA (cpDNA) regions (trnD-trnT, psbD-trnT, petL-psbE), one single copy nuclear gene (glyceraldehyde 3-phosphate dehydrogenase; G3pdh), and climatic data during the Last Interglacial (LIG; c. 120-140 ka), Last Glacial Maximum (LGM; c. 21 ka), and Current (c. 1950-2000) periods were used in this study. Six cpDNA haplotypes and 15 nuclear DNA (nDNA) haplotypes were identified in the 40 populations of O. schwerinae. Spatial Analysis of Molecular Variance, median-joining networks, and Bayesian phylogenetic trees based on the cpDNA and nDNA datasets, all suggested population divergence between the QLM and HDM-YGP regions. Our climatic analysis identified significant heterogeneity of the climatic factors in the QLM and HDM-YGP regions during the aforementioned three periods. The divergence times based on cpDNA and nDNA haplotypes were estimated to be 466.4-159.4 ka and 315.8-160.3 ka, respectively, which coincide with the time of the weakening of the Asian monsoons in these regions. In addition, unimodal pairwise mismatch distribution curves, expansion times, and Ecological Niche Modeling suggested a history of population expansion (rather than contraction) during the last glaciation. Interestingly, the expansion times were found being well consistent with the intensification of the Asian monsoons during this period. We inferred that the divergence between the two main lineages is probably caused by disruption of more continuous distribution because of weakening of monsoons/less precipitation, whilst subsequent intensification of the Asian monsoons during the last glaciation facilitated the expansion of O. schwerinae populations.	[Wang, Zhi-Wei; Chen, Shao-Tian; Nie, Ze-Long; Zhang, Jian-Wen; Zhou, Zhuo; Deng, Tao; Sun, Hang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming 650201, Peoples R China; [Wang, Zhi-Wei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, H (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming 650201, Peoples R China.	hsun@mail.kib.ac.cn	ZHANG, Jianwen/AAG-7743-2020; , wenzi/ABB-4126-2021	ZHANG, Jianwen/0000-0002-4735-168X; 	Strategic Priority Research Program (B) of the Chinese Academy of Sciences [XDB03030112]; NSFC-Yunnan Natural Science Foundation Combining Program [U1136601]; Hundred Talents Program of the Chinese Academy of Sciences [2011312D11022]; CAS/SAFEA International Partnership Program for Creative Teams	Strategic Priority Research Program (B) of the Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC-Yunnan Natural Science Foundation Combining Program; Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Teams	The study was supported by the Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB03030112 to HS), NSFC-Yunnan Natural Science Foundation Combining Program (U1136601 to HS), the Hundred Talents Program of the Chinese Academy of Sciences (2011312D11022 to HS) and the CAS/SAFEA International Partnership Program for Creative Teams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Z.S., 1990, QUATERN INT, V7, P91, DOI DOI 10.1016/1040-6182(90)90042-3; Andrew RL, 2010, ANN BOT-LONDON, V105, P707, DOI 10.1093/aob/mcq034; Ao H, 2012, GLOBAL PLANET CHANGE, V80-81, P51, DOI 10.1016/j.gloplacha.2011.09.012; Ao H, 2011, QUATERNARY SCI REV, V30, P1560, DOI 10.1016/j.quascirev.2011.04.009; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boulay S, 2005, PALAEOGEOGR PALAEOCL, V228, P260, DOI 10.1016/j.palaeo.2005.06.005; Bush ABG, 1999, J GEOPHYS RES-ATMOS, V104, P24509, DOI 10.1029/1999JD900447; Caicedo AL, 2004, MOL ECOL, V13, P1871, DOI 10.1111/j.1365-294X.2004.02191.x; Chen SY, 2008, BOT J LINN SOC, V157, P125, DOI 10.1111/j.1095-8339.2008.00785.x; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; Clift PD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027772; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; DING ZL, 1995, QUATERNARY RES, V44, P149, DOI 10.1006/qres.1995.1059; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fan DM, 2013, MOL ECOL, V22, P4270, DOI 10.1111/mec.12388; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Garfin GM, 2005, TREE-RING RES, V61, P59, DOI 10.3959/1536-1098-61.2.59; Hao QZ, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003765; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Jaramillo-Correa JP, 2008, MOL ECOL, V17, P2476, DOI 10.1111/j.1365-294X.2008.03762.x; Jaramillo-Correa JP, 2006, MOL ECOL, V15, P2787, DOI 10.1111/j.1365-294X.2006.02974.x; Jin Z, 1993, ACTA BOT YUNNANICA, V16, P1; Jin Z, 1998, GUIHAIA, V18, P313; Li FL, 2014, J ARID ENVIRON, V108, P1, DOI 10.1016/j.jaridenv.2014.04.011; Li Y, 2011, MOL PHYLOGENET EVOL, V59, P412, DOI 10.1016/j.ympev.2011.01.009; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu J, 2013, NEW PHYTOL, V199, P1093, DOI 10.1111/nph.12336; Olsen KM, 1999, P NATL ACAD SCI USA, V96, P5586, DOI 10.1073/pnas.96.10.5586; Opgenoorth L, 2010, NEW PHYTOL, V185, P332, DOI 10.1111/j.1469-8137.2009.03007.x; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Rambaut A, 2009, TRACER VERSION 1 5 0; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Schneider von Deimling T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026484; Schoenbohm LM, 2006, GEOL SOC AM BULL, V118, P672, DOI 10.1130/B25816.1; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shui Y. M., 2003, SEED PLANTS HONGHE R; Statistics P, 2009, STAT PROGR SOC SCI V; Steinhoff DF, 2013, Q J ROY METEOR SOC, V139, P1615, DOI 10.1002/qj.2038; Tang Y., 2004, J MT SCI-ENGL, V1, P38, DOI DOI 10.1007/BF02919358; Tian S, 2010, PLANT SYST EVOL, V284, P219, DOI 10.1007/s00606-009-0246-9; [万云霞 WAN Yunxia], 2008, [自然资源学报, Journal of Natural Resources], V23, P657; Wang FY, 2008, J SYST EVOL, V46, P13, DOI 10.3724/SP.J.1002.2008.07049; Wang IJ, 2013, ECOL LETT, V16, P175, DOI 10.1111/ele.12025; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wang R, 2011, NEW PHYTOL, V191, P828, DOI 10.1111/j.1469-8137.2011.03720.x; Wang YH, 2015, NEW PHYTOL, V206, P852, DOI 10.1111/nph.13261; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wright S, 1978, VARIABILITY NATURAL; Wu ZY, 2001, FLORA CHINA, P28; Xia K, 2009, PALAEOGEOGR PALAEOCL, V276, P80, DOI 10.1016/j.palaeo.2009.02.024; [肖霞云 XIAO Xia-yun], 2009, [古生物学报, Acta Palaeontologica Sinica], V48, P185; Yang FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057638; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yue LL, 2012, AM J BOT, V99, P1726, DOI 10.3732/ajb.1100506; Zhang TC, 2011, MOL PHYLOGENET EVOL, V60, P1, DOI 10.1016/j.ympev.2011.04.009	70	15	19	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145014	10.1371/journal.pone.0145014	http://dx.doi.org/10.1371/journal.pone.0145014			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689776	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300031
J	Xiao, LS; Lin, T; Chen, SH; Zhang, GQ; Ye, ZL; Yu, ZW				Xiao, Lishan; Lin, Tao; Chen, Shaohua; Zhang, Guoqin; Ye, Zhilong; Yu, Zhaowu			Characterizing Urban Household Waste Generation and Metabolism Considering Community Stratification in a Rapid Urbanizing Area of China	PLOS ONE			English	Article							MULTISCALE INTEGRATED ANALYSIS; SOCIOECONOMIC BASED SURVEY; MANAGEMENT; SOCIETAL; IRELAND; DUBLIN; CITY	The relationship between social stratification and municipal solid waste generation remains uncertain under current rapid urbanization. Based on a multi-object spatial sampling technique, we selected 191 households in a rapidly urbanizing area of Xiamen, China. The selected communities were classified into three types: work-unit, transitional, and commercial communities in the context of housing policy reform in China. Field survey data were used to characterize household waste generation patterns considering community stratification. Our results revealed a disparity in waste generation profiles among different households. The three community types differed with respect to family income, living area, religious affiliation, and homeowner occupation. Income, family structure, and lifestyle caused significant differences in waste generation among work-unit, transitional, and commercial communities, respectively. Urban waste generation patterns are expected to evolve due to accelerating urbanization and associated community transition. A multi-scale integrated analysis of societal and ecosystem metabolism approach was applied to waste metabolism linking it to particular socioeconomic conditions that influence material flows and their evolution. Waste metabolism, both pace and density, was highest for family structure driven patterns, followed by lifestyle and income driven. The results will guide community-specific management policies in rapidly urbanizing areas.	[Xiao, Lishan; Lin, Tao; Chen, Shaohua; Zhang, Guoqin; Ye, Zhilong; Yu, Zhaowu] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China; [Xiao, Lishan; Lin, Tao; Zhang, Guoqin; Yu, Zhaowu] Xiamen Key Lab Urban Metab, Xiamen, Peoples R China	Chinese Academy of Sciences; Institute of Urban Environment, CAS	Lin, T (corresponding author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China.	tlin@iue.ac.cn	CAS, KLUEH/T-5743-2019; Lin, Tao/B-7256-2009; , Zhaowu/E-8032-2016; Chen, Shaohua/K-1709-2013	Lin, Tao/0000-0002-7479-2333; , Zhaowu/0000-0003-4576-4541; Chen, Shaohua/0000-0002-8064-0504; ZHANG, Guo-qin/0000-0002-4148-5513	National Natural Science Foundation of China [41301621, 41201155, 41201598]; Science and Technology Foundation of Xiamen City [3502Z20111049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Xiamen City	The research was supported by National Natural Science Foundation of China, Grant No. 41301621, 41201155, 41201598, and the Science and Technology Foundation of Xiamen City, Grant No. 3502Z20111049.	Arbulu I, 2015, WASTE MANAGE, V46, P628, DOI 10.1016/j.wasman.2015.04.014; Barles S, 2009, J IND ECOL, V13, P898, DOI 10.1111/j.1530-9290.2009.00169.x; Briggs D, 2008, SOC SCI MED, V67, P1612, DOI 10.1016/j.socscimed.2008.06.040; Cantore N, 2010, ENERGY, V35, P298, DOI 10.1016/j.energy.2009.09.022; Chai Y., 1996, GEOGRAPHY RES, V1, P30; Chakravarty S, 2009, P NATL ACAD SCI USA, V106, P11884, DOI 10.1073/pnas.0905232106; Cleary J, 2009, ENVIRON INT, V35, P1256, DOI 10.1016/j.envint.2009.07.009; Cox J, 2010, WASTE MANAGE RES, V28, P193, DOI 10.1177/0734242X10361506; D'Alisa G, 2013, J CLEAN PROD, V38, P71, DOI 10.1016/j.jclepro.2011.11.058; D'Alisa G, 2012, J CLEAN PROD, V35, P59, DOI 10.1016/j.jclepro.2012.05.017; Davies S, 2012, RES SOC STRAT MOBIL, V30, P143, DOI 10.1016/j.rssm.2011.05.003; Dennison GJ, 1996, RESOUR CONSERV RECY, V17, P227, DOI 10.1016/0921-3449(96)01070-1; Dennison GJ, 1996, RESOUR CONSERV RECY, V17, P245, DOI 10.1016/0921-3449(96)01155-X; Gallardo A, 2014, WASTE MANAGE, V34, P1920, DOI 10.1016/j.wasman.2014.05.014; [高丽玲 Gao Liling], 2010, 地球信息科学学报, V12, P358; Garnett K, 2014, WASTE MANAGE, V34, P2709, DOI 10.1016/j.wasman.2014.08.011; Gellynck X, 2011, J ENVIRON MANAGE, V92, P2683, DOI 10.1016/j.jenvman.2011.06.006; Giampietro M, 2009, ENERGY, V34, P313, DOI 10.1016/j.energy.2008.07.020; Giusti L, 2009, WASTE MANAGE, V29, P2227, DOI 10.1016/j.wasman.2009.03.028; Hadden WC, 2003, SOC SCI MED, V57, P1863, DOI 10.1016/S0277-9536(03)00052-2; Hou DY, 2012, ENVIRON SCI TECHNOL, V46, P2494, DOI 10.1021/es3004552; Huang SL, 2005, ECOL MODEL, V189, P49, DOI 10.1016/j.ecolmodel.2005.03.004; Huang WF, 2014, J CLEAN PROD, V67, P107, DOI 10.1016/j.jclepro.2013.12.019; Kaufman SM, 2010, ENVIRON SCI TECHNOL, V44, P5949, DOI 10.1021/es100505u; Kennedy C, 2011, ENVIRON POLLUT, V159, P1965, DOI 10.1016/j.envpol.2010.10.022; Kennedy C, 2007, J IND ECOL, V11, P43, DOI 10.1162/jie.2007.1107; Keser S, 2012, WASTE MANAGE, V32, P359, DOI 10.1016/j.wasman.2011.10.017; Lebersorger S, 2011, WASTE MANAGE, V31, P1907, DOI 10.1016/j.wasman.2011.05.016; Lee S, 2011, BUILD ENVIRON, V46, P1159, DOI 10.1016/j.buildenv.2010.12.005; Li ZS, 2011, SCI TOTAL ENVIRON, V409, P4406, DOI 10.1016/j.scitotenv.2011.07.018; Lin T, 2014, ENVIRON POLLUT, V192, P244, DOI 10.1016/j.envpol.2014.03.038; Lin T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055642; Liu J. Y., 2010, THESIS; Lu LT, 2006, WASTE MANAGE, V26, P661, DOI 10.1016/j.wasman.2005.10.005; Marshall RE, 2013, WASTE MANAGE, V33, P988, DOI 10.1016/j.wasman.2012.12.023; Mazzanti M, 2009, ENVIRON RESOUR ECON, V44, P203, DOI 10.1007/s10640-009-9280-x; Murie A, 1999, URBAN STUDIES, V36; Ojeda-Benitez S, 2008, RESOUR CONSERV RECY, V52, P992, DOI 10.1016/j.resconrec.2008.03.004; Othman SN, 2013, J CLEAN PROD, V41, P251, DOI 10.1016/j.jclepro.2012.09.043; Quan ZX, 2006, HABITAT INT, V30, P327, DOI 10.1016/j.habitatint.2004.02.008; Ramos-Martin J, 2007, ECOL ECON, V63, P174, DOI 10.1016/j.ecolecon.2006.10.020; Siciliano G, 2012, LAND USE POLICY, V29, P165, DOI 10.1016/j.landusepol.2011.06.003; Singh J, 2014, WASTE MANAGE RES, V32, P800, DOI 10.1177/0734242X14537868; Sterner T, 1999, ENVIRON RESOUR ECON, V13, P473; Sujauddin M, 2008, WASTE MANAGE, V28, P1688, DOI 10.1016/j.wasman.2007.06.013; Sun T, 2010, RESOUR CONSERV RECY, V54, P601, DOI 10.1016/j.resconrec.2009.10.017; Tai J, 2011, WASTE MANAGE, V31, P1673, DOI 10.1016/j.wasman.2011.03.014; Wang J, 2002, INT J REMOTE SENS, V23, P263, DOI 10.1080/01431160010025998; Warren-Rhodes K, 2001, AMBIO, V30, P429, DOI 10.1639/0044-7447(2001)030[0429:ETITUM]2.0.CO;2; Wigginton N, 2012, SCIENCE, V337, P663, DOI 10.1126/science.337.6095.664; Wu Y., 2008, THESIS; Zhao W, 2012, RES SOC STRAT MOBIL, V30, P433, DOI 10.1016/j.rssm.2012.07.001	52	15	15	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145405	10.1371/journal.pone.0145405	http://dx.doi.org/10.1371/journal.pone.0145405			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SF	26690056	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300073
J	Espindola, MS; Lima, LJG; Soares, LS; Cacemiro, MC; Zambuzi, FA; Gomes, MD; Amaral, LR; Bollela, VR; Martins, OA; Frantz, FG				Espindola, Milena S.; Lima, Leonardo J. G.; Soares, Luana S.; Cacemiro, Maira C.; Zambuzi, Fabiana A.; Gomes, Matheus de Souza; Amaral, Laurence R.; Bollela, Valdes R.; Martins-Filho, Olindo A.; Frantz, Fabiani G.			Dysregulated Immune Activation in Second-Line HAART HIV plus Patients Is Similar to That of Untreated Patients	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; INDEPENDENT PREDICTORS; SOLUBLE CD163; CELL COUNT; INFECTION; INFLAMMATION; REPLICATION; MARKERS; SUPPRESSION	Background Successful highly active antiretroviral therapy (HAART) has changed the outcome of AIDS patients worldwide because the complete suppression of viremia improves health and prolongs life expectancy of HIV-1+ patients. However, little attention has been given to the immunological profile of patients under distinct HAART regimens. This work aimed to investigate the differences in the immunological pattern of HIV-1+ patients under the first- or second-line HAART in Brazil. Methods CD4+ T cell counts, Viral load, and plasma concentration of sCD14, sCD163, MCP-1, RANTES, IP-10, IL-1 beta, IL-6, TNF-alpha, IL-12, IFN-alpha, IFN-gamma, IL-4, IL-5, and IL-10 were assessed for immunological characterization of the following clinical groups: Non-infected individuals (NI; n = 66), HIV-1+ untreated (HIV; n = 46), HIV-1+ treated with first-line HAART (HAART 1; n = 15); and HIV-1+ treated with second-line HAART (HAART 2; n = 15). Results We found that the immunological biosignature pattern of HAART 1 is similar to that of NI individuals, especially in patients presenting slow progression of the disease, while patients under HAART 2 remain in a moderate inflammatory state, which is similar to that of untreated HIV patients pattern. Network correlations revealed that differences in IP-10, TNF-alpha, IL-6, IFN-alpha, and IL-10 interactions were primordial in HIV disease and treatment. Heat map and decision tree analysis identified that IP-10> TNF-alpha > IFN-alpha were the best respective HAART segregation biomarkers. Conclusion HIV patients in different HAART regimens develop distinct immunological biosignature, introducing a novel perspective into disease outcome and potential new therapies that consider HAART patients as a heterogeneous group.	[Espindola, Milena S.; Lima, Leonardo J. G.; Soares, Luana S.; Cacemiro, Maira C.; Zambuzi, Fabiana A.; Frantz, Fabiani G.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-14041903 Ribeirao Preto, SP, Brazil; [Gomes, Matheus de Souza; Amaral, Laurence R.] Univ Fed Uberlandia, FACOM, INGEB, Lab Bioinformat & Anal Mol, Patos De Minas, MG, Brazil; [Bollela, Valdes R.] Univ Sao Paulo, Fac Med Ribeirao Preto, BR-14041903 Ribeirao Preto, SP, Brazil; [Martins-Filho, Olindo A.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Biomarcadores Diagnost & Monitoramento, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Uberlandia; Universidade de Sao Paulo; Fundacao Oswaldo Cruz	Frantz, FG (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, DACTB, BR-14041903 Ribeirao Preto, SP, Brazil.	frantz@usp.br	Soares, Luana/AAL-1909-2020; Frantz, Fabiani Gai/B-9204-2016; Cacemiro, Maira C/S-4458-2017; Martins-Filho, Olindo Assis/ABE-6278-2021; de Souza Gomes, Matheus/G-3480-2012; Amaral, Laurence/G-5905-2012; Amaral, Laurence Rodrigues do/R-2209-2019	Soares, Luana/0000-0001-5924-1691; Frantz, Fabiani Gai/0000-0001-6960-2438; Cacemiro, Maira C/0000-0002-4170-2063; Martins-Filho, Olindo Assis/0000-0002-5494-4889; de Souza Gomes, Matheus/0000-0001-7352-3089; Amaral, Laurence/0000-0003-4681-5451; Amaral, Laurence Rodrigues do/0000-0003-4681-5451	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/12512-0, 2011/12199-0, 2011/24026-3, 2012/02799-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grants: MSE #2011/12512-0; FGF #2011/12199-0; LSS #2011/24026-3; LJGL #2012/02799-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti F, 2006, AIDS REV, V8, P88; Coelho-dos-Reis JGA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002328; Badley AD, 2005, CELL DEATH DIFFER, V12, P924, DOI 10.1038/sj.cdd.4401580; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Cha L, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.1; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Danaher RJ, 2010, AIDS, V24, P2578, DOI 10.1097/QAD.0b013e32833f4022; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; French MA, 2015, AIDS; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Funderburg NT, 2014, CURR OPIN HIV AIDS, V9, P80, DOI 10.1097/COH.0000000000000019; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Guimaraes AGDP, 2015, JAIDS-J ACQ IMM DEF, V68, P112, DOI 10.1097/QAI.0000000000000412; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hattab S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-122; Hayes TL, 2013, AIDS, V27, P867, DOI 10.1097/QAD.0b013e32835d85b4; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Juompan LY, 2008, AIDS RES HUM RETROV, V24, P573, DOI 10.1089/aid.2007.0182; Kalayjian RC, 2010, J INFECT DIS, V201, P1796, DOI 10.1086/652750; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lapadula G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124741; Latronico T, 2007, AIDS, V21, P677, DOI 10.1097/QAD.0b013e328018751d; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Leeansyah E, 2013, CURR OPIN HIV AIDS, V8, P117, DOI 10.1097/COH.0b013e32835c7134; Lepri AC, 1998, AIDS, V12, P1639, DOI 10.1097/00002030-199813000-00011; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lichtfuss GF, 2011, BIOMARK MED, V5, P171, DOI [10.2217/bmm.11.15, 10.2217/BMM.11.15]; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439; Marchetti G, 2011, AIDS, V25, P1385, DOI 10.1097/QAD.0b013e3283471d10; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; Mastroianni CM, 2007, TRENDS MOL MED, V13, P449, DOI 10.1016/j.molmed.2007.09.001; Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de DST AIDS e Hepatites Virais, 2013, PROTOCOLO CLINICO E; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN, P302; Regidor DL, 2011, AIDS, V25, P303, DOI 10.1097/QAD.0b013e32834273ad; Alves EAR, 2015, INT IMMUNOPHARMACOL, V24, P314, DOI 10.1016/j.intimp.2014.12.025; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Starling AL, 2015, BIOMARKERS, P1; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; UNIAIDS, 2013, GLOBAL REPORT UNAIDS; Valdez H, 2002, AIDS, V16, P1859, DOI 10.1097/00002030-200209270-00002	54	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145261	10.1371/journal.pone.0145261	http://dx.doi.org/10.1371/journal.pone.0145261			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684789	Green Submitted, Green Published, gold			2022-12-27	WOS:000366725800054
J	Liu, TT; You, HL; Weng, SW; Wei, YC; Eng, HL; Huang, WT				Liu, Ting-Ting; You, Huey-Ling; Weng, Shao-Wen; Wei, Yu-Ching; Eng, Hock-Liew; Huang, Wan-Ting			Recurrent Amplification at 13q34 Targets at CUL4A, IRS2, and TFDP1 As an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma	PLOS ONE			English	Article							HUMAN BREAST-CANCER; POLYMORPHISM ARRAY ANALYSIS; GENE AMPLIFICATION; COLORECTAL-CANCER; HEPATOCELLULAR CARCINOMAS; LUNG-CANCER; OVEREXPRESSION; METASTASIS; EXPRESSION; PATTERNS	Amplification of genes at 13q34 has been reported to be associated with tumor proliferation and progression in diverse types of cancers. However, its role in intrahepatic cholangiocarcinoma (iCCA) has yet to be explored. We examined two iCCA cell lines and 86 cases of intrahepatic cholangiocarcinoma to analyze copy number of three target genes, including cullin 4A (CUL4A), insulin receptor substrate 2 (IRS2), and transcription factor Dp-1 (TFDP1) at 13q34 by quantitative real-time polymerase chain reaction. The cell lines and all tumor samples were used to test the relationship between copy number (CN) alterations and protein expression by western blotting and immunohistochemical assays, respectively. IRS2 was introduced, and each target gene was silenced in cell lines. The mobility potential of cells was compared in the basal condition and after manipulation using cell migration and invasion assays. CN alterations correlated with protein expression levels. The SNU1079 cell line containing deletions of the target genes demonstrated decreased protein expression levels and significantly lower numbers of migratory and invasive cells, as opposed to the RBE cell line, which does not contain CN alterations. Overexpression of IRS2 by introducing IRS2 in SUN1079 cells increased the mobility potential. In contrast, silencing each target gene showed a trend or statistical significance toward inhibition of migratory and invasive capacities in RBE cells. In tumor samples, the amplification of each of these genes was associated with poor disease-free survival. Twelve cases (13.9%) demonstrated copy numbers > 4 for all three genes tested (CUL4A, IRS2, and TFDP1), and showed a significant difference in disease-free survival by both univariate and multivariate survival analyses (hazard ratio, 2.69; 95% confidence interval, 1.23 to 5.88; P = 0.013). Our data demonstrate that amplification of genes at 13q34 plays an oncogenic role in iCCA featuring adverse disease-free survival, which may provide new directions for targeted therapy.	[Liu, Ting-Ting; Eng, Hock-Liew; Huang, Wan-Ting] Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan; [Liu, Ting-Ting; You, Huey-Ling; Weng, Shao-Wen; Eng, Hock-Liew; Huang, Wan-Ting] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Liu, Ting-Ting; You, Huey-Ling; Huang, Wan-Ting] Kaohsiung Chang Gung Mem Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Weng, Shao-Wen] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan; [You, Huey-Ling] Fooyin Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Wei, Yu-Ching] Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Pathol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Fooyin University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital	Huang, WT (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan.	huangwanting5@gmail.com	Weng, Shao wen/GYU-9746-2022		Chang Gung Memorial Hospital [CMRPG8A1162, CMRPG8D1321]; National Science Council, Taiwan [NSC 104-2320-B-182A-004]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported in part by grants from Chang Gung Memorial Hospital (CMRPG8A1162, CMRPG8D1321) and National Science Council, Taiwan (NSC 104-2320-B-182A-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2007, CANCER RES, V67, P4104, DOI 10.1158/0008-5472.CAN-06-4672; Andersen JB, 2012, CURR OPIN GASTROEN, V28, P266, DOI 10.1097/MOG.0b013e3283523c7e; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Castillo SD, 2010, J PATHOL, V222, P89, DOI 10.1002/path.2732; Day E, 2013, INT J EXP PATHOL, V94, P203, DOI 10.1111/iep.12021; Dearth RK, 2007, CELL CYCLE, V6, P705, DOI 10.4161/cc.6.6.4035; Garcia MJ, 2013, MOL CANCER THER, V12, P530, DOI 10.1158/1535-7163.MCT-12-0768; Gibson SL, 2007, CELL CYCLE, V6, P631, DOI 10.4161/cc.6.6.3987; Gupta A, 2002, INT J RADIAT ONCOL, V52, P822, DOI 10.1016/S0360-3016(01)02739-0; Huang HY, 2010, ANN SURG ONCOL, V17, P3212, DOI 10.1245/s10434-010-1185-y; Huang WT, 2014, INT J CLIN EXP PATHO, V7, P6841; Huang WT, 2012, APMIS, V120, P872, DOI 10.1111/j.1600-0463.2012.02915.x; Jackson JG, 2001, ONCOGENE, V20, P7318, DOI 10.1038/sj.onc.1204920; Jacquemier J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-351; Lips EH, 2007, J PATHOL, V212, P269, DOI 10.1002/path.2180; Liu G, 2015, TUMOUR BIOL; Martin ES, 2007, CANCER RES, V67, P10736, DOI 10.1158/0008-5472.CAN-07-2742; Melchor L, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2456; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Ren SC, 2012, J MOL MED, V90, P1121, DOI 10.1007/s00109-012-0885-0; Shan B, 1996, CELL GROWTH DIFFER, V7, P689; Sia D, 2013, ONCOGENE, V32, P4861, DOI 10.1038/onc.2012.617; Sia D, 2013, GASTROENTEROLOGY, V144, P829, DOI 10.1053/j.gastro.2013.01.001; Sugimachi K, 2001, J HEPATOL, V35, P74, DOI 10.1016/S0168-8278(01)00079-4; Temam S, 2007, J CLIN ONCOL, V25, P2164, DOI 10.1200/JCO.2006.06.6605; Ukita Y, 2002, J HEPATOL, V36, P780, DOI 10.1016/S0168-8278(02)00057-0; Wang YS, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-252; Wang YS, 2014, CANCER RES, V74, P520, DOI 10.1158/0008-5472.CAN-13-2182; Yasui K, 2003, J HUM GENET, V48, P609, DOI 10.1007/s10038-003-0086-3; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; You HL, 2012, EXP MOL PATHOL, V92, P281, DOI 10.1016/j.yexmp.2012.01.009; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	32	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145388	10.1371/journal.pone.0145388	http://dx.doi.org/10.1371/journal.pone.0145388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684807	gold, Green Published, Green Submitted			2022-12-27	WOS:000366725800072
J	Pershina, E; Valkonen, J; Kurki, P; Ivanova, E; Chirak, E; Korvigo, I; Provorov, N; Andronov, E				Pershina, Elizaveta; Valkonen, Jari; Kurki, Paivi; Ivanova, Ekaterina; Chirak, Evgeny; Korvigo, Ilia; Provorov, Nykolay; Andronov, Evgeny			Comparative Analysis of Prokaryotic Communities Associated with Organic and Conventional Farming Systems	PLOS ONE			English	Article							SOIL BACTERIAL COMMUNITIES; RIBOSOMAL-RNA; MANAGEMENT; DIVERSITY; STRATIFICATION; FERTILIZATION; POPULATIONS; SEQUENCES; MATTER; ROOTS	One of the most important challenges in agriculture is to determine the effectiveness and environmental impact of certain farming practices. The aim of present study was to determine and compare the taxonomic composition of the microbiomes established in soil following long-term exposure (14 years) to a conventional and organic farming systems (CFS and OFS accordingly). Soil from unclared forest next to the fields was used as a control. The analysis was based on RT-PCR and pyrosequencing of 16S rRNA genes of bacteria and archaea. The number of bacteria was significantly lower in CFS than in OFS and woodland. The highest amount of archaea was detected in woodland, whereas the amounts in CFS and OFS were lower and similar. The most common phyla in the soil microbial communities analyzed were Proteobacteria (57.9%), Acidobacteria (16.1%), Actinobacteria (7.9%), Verrucomicrobia (2.0%), Bacteroidetes (2.7%) and Firmicutes (4.8%). Woodland soil differed from croplands in the taxonomic composition of microbial phyla. Croplands were enriched with Proteobacteria (mainly the genus Pseudomonas), while Acidobacteria were detected almost exclusively in woodland soil. The most pronounced differences between the CFS and OFS microbiomes were found within the genus Pseudomonas, which significantly (p< 0,05) increased its number in CFS soil compared to OFS. Other differences in microbiomes of cropping systems concerned minor taxa. A higher relative abundance of bacteria belonging to the families Oxalobacteriaceae, Koribacteriaceae, Nakamurellaceae and genera Ralstonia, Paenibacillus and Pedobacter was found in CFS as compared with OFS. On the other hand, microbiomes of OFS were enriched with proteobacteria of the family Comamonadaceae (genera Hylemonella) and Hyphomicrobiaceae, actinobacteria from the family Micrococcaceae, and bacteria of the genera Geobacter, Methylotenera, Rhizobium (mainly Rhizobium leguminosarum) and Clostridium. Thus, the fields under OFS and CFS did not differ greatly for the composition of the microbiome. These results, which were also confirmed by cluster analysis, indicated that microbial communities in the field soil do not necessarily differ largely between conventional and organic farming systems.	[Pershina, Elizaveta; Ivanova, Ekaterina; Chirak, Evgeny; Korvigo, Ilia; Provorov, Nykolay; Andronov, Evgeny] All Russia Res Inst Agr Microbiol, Lab Microbiol Monitoring & Bioremediat Soils, St Petersburg, Russia; [Pershina, Elizaveta; Andronov, Evgeny] St Petersburg State Univ, St Petersburg 199034, Russia; [Valkonen, Jari] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Kurki, Paivi] Nat Resources Inst Finland, Mikkeli, Finland; [Ivanova, Ekaterina] VV Dokuchaev Soil Sci Inst, Lab Biol & Biochem Soils, Moscow, Russia	Saint Petersburg State University; University of Helsinki; Natural Resources Institute Finland (Luke); Dokuchaev Soil Science Institute	Pershina, E (corresponding author), All Russia Res Inst Agr Microbiol, Lab Microbiol Monitoring & Bioremediat Soils, St Petersburg, Russia.	pershina.elizaveta@yandex.ru	Andronov, Evgeny Evgeny/S-1688-2016; Ivanova, Ekaterina/AAN-7257-2020; Provorov, Nikolay/AAB-3908-2021; Ivanova, Ekaterina/F-9279-2017; Andronov, Evgeny/AAE-4235-2021; Pershina, Elizaveta/N-2985-2015	Andronov, Evgeny Evgeny/0000-0002-5204-262X; Ivanova, Ekaterina/0000-0003-1589-9875; Ivanova, Ekaterina/0000-0003-1589-9875; Andronov, Evgeny/0000-0002-5204-262X; Pershina, Elizaveta/0000-0003-0834-3211; Valkonen, Jari/0000-0002-3704-9911; Chirak, Evgenii/0000-0001-9167-5000	Norden/NordForsk; Russian Science Foundation (RSF) [14-26-00094, 14-26-00079]; Russian Science Foundation [14-26-00094] Funding Source: Russian Science Foundation	Norden/NordForsk; Russian Science Foundation (RSF)(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	Financial support to the Agro-Biotechnology focused on Root-Microbe Systems Baltic Sea region network (AB-RMS) was received from Norden/NordForsk (Authors: Jari Valkonen, Paivi Kurki): http://www.nordforsk.org/en. Financial support for bioinformatics data analysis was obtained from Russian Science Foundation (RSF) grant 14-26-00094: "Analysis of the genetic and evolutionary potential of the soil microbiome to improve plant productivity and soil fertility" (Authors: Evgeny Chirak, Ilia Korvigo, Elizaveta Pershina, Evgeny Andronov): http://grant.rscf.ru/forms?rid=2Wv-G10JrV8-3i8XBU2cLb00. Discussion chapter was prepared together with the research scientists participating in Russian Science Foundation (RSF) grant 14-26-00079: "Bio-physical and chemical diagnosis of soil organic matter quality for the development of scientific and theoretical basis of Agrobiotechnology" (Author: Ekaterina Ivanova, http://grant.rscf.ru/forms?rid=1IgCW10JqtDX3i8WD72cLb00.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Arja Nykanen for collaboration. Financial support to the Agro-Biotechnology focused on Root-Microbe Systems Baltic Sea region network (AB-RMS, to J.P.T.V.) from Norden/NordForsk is gratefully acknowledged. Financial support for bioinformatics data analysis was obtained from Russian Science Foundation (RSF) grant 14-26-00094, discussion chapter was prepared together with the research scientists participating in Russian Science Foundation (RSF) grant 14-26-00079.	Arnhold S, 2014, GEODERMA, V219, P89, DOI 10.1016/j.geoderma.2013.12.023; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chaudhry V, 2012, MICROB ECOL, V64, P450, DOI 10.1007/s00248-012-0025-y; da Rocha UN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082443; Davinic M, 2012, SOIL BIOL BIOCHEM, V46, P63, DOI 10.1016/j.soilbio.2011.11.012; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doran JW, 2000, APPL SOIL ECOL, V15, P3, DOI 10.1016/S0929-1393(00)00067-6; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Ge Y, 2008, J SOIL SEDIMENT, V8, P43, DOI 10.1065/jss2008.01.270; Gomiero T, 2011, CRIT REV PLANT SCI, V30, P95, DOI 10.1080/07352689.2011.554355; Hartmann M, 2015, ISME J, V9, P1177, DOI 10.1038/ismej.2014.210; Hiddink GA, 2005, EUR J PLANT PATHOL, V113, P417, DOI 10.1007/s10658-005-5402-7; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Jackson CR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-274; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Kim SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113593; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Laws MT, 2005, J AM SOC HORTIC SCI, V130, P496, DOI 10.21273/JASHS.130.4.496; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Li R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051897; Lombard N, 2011, FEMS MICROBIOL ECOL, V78, P31, DOI 10.1111/j.1574-6941.2011.01140.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MANTEL N, 1967, CANCER RES, V27, P209; Misko AL, 2002, FEMS MICROBIOL ECOL, V42, P399, DOI 10.1111/j.1574-6941.2002.tb01029.x; Mummey D, 2006, MICROB ECOL, V51, P404, DOI 10.1007/s00248-006-9020-5; Ojo O. A., 2007, Biotechnology and Molecular Biology Reviews, V2, P001; Pesaro M, 2006, APPL ENVIRON MICROB, V72, P37, DOI 10.1128/AEM.72.1.37-43.2006; Raupp J., 2006, LONG TERM FIELD EXPT; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Senechkin IV, 2010, MICROB ECOL, V60, P829, DOI 10.1007/s00248-010-9670-1; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Shange RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040338; Shannon D, 2002, SOIL USE MANAGE, V18, P274, DOI 10.1079/SUM2002130; Shein EV, 2003, EURASIAN SOIL SCI+, V36, P51; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Stacheter A, 2013, ISME J, V7, P1051, DOI 10.1038/ismej.2012.167; Sudhakaran M., 2013, International Journal of Environmental Sciences, V4, P28; Sun HY, 2004, APPL ENVIRON MICROB, V70, P5868, DOI 10.1128/AEM.70.10.5868-5874.2004; Sylvia D., 2005, PRINCIPLES APPL SOIL, Vsecond; Upchurch R, 2008, SOIL BIOL BIOCHEM, V40, P1294, DOI 10.1016/j.soilbio.2007.06.027; Uroz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055929; van Bruggen AHC, 2008, MICROB ECOL, V55, P466, DOI 10.1007/s00248-007-9292-4; van Diepeningen AD, 2005, MICROB ECOL, V50, P506, DOI 10.1007/s00248-005-0012-7; van Diepeningen AD, 2006, APPL SOIL ECOL, V31, P120, DOI 10.1016/j.apsoil.2005.03.003; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner D., 2005, NITROGEN FIXATION AG, DOI DOI 10.1007/1-4020-3544-6; Wiegel J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P654, DOI 10.1007/0-387-30744-3_20; Yildirim E, 2011, HORTSCIENCE, V46, P932, DOI 10.21273/HORTSCI.46.6.932; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zelenev VV, 2006, SOIL BIOL BIOCHEM, V38, P1690, DOI 10.1016/j.soilbio.2005.11.024	52	63	65	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145072	10.1371/journal.pone.0145072	http://dx.doi.org/10.1371/journal.pone.0145072			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684619	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800034
J	Dhaliwal, AK; Mohan, A; Sidhu, G; Maqbool, R; Gill, KS				Dhaliwal, Amandeep K.; Mohan, Amita; Sidhu, Gaganjot; Maqbool, Rizwana; Gill, Kulvinder S.			An Ethylmethane Sulfonate Mutant Resource in Pre-Green Revolution Hexaploid Wheat	PLOS ONE			English	Article							INDUCED MUTATIONS; GENES	Mutagenesis is a powerful tool used for studying gene function as well as for crop improvement. It is regaining popularity because of the development of effective and cost efficient methods for high-throughput mutation detection. Selection for semi-dwarf phenotype during green revolution has reduced genetic diversity including that for agronomically desirable traits. Most of the available mutant populations in wheat (Triticum aestivum L.) were developed in post-green revolution cultivars. Besides the identification and isolation of agronomically important alleles in the mutant population of pre-green revolution cultivar, this population can be a vital resource for expanding the genetic diversity for wheat breeding. Here we report an Ethylmethane Sulfonate (EMS) generated mutant population consisting of 4,180 unique mutant plants in a pre-green revolution spring wheat cultivar 'Indian'. Released in early 1900s, 'Indian' is devoid of any known height-reducing mutations. Unique mutations were captured by proceeding with single M-2 seed from each of the 4,180 M-1 plants. Mutants for various phenotypic traits were identified by detailed phenotyping for altered morphological and agronomic traits on M-2 plants in the greenhouse and M-3 plants in the field. Of the 86 identified mutants, 75 (87%) were phenotypically stable at the M-4 generation. Among the observed phenotypes, variation in plant height was the most frequent followed by the leaf morphology. Several mutant phenotypes including looped peduncle, crooked plant morphology, 'gritty' coleoptiles, looped lower internodes, and burnt leaf tips are not reported in other plant species. Considering the extent and diversity of the observed mutant phenotypes, this population appears to be a useful resource for the forward and reverse genetic studies. This resource is available to the scientific community.	[Dhaliwal, Amandeep K.; Mohan, Amita; Sidhu, Gaganjot; Maqbool, Rizwana; Gill, Kulvinder S.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	Washington State University	Gill, KS (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	ksgill@wsu.edu	Sidhu, Gaganjot/O-7667-2019; Dhaliwal, Amandeep Kaur/R-9254-2017		National Science Foundation-Basic Research to Enable Agriculture Development (NSF-BREAD) [0965533]	National Science Foundation-Basic Research to Enable Agriculture Development (NSF-BREAD)(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was funded by National Science Foundation-Basic Research to Enable Agriculture Development (NSF-BREAD) grant # 0965533 (http://www.nsf.gov/funding/pgm_summ.jsp? pims_id=503285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031005, 10.1371/journal.pone.0046239, 10.1371/journal.pone.0041570, 10.1371/journal.pone.0035254]; Clark JA, 1926, AGRONJ, V18, P920; Dong CM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-143; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Feiz L, 2009, THEOR APPL GENET, V118, P247, DOI 10.1007/s00122-008-0893-1; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; GOUD JV, 1967, CURR SCI INDIA, V36, P557; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Greene EA, 2003, GENETICS, V164, P731; Howard TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087053; Kuraparthy V, 2007, THEOR APPL GENET, V114, P1379, DOI 10.1007/s00122-007-0524-2; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Mohan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073314; Mutti J, 2007, TARGETED IMPROVEMENT; NEWHOUSE KE, 1992, PLANT PHYSIOL, V100, P882, DOI 10.1104/pp.100.2.882; Ordonio RL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05287; Pepper GE, 1974, THESIS; RICHARDS RA, 1992, AUST J AGR RES, V43, P517, DOI 10.1071/AR9920517; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Schumacher K, 1999, P NATL ACAD SCI USA, V96, P290, DOI 10.1073/pnas.96.1.290; Sestili F, 2010, MOL BREEDING, V25, P145, DOI 10.1007/s11032-009-9314-7; Sidhu G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2112-1; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Waines JG, 2007, ANN BOT-LONDON, V100, P991, DOI 10.1093/aob/mcm180; Zaccai M, 2009, PLANT SCI, V176, P736, DOI 10.1016/j.plantsci.2009.02.014	28	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145227	10.1371/journal.pone.0145227	http://dx.doi.org/10.1371/journal.pone.0145227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678261	gold, Green Published, Green Submitted			2022-12-27	WOS:000366723400059
J	Godefay, H; Byass, P; Graham, WJ; Kinsman, J; Mulugeta, A				Godefay, Hagos; Byass, Peter; Graham, Wendy J.; Kinsman, John; Mulugeta, Afework			Risk Factors for Maternal Mortality in Rural Tigray, Northern Ethiopia: A Case-Control Study	PLOS ONE			English	Article							HEALTH-CARE; SERVICES; DEATH	Background Maternal mortality continues to have devastating impacts in many societies, where it constitutes a leading cause of death, and thus remains a core issue in international development. Nevertheless, individual determinants of maternal mortality are often unclear and subject to local variation. This study aims to characterise individual risk factors for maternal mortality in Tigray, Ethiopia. Methods A community-based case-control study was conducted, with 62 cases and 248 controls from six randomly-selected rural districts. All maternal deaths between May 2012 and September 2013 were recruited as cases and a random sample of mothers who delivered in the same communities within the same time period were taken as controls. Multiple logistic regression was used to identify independent determinants of maternal mortality. Results Four independent individual risk factors, significantly associated with maternal death, emerged. Women who were not members of the voluntary Women's Development Army were more likely to experience maternal death (OR 2.07, 95% CI 1.04-4.11), as were women whose husbands or partners had below-median scores for involvement during pregnancy (OR 2.19, 95% CI 1.14-4.18). Women with a pre-existing history of other illness were also at increased risk (OR 5.58, 95% CI 2.17-14.30), as were those who had never used contraceptives (OR 2.58, 95% CI 1.37-4.85). Previous pregnancy complications, a below-median number of antenatal care visits and a woman's lack of involvement in health care decision making were significant bivariable risks that were not significant in the multivariable model. Conclusions The findings suggest that interventions aimed at reducing maternal mortality need to focus on encouraging membership of the Women's Development Army, enhancing husbands' involvement in maternal health services, improving linkages between maternity care and other disease-specific programmes and ensuring that women with previous illnesses or non-users of contraceptive services are identified and followed-up as being at increased risk during pregnancy and childbirth.	[Godefay, Hagos] Tigray Reg Hlth Bur, Mekelle, Ethiopia; [Byass, Peter; Kinsman, John] Umea Univ, Umea Ctr Global Hlth Res, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden; [Byass, Peter; Graham, Wendy J.] Univ Aberdeen, Sch Med & Dent, Inst Appl Hlth Sci, Aberdeen, Scotland; [Byass, Peter] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Mulugeta, Afework] Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia	Umea University; University of Aberdeen; University of Witwatersrand; Mekelle University	Godefay, H (corresponding author), Tigray Reg Hlth Bur, Mekelle, Ethiopia.	hgodefay@yahoo.com		Mulugeta, Afework/0000-0003-0707-4363; Graham, Wendy/0000-0003-1473-5342	Tigray Regional Health Bureau; Swedish Research Council [C0615601]	Tigray Regional Health Bureau; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was primarily supported as part of the routine activities of the Tigray Regional Health Bureau. The authors thank the Swedish Research Council for Swedish Research Links collaboration grant C0615601 which facilitated external participation in this research.	Aggarwal Abha, 2007, Indian J Med Sci, V61, P517; ANANDALAKSHMY PN, 1993, J FAM WELFARE, V39, P1; Leite RMB, 2011, CAD SAUDE PUBLICA, V27, P1977, DOI 10.1590/S0102-311X2011001000011; Bedford J, 2013, MATERN CHILD HLTH J, V17, P230, DOI 10.1007/s10995-012-0965-3; Berihun E, 2007, ETHIOPIAN J REPROD H, V1, P4; Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; FREEDMAN L, 2003, BACKGROUND PAPER TAS; Ganatra BR, 1998, B WORLD HEALTH ORGAN, V76, P591; Gebreamlak G, 2013, J INT PHARM SCI RES, V4, P1918; Godefay H, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25264; Godefay H, 2015, J GLOB HEALTH, V5, P83, DOI 10.7189/jogh.05.010404; Hunt P, 2008, UN POPULATION FUND R; Leitao J, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21518; Mangeni JN, 2013, 93 DHS ICF INT; Mekonnen Y, 2003, J HEALTH POPUL NUTR, V21, P374; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; Nair M, 2015, BJOG-INT J OBSTET GY, V122, P653, DOI 10.1111/1471-0528.13279; Nasreen HE, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-18; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Singh D, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-68; Story WT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-28; UNFPA, 2012, TRENDS MAT HLTH ETH; United Nations, 2014, MILL DEV GOALS REP 2; WHO UNICEF, 2013, TRENDS MAT MORT 1990; Yego F, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-38	26	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144975	10.1371/journal.pone.0144975	http://dx.doi.org/10.1371/journal.pone.0144975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678047	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400038
J	Jahromi, GP; Ghanei, M; Hosseini, SK; Shamsaei, A; Gholipourmalekabadi, M; Koochaki, A; Osguei, NK; Samadikuchaksaraei, A				Jahromi, Gila Pirzad; Ghanei, Mostafa; Hosseini, Seyed Kazem; Shamsaei, Alireza; Gholipourmalekabadi, Mazaher; Koochaki, Ameneh; Osguei, Nushin Karkuki; Samadikuchaksaraei, Ali			Characterization of Lung Fibroblasts More than Two Decades after Mustard Gas Exposure	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; SULFUR MUSTARD; BRONCHOALVEOLAR LAVAGE; BRONCHIOLITIS OBLITERANS; EPITHELIAL-CELLS; MILD ASTHMA; APOPTOSIS; DIFFER; DIFFERENTIATION; PROLIFERATION	Purpose In patients with short-term exposure to the sulfur mustard gas, the delayed cellular effects on lungs have not been well understood yet. The lung pathology shows a dominant feature consistent with obliterative bronchiolitis, in which fibroblasts play a central role. This study aims to characterize alterations to lung fibroblasts, at the cellular level, in patients with delayed respiratory complications after short-term exposure to the sulfur mustard gas. Methods Fibroblasts were isolated from the transbronchial biopsies of patients with documented history of exposure to single high-dose sulfur mustard during 1985-7 and compared with the fibroblasts of control subjects. Results Compared with controls, patients' fibroblasts were thinner and shorter, and showed a higher population doubling level, migration capacity and number of filopodia. Sulfur mustard decreased the in vitro viability of fibroblasts and increased their sensitivity to induction of apoptosis, but did not change the rate of spontaneous apoptosis. In addition, higher expression of alpha smooth muscle actin showed that the lung's microenvironment in these patients is permissive for myofibroblastic differentiation. Conclusions These findings suggest that in patients under the study, the delayed pulmonary complications of sulfur mustard should be considered as a unique pathology, which might need a specific management by manipulation of cellular components.	[Jahromi, Gila Pirzad] Baqiyatallah Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Ghanei, Mostafa] Baqiyatallah Univ Med Sci, Chem Injury Res Ctr, Tehran, Iran; [Ghanei, Mostafa] Baqiyatallah Univ Med Sci, Fac Med, Dept Resp Med, Tehran, Iran; [Hosseini, Seyed Kazem] Univ Tehran Med Sci, Tissue Bank, Tehran, Iran; [Hosseini, Seyed Kazem] Univ Tehran Med Sci, Preparat Res Ctr, Tehran, Iran; [Shamsaei, Alireza] Baqiyatallah Univ Med Sci, Fac Med, Dept Pathol, Tehran, Iran; [Gholipourmalekabadi, Mazaher] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Biotechnol, Tehran, Iran; [Koochaki, Ameneh] Shahid Beheshti Univ Med Sci, Cellular & Mol Biol Res Ctr, Tehran, Iran; [Osguei, Nushin Karkuki] Eposci Millennium Inst, Tehran, Iran; [Samadikuchaksaraei, Ali] Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran, Iran; [Samadikuchaksaraei, Ali] Iran Univ Med Sci, Fac Adv Technol Med, Dept Tissue Engn & Regenerat Med, Tehran, Iran; [Samadikuchaksaraei, Ali] Iran Univ Med Sci, Fac Allied Med, Dept Med Biotechnol, Tehran, Iran	Baqiyatallah University of Medical Sciences (BMSU); Baqiyatallah University of Medical Sciences (BMSU); Baqiyatallah University of Medical Sciences (BMSU); Tehran University of Medical Sciences; Tehran University of Medical Sciences; Baqiyatallah University of Medical Sciences (BMSU); Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences	Samadikuchaksaraei, A (corresponding author), Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran, Iran.	samadikuchaksaraei@yahoo.com	Samadikuchaksaraei, Ali/H-6402-2019; Ghanei, Mostafa/V-1975-2019; jahromi, gila pirzad/X-5341-2019; Gholipourmalekabadi, Mazaher/P-3019-2018	Samadikuchaksaraei, Ali/0000-0002-2108-9927; Ghanei, Mostafa/0000-0001-9372-0928; Gholipourmalekabadi, Mazaher/0000-0001-6287-6831; pirzad jahromi, gila/0000-0002-2683-1625; Karkuki Osguei, Nushin/0000-0001-9585-2908	Ministry of Health and Medical Education of Iran	Ministry of Health and Medical Education of Iran	This project was supported with a research grant from the Ministry of Health and Medical Education of Iran. Other than the named authors, no one employed or contracted by the funder played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghanouri R, 2004, AM J PHYSIOL-LUNG C, V287, pL1160, DOI 10.1152/ajplung.00169.2003; Andersson-Sjoland A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-76; Andersson-Sjoland A, 2011, J HEART LUNG TRANSPL, V30, P945, DOI 10.1016/j.healun.2011.04.006; Balali-Mood M, 2006, BASIC CLIN PHARMACOL, V99, P273, DOI 10.1111/j.1742-7843.2006.pto_429.x; BALALIMOOD M, 2005, J MED CHEM BIOL RADI, V3, P1; Barker AF, 2014, NEW ENGL J MED, V370, P1820, DOI 10.1056/NEJMra1204664; Barman SA, 2014, ARTERIOSCL THROM VAS, V34, P1704, DOI 10.1161/ATVBAHA.114.303848; Beheshti J, 2006, PATHOL RES PRACT, V202, P739, DOI 10.1016/j.prp.2006.04.008; Bermudez O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063226; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Dompeling E, 2004, EUR RESPIR J, V23, P343, DOI 10.1183/09031936.04.00100004; Ekstrand-Hammarstrom B, 2011, TOXICOLOGY, V280, P88, DOI 10.1016/j.tox.2010.11.012; Gao X, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-17; Ghabili K, 2011, CRIT REV TOXICOL, V41, P384, DOI 10.3109/10408444.2010.541224; Ghabili K, 2010, J APPL TOXICOL, V30, P627, DOI 10.1002/jat.1581; Ghanei M, 2008, RESP MED, V102, P825, DOI 10.1016/j.rmed.2008.01.016; Ghanei M, 2011, INHAL TOXICOL, V23, P363, DOI 10.3109/08958378.2011.576278; Harris DA, 2013, J THORAC CARDIOV SUR, V145, P854, DOI 10.1016/j.jtcvs.2012.03.079; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Jia N, 2014, J FUNCT FOODS, V11, P142, DOI 10.1016/j.jff.2014.09.011; Johnson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016175; Kehe K, 2005, TOXICOLOGY, V214, P198, DOI 10.1016/j.tox.2005.06.014; Kehe K, 2009, TOXICOLOGY, V263, P3, DOI 10.1016/j.tox.2009.04.060; Khateri S, 2003, J OCCUP ENVIRON MED, V45, P1136, DOI 10.1097/01.jom.0000094993.20914.d1; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Larsen K, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-11; Larsen K, 2004, AM J RESP CRIT CARE, V170, P1049, DOI 10.1164/rccm.200404-507OC; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McAteer J., 2002, BASIC CELL CULTURE; MIO T, 1992, CHEST, V102, P832, DOI 10.1378/chest.102.3.832; Mishra NC, 2012, INT IMMUNOPHARMACOL, V13, P101, DOI 10.1016/j.intimp.2012.03.010; Moodley YP, 2003, AM J PATHOL, V163, P345, DOI 10.1016/S0002-9440(10)63658-9; Nowrouzi Azin, 2010, Iran Biomed J, V14, P23; Panahi Y, 2005, IRAN J ALLERGY ASTHM, V4; Poursaleh Z, 2012, DARU, V20, DOI 10.1186/2008-2231-20-27; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Ray R, 2008, DRUG CHEM TOXICOL, V31, P137, DOI 10.1080/01480540701688840; Ruff Albert L, 2007, Eplasty, V8, pe2; Saki M, 2009, YAKHTEH, V11, P55; Scheja A, 2007, EUR RESPIR J, V29, P446, DOI 10.1183/09031936.00135205; Sheridan JA, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0214-6; Sohal SS, 2010, RESPIROLOGY, V15, P930, DOI 10.1111/j.1440-1843.2010.01808.x; Thomason JWW, 2003, JAMA-J AM MED ASSOC, V290, P598, DOI 10.1001/jama.290.5.598; Tufvesson E, 2003, J CELL SCI, V116, P4857, DOI 10.1242/jcs.00808; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551	46	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145148	10.1371/journal.pone.0145148	http://dx.doi.org/10.1371/journal.pone.0145148			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679937	Green Submitted, Green Published, gold			2022-12-27	WOS:000366723400050
J	Schorr, GS; Falcone, EA; Moretti, DJ; Andrews, RD				Schorr, Gregory S.; Falcone, Erin A.; Moretti, David J.; Andrews, Russel D.			Rebuttal to the Formal Comment on Schorr et al. (2014) submitted by Tyack et al. (2015)	PLOS ONE			English	Editorial Material									[Schorr, Gregory S.; Falcone, Erin A.] Cascadia Res Collect, Olympia, WA 98501 USA; [Moretti, David J.] Naval Undersea Warfare Ctr, Newport, RI 02841 USA; [Andrews, Russel D.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK 99709 USA; [Andrews, Russel D.] Alaska SeaLife Ctr, Seward, AK 99664 USA	United States Department of Defense; United States Navy; US Navy Naval Sea Systems Command; University of Alaska System; University of Alaska Fairbanks	Schorr, GS (corresponding author), Cascadia Res Collect, Olympia, WA 98501 USA.	gschorr@cascadiaresearch.org						DeRuiter SL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0223; Schorr GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092633; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505	4	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0142437	10.1371/journal.pone.0142437	http://dx.doi.org/10.1371/journal.pone.0142437			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678543	Green Submitted, gold, Green Published			2022-12-27	WOS:000366723400002
J	Ranglack, DH; Dobson, LK; du Toit, JT; Derr, J				Ranglack, Dustin H.; Dobson, Lauren K.; du Toit, Johan T.; Derr, James			Genetic Analysis of the Henry Mountains Bison Herd	PLOS ONE			English	Article							NORTH-AMERICAN BISON; MITOCHONDRIAL-DNA; CATTLE; CONSERVATION; IDENTIFICATION; INTROGRESSION; SCIENCE; RANGE	Wild American plains bison (Bison bison) populations virtually disappeared in the late 1800s, with some remnant animals retained in what would become Yellowstone National Park and on private ranches. Some of these private bison were intentionally crossbred with cattle for commercial purposes. This forced hybridization resulted in both mitochondrial and nuclear introgression of cattle genes into some of the extant bison genome. As the private populations grew, excess animals, along with their history of cattle genetics, provided founders for newly established public bison populations. Of the US public bison herds, only those in Yellowstone and Wind Cave National Parks (YNP and WCNP) appear to be free of detectable levels of cattle introgression. However, a small free-ranging population (similar to 350 animals) exists on public land, along with domestic cattle, in the Henry Mountains (HM) of southern Utah. This isolated bison herd originated from a founder group translocated from YNP in the 1940s. Using genetic samples from 129 individuals, we examined the genetic status of the HM population and found no evidence of mitochondrial or nuclear introgression of cattle genes. This new information confirms it is highly unlikely for free-living bison to crossbreed with cattle, and this disease-free HM bison herd is valuable for the long-term conservation of the species. This bison herd is a subpopulation of the YNP/WCNP/HM metapopulation, within which it can contribute significantly to national efforts to restore the American plains bison to more of its native range.	[Ranglack, Dustin H.; du Toit, Johan T.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Ranglack, Dustin H.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Dobson, Lauren K.; Derr, James] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Texas A&M University System; Texas A&M University College Station	Ranglack, DH (corresponding author), Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA.	dhranglack@gmail.com	Ranglack, Dustin/AAU-6451-2020; du Toit, Johan T./D-3390-2009	Ranglack, Dustin/0000-0003-4534-9487; du Toit, Johan T./0000-0003-0705-7117; Dobson, Lauren/0000-0001-8111-8542	Utah Division of Wildlife Resources	Utah Division of Wildlife Resources	The work was funded by the Utah Division of Wildlife Resources. The funder had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Boyd DP, 2006, J WEST, V45, P15; BOYD DP, 2003, CONSERVATION N AM BI; Coder G. D., 1975, NATL MOVEMENT PRESER; CRONIN MA, 1991, WILDLIFE SOC B, V19, P94; Cronin MA, 2013, J HERED, V104, P500, DOI 10.1093/jhered/est030; Department of the Interior, 2014, DOI BIS REP LOOK FOR; Derr JN, 2012, CONSERV BIOL, V26, P1130, DOI 10.1111/j.1523-1739.2012.01905.x; Dickson BG, 2014, BIOL CONSERV, V178, P117, DOI 10.1016/j.biocon.2014.08.001; Dobson LK, 2015, SEQUENCING GENOME N; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Freese CH, 2007, BIOL CONSERV, V136, P175, DOI 10.1016/j.biocon.2006.11.019; Gates C, 2010, AM BISON STATUS SURV, P55; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Halbert ND, 2007, J HERED, V98, P1, DOI 10.1093/jhered/esl051; Halbert ND, 2008, MOL ECOL, V17, P4963, DOI 10.1111/j.1365-294X.2008.03973.x; Halbert ND, 2005, MOL ECOL, V14, P2343, DOI 10.1111/j.1365-294X.2005.02591.x; Halbert ND, 2004, J MAMMAL, V85, P924, DOI 10.1644/BER-029; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Hedrick PW, 2009, J HERED, V100, P411, DOI 10.1093/jhered/esp024; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Koons DN, 2012, J MAMMAL, V93, P475, DOI 10.1644/11-MAMM-A-281.1; Meagher M, 2008, WILDLIFE SOC B, V17, P15; Nelson K, 1965, STATUS HABITS AM BUF; Park SDE, 2001, THESIS; Popov B, 1950, GAME ANIMALS FISH IN; Pritchard JK, 2000, GENETICS, V155, P945; Ranglack DH, 2015, ORYX, P1; Ranglack DH, 2015, RANGELAND ECOL MANAG, V68, P349, DOI 10.1016/j.rama.2015.05.008; Ranglack DH, 2015, ECOL INDIC, V56, P145, DOI 10.1016/j.ecolind.2015.04.009; Ranglack DH, 2015, J APPL ECOL, V52, P467, DOI 10.1111/1365-2664.12386; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sanderson EW, 2008, CONSERV BIOL, V22, P252, DOI 10.1111/j.1523-1739.2008.00899.x; Schnabel RD, 2000, ANIM GENET, V31, P360, DOI 10.1046/j.1365-2052.2000.00685.x; Van Vuren D. H., 2001, Animal Biodiversity and Conservation, V24, P117; VANVUREN D, 1983, J RANGE MANAGE, V36, P499, DOI 10.2307/3897952; VANVUREN D, 1986, J MAMMAL, V67, P503, DOI 10.2307/1381282; Ward TJ, 1999, ANIM CONSERV, V2, P51, DOI 10.1111/j.1469-1795.1999.tb00048.x	37	4	4	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144239	10.1371/journal.pone.0144239	http://dx.doi.org/10.1371/journal.pone.0144239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673758	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700031
J	Benet, T; Sylla, M; Messaoudi, M; Picot, VS; Telles, JN; Diakite, AA; Komurian-Pradel, F; Endtz, H; Diallo, S; Paranhos-Baccala, G; Vanhems, P				Benet, Thomas; Sylla, Mariam; Messaoudi, Melina; Picot, Valentina Sanchez; Telles, Jean-Noel; Diakite, Abdoul-Aziz; Komurian-Pradel, Florence; Endtz, Hubert; Diallo, Souleymane; Paranhos-Baccala, Glaucia; Vanhems, Philippe			Etiology and Factors Associated with Pneumonia in Children under 5 Years of Age in Mali: A Prospective Case-Control Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CHILDHOOD PNEUMONIA; SYSTEMATIC ANALYSIS; NATIONAL CAUSES; GLOBAL BURDEN; INFECTIONS; MORTALITY; HEALTH; COUNTRIES	Background There are very limited data on children with pneumonia in Mali. The objective was to assess the etiology and factors associated with community-acquired pneumonia in hospitalized children <5 years of age in Mali. Methods A prospective hospital-based case-control study was implemented in the Pediatric department of Gabriel Toure University Hospital at Bamako, Mali, between July 2011-December 2012. Cases were children with radiologically-confirmed pneumonia; Controls were hospitalized children without respiratory features, matched for age and period. Respiratory specimens, were collected to identify 19 viruses and 5 bacteria. Whole blood was collected from cases only. Factors associated with pneumonia were assessed by multivariate logistic regression. Results Overall, 118 cases and 98 controls were analyzed; 44.1% were female, median age was 11 months. Among pneumonia cases, 30.5% were hypoxemic at admission, mortality was 4.2%. Pneumonia cases differed from the controls regarding clinical signs and symptoms but not in terms of past medical history. Multivariate analysis of nasal swab findings disclosed that S. pneumoniae (adjusted odds ratio [aOR] = 3.4, 95% confidence interval [95% CI]: 1.6-7.0), human metapneumovirus (aOR = 17.2, 95% CI: 2.0-151.4), respiratory syncytial virus [RSV] (aOR = 7.4, 95% CI: 2.3-23.3), and influenza A virus (aOR = 10.7, 95% CI: 1.0-112.2) were associated with pneumonia, independently of patient age, gender, period, and other pathogens. Distribution of S. pneumoniae and RSV differed by season with higher rates of S. pneumoniae in January-June and of RSV in July-September. Pneumococcal serotypes 1 and 5 were more frequent in pneumonia cases than in the controls (P = 0.009, and P = 0.04, respectively). Conclusions In this non-PCV population from Mali, pneumonia in children was mainly attributed to S. pneumoniae, RSV, human metapneumovirus, and influenza A virus. Increased pneumococcal conjugate vaccine coverage in children could significantly reduce the burden of pneumonia in sub-Saharan African countries.	[Benet, Thomas; Vanhems, Philippe] Hosp Civils Lyon, Edouard Herriot Hosp, Infect Control & Epidemiol Unit, Lyon, France; [Benet, Thomas; Vanhems, Philippe] Univ Lyon 1, F-69365 Lyon, France; [Benet, Thomas; Messaoudi, Melina; Picot, Valentina Sanchez; Telles, Jean-Noel; Komurian-Pradel, Florence; Endtz, Hubert; Paranhos-Baccala, Glaucia; Vanhems, Philippe] Int Ctr Infectiol Res CIRI, Lyon, France; [Sylla, Mariam; Diakite, Abdoul-Aziz] Gabriel Toure Hosp, Dept Pediat, Bamako, Mali; [Messaoudi, Melina; Picot, Valentina Sanchez; Telles, Jean-Noel; Komurian-Pradel, Florence; Endtz, Hubert; Paranhos-Baccala, Glaucia] Fdn Merieux, Emerging Pathogens Lab, Lyon, France; [Endtz, Hubert] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Diallo, Souleymane] Ctr Infectiol Charles Merieux, Bamako, Mali	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Erasmus University Rotterdam; Erasmus MC	Benet, T (corresponding author), Hosp Civils Lyon, Edouard Herriot Hosp, Infect Control & Epidemiol Unit, Lyon, France.	thomas.benet@chu-lyon.fr		MESSAOUDI, Melina/0000-0002-7049-7206; Pradel, Florence/0000-0002-1023-0796	Fondation Merieux	Fondation Merieux	This study was funded by Fondation Merieux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P258; Ayieko P, 2007, PEDIATR INFECT DIS J, V26, P432, DOI 10.1097/01.inf.0000260107.79355.7d; Ayieko P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047622; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Burchett HED, 2014, VACCINE, V32, P6505, DOI 10.1016/j.vaccine.2014.09.031; Campbell D, 2004, J TROP PEDIATRICS, V50, P158, DOI 10.1093/tropej/50.3.158; Campbell JD, 2004, PEDIATR INFECT DIS J, V23, P642, DOI 10.1097/01.inf.0000130951.85974.79; Chaibou Y, 2014, MED MALADIES INFECT, V44, P117, DOI 10.1016/j.medmal.2014.01.014; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066; Donkor ES, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00012; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Gilani Z, 2012, CLIN INFECT DIS, V54, pS102, DOI 10.1093/cid/cir1053; Howie SRC, 2014, CLIN INFECT DIS, V59, P682, DOI 10.1093/cid/ciu384; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Komurian-Pradel F, 2013, CLIN EPIDEMIOL GLOB, V1, P40, DOI 10.1016/j.cegh.2012.11.002; le Roux DM, 2015, LANCET GLOB HEALTH, V3, pE95, DOI 10.1016/S2214-109X(14)70360-2; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Louie JK, 2009, PEDIATR INFECT DIS J, V28, P337, DOI 10.1097/INF.0b013e31818ffc1b; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Picot VS, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0635-8; Ramachandran P, 2012, INDIAN PEDIATR, V49, P889, DOI 10.1007/s13312-012-0221-3; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Self WH, 2016, J INFECT DIS, V213, P584, DOI 10.1093/infdis/jiv323; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization, GLOB HLTH OBS DAT RE; Wurzel DF, 2013, J CLIN VIROL, V58, P683, DOI 10.1016/j.jcv.2013.09.016	30	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145447	10.1371/journal.pone.0145447	http://dx.doi.org/10.1371/journal.pone.0145447			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696249	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500049
J	Chen, XP; Wang, JM; Zhu, HJ; Li, YH; Ding, JT; Peng, YF				Chen, Xiuping; Wang, Jiamei; Zhu, Haojun; Li, Yunhe; Ding, Jiatong; Peng, Yufa			Effects of Transgenic cry1Ca Rice on the Development of Xenopus laevis	PLOS ONE			English	Article							GENETICALLY-MODIFIED RICE; BT RICE; SAFETY ASSESSMENT; BY-PRODUCTS; PROTEIN; RESPONSES; EXPOSURE; LINES; GENE; METAMORPHOSIS	In fields of genetically modified, insect-resistant rice expressing Bacillus thuringiensis (Bt) proteins, frogs are exposed to Bt Cry proteins by consuming both target and non-target insects, and through their highly permeable skin. In the present study, we assessed the potential risk posed by transgenic cry1Ca rice (T1C-19) on the development of a frog species by adding purified Cry1Ca protein or T1C-19 rice straw into the rearing water of Xenopus laevis tadpoles, and by feeding X. laevis froglets diets containing rice grains of T1C-19 or its non-transformed counterpart MH63. Our results showed that there were no significant differences among groups receiving 100 mu g L-1 or 10 mu g L-1 Cry1Ca and the blank control in terms of time to completed metamorphosis, survival rate, body weight, body length, organ weight and liver enzyme activity after being exposed to the Cry1Ca (P > 0.05). Although some detection indices in the rice straw groups were significantly different from those of the blank control group (P < 0.05), there was no significant difference between the T1C-19 and MH63 rice straw groups. Moreover, there were no significant differences in the mortality rate, body weight, daily weight gain, liver and fat body weight of the froglets between the T1C-19 and MH63 dietary groups after 90 days, and there were no abnormal pathological changes in the stomach, intestines, livers, spleens and gonads. Thus, we conclude that the planting of transgenic cry1Ca rice will not adversely affect frog development.	[Chen, Xiuping; Wang, Jiamei; Zhu, Haojun; Li, Yunhe; Peng, Yufa] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Wang, Jiamei; Zhu, Haojun; Ding, Jiatong] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China; [Wang, Jiamei] Jiangsu Agrianim Husb Vocat Coll, Taizhou 225300, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Yangzhou University; Jiangsu Agri-animal Husbandry Vocational College	Chen, XP (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	cxpyuan@gmail.com; yfpeng@vip.qq.com	peng, yu/GXW-2071-2022		National GMO New Variety Breeding Program of the People's Republic of China [2012ZX08011-002, 2014ZX08011-001]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National GMO New Variety Breeding Program of the People's Republic of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National GMO New Variety Breeding Program of the People's Republic of China (2012ZX08011-002 and 2014ZX08011-001), and a Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Akhtar ZR, 2010, ENVIRON ENTOMOL, V39, P715, DOI 10.1603/EN09095; Avisar D, 2009, PLANT SCI, V176, P315, DOI 10.1016/j.plantsci.2008.12.010; Blaustein AR, 2011, ANN NY ACAD SCI, V1223, P108, DOI 10.1111/j.1749-6632.2010.05909.x; Bohn T, 2008, ARCH ENVIRON CON TOX, V55, P584, DOI 10.1007/s00244-008-9150-5; Bohn T, 2010, ECOTOXICOLOGY, V19, P419, DOI 10.1007/s10646-009-0427-x; Cao SS, 2010, REGUL TOXICOL PHARM, V58, P474, DOI 10.1016/j.yrtph.2010.08.018; Cao ZhengHui, 2014, Chinese Journal of Animal Nutrition, V26, P1908; Carstens K, 2012, TRANSGENIC RES, V21, P813, DOI 10.1007/s11248-011-9569-8; Chambers CP, 2010, ECOL APPL, V20, P1949, DOI 10.1890/09-0598.1; Coady KK, 2005, ECOTOX ENVIRON SAFE, V62, P160, DOI 10.1016/j.ecoenv.2004.10.010; Dobrovoljc K, 2012, BIOL TRACE ELEM RES, V150, P178, DOI 10.1007/s12011-012-9461-2; Douville M, 2009, ECOTOX ENVIRON SAFE, V72, P17, DOI 10.1016/j.ecoenv.2008.02.006; Douville M, 2007, ECOTOX ENVIRON SAFE, V66, P195, DOI 10.1016/j.ecoenv.2006.01.002; Geng BR, 2005, B ENVIRON CONTAM TOX, V75, P343, DOI 10.1007/s00128-005-0759-z; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P40, DOI 10.1289/ehp.8051; HOFMANN C, 1988, P NATL ACAD SCI USA, V85, P7844, DOI 10.1073/pnas.85.21.7844; Indermaur L, 2010, OECOLOGIA, V163, P637, DOI 10.1007/s00442-010-1586-4; Jensen PD, 2010, ENVIRON ENTOMOL, V39, P707, DOI 10.1603/EN09037; Jones DK, 2009, ENVIRON TOXICOL CHEM, V28, P1939, DOI 10.1897/09-033.1; Li YH, 2014, INSECT SCI, V21, P125, DOI 10.1111/1744-7917.12044; Li YH, 2014, ENVIRON TOXICOL CHEM, V33, P1391, DOI 10.1002/etc.2567; Liu W, 2008, SOIL BIOL BIOCHEM, V40, P475, DOI 10.1016/j.soilbio.2007.09.017; Lu Changming, 2010, GM Crops, V1, P113, DOI 10.4161/gmcr.1.3.12377; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Mannakkara A, 2013, J INSECT PHYSIOL, V59, P985, DOI 10.1016/j.jinsphys.2013.07.009; Morey S, 2001, ECOLOGY, V82, P510, DOI 10.2307/2679876; O'Rourke DP, 2007, ILAR J, V48, P183, DOI 10.1093/ilar.48.3.183; Oka T, 2008, AQUAT TOXICOL, V87, P215, DOI 10.1016/j.aquatox.2008.02.009; Qin HF, 2012, THESIS; Raybould A, 2011, TRANSGENIC RES, V20, P599, DOI 10.1007/s11248-010-9442-1; Rimando AM, 2002, W CROP SCI, P221; Rosi-Marshall EJ, 2007, P NATL ACAD SCI USA, V104, P16204, DOI 10.1073/pnas.0707177104; Schroder M, 2007, FOOD CHEM TOXICOL, V45, P339, DOI 10.1016/j.fct.2006.09.001; Sparling DW, 2007, ENVIRON POLLUT, V147, P535, DOI 10.1016/j.envpol.2006.10.036; Tank JL, 2010, P NATL ACAD SCI USA, V107, P17645, DOI 10.1073/pnas.1006925107; Tian JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035164; Viktorov AG, 2011, RUSS J PLANT PHYSL+, V58, P543, DOI 10.1134/S1021443711040224; Wang JM, 2014, ENVIRON TOXICOL CHEM, V33, P1156, DOI 10.1002/etc.2535; Wang YN, 2016, INSECT SCI, V23, P78, DOI 10.1111/1744-7917.12178; Wang YM, 2013, SOIL BIOL BIOCHEM, V58, P107, DOI 10.1016/j.soilbio.2012.11.007; Wang YY, 2012, BIOL CONTROL, V61, P246, DOI 10.1016/j.biocontrol.2012.02.011; Wang ZH, 2002, J SCI FOOD AGR, V82, P738, DOI 10.1002/jsfa.1105; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102302; Yao HW, 2008, ENVIRON ENTOMOL, V37, P825, DOI 10.1603/0046-225X(2008)37[825:TAOPFD]2.0.CO;2; Zhang Qing-ling, 2013, Yingyong Shengtai Xuebao, V24, P1647; Zheng XS, 2011, J ECON ENTOMOL, V104, P1730, DOI 10.1603/EC10389; Zhou J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084724, 10.1371/journal.pone.0096989, 10.1371/journal.pone.0087161]; Zhu HJ, 2015, J AGR FOOD CHEM, V63, P3627, DOI 10.1021/jf5055547	48	5	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145412	10.1371/journal.pone.0145412	http://dx.doi.org/10.1371/journal.pone.0145412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695426	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092500044
J	Heylman, C; Datta, R; Sobrino, A; George, S; Gratton, E				Heylman, Christopher; Datta, Rupsa; Sobrino, Agua; George, Steven; Gratton, Enrico			Supervised Machine Learning for Classification of the Electrophysiological Effects of Chronotropic Drugs on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							VOLTAGE; CARDIOTOXICITY; TOXICITY	Supervised machine learning can be used to predict which drugs human cardiomyocytes have been exposed to. Using electrophysiological data collected from human cardiomyocytes with known exposure to different drugs, a supervised machine learning algorithm can be trained to recognize and classify cells that have been exposed to an unknown drug. Furthermore, the learning algorithm provides information on the relative contribution of each data parameter to the overall classification. Probabilities and confidence in the accuracy of each classification may also be determined by the algorithm. In this study, the electrophysiological effects of beta-adrenergic drugs, propranolol and isoproterenol, on cardiomyocytes derived from human induced pluripotent stem cells (hiPS-CM) were assessed. The electrophysiological data were collected using high temporal resolution 2-photon microscopy of voltage sensitive dyes as a reporter of membrane voltage. The results demonstrate the ability of our algorithm to accurately assess, classify, and predict hiPS-CM membrane depolarization following exposure to chronotropic drugs.	[Heylman, Christopher; Datta, Rupsa; George, Steven; Gratton, Enrico] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Heylman, Christopher; Datta, Rupsa; Gratton, Enrico] Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA USA; [Heylman, Christopher; George, Steven] Univ Calif Irvine, Edwards Lifesci Ctr Adv Cardiovasc Technol, Irvine, CA USA; [Sobrino, Agua] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [George, Steven] Washington Univ, Dept Biomed Engn, St Louis, MO USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Washington University (WUSTL)	Gratton, E (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.	egratton@uci.edu	Datta, Rupsa/I-5436-2019	Datta, Rupsa/0000-0002-6432-2389	George E. Hewitt Foundation for Medical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000481] Funding Source: NIH RePORTER	George E. Hewitt Foundation for Medical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	CH received fellowship from the George E. Hewitt Foundation for Medical Research.	Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cerignoli F, 2012, J PHARMACOL TOX MET, V66, P246, DOI 10.1016/j.vascn.2012.08.167; Colombo A, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0362-6; Dague E, 2014, J MOL CELL CARDIOL, V74, P162, DOI 10.1016/j.yjmcc.2014.05.006; Ewer MS, 2010, NAT REV CARDIOL, V7, P564, DOI 10.1038/nrcardio.2010.121; Ferri N, 2013, PHARMACOL THERAPEUT, V138, P470, DOI 10.1016/j.pharmthera.2013.03.005; Geurts P, 2009, MOL BIOSYST, V5, P1593, DOI 10.1039/b907946g; Ghouri I, 2013, J BIOPHOTONICS, V123, P112; Goldsmith CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103459; Herron TJ, 2012, CIRC RES, V110, P609, DOI 10.1161/CIRCRESAHA.111.247494; Heylman C, 2014, EXP BIOL MED, V239, P1240, DOI 10.1177/1535370214525295; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; Juhola M, 2014, IEEE ENG MED BIO, P1444, DOI 10.1109/EMBC.2014.6943872; LaConte SM, 2011, NEUROIMAGE, V56, P440, DOI 10.1016/j.neuroimage.2010.06.052; Leyton-Mange JS, 2014, STEM CELL REP, V2, P163, DOI 10.1016/j.stemcr.2014.01.003; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lopez-Izquierdo A, 2014, AM J PHYSIOL-HEART C, V307, pH1370, DOI 10.1152/ajpheart.00344.2014; Mordwinkin NM, 2013, J CARDIOVASC TRANSL, V6, P22, DOI 10.1007/s12265-012-9423-2; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Navarrete EG, 2013, CIRCULATION, V128, pS3, DOI 10.1161/CIRCULATIONAHA.112.000570; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Raschi E, 2010, PHARMACOL THERAPEUT, V125, P196, DOI 10.1016/j.pharmthera.2009.10.002; Redmond SJ, 2012, IEEE ENG MED BIO, P57, DOI 10.1109/EMBC.2012.6345870; Scheel O, 2014, ASSAY DRUG DEV TECHN, V12, P457, DOI 10.1089/adt.2014.601; Sinnecker D, 2014, PHARMACOL THERAPEUT, V143, P246, DOI 10.1016/j.pharmthera.2014.03.004; Veerman CC, 2015, STEM CELLS DEV, V24, P1035, DOI 10.1089/scd.2014.0533; Yan P, 2012, P NATL ACAD SCI USA, V109, P20443, DOI 10.1073/pnas.1214850109; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Zeevi-Levin N, 2012, PHARMACOL THERAPEUT, V134, P180, DOI 10.1016/j.pharmthera.2012.01.005	30	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144572	10.1371/journal.pone.0144572	http://dx.doi.org/10.1371/journal.pone.0144572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695765	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500007
J	Torres-Perez, M; Tellez-Ballesteros, RI; Ortiz-Lopez, L; Ichwan, M; Vega-Rivera, NM; Castro-Garcia, M; Gomez-Sanchez, A; Kempermann, G; Ramirez-Rodriguez, GB				Torres-Perez, Mario; Ivonne Tellez-Ballesteros, Ruth; Ortiz-Lopez, Leonardo; Ichwan, Muhammad; Maritza Vega-Rivera, Nelly; Castro-Garcia, Mario; Gomez-Sanchez, Ariadna; Kempermann, Gerd; Bernabe Ramirez-Rodriguez, Gerardo			Resveratrol Enhances Neuroplastic Changes, Including Hippocampal Neurogenesis, and Memory in Balb/C Mice at Six Months of Age	PLOS ONE			English	Article							DENTATE GYRUS; ENVIRONMENTAL ENRICHMENT; NEUROTROPHIC FACTOR; NITRIC-OXIDE; BRAIN; EXPRESSION; MECHANISM; SIRT1; PKC; ACTIVATION	Resveratrol (RVTL) is a flavonoid found in red wine and has been publicized heavily as an anti-aging compound. Indeed, basic research confirms that although there is much hype in the promotion of RVTL, flavonoids such as RVTL have a wide range of biological effects. We here investigated the effects of RVTL treatment on hippocampal plasticity and memory performance in female Balb/C mice, a strain with low baseline levels of adult neurogenesis. Two weeks of treatment with RVTL (40 mg/kg) induced the production of new neurons in vivo by increasing cell survival and possibly precursor cell proliferation. In addition, RVTL decreased the number of apoptotic cells. The number of doublecortin (DCX)-expressing intermediate cells was increased. RVTL stimulated neuronal differentiation in vitro without effects on proliferation. In the dentate gyrus, RVTL promoted the formation and maturation of spines on granule cell dendrites. RVTL also improved performance in the step down passive avoidance test. The RVTL-treated mice showed increase in the levels of two key signaling proteins, phospho-Akt and phospho-PKC, suggesting the involvement of these signaling pathways. Our results support the vision that flavonoids such as resveratrol deserve further examination as plasticity-inducing compounds in the context of successful cognitive aging.	[Torres-Perez, Mario; Ivonne Tellez-Ballesteros, Ruth; Ortiz-Lopez, Leonardo; Gomez-Sanchez, Ariadna; Bernabe Ramirez-Rodriguez, Gerardo] Natl Inst Psychiat Ramon de la Fuente Muniz, Lab Neurogenesis, Div Clin Invest, Mexico City 14370, DF, Mexico; [Ichwan, Muhammad; Kempermann, Gerd] CRTD Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany; [Ichwan, Muhammad] Univ Sumatera Utara, Fac Med, Dept Pharmacol & Therapeut, Medan, Indonesia; [Maritza Vega-Rivera, Nelly; Castro-Garcia, Mario] Natl Inst Psychiat Ramon de la Fuente Muniz, Lab Neuropsychopharmacol, Div Neurosci, Mexico City 14370, DF, Mexico; [Kempermann, Gerd] DZNE, German Ctr Neurodegenerat Dis, D-01307 Dresden, Germany	Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Technische Universitat Dresden; University of North Sumatra; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden	Kempermann, G (corresponding author), CRTD Ctr Regenerat Therapies Dresden, Tatzberg 47-79, D-01307 Dresden, Germany.	gerd.kempermann@dzne.de; gbernabe@imp.edu.mx	Kempermann, Gerd/F-5416-2010; Ichwan, muhammad/AAE-3802-2020; Ichwan, Muhammad/AAF-9949-2021; Ramirez-Rodriguez, Gerardo Bernabe/GQG-9370-2022	Kempermann, Gerd/0000-0002-5304-4061; Ichwan, Muhammad/0000-0001-8380-9099; Vega-Rivera, Nelly Maritza/0000-0003-0516-3880; ramirez-rodriguez, gerardo/0000-0003-3243-1588	"Instituto de Ciencia y Tecnologia de la Ciudad de Mexico, Distrito Federal" (ICYTDF) [PICSA-1170]; Ministry of Health (SSA) through the Program for Initiation in Scientific Research (PROBEI); "Consejo Nacional de Ciencia y Tecnologia" (CONACYT) [119182]; CONACYT-BMBF [147377, 01DN12086]	"Instituto de Ciencia y Tecnologia de la Ciudad de Mexico, Distrito Federal" (ICYTDF); Ministry of Health (SSA) through the Program for Initiation in Scientific Research (PROBEI); "Consejo Nacional de Ciencia y Tecnologia" (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT-BMBF	This work was supported by the "Instituto de Ciencia y Tecnologia de la Ciudad de Mexico, Distrito Federal" (ICYTDF; grant PICSA-1170). MTP was a fellowship-recipient of the Ministry of Health (SSA) through the Program for Initiation in Scientific Research (PROBEI). RTB was a fellowship of "Consejo Nacional de Ciencia y Tecnologia" (CONACYT; Grant 119182). MI, LOL, NMVR, GRR and GK were supported by a CONACYT-BMBF cooperation project for exchange researchers (GRR: 147377; GK: 01DN12086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2008, PROG NEURO-PSYCHOPH, V32, P1484, DOI 10.1016/j.pnpbp.2008.05.005; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Babu H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00089; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beltran-Campos V, 2011, BRAIN RES, V1369, P119, DOI 10.1016/j.brainres.2010.10.105; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Bhullar KS, 2015, BBA-MOL BASIS DIS, V1852, P1209, DOI 10.1016/j.bbadis.2015.01.012; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Catley MC, 2004, J BIOL CHEM, V279, P18457, DOI 10.1074/jbc.M400765200; Clark PJ, 2011, GENES BRAIN BEHAV, V10, P345, DOI 10.1111/j.1601-183X.2010.00674.x; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Dias GP, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/541971; Donmez G, 2012, TRENDS PHARMACOL SCI, V33, P494, DOI 10.1016/j.tips.2012.05.007; Giacosa A, 2014, CRIT REV FOOD SCI NU; Granados-Soto V, 2000, PAIN, V85, P395, DOI 10.1016/S0304-3959(99)00281-X; Harada N, 2011, J NUTR BIOCHEM, V22, P1150, DOI 10.1016/j.jnutbio.2010.09.016; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Huang HM, 2005, ANN NY ACAD SCI, V1042, P349, DOI 10.1196/annals.1338.032; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Kang OH, 2009, PHARMACOL RES, V59, P330, DOI 10.1016/j.phrs.2009.01.009; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kim YA, 2007, J MED FOOD, V10, P218, DOI 10.1089/jmf.2006.143; Kodali M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08075; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kulkarni SS, 2015, BBA-MOL BASIS DIS, V1852, P1114, DOI 10.1016/j.bbadis.2014.10.005; Madhyastha S, 2013, INT J DEV NEUROSCI, V31, P580, DOI 10.1016/j.ijdevneu.2013.06.010; Maurice T, 1997, EUR J PHARMACOL, V328, P9, DOI 10.1016/S0014-2999(97)83020-8; Menard C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00281; Moriya J, 2011, BIOL PHARM BULL, V34, P354, DOI 10.1248/bpb.34.354; Myhrer T, 2003, BRAIN RES REV, V41, P268, DOI 10.1016/S0165-0173(02)00268-0; Oh YC, 2009, AM J CHINESE MED, V37, P1203, DOI 10.1142/S0192415X09007600; Pallauf K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/707421; Park HR, 2012, J BIOL CHEM, V287, P42588, DOI 10.1074/jbc.M112.406413; Perkins GA, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-17; Ramirez-Rodriguez G, 2014, NEUROSCIENCE, V260, P158, DOI 10.1016/j.neuroscience.2013.12.026; Ramirez-Rodriguez G, 2014, EXP GERONTOL, V60, P147, DOI 10.1016/j.exger.2014.10.014; Ramirez-Rodriguez G, 2012, NEUROSCI LETT, V530, P53, DOI 10.1016/j.neulet.2012.09.045; Russo MA, 2014, ENDOCR METAB IMMUNE, V14, P300, DOI 10.2174/1871530314666140709093305; Saharan S, 2013, J NEUROSCI RES, V91, P642, DOI 10.1002/jnr.23199; Sharma M, 2002, LIFE SCI, V71, P2489, DOI 10.1016/S0024-3205(02)02083-0; Singh CK, 2015, BBA-MOL BASIS DIS, V1852, P1178, DOI 10.1016/j.bbadis.2014.11.004; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Stangl D, 2009, GENES NUTR, V4, P271, DOI 10.1007/s12263-009-0134-5; Toth LA, 2011, COMPARATIVE MED, V61, P314; Tsai SK, 2007, J VASC SURG, V46, P346, DOI 10.1016/j.jvs.2007.04.044; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Witte AV, 2014, J NEUROSCI, V34, P7862, DOI 10.1523/JNEUROSCI.0385-14.2014; Xu Y, 2007, BRAIN RES, V1162, P9, DOI 10.1016/j.brainres.2007.05.071; Zainuddin MSA, 2012, BRIT MED BULL, V103, P89, DOI 10.1093/bmb/lds021; Zordoky BNM, 2015, BBA-MOL BASIS DIS, V1852, P1155, DOI 10.1016/j.bbadis.2014.10.016	55	29	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145687	10.1371/journal.pone.0145687	http://dx.doi.org/10.1371/journal.pone.0145687			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695764	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500067
J	Affo, S; Rodrigo-Torres, D; Blaya, D; Morales-Ibanez, O; Coll, M; Millan, C; Altamirano, J; Arroyo, V; Caballeria, J; Bataller, R; Gines, P; Sancho-Bru, P				Affo, Silvia; Rodrigo-Torres, Daniel; Blaya, Delia; Morales-Ibanez, Oriol; Coll, Mar; Millan, Cristina; Altamirano, Jose; Arroyo, Vicente; Caballeria, Joan; Bataller, Ramon; Gines, Pere; Sancho-Bru, Pau			Chemokine Receptor Ccr6 Deficiency Alters Hepatic Inflammatory Cell Recruitment and Promotes Liver Inflammation and Fibrosis	PLOS ONE			English	Article							DELTA-T-CELLS; DISEASE PATHOGENESIS; ALCOHOLIC HEPATITIS; EXPRESSION; DIFFERENTIATION; REGENERATION; MIGRATION; SUBSETS; TARGETS; INJURY	Chronic liver diseases are characterized by a sustained inflammatory response in which chemokines and chemokine-receptors orchestrate inflammatory cell recruitment. In this study we investigated the role of the chemokine receptor CCR6 in acute and chronic liver injury. In the absence of liver injury Ccr6(-/-) mice presented a higher number of hepatic macrophages and increased expression of pro-inflammatory cytokines and M1 markers Tnf-alpha, II6 and Mcp1. Inflammation and cell recruitment were increased after carbon tetrachloride-induced acute liver injury in Ccr6(-/-) mice. Moreover, chronic liver injury by carbon tetrachloride in Ccr6(-/-) mice was associated with enhanced inflammation and fibrosis, altered macrophage recruitment, enhanced CD4(+) cells and a reduction in Th17 (CD4(+)IL17(+)) and mature dendritic (MHCII(+)CD11c(+)) cells recruitment. Clodronate depletion of macrophages in Ccr6(-/-) mice resulted in a reduction of hepatic pro-inflammatory and pro-fibrogenic markers in the absence and after liver injury. Finally, increased CCR6 hepatic expression in patients with alcoholic hepatitis was found to correlate with liver expression of CCL20 and severity of liver disease. In conclusion, CCR6 deficiency affects hepatic inflammatory cell recruitment resulting in the promotion of hepatic inflammation and fibrosis.	[Affo, Silvia; Rodrigo-Torres, Daniel; Blaya, Delia; Morales-Ibanez, Oriol; Coll, Mar; Millan, Cristina; Altamirano, Jose; Arroyo, Vicente; Caballeria, Joan; Gines, Pere; Sancho-Bru, Pau] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Altamirano, Jose] VHIR, Barcelona, Spain; [Arroyo, Vicente; Caballeria, Joan; Gines, Pere; Sancho-Bru, Pau] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Arroyo, Vicente; Caballeria, Joan; Gines, Pere] Univ Barcelona, Fac Med, Hosp Clin, Liver Unit, Barcelona 7, Spain; [Bataller, Ramon] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Bataller, Ramon] Univ N Carolina, Dept Nutr, Div Gastroenterol & Hepatol, Chapel Hill, NC USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sancho-Bru, P (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	psancho@clinic.ub.es	Coll, Mar/N-1957-2014; Gines, Pere/B-6646-2009; Rodrigo, Teresa/F-6183-2018; Affo, Silvia/AAX-1492-2021; Ginès, Pere/C-7730-2014; Sancho-Bru, Pau/D-4900-2014; Arroyo, Vicente/F-9189-2015	Coll, Mar/0000-0003-3726-0087; Gines, Pere/0000-0003-4657-4504; Ginès, Pere/0000-0003-4657-4504; Sancho-Bru, Pau/0000-0001-5569-9259; Arroyo, Vicente/0000-0002-2728-1848; Affo, Silvia/0000-0002-9731-3913; Bataller, Ramon/0000-0002-1119-7799	Instituto de Salud Carlos III: FIS-Fondo de Investigacion Sanitaria Carlos III; ISCIII Subdirecion General de evaluacion; European Regional Development Fund [FIS PI14/ 00330, PI13/080126, PI12/01274, PI12/042380, PI11/041538]; National Institutes of Health (NIH)-National Institute on Alcohol Abuse and Alcoholism (NIAAA) [1U01AA021908-01-33490, 1U01AA021908]; Instituto de Salud Carlos III; Miguel Servet; Fondo Europeo de Desarrollo Europeo (FEDER); Union Europea, "Una manera de hacer Europa" [CP11/00071]; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Ministerio de Educacion, Cultura y Deporte, FPU program; Instituto de Salud Carlos III, Sara Borrell; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA020821, U01AA021908] Funding Source: NIH RePORTER	Instituto de Salud Carlos III: FIS-Fondo de Investigacion Sanitaria Carlos III(Instituto de Salud Carlos III); ISCIII Subdirecion General de evaluacion; European Regional Development Fund(European Commission); National Institutes of Health (NIH)-National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Miguel Servet; Fondo Europeo de Desarrollo Europeo (FEDER); Union Europea, "Una manera de hacer Europa"; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Ministerio de Educacion, Cultura y Deporte, FPU program(German Research Foundation (DFG)); Instituto de Salud Carlos III, Sara Borrell(Instituto de Salud Carlos III); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from Instituto de Salud Carlos III: FIS-Fondo de Investigacion Sanitaria Carlos III, which is part of the Spanish National Plan of I<SUP>+</SUP>D<SUP>+</SUP>I, co-financed by the ISCIII Subdirecion General de evaluacion and the European Regional Development Fund (FIS PI14/ 00330, PI13/080126, PI12/01274, PI12/042380 and PI11/041538 to PS-B, PG, VA, JC, and RB, respectively); National Institutes of Health (NIH)-National Institute on Alcohol Abuse and Alcoholism (NIAAA)(1U01AA021908-01-33490 to PS-B and 1U01AA021908 to RB); a grant to PS-B from the Instituto de Salud Carlos III, Miguel Servet and co-financed by Fondo Europeo de Desarrollo Europeo (FEDER), Union Europea, "Una manera de hacer Europa" (CP11/00071); a grant to SA from Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); and a grant to DR-T from the Ministerio de Educacion, Cultura y Deporte, FPU program. MC was funded by Instituto de Salud Carlos III, Sara Borrell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affo S, 2014, GUT, V63, P1782, DOI 10.1136/gutjnl-2013-306098; Affo S, 2013, GUT, V62, P452, DOI 10.1136/gutjnl-2011-301146; Altamirano J, 2011, NAT REV GASTRO HEPAT, V8, P491, DOI 10.1038/nrgastro.2011.134; Colmenero J, 2007, GASTROENTEROLOGY, V132, P687, DOI 10.1053/j.gastro.2006.12.036; Dominguez M, 2009, GASTROENTEROLOGY, V136, P1639, DOI 10.1053/j.gastro.2009.01.056; Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gao B, 2014, GUT, V63, P1683, DOI 10.1136/gutjnl-2013-306603; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gieling RG, 2008, CLIN LIVER DIS, V12, P915, DOI 10.1016/j.cld.2008.07.001; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Hammerich L, 2014, HEPATOLOGY, V59, P630, DOI 10.1002/hep.26697; Heymann F, 2012, HEPATOLOGY, V55, P898, DOI 10.1002/hep.24764; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Karlmark KR, 2010, HEPATOLOGY, V52, P1769, DOI 10.1002/hep.23894; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; Kucharzik T, 2002, EUR J IMMUNOL, V32, P104, DOI 10.1002/1521-4141(200201)32:1<104::AID-IMMU104>3.0.CO;2-C; Liao F, 1999, J IMMUNOL, V162, P186; Lloyd CM, 2008, J IMMUNOL METHODS, V334, P70, DOI 10.1016/j.jim.2008.02.005; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Rahman AH, 2013, BBA-MOL BASIS DIS, V1832, P998, DOI 10.1016/j.bbadis.2013.01.005; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Rao R, 2014, GASTROENTEROLOGY, V147, P473, DOI 10.1053/j.gastro.2014.04.042; Shu SA, 2007, CLIN EXP IMMUNOL, V149, P335, DOI 10.1111/j.1365-2249.2007.03419.x; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Zimmermann Henning W., 2011, Inflammation & Allergy Drug Targets, V10, P509	36	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145147	10.1371/journal.pone.0145147	http://dx.doi.org/10.1371/journal.pone.0145147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691857	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300043
J	Jang, JW; Park, YH; Park, SY; Wang, MJ; Lim, JS; Kim, SH; Chun, IK; Yang, Y; Kim, S				Jang, Jae-Won; Park, Young Ho; Park, So Young; Wang, Min Jeong; Lim, Jae-Sung; Kim, Sung-Hun; Chun, In Kook; Yang, Youngsoon; Kim, SangYun			Longitudinal Cerebral Perfusion Change in Transient Global Amnesia Related to Left Posterior Medial Network Disruption	PLOS ONE			English	Article							JUGULAR VALVE INCOMPETENCE; TEMPORAL-LOBE; RISK-FACTORS; HIPPOCAMPAL; SPECT; HYPOPERFUSION; CONNECTIVITY; EVOLUTION; ACETAZOLAMIDE; ACTIVATION	Background The pathophysiology of transient global amnesia (TGA) is not fully understood. Previous studies using single photon emission computed tomography (SPECT) have reported inconclusive results regarding cerebral perfusion. This study was conducted to identify the patterns of regional cerebral blood flow (rCBF) in TGA patients via longitudinal SPECT analysis. An association between the observed SPECT patterns and a pathophysiological mechanism was considered. Methods Based on the TGA registry database of Seoul National University Bundang Hospital, 22 TGA patients were retrospectively identified. The subjects underwent initial Tc-99m-ethyl cysteinate dimer (ECD) SPECT within 4 days of an amnestic event and underwent follow-up scans approximately 6 months later. The difference in ECD uptake between the two scans was measured via voxel-based whole brain analysis, and the quantified ECD uptake was tested using a paired t-test. Results The TGA patients had significantly decreased cerebral perfusion at the left precuneus (P<0.001, uncorrected) and at the left superior parietal and inferior temporal gyrus according to the voxel-based whole brain analysis (P<0.005, uncorrected). A difference in the quantified ECD uptake between the 2 scans was also found at the left precuneus among the 62 cortical volumes of interest (P = 0.018, Cohen's d = -0.25). Conclusion We identified left hemispheric lateralized hypoperfusion that may be related to posterior medial network disruption. These findings may be a contributing factor to the pathophysiology of TGA.	[Jang, Jae-Won; Kim, Sung-Hun] Kangwon Natl Univ Hosp, Dept Neurol, Chunchon, South Korea; [Park, Young Ho; Park, So Young; Wang, Min Jeong; Kim, SangYun] Seoul Natl Univ, Bundang Hosp, Clin Neurosci Ctr, Seongnam, South Korea; [Park, Young Ho; Park, So Young; Wang, Min Jeong; Lim, Jae-Sung; Kim, SangYun] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Lim, Jae-Sung] Seoul Natl Univ, Boramae Med Ctr, Dept Neurol, Seoul, South Korea; [Chun, In Kook] Kangwon Natl Univ Hosp, Dept Nucl Med, Chunchon, South Korea; [Yang, Youngsoon] Seoul Vet Hosp, Dept Neurol, Seoul, South Korea	Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Kangwon National University; Kangwon National University Hospital; Seoul Veterans Hospital	Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Clin Neurosci Ctr, Seongnam, South Korea.	neuroksy@snu.ac.kr	Chun, In Kook/V-9034-2019; Lim, Jae-Sung/D-5555-2012	Chun, In Kook/0000-0002-4144-3647; Lim, Jae-Sung/0000-0001-6157-2908				Agosti C, 2010, EUR NEUROL, V63, P291, DOI 10.1159/000292502; Akkawi NM, 2001, LANCET, V357, P957, DOI 10.1016/S0140-6736(05)71655-X; Baracchini C, 2015, J NEUROIMAGING, V25, P92, DOI 10.1111/jon.12090; Baracchini C, 2012, STROKE, V43, P2289, DOI 10.1161/STROKEAHA.112.654087; Bartsch T, 2007, ANN NEUROL, V62, P475, DOI 10.1002/ana.21189; Bartsch T, 2015, J CEREBR BLOOD F MET, V35, P1836, DOI 10.1038/jcbfm.2015.137; Caffarra P, 2009, BEHAV NEUROL, V22, P131, DOI [10.3233/BEN-2009-0253, 10.3233/ben-2009-0253]; Caplan L, 1985, TRANSIENT GLOBAL AMN, P205; Caplan LR, 2010, STROKE, V41, pE568, DOI 10.1161/STROKEAHA.110.579789; Caplan LR, 2010, STROKE, V41, pe9, DOI [10.1161/strokeaha.110.579789, DOI 10.1161/STR0KEAHA.110.579789]; Cejas C, 2010, STROKE, V41, P67, DOI 10.1161/STROKEAHA.109.566315; Chung YA, 2009, NEUROIMAGE, V47, P50, DOI 10.1016/j.neuroimage.2008.11.011; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Donnet A, 2015, HEADACHE, V55, P853, DOI 10.1111/head.12545; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Enzinger C, 2008, STROKE, V39, P2219, DOI 10.1161/STROKEAHA.107.508655; EVANS J, 1993, J NEUROL NEUROSUR PS, V56, P1227, DOI 10.1136/jnnp.56.11.1227; FISHER CM, 1964, ACTA NEUROL SCAND, V40, P7; Forster A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122537; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; GOLDENBERG G, 1991, NEUROLOGY, V41, P1748, DOI 10.1212/WNL.41.11.1748; Han K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132893; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; HODGES JR, 1990, BRAIN, V113, P639, DOI 10.1093/brain/113.3.639; Jovin TG, 2000, J NEUROIMAGING, V10, P238, DOI 10.1111/jon2000104238; Jung HH, 1996, J NEUROL NEUROSUR PS, V61, P654, DOI 10.1136/jnnp.61.6.654-a; Kang Y, 2015, EUR RADIOL, V25, P703, DOI 10.1007/s00330-014-3448-7; Kapucu OL, 2009, EUR J NUCL MED MOL I, V36, P2093, DOI 10.1007/s00259-009-1266-y; Kim J, 2013, J NEUROIMAGING OFFIC, DOI [10.1111/jon.12021, DOI 10.1111/J0N.12021]; Kwon Y, 2014, SEIZURE-EUR J EPILEP, V23, P825, DOI 10.1016/j.seizure.2014.06.014; La Joie R, 2014, NEURON, V81, P1417, DOI 10.1016/j.neuron.2014.01.026; LALOUX P, 1992, ARCH NEUROL-CHICAGO, V49, P543, DOI 10.1001/archneur.1992.00530290131022; Lewis SL, 1998, LANCET, V352, P397, DOI 10.1016/S0140-6736(98)01442-1; Libby LA, 2012, J NEUROSCI, V32, P6550, DOI 10.1523/JNEUROSCI.3711-11.2012; Lin KH, 2014, EUR J NEUROL, V21, P718, DOI 10.1111/ene.12346; LIN KN, 1993, STROKE, V24, P1093, DOI 10.1161/01.STR.24.7.1093; Lochner P, 2014, J NEUROIMAGING, V24, P479, DOI 10.1111/jon.12042; MATSUDA H, 1993, CLIN NUCL MED, V18, P46, DOI 10.1097/00003072-199301000-00011; MELO TP, 1992, BRAIN, V115, P261, DOI 10.1093/brain/115.1.261; Modabbernia A, 2012, ACTA NEUROL BELG, V112, P237, DOI 10.1007/s13760-012-0072-7; Moon Y, 2016, ACTA NEUROL SCAND, V134, P160, DOI 10.1111/ane.12518; Nardone R, 2004, J NEUROL, V251, P42, DOI 10.1007/s00415-004-0270-1; Pantoni L, 2005, EUR J NEUROL, V12, P350, DOI 10.1111/j.1468-1331.2004.00982.x; Park YH, 2016, CLIN EEG NEUROSCI, V47, P69, DOI 10.1177/1550059414543684; Park YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067447; Peer M, 2014, ANN NEUROL, V75, P634, DOI 10.1002/ana.24137; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Ritchey M, 2015, PROG BRAIN RES, V219, P45, DOI 10.1016/bs.pbr.2015.04.001; Ryoo I, 2012, NEURORADIOLOGY, V54, P329, DOI 10.1007/s00234-011-0889-4; Sakashita Y, 1997, J NEUROL NEUROSUR PS, V63, P605, DOI 10.1136/jnnp.63.5.605; Sander K, 2005, LANCET NEUROL, V4, P437, DOI 10.1016/S1474-4422(05)70121-6; Schmidtke K, 1998, J NUCL MED, V39, P155; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; STILLHARD G, 1990, J NEUROL NEUROSUR PS, V53, P339, DOI 10.1136/jnnp.53.4.339; Takeuchi R, 1998, J NUCL MED, V39, P1360; Warren JD, 2000, J CLIN NEUROSCI, V7, P57, DOI 10.1054/jocn.1998.0129; Winbeck K, 2005, J NEUROL NEUROSUR PS, V76, P438, DOI 10.1136/jnnp.2004.042432; Yamane Y, 2008, J COMPUT ASSIST TOMO, V32, P415, DOI 10.1097/RCT.0b013e3180de5b9b; Yang Y, 2008, J CLIN NEUROL, V4, P59, DOI 10.3988/jcn.2008.4.2.59; Yang Y, 2009, J CLIN NEUROL, V5, P74, DOI 10.3988/jcn.2009.5.2.74; ZORZON M, 1995, STROKE, V26, P1536, DOI 10.1161/01.STR.26.9.1536	62	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145658	10.1371/journal.pone.0145658	http://dx.doi.org/10.1371/journal.pone.0145658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690067	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092300093
J	Lee, SY; Park, HJ; Best-Popescu, C; Jang, S; Park, YK				Lee, Sang Yun; Park, Hyun Joo; Best-Popescu, Catherine; Jang, Seongsoo; Park, Yong Keun			The Effects of Ethanol on the Morphological and Biochemical Properties of Individual Human Red Blood Cells	PLOS ONE			English	Article							OPTICAL DIFFRACTION TOMOGRAPHY; ERYTHROCYTE-MEMBRANE FLUIDITY; PLASMODIUM-FALCIPARUM; PHASE MICROSCOPY; REFRACTIVE-INDEX; ALCOHOL; DYNAMICS; DEFORMABILITY; VISUALIZATION; HEMOGLOBIN	Here, we report the results of a study on the effects of ethanol exposure on human red blood cells (RBCs) using quantitative phase imaging techniques at the level of individual cells. Three-dimensional refractive index tomograms and dynamic membrane fluctuations of RBCs were measured using common-path diffraction optical tomography, from which morphological (volume, surface area, and sphericity); biochemical (hemoglobin (Hb) concentration and Hb content); and biomechanical (membrane fluctuation) parameters were retrieved at various concentrations of ethanol. RBCs exposed to the ethanol concentration of 0.1 and 0.3% v/v exhibited cell sphericities higher than those of normal cells. However, mean surface area and sphericity of RBCs in a lethal alcoholic condition (0.5% v/v) are not statistically different with those of healthy RBCs. Meanwhile, significant decreases of Hb content and concentration in RBC cytoplasm at the lethal condition were observed. Furthermore, dynamic fluctuation of RBC membranes increased significantly upon ethanol treatments, indicating ethanol-induced membrane fluidization.	[Lee, Sang Yun; Park, Hyun Joo; Park, Yong Keun] Korea Adv Inst Sci & Technol, Dept Phys, Daejeon, South Korea; [Best-Popescu, Catherine] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Jang, Seongsoo] Univ Ulsan, Coll Med, Dept Lab Med, Seoul, South Korea; [Jang, Seongsoo] Univ Ulsan, Asan Med Ctr, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); University of Illinois System; University of Illinois Urbana-Champaign; University of Ulsan; University of Ulsan	Park, YK (corresponding author), Korea Adv Inst Sci & Technol, Dept Phys, Daejeon, South Korea.	yk.park@kaist.ac.kr	Park, YongKeun/B-9017-2009	Park, YongKeun/0000-0003-0528-6661; Best-Popescu, Catherine/0000-0003-3857-5953	Korea Advanced Institute of Science and Technology (KAIST); National Research Foundation (NRF) of Korea [2014K1A3A1A09063027, 2013M3C1A3063046, 2012-M3C1A1-048860, 2014M3C1A3052537]; Asia Pacific Center for Theoretical Physics (APCTP); KAIST-Khalifa University; KAIST Endrun-project	Korea Advanced Institute of Science and Technology (KAIST); National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Asia Pacific Center for Theoretical Physics (APCTP); KAIST-Khalifa University; KAIST Endrun-project	This work was supported by Korea Advanced Institute of Science and Technology (KAIST), National Research Foundation (NRF) of Korea (2014K1A3A1A09063027, 2013M3C1A3063046, 2012-M3C1A1-048860, 2014M3C1A3052537), Asia Pacific Center for Theoretical Physics (APCTP), KAIST-Khalifa University, KAIST Endrun-project.	Ballard HS, 1997, ALCOHOL HEALTH RES W, V21, P42; BARER R, 1953, NATURE, V172, P1097, DOI 10.1038/1721097a0; BEAUGE F, 1985, ALCOHOL CLIN EXP RES, V9, P322, DOI 10.1111/j.1530-0277.1985.tb05552.x; BEAUGE F, 1988, BIOCHEM PHARMACOL, V37, P3823, DOI 10.1016/0006-2952(88)90062-7; Beauge F, 1986, ALCOHOL ALCOHOLISM S, V1, P561; Ben-Isaac E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238103; BENEDETTI A, 1986, PHARMACOL RES, V18, P1003, DOI 10.1016/0031-6989(86)90018-4; Byun H, 2012, ACTA BIOMATER, V8, P4130, DOI 10.1016/j.actbio.2012.07.011; Chandramohanadas R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020869; CHI LM, 1991, BIOCHIM BIOPHYS ACTA, V1062, P46, DOI 10.1016/0005-2736(91)90333-4; CHIEN S, 1987, ANNU REV PHYSIOL, V49, P177, DOI 10.1146/annurev.ph.49.030187.001141; CHIN JH, 1977, MOL PHARMACOL, V13, P435; CRANSTON HA, 1984, SCIENCE, V223, P400, DOI 10.1126/science.6362007; Debnath SK, 2011, OPT LETT, V36, P4677, DOI 10.1364/OL.36.004677; Deng JL, 2005, J RAMAN SPECTROSC, V36, P257, DOI 10.1002/jrs.1301; Diez-Silva M, 2012, SCI REPORTS, V2; Fehr M, 2008, CLIN HEMORHEOL MICRO, V39, P351, DOI 10.3233/CH-2008-1102; Friebel M, 2006, APPL OPTICS, V45, P2838, DOI 10.1364/AO.45.002838; GOLDSTEIN DB, 1986, ANN EMERG MED, V15, P1013, DOI 10.1016/S0196-0644(86)80120-2; Halsted CH, 2002, J NUTR, V132, p2367S, DOI 10.1093/jn/132.8.2367S; HARRIS RA, 1981, MOL PHARMACOL, V20, P128; HERBERT V, 1963, ANN INTERN MED, V58, P977, DOI 10.7326/0003-4819-58-6-977; HILLBOM ME, 1983, EUR J CLIN INVEST, V13, P45, DOI 10.1111/j.1365-2362.1983.tb00063.x; HRELIA S, 1986, BIOCHEM INT, V12, P741; Ioannou GN, 2004, GASTROENTEROLOGY, V126, P1293, DOI 10.1053/j.gastro.2004.01.020; Jensen T, 2006, BLOOD COAGUL FIBRIN, V17, P471, DOI 10.1097/01.mbc.0000240920.72930.63; Kim K, 2015, OPTICA, V2, P343, DOI 10.1364/OPTICA.2.000343; Kim K, 2014, OPT LETT, V39, P6935, DOI 10.1364/OL.39.006935; Kim K, 2013, OPT EXPRESS, V21, P32269, DOI 10.1364/OE.21.032269; Kim Y., 2012, MEASUREMENT TECHNIQU; Kim Y, 2014, STUDY EFFECT LEADERS, P4; Kim Y, 2014, OPT EXPRESS, V22, P10398, DOI 10.1364/OE.22.010398; Lauer V, 2002, J MICROSC-OXFORD, V205, P165, DOI 10.1046/j.0022-2720.2001.00980.x; Lee K, 2014, OPT LETT, V39, P3630, DOI 10.1364/OL.39.003630; Lee K, 2013, SENSORS-BASEL, V13, P4170, DOI 10.3390/s130404170; Lim J, 2015, OPT EXPRESS, V23, P16933, DOI 10.1364/OE.23.016933; MCLAWHON RW, 1987, J MEMBRANE BIOL, V99, P73, DOI 10.1007/BF01870623; Mohandas N, 1993, SEMINARS HEMATOLOGY; Oonishi T, 2000, ALCOHOL CLIN EXP RES, V24, P352, DOI 10.1097/00000374-200003000-00017; Palmieri VO, 2006, ADV EXP MED BIOL, V578, P125; Park H, 2015, ARXIV150500832; Park H., 2015, ARXIV150504232; Park YK, 2008, P NATL ACAD SCI USA, V105, P13730, DOI 10.1073/pnas.0806100105; Park YK, 2006, OPT EXPRESS, V14, P8263, DOI 10.1364/OE.14.008263; Park Y, 2011, MECHANOBIOLOGY OF CELL-CELL AND CELL-MATRIX INTERACTIONS, P279, DOI 10.1007/978-1-4419-8083-0_13; Park YK, 2010, P NATL ACAD SCI USA, V107, P1289, DOI 10.1073/pnas.0910785107; Park Y, 2009, OPT LETT, V34, P3668, DOI 10.1364/OL.34.003668; Popescu G, 2006, OPT LETT, V31, P775, DOI 10.1364/OL.31.000775; Popescu G., 2011, QUANTITATIVE PHASE I; Popescu G, 2008, BLOOD CELL MOL DIS, V41, P10, DOI 10.1016/j.bcmd.2008.01.010; Rabai M, 2010, CLIN HEMORHEOL MICRO, V44, P227, DOI 10.3233/CH-2010-1267; Ruef P, 1999, PEDIATR RES, V45, P114, DOI 10.1203/00006450-199901000-00019; Shaked NT, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3556717; Shin S, 2015, SPIE BIOS; Shin S., 2015, ARXIV150606237; Sonmez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076579; STIBLER H, 1991, SCAND J CLIN LAB INV, V51, P309, DOI 10.3109/00365519109091621; Sung YJ, 2009, OPT EXPRESS, V17, P266, DOI 10.1364/OE.17.000266; TAKEDA M, 1982, J OPT SOC AM, V72, P156, DOI 10.1364/JOSA.72.000156; Tomaiuolo G, 2012, CYTOM PART A, V81A, P1040, DOI 10.1002/cyto.a.22215; Toth A, 2014, CLIN HEMORHEOL MICRO, V56, P13, DOI 10.3233/CH-2012-1640; Tyulina OV, 2002, ALCOHOL ALCOHOLISM, V37, P179, DOI 10.1093/alcalc/37.2.179; Tyulina OV, 2000, BBA-MOL BASIS DIS, V1535, P69, DOI 10.1016/S0925-4439(00)00086-7; Vent-Schmidt J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114412; WAUGH RE, 1992, BLOOD, V79, P1351; Wolf E., 1969, Optics Communications, V1, P153, DOI 10.1016/0030-4018(69)90052-2; WOOD WG, 1987, ALCOHOL CLIN EXP RES, V11, P332, DOI 10.1111/j.1530-0277.1987.tb01320.x; Yoo M, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.128005	68	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145327	10.1371/journal.pone.0145327	http://dx.doi.org/10.1371/journal.pone.0145327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690915	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092300057
J	Briffa, R; Um, I; Faratian, D; Zhou, Y; Turnbull, AK; Langdon, SP; Harrison, DJ				Briffa, Romina; Um, Inhwa; Faratian, Dana; Zhou, Ying; Turnbull, Arran K.; Langdon, Simon P.; Harrison, David J.			Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DNA MISMATCH-REPAIR; COPY NUMBER ALTERATIONS; GENE-EXPRESSION; PROTEIN EXPRESSION; PROMOTER HYPERMETHYLATION; MICROARRAY ANALYSIS; CARCINOMA-CELLS; DEATH 6; MUTATIONS	Selecting colorectal cancer (CRC) patients likely to respond to therapy remains a clinical challenge. The objectives of this study were to establish which genes were differentially expressed with respect to treatment sensitivity and relate this to copy number in a panel of 15 CRC cell lines. Copy number variations of the identified genes were assessed in a cohort of CRCs. IC50's were measured for 5-fluorouracil, oxaliplatin, and BEZ-235, a PI3K/mTOR inhibitor. Cell lines were profiled using array comparative genomic hybridisation, Illumina gene expression analysis, reverse phase protein arrays, and targeted sequencing of KRAS hotspot mutations. Frequent gains were observed at 2p, 3q, 5p, 7p, 7q, 8q, 12p, 13q, 14q, and 17q and losses at 2q, 3p, 5q, 8p, 9p, 9q, 14q, 18q, and 20p. Frequently gained regions contained EGFR, PIK3CA, MYC, SMO, TRIB1, FZD1, and BRCA2, while frequently lost regions contained FHIT and MACROD2. TRIB1 was selected for further study. Gene enrichment analysis showed that differentially expressed genes with respect to treatment response were involved in Wnt signalling, EGF receptor signalling, apoptosis, cell cycle, and angiogenesis. Stepwise integration of copy number and gene expression data yielded 47 candidate genes that were significantly correlated. PDCD6 was differentially expressed in all three treatment responses. Tissue microarrays were constructed for a cohort of 118 CRC patients and TRIB1 and MYC amplifications were measured using fluorescence in situ hybridisation. TRIB1 and MYC were amplified in 14.5% and 7.4% of the cohort, respectively, and these amplifications were significantly correlated (p <= 0.0001). TRIB1 protein expression in the patient cohort was significantly correlated with pERK, Akt, and Caspase 3 expression. In conclusion, a set of candidate predictive biomarkers for 5-fluorouracil, oxaliplatin, and BEZ235 are described that warrant further study. Amplification of the putative oncogene TRIB1 has been described for the first time in a cohort of CRC patients.	[Briffa, Romina; Faratian, Dana; Zhou, Ying; Turnbull, Arran K.; Langdon, Simon P.] Univ Edinburgh, Inst Genet & Mol Med, Div Pathol, Edinburgh EH4 2XU, Midlothian, Scotland; [Um, Inhwa; Harrison, David J.] Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland	University of Edinburgh; University of St Andrews	Langdon, SP (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Div Pathol, Crewe Rd South, Edinburgh EH4 2XU, Midlothian, Scotland.	simon.langdon@ed.ac.uk		Briffa, Romina/0000-0002-2223-1403; harrison, david/0000-0001-9041-9988; Turnbull, Arran/0000-0002-2287-0889	Strategic Educational Pathways Scholarship (Malta); European Union - European Social Fund (ESF) under Operational Programme II - Cohesion Policy "Empowering People for More Jobs and a Better Quality of Life"; Medical Research Scotland	Strategic Educational Pathways Scholarship (Malta); European Union - European Social Fund (ESF) under Operational Programme II - Cohesion Policy "Empowering People for More Jobs and a Better Quality of Life"; Medical Research Scotland	This work was partially funded by the Strategic Educational Pathways Scholarship (Malta). The scholarship is part-financed by the European Union - European Social Fund (ESF) under Operational Programme II - Cohesion Policy 2007-2013, "Empowering People for More Jobs and a Better Quality of Life". This project was additionally funded by Medical Research Scotland.	American Cancer Society, 2011, GLOB CANC FACTS FIG; Arnold CN, 2003, INT J CANCER, V106, P66, DOI 10.1002/ijc.11176; Barnetson RA, 2006, NEW ENGL J MED, V354, P2751, DOI 10.1056/NEJMoa053493; Barsotti AM, 2012, J BIOL CHEM, V287, P2509, DOI 10.1074/jbc.M111.322875; Baselga J, 2002, ONCOLOGIST, V7, P2; Bertrand FE, 2012, CELL CYCLE, V11, P4344, DOI 10.4161/cc.22134; Bhushan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022484; Boyer J, 2004, CLIN CANCER RES, V10, P2158, DOI 10.1158/1078-0432.CCR-03-0362; Bracht K, 2010, BRIT J CANCER, V103, P340, DOI 10.1038/sj.bjc.6605780; Brough R, 2012, EMBO J, V31, P1160, DOI 10.1038/emboj.2011.490; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Camps J, 2009, GENE CHROMOSOME CANC, V48, P1002, DOI 10.1002/gcc.20699; Cervigne NK, 2014, HUM MOL GENET, V23, P2618, DOI 10.1093/hmg/ddt657; Chu E, 2012, CLIN COLORECTAL CANC, V11, P1, DOI 10.1016/j.clcc.2011.05.005; Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365; Correia JD, 2007, CELL DEATH DIFFER, V14, P830, DOI 10.1038/sj.cdd.4402070; Custodio A, 2013, CRIT REV ONCOL HEMAT, V85, P45, DOI 10.1016/j.critrevonc.2012.05.001; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Edwards MC, 1997, GENETICS, V147, P1063; Ellison V, 1998, J BIOL CHEM, V273, P5979, DOI 10.1074/jbc.273.10.5979; Faratian D, 2011, JOVE-J VIS EXP, DOI 10.3791/3334; Faratian D, 2009, CANCER RES, V69, P6713, DOI 10.1158/0008-5472.CAN-09-0777; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Ferlay J, 2010, GLOBOCAN 2008 CANC I; Fink D, 1996, CANCER RES, V56, P4881; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Glaab E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-358; Goel A, 2004, CANCER RES, V64, P3014, DOI 10.1158/0008-5472.CAN-2401-2; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huppi Konrad, 2012, Frontiers in Genetics, V3, P69, DOI 10.3389/fgene.2012.00069; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Jones AM, 2005, ONCOGENE, V24, P118, DOI 10.1038/sj.onc.1208194; Jung JJ, 2007, ONCOL REP, V18, P593; Kim H, 2009, NUCLEIC ACIDS RES, V37, P2940, DOI 10.1093/nar/gkp149; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Knutsen T, 2010, GENE CHROMOSOME CANC, V49, P204, DOI 10.1002/gcc.20730; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; la Cour JM, 2003, AM J PATHOL, V163, P81, DOI 10.1016/S0002-9440(10)63632-2; Lagerstedt KK, 2010, CANCER INFORM, V9, P79; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Li WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033653; Linnebacher M, 2013, ONCOL LETT, V5, P173, DOI 10.3892/ol.2012.1006; Lockwood WW, 2012, CLIN CANCER RES, V18, P1936, DOI 10.1158/1078-0432.CCR-11-1431; Longley DB, 2007, 5 FLUOROURACIL APOPT, P263; Loo LWM, 2013, GENE CHROMOSOME CANC, V52, P450, DOI 10.1002/gcc.22043; Mackay A, 2009, BREAST CANCER RES TR, V118, P481, DOI 10.1007/s10549-008-0296-7; Mady HH, 2002, CLIN EXP METASTAS, V19, P351, DOI 10.1023/A:1015594702522; Mariadason JM, 2003, CANCER RES, V63, P8791; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; Meyer C, 2013, ENDOCR-RELAT CANCER, V20, P123, DOI 10.1530/ERC-12-0192; Mojica W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-5; Moser R, 2012, MOL CANCER RES, V10, P535, DOI 10.1158/1541-7786.MCR-11-0508; Naccarati A, 2012, MUTAGENESIS, V27, P211, DOI 10.1093/mutage/ger067; National Comprehensive Cancer Network (NCCN), 2013, CLIN PRACT GUID ONC; Park SH, 2012, CELL SIGNAL, V24, P726, DOI 10.1016/j.cellsig.2011.11.006; Peng XW, 2015, CANCER BIOL THER, V16, P261, DOI 10.1080/15384047.2014.1001287; Pietrantonio F, 2014, ONCOLOGY, V86, P89; Raghavan Arvind, 2004, Briefings in Functional Genomics & Proteomics, V3, P112, DOI 10.1093/bfgp/3.2.112; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Rho SB, 2012, CELL SIGNAL, V24, P131, DOI 10.1016/j.cellsig.2011.08.013; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rochette PJ, 2002, ONCOGENE, V21, P5743, DOI 10.1038/sj.onc.1205641; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Scartozzi M, 2011, BRIT J CANCER, V104, P1786, DOI 10.1038/bjc.2011.161; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shi ZZ, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-52; Shortt J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009829; Smith G, 2002, P NATL ACAD SCI USA, V99, P9433, DOI 10.1073/pnas.122612899; Spitzner M, 2010, INT J RADIAT ONCOL, V78, P1184, DOI 10.1016/j.ijrobp.2010.06.023; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; Su D, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-31; Suzuki K, 2012, CANCER SCI, V103, P1788, DOI 10.1111/j.1349-7006.2012.02362.x; Tan J, 2013, CHIN J CANCER, V32, P376, DOI 10.5732/cjc.012.10287; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Varella-Garcia M, 2009, J CLIN PATHOL, V62, P970, DOI 10.1136/jcp.2009.066548; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang Huixia, 2006, BMC Genomics, V7, P166; Weidlich S, 2011, BRIT J CANCER, V105, P246, DOI 10.1038/bjc.2011.197; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Williams JR, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-71; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xie T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042001, 10.1371/journal.pone.0047577]; Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107; Yao Y, 2009, BBA-PROTEINS PROTEOM, V1794, P1433, DOI 10.1016/j.bbapap.2009.06.005; Yokoyama T, 2011, CANCER SCI, V102, P1115, DOI 10.1111/j.1349-7006.2011.01914.x; Zhang C.J., 2011, DYE FINISH, V8, P1, DOI DOI 10.1371/J0URNAL.P0NE.0023849	102	33	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144708	10.1371/journal.pone.0144708	http://dx.doi.org/10.1371/journal.pone.0144708			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678268	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000366723400019
J	Cameron, SJ; Morrell, CN; Bao, C; Swaim, AF; Rodriguez, A; Lowenstein, CJ				Cameron, Scott J.; Morrell, Craig N.; Bao, Clare; Swaim, AnneMarie F.; Rodriguez, Annabelle; Lowenstein, Charles J.			A Novel Anti-Inflammatory Effect for High Density Lipoprotein	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; B TYPE-I; SCAVENGER RECEPTOR; SR-BI; HDL RECEPTOR; CHOLESTEROL; EXPRESSION; MYELOPEROXIDASE; PROTEIN; CELLS	High density lipoprotein has anti-inflammatory effects in addition to mediating reverse cholesterol transport. While many of the chronic anti-inflammatory effects of high density lipoprotein (HDL) are attributed to changes in cell adhesion molecules, little is known about acute signal transduction events elicited by HDL in endothelial cells. We now show that high density lipoprotein decreases endothelial cell exocytosis, the first step in leukocyte trafficking. ApoA-I, a major apolipoprotein of HDL, mediates inhibition of endothelial cell exocytosis by interacting with endothelial scavenger receptor-BI which triggers an intracellular protective signaling cascade involving protein kinase C (PKC). Other apolipoproteins within the HDL particle have only modest effects upon endothelial exocytosis. Using a human primary culture of endothelial cells and murine apo-AI knockout mice, we show that apo-AI prevents endothelial cell exocytosis which limits leukocyte recruitment. These data suggest that high density lipoprotein may inhibit diseases associated with vascular inflammation in part by blocking endothelial exocytosis.	[Cameron, Scott J.; Lowenstein, Charles J.] Univ Rochester, Sch Med, Div Cardiol, Dept Med, Rochester, NY 14652 USA; [Cameron, Scott J.; Morrell, Craig N.; Lowenstein, Charles J.] Univ Rochester, Sch Med, Aab Cardiovasc Res Inst, Rochester, NY 14652 USA; [Bao, Clare] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Morrell, Craig N.; Swaim, AnneMarie F.] Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA; [Rodriguez, Annabelle] Univ Connecticut, Sch Med, Dept Cell Biol, Farmington, CT 06030 USA	University of Rochester; University of Rochester; Johns Hopkins University; Johns Hopkins University; University of Connecticut	Cameron, SJ (corresponding author), Univ Rochester, Sch Med, Div Cardiol, Dept Med, Box 679,601 Elmwood Ave, Rochester, NY 14652 USA.	scott_cameron@urmc.rochester.edu	Cameron, Scott/AAW-8429-2021	Cameron, Scott/0000-0002-9616-1540; Lowenstein, Charles/0000-0003-0485-7514	NIH/NHLBI [R21 HL108372]; Pfizer; American Heart Association [14GRNT19020033, 13EIA14250023]; NIH training grant [5T32HL066988-1]; Sable Heart Fund, Independent Order of Oddfellows; Bayer Diagnostics; National Institutes of Health [R01HL124018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL108372, R01HL124018, T32HL066988] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pfizer(Pfizer); American Heart Association(American Heart Association); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sable Heart Fund, Independent Order of Oddfellows; Bayer Diagnostics(Bayer AG); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH/NHLBI grant R21 HL108372 (to CJL); an International HDL Research Awards Program from Pfizer (to CJL); American Heart Association grants 14GRNT19020033 (to CJL); NIH training grant 5T32HL066988-1 (to SJC); by Sable Heart Fund, Independent Order of Oddfellows (to SJC); by Bayer Diagnostics (to SJC); and by American Heart Association 13EIA14250023 and National Institutes of Health R01HL124018 (to CNM).; This study was supported by the following grants: NIH/NHLBI grant R21 HL108372 (to CJL); an International HDL Research Awards Program from Pfizer (to CJL); American Heart Association grants 14GRNT19020033 (to CJL); NIH training grant 5T32HL066988-1(to SJC); by Sable Heart Fund, Independent Order of Oddfellows (to SJC); by Bayer Diagnostics (to SJC); by American Heart Association 13EIA14250023 and National Institutes of Health R01HL124018 (to CNM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We are indebted to the late Dr. Peter O. Kwiterovich Jr as well as to Donna Virgil for isolation of HDL fractions and for some helpful discussions during the early part of this study.	ACTON SL, 1994, J BIOL CHEM, V269, P21003; Al-Jarallah A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106487; Ansell BJ, 2007, AM J CARDIOL, V100, p3N, DOI 10.1016/j.amjcard.2007.08.006; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Barragan M, 2006, J LEUKOCYTE BIOL, V80, P1473, DOI 10.1189/jlb.0106041; Barter Philip J, 2007, Curr Cardiol Rep, V9, P493, DOI 10.1007/BF02938394; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; BODEN WE, 2000, AM J CARDIOL, V86, P19, DOI DOI 10.1016/S0002-9149(00)01464-8; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Dorfman SE, 2005, J NUTR, V135, P492, DOI 10.1093/jn/135.3.492; FREEMAN M, 1991, P NATL ACAD SCI USA, V88, P4931, DOI 10.1073/pnas.88.11.4931; Gomaraschi M, 2008, J PHARMACOL EXP THER, V324, P776, DOI 10.1124/jpet.107.129411; Gong M, 2003, J CLIN INVEST, V111, P1579, DOI 10.1172/JCI200316777; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; HABERLAND ME, 1985, P NATL ACAD SCI USA, V82, P2693, DOI 10.1073/pnas.82.9.2693; Huby T, 2006, J CLIN INVEST, V116, P2767, DOI 10.1172/JCI26893; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; LAAKSO M, 1993, CIRCULATION, V88, P1421, DOI 10.1161/01.CIR.88.4.1421; LEES RS, 1963, J LAB CLIN MED, V61, P518; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Martin SS, 2015, EUR HEART J, V36, P22, DOI 10.1093/eurheartj/ehu264; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; McDonald MC, 2003, SHOCK, V20, P551, DOI 10.1097/01.shk.0000097249.97298.a3; Navab M, 2005, TRENDS CARDIOVAS MED, V15, P158, DOI 10.1016/j.tcm.2005.05.008; Navab M, 2004, CURR OPIN LIPIDOL, V15, P645, DOI 10.1097/00041433-200412000-00004; NAVAB M, 1991, J CLIN INVEST, V88, P2039, DOI 10.1172/JCI115532; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Parastatidis I, 2007, CIRC RES, V101, P368, DOI 10.1161/CIRCRESAHA.107.157537; Rader DJ, 2003, AM J CARDIOL, V92, p42J, DOI 10.1016/S0002-9149(03)00615-5; Reddy ST, 2006, EXPERT OPIN INV DRUG, V15, P13, DOI 10.1517/13543784.15.1.13; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rodriguez C, 2009, THROMB HAEMOSTASIS, V101, P665, DOI 10.1160/TH08-10-0675; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Shaul PW, 2004, J CLIN INVEST, V113, P509, DOI 10.1172/JCI200421072; Silver DL, 2001, CURR OPIN LIPIDOL, V12, P497, DOI 10.1097/00041433-200110000-00004; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Subramaniam M, 1996, BLOOD, V87, P1238, DOI 10.1182/blood.V87.4.1238.bloodjournal8741238; Tall AR, 2002, J CLIN INVEST, V110, P899, DOI 10.1172/JCI200216391; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; Teiber JF, 2004, J LIPID RES, V45, P2260, DOI 10.1194/jlr.M400213-JLR200; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; van der Veen JN, 2005, J LIPID RES, V46, P526, DOI 10.1194/jlr.M400400-JLR200; Van Lenten BJ, 2002, CIRCULATION, V106, P1127, DOI 10.1161/01.CIR.0000030182.35880.3E; WAGNER DD, 1993, THROMB HAEMOSTASIS, V70, P105; Walldius G, 2004, CLIN CHEM LAB MED, V42, P1355, DOI 10.1515/CCLM.2004.254; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Wiejak J, 2012, MOL PHARMACOL, V81, P657, DOI 10.1124/mol.111.076976; Williams PT, 2011, ATHEROSCLEROSIS, V214, P196, DOI 10.1016/j.atherosclerosis.2010.10.024; Xia P, 1999, J BIOL CHEM, V274, P33143, DOI 10.1074/jbc.274.46.33143; Xu SZ, 1997, J LIPID RES, V38, P1289; Yamakuchi M, 2005, CIRC RES, V96, P1185, DOI 10.1161/01.RES.0000170229.49776.81; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109; Zhu QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118737; ZHU W, 2008, CIRCRESAHA AHA, V107, DOI DOI 10.1161/CIRCRESAHA.107.159079	62	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144372	10.1371/journal.pone.0144372	http://dx.doi.org/10.1371/journal.pone.0144372			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680360	Green Submitted, Green Published, gold			2022-12-27	WOS:000366723400012
J	Chen, HY; Sun, MN; Liu, J; Tong, CX; Meng, T				Chen, Haiying; Sun, Manni; Liu, Jing; Tong, Chunxiao; Meng, Tao			Silencing of Paternally Expressed Gene 10 Inhibits Trophoblast Proliferation and Invasion	PLOS ONE			English	Article							IMPRINTED GENES; HUMAN PLACENTAS; PEG10; METALLOPROTEINASES; RETROTRANSPOSON; COLLAGENASE; MIGRATION; CELLS	Paternally expressed gene 10 (PEG10) is an imprinted and monoallelic expressed gene. Previous study using a knockout mouse model revealed a crucial role of PEG10 in placental development, yet the exact function of PEG10 during placentation remains to be elucidated. In this study, denuded chorionic villi were prepared from first trimester human placentas, and transduced with PEG10 small interference RNA (siRNA) or non-targeting control sequence by lentiviral infection. Immunohistochemical staining revealed that silencing of PEG10 in the chorionic villous explants resulted in reduced immune-reactivity to CK7, Ki67 and integrin alpha 5, implying that silencing of PEG10 impaired the proliferation of villous trophoblasts and may interfere with the activity of extravillous trophoblasts. We further investigated the role of PEG10 in the proliferation, migration and invasion of JEG-3 trophoblast cell line and the primary chorionic villous cells. PEG10-silenced JEG-3 cells and primary chorionic villous cells displayed a reduced proliferation rate and impaired invasiveness in vitro. Silencing of PEG10 in trophoblast cells led to upregulated expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) as well as downregulated expression of matrix metalloproteinase (MMP)-2 and MMP-9. Furthermore, knockdown of TIMP-1 reversed the suppressed invasiveness of PEG10 siRNA-transduced JEG-3 cells. In conclusion, our study demonstrates that PEG10 plays an important role in trophoblast proliferation and promotes trophoblast invasion through TIMP-1.	[Chen, Haiying; Sun, Manni; Liu, Jing; Tong, Chunxiao; Meng, Tao] China Med Univ, Affiliated Hosp 1, Dept Obstet, Shenyang 110001, Peoples R China	China Medical University	Meng, T (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Obstet, Shenyang 110001, Peoples R China.	mengtao1995@163.com			National Natural Science Foundation of China [81270711]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (http://www.nsfc.gov.cn): No. 81270711. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010; AUTIOHARMAINEN H, 1992, LAB INVEST, V67, P191; Baczyk D, 2006, PLACENTA, V27, P367, DOI 10.1016/j.placenta.2005.03.006; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bischof P, 1995, Early Pregnancy, V1, P263; Chen HY, 2012, ACTA HISTOCHEM, V114, P589, DOI 10.1016/j.acthis.2011.11.003; Cohen M, 2007, GYNECOL OBSTET INVES, V64, P126, DOI 10.1159/000101734; Deng XZ, 2014, ONCOL REP, V32, P2159, DOI 10.3892/or.2014.3469; Diplas AI, 2009, EPIGENETICS-US, V4, P235, DOI 10.4161/epi.9019; Doria S, 2010, EPIGENETICS-US, V5, P444, DOI 10.4161/epi.5.5.12118; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Hunt JS, 2009, CURR OPIN PHARMACOL, V9, P462, DOI 10.1016/j.coph.2009.05.007; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liang Xiao-Yan, 2008, Yichuan, V30, P735, DOI 10.3724/SP.J.1005.2008.00735; Metsalu T, 2014, EPIGENETICS-US, V9, P1397, DOI 10.4161/15592294.2014.970052; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; PUISTOLA U, 1989, HUM REPROD, V4, P309, DOI 10.1093/oxfordjournals.humrep.a136894; Smallwood A, 2003, BIOL REPROD, V69, P286, DOI 10.1095/biolreprod.102.013078; WOOLLEY DE, 1975, BIOCHEM BIOPH RES CO, V66, P747, DOI 10.1016/0006-291X(75)90573-2; Xiong J, 2012, CLIN INVEST MED, V35, pE117; Zhang L, 2011, HUM REPROD, V26, P2146, DOI 10.1093/humrep/der153	24	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144845	10.1371/journal.pone.0144845	http://dx.doi.org/10.1371/journal.pone.0144845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680220	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400031
J	Milford, D; Rosbach, N; Bendszus, M; Heiland, S				Milford, David; Rosbach, Nicolas; Bendszus, Martin; Heiland, Sabine			Mono-Exponential Fitting in T2-Relaxometry: Relevance of Offset and First Echo	PLOS ONE			English	Article							TRANSVERSE RELAXOMETRY; ARTICULAR-CARTILAGE; SPATIAL VARIATION; T2 RELAXOMETRY; HIPPOCAMPAL T2; MRI; RELAXATION	Introduction T2 relaxometry has become an important tool in quantitative MRI. Little focus has been put on the effect of the refocusing flip angle upon the offset parameter, which was introduced to account for a signal floor due to noise or to long T2 components. The aim of this study was to show that B1 imperfections contribute significantly to the offset. We further introduce a simple method to reduce the systematic error in T2 by discarding the first echo and using the offset fitting approach. Materials and Methods Signal curves of T2 relaxometry were simulated based on extended phase graph theory and evaluated for 4 different methods (inclusion and exclusion of the first echo, while fitting with and without the offset). We further performed T2 relaxometry in a phantom at 9.4T magnetic resonance imaging scanner and used the same methods for post-processing as in the extended phase graph simulated data. Single spin echo sequences were used to determine the correct T2 time. Results The simulation data showed that the systematic error in T2 and the offset depends on the refocusing pulse, the echo spacing and the echo train length. The systematic error could be reduced by discarding the first echo. Further reduction of the systematic T2 error was reached by using the offset as fitting parameter. The phantom experiments confirmed these findings. Conclusion The fitted offset parameter in T2 relaxometry is influenced by imperfect refocusing pulses. Using the offset as a fitting parameter and discarding the first echo is a fast and easy method to minimize the error in T2, particularly for low to intermediate echo train length.	[Milford, David; Rosbach, Nicolas; Bendszus, Martin; Heiland, Sabine] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Milford, D (corresponding author), Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany.	David.Milford@med.uni-heidelberg.de			Deutsche Forschungsgemeinschaft (DFG) [SFB 1118]; Dietmar-Hopp-Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Dietmar-Hopp-Stiftung	This research was supported by grants of the Deutsche Forschungsgemeinschaft (DFG, SFB 1118) and of the Dietmar-Hopp-Stiftung.	Akhondi-Asl A, 2014, LECT NOTES COMPUT SC, V8675, P145, DOI 10.1007/978-3-319-10443-0_19; Andreychenko A, 2013, MAGN RESON MED, V70, P885, DOI 10.1002/mrm.24512; ARMSPACH JP, 1991, MAGN RESON IMAGING, V9, P107, DOI 10.1016/0730-725X(91)90104-T; Bevington P. R., 2003, DATA REDUCTION ERROR, DOI 10.2307/2284752; Carneiro AAO, 2006, BRAZ J PHYS, V36, P9, DOI 10.1590/S0103-97332006000100005; DAMADIAN R, 1971, SCIENCE, V171, P1151, DOI 10.1126/science.171.3976.1151; Dietrich O, 2008, EUR J RADIOL, V65, P29, DOI 10.1016/j.ejrad.2007.11.005; Duncan JS, 1997, AM J NEURORADIOL, V18, P1791; Duncan JS, 1996, AM J NEURORADIOL, V17, P1805; Feng YQ, 2013, MAGN RESON MED, V70, P1765, DOI 10.1002/mrm.24607; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Harms S E, 1986, Radiographics, V6, P117; HENNIG J, 1988, J MAGN RESON, V78, P397, DOI 10.1016/0022-2364(88)90128-X; Hennig J., 1991, CONCEPT MAGNETIC RES, V3, P179, DOI 10.1002/cmr.1820030402; Hennig J., 1991, CONCEPT MAGNETIC RES, V3, P125, DOI [10.1002/cmr.1820030302, DOI 10.1002/CMR.1820030302]; Kanzow C, 2004, J COMPUT APPL MATH, V172, P375, DOI 10.1016/j.cam.2004.02.013; Kosior RK, 2011, NEUROIMAGE, V58, P189, DOI 10.1016/j.neuroimage.2011.06.002; Lebel RM, 2010, MAGN RESON MED, V64, P1005, DOI 10.1002/mrm.22487; Lourakis M. I., LEVENBERG MARQUARDT; Maier CF, 2003, J MAGN RESON IMAGING, V17, P358, DOI 10.1002/jmri.10263; MAJUMDAR S, 1987, MAGNET RESON MED, V4, P203, DOI 10.1002/mrm.1910040302; MAJUMDAR S, 1986, MAGNET RESON MED, V3, P397, DOI 10.1002/mrm.1910030305; MAUDSLEY AA, 1986, J MAGN RESON, V69, P488, DOI 10.1016/0022-2364(86)90160-5; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Mosher TJ, 2000, RADIOLOGY, V214, P259, DOI 10.1148/radiology.214.1.r00ja15259; Neumann D, 2014, MAGN RESON MATER PHY, V27, P567, DOI 10.1007/s10334-014-0438-3; Pell GS, 2006, J MAGN RESON IMAGING, V23, P248, DOI 10.1002/jmri.20490; Pell GS, 2004, NEUROIMAGE, V21, P707, DOI 10.1016/j.neuroimage.2003.09.059; Pell GS, 2003, P ISMRM 11 ANN M; Petrovic A, 2015, MAGN RESON MED, V73, P818, DOI 10.1002/mrm.25170; Prasloski T, 2012, MAGN RESON MED, V67, P1803, DOI 10.1002/mrm.23157; Schar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139859; Smith HE, 2001, J MAGN RESON IMAGING, V14, P50, DOI 10.1002/jmri.1150; St Pierre TG, 2004, NMR BIOMED, V17, P446, DOI 10.1002/nbm.905; THORPE JW, 1995, J NEUROL NEUROSUR PS, V59, P487, DOI 10.1136/jnnp.59.5.487; Tofts P., 2005, QUANTITATIVE MRI BRA, P143; Weigel M., 2014, J MAGN RESON IMAGING; Whittall KP, 1999, MAGNET RESON MED, V41, P1255, DOI 10.1002/(SICI)1522-2594(199906)41:6<1255::AID-MRM23>3.0.CO;2-I; Wood JC, 2005, BLOOD, V106, P1460, DOI 10.1182/blood-2004-10-3982; Zelaya FO, 1997, MAGN RESON IMAGING, V15, P497, DOI 10.1016/S0730-725X(96)00396-7	41	60	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145255	10.1371/journal.pone.0145255	http://dx.doi.org/10.1371/journal.pone.0145255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678918	gold, Green Published, Green Submitted			2022-12-27	WOS:000366723400064
J	Richards, CL; Lawrence, KA; Su, H; Yang, YY; Yang, XF; Dulebohn, DP; Gherardini, FC				Richards, Crystal L.; Lawrence, Kevin A.; Su, Hua; Yang, Youyun; Yang, X. Frank; Dulebohn, Daniel P.; Gherardini, Frank C.			Acetyl-Phosphate Is Not a Global Regulatory Bridge between Virulence and Central Metabolism in Borrelia burgdorferi	PLOS ONE			English	Article							RESPONSE REGULATOR; ESCHERICHIA-COLI; LYME-DISEASE; GENE-EXPRESSION; IN-VITRO; LIPID-II; RPOS; PHOSPHORYLATION; SPIROCHETE; RESISTANCE	In B. burgdorferi, the Rrp2-RpoN-RpoS signaling cascade is a distinctive system that coordinates the expression of virulence factors required for successful transition between its arthropod vector and mammalian hosts. Rrp2 (BB0763), an RpoN specific response regulator, is essential to activate this regulatory pathway. Previous investigations have attempted to identify the phosphate donor of Rrp2, including the cognate histidine kinase, Hk2 (BB0764), non-cognate histidine kinases such as Hk1, CheA1, and CheA2, and small molecular weight P-donors such as carbamoyl-phosphate and acetyl-phosphate (AcP). In a report by Xu et al., exogenous sodium acetate led to increased expression of RpoS and OspC and it was hypothesized this effect was due to increased levels of AcP via the enzyme AckA (BB0622). Genome analyses identified only one pathway that could generate AcP in B. burgdorferi: the acetate/mevalonate pathway that synthesizes the lipid, undecaprenyl phosphate (C-55-P, lipid I), which is essential for cell wall biogenesis. To assess the role of AcP in Rrp2-dependent regulation of RpoS and OspC, we used a unique selection strategy to generate mutants that lacked ackA (bb0622: acetate to AcP) or pta (bb0589: AcP to acetyl-CoA). These mutants have an absolute requirement for mevalonate and demonstrate that ackA and pta are required for cell viability. When the Delta ackA or Delta pta mutant was exposed to conditions (i.e., increased temperature or cell density) that up-regulate the expression of RpoS and OspC, normal induction of those proteins was observed. In addition, adding 20mM acetate or 20mM benzoate to the growth media of B. burgdorferi strain B31 Delta ackA induced the expression of RpoS and OspC. These data suggest that AcP (generated by AckA) is not directly involved in modulating the Rrp2-RpoN-RpoS regulatory pathway and that exogenous acetate or benzoate are triggering an acid stress response in B. burgdorferi.	[Richards, Crystal L.; Lawrence, Kevin A.; Su, Hua; Dulebohn, Daniel P.; Gherardini, Frank C.] NIH, Lab Zoonot Pathogens, Rocky Mt Labs, Hamilton, MT 59840 USA; [Yang, Youyun; Yang, X. Frank] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	National Institutes of Health (NIH) - USA; Indiana University System; Indiana University Bloomington	Gherardini, FC (corresponding author), NIH, Lab Zoonot Pathogens, Rocky Mt Labs, Hamilton, MT 59840 USA.	Fgherardini@niaid.nih.gov			Intramural Research Program of the NIAID (National Institute of Allergy and Infectious Diseases (US)), NIH (National Institutes of Health (US)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000905] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID (National Institute of Allergy and Infectious Diseases (US)), NIH (National Institutes of Health (US)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIAID (National Institute of Allergy and Infectious Diseases (US)), NIH (National Institutes of Health (US)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; BARBOUR AG, 1986, INFECT IMMUN, V52, P549, DOI 10.1128/IAI.52.2.549-554.1986; Blevins JS, 2009, J BACTERIOL, V191, P2902, DOI 10.1128/JB.01721-08; Boardman BK, 2008, INFECT IMMUN, V76, P3844, DOI 10.1128/IAI.00467-08; Bouche S, 1998, MOL MICROBIOL, V27, P787, DOI 10.1046/j.1365-2958.1998.00725.x; Brooks CS, 2003, INFECT IMMUN, V71, P3371, DOI 10.1128/IAI.71.6.3371-3383.2003; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Caimano MJ, 2004, INFECT IMMUN, V72, P6433, DOI 10.1128/IAI.72.11.6433-6445.2004; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; DEVER LL, 1993, ANTIMICROB AGENTS CH, V37, P1115, DOI 10.1128/AAC.37.5.1115; Dulebohn DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093141; Elias AF, 2003, J MOL MICROB BIOTECH, V6, P29, DOI 10.1159/000073406; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Ferry James G., 2015, Life-Basel, V5, P1454, DOI 10.3390/life5021454; Frank KL, 2003, J BACTERIOL, V185, P6723, DOI 10.1128/JB.185.22.6723-6727.2003; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gherardini F., 2010, BORRELIA MOL BIOL HO, P103; Honda M, 2000, J INHERIT METAB DIS, V23, P464, DOI 10.1023/A:1005660130109; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Kazragis RJ, 1996, ANTIMICROB AGENTS CH, V40, P2632, DOI 10.1128/AAC.40.11.2632; Kim SB, 2001, FEMS MICROBIOL LETT, V195, P179, DOI 10.1111/j.1574-6968.2001.tb10518.x; Klein AH, 2007, J BACTERIOL, V189, P5574, DOI 10.1128/JB.00564-07; Kramer NE, 2004, FEMS MICROBIOL LETT, V239, P157, DOI 10.1016/j.femsle.2004.08.033; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Liu XQ, 2009, J MICROBIOL, V47, P657, DOI 10.1007/s12275-009-0087-9; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Martin NI, 2007, FUTURE MICROBIOL, V2, P513, DOI 10.2217/17460913.2.5.513; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; SMITH PJC, 1960, BIOCHEM J, V76, P514, DOI 10.1042/bj0760514; STORM DR, 1974, J BIOL CHEM, V249, P1823; Sze CW, 2011, INFECT IMMUN, V79, P1270, DOI 10.1128/IAI.00871-10; Van Laar TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038171; von Lackum K, 2005, FEMS MICROBIOL LETT, V243, P173, DOI 10.1016/j.femsle.2004.12.002; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002; Xu HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001104; Yang XF, 2000, MOL MICROBIOL, V37, P1470, DOI 10.1046/j.1365-2958.2000.02104.x; Zhao YS, 2005, APPL ENVIRON MICROB, V71, P530, DOI 10.1128/AEM.71.1.530-537.2005	45	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144472	10.1371/journal.pone.0144472	http://dx.doi.org/10.1371/journal.pone.0144472			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26681317	gold, Green Published			2022-12-27	WOS:000366723400016
J	Lorenzo, JR; Alonso, LG; Sanchez, IE				Lorenzo, J. Ramiro; Alonso, Leonardo G.; Sanchez, Ignacio E.			Prediction of Spontaneous Protein Deamidation from Sequence-Derived Secondary Structure and Intrinsic Disorder	PLOS ONE			English	Article							ISOASPARTATE; PEPTIDES; RESIDUES; SERVER; DAMAGE; RATES	Asparagine residues in proteins undergo spontaneous deamidation, a post-translational modification that may act as a molecular clock for the regulation of protein function and turnover. Asparagine deamidation is modulated by protein local sequence, secondary structure and hydrogen bonding. We present NGOME, an algorithm able to predict non-enzymatic deamidation of internal asparagine residues in proteins in the absence of structural data, using sequence-based predictions of secondary structure and intrinsic disorder. Compared to previous algorithms, NGOME does not require three-dimensional structures yet yields better predictions than available sequence-only methods. Four case studies of specific proteins show how NGOME may help the user identify deamidation-prone asparagine residues, often related to protein gain of function, protein degradation or protein misfolding in pathological processes. A fifth case study applies NGOME at a proteomic scale and unveils a correlation between asparagine deamidation and protein degradation in yeast. NGOME is freely available as a webserver at the National EMBnet node Argentina, URL: http://www.embnet.qb.fcen.uba.ar/in the subpage "Protein and nucleic acid structure and sequence analysis".	[Lorenzo, J. Ramiro] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol, Buenos Aires, DF, Argentina; [Alonso, Leonardo G.] Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Buenos Aires, DF, Argentina; [Alonso, Leonardo G.] IIBBA CONICET, Buenos Aires, DF, Argentina; [Sanchez, Ignacio E.] Univ Buenos Aires, Prot Physiol Lab, Dept Quim Biol, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Sanchez, Ignacio E.] Univ Buenos Aires, IQUIBICEN CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Alonso, LG (corresponding author), Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Buenos Aires, DF, Argentina.	leonardoe7@gmail.com; isanchez@qb.fcen.uba.ar		Sanchez, Ignacio Enrique/0000-0003-4284-9013; Alonso, Leonardo Gabriel/0000-0002-0596-703X; Lorenzo Lopez, Juan Ramiro/0000-0002-1860-9418	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) [PICT 2012-2550]; CONICET graduate fellowship	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); CONICET graduate fellowship	Funding was provided by Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina, www.agencia.mincyt.gob.ar), grant number PICT 2012-2550 to IES. Funding was also provided by CONICET graduate fellowship to RL; IES and LGA are career investigators from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Daughdrill GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029207; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Diepold K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030295; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Furuya K, 2009, DEAMIDATED INTERFERO; GEIGER T, 1987, J BIOL CHEM, V262, P785; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Kosky AA, 1999, PROTEIN SCI, V8, P2519; Kosky AA, 2009, PHARM RES-DORDR, V26, P2417, DOI 10.1007/s11095-009-9953-8; Lowenson JD, 2001, J BIOL CHEM, V276, P20695, DOI 10.1074/jbc.M100987200; Patananan AN, 2014, J BIOL CHEM, V289, P16936, DOI 10.1074/jbc.M114.564385; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; Robinson NE, 2002, P NATL ACAD SCI USA, V99, P5283, DOI 10.1073/pnas.082102799; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P4367, DOI 10.1073/pnas.071066498; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; Shi YH, 2013, J AM CHEM SOC, V135, P15897, DOI 10.1021/ja407801x; Sydow JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100736; Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265	21	20	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145186	10.1371/journal.pone.0145186	http://dx.doi.org/10.1371/journal.pone.0145186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674530	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700113
J	Tampubolon, G				Tampubolon, Gindo			Growing Up in Poverty, Growing Old in Infirmity: The Long Arm of Childhood Conditions in Great Britain	PLOS ONE			English	Article							QUALITY-OF-LIFE; ADULTHOOD; HEALTH; CHILDREN; PEOPLE; LEAD; AGE	Background The ageing population poses a tremendous challenge in understanding the sources of inequalities in health. Though they appear to be far removed, childhood conditions are known to be inextricably linked with adult health, and in turn on health in later life. The long arm of childhood conditions hypothesis is often tested using recollection of childhood circumstances, but such subjective recall can yield potentially inaccurate or possibly biased inferences. We tested the long arm hypothesis on three outcomes in later life, arrayed from objective to subjective health, namely: gait speed, episodic memory and mental health. Methods and Findings We used the English Longitudinal Study of Ageing 2006 enriched with retrospective life history (N = 5,913). To deal with recall problems two solutions, covariate measurement and endogenous treatment models, were applied. Retrospective childhood material lack includes growing up without running hot or cold water, fixed bath, indoor lavatory and central heating. Adjustment is made for an extensive set of confounders including sex, age, adult health, wealth, education, occupation, social support, social connections, chronic conditions, smoking, drinking, and physical exercise. It is found that material poverty when growing up shows no association with health when growing old, assuming accurate recall. Once recall problems are controlled, we found that childhood material poverty changes inversely with later life health. Conclusion A poorer childhood goes with slower gait, poorer memory and more depression in later life. This result provides a further impetus to eliminate child poverty.	[Tampubolon, Gindo] Univ Manchester, Cathie Marsh Inst Social Res, Manchester, Lancs, England	University of Manchester	Tampubolon, G (corresponding author), Univ Manchester, Cathie Marsh Inst Social Res, Manchester, Lancs, England.	tampubolon@manchester.ac.uk		Tampubolon, Gindo/0000-0002-9081-2349	Medical Research Council; Economic & Social Research Council [G1001375/1]; Medical Research Council [G1001375] Funding Source: researchfish; MRC [G1001375] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic & Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (www.mrc.ac.uk) and Economic & Social Research Council (www.esrc.ac.uk) to the project "Frailty and inequalities in later life" (Grant number G1001375/1).; This work was supported by the Medical Research Council (www.mrc.ac.uk) and Economic and Social Research Council (www.esrc.ac.uk) through the Lifelong Health and Wellbeing programme to the project 'Frailty and inequalities in later life' (Grant number G1001375/1). We are grateful to comments and questions received from participants in seminars at Lausanne and Manchester, particularly from Eduwin Pakpahan, Rasmus Hoffmann, and Maria Fajarini, Devi Femina, Wulung Hanandita, Asri Maharani.	Alastalo H, 2013, J HUM HYPERTENS, V27, P90, DOI 10.1038/jhh.2012.6; [Anonymous], 2004, LIFE COURSE APPROACH; Banks J, 2008, LIVING 21 CENTURY OL; Banks J., 2006, RETIREMENT HLTH RELA; Berkman LF., 2014, SOCIAL EPIDEMIOLOGY, V2nd ed.; Berndt H, 2016, AGEING SOC, V36, P631, DOI 10.1017/S0144686X14001470; Brown M, 2014, LONGITUD LIFE COURSE, V5, P64, DOI 10.14301/llcs.v5i1.232; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Conger R.D., 1997, CONSEQUENCES GROWING, P288; Coscia JM, 2003, CHILD NEUROPSYCHOL, V9, P10, DOI 10.1076/chin.9.1.10.14498; Freedman D. A., 2005, STAT MODELS THEORY P; Gale CR, 2012, PSYCHOL MED, V42, P2057, DOI 10.1017/S0033291712000402; Holland P, 2000, SOC SCI MED, V50, P1285, DOI 10.1016/S0277-9536(99)00375-5; Hyde M, 2003, AGING MENT HEALTH, V7, P186, DOI 10.1080/1360786031000101157; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY, V174, P290; Kawachi I, 2013, GLOBAL PERSPECTIVES, P87; Kelnar CJH, 2007, GROWTH DISORDERS; Krieger N., 2011, EPIDEMIOLOGY PEOPLES, DOI [DOI 10.1093/ACPROF:OSO/9780195383874.001.0001, DOI 10.1007/s10803-010-0982-2]; Marmot M, 2003, HLTH WEALTH LIFESTYL; Marmot Review, 2010, FAIR SOC HLTH LIV ST; Marsh A, 1999, IMPACT POOR HOUSING; OSTBERG V, 1991, SOC SCI MED, V32, P403, DOI 10.1016/0277-9536(91)90341-9; Rose D, 2003, RES GUIDE NATL STAT; Rosenbaum P. R., 2002, OBSERVATIONAL STUDIE; Schoon I, 2006, RISK AND RESILIENCE: ADAPTATIONS IN CHANGING TIMES, P1, DOI 10.2277/ 0521833744; Skrondal A., 2004, GEN LATENT VARIABLE; Szanton SL, 2010, SOC SCI MED, V71, P259, DOI 10.1016/j.socscimed.2010.04.001; Tampubolon G, 2015, AGING MENT HEALTH, V19, P576, DOI 10.1080/13607863.2014.1003279; Vermunt JK, 2013, LG SYNTAX USERS GUID; Viner RM, 2015, J EPIDEMIOL COMMUN H, V69, P719, DOI 10.1136/jech-2014-205300; Wasserman GA, 2003, CHILD NEUROPSYCHOL, V9, P22, DOI 10.1076/chin.9.1.22.14497; Yohannes AM, 2014, EXPERT REV RESP MED, V8, P515, DOI 10.1586/17476348.2014.919226	33	15	15	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144722	10.1371/journal.pone.0144722	http://dx.doi.org/10.1371/journal.pone.0144722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JH	26675009	Green Submitted, gold, Green Published			2022-12-27	WOS:000366722700057
J	Vitor-Costa, M; Okuno, NM; Bortolotti, H; Bertollo, M; Boggio, PS; Fregni, F; Altimari, LR				Vitor-Costa, Marcelo; Okuno, Nilo Massaru; Bortolotti, Henrique; Bertollo, Maurizio; Boggio, Paulo Sergio; Fregni, Felipe; Altimari, Leandro Ricardo			Improving Cycling Performance: Transcranial Direct Current Stimulation Increases Time to Exhaustion in Cycling	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; BRAIN ACTIVATION; FATIGUE; EXERCISE; EXCITABILITY; ENDURANCE; HUMANS; FORCE	The central nervous system seems to have an important role in fatigue and exercise tolerance. Novel noninvasive techniques of neuromodulation can provide insights on the relationship between brain function and exercise performance. The purpose of this study was to determine the effects of transcranial direct current stimulation (tDCS) on physical performance and physiological and perceptual variables with regard to fatigue and exercise tolerance. Eleven physically active subjects participated in an incremental test on a cycle simulator to define peak power output. During 3 visits, the subjects experienced 3 stimulation conditions (anodal, cathodal, or sham tDCS-with an interval of at least 48 h between conditions) in a randomized, counterbalanced order to measure the effects of tDCS on time to exhaustion at 80% of peak power. Stimulation was administered before each test over 13 min at a current intensity of 2.0 mA. In each session, the Brunel Mood State questionnaire was given twice: after stimulation and after the time-to-exhaustion test. Further, during the tests, the electromyographic activity of the vastus lateralis and rectus femoris muscles, perceived exertion, and heart rate were recorded. RM-ANOVA showed that the subjects performed better during anodal primary motor cortex stimulation (491 +/- 100 s) compared with cathodal stimulation (443 +/- 11 s) and sham (407 +/- 69 s). No significant difference was observed between the cathodal and sham conditions. The effect sizes confirmed the greater effect of anodal M1 tDCS (anodal x cathodal = 0.47; anodal x sham = 0.77; and cathodal x sham = 0.29). Magnitude-based inference suggested the anodal condition to be positive versus the cathodal and sham conditions. There were no differences among the three stimulation conditions in RPE (p = 0.07) or heart rate (p = 0.73). However, as hypothesized, RM-ANOVA revealed a main effect of time for the two variables (RPE and HR: p < 0.001). EMG activity also did not differ during the test accross the different conditions. We conclude that anodal tDCS increases exercise tolerance in a cycling-based, constant-load exercise test, performed at 80% of peak power. Performance was enhanced in the absence of changes in physiological and perceptual variables.	[Vitor-Costa, Marcelo; Bortolotti, Henrique; Altimari, Leandro Ricardo] Univ Estadual Londrina, Grp Study & Res Neuromuscular Syst & Exercise, Londrina, PR, Brazil; [Vitor-Costa, Marcelo; Okuno, Nilo Massaru; Bortolotti, Henrique] Univ Estadual Ponta Grossa, Study Grp Physiol Responses & Adaptat Exercise, Ponta Grossa, PR, Brazil; [Bertollo, Maurizio] Univ G DAnnunzio, Behav Imaging & Neural Dynam Ctr, Dept Med & Aging Sci, Chieti, Italy; [Boggio, Paulo Sergio] Univ Prebiteriana Mackenzie, Cognit Neurosci Lab, Ctr Hlth & Biol Sci, Sao Paulo, Brazil; [Boggio, Paulo Sergio] Univ Prebiteriana Mackenzie, Dev Disorders Program, Ctr Hlth & Biol Sci, Sao Paulo, Brazil; [Fregni, Felipe] Harvard Univ, Sch Med, Spaulding Neuromodulat Ctr, Spaulding Rehabil Hosp, Boston, MA USA; [Fregni, Felipe] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA	Universidade Estadual de Londrina; Universidade Estadual de Ponta Grossa; G d'Annunzio University of Chieti-Pescara; Universidade Presbiteriana Mackenzie; Universidade Presbiteriana Mackenzie; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Vitor-Costa, M (corresponding author), Univ Estadual Londrina, Grp Study & Res Neuromuscular Syst & Exercise, Londrina, PR, Brazil.	marcelovitordacosta@gmail.com	Bortolotti, Henrique/AAC-8240-2020; Bortolotti, Henrique/I-5140-2012; Boggio, Paulo S/K-6272-2012; Bertollo, Maurizio/K-5469-2013	Bortolotti, Henrique/0000-0002-1852-1395; Boggio, Paulo S/0000-0002-6109-0447; Bertollo, Maurizio/0000-0002-0972-9178; Fregni, Felipe/0000-0001-9359-8643	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Support was provided by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2008, MED SCI SPORT EXER, V40, P574, DOI [10.1249/mss.0b013e31815e728f, 10.1249/MSS.0b013e31815e728f]; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Borg G., 1998, BORGS PERCEIVED EXER; Camata T V, 2009, Electromyogr Clin Neurophysiol, V49, P305; Cogiamanian F, 2007, EUR J NEUROSCI, V26, P242, DOI 10.1111/j.1460-9568.2007.05633.x; de Morree HM, 2012, PSYCHOPHYSIOLOGY, V49, P1242, DOI 10.1111/j.1469-8986.2012.01399.x; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Gibson AS, 2003, SPORTS MED, V33, P167; Halheimer W, 2002, CALCULATE EFFECT SIZ; Hermens HJ, 1999, EUROPEAN RECOMMENDAT, V8, P13, DOI [10.1016/S1050-6411(00)00027-4, DOI 10.1016/S1050-6411(00)00027-4]; Hopkins W.G., 2006, SPORTSCIENCE, V10, P46; IKAI M, 1961, J APPL PHYSIOL, V16, P157, DOI 10.1152/jappl.1961.16.1.157; Kaski D, 2014, NEUROSCI LETT, V568, P39, DOI 10.1016/j.neulet.2014.03.043; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Marcora SM, 2009, J APPL PHYSIOL, V106, P857, DOI 10.1152/japplphysiol.91324.2008; Mosso A., 1906, FATIGUE; Nitsche MA, 2003, SUPPL CLIN NEUROPHYS, V56, P255; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Okano AH, 2015, BRIT J SPORT MED, V49, P1213, DOI 10.1136/bjsports-2012-091658; Rohlfs ICPD, 2008, REV BRAS MED ESPORTE, V14, P176, DOI 10.1590/S1517-86922008000300003; Reidler JS, 2011, NEUROFEEDBACK AND NEUROMODULATION TECHNIQUES AND APPLICATIONS, P319, DOI 10.1016/B978-0-12-382235-2.00012-3; Rosenkranz K, 2000, NEUROSCI LETT, V296, P61, DOI 10.1016/S0304-3940(00)01621-9; Rouffet DM, 2008, J ELECTROMYOGR KINES, V18, P866, DOI 10.1016/j.jelekin.2007.03.008; Sidhu SK, 2009, J APPL PHYSIOL, V106, P556, DOI 10.1152/japplphysiol.90911.2008; Tanaka M, 2012, NEUROSCI BIOBEHAV R, V36, P727, DOI 10.1016/j.neubiorev.2011.10.004; Tanaka S, 2011, NEUROREHAB NEURAL RE, V25, P565, DOI 10.1177/1545968311402091; Tanaka S, 2009, EXP BRAIN RES, V196, P459, DOI 10.1007/s00221-009-1863-9; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Tergau F, 2000, MED SCI SPORT EXER, V32, P1942, DOI 10.1097/00005768-200011000-00019; Williams PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081418; Williamson JW, 2001, J APPL PHYSIOL, V90, P1392, DOI 10.1152/jappl.2001.90.4.1392; Williamson JW, 2002, J APPL PHYSIOL, V92, P1317, DOI 10.1152/japplphysiol.00939.2001; Yamaguchi T, 2012, EXP BRAIN RES, V218, P401, DOI 10.1007/s00221-012-3026-7	34	72	76	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144916	10.1371/journal.pone.0144916	http://dx.doi.org/10.1371/journal.pone.0144916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674200	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700072
J	Schneck, H; Gierke, B; Uppenkamp, F; Behrens, B; Niederacher, D; Stoecklein, NH; Templin, MF; Pawlak, M; Fehm, T; Neubauer, H				Schneck, Helen; Gierke, Berthold; Uppenkamp, Frauke; Behrens, Bianca; Niederacher, Dieter; Stoecklein, Nikolas H.; Templin, Markus F.; Pawlak, Michael; Fehm, Tanja; Neubauer, Hans		Disseminated Canc Cell Network DCC	EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer	PLOS ONE			English	Article							ADHESION MOLECULE EXPRESSION; SURFACE CYTOKERATIN 8; STEM-CELL; PROSTATE-CANCER; E-CADHERIN; EP-CAM; BLOOD; PLASMINOGEN; SURVIVAL; PROTEIN	Circulating tumor cells (CTCs) are the potential precursors of metastatic disease. Most assays established for the enumeration of CTCs so far-including the gold standard Cell-Search-rely on the expression of the cell surface marker epithelial cell adhesion molecule (EpCAM). But, these approaches may not detect CTCs that express no/low levels of EpCAM, e.g. by undergoing epithelial-to-mesenchymal transition (EMT). Here we present an enrichment strategy combining different antibodies specific for surface proteins and extracellular matrix (ECM) components to capture an EpCAM(low/neg) cell line and EpCAM(neg) CTCs from blood samples of breast cancer patients depleted for EpCAM-positive cells. The expression of respective proteins (Trop2, CD49f, c-Met, CK8, CD44, ADAM8, CD146, TEM8, CD47) was verified by immunofluorescence on EpCAM(pos) (e.g. MCF7, SKBR3) and EpCAM(low/neg) (MDA-MB-231) breast cancer cell lines. To test antibodies and ECM proteins (e.g. hyaluronic acid (HA), collagen I, laminin) for capturing EpCAMneg cells, the capture molecules were first spotted in a single-and multi-array format onto aldehyde-coated glass slides. Tumor cell adhesion of EpCAM(pos/neg) cell lines was then determined and visualized by Coomassie/MitoTracker staining. In consequence, marginal binding of EpCAM(low/neg) MDA-MB-231 cells to EpCAM-antibodies could be observed. However, efficient adhesion/capturing of EpCAM(low/neg) cells could be achieved via HA and immobilized antibodies against CD49f and Trop2. Optimal capture conditions were then applied to immunomagnetic beads to detect EpCAMneg CTCs from clinical samples. Captured CTCs were verified/quantified by immunofluorescence staining for anti-pan-Cytokeratin (CK)-FITC/anti-CD45 AF647/DAPI. In total, in 20 out of 29 EpCAM-depleted fractions (69%) from 25 metastatic breast cancer patients additional EpCAMneg CTCs could be identified [range of 1-24 CTCs per sample] applying Trop2, CD49f, c-Met, CK8 and/or HA magnetic enrichment. EpCAMneg dual-positive (CKpos/CD45(pos)) cells could be traced in 28 out of 29 samples [range 1-480]. By single-cell array-based comparative genomic hybridization we were able to demonstrate the malignant nature of one EpCAM(neg) subpopulation. In conclusion, we established a novel enhanced CTC enrichment strategy to capture EpCAM(neg) CTCs from clinical blood samples by targeting various cell surface antigens with antibody mixtures and ECM components.	[Schneck, Helen; Uppenkamp, Frauke; Niederacher, Dieter; Fehm, Tanja; Neubauer, Hans] Univ Dusseldorf, Univ Hosp, Dept Obstet & Gynecol, Dusseldorf, Germany; [Schneck, Helen; Uppenkamp, Frauke; Behrens, Bianca; Niederacher, Dieter; Stoecklein, Nikolas H.; Fehm, Tanja; Neubauer, Hans] Univ Dusseldorf, Fac Med, Dusseldorf, Germany; [Gierke, Berthold; Templin, Markus F.; Pawlak, Michael] Univ Tubingen, NMI Nat & Med Sci Inst, Reutlingen, Germany; [Behrens, Bianca; Stoecklein, Nikolas H.] Univ Dusseldorf, Univ Hosp, Dept Gen Visceral & Pediat Surg, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen; Heinrich Heine University Dusseldorf	Neubauer, H (corresponding author), Univ Dusseldorf, Univ Hosp, Dept Obstet & Gynecol, Dusseldorf, Germany.	Hans.Neubauer@med.uni-duesseldorf.de	Neubauer, Hans/C-4467-2016	Neubauer, Hans/0000-0002-3467-4105; Fehm, Tanja/0000-0002-4926-0108	German Ministry for Research and Education ('CTC-Detect') [16SV5121K]	German Ministry for Research and Education ('CTC-Detect')	This project was funded by the German Ministry for Research and Education ('CTC-Detect', no. 16SV5121K).	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Alix-Panabieres Catherine, 2012, Recent Results Cancer Res, V195, P69, DOI 10.1007/978-3-642-28160-0_6; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Baccelli I, 2014, ONCOTARGET, V5, P8147, DOI 10.18632/oncotarget.2385; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Barradas Ana M C, 2013, Cancers (Basel), V5, P1619, DOI 10.3390/cancers5041619; Bidard FC, 2014, LANCET ONCOL, V15, P406, DOI 10.1016/S1470-2045(14)70069-5; Brown TJ, 2009, HYALURONAN CANC BIOL; Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769; BUTLER TP, 1975, CANCER RES, V35, P512; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Chen DH, 2013, CANCER RES, V73, P5821, DOI 10.1158/0008-5472.CAN-13-1080; Cho EH, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016001; Choi H, 2013, LAB CHIP, V13, P970, DOI 10.1039/c2lc41376k; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061770; Coumans FAW, 2012, CLIN CANCER RES, V18, P5711, DOI 10.1158/1078-0432.CCR-12-1585; Driemel C, 2014, ONCOGENE, V33, P4904, DOI 10.1038/onc.2013.441; Fischer JC, 2013, P NATL ACAD SCI USA, V110, P16580, DOI 10.1073/pnas.1313594110; FORNARO M, 1995, INT J CANCER, V62, P610, DOI 10.1002/ijc.2910620520; Gancberg D, 2002, ANN ONCOL, V13, P1036, DOI 10.1093/annonc/mdf252; Gasch C, 2013, CLIN CHEM, V59, P252, DOI 10.1373/clinchem.2012.188557; Gires O, 2014, CELL MOL LIFE SCI, V71, P4393, DOI 10.1007/s00018-014-1693-1; GODFROID E, 1991, J CELL SCI, V99, P595; Gonias Steven L., 2001, Frontiers in Bioscience, V6, pd1403, DOI 10.2741/Gonias; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Gosens MJEM, 2007, MODERN PATHOL, V20, P221, DOI 10.1038/modpathol.3800733; Gozgit JM, 2006, MOL CANCER RES, V4, P905, DOI 10.1158/1541-7786.MCR-06-0147; Grossman HB, 2000, ONCOL REP, V7, P13; Guerra E, 2013, ONCOGENE, V32, P1594, DOI 10.1038/onc.2012.151; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harb W, 2013, TRANSL ONCOL, V6, P528, DOI 10.1593/tlo.13367; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; HEMBROUGH TA, 1995, J CELL SCI, V108, P1071; Hembrough TA, 1996, J BIOL CHEM, V271, P25684, DOI 10.1074/jbc.271.41.25684; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Joosse SA, 2015, EMBO MOL MED, V7, P1, DOI 10.15252/emmm.201303698; Khoo BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099409; Kim YJ, 2014, BIOMATERIALS, V35, P7501, DOI 10.1016/j.biomaterials.2014.05.039; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu F, 2008, NEOPLASIA, V10, P1275, DOI 10.1593/neo.08810; Lu J, 2010, INT J CANCER, V126, P669, DOI 10.1002/ijc.24814; Massoner P, 2014, BRIT J CANCER, V111, P955, DOI 10.1038/bjc.2014.366; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Mikolajczyk SD, 2011, J ONCOL, V2011, DOI 10.1155/2011/252361; Mohlendick B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067031; Mohlendick Birte, 2014, Curr Protoc Cell Biol, V65, DOI 10.1002/0471143030.cb2219s65; Mostert B, 2012, CANCER LETT, V319, P49, DOI 10.1016/j.canlet.2011.12.031; Mostert B, 2011, BREAST CANCER RES TR, V127, P33, DOI 10.1007/s10549-010-0879-y; Muller V, 2009, BREAST CANCER RES TR, V117, P535, DOI 10.1007/s10549-008-0276-y; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nel I, 2014, TRANSL LUNG CANCER R, V3, P100, DOI 10.3978/j.issn.2218-6751.2014.03.05; Neves RPL, 2014, CLIN CHEM, V60, P1290, DOI 10.1373/clinchem.2014.222331; Obermajer N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-88; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pantel K, 2010, TRENDS MOL MED, V16, P398, DOI 10.1016/j.molmed.2010.07.001; Patriarca C, 2012, CANCER TREAT REV, V38, P68, DOI 10.1016/j.ctrv.2011.04.002; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; Powell AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033788; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Qu Q, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-93; Ramakrishnan M, 2013, CANCER RES, V73, P5360, DOI 10.1158/0008-5472.CAN-13-0896; Rao CG, 2005, INT J ONCOL, V27, P49; Romagnoli M, 2014, EMBO MOL MED, V6, P278, DOI 10.1002/emmm.201303373; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneck H, 2013, MOL ONCOL, V7, P976, DOI 10.1016/j.molonc.2013.07.007; Songun I, 2005, BRIT J CANCER, V92, P1767, DOI 10.1038/sj.bjc.6602519; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Tai KY, 2007, ONCOGENE, V26, P3989, DOI 10.1038/sj.onc.1210176; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thurm H, 2003, CLIN CANCER RES, V9, P2598; Trerotola M, 2013, CANCER RES, V73, P3155, DOI 10.1158/0008-5472.CAN-12-3266; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Vannier C, 2013, J BIOL CHEM, V288, P18643, DOI 10.1074/jbc.M113.467787; Vieira AF, 2012, STEM CELLS, V30, P854, DOI 10.1002/stem.1075; Wang C, 1998, CLIN CANCER RES, V4, P567; Wang Y, 2011, INT CONF ACOUST SPEE, P1, DOI 10.1109/PLASMA.2011.5993071; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zhang LL, 2012, CLIN CANCER RES, V18, P5701, DOI 10.1158/1078-0432.CCR-12-1587	87	69	72	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144535	10.1371/journal.pone.0144535	http://dx.doi.org/10.1371/journal.pone.0144535			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695635	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500006
J	Eboreime, E; Abimbola, S; Bozzani, F				Eboreime, Ejemai; Abimbola, Seye; Bozzani, Fiammetta			Access to Routine Immunization: A Comparative Analysis of Supply-Side Disparities between Northern and Southern Nigeria	PLOS ONE			English	Article							HEALTH; DISTANCE; CARE	Background The available data on routine immunization in Nigeria show a disparity in coverage between Northern and Southern Nigeria, with the former performing worse. The effect of socio-cultural differences on health-seeking behaviour has been identified in the literature as the main cause of the disparity. Our study analyses the role of supply-side determinants, particularly access to services, in causing these disparities. Methods Using routine government data, we compared supply-side determinants of access in two Northern states with two Southern states. The states were identified using criteria-based purposive selection such that the comparisons were made between a low-coverage state in the South and a low-coverage state in the North as well as between a high-coverage state in the South and a high-coverage state in the North. Results Human resources and commodities at routine immunization service delivery points were generally insufficient for service delivery in both geographical regions. While disparities were evident between individual states irrespective of regional location, compared to the South, residents in Northern Nigeria were more likely to have vaccination service delivery points located within a 5km radius of their settlements. Conclusion Our findings suggest that regional supply-side disparities are not apparent, reinforcing the earlier reported socio-cultural explanations for disparities in routine immunization service uptake between Northern and Southern Nigeria. Nonetheless, improving routine immunisation coverage services require that there are available human resources and that health facilities are equitably distributed.	[Eboreime, Ejemai; Abimbola, Seye] Natl Primary Hlth Care Dev Agcy, Dept Planning Res & Stat, Abuja, Nigeria; [Abimbola, Seye] Univ Sydney, Sydney Med Sch, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Bozzani, Fiammetta] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England	University of Sydney; University of London; London School of Hygiene & Tropical Medicine	Eboreime, E (corresponding author), Natl Primary Hlth Care Dev Agcy, Dept Planning Res & Stat, Abuja, Nigeria.	ejemaim@gmail.com	Eboreime, Ejemai/J-4321-2019	Eboreime, Ejemai/0000-0001-8277-2570; Abimbola, Seye/0000-0003-1294-3850				Abdul M., 2012, ANAL SOCIOECONOMIC R; Abimbola S, 2014, HEALTH POLICY PLANN, V29, P29, DOI 10.1093/heapol/czu069; Africa Health Workforce Observatory (AHWO), 2008, HUM RES HLTH COUNTR; Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; Antai D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-181; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Baker JB, 2008, FIELD METHOD, V20, P296, DOI 10.1177/1525822X08317114; Centres for Disease Control and Prevention (CDC), 2013, GLOB ROUT VACC COV 2; EIU Canback, CANB GLOB INC DISTR; Federal Government of Nigeria, 2009, NAT IMM POL; Federal Ministry of Health, NAT HLTH MAN INF SYS; Federal Ministry of Health (FMOH), 2004, REV NAT HLTH POL; Federal Republic of Nigeria, 1979, CONSTITUTION FEDERAL; Feikin DR, 2009, TROP MED INT HEALTH, V14, P54, DOI 10.1111/j.1365-3156.2008.02193.x; FMOH Nigeria, 2010, NAT STRAT HLTH DEV P; Gupta M. D., 2003, DECENTRALIZED DELIVE; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Howard N., 2011, MEASURES ASS IMPACT, P28; International Vaccine Access Center [IVAC], 2012, NIG 1 NAT VACC SUMM; Jarol M, 2012, GLOBAL ADV RES J SOC, V1, P72; Lukpata VI., 2013, INT J PUBLIC ADM MAN, V2, P32; Mangal TD, 2014, LANCET GLOB HEALTH, V2, pE90, DOI 10.1016/S2214-109X(13)70168-2; Muller I, 1998, INT J EPIDEMIOL, V27, P878, DOI 10.1093/ije/27.5.878; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; National Primary Health Care Development Agency, 2013, ANN REP NAT PRIM HEA; [National Primary Health Care Development Agency (NPHCDA) National Primary Health Care Development Agency (NPHCDA)], 2010, NIG IMM COV SURV NIC; Nigeria EVM Assessment, 2012, ROUT IMM PROGR NIG V; NPHCDA, 2013, I PRIM HLTH CAR REV; NPHCDA, 2012, GUID TRAIN RES PERS; Ojo K, 2011, CHECOD WORKING PAPER; Okehie-Offoha, 1996, ETHNIC CULTURAL DIVE; Pullan R., 2014, PLOS MED, V11; STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8; Stokes-Prindle C., 2012, LANDSCAPE ANAL ROUTI; Suberu R.T., 2005, HIST IDENTITIES VIOL; World Health Organization (WHO), 2014, WHO UNICEF EST NAT I	36	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144876	10.1371/journal.pone.0144876	http://dx.doi.org/10.1371/journal.pone.0144876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692215	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000367092300025
J	Hernandez-Pliego, J; Rodriguez, C; Bustamante, J				Hernandez-Pliego, Jesus; Rodriguez, Carlos; Bustamante, Javier			Why Do Kestrels Soar?	PLOS ONE			English	Article							FALCO-NAUMANNI; FLIGHT STRATEGIES; ECOLOGICAL ENERGETICS; THERMAL-CONVECTION; ENERGY LANDSCAPES; MIGRATING RAPTORS; LESSER KESTRELS; GLIDING FLIGHT; BIRDS; MOVEMENT	Individuals allocate considerable amounts of energy to movement, which ultimately affects their ability to survive and reproduce. Birds fly by flapping their wings, which is dependent on the chemical energy produced by muscle work, or use soaring-gliding flight, in which chemical energy is replaced with energy harvested from moving air masses, such as thermals. Flapping flight requires more energy than soaring-gliding flight, and this difference in the use of energy increases with body mass. However, soaring-gliding results in lower speeds than flapping, especially for small species. Birds therefore face a trade-off between energy and time costs when deciding which flight strategy to use. Raptors are a group of large birds that typically soar. As relatively light weight raptors, falcons can either soar on weak thermals or fly by flapping with low energy costs. In this paper, we study the flight behavior of the insectivorous lesser kestrel (Falco naumanni) during foraging trips and the influence of solar radiation, which we have adopted as a proxy for thermal formation, on kestrel flight variables. We tracked 35 individuals from two colonies using high frequency GPS-dataloggers over four consecutive breeding seasons. Contrary to expectations, kestrels relied heavily on thermal soaring when foraging, especially during periods of high solar radiation. This produced a circadian pattern in the kestrel flight strategy that led to a spatial segregation of foraging areas. Kestrels flapped towards foraging areas close to the colony when thermals were not available. However, as soon as thermals were formed, they soared on them towards foraging areas far from the colony, especially when they were surrounded by poor foraging habitats. This reduced the chick provisioning rate at the colony. Given that lesser kestrels have a preference for feeding on large insects, and considering the average distance they cover to capture them during foraging trips, to commute using flapping flight would result in a negative energy balance for the family group. Our results show that lesser kestrels prioritize saving energy when foraging, suggesting that kestrels are more energy than time-constrained during the breeding season.	[Hernandez-Pliego, Jesus; Bustamante, Javier] EBD CSIC, Dept Wetland Ecol, Seville 41092, Spain; [Rodriguez, Carlos] EBD CSIC, Dept Conservat Biol, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Hernandez-Pliego, J (corresponding author), EBD CSIC, Dept Wetland Ecol, C Americo Vespucio S-N, Seville 41092, Spain.	jhpliego@ebd.csic.es	Bustamante, Javier/C-2735-2008; Bustamante, Javier/AAA-7273-2019; Hernández-Pliego, Jesús/M-4067-2015	Bustamante, Javier/0000-0001-7515-0677; Bustamante, Javier/0000-0001-7515-0677; Hernández-Pliego, Jesús/0000-0002-7343-4518	Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia [P09-RNM-04588]; FEDER funds from the European Union; JAE; Spanish National Research Council; European Social Fund	Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia(Junta de Andalucia); FEDER funds from the European Union(European Commission); JAE; Spanish National Research Council; European Social Fund(European Social Fund (ESF))	This study was funded by the "HORUS" project (ref: P09-RNM-04588) financed by the Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia and FEDER funds from the European Union. J. Hernandez-Pliego and C. Rodriguez were supported by JAE-predoc and a JAE-doc fellowships, respectively, co-funded by the Spanish National Research Council and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank J.A. Bellas, E. Munoz, I. Piudo, and A. Quilez for their support during field work. We are also grateful to G. Anastasiou and C. Morrison for revising the English. Sergio A. Lambertucci, Zsuzsa Akos, Todd Katzner, and Judy Shamoun-Baranes made useful comments on an early draft of this manuscript. This study was funded by the "HORUS" project (ref: P09-RNM-04588) financed by the Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia and FEDER funds from the European Union. J. Hernandez-Pliego and C. Rodriguez were supported by JAE-predoc and a JAE-doc fellowships, respectively, co-funded by the Spanish National Research Council and the European Social Fund.	Agostini N, 2015, ITAL J ZOOL, V82, P186, DOI 10.1080/11250003.2015.1009404; Agostini N, 2015, CURR ZOOL IN PRESS, V61; Akos Z, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/4/045003; Alerstam T, 2001, J THEOR BIOL, V209, P319, DOI 10.1006/jtbi.2001.2266; ALES RF, 1992, LANDSCAPE ECOL, V7, P3, DOI 10.1007/BF02573953; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; BAUDINETTE RV, 1974, NATURE, V248, P83, DOI 10.1038/248083b0; Bishop CM, 2015, SCIENCE, V347, P250, DOI 10.1126/science.1258732; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; Bonal R, 2008, J AVIAN BIOL, V39, P189, DOI 10.1111/j.2008.0908-8857.04125.x; Bustamante J, 1997, BIOL CONSERV, V80, P153, DOI 10.1016/S0006-3207(96)00136-X; Catry I, 2014, BIRD STUDY, V61, P447, DOI 10.1080/00063657.2014.953031; Cramp S, 1980, THE BIRDS OF THE WES, VII; Dodge S, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-3; Duerr AE, 2015, FUNCT ECOL, V29, P779, DOI 10.1111/1365-2435.12381; Duerr AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035548; Duriez O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084887; ELLINGTON CP, 1991, J EXP BIOL, V160, P71; Fagan WF, 2013, ECOL LETT, V16, P1316, DOI 10.1111/ele.12165; GARRATT JR, 1994, EARTH-SCI REV, V37, P89, DOI 10.1016/0012-8252(94)90026-4; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; HEDENSTROM A, 1993, PHILOS T ROY SOC B, V342, P353, DOI 10.1098/rstb.1993.0164; Hedenstrom A, 2008, PHILOS T R SOC B, V363, P287, DOI 10.1098/rstb.2007.2140; Hernandez-Pliego J, 2014, CURR ZOOL, V60, P604, DOI 10.1093/czoolo/60.5.604; Kumar RS, 2014, MISTNESY, V15, P14; Lanzone MJ, 2012, BIOL LETTERS, V8, P710, DOI 10.1098/rsbl.2012.0359; LASIEWSKI RC, 1967, CONDOR, V69, P13, DOI 10.2307/1366368; Liminana R, 2013, BEHAV ECOL SOCIOBIOL, V67, P823, DOI 10.1007/s00265-013-1506-9; Liminana R, 2012, IBIS, V154, P389, DOI 10.1111/j.1474-919X.2011.01210.x; Lopez-Lopez P, 2010, LANDSCAPE ECOL, V25, P803, DOI 10.1007/s10980-010-9460-7; MASMAN D, 1986, ARDEA, V74, P24; MASMAN D, 1988, ARDEA, V76, P64; Mateos-Rodriguez M, 2012, BEHAV ECOL, V23, P403, DOI 10.1093/beheco/arr204; Mellone U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039833; MENDELSOHN JM, 1989, OSTRICH, V60, P35, DOI 10.1080/00306525.1989.9634503; Norberg Ulla M., 1996, P199; Pennycuick CJ, 2008, THEOR ECOL SER, P1; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; PENNYCUICK CJ, 1971, J EXP BIOL, V55, P13; Portugal SJ, 2014, NATURE, V505, P399, DOI 10.1038/nature12939; R Core Team, 2014, LANG ENV STAT COMP; Rodriguez A, 2014, J EXP ZOOL PART A, V321, P376, DOI 10.1002/jez.1868; Rodriguez C, 2008, BIODIVERS CONSERV, V17, P1753, DOI 10.1007/s10531-008-9381-9; Rodriguez C, 2014, BIRD CONSERV INT, V24, P438, DOI 10.1017/S0959270913000129; Rodriguez C, 2010, J RAPTOR RES, V44, P120, DOI 10.3356/JRR-09-34.1; RUDOLPH SG, 1982, ECOLOGY, V63, P1268, DOI 10.2307/1938854; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Sachs G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041449; Sapir N, 2011, P ROY SOC B-BIOL SCI, V278, P3380, DOI 10.1098/rspb.2011.0358; Sapir N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013956; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schmidt-Nielsen K, 1997, ANIMAL PHYSIOLOGY; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; Shamoun-Baranes J, 2003, CONDOR, V105, P208, DOI 10.1650/0010-5422(2003)105[0208:DUOTCB]2.0.CO;2; Shannon HD, 2002, CONDOR, V104, P679, DOI 10.1650/0010-5422(2002)104[0679:AWPSFT]2.0.CO;2; Shepard ELC, 2013, AM NAT, V182, P298, DOI 10.1086/671257; Spaar R, 1997, IBIS, V139, P523, DOI 10.1111/j.1474-919X.1997.tb04669.x; Spaar R, 1997, CONDOR, V99, P458, DOI 10.2307/1369952; Strandberg R, 2009, ARDEA, V97, P287, DOI 10.5253/078.097.0304; Telia J, 1996, THESIS; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Van Huis A., 2013, EDIBLE INSECTS FUTUR, P67; Vansteelant WMG, 2014, J FIELD ORNITHOL, V85, P40, DOI 10.1111/jofo.12048; VISCOR G, 1987, COMP BIOCHEM PHYS A, V87, P231, DOI 10.1016/0300-9629(87)90118-6; Wall J, 2006, CURR BIOL, V16, pR527, DOI 10.1016/j.cub.2006.06.049; Wilson RP, 2012, P ROY SOC B-BIOL SCI, V279, P975, DOI 10.1098/rspb.2011.1544; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; YOUNG GS, 1988, EARTH-SCI REV, V25, P179, DOI 10.1016/0012-8252(88)90020-7	70	15	15	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145402	10.1371/journal.pone.0145402	http://dx.doi.org/10.1371/journal.pone.0145402			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689780	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092300071
J	Hurtado, R; Fabrizio, T; Vanstreels, RET; Krauss, S; Webby, RJ; Webster, RG; Durigon, EL				Hurtado, Renata; Fabrizio, Thomas; Vanstreels, Ralph Eric Thijl; Krauss, Scott; Webby, Richard J.; Webster, Robert G.; Durigon, Edison Luiz			Molecular Characterization of Subtype H11N9 Avian Influenza Virus Isolated from Shorebirds in Brazil	PLOS ONE			English	Article							CONTAINS GENES; WILD BIRDS; SEQUENCE; WATERFOWL; OUTBREAK; EQUINE; DUCK	Migratory aquatic birds play an important role in the maintenance and spread of avian influenza viruses (AIV). Many species of aquatic migratory birds tend to use similar migration routes, also known as flyways, which serve as important circuits for the dissemination of AIV. In recent years there has been extensive surveillance of the virus in aquatic birds in the Northern Hemisphere; however in contrast only a few studies have been attempted to detect AIV in wild birds in South America. There are major flyways connecting South America to Central and North America, whereas avian migration routes between South America and the remaining continents are uncommon. As a result, it has been hypothesized that South American AIV strains would be most closely related to the strains from North America than to those from other regions in the world. We characterized the full genome of three AIV subtype H11N9 isolates obtained from ruddy turnstones (Arenaria interpres) on the Amazon coast of Brazil. For all gene segments, all three strains consistently clustered together within evolutionary lineages of AIV that had been previously described from aquatic birds in North America. In particular, the H11N9 isolates were remarkably closely related to AIV strains from shorebirds sampled at the Delaware Bay region, on the Northeastern coast of the USA, more than 5000 km away from where the isolates were retrieved. Additionally, there was also evidence of genetic similarity to AIV strains from ducks and teals from interior USA and Canada. These findings corroborate that migratory flyways of aquatic birds play an important role in determining the genetic structure of AIV in the Western hemisphere, with a strong epidemiological connectivity between North and South America.	[Hurtado, Renata] Univ Sao Paulo, Sch Vet Med, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, Brazil; [Fabrizio, Thomas; Krauss, Scott; Webby, Richard J.; Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; [Vanstreels, Ralph Eric Thijl] Univ Sao Paulo, Sch Vet Med, Dept Pathol, Lab Wildlife Comparat Pathol, Sao Paulo, Brazil; [Hurtado, Renata; Durigon, Edison Luiz] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Biosafety Level 3, Sao Paulo, Brazil	Universidade de Sao Paulo; St Jude Children's Research Hospital; Universidade de Sao Paulo; Universidade de Sao Paulo	Hurtado, R (corresponding author), Univ Sao Paulo, Sch Vet Med, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, Brazil.	renata_fh@yahoo.com.br	Fabrizio, Thomas/J-9935-2013; Webby, Richard J/N-5657-2018	Fabrizio, Thomas/0000-0002-8960-0728; Durigon, Edison/0000-0003-4898-6553	Sao Paulo Research Foundation; National Counsel of Technological and Scientific Development, and Coordination for the Improvement of Higher Education Personnel	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development, and Coordination for the Improvement of Higher Education Personnel	This research was funded by Sao Paulo Research Foundation, National Counsel of Technological and Scientific Development, and Coordination for the Improvement of Higher Education Personnel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTAS P. T. Z., 1983, WADER STUDY GROUP B, V39, P52; Bahl J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003570; BECKER WB, 1966, J HYG-CAMB, V64, P309, DOI 10.1017/S0022172400040596; BirdLife International, 2012, IUCN RED LIST THREAT, V2012, DOI [http://dx.doi.org/10.2305/lUCN.UK.2012-1.RLTS, DOI 10.2305/IUCN.UK.2012-1.RLTS.]; Blanco DE, 2008, MAPPING WATERBIRD DI; Boere CG, 2006, WATERBIRDS WORLD, P40; Chen CY, 2012, J VIROL, V86, P11950, DOI 10.1128/JVI.02167-12; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; Gill JS, 2006, EMERG INFECT DIS, V12, P1284, DOI 10.3201/eid1708.060492; Hallgrimsson Gunnar Thor, 2011, Marine Ornithology, V39, P137; Hanson BA, 2008, J WILDLIFE DIS, V44, P351, DOI 10.7589/0090-3558-44.2.351; Hay AJ, 1998, TXB INFLUENZA, P43; Hurt AC, 2014, MBIO, V5, DOI 10.1128/mBio.01098-14; Karlsson EA, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.20; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; Kayali G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026818; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Mathieu C, 2015, VIRUS RES, V199, P42, DOI 10.1016/j.virusres.2015.01.008; Maximino C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103943; Minton C, 2010, EXCITING RESULTS GEO; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pasick J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09484; Pawar SD, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-251; Ramey AM, 2010, VIROLOGY, V401, P179, DOI 10.1016/j.virol.2010.02.006; Rimondi A, 2011, J VIROL, V85, P13354, DOI 10.1128/JVI.05946-11; Spackman E, 2007, AVIAN DIS, V51, P273, DOI 10.1637/7529-032106R.1; Spackman E, 2006, J VIROL, V80, P7760, DOI 10.1128/JVI.00445-06; Stailknecht DE, 2007, J WILDLIFE DIS, V43, pS15; Stallknecht DE, 2012, J WILDLIFE DIS, V48, P382, DOI 10.7589/0090-3558-48.2.382; Stallknecht D. E., 2008, AVIAN INFLUENZA, V1, P43, DOI DOI 10.1002/9780813818634.ch3; Suarez D. L., 2008, AVIAN INFLUENZA, P3; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; World Health Organization, 2014, AV INFL FACT SHEET; Wu HB, 2015, ARCH VIROL, V160, P2595, DOI 10.1007/s00705-015-2528-6; Wu Y, 2014, TRENDS MICROBIOL, V22, P183, DOI 10.1016/j.tim.2014.01.010; Xu KM, 2012, VIRUS RES, V168, P41, DOI 10.1016/j.virusres.2012.06.010; Zhang Y, 2012, J VIROL, V86, P12443, DOI 10.1128/JVI.02236-12	45	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145627	10.1371/journal.pone.0145627	http://dx.doi.org/10.1371/journal.pone.0145627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689791	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300091
J	Vancova, M; Nebesarova, J				Vancova, Marie; Nebesarova, Jana			Correlative Fluorescence and Scanning Electron Microscopy of Labelled Core Fucosylated Glycans Using Cryosections Mounted on Carbon-Patterned Glass Slides	PLOS ONE			English	Article							SALIVARY-GLAND; N-GLYCANS; TICK; GLYCOSYLATION; FUCOSE	The aim of the study is co-localization of N-glycans with fucose attached to N-acetylglucosamine in alpha 1,3 linkage, that belong to immunogenic carbohydrate epitopes in humans, and N-glycans with alpha 1,6-core fucose typical for mammalian type of N-linked glycosylation. Both glycan epitopes were labelled in cryosections of salivary glands isolated from the tick Ixodes ricinus. Salivary glands secrete during feeding many bioactive molecules and influence both successful feeding and transmission of tick-borne pathogens. For accurate and reliable localization of labelled glycans in both fluorescence and scanning electron microscopes, we used carbon imprints of finder or indexed EM grids on glass slides. We discuss if the topographical images can provide information about labelled structures, the working setting of the field-emission scanning electron microscope and the influence of the detector selection (a below-the-lens Autrata improved YAG detector of back-scattered electrons; in-lens and conventional Everhart-Thornley detectors of secondary electrons) on the imaging of gold nanoparticles, quantum dots and osmium-stained membranes.	[Vancova, Marie; Nebesarova, Jana] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Vvi, CR-37005 Ceske Budejovice, Czech Republic; [Vancova, Marie] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Nebesarova, Jana] Charles Univ Prague, Fac Sci, Prague, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Charles University Prague	Vancova, M (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Vvi, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	vancova@paru.cas.cz	Vancova, Marie/G-8347-2014; Nebesarova, Jana/G-7351-2014	Vancova, Marie/0000-0003-0678-8268; Nebesarova, Jana/0000-0002-0897-7487	Biology Centre of the ASCR [TTE01020118]; EU-FP7 ANTIGONE, Biology Centre of the ASCR [278976]	Biology Centre of the ASCR; EU-FP7 ANTIGONE, Biology Centre of the ASCR	This work was supported by TTE01020118 - Biology Centre of the ASCR (JN); EU-FP7 ANTIGONE, project number 278976 Biology Centre of the ASCR (MV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht RM, 2013, ADV MICROS MICROANAL, P83; Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Benedetti L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07033; BINNINGTON KC, 1978, INT J PARASITOL, V8, P97, DOI 10.1016/0020-7519(78)90004-8; Brown E, 2009, SEMIN CELL DEV BIOL, V20, P910, DOI 10.1016/j.semcdb.2009.07.006; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dupejova J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-4; Erlandsen SL, 1999, SCANNING MICROSCOPY, V13, P43; FAWCETT DW, 1981, TISSUE CELL, V13, P231, DOI 10.1016/0040-8166(81)90003-3; Hermann R, 1996, HISTOCHEM CELL BIOL, V106, P31; Intra J, 2015, INSECT BIOCHEM MOLEC, V63, P133, DOI 10.1016/j.ibmb.2015.06.011; Kaufman W.R., 1982, PHYSL TICKS, P213; Kopek BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077209; Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Liv N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055707; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Man P, 2008, EUR J MASS SPECTROM, V14, P345, DOI 10.1255/ejms.979; Morandi V, 2007, J APPL PHYS, V101, DOI 10.1063/1.2745333; Nebesarova J, 2015, NANOMED-NANOTECHNOL, DOI [10.1016/j.nano.2015.09.008, DOI 10.1016/J.NAN0.2015.09.008]; Nisman R, 2004, J HISTOCHEM CYTOCHEM, V52, P13, DOI 10.1177/002215540405200102; Pedra JHF, 2010, CELL MICROBIOL, V12, P1222, DOI 10.1111/j.1462-5822.2010.01464.x; Reimer L., 1998, SCAN ELECTRON MICROS, V2nd ed, DOI [10.1007/978-3-540-38967-5, DOI 10.1007/978-3-540-38967-5]; Seiter J, 2014, J MICROSC-OXFORD, V254, P75, DOI 10.1111/jmi.12120; Staudacher E, 1999, BBA-GEN SUBJECTS, V1473, P216, DOI 10.1016/S0304-4165(99)00181-6; Sterba J, 2014, CARBOHYD RES, V389, P93, DOI 10.1016/j.carres.2014.02.017; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; TOKUYASU KT, 1978, J ULTRA MOL STRUCT R, V63, P287, DOI 10.1016/S0022-5320(78)80053-7; van Die I, 1999, FEBS LETT, V463, P189, DOI 10.1016/S0014-5793(99)01508-2; Vancova M, 2011, MICROSC MICROANAL, V17, P810, DOI 10.1017/S1431927611000547; Wandrol P, 2014, MICROSC MICROANAL S3, V20, P1266; Watanabe S, 2012, METHOD CELL BIOL, V111, P283, DOI 10.1016/B978-0-12-416026-2.00015-7; Zonnevylle AC, 2013, J MICROSC-OXFORD, V252, P58, DOI 10.1111/jmi.12071	33	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145034	10.1371/journal.pone.0145034	http://dx.doi.org/10.1371/journal.pone.0145034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690057	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092300033
J	Agnarson, AM; Stromdahl, S; Levira, F; Masanja, H; Thorson, AE				Agnarson, Abela Mpobela; Stromdahl, Susanne; Levira, Francis; Masanja, Honorati; Thorson, Anna Ekeus			Female-Driven Multiple Concurrent Sexual Partnership Systems in a Rural Part of a Southern Tanzanian Province	PLOS ONE			English	Article							HIV EPIDEMICS; AFRICA	Background Multiple concurrent sexual relationships are one of the major challenges to HIV prevention in Tanzania. This study aims to explore sexual behaviour patterns including the practice of multiple concurrent sexual partnerships in a rural Tanzanian setting. Methods This qualitative study used focus group discussions and in-depth interviews with men and women from the community as well as ethnographic participant observations. The data was collected during 16 months of fieldwork in 2007, 2008, and 2009. The focus group discussions and in-depth interviews were transcribed verbatim and translated into English. The data was analysed through the process of latent content analysis. An open coding coding process was applied to create categories and assign themes. Findings Mafiga matatu was an expression used in this society to describe women's multiple concurrent sexual partners, usually three partners, which was described as a way to ensure social and financial security for their families as well as to achieve sexual pleasure. Adolescent initiation ceremonies initiated and conducted by grand mothers taught young women why and how to engage successfully in multiple concurrent sexual relationships. Some men expressed support for their female partners to behave according to mafiga matatu, while other men were hesitant around this behaviour. Our findings indicate that having multiple concurrent sexual partners is common and a normative behaviour in this setting. Economical factors and sexual pleasure were identified as drivers and viewed as legitimate reason for women to have multiple concurrent sexual partnerships. Conclusions Structural changes improving women's financial opportunities and increasing gender equality will be important to enable women to not depend on multiple concurrent sexual partnerships for financial security. Future research should explore how normative sexual behaviour changes as these structural changes take place.	[Agnarson, Abela Mpobela; Stromdahl, Susanne; Thorson, Anna Ekeus] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Levira, Francis; Masanja, Honorati] Ifakara Hlth Inst, Dar Es Salaam, Tanzania	Karolinska Institutet; Ifakara Health Institute	Agnarson, AM (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	abela.agnarson@ki.se		Thorson, Anna/0000-0002-8703-6561; Levira, Francis/0000-0002-7063-2447; Stromdahl, Susanne/0000-0002-6706-0177	Swedish Medical Research Council (Vetenskapsradet, VR)	Swedish Medical Research Council (Vetenskapsradet, VR)	This research project was part of a project financed by the Swedish Medical Research Council (Vetenskapsradet, VR), (http://www.vr.se). AA SS AT received funding. The funders of this project did not play a role in the analysis of the data, preparation of the manuscript, or decision to publish the results.	[Anonymous], 2007, QUALITATIVE METHODOL; Baird S, 2010, HEALTH ECON, V19, P55, DOI 10.1002/hec.1569; Beidelman T., 1967, MATRILINEAL PEOPLES; Caplan A, 1976, BOYS CIRCUMCISION GI; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Dahlgren LE, 2014, QUALITATIVE METHODOL; Dewalt K., 2002, PARTICIPANT OBSERVAT; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Halley Meghan., 2012, THESIS; Helle-Valle J, 2005, UNDERSTANDING SEXUAL; Hennink MM, 2007, INTERNATIONAL FOCUS GROUP RESEARCH: A HANDBOOK FOR THE HEALTH AND SOCIAL SCIENCES, P1, DOI 10.1017/CBO9780511619458; Hobbs D., 2001, HDB ETHNOGRAPHY, P204; Huygens P, 1996, SOC SCI MED, V42, P221, DOI 10.1016/0277-9536(95)00088-7; Kinsman J, 2000, Cult Health Sex, V2, P151, DOI 10.1080/136910500300778; Larsen Kjersti., 1990, OCCASIONAL PAPERS SO; Leclerc-Madlala S, 2009, SEX HEALTH, V6, P103, DOI 10.1071/SH08032; Liv H, 2015, AFR TODAY, V51, P57; Mah TL, 2010, AIDS BEHAV, V14, P11, DOI 10.1007/s10461-008-9433-x; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Malisha L, 2008, HEALTH RISK SOC, V10, P585, DOI 10.1080/13698570802533713; Mamuya S, 1972, JANDO UNYAGO; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2011, LANCET, V378, P1843, DOI 10.1016/S0140-6736(11)61803-5; National AIDS Control Program, 2011, HIV AIDS STI SURV RE; Patton MQ, 2002, QUALITATIVE METHODS; Philemon MN, 2007, FACTORS CONTRIBUTING; Plotkin M, 2011, UNPEELED MANGO QUALI; Schneider D. M., 1961, MATRILINEAL KINSHIP; Stoebenau Kirsten, 2011, Global Health, V7, P34, DOI 10.1186/1744-8603-7-34; Stovall James G., 2005, JOURNALISM WHO WHAT; Swantz M, 1969, RELIG MAGICAL RITES; Tanzania Commission for AIDS, 2012, COUNTRY PROGRESS REP; UNAIDS, 2009, CONS HELD DEF MEAS C; UNICEF, 2001, EQ GIRLS BOYS BAS ED; United Nations Educational Scientific and Cultural Organization and The United Republic of Tanzania Ministry of Education and Vocational Training, 2011, TANZ ED SECT AN; Van de Walle E, 1995, SEXUAL INITIATION TR; Wamoyi J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-742; WEMBAH-RASHID J.A., 1975, ETHNO HIST MATRILINE; Wembah-Rashid JAR, 1994, AFRICAN ANTHR, V1, P49; Zembe YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051998	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145297	10.1371/journal.pone.0145297	http://dx.doi.org/10.1371/journal.pone.0145297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9KM	26683189	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800060
J	Ge, CM; Che, LX; Du, CY				Ge, Chunmin; Che, Lixiao; Du, Chunying			The UBC Domain Is Required for BRUCE to Promote BRIT1/MCPH1 Function in DSB Signaling and Repair Post Formation of BRUCE-USP8-BRIT1 Complex	PLOS ONE			English	Article							DAMAGE RESPONSIVE PROTEIN; DOUBLE-STRAND BREAKS; FANCONI-ANEMIA; UBIQUITIN LIGASE; DNA; RNF168; IAP; APOPTOSIS; RNF8; CYTOKINESIS	BRUCE is implicated in the regulation of DNA double-strand break response to preserve genome stability. It acts as a scaffold to tether USP8 and BRIT1, together they form a nuclear BRUCE-USP8-BRIT1 complex, where BRUCE holds K63-ubiquitinated BRIT1 from access to DSB in unstressed cells. Following DSB induction, BRUCE promotes USP8 mediated deubiquitination of BRIT1, a prerequisite for BRIT1 to be released from the complex and recruited to DSB by binding to gamma-H2AX. BRUCE contains UBC and BIR domains, but neither is required for the scaffolding function of BRUCE mentioned above. Therefore, it remains to be determined whether they are required for BRUCE in DSB response. Here we show that the UBC domain, not the BIR domain, is required for BRUCE to promote DNA repair at a step post the formation of BRUCE-USP8-BRIT1 complex. Mutation or deletion of the BRUCE UBC domain did not disrupt the BRUCE-USP8-BRIT1 complex, but impaired deubiquitination and consequent recruitment of BRIT1 to DSB. This leads to impaired chromatin relaxation, decreased accumulation of MDC1, NBS1, pATM and RAD51 at DSB, and compromised homologous recombination repair of DNA DSB. These results demonstrate that in addition to the scaffolding function in complex formation, BRUCE has an E3 ligase function to promote BRIT1 deubiquitination by USP8 leading to accumulation of BRIT1 at DNA double-strand break. These data support a crucial role for BRUCE UBC activity in the early stage of DSB response.	[Ge, Chunmin; Che, Lixiao; Du, Chunying] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Du, CY (corresponding author), Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA.	ducg@ucmail.uc.edu			National Institutes of Health [CA158323]; NATIONAL CANCER INSTITUTE [R01CA158323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health Grants CA158323 (to C.D.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Rachid Drissi at Cincinnati Children Hospital Medical Center for MNase protocol; Dr. Jeremy Stark at City of Hope for HR reporter; Karen Domenico at Shiners Hospitals for Children for flow cytometric analysis of HR repair; Glenn Doerman for figure preparation; and Du lab members for helpful discussion. This work was supported by the National Institutes of Health Grant CA158323 (to C. D.).	Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Chen ZH, 1999, BIOCHEM BIOPH RES CO, V264, P847, DOI 10.1006/bbrc.1999.1585; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cohn MA, 2008, MOL CELL, V32, P306, DOI 10.1016/j.molcel.2008.10.009; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gatti M, 2015, CELL REP, V10, P226, DOI 10.1016/j.celrep.2014.12.021; Ge C, 2015, P NATL ACAD SCI US; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Lotz K, 2004, MOL CELL BIOL, V24, P9339, DOI 10.1128/MCB.24.21.9339-9350.2004; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Naito Mikihiko, 2006, Tanpakushitsu Kakusan Koso, V51, P1391; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nishi R, 2014, NAT CELL BIOL, V16, P1016, DOI 10.1038/ncb3028; Peng G, 2009, CELL CYCLE, V8, P3071, DOI 10.4161/cc.8.19.9411; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Rajendra E, 2014, MOL CELL, V54, P858, DOI 10.1016/j.molcel.2014.05.001; Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102; Sharma N, 2014, CELL CYCLE, V13, P106, DOI 10.4161/cc.26814; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Zhang Z, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.599605	46	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144957	10.1371/journal.pone.0144957	http://dx.doi.org/10.1371/journal.pone.0144957			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683461	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800026
J	He, ZW; Zhang, Z; Guo, WX; Zhang, Y; Zhou, RC; Shi, SH				He, Ziwen; Zhang, Zhang; Guo, Wuxia; Zhang, Ying; Zhou, Renchao; Shi, Suhua			De Novo Assembly of Coding Sequences of the Mangrove Palm (Nypa fruticans) Using RNA-Seq and Discovery of Whole-Genome Duplications in the Ancestor of Palms	PLOS ONE			English	Article							ANNOTATION; EVOLUTION; SELECTION; ALIGNMENT; RESOURCE; TOOL	Nypa fruticans (Arecaceae) is the only monocot species of true mangroves. This species represents the earliest mangrove fossil recorded. How N. fruticans adapts to the harsh and unstable intertidal zone is an interesting question. However, the 60 gene segments deposited in NCBI are insufficient for solving this question. In this study, we sequenced, assembled and annotated the transcriptome of N. fruticans using next-generation sequencing technology. A total of 19,918,800 clean paired-end reads were de novo assembled into 45,368 unigenes with a N50 length of 1,096 bp. A total of 41.35% unigenes were functionally annotated using Blast2GO. Many genes annotated to "response to stress" and 15 putative positively selected genes were identified. Simple sequence repeats were identified and compared with other palms. The divergence time between N. fruticans and other palms was estimated at 75 million years ago using the genomic data, which is consistent with the fossil record. After calculating the synonymous substitution rate between paralogs, we found that two whole-genome duplication events were shared by N. fruticans and other palms. These duplication events provided a large amount of raw material for the more than 2,000 later speciation events in Arecaceae. This study provides a high quality resource for further functional and evolutionary studies of N. fruticans and palms in general.	[He, Ziwen; Zhang, Zhang; Guo, Wuxia; Zhou, Renchao; Shi, Suhua] Sun Yat Sen Univ, Guangdong Prov Key Lab Plant Resources, Key Lab Biodivers Dynam & Conservat, State Key Lab Biocontrol,Guangdong Higher Educ In, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Ying] Hainan Normal Univ, Coll Life Sci, Haikou 571158, Hainan, Peoples R China	Sun Yat Sen University; Hainan Normal University	Shi, SH (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Plant Resources, Key Lab Biodivers Dynam & Conservat, State Key Lab Biocontrol,Guangdong Higher Educ In, Guangzhou 510275, Guangdong, Peoples R China.	lssssh@mail.sysu.edu.cn			National Natural Science Foundation of China [91331202, 41130208, 31170213]; Science Foundation of State Key Laboratory of Biocontrol [SKLBC13A03]; China Postdoctoral Science Foundation [2014M552264, 2015T80931]; Chang Hungta Science Foundation of Sun Yat-Sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of State Key Laboratory of Biocontrol; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chang Hungta Science Foundation of Sun Yat-Sen University	SS and RZ were supported by grants from the National Natural Science Foundation of China 91331202, 41130208 and 31170213, http://www.nsfc.gov.cn/) and the Science Foundation of State Key Laboratory of Biocontrol (SKLBC13A03). ZH was supported by grants from China Postdoctoral Science Foundation (2014M552264 and 2015T80931, http://jj.chinapostdoctor.org.cn/). This work was also supported by the Chang Hungta Science Foundation of Sun Yat-Sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants 91331202, 41130208 and 31170213 from the National Natural Science Foundation of China (NSFC), grant SKLBC13A03 from the Science Foundation of State Key Laboratory of Biocontrol and the project funded by China Postdoctoral Science Foundation (2014M552264 and 2015T80931). We would also like to acknowledge the Chang Hungta Science Foundation of Sun Yat-Sen University.	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Al-Mssallem IS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3274; Asmussen CB, 2006, BOT J LINN SOC, V151, P15, DOI 10.1111/j.1095-8339.2006.00521.x; Baud S, 2009, PLANT CELL PHYSIOL, V50, P1463, DOI 10.1093/pcp/pcp092; Beick S, 2008, MOL CELL BIOL, V28, P5337, DOI 10.1128/MCB.00563-08; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Cushing DA, 2005, PLANTA, V221, P424, DOI 10.1007/s00425-004-1452-x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Paolo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102155; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gao F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124382; Gee Carole T., 2001, Wetlands Ecology and Management, V9, P181, DOI 10.1023/A:1011148522181; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harley MM, 2006, BOT J LINN SOC, V151, P39, DOI 10.1111/j.1095-8339.2006.00522.x; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; Jian SG, 2010, AQUAT BOT, V92, P23, DOI 10.1016/j.aquabot.2009.09.003; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li FL, 2007, PLANT PHYSIOL, V145, P87, DOI 10.1104/pp.107.100560; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; McKain MR, 2012, AM J BOT, V99, P397, DOI 10.3732/ajb.1100537; O'Neill CM, 2012, HEREDITY, V108, P115, DOI 10.1038/hdy.2011.54; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schrank E, 1987, BERLINER GEOWISS ABH, V75, P249; Shi T, 2010, ANN BOT-LONDON, V106, P497, DOI 10.1093/aob/mcq129; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Sunderland Terry C. H., 2002, Palms, V46, P154; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tomlinson P, 1986, THE BOTANY OF MANGRO, p[147, 295]; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Vanneste K, 2014, GENOME RES, V24, P1334, DOI 10.1101/gr.168997.113; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	46	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145385	10.1371/journal.pone.0145385	http://dx.doi.org/10.1371/journal.pone.0145385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684618	gold, Green Submitted, Green Published			2022-12-27	WOS:000366725800070
J	Mandel, A; Realo, A				Mandel, Anne; Realo, Anu			Across-Time Change and Variation in Cultural Tightness-Looseness	PLOS ONE			English	Article							VALUE PRIORITIES; SEX-DIFFERENCES; VALUES; COLLECTIVISM; MULTILEVEL; STABILITY; AMERICAN; PATTERNS; ESTONIA; IMPACT	Cultural tightness-looseness, a dimension which describes the strength, multitude, and clarity of social norms in a culture, has proved significant in explaining differences between cultures. Although several studies have compared different cultures on this domain, this study is the first that targets both within-country differences and across-time variation in tightness-looseness. Using data from two nationally representative samples of Estonians, we found that the general tightness level had changed over a period of 10 years but the effect size of the change was small. A significant within country variance in 2002 had disappeared by 2012. Our results suggest that tightness-looseness, similarly to cultural value orientations, is a relatively stable and robust characteristic of culture-that is, change indeed takes place, but slowly. Future studies about across-time change and within-country variance in tightness-looseness should target more culturally diverse and socially divided societies.	[Mandel, Anne] Aalto Univ, Brain Res Unit, OV Lounasmaa Lab, Helsinki, Finland; [Realo, Anu] Univ Tartu, Dept Psychol, EE-50090 Tartu, Estonia	Aalto University; University of Tartu	Realo, A (corresponding author), Univ Tartu, Dept Psychol, Ulikooli 18, EE-50090 Tartu, Estonia.	anu.realo@ut.ee	Realo, Anu/M-9524-2016		Estonian Ministry of Education and Science [IUT2-13]; Netherlands Institute for Advanced Study (NIAS)	Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); Netherlands Institute for Advanced Study (NIAS)	This study was supported by institutional research funding (IUT2-13) from the Estonian Ministry of Education and Science. Anu Realo was supported by a grant from the Netherlands Institute for Advanced Study (NIAS) during the writing of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrov A, 2009, RUSS POLIT LAW, V47, P66, DOI 10.2753/RUP1061-1940470505; Beilmann M, 2012, TRAMES-J HUMANIT SOC, V16, P205, DOI 10.3176/tr.2012.3.01; Church AT, 2012, J RES PERS, V46, P556, DOI 10.1016/j.jrp.2012.06.003; Crossland C, 2011, STRATEGIC MANAGE J, V32, P797, DOI 10.1002/smj.913; Davidov E., 2008, SURVEY RES METHODS, V2, P33, DOI [DOI 10.1348/014466608X314935, DOI 10.18148/SRM/2008.V2I1.365]; Davies PG, 2008, J PERS SOC PSYCHOL, V95, P308, DOI 10.1037/0022-3514.95.2.308; Eun CS, 2015, J FINANC ECON, V115, P283, DOI 10.1016/j.jfineco.2014.09.003; Fischer R, 2009, INT J CROSS CULT MAN, V9, P25, DOI 10.1177/1470595808101154; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; Gelfand MJ, 2012, CURR DIR PSYCHOL SCI, V21, P420, DOI 10.1177/0963721412460048; Gelfand MJ, 2011, SCIENCE, V332, P1100, DOI 10.1126/science.1197754; Grossmann I, 2015, PSYCHOL SCI, V26, P311, DOI 10.1177/0956797614563765; Hall E. T., 1976, CULTURE; Harrington JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127173; Harrington JR, 2014, P NATL ACAD SCI USA, V111, P7990, DOI 10.1073/pnas.1317937111; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hofstede G., 1980, CULTURES CONSEQUENCE; Hofstede G., 2001, CULTURES CONSEQUENCE; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Inglehart R, 2000, AM SOCIOL REV, V65, P19, DOI 10.2307/2657288; Inglehart R., 2018, CULTURE SHIFT ADV IN; Inglehart R., 2005, MODERNIZATION CULTUR; Kalmus V., 2004, EESTI ELAVIK 21 SAJA, P31; Kim H, 1999, J PERS SOC PSYCHOL, V77, P785, DOI 10.1037/0022-3514.77.4.785; Kluckhohn F. R., 1961, VARIATIONS VALUE ORI, P450; Lauristin M, 2008, PUNANE JA SININE, P300; Lauristin M., 2011, BALTIC WAYS HUMAN DE, P10; Lehti M, 2008, J BALTIC STUD, V39, P393, DOI 10.1080/01629770802461175; Leung K, 2004, ADV EXP SOC PSYCHOL, V36, P119, DOI 10.1016/S0065-2601(04)36003-X; Li Q, 2004, POLIT PSYCHOL, V25, P727, DOI 10.1111/j.1467-9221.2004.00395.x; Magun V., 2010, SOCIOLOGICAL RES, V49, P3, DOI DOI 10.2753/SOR1061-0154490401; Mizera L, 2012, TRAMES-J HUMANIT SOC, V16, P145, DOI 10.3176/tr.2012.2.03; Norenzayan A, 2011, SCIENCE, V332, P1041, DOI 10.1126/science.1207050; Pullmann H, 2009, EXP AGING RES, V35, P20, DOI 10.1080/03610730802544708; Raudsepp M, 2013, BACK W CHANGES CONTI, P53; Realo A, 1997, J RES PERS, V31, P93, DOI 10.1006/jrpe.1997.2170; Realo A, 1999, J SOC PSYCHOL, V139, P133, DOI 10.1080/00224549909598367; Realo A., 2013, ESTONIAN HUMAN DEV R, P48; Realo A, 2002, ONLINE READINGS PSYC; Realo A, 2015, INT J PSYCHOL, V50, P193, DOI 10.1002/ijop.12097; Realo A, 2011, J RES PERS, V45, P297, DOI 10.1016/j.jrp.2011.03.004; Rikmann E., 2013, STUDY SOCIAL GROUPS; ROHNER RP, 1984, J CROSS CULT PSYCHOL, V15, P111, DOI 10.1177/0022002184015002002; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Schwartz S.H., 2000, POLIT PSYCHOL, P217, DOI [10.1057/9780230598744_13, DOI 10.1057/9780230598744_13]; Schwartz SH, 2005, J PERS SOC PSYCHOL, V89, P1010, DOI 10.1037/0022-3514.89.6.1010; Schwartz SH., 1994, INDIVIDUALISM COLLEC; Schwartz SH, 2006, COMP SOCIOL, V5, P137, DOI 10.1163/156913306778667357; Taras V, 2010, J APPL PSYCHOL, V95, P405, DOI 10.1037/a0018938; Triandis HC, 1996, AM PSYCHOL, V51, P407, DOI 10.1037/0003-066X.51.4.407; Tulviste T, 2014, INT J INTERCULT REL, V39, P93, DOI 10.1016/j.ijintrel.2013.10.003; Tulviste T, 2012, J CROSS CULT PSYCHOL, V43, P480, DOI 10.1177/0022022111401393; Uz I, 2015, J CROSS CULT PSYCHOL, V46, P319, DOI 10.1177/0022022114563611; Valsiner J., 2003, ONLINE READINGS PSYC; van de Schoot R, 2012, EUR J DEV PSYCHOL, V9, P486, DOI 10.1080/17405629.2012.686740; Van de Vliert E, 2013, J CROSS CULT PSYCHOL, V44, P589, DOI 10.1177/0022022112463605; Vandello JA, 1999, J PERS SOC PSYCHOL, V77, P279, DOI 10.1037/0022-3514.77.2.279; Verkasalo M, 2009, EUR J SOC PSYCHOL, V39, P780, DOI 10.1002/ejsp.580; Vihalemm T, 2008, E EUR POLIT SOC, V22, P901, DOI 10.1177/0888325408316537; Welzel C, 2013, FREEDOM RISING: HUMAN EMPOWERMENT AND THE QUEST FOR EMANCIPATION, P1; Yoon G., 1994, INDIVIDUALISM COLLEC, P225	61	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145213	10.1371/journal.pone.0145213	http://dx.doi.org/10.1371/journal.pone.0145213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9KM	26683813	Green Submitted, Green Published, gold			2022-12-27	WOS:000366725800047
J	Rieger, CT; Wischumerski, I; Rust, C; Fiegl, M				Rieger, Christina T.; Wischumerski, Isabel; Rust, Christian; Fiegl, Michael			Weight Loss and Decrease of Body Mass Index during Allogeneic Stem Cell Transplantation Are Common Events with Limited Clinical Impact	PLOS ONE			English	Article							RISK; NUTRITION	Purpose Weight loss in cancer patients has been attributed with significant morbidity and mortality. During allogeneic stem cell transplantation (SCT), oral nutrition is often hampered and hence total parenteral nutrition (TPN) is necessary. We therefore investigated the course of weight during stem cell transplantation and the clinical consequences of weight change. Methods 180 consecutive patients who received allogeneic SCT between January 2010 and December 2011 at our center were analyzed for weight loss, laboratory and clinical parameters. Results During SCT, a median decrease of 6.6% of body mass index (BMI) was observed for the whole population (from 25.3 at admission to 23.6 at discharge), and a 1.6fold increase of malnutrition despite use of TPN (28.3% to 45.0%). 55.6% of patients experienced a significant weight loss of >= 5% with a median decrease of 9.2% in BMI. Serum levels of albumin, total protein and cholesterol rapidly decreased during conditioning therapy. After a median of 2.4 years, the median BMI was still only 23.4 (not different from discharge). However, we did not observe a meaningful difference in side effects and survival between patients that did or did not lose weight. Conclusion Weight loss is commonly observed during allogeneic SCT despite TPN, but the clinical consequences thereof seem limited: we observed no significant impact on patients with a decrease >= 5% in BMI on transplant outcome, side effects or survival.	[Rieger, Christina T.; Wischumerski, Isabel; Fiegl, Michael] Klinikum Univ mUNCHEN, Dept Internal Med 3, Munich, Germany; [Rust, Christian] Krankenhaus Barmherzigen bRUDER, Dept Internal Med 1, Munich, Germany	University of Munich	Fiegl, M (corresponding author), Klinikum Univ mUNCHEN, Dept Internal Med 3, Munich, Germany.	michael.fiegl@med.uni-muenchen.de						Burden S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008879.pub2; Jaime-Perez JC, 2013, BLOOD CELL MOL DIS, V51, P61, DOI 10.1016/j.bcmd.2013.01.010; DESTATIS, 2013, MIKROZENSUS 2013; DIMDI, ICD 10 GM VERSION 20; Ford ES, 2009, ARCH INTERN MED, V169, P1355, DOI 10.1001/archinternmed.2009.237; Fuji S, 2015, BONE MARROW TRANSPL, V50, P100, DOI 10.1038/bmt.2014.228; Fuji S, 2014, BONE MARROW TRANSPL, V49, P1505, DOI 10.1038/bmt.2014.178; Jatoi A, 2014, THE ROLE OF PARENTER; KINNEY JM, 1986, CLIN CHEST MED, V7, P19; Masszi T, 2012, THE EBMT HANDBOOK, P156; Murray SM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002920.pub3; NIH, 2009, COMMON TERMINOLOGY C; Nitenberg G, 2000, CRIT REV ONCOL HEMAT, V34, P137, DOI 10.1016/S1040-8428(00)00048-2; Reikvam H, 2015, DIS MARKERS IN PRESS; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Sucak GT, 2012, INT J HEMATOL, V95, P95, DOI 10.1007/s12185-011-0980-y; Thomas E D, 1999, Biol Blood Marrow Transplant, V5, P341; Tvedt TH, CURR PHARM BIOTECHNO, V17, P92; Urbain P, 2013, BONE MARROW TRANSPL, V48, P446, DOI 10.1038/bmt.2012.158; Urbain P, 2013, ANN HEMATOL, V92, P111, DOI 10.1007/s00277-012-1573-4; WEISDORF SA, 1987, TRANSPLANTATION, V43, P833, DOI 10.1097/00007890-198743060-00012	21	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145445	10.1371/journal.pone.0145445	http://dx.doi.org/10.1371/journal.pone.0145445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683031	Green Submitted, gold, Green Published			2022-12-27	WOS:000366725800077
J	Tian, CY; Chen, ZQ; Ma, XX; Yang, M; Wang, ZZ; Dong, Y; Yang, T; Yang, WJ				Tian, Chaoyong; Chen, Zhiqiang; Ma, Xixian; Yang, Ming; Wang, Zhizhong; Dong, Ying; Yang, Ting; Yang, Wenjun			Comparison of Genetic Variants in Cancer-Related Genes between Chinese Hui and Han Populations	PLOS ONE			English	Article							ARG72PRO POLYMORPHISM; P53; RISK; SUSCEPTIBILITY; LUNG; ASSOCIATION; DIVERSITY; PATTERNS; CODON-72; AFRICAN	Background The Chinese Hui population, as the second largest minority ethnic group in China, may have a different genetic background from Han people because of its unique demographic history. In this study, we aimed to identify genetic differences between Han and Hui Chinese from the Ningxia region of China by comparing eighteen single nucleotide polymorphisms in cancer-related genes. Methods DNA samples were collected from 99 Hui and 145 Han people from the Ningxia Hui Autonomous Region in China, and SNPs were detected using an improved multiplex ligase detection reaction method. Genotyping data from six 1000 Genomes Project population samples (99 Utah residents with northern and western European ancestry (CEU), 107 Toscani in Italy (TSI), 108 Yoruba in Ibadan (YRI), 61 of African ancestry in the southwestern US (ASW), 103 Han Chinese in Beijing (CHB), and 104 Japanese in Tokyo (JPT)) were also included in this study. Differences in the distribution of alleles among the populations were assessed using. 2 tests, and FST was used to measure the degree of population differentiation. Results We found that the genetic diversity of many SNPs in cancer-related genes in the Hui Chinese in Ningxia was different from that in the Han Chinese in Ningxia. For example, the allele frequencies of four SNPs (rs13361707, rs2274223, rs465498, and rs753955) showed different genetic distributions (p<0.05) between Chinese Ningxia Han and Chinese Ningxia Hui. Five SNPs (rs730506, rs13361707, rs2274223, rs465498 and rs753955) had different F-ST values (F-ST>0.000) between the Hui and Han populations. Conclusions These results suggest that some SNPs associated with cancer-related genes vary among different Chinese ethnic groups. We suggest that population differences should be carefully considered in evaluating cancer risk and prognosis as well as the efficacy of cancer therapy.	[Tian, Chaoyong; Dong, Ying; Yang, Wenjun] Ningxia Med Univ, Gen Hosp, Canc Res Inst, Yinchuan, Ningxia, Peoples R China; [Tian, Chaoyong; Yang, Wenjun] Ningxia Med Univ, Key Lab Ningxia Reprod & Hered, Yinchuan, Ningxia, Peoples R China; [Chen, Zhiqiang] Ningxia Med Univ, Gen Hosp, Dept Radiol, Yinchuan, Ningxia, Peoples R China; [Ma, Xixian] Chinese Acad Sci, Max Planck Independent Res Grp Populat Genom, CAS MPG Partner Inst Computat Biol PICB, Key Lab Computat Biol,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yang, Ming] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Lab Biomed Mat, Beijing 100029, Peoples R China; [Wang, Zhizhong; Yang, Ting; Yang, Wenjun] Ningxia Med Univ, Sch Publ Hlth, Dept Epidemiol, Yinchuan, Ningxia, Peoples R China	Ningxia Medical University; Ningxia Medical University; Ningxia Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Beijing University of Chemical Technology; Ningxia Medical University	Yang, WJ (corresponding author), Ningxia Med Univ, Gen Hosp, Canc Res Inst, Yinchuan, Ningxia, Peoples R China.	yw001@nxmu.edu.cn	Yang, Ming/G-4705-2012	Yang, Ming/0000-0002-7722-7487; Wang, zhizhong/0000-0002-0612-3218; Yang, Wenjun/0000-0001-5671-1344	National Natural Science Foundation of China [81460434, 81160249]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant numbers 81460434, 81160249 to WJY; http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bu DY, 2014, ASIAN PAC J CANCER P, V15, P5895, DOI 10.7314/APJCP.2014.15.14.5895; Chen BF, 2014, J MOL NEUROSCI, V52, P481, DOI 10.1007/s12031-013-0160-z; Chen X, 2003, PHARMACOGENOMICS J, V3, P77, DOI 10.1038/sj.tpj.6500167; Choi YY, 2008, J HUM GENET, V53, P87, DOI 10.1007/s10038-007-0222-6; Dahabreh IJ, 2013, AM J EPIDEMIOL, V177, P1317, DOI 10.1093/aje/kws394; Dong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132797; Gao SP, 2014, INT J CLIN EXP MED, V7, P2851; Gemignani F, 2004, ONCOGENE, V23, P1954, DOI 10.1038/sj.onc.1207305; Granja F, 2004, CANCER LETT, V210, P151, DOI 10.1016/j.canlet.2004.01.016; Gravina S, 2009, AGING-US, V1, P470, DOI 10.18632/aging.100041; Guo G, 2014, DEMOGRAPHY, V51, P2337, DOI 10.1007/s13524-014-0349-y; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hu XS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131039; Koushik A, 2006, INT J CANCER, V119, P1863, DOI 10.1002/ijc.22057; Li J., 2014, ELECTRON J DIFFER EQ, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0089893; Li J, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-52; Li J, 2011, HUM MOL GENET, V20, P528, DOI 10.1093/hmg/ddq498; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Pietsch EC, 2006, ONCOGENE, V25, P1602, DOI 10.1038/sj.onc.1209367; Shen HB, 2004, ONCOL REP, V11, P1115; Sheng XL, 2014, INT J OPHTHALMOL-CHI, V7, P557, DOI 10.3980/j.issn.2222-3959.2014.03.30; Shi YY, 2004, GENOME RES, V14, P1345, DOI 10.1101/gr.1758204; Song HR, 2011, GASTRIC CANCER, V14, P242, DOI 10.1007/s10120-011-0034-4; Wang K, 2014, INT J BIOL MARKER, V29, pE160, DOI 10.5301/jbm.5000061; Wang SY, 2013, TUMOR BIOL, V34, P2511, DOI 10.1007/s13277-013-0678-2; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Weir BS, 2012, PHILOS SCI, V79, P637, DOI 10.1086/667904; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Zhang M, 2014, WORLD J GASTROENTERO, V20, P5082, DOI 10.3748/wjg.v20.i17.5082; Zhao JD, 2012, WORLD J GASTROENTERO, V18, P7093, DOI 10.3748/wjg.v18.i47.7093	31	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145170	10.1371/journal.pone.0145170	http://dx.doi.org/10.1371/journal.pone.0145170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683024	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800041
J	de Sandes-Freitas, TV; Felipe, CR; Aguiar, WF; Cristelli, MP; Tedesco-Silva, H; Medina-Pestana, JO				de Sandes-Freitas, Taina Veras; Felipe, Claudia Rosso; Aguiar, Wilson Ferreira; Cristelli, Marina Pontello; Tedesco-Silva, Helio; Medina-Pestana, Jose Osmar			Prolonged Delayed Graft Function Is Associated with Inferior Patient and Kidney Allograft Survivals	PLOS ONE			English	Article							BEATING DONOR KIDNEYS; RENAL-TRANSPLANTATION; ACUTE REJECTION; IMPACT	It is unclear if there is an association between the duration of delayed graft function (DGF) and kidney transplant (KT) outcomes. This study investigated the impact of prolonged DGF on patient and graft survivals, and renal function one year after KT. This single center retrospective analysis included all deceased donor KT performed between Jan/1998 and Dec/2008 (n = 1412). Patients were grouped in quartiles according to duration of DGF (1-5, 6-10, 1115, and > 15 days, designated as prolonged DGF). The overall incidence of DGF was 54.2%. Prolonged DGF was associated with retransplantation (OR 2.110, CI95% 1.064-4.184, p = 0.033) andmore than 3 HLAmismatches (OR 1.819, CI95% 1.117-2.962, p = 0.016). The incidence of acute rejection was higher in patients with DGF compared with those without DGF (36.2% vs. 12.2%, p<0.001). Compared to patients without DGF, DGF(1-5), DGF(6-10), and DGF(11-15), patients with prolonged DGF showed inferior one year patient survival (95.2% vs. 95.4% vs. 95.5% vs. 93.4% vs. 88.86%, p = 0.003), graft survival (91% vs. 91.4% vs. 92% vs. 88.7% vs. 70.5%, p<0.001), death-censored graft survival (95.7% vs. 95.4% vs. 96.4% vs. 94% vs. 79.3%, p<0.001), and creatinine clearance (58.0 +/- 24.6 vs. 55.8 +/- 22.2 vs. 53.8 +/- 24.1 vs. 53.0 +/- 27.2 vs. 36.8 +/- 27.0mL/min, p<0.001), respectively. Multivariable analysis showed that prolonged DGF was an independent risk factor for graft loss (OR 3.876, CI95% 2.270-6.618, p<0.001), death censored graft loss (OR 4.103, CI95% 2.055-8.193, p<0.001), and death (OR 3.065, CI95% 1.536-6.117, p = 0.001). Prolonged DGF, determined by retransplantation and higher HLA mismatches, was associated with inferior renal function, and patient and graft survivals at one year.	[de Sandes-Freitas, Taina Veras; Felipe, Claudia Rosso; Cristelli, Marina Pontello; Tedesco-Silva, Helio; Medina-Pestana, Jose Osmar] Univ Fed Sao Paulo UNIFESP, Hosp Rim, Div Nephrol, Sao Paulo, Brazil; [Aguiar, Wilson Ferreira] Univ Fed Sao Paulo UNIFESP, Hosp Rim, Div Urol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	de Sandes-Freitas, TV (corresponding author), Univ Fed Sao Paulo UNIFESP, Hosp Rim, Div Nephrol, Sao Paulo, Brazil.	taina.sandes@gmail.com	Aguiar, Wilson/I-3876-2016	Aguiar, Wilson/0000-0002-7581-096X; Medina Pestana, Jose/0000-0003-3912-2980				Arias M, 2003, TRANSPLANT P, V35, P1655, DOI 10.1016/S0041-1345(03)00564-5; Azevedo LS, 2005, TRANSPLANT P, V37, P2746, DOI 10.1016/j.transproceed.2005.05.005; Baptista Ana Paula Maia, 2013, Braz. J. Nephrol., V35, P289, DOI 10.5935/0101-2800.20130048; Brook NR, 2003, AM J TRANSPLANT, V3, P614, DOI 10.1034/j.1600-6143.2003.00113.x; Butala NM, 2013, TRANSPLANTATION, V95, P1008, DOI 10.1097/TP.0b013e3182855544; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Fernandez-Juarez G, 2002, TRANSPLANT P, V34, P338, DOI 10.1016/S0041-1345(01)02789-0; Fontan MP, 1996, TRANSPLANTATION, V62, P42, DOI 10.1097/00007890-199607150-00009; Johnston O, 2006, NEPHROL DIAL TRANSPL, V21, P2270, DOI 10.1093/ndt/gfl103; Klein R, 2013, TRANSPLANTATION, V95, P611, DOI 10.1097/TP.0b013e318279153c; Malinoski DJ, 2013, AM J TRANSPLANT, V13, P993, DOI 10.1111/ajt.12090; Mallon DH, 2013, TRANSPLANTATION, V96, P885, DOI 10.1097/TP.0b013e3182a19348; Organ Procurement and Transplantation Network (OPTN) and Scientic Registry of Transplant Recipients (SRTR), 2014, OPTN SRTR 2012 ANN D; Qureshi F, 2002, TRANSPLANTATION, V74, P1400, DOI 10.1097/00007890-200211270-00010; Renkens JJM, 2005, AM J TRANSPLANT, V5, P2704, DOI 10.1111/j.1600-6143.2005.01072.x; Salamzadeh J, 2012, ANN TRANSPL, V17, P69; SHOSKES DA, 1990, TRANSPLANTATION, V49, P201, DOI 10.1097/00007890-199001000-00045; TROPPMANN C, 1995, TRANSPLANTATION, V59, P962, DOI 10.1097/00007890-199504150-00007; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667; YOKOYAMA I, 1994, CLIN TRANSPLANT, V8, P101	20	47	50	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144188	10.1371/journal.pone.0144188	http://dx.doi.org/10.1371/journal.pone.0144188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679933	gold, Green Published, Green Submitted			2022-12-27	WOS:000366723400010
J	Mulley, G; Beeton, ML; Wilkinson, P; Vlisidou, I; Ockendon-Powell, N; Hapeshi, A; Tobias, NJ; Nollmann, FI; Bode, HB; van den Elsen, J; Ffrench-Constant, RH; Waterfield, NR				Mulley, Geraldine; Beeton, Michael L.; Wilkinson, Paul; Vlisidou, Isabella; Ockendon-Powell, Nina; Hapeshi, Alexia; Tobias, Nick J.; Nollmann, Friederike I.; Bode, Helge B.; van den Elsen, Jean; Ffrench-Constant, Richard H.; Waterfield, Nicholas R.			From Insect to Man: Photorhabdus Sheds Light on the Emergence of Human Pathogenicity	PLOS ONE			English	Article							SP NOV.; YERSINIA-PSEUDOTUBERCULOSIS; FUNCTIONAL-ANALYSIS; VIRULENCE FACTORS; SUBSP NOV.; PMRA-PMRB; LUMINESCENS; EXPRESSION; ASYMBIOTICA; IDENTIFICATION	Photorhabdus are highly effective insect pathogenic bacteria that exist in a mutualistic relationship with Heterorhabditid nematodes. Unlike other members of the genus, Photorhabdus asymbiotica can also infect humans. Most Photorhabdus cannot replicate above 34 degrees C, limiting their host-range to poikilothermic invertebrates. In contrast, P. asymbiotica must necessarily be able to replicate at 37 degrees C or above. Many well-studied mammalian pathogens use the elevated temperature of their host as a signal to regulate the necessary changes in gene expression required for infection. Here we use RNA-seq, proteomics and phenotype microarrays to examine temperature dependent differences in transcription, translation and phenotype of P. asymbiotica at 28 degrees C versus 37 degrees C, relevant to the insect or human hosts respectively. Our findings reveal relatively few temperature dependant differences in gene expression. There is however a striking difference in metabolism at 37 degrees C, with a significant reduction in the range of carbon and nitrogen sources that otherwise support respiration at 28 degrees C. We propose that the key adaptation that enables P. asymbiotica to infect humans is to aggressively acquire amino acids, peptides and other nutrients from the human host, employing a so called "nutritional virulence" strategy. This would simultaneously cripple the host immune response while providing nutrients sufficient for reproduction. This might explain the severity of ulcerated lesions observed in clinical cases of Photorhabdosis. Furthermore, while P. asymbiotica can invade mammalian cells they must also resist immediate killing by humoral immunity components in serum. We observed an increase in the production of the insect Phenol-oxidase inhibitor Rhabduscin normally deployed to inhibit the melanisation immune cascade. Crucially we demonstrated this molecule also facilitates protection against killing by the alternative human complement pathway.	[Mulley, Geraldine] Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England; [Beeton, Michael L.] Cardiff Metropolitan Univ, Cardiff Sch Hlth Sci, Cardiff CF5 2YB, S Glam, Wales; [Wilkinson, Paul; Vlisidou, Isabella] Univ Bristol, Bristol BS8 1TQ, Avon, England; [Ockendon-Powell, Nina] Gloucester Royal Hosp, Publ Hlth England, Dept Microbiol, Primary Care Unit, Gloucester GL1 3NN, England; [Hapeshi, Alexia; Waterfield, Nicholas R.] Univ Warwick, Warwick Med Sch, Div Biomed Sci, Coventry CV4 7AL, W Midlands, England; [Tobias, Nick J.; Nollmann, Friederike I.; Bode, Helge B.] Goethe Univ Frankfurt, Fachbereich Biowissensch, Buchmann Ctr Life Sci BMLS, D-60438 Frankfurt, Germany; [van den Elsen, Jean] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Ffrench-Constant, Richard H.] Univ Exeter, Biosci, Penryn TR10 9EZ, England	University of Reading; Cardiff Metropolitan University; Cardiff University; University of Bristol; Public Health England; University of Warwick; Goethe University Frankfurt; University of Bath; University of Exeter	Waterfield, NR (corresponding author), Univ Warwick, Warwick Med Sch, Div Biomed Sci, Med Sch Bldg,Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	N.R.Waterfield@warwick.ac.uk	Bode, Helge B/F-7022-2014	Bode, Helge B/0000-0001-6048-5909; Hapeshi, Alexia/0000-0002-5717-0532; ffrench-Constant, Richard/0000-0001-5385-9888; Waterfield, Nicholas/0000-0002-8044-7763; Beeton, Michael/0000-0002-6292-0772; Tobias, Nicholas/0000-0003-2725-3043; van den Elsen, Jean/0000-0002-0367-1956; Ockendon-Powell, Nina/0000-0001-5809-5397	BBSRC [BBE0213281]; EU [211436, 223328]; Warwick University Medical School; BBSRC [BB/E021328/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission); Warwick University Medical School; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC (grant number BBE0213281), EU FP7 consortium grant EMBEK1 (number 211436), EU FP7 consortium grant GAMEXP (number 223328), and Warwick University Medical School.	Abu Kwaik Y, 2013, CELL MICROBIOL, V15, P882, DOI 10.1111/cmi.12138; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bishop AH, 2014, J INVERTEBR PATHOL, V121, P85, DOI 10.1016/j.jip.2014.07.001; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Brachmann AO, 2013, NAT CHEM BIOL, V9, P573, DOI [10.1038/NCHEMBIO.1295, 10.1038/nchembio.1295]; Brameyer S, 2015, P NATL ACAD SCI USA, V112, P572, DOI 10.1073/pnas.1417685112; Brameyer S, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00166; Costa SCP, 2009, INFECT IMMUN, V77, P1022, DOI 10.1128/IAI.01064-08; Crawford JM, 2012, P NATL ACAD SCI USA, V109, P10821, DOI 10.1073/pnas.1201160109; Croucher NJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp811; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; Daborn PJ, 2001, J BACTERIOL, V183, P5834, DOI 10.1128/JB.183.20.5834-5839.2001; Dowling AJ, 2007, CELL MICROBIOL, V9, P2470, DOI 10.1111/j.1462-5822.2007.00974.x; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Felfoldi G, 2009, APPL ENVIRON MICROB, V75, P3120, DOI 10.1128/AEM.02271-08; Feret R., 2014, CURR PROTOC PROTEIN, V75; Ferreira T, 2014, INT J SYST EVOL MICR, V64, P1540, DOI 10.1099/ijs.0.059840-0; Fischer-Le Saux M, 1999, INT J SYST BACTERIOL, V49, P1645, DOI 10.1099/00207713-49-4-1645; Fuchs SW, 2013, ANGEW CHEM INT EDIT, V52, P4108, DOI 10.1002/anie.201210116; Gerrard J, 2004, MICROBES INFECT, V6, P229, DOI 10.1016/j.micinf.2003.10.018; Gerrard JG, 2003, EMERG INFECT DIS, V9, P251; Gerrard JG, 2006, EMERG INFECT DIS, V12, P1562, DOI 10.3201/eid1210.060464; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Heroven AK, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00158; Hu K, 2000, FEMS MICROBIOL LETT, V189, P219, DOI 10.1111/j.1574-6968.2000.tb09234.x; HULTMARK D, 1993, TRENDS GENET, V9, P178, DOI 10.1016/0168-9525(93)90165-E; Jones RT, 2010, BMC MICROBIOL, P10; Joyce SA, 2011, ADV APPL MICROBIOL, V76, P1, DOI 10.1016/B978-0-12-387048-3.00001-5; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Krin E, 2008, ENVIRON MICROBIOL, V10, P1118, DOI 10.1111/j.1462-2920.2007.01528.x; Krin E, 2006, APPL ENVIRON MICROB, V72, P6439, DOI 10.1128/AEM.00398-06; Kronenwerth M, 2014, CHEMBIOCHEM, V15, P2689, DOI 10.1002/cbic.201402447; Kullas AL, 2012, CELL HOST MICROBE, V12, P791, DOI 10.1016/j.chom.2012.10.018; KURASHIGE S, 1985, SCAND J IMMUNOL, V22, P1, DOI 10.1111/j.1365-3083.1985.tb01853.x; la Buscato E, 2013, CHEMMEDCHEM, V8, P919, DOI 10.1002/cmdc.201300057; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; LI JX, 1995, APPL ENVIRON MICROB, V61, P4329, DOI 10.1128/AEM.61.12.4329-4333.1995; Lilley KS, 2004, EXPERT REV PROTEOMIC, V1, P401, DOI 10.1586/14789450.1.4.401; Marceau M, 2005, CURR ISSUES MOL BIOL, V7, P151; Marceau M, 2004, MICROBIOL-SGM, V150, P3947, DOI 10.1099/mic.0.27426-0; Martin B, ANGELS GLOW BATTLE S; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Meylaers K, 2003, CURR PHARM DESIGN, V9, P159, DOI 10.2174/1381612033392279; Mignot T, 2001, MOL MICROBIOL, V42, P1189, DOI 10.1046/j.1365-2958.2001.02692.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mouammine A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110060; Mulley G, 2010, J BACTERIOL, V192, P4944, DOI 10.1128/JB.00294-10; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nollmann FI, 2015, CHEMBIOCHEM, V16, P205, DOI 10.1002/cbic.201402603; Nuss AM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005087; Orozco RA, 2013, CURR MICROBIOL, V66, P30, DOI 10.1007/s00284-012-0220-6; Plichta KL, 2009, J HELMINTHOL, V83, P309, DOI 10.1017/S0022149X09222942; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Reichenbach B, 2008, NUCLEIC ACIDS RES, V36, P2570, DOI 10.1093/nar/gkn091; REYNOLDS SE, 1985, J INSECT PHYSIOL, V31, P119, DOI 10.1016/0022-1910(85)90016-2; RICHARDSON WH, 1988, APPL ENVIRON MICROB, V54, P1602, DOI 10.1128/AEM.54.6.1602-1605.1988; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; Sandberg TE, 2014, MOL BIOL EVOL, V31, P2647, DOI 10.1093/molbev/msu209; Scotti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013892; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Sharma V, 2014, BIOCHEM BIOPH RES CO, V453, P220, DOI 10.1016/j.bbrc.2014.06.021; Silva CP, 2002, CELL MICROBIOL, V4, P329, DOI 10.1046/j.1462-5822.2002.00194.x; Smith KS, 2000, FEMS MICROBIOL REV, V24, P335, DOI 10.1016/S0168-6445(00)00030-9; Stark RM, 1997, J MED MICROBIOL, V46, P793, DOI 10.1099/00222615-46-9-793; Tailliez P, 2010, INT J SYST EVOL MICR, V60, P1921, DOI 10.1099/ijs.0.014308-0; Tala A, 2011, MOL MICROBIOL, V81, P1330, DOI 10.1111/j.1365-2958.2011.07766.x; Theopold U, 2014, DEV COMP IMMUNOL, V42, P42, DOI 10.1016/j.dci.2013.03.014; Urbanowski ML, 2000, MOL MICROBIOL, V37, P856, DOI 10.1046/j.1365-2958.2000.02051.x; Grosso-Becera MV, 2015, TRENDS MICROBIOL, V23, P509, DOI 10.1016/j.tim.2015.04.004; Vilcinskas A, 2013, J INSECT PHYSIOL, V59, P123, DOI 10.1016/j.jinsphys.2012.08.018; Waterfield N, 2005, FEMS MICROBIOL LETT, V245, P47, DOI 10.1016/j.femsle.2005.02.018; Waterfield NR, 2008, P NATL ACAD SCI USA, V105, P15967, DOI 10.1073/pnas.0711114105; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Watson RJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-177; Weissfeld AS, 2005, J CLIN MICROBIOL, V43, P4152, DOI 10.1128/JCM.43.8.4152-4155.2005; Wilkinson P, 2010, FEMS MICROBIOL LETT, V309, P136, DOI 10.1111/j.1574-6968.2010.02030.x; Wilkinson P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-302; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yang G, 2006, J BACTERIOL, V188, P2254, DOI 10.1128/JB.188.6.2254-2261.2006; Zhang YJJ, 2013, CELL MICROBIOL, V15, P1079, DOI 10.1111/cmi.12140; Zhao LB, 2012, J CHROMATOGR B, V885, P160, DOI 10.1016/j.jchromb.2011.12.026	84	22	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144937	10.1371/journal.pone.0144937	http://dx.doi.org/10.1371/journal.pone.0144937			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26681201	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000366723400035
J	Humphries, AT; McQuaid, CD; McClanahan, TR				Humphries, Austin T.; McQuaid, Christopher D.; McClanahan, Tim R.			Context-Dependent Diversity-Effects of Seaweed Consumption on Coral Reefs in Kenya	PLOS ONE			English	Article							GREAT-BARRIER-REEF; FEEDING-PREFERENCE EXPERIMENTS; PHASE-SHIFTS; HERBIVOROUS FISHES; ALGAL SUCCESSION; COMPETITION; CLOSURES; RECOVERY; RESILIENCE; MANAGEMENT	Consumers and prey diversity, their interactions, and subsequent effects on ecosystem function are important for ecological processes but not well understood in high diversity ecosystems such as coral reefs. Consequently, we tested the potential for diversity-effects with a series of surveys and experiments evaluating the influence of browsing herbivores on macroalgae in Kenya's fringing reef ecosystem. We surveyed sites and undertook experiments in reefs subject to three levels of human fishing influence: open access fished reefs, small and recently established community-managed marine reserves, and larger, older government-managed marine reserves. Older marine reserves had a greater overall diversity of herbivores and browsers but this was not clearly associated with reduced macroalgal diversity or abundance. Experiments studying succession on hard substrata also found no effects of consumer diversity. Instead, overall browser abundance of either sea urchins or fishes was correlated with declines in macroalgal cover. An exception was that the absence of a key fish browser genus, Naso, which was correlated with the persistence of Sargassum in a marine reserve. Algal selectivity assays showed that macroalgae were consumed at variable rates, a product of strong species-specific feeding and low overlap in the selectivity of browsing fishes. We conclude that the effects of browser and herbivore diversity are less than the influences of key species, whose impacts emerge in different contexts that are influenced by fisheries management. Consequently, identifying key herbivore species and managing to protect them may assist protecting reef functions.	[Humphries, Austin T.; McQuaid, Christopher D.] Rhodes Univ, Dept Zool & Entomol, Coastal Res Grp, ZA-6140 Grahamstown, South Africa; [Humphries, Austin T.] Wildlife Conservat Soc, Coral Reef Conservat Project, Mombasa, Kenya; [McClanahan, Tim R.] Wildlife Conservat Soc, Marine Programs, Bronx, NY USA	Rhodes University; Wildlife Conservation Society	Humphries, AT (corresponding author), Univ Rhode Isl, Dept Fisheries Anim & Vet Sci, Coll Environm & Life Sci, Kingston, RI 02881 USA.	humphries@uri.edu	McClanahan, Tim/K-4998-2019; McQuaid, Christopher/AAT-3725-2020	McQuaid, Christopher/0000-0002-3473-8308	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Wildlife Conservation Society from the Western Indian Ocean Marine Science Association; Tiffany Foundation; McBean Foundation; John D. and Catherine T. MacArthur Foundation	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Wildlife Conservation Society from the Western Indian Ocean Marine Science Association; Tiffany Foundation; McBean Foundation; John D. and Catherine T. MacArthur Foundation	This work is based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation to C. McQuaid. T. McClanahan was supported by grants to the Wildlife Conservation Society from the Western Indian Ocean Marine Science Association, the Tiffany, McBean, and John D. and Catherine T. MacArthur Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TC, 2015, MAR ECOL PROG SER, V520, P1, DOI 10.3354/meps11170; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 1994, RECORDS AUSTR MUSEUM; Bennett S, 2011, MAR ECOL PROG SER, V426, P241, DOI 10.3354/meps09016; Brandl SJ, 2014, J ANIM ECOL, V83, P661, DOI 10.1111/1365-2656.12171; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; Byrnes JEK, 2013, ECOLOGY, V94, P1636, DOI 10.1890/11-2310.1; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Chong-Seng KM, 2014, CORAL REEFS, V33, P409, DOI 10.1007/s00338-014-1134-5; Clements KD, 2009, FUNCT ECOL, V23, P79, DOI 10.1111/j.1365-2435.2008.01524.x; Condy M, 2015, AQUAT CONSERV, V25, P396, DOI 10.1002/aqc.2482; Cvitanovic C, 2009, CORAL REEFS, V28, P127, DOI 10.1007/s00338-008-0433-0; Dixson DL, 2014, SCIENCE, V345, P892, DOI 10.1126/science.1255057; Edwards CB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1835; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Green A.L., 2009, MONITORING FUNCTIONA; Hay ME, 1997, CORAL REEFS, V16, pS67, DOI 10.1007/s003380050243; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; Hixon MA, 1996, ECOL MONOGR, V66, P67, DOI 10.2307/2963481; Hoey AS, 2010, MAR BIOL, V157, P189, DOI 10.1007/s00227-009-1309-8; Hoey AS, 2009, ECOSYSTEMS, P1; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Humphries AT, 2014, MAR ECOL PROG SER, V504, P119, DOI 10.3354/meps10744; LESSIOS HA, 1984, CORAL REEFS, V3, P173, DOI 10.1007/BF00288252; Letourneur Y, 1998, NAGA, V21, P39; Lockwood JR, 1998, OECOLOGIA, V116, P475, DOI 10.1007/s004420050612; Mantyka CS, 2007, MAR ECOL PROG SER, V352, P177, DOI 10.3354/meps07055; Marshell A, 2015, J EXP MAR BIOL ECOL, V473, P152, DOI 10.1016/j.jembe.2015.09.002; Mbaru EK, 2013, FISH RES, V148, P90, DOI 10.1016/j.fishres.2013.08.011; McClanahan TR, 2012, MAR ECOL PROG SER, V469, P121, DOI 10.3354/meps10009; McClanahan TR, 2011, AQUAT CONSERV, V21, P658, DOI 10.1002/aqc.1225; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McClanahan TR, 2014, MAR ECOL PROG SER, V497, P13, DOI 10.3354/meps10605; MCCLANAHAN TR, 1990, OECOLOGIA, V83, P362, DOI 10.1007/BF00317561; MCCLANAHAN TR, 1994, J EXP MAR BIOL ECOL, V184, P237, DOI 10.1016/0022-0981(94)90007-8; MCCLANAHAN TR, 1988, MAR ECOL PROG SER, V44, P191, DOI 10.3354/meps044191; McClanahan TR, 1997, ENVIRON CONSERV, V24, P105, DOI 10.1017/S0376892997000179; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Nakamura Y, 2003, ICHTHYOL RES, V50, P15, DOI 10.1007/s102280300002; OGDEN J C, 1978, Environmental Biology of Fishes, V3, P49, DOI 10.1007/BF00006308; Persson A, 1999, CAN J FISH AQUAT SCI, V56, P70, DOI 10.1139/cjfas-56-1-70; Petchey OL, 2008, P NATL ACAD SCI USA, V105, P4191, DOI 10.1073/pnas.0710672105; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; ROA R, 1992, OECOLOGIA, V89, P509, DOI 10.1007/BF00317157; Sandin SA, 2012, OECOLOGIA, V168, P1079, DOI 10.1007/s00442-011-2156-0; SCOTT FJ, 1987, MAR ECOL PROG SER, V39, P293, DOI 10.3354/meps039293; Team RDC, 2013, LANG ENV STAT COMP; Thibaut LM, 2013, ECOL LETT, V16, P140, DOI 10.1111/ele.12019; Verges A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045543; Wilson SK, 2012, CONSERVATION BIOL	57	9	9	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144204	10.1371/journal.pone.0144204	http://dx.doi.org/10.1371/journal.pone.0144204			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673609	Green Submitted, gold, Green Published			2022-12-27	WOS:000366722700030
J	Gasulla, JM; Escaso, F; Narvaez, I; Ortega, F; Sanz, JL				Miguel Gasulla, Jose; Escaso, Fernando; Narvaez, Ivan; Ortega, Francisco; Luis Sanz, Jose			A New Sail-Backed Styracosternan (Dinosauria: Ornithopoda) from the Early Cretaceous of Morella, Spain	PLOS ONE			English	Article							BASAL IGUANODONT DINOSAURIA; DELAPPARENTIA-TUROLENSIS; ORNITHISCHIA ORNITHOPODA; TERUEL; ARCILLAS; POSITION	A new styracosternan ornithopod genus and species is here described based on a partial postcranial skeleton and an associated dentary tooth of a single specimen from the Arcillas de Morella Formation (Early Cretaceous, late Barremian) at the Morella locality, (Castellen Spain). Morelladon beltrani gen. et sp. nov. is diagnosed by eight autapomorphic features. The set of autapomorphies includes: very elongated and vertical neural spines of the dorsal vertebrae, midline keel on ventral surface of the second to fourth sacral vertebrae restricted to the anterior half of the centrum, a posterodorsally inclined medial ridge on the postacetabular process of the ilium that meets its dorsal margin and distal end of the straight ischial shaft laterally expanded, among others. Phylogenetic analyses reveal that the new Iberian form is more closely related to its synchronic and sympatric contemporary European taxa Iguanodon bernissartensis and Mantellisaurus atherfieldensis, known from Western Europe, than to other Early Cretaceous Iberian styracosternans (Delapparentia turolensis and Proa valdearinnoensis). The recognition of Morelladon beltrani gen. et sp. nov. indicates that the Iberian Peninsula was home to a highly diverse medium to large bodied styracosternan assemblage during the Early Cretaceous.	[Miguel Gasulla, Jose; Luis Sanz, Jose] Univ Autonoma Madrid, Unidad Paleontol, Madrid, Spain; [Escaso, Fernando; Narvaez, Ivan; Ortega, Francisco] Univ Nacl Educ Distancia, Grp Biol Evolut, E-28040 Madrid, Spain	Autonomous University of Madrid; Universidad Nacional de Educacion a Distancia (UNED)	Escaso, F (corresponding author), Univ Nacl Educ Distancia, Grp Biol Evolut, E-28040 Madrid, Spain.	fescaso@ccia.uned.es	Sanz, Jose Luis/O-1421-2019; Ortega, Francisco/K-3255-2015; Narvaez, Ivan/D-8147-2018; Ortega, Francisco/B-5760-2009; Escaso, Fernando/H-9782-2015	Ortega, Francisco/0000-0002-7431-354X; Narvaez, Ivan/0000-0003-0114-7058; Ortega, Francisco/0000-0002-7431-354X; Escaso, Fernando/0000-0001-7642-1555; Sanz, Jose Luis/0000-0002-5214-5725				Chabli S., 1988, THESIS; DOLLO L, 1888, CR HEBD ACAD SCI, V106, P775; Gasca JM, 2015, J IBER GEOL, V41, P57, DOI 10.5209/rev_JIGE.2015.v41.n1.48655; Gasulla J.M., 2009, P PROGR ABSTR FIELD, P44; Gasulla JM, 2014, CRETACEOUS RES, V47, P19, DOI 10.1016/j.cretres.2013.10.004; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hooley R. W., 1925, Quarterly Journal of the Geological Society of London, V81, P1; Gasca JM, 2014, CRETACEOUS RES, V50, P264, DOI 10.1016/j.cretres.2014.05.009; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mcdonald AT, 2011, ZOOTAXA, P52, DOI 10.11646/zootaxa.2783.1.4; Mcdonald AT, 2012, ZOOTAXA, P61; McDonald AT, 2012, CRETACEOUS RES, V33, P1, DOI 10.1016/j.cretres.2011.03.002; McDonald AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014075; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Norman David B., 2011, Palaeontological Association Field Guides to Fossils, V14, P407; Norman DB, 2015, ZOOL J LINN SOC-LOND, V173, P92, DOI 10.1111/zoj.12193; Norman David B., 2012, P174; Norman DB, 2011, SPEC PAP PALAEONTOL, P165, DOI 10.1111/j.1475-4983.2011.01082.x; Norman DB., 1980, MEMOIRES I ROYAL SCI, V178, P1; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Pereda-Suberbiola X, 2011, CR PALEVOL, V10, P551, DOI 10.1016/j.crpv.2011.04.003; Ruiz-Omenaca JI, 2011, ESTUD GEOL-MADRID, V67, P83, DOI 10.3989/egeol.40276.124; SALAS R, 2005, GEOGACETA, V38, P15; Sanz JL., 1982, GEOLOGIA PALEONTOLOG, P69; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Serrano ML, 2013, GEOL MAG, V150, P572, DOI 10.1017/S0016756813000095; Shibata M, 2015, ZOOTAXA, V3914, P421, DOI 10.11646/zootaxa.3914.4.3; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taquet Philippe, 1999, Annales de Paleontologie, V85, P85, DOI 10.1016/S0753-3969(99)80009-3; Taquet R, 1976, CHAPITRE, P57; Verdu FJ, 2015, CRETACEOUS RES, V56, P250, DOI 10.1016/j.cretres.2015.05.010; Villanueva-Amadoz U, 2015, HIST BIOL, V27, P389, DOI 10.1080/08912963.2013.874422; Wang XL, 2010, EARTH ENV SCI T R SO, V101, P135, DOI 10.1017/S1755691010009266; Wu W-H, 2012, BERNISSART DINOSAURS, P174; [You Hailu 尤海鲁], 2005, [地质通报, Geological Bulletin of China], V24, P785	37	21	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144167	10.1371/journal.pone.0144167	http://dx.doi.org/10.1371/journal.pone.0144167			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673161	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700027
J	Sutton, GJ; Hoskins, AJ; Arnould, JPY				Sutton, Grace J.; Hoskins, Andrew J.; Arnould, John P. Y.			Benefits of Group Foraging Depend on Prey Type in a Small Marine Predator, the Little Penguin	PLOS ONE			English	Article							EUDYPTULA-MINOR; BASS STRAIT; BEHAVIOR; ENVIRONMENTS; CONSUMPTION; JELLYFISH; ENERGY; FOOD	Group foraging provides predators with advantages in over-powering prey larger than themselves or in aggregating small prey for efficient exploitation. For group-living predatory species, cooperative hunting strategies provide inclusive fitness benefits. However, for colonial-breeding predators, the benefit pay-offs of group foraging are less clear due to the potential for intra-specific competition. We used animal-borne cameras to determine the prey types, hunting strategies, and success of little penguins (Eudyptula minor), a small, colonial breeding air-breathing marine predator that has recently been shown to display extensive at-sea foraging associations with conspecifics. Regardless of prey type, little penguins had a higher probability of associating with conspecifics when hunting prey that were aggregated than when prey were solitary. In addition, success was greater when individuals hunted schooling rather than solitary prey. Surprisingly, however, success on schooling prey was similar or greater when individuals hunted on their own than when with conspecifics. These findings suggest individuals may be trading-off the energetic gains of solitary hunting for an increased probability of detecting prey within a spatially and temporally variable prey field by associating with conspecifics.	[Sutton, Grace J.; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic 3217, Australia; [Hoskins, Andrew J.] CSIRO Land & Water, Canberra, ACT, Australia	Deakin University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Sutton, GJ (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood Campus, Geelong, Vic 3217, Australia.	gsutton@deakin.edu.au	Hoskins, Andrew/T-2694-2019	Hoskins, Andrew/0000-0001-8907-6682	Deakin University internal funds	Deakin University internal funds	This project was supported by Deakin University internal funds.	Agnew P, 2013, MAR BIOL, V160, P2375, DOI 10.1007/s00227-013-2231-7; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 2014, R LANG ENV STAT COMP; Arnould JPY, 2004, EMU, V104, P261, DOI 10.1071/MU04035; Bates D, IME4 LINEAR MIXED EF; Beauchamp Guy, 2013, SOCIAL PREDATION GRO; BELOVSKY GE, 1989, THEOR POPUL BIOL, V36, P144, DOI 10.1016/0040-5809(89)90026-9; Berlincourt M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105065; Bunce A, 2001, ICES J MAR SCI, V58, P904, DOI 10.1006/jmsc.2001.1083; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; CULLEN JM, 1992, EMU, V91, P318, DOI 10.1071/MU9910318; Daniel TA, 2007, ANIM BEHAV, V74, P1241, DOI 10.1016/j.anbehav.2007.01.029; Doyle TK, 2007, J EXP MAR BIOL ECOL, V343, P239, DOI 10.1016/j.jembe.2006.12.010; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; GREEN B, 1989, PHYSIOL ZOOL, V62, P702, DOI 10.1086/physzool.62.3.30157922; HARRISON NM, 1984, LIMNOL OCEANOGR, V29, P1335, DOI 10.4319/lo.1984.29.6.1335; Hoese D.F., 1994, FISHES AUSTR S COAST, P781; Hoskins AJ, 2008, MAR ECOL PROG SER, V366, P293, DOI 10.3354/meps07507; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; KLOMP NI, 1991, EMU, V91, P32, DOI 10.1071/MU9910032; OBRIEN DP, 1988, MAR ECOL PROG SER, V42, P219, DOI 10.3354/meps042219; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Pinheiro J., 2006, MIXED EFFECTS MODELS; Pinheiro J, 2015, NLME LINEAR NONLINEA; Ponganis PJ, 2000, J EXP BIOL, V203, P3275; POYSA H, 1992, ORNIS SCAND, V23, P159, DOI 10.2307/3676444; Preston Tiana J., 2008, Endangered Species Research, V4, P95, DOI 10.3354/esr00069; RYPSTRA AL, 1991, OECOLOGIA, V86, P25, DOI 10.1007/BF00317384; Scantlebury DM, 2014, SCIENCE, V346, P79, DOI 10.1126/science.1256424; Schrimpf MB, 2012, MAR ECOL PROG SER, V460, P247, DOI 10.3354/meps09750; Takahashi A, 2008, POLAR BIOL, V31, P1291, DOI 10.1007/s00300-008-0502-4; Thiebault A, 2014, BEHAV ECOL, V25, P1302, DOI 10.1093/beheco/aru132; Wakefield ED, 2009, MAR ECOL PROG SER, V391, P165, DOI 10.3354/meps08203; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Wiley D, 2011, BEHAVIOUR, V148, P575, DOI 10.1163/000579511X570893; Wilson RP, 2007, DEEP-SEA RES PT II, V54, P193, DOI 10.1016/j.dsr2.2006.11.017; Zuur Alain F., 2009, P1	37	38	39	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144297	10.1371/journal.pone.0144297	http://dx.doi.org/10.1371/journal.pone.0144297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674073	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700033
J	Bank, S; Andersen, PS; Burisch, J; Pedersen, N; Roug, S; Galsgaard, J; Turino, SY; Brodersen, JB; Rashid, S; Rasmussen, BK; Avlund, S; Olesen, TB; Hoffmann, HJ; Nexo, BA; Sode, J; Vogel, U; Andersen, V				Bank, Steffen; Andersen, Paal Skytt; Burisch, Johan; Pedersen, Natalia; Roug, Stine; Galsgaard, Julied; Turino, Stine Ydegaard; Brodersen, Jacob Broder; Rashid, Shaista; Rasmussen, Britt Kaiser; Avlund, Sara; Olesen, Thomas Bastholm; Hoffmann, Hans Jurgen; Nexo, Bjorn Andersen; Sode, Jacob; Vogel, Ulla; Andersen, Vibeke			Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort	PLOS ONE			English	Article							ULCERATIVE-COLITIS RISK; CROHNS-DISEASE; GENE-EXPRESSION; NUMBER	Background The inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), result from the combined effects of susceptibility genes and environmental factors. Previous studies have shown that polymorphisms in the Toll-like receptor (TLR), the apoptosis, the IL-23/IL-17 and the interferon gamma (IFNG) pathways are associated with risk of both CD and UC. Methods Using a candidate gene approach, 21 functional single nucleotide polymorphisms (SNPs) in 15 genes were assessed in a clinical homogeneous group of severely diseased ethnic Danish patients consisting of 624 patients with CD, 411 patients with UC and 795 controls. The results were analysed using logistic regression. Results The polymorphisms TLR5 (rs5744174) and IL12B (rs6887695) were associated with risk of CD, and TLR1 (rs4833095) and IL18 (rs187238) were associated with risk of both CD and UC (p<0.05). After Bonferroni correction for multiple testing, the homozygous variant genotype of TLR1 743 T>C (rs4833095) was associated with increased risk CD (OR: 3.15, 95% CI: 1.59-6.26, p = 0.02) and CD and UC combined (OR: 2.96, 95% CI: 1.64-5.32, p = 0.005). Conclusion Our results suggest that genetically determined high activity of TLR1 and TLR5 was associated with increased risk of both CD and UC and CD, respectively. This supports that the host microbial composition or environmental factors in the gut are involved in risk of IBD. Furthermore, genetically determined high activity of the IL-23/IL-17 pathway was associated with increased risk of CD and UC. Overall, our results support that genetically determined high inflammatory response was associated with increased risk of both CD and UC.	[Bank, Steffen; Andersen, Vibeke] Viborg Reg Hosp, Dept Med, Viborg, Denmark; [Bank, Steffen; Nexo, Bjorn Andersen] Univ Aarhus, Biomed, Aarhus, Denmark; [Andersen, Paal Skytt] Statens Serum Inst, Microbiol & Infect Control, DK-2300 Copenhagen, Denmark; [Andersen, Paal Skytt] Univ Copenhagen, Vet Dis Biol, Copenhagen, Denmark; [Burisch, Johan; Pedersen, Natalia] Herlev Hosp, Dept Gastroenterol, DK-2730 Herlev, Denmark; [Roug, Stine] Univ Copenhagen, Hvidovre Hosp, Dept Gastroenterol, DK-2650 Hvidovre, Denmark; [Galsgaard, Julied] Koge Hosp, Dept Med, Koge, Denmark; [Turino, Stine Ydegaard] Hillerod Hosp, Dept Med, Hillerod, Denmark; [Brodersen, Jacob Broder] Sydvestjysk Hosp, Dept Med, Esbjerg, Denmark; [Brodersen, Jacob Broder] Odense Univ Hosp, Dept Med Gastroenterol, DK-5000 Odense, Denmark; [Rashid, Shaista] Bispebjerg Hosp, Dept Med, Bispebjerg, Denmark; [Rasmussen, Britt Kaiser] Nykobing Falster Hosp, Dept Med, Nykobing, Denmark; [Avlund, Sara] Aarhus Univ Hosp, Med Dept 5, DK-8000 Aarhus, Denmark; [Olesen, Thomas Bastholm] Slagelse Hosp, Dept Med, Slagelse, Denmark; [Hoffmann, Hans Jurgen] Aarhus Univ Hosp, Dept Resp Dis B, Inst Clin Med, DK-8000 Aarhus, Denmark; [Sode, Jacob; Andersen, Vibeke] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Sode, Jacob] Statens Serum Inst, Dept Autoimmunol & Biomarkers, DK-2300 Copenhagen, Denmark; [Sode, Jacob] Frederiksberg Univ Hosp, Dept Rheumatol, Frederiksberg, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Andersen, Vibeke] Hosp Southern Jutland Aabenraa, Res Unit Mol Diagnost, Aabenraa, Denmark; [Andersen, Vibeke] Odense Univ Hosp, OPEN Odense Patient Data Explorat Network, Odense, Denmark	Aarhus University; Aarhus University; Statens Serum Institut; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Bispebjerg Hospital; Aarhus University; Aarhus University; University of Southern Denmark; Statens Serum Institut; National Research Centre for the Working Environment; University of Southern Denmark; Odense University Hospital	Bank, S (corresponding author), Viborg Reg Hosp, Dept Med, Viborg, Denmark.	stb@mb.au.dk	Andersen, Vibeke/I-7932-2012; Olesen, Thomas/AFS-2588-2022; Sode, Jacob/AAD-9615-2020; Vogel, Ulla B/I-5048-2012; Burisch, Johan/AGJ-3893-2022; Hoffman, Hans Jurgen/I-6969-2018; Andersen, Paal S/H-2087-2015; Vogel, Ulla/ABC-2212-2020	Andersen, Vibeke/0000-0002-0127-2863; Olesen, Thomas/0000-0003-1464-7342; Sode, Jacob/0000-0002-2718-9320; Vogel, Ulla B/0000-0001-6807-1524; Burisch, Johan/0000-0002-3312-5139; Hoffman, Hans Jurgen/0000-0002-6743-7931; Andersen, Paal S/0000-0001-5656-0427; Vogel, Ulla/0000-0001-6807-1524; Brodersen, Jacob Broder/0000-0003-2530-7554	Health Research Fund of Central Denmark Region; Colitis-Crohn Foreningen; University of Aarhus	Health Research Fund of Central Denmark Region; Colitis-Crohn Foreningen; University of Aarhus	The work was funded by Health Research Fund of Central Denmark Region, Colitis-Crohn Foreningen and University of Aarhus (PhD grant).	Aguilera M, 2014, CYTOKINE GROWTH F R, P10; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Bank S, 2014, PHARMACOGENOMICS J, V14, P526, DOI 10.1038/tpj.2014.19; Bank S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098815; Bank S, 2013, GENET TEST MOL BIOMA, V17, P501, DOI 10.1089/gtmb.2012.0429; Buning C, 2008, INFLAMM BOWEL DIS, V14, P332, DOI 10.1002/ibd.20337; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Chang HD, 2007, ANN NY ACAD SCI, V1109, P40, DOI 10.1196/annals.1398.006; D'Osualdo A, 2012, PIGM CELL MELANOMA R, V25, P5, DOI 10.1111/j.1755-148X.2011.00942.x; Dinarello CA, 2012, FRONT IMMUNOL, P289; Ernst A, 2007, SCAND J GASTROENTERO, V42, P1445, DOI 10.1080/00365520701427102; Fowler EV, 2008, AM J GASTROENTEROL, V103, P2519, DOI 10.1111/j.1572-0241.2008.02023.x; Franke A, 2007, GASTROENTEROLOGY, V132, P2080, DOI 10.1053/j.gastro.2007.03.087; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gologan S, 2013, J CROHNS COLITIS, V7, P622, DOI 10.1016/j.crohns.2012.08.015; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; Hong GS, 2002, J BIOCHEM MOL BIOL, V35, P19; Kappelman MD, 2013, DIGEST DIS SCI, V58, P519, DOI 10.1007/s10620-012-2371-5; Li JG, 2012, IMMUNOGENETICS, V64, P361, DOI 10.1007/s00251-011-0597-6; Liu ZJ, 2011, J LEUKOCYTE BIOL, V89, P597, DOI 10.1189/jlb.0810456; Ng SC, 2011, INFLAMM BOWEL DIS, V17, P2027, DOI 10.1002/ibd.21590; Paramel GV, 2013, CLIN SCI, V125, P401, DOI 10.1042/CS20120572; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Pugazhendhi S, 2013, INT J TUBERC LUNG D, V17, P662, DOI 10.5588/ijtld.12.0600; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sheridan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061326; Sode J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100361; Thompson AI, 2011, INFLAMM BOWEL DIS, V17, P831, DOI 10.1002/ibd.21375; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Wang Y, 2014, DNA CELL BIOL, V33, P438, DOI 10.1089/dna.2013.2310; Yamazaki K, 2009, GUT, V58, P228, DOI 10.1136/gut.2007.140764	34	40	45	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145302	10.1371/journal.pone.0145302	http://dx.doi.org/10.1371/journal.pone.0145302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698117	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600061
J	Jeewandara, C; Gomes, L; Paranavitane, SA; Tantirimudalige, M; Panapitiya, SS; Jayewardene, A; Fernando, S; Fernando, RH; Prathapan, S; Ogg, GS; Malavige, GN				Jeewandara, Chandima; Gomes, Laksiri; Paranavitane, S. A.; Tantirimudalige, Mihiri; Panapitiya, Sumedha Sandaruwan; Jayewardene, Amitha; Fernando, Samitha; Fernando, R. H.; Prathapan, Shamini; Ogg, Graham S.; Malavige, Gathsaurie Neelika			Change in Dengue and Japanese Encephalitis Seroprevalence Rates in Sri Lanka	PLOS ONE			English	Article							CROSS-REACTIVITY; PEDIATRIC COHORT; PHASE-III; INFECTION; VACCINE; VIRUS; IMMUNOGENICITY; CHILDREN; BURDEN; POPULATION	Background Sri Lanka has been affected by epidemics of dengue infections for many decades and the incidence and severity of dengue infections have been rising each year. Therefore, we investigated the age stratified seroprevalence of dengue infections in order to facilitate future dengue vaccine strategies. In addition, since the symptomatic dengue infections have increased during the past few decades, we also investigated the possible association with Japanese Encephalitis Virus (JEV) antibody seropositivity with symptomatic dengue in a community cohort in Sri Lanka. Methods 1689 healthy individuals who were attending a primary health care facility were recruited. Dengue and JEV antibody status was determined in all individuals and JEV vaccination status was recorded. Results 1152/1689 (68.2%) individuals were seropositive for dengue and only 133/1152 (11.5%) of them had been hospitalized to due to dengue. A significant and positive correlation was observed for dengue antibody seropositivity and age in children (Spearmans R = 0.84, p = 0.002) and in adults (Spearmans R = 0.96, p = 0.004). We observed a significant rise in the age stratified seroprevalence rates in children over a period of 12 years. For instance, in year 2003 the annual seroconversion rate was 1.5% per annum, which had risen to 3.79% per annum by 2014. We also found that both adults (p<0.001) and in children (p = 0.03) who were hospitalized due to dengue were more likely to be seropositive for JEV antibodies. However, 244 (91.4%) of adults who were seropositive for JEV had not had the JEV vaccine. Conclusions Dengue seroprevalence rates have risen significantly over the last 12 years in Sri Lanka, possibly due to increased transmission. As individuals who were hospitalized due to dengue were more likely to be seropositive for JEV, the possibility of cross-reactive assays and/or of JEV infection on immunity to the DENV and clinical disease severity should be further investigated.	[Jeewandara, Chandima; Gomes, Laksiri; Paranavitane, S. A.; Tantirimudalige, Mihiri; Panapitiya, Sumedha Sandaruwan; Fernando, Samitha; Fernando, R. H.; Prathapan, Shamini; Malavige, Gathsaurie Neelika] Univ Sri Jayawardenapura, Fac Med Sci, Dept Microbiol, Ctr Dengue Res, Nugegoda, Sri Lanka; [Jeewandara, Chandima; Jayewardene, Amitha] Univ Sri Jayawardanapura, Dept Family Med, Fac Med Sci, Nugegoda, Sri Lanka; [Ogg, Graham S.; Malavige, Gathsaurie Neelika] MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford NIHR Biomed Res Ctr, London W1N 4AL, England; [Ogg, Graham S.; Malavige, Gathsaurie Neelika] Univ Oxford, Oxford OX1 2JD, England; [Ogg, Graham S.] Churchill Hosp, Dept Dermatol, Oxford OX3 7LJ, England	University Sri Jayewardenepura; University Sri Jayewardenepura; University of Oxford; University of Oxford	Malavige, GN (corresponding author), Univ Sri Jayawardenapura, Fac Med Sci, Dept Microbiol, Ctr Dengue Res, Nugegoda, Sri Lanka.	gathsaurie.malavige@ndm.ox.ac.uk	; Malavige, Gathsaurie/J-5483-2015	Tantirimudalige, Mihiri/0000-0002-5644-1556; Malavige, Gathsaurie/0000-0001-9201-0449; Fernando, Bentotage/0000-0002-5613-5807; Ogg, Graham/0000-0002-3097-045X	Centre for Dengue Research; National Research Foundation, Sri Lanka [NSF2011/RG/HS/22]; MRC [MC_UU_12010/5] Funding Source: UKRI; Medical Research Council [MC_UU_12010/5] Funding Source: researchfish	Centre for Dengue Research; National Research Foundation, Sri Lanka; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funds were provided by the Centre for Dengue Research and the National Research Foundation, Sri Lanka (NSF2011/RG/HS/22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Chokephaibulkit K, 2010, PEDIATR INFECT DIS J, V29, P1111, DOI 10.1097/INF.0b013e3181f68e9c; Conlan JV, 2015, AM J TROP MED HYG, V93, P1010, DOI 10.4269/ajtmh.15-0072; Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481; Epidemiology unit MoH Sri Lanka, JAP ENC MANN MED OFF; Epidemiology unit MoH Sri Lanka, 2004, Q EP REP 1 QUAT; Fox A, 2014, AM J TROP MED HYG, V90, P892, DOI 10.4269/ajtmh.13-0077; Hsu LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003030; Konishi E, 2009, VACCINE, V27, P7129, DOI 10.1016/j.vaccine.2009.09.052; Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7; Litzba N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000883; Malavige GN, 2012, CEYLON MED J, V57, P97, DOI 10.4038/cmj.v57i3.4701; Malavige G. N., 2006, Dengue Bulletin, V30, P68; Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0; Mendis N M, 1967, Ceylon Med J, V12, P67; Messer William B., 2002, American Journal of Tropical Medicine and Hygiene, V66, P765; Miyazaki C, 2014, CLIN VACCINE IMMUNOL, V21, P188, DOI 10.1128/CVI.00377-13; Moran E, 2008, EUR J IMMUNOL, V38, P1050, DOI 10.1002/eji.200737699; Munasinghe D R, 1966, Ceylon Med J, V11, P129; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Nguyen TY, 2010, AM J TROP MED HYG, V83, P816, DOI 10.4269/ajtmh.2010.10-0262; Pipattanaboon C, 2013, BIOL-TARGETS THER, V7, P175, DOI 10.2147/BTT.S47438; Sankar SG, 2014, J IMMUNOL METHODS, V407, P116, DOI 10.1016/j.jim.2014.03.028; Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Singh KP, 2014, ASIAN PAC J TROP MED, V7, P124, DOI 10.1016/S1995-7645(14)60007-9; Sohn YM, 2008, VACCINE, V26, P1638, DOI 10.1016/j.vaccine.2008.01.021; Tam CC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002259; Tissera H, 2014, AM J TROP MED HYG, V91, P132, DOI 10.4269/ajtmh.13-0540; Unit E, 2015, NAT IMM SUMM 2015; Verma R, 2012, HUM VACC IMMUNOTHER, V8, P491, DOI 10.4161/hv.18925; World Health Organization ROfS-EA, 2011, COMPR GUID PREV CONT; Yun KW, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0744-4	35	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144799	10.1371/journal.pone.0144799	http://dx.doi.org/10.1371/journal.pone.0144799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696417	Green Published, gold			2022-12-27	WOS:000367092500011
J	Stark, AY; Palecek, AM; Argenbright, CW; Bernard, C; Brennan, AB; Niewiarowski, PH; Dhinojwala, A				Stark, Alyssa Y.; Palecek, Amanda M.; Argenbright, Clayton W.; Bernard, Craig; Brennan, Anthony B.; Niewiarowski, Peter H.; Dhinojwala, Ali			Gecko Adhesion on Wet and Dry Patterned Substrates	PLOS ONE			English	Article							LOCOMOTOR PERFORMANCE; CLINGING ABILITY; SETAL FIELDS; MORPHOLOGY; ATTACHMENT; REPTILIA; SYSTEM; WATER; TOKAY; TOE	Perhaps one of the most astounding characteristics of the gecko adhesive system is its versatility. Geckos can locomote across complex substrates in a variety of conditions with apparent ease. In contrast, many of our synthetic pressure sensitive adhesives fail on substrates that are dirty, wet or rough. Although many studies have investigated the effect of environmental challenges on performance, the interaction of multiple, potentially compromising variables is studied less often. Here we focus on substrate structure and surface water, both of which are highly relevant to the biological system and to synthetic design. To do this we utilized a highly controlled, patterned substrate (Sharklet (R), by Sharklet (R) Technologies Inc.). This allowed us to test independently and jointly the effects of reduced surface area substrates, with a defined pattern, on adhesion in both air and water. Our results show that adhesion is not significantly impaired in air, whereas surface area and pattern significantly affect adhesion in water. These findings highlight the need to study multiple parameters that are relevant to the gecko adhesive system to further improve our understanding of the biological system and to design better, more versatile synthetics.	[Stark, Alyssa Y.; Palecek, Amanda M.; Bernard, Craig; Niewiarowski, Peter H.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Argenbright, Clayton W.; Brennan, Anthony B.] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA; [Dhinojwala, Ali] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA	University System of Ohio; University of Akron; State University System of Florida; University of Florida; University System of Ohio; University of Akron	Stark, AY (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	ays3@zips.uakron.edu	niewiarowski, peter/AAA-7060-2022	niewiarowski, peter/0000-0002-8952-3013; Stark, Alyssa/0000-0002-4217-2850; Palecek, Amanda/0000-0002-9908-3103	Office of Naval Research [N000141310443]	Office of Naval Research(Office of Naval Research)	CWA and ABB wish to acknowledge the support of the Office of Naval Research Grant #N000141310443; http://www.onr.navy.mil/en.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autumn K, 2006, J EXP BIOL, V209, P3558, DOI 10.1242/jeb.02469; Autumn K, 2006, AM SCI, V94, P124, DOI 10.1511/2006.58.124; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Badge I, 2014, SCI REP-UK, V4, DOI 10.1038/srep06643; Bergmann PJ, 2005, J EXP ZOOL PART A, V303A, P785, DOI 10.1002/jez.a.210; Boesel LF, 2010, ADV MATER, V22, P2125, DOI 10.1002/adma.200903200; Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405; Collins CE, 2015, FUNCT ECOL, V29, P66, DOI 10.1111/1365-2435.12312; Defante AP, 2015, LANGMUIR, V31, P2398, DOI 10.1021/la504564w; Ditsche P, 2014, J EXP BIOL, V217, P2548, DOI 10.1242/jeb.100149; Ditsche-Kuru P, 2010, J EXP BIOL, V213, P1950, DOI 10.1242/jeb.037218; Endlein T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073810; Gillies AG, 2014, J EXP BIOL, V217, P283, DOI 10.1242/jeb.092015; GREEN DM, 1988, CAN J ZOOL, V66, P1610, DOI 10.1139/z88-235; Hansen WR, 2005, P NATL ACAD SCI USA, V102, P385, DOI 10.1073/pnas.0408304102; Higham TE, 2010, BIOL J LINN SOC, V101, P860, DOI 10.1111/j.1095-8312.2010.01539.x; Hsu PY, 2012, J R SOC INTERFACE, V9, P657, DOI 10.1098/rsif.2011.0370; Hu SH, 2012, J R SOC INTERFACE, V9, P2781, DOI 10.1098/rsif.2012.0108; Huber G, 2007, ACTA BIOMATER, V3, P607, DOI 10.1016/j.actbio.2007.01.007; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Jain D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09594; Johnson MK, 2009, J ANAT, V214, P937, DOI 10.1111/j.1469-7580.2009.01075.x; Lepore E, 2008, J NANOMATER, V2008, DOI 10.1155/2008/194524; Long CJ, 2009, LANGMUIR, V25, P12982, DOI 10.1021/la901836w; Losos J.B., 1990, Asiatic Herpetological Research, V3, P54; MADERSON PF, 1964, NATURE, V203, P780, DOI 10.1038/203780a0; Magin CM, 2010, MATER TODAY, V13, P36, DOI 10.1016/S1369-7021(10)70058-4; Niewiarowski PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002192; Pugno NM, 2008, J ADHESION, V84, P949, DOI 10.1080/00218460802505374; Pugno NM, 2008, BIOSYSTEMS, V94, P218, DOI 10.1016/j.biosystems.2008.06.009; Rizzo NW, 2006, J R SOC INTERFACE, V3, P441, DOI 10.1098/rsif.2005.0097; RUIBAL R, 1965, J MORPHOL, V117, P271, DOI 10.1002/jmor.1051170302; Russell AP, 2007, CAN J ZOOL, V85, P1228, DOI 10.1139/Z07-103; Russell AP, 2014, ACTA ZOOL-STOCKHOLM, V95, P299, DOI 10.1111/azo.12028; RUSSELL AP, 1975, J ZOOL, V176, P437, DOI 10.1111/j.1469-7998.1975.tb03215.x; Russell AP, 2002, INTEGR COMP BIOL, V42, P1154, DOI 10.1093/icb/42.6.1154; RUSSELL AP, 1981, J MORPHOL, V169, P293, DOI 10.1002/jmor.1051690305; RUSSELL AP, 1986, CAN J ZOOL, V64, P948, DOI 10.1139/z86-144; Schumacher JF, 2008, LANGMUIR, V24, P4931, DOI 10.1021/la703421v; Stark AY, 2015, J EXP BIOL, V218, P2435, DOI 10.1242/jeb.120683; Stark AY, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0464; Stark AY, 2014, INTEGR COMP BIOL, V54, P1026, DOI 10.1093/icb/icu066; Stark AY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101885; Stark AY, 2013, P NATL ACAD SCI USA, V110, P6340, DOI 10.1073/pnas.1219317110; Stark AY, 2012, J EXP BIOL, V215, P3080, DOI 10.1242/jeb.070912; Vanhooydonck B, 2005, BIOL J LINN SOC, V85, P385, DOI 10.1111/j.1095-8312.2005.00495.x; Wainwright DK, 2013, STICK TIGHT SUCTION; WILLIAMS EE, 1982, SCIENCE, V215, P1509, DOI 10.1126/science.215.4539.1509; Zani PA, 2000, J EVOLUTION BIOL, V13, P316, DOI 10.1046/j.1420-9101.2000.00166.x	49	14	14	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145756	10.1371/journal.pone.0145756	http://dx.doi.org/10.1371/journal.pone.0145756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696412	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092500071
J	Azage, M; Kumie, A; Worku, A; Bagtzoglou, AC				Azage, Muluken; Kumie, Abera; Worku, Alemayehu; Bagtzoglou, Amvrossios C.			Childhood Diarrhea Exhibits Spatiotemporal Variation in Northwest Ethiopia: A SaTScan Spatial Statistical Analysis	PLOS ONE			English	Article							RISK-FACTORS; CLIMATE VARIABILITY; UNDER-5 CHILDREN; DISEASE; CHOLERA; EPIDEMIOLOGY; PREVALENCE; HOUSEHOLD; COMMUNITY; PATTERNS	Background Childhood diarrhea continues to be a public health problem in developing countries, including Ethiopia. Detecting clusters and trends of childhood diarrhea is important to designing effective interventions. Therefore, this study aimed to investigate spatiotemporal clustering and seasonal variability of childhood diarrhea in northwest Ethiopia. Methods Retrospective record review of childhood diarrhea was conducted using quarterly reported data to the district health office for the seven years period beginning July 1, 2007. Thirty three districts were included and geo-coded in this study. Spatial, temporal and space-time scan spatial statistics were employed to identify clusters of childhood diarrhea. Smoothing using a moving average was applied to visualize the trends and seasonal pattern of childhood diarrhea. Statistical analyses were performed using Excel (R) and SaTScan programs. The maps were plotted using ArcGIS 10.0. Results Childhood diarrhea in northwest Ethiopia exhibits statistical evidence of spatial, temporal, and spatiotemporal clustering, with seasonal patterns and decreasing temporal trends observed in the study area. A most likely purely spatial cluster was found in the East Gojjam administrative zone of Gozamin district (LLR = 7123.89, p < 0.001). The most likely spatiotemporal cluster was detected in all districts of East Gojjam zone and a few districts of the West Gojjam zone (LLR = 24929.90, p<0.001), appearing from July 1, 2009 to June 30, 2011. One high risk period from July 1, 2008 to June 30, 2010 (LLR = 9655.86, p = 0.001) was observed in all districts. Peak childhood diarrhea cases showed a seasonal trend, occurring more frequently from January to March and April to June. Conclusion Childhood diarrhea did not occur at random. It has spatiotemporal variation and seasonal patterns with a decreasing temporal trend. Accounting for the spatiotemporal variation identified in the study areas is advised for the prevention and control of diarrhea.	[Azage, Muluken] Univ Addis Ababa, Ethiopian Inst Water Resources, Addis Ababa, Ethiopia; [Kumie, Abera; Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia; [Bagtzoglou, Amvrossios C.] Univ Connecticut, Sch Engn, Dept Civil & Environm Engn, Storrs, CT 06269 USA	Addis Ababa University; Addis Ababa University; University of Connecticut	Azage, M (corresponding author), Univ Addis Ababa, Ethiopian Inst Water Resources, Addis Ababa, Ethiopia.	mulukenag@yahoo.com	Kumie, Abera/AAC-8537-2022; Azage, Muluken/AAF-6515-2020; Bagtzoglou, Amvrossios/AAG-6598-2019	Azage, Muluken/0000-0003-3222-0158; Bagtzoglou, Amvrossios/0000-0002-4707-4336	Addis Ababa University; Bahir Dar University; University of Connecticut; USAID	Addis Ababa University; Bahir Dar University; University of Connecticut; USAID(United States Agency for International Development (USAID))	The Addis Ababa University, Bahir Dar University, the University of Connecticut and USAID provided funding to collect data for the study by covering expenses during field visits and for software to analyze the data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alebachew A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001696; Alexander KA, 2013, INT J ENV RES PUB HE, V10, P1202, DOI 10.3390/ijerph10041202; Amare Deribew, 2007, Ethiopian Journal of Health Development, V21, P117; Bentham G, 2001, INT J BIOMETEOROL, V45, P22, DOI 10.1007/s004840000083; Berhe F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-187; Bezatu Mengistie, 2013, Open Journal of Preventive Medicine, V3, P446, DOI 10.4236/ojpm.2013.37060; Bhandari G P, 2012, J Nepal Health Res Counc, V10, P181; Borroto RJ, 2000, INT J EPIDEMIOL, V29, P764, DOI 10.1093/ije/29.4.764; Brooks JT, 2003, AM J TROP MED HYG, V68, P671, DOI 10.4269/ajtmh.2003.68.671; Bums JM, 2007, HIST SUB SAHARAN AFR; Caimcross S, 2010, INT J EPIDEMIOL, V39; Chaikaew N, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-36; Checkley W, 2000, LANCET, V355, P442, DOI 10.1016/S0140-6736(00)82010-3; Checkley W, 2003, AM J EPIDEMIOL, V157, P166, DOI 10.1093/aje/kwf179; Cheng YJ, 2013, GEOSPATIAL HEALTH, V7, P279, DOI 10.4081/gh.2013.86; Chou WC, 2010, SCI TOTAL ENVIRON, V409, P43, DOI 10.1016/j.scitotenv.2010.09.001; Clasen TF, 2010, COCHRANE DB SYST REV, V16; D'Souza RM, 2008, EPIDEMIOL INFECT, V136, P56, DOI 10.1017/S0950268807008229; Dereje Ayalew, 2012, Agricultural Sciences, V3, P608, DOI 10.4236/as.2012.34074; Dessalegn M, 2011, ETHIOP J HEALTH DEV, V25, P192; Development BoFaE, 2014, POPULATION SIZE OF A; El-Fadel M, 2013, ENVIRON MONIT ASSESS, V29, P29; Elliott P, 2004, ENVIRON HEALTH PERSP, V112, P998, DOI 10.1289/ehp.6735; Emch M, 2001, ENVIRON PLANN A, V33, P339, DOI 10.1068/a33132; Eshete Wondwossen Birke, 2008, East Afr J Public Health, V5, P193; ESRI, 2011, ARCGIS DESKT REL 10; FDRE/MoH, 2011, HEALTH AND HEALTH RE; FDRE/MoH, 2010, HEALTH AND HEALTH RE; FMOH, 2013, HEALTH SECTOR DEVELO; FMOH, 2005, HEALTH SECTOR STRATE; Galan DI, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-527; Gebru T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-395; Godana W, 2013, RURAL REMOTE HEALTH, V13; Hasan KZ, 2006, J HEALTH POPUL NUTR, V24, P25; Hashizume M, 2007, INT J EPIDEMIOL, V36, P1030, DOI 10.1093/ije/dym148; Hickman D, 2014, MBIO, V5, DOI 10.1128/mBio.01032-13; Hoque BA, 2006, INT J HYG ENVIR HEAL, V209, P451, DOI 10.1016/j.ijheh.2006.04.008; Huang DS, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-130; International CSAEal, 2012, ETHIOPIA DEMOGRAPHIC; Islam MS, 2009, T ROY SOC TROP MED H, V103, P1165, DOI 10.1016/j.trstmh.2009.04.016; Jackson MC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-55; Jagai JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038168; Jenkins G., 1994, TIME SERIES ANAL FOR; Kelly-Hope LA, 2007, AM J TROP MED HYG, V76, P706, DOI 10.4269/ajtmh.2007.76.706; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2003, COMPUT STAT DATA AN, V42, P665, DOI 10.1016/S0167-9473(02)00160-3; Kulldorff M, 2013, SATSCAN TMSER GUIDE; Kulldorff M., 1999, J NATL I PUBLIC HLTH, V48, P94; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luquero FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019005; Macro CSAEaO, 2006, ETHIOPIA DEMOGRAPHIC; Macro CSAEaO, 2001, ETHIOPIAN DEMOGRAPHI; Mediratta RP, 2010, J HEALTH POPUL NUTR, V28, P253; Mekasha A, 2003, East Afr Med J, V80, P77; Mellander PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068461; Mitike G, 2001, East Afr Med J, V78, P433; Nkoko DB, 2011, EMERG INFECT DIS, V17, P2026, DOI 10.3201/eid1711.110170; Nykiforuk JC, 2008, TECHNICAL REPORT 08; Odoi Agricola, 2004, Int J Health Geogr, V3, P11, DOI 10.1186/1476-072X-3-11; Osei FB, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-62; Pardhan-Ali A, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-17; Pruss-Ustun A CC, 2006, PREVENTING DISEASE T; Shikur M, 2013, SCI J PUBLIC HLTH, V1, P102, DOI DOI 10.11648/J.SJPH.20130102.19; Song C, 2003, INT J HEALTH GEOGR, V2, P9, DOI [10.1186/1476-072X-2-9, DOI 10.1186/1476-072X-2-9]; Tang FY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083487; Teklemariam S, 2000, ETHIOPIAN MED J, V38, P27; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; [UNICEF WHO], 2014, PROGRESS ON SANITATI; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walker CLF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-220; Walker CLF, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000768; [WHO UNICEF], 2009, DIARRHOEAWHY CHILDRE; [WHO UNICEF FMOH], 2007, RAPID ASSESSMENT OF	75	26	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144690	10.1371/journal.pone.0144690	http://dx.doi.org/10.1371/journal.pone.0144690			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690058	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300013
J	Jwa, E; Shin, KH; Lim, HW; Jung, SY; Lee, S; Kang, HS; Lee, E; Park, YH				Jwa, Eunjin; Shin, Kyung Hwan; Lim, Hyeon Woo; Jung, So-Youn; Lee, Seeyoun; Kang, Han-Sung; Lee, EunSook; Park, Young Hee			Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; POSITIVE LYMPH-NODES; POSTOPERATIVE RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; COOPERATIVE-GROUP; AMERICAN-SOCIETY; PRIMARY THERAPY; MASTECTOMY; WOMEN; HIGHLIGHTS	Introduction The locoregional recurrence (LRR) rate was reported as high as approximately 20% in stage I-II breast cancer following mastectomy. To investigate the risk factors for LRR in pT1-2N0-1 breast cancer patients treated with mastectomy but not radiation, and to define a subgroup of patients at high risk of LRR who may benefit from postmastectomy radiotherapy (PMRT). Methods and Materials In total, 390 patients with pT1-2N0M0 (n = 307) and pT1-2N1M0 (n = 83) breast cancer who underwent total mastectomy without adjuvant radiotherapy from 2002 to 2011 were enrolled in the study. Results After a median follow-up period of 5.6 years (range, 0.6-11.3 years), 21 patients had 18 systemic relapses and 12 LRRs including six in the chest wall and eight in the regional nodal area. The 5-year LRR-free survival (LRRFS) rates were 97.0% in pN0, 98.8% in pN1, and 97.4% in all patients. Multivariate analysis revealed that age < 50 years (Hazard Ratio, 11.4; p = 0.01) and no adjuvant chemotherapy (Hazard Ratio, 10.2; p = 0.04) were independent risk factors for LRR in pN0 patients. Using these factors, the 5-year LRRFS rates were 100% without any risk factors, 96.4% with one risk factor, and 86.7% with two risk factors. In pN1 patients, multivariate analysis revealed that having a hormone receptor negative tumor (Hazard Ratio, 18.3; p = 0.03) was the only independent risk factor for LRR. The 5-year LRRFS rates were 100.0% for luminal type, and 92.3% for non-luminal type cancer. Conclusion Patients with pT1-2N0-1 breast cancer who underwent total mastectomy without PMRT could be stratified by nodal stage and risk factors for LRR. PMRT may have of value for node negative patients aged less than 50 years and who are not treated with adjuvant chemotherapy, and for non-luminal type patients with one to three positive nodes.	[Jwa, Eunjin; Shin, Kyung Hwan; Lim, Hyeon Woo; Jung, So-Youn; Lee, Seeyoun; Kang, Han-Sung; Lee, EunSook; Park, Young Hee] Natl Canc Ctr, Ctr Breast Canc, Res Inst & Hosp, Goyang, South Korea; [Jwa, Eunjin] Soonchunhyang Univ, Dept Radiat Oncol, Coll Med, Cheonan, South Korea; [Shin, Kyung Hwan] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Park, Young Hee] Soonchunhyang Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea	National Cancer Center - Korea (NCC); Soonchunhyang University; Seoul National University (SNU); Soonchunhyang University	Shin, KH (corresponding author), Natl Canc Ctr, Ctr Breast Canc, Res Inst & Hosp, Goyang, South Korea.	radiat@snu.ac.kr						Abi-Raad R, 2011, INT J RADIAT ONCOL, V81, P21; Allred DC, 1998, MODERN PATHOL, V11, P155; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Fodor J, 2003, STRAHLENTHER ONKOL, V179, P197, DOI 10.1007/s00066-003-1010-7; Goldhirsch A, 1998, J NATL CANCER I, V90, P1601, DOI 10.1093/jnci/90.21.1601; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gradishar WJ, 2015, J NATL COMPR CANC NE, V13, P448, DOI 10.6004/jnccn.2015.0060; Jagsi R, 2004, INTERNATIONAL JOURNA, V62, P1035, DOI [10.1016/i.iifobp.2004.12.014, DOI 10.1016/J.IJR0BP.2004.12.014]; Karlsson P, 2007, J CLIN ONCOL, V25, P2019, DOI 10.1200/JCO.2006.09.8152; Kyndi M, 2008, J CLIN ONCOL, V26, P1419, DOI 10.1200/JCO.2007.14.5565; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; Moo TA, 2014, ANN SURG ONCOL, V21, P1569, DOI 10.1245/s10434-014-3488-x; Olivotto LA, 2004, J CLIN ONCOL, V22, P4237, DOI 10.1200/JCO.2004.06.974; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Recht A, 2001, J CLIN ONCOL, V19, P1539, DOI 10.1200/JCO.2001.19.5.1539; Selz J, 2012, INT J RADIAT ONCOL, V84, P1123, DOI 10.1016/j.ijrobp.2012.02.047; Sharma R, 2010, ANN SURG ONCOL, V17, P2899, DOI 10.1245/s10434-010-1089-x; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; Tendulkar RD, 2012, INT J RADIAT ONCOL, V83, pE577, DOI 10.1016/j.ijrobp.2012.01.076; Truong PT, 2014, INT J RADIAT ONCOL, V88, P57, DOI 10.1016/j.ijrobp.2013.09.024; Truong PT, 2005, INT J RADIAT ONCOL, V62, P175, DOI 10.1016/j.ijrobp.2004.09.013; Truong PT, 2005, J AM COLL SURGEONS, V200, P912, DOI 10.1016/j.jamcollsurg.2005.02.010; Truong PT, 2004, INT J RADIAT ONCOL, V58, P797, DOI 10.1016/S0360-3016(03)01626-2; Wallgren A, 2003, J CLIN ONCOL, V21, P1205, DOI 10.1200/JCO.2003.03.130; Wang JH, 2011, RADIOTHER ONCOL, V100, P200, DOI 10.1016/j.radonc.2011.07.007; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yang TJ, 2015, ANN SURG ONCOL, V22, pS495, DOI 10.1245/s10434-015-4697-7; Yu JI, 2013, ONCOLOGY-BASEL, V85, P14, DOI 10.1159/000352002	30	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145463	10.1371/journal.pone.0145463	http://dx.doi.org/10.1371/journal.pone.0145463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691445	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092300080
J	Yamaoka, Y; Tamiya, N; Moriyama, Y; Garrido, FAS; Sumazaki, R; Noguchi, H				Yamaoka, Yui; Tamiya, Nanako; Moriyama, Yoko; Garrido, Felipe Alfonso Sandoval; Sumazaki, Ryo; Noguchi, Haruko			Mental Health of Parents as Caregivers of Children with Disabilities: Based on Japanese Nationwide Survey	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; CARE NEEDS; MATERNAL DEPRESSION; PSYCHOLOGICAL DISTRESS; CEREBRAL-PALSY; FAMILY; POPULATION; MOTHERS; STRESS; BURDEN	The number of children with disability is increasing gradually in Japan. Previous researches in other countries have reported that parents as caregivers (CGs) of children with disability have mental health problems, but the actual situation has not been examined nationwide in Japan so far. The aim of this study was to evaluate the association between mental health of CGs who had children with disability and characteristics of children, CGs, and household based on the nation-wide survey. This study utilized data from 2010 Comprehensive Survey of the Living Conditions, and defined children with disability aged 6 to 17. Individual data of children and CGs were linked, and 549 pairs of them were extracted. The Japanese version of Kessler 6 (K6) was used to assess mental health status of caregiver, scored 5 and over represented to general psychological distress. Logistic regression was used to evaluate the associations of interest. The almost half (44.4%) of CGs had psychological distress (k6 score; 5 +) in nationwide, and 8.9% of CGs might have serious mental illness (K6 score; 13 +). After adjusting covariates of child, CG, and household factors, CG having a current symptom (OR, 95% CI: 3.26, 1.97-5.39), CG's activity restriction (OR, 95% CI: 2.95, 1.38-6.32), low social support (OR, 95% CI: 9.31, 1.85-46.8), three generation family (OR, 95% CI: 0.49, 0.26-0.92), and lower 25% tile group of monthly household expenditure (OR, 95% CI: 1.92, 1.05-3.54), were significantly associated with psychological distress of CGs. This study encourages health care providers to pay more attentions toward parent's mental health, especially for in case of having low social support, and lower income family. Further research should examine the detailed information of child's disease and disability, medical service use, and quality and quantity of social support in nationwide to straighten the system for supporting services of both children with disabilities and their CGs.	[Yamaoka, Yui; Tamiya, Nanako; Moriyama, Yoko; Garrido, Felipe Alfonso Sandoval] Univ Tsukuba, Fac Med, Dept Hlth Serv Res, Tsukuba, Ibaraki, Japan; [Moriyama, Yoko] Natl Inst Publ Hlth, Dept Hlth & Welf Serv, Wako, Saitama, Japan; [Garrido, Felipe Alfonso Sandoval; Noguchi, Haruko] Waseda Univ, Fac Polit Sci & Econ, Shinjuku Ku, Tokyo, Japan; [Yamaoka, Yui; Sumazaki, Ryo] Univ Tsukuba, Fac Med, Dept Pediat, Tsukuba, Ibaraki, Japan	University of Tsukuba; National Institute of Public Health - Japan; Waseda University; University of Tsukuba	Tamiya, N (corresponding author), Univ Tsukuba, Fac Med, Dept Hlth Serv Res, Tsukuba, Ibaraki, Japan.	ntamiya@md.tsukuba.ac.jp	Noguchi, Haruko/ABF-3059-2020; Yamaoka, Yui/ABF-1748-2020; Sandoval, felipe/X-9614-2019	Noguchi, Haruko/0000-0002-4437-8238; Yamaoka, Yui/0000-0002-4682-4262; Sandoval, felipe/0000-0001-7422-3758	Japan Society for the Promotion of Science [24249031, 26870084]; Japanese Ministry of Education, Culture, Sports, Science and Technology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by Japan Society for the Promotion of Science KAKENHI # 24249031 (Grant-in-Aid for Scientific Research A) that NT received, and Japan Society for the Promotion of Science KAKENHI # 26870084 (Grant-in-Aid for Young Scientist B) that YM received from the Japanese Ministry of Education, Culture, Sports, Science and Technology. Japan Society for the Promotion of Science https://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Estes A, 2013, BRAIN DEV-JPN, V35, P133, DOI 10.1016/j.braindev.2012.10.004; Evans GW, 2002, CHILD DEV, V73, P1238, DOI 10.1111/1467-8624.00469; Ferro MA, 2009, EPILEPSIA, V50, P2344, DOI 10.1111/j.1528-1167.2009.02276.x; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Ha JH, 2011, FAM SOC, V92, P405, DOI 10.1606/1044-3894.4150; Horiuchi T, 2006, J JAPAN PEDIAT SOC, V106, P603; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Kuo DZ, 2011, ARCH PEDIAT ADOL MED, V165, P1020, DOI 10.1001/archpediatrics.2011.172; Lee S, 2015, J PSYCHOSOM RES, V78, P71, DOI 10.1016/j.jpsychores.2014.11.012; Lindley LC, 2010, J CHILD FAM STUD, V19, P79, DOI 10.1007/s10826-009-9286-6; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Ministory of Health Labour and Welfare, 2014, VIT STAT 2014; Montes G, 2008, PEDIATRICS, V122, pE202, DOI 10.1542/peds.2007-3037; Montes G, 2008, PEDIATRICS, V121, pE821, DOI 10.1542/peds.2007-1594; Nes RB, 2014, J FAM ECON ISS, V35, P351, DOI 10.1007/s10834-013-9378-8; Newacheck PW, 2004, PEDIATRICS, V114, P79, DOI 10.1542/peds.114.1.79; Newacheck PW, 1998, PEDIATRICS, V102, P117, DOI 10.1542/peds.102.1.117; Okamoto R., 2014, J HLTH WELFARE STAT, V12, P1; Oshio T, 2014, SOC SCI MED, V115, P121, DOI 10.1016/j.socscimed.2014.06.016; Parish SL, 2012, SOC SCI MED, V74, P399, DOI 10.1016/j.socscimed.2011.10.035; Parkes J, 2011, DEV MED CHILD NEUROL, V53, P815, DOI 10.1111/j.1469-8749.2011.04014.x; Phelan KJ, 2014, J PEDIATR PSYCHOL, V39, P349, DOI 10.1093/jpepsy/jst090; Raina P, 2005, PEDIATRICS, V115, pE626, DOI 10.1542/peds.2004-1689; Raina Parminder, 2004, BMC Pediatr, V4, P1, DOI 10.1186/1471-2431-4-1; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Schor EL, 2003, PEDIATRICS, V111, P1541; Singer GHS, 2006, AM J MENT RETARD, V111, P155, DOI 10.1352/0895-8017(2006)111[155:MOCSOD]2.0.CO;2; Spencer N, 2015, ARCH DIS CHILD, V100, P317, DOI 10.1136/archdischild-2013-305634; Statistics Bureau Ministry of Internal Affairs and Communications Japan, 2010, FIN REP 2010 POP CEN; Statistics Bureau MolAaC, 2011, 2011 SURV TIM US LEI; The Ministory of Health Labour and Welfare, 2013, SURV PERS PHYS DIS 2; The Ministry of Education Science Sports and Culture, 2012, SUR CHILDR REG CLASS; The Ministry of Health Labour and Welfare, 2011, COMPR SURV LIV COND; The Ministry of Health Labour and Welfare, 2013, COMPR SURV LIV COND; Toki M., 2010, JAPANESE J REHABILIT, V47, P396; Tsuchiya KJ, 2008, BRIT J PSYCHIAT, V193, P316, DOI 10.1192/bjp.bp.107.045120; Ueda K, 2010, J JAPAN PEDIAT SOC, V114, P1419; Uetani Y., 2012, NATIONWIDE SURVEY DE; White N, 2004, J APPL RES INTELLECT, V17, P181, DOI 10.1111/j.1468-3148.2004.00197.x; Yamada A, 2007, PSYCHIAT CLIN NEUROS, V61, P651, DOI 10.1111/j.1440-1819.2007.01736.x; Yamaguchi S, 2005, YAMANASHI NURSING J, V4, P41; Yatsugi S., 2013, NIHON KOSHU EISEI ZA, V60, P387	44	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145200	10.1371/journal.pone.0145200	http://dx.doi.org/10.1371/journal.pone.0145200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SF	26692344	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300046
J	Zilian, E; Saragih, H; Vijayan, V; Hiller, O; Figueiredo, C; Aljabri, A; Blasczyk, R; Theilmeier, G; Becker, JU; Larmann, J; Immenschuh, S				Zilian, Eva; Saragih, Hendry; Vijayan, Vijith; Hiller, Oliver; Figueiredo, Constanca; Aljabri, Abid; Blasczyk, Rainer; Theilmeier, Gregor; Becker, Jan Ulrich; Larmann, Jan; Immenschuh, Stephan			Heme Oxygenase-1 Inhibits HLA Class I Antibody-Dependent Endothelial Cell Activation	PLOS ONE			English	Article							NF-KAPPA-B; MEDIATED ALLOGRAFT-REJECTION; INTRAVENOUS IMMUNE GLOBULIN; CARBON-MONOXIDE; TRANSPLANT VASCULOPATHY; CARDIAC ALLOGRAFTS; OXIDATIVE STRESS; COMPLEMENT; MECHANISMS; EXPRESSION	Antibody-mediated rejection (AMR) is a key limiting factor for long-term graft survival in solid organ transplantation. Human leukocyte antigen (HLA) class I (HLA I) antibodies (Abs) play a major role in the pathogenesis of AMR via their interactions with HLA molecules on vascular endothelial cells (ECs). The antioxidant enzyme heme oxygenase (HO)-1 has anti-inflammatory functions in the endothelium. As complement-independent effects of HLA I Abs can activate ECs, it was the goal of the current study to investigate the role of HO-1 on activation of human ECs by HLA I Abs. In cell cultures of various primary humanmacro- and microvascular ECs treatment with monoclonal pan-and allele-specific HLA I Abs up-regulated the expression of inducible proinflammatory adhesion molecules and chemokines (vascular cell adhesion molecule-1 [VCAM-1], intercellular cell adhesion molecule-1 [ICAM-1], interleukin-8 [IL-8] and monocyte chemotactic protein 1 [MCP-1]). Pharmacological induction of HO-1 with cobalt-protoporphyrin IX reduced, whereas inhibition of HO-1 with either zinc-protoporphyrin IX or siRNA-mediated knockdown increased HLA I Ab-dependent up-regulation of VCAM-1. Treatment with two carbon monoxide (CO)-releasing molecules, which liberate the gaseous HO product CO, blocked HLA I Ab-dependent EC activation. Finally, in an in vitro adhesion assay exposure of ECs to HLA I Abs led to increased monocyte binding, which was counteracted by up-regulation of HO-1. In conclusion, HLA I Ab-dependent EC activation is modulated by endothelial HO-1 and targeted induction of this enzyme may be a novel therapeutic approach for the treatment of AMR in solid organ transplantation.	[Zilian, Eva; Saragih, Hendry; Vijayan, Vijith; Hiller, Oliver; Figueiredo, Constanca; Aljabri, Abid; Blasczyk, Rainer; Immenschuh, Stephan] Hannover Med Sch, Inst Transfus Med, Hannover, Germany; [Saragih, Hendry] Gadjah Mada Univ, Fac Biol, Yogyakarta, Indonesia; [Theilmeier, Gregor; Larmann, Jan] Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Hannover, Germany; [Becker, Jan Ulrich] Univ Hosp Cologne, Inst Pathol, Cologne, Germany	Hannover Medical School; Gadjah Mada University; Hannover Medical School; University of Cologne	Immenschuh, S (corresponding author), Hannover Med Sch, Inst Transfus Med, Hannover, Germany.	immenschuh.stephan@mh-hannover.de	Vijayan, Vijith/AAP-9913-2020; Immenschuh, Stephan/AAM-9181-2020; Larmann, Jan/ABI-3699-2020; Larmann, Jan/B-4034-2011; Saragih, Hendry Tri Sakti/AAZ-9800-2021	Immenschuh, Stephan/0000-0003-3722-5791; Larmann, Jan/0000-0003-3365-4572; Larmann, Jan/0000-0003-3365-4572; Saragih, Hendry Tri Sakti/0000-0003-0696-6191; Blasczyk, Rainer/0000-0003-3875-3190; Becker, Jan Ulrich/0000-0003-2929-8085	Else Kroner-Fresenius-Stiftung [EKFS A309_2012]; Deutsche Forschungsgemeinschaft [IM 20/4-1, LA 2343/7-1]	Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the following: Else Kroner-Fresenius-Stiftung, http://www.ekfs.de/de/start.html, grant number EKFS A309_2012 (to SI and JUB); and Deutsche Forschungsgemeinschaft, http://www.dfg.de/, grant number IM 20/4-1 (to SI), grant number LA 2343/7-1 (to JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Bian H, 2001, TRANSPLANT P, V33, P311, DOI 10.1016/S0041-1345(00)02022-4; Bieri M, 2009, INT J BIOCHEM CELL B, V41, P2422, DOI 10.1016/j.biocel.2009.06.009; Calay D, 2014, ANTIOXID REDOX SIGN, V20, P1789, DOI 10.1089/ars.2013.5659; Chauveau C, 2002, AM J TRANSPLANT, V2, P581, DOI 10.1034/j.1600-6143.2002.20702.x; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; Djamali A, 2014, AM J TRANSPLANT, V14, P255, DOI 10.1111/ajt.12589; Galvani S, 2011, CIRCULATION, V124, P2725, DOI 10.1161/CIRCULATIONAHA.111.021790; Greenwood J, 2007, TRENDS IMMUNOL, V28, P88, DOI 10.1016/j.it.2006.12.003; Grosser N, 2004, FREE RADICAL BIO MED, V37, P2064, DOI 10.1016/j.freeradbiomed.2004.09.009; Hirohashi T, 2010, AM J TRANSPLANT, V10, P510, DOI 10.1111/j.1600-6143.2009.02958.x; Immenschuh S, 2006, HISTOL HISTOPATHOL, V21, P679, DOI 10.14670/HH-21.679; Immenschuh S, 2013, FREE RADICAL BIO MED, V54, P85, DOI 10.1016/j.freeradbiomed.2012.10.551; Jane-wit D, 2013, CIRCULATION, V128, P2504, DOI 10.1161/CIRCULATIONAHA.113.002972; Jindra PT, 2008, J IMMUNOL, V180, P2214, DOI 10.4049/jimmunol.180.4.2214; Jindra PT, 2008, J IMMUNOL, V180, P2357, DOI 10.4049/jimmunol.180.4.2357; Kittleson MM, 2012, CURR OPIN ORGAN TRAN, V17, P551, DOI 10.1097/MOT.0b013e3283577fef; Koh KK, 2009, CARDIOVASC RES, V81, P649, DOI 10.1093/cvr/cvn354; Larmann J, 2010, ANESTHESIOLOGY, V113, P610, DOI 10.1097/ALN.0b013e3181e99bfc; Lee CY, 2007, TRANSPLANTATION, V84, P1324, DOI 10.1097/01.tp.0000287457.54761.53; Lee TS, 2004, CIRCULATION, V110, P1296, DOI 10.1161/01.CIR.0000140694.67251.9C; Lucchiari N, 2000, HUM IMMUNOL, V61, P518, DOI 10.1016/S0198-8859(00)00109-9; Mark KS, 2001, J PHARMACOL EXP THER, V297, P1051; Mitchell RN, 2009, ANNU REV PATHOL-MECH, V4, P19, DOI 10.1146/annurev.pathol.3.121806.151449; Montgomery RA, 2000, TRANSPLANTATION, V70, P887, DOI 10.1097/00007890-200009270-00006; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Naemi FMA, 2013, TRANSPLANTATION, V96, P258, DOI 10.1097/TP.0b013e3182985504; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Narayanan K, 2006, TRANSPL IMMUNOL, V15, P187, DOI 10.1016/j.trim.2005.09.005; Narayanan K, 2004, EUR J IMMUNOL, V34, P2303, DOI 10.1002/eji.200324843; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Rahimi S, 2004, AM J TRANSPLANT, V4, P326, DOI 10.1111/j.1600-6143.2004.00334.x; Saragih H, 2014, THROMB HAEMOSTASIS, V111, P1077, DOI 10.1160/TH13-11-0923; Sato K, 2001, J IMMUNOL, V166, P4185, DOI 10.4049/jimmunol.166.6.4185; Sehnert B, 2013, P NATL ACAD SCI USA, V110, P16556, DOI 10.1073/pnas.1218219110; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Sis B, 2009, AM J TRANSPLANT, V9, P2312, DOI 10.1111/j.1600-6143.2009.02761.x; Smith JD, 2000, INT IMMUNOL, V12, P563, DOI 10.1093/intimm/12.4.563; Soares MP, 2004, J IMMUNOL, V172, P3553, DOI 10.4049/jimmunol.172.6.3553; Soares MP, 1998, NAT MED, V4, P1073, DOI 10.1038/2063; Stocker R, 2006, CIRCULATION, V114, P2178, DOI 10.1161/CIRCULATIONAHA.105.598698; Sumitran-Holgersson S, 2008, CURR OPIN IMMUNOL, V20, P607, DOI 10.1016/j.coi.2008.07.005; Taflin C, 2011, IMMUNOL LETT, V139, P1, DOI 10.1016/j.imlet.2011.04.014; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; True AL, 2007, CIRC RES, V101, P893, DOI 10.1161/CIRCRESAHA.107.158998; Valenzuela NM, 2014, CURR OPIN ORGAN TRAN, V19, P33, DOI 10.1097/MOT.0000000000000040; Valenzuela NM, 2013, J IMMUNOL, V190, P6635, DOI 10.4049/jimmunol.1201434; Vo AA, 2008, NEW ENGL J MED, V359, P242, DOI 10.1056/NEJMoa0707894; Wasowska BA, 2010, IMMUNOL RES, V47, P25, DOI 10.1007/s12026-009-8136-3; Wehner J, 2007, CIRC RES, V100, P191, DOI 10.1161/01.RES.0000255032.33661.88; Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44; Wu ML, 2011, ANTIOXID REDOX SIGN, V15, P1835, DOI 10.1089/ars.2010.3726; Xiao L, 2014, AM J PHYSIOL-HEART C, V306, pH317, DOI 10.1152/ajpheart.00182.2013; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yamakuchi M, 2007, P NATL ACAD SCI USA, V104, P1301, DOI 10.1073/pnas.0602035104; Zhang X, 2009, AM J TRANSPLANT, V9, P2459, DOI 10.1111/j.1600-6143.2009.02819.x; Zhang XH, 2012, CURR OPIN ORGAN TRAN, V17, P446, DOI 10.1097/MOT.0b013e328355f1c2	60	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145306	10.1371/journal.pone.0145306	http://dx.doi.org/10.1371/journal.pone.0145306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690352	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300054
J	Chen, JH; Lan, JL; Cheng, CF; Liang, WM; Lin, HY; Tsay, GJ; Yeh, WT; Pan, WH				Chen, Jiunn-Horng; Lan, Joung-Liang; Cheng, Chi-Fung; Liang, Wen-Miin; Lin, Hsiao-Yi; Tsay, Gregory J.; Yeh, Wen-Ting; Pan, Wen-Harn			Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study	PLOS ONE			English	Article							SERUM URIC-ACID; BLOOD-PRESSURE; RISK-FACTOR; ALLOPURINOL; TAIWAN; PREVALENCE; DISEASE; HLA-B-ASTERISK-5801; HYPERTENSION; ADOLESCENTS	Objectives An increased risk of mortality in patients with hyperuricemia has been reported. We examined (1) the risk of all-cause and cardiovascular disease (CVD) mortality in untreated hyperuricemic patients who did not receive urate-lowering therapy (ULT), and (2) the impact of ULT on mortality risk in patients with hyperuricemia. Methods In this retrospective case-matched cohort study during a mean follow-up of 6.4 years, 40,118 Taiwanese individuals aged >= 17 years who had never used ULT and who had never had gout were examined. The mortality rate was compared between 3,088 hyperuricemic patients who did not receive ULT and reference subjects (no hyperuricemia, no gout, no ULT) matched for age and sex (1: 3 hyperuricemic patients/reference subjects), and between 1,024 hyperuricemic patients who received ULT and 1,024 hyperuricemic patients who did not receive ULT (matched 1: 1 based on their propensity score and the index date of ULT prescription). Cox proportional hazard modeling was used to estimate the respective risk of all-cause and CVD (ICD-9 code 390-459) mortality. Results After adjustment, hyperuricemic patients who did not receive ULT had increased risks of all-cause (hazard ratio, 1.24; 95% confidence interval, 0.97-1.59) and CVD (2.13; 1.34-3.39) mortality relative to the matched reference subjects. Hyperuricemic patients treated with ULT had a lower risk of all-cause death (0.60; 0.41-0.88) relative to hyperuricemic patients who did not receive ULT. Conclusion Under-treatment of hyperuricemia has serious negative consequences. Hyperuricemic patients who received ULT had potentially better survival than patients who did not.	[Chen, Jiunn-Horng; Lan, Joung-Liang; Tsay, Gregory J.] China Med Univ, Sch Med, Taichung, Taiwan; [Chen, Jiunn-Horng; Lan, Joung-Liang; Tsay, Gregory J.] China Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Cheng, Chi-Fung; Liang, Wen-Miin] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Cheng, Chi-Fung; Liang, Wen-Miin] China Med Univ, Grad Inst Biostat, Biostat Ctr, Taichung, Taiwan; [Lin, Hsiao-Yi] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Lin, Hsiao-Yi] Vet Gen Hosp, Dept Internal Med, Taipei, Taiwan; [Yeh, Wen-Ting; Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Pan, Wen-Harn] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Miaoli County, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan	Chen, JH (corresponding author), China Med Univ, Sch Med, Taichung, Taiwan.	d91842001@ntu.edu.tw	Pan, Wen-Harn/F-9972-2010	Pan, Wen-Harn/0000-0001-9136-0658	Department of Health, Executive Yuan, Taiwan [NSC97-2314-B-039-010-MY3, NSC100-2314-B-039-012, NSC101-2314-B-039-020, MOST103-2314-B-039-020]; China Medical University Hospital [DMR-101-010]	Department of Health, Executive Yuan, Taiwan; China Medical University Hospital	This work was supported by grants from the Department of Health, Executive Yuan, Taiwan (NSC97-2314-B-039-010-MY3; NSC100-2314-B-039-012; NSC101-2314-B-039-020; MOST103-2314-B-039-020) and China Medical University Hospital (DMR-101-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir H, 2001, NEUROSURG REV, V24, P131, DOI 10.1007/PL00012397; Chen JH, 2015, ANN RHEUM DIS, V74, P2034, DOI 10.1136/annrheumdis-2014-205312; Chen JH, 2015, J RHEUMATOL, V42, P1694, DOI 10.3899/jrheum.141542; Chen JH, 2012, CLIN RHEUMATOL, V31, P239, DOI 10.1007/s10067-011-1802-6; Chen JH, 2009, ARTHRIT RHEUM-ARTHR, V61, P225, DOI 10.1002/art.24164; Chien KL, 2005, ATHEROSCLEROSIS, V183, P147, DOI 10.1016/j.atherosclerosis.2005.01.018; Choi HK, 2007, AM J MED, V120, P442, DOI 10.1016/j.amjmed.2006.06.040; Chuang SY, 2011, ASIA PAC J CLIN NUTR, V20, P301; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; D'Agostino RB, 2007, CIRCULATION, V115, P2340, DOI 10.1161/CIRCULATIONAHA.105.594952; Dubreuil M, 2015, ANN RHEUM DIS, V74, P1368, DOI 10.1136/annrheumdis-2014-205269; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Feher MD, 2003, RHEUMATOLOGY, V42, P321, DOI 10.1093/rheumatology/keg103; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; Hamada T, 2008, AM J HYPERTENS, V21, P1157, DOI 10.1038/ajh.2008.245; Harrold LR, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2659; Hiramitsu S, 2014, CLIN EXP HYPERTENS, V36, P433, DOI 10.3109/10641963.2013.846358; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kok VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099102; Krzystek-Korpacka M, 2011, CLIN CHEM LAB MED, V49, P915, DOI 10.1515/CCLM.2011.130; Kuo CF, 2013, RHEUMATOLOGY, V52, P111, DOI 10.1093/rheumatology/kes169; Lu TH, 2006, AM J FOREN MED PATH, V27, P352, DOI 10.1097/01.paf.0000233555.31211.78; Luk AJ, 2009, RHEUMATOLOGY, V48, P804, DOI 10.1093/rheumatology/kep069; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; Reinders MK, 2009, ANN RHEUM DIS, V68, P892, DOI 10.1136/ard.2008.091462; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V295, pF1134, DOI 10.1152/ajprenal.00104.2008; So A, 2013, NAT REV RHEUMATOL, V9, P391, DOI 10.1038/nrrheum.2013.61; Taiwan Drug Relief Foundation (TDRF) for Drug Hazard, 2012, DRUG SAFETY NEWSLETT, V37, P20; Taiwan Rheumatology Association, 2013, FORMASAN J RHEUMATOL, V27, P1; Takahashi S, 2003, ANN RHEUM DIS, V62, P572, DOI 10.1136/ard.62.6.572; Tassaneeyakul W, 2009, PHARMACOGENET GENOM, V19, P704, DOI 10.1097/FPC.0b013e328330a3b8; Vazquez-Mellado J, 2001, ANN RHEUM DIS, V60, P981, DOI 10.1136/ard.60.10.981; Wagayama H, 2000, J HEPATOL, V32, P874, DOI 10.1016/S0168-8278(00)80263-9; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wen CP, 2010, AM J KIDNEY DIS, V56, P273, DOI 10.1053/j.ajkd.2010.01.024; Yamanaka Hisashi, 2012, Japan Med Assoc J, V55, P324	41	34	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145193	10.1371/journal.pone.0145193	http://dx.doi.org/10.1371/journal.pone.0145193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683302	Green Submitted, gold, Green Published			2022-12-27	WOS:000366725800043
J	Gu, Y; Chen, C; Yi, S; Wang, SS; Gong, LL; Liu, J; Gu, XS; Zhao, Q; Li, SY				Gu, Yun; Chen, Chu; Yi, Sheng; Wang, Shanshan; Gong, Leilei; Liu, Jie; Gu, Xiaosong; Zhao, Qing; Li, Shiying			miR-sc8 Inhibits Schwann Cell Proliferation and Migration by Targeting Egfr	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; SCIATIC-NERVE; GROWTH-FACTOR; ESOPHAGOGASTRIC CANCER; BREAST-CANCER; MICRORNAS; FAMILY; INJURY; IDENTIFICATION; PARTNERSHIP	MicroRNAs (miRNAs) negatively regulate the expression of target genes at the post-transcriptional level in diverse biological processes. We have previously identified a group of novel miRNAs in proximal nerve following rat sciatic nerve transection by Solexa sequencing. In this study, the biological function and action mode of miR-sc8, one of the above identified miRNAs, were investigated. An increased expression of miR-sc8 inhibited cell proliferation and migration of Schwann cells (SCs), and inversely, silencing of the miR-sc8 expression promoted cell proliferation and migration of SCs. The epidermal growth factor receptor (Egfr) was identified as the target gene of miR-sc8, which exerted negative regulation of Egfr by translational suppression. The temporal change profile of the miR-sc8 expression was negatively correlated with that of the Egfr expression in proximal nerve following sciatic nerve transection. Moreover, Knockdown of Egfr attenuated the promoting effects of miR-sc8 inhibitor on SC proliferation and migration. Overall, our data indicate that miR-sc8 affects phenotype modulation of SCs by targeting Egfr, providing further insights into the regulatory role of miRNAs in peripheral nerve regeneration.	[Gu, Yun; Chen, Chu; Yi, Sheng; Gong, Leilei; Liu, Jie; Gu, Xiaosong; Li, Shiying] Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuroregenerat, Nantong, Jiangsu, Peoples R China; [Wang, Shanshan] Nantong Univ, Affiliated Hosp, Dept Obstet & Gynecol, Nantong, Jiangsu, Peoples R China; [Zhao, Qing] Chinese Peoples Liberat Army Gen Hosp, Inst Orthopaed, Peoples Liberat Army, Key Lab, Beijing, Peoples R China	Nantong University; Nantong University; Chinese People's Liberation Army General Hospital	Zhao, Q (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Orthopaed, Peoples Liberat Army, Key Lab, Beijing, Peoples R China.	drzhaoqing@sina.com; lisy0379@ntu.edu.cn	Yi, Sheng/AAA-6017-2020	Yi, Sheng/0000-0003-1316-3370	National Key Basic Research Program of China (973 and 863 programs) [2014CB542202, 2012AA020502]; National Natural Science Foundation of China [81130080, 31170946, 31300879]; Jiangsu Provincial Natural Science Foundation [BK2012230]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Key Basic Research Program of China (973 and 863 programs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by National Key Basic Research Program of China (973 and 863 programs, Grant Nos. 2014CB542202, 2012AA020502), National Natural Science Foundation of China (Grant No. 81130080, 31170946, 31300879), Jiangsu Provincial Natural Science Foundation (BK2012230), and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Acunzo M, 2013, P NATL ACAD SCI USA, V110, P8573, DOI 10.1073/pnas.1302107110; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Atalay G, 2003, ANN ONCOL, V14, P1346, DOI 10.1093/annonc/mdg365; Ayyappan S, 2013, ANTICANCER RES, V33, P4139; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bremer J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012450; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; Cho WCS, 2011, RNA BIOL, V8, P125, DOI 10.4161/rna.8.1.14259; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Howe LR, 2011, CANCER PREV RES, V4, P1149, DOI 10.1158/1940-6207.CAPR-11-0334; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee S K, 2000, J Am Acad Orthop Surg, V8, P243; Li SY, 2015, MOL THER, V23, P423, DOI 10.1038/mt.2014.220; Li SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057000; Li SY, 2012, J NEUROSCI RES, V90, P791, DOI 10.1002/jnr.22814; Li SY, 2011, SCI CHINA LIFE SCI, V54, P806, DOI 10.1007/s11427-011-4213-7; Liu KL, 2011, NUCLEIC ACIDS RES, V39, P2869, DOI 10.1093/nar/gkq904; Okines A, 2011, NAT REV CLIN ONCOL, V8, P492, DOI 10.1038/nrclinonc.2011.45; Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010; Suto T, 2015, CARCINOGENESIS, V36, P338, DOI 10.1093/carcin/bgu242; Viader A, 2011, J NEUROSCI, V31, P17358, DOI 10.1523/JNEUROSCI.3931-11.2011; Webber C, 2010, EXP NEUROL, V223, P51, DOI 10.1016/j.expneurol.2009.05.037; Xie J, 2014, ONCOL REP, V31, P1715, DOI 10.3892/or.2014.3052; Xu B, 2012, PROSTATE, V72, P1171, DOI 10.1002/pros.22466; Yu B, 2012, NUCLEIC ACIDS RES, V40, P10356, DOI 10.1093/nar/gks750; Yu B, 2012, J CELL SCI, V125, P2675, DOI 10.1242/jcs.098996; Yun B, 2010, J NEUROSCI, V30, P7722, DOI 10.1523/JNEUROSCI.0876-10.2010; Zhou X, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-22	29	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145185	10.1371/journal.pone.0145185	http://dx.doi.org/10.1371/journal.pone.0145185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683191	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800042
J	Bauer, GR; Zong, XC; Scheim, AI; Hammond, R; Thind, A				Bauer, Greta R.; Zong, Xuchen; Scheim, Ayden I.; Hammond, Rebecca; Thind, Amardeep			Factors Impacting Transgender Patients' Discomfort with Their Family Physicians: A Respondent-Driven Sampling Survey	PLOS ONE			English	Article							HEALTH-CARE; HIDDEN POPULATIONS; ONTARIO; CANADA; EXPERIENCES; RISK; HIV; RECOMMENDATIONS; DISCRIMINATION; AVOIDANCE	Background Representing approximately 0.5% of the population, transgender (trans) persons in Canada depend on family physicians for both general and transition-related care. However, physicians receive little to no training on this patient population, and trans patients are often profoundly uncomfortable and may avoid health care. This study examined factors associated with patient discomfort discussing trans health issues with a family physician in Ontario, Canada. Methods 433 trans people age 16 and over were surveyed using respondent-driven sampling for the Trans PULSE Project; 356 had a family physician. Weighted logistic regression models were fit to produce prevalence risk ratios (PRRs) via average marginal predictions, for transmasculine (n = 184) and transfeminine (n = 172) trans persons. Results Among the 83.1%(95% CI = 77.4, 88.9) of trans Ontarians who had a family physician, approximately half reported discomfort discussing trans health issues. 37.2% of transmasculine and 38.1% of transfeminine persons reported at least one trans-specific negative experience. In unadjusted analysis, sociodemographics did not predict discomfort, but those who planned to medically transition sex, but had not begun, were more likely to report discomfort (transmasculine: PRR = 2.62 (95% CI = 1.44, 4.77); transfeminine: PRR = 1.85 (95% CI = 1.08, 3.15)). Adjusted for other factors, greater perceived physician knowledge about trans issues was associated with reduced likelihood of discomfort, and previous trans-specific negative experiences with a family physician with increased discomfort. Transfeminine persons who reported three or more types of negative experiences were 2.26 times as likely, and transmasculine persons 1.61 times as likely, to report discomfort. In adjusted analyses, sociodemographic associations differed by gender, with being previously married or having higher education associated with increased risk of discomfort among transfeminine persons, but decreased risk among transmasculine persons. Conclusions Within this transgender population, discomfort in discussing trans health issues with a family physician was common, presenting a barrier to accessing primary care despite having a regular family physician and "universal" health insurance.	[Bauer, Greta R.; Zong, Xuchen; Scheim, Ayden I.; Thind, Amardeep] Univ Western Ontario, Dept Epidemiol & Biostat, Schulich Sch Med & Dent, London, ON, Canada; [Hammond, Rebecca] Sherbourne Hlth Ctr, Toronto, ON, Canada; [Thind, Amardeep] Univ Western Ontario, Schulich Interfac Program Publ Hlth, London, ON, Canada; [Thind, Amardeep] Univ Western Ontario, Dept Family Med, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Bauer, GR (corresponding author), Univ Western Ontario, Dept Epidemiol & Biostat, Schulich Sch Med & Dent, London, ON, Canada.	Greta.bauer@schulich.uwo.ca	Bauer, Greta/ABG-1472-2020	Scheim, Ayden/0000-0001-8498-9829; Bauer, Greta/0000-0003-0663-7160	Canadian Institutes for Health Research, Institute of Gender and Health [MOP-106478]; Trudeau Doctoral Award; Vanier Doctoral Award	Canadian Institutes for Health Research, Institute of Gender and Health; Trudeau Doctoral Award; Vanier Doctoral Award	This study was funded by an operating grant from the Canadian Institutes for Health Research, Institute of Gender and Health (Funding Reference #MOP-106478). Ayden Scheim's work was supported by Trudeau and Vanier Doctoral Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by an operating grant from the Canadian Institutes for Health Research, Institute of Gender and Health (Funding Reference #MOP-106478). Xuchen Zong is now a research coordinator at Mount Sinai Hospital, Toronto, Ontario. Ayden Scheim's work was supported by Trudeau and Vanier Doctoral Awards. Partners in Trans PULSE included the Sherbourne Health Centre (Toronto), The 519 Church Street Community Centre (Toronto), The University of Western Ontario (London), Wilfrid Laurier University (Waterloo), the Ontario HIV Treatment Network, and Rainbow Health Ontario. The Trans PULSE Steering Committee members were Greta Bauer, Robb Travers, Rebecca Hammond, Anjali K, Matthias Kaay, Jake Pyne, Nik Redman, Kyle Scanlon (deceased), and Anna Travers. The authors wish to acknowledge the 16 Community Engagement Team members and other contributors who aided survey development, the 85 trans people and 4 allies who contributed to the first phase of the study that shaped this survey, and the 433 trans people who shared their experiences through their survey participation.	[Anonymous], 2011, CANADIAN J COMMUNITY, DOI [DOI 10.7870/CJCMH-2011-0021, 10.7870/cjcmh-2011-0021]; Ardalan A., 2014, REHABILITATION DISAS; Asanin J, 2008, SOC SCI MED, V66, P1271, DOI 10.1016/j.socscimed.2007.11.043; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Bauer G. R., 2013, SERVICE SOCIAL, V59, P35, DOI [10.7202/1017478ar, DOI 10.7202/1017478AR]; Bauer GR, 2014, ANN EMERG MED, V63, P713, DOI 10.1016/j.annemergmed.2013.09.027; Bauer GR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-292; Bauer GR, 2009, J ASSOC NURSE AIDS C, V20, P348, DOI 10.1016/j.jana.2009.07.004; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; Bradford J, 2013, AM J PUBLIC HEALTH, V103, P1820, DOI 10.2105/AJPH.2012.300796; Callahan EJ, 2015, ACAD MED, V90, P154, DOI 10.1097/ACM.0000000000000467; Coleman E, 2012, INT J TRANSGENDERISM, V13, P165, DOI 10.1080/15532739.2011.700873; Conron KJ, 2012, AM J PUBLIC HEALTH, V102, P118, DOI 10.2105/AJPH.2011.300315; Deutsch MB, 2015, J GEN INTERN MED, V30, P843, DOI 10.1007/s11606-014-3148-7; Deutsch MB, 2013, J AM MED INFORM ASSN, V20, P700, DOI 10.1136/amiajnl-2012-001472; Socias ME, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0081-7; Feldman JL, 2006, INT J TRANSGENDERISM, V9, P3, DOI 10.1300/J485v09n03_02; Goldberg J, 2006, RECOMMENDED FRAMEWOR; Grant J.M., 2011, INJUSTICE EVERY TURN; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hendricks ML, 2012, PROF PSYCHOL-RES PR, V43, P460, DOI 10.1037/a0029597; Herbst JH, 2008, AIDS BEHAV, V12, P1, DOI 10.1007/s10461-007-9299-3; Institute of Medicine (US) Committee on Lesbian Gay Bisexual and Transgender Health Issues and Research Gaps and Opportunities., 2011, HLTH LESB GAY BISEX; Kattari S. K., 2015, J AGING HLTH; Marcellin RL, 2013, ETHNICITY INEQUALITI, DOI DOI 10.1108/EIHSC-.09-.2013-.0017; Obedin-Maliver J, 2011, JAMA-J AM MED ASSOC, V306, P971, DOI 10.1001/jama.2011.1255; Ontario Human Rights Commission, POLICY AND GUIDELINE; Pong RW, 2005, OTTAWA CAN I HLTH IN, P11; Poteat T, 2013, SOC SCI MED, V84, P22, DOI 10.1016/j.socscimed.2013.02.019; Rotondi N, 2011, CAN J COMMUN MENT HL, V30, P113, DOI [DOI 10.7870/CJCMH-2011-0020, 10.7870/cjcmh-2011-0020]; Rotondi NK, 2013, AM J PUBLIC HEALTH, V103, P1830, DOI 10.2105/AJPH.2013.301348; RTI Institute, 2013, SUDAAN VERS 11 0 1; SAS Institute Inc, 2012, SAS VERSION 9 3; Scheim AI, 2015, J SEX RES, V52, P1, DOI 10.1080/00224499.2014.893553; Shires DA, 2015, HEALTH SOC WORK, V40, P134, DOI 10.1093/hsw/hlv025; Snelgrove JW, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-110; Statistics Canada, 2012, ACC REG MED DOCT 201; Suarez-Almazor ME, 2004, CURR OPIN RHEUMATOL, V16, P91, DOI 10.1097/00002281-200403000-00003; Volz E, 2008, J OFF STAT, V24, P79	40	54	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145046	10.1371/journal.pone.0145046	http://dx.doi.org/10.1371/journal.pone.0145046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JO	26678997	Green Submitted, Green Published, gold			2022-12-27	WOS:000366723400045
J	Hall, JS; Russell, RE; Franson, JC; Soos, C; Dusek, RJ; Allen, RB; Nashold, SW; TeSlaa, JL; Jonsson, JE; Ballard, JR; Harms, NJ; Brown, JD				Hall, Jeffrey S.; Russell, Robin E.; Franson, J. Christian; Soos, Catherine; Dusek, Robert J.; Allen, R. Bradford; Nashold, Sean W.; TeSlaa, Joshua L.; Jonsson, Jon Einar; Ballard, Jennifer R.; Harms, Naomi Jane; Brown, Justin D.			Avian Influenza Ecology in North Atlantic Sea Ducks: Not All Ducks Are Created Equal	PLOS ONE			English	Article							MIGRATORY BIRDS; A VIRUSES; EVOLUTION; AMERICAN; REASSORTMENT; PERSISTENCE; INFECTION; WATERFOWL; DYNAMICS; PATTERNS	Wild waterfowl are primary reservoirs of avian influenza viruses (AIV). However the role of sea ducks in the ecology of avian influenza, and how that role differs from freshwater ducks, has not been examined. We obtained and analyzed sera from North Atlantic sea ducks and determined the seroprevalence in those populations. We also tested swab samples from North Atlantic sea ducks for the presence of AIV. We found relatively high serological prevalence (61%) in these sea duck populations but low virus prevalence (0.3%). Using these data we estimated that an antibody half-life of 141 weeks (3.2 years) would be required to attain these prevalences. These findings are much different than what is known in freshwater waterfowl and have implications for surveillance efforts, AIV in marine environments, and the roles of sea ducks and other long-lived waterfowl in avian influenza ecology.	[Hall, Jeffrey S.; Russell, Robin E.; Franson, J. Christian; Dusek, Robert J.; Nashold, Sean W.; TeSlaa, Joshua L.] USGS Natl Wildlife Hlth Ctr, Madison, WI 53711 USA; [Soos, Catherine] Environm Canada, Sci & Technol Branch, Saskatoon, SK S7N 5B4, Canada; [Allen, R. Bradford] Maine Dept Inland Fisheries & Wildlife, Bangor, ME 04401 USA; [Jonsson, Jon Einar] Univ Iceland, Snaefellsnes Res Ctr, IS-245 Stykkisholmur, Iceland; [Ballard, Jennifer R.; Brown, Justin D.] Univ Georgia, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Harms, Naomi Jane] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Pathol, Saskatoon, SK S7N 5B4, Canada	United States Department of the Interior; United States Geological Survey; Environment & Climate Change Canada; University of Iceland; University System of Georgia; University of Georgia; University of Saskatchewan	Hall, JS (corresponding author), USGS Natl Wildlife Hlth Ctr, Madison, WI 53711 USA.	jshall@usgs.gov	Soos, Catherine/Q-4983-2019; Jónsson, Jón Einar/K-7482-2015	Soos, Catherine/0000-0003-4610-3614; Jónsson, Jón Einar/0000-0003-1198-786X; Franson, J/0000-0002-0251-4238; Hall, Jeffrey/0000-0001-5599-2826; TeSlaa, Joshua/0000-0001-7802-3454; Dusek, Robert/0000-0001-6177-7479; Nashold, Sean/0000-0002-8869-6633; Russell, Robin/0000-0001-8726-7303	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200400041C, HHSN266200700007C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract Nos. HHSN266200400041C and HHSN266200700007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 1926, P EDINBURGH MATH SOC, V1, P98, DOI 10.1017/S0013091500034428; [Anonymous], 2006, US INTERAGENCY STRAT; Anthony SJ, 2012, MBIO, V3, DOI 10.1128/mBio.00166-12; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Dusek RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092075; Fereidouni SR, 2010, AVIAN DIS, V54, P79, DOI 10.1637/9005-073109-Reg.1; Fouchier RAM, 2003, AVIAN DIS, V47, P857, DOI 10.1637/0005-2086-47.s3.857; Hall JS, 2014, INFECT GENET EVOL, V28, P130, DOI 10.1016/j.meegid.2014.09.013; Hall JS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-179; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Karlsson EA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5791; Keeler SP, 2014, APPL ENVIRON MICROB, V80, P2910, DOI 10.1128/AEM.03790-13; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Krementz DG, 1996, J WILDLIFE MANAGE, V60, P855, DOI 10.2307/3802386; Miller MR, 2007, EVOLUTION, V61, P2, DOI 10.1111/j.1558-5646.2007.00001.x; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Ramey AM, J WILDL DIS IN PRESS; Ramey AM, 2011, ARCH VIROL, V156, P1813, DOI 10.1007/s00705-011-1059-z; REED L. J., 1938, AMER JOUR HYG, V27, P493; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stailknecht DE, 2007, J WILDLIFE DIS, V43, pS15; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; Tolf C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061201; Wahlgren J, 2008, VECTOR-BORNE ZOONOT, V8, P783, DOI 10.1089/vbz.2007.0274; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wille M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020664; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1; Wilson HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058308; Woolcock P.R., 2008, AVIAN INFLUENZA VIRU	37	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144524	10.1371/journal.pone.0144524	http://dx.doi.org/10.1371/journal.pone.0144524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26677841	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400017
J	Houska, T; Kraft, P; Chamorro-Chavez, A; Breuer, L				Houska, Tobias; Kraft, Philipp; Chamorro-Chavez, Alejandro; Breuer, Lutz			SPOTting Model Parameters Using a Ready-Made Python Package	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; RAINFALL-RUNOFF MODELS; UNCERTAINTY ANALYSIS; GLOBAL OPTIMIZATION; EFFICIENT ALGORITHM; HYDROLOGIC-MODELS; CALIBRATION; RELIABILITY; QUANTIFICATION; IDENTIFICATION	The choice for specific parameter estimation methods is often more dependent on its availability than its performance. We developed SPOTPY (Statistical Parameter Optimization Tool), an open source python package containing a comprehensive set of methods typically used to calibrate, analyze and optimize parameters for a wide range of ecological models. SPOTPY currently contains eight widely used algorithms, 11 objective functions, and can sample from eight parameter distributions. SPOTPY has a model-independent structure and can be run in parallel from the workstation to large computation clusters using the Message Passing Interface (MPI). We tested SPOTPY in five different case studies to parameterize the Rosenbrock, Griewank and Ackley functions, a one-dimensional physically based soil moisture routine, where we searched for parameters of the van Genuchten-Mualem function and a calibration of a biogeochemistry model with different objective functions. The case studies reveal that the implemented SPOTPY methods can be used for any model with just a minimal amount of code for maximal power of parameter optimization. They further show the benefit of having one package at hand that includes number of well performing parameter search methods, since not every case study can be solved sufficiently with every algorithm or every objective function.	[Houska, Tobias; Kraft, Philipp; Chamorro-Chavez, Alejandro; Breuer, Lutz] Univ Giessen, Inst Landscape Ecol & Resources Management, Res Ctr BioSyst Land Use & Nutr IFZ, D-35390 Giessen, Germany; [Breuer, Lutz] Univ Giessen, Ctr Int Dev & Environm Res, D-35390 Giessen, Germany	Justus Liebig University Giessen	Houska, T (corresponding author), Univ Giessen, Inst Landscape Ecol & Resources Management, Res Ctr BioSyst Land Use & Nutr IFZ, D-35390 Giessen, Germany.	tobias.houska@umwelt.uni-giessen.de	Kraft, Philipp/Q-6051-2019; Griewank, Klaus G/A-9097-2017; Houska, Tobias/AAG-2276-2020; Breuer, Lutz/C-6652-2013	Kraft, Philipp/0000-0002-0991-8366; Griewank, Klaus G/0000-0003-3899-9449; Houska, Tobias/0000-0001-7780-2376; Breuer, Lutz/0000-0001-9720-1076	LOEWE excellence cluster FACE2FACE of the Hessen State Ministry of Higher Education, Research and the Arts; DFG [BR2238/13-1, BR2238/5 2]; Marie Curie Training Network: Quantifying Uncertainty in Integrated Catchment Studies (QUICS) [PITN-GA-2013-607000]	LOEWE excellence cluster FACE2FACE of the Hessen State Ministry of Higher Education, Research and the Arts; DFG(German Research Foundation (DFG)); Marie Curie Training Network: Quantifying Uncertainty in Integrated Catchment Studies (QUICS)	This work was funded by the LOEWE excellence cluster FACE2FACE of the Hessen State Ministry of Higher Education, Research and the Arts. Further support was received by the DFG for Tobias Houska (BR2238/13-1) and Alejandro Chamorro-Chavez (BR2238/5 2). Lutz Breuer would like to acknowledge funding of the Marie Curie Training Network: Quantifying Uncertainty in Integrated Catchment Studies (QUICS), PITN-GA-2013-607000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ackley D. H., 1987, GENETIC ALGORITHMS S, P170; Alireza Alfi, 2011, Acta Automatica Sinica, V37, P541, DOI 10.3724/SP.J.1004.2011.00541; Bardossy A, 2008, HYDROL EARTH SYST SC, V12, P1273, DOI 10.5194/hess-12-1273-2008; Behrangi A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006429; Bergstrom S., 1995, Computer models of watershed hydrology., P443; Beven K, 2006, J HYDROL, V320, P18, DOI 10.1016/j.jhydrol.2005.07.007; BEVEN K, 1992, HYDROL PROCESS, V6, P279, DOI 10.1002/hyp.3360060305; Beven K, 2001, J HYDROL, V249, P11, DOI 10.1016/S0022-1694(01)00421-8; Buytaert W, 2008, HYDROL PROCESS, V22, P4175, DOI 10.1002/hyp.7125; Clark MP, 2015, WATER RESOUR RES, V51, P2498, DOI 10.1002/2015WR017198; Dalcin L, 2008, J PARALLEL DISTR COM, V68, P655, DOI 10.1016/j.jpdc.2007.09.005; Doherty J, 2003, J AM WATER RESOUR AS, V39, P251, DOI 10.1111/j.1752-1688.2003.tb04381.x; DUAN QY, 1994, J HYDROL, V158, P265, DOI 10.1016/0022-1694(94)90057-4; Efstratiadis A, 2010, HYDROLOG SCI J, V55, P58, DOI 10.1080/02626660903526292; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Gong ZJ, 2006, RELIAB ENG SYST SAFE, V91, P915, DOI 10.1016/j.ress.2005.09.007; Goodman J, 2010, COMM APP MATH COM SC, V5, P65, DOI 10.2140/camcos.2010.5.65; Guinot V, 2011, J HYDROL, V401, P1, DOI 10.1016/j.jhydrol.2011.02.004; Haan CT, 1998, T ASAE, V41, P65, DOI 10.13031/2013.17158; Haas E, 2013, LANDSCAPE ECOL, V28, P615, DOI 10.1007/s10980-012-9772-x; Harp DR, 2012, COMPUT GEOSCI-UK, V40, P19, DOI 10.1016/j.cageo.2011.06.025; Hoffman M.D., 2011, ARXIV11114246CSSTAT; Hossain F, 2006, COMPUT GEOSCI-UK, V32, P776, DOI 10.1016/j.cageo.2005.10.006; Houska T, 2014, BIOGEOSCIENCES, V11, P2069, DOI 10.5194/bg-11-2069-2014; Huang MY, 2006, J HYDROL, V320, P37, DOI 10.1016/j.jhydrol.2005.07.010; Jager HJ, 2003, J APPL BOT-ANGEW BOT, V77, P117; Jung BS, 2006, J ENVIRON INFORM, V7, P24, DOI 10.3808/jei.200600064; Kammann C, 2001, EUR J SOIL SCI, V52, P297, DOI 10.1046/j.1365-2389.2001.00380.x; Kammann C, 2008, SOIL BIOL BIOCHEM, V40, P2194, DOI 10.1016/j.soilbio.2008.04.012; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; Kavetski D, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004368; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KITANIDIS PK, 1985, J HYDROL, V79, P53, DOI 10.1016/0022-1694(85)90181-7; Kraft P, 2012, AGU FALL M, P0688; Kraft P, 2011, ENVIRON MODELL SOFTW, V26, P828, DOI 10.1016/j.envsoft.2010.12.009; Krausse T, 2012, HYDROL EARTH SYST SC, V16, P603, DOI 10.5194/hess-16-603-2012; Legates DR, 1999, WATER RESOUR RES, V35, P233, DOI 10.1029/1998WR900018; Li L, 2010, J HYDROL, V390, P210, DOI 10.1016/j.jhydrol.2010.06.044; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Madsen H, 2002, J HYDROL, V261, P48, DOI 10.1016/S0022-1694(01)00619-9; Matott LS, 2013, COMPUT GEOSCI-UK, V60, P156, DOI 10.1016/j.cageo.2013.07.023; Matott LS, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007301; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Moeck C, 2015, ENVIRON MODELL SOFTW, V66, P78, DOI 10.1016/j.envsoft.2014.12.018; Montanari A, 2009, WATER RESOUR RES, V45, DOI 10.1029/2009WR008471; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Murphy C, 2006, AREA, V38, P65, DOI 10.1111/j.1475-4762.2006.00656.x; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Oliphant T.E., 2006, A GUIDE TO NUMPY, V1; Ortiz C, 2011, ECOL MODEL, V222, P3020, DOI 10.1016/j.ecolmodel.2011.05.034; Over MW, 2015, WATER RESOUR RES, V51, P861, DOI 10.1002/2014WR015252; Patil A, 2010, J STAT SOFTW, V35, P1; Perkel JM, 2015, NATURE, V518, P125, DOI 10.1038/518125a; Potter MA, 1994, LECT NOTES COMPUT SC, V866, P249; ROSENBROCK HH, 1960, COMPUT J, V3, P175, DOI 10.1093/comjnl/3.3.175; Santos CA, 2000, ANN J HYDRAUL ENG, P705; Schuller GI, 2007, STRUCT SAF, V29, P167, DOI 10.1016/j.strusafe.2006.07.010; Scott RL, 2000, WATER RESOUR RES, V36, P2233, DOI 10.1029/2000WR900116; Shafii M, 2015, J HYDROL, V523, P693, DOI 10.1016/j.jhydrol.2015.01.051; Smith T, 2015, J HYDROL, V528, P29, DOI 10.1016/j.jhydrol.2015.05.051; Smith T, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009514; Smith TJ, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006705; SOROOSHIAN S, 1993, WATER RESOUR RES, V29, P1185, DOI 10.1029/92WR02617; Stacey A, 2003, IEEE C EVOL COMPUTAT, P1425; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; ter Braak CJF, 2008, STAT COMPUT, V18, P435, DOI 10.1007/s11222-008-9104-9; Thyer M, 1999, WATER RESOUR RES, V35, P767, DOI 10.1029/1998WR900058; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Vrugt JA, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001746; Vrugt JA, 2009, STOCH ENV RES RISK A, V23, P1011, DOI 10.1007/s00477-008-0274-y; Wagener T, 2005, STOCH ENV RES RISK A, V19, P378, DOI 10.1007/s00477-005-0006-5; Wallach D., 2006, WORKING DYNAMIC CROP; Wang S, 2014, J INF COMPUT SCI, V11, P5631, DOI [10. 12733/ jics20104829, DOI 10.12733/jics20104829]; Weise T, 2008, GLOBAL OPTIMIZATION; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Windhorst D, 2014, HYDROL EARTH SYST SC, V18, P4113, DOI 10.5194/hess-18-4113-2014; Yang J, 2008, J HYDROL, V358, P1, DOI 10.1016/j.jhydrol.2008.05.012; Zhu GP, 2010, APPL MATH COMPUT, V217, P3166, DOI 10.1016/j.amc.2010.08.049	81	82	82	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145180	10.1371/journal.pone.0145180	http://dx.doi.org/10.1371/journal.pone.0145180			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680783	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400054
J	Shiozawa, S; Hirata, RP; Graven-Nielsen, T				Shiozawa, Shinichiro; Hirata, Rogerio Pessoto; Graven-Nielsen, Thomas			Center of Pressure Displacement of Standing Posture during Rapid Movements Is Reorganised Due to Experimental Lower Extremity Muscle Pain	PLOS ONE			English	Article							CONCURRENT COGNITIVE TASK; LOW-BACK-PAIN; KNEE OSTEOARTHRITIS; OLDER-ADULTS; QUIET STANCE; BALANCE; ADJUSTMENTS; STABILITY; GAIT; RISK	Background Postural control during rapid movements may be impaired due to musculoskeletal pain. The purpose of this study was to investigate the effect of experimental knee-related muscle pain on the center of pressure (CoP) displacement in a reaction time task condition. Methods Nine healthy males performed two reaction time tasks (dominant side shoulder flexion and bilateral heel lift) before, during, and after experimental pain induced in the dominant side vastus medialis or the tibialis anterior muscles by hypertonic saline injections. The CoP displacement was extracted from the ipsilateral and contralateral side by two force plates and the net CoP displacement was calculated. Results Compared with non-painful sessions, tibialis anterior muscle pain during the peak and peak-to-peak displacement for the CoP during anticipatory postural adjustments (APAs) of the shoulder task reduced the peak-to-peak displacement of the net CoP in the medial-lateral direction (P < 0.05). Tibialis anterior and vastus medialis muscle pain during shoulder flexion task reduced the anterior-posterior peak-to-peak displacement in the ipsilateral side (P < 0.05). Conclusions The central nervous system in healthy individuals was sufficiently robust in maintaining the APA characteristics during pain, although the displacement of net and ipsilateral CoP in the medial-lateral and anterior-posterior directions during unilateral fast shoulder movement was altered.	[Shiozawa, Shinichiro; Hirata, Rogerio Pessoto; Graven-Nielsen, Thomas] Aalborg Univ, Lab Musculoskeletal Pain & Motor Control, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI,Fac Med, Aalborg, Denmark	Aalborg University	Graven-Nielsen, T (corresponding author), Aalborg Univ, Lab Musculoskeletal Pain & Motor Control, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI,Fac Med, Aalborg, Denmark.	tgn@hst.aau.dk	; Hirata, Rogerio/G-8371-2011	Graven-Nielsen, Thomas/0000-0002-7787-4860; Hirata, Rogerio/0000-0002-9943-2713	Danish Agency for Science, Technology and Innovation; Japanese Science and Technology Agency; Japanese Society for the Promotion of Rehabilitation	Danish Agency for Science, Technology and Innovation; Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); Japanese Society for the Promotion of Rehabilitation	This work was supported by a collaboration grant between the Danish Agency for Science, Technology and Innovation and the Japanese Science and Technology Agency (2009-2012). The first author received a grant from Japanese Society for the Promotion of Rehabilitation.	Aliberti S, 2011, CLINICS, V66, P367, DOI 10.1590/S1807-59322011000300001; ArendtNielsen L, 1996, PAIN, V64, P231, DOI 10.1016/0304-3959(95)00115-8; ARUIN AS, 1995, EXP BRAIN RES, V106, P291; Aruin AS, 1996, ELECTROMYOGR MOTOR C, V101, P497, DOI 10.1016/S0013-4694(96)95219-4; Astephen JL, 2008, J BIOMECH, V41, P868, DOI 10.1016/j.jbiomech.2007.10.016; Bank PJM, 2013, EUR J PAIN, V17, P145, DOI 10.1002/j.1532-2149.2012.00186.x; Bouisset S, 2008, NEUROPHYSIOL CLIN, V38, P345, DOI 10.1016/j.neucli.2008.10.001; BOUISSET S, 1981, NEUROSCI LETT, V22, P263, DOI 10.1016/0304-3940(81)90117-8; BOUISSET S, 1987, J BIOMECH, V20, P735, DOI 10.1016/0021-9290(87)90052-2; Brauer SG, 2002, GAIT POSTURE, V15, P83, DOI 10.1016/S0966-6362(01)00163-1; Brown LA, 1999, J GERONTOL A-BIOL, V54, pM165, DOI 10.1093/gerona/54.4.M165; Creaby MW, 2012, ARCH PHYS MED REHAB, V93, P822, DOI 10.1016/j.apmr.2011.11.029; Foley SJ, 2006, OSTEOARTHR CARTILAGE, V14, P533, DOI 10.1016/j.joca.2005.12.007; Freitas SMSF, 2005, GAIT POSTURE, V22, P322, DOI 10.1016/j.gaitpost.2004.11.001; Graven-Nielsen T, 2006, SCAND J RHEUMATOL, V35, P1, DOI 10.1080/03009740600865980; Graven-Nielsen T, 2002, MUSCLE NERVE, V26, P708, DOI 10.1002/mus.10225; Hassan BS, 2001, ANN RHEUM DIS, V60, P612, DOI 10.1136/ard.60.6.612; Henriksen M, 2009, BRIT J SPORT MED, V43, P503, DOI 10.1136/bjsm.2008.050393; Henriksen M, 2007, J APPL PHYSIOL, V103, P132, DOI 10.1152/japplphysiol.01105.2006; Henriksen M, 2011, J PAIN, V12, P460, DOI 10.1016/j.jpain.2010.10.004; Hirata RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071253; Hirata RP, 2012, EUR J APPL PHYSIOL, V112, P2511, DOI 10.1007/s00421-011-2226-3; Hirata RP, 2011, J PAIN, V12, P911, DOI 10.1016/j.jpain.2011.02.356; Hirata RP, 2010, CLIN BIOMECH, V25, P931, DOI 10.1016/j.clinbiomech.2010.06.001; Hodges PW, 2009, ARTHRIT RHEUM-ARTHR, V61, P70, DOI 10.1002/art.24089; Hodges PW, 2003, EXP BRAIN RES, V151, P262, DOI 10.1007/s00221-003-1457-x; Hunt MA, 2010, ARTHRIT CARE RES, V62, P496, DOI 10.1002/acr.20046; Jacobs JV, 2009, EXP NEUROL, V215, P334, DOI 10.1016/j.expneurol.2008.10.019; Jadelis K, 2001, J AM GERIATR SOC, V49, P884, DOI 10.1046/j.1532-5415.2001.49178.x; Jover M, 2010, DEV MED CHILD NEUROL, V52, P850, DOI 10.1111/j.1469-8749.2009.03611.x; Karayannis NV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067779; Kelly VE, 2008, J GERONTOL A-BIOL, V63, P1329, DOI 10.1093/gerona/63.12.1329; King LA, 2010, ARCH PHYS MED REHAB, V91, P1332, DOI 10.1016/j.apmr.2010.05.013; Leveille SG, 2002, J AM GERIATR SOC, V50, P671, DOI 10.1046/j.1532-5415.2002.50161.x; Lin SI, 2002, J MOTOR BEHAV, V34, P37, DOI 10.1080/00222890209601929; Messier SP, 2002, ARTHRIT RHEUM-ARTHR, V47, P141, DOI 10.1002/art.10339; Mouchnino L, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-21; Nagai K, 2011, ARCH GERONTOL GERIAT, V53, P338, DOI 10.1016/j.archger.2011.01.003; Pua YH, 2011, ARTHRIT CARE RES, V63, P1706, DOI 10.1002/acr.20615; Rankin JK, 2000, J GERONTOL A-BIOL, V55, pM112, DOI 10.1093/gerona/55.3.M112; Rathleff MS, 2013, MED SCI SPORT EXER, V45, P1730, DOI 10.1249/MSS.0b013e318292be30; Rocchi L, 2006, NEUROSCI LETT, V406, P128, DOI 10.1016/j.neulet.2006.07.027; Saito H, 2014, HUM MOVEMENT SCI, V37, P69, DOI 10.1016/j.humov.2014.07.001; Salomoni SE, 2012, EUR J APPL PHYSIOL, V112, P3607, DOI 10.1007/s00421-012-2343-7; Santos MJ, 2010, J ELECTROMYOGR KINES, V20, P398, DOI 10.1016/j.jelekin.2010.01.002; Schrager MA, 2008, GAIT POSTURE, V28, P466, DOI 10.1016/j.gaitpost.2008.02.009; Shiozawa S, 2015, EUR J PAIN; Shiozawa S, 2013, HUM MOVEMENT SCI, V32, P1239, DOI 10.1016/j.humov.2013.01.009; Smith M, 2005, EXP BRAIN RES, V166, P109, DOI 10.1007/s00221-005-2352-4; Suzuki S, 2010, MED BIOL ENG COMPUT, V48, P845, DOI 10.1007/s11517-010-0664-4; Szabo SM, 2008, J AM GERIATR SOC, V56, P800, DOI 10.1111/j.1532-5415.2008.01666.x; Tsao H, 2010, PAIN, V150, P167, DOI 10.1016/j.pain.2010.04.023; Tucker KJ, 2009, PAIN, V141, P151, DOI 10.1016/j.pain.2008.10.029; Uemura K, 2011, J GERONTOL A-BIOL, V66, P904, DOI 10.1093/gerona/glr081; VOIGHT ML, 1991, AM J SPORT MED, V19, P131, DOI 10.1177/036354659101900207; WHIPPLE R, 1993, J GERONTOL, V48, P71, DOI 10.1093/geronj/48.Special_Issue.71; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 2003, J ELECTROMYOGR KINES, V13, P49, DOI 10.1016/S1050-6411(02)00085-8; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Winter DA, 1995, WATERLOO BIOMECHANIC, P3; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X	61	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144933	10.1371/journal.pone.0144933	http://dx.doi.org/10.1371/journal.pone.0144933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680777	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400034
J	Yabe, R; Miura, A; Usui, T; Mudrak, I; Ogris, E; Ohama, T; Sato, K				Yabe, Ryotaro; Miura, Akane; Usui, Tatsuya; Mudrak, Ingrid; Ogris, Egon; Ohama, Takashi; Sato, Koichi			Protein Phosphatase Methyl-Esterase PME-1 Protects Protein Phosphatase 2A from Ubiquitin/Proteasome Degradation	PLOS ONE			English	Article							CATALYTIC SUBUNIT; KINASE PATHWAY; PP2A; PHOSPHORYLATION; BINDING; ALPHA; SET; METHYLESTERASE; INACTIVATION; ASSOCIATION	Protein phosphatase 2A (PP2A) is a conserved essential enzyme that is implicated as a tumor suppressor based on its central role in phosphorylation-dependent signaling pathways. Protein phosphatase methyl esterase (PME-1) catalyzes specifically the demethylation of the C-terminal Leu309 residue of PP2A catalytic subunit (PP2Ac). It has been shown that PME-1 affects the activity of PP2A by demethylating PP2Ac, but also by directly binding to the phosphatase active site, suggesting loss of PME-1 in cells would enhance PP2A activity. However, here we show that PME-1 knockout mouse embryonic fibroblasts (MEFs) exhibit lower PP2A activity than wild type MEFs. Loss of PME-1 enhanced poly-ubiquitination of PP2Ac and shortened the half-life of PP2Ac protein resulting in reduced PP2Ac levels. Chemical inhibition of PME-1 and rescue experiments with wild type and mutated PME-1 revealed methyl-esterase activity was necessary to maintain PP2Ac protein levels. Our data demonstrate that PME-1 methyl-esterase activity protects PP2Ac from ubiquitin/proteasome degradation.	[Yabe, Ryotaro; Miura, Akane; Ohama, Takashi; Sato, Koichi] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pharmacol, Yamaguchi 7538515, Japan; [Usui, Tatsuya] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Toxicol, Yamaguchi 7538515, Japan; [Mudrak, Ingrid; Ogris, Egon] Med Univ Vienna, Max F Perutz Labs, Dept Med Biochem, A-1030 Vienna, Austria	Yamaguchi University; Yamaguchi University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Ohama, T (corresponding author), Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pharmacol, Yamaguchi 7538515, Japan.	t.ohama@yamaguchi-u.ac.jp	Usui, Tatsuya/Q-5170-2017	Usui, Tatsuya/0000-0002-1818-2127; Ogris, Egon/0000-0001-5950-9264	Japan Society for the Promotion of Science (JSPS);  [25660227];  [15K14856];  [15J07273]; Grants-in-Aid for Scientific Research [15J07273] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Thus study was supported by Japan Society for the Promotion of Science (JSPS); Grant number and the funder's URLs are: (https://www.jsps.go.jp/english/index.html) Grant Number 25660227: TO, 15K14856: TO, 15J07273: RY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachovchin DA, 2011, P NATL ACAD SCI USA, V108, P6811, DOI 10.1073/pnas.1015248108; Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chung HY, 1999, BIOCHEMISTRY-US, V38, P10371, DOI 10.1021/bi990902g; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Enjoji S, 2015, J VET MED SCI, V77, P1451, DOI 10.1292/jvms.15-0193; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Katsiari CG, 2005, J CLIN INVEST, V115, P3193, DOI 10.1172/JCI24895; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Longin S, 2004, BIOCHEM J, V380, P111, DOI 10.1042/BJ20031643; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Ohama T, 2010, J BIOL CHEM, V285, P8711, DOI 10.1074/jbc.M109.099788; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ortega-Gutierrez S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002486; Puustinen P, 2009, CANCER RES, V69, P2870, DOI 10.1158/0008-5472.CAN-08-2760; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Slupe Andrew M, 2011, Enzyme Res, V2011, P398751, DOI 10.4061/2011/398751; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Trotta R, 2007, J EXP MED, V204, P2397, DOI 10.1084/jem.20070419; Wandzioch E, 2014, CANCER RES, V74, P4295, DOI 10.1158/0008-5472.CAN-13-3130; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041	41	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145226	10.1371/journal.pone.0145226	http://dx.doi.org/10.1371/journal.pone.0145226			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678046	gold, Green Submitted, Green Published			2022-12-27	WOS:000366723400058
J	Berthelot, CC; Kamita, SG; Sacchi, R; Yang, J; Nording, ML; Georgi, K; Karbowski, CH; German, JB; Weiss, RH; Hogg, RJ; Hammock, BD; Zivkovic, AM				Berthelot, Claire C.; Kamita, Shizuo George; Sacchi, Romina; Yang, Jun; Nording, Malin L.; Georgi, Katrin; Karbowski, Christine Hegedus; German, J. Bruce; Weiss, Robert H.; Hogg, Ronald J.; Hammock, Bruce D.; Zivkovic, Angela M.			Changes in PTGS1 and ALOX12 Gene Expression in Peripheral Blood Mononuclear Cells Are Associated with Changes in Arachidonic Acid, Oxylipins, and Oxylipin/Fatty Acid Ratios in Response to Omega-3 Fatty Acid Supplementation	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; FATTY-ACIDS; PROSTAGLANDIN	Introduction There is a high degree of inter-individual variability among people in response to intervention with omega-3 fatty acids (FA), which may partly explain conflicting results on the effectiveness of omega-3 FA for the treatment and prevention of chronic inflammatory diseases. In this study we sought to evaluate whether part of this inter-individual variability in response is related to the regulation of key oxylipin metabolic genes in circulating peripheral blood mononuclear cells (PBMCs). Methods Plasma FA and oxylipin profiles from 12 healthy individuals were compared to PBMC gene expression profiles following six weeks of supplementation with fish oil, which delivered 1.9 g/d eicosapentaenoic acid (EPA) and 1.5 g/d docosahexaenoic acid (DHA). Fold changes in gene expression were measured by a quantitative polymerase chain reaction (qPCR). Results Healthy individuals supplemented with omega-3 FA had differential responses in prostaglandin-endoperoxide synthase 1 (PTGS1), prostaglandin-endoperoxide synthase 2 (PTGS2), arachidonate 12-lipoxygenase (ALOX12), and interleukin 8 (IL-8) gene expression in isolated PBMCs. In those individuals for whom plasma arachidonic acid (ARA) in the phosphatidylethanolamine (PE) lipid class decreased in response to omega-3 intervention, there was a corresponding decrease in gene expression for PTGS1 and ALOX12. Several oxylipin product/FA precursor ratios (e.g. prostaglandin E-2 (PGE(2))/ARA for PTGS1 and 12-hydroxyeicosatetraenoic acid (12-HETE)/ARA for ALOX12) were also associated with fold change in gene expression, suggesting an association between enzyme activity and gene expression. The fold-change in PTGS1 gene expression was highly positively correlated with ALOX12 gene expression but not with PTGS2, whereas IL-8 and PTGS2 were positively correlated. Conclusions The regulation of important oxylipin metabolic genes in PBMCs varied with the extent of change in ARA concentrations in the case of PTGS1 and ALOX12 regulation. PBMC gene expression changes in response to omega-3 supplementation varied among healthy individuals, and were associated with changes in plasma FA and oxylipin composition to different degrees in different individuals.	[Berthelot, Claire C.] Univ Picardie Jules Verne, Amiens, France; [Berthelot, Claire C.] Univ Technol Compiegne, Compiegne, France; [Berthelot, Claire C.; Sacchi, Romina; Zivkovic, Angela M.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Kamita, Shizuo George; Yang, Jun; Nording, Malin L.; Georgi, Katrin; Karbowski, Christine Hegedus; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Nording, Malin L.] Umea Univ, Dept Chem, Umea, Sweden; [Yang, Jun; Hammock, Bruce D.] Univ Calif Davis, Ctr Comprehens Canc, Davis, CA 95616 USA; [German, J. Bruce] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [German, J. Bruce; Zivkovic, Angela M.] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA; [Weiss, Robert H.] Univ Calif Davis, Div Nephrol, Dept Med, Davis, CA 95616 USA; [Weiss, Robert H.] Sacramento VA Med Ctr, Med Serv, Sacramento, CA USA; [Hogg, Ronald J.] Scott & White Mem Hosp & Clin, Temple, TX USA	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Technologie de Compiegne; University of California System; University of California Davis; University of California System; University of California Davis; Umea University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Scott & White Medical Center	Zivkovic, AM (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	amzivkovic@ucdavis.edu	Yang, Jun/B-2262-2010	Yang, Jun/0000-0001-8126-1728; Zivkovic, Angela/0000-0002-2828-7862	Center for Health and Nutrition Research (CHNR) Pilot Grant Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK49368]; University of California Discovery Program [05GEB01NHB]; National Institute of Environmental Health Sciences (NIEHS) [P42ES004699]; NIEHS [R01 ES002710]; NIEHS Superfund Research Program [P42 ES011269]; California Dairy Research Foundation; American Asthma Association [09-0269]; Cystic Fibrosis Research Inc.; Swedish Research Councils VR [2011-6044]; Formas [2010-303]; Vinnova [2010-02070]; West Coast Comprehensive Metabolomics Center National Institutes of Health/NIDDK [U24 DK097154]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011269, P42ES004699, R01ES002710] Funding Source: NIH RePORTER	Center for Health and Nutrition Research (CHNR) Pilot Grant Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of California Discovery Program; National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS Superfund Research Program; California Dairy Research Foundation; American Asthma Association; Cystic Fibrosis Research Inc.; Swedish Research Councils VR(Swedish Research Council); Formas(Swedish Research Council Formas); Vinnova(Vinnova); West Coast Comprehensive Metabolomics Center National Institutes of Health/NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided in part by The Center for Health and Nutrition Research (CHNR) Pilot Grant Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01 DK49368; The University of California Discovery Program (05GEB01NHB); the National Institute of Environmental Health Sciences (NIEHS) P42ES004699, NIEHS R01 ES002710, and NIEHS Superfund Research Program P42 ES011269; the California Dairy Research Foundation; the American Asthma Association #09-0269; JY was supported by the Elizabeth Nash Memorial fellowship from the Cystic Fibrosis Research Inc.; BDH is a George and Judy Marcus Senior Fellow of the American Asthma Foundation; the Swedish Research Councils VR (#2011-6044), Formas (#2010-303), and Vinnova (#2010-02070); West Coast Comprehensive Metabolomics Center National Institutes of Health/NIDDK U24 DK097154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouwens M, 2009, AM J CLIN NUTR, V90, P415, DOI 10.3945/ajcn.2009.27680; Bryan DL, 2005, LIPIDS, V40, P1007, DOI 10.1007/s11745-005-1463-4; Deckelbaum RJ, 2006, AM J CLIN NUTR, V83, p1520S, DOI 10.1093/ajcn/83.6.1520S; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hogg RJ, 2006, CLIN J AM SOC NEPHRO, V1, P1167, DOI 10.2215/CJN.02300606; Maldve RE, 2000, J LIPID RES, V41, P873; Nording ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076575; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Vichai V, 2005, INFLAMM RES, V54, P163, DOI 10.1007/s00011-004-1338-1; Warensjo E, 2008, NUTR METAB CARDIOVAS; Watkins SM, 2002, J LIPID RES, V43, P1809, DOI 10.1194/jlr.M200169-JLR200; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Zivkovic AM, 2009, METABOLOMICS, V5, P507, DOI 10.1007/s11306-009-0174-2	18	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144996	10.1371/journal.pone.0144996	http://dx.doi.org/10.1371/journal.pone.0144996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672987	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700083
J	Chen, QJ; Tao, J; Hei, HY; Li, FP; Wang, YM; Peng, W; Zhang, XM				Chen, Qijing; Tao, Jie; Hei, Hongya; Li, Fangping; Wang, Yunman; Peng, Wen; Zhang, Xuemei			Up-Regulatory Effects of Curcumin on Large Conductance Ca2+-Activated K+ Channels	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ION CHANNELS; MAPK; DEGRADATION; INHIBITION; BETA(1)-SUBUNIT; UBIQUITINATION; MODULATION; ACTIVATION; EXPRESSION	Large conductance Ca2+-activated potassium channels (BK) are targets for research that explores therapeutic means to various diseases, owing to the roles of the channels in mediating multiple physiological processes in various cells and tissues. We investigated the pharmacological effects of curcumin, a compound isolated from the herb Curcuma longa, on BK channels. As recorded by whole-cell patch-clamp, curcumin increased BK (a) and BK (alpha+beta 1) currents in transfected HEK293 cells as well as the current density of BK in A7r5 smooth muscle cells in a dose-dependent manner. By incubating with curcumin for 24 hours, the current density of exogenous BK (a) in HEK293 cells and the endogenous BK in A7r5 cells were both enhanced notably, though the steady-state activation of the channels did not shift significantly, except for BK (alpha+beta 1). Curcumin up-regulated the BK protein expression without changing its mRNA level in A7r5 cells. The surface expression and the half-life of BK channels were also increased by curcumin in HEK293 cells. These effects of curcumin were abolished by MG-132, a proteasome inhibitor. Curcumin also increased ERK 1/2 phosphorylation, while inhibiting ERK by U0126 attenuated the curcumin-induced up-regulation of BK protein expression. We also observed that the curcumin-induced relaxation in the isolated rat aortic rings was significantly attenuated by paxilline, a BK channel specific blocker. These results show that curcumin enhances the activity of the BK channels by interacting with BK directly as well as enhancing BK protein expression through inhibiting proteasomal degradation and activating ERK signaling pathway. The findings suggest that curcumin is a potential BK channel activator and provide novel insight into its complicated pharmacological effects and the underlying mechanisms.	[Chen, Qijing; Tao, Jie; Hei, Hongya; Li, Fangping; Zhang, Xuemei] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 201203, Peoples R China; [Tao, Jie; Wang, Yunman; Peng, Wen] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Nephrol, Shanghai 200062, Peoples R China	Fudan University; Shanghai University of Traditional Chinese Medicine	Peng, W (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Nephrol, 164 Lanxi Rd, Shanghai 200062, Peoples R China.	pengwen01@vip.sina.com; xuemzhang@fudan.edu.cn	Tao, Jie/AAF-7766-2020		National Science Foundation of China [81370979, 81573478]; Shanghai Science and Technology Innovation [14140903202]; Key Medical Discipline project of Shanghai Municipal Health Bureau [ZK2012A34]; Shanghai Municipal Education Commission [15ZZ063]; Putuo Hospital, Shanghai University of Traditional Chinese Medicine [2014YJ002]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Innovation; Key Medical Discipline project of Shanghai Municipal Health Bureau; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Putuo Hospital, Shanghai University of Traditional Chinese Medicine	Funding provided by National Science Foundation of China No 81370979 and 81573478 (X. Zhang)(http://www.nsfc.gov.cn/): data collection and decision to publish, Shanghai Science and Technology Innovation Grant NO. 14140903202 (X. Zhang) (http://www.stcsm.gov.cn/): study design and data collection, Leading Academic Discipline Project of SATC (W. Peng)(http://www.satcm.gov.cn/): data collection and analysis, decision to publish, the Key Medical Discipline project of Shanghai Municipal Health Bureau (NO. ZK2012A34) (W. Peng) (http://www.wsjsw.gov.cn/wsj/): preparation of the manuscript, Innovation Program of Shanghai Municipal Education Commission (NO. 15ZZ063) (J. Tao) (http://www.shmec.gov.cn/): preparation of the manuscript and Research Project of Putuo Hospital, Shanghai University of Traditional Chinese Medicine (NO. 2014YJ002) (J. Tao) (http://www.sptdch.cn/): data collection and analysis and preparation of the manuscript.	Ahluwalia J, 2004, NATURE, V427, P853, DOI 10.1038/nature02356; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Choi SW, 2013, PFLUG ARCH EUR J PHY, V465, P1121, DOI 10.1007/s00424-013-1239-7; Darvesh AS, 2012, EXPERT OPIN INV DRUG, V21, P1123, DOI 10.1517/13543784.2012.693479; Dutta K, 2009, J NEUROIMMUNE PHARM, V4, P328, DOI 10.1007/s11481-009-9158-2; Foutz RM, 2008, AM J PHYSIOL-RENAL, V294, pF1465, DOI 10.1152/ajprenal.00012.2008; Hasima N, 2013, CURR MED CHEM; Hong DH, 2013, BIOCHEM BIOPH RES CO, V430, P307, DOI 10.1016/j.bbrc.2012.10.132; Jordan WC, 1996, J NATL MED ASSOC, V88, P333; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Leamy AW, 2011, NEUROSCI LETT, V503, P157, DOI 10.1016/j.neulet.2011.07.054; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Li DM, 2006, P NATL ACAD SCI USA, V103, P19569, DOI 10.1073/pnas.0609555104; Li M, 2013, J BIOL CHEM, V288, P3668, DOI 10.1074/jbc.M112.426585; Lian YT, 2013, PHYTOTHER RES, V27, P1321, DOI 10.1002/ptr.4863; Liu YL, 2015, J AM SOC NEPHROL, V26, P844, DOI 10.1681/ASN.2014020186; Liu Z, 2014, ONCOGENE, V33, P65, DOI 10.1038/onc.2012.544; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Nardi A, 2008, CURR MED CHEM, V15, P1126, DOI 10.2174/092986708784221412; Navarro-Antolin J, 2005, CIRCULATION, V112, P1309, DOI 10.1161/CIRCULATIONAHA.104.529404; Novakovic A, 2006, BASIC CLIN PHARMACOL, V99, P360, DOI 10.1111/j.1742-7843.2006.pto_531.x; O'Malley D, 2007, EUR J NEUROSCI, V25, P673, DOI 10.1111/j.1460-9568.2007.05347.x; Park SY, 2008, FOOD CHEM TOXICOL, V46, P2881, DOI 10.1016/j.fct.2008.05.030; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Tao J, 2014, TOXINS, V6, P1419, DOI 10.3390/toxins6041419; Tao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015896; Vial E, 2003, J CELL SCI, V116, P4957, DOI 10.1242/jcs.00812; Wan SB, 2010, INT J MOL MED, V26, P447, DOI 10.3892/ijmm_00000484; Wang M, 2011, EUR J PHARMACOL, V650, P41, DOI 10.1016/j.ejphar.2010.09.049; Xu PH, 2007, VASC PHARMACOL, V47, P25, DOI 10.1016/j.vph.2007.03.003; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Zhang DM, 2010, CIRC RES, V107, P1454, DOI 10.1161/CIRCRESAHA.110.228361; Zhang XM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00094; Zhao J, 2012, J BIOL CHEM, V287, P19105, DOI 10.1074/jbc.M112.339507; Zheng YM, 2013, AM J PHYSIOL-CELL PH, V304, pC780, DOI 10.1152/ajpcell.00006.2012; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356; Zhou XB, 2010, P NATL ACAD SCI USA, V107, P8005, DOI 10.1073/pnas.0912029107; Zhu MM, 2009, BRIT J PHARMACOL, V158, P1895, DOI 10.1111/j.1476-5381.2009.00471.x; Zhuang JQ, 2011, AM J PHYSIOL-RENAL, V301, pF410, DOI 10.1152/ajprenal.00518.2010	40	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144800	10.1371/journal.pone.0144800	http://dx.doi.org/10.1371/journal.pone.0144800			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672753	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700063
J	Santos, ESL; Cerqueira-Silva, CBM; Mori, GM; Ahnert, D; Mello, DLN; Pires, JL; Correa, RX; de Souza, AP				Santos, Elisa S. L.; Cerqueira-Silva, Carlos Bernard M.; Mori, Gustavo M.; Ahnert, Dario; Mello, Durval L. N.; Pires, Jose Luis; Correa, Ronan X.; de Souza, Anete P.			Genetic Structure and Molecular Diversity of Cacao Plants Established as Local Varieties for More than Two Centuries: The Genetic History of Cacao Plantations in Bahia, Brazil	PLOS ONE			English	Article							WITCH-BROOM DISEASE; POPULATION-STRUCTURE; MICROSATELLITES; DOMESTICATION; L.; SOFTWARE; PROGRAM; ORIGIN; AMAZON	Bahia is the most important cacao-producing state in Brazil, which is currently the sixth-largest country worldwide to produce cacao seeds. In the eighteenth century, the Comum, Para and Maranhao varieties of cacao were introduced into southern Bahia, and their descendants, which are called 'Bahian cacao' or local Bahian varieties, have been cultivated for over 200 years. Comum plants have been used to start plantations in African countries and extended as far as countries in South Asia and Oceania. In Brazil, two sets of clones selected from Bahian varieties and their mutants, the Agronomic Institute of East (SIAL) and Bahian Cacao Institute (SIC) series, represent the diversity of Bahian cacao in germplasm banks. Because the genetic diversity of Bahian varieties, which is essential for breeding programs, remains unknown, the objective of this work was to assess the genetic structure and diversity of local Bahian varieties collected from farms and germplasm banks. To this end, 30 simple sequence repeat (SSR) markers were used to genotype 279 cacao plants from germplasm and local farms. The results facilitated the identification of 219 cacao plants of Bahian origin, and 51 of these were SIAL or SIC clones. Bahian cacao showed low genetic diversity. It could be verified that SIC and SIAL clones do not represent the true diversity of Bahian cacao, with the greatest amount of diversity found in cacao trees on the farms. Thus, a core collection to aid in prioritizing the plants to be sampled for Bahian cacao diversity is suggested. These results provide information that can be used to conserve Bahian cacao plants and applied in breeding programs to obtain more productive Bahian cacao with superior quality and tolerance to major diseases in tropical cacao plantations worldwide.	[Santos, Elisa S. L.; Cerqueira-Silva, Carlos Bernard M.] State Univ Southwest Bahia, Lab Appl Mol Genet, Dept Exact & Nat Sci, Itapetinga, BA, Brazil; [Santos, Elisa S. L.; Cerqueira-Silva, Carlos Bernard M.; Mori, Gustavo M.; de Souza, Anete P.] Univ Estadual Campinas, Ctr Mol Biol & Genet Engn, Campinas, SP, Brazil; [Ahnert, Dario; Correa, Ronan X.] Univ Estadual Santa Cruz, Dept Biol Sci, Genet & Biotechnol Ctr, Ilheus, BA, Brazil; [Mello, Durval L. N.] Bahian Fed Inst Educ Sci & Technol, Urucuca, BA, Brazil; [Pires, Jose Luis] Execut Comm Plan Cacao Farming, Cocoa Res Ctr, Itabuna, BA, Brazil; [de Souza, Anete P.] Univ Estadual Campinas, Inst Biol, Dept Plant Biol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Santa Cruz; Universidade de Sao Paulo; Universidade Estadual de Campinas	de Souza, AP (corresponding author), Univ Estadual Campinas, Ctr Mol Biol & Genet Engn, Campinas, SP, Brazil.	anete@unicamp.br	Mori, Gustavo Maruyama/D-5700-2013; DE SOUZA, ANETE PEREIRA/B-8663-2012; Corrêa, Ronan X/K-7976-2012	Mori, Gustavo Maruyama/0000-0003-2308-2224; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Corrêa, Ronan X/0000-0002-4010-1565	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/52197-4, 2010/50033-4, 2013/08086-1]; Conselho de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, PROCAD-NF); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [620239/2008-5, 555432/2009-2]; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) [DTE0035/2013]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, PROCAD-NF); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	The authors gratefully acknowledge the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2008/52197-4) for financial support and scholarships to GMM (2010/50033-4, 2013/08086-1); Conselho de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, PROCAD-NF2008); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq process 620239/2008-5 and 555432/2009-2) for financial support and the graduate fellowship to ESLS and research fellowships to APS; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) (DTE0035/2013) for financial support.	Ahnert D, 2013, GUIA DE MANEJO DO AG, P24; Aikpokpodion PO, 2009, TREE GENET GENOMES, V5, P699, DOI 10.1007/s11295-009-0221-1; Araujo M, 1998, RESERVA DA BIOSFERA; Bartley BGD, 2005, THE GENETIC DIVERSIT; Bennett AB, 2003, TRENDS PLANT SCI, V8, P561, DOI 10.1016/j.tplants.2003.10.004; Caldas MM, 2013, GEOFORUM, V47, P147, DOI 10.1016/j.geoforum.2013.01.006; Cascardo JC, 1993, ANNALS OF THE BRAZIL, P47; Cheesman E. E., 1944, TROP AGRIC [TRINIDAD], V21, P144; Cipriani G, 2010, THEOR APPL GENET, V121, P1569, DOI 10.1007/s00122-010-1411-9; Clement C. R., 2010, Diversity, V2, P72; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faleiro FG, AGROTROPICA, V14, P31; Faria D, 2007, BIODIVERS CONSERV, V16, P2335, DOI 10.1007/s10531-007-9189-z; Figueiredo GSF, 2008, THESIS; Instituto Brasileiro de Geografia e Estatistica, 2013, COORDENACAO DE AGROP; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Lanaud C, 1999, MOL ECOL, V8, P2141, DOI 10.1046/j.1365-294x.1999.00802.x; Lanaud C, 1897, CAFE CACAO THE, V31, P267; Leite PB, 2013, CIENC AGROTEC, V37, P244, DOI 10.1590/S1413-70542013000300007; Lima LS, 2008, MOL BREEDING, V22, P315, DOI 10.1007/s11032-008-9174-6; Loor Solorzano RG, 2009, TREE GENET GENOMES, V5, P421, DOI [10.1007/s11295-008-0196-3, DOI 10.1007/S11295-008-0196-3]; Lopes UV, 2011, CROP BREED APPL BIOT, V11, P73, DOI 10.1590/S1984-70332011000500011; Monteiro Wilson Reis, 2009, P589, DOI 10.1007/978-0-387-71201-7_16; Motamayor JC, 2003, HEREDITY, V91, P322, DOI 10.1038/sj.hdy.6800298; Motamayor JC, 2002, HEREDITY, V89, P380, DOI 10.1038/sj.hdy.6800156; Motamayor JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003311; Motilal LA, 2013, TREE GENET GENOMES, V9, P1395, DOI 10.1007/s11295-013-0645-5; N'Goran JAK, 2000, EUPHYTICA, V115, P83, DOI 10.1023/A:1003980411485; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pereira MG, 1987, THEOBROMA, V17, P209; Pires JL, 2003, THESIS U VICOSA BRAZ; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sambuichi Regina Helena Rosa, 2006, Acta Bot. Bras., V20, P943, DOI 10.1590/S0102-33062006000400018; SANTOS E. S., 2014, THESIS; Santos ESL, 2012, BIOL PLANTARUM, V56, P789, DOI 10.1007/s10535-012-0134-y; Sereno ML, 2006, CONSERV GENET, V7, P13, DOI 10.1007/s10592-005-7568-0; Silva A., 2013, THESIS; Solorzano RGL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048438; Valle, 2007, CIENCIA TECNOLOGIA E, P1; Vello F, 1972, THEOBROMA, V2, P15; Vello F., 1971, THEOBROMA, V1, P3; Yamada M. M., 2001, Crop Breeding and Applied Biotechnology, V1, P377; Young AM, 2007, THE CHOCOLATE TREE A	46	14	15	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145276	10.1371/journal.pone.0145276	http://dx.doi.org/10.1371/journal.pone.0145276			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675449	Green Submitted, gold, Green Published			2022-12-27	WOS:000366722700119
J	Su, XW; Chan, AHY; Lu, G; Lin, M; Sze, J; Zhou, JY; Poon, WS; Liu, Q; Zheng, VZY; Wong, GKC				Su, Xian Wei; Chan, Anna Ho Yin; Lu, Gang; Lin, Marie; Sze, Johnny; Zhou, Jing Ye; Poon, Wai Sang; Liu, Qiang; Zheng, Vera Zhi Yuan; Wong, George Kwok Chu			Circulating microRNA 132-3p and 324-3p Profiles in Patients after Acute Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							TRANSIENT FOCAL ISCHEMIA; MYOCARDIAL-INFARCTION; POTENTIAL BIOMARKER; CEREBRAL INFARCTION; EARLY-DIAGNOSIS; EXPRESSION; BRAIN; REGION; ANGIOGENESIS; HYPERTENSION	Background Aneurysmal subarachnoid hemorrhage (SAH) is a highly morbid and fatal condition with high rate of cognitive impairment and negative impact in quality of life among survivors. Delayed cerebral infarction (DCI) is one the major factors for these negative outcomes. In this study we compared the circulating microRNA profiles of SAH patients and healthy individuals, and the circulating microRNA profiles of SAH patients with and without DCI. Methods Peripheral blood samples on Day 7 after the onset of SAH were subjected to microarray analysis with Affymetrix miRNA 3.0 array and quantitative PCR analysis. SAH patients with (N = 20) and without DCI (N = 20) and Healthy controls (N = 20) were included for analyses. Results We demonstrated that 99 miRNAs were found to be dysregulated in the SAH patient group with DCI. 81 miRNAs were upregulated and 18 were downregulated. Findings from KEGG pathway analysis showed that miRNAs and target genes for axon guidance and TGF-beta signaling were involved, implying that the resulted differential miRNA expression pattern reflect the results of SAH instead of etiology of the disease. miR-132-3p and miR-324-3p showed distinctive upregulations in qPCR [miR-132: 9.5 fold (95% CI: 2.3 to 16.7) in DCI group and 3.4 fold (95% CI: 1.0 to 5.8) in Non-DCI group; miR-324: 4924 fold (95% CI: 2620 to 7228) in DCI group and 4545 fold (95% CI: 2408 to 6683) in non-DCI group]. However, there were no significant differences in fold changes between SAH patients with and without DCI [fold change ratios (mean+/-SD): 2.7+/-4.2 and 1.1+/-1.1 for miRNA-132 and miRNA-324]. Conclusion Our study demonstrated that as compared to healthy control, miR-132 and miR-324 showed a upregulation in both SAH DCI and Non-DCI groups. However, the differences between the SAH DCI and non-DCI groups were not statistically significant.	[Su, Xian Wei; Chan, Anna Ho Yin; Lu, Gang; Lin, Marie; Sze, Johnny; Poon, Wai Sang; Zheng, Vera Zhi Yuan; Wong, George Kwok Chu] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China; [Lu, Gang; Zhou, Jing Ye; Liu, Qiang] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong	Wong, GKC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China.	georgewong@surgery.cuhk.edu.hk	Poon, Wai S/HGD-3084-2022; Poon, Wai Sang/F-1558-2011; Wong, George Kwok Chu/L-4344-2016; Wong, George KC/A-6378-2011	Wong, George KC/0000-0002-6078-2548	Chinese University of Hong Kong Direct Grant for Research [MD11782]	Chinese University of Hong Kong Direct Grant for Research	This work was supported by a Chinese University of Hong Kong Direct Grant for Research (MD11782). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by a Chinese University of Hong Kong Direct Grant for Research (MD11782).	Adlakha YK, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-33; *AFF, EX ARR BACKGR CORR; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Araldi E, 2015, CURR VASC PHARMACOL, V13, P291, DOI 10.2174/15701611113119990012; Chen S, 2014, PROG NEUROBIOL, V115, P64, DOI 10.1016/j.pneurobio.2013.09.002; Cui LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027071; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Ding Q, 2014, NEUROSCI BULL, V30, P683, DOI 10.1007/s12264-013-1441-9; Dodel R, 2010, STROKE, V41, P2918, DOI 10.1161/STROKEAHA.110.586826; Ertekin S, 2014, MOL VIS, V20, P1057; Fiedler SD, 2010, METHODS MOL BIOL, V630, P49, DOI 10.1007/978-1-60761-629-0_4; Gaal EI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002563; Heggermont WA, 2012, HYPERTENSION, V60, P1088, DOI 10.1161/HYPERTENSIONAHA.111.187104; Huang JK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/364316; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Jiang YG, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-36; Jin HW, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-296; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KASSELL NF, 1990, J NEUROSURG, V73, P37, DOI 10.3171/jns.1990.73.1.0037; Koch W, 2011, ATHEROSCLEROSIS, V217, P220, DOI 10.1016/j.atherosclerosis.2011.03.014; Krupinski J, 1996, STROKE, V27, P852, DOI 10.1161/01.STR.27.5.852; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lei ZY, 2015, J CELL MOL MED, V19, P1994, DOI 10.1111/jcmm.12586; Li CC, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0148-y; Li PX, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000972; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Liu DH, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0188-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Rabinstein AA, 2004, STROKE, V35, P1862, DOI 10.1161/01.STR.0000133132.76983.8e; Sanders I, 2012, INT J UROL, V19, P1017, DOI 10.1111/j.1442-2042.2012.03082.x; Sano H, 2015, WORLD NEUROSURG, V83, P801, DOI 10.1016/j.wneu.2014.12.032; Schmidt JM, 2007, NEUROCRIT CARE, V7, P10, DOI 10.1007/s12028-007-0003-2; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; TEASDALE G, 1974, LANCET, V2, P81; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Vucic EA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-778; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wei YQ, 2014, J VASC SURG, V59, P879, DOI 10.1016/j.jvs.2013.10.095; Wong GKC, 2011, NEUROSURGERY, V68, P1556, DOI 10.1227/NEU.0b013e31820cd40d; Wong GKC, 2014, WORLD NEUROSURG, V81, P552, DOI 10.1016/j.wneu.2013.07.128; Wong GKC, 2012, J NEUROL NEUROSUR PS, V83, P1112, DOI 10.1136/jnnp-2012-302217; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164; Yasuno K, 2011, P NATL ACAD SCI USA, V108, P19707, DOI 10.1073/pnas.1117137108; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Yu HC, 2015, PROG NEURO-PSYCHOPH, V63, P23, DOI 10.1016/j.pnpbp.2015.05.007	50	41	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144724	10.1371/journal.pone.0144724	http://dx.doi.org/10.1371/journal.pone.0144724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675167	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700058
J	Liu, XQ; Liu, CY; Guo, Q; Zhang, M; Cao, BN; Xiang, ZH; Zhao, AC				Liu, Xue-Qin; Liu, Chang-Ying; Guo, Qing; Zhang, Meng; Cao, Bo-Ning; Xiang, Zhong-Huai; Zhao, Ai-Chun			Mulberry Transcription Factor MnDREB4A Confers Tolerance to Multiple Abiotic Stresses in Transgenic Tobacco	PLOS ONE			English	Article							GENE-EXPRESSION; SALT-STRESS; ARABIDOPSIS-THALIANA; LOW-TEMPERATURE; MOLECULAR-CLONING; CROP IMPROVEMENT; WATER-DEFICIT; AP2 DOMAIN; DROUGHT; PLANTS	The dehydration responsive element binding (DREB) transcription factors have been reported to be involved in stress responses. Most studies have focused on DREB genes in subgroups A-1 and A-2 in herbaceous plants, but there have been few reports on the functions of DREBs from the A-3-A-6 subgroups and in woody plants. Moreover, mulberry trees are ecologically and economically important perennial woody plants, but there has been little research on its stress physiology, biochemistry and molecular biology. In this study, a DREB gene from the mulberry tree, designated as MnDREB4A, classified into the A-4 subgroup by our previous study, was selected for further characterization. Our results showed that the MnDREB4A protein was localized to the nucleus where it activated transcription. The promoter of MnDREB4A can direct prominent expression downstream of the beta-glucuronidase (GUS) gene under heat, cold, drought and salt stress, and GUS staining was deepest after 12 h of stress treatment. The MnDREB4A-overexpression transgenic tobacco showed the improved growth phenotype under untreated conditions, such as greener leaves, longer roots, and lower water loss and senescence rates. Overexpression of MnDREB4A in tobacco can significantly enhance tolerance to heat, cold, drought, and salt stresses in transgenic plants. The leaf discs and seedlings of transgenic plants reduced leaf wilting and senescence rates compared to the wild type plants under the different stress conditions. Further investigation showed that transgenic plants also had higher water contents and proline contents, and lower malondialdehyde contents under untreated condition and stress conditions. Our results indicate that the MnDREB4A protein plays an important role in plant stress tolerance.	[Liu, Xue-Qin; Liu, Chang-Ying; Guo, Qing; Zhang, Meng; Cao, Bo-Ning; Xiang, Zhong-Huai; Zhao, Ai-Chun] Southwest Univ, State Key Lab Silkworm Genome Biol, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing 400716, Peoples R China	Ministry of Agriculture & Rural Affairs; Southwest University - China	Zhao, AC (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing 400716, Peoples R China.	zhaoaichun@hotmail.com	Zhao, Aichun/T-4308-2018	Zhao, Aichun/0000-0001-6140-0102	National Hi-Tech Research and Development Program of China [2013AA100605-3]; China Agriculture Research System [CARS-22-ZJ0102]	National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); China Agriculture Research System	The National Hi-Tech Research and Development Program of China (No. 2013AA100605-3) and the China Agriculture Research System (No. CARS-22-ZJ0102).	Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Ashraf M, 2009, BIOTECHNOL ADV, V27, P744, DOI 10.1016/j.biotechadv.2009.05.026; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bais HP, 2002, PLANT CELL TISS ORG, V69, P1, DOI 10.1023/A:1015064227278; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; Bohnert HJ, 2001, PLANT PHYSIOL BIOCH, V39, P295, DOI 10.1016/S0981-9428(00)01237-7; Bouaziz D, 2013, MOL BIOTECHNOL, V54, P803, DOI 10.1007/s12033-012-9628-2; Checker VG, 2013, PLANT CELL REP, V32, P1729, DOI 10.1007/s00299-013-1483-5; CHEN H, 1994, BIOTECHNIQUES, V16, P664; Chen H, 2012, J INTEGR PLANT BIOL, V54, P640, DOI 10.1111/j.1744-7909.2012.01137.x; Chen JR, 2009, IN VITRO CELL DEV-PL, V45, P1, DOI 10.1007/s11627-008-9163-9; Chen P, 2008, J CEREAL SCI, V48, P734, DOI 10.1016/j.jcs.2008.04.002; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Dunwell JM, 2000, J EXP BOT, V51, P487, DOI 10.1093/jexbot/51.suppl_1.487; FUJIMOTO H, 1993, BIO-TECHNOL, V11, P1151, DOI 10.1038/nbt1093-1151; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Hussain SS, 2011, BIOTECHNOL PROGR, V27, P297, DOI 10.1002/btpr.514; Jin XF, 2013, MOL BIOL REP, V40, P1743, DOI 10.1007/s11033-012-2228-1; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; KOZIEL MG, 1993, BIO-TECHNOL, V11, P194, DOI 10.1038/nbt0293-194; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-44; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Liu LQ, 2008, J PLANT RES, V121, P215, DOI 10.1007/s10265-007-0140-x; Liu XQ, 2015, BIOL PLANTARUM, V59, P253, DOI 10.1007/s10535-015-0498-x; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; Mizoi J, 2013, PLANT PHYSIOL, V161, P346, DOI 10.1104/pp.112.204875; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Rae L, 2011, PLANTA, V234, P429, DOI 10.1007/s00425-011-1414-z; Rashid M, 2001, EVOLUTIONARY BIOINFO, V8, P321; Reddy AR, 2004, ENVIRON EXP BOT, V52, P33, DOI 10.1016/j.envexpbot.2004.01.002; Reguera M, 2012, BBA-GENE REGUL MECH, V1819, P186, DOI 10.1016/j.bbagrm.2011.08.005; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sathiyaraj G, 2011, MOL BIOL REP, V38, P2761, DOI 10.1007/s11033-010-0421-7; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Tong Z, 2009, PLANT MOL BIOL, V71, P115, DOI 10.1007/s11103-009-9513-y; Varshney RK, 2011, TRENDS PLANT SCI, V16, P363, DOI 10.1016/j.tplants.2011.03.004; VASIL V, 1992, BIO-TECHNOL, V10, P667, DOI 10.1038/nbt0692-667; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; VOELKER T, 1987, EMBO J, V6, P3571, DOI 10.1002/j.1460-2075.1987.tb02687.x; Wang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065120, 10.1371/journal.pone.0068807]; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; WANG ZL, 2008, FOREST STUD CHINA, V10, P143; Wei CJ, 2014, PLANT PHYSIOL BIOCH, V77, P108, DOI 10.1016/j.plaphy.2014.02.002; WU GS, 1995, PLANT CELL, V7, P1357, DOI 10.1105/tpc.7.9.1357; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Xue GP, 2003, PLANT J, V33, P373, DOI 10.1046/j.1365-313X.2003.01630.x; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824	60	19	27	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145619	10.1371/journal.pone.0145619	http://dx.doi.org/10.1371/journal.pone.0145619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695076	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092500062
J	Magi, T; Kuehni, CE; Torchetti, L; Wengenroth, L; Luer, S; Frei-Erb, M				Magi, Tatjana; Kuehni, Claudia E.; Torchetti, Loredana; Wengenroth, Laura; Lueer, Sonja; Frei-Erb, Martin			Use of Complementary and Alternative Medicine in Children with Cancer: A Study at a Swiss University Hospital	PLOS ONE			English	Article							PEDIATRIC ONCOLOGY PATIENTS; HERB-DRUG INTERACTIONS; CHILDHOOD-CANCER; PREVALENCE; POPULATION; CHEMOTHERAPY; THERAPIES; GERMANY	Background Though complementary and alternative medicine (CAM) are frequently used by children and adolescents with cancer, there is little information on how and why they use it. This study examined prevalence and methods of CAM, the therapists who applied it, reasons for and against using CAM and its perceived effectiveness. Parent-perceived communication was also evaluated. Parents were asked if medical staff provided information on CAM to patients, if parents reported use of CAM to physicians, and what attitude they thought physicians had toward CAM. Study Design All childhood cancer patients treated at the University Children's Hospital Bern between 2002-2011 were retrospectively surveyed about their use of CAM. Results Data was collected from 133 patients (response rate: 52%). Of those, 53% had used CAM (mostly classical homeopathy) and 25% of patients received information about CAM from medical staff. Those diagnosed more recently were more likely to be informed about CAM options. The most frequent reason for choosing CAM was that parents thought it would improve the patient's general condition. The most frequent reason for not using CAM was lack of information. Of those who used CAM, 87% perceived positive effects. Conclusions Since many pediatric oncology patients use CAM, patients' needs should be addressed by open communication between families, treating oncologists and CAM therapists, which will allow parents to make informed and safe choices about using CAM.	[Magi, Tatjana; Kuehni, Claudia E.; Wengenroth, Laura] Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland; [Magi, Tatjana; Torchetti, Loredana; Frei-Erb, Martin] Univ Bern, Inst Complementary Med, Bern, Switzerland; [Lueer, Sonja] Univ Bern, Inselspital, Univ Childrens Hosp Bern, Div Pediat Hematol Oncol, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University of Bern; University Hospital of Bern	Frei-Erb, M (corresponding author), Univ Bern, Inst Complementary Med, Bern, Switzerland.	martin.frei@ikom.unibe.ch		Kuehni, Claudia E./0000-0001-8957-2002; Frei-Erb, Martin/0000-0002-7923-3741	Swiss Paediatric Oncology Group; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Swiss Cancer Research; Kinderkrebshilfe Schweiz; Ernst-Gohner Stiftung; Stiftung Domarena; CSL Behring; National Institute of Cancer Epidemiology and Registration	Swiss Paediatric Oncology Group; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Swiss Cancer Research; Kinderkrebshilfe Schweiz; Ernst-Gohner Stiftung; Stiftung Domarena; CSL Behring; National Institute of Cancer Epidemiology and Registration	The work of the Swiss Childhood Cancer Registry is supported by the Swiss Paediatric Oncology Group (www.spog.ch), Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren (www.gdk-cds.ch), Swiss Cancer Research (www.krebsforschung.ch), Kinderkrebshilfe Schweiz (www.kinderkrebshilfe.ch), Ernst-Gohner Stiftung (http://www.ernst-goehner-stiftung.ch), Stiftung Domarena, CSL Behring (www.cslbehring.ch) and National Institute of Cancer Epidemiology and Registration (www.nicer.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Arush M, 2006, J PEDIAT HEMATOL ONC, V28, P141; Bishop FL, 2010, PEDIATRICS, V125, P768, DOI 10.1542/peds.2009-1775; Clerici CA, 2009, PEDIATR BLOOD CANCER, V53, P599, DOI 10.1002/pbc.22093; ErfahrungsMedizinisches Register (EMR), BAS SWITZ EMR REG QU; Falkenberg T, 2012, FORSCH KOMPLEMENTMED, V19, P6, DOI 10.1159/000343812; Fernandez CV, 1998, J CLIN ONCOL, V16, P1279, DOI 10.1200/JCO.1998.16.4.1279; Gozum S, 2007, CANCER NURS, V30, P38, DOI 10.1097/00002820-200701000-00007; Gomez-Martinez R, 2007, PEDIATR BLOOD CANCER, V49, P820, DOI 10.1002/pbc.21101; Hamidah A, 2009, PEDIATR BLOOD CANCER, V52, P70, DOI 10.1002/pbc.21798; Hu ZP, 2005, PHARM RES-DORDR, V22, P902, DOI 10.1007/s11095-005-4585-0; Izzo AA, 2005, FUND CLIN PHARMACOL, V19, P1, DOI 10.1111/j.1472-8206.2004.00301.x; Klein SD, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13666; Laengler A, 2008, EUR J CANCER, V44, P2233, DOI 10.1016/j.ejca.2008.07.020; Langler A, 2005, KLIN PADIATR, V217, P357, DOI 10.1055/s-2005-872522; Martel D, 2005, PEDIATR BLOOD CANCER, V44, P660, DOI 10.1002/pbc.20205; McCune JS, 2004, SUPPORT CARE CANCER, V12, P454, DOI 10.1007/s00520-004-0598-1; Meijerman I, 2006, ONCOLOGIST, V11, P742, DOI 10.1634/theoncologist.11-7-742; Michel G, 2007, SWISS MED WKLY, V137, P502; National Center for Complementary and Integrative Health (NCCIH). Bethesda (MD), 2014, NCCIH PUBL D, VD156; Roth M, 2009, J PEDIAT HEMATOL ONC, V31, P177, DOI 10.1097/MPH.0b013e3181984f5a; Seely D, 2007, J PEDIAT HEMATOL ONC, V29, P32, DOI 10.1097/MPH.0b013e3180310521; Singendonk M, 2013, EUR J PEDIATR, V172, P31, DOI 10.1007/s00431-012-1821-6; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Zuzak TJ, 2009, EUR J PEDIATR, V168, P431, DOI 10.1007/s00431-008-0765-3	24	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145787	10.1371/journal.pone.0145787	http://dx.doi.org/10.1371/journal.pone.0145787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694320	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500076
J	Mendes, JS; Santiago, AD; Toledo, MAS; Rosselli-Murai, LK; Favaro, MTP; Santos, CA; Horta, MAC; Crucello, A; Beloti, LL; Romero, F; Tasic, L; de Souza, AA; de Souza, AP				Mendes, Juliano S.; Santiago, Andre da S.; Toledo, Marcelo A. S.; Rosselli-Murai, Luciana K.; Favaro, Marianna T. P.; Santos, Clelton A.; Horta, Maria Augusta C.; Crucello, Aline; Beloti, Lilian L.; Romero, Fabian; Tasic, Ljubica; de Souza, Alessandra A.; de Souza, Anete P.			VapD in Xylella fastidiosa Is a Thermostable Protein with Ribonuclease Activity	PLOS ONE			English	Article							BIOFILM FORMATION; STRUCTURE PREDICTION; ANTISENSE RNAS; VIRULENCE; PLANT; EXPRESSION; BACTERIA; SEQUENCE; STRAIN	Xylella fastidiosa strain 9a5c is a gram-negative phytopathogen that is the causal agent of citrus variegated chlorosis (CVC), a disease that is responsible for economic losses in Brazilian agriculture. The most well-known mechanism of pathogenicity for this bacterial pathogen is xylem vessel occlusion, which results from bacterial movement and the formation of biofilms. The molecular mechanisms underlying the virulence caused by biofilm formation are unknown. Here, we provide evidence showing that virulence-associated protein D in X. fastidiosa (Xf-VapD) is a thermostable protein with ribonuclease activity. Moreover, protein expression analyses in two X. fastidiosa strains, including virulent (Xf9a5c) and nonpathogenic (XfJ1a12) strains, showed that Xf-VapD was expressed during all phases of development in both strains and that increased expression was observed in Xf9a5c during biofilm growth. This study is an important step toward characterizing and improving our understanding of the biological significance of Xf-VapD and its potential functions in the CVC pathosystem.	[Mendes, Juliano S.; Santiago, Andre da S.; Toledo, Marcelo A. S.; Rosselli-Murai, Luciana K.; Favaro, Marianna T. P.; Santos, Clelton A.; Horta, Maria Augusta C.; Crucello, Aline; Beloti, Lilian L.; de Souza, Anete P.] Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, BR-13083875 Campinas, SP, Brazil; [Romero, Fabian; Tasic, Ljubica] Univ Estadual Campinas, Inst Quim, Dept Quim Organ, BR-13083970 Campinas, SP, Brazil; [de Souza, Alessandra A.] Ctr APTA Citros Sylvio Moreira IAC, BR-13490970 Cordeiropolis, SP, Brazil; [de Souza, Anete P.] Univ Estadual Campinas, Inst Biol, Dept Biol Vegetal, BR-13083862 Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Instituto Agronomico de Campinas (IAC); Universidade Estadual de Campinas	de Souza, AP (corresponding author), Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, BR-13083875 Campinas, SP, Brazil.	anete@unicamp.br	Favaro, Marianna/G-5011-2018; Crucello, Aline/AHD-3584-2022; Santos, Clelton A/I-2202-2012; Horta, Maria/N-5051-2016; Mendes, Juliano/S-8023-2016; Tasic, Ljubica/C-3760-2013; Horta, Maria/Q-6194-2019; DE SOUZA, ANETE PEREIRA/B-8663-2012	Favaro, Marianna/0000-0003-2942-247X; Santos, Clelton A/0000-0002-6725-8925; Horta, Maria/0000-0003-2159-5296; Mendes, Juliano/0000-0001-7249-2292; Tasic, Ljubica/0000-0003-2930-7332; Horta, Maria/0000-0003-2159-5296; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829	CAPES; FAPESP [2011/50268-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CNPq; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/51580-4, 2001/07533-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors gratefully acknowledge the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Process 2012/51580-4 and 2001/07533-7) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Computational Biology Program). JSM received a Ph.D. fellowship from CAPES, ASS was partially supported by a Ph.D. fellowship from FAPESP (Process 2011/50268-4) and CAPES (Computational Biology Program); CAS is the recipient of a post-doctoral fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). APS and AAS are the recipients of a research fellowship from CNPq.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Bove JM, 2007, IUBMB LIFE, V59, P346, DOI 10.1080/15216540701299326; BRANDTS JF, 1965, J AM CHEM SOC, V87, P2759, DOI 10.1021/ja01090a043; Caserta R, 2014, MOL PLANT MICROBE IN, V27, P1241, DOI 10.1094/MPMI-03-14-0090-R; Caserta R, 2010, APPL ENVIRON MICROB, V76, P4250, DOI 10.1128/AEM.02114-09; Catani CF, 2004, PROTEIN EXPRES PURIF, V37, P320, DOI 10.1016/j.pep.2004.07.002; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; de Souza AA, 2004, FEMS MICROBIOL LETT, V237, P341, DOI [10.1016/j.femsle.2004.06.055, 10.1111/j.1574-6968.2004.tb09716.x]; Gunderson FF, 2015, INFECT IMMUN, V83, P1008, DOI 10.1128/IAI.03102-14; Haddad N, 2014, J BIOL CHEM, V289, P27814, DOI 10.1074/jbc.M114.561795; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; Janissen R, 2015, SCI REP-UK, V5, DOI 10.1038/srep09856; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koide T, 2004, J BACTERIOL, V186, P5442, DOI 10.1128/JB.186.16.5442-5449.2004; Kumar L, 2015, FITOTERAPIA, V102, P84, DOI 10.1016/j.fitote.2015.02.002; Kumwenda B, 2013, EVOL BIOINFORM, V9, P327, DOI 10.4137/EBO.S12539; Kwon AR, 2012, NUCLEIC ACIDS RES, V40, P4216, DOI 10.1093/nar/gkr1305; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambais MR, 2000, CURR OPIN MICROBIOL, V3, P459, DOI 10.1016/S1369-5274(00)00121-1; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Machado Edduardo Caruso, 1994, Revista Brasileira de Fisiologia Vegetal, V6, P53; Marques LLR, 2002, PLANT DIS, V86, P633, DOI 10.1094/PDIS.2002.86.6.633; Marques MV, 2001, PLASMID, V45, P184, DOI 10.1006/plas.2000.1514; Matos RG, 2014, FRONT CELL INFECT MI, V4, P1; Nylander JAA, 2004, PROGRAM DISTRIBUTED; Purcell AH, 2012, ADV DIS VECTOR RES, P243; Rahmati S, 2002, MOL MICROBIOL, V43, P677, DOI 10.1046/j.1365-2958.2002.02773.x; Ren D, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-263; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santos CA, 2013, MICROB PATHOGENESIS, V59-60, P1, DOI 10.1016/j.micpath.2013.02.007; Saramago M, 2015, PLASMID, V78, P26, DOI 10.1016/j.plasmid.2014.09.003; Saramago M, 2014, CURR OPIN MICROBIOL, V18, P105, DOI 10.1016/j.mib.2014.02.009; Sauer K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-219; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan CJ, 2007, LANGMUIR, V23, P2722, DOI 10.1021/la062178q; Teixeira DD, 2004, CURR MICROBIOL, V49, P396, DOI 10.1007/s00284-004-4363-y; Toledo MAS, 2013, BBA-PROTEINS PROTEOM, V1834, P697, DOI 10.1016/j.bbapap.2012.12.017; Toledo MAS, 2011, PROTEIN EXPRES PURIF, V75, P204, DOI 10.1016/j.pep.2010.10.004; Trivedi S, 2006, GENET MOL RES, V5, P816; Vercruysse M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004175; Viegas SC, 2008, RNA BIOL, V5, P230, DOI 10.4161/rna.6915; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; Wagner EGH, 2002, ADV GENET, V46, P361; Wassenaar TM, 2001, FEMS MICROBIOL LETT, V201, P1; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whittingham JL, 2014, ACTA CRYSTALLOGR D, V70, P2139, DOI 10.1107/S1399004714012632; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; ZALE SE, 1986, BIOCHEMISTRY-US, V25, P5432, DOI 10.1021/bi00367a014	58	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145765	10.1371/journal.pone.0145765	http://dx.doi.org/10.1371/journal.pone.0145765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694028	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092500074
J	Saulou-Berion, C; Gonzalez, I; Enjalbert, B; Audinot, JN; Fourquaux, I; Jamme, F; Cocaign-Bousquet, M; Mercier-Bonin, M; Girbal, L				Saulou-Berion, Claire; Gonzalez, Ignacio; Enjalbert, Brice; Audinot, Jean-Nicolas; Fourquaux, Isabelle; Jamme, Frederic; Cocaign-Bousquet, Muriel; Mercier-Bonin, Muriel; Girbal, Laurence			Escherichia coli under Ionic Silver Stress: An Integrative Approach to Explore Transcriptional, Physiological and Biochemical Responses	PLOS ONE			English	Article							UNSATURATED FATTY-ACIDS; RESPIRATORY-CHAIN; NANOPARTICLES; TOXICITY; PSEUDOMONAS; NANOSIMS; IDENTIFICATION; LOCALIZATION; MECHANISMS; EXPRESSION	For a better understanding of the systemic effect of sub-lethal micromolar concentrations of ionic silver on Escherichia coli, we performed a multi-level characterization of cells under Ag+-mediated stress using an integrative biology approach combining physiological, biochemical and transcriptomic data. Physiological parameters, namely bacterial growth and survival after Ag+ exposure, were first quantified and related to the accumulation of intracellular silver, probed for the first time by nano secondary ion mass spectroscopy at submicrometer lateral resolution. Modifications in E. coli biochemical composition were evaluated under Ag+-mediated stress by in situ synchrotron Fourier-transform infrared microspectroscopy and a comprehensive transcriptome response was also determined. Using multivariate statistics, correlations between the physiological parameters, the extracellular concentration of AgNO3 and the intracellular silver content, gene expression profiles and micro-spectroscopic data were investigated. We identified Ag+-dependent regulation of gene expression required for growth (e.g. transporter genes, transcriptional regulators, ribosomal proteins), for ionic silver transport and detoxification (e.g. copA, cueO, mgtA, nhaR) and for coping with various types of stress (dnaK, pspA, metA, R, oxidoreductase genes). The silver-induced shortening of the acyl chain of fatty acids, mostly encountered in cell membrane, was highlighted by microspectroscopy and correlated with the down-regulated expression of genes involved in fatty acid transport (fadL) and synthesis/modification of lipid A (lpxA and arnA). The increase in the disordered secondary structure of proteins in the presence of Ag+ was assessed through the conformational shift shown for amides I and II, and further correlated with the up-regulated expression of peptidase (hfq) and chaperone (dnaJ), and regulation of transpeptidase expression (ycfS and ycbB). Interestingly, as these transpeptidases act on the structural integrity of the cell wall, regulation of their expression may explain the morphological damage reported under Ag+-mediated stress. This result clearly demonstrates that the cell membrane is a key target of ionic silver.	[Saulou-Berion, Claire; Gonzalez, Ignacio; Enjalbert, Brice; Cocaign-Bousquet, Muriel; Mercier-Bonin, Muriel; Girbal, Laurence] Univ Toulouse, INSA, UPS, INPT,LISBP, Toulouse, France; [Saulou-Berion, Claire; Gonzalez, Ignacio; Enjalbert, Brice; Cocaign-Bousquet, Muriel; Mercier-Bonin, Muriel; Girbal, Laurence] INRA, Ingn Syst Biol & Proc UMR792, F-31931 Toulouse, France; [Saulou-Berion, Claire; Gonzalez, Ignacio; Enjalbert, Brice; Cocaign-Bousquet, Muriel; Mercier-Bonin, Muriel; Girbal, Laurence] CNRS, UMR5504, Toulouse, France; [Audinot, Jean-Nicolas] Luxembourg Inst Sci & Technol LIST, Mat Res & Technol Dept MRT, Belvaux, Luxembourg; [Fourquaux, Isabelle] CMEAB, Fac Med Rangueil, Toulouse, France; [Jamme, Frederic] INRA, UAR1008, CEPIA, F-44026 Nantes, France; [Jamme, Frederic] Synchrotron SOLEIL, Gif Sur Yvette, France	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Luxembourg Institute of Science & Technology; INRAE; SOLEIL Synchrotron	Girbal, L (corresponding author), Univ Toulouse, INSA, UPS, INPT,LISBP, Toulouse, France.	Laurence.girbal@insa-toulouse.fr	JAMME, Frederic/E-2170-2011; Audinot, Jean-Nicolas/I-5114-2013; MERCIER-BONIN, Muriel/AAO-5286-2021	JAMME, Frederic/0000-0002-7398-7868; Audinot, Jean-Nicolas/0000-0002-4966-7653; Enjalbert, Brice/0000-0003-1291-1373; GIRBAL, Laurence/0000-0002-8773-4829; SAULOU, Claire/0000-0003-4843-6076	French National Research Agency [ANR-07-BLAN-0196-01]	French National Research Agency(French National Research Agency (ANR))	Funding was received from the French National Research Agency (http://www.agence-nationale-recherche.fr/), grant number: ANR-07-BLAN-0196-01 to CSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A., 2019, TOPGO ENRICHMENT ANA; Audinot JN, 2013, SURF INTERFACE ANAL, V45, P230, DOI 10.1002/sia.5099; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Di Pasqua R, 2006, J AGR FOOD CHEM, V54, P2745, DOI 10.1021/jf052722l; Du HM, 2012, BIOCHEM BIOPH RES CO, V424, P657, DOI 10.1016/j.bbrc.2012.06.134; Eybe T, 2009, CHEMOSPHERE, V76, P134, DOI 10.1016/j.chemosphere.2009.02.005; Fantino JR, 2010, ENVIRON MICROBIOL, V12, P2846, DOI 10.1111/j.1462-2920.2010.02265.x; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Georgantzopoulou A, 2013, NANOTOXICOLOGY, V7, P1168, DOI 10.3109/17435390.2012.715312; Gonzalez I, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-19; Gordon O, 2010, ANTIMICROB AGENTS CH, V54, P4208, DOI 10.1128/AAC.01830-09; Gutleb AC, 2012, ANAL BIOANAL CHEM, V404, P2693, DOI 10.1007/s00216-012-6066-8; Hartig C, 2005, APPL ENVIRON MICROB, V71, P1915, DOI 10.1128/AEM.71.4.1915-1922.2005; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; Helbig K, 2008, J BACTERIOL, V190, P5439, DOI 10.1128/JB.00272-08; Holt KB, 2005, BIOCHEMISTRY-US, V44, P13214, DOI 10.1021/bi0508542; Hoppe P, 2013, GEOSTAND GEOANAL RES, V37, P111, DOI 10.1111/j.1751-908X.2013.00239.x; Inoue Y, 2002, J INORG BIOCHEM, V92, P37, DOI 10.1016/S0162-0134(02)00489-0; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Ivask A, 2014, ACS NANO, V8, P374, DOI 10.1021/nn4044047; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kershaw CJ, 2005, MICROBIOL-SGM, V151, P1187, DOI 10.1099/mic.0.27650-0; KIERANS M, 1991, BIOL MET, V4, P100, DOI 10.1007/BF01135386; Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4; Lansdown A B G, 2002, J Wound Care, V11, P173; Lansdown A B G, 2002, J Wound Care, V11, P125; Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515; Le Cao KA, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1390; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lee LJ, 2005, J BACTERIOL, V187, P1124, DOI 10.1128/JB.187.3.1124-1134.2005; Liau SY, 1997, LETT APPL MICROBIOL, V25, P279, DOI 10.1046/j.1472-765X.1997.00219.x; Loffeld B, 1996, LIPIDS, V31, P811, DOI 10.1007/BF02522976; Magnet S, 2008, J BACTERIOL, V190, P4782, DOI 10.1128/JB.00025-08; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003; McLean S, 2010, J BIOL CHEM, V285, P20724, DOI 10.1074/jbc.M109.085506; Moen B, 2009, CAN J MICROBIOL, V55, P714, DOI [10.1139/W09-016, 10.1139/w09-016]; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Mueller CW, 2013, ADV AGRON, V121, P1, DOI 10.1016/B978-0-12-407685-3.00001-3; Park HJ, 2009, WATER RES, V43, P1027, DOI 10.1016/j.watres.2008.12.002; Partridge JD, 2006, J BIOL CHEM, V281, P27806, DOI 10.1074/jbc.M603450200; Patrignani F, 2008, INT J FOOD MICROBIOL, V123, P1, DOI 10.1016/j.ijfoodmicro.2007.09.009; R Core Team, 2012, R LANG ENV STAT COMP; Radzig MA, 2013, COLLOID SURFACE B, V102, P300, DOI 10.1016/j.colsurfb.2012.07.039; Saulou C, 2013, ANAL BIOANAL CHEM, V405, P2685, DOI 10.1007/s00216-013-6725-4; Saulou C, 2012, PLASMA PROCESS POLYM, V9, P324, DOI 10.1002/ppap.201100033; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Wu MY, 2007, WATER SCI TECHNOL, V55, P413, DOI 10.2166/wst.2007.285; Yang HC, 2003, DRUG CHEM TOXICOL, V26, P75, DOI 10.1081/DCT-120020403	57	14	15	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145748	10.1371/journal.pone.0145748	http://dx.doi.org/10.1371/journal.pone.0145748			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696268	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500070
J	Carr, BJ; Canapp, SO; Zink, MC				Carr, Brittany Jean; Canapp, Sherman O., Jr.; Zink, M. Christine			Quantitative Comparison of the Walk and Trot of Border Collies and Labrador Retrievers, Breeds with Different Performance Requirements	PLOS ONE			English	Article							GROUND REACTION FORCES; PLATE GAIT ANALYSIS; VERTICAL FORCES; BODY-WEIGHT; DOGS; GREYHOUNDS; PLATFORM; VARIABLES; SYSTEM	Introduction We hypothesized that breed differences of Border Collies and Labrador Retrievers would be reflected in the temporospatial characteristics of the walk and trot. Materials and Methods Twenty healthy Border Collies and 20 healthy Labrador Retrievers made three passes across a pressure sensing walkway system that recorded quantitative temporospatial information at a walk and a trot. The following variables were measured for each dog: velocity, total pressure index percentage (TPI%), ratio of weight borne on the thoracic vs. pelvic limbs (T/P TPI%), stance time percentage (ST%), and thoracic limb stride length (TSrL). Results The mean T/P TPI% for Border Collies at a walk and at a trot were significantly lower than for Labrador Retrievers (p = 0.0007 and p = 0.0003). Border Collies had a significantly lower ST% than Labrador Retrievers for the thoracic limbs and pelvic limbs at a walk (p = 0.0058 and 0.0003) and the trot (p = 0.0280 and 0.0448). There was no relationship between ST% and TSrL in Border Collies and an inverse correlation between ST% and TSrL in Labrador Retrievers (p = 0.0002). Discussion Key quantitative gait differences were identified in Border Collies and Labrador Retrievers, which could potentially provide each breed with an advantage for their working function.	[Carr, Brittany Jean; Canapp, Sherman O., Jr.; Zink, M. Christine] Vet Orthoped & Sports Med, Annapolis Jct, MD 20701 USA; [Zink, M. Christine] Zink Integrat Sports Med, Ellicott City, MD 21042 USA		Zink, MC (corresponding author), Vet Orthoped & Sports Med, 10975 Guilford Rd, Annapolis Jct, MD 20701 USA.	mczink@caninesports.com						Agostinho FS, 2011, VET COMP ORTHOPAED, V24, P185, DOI 10.3415/VCOT-10-03-0039; Bertram JEA, 2000, AM J VET RES, V61, P832, DOI 10.2460/ajvr.2000.61.832; Besancon MF, 2004, AM J VET RES, V65, P1497, DOI 10.2460/ajvr.2004.65.1497; Besancon MF, 2003, VET COMP ORTHOPAED, V16, P153, DOI 10.1055/s-0038-1632766; Brady RB, 2013, AM J VET RES, V74, P757, DOI 10.2460/ajvr.74.5.757; Brown CM, 1986, DOG LOCOMOTION GAIT; Colborne GR, 2005, AM J VET RES, V66, P1563, DOI 10.2460/ajvr.2005.66.1563; Evans R, 2005, VET SURG, V34, P445, DOI 10.1111/j.1532-950X.2005.00067.x; Gillette RL, 2008, VET J, V178, P165, DOI 10.1016/j.tvjl.2008.01.009; Gutmann A, 2009, J R SOC INTERFACE, V6, P549, DOI [10.1098/rsjf.2008.0328, DOI 10.1098/RSIF.2008.0328]; Hudson PE, 2012, J EXP BIOL, V215, P2425, DOI 10.1242/jeb.066720; Kim J, 2011, AM J VET RES, V72, P1171, DOI 10.2460/ajvr.72.9.1171; Lascelles BDX, 2006, AM J VET RES, V67, P277, DOI 10.2460/ajvr.67.2.277; Light VA, 2010, AM J VET RES, V71, P997, DOI 10.2460/ajvr.71.9.997; Molsa SH, 2010, VET SURG, V39, P701, DOI 10.1111/j.1532-950X.2010.00651.x; Moreau M, 2010, VET SURG, V39, P43, DOI 10.1111/j.1532-950X.2009.00621.x; Nordquist B, 2011, VET COMP ORTHOPAED, V24, P435, DOI 10.3415/VCOT-11-01-0015; NUNAMAKER DM, 1985, TXB SMALL ANIMAL ORT, P1084; Quinn MM, 2007, VET SURG, V36, P360, DOI 10.1111/j.1532-950X.2007.00276.x; Stephen Smith, 2015, MOST POPULAR DOG BRE, P2; Torres BT, 2013, AM J VET RES, V74, P535, DOI 10.2460/ajvr.74.4.535; Voss K, 2007, VET COMP ORTHOPAED, V20, P299, DOI 10.1160/VCOT-07-01-0008; Voss K, 2010, VET SURG, V39, P863, DOI 10.1111/j.1532-950X.2010.00729.x	23	11	11	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145396	10.1371/journal.pone.0145396	http://dx.doi.org/10.1371/journal.pone.0145396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689372	gold, Green Published			2022-12-27	WOS:000367092300068
J	Gaydos, JK; Thixton, S; Donatuto, J				Gaydos, Joseph K.; Thixton, Sofie; Donatuto, Jamie			Evaluating Threats in Multinational Marine Ecosystems: A Coast Salish First Nations and Tribal Perspective	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PRINCE-WILLIAM-SOUND; PETROLEUM-HYDROCARBONS; RISK-ASSESSMENT; OIL-SPILL; EMBRYOS; POPULATION; EXPOSURE; COLUMBIA; IMPACTS	Despite the merit of managing natural resources on the scale of ecosystems, evaluating threats and managing risk in ecosystems that span multiple countries or jurisdictions can be challenging. This requires each government involved to consider actions in concert with actions being taken in other countries by co-managing entities. Multiple proposed fossil fuel-related and port development projects in the Salish Sea, a 16,925 km(2) inland sea shared by Washington State (USA), British Columbia (Canada), and Indigenous Coast Salish governments, have the potential to increase marine vessel traffic and negatively impact natural resources. There is no legal mandate or management mechanism requiring a comprehensive review of the potential cumulative impacts of these development activities throughout the Salish Sea and across the international border. This project identifies ongoing and proposed energy-related development projects that will increase marine vessel traffic in the Salish Sea and evaluates the threats each project poses to natural resources important to the Coast Salish. While recognizing that Coast Salish traditions identify all species as important and connected, we used expert elicitation to identify 50 species upon which we could evaluate impact. These species were chosen because Coast Salish depend upon them heavily for harvest revenue or as a staple food source, they were particularly culturally or spiritually significant, or they were historically part of Coast Salish lifeways. We identified six development projects, each of which had three potential impacts (pressures) associated with increased marine vessel traffic: oil spill, vessel noise and vessel strike. Projects varied in their potential for localized impacts (pressures) including shoreline development, harbor oil spill, pipeline spill, coal dust accumulation and nearshore LNG explosion. Based on available published data, impact for each pressure/species interaction was rated as likely, possible or unlikely. Impacts are likely to occur in 23 to 28% of the possible pressure/species scenarios and are possible in another 15 to 28% additional pressure/species interactions. While it is not clear which impacts will be additive, synergistic, or potentially antagonistic, studies that manipulate multiple stressors in marine ecosystems suggest that threats associated with these six projects are likely to have an overall additive or even synergistic interaction and therefore impact species of major cultural importance to the Coast Salish, an important concept that would be lost by merely evaluating each project independently. Failure to address multiple impacts will affect the Coast Salish and the 7 million other people that also depend on this ecosystem. These findings show the value of evaluating multiple threats, and ultimately conducting risk assessments at the scale of ecosystems and highlight the serious need for managers of multinational ecosystems to actively collaborate on evaluating threats, assessing risk, and managing resources.	[Gaydos, Joseph K.; Thixton, Sofie] UC Davis Karen C Drayer Wildlife Hlth Ctr, Orcas Isl Off, SeaDoc Soc, Eastsound, WA 98245 USA; [Donatuto, Jamie] Swinomish Indian Tribal Community, La Conner, WA USA		Gaydos, JK (corresponding author), UC Davis Karen C Drayer Wildlife Hlth Ctr, Orcas Isl Off, SeaDoc Soc, Eastsound, WA 98245 USA.	jkgaydos@ucdavis.edu			U.S. EPA sub-award via the Northwest Indian Fish Commission (NWIFC) [EPA320-438(2)]; UC Davis School of Veterinary Medicine's Karen C. Drayer Wildlife Health Center	U.S. EPA sub-award via the Northwest Indian Fish Commission (NWIFC); UC Davis School of Veterinary Medicine's Karen C. Drayer Wildlife Health Center	This project was supported by funds from a U.S. EPA sub-award to the Swinomish Indian Tribal Community via the Northwest Indian Fish Commission (NWIFC EPA320-438(2)), with a sub award to the SeaDoc Society, a program of the UC Davis School of Veterinary Medicine's Karen C. Drayer Wildlife Health Center (www.seadocsociety.org). The U.S. EPA was not involved in any aspect of this study design, data collection or analysis, or writing of this manuscript. The SeaDoc Society and the Coast Salish Gathering (www.coastsalishgathering.com) also provided in-kind support.	Ahrens MJ, 2005, OCEANOGR MAR BIOL, V43, P69; ANTRIM LD, 1995, MAR BIOL, V122, P23, DOI 10.1007/BF00349274; Arquette M, 2002, ENVIRON HEALTH PERSP, V110, P259, DOI 10.1289/ehp.02110s2259; Ayres KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036842; Bounds WJ, 2007, WATER AIR SOIL POLL, V185, P195, DOI 10.1007/s11270-007-9442-9; Bowman TD, 1997, J WILDLIFE MANAGE, V61, P962, DOI 10.2307/3802206; Buscaino G, 2010, MAR ENVIRON RES, V69, P136, DOI 10.1016/j.marenvres.2009.09.004; Buscher B., 2009, J INT WILDL LAW POLI, V12, P33, DOI [10.1080/13880290902938138, DOI 10.1080/13880290902938138]; Carls MG, 2010, MAR ENVIRON RES, V69, P318, DOI 10.1016/j.marenvres.2009.12.006; Carro N, 2005, ENV RES J, V100, P339; Carvalho FP, 1999, TRAC-TREND ANAL CHEM, V18, P656, DOI 10.1016/S0165-9936(99)00148-X; Chang SE, 2014, ECOL SOC, V19, DOI 10.5751/ES-06406-190226; Codarin A, 2009, MAR POLLUT BULL, V58, P1880, DOI 10.1016/j.marpolbul.2009.07.011; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Dean TA, 1998, MAR POLLUT BULL, V36, P201, DOI 10.1016/S0025-326X(97)00184-7; Donatuto JL, 2011, HEALTH RISK SOC, V13, P103, DOI 10.1080/13698575.2011.556186; Dunlop RA, 2010, P ROY SOC B-BIOL SCI, V277, P2521, DOI 10.1098/rspb.2009.2319; Etkin DS, 2014, WASHINGTON STATE DEP; Frittelli J, 2014, C RES SERVICE, P25; GARIBALDI A, 2004, ECOLOGY SOC, V9, pR2; Gaydos JK, 2014, P SAL SEA C SEATTL W; Gaydos Joseph K., 2011, Northwestern Naturalist, V92, P79; Gaydos JK, 2008, ECOHEALTH, V5, P460, DOI 10.1007/s10393-009-0209-1; Gregory R., 2012, STRUCTURED DECISION, DOI [DOI 10.1002/9781444398557, 10.1002/9781444398557]; Guzman HM, 2013, MAR MAMMAL SCI, V29, P629, DOI 10.1111/j.1748-7692.2012.00605.x; Harris SG, 1997, RISK ANAL, V17, P789, DOI 10.1111/j.1539-6924.1997.tb01284.x; Harris SG, 2000, ENVIRON SCI POLLUT R, P91; Henkel LA, 2014, MAR POLLUT BULL, V79, P155, DOI 10.1016/j.marpolbul.2013.12.023; Incardona JP, 2012, P NATL ACAD SCI USA, V109, pE51, DOI 10.1073/pnas.1108884109; Johnson R, 2006, INT J COAL GEOL, V68, P57, DOI 10.1016/j.coal.2005.10.003; Lackey RT, 1998, LANDSCAPE URBAN PLAN, V40, P21, DOI 10.1016/S0169-2046(97)00095-9; Lage-Yusty MA, 2009, B ENVIRON CONTAM TOX, V82, P158, DOI 10.1007/s00128-008-9503-9; Lee RF, 1997, MAR POLLUT BULL, V34, P928, DOI 10.1016/S0025-326X(97)00078-7; Maccarone AD, 2000, WATERBIRDS, V23, P246; Matkin CO, 2008, MAR ECOL PROG SER, V356, P269, DOI 10.3354/meps07273; Merrick, 2014, PREVENTING OIL SPILL; Morrow JE, 1974, EPA660373019, P37; Northwest Clean Air Agency, 2014, 1179 NOC NW CLEAN AI, V1179, P8; Northwest Indian Fisheries Commission, 2011, TREAT RIGHTS RISK ON, P35; Pacific International Terminals, 2012, GAT PAC TERM MAJ PRO, P312; Parihar A, 2011, SAFETY SCI, V49, P686, DOI 10.1016/j.ssci.2011.01.004; Pasquevich MY, 2013, COMP BIOCHEM PHYS C, V157, P390, DOI 10.1016/j.cbpc.2013.03.006; Pietsch T.W., 2015, NOAA PROFESSIONAL PA, DOI [10.7755/PP.18, DOI 10.7755/PZRP.18]; RailWorks Corporation, 2014, TES CRUD OIL UNL FAC; Ritter L, 2013, SNC LAVALIN INT REFE; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Tengberg A, 2013, MAR POLICY, V38, P355, DOI 10.1016/j.marpol.2012.06.013; Vancouver Port Metro, 2014, 2012072 EAP PORT MET, P35; Vancouver Port Metro, 2014, EAP 2012 072, P19; Vancouver Port Metro, 2013, ROB BANK TERM 2 PROJ, P105; Von Ziegesar Olga, 1994, P173; West JE, 2014, SCI TOTAL ENVIRON, V499, P114, DOI 10.1016/j.scitotenv.2014.08.042; Williams R, 2014, ANIM CONSERV, V17, P174, DOI 10.1111/acv.12076; Wolfley J, 1998, AM INDIAN CULT RES J, V22, P151, DOI 10.17953/aicr.22.2.gn5w81421k243111; Woodfibre LNG Limited, 2014, UPD PROJ DESCR, P34; Yanagida GK, 2012, ARCH ENVIRON CON TOX, V62, P282, DOI 10.1007/s00244-011-9704-9; Zimmerman JR, 2004, ENVIRON SCI TECHNOL, V38, P5458, DOI 10.1021/es034992v	59	9	9	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144861	10.1371/journal.pone.0144861	http://dx.doi.org/10.1371/journal.pone.0144861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SF	26691860	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092300023
J	Just, PA; Poncy, A; Charawi, S; Dahmani, R; Traore, M; Dumontet, T; Drouet, V; Dumont, F; Gilgenkrantz, H; Colnot, S; Terris, B; Coulouarn, C; Lemaigre, F; Perret, C				Just, Pierre-Alexandre; Poncy, Alexis; Charawi, Sara; Dahmani, Rajae; Traore, Massire; Dumontet, Typhanie; Drouet, Valerie; Dumont, Florent; Gilgenkrantz, Helene; Colnot, Sabine; Terris, Benoit; Coulouarn, Cedric; Lemaigre, Frederic; Perret, Christine			LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis	PLOS ONE			English	Article							INTRAHEPATIC BILE-DUCTS; ALAGILLE-SYNDROME; LIVER DEVELOPMENT; SIGNALING PATHWAYS; HUMAN JAGGED1; MICE; ACTIVATION; KINASE; GENE; DIFFERENTIATION	Background LKB1 is an evolutionary conserved kinase implicated in a wide range of cellular functions including inhibition of cell proliferation, regulation of cell polarity and metabolism. When Lkb1 is inactivated in the liver, glucose homeostasis is perturbed, cellular polarity is affected and cholestasis develops. Cholestasis occurs as a result from deficient bile duct development, yet how LKB1 impacts on biliary morphogenesis is unknown. Methodology/Principal Findings We characterized the phenotype of mice in which deletion of the Lkb1 gene has been specifically targeted to the hepatoblasts. Our results confirmed that lack of LKB1 in the liver results in bile duct paucity leading to cholestasis. Immunostaining analysis at a prenatal stage showed that LKB1 is not required for differentiation of hepatoblasts to cholangiocyte precursors but promotes maturation of the primitive ductal structures to mature bile ducts. This phenotype is similar to that obtained upon inactivation of Notch signaling in the liver. We tested the hypothesis of a functional overlap between the LKB1 and Notch pathways by gene expression profiling of livers deficient in Lkb1 or in the Notch mediator RbpJ. and identified a mutual cross-talk between LKB1 and Notch signaling. In vitro experiments confirmed that Notch activity was deficient upon LKB1 loss. Conclusion LKB1 and Notch share a common genetic program in the liver, and regulate bile duct morphogenesis.	[Just, Pierre-Alexandre; Charawi, Sara; Dahmani, Rajae; Traore, Massire; Dumontet, Typhanie; Drouet, Valerie; Dumont, Florent; Gilgenkrantz, Helene; Colnot, Sabine; Terris, Benoit; Perret, Christine] INSERM, Inst Cochin, U1016, F-75014 Paris, France; [Just, Pierre-Alexandre; Charawi, Sara; Dahmani, Rajae; Traore, Massire; Dumontet, Typhanie; Drouet, Valerie; Dumont, Florent; Gilgenkrantz, Helene; Colnot, Sabine; Terris, Benoit; Perret, Christine] CNRS, UMR8104, F-75014 Paris, France; [Just, Pierre-Alexandre; Charawi, Sara; Dahmani, Rajae; Traore, Massire; Dumontet, Typhanie; Drouet, Valerie; Dumont, Florent; Gilgenkrantz, Helene; Colnot, Sabine; Terris, Benoit; Perret, Christine] Univ Paris 05, F-75014 Paris, France; [Just, Pierre-Alexandre; Charawi, Sara; Dahmani, Rajae; Traore, Massire; Dumontet, Typhanie; Drouet, Valerie; Gilgenkrantz, Helene; Colnot, Sabine; Terris, Benoit; Perret, Christine] Equipe Labellisee LNCC Paris, Paris, France; [Just, Pierre-Alexandre; Terris, Benoit] Hop Cochin, AP HP, Hop Univ Paris Ctr, Dept Pathol, F-75014 Paris, France; [Poncy, Alexis; Lemaigre, Frederic] de Duve Inst, B-1200 Brussels, Belgium; [Poncy, Alexis; Lemaigre, Frederic] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Coulouarn, Cedric] Univ Rennes 1, INSERM, UMR991, F-35033 Rennes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Perret, C (corresponding author), INSERM, Inst Cochin, U1016, F-75014 Paris, France.	christine.perret@inserm.fr	Perret-Mayeux, Christine/L-3297-2017; JUST, Pierre-Alexandre/P-1972-2017; Gilgenkrantz, Helene/G-5534-2017; Coulouarn, Cedric/E-5472-2011; Terris, Benoit/P-1497-2017; Colnot, Sabine/A-9169-2008	Coulouarn, Cedric/0000-0002-5692-9586; Colnot, Sabine/0000-0002-3949-9107; perret, christine/0000-0003-4710-7051; gilgenkrantz, helene/0000-0001-6770-4561	INSERM; CNRS; Ligue Nationale Contre le Cancer LNCC (France) "Equipe labelisee Ligue Nationale Contre le Cancer"; INCA; ANR; LABEX Who am I? grants; Poste d'accueil AP-HP-CNRS/CEA; Interuniversity Attraction Pole Programme (Belgian Science Policy (BELSPO)) [PVII-47]; D.G. Higher Education and Scientific Research of the French Community of Belgium [10/15-029]; Alphonse and Jean Forton Fund [2011-R10150-004]; Fonds de la Recherche Scientifique Medicale [3.4536.10F]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ligue Nationale Contre le Cancer LNCC (France) "Equipe labelisee Ligue Nationale Contre le Cancer"; INCA(Institut National du Cancer (INCA) France); ANR(French National Research Agency (ANR)); LABEX Who am I? grants; Poste d'accueil AP-HP-CNRS/CEA; Interuniversity Attraction Pole Programme (Belgian Science Policy (BELSPO)); D.G. Higher Education and Scientific Research of the French Community of Belgium; Alphonse and Jean Forton Fund; Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS)	Core fundings came from INSERM, CNRS, grants from Ligue Nationale Contre le Cancer LNCC (France) "Equipe labelisee Ligue Nationale Contre le Cancer" (CP), INCA, ANR and LABEX Who am I? grants (CP). PAJ was a recipient of Poste d'accueil AP-HP-CNRS/CEA. This work was also supported by the Interuniversity Attraction Pole Programme (Belgian Science Policy (BELSPO), grant PVII-47; http://www.belspo.be/) (FL), the D.G. Higher Education and Scientific Research of the French Community of Belgium (grant 10/15-029) (FL), the Alphonse and Jean Forton Fund (grant 2011-R10150-004; http://www.kbs.frb.be/fund.aspxid=293586&langtype=2060) (FL), and the Fonds de la Recherche Scientifique Medicale (grant 3.4536.10F; http://www.fnrs.be/) (FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Clotman F, 2002, DEVELOPMENT, V129, P1819; Coffinier C, 2002, DEVELOPMENT, V129, P1829; Coulouarn C, 2006, HEPATOLOGY, V44, P1003, DOI 10.1002/hep.21293; Coulouarn C, 2012, CARCINOGENESIS, V33, P1791, DOI 10.1093/carcin/bgs208; Emerick KM, 1999, HEPATOLOGY, V29, P822, DOI 10.1002/hep.510290331; Fu D, 2010, J CELL SCI, V123, P3294, DOI 10.1242/jcs.068098; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Geisler F, 2015, HEPATOLOGY, V61, P382, DOI 10.1002/hep.27268; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Kodama Y, 2004, GASTROENTEROLOGY, V127, P1775, DOI 10.1053/j.gastro.2004.09.004; Lahmar M, 2008, STEM CELLS, V26, P621, DOI 10.1634/stemcells.2007-0428; Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lo B, 2012, J CELL BIOL, V199, P1117, DOI 10.1083/jcb.201208080; Loomes KM, 2007, HEPATOLOGY, V45, P323, DOI 10.1002/hep.21460; Lozier J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001851; McCright B, 2002, DEVELOPMENT, V129, P1075; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Mirouse V, 2011, FEBS LETT, V585, P981, DOI 10.1016/j.febslet.2010.12.025; Noah TK, 2013, ANNU REV PHYSIOL, V75, P263, DOI 10.1146/annurev-physiol-030212-183741; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259; Pajvani UB, 2011, NAT MED, V17, P961, DOI 10.1038/nm.2378; Patel K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5535; Raynaud P, 2011, HEPATOLOGY, V53, P1959, DOI 10.1002/hep.24292; Raynaud P, 2011, INT J BIOCHEM CELL B, V43, P245, DOI 10.1016/j.biocel.2009.07.020; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sebbagh M, 2009, CURR BIOL, V19, P37, DOI 10.1016/j.cub.2008.11.033; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shorning BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004264; Sparks EE, 2010, HEPATOLOGY, V51, P1391, DOI 10.1002/hep.23431; Takashima Y, 2015, HEPATOLOGY, V61, P1003, DOI 10.1002/hep.27436; Woods A, 2011, BIOCHEM J, V434, P49, DOI 10.1042/BJ20101721; Xiao SY, 2001, AM J PATHOL, V159, P1415, DOI 10.1016/S0002-9440(10)62528-X; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	47	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145400	10.1371/journal.pone.0145400	http://dx.doi.org/10.1371/journal.pone.0145400			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689699	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300070
J	McCabe, KL; Kunzevitzky, NJ; Chiswell, BP; Xia, X; Goldberg, JL; Lanza, R				McCabe, Kathryn L.; Kunzevitzky, Noelia J.; Chiswell, Brian P.; Xia, Xin; Goldberg, Jeffrey L.; Lanza, Robert			Efficient Generation of Human Embryonic Stem Cell-Derived Corneal Endothelial Cells by Directed Differentiation	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; IN-VITRO; SURFACE MARKERS; GENE-EXPRESSION; OCULAR SURFACE; NEURAL CREST; TRANSPLANTATION; FATE; PLURIPOTENT; PHENOTYPE	Aim To generate human embryonic stem cell derived corneal endothelial cells (hESC-CECs) for transplantation in patients with corneal endothelial dystrophies. Materials and Methods Feeder-free hESC-CECs were generated by a directed differentiation protocol. hESC-CECs were characterized by morphology, expression of corneal endothelial markers, and microarray analysis of gene expression. Results hESC-CECs were nearly identical morphologically to primary human corneal endothelial cells, expressed Zona Occludens 1 (ZO-1) and Na+/K+ ATPase alpha 1 (ATPA1) on the apical surface in monolayer culture, and produced the key proteins of Descemet's membrane, Collagen VIII alpha 1 and VIII alpha 2 (COL8A1 and 8A2). Quantitative PCR analysis revealed expression of all corneal endothelial pump transcripts. hESC-CECs were 96% similar to primary human adult CECs by microarray analysis. Conclusion hESC-CECs are morphologically similar, express corneal endothelial cell markers and express a nearly identical complement of genes compared to human adult corneal endothelial cells. hESC-CECs may be a suitable alternative to donor-derived corneal endothelium.	[McCabe, Kathryn L.; Chiswell, Brian P.; Lanza, Robert] Ocata Therapeut, Marlborough, MA 01752 USA; [Kunzevitzky, Noelia J.; Goldberg, Jeffrey L.] Univ Miami, Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Kunzevitzky, Noelia J.] Emmecell, Key Biscayne, FL 33149 USA; [Kunzevitzky, Noelia J.; Xia, Xin; Goldberg, Jeffrey L.] Univ Calif San Diego, Shiley Eye Inst, La Jolla, CA 92093 USA; [Goldberg, Jeffrey L.] Stanford Univ, Sch Med, Byers Eye Inst, Palo Alto, CA 94303 USA	Bascom Palmer Eye Institute; University of Miami; University of California System; University of California San Diego; Stanford University	Lanza, R (corresponding author), Ocata Therapeut, Marlborough, MA 01752 USA.	rlanza@ocata.com		Kunzevitzky, Noelia/0000-0002-8993-6520; Goldberg, Jeffrey/0000-0002-1390-7360; Lanza, Robert/0000-0002-3047-3074	Ocata Therapeutics	Ocata Therapeutics	The study was funded by Ocata Therapeutics and associated collaborators (listed as authors). All had a role in the above. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bartakova Alena, 2014, Curr Ophthalmol Rep, V2, P81; Busin M, 2014, CURR OPIN OPHTHALMOL, V25, P312, DOI 10.1097/ICU.0000000000000071; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cheong YK, 2013, INVEST OPHTH VIS SCI, V54, P4538, DOI 10.1167/iovs.13-11754; Chng ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067546; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; CONSIGLI SA, 1993, INVEST OPHTH VIS SCI, V34, P559; Doane KJ, 1998, INVEST OPHTH VIS SCI, V39, P263; Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626; Feizi S, 2014, EXP EYE RES, V122, P132, DOI 10.1016/j.exer.2014.04.002; Figueira EC, 2007, INVEST OPHTH VIS SCI, V48, P144, DOI 10.1167/iovs.06-0346; Gage PJ, 2005, INVEST OPHTH VIS SCI, V46, P4200, DOI 10.1167/iovs.05-0691; GOSPODAROWICZ D, 1979, P NATL ACAD SCI USA, V76, P464, DOI 10.1073/pnas.76.1.464; Gottsch JD, 2003, ARCH OPHTHALMOL-CHIC, V121, P252; Greenhill NS, 2000, MATRIX BIOL, V19, P19, DOI 10.1016/S0945-053X(99)00053-0; Grossniklaus HE, 2012, INVESTIG OPHTHALMOL, V54; GrushkinLerner LS, 1997, EXP EYE RES, V64, P323, DOI 10.1006/exer.1996.0207; Hamann S, 1998, AM J PHYSIOL-CELL PH, V274, pC1332, DOI 10.1152/ajpcell.1998.274.5.C1332; Hara S, 2014, STEM CELLS DEV, V23, P2190, DOI 10.1089/scd.2013.0387; Hirata-Tominaga K, 2013, STEM CELLS, V31, P1396, DOI 10.1002/stem.1390; Huang L, 2010, INVEST OPHTH VIS SCI, V51, P3943, DOI 10.1167/iovs.09-4970; Inagaki E, 2013, INVEST OPHTH VIS SCI, V54, P7258, DOI 10.1167/iovs.13-12022; JUMBLATT MM, 1978, INVEST OPHTH VIS SCI, V17, P1135; Kim E, 2014, INVEST OPHTH VIS SCI, V55, P5099, DOI 10.1167/iovs.14-14564; Klimanskaya I, 2007, NAT PROTOC, V2, P1963, DOI 10.1038/nprot.2007.274; Koizumi N, 2008, CORNEA, V27, pS48, DOI 10.1097/ICO.0b013e31817f2298; Larsson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031573; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljubimov AV, 1996, INVEST OPHTH VIS SCI, V37, P997; LOVICU FJ, 1993, INVEST OPHTH VIS SCI, V34, P3355; Lwigale PY, 2009, DEV BIOL, V336, P257, DOI 10.1016/j.ydbio.2009.10.008; Masur SK, 1999, INVEST OPHTH VIS SCI, V40, P904; McCabe KL, 2014, PRINCIPLES OF TISSUE ENGINEERING, 4TH EDITION, P1413, DOI 10.1016/B978-0-12-398358-9.00067-7; Mohan R, 1995, CURR EYE RES, V14, P1135, DOI 10.3109/02713689508995820; Moysidis SN, 2015, NANOMED-NANOTECHNOL, V11, P499, DOI 10.1016/j.nano.2014.12.002; Mukhopadhyay M, 2006, DEVELOPMENT, V133, P2149, DOI 10.1242/dev.02381; Nakahara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069009; Narsinh KH, 2011, MOL THER, V19, P635, DOI 10.1038/mt.2011.41; Neumann LC, 2012, HUM MOL GENET, V21, P4038, DOI 10.1093/hmg/dds228; Nguyen TT, 2012, INVEST OPHTH VIS SCI, V53, P2020, DOI 10.1167/iovs.12-9475; Numata R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088169; Okumura N, 2014, INVEST OPHTH VIS SCI, V55, P7610, DOI 10.1167/iovs.14-14980; Okumura N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058000, 10.1371/journal.pone.0075961]; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Piao JH, 2015, CELL STEM CELL, V16, P198, DOI 10.1016/j.stem.2015.01.004; Qin P, 1997, DEV DYNAM, V209, P367, DOI 10.1002/(SICI)1097-0177(199708)209:4<367::AID-AJA4>3.0.CO;2-G; Reh TA, 2010, METHODS MOL BIOL, V636, P139, DOI 10.1007/978-1-60761-691-7_9; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Sha XY, 2013, EXP EYE RES, V116, P36, DOI 10.1016/j.exer.2013.08.008; Simoes-Costa M, 2013, GENOME RES, V23, P1069, DOI 10.1101/gr.157586.113; Song WK, 2015, STEM CELL REPORTS, P4; SPEEDWELL L, 1988, ARCH OPHTHALMOL-CHIC, V106, P771; Stephan S, 2004, J BIOL CHEM, V279, P21469, DOI 10.1074/jbc.M305805200; Sugino IK, 2011, INVEST OPHTH VIS SCI, V52, P1345, DOI 10.1167/iovs.10-6112; Sun TT, 2004, J INVEST DERM SYMP P, V9, P202, DOI 10.1111/j.1087-0024.2004.09311.x; Sun XC, 2001, CURR EYE RES, V22, P1; Sun XC, 2008, INVEST OPHTH VIS SCI, V49, P1048, DOI 10.1167/iovs.07-1188; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Umeda K, 2015, STEM CELL REP, V4, P712, DOI 10.1016/j.stemcr.2015.02.012; Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434; Wallace DF, 2010, AM J PHYSIOL-CELL PH, V298, pC75, DOI 10.1152/ajpcell.00621.2008; Woodward MA, 2013, CORNEA, V32, P737, DOI 10.1097/ICO.0b013e3182685cb2; World Health Organization, 2010, GLOB DAT VIS IMP 201; Yoshihara M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117581; Zhang K, 2014, STEM CELLS DEV, V23, P1340, DOI 10.1089/scd.2013.0510; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814; Zhu YT, 2008, INVEST OPHTH VIS SCI, V49, P3879, DOI 10.1167/iovs.08-1693; Zhu YT, 2014, J CELL BIOL, V206, P799, DOI 10.1083/jcb.201404032; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	72	56	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145266	10.1371/journal.pone.0145266	http://dx.doi.org/10.1371/journal.pone.0145266			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689688	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300050
J	Wiberg, R; Jonsson, S; Novikova, LN; Kingham, PJ				Wiberg, Rebecca; Jonsson, Samuel; Novikova, Liudmila N.; Kingham, Paul J.			Investigation of the Expression of Myogenic Transcription Factors, microRNAs and Muscle-Specific E3 Ubiquitin Ligases in the Medial Gastrocnemius and Soleus Muscles following Peripheral Nerve Injury	PLOS ONE			English	Article							POOR FUNCTIONAL RECOVERY; CHAIN ISOFORM EXPRESSION; ADULT SKELETAL-MUSCLE; SWI/SNF ATPASE BRG1; CONTRIBUTING FACTORS; GENE-EXPRESSION; SATELLITE CELLS; MESSENGER-RNA; MYOD FAMILY; DIFFERENTIATION	Despite surgical innovation, the sensory and motor outcome after a peripheral nerve injury remains incomplete. One contributing factor to the poor outcome is prolonged denervation of the target organ, leading to apoptosis of both mature myofibres and satellite cells with subsequent replacement of the muscle tissue with fibrotic scar and adipose tissue. In this study, we investigated the expression of myogenic transcription factors, muscle specific microRNAs and muscle-specific E3 ubiquitin ligases at several time points following denervation in two different muscles, the gastrocnemius (containing predominantly fast type fibres) and soleus (slow type) muscles, since these molecules may influence the degree of atrophy following denervation. Both muscles exhibited significant atrophy (compared with the contra-lateral sides) at 7 days following either a nerve transection or crush injury. In the crush model, the soleus muscle showed significantly increased muscle weights at days 14 and 28 which was not the case for the gastrocnemius muscle which continued to atrophy. There was a significantly more pronounced up-regulation of MyoD expression in the denervated soleus muscle compared with the gastrocnemius muscle. Conversely, myogenin was more markedly elevated in the gastrocnemius versus soleus muscles. The muscles also showed significantly contrasting transcriptional regulation of the microRNAs miR-1 and miR-206. MuRF1 and Atrogin-1 showed the highest levels of expression in the denervated gastrocnemius muscle. This study provides further insights regarding the intracellular regulatory molecules that generate and maintain distinct patterns of gene expression in different fibre types following peripheral nerve injury.	[Wiberg, Rebecca; Jonsson, Samuel; Novikova, Liudmila N.; Kingham, Paul J.] Umea Univ, Dept Integrat Med Biol, Sect Anat, Umea, Sweden; [Wiberg, Rebecca; Jonsson, Samuel] Umea Univ, Dept Surg & Perioperat Sci, Sect Hand & Plast Surg, Umea, Sweden	Umea University; Umea University	Kingham, PJ (corresponding author), Umea Univ, Dept Integrat Med Biol, Sect Anat, Umea, Sweden.	paul.kingham@umu.se		Kingham, Paul/0000-0003-2596-5936	Swedish Research Council; Umea University/Insamlingsstiftelsen	Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea University/Insamlingsstiftelsen	Funding was from the Swedish Research Council (LN) and Umea University/Insamlingsstiftelsen (LN, PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Borisov AB, 2005, ANAT EMBRYOL, V209, P269, DOI 10.1007/s00429-004-0429-7; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; BUONANNO A, 1992, NUCLEIC ACIDS RES, V20, P539, DOI 10.1093/nar/20.3.539; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Chen DH, 2010, ACTA OTO-LARYNGOL, V130, P1411, DOI 10.3109/00016489.2010.496464; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cohen TJ, 2007, J BIOL CHEM, V282, P33752, DOI 10.1074/jbc.M706268200; Davie JK, 2007, DEV BIOL, V311, P650, DOI 10.1016/j.ydbio.2007.08.014; Egawa T, 2014, AM J PHYSIOL-ENDOC M, V306, pE344, DOI 10.1152/ajpendo.00495.2013; Ekmark M, 2007, J PHYSIOL-LONDON, V584, P637, DOI 10.1113/jphysiol.2007.141457; FU SY, 1995, J NEUROSCI, V15, P3876; FU SY, 1995, J NEUROSCI, V15, P3886; HUGHES SM, 1993, DEVELOPMENT, V118, P1137; Jeng SF, 2009, J NEUROTRAUM, V26, P2345, DOI 10.1089/neu.2009.0960; Jonsson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056484; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Krawiec BJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1555, DOI 10.1152/ajpendo.00622.2006; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krichevsky Anna M, 2007, ScientificWorldJournal, V7, P155; Kukreti H, 2013, J BIOL CHEM, V288, P6663, DOI 10.1074/jbc.M112.390369; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Maves L, 2007, DEVELOPMENT, V134, P3371, DOI 10.1242/dev.003905; Megeney LA, 1995, BIOCHEM CELL BIOL, V73, P723, DOI 10.1139/o95-080; MERLIE JP, 1994, J BIOL CHEM, V269, P2461; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Nystrom GJ, 2008, INT J CLIN EXP MED, V1, P50; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Ohkawa Y, 2007, J BIOL CHEM, V282, P6564, DOI 10.1074/jbc.M608898200; Park KHJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3906; Perry RLS, 2000, FRONT BIOSCI, V5, pD750, DOI 10.2741/Perry; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Senf SM, 2010, AM J PHYSIOL-CELL PH, V298, pC38, DOI 10.1152/ajpcell.00315.2009; Soares RJ, 2014, J BIOL CHEM, V289, P21909, DOI 10.1074/jbc.M114.561845; SUGIURA T, 1993, INT J BIOCHEM, V25, P1609, DOI 10.1016/0020-711X(93)90519-K; Talmadge RJ, 2000, MUSCLE NERVE, V23, P661, DOI 10.1002/(SICI)1097-4598(200005)23:5<661::AID-MUS3>3.0.CO;2-J; Tang HB, 2006, P NATL ACAD SCI USA, V103, P16977, DOI 10.1073/pnas.0601565103; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046	48	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0142699	10.1371/journal.pone.0142699	http://dx.doi.org/10.1371/journal.pone.0142699			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691660	gold, Green Submitted, Green Published			2022-12-27	WOS:000367092300002
J	Yang, ZH; Augustin, J; Hu, J; Jiang, H				Yang, Zhenhua; Augustin, Jonathan; Hu, Jing; Jiang, Hao			Physical Interactions and Functional Coordination between the Core Subunits of Set1/MII Complexes and the Reprogramming Factors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN SOMATIC-CELLS; C-MYC; BINDING PROTEIN; METHYLTRANSFERASE ACTIVITY; HUMAN FIBROBLASTS; H3K4 METHYLATION; OPEN CHROMATIN; SELF-RENEWAL; HISTONE H3	Differentiated cells can be reprogrammed to the pluripotent state by overexpression of defined factors, and this process is profoundly influenced by epigenetic mechanisms including dynamic histone modifications. Changes in H3K4 methylation have been shown to be the predominant activating response in the early stage of cellular reprogramming. Mechanisms underlying such epigenetic priming, however, are not well understood. Here we show that the expression of the reprogramming factors (Yamanaka factors, Oct4, Sox2, Klf4 and Myc), especially Myc, directly promotes the expression of certain core subunits of the Set1/MII family of H3K4 methyltransferase complexes. A dynamic recruitment of the Set1/MII complexes largely, though not sufficiently in its own, explains the dynamics of the H3K4 methylation during cellular reprogramming. We then demonstrate that the core subunits of the Set1/MII complexes physically interact with mainly Sox2 and Myc among the Yamanaka factors. We further show that Sox2 directly binds the Ash2l subunit in the Set1/MII complexes and this binding is mediated by the HMG domain of Sox2. Functionally, we show that the Set1/MII complex core subunits are required for efficient cellular reprogramming. We also show that Dpy30, one of the core subunits in the complexes, is required for the efficient target binding of the reprogramming factors. Interestingly, such requirement is not necessarily dependent on locus-specific H3K4 methylation. Our work provides a better understanding of how the reprogramming factors physically interact and functionally coordinate with a key group of epigenetic modulators to mediate transitions of the chromatin state involved in cellular reprogramming.	[Jiang, Hao] Univ Alabama Birmingham, Med Sch Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Med Sch Birmingham, UAB Stem Cell Inst, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Jiang, H (corresponding author), Univ Alabama Birmingham, Med Sch Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	haojiang@uab.edu		Augustin, Jonathan/0000-0002-3302-4426	University of Alabama at Birmingham Start-up fund	University of Alabama at Birmingham Start-up fund	This work was supported by the University of Alabama at Birmingham Start-up fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Barrero MJ, 2010, CELL STEM CELL, V7, P565, DOI 10.1016/j.stem.2010.10.009; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bledau AS, 2014, DEVELOPMENT, V141, P1022, DOI 10.1242/dev.098152; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hussein SMI, 2014, NATURE, V516, P198, DOI 10.1038/nature14046; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007839; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sindhu C, 2012, J BIOL CHEM, V287, P30922, DOI 10.1074/jbc.R111.319046; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Ullius A, 2014, NUCLEIC ACIDS RES, V42, P6901, DOI 10.1093/nar/gku312; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wan M, 2013, J BIOL CHEM, V288, P5039, DOI 10.1074/jbc.M112.424515; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xu YY, 2013, J BIOL CHEM, V288, P9767, DOI 10.1074/jbc.M112.403881; Yang ZH, 2014, BLOOD, V124, P2025, DOI 10.1182/blood-2014-01-549220; Zhang Z, 2011, STEM CELLS, V29, P229, DOI 10.1002/stem.578; Zhao W, 2013, CELL, V152, P1037, DOI 10.1016/j.cell.2013.02.006; Zuryn S, 2014, SCIENCE, V345, P826, DOI 10.1126/science.1255885	63	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145336	10.1371/journal.pone.0145336	http://dx.doi.org/10.1371/journal.pone.0145336			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691508	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300060
J	Youkee, D; Brown, CS; Lilburn, P; Shetty, N; Brooks, T; Simpson, A; Bentley, N; Lado, M; Kamara, TB; Walker, NF; Johnson, O				Youkee, Daniel; Brown, Colin S.; Lilburn, Paul; Shetty, Nandini; Brooks, Tim; Simpson, Andrew; Bentley, Neil; Lado, Marta; Kamara, Thaim B.; Walker, Naomi F.; Johnson, Oliver			Assessment of Environmental Contamination and Environmental Decontamination Practices within an Ebola Holding Unit, Freetown, Sierra Leone	PLOS ONE			English	Article							TRANSMISSION; FILOVIRUSES; FLUIDS; FEVER; RISK	Evidence to inform decontamination practices at Ebola holding units (EHUs) and treatment centres is lacking. We conducted an audit of decontamination procedures inside Connaught Hospital EHU in Freetown, Sierra Leone, by assessing environmental swab specimens for evidence of contamination with Ebola virus by RT-PCR. Swabs were collected following discharge of Ebola Virus Disease (EVD) patients before and after routine decontamination. Prior to decontamination, Ebola virus RNA was detected within a limited area at all bedside sites tested, but not at any sites distant to the bedside. Following decontamination, few areas contained detectable Ebola virus RNA. In areas beneath the bed there was evidence of transfer of Ebola virus material during cleaning. Retraining of cleaning staff reduced evidence of environmental contamination after decontamination. Current decontamination procedures appear to be effective in eradicating persistence of viral RNA. This study supports the use of viral swabs to assess Ebola viral contamination within the clinical setting. We recommend that regular refresher training of cleaning staff and audit of environmental contamination become standard practice at all Ebola care facilities during EVD outbreaks.	[Youkee, Daniel; Brown, Colin S.; Lilburn, Paul; Lado, Marta; Walker, Naomi F.; Johnson, Oliver] Kings Coll London, Kings Ctr Global Hlth, Kings Sierra Leone Partnership, London WC2R 2LS, England; [Youkee, Daniel; Brown, Colin S.; Lilburn, Paul; Lado, Marta; Walker, Naomi F.; Johnson, Oliver] Kings Hlth Partners, London, England; [Brown, Colin S.] UCL, Hosp Trop Dis, London, England; [Shetty, Nandini; Brooks, Tim; Simpson, Andrew; Bentley, Neil] Publ Hlth England, Salisbury, Wilts, England; [Kamara, Thaim B.] Connaught Hosp, Freetown, Sierra Leone; [Walker, Naomi F.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England; [Walker, Naomi F.] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa	University of London; King's College London; University of London; King's College London; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University College London; Public Health England; Connaught Hospital; Imperial College London; University of Cape Town	Youkee, D (corresponding author), Kings Coll London, Kings Ctr Global Hlth, Kings Sierra Leone Partnership, London WC2R 2LS, England.	daniel.youkee@kcl.ac.uk	Brown, Colin/AAF-9597-2021	Brown, Colin/0000-0003-4776-3403; Johnson, Oliver/0000-0001-8698-0553; Lilburn, Paul/0000-0001-7449-3854; Youkee, Daniel/0000-0002-2383-4425; Walker, Naomi/0000-0002-3345-7694				[Aip PED Hse WHO], 2014, CLIN MAN PAT VHF POC; Alfson K. J., 2015, J VIROL; Arkell P, QUANTIFYING RISK NOS; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Bibby K, 2015, AM CHEM SOC, V2, P2; Cook BWM, 2015, VIRUSES-BASEL, V7, P1975, DOI 10.3390/v7041975; Fischer R, 2015, EMERG INFECT DIS, V21, P1243, DOI 10.3201/eid2107.150253; FISHERHOCH SP, 1995, BRIT MED J, V311, P857, DOI 10.1136/bmj.311.7009.857; Fitzpatrick G, 2014, DESCRIBING READMISSI, V2014, P1; Francesconi P, 2003, EMERG INFECT DIS, V9, P1430, DOI 10.3201/eid0911.030339; Ftika L, 2013, J HOSP INFECT, V83, P185, DOI 10.1016/j.jhin.2012.10.013; Lado M, 2015, LANCET INFECT DIS, V3099, P1; Paweska JT, 2009, EMERG INFECT DIS, V15, P1598, DOI 10.3201/eid1510.090211; Piercy TJ, 2010, J APPL MICROBIOL, V109, P1531, DOI 10.1111/j.1365-2672.2010.04778.x; Sagripanti JL, 2011, ARCH VIROL, V156, P489, DOI 10.1007/s00705-010-0847-1; Shears P, 2015, J HOSP INFECT, V90, P1, DOI 10.1016/j.jhin.2015.01.002; Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636	17	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145167	10.1371/journal.pone.0145167	http://dx.doi.org/10.1371/journal.pone.0145167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692018	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300044
J	Buijsse, B; Jacobs, DR; Steffen, LM; Kromhout, D; Gross, MD				Buijsse, Brian; Jacobs, David R., Jr.; Steffen, Lyn M.; Kromhout, Daan; Gross, Myron D.			Plasma Ascorbic Acid, A Priori Diet Quality Score, and Incident Hypertension: A Prospective Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ARTERY RISK DEVELOPMENT; BLOOD-PRESSURE; VITAMIN-C; METAANALYSIS; SUPPLEMENTATION; ASSOCIATIONS; STROKE; MORTALITY; CARDIA	Vitamin C may reduce risk of hypertension, either in itself or by marking a healthy diet pattern. We assessed whether plasma ascorbic acid and the a priori diet quality score relate to incident hypertension and whether they explain each other's predictive abilities. Data were from 2884 black and white adults (43% black, mean age 35 years) initially hypertensionfree in the Coronary Artery Risk Development in Young Adults Study (study year 10, 19951996). Plasma ascorbic acid was assessed at year 10 and the diet quality score at year 7. Eight-hundred-and-forty cases of hypertension were documented between years 10 and 25. After multiple adjustments, each 12-point (1 SD) higher diet quality score at year 7 related to mean 3.7 mu mol/L (95% CI 2.9 to 4.6) higher plasma ascorbic acid at year 10. In separate multiple-adjusted Cox regression models, the hazard ratio of hypertension per 19.6- mu mol/L (1 SD) higher ascorbic acid was 0.85 (95% CI 0.79-0.92) and per 12-points higher diet score 0.86 (95% CI 0.79-0.94). These hazard ratios changed little with mutual adjustment of ascorbic acid and diet quality score for each other, or when adjusted for anthropometric variables, diabetes, and systolic blood pressure at year 10. Intake of dietary vitamin C and several food groups high in vitamin C content were inversely related to hypertension, whereas supplemental vitamin C was not. In conclusion, plasma ascorbic acid and the a priori diet quality score independently predict hypertension. This suggests that hypertension risk is reduced by improving overall diet quality and/or vitamin C status. The inverse association seen for dietary but not for supplemental vitamin C suggests that vitamin C status is preferably improved by eating foods rich in vitamin C, in addition to not smoking and other dietary habits that prevent ascorbic acid from depletion.	[Buijsse, Brian; Jacobs, David R., Jr.; Steffen, Lyn M.; Kromhout, Daan] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Buijsse, Brian] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Kromhout, Daan] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Gross, Myron D.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Wageningen University & Research; University of Minnesota System; University of Minnesota Twin Cities	Jacobs, DR (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	jacob004@umn.edu		Jacobs, David/0000-0002-7232-0543; Steffen, Lyn M/0000-0002-4053-6729	National Heart, Lung, and Blood Institute [HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, HHSN268200900041C]; Intramural Research Program of the National Institute on Aging; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053560] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Coronary Artery Risk Development in Young Adults Study (CARDIA) is supported by contracts HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, and HHSN268200900041C from the National Heart, Lung, and Blood Institute and the Intramural Research Program of the National Institute on Aging. Ascorbic acid was assessed as part of an ancillary study to CARDIA called Young Adult Longitudinal Trends in Antioxidants (YALTA), R01 HL 053560 (DRJ and MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrogue HJ, 2007, NEW ENGL J MED, V356, P1966, DOI 10.1056/NEJMra064486; Bach-Faig A, 2006, PUBLIC HEALTH NUTR, V9, P1110, DOI 10.1017/S1368980007668499; Block G, 2001, AM J EPIDEMIOL, V154, P1113, DOI 10.1093/aje/154.12.1113; Block G, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-35; Conlin PR, 2000, AM J HYPERTENS, V13, P949, DOI 10.1016/S0895-7061(99)00284-8; d'Uscio LV, 2003, CIRC RES, V92, P88, DOI 10.1161/01.RES.0000049166.33035.62; Dinh QN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/406960; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; GALE CR, 1995, BRIT MED J, V310, P1563, DOI 10.1136/bmj.310.6994.1563; Genuth S, 2003, DIABETES CARE, V26, P3160; GEY KF, 1993, CLIN INVESTIGATOR, V71, P3, DOI 10.1007/BF00210955; Hertog MGL, 1997, LANCET, V349, P699, DOI 10.1016/S0140-6736(05)60135-3; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Jee SH, 2002, AM J HYPERTENS, V15, P691, DOI 10.1016/S0895-7061(02)02964-3; Juraschek SP, 2012, AM J CLIN NUTR, V95, P1079, DOI 10.3945/ajcn.111.027995; Khaw KT, 2001, LANCET, V357, P657, DOI 10.1016/S0140-6736(00)04128-3; Larsson SC, 2011, STROKE, V42, P2746, DOI 10.1161/STROKEAHA.111.622142; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MCDONALD A, 1991, J AM DIET ASSOC, V91, P1104; Myung SK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f10; Ness AR, 1999, PUBLIC HEALTH NUTR, V2, P51, DOI 10.1017/S1368980099000063; Pereira MA, 2004, ARCH INTERN MED, V164, P370, DOI 10.1001/archinte.164.4.370; Pfister R, 2011, AM HEART J, V162, P246, DOI 10.1016/j.ahj.2011.05.007; Royston P., 2008, MULTIVARIABLE MODEL; Sijtsma FPC, 2012, AM J CLIN NUTR, V95, P580, DOI 10.3945/ajcn.111.020719; Steffen LM, 2005, AM J CLIN NUTR, V82, P1169, DOI 10.1093/ajcn/82.6.1169; Steinberg D, 2002, CIRCULATION, V105, P2107, DOI 10.1161/01.CIR.0000014762.06201.06; Streppel MT, 2005, ARCH INTERN MED, V165, P150, DOI 10.1001/archinte.165.2.150; van Mierlo LAJ, 2006, J HUM HYPERTENS, V20, P571, DOI 10.1038/sj.jhh.1002038; Wannamethee SG, 2013, CIRC-HEART FAIL, V6, P647, DOI 10.1161/CIRCHEARTFAILURE.112.000281; Wannamethee SG, 2006, AM J CLIN NUTR, V83, P567, DOI 10.1093/ajcn.83.3.567; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424	32	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144920	10.1371/journal.pone.0144920	http://dx.doi.org/10.1371/journal.pone.0144920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683190	Green Published, gold			2022-12-27	WOS:000366725800024
J	Dave, KK; Punekar, NS				Dave, Khyati K.; Punekar, Narayan S.			Expression of Lactate Dehydrogenase in Aspergillus niger for L-Lactic Acid Production	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; EFFICIENT PRODUCTION; RENEWABLE MATERIALS; ENGINEERED YEASTS; GENE; RHIZOPUS; FERMENTATION; ENZYME; CITRATE; GENOME	Different engineered organisms have been used to produce L-lactate. Poor yields of lactate at low pH and expensive downstream processing remain as bottlenecks. Aspergillus niger is a prolific citrate producer and a remarkably acid tolerant fungus. Neither a functional lactate dehydrogenase (LDH) from nor lactate production by A. niger is reported. Its genome was also investigated for the presence of a functional ldh. The endogenous A. niger citrate synthase promoter relevant to A. niger acidogenic metabolism was employed to drive constitutive expression of mouse lactate dehydrogenase (mldhA). An appraisal of different branches of the A. niger pyruvate node guided the choice of mldhA for heterologous expression. A high copy number transformant C12 strain, displaying highest LDH specific activity, was analyzed under different growth conditions. The C12 strain produced 7.7 g/l of extracellular L-lactate from 60 g/l of glucose, in non-neutralizing minimal media. Significantly, lactate and citrate accumulated under two different growth conditions. Already an established acidogenic platform, A. niger now promises to be a valuable host for lactate production.	[Dave, Khyati K.; Punekar, Narayan S.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Punekar, NS (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	nsp@iitb.ac.in			Council of Scientific and Industrial Research (CSIR) research fellowship	Council of Scientific and Industrial Research (CSIR) research fellowship	Khyati Dave received Council of Scientific and Industrial Research (CSIR) research fellowship.	Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; Andersen MR, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.12; Bianchi MM, 2001, APPL ENVIRON MICROB, V67, P5621, DOI 10.1128/AEM.67.12.5621-5625.2001; Blumhoff ML, 2013, METAB ENG, V19, P26, DOI 10.1016/j.ymben.2013.05.003; Branduardi P, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-4; CLARKE AR, 1988, BIOCHEMISTRY-US, V27, P1617, DOI 10.1021/bi00405a034; Dave K, 2011, J BIOTECHNOL, V155, P173, DOI 10.1016/j.jbiotec.2011.06.012; FEIR HA, 1969, CAN J BIOCHEM CELL B, V47, P697, DOI 10.1139/o69-107; Flipphi M, 2009, FUNGAL GENET BIOL, V46, pS19, DOI 10.1016/j.fgb.2008.07.018; HAWTREY CO, 1970, J EXP ZOOL, V174, P451, DOI 10.1002/jez.1401740408; Hynes MJ, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P312; Ikushima S, 2009, BIOSCI BIOTECH BIOCH, V73, P1818, DOI 10.1271/bbb.90186; Ilmen M, 2007, APPL ENVIRON MICROB, V73, P117, DOI 10.1128/AEM.01311-06; Ilmen M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-53; Ishida N, 2005, APPL ENVIRON MICROB, V71, P1964, DOI 10.1128/AEM.71.4.1964-1970.2005; Ishida N, 2006, BIOSCI BIOTECH BIOCH, V70, P1148, DOI 10.1271/bbb.70.1148; Jernejc K, 2002, FEMS MICROBIOL LETT, V217, P185, DOI 10.1111/j.1574-6968.2002.tb11473.x; Kobayashi K, 2014, J IND MICROBIOL BIOT, V41, P749, DOI 10.1007/s10295-014-1419-2; Kumar S, 2015, APPL ENV MICROBIOL, V81; LEGISA M, 1989, APPL MICROBIOL BIOT, V31, P453, DOI 10.1007/BF00270775; Li A, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-57; Li A, 2011, FUNGAL GENET BIOL, V48, P602, DOI 10.1016/j.fgb.2011.01.013; Liaud N, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0249-x; Magnuson J.K., 2004, ADV FUNGAL BIOTECHNO, P307, DOI DOI 10.1007/978-1-4419-8859-1_12; Meijer S, 2009, METAB ENG, V11, P107, DOI 10.1016/j.ymben.2008.12.002; MEIXNERMONORI B, 1984, CAN J MICROBIOL, V30, P16, DOI 10.1139/m84-003; Noor S, 2005, MICROBIOL-SGM, V151, P1409, DOI 10.1099/mic.0.27751-0; Okano K, 2010, APPL MICROBIOL BIOT, V85, P413, DOI 10.1007/s00253-009-2280-5; Ookubo A, 2008, BIOSCI BIOTECH BIOCH, V72, P3063, DOI 10.1271/bbb.80493; Pacheco A, 2012, FEMS YEAST RES, V12, P375, DOI 10.1111/j.1567-1364.2012.00790.x; Papagianni M, 2007, BIOTECHNOL ADV, V25, P244, DOI 10.1016/j.biotechadv.2007.01.002; PETRARULO M, 1995, CLIN CHEM, V41, P1518; Porro D, 1999, APPL ENVIRON MICROB, V65, P4211; Punekar NS, 2009, India patent, Patent No. [2542/MUM/2009, 2542MUM2009]; Ruijter GJG, 1996, J MICROBIOL METH, V25, P295, DOI 10.1016/0167-7012(95)00104-2; Saitoh S, 2005, APPL ENVIRON MICROB, V71, P2789, DOI 10.1128/AEM.71.5.2789-2792.2005; Sambrook J., 2001, MOL CLONING LAB MANU; Skory CD, 2003, J IND MICROBIOL BIOT, V30, P22, DOI 10.1007/s10295-002-0004-2; Skory CD, 2007, CURR GENET, V52, P23, DOI 10.1007/s00294-007-0135-0; Skory CD, 2010, ENZYME MICROB TECH, V46, P43, DOI 10.1016/j.enzmictec.2009.08.014; Skulj M, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-6; SOCCOL CR, 1994, WORLD J MICROB BIOT, V10, P433, DOI 10.1007/BF00144467; Terabayashi Y, 2012, APPL MICROBIOL BIOT, V93, P305, DOI 10.1007/s00253-011-3767-4; Tokuhiro K, 2009, APPL MICROBIOL BIOT, V82, P883, DOI 10.1007/s00253-008-1831-5; van der Straat L, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-11; Wakai S, 2014, BIORESOURCE TECHNOL, V173, P376, DOI 10.1016/j.biortech.2014.09.094; Wang Y, 2015, J BIOSCI BIOENG, V119, P10, DOI 10.1016/j.jbiosc.2014.06.003; Zhang ZY, 2007, BIOCHEM ENG J, V35, P251, DOI 10.1016/j.bej.2007.01.028	48	19	19	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145459	10.1371/journal.pone.0145459	http://dx.doi.org/10.1371/journal.pone.0145459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683313	gold, Green Submitted, Green Published			2022-12-27	WOS:000366725800079
J	Jin, XC; Steinbach, JH				Jin, Xiaochun; Steinbach, Joe Henry			Potentiation of Neuronal Nicotinic Receptors by 17 beta-Estradiol: Roles of the Carboxy-Terminal and the Amino-Terminal Extracellular Domains	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTORS; ALPHA-4-BETA-2 RECEPTOR; NERVOUS-SYSTEM; BINDING; PROTEINS; SUBTYPES; SUBUNIT; REGIONS; SITE	The endogenous steroid 17 beta-estradiol (beta EST) potentiates activation of neuronal nicotinic receptors containing alpha 4 subunits. Previous work has shown that the final 4 residues of the alpha 4 subunit are required for potentiation. However, receptors containing the alpha 2 subunit are not potentiated although it has these 4 residues, and only one amino acid difference in the C-terminal tail (FLAGMI vs. WLAGMI). Previous work had indicated that the tryptophan residue was involved in binding an analog of beta EST, but not in potentiation by beta EST. To determine the structural basis for the loss of potentiation we analyzed data from chimeric subunits, which indicated that the major factor underlying the difference between alpha 2 and alpha 4 is the tryptophan/phenylalanine difference, while the N-terminal extracellular domain is a less significant factor. When the tryptophan in alpha 4 was mutated, both phenylalanine and tyrosine conferred lower potentiation while lysine and leucine did not. The reduction reflected a reduced maximal magnitude of potentiation, indicating that the tryptophan is involved in transduction of steroid effects. The regions of the alpha 4 N-terminal extracellular domain involved in potentiation lie near the agonist-binding pocket, rather than close to the membrane or the C-terminal tail, and appear to be involved in transduction rather than binding. These observations indicate that the C-terminal region is involved in both steroid binding (AGMI residues) and transduction (W). The role of the N-terminus appears to be independent of the C-terminal tryptophan and likely reflects an influence on conformational changes caused during channel activation by agonist and potentiation by estradiol.	[Jin, Xiaochun; Steinbach, Joe Henry] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Steinbach, Joe Henry] Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Steinbach, JH (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	jhs@morpheus.wustl.edu			National Institute of Neurological Disorders and Stroke [NS22356]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022356] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke grant NS22356 (JHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGOS P, 1987, J MOL BIOL, V193, P385, DOI 10.1016/0022-2836(87)90226-9; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; Curtis L, 2002, MOL PHARMACOL, V61, P127, DOI 10.1124/mol.61.1.127; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dash B, 2014, NEUROPHARMACOLOGY, V79, P715, DOI 10.1016/j.neuropharm.2014.01.021; Dash B, 2012, J NEUROCHEM, V121, P349, DOI 10.1111/j.1471-4159.2012.07685.x; Dayhoff MO, 1983, SEQUENCE DETERMINATI; Di Resta C, 2010, EUR J PHARMACOL, V643, P13, DOI 10.1016/j.ejphar.2010.05.063; Dwyer Donard S, 2005, BMC Chem Biol, V5, P2, DOI 10.1186/1472-6769-5-2; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Higley MJ, 2014, CURR OPIN NEUROBIOL, V29, P88, DOI 10.1016/j.conb.2014.06.004; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Jin XC, 2014, MOL PHARMACOL, V85, P11, DOI 10.1124/mol.113.089979; Jin XC, 2011, J NEUROSCI, V31, P5045, DOI 10.1523/JNEUROSCI.4802-10.2011; Jin XC, 2009, J PHYSIOL-LONDON, V587, P981, DOI 10.1113/jphysiol.2008.159343; Ke L, 1996, J NEUROCHEM, V67, P1100; Khiroug SS, 2004, NEUROSCIENCE, V124, P817, DOI 10.1016/j.neuroscience.2004.01.017; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Ley CKK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103244; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Paradiso K, 2000, MOL PHARMACOL, V58, P341, DOI 10.1124/mol.58.2.341; Paradiso K, 2001, J NEUROSCI, V21, P6561, DOI 10.1523/JNEUROSCI.21-17-06561.2001; PERSSON B, 1994, J MOL BIOL, V237, P182, DOI 10.1006/jmbi.1994.1220; Picciotto MR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012112; Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; Wang J, 2015, NEUROPHARMACOLOGY, V96, P194, DOI 10.1016/j.neuropharm.2014.10.009; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144631	10.1371/journal.pone.0144631	http://dx.doi.org/10.1371/journal.pone.0144631			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684647	gold, Green Submitted, Green Published			2022-12-27	WOS:000366725800016
J	Khan, MAH; Sharma, A; Rarick, KR; Roman, RJ; Harder, DR; Imig, JD				Khan, Md Abdul Hye; Sharma, Amit; Rarick, Kevin R.; Roman, Richard J.; Harder, David R.; Imig, John D.			Elevated Aminopeptidase P Attenuates Cerebral Arterial Responses to Bradykinin in Fawn-Hooded Hypertensive Rats	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; MYOGENIC RESPONSE; PHOSPHORYLATION; IDENTIFICATION; DEGRADATION; INHIBITION; PROTEIN; AUTOREGULATION; INACTIVATION; DYSFUNCTION	Cerebral arterial myogenic and autoregulatory responses are impaired in Fawn Hooded hypertensive (FHH) rats. Cerebral autoregulatory responses are restored in the congenic rat strain in which a segment of chromosome 1 from the Brown Norway (BN) rat was transferred into the FHH genetic background (FHH. 1BN). The impact of this region on cerebral arterial dilator responses remains unknown. Aminopeptidase is a gene that was transferred into the FHH genetic background to generate the FHH. 1BN rats and is responsible for degradation of the vasodilator bradykinin. Thus, we hypothesized that FHH rats will have increased aminopeptidase P levels with impaired cerebral arterial responses to bradykinin compared to BN and FHH. 1BN rats. We demonstrated higher cerebral arterial expression of aminopeptidase P in FHH compared to BN rats. Accordingly, we demonstrated markedly impaired cerebral arterial dilation to bradykinin in FHH compared to BN rats. Interestingly, aminopeptidase P expression was lower in FHH. 1BN compared to FHH rats. Decreased aminopeptidase P levels in FHH. 1BN rats were associated with increased cerebral arterial bradykinin-induced dilator responses. Aminopeptidase P inhibition by apstatin improved cerebral arterial bradykinin dilator responses in FHH rats to a level similar to FHH. 1BN rats. Unlike bradykinin, cerebral arterial responses to acetylcholine were similar between FHH and FHH. 1BN groups. These findings indicate decreased bradykinin bioavailability contributes to impaired cerebral arterial dilation in FHH rats. Overall, these data indicate an important role of aminopeptidase P in the impaired cerebral arterial function in FHH rat.	[Khan, Md Abdul Hye; Sharma, Amit; Imig, John D.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Rarick, Kevin R.; Harder, David R.; Imig, John D.] Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA; [Roman, Richard J.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Harder, David R.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; University of Mississippi; University of Mississippi Medical Center; Medical College of Wisconsin	Imig, JD (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.	jdimig@mcw.edu	sharma, amit/L-8162-2019	sharma, amit/0000-0002-4492-2248; Imig, John/0000-0002-9668-2899; Khan, Md Abdul Hye/0000-0001-5940-9300	National Heart, Lung, and Blood Institute [R01 HL033833, HL105997]; Veterans Administration Research Career Scientist Award; American Heart Association Midwest Affiliate; Midwest Affiliate of the American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033833, R01HL105997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104184] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Administration Research Career Scientist Award; American Heart Association Midwest Affiliate(American Heart Association); Midwest Affiliate of the American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Heart, Lung, and Blood Institute Grants R01 HL033833 and HL105997 and the Veterans Administration Research Career Scientist Award (DRH), an American Heart Association Midwest Affiliate Grant-in-Aid (JDI), and a postdoctoral fellowship from the Midwest Affiliate of the American Heart Association (Md. AHK) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagate K, 2000, EUR J PHARMACOL, V407, P317, DOI 10.1016/S0014-2999(00)00744-5; BIANCHI G, 1994, P NATL ACAD SCI USA, V91, P3999, DOI 10.1073/pnas.91.9.3999; Burke M, 2013, AM J PHYSIOL-RENAL, V304, pF565, DOI 10.1152/ajprenal.00404.2012; Efendiev R, 2004, CIRC RES, V95, P1100, DOI 10.1161/01.RES.0000149570.20845.89; Ersahin C, 1997, J CARDIOVASC PHARM, V30, P96, DOI 10.1097/00005344-199707000-00014; Fagan SC, 2004, STROKE, V35, P2220, DOI 10.1161/01.STR.0000138023.60272.9e; Fan F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112878; GARDNER K, 1986, J BIOL CHEM, V261, P1339; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; JOSHI R, 1990, J BIOL CHEM, V265, P13130; Kim KS, 2000, J PHARMACOL EXP THER, V292, P295; Kitamura S, 1999, AM J PHYSIOL-HEART C, V276, pH1664, DOI 10.1152/ajpheart.1999.276.5.H1664; KITAMURA S, 1995, BRIT J PHARMACOL, V114, P6, DOI 10.1111/j.1476-5381.1995.tb14897.x; La Corte AIC, 2008, J RENIN-ANGIO-ALDO S, V9, P221, DOI 10.1177/1470320308096405; Lopez B, 2006, AM J PHYSIOL-RENAL, V290, pF1213, DOI 10.1152/ajprenal.00335.2005; Matsuoka Y, 1996, J BIOL CHEM, V271, P25157, DOI 10.1074/jbc.271.41.25157; Murphy TV, 2002, CLIN EXP PHARMACOL P, V29, P612, DOI 10.1046/j.1440-1681.2002.03698.x; Nowak W, 2011, EUR J PHARMACOL, V667, P271, DOI 10.1016/j.ejphar.2011.05.045; Ochodnicky P, 2010, AM J PHYSIOL-RENAL, V298, pF625, DOI 10.1152/ajprenal.00289.2009; Pabbidi MR, 2014, AM J PHYSIOL-HEART C, V306, pH989, DOI 10.1152/ajpheart.00636.2013; Pabbidi MR, 2013, AM J PHYSIOL-HEART C, V304, pH311, DOI 10.1152/ajpheart.00622.2012; Peterson EC, 2011, INT J VASC MED, V2011, DOI 10.1155/2011/823525; Prechel MM, 1995, J PHARMACOL EXP THER, V275, P1136; Rodriguez-Yanez Manuel, 2006, Cerebrovasc Dis, V21 Suppl 2, P21, DOI 10.1159/000091700; RYAN JW, 1994, J PHARMACOL EXP THER, V269, P941; SIMMONS WH, 1992, J BIOL CHEM, V267, P4897; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Tripodi G, 1997, BIOCHEM BIOPH RES CO, V237, P685, DOI 10.1006/bbrc.1997.7173; VANHOUTTE PM, 1989, HYPERTENSION, V13, P658, DOI 10.1161/01.HYP.13.6.658; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Williams JM, 2011, AM J PHYSIOL-RENAL, V300, pF330, DOI 10.1152/ajprenal.00261.2010; YARON A, 1993, CRIT REV BIOCHEM MOL, V28, P31, DOI 10.3109/10409239309082572; Zagato L, 2000, HYPERTENSION, V36, P734, DOI 10.1161/01.HYP.36.5.734	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145335	10.1371/journal.pone.0145335	http://dx.doi.org/10.1371/journal.pone.0145335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683993	Green Submitted, Green Published, gold			2022-12-27	WOS:000366725800066
J	Pereira, BD; Bouillet, LEM; Dorigo, NA; Fraefel, C; Bruna-Romero, O				Pereira, Bruna de Andrade; Maduro Bouillet, Leoneide E.; Dorigo, Natalia A.; Fraefel, Cornel; Bruna-Romero, Oscar			Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice	PLOS ONE			English	Article							T-CELL RESPONSES; NEUTRALIZING ANTIBODIES; PROTECTIVE IMMUNITY; PREEXISTING IMMUNITY; ANTI-AD5 IMMUNITY; GENE-THERAPY; IMMUNOGENICITY; TYPE-5; SEROPREVALENCE; SEROTYPE-35	Recombinant human adenovirus serotype 5 (HAd5V) vectors are gold standards of T-cell immunogenicity as they efficiently induce also humoral responses to exogenous antigens, in particular when used in prime-boost protocols. Some investigators have shown that preexisting immunity to adenoviruses interferes with transduction by adenoviral vectors, but the actual extent of this interference is not known since it has been mostly studied in mice using unnatural routes of infection and virus doses. Here we studied the effects of HAd5V-specific immune responses induced by intranasal infection on the transduction efficiency of recombinant adenovirus vectors. Of interest, when HAd5V immunity was induced in mice by the natural respiratory route, the pre-existing immunity against HAd5V did not significantly interfere with the B and T-cell immune responses against the transgene products induced after a prime/boost inoculation protocol with a recombinant HAd5V-vector, as measured by ELISA and in vivo cytotoxic T-cell assays, respectively. We also correlated the levels of HAd5V-specific neutralizing antibodies (Ad5NAbs) induced in mice with the levels of Ad5NAb titers found in humans. The data indicate that approximately 60% of the human serum samples tested displayed Ad5NAb levels that could be overcome with a prime-boost vaccination protocol. These results suggest that recombinant HAd5V vectors are potentially useful for prime-boost vaccination strategies, at least when pre-existing immunity against HAd5V is at low or medium levels.	[Pereira, Bruna de Andrade; Maduro Bouillet, Leoneide E.; Dorigo, Natalia A.; Bruna-Romero, Oscar] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil; [Pereira, Bruna de Andrade; Fraefel, Cornel] Univ Zurich, Inst Virol, Zurich, Switzerland	Universidade Federal de Minas Gerais; University of Zurich	Pereira, BD (corresponding author), Univ Zurich, Inst Virol, Zurich, Switzerland.	brunap@vetvir.uzh.ch	Bouillet, Leoneide/GRO-4340-2022; BRUNA-ROMERO, OSCAR/B-3918-2010	BRUNA-ROMERO, OSCAR/0000-0002-8855-4969; Fraefel, Cornel/0000-0001-7221-6706	Brazilian agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [482029/2007-2]; CNPq productivity fellowship	Brazilian agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq productivity fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This project was funded by the Brazilian agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq project 482029/2007-2). OBR was also granted with a CNPq productivity fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare to have no competing interests. This project was funded by the Brazilian agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq project 482029/2007-2). OBR was also granted with a CNPq productivity fellowship.	Barbosa RPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061795; Andrade BP de, 2007, INT MICROBIOL, V10, P261; Appaiahgari MB, 2007, CLIN VACCINE IMMUNOL, V14, P1053, DOI 10.1128/CVI.00173-07; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Bruna-Romera O, 2001, P NATL ACAD SCI USA, V98, P11491, DOI 10.1073/pnas.191380898; Caetano BC, 2006, HUM GENE THER, V17, P415, DOI 10.1089/hum.2006.17.415; Chuang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055571; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Curlin ME, 2011, AIDS, V25, P153, DOI 10.1097/QAD.0b013e328342115c; Ersching J, 2010, VIROLOGY, V407, P1, DOI 10.1016/j.virol.2010.07.043; Gabitzsch ES, 2009, VACCINE, V27, P6394, DOI 10.1016/j.vaccine.2009.06.028; Grimaldi G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002853; Guan M, 2008, CANCER GENE THER, V15, P371, DOI 10.1038/cgt.2008.13; Haut LH, 2011, J INFECT DIS, V203, P1073, DOI 10.1093/infdis/jiq161; Holst PJ, 2010, J IMMUNOL, V184, P4431, DOI 10.4049/jimmunol.0900537; Lemckert AAC, 2005, J VIROL, V79, P9694, DOI 10.1128/JVI.79.15.9694-9701.2005; Lemckert AAC, 2006, J GEN VIROL, V87, P2891, DOI 10.1099/vir.0.82079-0; Machado AV, 2006, HUM GENE THER, V17, P898, DOI 10.1089/hum.2006.17.898; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Mendes EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063201; Morse MA, 2013, CANCER IMMUNOL IMMUN, V62, P1293, DOI 10.1007/s00262-013-1400-3; Nanda A, 2005, J VIROL, V79, P14161, DOI 10.1128/JVI.79.22.14161-14168.2005; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Osada T, 2009, CANCER GENE THER, V16, P673, DOI 10.1038/cgt.2009.17; Pandey A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033428; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Resende DM, 2008, VACCINE, V26, P4585, DOI 10.1016/j.vaccine.2008.05.091; Smaill F, 2014, EXPERT REV VACCINES, V13, P927, DOI 10.1586/14760584.2014.929947; Tazawa H, 2013, EXPERT OPIN BIOL TH, V13, P1569, DOI 10.1517/14712598.2013.845662; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; Tian G, 2009, ANTI-CANCER DRUG, V20, P389, DOI 10.1097/CAD.0b013e32832a2df9; Zeng MT, 2007, VACCINE, V25, P7540, DOI 10.1016/j.vaccine.2007.08.035; Zhang SJ, 2013, J MED VIROL, V85, P1077, DOI 10.1002/jmv.23546	34	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145260	10.1371/journal.pone.0145260	http://dx.doi.org/10.1371/journal.pone.0145260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679149	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400065
J	Ying, JM; Lin, C; Wu, J; Guo, L; Qiu, T; Ling, Y; Shan, L; Zhou, HT; Zhao, DB; Wang, J; Liang, JW; Zhao, JJ; Jiao, YC; Lu, N; Zhao, H				Ying, Jianming; Lin, Chen; Wu, Jian; Guo, Lei; Qiu, Tian; Ling, Yun; Shan, Ling; Zhou, Haitao; Zhao, Dongbing; Wang, Jian; Liang, Jianwei; Zhao, Jianjun; Jiao, Yuchen; Lu, Ning; Zhao, Hong			Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population	PLOS ONE			English	Article							CELL LUNG-CANCER; ALK; GENE; CRIZOTINIB; SPECTRIN; EXPRESSION; FUSION; IDENTIFICATION; CHEMOTHERAPY; PROTEINS	Background Anaplastic lymphoma kinase (ALK) rearrangements define a subgroup of lung cancer which is eligible to targeted kinase inhibition. The aim of this study is to observe the incidence rate of ALK fusion in a large cohort of Chinese digestive tract cancer patients. Patients and Methods Tissue microarray (TMA) was constructed from 808 digestive tract cancer cases, including 169 esophageal squamous cell carcinoma, 182 gastric cancer and 457 colorectal cancer (CRC) cases. We tested all cases for ALK expression via a fully automated immunohistochemistry (IHC) assay. The IHC-positive cases were subjected to fluorescence in situ hybridization (FISH), real-time polymerase chain reaction (qRT-PCR), target gene enrichment and sequencing for confirmation of ALK gene rearrangement and discovery of novel fusion partner. Results Among the tested cases, 2 (0.44%) CRC cases showed positive both by IHC and FISH. By qRT-PCR, EML4-ALK fusion was found in one IHC-positive CRC case. In another IHC-positive CRC case, target gene enrichment and sequencing revealed ALK was fused to a novel partner, spectrin beta non-erythrocytic 1 (SPTBN1). One gastric cancer case showed partially positive IHC result, but no fusion was found by FISH and gene sequencing. Conclusions The incidence rate of ALK gene fusion in Chinese CRC patients was 0.44%, but not detectable in gastric and esophageal cancers. The novel SPTBN1-ALK fusion, together with other ALK fusion genes, may become a potential target for anti-ALK therapy.	[Ying, Jianming; Guo, Lei; Qiu, Tian; Ling, Yun; Shan, Ling; Lu, Ning] Chinese Acad Med Sci, Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Lin, Chen; Zhou, Haitao; Zhao, Dongbing; Wang, Jian; Liang, Jianwei; Zhao, Jianjun; Zhao, Hong] Chinese Acad Med Sci, Canc Hosp, Dept Abdominal Surg Oncol, Beijing 100730, Peoples R China; [Wu, Jian] MyGenostics Inc, Baltimore, MD USA; [Jiao, Yuchen] Chinese Acad Med Sci, Lab Cell & Mol Biol, Canc Inst, Beijing 100730, Peoples R China; [Jiao, Yuchen] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst, Beijing 100730, Peoples R China; [Jiao, Yuchen] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China; [Jiao, Yuchen] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhao, H (corresponding author), Chinese Acad Med Sci, Canc Hosp, Dept Abdominal Surg Oncol, Beijing 100730, Peoples R China.	jiaoyuchen@cicams.ac.cn; nlu03@126.com; zhaohong9@sina.com	Guo, Lei/AEU-0178-2022		Natural Basic Research Program of China [2014CB542002]; National Natural Science Foundation of China [31470073, 81201967]; Beijing Natural Science Foundation [7144238]; Beijing Nova PrograM [2009A69]	Natural Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova PrograM(Beijing Municipal Science & Technology Commission)	This study was supported by grants from the Natural Basic Research Program of China (973 program 2014CB542002) and the National Natural Science Foundation of China (31470073), National Natural Science Foundation of China (81201967), the Beijing Natural Science Foundation (7144238) and Beijing Nova Program (No. 2009A69). MyGenostics Inc., provided support in the form of salaries for author Jian Wu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.; This study was supported by grants from the Natural Basic Research Program of China (973 program 2014CB542002) and the National Natural Science Foundation of China (31470073), National Natural Science Foundation of China (81201967), the Beijing Natural Science Foundation (7144238) and Beijing Nova Program (No. 2009A69).	Aisner DL, 2013, MOL CANC RES; An XL, 2005, BIOCHEM BIOPH RES CO, V327, P794, DOI 10.1016/j.bbrc.2004.12.063; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Bang YJ, 2010, LANCET, V376, P1302; Bang YJ, 2012, ARCH PATHOL LAB MED, V136, P1201, DOI 10.5858/arpa.2012-0246-RA; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Coffin CM, 2001, MODERN PATHOL, V14, P569, DOI 10.1038/modpathol.3880352; Curran MP, 2012, DRUGS, V72, P99, DOI 10.2165/11207680-000000000-00000; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Gallagher G, 2008, CANCER GENET CYTOGEN, V181, P46, DOI 10.1016/j.cancergencyto.2007.10.021; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; Grand FH, 2007, EXP HEMATOL, V35, P1723, DOI 10.1016/j.exphem.2007.07.002; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Jazii FR, 2006, WORLD J GASTROENTERO, V12, P7104, DOI 10.3748/wjg.v12.i44.7104; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Nakamura H, 2013, J CLIN PATHOL, V66, P705, DOI 10.1136/jclinpath-2012-201329; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; WATKINS PC, 1989, CYTOGENET CELL GENET, V51, P1103; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Ying J, 2013, ANN ONCOL, V24, P2589, DOI 10.1093/annonc/mdt295; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	30	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144731	10.1371/journal.pone.0144731	http://dx.doi.org/10.1371/journal.pone.0144731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678488	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400021
J	Dong, CJ; Jiang, LK; Peng, WZ; Xu, J; Mahboob, S; Al-Ghanim, KA; Sun, XW; Xu, P				Dong, Chuanju; Jiang, Likun; Peng, Wenzhu; Xu, Jian; Mahboob, Shahid; Al-Ghanim, Khalid A.; Sun, Xiaowen; Xu, Peng			Phylogenetic and Evolutionary Analyses of the Frizzled Gene Family in Common Carp (Cyprinus carpio) Provide Insights into Gene Expansion from Whole-Genome Duplications	PLOS ONE			English	Article							EXPRESSION; IDENTIFICATION; ZEBRAFISH; RECEPTOR; LOCALIZATION; GUIDANCE; SEQUENCE; GROWTH; OVARY; FATE	In humans, the frizzled (FZD) gene family encodes 10 homologous proteins that commonly localize to the plasma membrane. Besides being associated with three main signaling pathways for cell development, most FZDs have different physiological effects and are major determinants in the development process of vertebrates and. Here, we identified and annotated the FZD genes in the whole-genome of common carp (Cyprinus carpio), a teleost fish, and determined their phylogenetic relationships to FZDs in other vertebrates. Our analyses revealed extensive gene duplications in the common carp that have led to the 26 FZD genes that we detected in the common carp genome. All 26 FZD genes were assigned orthology to the 10 FZD genes of on-land vertebrates, with none of genes being specific to the fish lineage. We postulated that the expansion of the FZD gene family in common carp was the result of an additional whole genome duplication event and that the FZD gene family in other teleosts has been lost in their evolution history with the reason that the functions of genes are redundant and conservation. Through the expression profiling of FZD genes in common carp, we speculate that the ancestral gene was likely capable of performing all functions and was expressed broadly, while some descendant duplicate genes only performed partial functions and were specifically expressed at certain stages of development.	[Dong, Chuanju; Jiang, Likun; Peng, Wenzhu; Xu, Jian; Sun, Xiaowen; Xu, Peng] Chinese Acad Fishery Sci, CAFS Key Lab Aquat Genom, Beijing, Peoples R China; [Dong, Chuanju; Jiang, Likun; Peng, Wenzhu; Xu, Jian; Sun, Xiaowen; Xu, Peng] Chinese Acad Fishery Sci, Beijing Key Lab Fishery Biotechnol, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Dong, Chuanju; Jiang, Likun; Peng, Wenzhu] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Mahboob, Shahid; Al-Ghanim, Khalid A.] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Mahboob, Shahid] GC Univ, Dept Zool, Faisalabad, Pakistan	Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; Shanghai Ocean University; King Saud University; Government College University Faisalabad	Xu, P (corresponding author), Chinese Acad Fishery Sci, CAFS Key Lab Aquat Genom, Beijing, Peoples R China.	xupeng@cafs.ac.cn	Rana, Shahid Mahboob/P-1131-2014; Xu, Peng/J-4018-2012	Rana, Shahid Mahboob/0000-0003-4969-5387; Xu, Peng/0000-0002-1531-5078	National Natural Science Foundation of China [31422057]; National High-Technology Research and Development Program of China ( 863 program) [2011AA100401]; Central Non-profit Institutes of Chinese Academy of Fishery Sciences [2014A03YQ01]; agricultural science and technology key projects [2011-G12]; Deanship of Scientific Research at King Saud University [RG 1435-012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Technology Research and Development Program of China ( 863 program)(National High Technology Research and Development Program of China); Central Non-profit Institutes of Chinese Academy of Fishery Sciences; agricultural science and technology key projects; Deanship of Scientific Research at King Saud University(King Saud University)	The authors acknowledge grant support from the National Natural Science Foundation of China (No. 31422057), National High-Technology Research and Development Program of China (863 program; 2011AA100401), Special Scientific Research Funds for Central Non-profit Institutes of Chinese Academy of Fishery Sciences (2014A03YQ01) and the introduction of advanced agricultural science and technology key projects (2011-G12). The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this research (No. RG 1435-012).; We acknowledge grant support from the National Natural Science Foundation of China (No. 31422057), National High-Technology Research and Development Program of China (863 program; 2011AA100401), Special Scientific Research Funds for Central Non-profit Institutes of Chinese Academy of Fishery Sciences (2014A03YQ01) and the introduction of advanced agricultural science and technology key projects (2011-G12). The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this Research (No. RG 1435-012).	Adell T, 2003, FEBS LETT, V554, P363, DOI 10.1016/S0014-5793(03)01190-6; Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Allendorf F.W., 1984, P1; Bhanot P, 1996, NEW MEMBER FRIZZLED; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; Davis JC, 2004, PLOS BIOL, V2, P318, DOI 10.1371/journal.pbio.0020055; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gates MA, 1999, GENOME RES, V9, P334; Gradl D, 1999, MECH DEVELOP, V86, P3, DOI 10.1016/S0925-4773(99)00129-X; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Hahn MW, 2009, J HERED, V100, P605, DOI 10.1093/jhered/esp047; Hasan MR, 2007, STUDY ANAL FEEDS FER; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Hsieh M, 2005, BIOL REPROD, V73, P1135, DOI 10.1095/biolreprod.105.042739; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Ji PF, 2012, PLOS ONE, V7; Jiang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108200; Jiang YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091609, 10.1371/journal.pone.0093563, 10.1371/journal.pone.0105989]; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kirikoshi H, 2001, INT J ONCOL, V19, P111; Liu C, 2008, J NEUROSCI, V28, P5641, DOI 10.1523/JNEUROSCI.1056-08.2008; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Minobe S, 2000, DEV GENES EVOL, V210, P258, DOI 10.1007/s004270050312; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; OHNO S, 1967, CHROMOSOMA, V23, P1, DOI 10.1007/BF00293307; Phillips R, 2001, BIOL REV, V76, P1, DOI 10.1017/S1464793100005613; Ricken A, 2002, ENDOCRINOLOGY, V143, P2741, DOI 10.1210/en.143.7.2741; Schenkelaars Q, 2015, EVOL DEV, V17, P160, DOI 10.1111/ede.12115; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Sundfeldt K, 2000, J REPROD FERTIL, V118, P375, DOI 10.1530/reprod/118.2.375; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thorpe CJ, 2000, TRENDS CELL BIOL, V10, P10, DOI 10.1016/S0962-8924(99)01672-4; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Wang YS, 2006, J NEUROSCI, V26, P355, DOI 10.1523/JNEUROSCI.3221-05.2006; Wang YS, 2002, J NEUROSCI, V22, P8563; Welcomme RL., 1988, FAO FISHERIES TECHNI; WOLF U, 1969, HUMANGENETIK, V7, P240, DOI 10.1007/BF00273173; Xu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-307; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-537; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Ye X, 2011, DEVELOPMENT, V138, P1161, DOI 10.1242/dev.057620; Yu HM, 2010, DEVELOPMENT, V137, P3707, DOI 10.1242/dev.052001; Zhao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063928	55	10	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144037	10.1371/journal.pone.0144037	http://dx.doi.org/10.1371/journal.pone.0144037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675214	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700020
J	Laitinen, A; Bockelman, C; Hagstrom, J; Kokkola, A; Fermer, C; Nilsson, O; Haglund, C				Laitinen, Alli; Bockelman, Camilla; Hagstrom, Jaana; Kokkola, Arto; Fermer, Christian; Nilsson, Olle; Haglund, Caj			Podocalyxin as a Prognostic Marker in Gastric Cancer	PLOS ONE			English	Article							POOR-PROGNOSIS; INDEPENDENT FACTOR; PROTEIN; OVEREXPRESSION; METASTASIS	Background Podocalyxin-like 1 (PODXL) is a cell-adhesion glycoprotein associated with aggressive tumor phenotype and poor prognosis in several forms of cancer. The aim of this study was to investigate PODXL expression in gastric cancer by use of two different antibodies. Methods By tumor-tissue microarrays and immunohistochemistry we evaluated PODXL expression in tumor specimens from 337 patients who underwent surgery for gastric adenocarcinoma at Helsinki University Hospital. We used two different antibodies: HPA2110, which is a polyclonal antibody and an in-house monoclonal antibody called HES9, to investigate the association of PODXL expression with clinicopathologic variables and patient survival. Results PODXL staining was positive by the polyclonal antibody in 153 (57.5%) cases and by the monoclonal antibody in 212 (76%). Polyclonal antibody expression was associated with intestinal cancer type (p<0.001). Monoclonal antibody staining was associated with age over 66 (p = 0.001), with intestinal cancer (p< 0.001), and with small tumor size (<= 5 cm; p = 0.024). Both antibodies were associated with high S-phase fraction (p = 0.022; p = 0.010), and high tumor proliferation index (Ki-67; p = 0.003; p = 0.001). PODXL positivity by the polyclonal antibody indicated reduced gastric-cancer-specific 5-year survival of 24.0% (95% CI 16.9-31.1), compared to 43.3% (95% CI 33.7-52.9) for patients with PODXL negativity (p = 0.001). The result remained significant in multivariable analysis (HR = 3.17; 95% CI 1.37-7.34, p = 0.007). Conclusion In gastric cancer, PODXL expression by the polyclonal antibody HPA2110 is an independent marker of poor prognosis.	[Laitinen, Alli; Bockelman, Camilla; Kokkola, Arto; Haglund, Caj] Univ Helsinki, Dept Surg, Helsinki, Finland; [Laitinen, Alli; Bockelman, Camilla; Hagstrom, Jaana; Kokkola, Arto; Haglund, Caj] Helsinki Univ Hosp, Helsinki, Finland; [Laitinen, Alli; Bockelman, Camilla; Hagstrom, Jaana; Haglund, Caj] Univ Helsinki, Res Programs Unit, Translat Canc Biol, Helsinki, Finland; [Hagstrom, Jaana] Univ Helsinki, Dept Pathol & Oral Pathol, Helsinki, Finland; [Fermer, Christian] Fujirebio Diagnost AB, Gothenburg, Sweden; [Nilsson, Olle] Onson Consulting, Gothenburg, Sweden	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; H.U. Group Holdings Inc	Laitinen, A (corresponding author), Univ Helsinki, Dept Surg, Helsinki, Finland.	alli.laitinen@helsinki.fi	Böckelman, Camilla/AFX-4447-2022; Hagström, Jaana/G-1468-2018; Haglund, Caj/N-1240-2019	Hagström, Jaana/0000-0001-6079-7881; Bockelman, Camilla/0000-0002-1628-0305	Finska Lakaresallskapet; Kurt och Doris Palander Foundation; Sigrid Juselius Foundation; Medicinska understodsforeningen Liv och Halsa; Fujirebio Diagnostics AB; Onson Consulting	Finska Lakaresallskapet; Kurt och Doris Palander Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medicinska understodsforeningen Liv och Halsa; Fujirebio Diagnostics AB; Onson Consulting	This study was supported by grants from Finska Lakaresallskapet, the Kurt och Doris Palander Foundation, the Sigrid Juselius Foundation, and Medicinska understodsforeningen Liv och Halsa. Fujirebio Diagnostics AB and Onson Consulting provided support in the form of salaries for authors CF and ON, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie V, 2006, CRIT REV ONCOL HEMAT, V57, P123, DOI 10.1016/j.critrevonc.2005.09.004; Boman K, 2013, BRIT J CANCER, V108, P2321, DOI 10.1038/bjc.2013.215; Casey G, 2006, HUM MOL GENET, V15, P735, DOI 10.1093/hmg/ddi487; Cipollone JA, 2012, CLIN EXP METASTAS, V29, P239, DOI 10.1007/s10585-011-9446-0; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Doyonnas R, 2005, BLOOD, V105, P4170, DOI 10.1182/blood-2004-10-4077; Heby M, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/s12907-015-0009-1; HORVAT R, 1986, J CELL BIOL, V102, P484, DOI 10.1083/jcb.102.2.484; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaprio T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-493; Kaprio T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-494; KERJASCHKI D, 1984, J CELL BIOL, V98, P1505, DOI 10.1083/jcb.98.4.1505; Larsson A, 2011, BRIT J CANCER, V105, P666, DOI 10.1038/bjc.2011.295; Larsson A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-282; Larsson AH, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-109; Mrena J, 2010, TUMOR BIOL, V31, P1, DOI 10.1007/s13277-009-0001-4; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Ponnusamy MP, 2013, CURR CANCER DRUG TAR, V13, P945, DOI 10.2174/15680096113136660100; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Saukkonen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129012; Schopperle WM, 2003, BIOCHEM BIOPH RES CO, V300, P285; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Wiksten JP, 2008, ANTICANCER RES, V28, P2279	24	20	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145079	10.1371/journal.pone.0145079	http://dx.doi.org/10.1371/journal.pone.0145079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674770	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700095
J	Linhares, DCL; Johnson, C; Morrison, RB				Linhares, Daniel C. L.; Johnson, Clayton; Morrison, Robert B.			Economic Analysis of Vaccination Strategies for PRRS Control	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; SOW HERDS; UNITED-STATES; PERFORMANCE; IMPACT	Porcine reproductive and respiratory syndrome virus (PRRSv) is a swine-specific pathogen that causes significant increases in production costs. When a breeding herd becomes infected, in an attempt to hasten control and elimination of PRRSv, some veterinarians have adopted a strategy called load-close-expose which consists of interrupting replacement pig introductions into the herd for several weeks (herd closure) and exposing the whole herd to a replicating PRRSv to boost herd immunity. Either modified-live virus (MLV) vaccine or live field-virus inoculation (FVI) is used. This study consisted of partial budget analyses to compare MLV to FVI as the exposure method of load-close-expose program to control and eliminate PRRSv from infected breeding herds, and secondly to estimate benefit/cost of vaccinating sow herds preventatively. Under the assumptions used in this study, MLV held economic advantage over FVI. However, sensitivity analysis revealed that decreasing margin over variable costs below $47.32, or increasing PRRSv-attributed cost above $18.89 or achieving time-to-stability before 25 weeks resulted in advantage of FVI over MLV. Preventive vaccination of sow herds was beneficial when the frequency of PRRSv infection was at least every 2.1 years. The economics of preventative vaccination was minimally affected by cost attributed to field-type PRRSv infection on growing pigs or by the breeding herd productivity level. The models developed and described in this paper provide valuable tools to assist veterinarians in their efforts to control PRRSv.	[Linhares, Daniel C. L.] Iowa State Univ, Coll Vet Med, Vet Diagnost & Prod Anim Med Dept, Ames, IA 50011 USA; [Johnson, Clayton] Maschhoffs LLC, Swine Hlth Dept, Carlyle, IL USA; [Morrison, Robert B.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	Iowa State University; University of Minnesota System; University of Minnesota Twin Cities	Linhares, DCL (corresponding author), Iowa State Univ, Coll Vet Med, Vet Diagnost & Prod Anim Med Dept, Ames, IA 50011 USA.	Linhares@IAstate.edu		Correia Lima Linhares, Daniel/0000-0001-7788-9942	Maschhoffs, LLC (Carlyle, IL)	Maschhoffs, LLC (Carlyle, IL)	The Maschhoffs, LLC (Carlyle, IL) provided support in the form of salary for CJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abbitt B, 1979, CITRUS VEGETABLE MAG, V42; Arruda AG, 2015, TRANSBOUND IN PRESS, DOI [10.1111/tbed.12343, DOI 10.1111/TBED.12343]; Botner A, 1997, VET REC, V141, P497, DOI 10.1136/vr.141.19.497; Chaminuka P, 2012, SOC NATUR RESOUR, V25, P235, DOI 10.1080/08941920.2011.580417; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; Desrosiers R, 2002, J SWINE HEALTH PROD, V10, P23; Dewey CE, 2004, PREV VET MED, V62, P299, DOI 10.1016/j.prevetmed.2003.11.007; Dewey CE, 1999, PREV VET MED, V40, P233, DOI 10.1016/S0167-5877(99)00025-2; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Li MHH, 2012, N AM J AQUACULT, V74, P142, DOI 10.1080/15222055.2012.672373; Linhares D., 2013, THESIS; Linhares DCL, 2014, PREV VET MED, V116, P111, DOI 10.1016/j.prevetmed.2014.05.010; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Murtaugh MP, 2011, VACCINE, V29, P8192, DOI 10.1016/j.vaccine.2011.09.013; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Nielsen J, 2002, VET MICROBIOL, V84, P1, DOI 10.1016/S0378-1135(01)00450-3; Nieuwenhuis N, 2012, VET REC, V170, P225, DOI 10.1136/vr.100101; Rodgers JC, 2012, J ANIM SCI, V90, P4055, DOI 10.2527/jas.2011-4836; Sami AS, 2012, J ANIM VET ADV, V11, P803, DOI 10.3923/javaa.2012.803.808; Torremorell M., 2003, PORK CHECKOFF, P157; Velayudhan DE, 2015, ASIAN AUSTRAL J ANIM, V28, P1, DOI 10.5713/ajas.14.0001R	21	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144265	10.1371/journal.pone.0144265	http://dx.doi.org/10.1371/journal.pone.0144265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673898	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700032
J	Otero, O; Pinton, A; Cappetta, H; Adnet, S; Valentin, X; Salem, M; Jaeger, JJ				Otero, Olga; Pinton, Aurelie; Cappetta, Henri; Adnet, Sylvain; Valentin, Xavier; Salem, Mustapha; Jaeger, Jean-Jacques			A Fish Assemblage from the Middle Eocene from Libya (Dur At-Talah) and the Earliest Record of Modern African Fish Genera	PLOS ONE			English	Article							LATE MIOCENE; FAYUM; OLIGOCENE; ICHTHYOFAUNA; TELEOSTEI; TERTIARY	In the early nineteen sixties, Arambourg and Magnier found some freshwater fish (i.e., Polypterus sp., Siluriformes indet. and Lates sp.) mixed with marine members in an Eocene vertebrate assemblage at Gebel Coquin, in the southern Libyan Desert. This locality, aged ca 37-39Ma and now known under the name of Dur At-Talah, has been recently excavated. A new fish assemblage, mostly composed of teeth, was collected by the Mission Paleontologique Franco-Libyenne. In this paper, we describe freshwater fish members including a dipnoan (Protopterus sp.), and several actinopterygians: bichir (Polypterus sp.), aba fish (Gymnarchus sp.), several catfishes (Chrysichthys sp. and a mochokid indet.), several characiforms (including the tiger fish Hydrocynus sp., and one or two alestin-like fish), and perciforms (including the snake-head fish Parachanna sp. and at least one cichlid). Together with the fossiliferous outcrops at Birket Qarun in Egypt, the Libyan site at Dur At-Talah reduces a 10-Ma chronological gap in the fossil record of African freshwater fish. Their fish assemblages overlap in their composition and thus constitute a rather homogenous, original and significant amount of new elements regarding the Paleogene African ichthyofauna. This supports the establishment of the modern African freshwater fish fauna during this time period because these sites mostly contain the earliest members known in modern genera.	[Otero, Olga; Pinton, Aurelie; Valentin, Xavier; Jaeger, Jean-Jacques] Univ Poitiers, CNRS, Inst Paleoprimatol Paleontol Humaine Evolut & Pa, UMR 7262, Poitiers, France; [Cappetta, Henri; Adnet, Sylvain] Univ Montpellier 2, Inst Sci Evolut Montpellier ISE M, UMR5554, Montpellier, France; [Salem, Mustapha] Univ Al Fatah, Dept Geol, Tripoli, Libya	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; Al Fateh University	Otero, O (corresponding author), Univ Poitiers, CNRS, Inst Paleoprimatol Paleontol Humaine Evolut & Pa, UMR 7262, Poitiers, France.	olga.otero@univ-poitiers.fr	Otero, Olga/T-5467-2018	Otero, Olga/0000-0002-8129-2054	Agence Nationale pour la Recherche programme EVAH [ANR05-blan-0235]; Agence National pour la Recherche (program EVAH) [ANR05-blan-0235]	Agence Nationale pour la Recherche programme EVAH(French National Research Agency (ANR)); Agence National pour la Recherche (program EVAH)(French National Research Agency (ANR))	This research was funded by the Agence Nationale pour la Recherche (http://www.agence-nationale-recherche.fr/) programme EVAH, number ANR05-blan-0235.; We thank all of the members of the French-Libyan Paleontological Mission, notably Awad A. Bilal (Benghazi), Mouloud Benammi, Yaowalak Chaimanee and Olivier Chavasseau (Poitiers), Pauline Coster (Kansas), Bernard Marandat and Laurent Marivaux (Montpellier). The MPFL research project is a scientific collaboration between the University of Poitiers (France) and the University of Tripoli (Libya). The MPFL fieldwork and research is supported by the Agence National pour la Recherche (program EVAH, number ANR05-BLAN-0235). We extend gratitude to the editor who handled the manuscript and to the anonymous reviewer and to Alison Murray (Canada) for their comments.	ARAMBOURG C, 1961, CR HEBD ACAD SCI, V252, P1181; Arambourg C., 1963, Publications in Anthropology Viking Fund, V36, P55; Ashour A, 2012, J AFR EARTH SCI, V65, P72, DOI 10.1016/j.jafrearsci.2012.02.004; BELLAIR P, 1954, CR HEBD ACAD SCI, V239, P1822; Bleeker P, 1858, ACTA SOC REGIAE SCIE, V4; Churcher CS, 2001, PALAEONTOLOGY, V44, P305, DOI 10.1111/1475-4983.00181; Cocchi I, 1824, ANNALI MUSEO FIRENZE, V4, P63; Cuvier G., 1829, REGNE ANIMAL DISTRIB; Cuvier G J L r., 1816, POISSONS MOLLUSQUESE; ESTES R, 1969, COPEIA, P317; GINGERICH PD, 1992, U MICHIGAN PAPERS PA, V30, P1; Jaeger JJ, 2010, NATURE, V467, P1096, DOI 10.1038/nature09425; Jaeger JJ, 2010, ZOOL J LINN SOC-LOND, V160, P195, DOI 10.1111/j.1096-3642.2009.00600.x; Jordan DS, 1923, STANFORD U PUBL U BS, V3, P77, DOI [10.5962/bhl.title.161386, DOI 10.5962/BHL.TITLE.161386]; Kner R, 1855, MATH NATURWISSENSCHA, V17, P313; Lacepede B. G. E., 1803, HIST NATURELLE POISS, V5; Longbottom A, 2010, PALAEONTOLOGY, V53, P571, DOI 10.1111/j.1475-4983.2010.00946.x; Martin M., 1997, EARTH PLANETARY S 2A, V325, P635; Martin Michel, 1995, Geobios Memoire Special (Villeurbanne), V19, P275; Murray AM, 2010, J VERTEBR PALEONTOL, V30, P665, DOI 10.1080/02724631003758060; Murray AM, 2006, J PALEONTOL, V80, P1172, DOI 10.1666/0022-3360(2006)80[1172:ANCTCF]2.0.CO;2; Murray AM, 2003, CAN J EARTH SCI, V40, P983, DOI 10.1139/E03-031; Murray AM, 2002, J VERTEBR PALEONTOL, V22, P453, DOI 10.1671/0272-4634(2002)022[0453:LPJOAC]2.0.CO;2; Murray AM, 2004, J VERTEBR PALEONTOL, V24, P299, DOI 10.1671/1948; Murray AM, 2004, PALAEONTOLOGY, V47, P711, DOI 10.1111/j.0031-0239.2004.00384.x; Otero O, 1999, NEUES JAHRB GEOL P-M, P81; Otero O, 2008, GEOL SOC SPEC PUBL, V295, P155, DOI 10.1144/SP295.10; Otero O, 2011, FISH FISH, V12, P235, DOI 10.1111/j.1467-2979.2010.00389.x; Otero O, 2010, PALAEONTOGR ABT A, V292, P21, DOI 10.1127/pala/292/2010/21; Otero O, 2010, CYBIUM, V34, P93; Otero O, 2009, J AFR EARTH SCI, V54, P62, DOI 10.1016/j.jafrearsci.2009.03.004; Owen R., 1839, P LINN SOC LONDON, V1, P27; Paugy D, 2008, FAUNAFRI VERSION; Pinton A, 2011, J VERTEBR PALEONTOL, V31, P22, DOI 10.1080/02724634.2011.539648; Rasmussen DT, 2008, DEV PRIMATOL-PROG PR, P181, DOI 10.1007/978-0-387-73896-3_13; Regan C. T., 1920, Annals & Magazine of Natural History Series 9, V5; Risch Luc M., 1992, Faune Tropicale, V28, P395; Savage R. J. G., 1969, Proceedings of the Geological Society London, V1969, P167; Savage R. J. G., 1971, S GEOL LIB U LIB TRI, P215; Seiffert ER, 2008, DEV PRIMATOL-PROG PR, P71, DOI 10.1007/978-0-387-73896-3_8; Stewart KM, 2001, FISH FISH, V2, P177, DOI 10.1046/j.1467-2960.2001.00052.x; STEWART KM, 2003, LOTHAGAM DAWN HUMANI, P79; STIASSNY M L J, 1987, Bulletin of the Museum of Comparative Zoology, V151, P269; Stiassny M.L.J., 1989, ANN SCI ZOOL MARC TE, V258, P1; TEUGELS G G, 1984, Cybium, V8, P1; Wright AWR, 1980, GEOLOGY LIBYA, V1, P309	46	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144358	10.1371/journal.pone.0144358	http://dx.doi.org/10.1371/journal.pone.0144358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674637	Green Published, gold			2022-12-27	WOS:000366722700037
J	Schoene, D; Valenzuela, T; Toson, B; Delbaere, K; Severino, C; Garcia, J; Davies, TA; Russell, F; Smith, ST; Lord, SR				Schoene, Daniel; Valenzuela, Trinidad; Toson, Barbara; Delbaere, Kim; Severino, Connie; Garcia, Jaime; Davies, Thomas A.; Russell, Frances; Smith, Stuart T.; Lord, Stephen R.			Interactive Cognitive-Motor Step Training Improves Cognitive Risk Factors of Falling in Older Adults - A Randomized Controlled Trial	PLOS ONE			English	Article							DUAL-TASK CONDITIONS; VIDEO-GAME; DEPRESSION SEVERITY; EXERCISE; PEOPLE; SINGLE; GAIT; INTERVENTION; METAANALYSIS; PERFORMANCE	Purpose Interactive cognitive-motor training (ICMT) requires individuals to perform both gross motor movements and complex information processing. This study investigated the effectiveness of ICMT on cognitive functions associated with falls in older adults. Methods A single-blinded randomized controlled trial was conducted in community-dwelling older adults (N = 90, mean age 81.5 +/- 7) without major cognitive impairment. Participants in the intervention group (IG) played four stepping games that required them to divide attention, inhibit irrelevant stimuli, switch between tasks, rotate objects and make rapid decisions. The recommended minimum dose was three 20-minute sessions per week over a period of 16 weeks unsupervised at home. Participants in the control group (CG) received an evidence- based brochure on fall prevention. Measures of processing speed, attention/executive function (EF), visuo-spatial ability, concerns about falling and depression were assessed before and after the intervention. Results Eighty-one participants (90%) attended re-assessment. There were no improvements with respect to the Stroop Stepping Test (primary outcome) in the intervention group. Compared to the CG, the IG improved significantly in measures of processing speed, visuo-spatial ability and concern about falling. Significant interactions were observed for measures of EF and divided attention, indicating group differences varied for different levels of the covariate with larger improvements in IG participants with poorer baseline performance. The interaction for depression showed no change for the IG but an increase in the CG for those with low depressive symptoms at baseline. Additionally, low and high-adherer groups differed in their baseline performance and responded differently to the intervention. Compared to high adherers, low adherers improved more in processing speed and visual scanning while high-adherers improved more in tasks related to EF. Conclusions This study shows that unsupervised stepping ICMT led to improvements in specific cognitive functions associated with falls in older people. Low adherers improved in less complex functions while high-adherers improved in EF.	[Schoene, Daniel; Valenzuela, Trinidad; Toson, Barbara; Delbaere, Kim; Severino, Connie; Davies, Thomas A.; Smith, Stuart T.; Lord, Stephen R.] Univ New S Wales, Neurosci Res Australia, Sydney, NSW, Australia; [Schoene, Daniel] Univ Erlangen Nurnberg, Inst Biomed Aging, Nurnberg, Germany; [Valenzuela, Trinidad] Univ Finis Terrae, Fac Med, Sch Kinesiol, Exercise Sci Lab, Santiago, Chile; [Garcia, Jaime] Univ Technol Sydney, iNEXT, mHlth Lab, Sydney, NSW 2007, Australia; [Russell, Frances] Australian Catholic Univ, RSL LifeCare Chair Ageing, Sydney, NSW, Australia; [Smith, Stuart T.] Univ Sunshine Coast, Fac Arts & Business, Sippy Downs, Qld 4556, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of Erlangen Nuremberg; Universidad Finis Terrae; University of Technology Sydney; Australian Catholic University; University of the Sunshine Coast	Lord, SR (corresponding author), Univ New S Wales, Neurosci Res Australia, Sydney, NSW, Australia.	s.lord@neura.edu.au	Valenzuela, Trinidad/AAE-7451-2022; Schoene, Daniel/H-8861-2019; Delbaere, Kim/D-6370-2011; Toson, Barbara/M-4534-2019	Schoene, Daniel/0000-0003-0717-5746; Delbaere, Kim/0000-0002-5655-0234; Toson, Barbara/0000-0001-6661-9971; Lord, Stephen R/0000-0002-7111-8802; Garcia, Jaime/0000-0001-5718-1605; Valenzuela, Trinidad/0000-0001-7764-0223; Smith, Stuart/0000-0002-4735-6026	National Health and Medical Research Council [568975]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Partnership Grant (568975)-SRL, STS, KD; International Postgraduate Research Scholarship-DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Hanley C, 2012, AM J PREV MED, V42, P109, DOI 10.1016/j.amepre.2011.10.016; Anstey KJ, 2009, NEUROPSYCHOLOGY, V23, P500, DOI 10.1037/a0015389; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Berteau-Pavy D, 2011, PEBL TECHNICAL REPOR; Best JR, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00353; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Brach JS, 2013, J AM GERIATR SOC, V61, P1879, DOI 10.1111/jgs.12506; Bridle C, 2012, BRIT J PSYCHIAT, V201, P180, DOI 10.1192/bjp.bp.111.095174; Bula CJ, 2011, GERONTOLOGY, V57, P276, DOI 10.1159/000322241; Chatfield MD, 2005, J CLIN EPIDEMIOL, V58, P13, DOI 10.1016/j.jclinepi.2004.05.006; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; DEBRUIN ED, 2011, J NOV PHYSIOTHER, V1, P104, DOI DOI 10.4172/2165-7025.1000104; Delbaere K, 2011, J GERONTOLOGY A; Fabre C, 2002, INT J SPORTS MED, V23, P415, DOI 10.1055/s-2002-33735; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2009, BRAIN COGNITION, V70, P209, DOI 10.1016/j.bandc.2009.02.002; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Foley L. S., 2008, MENTAL HLTH PHYS ACT, V1, P69, DOI DOI 10.1016/J.MHPA.2008.07.001; Fraser SA, 2014, GAMES HEALTH J, V3, P172, DOI 10.1089/g4h.2013.0095; Gillespie L.D., 2012, COCHRANE DATABASE SY; Green CS, 2008, PSYCHOL AGING, V23, P692, DOI 10.1037/a0014345; Gregory MA, 2013, CURR SPORT MED REP, V12, P256, DOI 10.1249/JSR.0b013e31829a74fd; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; Hsu CL, 2012, OSTEOPOROSIS INT, V23, P2409, DOI 10.1007/s00198-012-1992-z; Kayama H, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3108; Kelly ME, 2014, AGEING RES REV, V16, P12, DOI 10.1016/j.arr.2014.05.002; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kueider AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040588; Kvelde T, 2013, J AM GERIATR SOC, V61, P694, DOI 10.1111/jgs.12209; Laver K, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-64; Lord SR, 2003, PHYS THER, V83, P237, DOI 10.1093/ptj/83.3.237; Lord SR, 2001, J GERONTOL A-BIOL, V56, pM627, DOI 10.1093/gerona/56.10.M627; Maillot P, 2012, PSYCHOL AGING, V27, P589, DOI 10.1037/a0026268; Martin K, 2009, DEMENT GERIATR COGN, V27, P451, DOI 10.1159/000216840; Martin KL, 2013, J GERONTOL A-BIOL, V68, P1091, DOI 10.1093/gerona/glt010; Martin M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006220.pub2; Mueller ST, 2014, J NEUROSCI METH, V222, P250, DOI 10.1016/j.jneumeth.2013.10.024; Oei AC, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00054; Oswald Wolf D, 2006, Eur J Ageing, V3, P179, DOI 10.1007/s10433-006-0035-z; Peng W, 2011, CYBERPSYCH BEH SOC N, V14, P681, DOI 10.1089/cyber.2010.0578; Pichierri G, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-74; Pichierri G, 2012, CLIN INTERV AGING, V7, P175, DOI 10.2147/CIA.S32558; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schoene D, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-107; Schoene D, 2014, AGE AGEING, V43, P285, DOI 10.1093/ageing/aft157; Schoene D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057734; Schoene D, 2011, ARCH PHYS MED REHAB, V92, P947, DOI 10.1016/j.apmr.2011.01.012; Silsupadol P, 2009, ARCH PHYS MED REHAB, V90, P381, DOI 10.1016/j.apmr.2008.09.559; Smith ST, 2013, IEEE ENG MED BIO, P7033, DOI 10.1109/EMBC.2013.6611177; Spreen O, 1998, COMPENDIUM NEUROPSYC; Studenski S, 2010, J NUTR HEALTH AGING, V14, P850, DOI 10.1007/s12603-010-0119-5; Theill N, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-103; Van Breukelen GJP, 2006, J CLIN EPIDEMIOL, V59, P920, DOI 10.1016/j.jclinepi.2006.02.007; Wolf SL, 2003, J AM GERIATR SOC, V51, P1693, DOI 10.1046/j.1532-5415.2003.51552.x; Zhou SS, 2011, BRAIN COGNITION, V75, P205, DOI 10.1016/j.bandc.2010.12.003	57	73	74	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145161	10.1371/journal.pone.0145161	http://dx.doi.org/10.1371/journal.pone.0145161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JH	26673919	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700109
J	Shan, HD; Ni, YQ; Xue, K; Yu, J; Huang, X				Shan, Haidong; Ni, Yinqing; Xue, Kang; Yu, Jia; Huang, Xin			Type 1 Retinopathy of Prematurity and Its Laser Treatment of Large Preterm Infants in East China	PLOS ONE			English	Article							AGGRESSIVE POSTERIOR RETINOPATHY; BIRTH-WEIGHT; RISK-FACTORS; DISEASE; BABIES; ROLES; GRAMS; UNITS	Purpose To describe Type 1 retinopathy of prematurity (ROP) and its laser treatment outcomes in premature infants with birth weight > 1250 g in Eastern China. Methods A retrospective review of 3175 ROP records was conducted at Shanghai Eye & ENT Hospital of Fudan University. The records were collected at the ROP clinic from 2006 to 2014, including their demographic and medical information such as gestational age, birth weight, supplemental oxygen therapy, systemic complications, ROP stage, location, presence of plus disease. All infants were examined by RetCam fundus camera. Those with Type 1 ROP were also examined by indirect ophthalmoscope before undergoing transpupillary laser treatment. Results A total of 12 infants (24 eyes) with Type 1 ROP and birth weight > 1250 g were enrolled. All infants enrolled had plus disease and ROP in zone II retina. Specifically, 16 eyes (67%) had stage 2 ROP. 8 eyes (33%) had stage 3 ROP. ROP regressed in 23 eyes (96%) following laser treatment. Partial retinal detachment developed in one eye (4%). No severe involution sequelaes or laser-related complications were recorded. Mean follow-up was 30 +/- 6 weeks. Conclusion Type 1 ROP may occur in large premature infants who have undergone supplemental oxygen therapy. This Type 1 ROP is mainly located in zone II retina. Laser treatment is a safe and effective intervention for these infants.	[Shan, Haidong; Ni, Yinqing; Xue, Kang; Yu, Jia; Huang, Xin] Fudan Univ, Dept Ophthalmol & Visual Sci, Eye & ENT Hosp, Shanghai 200031, Peoples R China; [Shan, Haidong; Ni, Yinqing; Xue, Kang; Yu, Jia; Huang, Xin] Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai 200031, Peoples R China; [Shan, Haidong] Kashgar Prefecture Second Peoples Hosp, Dept Ophthalmol, Xinjiang 844000, Peoples R China	Fudan University; Fudan University	Huang, X (corresponding author), Fudan Univ, Dept Ophthalmol & Visual Sci, Eye & ENT Hosp, Shanghai 200031, Peoples R China.	shanghaieent@yahoo.com			National Natural Science Foundation of China; Natural Science Foundation of Shanghai Municipality; Young Fellow Grant of Shanghai Health Bureau; Young Fellow Grant of Fudan University; China State Scholarship; Winkler Award of China Oxford Scholarship; Henry Lester Fund; Wing Yip Bursary	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai Municipality(Natural Science Foundation of Shanghai); Young Fellow Grant of Shanghai Health Bureau; Young Fellow Grant of Fudan University; China State Scholarship; Winkler Award of China Oxford Scholarship; Henry Lester Fund; Wing Yip Bursary	The authors thank support from National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality, Young Fellow Grant of Shanghai Health Bureau, Young Fellow Grant of Fudan University, China State Scholarship, Winkler Award of China Oxford Scholarship, Henry Lester Fund and Wing Yip Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Lu Ruan and Dr. Cheng Jiang for their help in data collection. The authors thank supports from National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality, Young Fellow Grant of Shanghai Health Bureau, Young Fellow Grant of Fudan University, China State Scholarship, Winkler Award of China Oxford Scholarship, Henry Lester Fund and Wing Yip Bursary.	Azuma N, 2006, AM J OPHTHALMOL, V142, P636, DOI 10.1016/j.ajo.2006.05.048; Chan-Ling T, 2004, INVEST OPHTH VIS SCI, V45, P2020, DOI 10.1167/iovs.03-1169; Chen Y, 2008, BRIT J OPHTHALMOL, V92, P326, DOI 10.1136/bjo.2007.131813; Chen Y, 2006, BRIT J OPHTHALMOL, V90, P268, DOI 10.1136/bjo.2005.078063; Chen Y, 2015, RETINA-J RET VIT DIS, V35, P1674, DOI 10.1097/IAE.0000000000000512; Chen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116669; Chen Yi-Hsing, 2013, Biomed J, V36, P84, DOI 10.4103/2319-4170.110399; Flynn JT, 2006, AM J OPHTHALMOL, V142, P46, DOI 10.1016/j.ajo.2006.02.018; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good William V, 2004, Trans Am Ophthalmol Soc, V102, P233; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Gu MH, 2011, MED PRIN PRACT, V20, P244, DOI 10.1159/000323764; Hughes S, 2000, INVEST OPHTH VIS SCI, V41, P1217; Hutchinson AK, 2003, J AAPOS, V7, P190, DOI 10.1016/S1091-8531(02)42018-6; Jandeck C, 1996, BRIT J OPHTHALMOL, V80, P728, DOI 10.1136/bjo.80.8.728; Lichtenstein SJ, 2006, PEDIATRICS, V117, P572, DOI 10.1542/peds.2005-2749; Murakami Y, 2008, BRIT J OPHTHALMOL, V92, P1456, DOI 10.1136/bjo.2008.138867; Nishina S, 2009, OPHTHALMOLOGY, V116, P2442, DOI 10.1016/j.ophtha.2009.05.011; Sanghi G, 2014, INDIAN J OPHTHALMOL, V62, DOI 10.4103/0301-4738.128639; Sanghi G, 2009, RETINA-J RET VIT DIS, V29, P1335, DOI 10.1097/IAE.0b013e3181a68f3a; Shah PK, 2012, ARCH DIS CHILD-FETAL, V97, pF371, DOI 10.1136/fetalneonatal-2011-301121; Stone J, 1996, INVEST OPHTH VIS SCI, V37, P290; Travassos A, 2007, OPHTHAL SURG LAS IM, V38, P233, DOI 10.3928/15428877-20070501-09; Wilkinson AR, 2009, EYE, V23, P2137, DOI 10.1038/eye.2008.128; Xu Y, 2013, INVEST OPHTH VIS SCI, V54, P8229, DOI 10.1167/iovs.13-12297; Yanovitch TL, 2006, J AAPOS, V10, P128, DOI 10.1016/j.jaapos.2005.08.005	26	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144313	10.1371/journal.pone.0144313	http://dx.doi.org/10.1371/journal.pone.0144313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674190	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700034
J	Gache, Y; Brellier, F; Rouanet, S; Al-Qaraghuli, S; Goncalves-Maia, M; Burty-Valin, E; Barnay, S; Scarzello, S; Ruat, M; Sevenet, N; Avril, MF; Magnaldo, T				Gache, Yannick; Brellier, Florence; Rouanet, Sophie; Al-Qaraghuli, Sahar; Goncalves-Maia, Maria; Burty-Valin, Elodie; Barnay, Stephanie; Scarzello, Sabine; Ruat, Martial; Sevenet, Nicolas; Avril, Marie-Francoise; Magnaldo, Thierry			Basal Cell Carcinoma in Gorlin's Patients: a Matter of Fibroblasts-Led Protumoral Microenvironment?	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; ANGIOPOIETIN-LIKE 4; SONIC HEDGEHOG; EPITHELIAL-CELLS; PTCH MUTATIONS; NEVUS SYNDROME; GROWTH-FACTOR; CANCER; SKIN; GENE	Basal cell carcinoma (BCC) is the commonest tumor in human. About 70% sporadic BCCs bear somatic mutations in the PATCHED1 tumor suppressor gene which encodes the receptor for the Sonic Hedgehog morphogen (SHH). PATCHED1 germinal mutations are associated with the dominant Nevoid Basal Cell Carcinoma Syndrome (NBCCS), a major hallmark of which is a high susceptibility to BCCs. Although the vast majority of sporadic BCCs arises exclusively in sun exposed skin areas, 40 to 50% BCCs from NBCCS patients develop in non photo-exposed skin. Since overwhelming evidences indicate that microenvironment may both be modified by-and influence the-epithelial tumor, we hypothesized that NBCCS fibroblasts could contribute to BCCs in NBCCS patients, notably those developing in non photo-exposed skin areas. The functional impact of NBCCS fibroblasts was then assessed in organotypic skin cultures with control keratinocytes. Onset of epidermal differentiation was delayed in the presence of primary NBCCS fibroblasts. Unexpectedly, keratinocyte proliferation was severely reduced and showed high levels of nuclear P53 in both organotypic skin cultures and in fibroblast-led conditioning experiments. However, in spite of increased levels of senescence associated beta-galactosidase activity in keratinocytes cultured in the presence of medium conditioned by NBCCS fibroblasts, we failed to observe activation of P16 and P21 and then of bona fide features of senescence. Constitutive extinction of P53 in WT keratinocytes resulted in an invasive phenotype in the presence of NBCCS fibroblasts. Finally, we found that expression of SHH was limited to fibroblasts but was dependent on the presence of keratinocytes. Inhibition of SHH binding resulted in improved epidermal morphogenesis. Altogether, these data suggest that the repertoire of diffusible factors (including SHH) expressed by primary NBCCS fibroblasts generate a stress affecting keratinocytes behavior and epidermal homeostasis. Our findings suggest that defects in dermo/epidermal interactions could contribute to BCC susceptibility in NBCCS patients.	[Gache, Yannick; Rouanet, Sophie; Al-Qaraghuli, Sahar; Goncalves-Maia, Maria; Scarzello, Sabine; Magnaldo, Thierry] UNS, UMR7284, CNRS, INSERM,U1081, Nice, France; [Gache, Yannick; Rouanet, Sophie; Al-Qaraghuli, Sahar; Goncalves-Maia, Maria; Scarzello, Sabine; Magnaldo, Thierry] Univ Nice Sophia Antipolis, Fac Med, F-06189 Nice, France; [Brellier, Florence; Burty-Valin, Elodie] Univ Paris 11, CNRS, FRE2939, Inst Gustave Roussy, Villejuif, France; [Ruat, Martial] CNRS, UMR9197, Neurosci Paris Saclay Inst, Gif Sur Yvette, France; [Sevenet, Nicolas] INSERM, U916, Bordeaux, France; [Sevenet, Nicolas] Inst Bergonie, Lab Genet Mol, Bordeaux, France; [Avril, Marie-Francoise] Univ Paris 05, APHP, Serv Dermatol, Paris, France; [Barnay, Stephanie] Univ Paris 06, UMR 7138, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Magnaldo, T (corresponding author), UNS, UMR7284, CNRS, INSERM,U1081, Nice, France.	thierry.magnaldo@unice.fr	Ruat, Martial/E-5544-2016	Gache, Yannick/0000-0002-5638-4854; Brellier, Florence/0000-0002-0143-472X; Barnay-Verdier, Stephanie/0000-0002-4615-3059; Thierry, Magnaldo/0000-0001-9174-8599	CNRS; Galderma Research International; Institut Gustave Roussy; French Government (National Research Agency, ANR) through the Investments for the Future "LABEX SIGNALIFE: program [ANR-11-LABX-0028-01]; Ligue Contre le Cancer; Comite de l'Essonne; Fondation ARC [SFI201212055859]; Fondation de l'Avenir; Societe Francaise de Dermatologie; Institut National du Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); Galderma Research International; Institut Gustave Roussy; French Government (National Research Agency, ANR) through the Investments for the Future "LABEX SIGNALIFE: program(French National Research Agency (ANR)); Ligue Contre le Cancer(Ligue nationale contre le cancer); Comite de l'Essonne; Fondation ARC; Fondation de l'Avenir; Societe Francaise de Dermatologie; Institut National du Cancer(Institut National du Cancer (INCA) France)	FB was supported by a PhD fellowship from CNRS; EB-V was supported by a PhD fellowship from Galderma Research International; SB was supported by a post-doctoral fellowship from the Institut Gustave Roussy. This work was supported by the French Government (National Research Agency, ANR) through the Investments for the Future "LABEX SIGNALIFE: program reference # ANR-11-LABX-0028-01; MR was supported by the Ligue Contre le Cancer, Comite de l'Essonne and the Fondation ARC. TM was supported by the Fondation ARC (SFI201212055859), the Fondation de l'Avenir, the Societe Francaise de Dermatologie, and The Institut National du Cancer.	Adolphe C, 2004, DEVELOPMENT, V131, P5009, DOI 10.1242/dev.01367; ASSELINEAU D, 1985, EXP CELL RES, V159, P536, DOI 10.1016/S0014-4827(85)80027-6; BERNERD F, 1992, J INVEST DERMATOL, V98, P902, DOI 10.1111/1523-1747.ep12460344; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; BONIFAS JM, 1994, HUM MOL GENET, V3, P447, DOI 10.1093/hmg/3.3.447; Boone MALM, 2012, BRIT J DERMATOL, V167, P856, DOI 10.1111/j.1365-2133.2012.11194.x; Brellier F, 2008, ONCOGENE, V27, P6601, DOI 10.1038/onc.2008.260; Brellier F, 2008, BRIT J DERMATOL, V159, P445, DOI 10.1111/j.1365-2133.2008.08650.x; Brellier F, 2004, CANCER RES, V64, P2699, DOI 10.1158/0008-5472.CAN-03-3477; Campisi J, 2009, AGING CELL, V8, P221, DOI 10.1111/j.1474-9726.2009.00475.x; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; de Gruijl FR, 2002, SKIN PHARMACOL APPL, V15, P316, DOI 10.1159/000064535; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Fine JD, 2009, J AM ACAD DERMATOL, V60, P203, DOI 10.1016/j.jaad.2008.09.035; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; GOLDSTEIN AM, 1993, J AM ACAD DERMATOL, V29, P34, DOI 10.1016/0190-9622(93)70148-M; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kim RH, 2015, AGING CELL, V14, P838, DOI 10.1111/acel.12364; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; LYLES TW, 1960, J INVEST DERMATOL, V34, P353, DOI 10.1038/jid.1960.61; MAGNALDO T, 1992, DIFFERENTIATION, V49, P39, DOI 10.1111/j.1432-0436.1992.tb00767.x; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Micke P, 2007, J INVEST DERMATOL, V127, P1516, DOI 10.1038/sj.jid.5700714; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Nishigori C, 2004, ANTIOXID REDOX SIGN, V6, P561, DOI 10.1089/152308604773934314; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pilarsky C, 2008, J CELL MOL MED, V12, P2823, DOI 10.1111/j.1582-4934.2008.00289.x; Pourreyron C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031827; Pruvost-Balland C, 2006, ANN DERMATOL VENER, V133, P117, DOI 10.1016/S0151-9638(06)70861-4; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Sarasin A, 1999, MUTAT RES-FUND MOL M, V428, P5, DOI 10.1016/S1383-5742(99)00025-3; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; SHANLEY S, 1994, AM J MED GENET, V50, P282, DOI 10.1002/ajmg.1320500312; Soufir N, 2006, BRIT J CANCER, V95, P548, DOI 10.1038/sj.bjc.6603303; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519; Traiffort E, 2001, EUR J NEUROSCI, V14, P839, DOI 10.1046/j.0953-816x.2001.01708.x; Ulrich M, 2011, J CUTAN PATHOL, V38, P190, DOI 10.1111/j.1600-0560.2010.01632.x; Valin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004818; VANSCOTT EJ, 1961, J INVEST DERMATOL, V36, P109, DOI 10.1038/jid.1961.21; Ng YZ, 2012, CANCER RES, V72, P3522, DOI 10.1158/0008-5472.CAN-11-2996; Zhang YQ, 2006, BIOCHEM BIOPH RES CO, V347, P100, DOI 10.1016/j.bbrc.2006.06.053; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018; Zuniga A, 2014, SCIENCE, V345, P516, DOI 10.1126/science.1257501	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145369	10.1371/journal.pone.0145369	http://dx.doi.org/10.1371/journal.pone.0145369			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694869	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500040
J	James, K; Al-Ali, S; Tarn, J; Cockell, SJ; Gillespie, CS; Hindmarsh, V; Locke, J; Mitchell, S; Lendrem, D; Bowman, S; Price, E; Pease, CT; Emery, P; Lanyon, P; Hunter, JA; Gupta, M; Bombardieri, M; Sutcliffe, N; Pitzalis, C; McLaren, J; Cooper, A; Regan, M; Giles, I; Isenberg, D; Saravanan, V; Coady, D; Dasgupta, B; McHugh, N; Young-Min, S; Moots, R; Gendi, N; Akil, M; Griffiths, B; Wipat, A; Newton, J; Jones, DE; Isaacs, J; Hallinan, J; Ng, WF				James, Katherine; Al-Ali, Shereen; Tarn, Jessica; Cockell, Simon J.; Gillespie, Colin S.; Hindmarsh, Victoria; Locke, James; Mitchell, Sheryl; Lendrem, Dennis; Bowman, Simon; Price, Elizabeth; Pease, Colin T.; Emery, Paul; Lanyon, Peter; Hunter, John A.; Gupta, Monica; Bombardieri, Michele; Sutcliffe, Nurhan; Pitzalis, Costantino; McLaren, John; Cooper, Annie; Regan, Marian; Giles, Ian; Isenberg, David; Saravanan, Vadivelu; Coady, David; Dasgupta, Bhaskar; McHugh, Neil; Young-Min, Steven; Moots, Robert; Gendi, Nagui; Akil, Mohammed; Griffiths, Bridget; Wipat, Anil; Newton, Julia; Jones, David E.; Isaacs, John; Hallinan, Jennifer; Ng, Wan-Fai		UK Primary Sjogren's Syndrome	A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjogren's Syndrome	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; GENE-EXPRESSION; CLASSIFICATION CRITERIA; DISEASE-ACTIVITY; CANCER; ASSOCIATION; PREVALENCE; ACTIVATION; ACTIN; IDENTIFICATION	Background Fatigue is a debilitating condition with a significant impact on patients' quality of life. Fatigue is frequently reported by patients suffering from primary Sjogren's Syndrome (pSS), a chronic autoimmune condition characterised by dryness of the eyes and the mouth. However, although fatigue is common in pSS, it does not manifest in all sufferers, providing an excellent model with which to explore the potential underpinning biological mechanisms. Methods Whole blood samples from 133 fully-phenotyped pSS patients stratified for the presence of fatigue, collected by the UK primary Sjogren's Syndrome Registry, were used for whole genome microarray. The resulting data were analysed both on a gene by gene basis and using pre-defined groups of genes. Finally, gene set enrichment analysis (GSEA) was used as a feature selection technique for input into a support vector machine (SVM) classifier. Classification was assessed using area under curve (AUC) of receiver operator characteristic and standard error of Wilcoxon statistic, SE(W). Results Although no genes were individually found to be associated with fatigue, 19 metabolic pathways were enriched in the high fatigue patient group using GSEA. Analysis revealed that these enrichments arose from the presence of a subset of 55 genes. A radial kernel SVM classifier with this subset of genes as input displayed significantly improved performance over classifiers using all pathway genes as input. The classifiers had AUCs of 0.866 (SE(W) 0.002) and 0.525 (SE(W) 0.006), respectively. Conclusions Systematic analysis of gene expression data from pSS patients discordant for fatigue identified 55 genes which are predictive of fatigue level using SVM classification. This list represents the first step in understanding the underlying pathophysiological mechanisms of fatigue in patients with pSS.	[James, Katherine; Wipat, Anil; Hallinan, Jennifer] Newcastle Univ, Interdisciplinary Comp & Complex BioSyst Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [James, Katherine; Al-Ali, Shereen; Tarn, Jessica; Locke, James; Lendrem, Dennis; Jones, David E.; Isaacs, John; Ng, Wan-Fai] Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Al-Ali, Shereen] Univ Basrah, Dept Biol, Coll Sci, Basrah, Iraq; [Cockell, Simon J.] Newcastle Univ, Bioinformat Support Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gillespie, Colin S.] Newcastle Univ, Dept Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hindmarsh, Victoria; Mitchell, Sheryl; Griffiths, Bridget; Newton, Julia] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Bowman, Simon] Univ Hosp Birmingham, Dept Rheumatol, Birmingham, W Midlands, England; [Price, Elizabeth] Great Western Hosp NHS Fdn Trust, Swindon, Wilts, England; [Pease, Colin T.; Emery, Paul] Univ Leeds, Sect Musculoskeletal Dis, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Pease, Colin T.; Emery, Paul] Leeds Teaching Hosp Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Lanyon, Peter] Univ Nottingham Hosp, Nottingham NG7 2UH, England; [Hunter, John A.; Gupta, Monica] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland; [Bombardieri, Michele; Sutcliffe, Nurhan; Pitzalis, Costantino] Barts & London NHS Trust, London, England; [Bombardieri, Michele; Sutcliffe, Nurhan; Pitzalis, Costantino] Barts & London Queen Marys Sch Med & Dent, London, England; [McLaren, John] Whytemans Brae Hosp, NHS Fife, Kirkcaldy, Scotland; [Cooper, Annie] Royal Hampshire Cty Hosp, Winchester, Hants, England; [Cooper, Annie; Young-Min, Steven] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England; [Regan, Marian] Royal Derby Hosp, Derby, England; [Giles, Ian; Isenberg, David] Univ Coll London Hosp NHS Fdn Trust, London, England; [Saravanan, Vadivelu] Queen Elizabeth Hosp, Gateshead, England; [Coady, David] Sunderland Royal Hosp, Sunderland, England; [Dasgupta, Bhaskar] Southend Univ Hosp, Southend On Sea, England; [McHugh, Neil] Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England; [Moots, Robert] Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England; [Gendi, Nagui] Basildon Hosp, Basildon, England; [Akil, Mohammed] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [Newton, Julia] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Isaacs, John; Ng, Wan-Fai] Newcastle Biomed Res Ctr, Natl Inst Hlth Res, Newcastle Upon Tyne, Tyne & Wear, England; [Hallinan, Jennifer] BioThink Pty Ltd, Brisbane, Qld, Australia	Newcastle University - UK; Newcastle University - UK; University of Basrah; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Birmingham; University of Leeds; Leeds Biomedical Research Centre; University of Leeds; University of Nottingham; Gartnavel Royal Hospital; Barts Health NHS Trust; University of London; Queen Mary University London; University of Dundee; Portsmouth Hospitals NHS Trust; University of Nottingham; University College London Hospitals NHS Foundation Trust; University of London; University College London; Sunderland Royal Hospital; Royal National Hospital for Rheumatic Diseases (RNHRD); Aintree University Hospitals NHS Foundation Trust; University of Sheffield; Newcastle University - UK	James, K (corresponding author), Newcastle Univ, Interdisciplinary Comp & Complex BioSyst Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.		Lanyon, Peter/K-8100-2019; emery, paul/B-3560-2013; Price, Elizabeth/Y-7061-2019; Moots, Robert/AAM-8091-2020; Giles, Ian/G-7471-2015; Lendrem, Dennis/H-2590-2013; Ng, Wan-Fai/R-8083-2016	Lanyon, Peter/0000-0002-9855-6802; James, Katherine/0000-0003-0167-8393; Andrews, Jacqueline/0000-0001-9888-8690; Young-Min, Steven/0000-0001-8270-6207; Rauz, Saaeha/0000-0003-4627-3496; Giles, Ian/0000-0001-8913-3894; Gillespie, Colin/0000-0003-1787-0275; Pitzalis, Costantino/0000-0003-1326-5051; Pauling, John/0000-0002-2793-2364; Symmons, Deborah/0000-0002-8625-1200; Lendrem, Dennis/0000-0001-6268-5509; Newton, Julia/0000-0002-1249-5253; Al-Ali, Shereen/0000-0003-4722-7125; Dimitroulas, Theodoros/0000-0002-0364-1642; Fedele, Stefano/0000-0001-9006-9412; Wipat, Anil/0000-0001-7310-4191; KITAS, GEORGE/0000-0002-0828-6176; Porter, Stephen/0000-0002-3328-2759; Cockell, Simon/0000-0002-6831-9806; Isaacs, John/0000-0002-6103-7056; Ng, Wan-Fai/0000-0002-5539-388X	Medical Research Council UK [MR/J002720/1]; Higher Committee of Education Development in Iraq (HCED); Biothink; Medical Research Council [MR/J002720/1, G0800629, MR/N003063/1] Funding Source: researchfish; Versus Arthritis [18475] Funding Source: researchfish; MRC [G0800629, MR/N003063/1, MR/J002720/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Higher Committee of Education Development in Iraq (HCED); Biothink; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by a grant from the Medical Research Council UK, http://www.mrc.ac.uk, Grant No. MR/J002720/1 to W-FN, AW, JH, CG, SC, JN, DEJ, JDI, SB & EP. This project also received infrastructural support from the Newcastle NIHR Biomedical Research Centre. SA-A sponsored by the Higher Committee of Education Development in Iraq (HCED), http://hcediraq.org/HCED_english_website/homeen.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biothink provided support in the form of salaries for an author [JH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Baraniuk James N, 2010, Allergy Asthma Clin Immunol, V6, P8, DOI 10.1186/1710-1492-6-8; Barendregt PJ, 1998, ANN RHEUM DIS, V57, P291, DOI 10.1136/ard.57.5.291; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; Bower JE, 2014, NAT REV CLIN ONCOL, V11, P597, DOI 10.1038/nrclinonc.2014.127; Bowman SJ, 2004, RHEUMATOLOGY, V43, P758, DOI 10.1093/rheumatology/keh170; Brkic Z, 2013, ANN RHEUM DIS, V72, P728, DOI 10.1136/annrheumdis-2012-201381; Burks TF, 2001, CANCER, V92, P1714, DOI 10.1002/1097-0142(20010915)92:6+<1714::AID-CNCR1502>3.0.CO;2-N; Byrnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005805; CARLSON KE, 1986, MOL PHARMACOL, V30, P463; Carlson M, LUMIHUMANALL DB R PA; Cauch-Dudek K, 1998, GUT, V43, P705, DOI 10.1136/gut.43.5.705; Cockell S, 2014, MICROARRAY IMAGE DAT, P459; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cotta-de-Almeida V, 2007, P NATL ACAD SCI USA, V104, P15424, DOI 10.1073/pnas.0706881104; DAVID A, 1990, BMJ-BRIT MED J, V301, P1199, DOI 10.1136/bmj.301.6762.1199; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Emamian ES, 2009, GENES IMMUN, V10, P285, DOI 10.1038/gene.2009.20; Fletcher MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010817; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Frampton D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016872; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gottenberg JE, 2006, P NATL ACAD SCI USA, V103, P2770, DOI 10.1073/pnas.0510837103; Gow JW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-38; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harhammer R, 1996, FEBS LETT, V399, P211, DOI 10.1016/S0014-5793(96)01327-0; HENDERSON AR, 1993, ANN CLIN BIOCHEM, V30, P521, DOI 10.1177/000456329303000601; Hjelmervik TOR, 2005, ARTHRITIS RHEUM, V52, P1534, DOI 10.1002/art.21006; Huyser BA, 1998, ARTHRITIS RHEUM, V41, P2230, DOI 10.1002/1529-0131(199812)41:12<2230::AID-ART19>3.3.CO;2-4; IRVINE D, 1994, CANCER NURS, V17, P367; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; KAMEOKA J, 1993, SCIENCE, V261, P466, DOI 10.1126/science.8101391; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kerr JR, 2008, J INFECT DIS, V197, P1171, DOI 10.1086/533453; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; KLIMAS NG, 1990, J CLIN MICROBIOL, V28, P1403, DOI 10.1128/JCM.28.6.1403-1410.1990; Krupp L B, 2001, Curr Neurol Neurosci Rep, V1, P294, DOI 10.1007/s11910-001-0033-7; KRUPP LB, 1990, J RHEUMATOL, V17, P1450; KRUPP LB, 1988, ARCH NEUROL-CHICAGO, V45, P435, DOI 10.1001/archneur.1988.00520280085020; Kuhn M., 2021, CARET CLASSIFICATION; Landmark-Hoyvik H, 2009, PHARMACOGENOMICS J, V9, P333, DOI 10.1038/tpj.2009.27; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Light AR, 2012, J INTERN MED, V271, P64, DOI 10.1111/j.1365-2796.2011.02405.x; Light KC, 2013, PSYCHONEUROENDOCRINO, V38, P2983, DOI 10.1016/j.psyneuen.2013.08.008; Lorusso L, 2009, AUTOIMMUN REV, V8, P287, DOI 10.1016/j.autrev.2008.08.003; Malik UR, 2001, CANCER, V92, P1664, DOI 10.1002/1097-0142(20010915)92:6+<1664::AID-CNCR1494>3.0.CO;2-9; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ng WF, 2011, RHEUMATOLOGY, V50, P32, DOI 10.1093/rheumatology/keq240; Ng WF, 2010, RHEUMATOLOGY, V49, P844, DOI 10.1093/rheumatology/keq009; Nishimura D, 2001, BIOTECH SOFTWARE INT, V2, P117, DOI DOI 10.1089/152791601750294344; Piche T, 2002, GUT, V51, P434, DOI 10.1136/gut.51.3.434; Pihur V, 2011, BIOINFORMATION, V6, P120, DOI 10.6026/97320630006120; Qin B, 2014, ANN RHEUM DIS; Raison CL, 2009, BRAIN BEHAV IMMUN, V23, P327, DOI 10.1016/j.bbi.2008.11.005; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Rosenbaum M, 2014, J ENDOCRINOL, V223, pT83, DOI 10.1530/JOE-14-0358; Schappi JM, 2014, BBA-BIOMEMBRANES, V1838, P674, DOI 10.1016/j.bbamem.2013.08.026; Scholkopf C, 1999, ADV KERNEL METHODS; Segal B, 2008, ARTHRIT RHEUM-ARTHR, V59, P1780, DOI 10.1002/art.24311; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Smets EMA, 1996, BRIT J CANCER, V73, P241, DOI 10.1038/bjc.1996.42; Smith AK, 2011, NEUROPSYCHOBIOLOGY, V64, P183, DOI 10.1159/000326692; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Staines D, 2005, MED HYPOTHESES, V65, P29, DOI 10.1016/j.mehy.2005.02.013; Stone P, 1999, BRIT J CANCER, V79, P1479, DOI 10.1038/sj.bjc.6690236; Stone P, 1998, EUR J CANCER, V34, P1670, DOI 10.1016/S0959-8049(98)00167-1; Stringer EA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-93; Strombeck B, 2003, ARTHRIT RHEUM-ARTHR, V49, P681, DOI 10.1002/art.11384; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tejera-Alhambra M, 2014, CLIN IMMUNOL, V150, P170, DOI 10.1016/j.clim.2013.11.011; van't Leven M, 2010, EUR J PUBLIC HEALTH, V20, P251, DOI 10.1093/eurpub/ckp113; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Vitali C, 2007, ARTHRITIS RHEUM-US, V56, P2223, DOI 10.1002/art.22658; Wang YT, 2013, ARCH IMMUNOL THER EX, V61, P309, DOI 10.1007/s00005-013-0230-5; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Wildenberg ME, 2008, EUR J IMMUNOL, V38, P2024, DOI 10.1002/eji.200738008; Zhang LH, 2010, J CLIN PATHOL, V63, P156, DOI 10.1136/jcp.2009.072561; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	86	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0143970	10.1371/journal.pone.0143970	http://dx.doi.org/10.1371/journal.pone.0143970			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694930	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000367092500001
J	Lohr, B; Vasquez-Ordonez, AA; Lopez-Lavalle, LAB				Loehr, Bernhard; Andres Vasquez-Ordonez, Aymer; Becerra Lopez-Lavalle, Luis Augusto			Rhynchophorus palmarum in Disguise: Undescribed Polymorphism in the "Black" Palm Weevil	PLOS ONE			English	Article							FERRUGINEUS OLIVIER; COLOR POLYMORPHISM; COLEOPTERA; CURCULIONIDAE; APHIDIDAE; PATTERNS; REGION; PCR	During studies to adapt pheromone trapping of Rhynchophorus palmarum to the special coconut growing conditions at the Colombian Pacific coast, 152 atypically-colored specimens were captured in a total collection of 53,802 of the normally completely black weevil. Five specimens had the typical coloration of Rhynchophorus ferrugineus, an invasive species recently introduced to Aruba and Curacao. A regional expansion of this invasion to the South American continent was feared and all atypical specimens were submitted to taxonomic analysis. Both conventional and molecular methods were employed. Conventional taxonomics confirmed the samples as belonging to R. palmarum but registered undescribed and species-atypical morphological variability in the subgular suture (wide vs. narrow), the ratio between intraocular distance and width of antennal scrobes (> 0.35 vs. < 0.29) and the indentation of the mandibles (up to three mandibular teeth vs. bilobed). Molecular analysis placed all samples inspected, black and reddish alike, firmly within the R. palmarum group and the hypothesis of having inter-specific hybrids was rejected using co-dominant single sequence repeat markers with allelic specificity for both species.	[Loehr, Bernhard] Ctr Invest Palmira, Corp Colombiana Invest Agr, Palmira, Valle Del Cauca, Colombia; [Andres Vasquez-Ordonez, Aymer] Ctr Int Agr Trop, Entomol Program, Cali 6713, Valle Del Cauca, Colombia; [Becerra Lopez-Lavalle, Luis Augusto] Ctr Int Agr Trop, Cassava Program, Cali 6713, Valle Del Cauca, Colombia	Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Alliance; International Center for Tropical Agriculture - CIAT; Alliance; International Center for Tropical Agriculture - CIAT	Lohr, B (corresponding author), Ctr Invest Palmira, Corp Colombiana Invest Agr, Palmira, Valle Del Cauca, Colombia.	blohr55@gmail.com	Vásquez-Ordóñez, Aymer Andrés/AGH-6088-2022; Lopez-Lavalle, Luis Augusto Becerra/H-4678-2019	Vásquez-Ordóñez, Aymer Andrés/0000-0002-4970-9067; Lopez-Lavalle, Luis Augusto Becerra/0000-0003-3520-2270	Colciencias [2236-502-27543]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was partially funded by Colciencias (www.colciencias.gov.co) grant no. 2236-502-27543 to Centro International de Agricultura Tropical (BL). The remaining costs were covered through CIAT core funds (BL, AAV, LABL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham V. A., 1998, Sultan Qaboos University Journal for Scientific Research - Agricultural Sciences, V3, P77; Abraham V. A., 1989, Journal of Plantation Crops, V16, P159; ANDERSON RS, 1986, J NAT HIST, V20, P283, DOI 10.1080/00222938600770241; [Anonymous], 2007, Bulletin OEPP/EPPO Bulletin, V37, P571, DOI 10.1111/j.1365-2338.2007.01165.x; Barranco P, 1995, B ASOC ESP ENT, V20, P257; Bond AB, 2007, 52 LINC U; Cabello T, 2007, 1 JORN INT PIC ROJ P; Capdevielle-Dulac C, MOL EOLO RES; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drosopoulos S, 2008, B INSECTOL, V61, P99; El-Mergawy RAAM, 2011, INT J AGRIC BIOL, V13, P227; EPPO, 2009, EPPO REP SERV, P01; Forsman A, 2002, EVOLUTION, V56, P349, DOI 10.1111/j.0014-3820.2002.tb01345.x; Giblin-Davis RM, 2013, CABI INVASIVE SER, P1, DOI 10.1079/9781845938291.0001; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; HAGLEY EAC, 1963, J ECON ENTOMOL, V56, P375, DOI 10.1093/jee/56.3.375; Hallett RH, 2004, J NAT HIST, V38, P2863, DOI 10.1080/00222930310001657874; Hochkirch A, 2008, EVOL DEV, V10, P350, DOI 10.1111/j.1525-142X.2008.00243.x; Johnson CW, 1920, J HERED, V11, P84, DOI 10.1093/oxfordjournals.jhered.a101975; Kairo MT, 2010, P CAR FOOD CROPS SOC, V46, P87; LAMBERS DHR, 1966, ANNU REV ENTOMOL, V11, P47, DOI 10.1146/annurev.en.11.010166.000403; Lohr B, 2014, MANUAL TRAMPEO PICUD; Lohr B, 2013, BIOCONT NEWS INF, V34, p19N; Machado Vilmar, 2001, Revista Brasileira de Zoologia, V18, P711, DOI 10.1590/S0101-81752001000300007; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Mozcek AP, 1999, ANIM BEHAV, V59, P459; Murphy ST, 1999, BIOCONTROL NEWS INF, V20, P35; Nilsson AN., 2012, DNA BARCODES, V1, P1, DOI DOI 10.2478/DNA-2012-0001; Oelschlager AC, 2002, ENTOMOL, V85, P507; Ovalle TM, 2014, ECOL EVOL, V4, P3778, DOI 10.1002/ece3.1204; Rampling LR, 2001, AUST J AGR RES, V52, P1131, DOI 10.1071/AR01027; Roda A., 2011, Bulletin OEPP, V41, P116, DOI 10.1111/j.1365-2338.2011.02446.x; Rugman-Jones PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078379; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; SEPÚLVEDA-CANO PAULA A, 2009, Acta biol.Colomb., V14, P49; Svensson EI, 2007, EVOL ECOL; Sword GA, 2000, P ROY SOC B-BIOL SCI, V267, P63, DOI 10.1098/rspb.2000.0967; Tambe JT, 2013, B INSECTOL, V66, P153; Thery M, 2008, BEHAV ECOL, V19, P627, DOI 10.1093/beheco/arn024; Vanderplanck KFL, 1960, J ANIM ECOL, V29, P15; WATTANAPONGSIRI A, 1966, DEP AGR SCI B, V1; WEBER G, 1985, Z ANGEW ENTOMOL, V100, P100	43	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0143210	10.1371/journal.pone.0143210	http://dx.doi.org/10.1371/journal.pone.0143210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683205	Green Published, gold, Green Submitted			2022-12-27	WOS:000366725800006
J	Igietseme, JU; Omosun, Y; Stuchlik, O; Reed, MS; Partin, J; He, Q; Joseph, K; Ellerson, D; Bollweg, B; George, Z; Eko, FO; Bandea, C; Liu, H; Yang, GY; Shieh, WJ; Pohl, J; Karem, K; Black, CM				Igietseme, Joseph U.; Omosun, Yusuf; Stuchlik, Olga; Reed, Matthew S.; Partin, James; He, Qing; Joseph, Kahaliah; Ellerson, Debra; Bollweg, Brigid; George, Zenas; Eko, Francis O.; Bandea, Claudiu; Liu, Hsi; Yang, Genyan; Shieh, Wun-Ju; Pohl, Jan; Karem, Kevin; Black, Carolyn M.			Role of Epithelial-Mesenchyme Transition in Chlamydia Pathogenesis	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; CANCER-CELL MIGRATION; HUMAN BREAST-CANCER; OXIDASE-LIKE 2; GENITAL-TRACT; MOUSE MODEL; CERVICAL-CANCER; DIFFERENTIAL EXPRESSION; MURIDARUM INFECTION; EMBRYO IMPLANTATION	Chlamydia trachomatis genital infection in women causes serious adverse reproductive complications, and is a strong co-factor for human papilloma virus (HPV)-associated cervical epithelial carcinoma. We tested the hypothesis that Chlamydia induces epithelial-mesenchyme transition (EMT) involving T cell-derived TNF-alpha signaling, caspase activation, cleavage inactivation of dicer and dysregulation of micro-RNA (miRNA) in the reproductive epithelium; the pathologic process of EMT causes fibrosis and fertility-related epithelial dysfunction, and also provides the co-factor function for HPV-related cervical epithelial carcinoma. Using a combination of microarrays, immunohistochemistry and proteomics, we showed that chlamydia altered the expression of crucial miRNAs that control EMT, fibrosis and tumorigenesis; specifically, miR-15a, miR-29b, miR-382 and MiR-429 that maintain epithelial integrity were down-regulated, while miR-9, mi-R-19a, miR-22 and miR-205 that promote EMT, fibrosis and tumorigenesis were up-regulated. Chlamydia induced EMT in vitro and in vivo, marked by the suppression of normal epithelial cell markers especially E-cadherin but up-regulation of mesenchymal markers of pathological EMT, including T-cadherin, MMP9, and fibronectin. Also, Chlamydia upregulated pro-EMT regulators, including the zinc finger E-box binding homeobox protein, ZEB1, Snail1/2, and thrombospondin1 (Thbs1), but down-regulated anti-EMT and fertility promoting proteins (i.e., the major gap junction protein connexin 43 (Cx43), Mets1, Add1Scarb1 and MARCKSL1). T cell-derived TNF-alpha signaling was required for chlamydial-induced infertility and caspase inhibitors prevented both infertility and EMT. Thus, chlamydial-induced T cell-derived TNF-alpha activated caspases that inactivated dicer, causing alteration in the expression of reproductive epithelial miRNAs and induction of EMT. EMT causes epithelial malfunction, fibrosis, infertility, and the enhancement of tumorigenesis of HPV oncogene-transformed epithelial cells. These findings provide a novel understanding of the molecular pathogenesis of chlamydia-associated diseases, which may guide a rational prevention strategy.	[Igietseme, Joseph U.; Omosun, Yusuf; Stuchlik, Olga; Reed, Matthew S.; Partin, James; He, Qing; Joseph, Kahaliah; Ellerson, Debra; Bollweg, Brigid; George, Zenas; Bandea, Claudiu; Liu, Hsi; Yang, Genyan; Shieh, Wun-Ju; Pohl, Jan; Karem, Kevin; Black, Carolyn M.] Ctr Dis Control & Prevent CDC Atlanta, Natl Ctr Emerging Zoonot & Infect Dis, Atlanta, GA 30333 USA; [Igietseme, Joseph U.; Omosun, Yusuf; He, Qing; Eko, Francis O.] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA	Centers for Disease Control & Prevention - USA; Morehouse School of Medicine	Igietseme, JU (corresponding author), Ctr Dis Control & Prevent CDC Atlanta, Natl Ctr Emerging Zoonot & Infect Dis, Atlanta, GA 30333 USA.	jigietseme@cdc.gov	Omosun, Yusuf/P-9944-2019	Omosun, Yusuf/0000-0003-4759-6254	National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention; National Institutes of Health [AI41231, GM 08248, RR03034, 1SC1GM098197]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI103041, R01AI041231] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	1. National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention. Internal research support to: JUI. 2. National Institutes of Health Grant #s: AI41231, GM 08248, RR03034 and 1SC1GM098197 to: JUI, FOE and QH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeit JM, 1996, P NATL ACAD SCI USA, V93, P2930, DOI 10.1073/pnas.93.7.2930; Arigoni M, 2013, AM J PATHOL, V182, P2058, DOI 10.1016/j.ajpath.2013.02.046; Ashida H, 2006, J BIOL CHEM, V281, P896, DOI 10.1074/jbc.M511311200; Boini KM, 2012, J CELL MOL MED, V16, P1674, DOI 10.1111/j.1582-4934.2011.01462.x; Brake T, 2005, P NATL ACAD SCI USA, V102, P2490, DOI 10.1073/pnas.0409883102; Bujak E, 2014, EXP CELL RES, V327, P135, DOI 10.1016/j.yexcr.2014.05.024; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Byrne A, 2010, EXP CELL RES, V316, P258, DOI 10.1016/j.yexcr.2009.08.018; Cano A, 2012, FUTURE ONCOL, V8, P1095, DOI [10.2217/FON.12.105, 10.2217/fon.12.105]; Castellano P, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00122; Catalano RD, 2005, P NATL ACAD SCI USA, V102, P8585, DOI 10.1073/pnas.0502343102; Chang CC, 2012, J IMMUNOL, V188, P3042, DOI 10.4049/jimmunol.1102899; Chen Q, 2013, MOL ASPECTS MED, V34, P1024, DOI 10.1016/j.mam.2012.07.017; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Christianson MS, 2012, CURR OPIN ENDOCRINOL, V19, P115, DOI 10.1097/MED.0b013e3283505771; Citi Sandra, 2014, Small GTPases, V5, P1, DOI 10.4161/21541248.2014.973760; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397; DeAngelis AM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119883; Debattista J, 2003, FERTIL STERIL, V79, P1273, DOI 10.1016/S0015-0282(03)00396-0; Diaz-Lopez A, 2014, CANCER MANAG RES, V6, P205, DOI 10.2147/CMAR.S38156; Elgamal OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076402; Fang ZY, 2013, J BIOL CHEM, V288, P7918, DOI 10.1074/jbc.M112.416842; Feng Y, 2014, INT J CLIN EXP PATHO, V7, P64; Feng Z, 2014, LAB INVEST, V94, P439, DOI 10.1038/labinvest.2014.4; Friso S, 2015, TRANSL RES, V165, P154, DOI 10.1016/j.trsl.2014.06.007; Grange C, 2014, FRONTIERS ONCOLOGY, V4, P1; Gupta R, 2015, AM J REPROD IMMUNOL, V73, P126, DOI 10.1111/aji.12281; Havelange V, 2014, BLOOD, V123, P2412, DOI 10.1182/blood-2013-10-532374; He Y, 2013, BIOCHIMIE, V95, P1355, DOI 10.1016/j.biochi.2013.03.010; Herrero AB, 2011, EMBO J, V30, P2008, DOI 10.1038/emboj.2011.117; Huang QH, 2015, CIRCULATION, V131, P1082, DOI 10.1161/CIRCULATIONAHA.114.012725; Igietseme JU, 2013, J INFECT DIS, V207, P1095, DOI 10.1093/infdis/jit009; Igietseme JU, 2009, J INFECT DIS, V200, P926, DOI 10.1086/605411; Jayachandran A, 2014, ONCOTARGET, V5, P5782, DOI 10.18632/oncotarget.2164; Jimenez-Salazar JE, 2014, HORM CANCER-US, V5, P161, DOI 10.1007/s12672-014-0180-3; Jonsdottir K, 2012, BREAST CANCER RES TR, V135, P381, DOI 10.1007/s10549-012-2155-9; Kang H, 2009, INT J ONCOL, V35, P205, DOI 10.3892/ijo_00000330; Kawahara H, 2013, J BIOCHEM, V153, P147, DOI 10.1093/jb/mvs149; Kim BR, 2014, CELL SIGNAL, V26, P1765, DOI 10.1016/j.cellsig.2014.05.010; Kim T, 2009, EMBO J, V28, P1612, DOI 10.1038/emboj.2009.118; Kiyamova R, 2012, BIOMARKERS, V17, P362, DOI 10.3109/1354750X.2012.677476; Kothari AN, 2014, CLIN TRANSL MED, V3, DOI 10.1186/s40169-014-0035-0; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Laws MJ, 2008, DEVELOPMENT, V135, P2659, DOI 10.1242/dev.019810; Lee K, 2012, INT REV CEL MOL BIO, V294, P171, DOI 10.1016/B978-0-12-394305-7.00004-5; Lee M. H., 2011, CELL CYCLE, V10, P3057, DOI [DOI 10.4161/CC.10.18, 10.4161/cc.10.18.17320, DOI 10.4161/CC.10.18.17320]; Legare C, 2014, J PROTEOME RES, V13, P5403, DOI 10.1021/pr501031x; Lin WY, 2015, J HEPATOL, V62, P1024, DOI 10.1016/j.jhep.2014.11.038; Liu Y, 2013, CANCER DISCOV, V3, P870, DOI 10.1158/2159-8290.CD-13-0015; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Moon HJ, 2014, BIOORG CHEM, V57, P231, DOI 10.1016/j.bioorg.2014.07.003; Moore R, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-39; Mtango NR, 2014, ADV EXP MED BIOL, V759, P89, DOI 10.1007/978-1-4939-0817-2_5; Muhlen S, 2010, INT J ONCOL, V37, P337, DOI 10.3892/ijo_00000682; Murthy AK, 2011, INFECT IMMUN, V79, P2928, DOI 10.1128/IAI.05022-11; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Nishikawa R, 2014, INT J ONCOL, V45, P401, DOI 10.3892/ijo.2014.2437; Nothnick WB, 2012, REPRODUCTION, V143, P559, DOI 10.1530/REP-11-0240; Oikonomou N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000108; Pal S, 1998, J MED MICROBIOL, V47, P599, DOI 10.1099/00222615-47-7-599; Pei XH, 2014, BIOCHEM BIOPH RES CO, V446, P322, DOI 10.1016/j.bbrc.2014.02.109; Prins JR, 2012, J REPROD IMMUNOL, V95, P1, DOI 10.1016/j.jri.2012.05.004; Ramon LA, 2012, HUM REPROD, V27, P3036, DOI 10.1093/humrep/des292; Ren LF, 2013, BIOCHEM BIOPH RES CO, V436, P192, DOI 10.1016/j.bbrc.2013.05.072; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Rubina KA, 2015, CANCERS, V7, P1349, DOI 10.3390/cancers7030840; Rylski M, 2008, J BIOL CHEM, V283, P35140, DOI 10.1074/jbc.M804540200; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Shao R, 2014, PROSTATE, V74, P970, DOI 10.1002/pros.22814; Shen YH, 2013, CELL BIOCHEM BIOPHYS, V66, P139, DOI 10.1007/s12013-012-9462-y; Shi ZQ, 2014, CRIT REV EUKAR GENE, V24, P55, DOI 10.1615/CritRevEukaryotGeneExpr.2014007798; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Simonetti AC, 2009, MICROBES INFECT, V11, P435, DOI 10.1016/j.micinf.2009.01.004; Song SJ, 2014, CELL CYCLE, V13, P11, DOI 10.4161/cc.27027; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Song SJ, 2013, CELL STEM CELL, V13, P87, DOI 10.1016/j.stem.2013.06.003; Streicher KL, 2007, ONCOGENE, V26, P2104, DOI 10.1038/sj.onc.1210002; Su LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054237; Sweetwyne MT, 2012, MATRIX BIOL, V31, P178, DOI 10.1016/j.matbio.2012.01.006; Takahashi R, 2014, FRONT GENET, V4, DOI 10.3389/fgene.2013.00295; TUFFREY M, 1981, FEMS MICROBIOL LETT, V12, P111; TUFFREY M, 1992, J REPROD FERTIL, V95, P31, DOI 10.1530/jrf.0.0950031; Veresov VG, 2014, CELL SIGNAL, V26, P370, DOI 10.1016/j.cellsig.2013.11.016; Wang RJ, 2015, CANCER LETT, V356, P568, DOI 10.1016/j.canlet.2014.10.003; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xiong GF, 2011, MOL CELL ENDOCRINOL, V331, P23, DOI 10.1016/j.mce.2010.06.003; Yamamoto N, 2013, INT J ONCOL, V43, P1855, DOI 10.3892/ijo.2013.2145; Yan JC, 2013, CURR CANCER DRUG TAR, V13, P930, DOI 10.2174/15680096113136660098; Yang DH, 2007, J BIOL CHEM, V282, P13114, DOI 10.1074/jbc.M611356200; Yeruva L, 2014, MBIO, V5, P01241; Yu JW, 2014, LAB INVEST, V94, P978, DOI 10.1038/labinvest.2014.91; Yu J, 2014, MOL HUM REPROD, V20, P260, DOI 10.1093/molehr/gat087; Yu J, 2011, MOL CELL ENDOCRINOL, V344, P25, DOI 10.1016/j.mce.2011.04.011; Yun UJ, 2012, CANCER LETT, V323, P155, DOI 10.1016/j.canlet.2012.04.003; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019; Zarnescu DC, 2013, TRENDS CARDIOVAS MED, V23, P275, DOI 10.1016/j.tcm.2013.03.003; Zhang C, 2009, CELL BIOL INT, V33, P632, DOI 10.1016/j.cellbi.2009.02.017; Zhang SN, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-14; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhang Y, 2014, MOL THER, V22, P974, DOI 10.1038/mt.2014.25; Zhang ZY, 2014, PAK J MED SCI, V30, P432	105	30	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145198	10.1371/journal.pone.0145198	http://dx.doi.org/10.1371/journal.pone.0145198			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26681200	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400055
J	Koellinger, P; Treffers, T				Koellinger, Philipp; Treffers, Theresa			Joy Leads to Overconfidence, and a Simple Countermeasure	PLOS ONE			English	Article							POSITIVE ILLUSIONS; CEO OVERCONFIDENCE; RISK-AVERSION; MOOD; CONFIDENCE; DECISION; ENTREPRENEURS; JUDGMENTS; REALISM; ERROR	Overconfidence has been identified as a source of suboptimal decision making in many real-life domains, with often far-reaching consequences. This study identifies a mechanism that can cause overconfidence and demonstrates a simple, effective countermeasure in an incentive-compatible experimental study. We observed that joy induced overconfidence if the reason for joy (an unexpected gift) was unrelated to the judgment task and if participants were not made specifically aware of this mood manipulation. In contrast, we observed well-calibrated judgments among participants in a control group who were in their resting mood. Furthermore, we found well-calibrated judgments among participants who received the joyful mood induction together with questions that forced them to reflect on their current mood and the (ir)relevance of its cause to our judgment tasks. Our findings suggest that being aware of one's positive mood and the reason for that mood may effectively reduce over-confidence for a short period.	[Koellinger, Philipp] Erasmus Univ, Erasmus Sch Econ, Rotterdam, Netherlands; [Koellinger, Philipp] Univ Amsterdam, Fac Econ & Business, Amsterdam, Netherlands; [Koellinger, Philipp] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Complex Trait Genet, Amsterdam, Netherlands; [Treffers, Theresa] Eindhoven Univ Technol, Sch Ind Engn & Innovat Sci, NL-5600 MB Eindhoven, Netherlands	Erasmus University Rotterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Eindhoven University of Technology	Koellinger, P (corresponding author), Erasmus Univ, Erasmus Sch Econ, Rotterdam, Netherlands.	p.d.koellinger@vu.nl		Koellinger, Philipp/0000-0001-7413-0412	Erasmus Research Institute of Management; German Research Foundation [PI 97/15-1]; Munich Experimental Laboratory for Economic and Social Sciences; Erasmus Behavioral Lab.	Erasmus Research Institute of Management; German Research Foundation(German Research Foundation (DFG)); Munich Experimental Laboratory for Economic and Social Sciences; Erasmus Behavioral Lab.	The authors acknowledge financial aid from the Erasmus Research Institute of Management and the German Research Foundation (PI 97/15-1). The authors are also grateful for organizational support from the Munich Experimental Laboratory for Economic and Social Sciences and the Erasmus Behavioral Lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2013, CURR OPIN CLIN NUTR, V16, P434, DOI 10.1097/MCO.0b013e328361c8b8; ALLWOOD CM, 1991, SCAND J PSYCHOL, V32, P358, DOI 10.1111/j.1467-9450.1991.tb00887.x; Allwood CM, 2002, SCAND J PSYCHOL, V43, P253, DOI 10.1111/1467-9450.00293; ARKES HR, 1987, ORGAN BEHAV HUM DEC, V39, P133, DOI 10.1016/0749-5978(87)90049-5; Astebro T, 2003, ECON J, V113, P226, DOI 10.1111/1468-0297.00089; Astebro T, 2007, J BEHAV DECIS MAKING, V20, P253, DOI 10.1002/bdm.554; Barber BM, 2001, Q J ECON, V116, P261, DOI 10.1162/003355301556400; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bengtsson C, 2005, ECON LETT, V86, P199, DOI 10.1016/j.econlet.2004.07.012; Benton D, 2002, NEUROSCI BIOBEHAV R, V26, P293, DOI 10.1016/S0149-7634(02)00004-0; Bernardo AE, 2001, J ECON MANAGE STRAT, V10, P301, DOI 10.1111/j.1430-9134.2001.00301.x; Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; Blavatskyy PR, 2009, J RISK UNCERTAINTY, V38, P39, DOI 10.1007/s11166-008-9048-7; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; Branas-Garza P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029842; Budescu DV, 1997, J BEHAV DECIS MAKING, V10, P173, DOI 10.1002/(SICI)1099-0771(199709)10:3<173::AID-BDM261>3.0.CO;2-6; Busenitz LW, 1997, J BUS VENTURING, V12, P9, DOI 10.1016/S0883-9026(96)00003-1; Camerer C, 1999, AM ECON REV, V89, P306, DOI 10.1257/aer.89.1.306; Cesarini D, 2006, J ECON BEHAV ORGAN, V61, P453, DOI 10.1016/j.jebo.2004.10.010; Cesarini D, 2009, J EUR ECON ASSOC, V7, P617, DOI 10.1162/JEEA.2009.7.2-3.617; CHRISTENSEN L, 1993, BEHAV NEUROSCI, V107, P346, DOI 10.1037/0735-7044.107.2.346; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Cohen J.E., 1988, STAT POWER ANAL BEHA; COLVIN CR, 1994, PSYCHOL BULL, V116, P3, DOI 10.1037/0033-2909.116.1.3; COLVIN CR, 1995, J PERS SOC PSYCHOL, V68, P1152, DOI 10.1037/0022-3514.68.6.1152; COOPER AC, 1988, J BUS VENTURING, V3, P97, DOI 10.1016/0883-9026(88)90020-1; Cummins RA., 2002, J HAPPINESS STUD, V3, P37, DOI [10.1023/A:1015678915305, DOI 10.1023/A:1015678915305, 10.1023/a:1015678915305]; Dalton PS, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00005; Davidson Richard, 1994, NATURE EMOTION FUNDA, P51; DellaVigna S, 2009, J ECON LIT, V47, P315, DOI 10.1257/jel.47.2.315; Diener E, 1991, SUBJECTIVE WELL BEIN, P119, DOI DOI 10.1007/978-90-481-2354-4_10; Dohmen T, 2005, 1730 DIW; Dunbar K., 1995, NATURE INSIGHT, P365, DOI DOI 10.1016/S0193-3973(99)00050-7; DUNNING D, 1991, J PERS SOC PSYCHOL, V61, P521, DOI 10.1037/0022-3514.61.4.521; Dunning David, 2004, Psychol Sci Public Interest, V5, P69, DOI 10.1111/j.1529-1006.2004.00018.x; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ely JW, 2011, ACAD MED, V86, P307, DOI 10.1097/ACM.0b013e31820824cd; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FISCHHOFF B, 1977, J EXP PSYCHOL HUMAN, V3, P552, DOI 10.1037/0096-1523.3.4.552; FORGAS JP, 1995, PSYCHOL BULL, V117, P39, DOI 10.1037/0033-2909.117.1.39; Freedman J., 1978, HAPPY PEOPLE WHAT HA; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Fu T, 2005, J PSYCHOPATHOL BEHAV, V27, P243, DOI 10.1007/s10862-005-2404-x; Galasso A, 2011, MANAGE SCI, V57, P1469, DOI 10.1287/mnsc.1110.1374; Gasper K, 2004, COGNITION EMOTION, V18, P405, DOI 10.1080/02699930341000068; Gasper K, 2000, PERS SOC PSYCHOL B, V26, P698, DOI 10.1177/0146167200268005; GERRARDSHESSE A, 1994, BRIT J PSYCHOL, V85, P55, DOI 10.1111/j.2044-8295.1994.tb02508.x; Goel AM, 2008, J FINANC, V63, P2737, DOI 10.1111/j.1540-6261.2008.01412.x; GOLEC J, 1995, J RISK UNCERTAINTY, V11, P51, DOI 10.1007/BF01132730; Gorn GJ, 2003, J CON PSYCH, V2, P237; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Hamann S, 2012, TRENDS COGN SCI, V16, P458, DOI 10.1016/j.tics.2012.07.006; Haran U, 2013, JUDGM DECIS MAK, V8, P188; Haran U, 2010, JUDGM DECIS MAK, V5, P467; Heath C, 1998, RES ORGAN BEHAV, V20, P1; Hirshleifer D, 2012, J FINANC, V67, P1457, DOI 10.1111/j.1540-6261.2012.01753.x; Hoelzl E, 2005, ECON J, V115, P305, DOI 10.1111/j.1468-0297.2005.00990.x; Hoffrage U, 2004, COGNITIVE ILLUSIONS: A HANDBOOK ON FALLACIES AND BIASES IN THINKING, JUDGEMENT AND MEMORY, P235; Holt CA, 2005, AM ECON REV, V95, P902, DOI 10.1257/0002828054201459; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Ifcher J., 2011, NEGATIVE AFFECT OVER; Ifcher J, 2014, J NEUROSCI PSYCHOL E, V7, P125, DOI 10.1037/npe0000022; ISEN AM, 1987, ORGAN BEHAV HUM DEC, V39, P145, DOI 10.1016/0749-5978(87)90034-3; ISEN AM, 1978, J PERS SOC PSYCHOL, V36, P1, DOI 10.1037/0022-3514.36.1.1; Isen AM., 2007, PERSONS CONTEXT BUIL, P130; Isen AM, 1987, CONNOTATIVE AFFECTIV, P125; Johnson DD., 2009, OVERCONFIDENCE WAR H; Kadous K, 2001, CONTEMP ACCOUNT RES, V18, P425, DOI 10.1506/GM8A-HNPH-LL3L-98FY; KAHNEMAN D, 1993, MANAGE SCI, V39, P17, DOI 10.1287/mnsc.39.1.17; Kahneman D., 2011, THINKING FAST SLOW; Kirchler E, 2002, J RISK UNCERTAINTY, V25, P65, DOI 10.1023/A:1016319430881; Koellinger P, 2008, SMALL BUS ECON, V31, P21, DOI 10.1007/s11187-008-9107-0; Koellinger P, 2007, J ECON PSYCHOL, V28, P502, DOI 10.1016/j.joep.2006.11.002; Koriat A, 2002, J EXP PSYCHOL GEN, V131, P147, DOI 10.1037//0096-3445.131.2.147; KORIAT A, 1980, J EXP PSYCHOL-HUM L, V6, P107, DOI 10.1037/0278-7393.6.2.107; Kuhn GJ, 2002, ACAD EMERG MED, V9, P740, DOI 10.1111/j.1553-2712.2002.tb02155.x; Kurtz JL, 2007, J EXP SOC PSYCHOL, V43, P979, DOI 10.1016/j.jesp.2006.10.020; Kuvaas B, 2004, J BEHAV DECIS MAKING, V17, P59, DOI 10.1002/bdm.461; Larrick RP, 2007, ORGAN BEHAV HUM DEC, V102, P76, DOI 10.1016/j.obhdp.2006.10.002; Lerner JS, 2003, PSYCHOL SCI, V14, P144, DOI 10.1111/1467-9280.01433; Malmendier U, 2005, J FINANC, V60, P2661, DOI 10.1111/j.1540-6261.2005.00813.x; Malmendier U, 2008, J FINANC ECON, V89, P20, DOI 10.1016/j.jfineco.2007.07.002; Maxwell SE, 2004, PSYCHOL METHODS, V9, P147, DOI 10.1037/1082-989X.9.2.147; McFarland C, 2003, J EXP SOC PSYCHOL, V39, P483, DOI 10.1016/S0022-1031(03)00025-8; Merrow E., 1981, UNDERSTANDING COST G; Moore DA, 2008, PSYCHOL REV, V115, P502, DOI 10.1037/0033-295X.115.2.502; Moore DA, 2007, J PERS SOC PSYCHOL, V92, P972, DOI 10.1037/0022-3514.92.6.972; Norman GR, 2010, MED EDUC, V44, P94, DOI 10.1111/j.1365-2923.2009.03507.x; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Pulford BD, 1997, PERS INDIV DIFFER, V23, P125, DOI 10.1016/S0191-8869(97)00028-7; Ren Y, 2013, MANAGE SCI; Russo JE, 2013, PALGRAVE ENCY STRATE; Schaefer PS, 2004, J RES PERS, V38, P473, DOI 10.1016/j.jrp.2003.09.010; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Seligman M., 1991, LEARNT OPTIMISM; Simonsohn U, 2010, MANAGE SCI, V56, P1060, DOI 10.1287/mnsc.1100.1180; SMITH VL, 1982, AM ECON REV, V72, P923; Soll JB, 2004, J EXP PSYCHOL LEARN, V30, P299, DOI 10.1037/0278-7393.30.2.299; Soll JB, 2014, JUDGMENT DECISION MA; TAYLOR SE, 1994, PSYCHOL BULL, V116, P21, DOI 10.1037/0033-2909.116.1.21; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Taylor SE, 2000, AM PSYCHOL, V55, P99, DOI 10.1037//0003-066X.55.1.99; THAYER RE, 1993, PERS INDIV DIFFER, V14, P97, DOI 10.1016/0191-8869(93)90178-6; Urbig D., 2009, DISCUSSION PAPER SER, V9; Vautier S, 2008, APPL PSYCH MEAS, V32, P575, DOI 10.1177/0146621607310646; Weinstein ND, 2003, BLACKW SER HLTH PSYC, P22; Westermann R, 1996, EUR J SOC PSYCHOL, V26, P557, DOI 10.1002/(SICI)1099-0992(199607)26:4<557::AID-EJSP769>3.0.CO;2-4; White K, 2009, J CONSUM PSYCHOL, V19, P526, DOI 10.1016/j.jcps.2009.05.004; Yeung CWM, 2004, J CONSUM RES, V31, P412, DOI 10.1086/422119	111	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0143263	10.1371/journal.pone.0143263	http://dx.doi.org/10.1371/journal.pone.0143263			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JO	26678704	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400003
J	Moorthy, AS; Brooks, SPJ; Kalmokoff, M; Eberl, HJ				Moorthy, Arun S.; Brooks, Stephen P. J.; Kalmokoff, Martin; Eberl, Hermann J.			A Spatially Continuous Model of Carbohydrate Digestion and Transport Processes in the Colon	PLOS ONE			English	Article							GUT MICROBIOTA; LARGE-INTESTINE; SURFACE-AREA; FERMENTATION; HEALTH; IMPACT; TRACT; PERSPECTIVES; DEGRADATION; RESPONSES	A spatially continuous mathematical model of transport processes, anaerobic digestion and microbial complexity as would be expected in the human colon is presented. The model is a system of first-order partial differential equations with context determined number of dependent variables, and stiff, non-linear source terms. Numerical simulation of the model is used to elucidate information about the colon-microbiota complex. It is found that the composition of materials on outflow of the model does not well-describe the composition of material in other model locations, and inferences using outflow data varies according to model reactor representation. Additionally, increased microbial complexity allows the total microbial community to withstand major system perturbations in diet and community structure. However, distribution of strains and functional groups within the microbial community can be modified depending on perturbation length and microbial kinetic parameters. Preliminary model extensions and potential investigative opportunities using the computational model are discussed.	[Moorthy, Arun S.; Eberl, Hermann J.] Univ Guelph, Biophys Interdept Grp, Guelph, ON N1G 2W1, Canada; [Moorthy, Arun S.; Eberl, Hermann J.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Brooks, Stephen P. J.] Hlth Canada, Food Directorate, Bur Nutr, Ottawa, ON K1A 0L2, Canada; [Kalmokoff, Martin] Agr & Agri Food Canada, Atlantic Food & Hort Res Stn, Kentville, NS, Canada	University of Guelph; University of Guelph; Health Canada; Agriculture & Agri Food Canada	Moorthy, AS (corresponding author), Univ Guelph, Biophys Interdept Grp, Guelph, ON N1G 2W1, Canada.	amoorthy@uoguelph.ca	Moorthy, Arun/AAS-2064-2021	Moorthy, Arun/0000-0002-5988-1389; Eberl, Hermann/0000-0001-5558-0872; Brooks, Stephen/0000-0002-1169-6221	Ontario Ministry of Agriculture Food and Rural Affairs [200130]; Ontario Ministry of Agriculture and Rural Affairs (OMAFRA) grant	Ontario Ministry of Agriculture Food and Rural Affairs; Ontario Ministry of Agriculture and Rural Affairs (OMAFRA) grant	This research was funded by an Ontario Ministry of Agriculture Food and Rural Affairs (grant no. 200130) received by HJE.; This research was funded by an Ontario Ministry of Agriculture and Rural Affairs (OMAFRA) grant. The authors would like to express their gratitude to Jesse Knight, Kathleen Songin and Richard Yam for their assistance developing compuGUT software tools.	Batstone Damien J., 2006, Reviews in Environmental Science and Bio/Technology, V5, P57, DOI 10.1007/s11157-005-7191-z; Batstone DJ, 2002, WATER SCI TECHNOL, V45, P65; Bonfrate L, 2013, SCAND J GASTROENTERO, V48, P995, DOI 10.3109/00365521.2013.799220; Brooks SPJ, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 4: AGRICULTURAL AND RELATED BIOTECHNOLOGIES, 2ND EDITION, P575; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Edlund C, 2000, J ANTIMICROB CHEMOTH, V46, P41, DOI 10.1093/jac/46.suppl_1.41; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Gesmann M, 2011, R J, V3, P40; Green-Johnson JM, 2012, J AOAC INT, V95, P35, DOI 10.5740/jaoacint.SGE_Green-Johnson; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Helander HF, 2014, SCAND J GASTROENTERO, V49, P681, DOI 10.3109/00365521.2014.898326; Hester RL, 2011, J PHYSIOL-LONDON, V589, P1053, DOI 10.1113/jphysiol.2010.201558; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Kettle H, 2014, ENV MICROBIOLOGY; Kovatchev Boris P, 2009, J Diabetes Sci Technol, V3, P44; Liotta SF, 2000, SIAM J NUMER ANAL, V38, P1337, DOI 10.1137/S0036142999363061; Macfarlane GT, 2007, CURR OPIN BIOTECH, V18, P156, DOI 10.1016/j.copbio.2007.01.011; Macia L, 2012, IMMUNOL REV, V245, P164, DOI 10.1111/j.1600-065X.2011.01080.x; Maqbool S, 2009, DIGEST DIS SCI, V54, P2167, DOI 10.1007/s10620-009-0899-9; Mc Caffrey C, 2008, IEEE PERVAS COMPUT, V7, P23, DOI 10.1109/MPRV.2008.17; Minekus M, 1999, APPL MICROBIOL BIOT, V53, P108, DOI 10.1007/s002530051622; MOLLY K, 1993, APPL MICROBIOL BIOT, V39, P254, DOI 10.1007/BF00228615; Moorthy AS, 2014, J BIOSCI BIOENG, V117, P478, DOI 10.1016/j.jbiosc.2013.09.015; Munoz-Tamayo R, 2010, J THEOR BIOL, V266, P189, DOI 10.1016/j.jtbi.2010.05.040; Payne AN, 2012, TRENDS BIOTECHNOL, V30, P17, DOI 10.1016/j.tibtech.2011.06.011; Ramirez I, 2009, WATER RES, V43, P2787, DOI 10.1016/j.watres.2009.03.034; Rostami-Hodjegan Amin, 2004, Drug Discov Today Technol, V1, P441, DOI 10.1016/j.ddtec.2004.10.002; Rubio R, 2014, FOOD MICROBIOL, V38, P303, DOI 10.1016/j.fm.2013.07.015; SADAHIRO S, 1992, SURG RADIOL ANAT, V14, P251, DOI 10.1007/BF01794949; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Taghipoor M, 2014, MATH BIOSCI, V258, P101, DOI 10.1016/j.mbs.2014.09.011; Taghipoor M, 2012, J THEOR BIOL, V294, P114, DOI 10.1016/j.jtbi.2011.10.024; Tortora GJ, 2008, PRINCIPLES ANATOMY P; Vardakou M, 2007, INT J BIOL MACROMOL, V41, P584, DOI 10.1016/j.ijbiomac.2007.07.017; Williams CF, 2015, ANNU REV FOOD SCI T, V6, P329, DOI 10.1146/annurev-food-022814-015429	42	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145309	10.1371/journal.pone.0145309	http://dx.doi.org/10.1371/journal.pone.0145309			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680208	Green Submitted, Green Published, gold			2022-12-27	WOS:000366723400070
J	Ruegsegger, GN; Company, JM; Toedebusch, RG; Roberts, CK; Roberts, MD; Booth, FW				Ruegsegger, Gregory N.; Company, Joseph M.; Toedebusch, Ryan G.; Roberts, Christian K.; Roberts, Michael D.; Booth, Frank W.			Rapid Alterations in Perirenal Adipose Tissue Transcriptomic Networks with Cessation of Voluntary Running	PLOS ONE			English	Article							GENE-EXPRESSION; ADIPOCYTE HYPERPLASIA; INSULIN-RESISTANCE; CHILDHOOD OBESITY; WEIGHT-REDUCTION; EPIDIDYMAL FAT; CELL-CYCLE; INFLAMMATION; PROTEIN; RATS	In maturing rats, the growth of abdominal fat is attenuated by voluntary wheel running. After the cessation of running by wheel locking, a rapid increase in adipose tissue growth to a size that is similar to rats that have never run (i.e. catch-up growth) has been previously reported by our lab. In contrast, diet-induced increases in adiposity have a slower onset with relatively delayed transcriptomic responses. The purpose of the present study was to identify molecular pathways associated with the rapid increase in adipose tissue after ending 6 wks of voluntary running at the time of puberty. Age-matched, male Wistar rats were given access to running wheels from 4 to 10 weeks of age. From the 10th to 11th week of age, one group of rats had continued wheel access, while the other group had one week of wheel locking. Perirenal adipose tissue was extracted, RNA sequencing was performed, and bioinformatics analyses were executed using Ingenuity Pathway Analysis (IPA). IPA was chosen to assist in the understanding of complex ` omics data by integrating data into networks and pathways. Wheel locked rats gained significantly more fat mass and significantly increased body fat percentage between weeks 10-11 despite having decreased food intake, as compared to rats with continued wheel access. IPA identified 646 known transcripts differentially expressed (p < 0.05) between continued wheel access and wheel locking. In wheel locked rats, IPA revealed enrichment of transcripts for the following functions: extracellular matrix, macrophage infiltration, immunity, and pro-inflammatory. These findings suggest that increases in visceral adipose tissue that accompanies the cessation of pubertal physical activity are associated with the alteration of multiple pathways, some of which may potentiate the development of pubertal obesity and obesity-associated systemic low-grade inflammation that occurs later in life.	[Ruegsegger, Gregory N.; Company, Joseph M.; Toedebusch, Ryan G.; Roberts, Michael D.; Booth, Frank W.] Univ Missouri, Coll Vet Med, Dept Biomed Sci, Columbia, MO 65211 USA; [Roberts, Christian K.] VA Greater Los Angeles Healthcare Syst, Geriatr Res Educ & Clin Ctr, Los Angeles, CA USA; [Booth, Frank W.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA; [Booth, Frank W.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA; [Booth, Frank W.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Booth, FW (corresponding author), Univ Missouri, Coll Vet Med, Dept Biomed Sci, Columbia, MO 65211 USA.	boothf@missouri.edu		Ruegsegger, Gregory/0000-0002-8018-0456				Adapala VJ, 2012, J NUTR BIOCHEM, V23, P567, DOI 10.1016/j.jnutbio.2011.02.013; Aydin S, 2014, NUTRITION, V30, P1, DOI 10.1016/j.nut.2013.05.013; Bragina O, 2015, J BIOENERG BIOMEMBR, V47, P209, DOI 10.1007/s10863-015-9609-9; Carobbio S, 2013, DIABETES, V62, P3697, DOI 10.2337/db12-1748; Cho KW, 2014, CELL REP, V9, P605, DOI 10.1016/j.celrep.2014.09.004; Company JM, 2013, AM J PHYSIOL-REG I, V305, pR1465, DOI 10.1152/ajpregu.00139.2013; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; Flintoff KA, 2014, J CELL PHYSIOL, V229, P1538, DOI 10.1002/jcp.24597; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Jackman MR, 2008, AM J PHYSIOL-REG I, V294, pR1117, DOI 10.1152/ajpregu.00808.2007; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kim DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083363; Kless C, 2015, MOL NUTR FOOD RES, V59, P968, DOI 10.1002/mnfr.201400840; Kump DS, 2006, AM J PHYSIOL-ENDOC M, V290, pE480, DOI 10.1152/ajpendo.00321.2005; Kump DS, 2005, J PHYSIOL-LONDON, V565, P911, DOI 10.1113/jphysiol.2005.084525; Kump DS, 2005, J PHYSIOL-LONDON, V562, P829, DOI 10.1113/jphysiol.2004.073593; Laye MJ, 2007, J APPL PHYSIOL, V102, P1341, DOI 10.1152/japplphysiol.01018.2006; Li JP, 2002, AM J PHYSIOL-ENDOC M, V282, pE1334, DOI 10.1152/ajpendo.00516.2001; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041610; MacLean PS, 2006, AM J PHYSIOL-REG I, V290, pR1577, DOI 10.1152/ajpregu.00810.2005; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; McQuaid SE, 2011, DIABETES, V60, P47, DOI 10.2337/db10-0867; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munoz A, 2013, J CLIN ENDOCR METAB, V98, pE1360, DOI 10.1210/jc.2012-3841; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Roberts MD, 2013, AM J PHYSIOL-REG I, V304, pR1024, DOI 10.1152/ajpregu.00581.2012; Roberts MD, 2012, AM J PHYSIOL-REG I, V303, pR247, DOI 10.1152/ajpregu.00167.2012; Rosini TC, 2012, REV ASSOC MED BRAS, V58, P383; Rustemeyer SM, 2011, J ANIM SCI, V89, P916, DOI 10.2527/jas.2010-3473; Schafer N, 2014, METABOLOMICS, V10, P461, DOI 10.1007/s11306-013-0590-1; Song HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035552; St-Amand J, 2001, FASEB J, V15, P684, DOI 10.1096/fj.00-0150com; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Tam CS, 2011, INT J PEDIATR OBES, V6, pE360, DOI 10.3109/17477166.2011.575152; Toedebusch RG, 2014, PHYSIOL GENOMICS, V46, P362, DOI 10.1152/physiolgenomics.00172.2013; Turaga RVN, 2009, CELL CYCLE, V8, P2080, DOI 10.4161/cc.8.13.8925; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Vadiveloo PK, 1998, J BIOL CHEM, V273, P23104, DOI 10.1074/jbc.273.36.23104; van Dijk A, 2008, CELL TISSUE RES, V332, P289, DOI 10.1007/s00441-008-0573-0; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang W, 2015, COMP BIOCHEM PHYS A, V181, P62, DOI 10.1016/j.cbpa.2014.11.012; Zhang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096997	47	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145229	10.1371/journal.pone.0145229	http://dx.doi.org/10.1371/journal.pone.0145229			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678390	gold, Green Submitted, Green Published			2022-12-27	WOS:000366723400060
J	Bennitt, E; Bonyongo, MC; Harris, S				Bennitt, Emily; Bonyongo, Mpaphi Casper; Harris, Stephen			Behaviour-Related Scalar Habitat Use by Cape Buffalo (Syncerus caffer caffer)	PLOS ONE			English	Article							AFRICAN BUFFALO; OKAVANGO DELTA; NATIONAL-PARK; LARGE HERBIVORE; MOVEMENT PATTERNS; SPECIES-DIVERSITY; ANIMAL MOVEMENTS; SPATIAL SCALES; TRADE-OFF; SELECTION	Studies of habitat use by animals must consider behavioural resource requirements at different scales, which could influence the functional value of different sites. Using Cape buffalo (Syncerus caffer caffer) in the Okavango Delta, Botswana, we tested the hypotheses that behaviour affected use between and within habitats, hereafter referred to as macro-and microhabitats, respectively. We fitted GPS-enabled collars to fifteen buffalo and used the distances and turning angles between consecutive fixes to cluster the resulting data into resting, grazing, walking and relocating behaviours. Distance to water and six vegetation characteristic variables were recorded in sites used for each behaviour, except for relocating, which occurred too infrequently. We used multilevel binomial and multinomial logistic regressions to identify variables that characterised seasonally-preferred macrohabitats and microhabitats used for different behaviours. Our results showed that macrohabitat use was linked to behaviour, although this was least apparent during the rainy season, when resources were most abundant. Behaviour-related microhabitat use was less significant, but variation in forage characteristics could predict some behaviour within all macrohabitats. The variables predicting behaviour were not consistent, but resting and grazing sites were more readily identifiable than walking sites. These results highlight the significance of resting, as well as foraging, site availability in buffalo spatial processes. Our results emphasise the importance of considering several behaviours and scales in studies of habitat use to understand the links between environmental resources and animal behavioural and spatial ecology.	[Bennitt, Emily; Harris, Stephen] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Bonyongo, Mpaphi Casper] Okavango Res Inst, Maun, Botswana	University of Bristol	Bennitt, E (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	ebennitt@ori.ub.bw	Bennitt, Emily/AAB-6032-2020; Bonyongo, Mpaphi Casper/AAS-1423-2021		Dulverton Trust; North of England Zoological Society; Idea Wild; Roberts Fund; Wilderness Safaris Wildlife Trust	Dulverton Trust; North of England Zoological Society; Idea Wild; Roberts Fund; Wilderness Safaris Wildlife Trust	Support was provided by the Dulverton Trust [http://www.dulverton.org/] to SH; the North of England Zoological Society [http://www.chesterzoo.org/global/north-of-england-zoological-society] to EB; Idea Wild [http://www.ideawild.org/] to EB; the Roberts Fund [https://www.cs.bris.ac.uk/Teaching/learning/roberts.html] to EB; the Wilderness Safaris Wildlife Trust [http://www.wildernesstrust.com/] to EB; Mr Rodney Fuhr to EB; Mr Ian Fuhr to EB; Mr Martin and Mrs Jenny Bennitt tp EB; Mr Harry Ferguson to EB; and Dr Dane Hawk to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alldredge JR, 2006, J WILDLIFE MANAGE, V70, P337, DOI 10.2193/0022-541X(2006)70[337:DAAORS]2.0.CO;2; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Bartlam H. L. A., 2010, THESIS; Basille M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065493; Bennitt E., 2012, THESIS; Bennitt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101346; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Bonyongo MC, 2007, AFR J ECOL, V45, P527, DOI 10.1111/j.1365-2028.2007.00764.x; Bowne DR, 1999, LANDSCAPE ECOL, V14, P53, DOI 10.1023/A:1008025827895; BRANSBY DI, 1977, AGRON J, V69, P393, DOI 10.2134/agronj1977.00021962006900030016x; Burkepile DE, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00078.1; Buxton DR, 1996, ANIM FEED SCI TECH, V59, P37, DOI 10.1016/0377-8401(95)00885-3; Chirima GJ, 2012, KOEDOE, V54, DOI 10.4102/koedoe.v54i1.1009; Cornelis D, 2011, J MAMMAL, V92, P1287, DOI 10.1644/10-MAMM-A-397.1; de Knegt HJ, 2007, BEHAV ECOL, V18, P1065, DOI 10.1093/beheco/arm080; de Omena PM, 2010, BEHAV ECOL, V21, P690, DOI 10.1093/beheco/arq040; Devereux CL, 2006, BEHAV ECOL, V17, P303, DOI 10.1093/beheco/arj032; Fortin D, 2003, OECOLOGIA, V134, P219, DOI 10.1007/s00442-002-1112-4; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Fynn RWS, 2014, S AFR J WILDL RES, V44, P1, DOI 10.3957/056.044.0103; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Ganskopp DC, 2007, RANGELAND ECOL MANAG, V60, P350, DOI 10.2111/1551-5028(2007)60[350:GEISAA]2.0.CO;2; GEORGIADIS NJ, 1989, J TROP ECOL, V5, P93, DOI 10.1017/S0266467400003254; Haby NA, 2013, J MAMMAL, V94, P801, DOI 10.1644/12-MAMM-A-220.1; Hardy M. B., 1993, African Journal of Range and Forage Science, V10, P77, DOI 10.1080/10220119.1993.9638327; Heinl M, 2006, LANDSCAPE ECOL, V21, P699, DOI 10.1007/s10980-005-5243-y; Knight TW, 1996, ECOLOGY, V77, P1756, DOI 10.2307/2265781; Korte LM, 2008, J MAMMAL, V89, P115, DOI 10.1644/06-MAMM-A-423.1; Laca EA, 2010, ECOL LETT, V13, P311, DOI 10.1111/j.1461-0248.2009.01423.x; Leblond M, 2010, ECOGRAPHY, V33, P1102, DOI 10.1111/j.1600-0587.2009.06104.x; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Ludwig F, 2004, PLANT ECOL, V170, P93, DOI 10.1023/B:VEGE.0000019023.29636.92; Macandza VA, 2012, J ZOOL, V287, P175, DOI 10.1111/j.1469-7998.2012.00900.x; Macandza VA, 2004, S AFR J WILDL RES, V34, P113; Masse A, 2009, J MAMMAL, V90, P961, DOI 10.1644/08-MAMM-A-148.1; Matawa F, 2012, ECOL MODEL, V242, P189, DOI 10.1016/j.ecolmodel.2012.05.010; Matson TK, 2005, J WILDLIFE MANAGE, V69, P1708, DOI 10.2193/0022-541X(2005)69[1708:MUBBII]2.0.CO;2; Mayor SJ, 2009, ECOSCIENCE, V16, P238, DOI 10.2980/16-2-3238; McCann NP, 2014, J MAMMAL, V95, P369, DOI 10.1644/13-MAMM-A-110; Megaze A, 2013, AFR J ECOL, V51, P393, DOI 10.1111/aje.12049; Melletti M, 2007, J ZOOL, V271, P178, DOI 10.1111/j.1469-7998.2006.00196.x; Melletti M, 2009, AFR J ECOL, V47, P121, DOI 10.1111/j.1365-2028.2008.00965.x; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Mugangu TE, 1995, MAMMALIA, V59, P349, DOI 10.1515/mamm.1995.59.3.349; Muposhi VK, 2014, TROP CONSERV SCI, V7, P440, DOI 10.1177/194008291400700306; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Omphile UJ, 2002, J RANGE MANAGE, V55, P341, DOI 10.2307/4003470; Owen-Smith N, 2004, LANDSCAPE ECOL, V19, P761, DOI 10.1007/s10980-005-0247-2; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Perrin MR, 1999, S AFR J WILDL RES, V29, P72; Peterson DW, 2008, PLANT ECOL, V194, P5, DOI 10.1007/s11258-007-9270-4; Prins HHT, 2014, ECOLOGY, EVOLUTION AND BEHAVIOUR OF WILD CATTLE: IMPLICATIONS FOR CONSERVATION, P21; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ramberg L, 2006, AQUAT SCI, V68, P310, DOI 10.1007/s00027-006-0857-y; Rasbash J., 2015, MLWIN VERSION 2 33; Russell RE, 2003, OIKOS, V103, P142, DOI 10.1034/j.1600-0706.2003.12418.x; Ryan SJ, 2006, J WILDLIFE MANAGE, V70, P764, DOI 10.2193/0022-541X(2006)70[764:RAHSOA]2.0.CO;2; Ryan SJ, 2012, J WILDLIFE MANAGE, V76, P1499, DOI 10.1002/jwmg.407; Schneider TC, 2013, MAMM BIOL, V78, P438, DOI 10.1016/j.mambio.2013.06.002; Semeniuk CAD, 2005, BEHAV ECOL, V16, P417, DOI 10.1093/beheco/ari005; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Shrader AM, 2007, BEHAV ECOL, V18, P103, DOI 10.1093/beheco/arl057; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sinclair A.R.E., 1977, AFRICAN BUFFALO STUD; Siziba N, 2012, AFR J ECOL, V50, P43, DOI 10.1111/j.1365-2028.2011.01289.x; Smit IPJ, 2011, ECOGRAPHY, V34, P67, DOI 10.1111/j.1600-0587.2010.06029.x; Taolo C., 2003, THESIS; Thornton A, 2009, BEHAV ECOL, V20, P103, DOI 10.1093/beheco/arn120; Thorson JM, 1998, BEHAV ECOL, V9, P151, DOI 10.1093/beheco/9.2.151; Valeix M, 2011, BIOL CONSERV, V144, P902, DOI 10.1016/j.biocon.2010.10.029; Van der Boogaart KG, 2006, GEOL SOC SPEC PUBL, V264, P119, DOI 10.1144/GSL.SP.2006.264.01.09; Van Moorter B, 2010, J WILDLIFE MANAGE, V74, P588, DOI 10.2193/2009-155; Venter JA, 2008, S AFR J WILDL RES, V38, P42, DOI 10.3957/0379-4369-38.1.42; WallisDeVries MF, 1999, OECOLOGIA, V121, P355, DOI 10.1007/s004420050939; Wilmshurst JF, 2000, P ROY SOC B-BIOL SCI, V267, P345, DOI 10.1098/rspb.2000.1007; Wilson RR, 2012, WILDLIFE BIOL, V18, P424, DOI 10.2981/12-044; Winnie JA, 2008, ECOLOGY, V89, P1457, DOI 10.1890/07-0772.1; Zollner PA, 2000, WILDLIFE SOC B, V28, P1003	83	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145145	10.1371/journal.pone.0145145	http://dx.doi.org/10.1371/journal.pone.0145145			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673623	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700107
J	Astone, M; Pizzi, M; Peron, M; Domenichini, A; Guzzardo, V; Tochterle, S; Tiso, N; Rugge, M; Meyer, D; Argenton, F; Vettori, A				Astone, Matteo; Pizzi, Marco; Peron, Margherita; Domenichini, Alice; Guzzardo, Vincenza; Toechterle, Sonja; Tiso, Natascia; Rugge, Massimo; Meyer, Dirk; Argenton, Francesco; Vettori, Andrea			A GFP-Tagged Gross Deletion on Chromosome 1 Causes Malignant Peripheral Nerve Sheath Tumors and Carcinomas in Zebrafish	PLOS ONE			English	Article							MUTATIONS; CANCER; GENE	Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive soft-tissue sarcomas, characterized by complex karyotypes. The molecular bases of such malignancy are poorly understood and efficient targeted molecular therapies are currently lacking. Here we describe a novel zebrafish model of MPNSTs, represented by the transgenic mutant line Tg (-8.5nkx2.2a:GFP)(ia2). ia2 homozygous animals displayed embryonic lethality by 72 hpf, while the heterozygotes develop visible tumor masses with high frequency in adulthood. Histological and immunohistochemical examination revealed aggressive tumors with either mesenchymal or epithelial features. The former (54% of the cases) arose either in the abdominal cavity, or as intrathecal/intraspinal lesions and is composed of cytokeratin-negative spindle cells with fascicular/storiform growth pattern consistent with zebrafish MPNSTs. The second histotype was composed by polygonal or elongated cells, immunohistochemically positive for the pan-cytokeratin AE1/AE3. The overall histologic and immunohistochemical features were consistent with a malignant epithelial neoplasm of possible gastrointestinal/pancreatic origin. With an integrated approach, based on microsatellite (VNTR) and STS markers, we showed that ia2 insertion, in Tg(-8.5nkx2.2a:GFP)(ia2) embryos, is associated with a deletion of 15.2 Mb in the telomeric portion of chromosome 1. Interestingly, among ia2 deleted genes we identified the presence of the 40S ribosomal protein S6 gene that may be one of the possible drivers for the MPNSTs in ia2 mutants. Thanks to the peculiar features of zebrafish as animal model of human cancer (cellular and genomic similarity, transparency and prolificacy) and the GFP tag, the Tg(-8.5nkx2.2a:GFP)(ia2) line provides a manageable tool to study in vivo with high frequency MPNST biology and genetics, and to identify, in concert with the existing zebrafish MPNST models, conserved relevant mechanisms in zebrafish and human cancer development.	[Astone, Matteo; Peron, Margherita; Domenichini, Alice; Tiso, Natascia; Argenton, Francesco; Vettori, Andrea] Univ Padua, Dept Biol, Padua, Italy; [Pizzi, Marco; Guzzardo, Vincenza; Rugge, Massimo] Univ Padua, Dept Med DIMED, Gen Pathol & Cytopathol Unit, Padua, Italy; [Toechterle, Sonja; Meyer, Dirk] Univ Innsbruck, Inst Mol Biol, CMBI, A-6020 Innsbruck, Austria	University of Padua; University of Padua; University of Innsbruck	Argenton, F (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	francesco.argenton@unipd.it	Tiso, Natascia/E-2182-2011; Argenton, Francesco/AAS-8494-2021; Rugge, Massimo/K-7525-2016; Vettori, Andrea/J-3951-2014; Pizzi, Marco/H-6273-2016	Tiso, Natascia/0000-0002-5444-9853; Argenton, Francesco/0000-0002-0803-8236; Vettori, Andrea/0000-0003-4958-0619; Pizzi, Marco/0000-0003-4006-7317; Astone, Matteo/0000-0003-3294-9942; Meyer, Dirk/0000-0002-4020-4484	Associazione Italiana per la Ricerca sul Cancro Project [IG 10274]; European Union Grant [ZF-HEALTH CT-2010-242048]; Italian Ministry of Health project Trambigen [RF-2010-2309484]; AFM-Telethon project Polygon [18572]	Associazione Italiana per la Ricerca sul Cancro Project(Fondazione AIRC per la ricerca sul cancro); European Union Grant; Italian Ministry of Health project Trambigen; AFM-Telethon project Polygon	This work was supported by Associazione Italiana per la Ricerca sul Cancro Project IG 10274, European Union Grant ZF-HEALTH CT-2010-242048, Italian Ministry of Health project Trambigen (RF-2010-2309484), and the AFM-Telethon project Polygon (18572). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu E, 2013, EUR J RADIOL, V82, P38, DOI 10.1016/j.ejrad.2011.04.036; Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Cagan R, 2014, DIS MODEL MECH, V7, P735, DOI 10.1242/dmm.016642; CHAKRABARTI S, 1983, GENETICS, V103, P109; Feitsma H, 2008, CANCER RES, V68, P5059, DOI 10.1158/0008-5472.CAN-08-0019; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lai K, 2009, DEV DYNAM, V238, P76, DOI 10.1002/dvdy.21815; MacInnes AW, 2008, P NATL ACAD SCI USA, V105, P10408, DOI 10.1073/pnas.0805036105; Nielsen GP, 2013, WHO CLASSIFICATION T, P187; Pauls S, 2007, DEV BIOL, V304, P875, DOI 10.1016/j.ydbio.2007.01.024; Pizzi M, 2015, ONCOTARGET, V6, P6544, DOI 10.18632/oncotarget.3446; Rhodes J, 2009, MOL CELL BIOL, V29, P5911, DOI 10.1128/MCB.00558-09; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Subramanian S, 2010, J PATHOL, V220, P58, DOI 10.1002/path.2633; THISSE C, 1993, DEVELOPMENT, V119, P1203; Thway K, 2014, ANN DIAGN PATHOL, V18, P109, DOI 10.1016/j.anndiagpath.2013.10.007; White R, 2013, NAT REV CANCER, V13, P624, DOI 10.1038/nrc3589; Yu JS, 2011, CLIN CANCER RES, V17, P1924, DOI 10.1158/1078-0432.CCR-10-1551; Zhang GJ, 2010, P NATL ACAD SCI USA, V107, P16940, DOI 10.1073/pnas.1011548107	21	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145178	10.1371/journal.pone.0145178	http://dx.doi.org/10.1371/journal.pone.0145178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695815	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092500027
J	Cardinali, A; Pizzeghello, D; Zanin, G				Cardinali, Alessandra; Pizzeghello, Diego; Zanin, Giuseppe			Fatty Acid Methyl Ester (FAME) Succession in Different Substrates as Affected by the Co-Application of Three Pesticides	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITIES; DEGRADATION; PROFILES; COMPOST; CARBON; AZOXYSTROBIN; FUNGICIDES; IMPACT; HERBICIDES; STABILITY	Introduction In intensive agriculture areas the use of pesticides can alter soil properties and microbial community structure with the risk of reducing soil quality. Materials and Methods In this study the fatty acid methyl esters (FAMEs) evolution has been studied in a factorial lab experiment combining five substrates (a soil, two aged composts and their mixtures) treated with a co-application of three pesticides (azoxystrobin, chlorotoluron and epoxiconazole), with two extraction methods, and two incubation times (0 and 58 days). FAMEs extraction followed the microbial identification system (MIDI) and ester-linked method (EL). Results and Discussion The pesticides showed high persistence, as revealed by half-life (t(1/2)) values ranging from 168 to 298 days, which confirms their recalcitrance to degradation. However, t(1/2) values were affected by substrate and compost age down to 8 days for chlorotoluron in S and up to 453 days for epoxiconazole in 12M. Fifty-six FAMEs were detected. Analysis of variance (ANOVA) showed that the EL method detected a higher number of FAMEs and unique FAMEs than the MIDI one, whereas principal component analysis (PCA) highlighted that the monosaturated 18:1 omega 9c and cyclopropane 19:0 omega 10c/19 omega 6 were the most significant FAMEs grouping by extraction method. The cyclopropyl to monoenoic acids ratio evidenced higher stress conditions when pesticides were applied to compost and compost+soil than solely soil, as well as with final time. Conclusion Overall, FAMEs profiles showed the importance of the extraction method for both substrate and incubation time, the t(1/2) values highlighted the effectiveness of solely soil and the less mature compost in reducing the persistence of pesticides.	[Cardinali, Alessandra; Pizzeghello, Diego; Zanin, Giuseppe] Univ Padua, DAFNAE, Dept Agron Food Nat Resources Anim & Environm, I-35020 Legnaro, PD, Italy	University of Padua	Pizzeghello, D (corresponding author), Univ Padua, DAFNAE, Dept Agron Food Nat Resources Anim & Environm, Viale Univ 16, I-35020 Legnaro, PD, Italy.	diego.pizzeghello@unipd.it	Pizzeghello, Diego/H-7173-2019	Pizzeghello, Diego/0000-0002-2455-8733				Andreu V, 2004, TRAC-TREND ANAL CHEM, V23, P772, DOI 10.1016/j.trac.2004.07.008; Arias-Estevez M, 2008, AGR ECOSYST ENVIRON, V123, P247, DOI 10.1016/j.agee.2007.07.011; Banks ML, 2014, APPL SOIL ECOL, V74, P12, DOI 10.1016/j.apsoil.2013.08.018; Bernard E, 2012, APPL SOIL ECOL, V52, P29, DOI 10.1016/j.apsoil.2011.10.002; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Boulter-Bitzer JI, 2006, APPL SOIL ECOL, V34, P65, DOI 10.1016/j.apsoil.2005.12.007; Bowles TM, 2014, SOIL BIOL BIOCHEM, V68, P252, DOI 10.1016/j.soilbio.2013.10.004; Cardinali A, 2010, APPL ENVIRON MICROB, V76, P6600, DOI 10.1128/AEM.00824-10; Coppola L, 2011, NEW BIOTECHNOL, V29, P99, DOI 10.1016/j.nbt.2011.03.005; Daniel DW, 2015, SCI TOTAL ENVIRON, V514, P290, DOI 10.1016/j.scitotenv.2015.01.066; Feld L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126080; Feng Y, 2003, SOIL BIOL BIOCHEM, V35, P1693, DOI 10.1016/j.soilbio.2003.08.016; Fenoll J, 2015, ENVIRON SCI POLLUT R, V22, P4336, DOI 10.1007/s11356-014-3652-7; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Garcia-Orenes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080522; Ghafoor A, 2011, ENVIRON SCI TECHNOL, V45, P6411, DOI 10.1021/es2012353; Ghosh RK, 2009, J AGR FOOD CHEM, V57, P632, DOI 10.1021/jf802716f; Glucksman AM, 2000, J APPL MICROBIOL, V88, P711, DOI 10.1046/j.1365-2672.2000.01058.x; HAACK SK, 1994, APPL ENVIRON MICROB, V60, P2483, DOI 10.1128/AEM.60.7.2483-2493.1994; Imfeld G, 2012, EUR J SOIL BIOL, V49, P22, DOI 10.1016/j.ejsobi.2011.11.010; IUSS Working Group, 2006, WORLD REF BAS SOIL R, V103; Jorgensen LF, 2012, CHEMOSPHERE, V88, P554, DOI 10.1016/j.chemosphere.2012.03.027; Karanasios EC, 2013, CHEMOSPHERE, V93, P20, DOI 10.1016/j.chemosphere.2013.04.049; KIEFT TL, 1994, APPL ENVIRON MICROB, V60, P3292, DOI 10.1128/AEM.60.9.3292-3299.1994; Lopes FM, 2010, WORLD J MICROB BIOT, V26, P1155, DOI 10.1007/s11274-009-0283-0; Marinozzi M, 2013, ENVIRON SCI POLLUT R, V20, P2546, DOI 10.1007/s11356-012-1165-9; Navarro S, 2012, J AGR FOOD CHEM, V60, P5279, DOI 10.1021/jf301094c; Petersen SO, 2002, SOIL SCI SOC AM J, V66, P826, DOI 10.2136/sssaj2002.0826; Rodrigues ET, 2013, ENVIRON INT, V53, P18, DOI 10.1016/j.envint.2012.12.005; Roldan ML, 2011, ANAL CHIM ACTA, V699, P87, DOI 10.1016/j.aca.2011.05.001; Schutter ME, 2000, SOIL SCI SOC AM J, V64, P1659, DOI 10.2136/sssaj2000.6451659x; Steger K, 2005, MICROB ECOL, V50, P163, DOI 10.1007/s00248-004-0139-y; Steger K, 2003, J MICROBIOL METH, V55, P371, DOI 10.1016/S0167-7012(03)00187-8; Stromberger ME, 2012, SOIL BIOL BIOCHEM, V46, P155, DOI 10.1016/j.soilbio.2011.11.024; Verdenelli RA, 2012, SCI TOTAL ENVIRON, V414, P210, DOI 10.1016/j.scitotenv.2011.10.066; Vischetti C, 2008, CHEMOSPHERE, V72, P1739, DOI 10.1016/j.chemosphere.2008.04.065; Wu L, 2002, J ENVIRON QUAL, V31, P1323, DOI 10.2134/jeq2002.1323; Zelles L, 1997, CHEMOSPHERE, V35, P275, DOI 10.1016/S0045-6535(97)00155-0; Zhen Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108555	40	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145501	10.1371/journal.pone.0145501	http://dx.doi.org/10.1371/journal.pone.0145501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694029	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092500054
J	Byrom, AE; Anderson, DP; Coleman, M; Thomson, C; Cross, ML; Pech, RP				Byrom, Andrea E.; Anderson, Dean P.; Coleman, Morgan; Thomson, Caroline; Cross, Martin L.; Pech, Roger P.			Assessing Movements of Brushtail Possums (Trichosurus vulpecula) in Relation to Depopulated Buffer Zones for the Management of Wildlife Tuberculosis in New Zealand	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS INFECTION; SPATIAL-DISTRIBUTION; DISPERSAL; PATTERNS; CATTLE; TB; CONTACT; FOREST; ERADICATION; POPULATIONS	In New Zealand, managing the threat of bovine tuberculosis (TB) to livestock includes population reduction of potentially infectious wildlife, primarily the brushtail possum (Trichosurus vulpecula). Population control is often targeted on forested buffer zones adjacent to farmland, in order to limit movements of possums across the buffer and reduce the risk of disease transmission to livestock. To assess the effectiveness of buffers in protecting livestock we analysed GPS telemetry data from possums located in untreated forest adjacent to buffers, and used these data to characterise patterns of movement that could lead to possums reaching farmland during the season when most dispersal occurs. Analyses of movement data showed that the direction of dispersal by sub-adult and adult possums and the extent of long exploratory movements were not biased toward forest buffers, even though these provided vacant habitat as suitable for possums as untreated forest. Instead, dispersal and exploratory movements were uncommon even for sub-adult possums and such events typically lasted < 10 days. Dispersing possums settled predominantly in river valleys. A simulation model was developed for the 3-6-month dispersal season; it demonstrated a probability of <0.001 that an infected possum, originating from a low-density population with low disease prevalence in untreated forest, would move across 3 km of recently controlled forest buffer to reach farmland. Our results indicate short-term reduction in the risk of TB transmission from possums to livestock in New Zealand by the use of depopulated buffer zones, while acknowledging that the threat of disease spread from untreated forest is likely to increase over time as possum population density and, potentially, TB prevalence among those possums, increase in the buffer zone.	[Byrom, Andrea E.; Anderson, Dean P.; Coleman, Morgan; Thomson, Caroline; Cross, Martin L.; Pech, Roger P.] Landcare Res, POB 69040, Lincoln 7640, New Zealand	Landcare Research - New Zealand	Byrom, AE (corresponding author), Landcare Res, POB 69040, Lincoln 7640, New Zealand.	byroma@landcareresearch.co.nz			TBfree New Zealand [R-10720, 795204-0022]; TBfree Ltd, New Zealand	TBfree New Zealand; TBfree Ltd, New Zealand	The research reported in this manuscript was supported by research grant number R-10720 awarded from TBfree New Zealand (www.tbfree.org.nz, formerly the Animal Health Board of New Zealand) to support Landcare Research project number 795204-0022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r P Livingstone, G Knowles, C Pullen and S Peters (TB Free NZ) helped with selection of study sites. The Greymouth Mawheranui Area Office and the Franz Josef Waiau Area Office of the West Coast Tai Poutini Conservancy of the Department of Conservation (DOC) gave permission to work on DOC land. Permission was obtained from the Greymouth Community and Public Health Office to use cyanide to retrieve collared possums. Te Runanga o Ngati Waewae gave consent to work at all sites. Landowners near the Upper Ahaura study sites (Waikiti Downs Station and Gloriavale Christian Community) and D Friend, who had grazing rights adjacent to the Whataroa study site, allowed access across their land. C Barnes and K Cohen (Vector Control Services) and J Mead, J Pari, N Fea, D Hurst and H de Meringo helped with fieldwork. Coastwide Helicopters and Alpine Adventures / Fox and Franz Josef Heliservices provided transport and tracked possums by helicopter. Ivor Yockney (Landcare Research) tracked possums from a fixed-wing aircraft. We thank Dr Phil Cowan (Landcare Research) for providing constructive comments on an earlier draft of this manuscript. Dave Latham and Cecilia Arienti-Latham (Landcare Research) provided helpful input during manuscript revision. This work was funded by TBfree Ltd, New Zealand.	[Anonymous], 2005, HDB NZ MAMMALS; Arthur A, 2002, LC0102102 AN HLTH BO, P1; BARLOW ND, 1991, J APPL ECOL, V28, P794, DOI 10.2307/2404208; BARLOW ND, 1993, J APPL ECOL, V30, P156, DOI 10.2307/2404279; Bielby J, 2014, P NATL ACAD SCI USA, V111, P9193, DOI 10.1073/pnas.1401503111; Byrom AE, 2002, J APPL ECOL, V39, P67, DOI 10.1046/j.1365-2664.2002.00689.x; Caley P, 1999, NEW ZEAL VET J, V47, P133, DOI 10.1080/00480169.1999.36130; Carter SP, 2007, P ROY SOC B-BIOL SCI, V274, P2769, DOI 10.1098/rspb.2007.0998; Clinchy M, 2001, J ANIM ECOL, V70, P515, DOI 10.1046/j.1365-2656.2001.00510.x; Coleman JD, 1999, NEW ZEAL VET J, V47, P119, DOI 10.1080/00480169.1999.36127; COLEMAN JD, 1994, NEW ZEAL VET J, V42, P128, DOI 10.1080/00480169.1994.35802; Coleman Jim, 2000, P92; Cowan PE, 1997, WILDLIFE RES, V24, P279, DOI 10.1071/WR96005; Cowan PE, 1996, WILDLIFE RES, V23, P237, DOI 10.1071/WR9960237; Cowan PE, 2000, SCI CONSERVATION PUB, V144, P1; Cowan Phil, 2000, P24; Delgado MD, 2008, AM NAT, V172, P475, DOI 10.1086/590964; Efford M, 2000, WILDLIFE RES, V27, P117, DOI 10.1071/WR99005; Efford M., 1991, 9173 AN HLTH BOARD, P1; Efford Murray, 2000, P47; Etherington TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088293; Glen AS, 2012, NEW ZEAL J ECOL, V36, P29; KAREIVA PM, 1983, OECOLOGIA, V56, P234, DOI 10.1007/BF00379695; Livingstone PG, 2015, NEW ZEAL VET J, V63, P98, DOI 10.1080/00480169.2015.1013581; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; NPCA, 2008, POSS POP MON US TRAP, P1; Nugent G, 2015, NEW ZEAL VET J, V63, P28, DOI 10.1080/00480169.2014.963791; Nugent G, 1997, OPTIMAL BUFFER WIDTH; Nugent G, 2013, PREV VET MED, V109, P168, DOI 10.1016/j.prevetmed.2012.09.008; Nugent G, 2011, WILDLIFE RES, V38, P249, DOI 10.1071/WR10198; Palmer MV, 2013, TRANSBOUND EMERG DIS, V60, P1, DOI 10.1111/tbed.12115; Paterson BM, 1995, NEW ZEAL VET J, V43, P281, DOI 10.1080/00480169./1995.35907; Pech R, 2010, WILDLIFE RES, V37, P283, DOI 10.1071/WR09161; Polo G, 2013, PREV VET MED, V111, P10, DOI 10.1016/j.prevetmed.2013.03.010; Porphyre T, 2011, PREV VET MED, V100, P221, DOI 10.1016/j.prevetmed.2011.03.014; Porphyre T, 2008, VET RES, V39, DOI 10.1051/vetres:2008007; Python Software Foundation, 2013, PYTH PROGR LANG; Ramsey D, 2005, WILDLIFE RES, V32, P229, DOI 10.1071/WR03119; Ramsey DSL, 2010, J APPL ECOL, V47, P911, DOI 10.1111/j.1365-2664.2010.01839.x; Recio MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028225; Rosatte R, 2001, J WILDLIFE DIS, V37, P265, DOI 10.7589/0090-3558-37.2.265; Sarre SD, 2014, MOL ECOL, V23, P3419, DOI 10.1111/mec.12834; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; Tompkins DM, 2013, VACCINE, V31, P893, DOI 10.1016/j.vaccine.2012.12.003; Turchin Peter, 1998; Warburton B, 2015, NEW ZEAL VET J, V63, P77, DOI 10.1080/00480169.2014.981315; Warburton B, 2014, POSSUM COST CONTROL; WARD GD, 1985, AUST WILDLIFE RES, V12, P145; Windsor PA, 2011, TRANSBOUND EMERG DIS, V58, P421, DOI 10.1111/j.1865-1682.2011.01225.x; Wiser SK, 2011, APPL VEG SCI, V14, P506, DOI 10.1111/j.1654-109X.2011.01146.x; Yockney IJ, 2013, EPIDEMIOL INFECT, V141, P1407, DOI 10.1017/S0950268813000289; Yockney IJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121865	52	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145636	10.1371/journal.pone.0145636	http://dx.doi.org/10.1371/journal.pone.0145636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689918	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300092
J	Delaplane, KS; Pietravalle, S; Brown, MA; Budge, GE				Delaplane, Keith S.; Pietravalle, Stephane; Brown, Mike A.; Budge, Giles E.			Honey Bee Colonies Headed by Hyperpolyandrous Queens Have Improved Brood Rearing Efficiency and Lower Infestation Rates of Parasitic Varroa Mites	PLOS ONE			English	Article							APIS-MELLIFERA; GENETIC DIVERSITY; EXTREME POLYANDRY; EVOLUTION; BEHAVIOR; HYMENOPTERA; INFECTIONS; DESTRUCTOR; DISEASE; NUMBER	A honey bee queen mates on wing with an average of 12 males and stores their sperm to produce progeny of mixed paternity. The degree of a queen's polyandry is positively associated with measures of her colony's fitness, and observed distributions of mating number are evolutionary optima balancing risks of mating flights against benefits to the colony. Effective mating numbers as high as 40 have been documented, begging the question of the upper bounds of this behavior that can be expected to confer colony benefit. In this study we used instrumental insemination to create three classes of queens with exaggerated range of polyandry- 15, 30, or 60 drones. Colonies headed by queens inseminated with 30 or 60 drones produced more brood per bee and had a lower proportion of samples positive for Varroa destructor mites than colonies whose queens were inseminated with 15 drones, suggesting benefits of polyandry at rates higher than those normally obtaining in nature. Our results are consistent with two hypotheses that posit conditions that reward such high expressions of polyandry: (1) a queen may mate with many males in order to promote beneficial non-additive genetic interactions among subfamilies, and (2) a queen may mate with many males in order to capture a large number of rare alleles that regulate resistance to pathogens and parasites in a breeding population. Our results are unique for identifying the highest levels of polyandry yet detected that confer colony-level benefit and for showing a benefit of polyandry in particular toward the parasitic mite V. destructor.	[Delaplane, Keith S.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Pietravalle, Stephane; Budge, Giles E.] Food & Environm Res Agcy, York YO41 1LZ, N Yorkshire, England; [Brown, Mike A.] Anim & Plant Hlth Agcy, York YO41 1LZ, N Yorkshire, England	University System of Georgia; University of Georgia; Food & Environment Research Agency; Animal & Plant Health Agency UK	Delaplane, KS (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	ksd@uga.edu	Delaplane, Keith/AAN-5197-2021	Delaplane, Keith/0000-0001-9323-441X	Trans-Atlantic exchange program of the Biotechnology and Biological Sciences Research Council; USDA Managed Pollinator Coordinated Agricultural Project; C.B. Dennis British Beekeepers Research Trust; BBSRC [BB/I025220/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025220/1] Funding Source: researchfish	Trans-Atlantic exchange program of the Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); USDA Managed Pollinator Coordinated Agricultural Project; C.B. Dennis British Beekeepers Research Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by the Trans-Atlantic exchange program of the Biotechnology and Biological Sciences Research Council, the USDA Managed Pollinator Coordinated Agricultural Project, and the C.B. Dennis British Beekeepers Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arechavaleta-Velasco ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047269; Behrens D, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.17; Belloy L, 2007, APIDOLOGIE, V38, P136, DOI [10.1051/apido:2006069, 10.1051/apido:2007039]; BURGETT M, 1985, J ECON ENTOMOL, V78, P1154, DOI 10.1093/jee/78.5.1154; Cobey SW, 2007, APIDOLOGIE, V38, P390, DOI 10.1051/apido:2007029; COLE BJ, 1983, BEHAV ECOL SOCIOBIOL, V12, P191, DOI 10.1007/BF00290771; CROZIER RH, 1976, THEOR POPUL BIOL, V10, P1, DOI 10.1016/0040-5809(76)90002-2; Delaplane KS, 2012, J APICULT RES, V51, DOI [http://dx.doi.org/10.3896/IBRA.1.51.5, DOI 10.3896/IBRA.1.51.5]; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Estroup A, 1994, P ROY SOC B, V258, P1; Fuchs S, 1999, BEHAV ECOL SOCIOBIOL, V45, P269, DOI 10.1007/s002650050561; HALLIDAY T, 1987, ANIM BEHAV, V35, P939, DOI 10.1016/S0003-3472(87)80138-0; HARBO JR, 1985, AM BEE J, V125, P197; Ingold T., 2011, REDRAWING ANTHR MAT, P1; KELLER L, 1994, EVOLUTION, V48, P694, DOI [10.2307/2410479, 10.1111/j.1558-5646.1994.tb01354.x]; Kraus FB, 2004, BEHAV ECOL SOCIOBIOL, V55, P494, DOI 10.1007/s00265-003-0706-0; Lapidge KL, 2002, NATURWISSENSCHAFTEN, V89, P565, DOI 10.1007/s00114-002-0371-6; Liersch S, 1998, P ROY SOC B-BIOL SCI, V265, P221, DOI 10.1098/rspb.1998.0285; MACKENSEN O, 1947, J ECON ENTOMOL, V40, P344, DOI 10.1093/jee/40.3.344; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Neumann P, 2000, INSECT SOC, V47, P271, DOI 10.1007/PL00001714; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; PAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P387, DOI 10.1007/BF00177334; PAGE RE, 1980, GENETICS, V96, P263; Palmer KA, 2000, APIDOLOGIE, V31, P235, DOI 10.1051/apido:2000119; Rinderer TE, 2001, APIDOLOGIE, V32, P381, DOI 10.1051/apido:2001138; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; SHERMAN PW, 1988, AM NAT, V131, P602, DOI 10.1086/284809; SHYKOFF JA, 1991, P ROY SOC B-BIOL SCI, V243, P55, DOI 10.1098/rspb.1991.0009; Tarpy DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118734; Tarpy DR, 2013, NATURWISSENSCHAFTEN, V100, P723, DOI 10.1007/s00114-013-1065-y; Tarpy DR, 2006, NATURWISSENSCHAFTEN, V93, P195, DOI 10.1007/s00114-006-0091-4; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; Tarpy DR, 2004, INSECT SOC, V51, P203, DOI 10.1007/s00040-004-0734-4; VSN INTERNATIONAL, 2014, GENSTAT WINDOWS; Yue C, 2006, J INVERTEBR PATHOL, V92, P105, DOI 10.1016/j.jip.2006.03.001	37	21	21	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0142985	10.1371/journal.pone.0142985	http://dx.doi.org/10.1371/journal.pone.0142985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691845	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092300003
J	Dudding, T; Thomas, SJ; Duncan, K; Lawlor, DA; Timpson, NJ				Dudding, Tom; Thomas, Steve J.; Duncan, Karen; Lawlor, Debbie A.; Timpson, Nicholas J.			Re-Examining the Association between Vitamin D and Childhood Caries	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENTAL-CARIES; MENDELIAN RANDOMIZATION; CHILDREN; EPIDEMIOLOGY; HEALTH; TRIALS; COHORT; MODEL; RISK	Background Previous studies have reported an inverse association between vitamin D and childhood dental caries, but whether this is causal is unclear. Objective To determine the causal effect of circulating 25-hydroxyvitamin D concentration on dental caries experience, early caries onset and the requirement for a dental general anesthetic. Design A Mendelian randomization study was undertaken, using genetic variants known to be associated with circulating 25-hydroxyvitamin D concentrations in 5,545 European origin children from the South West of England. Data on caries and related characteristics were obtained from parental and child completed questionnaires between 38 and 91 months and clinical assessments in a random 10% sample at 31, 44 and 61 months. Results In multivariable confounder adjusted analyses no strong evidence for an association of 25-hydroxyvitamin D with caries experience or severity was found but there was evidence for an association with early caries onset, or having a general anesthetic for dental problems. In Mendelian randomization analysis the odds ratio for caries experience per 10 nmol/L increase in 25-hydroxyvitamin D was 0.93 (95% confidence interval: 0.83, 1.05; P = 0.26) and the odds ratio for dental general anaesthetic per 10 nmol/L increase in 25-hydroxyvitamin D was 0.96 (95% confidence interval: 0.75, 1.22; P = 0.72). Conclusions This Mendelian randomization study provides little evidence to support an inverse causal effect of 25-hydroxyvitamin D on dental caries. However, the estimates are imprecise and a larger study is required to refine these analyses.	[Dudding, Tom; Lawlor, Debbie A.; Timpson, Nicholas J.] Univ Bristol, Sch Community & Social Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Dudding, Tom; Thomas, Steve J.; Duncan, Karen] Univ Bristol, Sch Oral & Dent Sci, Bristol, Avon, England	University of Bristol; University of Bristol	Timpson, NJ (corresponding author), Univ Bristol, Sch Community & Social Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England.	n.j.timpson@bris.ac.uk	Fox, Laura J/C-6249-2016; Attrill, Lauren/V-1688-2018; Timpson, Nicholas John/O-7548-2015	Timpson, Nicholas John/0000-0002-7141-9189; Dudding, Tom/0000-0003-3756-040X; Lawlor, Debbie A/0000-0002-6793-2262	Wellcome Trust [102215/2/13/2]; MRC [MC_UU_12013/5, G0701603, MC_UU_12013/3] Funding Source: UKRI; Medical Research Council [MC_PC_15018, MC_UU_12013/5, MC_UU_12013/3, G0701603] Funding Source: researchfish; National Institute for Health Research [ACF-2014-25-009] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The UK Medical Research Council and the Wellcome Trust (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Bohning D, 1999, J ROY STAT SOC A STA, V162, P195, DOI 10.1111/1467-985X.00130; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Bridgman CM, 1999, BRIT DENT J, V186, P245, DOI 10.1038/sj.bdj.4800076a; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Chadwick B., 2015, CHILDRENS DENT HLTH, P106; Clarke PS, 2010, BIOSTATISTICS, V11, P756, DOI 10.1093/biostatistics/kxq024; Del Valle H.B., 2011, DIETARY REFERENCE IN; Edelstein BL, 2009, ACAD PEDIATR, V9, P415, DOI 10.1016/j.acap.2009.09.010; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gombart AF, 2009, FUTURE MICROBIOL, V4, P1151, DOI 10.2217/FMB.09.87; Grant WB, 2011, DERM-ENDOCRINOL, V3, P193, DOI [10.4161/derm.3.3.15841, 10.4161/derm.15841]; Hooley M, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-57; Hu XP, 2015, GENET MOL RES, V14, P11631, DOI 10.4238/2015.September.28.15; Hujoel PP, 2013, NUTR REV, V71, P88, DOI 10.1111/j.1753-4887.2012.00544.x; Kay EJ, 2010, COMMUNITY DENT ORAL, V38, P408, DOI 10.1111/j.1600-0528.2010.00548.x; Kidd EAM, 2008, DENT CARIES DIS ITS, Vxxiii; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lawlor DA, 2013, LANCET, V381, P2176, DOI 10.1016/S0140-6736(12)62203-X; Mellanby M, 1928, BMJ-BRIT MED J, V1928, P1079, DOI 10.1136/bmj.2.3545.1079; Moles DR, 2009, BRIT DENT J, V206, DOI 10.1038/sj.bdj.2009.254; Nobile CGA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-206; SHARPENAK A E, 1964, Fed Proc Transl Suppl, V23, P423; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; STEPHEN KW, 1981, BRIT DENT J, V151, P287, DOI 10.1038/sj.bdj.4804690; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Tolppanen AM, 2012, J CLIN ENDOCR METAB, V97, P1202, DOI 10.1210/jc.2011-2516; Trummer O, 2013, CLIN CHEM, V59, P793, DOI 10.1373/clinchem.2012.193185; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Youssef DA, 2011, DERM-ENDOCRINOL, V3, P220, DOI 10.4161/derm.3.4.15027	32	23	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0143769	10.1371/journal.pone.0143769	http://dx.doi.org/10.1371/journal.pone.0143769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692013	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300004
J	Yang, C; Zhang, DM; Song, ZB; Hou, YQ; Bao, YL; Sun, LG; Yu, CL; Li, YX				Yang, Cheng; Zhang, Dong-Mei; Song, Zhen-Bo; Hou, Ya-Qin; Bao, Yong-Li; Sun, Lu-Guo; Yu, Chun-Lei; Li, Yu-Xin			Protumoral TSP50 Regulates Macrophage Activities and Polarization via Production of TNF-alpha and IL-1 beta, and Activation of the NF-kappa B Signaling Pathway	PLOS ONE			English	Article							CELL-PROLIFERATION; CANCER; EXPRESSION; PROTEASE; CYTOKINES; RESPONSES; SYSTEM; GROWTH; TESTES; CCL1	Testes-specific protease 50 (TSP50) is abnormally overexpressed in many kinds of cancers and promotes cell proliferation and migration. However, whether TSP50 can influence the tumor microenvironment, especially the function of immune cells in the microenvironment, remains largely unknown. We demonstrated that exposure to the conditioned medium from TSP50-overexpressing cells, or co-culture with TSP50-overexpressing cells, enhanced the cytokine production and phagocytic activities of macrophages, and induced M2b polarization. Further investigation showed that production of TNF-alpha and IL-1 beta was strongly induced by TSP50 in TSP50-overexpressing cells. TSP50-induced TNF-alpha and IL-1 beta were main factors that mediated the effects of TSP50-overexpressing cells on macrophages. The NF-kappa B pathway could be activated in macrophages upon the treatment of conditioned medium of TSP50-overexpressing cells and its activation is necessary for the observed effects on macrophages. Taken together, our results suggested that oncogenic TSP50 expressed in cells could activate surrounding macrophages and induce M2b polarization, partly through inducing TNF-alpha/IL-1 beta secretion and subsequent NF-kappa B pathway activation. This implies a potential mechanism by which oncogene TSP50 regulates tumor microenvironment to support tumor development.	[Yang, Cheng; Zhang, Dong-Mei; Hou, Ya-Qin; Bao, Yong-Li] NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun 130024, Peoples R China; [Song, Zhen-Bo; Sun, Lu-Guo; Yu, Chun-Lei; Li, Yu-Xin] NE Normal Univ, Inst Genet & Cytol, Changchun 130024, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Bao, YL (corresponding author), NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun 130024, Peoples R China.	baoyl800@nenu.edu.cn; sunlg388@nenu.edu.cn	Li, yu/HHZ-5236-2022; li, yu/HGL-9518-2022; li, Yu/HCI-9086-2022; Li, yuxin/GSD-1668-2022		National Natural Science Foundation of China [81272919, 81272242]; National High Technology Research and Development Program of China [2012AA02A407]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The work was supported by National Natural Science Foundation of China (Grant No. 81272919 and 81272242), and National High Technology Research and Development Program of China (No. 2012AA02A407).	Asai A, 2012, J LEUKOCYTE BIOL, V92, P859, DOI 10.1189/jlb.0212107; Bachireddy P, 2012, CLIN EXP IMMUNOL, V167, P188, DOI 10.1111/j.1365-2249.2011.04514.x; Bai J, 2015, ONCOTARGET; Balkwill F, 2010, FUTURE ONCOL, V6, P1833, DOI [10.2217/fon.10.155, 10.2217/FON.10.155]; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Ortiz MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130713; Dalrymple H, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-41; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Dinarello CA, 2006, CANCER METAST REV, V25, P307, DOI 10.1007/s10555-006-9000-8; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; HEUFF G, 1993, CANCER IMMUNOL IMMUN, V37, P125, DOI 10.1007/BF01517045; Keophiphath M, 2010, ARTERIOSCL THROM VAS, V30, P39, DOI 10.1161/ATVBAHA.109.197442; Kerkar SP, 2012, CANCER RES, V72, P3125, DOI 10.1158/0008-5472.CAN-11-4094; Kida Y, 2005, CYTOKINE, V29, P159, DOI 10.1016/j.cyto.2004.10.009; Lei Zheng GX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022203.g001, DOI 10.1371/JOURNAL.PONE.0022203.G001]; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Li Y, 2014, J INTERN MED, V276, P52, DOI 10.1111/joim.12237; Li YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035030; Liu F, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/498246; Liu J, 2011, WORLD J GASTROENTERO, V17, P1362, DOI 10.3748/wjg.v17.i10.1362; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ngo AN, 2014, J ANAL BIOANALYTICAL, V5, DOI [10.4172/2155-9872.1000198, DOI 10.4172/2155-9872.1000198]; Ning BT, 2012, ONCOL LETT, V3, P871, DOI 10.3892/ol.2012.557; Pagliari LJ, 2000, MOL CELL BIOL, V20, P8855, DOI 10.1128/MCB.20.23.8855-8865.2000; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Saperstein S, 2009, J INTERF CYTOK RES, V29, P273, DOI 10.1089/jir.2008.0076; Sato T, 2011, IMMUNOL RES, V51, P170, DOI 10.1007/s12026-011-8262-6; Shan JD, 2002, CANCER RES, V62, P290; Sironi M, 2006, J LEUKOCYTE BIOL, V80, P342, DOI 10.1189/jlb.1005586; Song ZB, 2011, BIOCHEM J, V436, P457, DOI 10.1042/BJ20101780; Sousa S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0621-0; Takei Y, 2004, CANCER RES, V64, P3365, DOI 10.1158/0008-5472.CAN-03-2682; Xie XF, 2015, CARBOHYD POLYM, V132, P323, DOI 10.1016/j.carbpol.2015.06.046; Xu HP, 2007, CANCER RES, V67, P1239, DOI 10.1158/0008-5472.CAN-06-3688; Xu HP, 2004, UROLOGY, V64, P826, DOI 10.1016/j.urology.2004.05.012; Yuan LM, 1999, CANCER RES, V59, P3215; Zhang B, 2015, EXP NEUROL, V273, P83, DOI 10.1016/j.expneurol.2015.08.001; Zhang XP, 2014, TUMOR BIOL, V35, P10781, DOI 10.1007/s13277-014-2090-y; Zhou LA, 2010, IUBMB LIFE, V62, P825, DOI 10.1002/iub.390	44	12	17	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145095	10.1371/journal.pone.0145095	http://dx.doi.org/10.1371/journal.pone.0145095			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684869	Green Submitted, gold, Green Published			2022-12-27	WOS:000366725800037
J	Lessard, CB; Cottrell, BA; Maruyama, H; Suresh, S; Golde, TE; Koo, EH				Lessard, Christian B.; Cottrell, Barbara A.; Maruyama, Hiroko; Suresh, Suraj; Golde, Todd E.; Koo, Edward H.			gamma-Secretase Modulators and APH1 Isoforms Modulate gamma-Secretase Cleavage but Not Position of epsilon-Cleavage of the Amyloid Precursor Protein (APP)	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ALZHEIMERS-DISEASE; BETA-SECRETASE; TRANSMEMBRANE DOMAIN; TERMINAL FRAGMENT; PRESENILIN-1; MUTATIONS; A-BETA-42; PURIFICATION; GENERATION	The relative increase in A beta 42 peptides from familial Alzheimer disease (FAD) linked APP and PSEN mutations can be related to changes in both epsilon-cleavage site utilization and subsequent step-wise cleavage. Cleavage at the epsilon-site releases the amyloid precursor protein (APP) intracellular domain (AICD), and perturbations in the position of epsilon-cleavage are closely associated with changes in the profile of amyloid beta-protein (A beta) species that are produced and secreted. The mechanisms by which gamma-secretase modulators (GSMs) or FAD mutations affect the various gamma-secretase cleavages to alter the generation of A beta peptides have not been fully elucidated. Recent studies suggested that GSMs do not modulate epsilon-cleavage of APP, but the data were derived principally from recombinant truncated epitope tagged APP substrate. Here, using full length APP from transfected cells, we investigated whether GSMs modify the epsilon-cleavage of APP under more native conditions. Our results confirmed the previous findings that epsilon-cleavage is insensitive to GSMs. In addition, fenofibrate, an inverse GSM (iGSM), did not alter the position or kinetics of epsilon-cleavage position in vitro. APH1A and APH1B, a subunit of the gamma-secretase complex, also modulated A beta 42/A beta 40 ratio without any alterations in epsilon-cleavage, a result in contrast to what has been observed with PS1 and APP FAD mutations. Consequently, GSMs and APH1 appear to modulate gamma-secretase activity and A beta 42 generation by altering processivity but not epsilon-cleavage site utilization.	[Lessard, Christian B.; Cottrell, Barbara A.; Maruyama, Hiroko; Suresh, Suraj; Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Golde, Todd E.] Univ Florida, Coll Med, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA; [Koo, Edward H.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Koo, Edward H.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore	University of California System; University of California San Diego; State University System of Florida; University of Florida; National University of Singapore; National University of Singapore	Koo, EH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	edkoo@ucsd.edu			NIH [AG 20206]; NATIONAL CANCER INSTITUTE [P01CA166009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020206] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH Grants AG 20206 to T.E.G. and E.H.K.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; Czirr E, 2007, J BIOL CHEM, V282, P24504, DOI 10.1074/jbc.M700618200; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Dimitrov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3246; Ebke A, 2011, J BIOL CHEM, V286, P37181, DOI 10.1074/jbc.C111.276972; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hahn S, 2011, J NEUROCHEM, V116, P385, DOI 10.1111/j.1471-4159.2010.07118.x; Jung JI, 2013, FASEB J, V27, P3775, DOI 10.1096/fj.12-225649; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kretner B, 2011, J BIOL CHEM, V286, P15240, DOI 10.1074/jbc.M110.213587; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; McLendon C, 2000, FASEB J, V14, P2383; Mori K, 2010, PSYCHOGERIATRICS, V10, P117, DOI 10.1111/j.1479-8301.2010.00330.x; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Olsson F, 2014, J BIOL CHEM, V289, P1540, DOI 10.1074/jbc.M113.498246; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Ran Y, 2014, J BIOL CHEM, V289, P3276, DOI 10.1074/jbc.M113.512921; Sagi SA, 2011, J BIOL CHEM; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato T, 2005, FEBS LETT, V579, P2907, DOI 10.1016/j.febslet.2005.04.037; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Singh R, 2009, J PHYS CHEM B, V113, P2990, DOI 10.1021/jp811154w; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Uemura K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1129; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Uljon SN, 2000, METH MOL B, V146, P439, DOI 10.1385/1-59259-045-4:439; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang LL, 2001, BIOCHEMISTRY-US, V40, P5049, DOI 10.1021/bi0028800	52	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144758	10.1371/journal.pone.0144758	http://dx.doi.org/10.1371/journal.pone.0144758			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678856	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400024
J	Jansen, SJ; Gho, JMIH; Koudstaal, S; van Hout, GPJ; Zwetsloot, PPM; van Oorschot, JWM; van Eeuwijk, ECM; Leiner, T; Hoefer, IE; Goumans, MJ; Doevendans, PA; Sluijter, JPG; Chamuleau, SAJ				Sanne J. Jansen of Lorkeers; Gho, Johannes M. I. H.; Koudstaal, Stefan; van Hout, Gerardus P. J.; Zwetsloot, Peter Paul M.; van Oorschot, Joep W. M.; van Eeuwijk, Esther C. M.; Leiner, Tim; Hoefer, Imo E.; Goumans, Marie-Jose; Doevendans, Pieter A.; Sluijter, Joost P. G.; Chamuleau, Steven A. J.			Xenotransplantation of Human Cardiomyocyte Progenitor Cells Does Not Improve Cardiac Function in a Porcine Model of Chronic Ischemic Heart Failure. Results from a Randomized, Blinded, Placebo Controlled Trial	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; STEM-CELLS; THERAPY; DELIVERY; INJECTION; DIFFERENTIATION; TRANSPLANTATION; REPERFUSION; MECHANISMS; SAFETY	Background Recently cardiomyocyte progenitor cells (CMPCs) were successfully isolated from fetal and adult human hearts. Direct intramyocardial injection of human CMPCs (hCMPCs) in experimental mouse models of acute myocardial infarction significantly improved cardiac function compared to controls. Aim Here, our aim was to investigate whether xenotransplantation via intracoronary infusion of fetal hCMPCs in a pig model of chronic myocardial infarction is safe and efficacious, in view of translation purposes. Methods & Results We performed a randomized, blinded, placebo controlled trial. Four weeks after ischemia/reperfusion injury by 90 minutes of percutaneous left anterior descending artery occlusion, pigs (n = 16, 68.5 +/- 5.4 kg) received intracoronary infusion of 10 million fetal hCMPCs or placebo. All animals were immunosuppressed by cyclosporin (CsA). Four weeks after infusion, endpoint analysis by MRI displayed no difference in left ventricular ejection fraction, left ventricular end diastolic and left ventricular end systolic volumes between both groups. Serial pressure volume (PV-)loop and echocardiography showed no differences in functional parameters between groups at any timepoint. Infarct size at follow-up, measured by late gadolinium enhancement MRI showed no difference between groups. Intracoronary pressure and flow measurements showed no signs of coronary obstruction 30 minutes after cell infusion. No premature death occurred in cell treated animals. Conclusion Xenotransplantation via intracoronary infusion of hCMPCs is feasible and safe, but not associated with improved left ventricular performance and infarct size compared to placebo in a porcine model of chronic myocardial infarction.	[Sanne J. Jansen of Lorkeers; Gho, Johannes M. I. H.; Koudstaal, Stefan; Zwetsloot, Peter Paul M.; Doevendans, Pieter A.; Chamuleau, Steven A. J.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Koudstaal, Stefan; Doevendans, Pieter A.; Sluijter, Joost P. G.; Chamuleau, Steven A. J.] ICIN Netherlands Heart Inst, Utrecht, Netherlands; [van Hout, Gerardus P. J.; van Eeuwijk, Esther C. M.; Hoefer, Imo E.; Sluijter, Joost P. G.] Univ Med Ctr Utrecht, Expt Cardiol Lab, Utrecht, Netherlands; [van Oorschot, Joep W. M.; Leiner, Tim] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Goumans, Marie-Jose] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Chamuleau, SAJ (corresponding author), Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands.	s.a.j.chamuleau@umcutrecht.nl	Goumans, Marie-José/AAG-4994-2021; Zwetsloot, Peter-Paul/N-8846-2019; Goumans, Marie Jose/U-1455-2019	Zwetsloot, Peter-Paul/0000-0002-2634-4667; Goumans, Marie Jose/0000-0001-9344-6746; Sluijter, Joost/0000-0003-2088-9102; Chamuleau, Steven/0000-0002-9952-6701	BioMedical Materials Institute [P1.04]; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Nederlandse Hartstichting; Alexandre Suerman program; Netherlands CardioVascular Research Initiative (CVON): the Dutch Heart Foundation; Netherlands CardioVascular Research Initiative (CVON): Dutch Federation of University Medical Centers; Netherlands CardioVascular Research Initiative (CVON): the Netherlands Organization for Health Research and Development; Netherlands CardioVascular Research Initiative (CVON): the Royal Netherlands Academy of Sciences; NOW Clinical Fellowship [90700432]	BioMedical Materials Institute; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Nederlandse Hartstichting; Alexandre Suerman program; Netherlands CardioVascular Research Initiative (CVON): the Dutch Heart Foundation; Netherlands CardioVascular Research Initiative (CVON): Dutch Federation of University Medical Centers; Netherlands CardioVascular Research Initiative (CVON): the Netherlands Organization for Health Research and Development; Netherlands CardioVascular Research Initiative (CVON): the Royal Netherlands Academy of Sciences; NOW Clinical Fellowship	This research forms part of the Project P1.04 SMARTCARE of the research program of the BioMedical Materials Institute, co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. The financial contribution of the Nederlandse Hartstichting is gratefully acknowledged. This project is co-funded by a grant from the Alexandre Suerman program for MD/PhD students of the University Medical Center Utrecht, the Netherlands. This work is also funded by the Netherlands CardioVascular Research Initiative (CVON): the Dutch Heart Foundation, Dutch Federation of University Medical Centers, the Netherlands Organization for Health Research and Development and the Royal Netherlands Academy of Sciences. Professor Leiner is recipient of a NOW Clinical Fellowship (90700432).	Ang KL, 2008, NAT CLIN PRACT CARD, V5, P663, DOI 10.1038/ncpcardio1321; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli R, 2013, CIRCULATION, V128, P122, DOI 10.1161/CIRCULATIONAHA.112.001075; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; De Rosa S, 2013, CIRC-CARDIOVASC INTE, V6, P44, DOI 10.1161/CIRCINTERVENTIONS.112.971705; Delewi R, 2014, EUR HEART J, V35, P989, DOI 10.1093/eurheartj/eht372; Eding JEC, 2015, CIRC RES, V116, P80, DOI 10.1161/CIRCRESAHA.116.304872; Felix NJ, 2007, NAT REV IMMUNOL, V7, P942, DOI 10.1038/nri2200; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Fukushima S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003071; Gaetani Roberto, 2014, J Cell Mol Med, V18, P2147, DOI 10.1111/jcmm.12458; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Goumans MJ, 2014, HEART, V100, P1153, DOI 10.1136/heartjnl-2014-305646; Goumans MJ, 2008, STEM CELL RES, V1, P138, DOI 10.1016/j.scr.2008.02.003; Jansen Lorkeers SJ, 2014, J CARDIOVASC TRANSL, V7, P475, DOI 10.1007/s12265-014-9570-8; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Kanazawa H, 2015, CIRC-HEART FAIL, V8, P322, DOI 10.1161/CIRCHEARTFAILURE.114.001484; Koudstaal S, 2014, JOVE-J VIS EXP, DOI 10.3791/51269; Koudstaal S, 2013, J CELL MOL MED, V17, P1128, DOI 10.1111/jcmm.12089; Koudstaal S, 2013, STEM CELL TRANSL MED, V2, P434, DOI 10.5966/sctm.2013-0001; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Malliaras Konstantinos, 2012, Circulation, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Penn EC, 2008, J MOL CELL CARDIOL, V44, P486, DOI 10.1016/j.yjmcc.2007.09.012; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; Smits AM, 2009, CARDIOVASC RES, V83, P527, DOI 10.1093/cvr/cvp146; van der Spoel TIG, 2012, J CELL MOL MED, V16, P2768, DOI 10.1111/j.1582-4934.2012.01594.x; van der Spoel TIG, 2011, CARDIOVASC RES, V91, P649, DOI 10.1093/cvr/cvr113; van Hout GPJ, 2013, EXP PHYSIOL, V98, P1565, DOI 10.1113/expphysiol.2013.074179; van Vliet P, 2010, J CELL MOL MED, V14, P861, DOI 10.1111/j.1582-4934.2010.01053.x; Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110; Ye L, 2014, CELL STEM CELL, V15, P750, DOI 10.1016/j.stem.2014.11.009; Yee K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113805; Zorginstituut Nederland, 2013, FARMACOTHERAPEUTISCH	42	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0143953	10.1371/journal.pone.0143953	http://dx.doi.org/10.1371/journal.pone.0143953			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678993	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400005
J	Daly, EA; Brodeur, RD				Daly, Elizabeth A.; Brodeur, Richard D.			Warming Ocean Conditions Relate to Increased Trophic Requirements of Threatened and Endangered Salmon	PLOS ONE			English	Article							COLUMBIA RIVER PLUME; EARLY MARINE RESIDENCE; CHINOOK SALMON; PACIFIC SALMON; NORTH PACIFIC; ONCORHYNCHUS-KISUTCH; SOCKEYE-SALMON; ENERGY DENSITY; CLIMATE-CHANGE; INTERDECADAL VARIABILITY	The trophic habits, size and condition of yearling Chinook salmon (Oncorhynchus tshawytscha) caught early in their marine residence were examined during 19 survey years (1981-1985; 1998-2011). Juvenile salmon consumed distinct highly piscivorous diets in cold and warm ocean regimes with major differences between ocean regimes driven by changes in consumption of juvenile rockfishes, followed by several other fish prey, adult euphausiids and decapod larvae. Notable, Chinook salmon consumed 30% more food in the warm versus cold ocean regime in both May and June. Additionally, there were about 30% fewer empty stomachs in the warm ocean regime in May, and 10% fewer in warm June periods. The total prey energy density consumed during the warmer ocean regime was also significantly higher than in cold. Chinook salmon had lower condition factor and were smaller in fork length during the warm ocean regime, and were longer and heavier for their size during the cold ocean regime. The significant increase in foraging during the warm ocean regime occurred concurrently with lower available prey biomass. Adult return rates of juvenile Chinook salmon that entered the ocean during a warm ocean regime were lower. Notably, our long term data set contradicts the long held assertion that juvenile salmon eat less in a warm ocean regime when low growth and survival is observed, and when available prey are reduced. Comparing diet changes between decades under variable ocean conditions may assist us in understanding the effects of projected warming ocean regimes on juvenile Chinook salmon and their survival in the ocean environment. Bioenergetically, the salmon appear to require more food resources during warm ocean regimes.	[Daly, Elizabeth A.] Oregon State Univ, Cooperat Inst Marine Resources Studies, Newport, OR 97365 USA; [Brodeur, Richard D.] NOAA, Fish Ecol Div, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Newport, OR USA	Oregon State University; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Daly, EA (corresponding author), Oregon State Univ, Cooperat Inst Marine Resources Studies, Newport, OR 97365 USA.	Elizabeth.daly@oregonstate.edu		Brodeur, Richard/0000-0002-6629-5564	Bonneville Power Administration [1998-014-00]	Bonneville Power Administration	This work was supported by the Bonneville Power Administration, project #1998-014-00 (http://www.bpa.gov/).	Anthony JA, 2000, J EXP MAR BIOL ECOL, V248, P53, DOI 10.1016/S0022-0981(00)00159-3; Atcheson ME, 2012, T AM FISH SOC, V141, P1081, DOI 10.1080/00028487.2012.675914; Auad G, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003219; Auth TD, 2015, PROG OCEANOGR, V137, P103, DOI 10.1016/j.pocean.2015.05.025; Aydin KY, 2005, DEEP-SEA RES PT II, V52, P757, DOI 10.1016/j.dsr2.2004.12.017; Beaubier Jessica, 2013, Marine Ornithology, V41, P35; Beauchamp David A., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P257; Beauchamp David A., 2009, V70, P53; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Benkwitt CE, 2009, T AM FISH SOC, V138, P111, DOI 10.1577/T08-060.1; Biro PA, 2005, P ROY SOC B-BIOL SCI, V272, P1443, DOI 10.1098/rspb.2005.3096; BRETT JR, 1969, J FISH RES BOARD CAN, V26, P2363, DOI 10.1139/f69-230; BRETT JR, 1971, AM ZOOL, V11, P99; BRODEUR RD, 1985, ESTUAR COAST SHELF S, V21, P365, DOI 10.1016/0272-7714(85)90017-4; BRODEUR RD, 1990, FISH B-NOAA, V88, P617; BRODEUR RD, 1992, MAR ECOL PROG SER, V84, P101, DOI 10.3354/meps084101; BRODEUR RD, 1992, CAN J FISH AQUAT SCI, V49, P1670, DOI 10.1139/f92-186; Brodeur RD, 2008, MAR ECOL PROG SER, V366, P187, DOI 10.3354/meps07539; Brodeur RD, 2007, FISH OCEANOGR, V16, P395, DOI 10.1111/j.1365-2419.2007.00438.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burke BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054134; Burla M, 2010, CAN J FISH AQUAT SCI, V67, P1671, DOI 10.1139/F10-083; Cheung WWL, 2015, PROG OCEANOGR, V130, P19, DOI 10.1016/j.pocean.2014.09.003; Chittaro PM, 2014, ENVIRON BIOL FISH, V97, P1397, DOI 10.1007/s10641-014-0230-2; Chust G, 2014, GLOBAL CHANGE BIOL, V20, P2124, DOI 10.1111/gcb.12562; Cole J, 2000, FISH OCEANOGR, V9, P1, DOI 10.1046/j.1365-2419.2000.00118.x; Cummins K.W., 1971, INT ASS THEORETICAL, V18, P1, DOI [DOI 10.1080/05384680.1971.11903918, 10. 1080/05384680. 1971. 11903918]; Daly EA, 2014, MAR COAST FISH, V6, P62, DOI 10.1080/19425120.2013.869284; Daly EA, 2013, MAR ECOL PROG SER, V484, P203, DOI 10.3354/meps10320; Daly EA, 2012, ENVIRON BIOL FISH, V94, P117, DOI 10.1007/s10641-011-9857-4; Daly EA, 2010, MAR BIOL, V157, P1975, DOI 10.1007/s00227-010-1466-9; Davis N.D., 1998, North Pacific Anadromous Fish Commission Bulletin, V1, P146; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Fergusson EA, 2013, N PAC ANADR FISH COM, V9, P112; Glaser SM, 2010, MAR ECOL PROG SER, V414, P209, DOI 10.3354/meps08723; Gorley C.K., 2006, GETTING STARTED PRIM; Guraslan C, 2014, FISH OCEANOGR, V23, P436, DOI 10.1111/fog.12080; Handeland SO, 2008, AQUACULTURE, V283, P36, DOI 10.1016/j.aquaculture.2008.06.042; Hannah RW, 2010, CAL COOP OCEAN FISH, V51, P119; Hare S. R., 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P357; Hickey BM, 1998, J GEOPHYS RES-OCEANS, V103, P10339, DOI 10.1029/97JC03290; Kaeriyama M, 2004, FISH OCEANOGR, V13, P197, DOI 10.1111/j.1365-2419.2004.00286.x; Koslow JA, 2002, FISH OCEANOGR, V11, P65, DOI 10.1046/j.1365-2419.2002.00187.x; Lienart GDH, 2014, ANIM BEHAV, V89, P199, DOI 10.1016/j.anbehav.2013.12.031; Litz MNC, 2010, MAR ECOL PROG SER, V405, P71, DOI 10.3354/meps08479; Logerwell EA, 2003, FISH OCEANOGR, V12, P554, DOI 10.1046/j.1365-2419.2003.00238.x; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Miller JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099814; Mills KE, 2013, GLOBAL CHANGE BIOL, V19, P3046, DOI 10.1111/gcb.12298; Morgan CA, 2005, MAR ECOL PROG SER, V299, P19, DOI 10.3354/meps299019; Morrison KW, 2014, MAR BIOL, V161, P2243, DOI 10.1007/s00227-014-2502-y; Mueter FJ, 2002, CAN J FISH AQUAT SCI, V59, P456, DOI 10.1139/f02-020; Nishiyama T., RES I N PAC FISH SPE, V1977, P289; Pearcy W. G., 1992, OCEAN ECOLOGY N PACI; Pearcy WG, 1990, NOAA TECH REP NMFS, V93, P1; Peterson JO, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004965; Pyper BJ, 2005, T AM FISH SOC, V134, P86, DOI 10.1577/T04-034.1; Renkawitz MD, 2015, MAR ECOL PROG SER, V538, P197, DOI 10.3354/meps11470; Roegner GC, 2013, CONT SHELF RES, V60, P70, DOI 10.1016/j.csr.2013.04.007; Rosa R, 2010, MAR ECOL PROG SER, V410, P205, DOI 10.3354/meps08635; Ryding KE, 1999, CAN J FISH AQUAT SCI, V56, P2374, DOI 10.1139/cjfas-56-12-2374; Schwing FB, 2010, J MARINE SYST, V79, P245, DOI 10.1016/j.jmarsys.2008.11.027; Shanks AL, 2013, FISH OCEANOGR, V22, P263, DOI 10.1111/fog.12020; Sharma R, 2013, FISH OCEANOGR, V22, P14, DOI 10.1111/fog.12001; Siddon EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084526; Sidwell VD., 1981, FSEC11 NOAA NMFS; SPEAR LB, 1993, J ANIM ECOL, V62, P399, DOI 10.2307/5190; Stachura MM, 2014, CAN J FISH AQUAT SCI, V71, P226, DOI 10.1139/cjfas-2013-0367; Sydeman WJ, 2014, SCIENCE, V345, P77, DOI [10.1126/science.1251635, 10.1126/science.1250830]; Sydeman WJ, 2014, PROG OCEANOGR, V120, P352, DOI 10.1016/j.pocean.2013.10.017; Tanasichuk RW, 2011, FISH OCEANOGR, V20, P462, DOI 10.1111/j.1365-2419.2011.00596.x; THAYER GW, 1973, FISH B-NOAA, V71, P289; Thayer JA, 2014, MAR ECOL PROG SER, V498, P249, DOI 10.3354/meps10608; Tomaro LM, 2012, MAR ECOL PROG SER, V452, P237, DOI 10.3354/meps09620; Van Pelt TI, 1997, COMP BIOCHEM PHYS A, V118, P1393, DOI 10.1016/S0300-9629(97)00240-5; Wainwright TC, 2013, NORTHWEST SCI, V87, P219, DOI 10.3955/046.087.0305; Wang DW, 2015, NATURE, V518, P390, DOI 10.1038/nature14235; Weitkamp LA, 2012, FISH B-NOAA, V110, P426; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woodworth-Jefcoats PA, 2013, GLOBAL CHANGE BIOL, V19, P724, DOI 10.1111/gcb.12076	80	28	28	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144066	10.1371/journal.pone.0144066	http://dx.doi.org/10.1371/journal.pone.0144066			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675673	gold, Green Submitted, Green Published			2022-12-27	WOS:000366722700023
J	Garcia-Cossio, E; Severens, M; Nienhuis, B; Duysens, J; Desain, P; Keijsers, N; Farquhar, J				Garcia-Cossio, Eliana; Severens, Marianne; Nienhuis, Bart; Duysens, Jacques; Desain, Peter; Keijsers, Noel; Farquhar, Jason			Decoding Sensorimotor Rhythms during Robotic-Assisted Treadmill Walking for Brain Computer Interface (BCI) Applications	PLOS ONE			English	Article							MOTOR RECOVERY; STROKE; GAIT; HAND; IMAGERY; REHABILITATION; CLASSIFICATION; OSCILLATIONS; INDIVIDUALS; SIGNALS	Locomotor malfunction represents a major problem in some neurological disorders like stroke and spinal cord injury. Robot-assisted walking devices have been used during rehabilitation of patients with these ailments for regaining and improving walking ability. Previous studies showed the advantage of brain-computer interface (BCI) based robot-assisted training combined with physical therapy in the rehabilitation of the upper limb after stroke. Therefore, stroke patients with walking disorders might also benefit from using BCI robot-assisted training protocols. In order to develop such BCI, it is necessary to evaluate the feasibility to decode walking intention from cortical patterns during robot-assisted gait training. Spectral patterns in the electroencephalogram (EEG) related to robot-assisted active and passive walking were investigated in 10 healthy volunteers (mean age 32.3 +/- 10.8, six female) and in three acute stroke patients (all male, mean age 46.7 +/- 16.9, Berg Balance Scale 20 +/- 12.8). A logistic regression classifier was used to distinguish walking from baseline in these spectral EEG patterns. Mean classification accuracies of 94.0 +/- 5.4% and 93.1 +/- 7.9%, respectively, were reached when active and passive walking were compared against baseline. The classification performance between passive and active walking was 83.4 +/- 7.4%. A classification accuracy of 89.9 +/- 5.7% was achieved in the stroke patients when comparing walking and baseline. Furthermore, in the healthy volunteers modulation of low gamma activity in central midline areas was found to be associated with the gait cycle phases, but not in the stroke patients. Our results demonstrate the feasibility of BCI-based robotic-assisted training devices for gait rehabilitation.	[Garcia-Cossio, Eliana; Severens, Marianne; Desain, Peter; Farquhar, Jason] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Severens, Marianne; Nienhuis, Bart; Duysens, Jacques; Keijsers, Noel] Sint Maartensklin, Res Dev & Educ Dept, Nijmegen, Netherlands; [Duysens, Jacques] Katholieke Univ Leuven, Dept Kinesiol, Leuven, Belgium	Radboud University Nijmegen; Sint Maartens Clinic; KU Leuven	Garcia-Cossio, E (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	e.garciacossio@donders.ru.nl	Desain, Peter/D-1267-2012	Duysens, Jacques/0000-0002-0043-8817	BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science	This study was supported by the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support of the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science.	Ang KK, 2010, IEEE ENG MED BIO, P5549, DOI 10.1109/IEMBS.2010.5626782; Antelis JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061976; Arya KN, 2011, J BODYW MOV THER, V15, P528, DOI 10.1016/j.jbmt.2011.01.023; Au SK, 2005, INT C REHAB ROBOT, P375; Billinger M., 2012, PRACTICAL BRAIN COMP, P333, DOI [10.1007/978-3-642-29746-5_17, DOI 10.1007/978-3-642-29746-5_17]; Birbaumer N, 2008, CURR OPIN NEUROL, V21, P634, DOI 10.1097/WCO.0b013e328315ee2d; Bishop C, 2006, PATTERN RECOGN; Bradberry TJ, 2010, J NEUROSCI, V30, P3432, DOI 10.1523/JNEUROSCI.6107-09.2010; Buch ER, 2012, BRAIN, V135, P596, DOI 10.1093/brain/awr331; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Castermans T, 2014, BRAIN SCI, V4, P1, DOI 10.3390/brainsci4010001; Castermans T, 2014, NEUROSCI LETT, V561, P166, DOI 10.1016/j.neulet.2013.12.059; Cipriani C, 2008, IEEE T ROBOT, V24, P170, DOI 10.1109/TRO.2007.910708; Collinger J, 2012, LANCET, V381, P347; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Daly JJ, 2009, J NEUROL PHYS THER, V33, P203, DOI 10.1097/NPT.0b013e3181c1fc0b; Do AH, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-111; Do AH, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-49; Englehart K, 2003, IEEE T BIO-MED ENG, V50, P848, DOI 10.1109/TBME.2003.813539; Farquhar J, 2013, NEUROINFORMATICS, V11, P175, DOI 10.1007/s12021-012-9171-0; Fitzsimmons NA, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.003.2009; Fleerkotte BM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-26; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gomez-Rodriguez M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036005; Gu Y, 2009, CLIN NEUROPHYSIOL, V120, P1596, DOI 10.1016/j.clinph.2009.05.006; Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066; Hesse S, 2008, DTSCH ARZTEBL INT, V105, P330, DOI 10.3238/arztebl.2008.0330; Hidler J, 2008, CLIN BIOMECH, V23, P1251, DOI 10.1016/j.clinbiomech.2008.08.004; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.2002.87.6.3070; Johansson BB, 2011, ACTA NEUROL SCAND, V123, P147, DOI 10.1111/j.1600-0404.2010.01417.x; Kamibayashi K, 2010, EXP BRAIN RES, V202, P385, DOI 10.1007/s00221-009-2145-2; King CE, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-77; Koenraadt KLM, 2014, NEUROIMAGE, V85, P415, DOI 10.1016/j.neuroimage.2013.04.070; Kotlowski Wojciech, 2011, P 28 INT C MACH LEAR, P1113; Krzanowski W., 1988, PRINCIPLES OF MULTIV; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lotze M, 2003, BRAIN, V126, P866, DOI 10.1093/brain/awg079; Magee DJ, 2014, ORTHOPEDIC PHYSICAL; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mehrholz J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub2; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Murguialday AR, 2007, INT C REHAB ROBOT, P609, DOI 10.1109/ICORR.2007.4428487; Omlor W, 2007, NEUROIMAGE, V34, P1191, DOI 10.1016/j.neuroimage.2006.10.018; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; Ramos-Murguialday A, 2015, ANN CLIN TRANSL NEUR, V2, P1, DOI 10.1002/acn3.122; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Ramos-Murguialday A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047048; Sale P, 2012, EUR J PHYS REHAB MED, V48, P313; Seeber M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00485; Severens M, 2012, IEEE ENG MED BIO, P2764, DOI 10.1109/EMBC.2012.6346537; Severens M, 2013, THESIS; Severens M, 2014, IEEE T NEUR SYS REH, VPP, P1, DOI DOI 10.1109/TNSRE.2014.2371391; Sitaram R, 2007, NEUROIMAGE, V34, P1416, DOI 10.1016/j.neuroimage.2006.11.005; Takeuchi N, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/128641; Takeuchi N, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/584727; Tenore FVG, 2009, IEEE T BIO-MED ENG, V56, P1427, DOI 10.1109/TBME.2008.2005485; Vos DM, 2010, NEUROINFORMATICS, V8, P135, DOI [10.1007/s12021-010-9076-8, 10.1007/s12021-010-9071-0]; Wagner J, 2012, NEUROIMAGE, V63, P1203, DOI 10.1016/j.neuroimage.2012.08.019; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008	63	33	34	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0137910	10.1371/journal.pone.0137910	http://dx.doi.org/10.1371/journal.pone.0137910			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675472	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700001
J	Sun, CC; Chiu, HT; Lin, YF; Lee, KY; Pang, JHS				Sun, Chi-Chin; Chiu, Hsiao-Ting; Lin, Yi-Fang; Lee, Kuo-Ying; Pang, Jong-Hwei Su			Y-27632, a ROCK Inhibitor, Promoted Limbal Epithelial Cell Proliferation and Corneal Wound Healing	PLOS ONE			English	Article							RHO-ASSOCIATED KINASE; EMBRYONIC STEM-CELLS; PROTEIN-KINASE; IN-VITRO; DEFICIENCY; TRANSPLANTATION; APOPTOSIS; PATHWAY; GTPASES; TISSUE	Transplantation of ex vivo cultured limbal epithelial cells is proven effective in restoring limbal stem cell deficiency. The present study aimed to investigate the promoting effect of Y-27632 on limbal epithelial cell proliferation. Limbal explants isolated from human donor eyes were expanded three weeks on culture dishes and outgrowth of epithelial cells was subsequently subcultured for in vitro experiments. In the presence of Y-27632, the ex vivo limbal outgrowth was accelerated, particularly the cells with epithelial cell-like morphology. Y-27632 dose-dependently promoted the proliferation of in vitro cultured human limbal epithelial cells as examined by phase contrast microscopy and luminescent cell-viability assay 30 hours after the treatment. The colony forming efficacy determined 7 days after the treatment was enhanced by Y-27632 also in a dose-dependent manner. The number of p63- or Ki67-positive cells was dose-dependently increased in Y-27632-treated cultures as detected by immunofluorescent staining and western blotanalysis. Cell cycle analysis by flow cytometric method revealed an increase in S-phase proliferating cells. The epithelial woundclosure rate was shown to be faster in experimental group received topical treatment withY-27632 than the sham control using a rat corneal wounding model. These resultsdemonstrate that Y-27632 can promote both the ex vivo and in vitro proliferation oflimbal epithelial cell proliferation. The in vivo enhanced epithelial wound healingfurther implies that the Y-27632 may act as a new strategy for treating limbal stem cell deficiency.	[Sun, Chi-Chin; Chiu, Hsiao-Ting; Lin, Yi-Fang; Lee, Kuo-Ying] Chang Gung Mem Hosp, Dept Ophthalmol, Keelung, Taiwan; [Sun, Chi-Chin] Chang Gung Univ, Coll Med, Dept Chinese Med, Taoyuan, Taiwan; [Pang, Jong-Hwei Su] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Pang, JHS (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan.	jonghwei@mail.cgu.edu.tw			Chang Gung Medical Research Foundation [CMRPG2A0271, CMRPG2A0272, CMRPG2A0273, CMRPG2C0181, CMRPG270403, CMRPG2C0182]; Ministry of Science and Technology, Taiwan [102-2314-B-182A-089-MY2]	Chang Gung Medical Research Foundation; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Funding was provided by CMRPG2A0271, CMRPG2A0272, CMRPG2A0273, CMRPG2C0181, CMRPG270403 and CMRPG2C0182 from the Chang Gung Medical Research Foundation (CCS), and the Ministry of Science and Technology, Taiwan (grant number 102-2314-B-182A-089-MY2) (CCS).	Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Chidambaranathan GP, 2015, CORNEA, V34, P1478, DOI 10.1097/ICO.0000000000000593; Coleman ML, 2002, CELL DEATH DIFFER, V9, P493, DOI 10.1038/sj.cdd.4400987; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Del Debbio CB, 2014, INVEST OPHTH VIS SCI, V55, P2631, DOI 10.1167/iovs.13-13162; Echevarria TJ, 2011, STEM CELL REV REP, V7, P256, DOI 10.1007/s12015-010-9199-1; Emre N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012148; Gauthaman K, 2010, STEM CELL REV REP, V6, P86, DOI [10.1007/s12015-010-9166-x, 10.1007/s12015-009-9107-8]; Gomes JAP, 2003, OPHTHALMOLOGY, V110, P466, DOI 10.1016/S0161-6420(02)01888-2; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Han ES, 2011, GRAEF ARCH CLIN EXP, V249, P1697, DOI 10.1007/s00417-011-1760-3; Holland EJ, 2015, CORNEA, V34, pS9, DOI 10.1097/ICO.0000000000000534; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Kamai T, 2002, BJU INT, V89, P449, DOI 10.1046/j.1464-4096.2001.01920.x; Kaneko K, 2002, PANCREAS, V24, P251, DOI 10.1097/00006676-200204000-00007; Kurosawa H, 2012, J BIOSCI BIOENG, V114, P577, DOI 10.1016/j.jbiosc.2012.07.013; Minambres R, 2006, J CELL SCI, V119, P271, DOI 10.1242/jcs.02723; Nakamura K, 2014, J PERIODONTAL RES, V49, P363, DOI 10.1111/jre.12114; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; O'Callaghan AR, 2011, STEM CELLS, V29, P1923, DOI 10.1002/stem.756; Okumura N, 2014, INVEST OPHTH VIS SCI, V55, P318, DOI 10.1167/iovs.13-12225; Okumura N, 2013, INVEST OPHTH VIS SCI, V54, P2493, DOI 10.1167/iovs.12-11320; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2011, BRIT J OPHTHALMOL, V95, P1006, DOI 10.1136/bjo.2010.194571; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Poli M, 2015, CORNEA, V34, P817, DOI 10.1097/ICO.0000000000000457; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Quiros M, 2014, SEMIN CELL DEV BIOL, V36, P194, DOI 10.1016/j.semcdb.2014.09.003; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Sangwan VS, 2011, BRIT J OPHTHALMOL, V95, P1525, DOI 10.1136/bjophthalmol-2011-300352; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Shortt AJ, 2014, STEM CELL TRANSL MED, V3, P265, DOI 10.5966/sctm.2013-0025; SundarRaj N, 1998, INVEST OPHTH VIS SCI, V39, P1266; Svoboda KKH, 2004, DEV DYNAM, V229, P579, DOI 10.1002/dvdy.20008; Terunuma A, 2010, TISSUE ENG PT A, V16, P1363, DOI [10.1089/ten.tea.2009.0339, 10.1089/ten.TEA.2009.0339]; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wright B, 2013, DRUG DISCOV TODAY, V18, P79, DOI 10.1016/j.drudis.2012.07.012; Yin J, 2008, AM J PHYSIOL-CELL PH, V295, pC378, DOI 10.1152/ajpcell.90624.2007; Zhao ZY, 2003, DEV DYNAM, V226, P24, DOI 10.1002/dvdy.10212; Zhou QJ, 2013, TISSUE ENG PART C-ME, V19, P531, DOI [10.1089/ten.tec.2012.0429, 10.1089/ten.TEC.2012.0429]	46	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144571	10.1371/journal.pone.0144571	http://dx.doi.org/10.1371/journal.pone.0144571			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673160	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700045
J	Gantner, P; Treger, M; De Miscault, C; Batard, ML; Bernard-Henry, C; Cheneau, C; De Mautort, E; Partisani, M; Priester, M; Rey, D				Gantner, Pierre; Treger, Michele; De Miscault, Constance; Batard, Marie-Laure; Bernard-Henry, Claudine; Cheneau, Christine; De Mautort, Erik; Partisani, Marialuisa; Priester, Michele; Rey, David			Predictors of Standard Follow-Up Completion after Sexual Exposure to HIV: Five-Year Retrospective Analysis in a French HIV-Infection Care Center	PLOS ONE			English	Article							NONOCCUPATIONAL POSTEXPOSURE PROPHYLAXIS; COMMUNITY-HEALTH CENTER; ADHERENCE; MEN; PERCEPTION; GUIDELINES; ADULTS; TRIAL	Objectives The care of exposed individuals to HIV remains a challenge regarding follow-up completion and HIV-testing of the partner. Identifying patients with risk of not fulfilling HIV-testing follow-up completion (FC), among patients demanding non-occupational post-exposure prophylaxis (nPEP), may improve clinical practice. Methods A retrospective chart review was conducted in a single French HIV-infection care center. FC predictors were assessed in a multivariate logistic regression model (Likelihood ratios test). Results Between 2009 and 2013, 646 sexual exposures to HIV were evaluated for nPEP, of which 507 effectively received nPEP (78%). FC rate was 30% (194/646). In the multivariate analysis, FC rates rose with age of exposed individuals (OR, 1.04 [0.25-4.28]; p<0.001) and decreased with the year of sexual exposure (OR, 0.74 [0.65-0.85]; p<0.001). FC was associated with sexual encounter with a sex worker (OR, 4.07 [0.98-16.82]; p<0.001) and nPEP use (OR, 2.69 [2.37-3.06]; p<0.001). nPEP early discontinuation was associated with decreased FC rates (OR, 0.18 [0.08-0.39]; p<0.001). No documented nPEP failure was identified. However, five Men who have Sex with Men (MSM) nPEP recipients for unprotected anal receptive intercourse subsequently seroconverted to HIV more than 6 months after nPEP. Seroconversion to HIV was associated with the lack of FC (p = 0.04) and multiple presentations for nPEP over the study period (p = 0.002). Conclusions We identified significant predictors of not fulfilling sequential HIV-testing. They appear to be linked with a self-perceived HIV risk, especially in young adults recently exposed. Enhanced counseling in targeted individuals with high risk behaviors and using smartphone and internet-based strategies may be interesting retention in care options.	[Gantner, Pierre; De Miscault, Constance; Batard, Marie-Laure; Bernard-Henry, Claudine; Cheneau, Christine; De Mautort, Erik; Partisani, Marialuisa; Priester, Michele; Rey, David] Hop Univ Strasbourg, Le Trait Union, HIV Infect Care Ctr, Strasbourg, France; [Treger, Michele] Univ Strasbourg, Fac Med, Biostat Lab, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gantner, P (corresponding author), Hop Univ Strasbourg, Le Trait Union, HIV Infect Care Ctr, Strasbourg, France.	pierre.gantner@chru-strasbourg.fr		Gantner, Pierre/0000-0002-3984-883X				Beltzer N, 2013, AIDS, V27, P1011, DOI 10.1097/QAD.0b013e32835e1583; Bennett A, 2015, INT J STD AIDS, V26, P746, DOI 10.1177/0956462414556329; Bentz L, 2010, AIDS CARE, V22, P1509, DOI 10.1080/09540121.2010.484457; Bogowicz P, 2015, INT J STD AIDS IN PR; Casalino E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104350; Clumeck N, 2008, HIV MED, V9, P65, DOI 10.1111/j.1468-1293.2007.00533.x; Fletcher JB, 2013, J SEX TRANSM DIS, V2013, DOI 10.1155/2013/210403; Gulholm T, 2013, SEX HEALTH, V10, P438, DOI 10.1071/SH13018; Jain S, 2015, AIDS PATIENT CARE ST, V29, P20, DOI 10.1089/apc.2014.0154; Jain S, 2015, JAIDS-J ACQ IMM DEF, V68, P97, DOI 10.1097/QAI.0000000000000403; Jain S, 2014, AIDS, V28, P1545, DOI 10.1097/QAD.0000000000000301; Kaai S, 2012, PATIENT EDUC COUNS, V88, P4, DOI 10.1016/j.pec.2011.11.011; Katz MH, 1997, NEW ENGL J MED, V336, P1097, DOI 10.1056/NEJM199704103361512; Krause KH, 2014, WOMEN HEALTH ISS, V24, pE407, DOI 10.1016/j.whi.2014.04.003; Livrozet JM, 2002, 6 INT C DRUG THER HI; McAllister J, 2014, HIV MED, V15, P13, DOI 10.1111/hiv.12075; McDougal SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105030; McFaul K, 2015, INT J STD AIDS, V26, P521, DOI 10.1177/0956462414547525; Morlat P, ACTUALISATION 2014 R; Muessig KE, 2015, CURR HIV-AIDS REP, V12, P173, DOI 10.1007/s11904-014-0239-3; Mulieri I, 2014, ANN I SUPER SANITA, V50, P363, DOI 10.4415/ANN_14_04_12; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Rey D, 2004, JAIDS-J ACQ IMM DEF, V37, P1454, DOI 10.1097/01.qai.0000136732.00354.bd; Rey D, 2011, EXPERT REV ANTI-INFE, V9, P431, DOI [10.1586/ERI.11.20, 10.1586/eri.11.20]; Roland ME, 2011, CLIN INFECT DIS, V53, P76, DOI 10.1093/cid/cir333; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; Sultan B, 2014, HIV AIDS-RES PALLIAT, V6, P147, DOI 10.2147/HIV.S46585; Takahashi TA, 2005, J GEN INTERN MED, V20, P618, DOI 10.1111/j.1525-1497.2005.0112.x; Tissot F, 2010, HIV MED, V11, P584, DOI 10.1111/j.1468-1293.2010.00826.x; Tosini W, 2010, AIDS, V24, P2375, DOI 10.1097/QAD.0b013e32833dfad1	30	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145440	10.1371/journal.pone.0145440	http://dx.doi.org/10.1371/journal.pone.0145440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SH	26696009	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092500048
J	Green, EM; Coleman, JA; Gouaux, E				Green, Evan M.; Coleman, Jonathan A.; Gouaux, Eric			Thermostabilization of the Human Serotonin Transporter in an Antidepressant-Bound Conformation	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; SCINTILLATION PROXIMITY ASSAY; SIZE-EXCLUSION CHROMATOGRAPHY; X-RAY STRUCTURES; MEMBRANE-PROTEINS; NEUROTRANSMITTER TRANSPORTERS; DOPAMINE TRANSPORTER; CRYSTAL-STRUCTURE; BACTERIAL HOMOLOG; SUBSTRATE-BINDING	Serotonin is a ubiquitous chemical transmitter with particularly important roles in the gastrointestinal, cardiovascular and central nervous systems. Modulation of serotonergic signaling occurs, in part, by uptake of the transmitter by the serotonin transporter (SERT). In the brain, SERT is the target for numerous antidepressants including tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs). Despite the importance of SERT in human physiology, biochemical, biophysical and high-resolution structural studies have been hampered due to the instability of SERT in detergent micelles. To identify a human SERT (hSERT) construct suitable for detailed biochemical and structural studies, we developed an efficient thermostability screening protocol and rapidly screened 219 mutations for thermostabilization of hSERT in complex with the SSRI paroxetine. We discovered three mutations-Y110A, I291A and T439S -that, when combined into a single construct, deemed TS3, yielded a hSERT variant with an apparent melting temperature (Tm) 19 degrees C greater than that of the wild-type transporter, albeit with a loss of transport activity. Further investigation yielded a double mutant-I291A and T439S-defined as TS2, with a 12 degrees C increase in Tm and retention of robust transport activity. Both TS2 and TS3 were more stable in short-chain detergents in comparison to the wild-type transporter. This thermostability screening protocol, as well as the specific hSERT variants, will prove useful in studies of other integral membrane receptors and transporters and in the investigation of structure and function relationships in hSERT.	[Green, Evan M.; Coleman, Jonathan A.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360; Coleman, Jonathan/0000-0003-0001-6195	NIMH/NIH [5R37MH070039]; Government of Canada, Banting Fellowship Program [317369]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH070039] Funding Source: NIH RePORTER	NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Government of Canada, Banting Fellowship Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The following funding supported this research: NIMH/NIH, 5R37MH070039 (EG): https://www.nimh.nih.gov/index.shtml. Government of Canada, Banting Fellowship Program, 317369 (JAC): http://banting.fellowships-bourses.gc.ca/home-accueil-eng.html. Howard Hughes Medical Institute: https://www.hhmi.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hussein S, 2013, J MOL BIOL, V425, P2198, DOI 10.1016/j.jmb.2013.03.025; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; BARKER EL, 1994, MOL PHARMACOL, V46, P799; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cool DR, 1990, AM J PHYSIOL, V259, P196; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Harder D, 2012, NAT PROTOC, V7, P1569, DOI 10.1038/nprot.2012.090; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Penmatsa A, 2015, NAT STRUCT MOL BIOL, V22, P506, DOI 10.1038/nsmb.3029; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rothman RB, 2003, EUR J PHARMACOL, V479, P23, DOI 10.1016/j.ejphar.2003.08.054; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Tate CG, 2012, TRENDS BIOCHEM SCI, V37, P343, DOI 10.1016/j.tibs.2012.06.003; UDENFRIEND S, 1987, ANAL BIOCHEM, V161, P494, DOI 10.1016/0003-2697(87)90479-9; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	32	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145688	10.1371/journal.pone.0145688	http://dx.doi.org/10.1371/journal.pone.0145688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695939	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500068
J	Janiszewska, J; Szaumkessel, M; Kostrzewska-Poczekaj, M; Bednarek, K; Paczkowska, J; Jackowska, J; Grenman, R; Szyfter, K; Wierzbicka, M; Giefing, M; Jarmuz-Szymczak, M				Janiszewska, Joanna; Szaumkessel, Marcin; Kostrzewska-Poczekaj, Magdalena; Bednarek, Kinga; Paczkowska, Julia; Jackowska, Joanna; Grenman, Reidar; Szyfter, Krzysztof; Wierzbicka, Malgorzata; Giefing, Maciej; Jarmuz-Szymczak, Malgorzata			Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LASER-CAPTURE MICRODISSECTION; NECK-CANCER; TUMOR-SUPPRESSOR; HEAD; APOPTOSIS; TISSUE; GENES; MICRORNAS; BIOMARKER	Background Laryngeal squamous cell carcinoma (LSCC) is the most common group among head and neck cancers. LSCC is characterized by a high incidence in Europe. With the aim of better understanding its genetic background we performed global miRNA expression profiling of LSCC cell lines and primary specimens. By this approach we identified a cohort of 33 upregulated and 9 downregulated miRNA genes in LSCC as compared to epithelial no tumor controls. Results Within this group we identified overexpression of the novel miR-1290 gene not reported in the context of LSCC before. Using a combined bioinformatical approach in connection with functional analysis we delineated two putative target genes of miR-1290 namely ITPR2 and MAF which are significantly downregulated in LSCC. They are interesting candidates for tumor suppressor genes as they are implicated in apoptosis and other processes deregulated in cancer. Conclusion Taken together, we propose miR-1290 as the new oncomiR involved in LSCC pathogenesis. Additionally, we suggest that the oncogenic potential of miR-1290 might be expressed by the involvement in downregulation of its target genes MAF and ITPR2.	[Janiszewska, Joanna; Szaumkessel, Marcin; Kostrzewska-Poczekaj, Magdalena; Bednarek, Kinga; Paczkowska, Julia; Szyfter, Krzysztof; Giefing, Maciej; Jarmuz-Szymczak, Malgorzata] Polish Acad Sci, Inst Human Genet, Dept Canc Genet, PL-60479 Poznan, Poland; [Jackowska, Joanna; Wierzbicka, Malgorzata; Giefing, Maciej] Univ Med Sci, Dept Otolaryngol & Laryngol Oncol, Poznan, Poland; [Grenman, Reidar] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, FIN-20520 Turku, Finland; [Grenman, Reidar] Turku Univ Hosp, Dept Med Biochem, FIN-20520 Turku, Finland; [Grenman, Reidar] Univ Turku, Turku, Finland; [Szyfter, Krzysztof] Univ Med Sci, Dept Audiol & Phoniatry, Poznan, Poland; [Jarmuz-Szymczak, Malgorzata] Poznan Univ Med Sci, Dept Hematol, Poznan, Poland	Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; University of Turku; University of Turku; University of Turku; Poznan University of Medical Sciences	Janiszewska, J (corresponding author), Polish Acad Sci, Inst Human Genet, Dept Canc Genet, PL-60479 Poznan, Poland.	jjanisz@man.poznan.pl	Bednarek, Kinga/HGF-0045-2022; Giefing, Maciej/D-2568-2009	Wierzbicka, Malgorzata/0000-0003-0006-6352; Bednarek, Kinga/0000-0003-0135-4663; Paczkowska, Julia/0000-0002-3976-4353; Jackowska, Joanna/0000-0002-5189-5823; Janiszewska, Joanna/0000-0002-1765-0152; Szyfter, Krzysztof/0000-0003-2631-6399; Kostrzewska-Poczekaj, Magdalena/0000-0001-8099-3839; Giefing, Maciej/0000-0002-4760-8246; Jarmuz-Szymczak, Malgorzata/0000-0003-0437-5806	Polish National Science Center [N N401 195839]	Polish National Science Center	The study was financed by the Polish National Science Center grant number N N401 195839 (https://www.ncn.gov.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker H, 2005, ORAL ONCOL, V41, P183, DOI 10.1016/j.oraloncology.2004.08.009; Baraniskin A, 2013, INT J CANCER, V132, pE48, DOI 10.1002/ijc.27791; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cao PY, 2013, HEAD NECK-J SCI SPEC, V35, P720, DOI 10.1002/hed.23011; Cervigne NK, 2009, HUM MOL GENET, V18, P4818, DOI 10.1093/hmg/ddp446; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Chuang HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104821; Dequanter D, 2012, ACTA CHIR BELG, V112, P423, DOI 10.1080/00015458.2012.11680866; DONALDSON KL, 1994, INT J CANCER, V57, P847, DOI 10.1002/ijc.2910570614; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fletcher AM, 2008, TRANSL ONCOL, V1, P202, DOI 10.1593/tlo.08163; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Giefing M, 2011, GENE CHROMOSOME CANC, V50, P154, DOI 10.1002/gcc.20840; Ha PK, 2009, ORAL ONCOL, V45, P335, DOI 10.1016/j.oraloncology.2008.05.015; Hale TK, 2000, J BIOL CHEM, V275, P17991, DOI 10.1074/jbc.M000921200; Harris T, 2012, AM J PATHOL, V180, P917, DOI 10.1016/j.ajpath.2011.12.004; Hsu CM, 2012, TUMOR BIOL, V33, P1933, DOI 10.1007/s13277-012-0454-8; Huang XY, 2015, EUR UROL, V67, P33, DOI 10.1016/j.eururo.2014.07.035; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Jarmuz M, 2005, CANCER GENET CYTOGEN, V160, P82, DOI 10.1016/j.cancergencyto.2004.12.006; Jarvinen AK, 2006, ONCOGENE, V25, P6997, DOI 10.1038/sj.onc.1209690; Kostrzewska-Poczekaj M, 2010, CANCER BIOMARK, V8, P11, DOI 10.3233/DMA-2011-0814; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Leethanakul C, 2000, ONCOGENE, V19, P3220, DOI 10.1038/sj.onc.1203703; Lencesova L, 2013, ACTA PHYSIOL, V208, P350, DOI 10.1111/apha.12105; Long XB, 2009, ONCOL REP, V22, P1189, DOI 10.3892/or_00000554; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Peng SP, 2009, IMMUNOLOGY, V127, P267, DOI 10.1111/j.1365-2567.2008.03014.x; Perri F, 2015, HEAD NECK-J SCI SPEC, V37, P763, DOI 10.1002/hed.23837; Ramdas L, 2009, HEAD NECK-J SCI SPEC, V31, P642, DOI 10.1002/hed.21017; Ren JY, 2010, EUR J CANCER, V46, P3409, DOI 10.1016/j.ejca.2010.07.047; Salazar C, 2014, EXPERT REV MOL DIAGN, V14, P1033, DOI 10.1586/14737159.2014.960519; Salazar C, 2014, CELL ONCOL, V37, P331, DOI 10.1007/s13402-014-0188-2; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith IM, 2009, ARCH OTOLARYNGOL, V135, P487, DOI 10.1001/archoto.2009.43; Song J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011456; Sun X, 2013, BIOMED REP, V1, P743, DOI 10.3892/br.2013.143; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Wanebo HJ, 2014, ANN ONCOL, V25, P2036, DOI 10.1093/annonc/mdu248; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wiel C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4792; Wu XL, 2013, ONCOTARGET, V4, P1388, DOI 10.18632/oncotarget.1239; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Yan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073656; Yang Ying, 2007, Einstein J Biol Med, V23, P2; Zhang B, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-118; Zhao XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056395; Zheng J, 2011, J CELL BIOCHEM, V112, P872, DOI 10.1002/jcb.22995	51	28	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144924	10.1371/journal.pone.0144924	http://dx.doi.org/10.1371/journal.pone.0144924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694163	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092500015
J	Ran, C; Huang, L; Liu, Z; Xu, L; Yang, YL; Tacon, P; Auclair, E; Zhou, ZG				Ran, Chao; Huang, Lu; Liu, Zhi; Xu, Li; Yang, Yalin; Tacon, Philippe; Auclair, Eric; Zhou, Zhigang			A Comparison of the Beneficial Effects of Live and Heat-Inactivated Baker's Yeast on Nile Tilapia: Suggestions on the Role and Function of the Secretory Metabolites Released from the Yeast	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; X MORONE-SAXATILIS; CHALLENGED IN-SITU; SACCHAROMYCES-CEREVISIAE; GROWTH-PERFORMANCE; RAINBOW-TROUT; BREWERS-YEAST; IMMUNE-RESPONSE; BETA-GLUCAN; MANNAN OLIGOSACCHARIDE	Yeast is frequently used as a probiotic in aquaculture with the potential to substitute for antibiotics. In this study, the involvement and extent to which the viability of yeast cells and thus the secretory metabolites released from the yeast contribute to effects of baker's yeast was investigated in Nile tilapia. No yeast, live yeast or heat-inactivated baker's yeast were added to basal diets high in fishmeal and low in soybean (diet A) or low in fishmeal and high in soybean (diet B), which were fed to fish for 8 weeks. Growth, feed utilization, gut microvilli morphology, and expressions of hsp70 and inflammation-related cytokines in the intestine and head kidney were assessed. Intestinal microbiota was investigated using 16S rRNA gene pyrosequencing. Gut alkaline phosphatase (AKP) activity was measured after challenging the fish with Aeromonas hydrophila. Results showed that live yeast significantly improved FBW and WG (P < 0.05), and tended to improve FCR (P = 0.06) of fish compared to the control (no yeast). No significant differences were observed between inactivated yeast and control. Live yeast improved gut microvilli length (P < 0.001) and density (P < 0.05) while inactivated yeast did not. The hsp70 expression level in both the intestine and head kidney of fish was significantly reduced by live yeast (P < 0.05) but not inactivated yeast. Live yeast but not inactivated yeast reduced intestinal expression of tnfa (P < 0.05), tgf beta (P < 0.05 under diet A) and il1 beta (P = 0.08). Intestinal Lactococcus spp. numbers were enriched by both live and inactivated yeast. Lastly, both live and inactivated yeast reduced the gut AKP activity compared to the control (P < 0.001), indicating protection of the host against infection by A. hydrophila. In conclusion, secretory metabolites did not play major roles in the growth promotion and disease protection effects of yeast. Nevertheless, secretory metabolites were the major contributing factor towards improved gut microvilli morphology, relieved stress status, and reduced intestinal inflammation of Nile tilapia fed diets supplemented with baker's yeast.	[Ran, Chao; Huang, Lu; Liu, Zhi; Xu, Li; Yang, Yalin; Zhou, Zhigang] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China; [Tacon, Philippe; Auclair, Eric] Phileo Lesaffre Anim Care, Soc Ind Lesaffre, Marcq En Baroeul, France	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Zhou, ZG (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China.	zhouzhigang03@caas.cn			National Natural Science Foundation of China [31272672]; National Science and Technology Support Program Project of China [2012BAD25B02]; Beijing earmarked fund for Modern Agro-industry Technology Research System [SCGWZJ 20151104-4]; Societe Industrielle Lesaffre	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program Project of China; Beijing earmarked fund for Modern Agro-industry Technology Research System; Societe Industrielle Lesaffre	This work was supported by the National Natural Science Foundation of China (31272672), the National Science and Technology Support Program Project of China (2012BAD25B02), and Beijing earmarked fund for Modern Agro-industry Technology Research System (SCGWZJ 20151104-4). The URL of funder's websites is not available. ZZ was the author who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Societe Industrielle Lesaffre provided support in the form of salaries for authors PT and EA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdel-Tawwab M, 2008, AQUACULTURE, V280, P185, DOI 10.1016/j.aquaculture.2008.03.055; Abdel-Tawwab M, 2010, J WORLD AQUACULT SOC, V41, P214, DOI 10.1111/j.1749-7345.2010.00361.x; ANDLID T, 1995, MICROBIAL ECOL, V30, P321, DOI 10.1007/BF00171938; Avella MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045572; Avella MA, 2011, AQUACULTURE, V315, P384, DOI 10.1016/j.aquaculture.2011.02.046; Avella MA, 2010, AM J PHYSIOL-REG I, V298, pR359, DOI 10.1152/ajpregu.00300.2009; Calder PC, 2006, J NUTR, V136, p288S, DOI 10.1093/jn/136.1.288S; Castillo M, 2008, J ANIM SCI, V86, P94, DOI 10.2527/jas.2005-686; Chang CI, 2002, J FISH DIS, V25, P311, DOI 10.1046/j.1365-2761.2002.00365.x; Chiu CH, 2010, FISH SHELLFISH IMMUN, V29, P1053, DOI 10.1016/j.fsi.2010.08.019; Dimitroglou A, 2009, J ANIM SCI, V87, P3226, DOI 10.2527/jas.2008-1428; Dimitroglou A, 2010, AQUACULTURE, V300, P182, DOI 10.1016/j.aquaculture.2010.01.015; Eicher SD, 2006, J ANIM SCI, V84, P2352, DOI 10.2527/jas.2005-770; Falco A, 2012, FISH SHELLFISH IMMUN, V32, P1051, DOI 10.1016/j.fsi.2012.02.028; FAO, 2015, WORLD AQ PROD INL MA; Ferrucci L, 2006, J CLIN ENDOCR METAB, V91, P439, DOI 10.1210/jc.2005-1303; Gao J, 2008, POULTRY SCI, V87, P1377, DOI 10.3382/ps.2007-00418; Gatesoupe FJ, 2007, AQUACULTURE, V267, P20, DOI 10.1016/j.aquaculture.2007.01.005; Gatesoupe FJ, 1999, AQUACULTURE, V180, P147, DOI 10.1016/S0044-8486(99)00187-8; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hooge D. M., 2004, International Journal of Poultry Science, V3, P163; Hoseinifar SH, 2011, AQUACULTURE, V318, P90, DOI 10.1016/j.aquaculture.2011.04.043; Iji PA, 2001, J SCI FOOD AGR, V81, P1186, DOI 10.1002/jsfa.925; Jensen GS, 2008, COMP IMMUNOL MICROB, V31, P487, DOI 10.1016/j.cimid.2007.08.005; Jung A, 2011, LETT APPL MICROBIOL, V52, P497, DOI 10.1111/j.1472-765X.2011.03030.x; Kim DH, 2006, VET IMMUNOL IMMUNOP, V114, P297, DOI 10.1016/j.vetimm.2006.08.015; Kuhlwein H, 2014, J ANIM PHYSIOL AN N, V98, P279, DOI 10.1111/jpn.12078; Lara-Flores M, 2003, AQUACULTURE, V216, P193, DOI 10.1016/S0044-8486(02)00277-6; Li P, 2005, AQUACULTURE, V248, P197, DOI 10.1016/j.aquaculture.2005.03.005; Li P, 2004, AQUACULTURE, V231, P445, DOI 10.1016/j.aquaculture.2003.08.021; Li P, 2006, AQUACULTURE, V251, P141, DOI 10.1016/j.aquaculture.2005.01.009; Li P, 2003, AQUACULTURE, V219, P681, DOI 10.1016/S0044-8486(02)00653-1; Liu WS, 2014, BRIT J NUTR, V112, P15, DOI 10.1017/S0007114514000610; Liu WS, 2013, FISH SHELLFISH IMMUN, V35, P54, DOI 10.1016/j.fsi.2013.04.010; Liu YC, 2008, AQUAC RES, V39, P635, DOI 10.1111/j.1365-2109.2008.01934.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lokesh J, 2012, FISH SHELLFISH IMMUN, V33, P626, DOI 10.1016/j.fsi.2012.06.017; Newaj-Fyzul A, 2014, AQUACULTURE, V431, P1, DOI 10.1016/j.aquaculture.2013.08.026; NEWBOLD CJ, 1995, J ANIM SCI, V73, P1811; Niewold TA, 2007, POULTRY SCI, V86, P605, DOI 10.1093/ps/86.4.605; Ortuno J, 2002, VET IMMUNOL IMMUNOP, V85, P41, DOI 10.1016/S0165-2427(01)00406-8; Panigrahi A, 2007, DEV COMP IMMUNOL, V31, P372, DOI 10.1016/j.dci.2006.07.004; Panigrahi A, 2004, VET IMMUNOL IMMUNOP, V102, P379, DOI 10.1016/j.vetimm.2004.08.006; Pirarat N, 2011, RES VET SCI, V91, pE92, DOI 10.1016/j.rvsc.2011.02.014; Qin CB, 2014, REPRODUCTION, V147, P53, DOI 10.1530/REP-13-0141; Refstie S, 2010, AQUACULTURE, V305, P109, DOI 10.1016/j.aquaculture.2010.04.005; Reyes-Becerril M, 2011, AQUAC RES, V42, P1676, DOI 10.1111/j.1365-2109.2010.02762.x; Ringo E., 2012, J MAR SCI RES DEV, V2, P104, DOI [10.4172/2155-9910.1000104, DOI 10.4172/2155-9910.1000104]; Rollo A, 2006, FISH PHYSIOL BIOCHEM, V32, P167, DOI 10.1007/s10695-006-0009-2; Salze G, 2008, AQUACULTURE, V274, P148, DOI 10.1016/j.aquaculture.2007.11.008; Shen YB, 2009, J ANIM SCI, V87, P2614, DOI 10.2527/jas.2008-1512; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tacchi L, 2011, FISH SHELLFISH IMMUN, V31, P704, DOI 10.1016/j.fsi.2011.02.023; Teuber M, 2001, CURR OPIN MICROBIOL, V4, P493, DOI 10.1016/S1369-5274(00)00241-1; van der Peet-Schwering CMC, 2007, J ANIM SCI, V85, P3099, DOI 10.2527/jas.2007-0110; Vizioli J, 2001, P NATL ACAD SCI USA, V98, P12630, DOI 10.1073/pnas.221466798; WALLACE RJ, 1994, J ANIM SCI, V72, P2992, DOI 10.2527/1994.72112992x; Zanello G, 2011, VET IMMUNOL IMMUNOP, V141, P133, DOI 10.1016/j.vetimm.2011.01.018	58	38	38	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145448	10.1371/journal.pone.0145448	http://dx.doi.org/10.1371/journal.pone.0145448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696403	Green Published, gold			2022-12-27	WOS:000367092500050
J	Ma, Y; Ma, N; Liu, QB; Qi, Y; Manabe, R; Furuyashiki, T				Ma, Yan; Ma, Ning; Liu, Qingbin; Qi, Yao; Manabe, Ri-ichiroh; Furuyashiki, Tomoyuki			Tor Signaling Regulates Transcription of Amino Acid Permeases through a GATA Transcription Factor Gaf1 in Fission Yeast	PLOS ONE			English	Article							GENE-EXPRESSION; CELL INTEGRITY; KINASE; PROTEIN; GROWTH; ACTIVATION; NUTRIENT; PATHWAY; PHOSPHORYLATION; IDENTIFICATION	In the fission yeast, two Tor isoforms, Tor1 and Tor2, oppositely regulate gene expression of amino acid permeases. To elucidate the transcriptional machinery for these regulations, here we have employed the cap analysis of gene expression (CAGE), a method of analyzing expression profiles and identifying transcriptional start sites (TSSs). The loss of Tor1 decreased, and Tor2 inhibition by its temperature sensitive mutation increased, mRNA expression of isp5(+), per1(+), put4(+) and SPBPB2B2.01. In contrast, the loss of Tor1 increased, and Tor2 inhibition decreased, the expression of cat1(+). These changes were confirmed by semi-quantitative RT-PCR. These opposite effects by the loss of Tor1 and Tor2 inhibition appeared to occur evenly across multiple TSSs for the respective genes. The motif discovery analysis based on the CAGE results identified the GATA motifs as a potential cis-regulatory element for Tor-mediated regulation. In the luciferase reporter assay, the loss of Tor1 reduced, and Tor2 inhibition and nitrogen depletion increased, the activity of isp5(+) promoter as well as that of a GATAAG reporter. One of the GATAAG motifs in isp5(+) promoter was critical for its transcriptional activity, and a GATA transcription factor Gaf1 was critical for the activities of isp5(+) promoter and the GATAAG reporter. Furthermore, Tor2 inhibition and nitrogen depletion induced nuclear localization of Gaf1 from the cytosol and its dephosphorylation. These results suggest that Tor2 inhibition, which is known to be induced by nitrogen depletion, promotes nuclear localization of Gaf1, thereby inducing isp5(+) transcription through Gaf1 binding to the GATAAG motif in its promoter. Since Gaf1 was also critical for transcription of per1(+) and put4(+), Tor-Gaf1 signaling may coordinate transcription of multiple amino acid permeases according to nutrient availability.	[Ma, Yan; Ma, Ning; Liu, Qingbin; Qi, Yao; Furuyashiki, Tomoyuki] Kobe Univ, Grad Sch Med, Div Pharmacol, Kobe, Hyogo 657, Japan; [Manabe, Ri-ichiroh] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan	Kobe University; RIKEN	Ma, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Pharmacol, Kobe, Hyogo 657, Japan.	mayan@med.kobe-u.ac.jp	Furuyashiki, Tomoyuki/AAG-5283-2019; Furuyashiki, Tomoyuki/B-8760-2014	Furuyashiki, Tomoyuki/0000-0001-8089-8399; Furuyashiki, Tomoyuki/0000-0001-8089-8399	Japan Society for the Promotion of Science [26460339]; MEXT; Platform Project for Supporting in Drug Discovery and Life Science Research from Japan Agency for Medical Research and Development; Innovative Cell Biology by Innovative Technology from MEXT; Grants-in-Aid for Scientific Research [15H01289, 24689015] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform Project for Supporting in Drug Discovery and Life Science Research from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Innovative Cell Biology by Innovative Technology from MEXT; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science to Y.M. (No. 26460339), a Research Grant from MEXT to the RIKEN Center for Life Science Technologies, a Grant of the Innovative Cell Biology by Innovative Technology from MEXT to Yoshihide Hayashizaki, and the Platform Project for Supporting in Drug Discovery and Life Science Research from Japan Agency for Medical Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin J, 2014, J CELL SCI, V127, P1346, DOI 10.1242/jcs.146373; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Coffman JA, 1996, MOL CELL BIOL, V16, P847; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hirayama S, 2003, J BIOL CHEM, V278, P18078, DOI 10.1074/jbc.M212900200; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Laor D, 2015, MBIO, V6, DOI 10.1128/mBio.00959-15; Laor D, 2014, MOL CELL BIOL, V34, P794, DOI 10.1128/MCB.01473-13; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Ma N, 2013, GENETICS, V195, P457, DOI 10.1534/genetics.113.154674; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; Murata M, 2014, METHODS MOL BIOL, V1164, P67, DOI 10.1007/978-1-4939-0805-9_7; Nakashima A, 2012, J CELL SCI, V125, P5840, DOI 10.1242/jcs.111146; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Ohmiya H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-269; Rallis C, 2013, AGING CELL; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Rowen DW, 1997, J BACTERIOL, V179, P3761, DOI 10.1128/jb.179.11.3761-3766.1997; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Stanbrough M, 1996, J BACTERIOL, V178, P2465, DOI 10.1128/jb.178.8.2465-2468.1996; Toda T, 1996, MOL CELL BIOL, V16, P6752; Uritani M, 2006, GENES CELLS, V11, P1367, DOI 10.1111/j.1365-2443.2006.01025.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zheng X, 2014, INT J MOL SCI, V15, P20753, DOI 10.3390/ijms151120753; Zhou X, 2012, J BIOL CHEM, V287, P23434, DOI 10.1074/jbc.C111.338715	34	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144677	10.1371/journal.pone.0144677	http://dx.doi.org/10.1371/journal.pone.0144677			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689777	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300011
J	Wang, XB; Qiao, C; Wei, L; Han, YD; Cui, NH; Huang, ZL; Li, ZH; Zheng, F; Yan, M				Wang, Xue-bin; Qiao, Chen; Wei, Li; Han, Ya-di; Cui, Ning-hua; Huang, Zhu-liang; Li, Zu-hua; Zheng, Fang; Yan, Ming			Associations of Polymorphisms in MTHFR Gene with the Risk of Age-Related Cataract in Chinese Han Population: A Genotype-Phenotype Analysis	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; PLASMA HOMOCYSTEINE; COMMON MUTATION; FOLATE; EXPRESSION; PREVALENCE; VARIANTS; DISEASE	Homocysteine (Hcy) is a potential risk factor for age-related cataract (ARC). Methylenetetrahydrofolate reductase (MTHFR) is the key enzyme for Hcy metabolism, and variants of MTHFR may affect MTHFR enzyme activity. This study mainly evaluated the associations between variants in MTHFR gene, plasma MTHFR enzyme activity, total Hcy (tHcy) levels and ARC risk in Chinese population. Four single nucleotide polymorphisms (SNPs) in MTHFR gene were genotyped using the high-resolution melting (HRM) method in 502 ARC patients (mean age, 70.2 [SD, 9.0], 46.0% male) and 890 healthy controls (mean age, 67.1 [SD, 11.1], 47.6% male). The plasma MTHFR activity, folic acid (FA), vitamins B12 and B6 levels were detected by enzyme-linked immunosorbent assays (ELISA). The plasma tHcy levels were measured by an automated enzymatic assay. After the Bonferroni correction, the minor allele T of SNP rs1801133 showed a significant association with an increased risk of overall ARC (OR = 1.26, P = 0.003). Consistent association was also found between SNP rs1801133 and cortical ARC risk (OR = 1.44, P = 0.003). Haplotype analyses revealed an adverse effect of the haplotype "C-A-T-C" (alleles in order of SNPs rs3737967, rs1801131, rs1801133 and rs9651118) on ARC risk (OR = 1.55, P = 0.003). Moreover, in a joint analysis of SNPs rs9651118 and rs1801133, subjects with two unfavorable genotypes had a 1.76-fold increased risk of ARC compared with the reference group, and a statistically significant dose-response trend (P-trend=0.001) was also observed. Further, in healthy controls and patients with cortical ARC, the allele T of SNP rs1801133 and the increasing number of unfavorable genotypes were significantly correlated with decreased MTHFR activity as well as increased tHcy levels. However, there was no significant association between FA, vitamins B12, B6 levels and MTHFR variants. Our data indicated that variants in MTHFR gene might individually and jointly influence susceptibility to ARC by affecting MTHFR enzyme activity and tHcy levels.	[Wang, Xue-bin; Qiao, Chen; Han, Ya-di; Huang, Zhu-liang; Li, Zu-hua; Zheng, Fang; Yan, Ming] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Hubei, Peoples R China; [Wei, Li; Yan, Ming] Wuhan Univ, Zhongnan Hosp, Dept Ophthalmol, Wuhan 430072, Hubei, Peoples R China; [Cui, Ning-hua] Childrens Hosp Zhengzhou, Dept Clin Lab, Zhengzhou, Henan, Peoples R China	Wuhan University; Wuhan University	Zheng, F (corresponding author), Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Hubei, Peoples R China.	zhengfang@whu.edu.cn; yanming72@whu.edu.cn			Health and Family Planning Commission of Hubei Province [WJ2015MB1-10]; National Basic Research Program of China (973 Program) [2012CB720600]	Health and Family Planning Commission of Hubei Province; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by grants from Health and Family Planning Commission of Hubei Province (WJ2015MB1-10) (http://www.hbwsjs.gov.cn/) and the National Basic Research Program of China (973 Program, 2012CB720600) (http://www.most.gov.cn/bszn/new/973/jbxx/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbell PA, 2005, LANCET, V365, P599; Ates O, 2010, ACTA OPHTHALMOL, V88, P891, DOI 10.1111/j.1755-3768.2009.01583.x; Benke K, 2015, THROMB HAEMOSTASIS, V114, P748, DOI 10.1160/TH15-02-0096; Bhagyalaxmi SG, 2009, BBA-MOL BASIS DIS, V1792, P974, DOI 10.1016/j.bbadis.2009.06.011; Burda P, 2015, HUM MUTAT; Cao SS, 2015, INFLAMM BOWEL DIS, V21, P636, DOI 10.1097/MIB.0000000000000238; Chen JX, 2014, BRIT J DERMATOL, V170, P1092, DOI 10.1111/bjd.12845; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Congdon N, 2005, OPHTHALMOLOGY, V112, P73, DOI 10.1016/j.ophtha.2004.07.012; Cotlarciuc I, 2014, STROKE, V45, P1920, DOI 10.1161/STROKEAHA.114.005208; Elanchezhian R, 2012, CHEM-BIOL INTERACT, V200, P1, DOI 10.1016/j.cbi.2012.08.017; Gong Y, 2015, OPTOM VIS SCI; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P601; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; HEIBA IM, 1995, INVEST OPHTH VIS SCI, V36, P227; Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6; Huang PR, 2015, SCI REP-UK, V5, DOI 10.1038/srep10585; Ikesugi K, 2006, EXP EYE RES, V83, P508, DOI 10.1016/j.exer.2006.01.033; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Luo XQ, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-55; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; MAGNO BV, 1993, INVEST OPHTH VIS SCI, V34, P2138; Marini NJ, 2008, P NATL ACAD SCI USA, V105, P8055, DOI 10.1073/pnas.0802813105; McGimpsey SJ, 2009, OPHTHALMOLOGY, V116, P1778, DOI 10.1016/j.ophtha.2009.02.033; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Pejchal R, 2006, BIOCHEMISTRY-US, V45, P4808, DOI 10.1021/bi052294c; Qin XH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000563; Roy SW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-208; Rozen R, 1997, THROMB HAEMOSTASIS, V78, P523; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sen SK, 2008, INDIAN J CLIN BIOCHE, V23, P255, DOI 10.1007/s12291-008-0057-8; Tan AG, 2015, INVEST OPHTH VIS SCI, V56, P216, DOI 10.1167/iovs.14-15531; Tan YY, 2003, CLIN CHEM, V49, P1029, DOI 10.1373/49.6.1029; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Wang X, 2012, J MOL CELL CARDIOL, V52, P753, DOI 10.1016/j.yjmcc.2011.12.009; Weisberg IS, 2001, ATHEROSCLEROSIS, V156, P409, DOI 10.1016/S0021-9150(00)00671-7; Weiss N, 2001, P NATL ACAD SCI USA, V98, P12503, DOI 10.1073/pnas.231428998; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wu H, 2014, INVEST OPHTH VIS SCI, V55, P3660, DOI 10.1167/iovs.13-13695; Xu F, 2012, OPHTHALMOLOGY, V119, P2493, DOI 10.1016/j.ophtha.2012.06.025; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Ye J, 2012, INVEST OPHTH VIS SCI, V53, P3885, DOI 10.1167/iovs.12-9820; Yu XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114012; Zetterberg M, 2005, AM J OPHTHALMOL, V140, P932, DOI 10.1016/j.ajo.2005.05.026; Zhang DQ, 2012, CIRC RES, V111, P37, DOI [10.1161/CIRCRESAHA.112.269472, 10.1161/circresaha.112.269472]; Zhang DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123423; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023	51	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145581	10.1371/journal.pone.0145581	http://dx.doi.org/10.1371/journal.pone.0145581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689687	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092300090
J	Krembel, A; Colin, R; Sourjik, V				Krembel, Anna; Colin, Remy; Sourjik, Victor			Importance of Multiple Methylation Sites in Escherichia coli Chemotaxis	PLOS ONE			English	Article							BACILLUS-SUBTILIS CHEMOTAXIS; BACTERIAL CHEMOTAXIS; ASPARTATE RECEPTOR; PROTEIN METHYLATION; ADAPTATION; COMPLEX; ATTRACTANT; METHYLTRANSFERASE; CHEMORECEPTORS; TRANSDUCTION	Bacteria navigate within inhomogeneous environments by temporally comparing concentrations of chemoeffectors over the course of a few seconds and biasing their rate of reorientations accordingly, thereby drifting towards more favorable conditions. This navigation requires a short-term memory achieved through the sequential methylations and demethylations of several specific glutamate residues on the chemotaxis receptors, which progressively adjusts the receptors' activity to track the levels of stimulation encountered by the cell with a delay. Such adaptation also tunes the receptors' sensitivity according to the background ligand concentration, enabling the cells to respond to fractional rather than absolute concentration changes, i.e. to perform logarithmic sensing. Despite the adaptation system being principally well understood, the need for a specific number of methylation sites remains relatively unclear. Here we systematically substituted the four glutamate residues of the Tar receptor of Escherichia coli by non-methylated alanine, creating a set of 16 modified receptors with a varying number of available methylation sites and explored the effect of these substitutions on the performance of the chemotaxis system. Alanine substitutions were found to desensitize the receptors, similarly but to a lesser extent than glutamate methylation, and to affect the methylation and demethylation rates of the remaining sites in a site-specific manner. Each substitution reduces the dynamic range of chemotaxis, by one order of magnitude on average. The substitution of up to two sites could be partly compensated by the adaptation system, but the full set of methylation sites was necessary to achieve efficient logarithmic sensing.	[Krembel, Anna; Sourjik, Victor] Heidelberg Univ, DKFZ ZMBH Alliance, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Colin, Remy; Sourjik, Victor] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Colin, Remy; Sourjik, Victor] LOEWE Ctr Synthet Microbiol SYNMIKRO, D-35043 Marburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society	Sourjik, V (corresponding author), Heidelberg Univ, DKFZ ZMBH Alliance, Zentrum Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	victor.sourjik@synmikro.mpi-marburg.mpg.de		Colin, Remy/0000-0001-9051-8003	European Research Council [294761-MicRobE]; National Institutes of Health [R01 GM082938]; Deutsche Forschungsgemeinschaft [SO 421/11-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082938] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant 294761-MicRobE from the European Research Council, by grant R01 GM082938 from the National Institutes of Health and by grant SO 421/11-1 from the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BERG HC, 1975, P NATL ACAD SCI USA, V72, P3235, DOI 10.1073/pnas.72.8.3235; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Bornhorst JA, 2000, BIOCHEMISTRY-US, V39, P9486, DOI 10.1021/bi0002737; Bornhorst JA, 2001, J GEN PHYSIOL, V118, P693, DOI 10.1085/jgp.118.6.693; Colin R, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0486; Dufour YS, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003694; Endres RG, 2006, P NATL ACAD SCI USA, V103, P13040, DOI 10.1073/pnas.0603101103; Endres RG, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.49; Glekas GD, 2011, MICROBIOL-SGM, V157, P56, DOI 10.1099/mic.0.044685-0; GOY MF, 1977, P NATL ACAD SCI USA, V74, P4964, DOI 10.1073/pnas.74.11.4964; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hazelbauer GL, 2010, CURR OPIN MICROBIOL, V13, P124, DOI 10.1016/j.mib.2009.12.014; Johnson KO, 2002, NEUROSCIENTIST, V8, P111, DOI 10.1177/107385840200800207; Kalinin YV, 2009, BIOPHYS J, V96, P2439, DOI 10.1016/j.bpj.2008.10.027; KEHRY MR, 1983, P NATL ACAD SCI-BIOL, V80, P3599, DOI 10.1073/pnas.80.12.3599; KEHRY MR, 1982, J BIOL CHEM, V257, P378; Lazova MD, 2011, P NATL ACAD SCI USA, V108, P13870, DOI 10.1073/pnas.1108608108; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; Mello BA, 2003, BIOPHYS J, V84, P2943, DOI 10.1016/S0006-3495(03)70021-6; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; Morton-Firth CJ, 1999, J MOL BIOL, V286, P1059, DOI 10.1006/jmbi.1999.2535; Neumann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084904; Neumann S, 2012, P NATL ACAD SCI USA, V109, P12159, DOI 10.1073/pnas.1205307109; Neumann S, 2010, EMBO J, V29, P3484, DOI 10.1038/emboj.2010.224; Nishiyama S, 1999, MOL MICROBIOL, V32, P357, DOI 10.1046/j.1365-2958.1999.01355.x; Nishiyama SI, 1997, J BACTERIOL, V179, P6573, DOI 10.1128/jb.179.21.6573-6580.1997; NOWLIN DM, 1987, J BIOL CHEM, V262, P6039; Oleksiuk O, 2011, CELL, V145, P312, DOI 10.1016/j.cell.2011.03.013; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; SHAPIRO MJ, 1995, P NATL ACAD SCI USA, V92, P1053, DOI 10.1073/pnas.92.4.1053; SHAPIRO MJ, 1995, J BIOL CHEM, V270, P751, DOI 10.1074/jbc.270.2.751; SHAPIRO MJ, 1994, J BIOL CHEM, V269, P11054; Shoval O, 2010, P NATL ACAD SCI USA, V107, P15995, DOI 10.1073/pnas.1002352107; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; Sourjik V, 2012, CURR OPIN CELL BIOL, V24, P262, DOI 10.1016/j.ceb.2011.11.008; SPRINGER MS, 1979, NATURE, V280, P279, DOI 10.1038/280279a0; TERWILLIGER TC, 1984, J BIOL CHEM, V259, P7719; Tu YH, 2008, P NATL ACAD SCI USA, V105, P14855, DOI 10.1073/pnas.0807569105; Vladimirov N, 2009, BIOL CHEM, V390, P1097, DOI 10.1515/BC.2009.130; Vladimirov N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000242; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Walukiewicz HE, 2014, MOL MICROBIOL, V93, P1104, DOI 10.1111/mmi.12721; Wilson LG, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.018101	46	11	11	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145582	10.1371/journal.pone.0145582	http://dx.doi.org/10.1371/journal.pone.0145582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683829	Green Submitted, Green Published, gold			2022-12-27	WOS:000366725800083
J	Meulman, N; Wieling, M; Sprenger, SA; Stowe, LA; Schmid, MS				Meulman, Nienke; Wieling, Martijn; Sprenger, Simone A.; Stowe, Laurie A.; Schmid, Monika S.			Age Effects in L2 Grammar Processing as Revealed by ERPs and How (Not) to Study Them	PLOS ONE			English	Article								In this study we investigate the effect of age of acquisition (AoA) on grammatical processing in second language learners as measured by event-related brain potentials (ERPs). We compare a traditional analysis involving the calculation of averages across a certain time window of the ERP waveform, analyzed with categorical groups (early vs. late), with a generalized additive modeling analysis, which allows us to take into account the full range of variability in both AoA and time. Sixty-six Slavic advanced learners of German listened to German sentences with correct and incorrect use of non-finite verbs and grammatical gender agreement. We show that the ERP signal depends on the AoA of the learner, as well as on the regularity of the structure under investigation. For gender agreement, a gradual change in processing strategies can be shown that varies by AoA, with younger learners showing a P600 and older learners showing a posterior negativity. For verb agreement, all learners show a P600 effect, irrespective of AoA. Based on their behavioral responses in an offline grammaticality judgment task, we argue that the late learners resort to computationally less efficient processing strategies when confronted with (lexically determined) syntactic constructions different from the L1. In addition, this study highlights the insights the explicit focus on the time course of the ERP signal in our analysis framework can offer compared to the traditional analysis.	[Meulman, Nienke; Sprenger, Simone A.; Stowe, Laurie A.; Schmid, Monika S.] Univ Groningen, Ctr Language & Cognit, Groningen, Netherlands; [Wieling, Martijn] Univ Groningen, Dept Humanities Comp, Groningen, Netherlands; [Schmid, Monika S.] Univ Essex, Dept Language & Linguist, Ctr Res Language Dev Lifespan LaDeLi, Colchester CO4 3SQ, Essex, England	University of Groningen; University of Groningen; University of Essex	Meulman, N (corresponding author), Univ Groningen, Ctr Language & Cognit, Groningen, Netherlands.	n.meulman@rug.nl	Wieling, Martijn/AAA-2462-2019	Wieling, Martijn/0000-0003-0434-1526; Schmid, Monika/0000-0002-3326-2766	Netherlands Organization for Scientific Research [016.104.602]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Netherlands Organization for Scientific Research [http://www.nwo.nl/] under grant 016.104.602, awarded to MSS.		0	24	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0143328	10.1371/journal.pone.0143328	http://dx.doi.org/10.1371/journal.pone.0143328			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683335	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000366725800007
J	Tanajewski, L; Franklin, M; Gkountouras, G; Berdunov, V; Harwood, RH; Goldberg, SE; Bradshaw, LE; Gladman, JRF; Elliott, RA				Tanajewski, Lukasz; Franklin, Matthew; Gkountouras, Georgios; Berdunov, Vladislav; Harwood, Rowan H.; Goldberg, Sarah E.; Bradshaw, Lucy E.; Gladman, John R. F.; Elliott, Rachel A.			Economic Evaluation of a General Hospital Unit for Older People with Delirium and Dementia (TEAM Randomised Controlled Trial)	PLOS ONE			English	Article							QUALITY-OF-LIFE; EFFECTIVENESS ACCEPTABILITY CURVES; COST-EFFECTIVENESS; HEALTH-CARE; CAPABILITY; SCALE; PREFERENCES; PREVALENCE; VALIDATION; EMERGENCY	Background One in three hospital acute medical admissions is of an older person with cognitive impairment. Their outcomes are poor and the quality of their care in hospital has been criticised. A specialist unit to care for older people with delirium and dementia (the Medical and Mental Health Unit, MMHU) was developed and then tested in a randomised controlled trial where it delivered significantly higher quality of, and satisfaction with, care, but no significant benefits in terms of health status outcomes at three months. Objective To examine the cost-effectiveness of the MMHU for older people with delirium and dementia in general hospitals, compared with standard care. Methods Six hundred participants aged over 65 admitted for acute medical care, identified on admission as cognitively impaired, were randomised to the MMHU or to standard care on acute geriatric or general medical wards. Cost per quality adjusted life year (QALY) gained, at 3-month follow-up, was assessed in trial-based economic evaluation (599/600 participants, intervention: 309). Multiple imputation and complete-case sample analyses were employed to deal with missing QALY data (55%). Results The total adjusted health and social care costs, including direct costs of the intervention, at 3 months was 7714 pound and 7862 pound for MMHU and standard care groups, respectively (difference -149 pound (95% confidence interval [CI]: -298, 4)). The difference in QALYs gained was 0.001 (95% CI: -0.006, 0.008). The probability that the intervention was dominant was 58%, and the probability that it was cost-saving with QALY loss was 39%. At 20,000 pound/QALY threshold, the probability of cost-effectiveness was 94%, falling to 59% when cost-saving QALY loss cases were excluded. Conclusions The MMHU was strongly cost-effective using usual criteria, although considerably less so when the less acceptable situation with QALY loss and cost savings were excluded. Nevertheless, this model of care is worthy of further evaluation.	[Tanajewski, Lukasz; Franklin, Matthew; Gkountouras, Georgios; Berdunov, Vladislav; Elliott, Rachel A.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England; [Harwood, Rowan H.] Queens Med Ctr, Nottingham Univ Hosp NHS Trust, Hlth Care Older People, Nottingham NG7 2UH, England; [Goldberg, Sarah E.] Univ Nottingham, Sch Hlth Sci, Nottingham NG7 2RD, England; [Bradshaw, Lucy E.; Gladman, John R. F.] Univ Nottingham, Div Rehabil & Ageing, Nottingham NG7 2RD, England	University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham; University of Nottingham; University of Nottingham	Elliott, RA (corresponding author), Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.	rachel.elliott@nottingham.ac.uk	Elliott, Rachel/P-5894-2018; Franklin, Matthew/J-8109-2019; Gladman, John/M-7429-2015	Elliott, Rachel/0000-0002-3650-0168; Franklin, Matthew/0000-0002-2774-9439; Harwood, Rowan/0000-0002-4920-6718; Berdunov, Vladislav/0000-0002-5743-2184; Goldberg, Sarah/0000-0001-5109-798X; Gkountouras, Georgios/0000-0003-2093-5359; Gladman, John/0000-0002-8506-7786; Tanajewski, Lukasz/0000-0002-4387-3093	National Institute for Health Research (NIHR) [RP-PG-0407-10147]	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This work was supported by National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10147), https://ccfrms.nihr.ac.uk/, Principal investigator: JG. After approval to fund the programme, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Janabi H, 2013, PATIENT, V6, P235, DOI 10.1007/s40271-013-0035-y; Al-Janabi H, 2012, QUAL LIFE RES, V21, P167, DOI 10.1007/s11136-011-9927-2; Al-Janabi H, 2011, PHARMACOECONOMICS, V29, P1015, DOI 10.2165/11593940-000000000-00000; Al-Janabi H, 2011, MED DECIS MAKING, V31, P458, DOI 10.1177/0272989X10381280; Boustani M, 2010, J HOSP MED, V5, P69, DOI 10.1002/jhm.589; Brazier JE, 1996, QUAL LIFE RES, V5, P195, DOI 10.1007/BF00434741; Briggs A, 1998, J Health Serv Res Policy, V3, P233; Coast J, 2008, QUAL LIFE RES, V17, P967, DOI 10.1007/s11136-008-9372-z; Coast J, 2008, SOC SCI MED, V67, P1190, DOI 10.1016/j.socscimed.2008.06.027; Coast J, 2008, SOC SCI MED, V67, P874, DOI 10.1016/j.socscimed.2008.05.015; Cooper R, 2014, AGE, V36, P445, DOI 10.1007/s11357-013-9553-8; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Curtis L., 2012, UNIT COSTS HLTH SOCI; Department of H, 2013, NHS OUTC FRAM 2014 1; Department of Health, 2009, LIVING WELL DEMENTIA; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; DUBOURG WR, 1994, J RISK UNCERTAINTY, V9, P115, DOI 10.1007/BF01064181; Ellis G, 2011, COMPREHENSIVE GERIAT; Ellis G, 2011, BMJ, V343; Fenwick E, 2005, BRIT J PSYCHIAT, V187, P106, DOI 10.1192/bjp.187.2.106; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franklin M, 2014, AGE AGEING, V43, P703, DOI 10.1093/ageing/afu073; George J, 2011, AGE AGEING, V40, P543, DOI 10.1093/ageing/afr080; Glick HA, 2007, HDB HLTH EC EVALUATI; Goldberg SE, 2012, AGE AGEING, V41, P80, DOI 10.1093/ageing/afr106; Goldberg SE, 2013, BMJ, V347; Harwood RH, 2010, MED CRISES OLDER PEO; Harwood RH, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-123; Haywood KL, 2005, QUAL LIFE RES, V14, P1651, DOI 10.1007/s11136-005-1743-0; Holland R, 2004, HEALTH ECON, V13, P793, DOI 10.1002/hec.858; Holmes J, 2010, LIAISON MENTAL HLTH; Knorr-Held L, 2000, ANAL INCOMPLETE MULT; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Mason A, 2007, HEALTH TECHNOL ASSES, V11, P1; McCaffrey N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115544; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Mulhern B, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17050; Mulhern B, 2012, VALUE HEALTH, V15, P323, DOI 10.1016/j.jval.2011.09.006; National Institute for Clinical E, 2013, GUID METH TECHN APPR; National Institute for Clinical Excellence, 2004, GUID METH TECHN APPR; NHS Careers, 2011, AG CHANG PAY RAT; Normand C, 2012, HEALTH ECON POLICY L, V7, P431, DOI 10.1017/S1744133112000229; O'Brien BJ, 2002, HEALTH ECON, V11, P175, DOI 10.1002/hec.655; Royal College of Psychiatrists, 2005, WHO CAR WINS IMPR OU; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Schneider J, 2003, AGEING SOC, V23, P303, DOI 10.1017/S0144686X02001149; Severens JL, 2005, PHARMACOECONOMICS, V23, P1207, DOI 10.2165/00019053-200523120-00005; Smith SC, 2005, HEALTH TECHNOL ASSES, V9, P1; Smith SC, 2005, HLTH TECHNOLOGY ASSE, V9, piii; StataCorp LP, 2008, STAT DAT AN STAT SOF; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; The National Audit Office, 2011, HC888SESSION20102010; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Wade D T, 1988, Int Disabil Stud, V10, P64; Welsh TJ, 2014, INT J CLIN PRACT, V68, P290, DOI 10.1111/ijcp.12313; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wolfs CAG, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-33	60	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0140662	10.1371/journal.pone.0140662	http://dx.doi.org/10.1371/journal.pone.0140662			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9KM	26684872	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000366725800001
J	Beck, EN; Martens, KAE; Almeida, QJ				Beck, Eric N.; Martens, Kaylena A. Ehgoetz; Almeida, Quincy J.			Freezing of Gait in Parkinson's Disease: An Overload Problem?	PLOS ONE			English	Article							GENERATED LIMB MOVEMENTS; PRIMATE MOTOR THALAMUS; BILATERAL COORDINATION; VISUAL-ATTENTION; BASAL GANGLIA; AUDITORY CUES; DUAL TASKING; LOCOMOTION; ANXIETY; INFORMATION	Freezing of gait (FOG) is arguably the most severe symptom associated with Parkinson's disease (PD), and often occurs while performing dual tasks or approaching narrowed and cluttered spaces. While it is well known that visual cues alleviate FOG, it is not clear if this effect may be the result of cognitive or sensorimotor mechanisms. Nevertheless, the role of vision may be a critical link that might allow us to disentangle this question. Gaze behaviour has yet to be carefully investigated while freezers approach narrow spaces, thus the overall objective of this study was to explore the interaction between cognitive and sensory-perceptual influences on FOG. In experiment #1, if cognitive load is the underlying factor leading to FOG, then one might expect that a dual-task would elicit FOG episodes even in the presence of visual cues, since the load on attention would interfere with utilization of visual cues. Alternatively, if visual cues alleviate gait despite performance of a dual-task, then it may be more probable that sensory mechanisms are at play. In compliment to this, the aim of experiment#2 was to further challenge the sensory systems, by removing vision of the lowerlimbs and thereby forcing participants to rely on other forms of sensory feedback rather than vision while walking toward the narrow space. Spatiotemporal aspects of gait, percentage of gaze fixation frequency and duration, as well as skin conductance levels were measured in freezers and non-freezers across both experiments. Results from experiment#1 indicated that although freezers and non-freezers both walked with worse gait while performing the dual-task, in freezers, gait was relieved by visual cues regardless of whether the cognitive demands of the dual-task were present. At baseline and while dual-tasking, freezers demonstrated a gaze behaviour that neglected the doorway and instead focused primarily on the pathway, a strategy that non-freezers adopted only when performing the dual-task. Interestingly, with the combination of visual cues and dual-task, freezers increased the frequency and duration of fixations toward the doorway, compared to non-freezers. These results suggest that although increasing demand on attention does significantly deteriorate gait in freezers, an increase in cognitive demand is not exclusively responsible for freezing (since visual cues were able to overcome any interference elicited by the dual-task). When vision of the lower limbs was removed in experiment#2, only the freezers' gait was affected. However, when visual cues were present, freezers' gait improved regardless of the dualtask. This gait behaviour was accompanied by greater amount of time spent looking at the visual cues irrespective of the dual-task. Since removing vision of the lower-limbs hindered gait even under low attentional demand, restricted sensory feedback may be an important factor to the mechanisms underlying FOG.	[Beck, Eric N.; Martens, Kaylena A. Ehgoetz; Almeida, Quincy J.] Wilfrid Laurier Univ, Sun Life Movement Disorders Res & Rehabil Ctr, Waterloo, ON N2L 3C5, Canada; [Beck, Eric N.; Almeida, Quincy J.] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Waterloo, ON N2L 3C5, Canada; [Martens, Kaylena A. Ehgoetz] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada	Wilfrid Laurier University; Wilfrid Laurier University; University of Waterloo	Almeida, QJ (corresponding author), Wilfrid Laurier Univ, Sun Life Movement Disorders Res & Rehabil Ctr, Waterloo, ON N2L 3C5, Canada.	qalmeida@wlu.ca	Ehgoetz Martens, Kaylena/G-9997-2016	Ehgoetz Martens, Kaylena/0000-0002-8488-2295	Canadian Institutes of Health Research; Parkinson Society Canada; North American Society for Psychology of Sport and Physical Activity; Canadian Foundation for Innovation [20774]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Parkinson Society Canada; North American Society for Psychology of Sport and Physical Activity; Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work has been funded by the Canadian Institutes of Health Research (KEM), Parkinson Society Canada (KEM), North American Society for Psychology of Sport and Physical Activity (KEM), and Canadian Foundation for Innovation (QJA #20774). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 2001, NEUROSCIENCE, V104, P1027, DOI 10.1016/S0306-4522(01)00099-9; Almeida QJ, 2010, J NEUROL NEUROSUR PS, V81, P513, DOI 10.1136/jnnp.2008.160580; Almeida QJ, 2005, NEUROSCIENCE, V134, P283, DOI 10.1016/j.neuroscience.2005.02.050; Azulay JP, 1999, BRAIN, V122, P111, DOI 10.1093/brain/122.1.111; Baker K, 2008, PARKINSONISM RELAT D, V14, P314, DOI 10.1016/j.parkreldis.2007.09.008; Baker K, 2007, ARCH PHYS MED REHAB, V88, P1593, DOI 10.1016/j.apmr.2007.07.026; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Bucci MP, 2014, RES DEV DISABIL, V35, P1292, DOI 10.1016/j.ridd.2014.03.029; Cerasa A, 2006, BRAIN RES BULL, V71, P259, DOI 10.1016/j.brainresbull.2006.09.014; Chee R, 2009, BRAIN, V132, P2151, DOI 10.1093/brain/awp053; Cowie D, 2012, MOVEMENT DISORD, V27, P492, DOI 10.1002/mds.23990; Ehgoetz Martens K.A., 2015, NEUROPSYCHOLOGIA, P1; Fox E, 2002, COGNITION EMOTION, V16, P355, DOI 10.1080/02699930143000527; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; GLICKSTEIN M, 1991, TRENDS NEUROSCI, V14, P480, DOI 10.1016/0166-2236(91)90055-Y; Hackney ME, 2010, NEUROREHAB NEURAL RE, V24, P97, DOI 10.1177/1545968309341061; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Iansek R, 2006, MOVEMENT DISORD, V21, P1419, DOI 10.1002/mds.20998; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; Keijsers NLW, 2005, EUR J NEUROSCI, V21, P239, DOI 10.1111/j.1460-9568.2004.03840.x; Knobl P, 2012, J NEUROL NEUROSUR PS, V83, P98, DOI 10.1136/jnnp-2011-300869; LADER MH, 1967, J PSYCHOSOM RES, V11, P271, DOI 10.1016/0022-3999(67)90021-9; Lazzaro I, 1999, INT J PSYCHOPHYSIOL, V34, P123, DOI 10.1016/S0167-8760(99)00068-9; Lebold CA, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/732508; Lebold CA, 2011, J CLIN NEUROSCI, V18, P798, DOI 10.1016/j.jocn.2010.07.151; Lee SJ, 2012, AM J PHYS MED REHAB, V91, P2, DOI 10.1097/PHM.0b013e31823c7507; Lewis SJG, 2009, PARKINSONISM RELAT D, V15, P333, DOI 10.1016/j.parkreldis.2008.08.006; Maidan I, 2015, J NEUROL, V262, P899, DOI 10.1007/s00415-015-7650-6; Martens KAE, 2015, EUR J NEUROSCI, V42, P2028, DOI 10.1111/ejn.12928; Martens KAE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062602; Matar E, 2013, PARKINSONISM RELAT D, V19, P937, DOI 10.1016/j.parkreldis.2013.06.002; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; Nieuwboer A, 2001, MOVEMENT DISORD, V16, P1066, DOI 10.1002/mds.1206; Nieuwboer A, 2013, MOVEMENT DISORD, V28, P1509, DOI 10.1002/mds.25683; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; Patla AE, 2004, EXP BRAIN RES, V155, P173, DOI 10.1007/s00221-003-1714-z; Pieruccini-Faria F, 2013, J MOTOR BEHAV, V45, P369, DOI 10.1080/00222895.2013.810139; Pieruccini-Faria F, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0250-8; Pieruccini-Faria F, 2014, BRAIN COGNITION, V87, P76, DOI 10.1016/j.bandc.2014.03.005; Plotnik M, 2005, ANN NEUROL, V57, P656, DOI 10.1002/ana.20452; Plotnik M, 2009, J NEUROL NEUROSUR PS, V80, P347, DOI 10.1136/jnnp.2008.157362; Plotnik M, 2008, EUR J NEUROSCI, V27, P1999, DOI 10.1111/j.1460-9568.2008.06167.x; Rochester L, 2007, J NEURAL TRANSM, V114, P1243, DOI 10.1007/s00702-007-0756-y; Shine JM, 2013, BRAIN, V136, P3671, DOI 10.1093/brain/awt272; Shine JM, 2013, BRAIN, V136, P1204, DOI 10.1093/brain/awt049; Shine JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052602; Suteerawattananon M, 2004, J NEUROL SCI, V219, P63, DOI 10.1016/j.jns.2003.12.007; Tan T, 2011, NEUROSCIENCE, V192, P746, DOI 10.1016/j.neuroscience.2011.06.071; van Donkelaar P, 1999, J NEUROPHYSIOL, V82, P934, DOI 10.1152/jn.1999.82.2.934; van Donkelaar P, 2000, J NEUROPHYSIOL, V83, P2780, DOI 10.1152/jn.2000.83.5.2780; Velik R, 2012, IEEE ENG MED BIO, P4656, DOI 10.1109/EMBC.2012.6347005; Vitorio R, 2014, NEUROSCIENCE, V277, P273, DOI 10.1016/j.neuroscience.2014.07.024; Vitorio R, 2013, GAIT POSTURE, V38, P330, DOI 10.1016/j.gaitpost.2012.12.019; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Yogev-Seligmann G, 2012, GAIT POSTURE, V35, P641, DOI 10.1016/j.gaitpost.2011.12.016; Young WR, 2012, J GERONTOL B-PSYCHOL, V67, P43, DOI 10.1093/geronb/gbr074	56	37	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144986	10.1371/journal.pone.0144986	http://dx.doi.org/10.1371/journal.pone.0144986			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678262	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400039
J	Kullberg, P; Toivonen, T; Pouzols, FM; Lehtomaki, J; Di Minin, E; Moilanen, A				Kullberg, Peter; Toivonen, Tuuli; Pouzols, Federico Montesino; Lehtomaki, Joona; Di Minin, Enrico; Moilanen, Atte			Complementarity and Area-Efficiency in the Prioritization of the Global Protected Area Network	PLOS ONE			English	Article							CONSERVATION PRIORITIES; BIODIVERSITY; EXPANSION; DIVERSITY; PERFORMANCE; RESOLUTION; TARGETS; COSTS	Complementarity and cost-efficiency are widely used principles for protected area network design. Despite the wide use and robust theoretical underpinnings, their effects on the performance and patterns of priority areas are rarely studied in detail. Here we compare two approaches for identifying the management priority areas inside the global protected area network: 1) a scoring-based approach, used in recently published analysis and 2) a spatial prioritization method, which accounts for complementarity and area-efficiency. Using the same IUCN species distribution data the complementarity method found an equal-area set of priority areas with double the mean species ranges covered compared to the scoringbased approach. The complementarity set also had 72% more species with full ranges covered, and lacked any coverage only for half of the species compared to the scoring approach. Protected areas in our complementarity-based solution were on average smaller and geographically more scattered. The large difference between the two solutions highlights the need for critical thinking about the selected prioritization method. According to our analysis, accounting for complementarity and area-efficiency can lead to considerable improvements when setting management priorities for the global protected area network.	[Kullberg, Peter; Pouzols, Federico Montesino; Lehtomaki, Joona; Di Minin, Enrico; Moilanen, Atte] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Toivonen, Tuuli] Univ Helsinki, Dept Geosci & Geog, Helsinki, Finland; [Di Minin, Enrico] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa	University of Helsinki; University of Helsinki; University of Kwazulu Natal	Kullberg, P (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	peter.kullberg@helsinki.fi	Di Minin, Enrico/J-6904-2013; Moilanen, Atte/A-5005-2011; Montesino Pouzols, Federico/D-7995-2014	Di Minin, Enrico/0000-0002-5562-318X; Montesino Pouzols, Federico/0000-0002-2981-5612; Toivonen, Tuuli/0000-0002-6625-4922	European research council (ERC) project Global Environmental Decision Analysis (GEDA) (ERC-StG) [260393]; Academy of Finland's Finnish Centre of Excellence Program	European research council (ERC) project Global Environmental Decision Analysis (GEDA) (ERC-StG); Academy of Finland's Finnish Centre of Excellence Program	Support was provided by the European research council (ERC, [erc.europa.eu/]) project Global Environmental Decision Analysis (GEDA) (ERC-StG grant #260393) and the Academy of Finland's [www.aka.fi] Finnish Centre of Excellence Program 2012-2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan P, 2005, BIODIVERS CONSERV, V14, P3457, DOI 10.1007/s10531-004-0550-1; Arponen A, 2012, CONSERV BIOL, V26, P294, DOI 10.1111/j.1523-1739.2011.01814.x; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Bertzky B, 2012, PROTECTED PLATET REP; Cantu-Salazar L, 2010, BIOSCIENCE, V60, P808, DOI 10.1525/bio.2010.60.10.7; Ceballos G, 2007, ECOL APPL, V17, P569, DOI 10.1890/06-0134; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Di Minin E, 2015, BIOSCIENCE, V65, P637, DOI 10.1093/biosci/biv064; Di Minin E, 2013, CONSERV BIOL, V27, P808, DOI 10.1111/cobi.12048; Di Minin E, 2012, BIOL CONSERV, V153, P187, DOI 10.1016/j.biocon.2012.04.015; Eklund J, 2011, PHILOS T R SOC B, V366, P2661, DOI 10.1098/rstb.2011.0114; FERRIER S, 2009, SPATIAL CONSERVATION, P1; Gaston KJ, 2006, BIOL CONSERV, V132, P76, DOI 10.1016/j.biocon.2006.03.013; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Harrop SR, 2011, GLOBAL ENVIRON CHANG, V21, P474, DOI 10.1016/j.gloenvcha.2011.01.014; Hockings M., 2006, EVALUATION EFFECTIVE; IUCN, 2013, IUCN RED LIST THREAT; Jenkins CN, 2008, CONSERV BIOL, V22, P1037, DOI 10.1111/j.1523-1739.2008.00974.x; Klein CJ, 2014, MAR POLICY, V48, P204, DOI 10.1016/j.marpol.2014.03.008; Knight A. T., 2009, SPATIAL CONSERVATION, P249; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kujala H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053315; Kukkala AS, 2013, BIOL REV, V88, P443, DOI 10.1111/brv.12008; Laitila J, 2012, ECOL MODEL, V247, P40, DOI 10.1016/j.ecolmodel.2012.08.010; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Lehtomaki J, 2013, ENVIRON MODELL SOFTW, V47, P128, DOI 10.1016/j.envsoft.2013.05.001; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marignani M, 2012, BIODIVERS CONSERV, V21, P1853, DOI 10.1007/s10531-012-0283-5; McCreless E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080893; Moilanen A., 2014, SPATIAL CONSERVATION; Moilanen A, 2013, DIVERS DISTRIB, V19, P171, DOI 10.1111/ddi.12000; Moilanen A, 2011, ECOL APPL, V21, P1419, DOI 10.1890/10-1865.1; Moilanen A, 2008, CONSERV BIOL, V22, P1655, DOI 10.1111/j.1523-1739.2008.01043.x; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Possingham HP, 2006, PRINCIPLES CONSERVAT, P516; Pouzols FM, 2014, NATURE, V516, P383, DOI 10.1038/nature14032; PRESSEY RL, 1989, BIOL CONSERV, V50, P199, DOI 10.1016/0006-3207(89)90010-4; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Soutullo A, 2008, DIVERS DISTRIB, V14, P604, DOI 10.1111/j.1472-4642.2007.00445.x; Traba J, 2007, BIODIVERS CONSERV, V16, P3255, DOI 10.1007/s10531-006-9138-2; UNEP WCMC, 2013, WORLD DAT PROT AR WD; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223	46	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145231	10.1371/journal.pone.0145231	http://dx.doi.org/10.1371/journal.pone.0145231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678497	Green Submitted, gold, Green Published			2022-12-27	WOS:000366723400061
J	Caruso, F; Sciacca, V; Bellia, G; De Domenico, E; Larosa, G; Papale, E; Pellegrino, C; Pulvirenti, S; Riccobene, G; Simeone, F; Speziale, F; Viola, S; Pavan, G				Caruso, Francesco; Sciacca, Virginia; Bellia, Giorgio; De Domenico, Emilio; Larosa, Giuseppina; Papale, Elena; Pellegrino, Carmelo; Pulvirenti, Sara; Riccobene, Giorgio; Simeone, Francesco; Speziale, Fabrizio; Viola, Salvatore; Pavan, Gianni			Size Distribution of Sperm Whales Acoustically Identified during Long Term Deep-Sea Monitoring in the Ionian Sea	PLOS ONE			English	Article							INTER-PULSE INTERVALS; PHYSETER-MACROCEPHALUS; MEDITERRANEAN SEA; POPULATION-STRUCTURE; SOUND PRODUCTION; CLICKS; LENGTH; MOVEMENTS; ABUNDANCE; NEUTRINO	The sperm whale (Physeter macrocephalus) emits a typical short acoustic signal, defined as a "click", almost continuously while diving. It is produced in different time patterns to acoustically explore the environment and communicate with conspecifics. Each emitted click has a multi-pulse structure, resulting from the production of the sound within the sperm whale's head. A Stable Inter Pulse Interval (Stable IPI) can be identified among the pulses that compose a single click. Applying specific algorithms, the measurement of this interval provides useful information to assess the total length of the animal recorded. In January 2005, a cabled hydrophone array was deployed at a depth of 2,100 m in the Central Mediterranean Sea, 25 km offshore Catania (Ionian Sea). The acoustic antenna, named OvDE (Ocean noise Detection Experiment), was in operation until November 2006. OvDE provided real time acoustic data used to perform Passive Acoustic Monitoring (PAM) of cetacean sound emissions. In this work, an innovative approach was applied to automatically measure the Stable IPI of the clicks, performing a cepstrum analysis to the energy (square amplitude) of the signals. About 2,100 five-minute recordings were processed to study the size distribution of the sperm whales detected during the OvDE long term deep-sea acoustic monitoring. Stable IPIs were measured in the range between 2.1 ms and 6.4 ms. The equations of Gordon (1991) and of Growcott (2011) were used to convert the IPIs into measures of size. The results revealed that the sperm whales recorded were distributed in length from about 7.5 m to 14 m. The size category most represented was from 9 m to 12 m (adult females or juvenile males) and specimens longer than 14 m (old males) seemed to be absent.	[Caruso, Francesco; Sciacca, Virginia; De Domenico, Emilio] Univ Messina, Dipartimento Sci Biol & Ambientali, Messina, Italy; [Caruso, Francesco; Sciacca, Virginia; Bellia, Giorgio; Larosa, Giuseppina; Pulvirenti, Sara; Riccobene, Giorgio; Speziale, Fabrizio; Viola, Salvatore] Ist Nazl Fis Nucl INFN, Lab Nazl Sud, Catania, Italy; [Bellia, Giorgio] Univ Catania, Dipartimento Fis & Astron, Catania, Italy; [Papale, Elena] CNR, Bioacoust Lab, IAMC Capo Granitola, Torretta Granitola, TP, Italy; [Pellegrino, Carmelo] Ist Nazl Fis Nucl INFN Bologna, Bologna, Italy; [Pellegrino, Carmelo] Univ Bologna, Dipartimento Fis & Astron, Bologna, Italy; [Simeone, Francesco] Ist Nazl Fis Nucl INFN Roma1, Rome, Italy; [Pavan, Gianni] Univ Pavia, Dipartimento Sci Terra & Ambiente, Ctr Interdisciplinare Bioacust & Ric Ambientali C, I-27100 Pavia, Italy	University of Messina; Istituto Nazionale di Fisica Nucleare (INFN); University of Catania; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Istituto Nazionale di Fisica Nucleare (INFN); University of Bologna; Istituto Nazionale di Fisica Nucleare (INFN); University of Pavia	Caruso, F (corresponding author), Univ Messina, Dipartimento Sci Biol & Ambientali, Messina, Italy.	fcaruso@unime.it	viola, Salvatore/C-1002-2014; Caruso, Francesco/AAB-4845-2019; Riccobene, Giorgio/A-4502-2010; Sciacca, Virginia/N-7205-2015; Sciacca, Virginia/AAD-1528-2022; Pulvirenti, Sara Rita/AAE-1289-2019; Simeone, Francesco/L-1057-2016; Pavan, Gianni/M-4619-2015; Bellia, Giorgio/A-5684-2008	viola, Salvatore/0000-0001-9511-8279; Caruso, Francesco/0000-0001-6881-3786; Riccobene, Giorgio/0000-0002-0600-2774; Sciacca, Virginia/0000-0002-7711-1249; Sciacca, Virginia/0000-0002-7711-1249; Pulvirenti, Sara Rita/0000-0003-3017-512X; Pavan, Gianni/0000-0002-4599-9028; Bellia, Giorgio/0000-0003-3063-5739; Pellegrino, Carmelo/0000-0003-1530-4595; papale, elena/0000-0002-5150-9240	Italian Ministry of Education, Universities and Research [RBFR08NRZE]; Italian Ministry of the Environment [DPN/2008/28401]	Italian Ministry of Education, Universities and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of the Environment	This work was conducted under the SMO (Submarine Multidisciplinary Observatory) FIRB 2008 activities, funded by the Italian Ministry of Education, Universities and Research (No. RBFR08NRZE) (GR) (https://web2.infn.it/smo/). The work of one of the authors (GP) was supported by a grant of the Italian Ministry of the Environment (DPN/2008/28401) (http://www.unipv.it/cibra/progettocetacei.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERFENCHEL HS, 1980, CAN J FISH AQUAT SCI, V37, P2358, DOI 10.1139/f80-283; Aiello S, 2015, ASTROPART PHYS, V66, P1, DOI 10.1016/j.astropartphys.2014.12.010; Aiello S, 2010, ASTROPART PHYS, V33, P263, DOI 10.1016/j.astropartphys.2010.02.009; Antunes R, 2010, J ACOUST SOC AM, V127, P3239, DOI 10.1121/1.3327509; Backus R. H., 1966, WHALES DOLPHINS PORP, P510; Bolognari A., 1951, Bollettino di Zoologia, V18, P253; Bolognari A, 1950, ITALIAN J ZOOLOGY, V17, P29; Caruso F., 2014, Biologia Marina Mediterranea, V21, P393; CLARKE MR, 1978, J MAR BIOL ASSOC UK, V58, P1, DOI 10.1017/S0025315400024371; Cranford TW, 1999, MAR MAMMAL SCI, V15, P1133, DOI 10.1111/j.1748-7692.1999.tb00882.x; DISCIARA GN, 2006, STATUS DISTRIBUTION, P48; Drouot V, 2004, J MAR BIOL ASSOC UK, V84, P675, DOI 10.1017/S0025315404009749h; Drouot Violaine, 2004, Journal of Cetacean Research and Management, V6, P29; Favali P, 2013, IEEE J OCEANIC ENG, V38, P358, DOI 10.1109/JOE.2012.2224536; Frantzis A, 2011, DEEP-SEA RES PT I, V58, P454, DOI 10.1016/j.dsr.2011.02.005; Frantzis A, 2008, CAN J ZOOL, V86, P62, DOI 10.1139/Z07-114; Frantzis A, 2014, AQUAT CONSERV, V24, P83, DOI 10.1002/aqc.2435; Gannier A, 2002, MAR ECOL PROG SER, V243, P281, DOI 10.3354/meps243281; Gillespie D., 2009, J ACOUST SOC AM, V125, P2547, DOI [10.1121/1.4808713, DOI 10.1121/1.4808713]; Goold JC, 1996, DEEP-SEA RES PT I, V43, P961, DOI 10.1016/0967-0637(96)00066-0; Goold JC, 1996, J ACOUST SOC AM, V100, P3431, DOI 10.1121/1.416984; Gordon J. C. D, 1987, BEHAV ECOLOGY SPERM; GORDON JCD, 1991, J ZOOL, V224, P301, DOI 10.1111/j.1469-7998.1991.tb04807.x; Growcott A, 2011, J ACOUST SOC AM, V130, P568, DOI 10.1121/1.3578455; Klinck H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036128; Laplanche C, 2006, J ACOUST SOC AM, V119, P4074, DOI 10.1121/1.2184987; Lewis T, 2007, J MAR BIOL ASSOC UK, V87, P353, DOI 10.1017/S0025315407054896; Madsen PT, 2002, J EXP BIOL, V205, P1899; Madsen PT, 2012, J AM CETACEAN SOC, V41, P9; Mathias D, 2009, J ACOUST SOC AM, V125, P3444, DOI 10.1121/1.3097758; Mazzariol S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019417; Miller BS, 2013, J ACOUST SOC AM, V134, P2438, DOI 10.1121/1.4816564; Mohl B, 2003, J ACOUST SOC AM, V114, P1143, DOI 10.1121/1.1586258; Mohl B., 1981, MAMM SEAS, V3, P327; Norris K.S., 1972, ANIMAL ORIENTATION N, P397; Nosengo N, 2009, NATURE, V462, P560, DOI 10.1038/462560a; Notarbartolo-Di-Sciara G, 2014, AQUAT CONSERV, V24, P4, DOI 10.1002/aqc.2409; Pace DS, 2014, AQUAT CONSERV, V24, P1, DOI 10.1002/aqc.2457; Pavan G., 1999, European Research on Cetaceans, V12, P254; Pavan G, 2000, J ACOUST SOC AM, V107, P3487, DOI 10.1121/1.429419; Pavan G., 1997, P I ACOUST, V19, P157; Pavan G., 2008, COMPUTATIONAL BIOACO, P7; Rhinelander MQ, 2004, J ACOUST SOC AM, V115, P1826, DOI 10.1121/1.1689346; Riccobene G, 2009, NUCL INSTRUM METH A, V604, pS149, DOI 10.1016/j.nima.2009.03.195; Riccobene G, 2008, J PHYS CONF SER, V136, DOI 10.1088/1742-6596/136/2/022053; Rice D.W., 1989, P177; Sciacca V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141838; Teloni Valeria, 2007, Journal of Cetacean Research and Management, V9, P127; Viola S, 2013, NUCL INSTRUM METH A, V725, P207, DOI 10.1016/j.nima.2012.11.150; Zimmer WMX, 2003, IEEE J OCEANIC ENG, V28, P13, DOI 10.1109/JOE.2002.808209; Zimmer WMX, 2005, J ACOUST SOC AM, V118, P3337, DOI 10.1121/1.2082707; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P1473, DOI 10.1121/1.1828501	52	22	22	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144503	10.1371/journal.pone.0144503	http://dx.doi.org/10.1371/journal.pone.0144503			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675588	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700041
J	Forcey, DS; Vodstrcil, LA; Hocking, JS; Fairley, CK; Law, M; McNair, RP; Bradshaw, CS				Forcey, Dana S.; Vodstrcil, Lenka A.; Hocking, Jane S.; Fairley, Christopher K.; Law, Matthew; McNair, Ruth P.; Bradshaw, Catriona S.			Factors Associated with Bacterial Vaginosis among Women Who Have Sex with Women: A Systematic Review	PLOS ONE			English	Review							PRETERM DELIVERY; GRAM STAIN; LESBIANS; PREVALENCE; BIRTH	Background Women who have sex with women (WSW) have a higher burden of bacterial vaginosis (BV) than heterosexual women; studies of risk factors specific to this population are limited. We summarised current knowledge regarding risk factors for BV among WSW by systematic review. Methods This systematic review was conducted according to the PRISMA statement. PUBMED, EMBASE, Web of Science and The Cochrane Library were searched to 31st December, 2014. Inclusion criteria: 1) WSW included in the study population; 2) accepted BV diagnostic method; 3) investigated or could extrapolate factors(s) associated with BV acquisition, persistence or transmission in WSW specifically by comparing BV positive to BV negative women. Search was limited to English-language publications. Results A limited number of studies have investigated BV in WSW. Of 71 unique references, 18 fulltext articles were assessed and 14 studies fulfilled inclusion criteria. BV was positively associated with higher numbers of female partners, both lifetime and in the three months prior to diagnosis, and confirmed BV in a female partner, but inconsistently associated with partners' BV history or symptoms. BV was not associated with ethnicity, vaginal douching or hormonal contraception. The impact of specific sexual activities, male sexual contact, smoking and the menstrual cycle varied considerably between study populations. Conclusion BV in WSW is associated with increased numbers of recent and past female partners and confirmed BV in a female partner. There are limited studies of BV in WSW populations, and research is needed to further elucidate risk factors for BV among WSW. However these data provide epidemiological evidence that BV risk in women is directly related to exposure to other female partners and a partner with BV, providing support for the concept that BV is likely to be transmitted between women.	[Forcey, Dana S.; Vodstrcil, Lenka A.; Fairley, Christopher K.; Bradshaw, Catriona S.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic 3053, Australia; [Forcey, Dana S.; Vodstrcil, Lenka A.; Hocking, Jane S.; Bradshaw, Catriona S.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Parkville, Vic 3010, Australia; [Fairley, Christopher K.; Bradshaw, Catriona S.] Monash Univ, Alfred Ctr, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Law, Matthew] Univ New S Wales, Kirby Inst, Darlinghurst, NSW 2010, Australia; [McNair, Ruth P.] Univ Melbourne, Dept Gen Practice, Parkville, Vic 3010, Australia	University of Melbourne; Monash University; University of New South Wales Sydney; Kirby Institute; University of Melbourne	Forcey, DS (corresponding author), Alfred Hlth, Melbourne Sexual Hlth Ctr, 580 Swanston St, Melbourne, Vic 3053, Australia.	D.Forcey@alfred.org.au; cbradshaw@mshc.org.au	Vodstrcil, Lenka/AAC-1896-2019; Hocking, Jane/AAD-5203-2021; Vodstrcil, Lenka/AAF-8722-2020; McNair, Ruth P/B-3027-2012	Hocking, Jane/0000-0001-9329-8501; Vodstrcil, Lenka/0000-0003-3679-9195; McNair, Ruth/0000-0002-4738-8781; Christopher, Fairley/0000-0001-9081-1664; bradshaw, catriona/0000-0002-6643-5678; Law, Matthew/0000-0002-3540-8837	University of Melbourne Medical School; Melbourne School of Population and Global Health, a National Health and Medical Research Council Project Grant [APP 102457, APP566576]	University of Melbourne Medical School; Melbourne School of Population and Global Health, a National Health and Medical Research Council Project Grant	This work is supported by The University of Melbourne Medical School and the Melbourne School of Population and Global Health, a National Health and Medical Research Council Project Grant (APP 102457) and Fellowship grant (APP566576) to JSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Bailey JV, 2004, SEX TRANSM DIS, V31, P691, DOI 10.1097/01.olq.0000143093.70899.68; Bailey JV, 2004, SEX TRANSM INFECT, V80, P244, DOI 10.1136/sti.2003.007641; Berger BJ, 1995, CLIN INFECT DIS, V21, P1402, DOI 10.1093/clinids/21.6.1402; Bilardi JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074378; Bradshaw CS, 2014, J INFECT DIS, V209, P1562, DOI 10.1093/infdis/jit664; Brotman RM, 2008, AM J EPIDEMIOL, V168, P188, DOI 10.1093/aje/kwn103; Chaim W, 1997, ARCH GYNECOL OBSTET, V259, P51, DOI 10.1007/BF02505309; Cu-Uvin S, 2001, CLIN INFECT DIS, V33, P894, DOI 10.1086/322613; Evans AL, 2007, SEX TRANSM INFECT, V83, P470, DOI 10.1136/sti.2006.022277; Fethers K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030633; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Forcey DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085263; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Hay PE, 1997, INT J STD AIDS, V8, P603, DOI 10.1258/0956462971918850; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Hellberg D, 2000, INT J STD AIDS, V11, P603, DOI 10.1258/0956462001916461; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Ison CA, 2002, SEX TRANSM INFECT, V78, P413, DOI 10.1136/sti.78.6.413; KROHN MA, 1991, J INFECT DIS, V164, P88, DOI 10.1093/infdis/164.1.88; Marrazzo JM, 2008, ANN INTERN MED, V149, P20, DOI 10.7326/0003-4819-149-1-200807010-00006; Marrazzo JM, 2011, SEX TRANSM INFECT, V87, P399, DOI 10.1136/sti.2011.049213; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P335, DOI 10.1097/OLQ.0b013e3181ca3cac; Marrazzo JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011139; Marrazzo JM, 2009, J INFECT DIS, V199, P680, DOI 10.1086/596632; Marrazzo JM, 2002, J INFECT DIS, V185, P1307, DOI 10.1086/339884; McCaffrey M, 1999, INT J STD AIDS, V10, P305, DOI 10.1258/0956462991914168; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mooney-Somers J, 2012, WOMEN CONTACT SYDNEY; Muzny CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080254; Muzny CA, 2013, SEX TRANSM DIS, V40, P751, DOI 10.1097/OLQ.0000000000000004; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Purwar M, 2001, J OBSTET GYNAECOL RE, V27, P175, DOI 10.1111/j.1447-0756.2001.tb01248.x; Sha BE, 2005, J CLIN MICROBIOL, V43, P4607, DOI 10.1128/JCM.43.9.4607-4612.2005; SPIEGEL CA, 1983, J CLIN MICROBIOL, V18, P170, DOI 10.1128/JCM.18.1.170-177.1983; SWEET RL, 1995, CLIN INFECT DIS, V20, pS271, DOI 10.1093/clinids/20.Supplement_2.S271; Trabert B, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.085; Vodstrcil LA, 2013, PLOS ONE, V8; Vodstrcil LA, 2015, CLIN INFECT DIS, V60, P1042, DOI 10.1093/cid/ciu1130; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012	41	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0141905	10.1371/journal.pone.0141905	http://dx.doi.org/10.1371/journal.pone.0141905			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675816	Green Published, gold			2022-12-27	WOS:000366722700003
J	Hovik, KT; Plessen, KJ; Cavanna, AE; Skogli, EW; Andersen, PN; Oie, M				Hovik, Kjell Tore; Plessen, Kerstin J.; Cavanna, Andrea E.; Skogli, Erik Winther; Andersen, Per Normann; Oie, Merete			Cognition, Emotion and Behavior in Children with Tourette's Syndrome and Children with ADHD-Combined Subtype-A Two-Year Follow-Up Study	PLOS ONE			English	Article							MANIFEST ANXIETY SCALE; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SOMATIC MARKER HYPOTHESIS; IOWA GAMBLING TASK; DECISION-MAKING; EXECUTIVE FUNCTIONS; RATING INVENTORY; TIC SEVERITY; I THINK; DSM-IV	Objective This two-year follow-up study investigates the course of and association among measures of cognitive control, focused attention, decision-making and symptom severity (anxiety, depression and behavior)in children and adolescents with Tourette's Syndrome (TS) or Attention-Deficit/Hyperactivity Disorder-Combined subtype (ADHD-C). Method 19 children with TS, 33 with ADHD-C, and 50 typically developing children (TDC) were examined with a battery of psychometric measures and rating forms at baseline and two years later. Results All three groups improved likewise in measures of cognitive control over time, whereas only the TDC improved in focused attention. The group of children with TS with comorbidities performed more similar to the children with ADHD-C in cognitive control at T1 and T2, whereas the children with TS without comorbidities performed more similar to the TDC in cognitive control at T1 and T2. In the decision-making task, the children with TS (with or without comorbidities) preferred a safer strategy in selecting advantageous choices than the children with ADHD-C and the TDC at T2. Children with TS and children with ADHD-C showed higher symptoms of anxiety and depression and more problems with emotional control compared with TDC at both time points. Finally, children with ADHD-C self-reported more depression symptoms than those with TS at both assessments. For the TS group, safer decision-making was related to better emotional control, and this relationship was stronger for the TS subgroup without comorbidities. Conclusion This study emphasizes the importance of addressing symptoms of anxiety and depression in children with TS or ADHD-C, identifying the effect of comorbidities in children with TS, and that children with TS or ADHD-C likely differ in their sensitivity to reinforcement contingencies.	[Hovik, Kjell Tore; Skogli, Erik Winther; Andersen, Per Normann; Oie, Merete] Innlandet Hosp Trust, Div Mental Hlth Care, Lillehammer, Norway; [Hovik, Kjell Tore; Oie, Merete] Univ Oslo, Inst Psychol, Oslo, Norway; [Plessen, Kerstin J.] Univ Copenhagen, Child & Adolescent Mental Hlth Ctr, Capital Reg Psychiat, Copenhagen, Denmark; [Plessen, Kerstin J.] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark; [Cavanna, Andrea E.] Univ Birmingham, Dept Neuropsychiat, Birmingham, W Midlands, England; [Cavanna, Andrea E.] BSMHFT, Birmingham, W Midlands, England; [Cavanna, Andrea E.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Cavanna, Andrea E.] Inst Neurol, Sobell Dept Movement Disorders, London WC1N 3BG, England; [Andersen, Per Normann] Lillehammer Univ Coll, Dept Educ & Social Work, Lillehammer, Norway	Innlandet Hospital Trust; University of Oslo; University of Copenhagen; University of Copenhagen; University of Birmingham; Aston University; University of London; University College London; Inland Norway University of Applied Sciences	Hovik, KT (corresponding author), Innlandet Hosp Trust, Div Mental Hlth Care, Lillehammer, Norway.	kjell.tore.hovik@sykehuset-innlandet.no	Andersen, Per Normann/I-1531-2013	Andersen, Per Normann/0000-0002-0242-7230; Skogli, Erik Winther/0000-0002-8450-2176	Innlandet Hospital Trust [150170]; Regional Resource Center for Autism, ADHD, Tourette's Syndrome and Narcolepsy, Oslo University Hospital [150182]	Innlandet Hospital Trust; Regional Resource Center for Autism, ADHD, Tourette's Syndrome and Narcolepsy, Oslo University Hospital	The work was supported by grants from Innlandet Hospital Trust (grant number 150170) and from Regional Resource Center for Autism, ADHD, Tourette's Syndrome and Narcolepsy, Oslo University Hospital (grant number 150182). The authors declare no conflict of interest with respect to authorship or publication of this article.	Aase H, 2006, J CHILD PSYCHOL PSYC, V47, P457, DOI 10.1111/j.1469-7610.2005.01468.x; Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Angold A, 1995, INT J METHOD PSYCH, V5, P237; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Barkley R.A., 2012, BARKLEY DEFICITS EXE; Baumeister RF, 2007, HDB EMOTION REGULATI; Bechara A, 2005, TRENDS COGN SCI, V9, P159, DOI 10.1016/j.tics.2005.02.002; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Berger A, 2007, PROG NEUROBIOL, V82, P256, DOI 10.1016/j.pneurobio.2007.06.004; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; BOEHNKE K, 1986, PERS INDIV DIFFER, V7, P553, DOI 10.1016/0191-8869(86)90132-7; Brand M, 2007, J CLIN EXP NEUROPSYC, V29, P86, DOI 10.1080/13803390500507196; Brown T.E., 2006, INT J DISABIL DEV ED, V53, P35, DOI [10.1080/10349120500510024, DOI 10.1080/10349120500510024]; Cavanna AE, 2013, NEUROSCI BIOBEHAV R, V37, P1008, DOI 10.1016/j.neubiorev.2012.10.011; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Clarke RA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.75; Coghill DR, 2014, PSYCHOL MED, V44, P1989, DOI 10.1017/S0033291713002547; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conners C.K., 2004, CONNERS CONTINUOUS P; COSTELLO EJ, 1988, J AM ACAD CHILD PSY, V27, P726, DOI 10.1097/00004583-198811000-00011; COSTELLO EJ, 1991, J AFFECT DISORDERS, V23, P199, DOI 10.1016/0165-0327(91)90101-W; Crone EA, 2004, DEV NEUROPSYCHOL, V25, P251, DOI 10.1207/s15326942dn2503_2; Daviss WB, 2006, J CHILD PSYCHOL PSYC, V47, P927, DOI 10.1111/j.1469-7610.2006.01646.x; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Denckla MB, 2002, CHILD NEUROPSYCHOL, V8, P304, DOI 10.1076/chin.8.4.304.13512; DeVito EE, 2008, BIOL PSYCHIAT, V64, P636, DOI 10.1016/j.biopsych.2008.04.017; DuPaul G. J., 1998, ADHD RATING SCALE 4; Eddy CM, 2012, PSYCHIAT RES, V200, P46, DOI 10.1016/j.psychres.2012.05.023; Egeland J, 2010, CHILD NEUROPSYCHOL, V16, P326, DOI 10.1080/09297041003601462; Egeland J, 2010, J ATTEN DISORD, V13, P339, DOI 10.1177/1087054708323019; Ehlers S, 1999, J AUTISM DEV DISORD, V29, P129, DOI 10.1023/A:1023040610384; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Fallmyr O., 2011, TIDSSKRIFT NORSK PSY, V48, P339; FERRANDO PJ, 1994, PERS INDIV DIFFER, V16, P693, DOI 10.1016/0191-8869(94)90211-9; Freeman RD, 2007, EUR CHILD ADOLES PSY, V16, P15, DOI 10.1007/s00787-007-1003-7; Gaub M, 1997, J ABNORM CHILD PSYCH, V25, P103, DOI 10.1023/A:1025775311259; Geurts HM, 2006, J ABNORM CHILD PSYCH, V34, P813, DOI 10.1007/s10802-006-9059-2; Gioia GA, 2000, BEHAV RATING INVENTO; Gorman DA, 2010, BRIT J PSYCHIAT, V197, P36, DOI 10.1192/bjp.bp.109.071050; Goudriaan AE, 2006, ADDICTION, V101, P534, DOI 10.1111/j.1360-0443.2006.01380.x; Goudriaan AE, 2005, COGNITIVE BRAIN RES, V23, P137, DOI 10.1016/j.cogbrainres.2005.01.017; Greenberg G, 2013, ADV CHILD DEV BEHAV, V44, P95, DOI 10.1016/B978-0-12-397947-6.00004-0; Greimel E, 2008, J NEURAL TRANSM, V115, P191, DOI 10.1007/s00702-007-0815-4; Groen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074909; Heilman RM, 2010, EMOTION, V10, P257, DOI 10.1037/a0018489; Hirschtritt ME, 2015, JAMA PSYCHIAT, V72, P325, DOI 10.1001/jamapsychiatry.2014.2650; Hoekstra PJ, 2013, EUR CHILD ADOLES PSY, V22, P185, DOI 10.1007/s00787-012-0337-y; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; HOLM S, 1979, SCAND J STAT, V6, P65; Hovik KT, 2016, J ATTEN DISORD, V20, P825, DOI 10.1177/1087054713512371; Hovik KT, 2017, J ATTEN DISORD, V21, P811, DOI 10.1177/1087054714550336; Jackson GM, 2007, EXP BRAIN RES, V182, P357, DOI 10.1007/s00221-007-0999-8; Jackson SR, 2011, CURR BIOL, V21, P580, DOI 10.1016/j.cub.2011.02.047; JOHNSON CA, 1973, J CHILD PSYCHOL PSYC, V14, P181, DOI 10.1111/j.1469-7610.1973.tb01186.x; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kovacs, 1983, CHILDRENS DEPRESSION; Lavin P., 2008, CLIN DEPRESSION OVER; Leckman JF, 2003, BRAIN DEV-JPN, V25, pS24, DOI 10.1016/S0387-7604(03)90004-0; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Lewin AB, 2011, J ANXIETY DISORD, V25, P164, DOI 10.1016/j.janxdis.2010.08.016; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Luman M, 2008, J CHILD PSYCHOL PSYC, V49, P712, DOI 10.1111/j.1469-7610.2008.01910.x; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Mathews CA, 2004, J NEUROL NEUROSUR PS, V75, P1149, DOI 10.1136/jnnp.2003.020693; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mueller SC, 2006, CURR BIOL, V16, P570, DOI 10.1016/j.cub.2006.01.064; O'Connor K, 2002, BEHAV RES THER, V40, P1113, DOI 10.1016/S0005-7967(02)00048-7; Overton WF, 2013, APPL DEV SCI, V17, P94, DOI 10.1080/10888691.2013.778717; Palminteri S, 2009, P NATL ACAD SCI USA, V106, P19179, DOI 10.1073/pnas.0904035106; Pashler H, 2001, ANNU REV PSYCHOL, V52, P629, DOI 10.1146/annurev.psych.52.1.629; PELA OA, 1982, PSYCHOL REP, V51, P1135, DOI 10.2466/pr0.1982.51.3f.1135; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pine DS, 1999, AM J PSYCHIAT, V156, P133, DOI 10.1176/ajp.156.1.133; Power TJ, 2004, J ABNORM CHILD PSYCH, V32, P27, DOI 10.1023/B:JACP.0000007578.30863.93; Reynolds C.R., 1985, REVISED CHILDRENS MA; REYNOLDS CR, 1981, J CONSULT CLIN PSYCH, V49, P352, DOI 10.1037/0022-006X.49.3.352; REYNOLDS CR, 1981, PERCEPT MOTOR SKILL, V53, P702, DOI 10.2466/pms.1981.53.3.702; REYNOLDS CR, 1980, J CONSULT CLIN PSYCH, V48, P774, DOI 10.1037/0022-006X.48.6.774; REYNOLDS CR, 1982, EDUC PSYCHOL MEAS, V42, P1205, DOI 10.1177/001316448204200429; Robertson MM, 2009, J PSYCHOSOM RES, V67, P475, DOI 10.1016/j.jpsychores.2009.07.010; Robertson MM, 2000, BRAIN, V123, P425, DOI 10.1093/brain/123.3.425; Roessner V, 2007, EUR CHILD ADOLES PSY, V16, P24, DOI 10.1007/s00787-007-1004-6; SCHOLWINSKI E, 1985, GIFTED CHILD QUART, V29, P125, DOI 10.1177/001698628502900305; Seidman LJ, 2006, CLIN PSYCHOL REV, V26, P466, DOI 10.1016/j.cpr.2006.01.004; Sergeant JA, 2002, BEHAV BRAIN RES, V130, P3, DOI 10.1016/S0166-4328(01)00430-2; Singer HS, 2005, LANCET NEUROL, V4, P149, DOI 10.1016/S1474-4422(05)01012-4; Skogli EW, 2017, J ATTEN DISORD, V21, P305, DOI 10.1177/1087054714524984; Skogli EW, 2014, CHILD NEUROPSYCHOL, V20, P162, DOI 10.1080/09297049.2012.753998; Smith DG, 2012, DEV PSYCHOL, V48, P1180, DOI 10.1037/a0026342; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; Spencer T, 1998, J CHILD PSYCHOL PSYC, V39, P1037, DOI 10.1017/S0021963098002984; Toplak ME, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-8; Turgeon L, 2003, PSYCHOL ASSESSMENT, V15, P378, DOI 10.1037/1040-3590.15.3.378; Vohs KD, 2004, HDB SELF REGULATION, P1; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; Watkins LH, 2005, PSYCHOL MED, V35, P571, DOI 10.1017/S0033291704003691; Wechsler D., 1991, WISC 3 WECHSLER INTE; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006	103	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144874	10.1371/journal.pone.0144874	http://dx.doi.org/10.1371/journal.pone.0144874			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JH	26673612	Green Published, gold			2022-12-27	WOS:000366722700068
J	Nim, HT; Furtado, MB; Costa, MW; Kitano, H; Rosenthal, NA; Boyd, SE				Nim, Hieu T.; Furtado, Milena B.; Costa, Mauro W.; Kitano, Hiroaki; Rosenthal, Nadia A.; Boyd, Sarah E.			CARFMAP: A Curated Pathway Map of Cardiac Fibroblasts	PLOS ONE			English	Article							SYSTEMS BIOLOGY; SIGNALING-NETWORK; GENE-EXPRESSION; REPAIR; HEART; REGENERATION; CELL; PATHOPHYSIOLOGY; SOFTWARE; PROMOTER	The adult mammalian heart contains multiple cell types that work in unison under tightly regulated conditions to maintain homeostasis. Cardiac fibroblasts are a significant and unique population of non-muscle cells in the heart that have recently gained substantial interest in the cardiac biology community. To better understand this renaissance cell, it is essential to systematically survey what has been known in the literature about the cellular and molecular processes involved. We have built CARFMAP (http://visionet.erc.monash.edu.au/CARFMAP), an interactive cardiac fibroblast pathway map derived from the biomedical literature using a software-assisted manual data collection approach. CARFMAP is an information-rich interactive tool that enables cardiac biologists to explore the large body of literature in various creative ways. There is surprisingly little overlap between the cardiac fibroblast pathway map, a foreskin fibroblast pathway map, and a whole mouse organism signalling pathway map from the REACTOME database. Among the use cases of CARFMAP is a common task in our cardiac biology laboratory of identifying new genes that are (1) relevant to cardiac literature, and (2) differentially regulated in high-throughput assays. From the expression profiles of mouse cardiac and tail fibroblasts, we employed CARFMAP to characterise cardiac fibroblast pathways. Using CARFMAP in conjunction with transcriptomic data, we generated a stringent list of six genes that would not have been singled out using bioinformatics analyses alone. Experimental validation showed that five genes (Mmp3, Il6, Edn1, Pdgfc and Fgf10) are differentially regulated in the cardiac fibroblast. CARFMAP is a powerful tool for systems analyses of cardiac fibroblasts, facilitating systems-level cardiovascular research.	[Nim, Hieu T.; Furtado, Milena B.; Costa, Mauro W.; Kitano, Hiroaki; Rosenthal, Nadia A.; Boyd, Sarah E.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Nim, Hieu T.; Boyd, Sarah E.] Monash Univ, Fac Informat Technol, Clayton, Vic 3800, Australia; [Kitano, Hiroaki] RIKEN Ctr Integrat Med Sci, Lab Dis Syst Modeling, Yokohama, Kanagawa, Japan; [Kitano, Hiroaki] Okinawa Inst Sci & Technol, Kunigami, Okinawa, Japan; [Rosenthal, Nadia A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0NN, England; [Rosenthal, Nadia A.] Jackson Lab, Bar Harbor, ME 04609 USA	Australian Regenerative Medicine Institute; Monash University; Monash University; RIKEN; Okinawa Institute of Science & Technology Graduate University; Imperial College London; Jackson Laboratory	Nim, HT (corresponding author), Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia.	hieu.nim@monash.edu; sarah.boyd@monash.edu	Boyd, Sarah E/I-9047-2012; Costa, Mauro W/S-9219-2018	Costa, Mauro W/0000-0003-3579-8625; Boyd, Sarah/0000-0002-7264-8602; Rosenthal, Nadia/0000-0002-7599-7365	ARC Discovery Grant [DP130104792]; NHMRC Australia Fellowship; NHRMC Project Grant [AP1069710]; State Government of Victoria; Australian Government	ARC Discovery Grant(Australian Research Council); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHRMC Project Grant; State Government of Victoria; Australian Government(Australian GovernmentCGIAR)	ARC Discovery Grant DP130104792 to SEB and HK; NHMRC Australia Fellowship to NR. NHRMC Project Grant AP1069710 to NAR and MWC. The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anversa P, 2013, MAYO CLIN PROC, V88, P871, DOI 10.1016/j.mayocp.2013.04.001; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Bassingthwaighte J, 2009, EXP PHYSIOL, V94, P597, DOI 10.1113/expphysiol.2008.044099; Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39; Bruno CM, 2003, PANMINERVA MED, V45, P151; Bujak M, 2008, J AM COLL CARDIOL, V51, P1384, DOI 10.1016/j.jacc.2008.01.011; Camelliti P, 2006, ADV CARDIOL, V42, P132, DOI 10.1159/000092566; Caron E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.108; Chen W, 2013, BBA-MOL CELL RES, V1833, P945, DOI 10.1016/j.bbamcr.2012.08.023; Choi SJ, 2009, EUR J HUM GENET, V17, P774, DOI 10.1038/ejhg.2008.245; de Jong HJI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041289; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Furtado MB, 2014, GENOM DATA, V2, P345, DOI 10.1016/j.gdata.2014.10.006; Furtado MB, 2014, CIRC RES, V114, P1422, DOI 10.1161/CIRCRESAHA.114.302530; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Gu CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074050; Gupta MK, 2013, OMICS, V17, P584, DOI 10.1089/omi.2013.0007; Hunter P, 2005, PHYSIOLOGY, V20, P316, DOI 10.1152/physiol.00022.2005; Hyduke DR, 2010, NAT REV GENET, V11, P297, DOI 10.1038/nrg2750; Ito N, 2007, AM J HYPERTENS, V20, P792, DOI 10.1016/j.amjhyper.2007.02.004; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kohl P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.51; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; Ma LP, 2012, INT J CARDIOL, V155, P20, DOI 10.1016/j.ijcard.2011.01.085; Moore-Morris T, 2014, CIRC RES, V115, P602, DOI 10.1161/CIRCRESAHA.114.304854; Ng A, 2006, BRIEF BIOINFORM, V7, P318, DOI 10.1093/bib/bbl036; Nim HT, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0578-0; Nim HT, 2015, PROG BIOPHYS MOL BIO, V117, P69, DOI 10.1016/j.pbiomolbio.2014.11.006; Padwal MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092481; Plichta JK, 2012, J BURN CARE RES, V33, P299, DOI 10.1097/BCR.0b013e318240540a; Poux S, 2014, J BIOL DATABASES CUR, V2014, P10; Qian L, 2013, CIRC RES, V113, P915, DOI 10.1161/CIRCRESAHA.112.300625; Rando TA, 2013, NEW ENGL J MED, V369, P575, DOI 10.1056/NEJMcibr1306063; Rebholz-Schuhmann D, 2012, NAT REV GENET, V13, P829, DOI 10.1038/nrg3337; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Van Landeghem S, 2013, PLANT CELL, V25, P794, DOI 10.1105/tpc.112.108753; Wagner JA, 1996, J EXP MED, V183, P2417, DOI 10.1084/jem.183.6.2417; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055	44	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143274	10.1371/journal.pone.0143274	http://dx.doi.org/10.1371/journal.pone.0143274			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673252	Green Submitted, gold, Green Published			2022-12-27	WOS:000366722700008
J	Smit, R; Postma, MJ				Smit, Renata; Postma, Maarten J.			The Burden of Tick-Borne Encephalitis in Disability-Adjusted Life Years (DALYs) for Slovenia	PLOS ONE			English	Article							GLOBAL BURDEN; COST-EFFECTIVENESS; CLINICAL-COURSE; VACCINATION; TBE; EPIDEMIOLOGY; DISEASE; AGE; AWARENESS; PREVENTION	Background Tick-borne encephalitis (TBE) presents an increasing burden in many parts of Europe, Asian Russia, Siberia, Asian former USSR and Far East. Incidence can be considered as one way to express the burden. A more comprehensive measure concerns disability-adjusted life years (DALYs), better characterizing the full burden of TBE. TBE burden in DALYs has not yet been estimated, nor has it been specified by the Global Burden of Disease (GBD) studies. Objective The purpose of the present study is to estimate the burden of TBE in Slovenia, expressed in DALYs, both from the population and individual perspectives. We discuss the impact of TBE burden on public health and potential strategies to reduce this burden in Slovenia. Methods The burden of TBE is estimated by using the updated DALYs' methodology first introduced in the GBD project. The DALYs. calculations are based on the health outcomes of the natural course of the disease being modelled. Corrections for under-reporting and under-ascertainment are applied. The impact of uncertainty in parameters in the model was assessed using sensitivity analyses. Results From the population perspective, total DALYs amount to 3,450 (167.8 per 100,000 population), while from the individual perspective they amount to 3.1 per case in 2011. Notably, the consequences of TBE present a larger burden than TBE itself. Conclusions TBE presents a relatively high burden expressed in DALYs compared with estimates for other infectious diseases from the GBD 2010 study for Slovenia. Raising awareness and increasing vaccination coverage are needed to reduce TBE and its consequences.	[Smit, Renata; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands; [Smit, Renata; Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Aging & healthcaRE SHARE, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Smit, R (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands.	renata_smit@t-2.net		Postma, Maarten/0000-0002-6306-3653; Smit, Dr. Renata/0000-0002-2175-3648				Airoldi M, 2009, HEALTH ECON, V18, P1237, DOI 10.1002/hec.1424; Amicizia D, 2013, HUM VACC IMMUNOTHER, V9, P1163, DOI 10.4161/hv.23802; Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; Arnesen T, 2004, HEALTH POLICY, V70, P137, DOI 10.1016/j.healthpol.2003.08.004; Barendregt JJ, 1996, B WORLD HEALTH ORGAN, V74, P439; Bognar G, 2008, ECON PHILOS, V24, P167, DOI 10.1017/S026626710800179X; Broker Michael, 2003, Travel Med Infect Dis, V1, P181, DOI 10.1016/j.tmaid.2003.07.001; Cizman M, 1999, WIEN KLIN WOCHENSCHR, V111, P484; Demicheli V, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000977.pub2; Dumpis U, 1999, CLIN INFECT DIS, V28, P882, DOI 10.1086/515195; European Centre for Disease Prevention and Control, 2012, EP SIT TICK BORN ENC; Gibbons CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-147; Grgic-Vitek M, 2014, VACCINE, V32, P2944, DOI 10.1016/j.vaccine.2013.05.093; Grgic-Vitek M, 2011, VACCINE, V29, P5178, DOI 10.1016/j.vaccine.2011.05.033; Haglund M, 2003, VACCINE, V21, pS11, DOI 10.1016/S0264-410X(02)00811-3; Hansmann Y, 2004, MED MALADIES INFECT, V34, pS28, DOI 10.1016/S0399-077X(04)90009-1; Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024; Institute for Health Metrics and Evaluation, 2019, GBD DAT, DOI DOI 10.6069/VFWJ-JF14; International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE), 2015, ECDC PRES TICK BORN; Jereb M, 2006, WIEN KLIN WOCHENSCHR, V118, P765, DOI 10.1007/s00508-006-0728-5; Kaiser R, 1999, BRAIN, V122, P2067, DOI 10.1093/brain/122.11.2067; Kaiser R, 2002, INT J MED MICROBIOL, V291, P58, DOI 10.1016/S1438-4221(02)80012-1; Kaiser R, 2008, INFECT DIS CLIN N AM, V22, P561, DOI 10.1016/j.idc.2008.03.013; Kelly TA, 2013, EMERG INFECT DIS, V19, P1428, DOI 10.3201/eid1909.130201; Kollaritsch H, BACKGROUND DOCUMENT; Kollaritsch H, 2011, VACCINE, V29, P4556, DOI 10.1016/j.vaccine.2011.04.061; Kretzschmar M, 2012, NEW METHODOLOGY ESTI, V9, DOI [10.1371/journal.pmed.1001205, DOI 10.1371/JOURNAL.PMED.1001205]; Kunz C., 1992, Acta Leidensia, V60, P1; Kunz C, 2003, VACCINE, V21, pS50, DOI 10.1016/S0264-410X(02)00813-7; Kunze U, 2005, WIEN MED WOCHENSCHR, V155, P289, DOI 10.1007/s10354-005-0178-0; Kunze U, 2010, WIEN MED WOCHENSCHR, V160, P252, DOI 10.1007/s10354-010-0798-x; Kunze Ursula, 2010, Vaccine, V28, P875, DOI 10.1016/j.vaccine.2009.11.032; Lesnicar G, 2003, PEDIATR INFECT DIS J, V22, P612, DOI 10.1097/00006454-200307000-00009; Lindenbach B.D., 2001, FIELDS VIROLOGY, V1, P991, DOI DOI 10.1016/J.JMB.2013.11.024; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Livartowski A, 1996, VACCINE, V14, P495, DOI 10.1016/0264-410X(95)00223-N; Logar M, 2000, INFECTION, V28, P74, DOI 10.1007/s150100050050; Logar M, 2006, WIEN KLIN WOCHENSCHR, V118, P702, DOI 10.1007/s00508-006-0699-6; Lyttkens Carl Hampus, 2003, Eur J Health Econ, V4, P195, DOI 10.1007/s10198-003-0169-2; Mangen M, 2011, METHODOLOGY PROTOCOL; Mangen MJJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079740; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; Mantke OD, 2008, SURVEY CASES TICK BO; Maximova OA, 2009, J HISTOCHEM CYTOCHEM, V57, P973, DOI 10.1369/jhc.2009.954180; Mickiene A, 2002, CLIN INFECT DIS, V35, P650, DOI 10.1086/342059; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJ, 2010, LANCET, V380, P2055; Murray CJ, 2010, COMPREHENSIVE SYSTEM, P2063; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; Murray CJL, 2003, POP STUD-J DEMOG, V57, P165, DOI 10.1080/0032472032000097083; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nacionalni institut za javno zdravje (NIJZ), 2014, EP SPREM NAL ZLIJ BO; Nacionalni institut za javno zdravje (NIJZ), 2014, NAV IZV PROGR CEPLJ; Nacionalni institut za javno zdravje (NIJZ), PRIP CEPLJ PROT KLOP; Radsel-Medvescek A, 1980, ARBOVIRUSES MEDITERR, V9, P281; Rakar R, BEDJ S TICK BORN MEN, P37; Randolph SE, 2010, VET PARASITOL, V167, P92, DOI 10.1016/j.vetpar.2009.09.011; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Smit R, 2014, REV TICK BORNE ENCEP, P1; Smit R, 2012, VACCINE, V30, P6301, DOI 10.1016/j.vaccine.2012.07.083; Statistical Office of the Republic of Slovenia, 2014, POP LARG 5 YEAR AG G; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; Suss J, 2010, WIEN MED WOCHENSCHR, V160, P94, DOI 10.1007/s10354-010-0756-7; Suss J, 2008, Euro Surveill, V13; Suss J, 2003, VACCINE, V21, pS19, DOI 10.1016/S0264-410X(02)00812-5; van Lier E A, 2007, Euro Surveill, V12, pE3; van Lier EA, DIS BURDEN INFECT DI; WHO, METH DAT SOURC GLOB; WHO, DISABILITY WEIGHTS D; World Health Organization, GLOB BURD DIS CONC; World Health Organization, WORLD HLTH REP 2000; World Health Organization, GLOB BURD DIS GBD; World Health Organization, 2004, GLOB BURD DIS 2004 U; World Health Organization (WHO), DEFINITION; Zavadska D, 2013, HUM VACC IMMUNOTHER, V9, P362, DOI 10.4161/hv.22766; Zent O, 2005, EXPERT REV VACCINES, V4, P747, DOI 10.1586/14760584.4.5.747	82	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144988	10.1371/journal.pone.0144988	http://dx.doi.org/10.1371/journal.pone.0144988			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672751	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700082
J	Xing, HY; Cai, YQ; Wang, XF; Wang, LL; Li, P; Wang, GY; Chen, JH				Xing, Hai-Yan; Cai, Yong-Qing; Wang, Xian-Feng; Wang, Lin-Li; Li, Pan; Wang, Guan-Ying; Chen, Jian-Hong			The Cytoprotective Effect of Hyperoside against Oxidative Stress Is Mediated by the Nrf2-ARE Signaling Pathway through GSK-3 beta Inactivation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; HYDROGEN-PEROXIDE; HEME OXYGENASE-1; ANTIOXIDANT RESPONSE; UP-REGULATION; CELL-DAMAGE; QUERCETIN; INVOLVEMENT; ACTIVATION; EXPRESSION	Glycogen synthase kinase-3 beta (GSK-3 beta) acts as a negative regulator of NF-E2 related factor 2 (Nrf2) by inducing Nrf2 degradation and nuclear export. Our previous study demonstrated that the flavonoid hyperoside elicits cytoprotection against oxidative stress by activating the Keap1-Nrf2-ARE signaling pathway, thus increasing the expression of antioxidant enzymes, such as heme oxygenase-1 (HO-1), superoxide dismutase (SOD) and catalase. However, the role of GSK-3 beta in hyperoside-mediated Nrf2 activation is unclear. Here, we demonstrate that in a normal human hepatocyte cell line, (L02), hyperoside is capable of inducing the phosphorylation of GSK-3 beta at Ser9 without affecting the protein levels of GSK-3 beta and its phosphorylation at Thr390. Lithium chloride (LiCl) and short interfering RNA (siRNA)-mediated inhibition of GSK-3 beta significantly enhanced the ability of hyperoside to protect L02 liver cells from H2O2-induced oxidative damage, leading to increased cell survival shown by the maintenance of cell membrane integrity and elevated levels of glutathione (GSH), one of the endogenous antioxidant biomarkers. Further study showed that LiCl and siRNA-mediated inhibition of GSK-3 beta increased hyperoside-induced HO-1 expression, and the effect was dependent upon enhanced Nrf2 nuclear translocation and gene expression. These activities were followed by ARE-mediated transcriptional activation in the presence of hyperoside, which was abolished by the transfection of the cells with Nrf2 siRNA. Furthermore, the siRNA-mediated inhibition of Keap1 also enhanced hyperoside-induced Nrf2 nuclear accumulation and HO-1 expression, which was relatively smaller than the effects obtained from GSK-3 beta siRNA administration. Moreover, Keap1 siRNA administration alone had no significant effect on the phosphorylation and protein expression of GSK-3 beta. Collectively, our data provide evidence that hyperoside attenuates H2O2 -induced L02 cell damage by activating the Nrf2-ARE signaling pathway through both an increase in GSK-3 beta inhibitory phosphorylation at Ser9 and an inhibition of Keap1 and that hyperoside-mediated GSK-3 beta inhibition exhibits more significant effects.	[Chen, Jian-Hong] Third Mil Med Univ, Daping Hosp, Dept Pharm, Chongqing 400042, Peoples R China; Third Mil Med Univ, Inst Surg Res, Chongqing 400042, Peoples R China	Army Medical University; Army Medical University	Chen, JH (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Pharm, Chongqing 400042, Peoples R China.	chenjh-110@263.net			National Natural Science Foundation of China [81302867, 81273608]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the grants from the National Natural Science Foundation of China (Grant No. 81302867 and 81273608) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martin MA, 2010, J NUTR BIOCHEM, V21, P196, DOI 10.1016/j.jnutbio.2008.10.009; Granado-Serrano AB, 2012, CHEM-BIOL INTERACT, V195, P154, DOI 10.1016/j.cbi.2011.12.005; Bitar MS, 2012, ADIPOCYTE, V1, P161, DOI 10.4161/adip.20235; Choi JH, 2011, J NAT PROD, V74, P1055, DOI 10.1021/np200001x; Dinkova-Kostova AT, 2010, J BIOL CHEM, V285, P33747, DOI 10.1074/jbc.M110.163485; Guo Y, 2015, FREE RADICAL BIO MED, V88, P337, DOI 10.1016/j.freeradbiomed.2015.06.013; Huang CS, 2013, ARCH TOXICOL, V87, P167, DOI 10.1007/s00204-012-0913-4; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jiang YF, 2015, GUT, V64, P168, DOI 10.1136/gutjnl-2013-306043; Kaspar JW, 2011, FASEB J, V25, P1076, DOI 10.1096/fj.10-171553; Khan RA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-114; Kim JS, 2010, FITOTERAPIA, V81, P85, DOI 10.1016/j.fitote.2009.08.008; Kronke G, 2003, J BIOL CHEM, V278, P51006, DOI 10.1074/jbc.M304103200; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lee KH, 2013, AM J PHYSIOL-LUNG C, V304, pL782, DOI 10.1152/ajplung.00348.2012; Li CC, 2014, NEUROTOXICOL TERATOL, V46, P1, DOI 10.1016/j.ntt.2014.08.007; Li LR, 2014, CHEM-BIOL INTERACT, V209, P56, DOI 10.1016/j.cbi.2013.12.005; Li ZL, 2013, FREE RADICAL BIO MED, V57, P132, DOI 10.1016/j.freeradbiomed.2012.12.023; Li ZL, 2012, J ETHNOPHARMACOL, V139, P388, DOI 10.1016/j.jep.2011.11.020; Mari M, 2010, ANTIOXID REDOX SIGN, V12, P1295, DOI 10.1089/ars.2009.2634; Morse D, 2002, AM J RESP CELL MOL, V27, P8, DOI 10.1165/ajrcmb.27.1.4862; Narasimhan M, 2014, TOXICOL LETT, V228, P179, DOI 10.1016/j.toxlet.2014.05.020; Narasimhan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051111; Piao MJ, 2008, BBA-GEN SUBJECTS, V1780, P1448, DOI 10.1016/j.bbagen.2008.07.012; Qiu LX, 2015, WORLD J GASTROENTERO, V21, P1099, DOI 10.3748/wjg.v21.i4.1099; Rada P, 2012, MOL CELL BIOL, V32, P3486, DOI 10.1128/MCB.00180-12; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Rojo AI, 2008, MOL CELL NEUROSCI, V39, P125, DOI 10.1016/j.mcn.2008.06.007; Rojo AI, 2014, ANTIOXID REDOX SIGN, V21, P2498, DOI 10.1089/ars.2014.5843; Rojo AI, 2012, FREE RADICAL BIO MED, V52, P473, DOI 10.1016/j.freeradbiomed.2011.11.003; Serviddio G, 2010, CURR MED CHEM, V17, P2325, DOI 10.2174/092986710791698530; Shang GG, 2015, J NUTR BIOCHEM, V26, P596, DOI 10.1016/j.jnutbio.2014.12.008; Sun GB, 2012, TOXICOL APPL PHARM, V265, P229, DOI 10.1016/j.taap.2012.10.002; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Weng CJ, 2011, NEW BIOTECHNOL, V28, P767, DOI 10.1016/j.nbt.2011.05.003; Xi YD, 2012, CURR NEUROVASC RES, V9, P32, DOI 10.2174/156720212799297092; Xia SF, 2015, PHYSIOL BEHAV, V138, P325, DOI 10.1016/j.physbeh.2014.09.008; Xing HY, 2011, BIOCHEM BIOPH RES CO, V410, P759, DOI 10.1016/j.bbrc.2011.06.046; Yang HP, 2015, ANTIOXID REDOX SIGN, V22, P259, DOI 10.1089/ars.2014.6027; Zenkov NK, 2013, BIOCHEMISTRY-MOSCOW+, V78, P19, DOI 10.1134/S0006297913010033; Zhou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101668; Zhou L, 2012, J MED FOOD, V15, P461, DOI 10.1089/jmf.2011.1921; Zhou YY, 2014, INT J NEUROPSYCHOPH, V17, P635, DOI 10.1017/S146114571300148X; Zou Y, 2013, FREE RADICAL RES, V47, P55, DOI 10.3109/10715762.2012.742518	44	51	55	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145183	10.1371/journal.pone.0145183	http://dx.doi.org/10.1371/journal.pone.0145183			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674355	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700112
J	Santos, CMML; Lira, R; Fischer, RG; Santos, APP; Oliveira, BH				Martins Lobo Santos, Caroline Moura; Lira-Junior, Ronaldo; Fischer, Ricardo Guimaraes; Pires Santos, Ana Paula; Oliveira, Branca Heloisa			Systemic Antibiotics in Periodontal Treatment of Diabetic Patients: A Systematic Review	PLOS ONE			English	Article							CONTROLLED CLINICAL-TRIAL; GLYCEMIC CONTROL; THERAPY; DISEASE; METAANALYSIS; DOXYCYCLINE; MELLITUS; METRONIDAZOLE; ADJUNCTS; SMOKERS	Aim To evaluate the effects of systemic antibiotics in combination with scaling and root planing (SRP) on periodontal parameters, tooth loss and oral health-related quality of life in diabetes patients. Materials and Methods Two independent reviewers screened for controlled clinical trials with at least 6-month follow- up in six electronic databases, registers of clinical trials, meeting abstracts and four major dental journals. After duplicates removal, electronic and hand searches yielded 1,878 records; 18 full-text articles were independently read by two reviewers. To evaluate the additional effect of antibiotic usage, pooled weighted mean differences and 95% confidence intervals were calculated using a fixed effects model. Results Five studies met the inclusion criteria, four of which were included in meta-analyses. The meta-analyses showed a significant effect favouring SRP plus antibiotic for reductions in mean probing depth (PD) (-0.22 mm [-0.34, -0.11]) and mean percentage of bleeding on probing (BoP) (4% [-7, -1]). There was no significant effect for clinical attachment level gain and plaque index reduction. No study reported on tooth loss and oral health-related quality of life. Conclusion Adjunctive systemic antibiotic use in diabetic patients provides a small additional benefit in terms of reductions in mean PD and mean percentage of BoP.	[Martins Lobo Santos, Caroline Moura; Lira-Junior, Ronaldo; Fischer, Ricardo Guimaraes] Univ Estado Rio De Janeiro, Sch Dent, Dept Periodontol, Rio De Janeiro, Brazil; [Pires Santos, Ana Paula; Oliveira, Branca Heloisa] Univ Estado Rio De Janeiro, Sch Dent, Dept Community & Prevent Dent, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Oliveira, BH (corresponding author), Univ Estado Rio De Janeiro, Sch Dent, Dept Community & Prevent Dent, Rio De Janeiro, Brazil.	branca@uerj.br	Santos, Caroline/A-8938-2019; Lira-Junior, Ronaldo/ABE-3863-2021; dos Santos, Ana Paula Pires/AAS-8673-2020; Lira Junior, Ronaldo/A-5695-2015; Oliveira, Branca Heloisa/AAP-3341-2021; Oliveira, Branca Heloisa/K-9576-2013; Oliveira, Branca Heloisa/ABD-8248-2021	Santos, Caroline/0000-0002-5816-5436; dos Santos, Ana Paula Pires/0000-0001-5688-4747; Lira Junior, Ronaldo/0000-0003-0297-5138; Oliveira, Branca Heloisa/0000-0002-0798-2479; Oliveira, Branca Heloisa/0000-0002-0798-2479; Oliveira, Branca Heloisa/0000-0002-0798-2479	Research Support Foundation of the State of Rio de Janeiro [FAPERJ E-26/111.315/2014]	Research Support Foundation of the State of Rio de Janeiro	This study was funded by Research Support Foundation of the State of Rio de Janeiro (FAPERJ E-26/111.315/2014).	Al-Mubarak S, 2002, J CLIN PERIODONTOL, V29, P295, DOI 10.1034/j.1600-051X.2002.290404.x; Altman DG, 1991, PRACTICAL STAT MED R, P396; Angaji M, 2010, J PERIODONTOL, V81, P1518, DOI 10.1902/jop.2010.100192; Botero JE, 2013, J PERIODONTAL RES, V48, P706, DOI 10.1111/jre.12058; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Cunha-Cruz J, 2008, J DENT RES, V87, P871, DOI 10.1177/154405910808700916; Deo V, 2010, J CONT DENT PRACT, V11; GOLUB LM, 1990, J PERIODONTAL RES, V25, P321, DOI 10.1111/j.1600-0765.1990.tb00923.x; Grossi SG, 1996, J PERIODONTOL, V67, P1094, DOI 10.1902/jop.1996.67.10s.1094; Grossi SG, 1997, J PERIODONTOL, V68, P713, DOI 10.1902/jop.1997.68.8.713; Herrera D, 2002, J CLIN PERIODONTOL, V29, P136, DOI 10.1034/j.1600-051X.29.s3.8.x; International Diabetes Federation, 2013, IDF DIABETES ATLAS; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; Kassebaum NJ, 2014, J DENT RES, V93, P1045, DOI 10.1177/0022034514552491; Keestra JAJ, 2015, J PERIODONTAL RES, V50, P294, DOI 10.1111/jre.12221; Labriola A, 2005, PERIODONTOL 2000, V37, P124, DOI 10.1111/j.1600-0757.2004.03793.x; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Liew AKC, 2013, AUST DENT J, V58, P350, DOI 10.1111/adj.12091; Llambes F, 2005, J CLIN PERIODONTOL, V32, P915, DOI 10.1111/j.1600-051X.2005.00736.x; Lowenguth RA, 1995, PERIODONTOL 2000, V9, P14, DOI 10.1111/j.1600-0757.1995.tb00052.x; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Chavarry NGM, 2009, ORAL HLTH PREV DENT, V7, P107; Miranda TS, 2014, J CLIN PERIODONTOL, V41, P890, DOI 10.1111/jcpe.12282; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Rodrigues DC, 2003, J PERIODONTOL, V74, P1361, DOI 10.1902/jop.2003.74.9.1361; Sgolastra F, 2014, J PERIODONTAL RES, V49, P10, DOI 10.1111/jre.12089; Sgolastra F, 2012, J PERIODONTOL, V83, P1257, DOI 10.1902/jop.2012.110625; Simpson TC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004714.pub2; Smiley CJ, 2015, J AM DENT ASSOC, V146, P525, DOI 10.1016/j.adaj.2015.01.026; Sweeney LC, 2004, J ANTIMICROB CHEMOTH, V53, P567, DOI 10.1093/jac/dkh137; Tsai C, 2002, COMMUNITY DENT ORAL, V30, P182, DOI 10.1034/j.1600-0528.2002.300304.x; Tsalikis L, 2014, J CLIN PERIODONTOL, V41, P972, DOI 10.1111/jcpe.12287; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7	33	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145262	10.1371/journal.pone.0145262	http://dx.doi.org/10.1371/journal.pone.0145262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26693909	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092500033
J	Wagner, T; Bartelt, A; Schlein, C; Heeren, J				Wagner, Tobias; Bartelt, Alexander; Schlein, Christian; Heeren, Joerg			Genetic Dissection of Tissue-Specific Apolipoprotein E Function for Hypercholesterolemia and Diet-Induced Obesity	PLOS ONE			English	Article							E-DEFICIENT MICE; BONE-MARROW-TRANSPLANTATION; FATTY LIVER-DISEASE; ADIPOSE-TISSUE; CHOLESTEROL EFFLUX; METABOLIC SYNDROME; IN-VIVO; ATHEROSCLEROSIS; EXPRESSION; MOUSE	ApoE deficiency in mice (Apoe(-/-)) results in severe hypercholesterolemia and atherosclerosis. In diet-induced obesity, Apoe(-/-) display steatohepatitis but reduced accumulation of triacylglycerides and enhanced insulin sensitivity in white adipose tissue (WAT). Although the vast majority of apoE is expressed by hepatocytes apoE is also abundantly expressed in WAT. As liver and adipose tissue play important roles for metabolism, this study aims to outline functions of both hepatocyte- and adipocyte-derived apoE separately by investigating a novel mouse model of tissue-specific apoE deficiency. Therefore we generated transgenic mice carrying homozygous floxed Apoe alleles. Mice lacking apoE either in hepatocytes (Apoe(Delta Hep)) or in adipose tissue (Apoe(Delta AT)) were fed experimental diets. Apoe(Delta Hep) exhibited slightly higher body weights, adiposity and liver weights on diabetogenic high fat diet (HFD). Accordingly, hepatic steatosis and markers of inflammation were more pronounced compared to controls. Hypercholesterolemia evoked by lipoprotein remnant accumulation was present in Apoe(Delta Hep) mice fed a Western type diet (WTD). Lipidation of VLDL particles and tissue uptake of VLDL were disturbed in Apoe(Delta Hep) while the plasma clearance rate remained unaltered. Apoe(Delta AT) did not display any detectable phenotype, neither on HFD nor on WTD. In conclusion, our novel conditional apoE deletion model has proven here the role of hepatocyte apoE for VLDL production and diet-induced dyslipidemia. Specific deletion of apoE in adipocytes cannot reproduce the adipose phenotype of global Apoe(-/-) mice, suggesting that apoE produced in other cell types than hepatocytes or adipocytes explains the lean and insulin-sensitive phenotype described for Apoe(-/-) mice.	[Wagner, Tobias; Bartelt, Alexander; Schlein, Christian; Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Heeren, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany.	heeren@uke.uni-hamburg.de	Bartelt, Alexander/ABC-2525-2020		Deutsche Forschungsgemeinschaft [SFB 841, GRK1459]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was financially supported by grants of the Deutsche Forschungsgemeinschaft (SFB 841) to JH. The work of TW and CS was supported by doctoral fellowships of the Deutsche Forschungsgemeinschaft (SFB 841, GRK1459).; The authors thank S. Ehret, E. Azizi and B. Henkel for excellent technical assistance. The development of the Apoe conditional mouse model was assisted by genOway. This work was financially supported by grants of the DFG (SFB 841) to J. H. The work of T. W. and C. S. was supported by doctoral fellowships of DFG (SFB 841, GRK1459).	Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Bartelt A., 2012, Journal of Molecular Medicine, V90, P887, DOI 10.1007/s00109-012-0858-3; Bartelt A, 2011, DIABETOLOGIA, V54, P2900, DOI 10.1007/s00125-011-2274-6; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bartelt A, 2010, BONE, V47, P736, DOI 10.1016/j.bone.2010.07.002; BOISVERT WA, 1995, J CLIN INVEST, V96, P1118, DOI 10.1172/JCI118098; DASHTI N, 1980, BIOCHIM BIOPHYS ACTA, V618, P347, DOI 10.1016/0005-2760(80)90041-7; Foley EM, 2013, ARTERIOSCL THROM VAS, V33, P2065, DOI 10.1161/ATVBAHA.113.301637; HAYEK T, 1994, BIOCHEM BIOPH RES CO, V205, P1072, DOI 10.1006/bbrc.1994.2775; Heeren J, 2006, ARTERIOSCL THROM VAS, V26, P442, DOI 10.1161/01.ATV.0000201282.64751.47; Hofmann SM, 2008, DIABETES, V57, P5, DOI 10.2337/db07-0403; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Huang YD, 1998, J BIOL CHEM, V273, P26388, DOI 10.1074/jbc.273.41.26388; Huang ZH, 2013, J LIPID RES, V54, P202, DOI 10.1194/jlr.M031906; Huang ZH, 2006, DIABETES, V55, P3394, DOI 10.2337/db06-0354; Huang ZH, 2009, AM J PHYSIOL-ENDOC M, V296, pE1110, DOI 10.1152/ajpendo.90964.2008; Krueger KC, 2014, STEM CELL REP, V3, P1147, DOI 10.1016/j.stemcr.2014.10.009; Kuipers F, 1997, J CLIN INVEST, V100, P2915, DOI 10.1172/JCI119841; Laatsch A, 2009, ATHEROSCLEROSIS, V204, P105, DOI 10.1016/j.atherosclerosis.2008.07.046; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchesini G, 2005, CURR OPIN LIPIDOL, V16, P421, DOI 10.1097/01.mol.0000174153.53683.f2; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Mensenkamp AR, 1999, J BIOL CHEM, V274, P35711, DOI 10.1074/jbc.274.50.35711; Mensenkamp AR, 2001, J HEPATOL, V35, P816, DOI 10.1016/S0168-8278(01)00249-5; Mullican SE, 2013, MOL ENDOCRINOL, V27, P127, DOI 10.1210/me.2012-1267; Nilsson SK, 2011, ATHEROSCLEROSIS, V219, P15, DOI 10.1016/j.atherosclerosis.2011.07.019; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rellin L, 2008, BBA-MOL CELL BIOL L, V1781, P232, DOI 10.1016/j.bbalip.2008.02.001; Surendran RP, 2012, J INTERN MED, V272, P185, DOI 10.1111/j.1365-2796.2012.02516.x; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; WILLIAMS DL, 1985, ANN NY ACAD SCI, V454, P222, DOI 10.1111/j.1749-6632.1985.tb11861.x; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; ZECHNER R, 1991, J BIOL CHEM, V266, P10583; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	36	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145102	10.1371/journal.pone.0145102	http://dx.doi.org/10.1371/journal.pone.0145102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695075	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092500022
J	Borghans, L; Golsteyn, BHH; Stenberg, A				Borghans, Lex; Golsteyn, Bart H. H.; Stenberg, Anders			Does Expert Advice Improve Educational Choice?	PLOS ONE			English	Article							PERSONALITY-TRAITS; EXPECTATIONS; IDENTIFICATION; ECONOMICS; IDENTITY; DEMAND; INFORMATION; INVESTMENT; RETURNS; STUDENT	This paper reports evidence that an individual meeting with a study counselor at high school significantly improves the quality of choice of tertiary educational field, as self-assessed 18 months after graduation from college. To address endogeneity, we explore the variation in study counseling practices between schools as an instrumental variable (IV). Following careful scrutiny of the validity of the IV, our results indicate a significant and positive influence of study counseling on the quality of educational choice, foremost among males and those with low educated parents. The overall result is stable across a number of robustness checks.	[Borghans, Lex; Golsteyn, Bart H. H.] Maastricht Univ, Dept Econ, NL-6200 MD Maastricht, Netherlands; [Borghans, Lex; Golsteyn, Bart H. H.] Maastricht Univ, Res Ctr Educ & Labour Market ROA, NL-6200 MD Maastricht, Netherlands; [Golsteyn, Bart H. H.; Stenberg, Anders] Stockholm Univ, Swedish Inst Social Res SOFI, S-10691 Stockholm, Sweden	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Stockholm University	Golsteyn, BHH (corresponding author), Maastricht Univ, Dept Econ, NL-6200 MD Maastricht, Netherlands.	b.golsteyn@maastrichtuniversity.nl		Stenberg, Anders/0000-0003-3024-9862; Golsteyn, Bart/0000-0002-2357-5857				Akerlof GA, 2002, J ECON LIT, V40, P1167, DOI 10.1257/002205102762203585; Akerlof GA, 2000, Q J ECON, V115, P715, DOI 10.1162/003355300554881; Angrist JD, 2001, J ECON PERSPECT, V15, P69, DOI 10.1257/jep.15.4.69; Arcidiacono P, 2012, J ECONOMETRICS, V166, P3, DOI 10.1016/j.jeconom.2011.06.002; Avery C, 2010, 16359 NAT BUR EC RES; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Beffy M, 2012, REV ECON STAT, V94, P334, DOI 10.1162/REST_a_00212; Behaghel L., 2012, 6518 IZA; Bettinger EP, 2012, Q J ECON, V127, P1205, DOI 10.1093/qje/qjs017; Betts JR, 1996, J HUM RESOUR, V31, P27, DOI 10.2307/146042; Borghans L, 2008, J HUM RESOUR, V43, P972; Borghans L, 2007, APPL ECON, V39, P1663, DOI 10.1080/00036840600675661; Card D, 1995, 4483 NBER; Carrell S.E, 2013, W19031 NBER; Crepon B., 2005, IZA DISCUSSION PAPER; Dominitz J, 1996, J HUM RESOUR, V31, P1, DOI 10.2307/146041; Favara M, 2011, EALE C CYPR SEPT 201; Hainmuller J, 2009, 13 IAB; Host A, 2012, INCREASING ADM UNPUB; Humlum MK, 2012, ECON INQ, V50, P39, DOI 10.1111/j.1465-7295.2009.00234.x; IMBENS GW, 1994, ECONOMETRICA, V62, P467, DOI 10.2307/2951620; Jensen R, 2010, Q J ECON, V125, P515, DOI 10.1162/qjec.2010.125.2.515; Jurgens JC, 2000, CAREER DEV Q, V48, P237, DOI 10.1002/j.2161-0045.2000.tb00289.x; Kauffman KM, 2009, UNDERSTANDING UNPUB; KODDE DA, 1986, REV ECON STAT, V68, P460, DOI 10.2307/1926023; Kraus L. J., 1999, PROFESSIONAL SCH COU, V2, P384; LEVHARI D, 1974, AM ECON REV, V64, P950; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Manski CF, 2004, ECONOMETRICA, V72, P1329, DOI 10.1111/j.1468-0262.2004.00537.x; Martmez C, 2011, 8375 CEPR DP; Miller T, 2009, INFORM DECISIO UNPUB; Moffitt R, 2003, POPUL DEV REV, V29, P448, DOI 10.1111/j.1728-4457.2003.00448.x; Murnane RJ, 2013, J ECON LIT, V51, P370, DOI 10.1257/jel.51.2.370; Nguyen Trang, 2008, INFORM ROLE MO UNPUB; OLSON L, 1979, J POLIT ECON, V87, P522, DOI 10.1086/260776; Oreopoulos P, 2013, SCAND J ECON, V115, P3, DOI 10.1111/j.1467-9442.2012.01742.x; Papay J.P., 2011, 17120 NBER; Pedersen JM, 2012, ESPE BONN JUN 2012; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Stenberg A, 2011, ECON EDUC REV, V30, P1262, DOI 10.1016/j.econedurev.2011.04.008; Stinebrickner T, 2012, J LABOR ECON, V30, P707, DOI 10.1086/666525; Stinebrickner Todd R., 2011, 16869 NBER; Whinston S, 1998, J COUNS PSYCHOL, V45, P150; Zafar B, 2011, J LABOR ECON, V29, P301, DOI 10.1086/658091	44	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145378	10.1371/journal.pone.0145378	http://dx.doi.org/10.1371/journal.pone.0145378			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SF	26692388	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092300066
J	Buffet, C; Catelli, MG; Hecale-Perlemoine, K; Bricaire, L; Garcia, C; Gallet-Dierick, A; Rodriguez, S; Cormier, F; Groussin, L				Buffet, Camille; Catelli, Maria-Grazia; Hecale-Perlemoine, Karine; Bricaire, Leopoldine; Garcia, Camille; Gallet-Dierick, Anne; Rodriguez, Stephanie; Cormier, Francoise; Groussin, Lionel			Dual Specificity Phosphatase 5, a Specific Negative Regulator of ERK Signaling, Is Induced by Serum Response Factor and EIk-1 Transcription Factor	PLOS ONE			English	Article							PROTEIN-KINASE PHOSPHATASE-3; TERNARY COMPLEX FACTORS; DNA-BINDING ACTIVITY; C-FOS PROMOTER; MAP KINASE; GENE-EXPRESSION; PHOSPHORYLATION SITES; CATALYTIC ACTIVATION; FEEDBACK-REGULATION; THYROID-CANCER	Serum stimulation of mammalian cells induces, via the MAPK pathway, the nuclear protein DUSP5 (dual-specificity phosphatase 5), which specifically interacts with and inactivates the ERK1/2 MAP kinases. However, molecular mechanisms underlying DUSP5 induction are not well known. Here, we found that the DUSP5 mRNA induction depends on a transcriptional regulation by the MAPK pathway, without any modification of the mRNA stability. Two contiguous CArG boxes that bind serum response factor (SRF) were found in a 1 Kb promoter region, as well as several E twenty-six transcription factor family binding sites (EBS). These sites potentially bind EIk-1, a transcription factor activated by ERK1/2. Using wild type or mutated DUSP5 promoter reporters, we demonstrated that SRF plays a crucial role in serum induction of DUSP5 promoter activity, the proximal CArG box being important for SRF binding in vitro and in living cells. Moreover, in vitro and in vivo binding data of EIk-1 to the same promoter region further demonstrate a role for EIk-1 in the transcriptional regulation of DUSP5. SRF and EIk-1 form a ternary complex (EIk-1-SRF-DNA) on DUSP5 promoter, consequently providing a link to an important negative feedback tightly regulating phosphorylated ERK levels.	[Buffet, Camille; Catelli, Maria-Grazia; Hecale-Perlemoine, Karine; Bricaire, Leopoldine; Garcia, Camille; Gallet-Dierick, Anne; Rodriguez, Stephanie; Cormier, Francoise; Groussin, Lionel] Univ Paris 05, Inst Cochin, Endocrinol Metabolism Diabet Dept, CNRS UMR8104,INSERM U1016, Paris, France; [Groussin, Lionel] Cochin Hosp, Dept Endocrinol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Groussin, L (corresponding author), Univ Paris 05, Inst Cochin, Endocrinol Metabolism Diabet Dept, CNRS UMR8104,INSERM U1016, Paris, France.	lionel.groussin@aphp.fr		Cormier, Francoise/0000-0002-6904-5122; Groussin, Lionel/0000-0003-1476-475X; Rodriguez, Stephanie/0000-0003-4520-144X	American Thyroid Association (ATA) [R06059KK]; French Fondation pour la recherche sur le cancer (ARC); French National Academy of Medicine; Ile de France Regional Health Agency	American Thyroid Association (ATA); French Fondation pour la recherche sur le cancer (ARC); French National Academy of Medicine; Ile de France Regional Health Agency	This work was supported by: the American Thyroid Association [ATA R06059KK], a predoctoral fellowship from the French Fondation pour la recherche sur le cancer (ARC), the French National Academy of Medicine, and a predoctoral and doctoral fellowship from the Ile de France Regional Health Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Arkell RS, 2008, CELL SIGNAL, V20, P836, DOI 10.1016/j.cellsig.2007.12.014; Bermudez O, 2010, AM J PHYSIOL-CELL PH, V299, pC189, DOI 10.1152/ajpcell.00347.2009; Bermudez O, 2011, J CELL PHYSIOL, V226, P276, DOI 10.1002/jcp.22339; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; Dowd S, 1998, J CELL SCI, V111, P3389; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; Fjeld CC, 2000, J BIOL CHEM, V275, P6749, DOI 10.1074/jbc.275.10.6749; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Furukawa T, 2008, BIOCHEM BIOPH RES CO, V377, P317, DOI 10.1016/j.bbrc.2008.10.003; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; Hassler M, 2001, EMBO J, V20, P3018, DOI 10.1093/emboj/20.12.3018; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; HILL CS, 1994, EMBO J, V13, P5421, DOI 10.1002/j.1460-2075.1994.tb06877.x; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; ISHIBASHI T, 1994, J BIOL CHEM, V269, P29897; Iyer D, 2006, P NATL ACAD SCI USA, V103, P4516, DOI 10.1073/pnas.0505338103; JANKNECHT R, 1992, EMBO J, V11, P1045, DOI 10.1002/j.1460-2075.1992.tb05143.x; JANKNECHT R, 1992, NUCLEIC ACIDS RES, V20, P3317, DOI 10.1093/nar/20.13.3317; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; KABNICK KS, 1988, MOL CELL BIOL, V8, P3244, DOI 10.1128/MCB.8.8.3244; Karlsson M, 2004, J BIOL CHEM, V279, P41882, DOI 10.1074/jbc.M406720200; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Knauf JA, 2009, CURR OPIN CELL BIOL, V21, P296, DOI 10.1016/j.ceb.2009.01.013; KONIG H, 1989, EMBO J, V8, P2559, DOI 10.1002/j.1460-2075.1989.tb08394.x; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; KWAK SP, 1995, J BIOL CHEM, V270, P1156, DOI 10.1074/jbc.270.3.1156; Lee JU, 2012, EUR J ENDOCRINOL, V167, P93, DOI 10.1530/EJE-12-0010; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; MANAK JR, 1993, ONCOGENE, V8, P703; MANAK JR, 1991, MOL CELL BIOL, V11, P3652, DOI 10.1128/MCB.11.7.3652; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; McCarthy SA, 1997, MOL CELL BIOL, V17, P2401, DOI 10.1128/MCB.17.5.2401; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mo Y, 2001, J MOL BIOL, V314, P495, DOI 10.1006/jmbi.2001.5138; Muda M, 1998, J BIOL CHEM, V273, P9323, DOI 10.1074/jbc.273.15.9323; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Nunes-Xavier CE, 2010, J BIOL CHEM, V285, P26417, DOI 10.1074/jbc.M110.121830; Odrowaz Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002694; PELLEGRINI L, 1995, NATURE, V376, P490, DOI 10.1038/376490a0; Plani-Lam JHC, 2015, INT J BIOCHEM CELL B, V61, P53, DOI 10.1016/j.biocel.2015.02.003; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; Schratt G, 2004, EMBO J, V23, P1834, DOI 10.1038/sj.emboj.7600188; Sharrocks AD, 2002, BIOCHEM SOC T, V30, P1; Shaw PE, 2003, INT J BIOCHEM CELL B, V35, P1210, DOI 10.1016/S1357-2725(03)00031-1; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Stritt C, 2009, NAT NEUROSCI, V12, P418, DOI 10.1038/nn.2280; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; TREISMAN R, 1992, EMBO J, V11, P4631, DOI 10.1002/j.1460-2075.1992.tb05565.x; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Ueda K, 2003, ONCOGENE, V22, P5586, DOI 10.1038/sj.onc.1206845; Vanhoutte P, 2001, J BIOL CHEM, V276, P5189, DOI 10.1074/jbc.M006678200; Vickers ER, 2004, MOL CELL BIOL, V24, P10340, DOI 10.1128/MCB.24.23.10340-10351.2004; Withers DA, 2000, J BIOL CHEM, V275, P40588, DOI 10.1074/jbc.M007262200; Yang BS, 1996, MOL CELL BIOL, V16, P538; Zeliadt NA, 2008, TOXICOL APPL PHARM, V232, P408, DOI 10.1016/j.taap.2008.08.007; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020	70	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145484	10.1371/journal.pone.0145484	http://dx.doi.org/10.1371/journal.pone.0145484			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691724	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092300082
J	Qureshi, O; Cho, H; Choudhary, M; Seeling, JM				Qureshi, Osama; Cho, Hyuk; Choudhary, Madhusudan; Seeling, Joni M.			A Nonsynonymous/Synonymous Substitution Analysis of the B56 Gene Family Aids in Understanding B56 Isoform Diversity	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; REGULATORY SUBUNIT; CODON BIAS; DUPLICATE GENES; BETA; HOLOENZYME; EVOLUTION; GENOME; IDENTIFICATION; COMPLEX	Gene duplication leads to the formation of gene families, wherein purifying or neutral selection maintains the original gene function, while diversifying selection confers new functions onto duplicated genes. The B56 gene family is highly conserved; it is encoded by one gene in protists and fungi, and five genes in vertebrates. B56 regulates protein phosphatase 2A (PP2A), an abundant heterotrimeric serine/threonine phosphatase that functions as a tumor suppressor and consists of a scaffolding "A" and catalytic "C" subunit heterodimer bound to a regulatory "B" subunit. Individual regulatory B56 subunits confer disparate functions onto PP2A in various cell-cell signaling pathways. B56 proteins share a conserved central core domain, but have divergent N- and C-termini which play a role in isoform specificity. We carried out a nonsynonymous/synonymous substitution analysis to better understand the divergence of vertebrate B56 genes. When five B56 paralogs from ten vertebrate species were analyzed, the gene family displayed purifying selection; stronger purifying selection was revealed when individual B56 isoforms were analyzed separately. The B56 core experienced stronger purifying selection than the N- and C-termini, which correlates with the presence of several contacts between the core and the AC heterodimer. Indeed, the majority of the contact points that we analyzed between B56 and the AC heterodimer experienced strong purifying selection. B56 subfamilies showed distinct patterns of selection in their Nand C-termini. The C-terminus of the B56-1 subfamily and the N-terminus of the B56-2 subfamily exhibited strong purifying selection, suggesting that these termini carry out subfamily-specific functions, while the opposite termini exhibited diversifying selection and likely carry out isoform-specific functions. We also found reduced synonymous substitutions at the N- and C-termini when grouping B56 genes by species but not by isoform, suggesting species-specific codon bias may have a role in regulating B56 gene expression.	[Qureshi, Osama; Choudhary, Madhusudan; Seeling, Joni M.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA; [Cho, Hyuk] Sam Houston State Univ, Dept Comp Sci, Huntsville, TX 77340 USA	Texas State University System; Sam Houston State University; Texas State University System; Sam Houston State University	Seeling, JM (corresponding author), Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA.	jms120@shsu.edu			JMS Sam Houston State University Enhancement Research Grant Program	JMS Sam Houston State University Enhancement Research Grant Program	This work was funded by JMS Sam Houston State University Enhancement Research Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AA, 2009, EVOL BIOINFORM, V5, P5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Baek S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-139; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Conant GC, 2003, GENOME RES, V13, P2052, DOI 10.1101/gr.1252603; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Huerta-Cepas J, 2011, BIOINFORMATICS, V27, P38, DOI 10.1093/bioinformatics/btq609; Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Magnusdottir A, 2009, PROTEINS, V74, P212, DOI 10.1002/prot.22150; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Nabiyouni M, 2013, GENE, V519, P113, DOI 10.1016/j.gene.2013.01.033; NEI M, 1986, MOL BIOL EVOL, V3, P418; Novichkov PS, 2009, J BACTERIOL, V191, P65, DOI 10.1128/JB.01237-08; Ohno S, 1970, EVOLUTION BY GENE DU; Pais FSM, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-4; Park M, 2014, BBA-MOL CELL BIOL L, V1841, P1608, DOI 10.1016/j.bbalip.2014.08.008; Peters Anne E, 2012, BMC Res Notes, V5, P192, DOI 10.1186/1756-0500-5-192; Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035; Robinson-Rechavi M, 2001, MOL BIOL EVOL, V18, P681, DOI 10.1093/oxfordjournals.molbev.a003849; Rodgers JT, 2011, MOL CELL, V41, P471, DOI 10.1016/j.molcel.2011.02.007; Rorick AM, 2007, DEV BIOL, V302, P477, DOI 10.1016/j.ydbio.2006.10.011; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sommer LM, 2015, INT J MOL SCI, V16, P10134, DOI 10.3390/ijms160510134; Van Kanegan MJ, 2009, MOL CELL BIOL, V29, P662, DOI 10.1128/MCB.01242-08; Varadkar P, 2014, DEV DYNAM, V243, P778, DOI 10.1002/dvdy.24111; Wang DP, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-13; Wang MC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-266; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yang J, 2003, DEVELOPMENT, V130, P5569, DOI 10.1242/dev.00762; Yang J, 2010, LIFE SCI, V87, P659, DOI 10.1016/j.lfs.2010.10.003	39	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145529	10.1371/journal.pone.0145529	http://dx.doi.org/10.1371/journal.pone.0145529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692027	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300084
J	Steins, A; Dik, P; Muller, WH; Vervoort, SJ; Reimers, K; Kuhbier, JW; Vogt, PM; van Apeldoorn, AA; Coffer, PJ; Schepers, K				Steins, Anne; Dik, Pieter; Muller, Wally H.; Vervoort, Stephin J.; Reimers, Kerstin; Kuhbier, Joern W.; Vogt, Peter M.; van Apeldoorn, Aart A.; Coffer, Paul J.; Schepers, Koen			In Vitro Evaluation of Spider Silk Meshes as a Potential Biomaterial for Bladder Reconstruction	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; AUGMENTATION CYSTOPLASTY; UROTHELIAL CELLS; URINARY-BLADDER; DRAGLINE SILK; STEM-CELLS; SPINA-BIFIDA; RESPONSES; BIOCOMPATIBILITY; DIFFERENTIATION	Reconstruction of the bladder by means of both natural and synthetic materials remains a challenge due to severe adverse effects such as mechanical failure. Here we investigate the application of spider major ampullate gland-derived dragline silk from the Nephila edulis spider, a natural biomaterial with outstanding mechanical properties and a slow degradation rate, as a potential scaffold for bladder reconstruction by studying the cellular response of primary bladder cells to this biomaterial. We demonstrate that spider silk without any additional biological coating supports adhesion and growth of primary human urothelial cells (HUCs), which are multipotent bladder cells able to differentiate into the various epithelial layers of the bladder. HUCs cultured on spider silk did not show significant changes in the expression of various epithelial-to-mesenchymal transition and fibrosis associated genes, and demonstrated only slight reduction in the expression of adhesion and cellular differentiation genes. Furthermore, flow cytometric analysis showed that most of the silk-exposed HUCs maintain an undifferentiated immunophenotype. These results demonstrate that spider silk from the Nephila edulis spider supports adhesion, survival and growth of HUCs without significantly altering their cellular properties making this type of material a suitable candidate for being tested in pre-clinical models for bladder reconstruction.	[Steins, Anne; Dik, Pieter; Coffer, Paul J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Div Pediat, Utrecht, Netherlands; [Muller, Wally H.] Univ Utrecht, Dept Chem, NL-3584 CH Utrecht, Netherlands; [Steins, Anne; Vervoort, Stephin J.; Coffer, Paul J.; Schepers, Koen] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands; [Reimers, Kerstin; Kuhbier, Joern W.; Vogt, Peter M.] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Hannover, Germany; [van Apeldoorn, Aart A.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Dev Bioengn, NL-7500 AE Enschede, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University; Utrecht University Medical Center; Hannover Medical School; University of Twente	Schepers, K (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands.	k.schepers@lumc.nl	Vervoort, Stephin/AAP-7854-2020; Coffer, Paul/AAF-7970-2020; Vogt, Peter M./AAL-1332-2020; van Apeldoorn, Aart/AAP-5433-2021; Schepers, Koen/H-7108-2013	van Apeldoorn, Aart/0000-0002-2940-5699; Schepers, Koen/0000-0003-2442-242X; Vervoort, Stephin/0000-0001-7459-126X				Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Apodaca G, 2004, TRAFFIC, V5, P117, DOI 10.1046/j.1600-0854.2003.00156.x; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003; BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077; Birder LA, 2004, SCAND J UROL NEPHROL, V38, P48, DOI 10.1080/03008880410015165; Blackledge TA, 2009, J EXP BIOL, V212, P1980, DOI 10.1242/jeb.028944; Brown CP, 2015, J MATER RES, V30, P108, DOI 10.1557/jmr.2014.365; BUBENIK J, 1970, INT J CANCER, V5, P310, DOI 10.1002/ijc.2910050303; Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0; Campodonico F, 2004, EUR UROL, V46, P531, DOI 10.1016/j.eururo.2004.04.019; Cunniff P.M., 1994, POLYM ADVAN TECHNOL, V5, P401; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Feil G, 2006, EUR UROL, V50, P1330, DOI 10.1016/j.eururo.2006.05.041; Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131; Franck D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056237; Frimberger D, 2012, PEDIATR CLIN N AM, V59, P757, DOI 10.1016/j.pcl.2012.05.006; Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6; Gellynck K, 2008, J MATER SCI-MATER M, V19, P2963, DOI 10.1007/s10856-007-3330-0; Gilbert SM, 2005, J UROLOGY, V173, P1080, DOI 10.1097/01.ju.0000155248.57049.4e; Gomes S, 2012, J TISSUE ENG REGEN M, V6, P356, DOI 10.1002/term.437; Gosline JM, 1999, J EXP BIOL, V202, P3295; Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012; Ho PL, 2012, NAT REV UROL, V9, P583, DOI 10.1038/nrurol.2012.142; Kawakami S, 2002, J CELL PHYSIOL, V191, P310, DOI 10.1002/jcp.10099; Kearns V, 2008, TOP TISSUE ENG, V4; Kuhbier JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012032; Lazzeri M, 2006, UROL INT, V76, P289, DOI 10.1159/000092049; Liberio MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112122; MARSHALL CJ, 1977, J NATL CANCER I, V58, P1743, DOI 10.1093/jnci/58.6.1743; Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047; MULLER LL, 1975, J HISTOCHEM CYTOCHEM, V23, P107, DOI 10.1177/23.2.1117127; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Ortlepp CS, 2004, BIOMACROMOLECULES, V5, P727, DOI 10.1021/bm034269x; Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.0.CO;2-7; Partridge MA, 2006, MOL BIOL CELL, V17, P4237, DOI 10.1091/mbc.E06-06-0496; Perez-Rigueiro J, 2005, J EXP BIOL, V208, P2633, DOI 10.1242/jeb.01701; Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990; Ram-Liebig G, 2004, BJU INT, V94, P922, DOI 10.1111/j.1464-410X.2004.05061.x; Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273; Rohrmann D, 1996, J UROLOGY, V156, P2094, DOI 10.1016/S0022-5347(01)65442-9; Romih R, 2005, CELL TISSUE RES, V320, P259, DOI 10.1007/s00441-004-1005-4; Sakakibara R, 2003, NEUROUROL URODYNAM, V22, P328, DOI 10.1002/nau.2150; Schafer-Nolte F, 2014, ANN SURG, V259, P781, DOI 10.1097/SLA.0b013e3182917677; Seth A, 2013, BIOMATERIALS, V34, P4758, DOI 10.1016/j.biomaterials.2013.03.038; Slotta U, 2012, CHEM ENG PROG; Soergel TM, 2004, J UROLOGY, V172, P1649, DOI 10.1097/01.ju.0000140194.87974.56; Sponner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000998; Strand W, 2004, J UROLOGY, V172, P1651; Tian H, 2010, TISSUE ENG PT A, V16, P1769, DOI [10.1089/ten.tea.2009.0625, 10.1089/ten.TEA.2009.0625]; Vollrath F, 2002, IN VIVO, V16, P229; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Wang DS, 2007, BJU INT, V99, P628, DOI 10.1111/j.1464-410X.2006.06662.x; WEN CM, 1990, ANN ALLERGY, V65, P375; Wen ZM, 1996, J INVEST ALLERG CLIN, V6, P237; Wendt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021833; Zhang YY, 2000, J UROLOGY, V164, P928, DOI 10.1016/S0022-5347(05)67220-5; Zhu YT, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-57	60	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145240	10.1371/journal.pone.0145240	http://dx.doi.org/10.1371/journal.pone.0145240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689371	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092300048
J	He, JL; Fu, Y; Chen, DB				He, Jia-Lin; Fu, Yan; Chen, Duan-Bing			A Novel Top-k Strategy for Influence Maximization in Complex Networks with Community Structure	PLOS ONE			English	Article							SPREADERS; NODES; IDENTIFICATION; SYSTEMS	In complex networks, it is of great theoretical and practical significance to identify a set of critical spreaders which help to control the spreading process. Some classic methods are proposed to identify multiple spreaders. However, they sometimes have limitations for the networks with community structure because many chosen spreaders may be clustered in a community. In this paper, we suggest a novel method to identify multiple spreaders from communities in a balanced way. The network is first divided into a great many super nodes and then k spreaders are selected from these super nodes. Experimental results on real and synthetic networks with community structure show that our method outperforms the classic methods for degree centrality, k-core and ClusterRank in most cases.	[He, Jia-Lin; Fu, Yan; Chen, Duan-Bing] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 611731, Peoples R China; [He, Jia-Lin; Fu, Yan; Chen, Duan-Bing] Univ Elect Sci & Technol China, Big Data Res Ctr, Chengdu 611731, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Chen, DB (corresponding author), Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 611731, Peoples R China.	dbchen@uestc.edu.cn			National Natural Science Foundation of China [61433014]; National High Technology Research and Development Program [2015AA7115089]; Fundamental Research Funds for the Central Universities [ZYGX2014Z002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is partially supported by the National Natural Science Foundation of China (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearchlist#) under Grant No. 61433014, by the National High Technology Research and Development Program under Grant No. 2015AA7115089 and by the Fundamental Research Funds for the Central Universities (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#) under Grant No. ZYGX2014Z002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is partially supported by the National Natural Science Foundation of China under Grant No. 61433014, by the National High Technology Research and Development Program under Grant No. 2015AA7115089 and by the Fundamental Research Funds for the Central Universities under Grant No. ZYGX2014Z002.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Bae J, 2014, PHYSICA A, V395, P549, DOI 10.1016/j.physa.2013.10.047; Bavelas A., 1950, J ACOUST SOC AM, V22, P725, DOI [10.1121/1.1906679, DOI 10.1121/1.1906679]; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chen DB, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/68006; Chen DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077455; Chen DB, 2012, PHYSICA A, V391, P1777, DOI 10.1016/j.physa.2011.09.017; Chen W, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P199, DOI 10.1145/1557019.1557047; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Cormen T.H., 2009, COMPUTATIONAL GEOMET, V3rd, P1022; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goldenberg J, 2001, MARKET LETT, V12, P211, DOI 10.1023/A:1011122126881; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kempe D., 2003, P 9 ACM SIGKDD INT C, V11, P105, DOI DOI 10.1145/956750.956769; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Narayanam R, 2011, IEEE T AUTOM SCI ENG, V8, P130, DOI 10.1109/TASE.2010.2052042; Pu J, 2014, EPL-EUROPHYS LETT, V107, DOI 10.1209/0295-5075/107/10010; Ren GM, 2014, CHAOS, V24, DOI 10.1063/1.4876436; Ren ZM, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/48005; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Starnini M, 2013, J THEOR BIOL, V337, P89, DOI 10.1016/j.jtbi.2013.07.004; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Weng J., 2010, P 3 ACM INT C WEB SE, P261, DOI [10.1145/1718487.1718520, DOI 10.1145/1718487.1718520]; Yang J, 2015, KNOWL INF SYST, V42, P181, DOI 10.1007/s10115-013-0693-z; Yang R, 2007, PHYS LETT A, V364, P189, DOI 10.1016/j.physleta.2006.12.021; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhang XH, 2013, KNOWL-BASED SYST, V42, P74, DOI 10.1016/j.knosys.2013.01.017; Zhao XY, 2014, EPL-EUROPHYS LETT, V108, DOI 10.1209/0295-5075/108/68005	40	30	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145283	10.1371/journal.pone.0145283	http://dx.doi.org/10.1371/journal.pone.0145283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682706	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800057
J	Giovannoni, I; Callea, F; Bellacchio, E; Torre, G; De Goyet, JD; Francalanci, P				Giovannoni, Isabella; Callea, Francesco; Bellacchio, Emanuele; Torre, Giuliano; De Goyet, Jean De Ville; Francalanci, Paola			Genetics and Molecular Modeling of New Mutations of Familial Intrahepatic Cholestasis in a Single Italian Center	PLOS ONE			English	Article							SALT EXPORT PUMP; MDCK-II CELLS; ABCB11 MUTATIONS; HEREDITARY CHOLESTASIS; PHENOTYPIC DIFFERENCES; DEFICIENCY; EXPRESSION; CHILDREN; PFIC2; SECRETION	Familial intrahepatic cholestases (FICs) are a heterogeneous group of autosomal recessive disorders of childhood that disrupt bile formation and present with cholestasis of hepatocellular origin. Three distinct forms are described: FIC1 and FIC2, associated with low/normal GGT level in serum, which are caused by impaired bile salt secretion due to defects in ATP8B1 encoding the FIC1 protein and defects in ABCB11 encoding bile salt export pump protein, respectively; FIC3, linked to high GGT level, involves impaired biliary phospholipid secretion due to defects in ABCB4, encoding multidrug resistance 3 protein. Different mutations in these genes may cause either a progressive familial intrahepatic cholestasis (PFIC) or a benign recurrent intrahepatic cholestasis (BRIC). For the purposes of the present study we genotyped 27 children with intrahepatic cholestasis, diagnosed on either a clinical or histological basis. Two BRIC, 23 PFIC and 2 BRIC/PFIC were identified. Thirty-four different mutations were found of which 11 were novel. One was a 2Mb deletion (5'UTR-exon 18) in ATP8B1. In another case microsatellite analysis of chromosome 2, including ABCB11, showed uniparental disomy. Two cases were compound heterozygous for BRIC/PFIC2 mutations. Our results highlight the importance of the pathogenic role of novel mutations in the three genes and unusual modes of their transmission.	[Giovannoni, Isabella; Callea, Francesco; Francalanci, Paola] Bambino Gesu Pediat Hosp, IRCCS, Dept Pathol & Mol Histopathol, Rome, Italy; [Bellacchio, Emanuele] Bambino Gesu Pediat Hosp, IRCCS, Res Labs, Rome, Italy; [Torre, Giuliano] Bambino Gesu Pediat Hosp, IRCCS, Dept Hepatol, Gastroenterol & Nutr Unit, Rome, Italy; [De Goyet, Jean De Ville] Bambino Gesu Pediat Hosp, IRCCS, Dept Pediat Surg & Transplantat, Rome, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Francalanci, P (corresponding author), Bambino Gesu Pediat Hosp, IRCCS, Dept Pathol & Mol Histopathol, Rome, Italy.	paola.francalanci@opbg.net	Francalanci, Paola/AAA-4908-2020; Giovannoni, Isabella/AAH-9206-2019; Goyet, Jean de Ville de/A-1708-2014; Goyet, Jean de Ville de/I-6913-2019; Bellacchio, Emanuele/AAH-9255-2019	Giovannoni, Isabella/0000-0002-9980-6594; Goyet, Jean de Ville de/0000-0001-7681-6178; Goyet, Jean de Ville de/0000-0001-7681-6178; Bellacchio, Emanuele/0000-0002-2757-849X				Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Byrne JA, 2009, HEPATOLOGY, V49, P553, DOI 10.1002/hep.22683; Chen HL, 2002, J PEDIATR-US, V140, P119, DOI 10.1067/mpd.2002.119993; Crawford AR, 1997, J CLIN INVEST, V100, P2562, DOI 10.1172/JCI119799; Davit-Spraul A, 2010, HEPATOLOGY, V51, P1645, DOI 10.1002/hep.23539; Francalanci P, 2013, HEPATOL RES, V43, P315, DOI 10.1111/j.1872-034X.2012.01061.x; Giovannoni I, 2012, HEPATOL RES, V42, P327, DOI 10.1111/j.1872-034X.2011.00925.x; Giovannoni I, 2011, DIGEST LIVER DIS, V43, P567, DOI 10.1016/j.dld.2011.03.004; Gonzales E, 2009, FRONT BIOSCI-LANDMRK, V14, P4242, DOI 10.2741/3526; Jacquemin E, 2012, CLIN RES HEPATOL GAS, V36, pS26, DOI 10.1016/S2210-7401(12)70018-9; Kagawa T, 2008, AM J PHYSIOL-GASTR L, V294, pG58, DOI 10.1152/ajpgi.00367.2007; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Lam CW, 2006, J HEPATOL, V44, P240, DOI 10.1016/j.jhep.2005.09.013; Lam P, 2007, AM J PHYSIOL-CELL PH, V293, pC1709, DOI 10.1152/ajpcell.00327.2007; Lam P, 2010, SEMIN LIVER DIS, V30, P125, DOI 10.1055/s-0030-1253222; Liu C, 2007, GASTROENTEROLOGY, V132, P119, DOI 10.1053/j.gastro.2006.10.034; Lykavieris P, 2003, J HEPATOL, V39, P447, DOI 10.1016/S0168-8278(03)00286-1; Mochizuki K, 2007, AM J PHYSIOL-GASTR L, V292, pG818, DOI 10.1152/ajpgi.00415.2006; Nobili V, 2006, J GASTROENTEROL, V41, P598, DOI 10.1007/s00535-006-1816-z; Noe J, 2005, J HEPATOL, V43, P536, DOI 10.1016/j.jhep.2005.05.020; Strautnieks SS, 2008, GASTROENTEROLOGY, V134, P1203, DOI 10.1053/j.gastro.2008.01.038; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; van der Woerd WL, 2010, BEST PRACT RES CL GA, V24, P541, DOI 10.1016/j.bpg.2010.07.010; Van Mil SWC, 2004, GASTROENTEROLOGY, V127, P379, DOI 10.1053/j.gastro.2004.04.065; van Mil SWC, 2001, SEMIN LIVER DIS, V21, P535, DOI 10.1055/s-2001-19034; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024	27	12	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145021	10.1371/journal.pone.0145021	http://dx.doi.org/10.1371/journal.pone.0145021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678486	gold, Green Published, Green Submitted			2022-12-27	WOS:000366723400041
J	Jenkins, CN; Alves, MAS; Uezu, A; Vale, MM				Jenkins, Clinton N.; Alves, Maria Alice S.; Uezu, Alexandre; Vale, Mariana M.			Patterns of Vertebrate Diversity and Protection in Brazil	PLOS ONE			English	Article							SPATIAL CONSERVATION PRIORITIES; ATLANTIC FOREST; AREAS; FUTURE	Most conservation decisions take place at national or finer spatial scales. Providing useful information at such decision-making scales is essential for guiding the practice of conservation. Brazil is one of the world's megadiverse countries, and consequently decisions about conservation in the country have a disproportionate impact on the survival of global biodiversity. For three groups of terrestrial vertebrates (birds, mammals, and amphibians), we examined geographic patterns of diversity and protection in Brazil, including that of endemic, small-ranged, and threatened species. To understand potential limitations of the data, we also explored how spatial bias in collection localities may influence the perceived patterns of diversity. The highest overall species richness is in the Amazon and Atlantic Forests, while the Atlantic Forest dominates in terms of country endemics and small-ranged species. Globally threatened species do not present a consistent pattern. Patterns for birds were similar to overall species richness, with higher concentrations of threatened species in the Atlantic Forest, while mammals show a more generalized pattern across the country and a high concentration in the Amazon. Few amphibians are listed as threatened, mostly in the Atlantic Forest. Data deficient mammals occur across the country, concentrating in the Amazon and southeast Atlantic Forest, and there are no data deficient birds in Brazil. In contrast, nearly a third of amphibians are data deficient, widespread across the country, but with a high concentration in the far southeast. Spatial biases in species locality data, however, possibly influence the perceived patterns of biodiversity. Regions with low sampling density need more biological studies, as do the many data deficient species. All biomes except the Amazon have less than 3% of their area under full protection. Reassuringly though, rates of protection do correlate with higher biodiversity, including higher levels of threatened and small-ranged species. Our results indicate a need for expanded formal protection in Brazil, especially in the Atlantic forest, and with an emphasis on fully protected areas.	[Jenkins, Clinton N.; Uezu, Alexandre] Inst Pesquisas Ecol, Sao Paulo, Brazil; [Alves, Maria Alice S.] Univ Estado Rio de Janeiro, Dept Ecol, BR-20550011 Rio De Janeiro, Brazil; [Vale, Mariana M.] Univ Fed Rio de Janeiro, Dept Ecol, Rio De Janeiro, Brazil	Instituto de Pesquisas Ecologicas; Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Jenkins, CN (corresponding author), Inst Pesquisas Ecol, Sao Paulo, Brazil.	Clinton.Jenkins@gmail.com	Jenkins, Clinton/D-6134-2011; Uezu, Alexandre/G-5435-2014; Alves, Maria Alice S./B-3548-2013; Vale, Mariana M./I-9408-2012	Jenkins, Clinton/0000-0003-2198-0637; Alves, Maria Alice S./0000-0002-0622-270X; Vale, Mariana M./0000-0003-0734-4925	Ciencia Sem Fronteiras program [A025_2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [08792/2009-2]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/102.837868/2012]; CNPq [444704/2014-0]; MCTI/CNPq/FAPs PELD [34/2012]; CNPq PPBio/Rede BioM.A. [477524/2012-2]; FAPERJ [E-26/111.577/2014]; RedeCLIMA Program [01.0405.01]	Ciencia Sem Fronteiras program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCTI/CNPq/FAPs PELD; CNPq PPBio/Rede BioM.A.(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); RedeCLIMA Program	CNJ received support from the Ciencia Sem Fronteiras program (A025_2013), MASA received support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, process 08792/2009-2), and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, process E-26/102.837868/2012). MMV received support from CNPq (grant no. 444704/2014-0), MCTI/CNPq/FAPs PELD (Grant No. 34/2012), CNPq PPBio/Rede BioM.A. (Grant No. 477524/2012-2), FAPERJ (grant no. E-26/111.577/2014) and RedeCLIMA Program (grant no. 01.0405.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABSABER Aziz, 2003, DOMINIOS NATUREZA BR; ANDRADE-LIMA D., 1982, BIOL DIVERSIFICATION, P245; Becker CG, 2010, DIVERS DISTRIB, V16, P10, DOI 10.1111/j.1472-4642.2009.00625.x; BirdLife International, 2014, NATURESERVE BIRD SPE; Bland LM, 2015, CONSERV BIOL, V29, P250, DOI 10.1111/cobi.12372; Canhos DAL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002204; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Convention on Biological Diversity, 2011, C PART DEC X 2 STRAT; Crouzeilles R, 2013, ENVIRON CONSERV, V40, P209, DOI 10.1017/S0376892912000367; Da Silva JMC, 2002, BIOSCIENCE, V52, P225, DOI 10.1641/0006-3568(2002)052[0225:BPACIT]2.0.CO;2; De Marques AAB, 2015, ORYX, V49, P25, DOI 10.1017/S0030605314000726; de Oliveira G, 2009, ACTA OECOL, V35, P630, DOI 10.1016/j.actao.2009.05.011; Diniz Filho J.A.F., 2009, OECOLOGIA BRAS, V13, P470, DOI DOI 10.4257/0EC0.2009.1303.05; Diniz JAF, 2004, AMPHIBIA-REPTILIA, V25, P63, DOI 10.1163/156853804322992841; Diniz JAF, 2008, ORYX, V42, P567, DOI 10.1017/S0030605308001129; ICMBio, 2014, ESP AM LIST 2014; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jenkins CN, 2008, CONSERV BIOL, V22, P1037, DOI 10.1111/j.1523-1739.2008.00974.x; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jenkins CN, 2010, BIOL CONSERV, V143, P992, DOI 10.1016/j.biocon.2010.01.014; Joppa LN, 2013, SCIENCE, V341, P1100, DOI 10.1126/science.1241706; Loyola RD, 2013, BIODIVERS CONSERV, V22, P483, DOI 10.1007/s10531-012-0424-x; Maldonado C, 2015, GLOBAL ECOL BIOGEOGR, V24, P973, DOI 10.1111/geb.12326; Marini MA, 2005, CONSERV BIOL, V19, P665, DOI 10.1111/j.1523-1739.2005.00706.x; Mello De PLH, 2015, CONSERVING BIOGEOGRA, P1, DOI [10.1371/journal.pone.0133995, DOI 10.1371/JOURNAL.PONE.0133995]; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ocampo-Penuela N, 2014, CONSERV BIOL, V28, P1260, DOI 10.1111/cobi.12312; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pinto MP, 2008, DIVERS DISTRIB, V14, P78, DOI 10.1111/j.1472-4642.2007.00421.x; Pinto MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105205; Pinto MP, 2012, ENVIRON CONSERV, V39, P30, DOI 10.1017/S0376892911000440; Pinto MP, 2009, BIODIVERS CONSERV, V18, P957, DOI 10.1007/s10531-008-9513-2; Por FD, 1992, ATLANTIC FOREST BRAZ; Pouzols FM, 2014, NATURE, V516, P383, DOI 10.1038/nature14032; Prado D.E., 2003, ECOLOGIA CONSERVACA; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rizzini C.T., 1976, TRATADO FITOGEOGRAFI; Silva da JMC, 2004, BIODIVERSIDADE CAATI; Sobral FL, 2014, NAT CONSERVACAO, V12, P150, DOI 10.1016/j.ncon.2014.09.008; Trindade J, 2012, BIODIVERS CONSERV, V21, P2709, DOI 10.1007/s10531-012-0326-y; Uezu A, 2011, BIODIVERS CONSERV, V20, P3627, DOI 10.1007/s10531-011-0154-5; Vale MM, 2008, CONSERV BIOL, V22, P1006, DOI 10.1111/j.1523-1739.2008.00939.x; Vale Mariana M., 2015, Oecologia Australis, V19, P63; Vale MM, 2012, J BIOGEOGR, V39, P1744, DOI 10.1111/j.1365-2699.2012.02750.x	47	39	40	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145064	10.1371/journal.pone.0145064	http://dx.doi.org/10.1371/journal.pone.0145064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679348	Green Submitted, Green Published, gold			2022-12-27	WOS:000366723400047
J	Kaptijn, R; Thomese, F; Liefbroer, AC; Van Poppel, F; Van Bodegom, D; Westendorp, RGJ				Kaptijn, Ralf; Thomese, Fleur; Liefbroer, Aart C.; Van Poppel, Frans; Van Bodegom, David; Westendorp, Rudi G. J.			The Trade-Off between Female Fertility and Longevity during the Epidemiological Transition in the Netherlands	PLOS ONE			English	Article							HUMAN LIFE-HISTORIES; MORTALITY; REPRODUCTION; POPULATION; SELECTION; CHILDBEARING; MOTHERS; ENGLAND; EUROPE; NUMBER	Several hypotheses have been put forward to explain the relationship between women's fertility and their post-reproductive longevity. In this study, we focus on the disposable soma theory, which posits that a negative relationship between women's fertility and longevity can be understood as an evolutionary trade-off between reproduction and survival. We examine the relationship between fertility and longevity during the epidemiological transition in the Netherlands. This period of rapid decline in mortality from infectious diseases offers a good opportunity to study the relationship between fertility and longevity, using registry data from 6,359 women born in The Netherlands between 1850 and 1910. We hypothesize that an initially negative relationship between women's fertility and their longevity gradually turns less negative during the epidemiological transition, because of decreasing costs of higher parities. An initially inversed U-shaped association between fertility and longevity changes to zero during the epidemiological transition. This does suggest a diminishing environmental pressure on fertility. However, we find no evidence of an initial linear trade-off between fertility and post-reproductive survival.	[Kaptijn, Ralf; Thomese, Fleur; Liefbroer, Aart C.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Liefbroer, Aart C.; Van Poppel, Frans] Netherlands Interdisciplinary Demog Inst, The Hague, Netherlands; [Liefbroer, Aart C.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Van Bodegom, David; Westendorp, Rudi G. J.] Leyden Acad Vital & Aging, Leiden, Netherlands; [Westendorp, Rudi G. J.] Univ Copenhagen, Copenhagen, Denmark	Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Interdisciplinary Demographic Institute (NIDI-KNAW); University of Groningen; University of Copenhagen	Thomese, F (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.	fleur.thomese@vu.nl		Liefbroer, Aart/0000-0002-7884-3150; van Bodegom, David/0000-0002-5691-8342	Dutch Scientific Foundation NWO [051-14-050]	Dutch Scientific Foundation NWO(Netherlands Organization for Scientific Research (NWO))	This paper is part of the project Aging Societies, funded of the Dutch Scientific Foundation NWO (grant number 051-14-050).	Alter G, 2007, DEMOGRAPHY, V44, P785, DOI 10.1353/dem.2007.0037; Ansart S, 2009, INFLUENZA OTHER RESP, V3, P99, DOI 10.1111/j.1750-2659.2009.00080.x; COX DR, 1972, J R STAT SOC B, V34, P187; Dior UR, 2013, ANN EPIDEMIOL, V23, P13, DOI 10.1016/j.annepidem.2012.10.005; Doblhammer G, 2003, P ROY SOC B-BIOL SCI, V270, P1541, DOI 10.1098/rspb.2003.2400; Dribe M, 2004, POP STUD-J DEMOG, V58, P297, DOI 10.1080/0032472042000272357; Gagnon A, 2015, FERTIL STERIL, V103, P1109, DOI 10.1016/j.fertnstert.2015.03.030; Gagnon A, 2009, AM J HUM BIOL, V21, P533, DOI 10.1002/ajhb.20893; Gogele M, 2011, J GERONTOL A-BIOL, V66, P26, DOI 10.1093/gerona/glq163; Grundy E, 2005, SOC SCI MED, V61, P217, DOI 10.1016/j.socscimed.2004.11.046; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hurt LS, 2006, POP STUD-J DEMOG, V60, P55, DOI 10.1080/00324720500436011; Jasienska G, 2006, AM J HUM BIOL, V18, P422, DOI 10.1002/ajhb.20497; Jasienska G, 2009, AM J HUM BIOL, V21, P524, DOI 10.1002/ajhb.20931; Joyner K, 2012, DEMOGRAPHY, V49, P101, DOI 10.1007/s13524-011-0073-9; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Korpelainen H, 2003, AM J PHYS ANTHROPOL, V120, P384, DOI 10.1002/ajpa.10191; Kuningas M, 2011, AGE, V33, P615, DOI 10.1007/s11357-010-9202-4; Le Bourg E, 2007, AGEING RES REV, V6, P141, DOI 10.1016/j.arr.2007.04.002; Lycett JE, 2000, P ROY SOC B-BIOL SCI, V267, P31, DOI 10.1098/rspb.2000.0962; Meij JJ, 2009, J EVOLUTION BIOL, V22, P1014, DOI 10.1111/j.1420-9101.2009.01713.x; Mostafa G, 2000, SOC SCI MED, V50, P763, DOI 10.1016/S0277-9536(99)00295-6; Omran AR, 2005, MILBANK Q, V83, P731, DOI 10.1111/j.1468-0009.2005.00398.x; Ronsmans C, 2001, INT J EPIDEMIOL, V30, P467, DOI 10.1093/ije/30.3.467; Smith KR, 2009, J GERONTOL A-BIOL, V64, P740, DOI 10.1093/gerona/glp055; Spence NJ, 2009, SOC SCI MED, V68, P1625, DOI 10.1016/j.socscimed.2009.02.018; Van Bodegom D, 2007, ANN NY ACAD SCI, V1100, P84, DOI 10.1196/annals.1395.007; Van De Putte BV, 2005, HIST METHOD, V38, P61, DOI 10.3200/HMTS.38.2.61-94; Wang Xiaofei, 2013, Evolution Medicine and Public Health, P241, DOI 10.1093/emph/eot013; Westendorp RGJ, 2004, EMBO REP, V5, P2, DOI 10.1038/sj.embor.7400059; Westendorp RGJ, 2001, NAT MED, V7, P873, DOI 10.1038/90868; WolleswinkelVandenBosch JH, 1997, INT J EPIDEMIOL, V26, P772, DOI 10.1093/ije/26.4.772; ZANDEN J. L, 2013, 4 MADD PROJ	33	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144353	10.1371/journal.pone.0144353	http://dx.doi.org/10.1371/journal.pone.0144353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JO	26680211	gold, Green Published, Green Submitted			2022-12-27	WOS:000366723400011
J	Sarkisyan, KS; Zlobovskaya, OA; Gorbachev, DA; Bozhanova, NG; Sharonov, GV; Staroverov, DB; Egorov, ES; Ryabova, AV; Solntsev, KM; Mishin, AS; Lukyanov, KA				Sarkisyan, Karen S.; Zlobovskaya, Olga A.; Gorbachev, Dmitry A.; Bozhanova, Nina G.; Sharonov, George V.; Staroverov, Dmitriy B.; Egorov, Evgeny S.; Ryabova, Anastasia V.; Solntsev, Kyril M.; Mishin, Alexander S.; Lukyanov, Konstantin A.			KillerOrange, a Genetically Encoded Photosensitizer Activated by Blue and Green Light	PLOS ONE			English	Article							FLUORESCENT PROTEIN; CHROMOPHORE; CELLS; REGULATOR; ABLATION; OXYGEN	Genetically encoded photosensitizers, proteins that produce reactive oxygen species when illuminated with visible light, are increasingly used as optogenetic tools. Their applications range from ablation of specific cell populations to precise optical inactivation of cellular proteins. Here, we report an orange mutant of red fluorescent protein KillerRed that becomes toxic when illuminated with blue or green light. This new protein, KillerOrange, carries a tryptophan-based chromophore that is novel for photosensitizers. We show that KillerOrange can be used simultaneously and independently from KillerRed in both bacterial and mammalian cells offering chromatic orthogonality for light-activated toxicity.	[Sarkisyan, Karen S.; Zlobovskaya, Olga A.; Gorbachev, Dmitry A.; Bozhanova, Nina G.; Sharonov, George V.; Staroverov, Dmitriy B.; Egorov, Evgeny S.; Mishin, Alexander S.; Lukyanov, Konstantin A.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Gorbachev, Dmitry A.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Sharonov, George V.] Moscow MV Lomonosov State Univ, Fac Med, Moscow, Russia; [Egorov, Evgeny S.] Pirogov Russian Natl Res Med Univ, Moscow, Russia; [Ryabova, Anastasia V.] Prokhorov Gen Phys Inst, Laser Biospect Lab, Moscow, Russia; [Solntsev, Kyril M.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Mishin, Alexander S.; Lukyanov, Konstantin A.] Nizhny Novgorod State Med Acad, Nizhnii Novgorod, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University; Lomonosov Moscow State University; Pirogov Russian National Research Medical University; Russian Academy of Sciences; Prokhorov General Physics Institute of the Russian Academy of Sciences; University System of Georgia; Georgia Institute of Technology; Privolzhsky Research Medical University	Sarkisyan, KS (corresponding author), Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	karen.s.sarkisyan@gmail.com	Sarkisyan, Karen/AAA-5784-2021; Staroverov, Dmitry/AAN-7359-2020; Lukyanov, Konstantin A/D-4030-2013; Ryabova, Anastasia V/I-7911-2014; Zlobovskaya, Olga/AAM-4307-2021; Sharonov, George V/B-1323-2014; Sarkisyan, Karen S/M-6821-2015; Mishin, Alexander/L-9420-2014	Sarkisyan, Karen/0000-0002-5375-6341; Staroverov, Dmitry/0000-0001-6789-9442; Lukyanov, Konstantin A/0000-0001-9845-2088; Ryabova, Anastasia V/0000-0003-3488-1128; Sharonov, George V/0000-0001-8610-5054; Sarkisyan, Karen S/0000-0002-5375-6341; Mishin, Alexander/0000-0002-4935-7030; Bozhanova, Nina/0000-0002-2164-5698; Gorbachev, Dmitry/0000-0001-6124-2511; Solntsev, Kyril/0000-0002-6855-462X; Zlobovskaya, Olga/0000-0002-9068-6768	Russian Science Foundation [14-25-00129]; OPTEC grant for young scientists [21/2014/51-Msk]; Science and Innovation Youth Contest Participant grant (UMNIK) [3616Gammay2/2014]; National Science Foundation [CHE-1213047]; Direct For Mathematical & Physical Scien [1213047] Funding Source: National Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); OPTEC grant for young scientists; Science and Innovation Youth Contest Participant grant (UMNIK); National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The work was supported by Russian Science Foundation (14-25-00129). KSS was supported by OPTEC grant for young scientists (21/2014/51-Msk) and Science and Innovation Youth Contest Participant grant (UMNIK, 3616 Gamma y2/2014). Experiments were partially carried out using the equipment provided by the IBCH core facility (CKP IBCH). KMS acknowledges generous support from the National Science Foundation (CHE-1213047).; We would like to thank J.T. Ripper (Department of Surgery, Whitechapel District Institute, London, UK) for fruitful discussions and technical assistance. The work was supported by Russian Science Foundation (14-25-00129). KSS was supported by OPTEC grant for young scientists (21/2014/51-Msk) and Science and Innovation Youth Contest Participant grant (UMNIK, 3616 Gamma y2/2014). Experiments were partially carried out using the equipment provided by the IBCH core facility (CKP IBCH). KMS acknowledges generous support from the National Science Foundation (CHE-1213047).	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Byrne LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076075; Carpentier P, 2009, FEBS LETT, V583, P2839, DOI 10.1016/j.febslet.2009.07.041; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Del Bene F, 2010, SCIENCE, V330, P669, DOI 10.1126/science.1192949; Destaing O, 2010, MOL BIOL CELL, V21, P4108, DOI 10.1091/mbc.E10-07-0580; Hansen MJ, 2015, CHEM SOC REV, V44, P3358, DOI 10.1039/c5cs00118h; Ivashchenko O, 2011, MOL BIOL CELL, V22, P1440, DOI 10.1091/mbc.E10-11-0919; Jarvela T, 2014, MOL BIOL CELL, V25, P133, DOI 10.1091/mbc.E13-07-0395; Jewhurst Kyle, 2014, J Cell Death, V7, P25, DOI 10.4137/JCD.S18368; Kobayashi J, 2013, NEUROSCI LETT, V548, P261, DOI 10.1016/j.neulet.2013.05.053; Kuznetsova DS, 2015, J BIOPHOTONICS, V8, P952, DOI 10.1002/jbio.201400130; Lan L, 2014, NUCLEIC ACIDS RES, V42, P2330, DOI 10.1093/nar/gkt1233; Lelimousin M, 2009, BIOCHEMISTRY-US, V48, P10038, DOI 10.1021/bi901093w; Levin E., 2015, ANGEW CHEM, V127, P12561, DOI [10.1002/ange.201500740, DOI 10.1002/ANGE.201500740]; Liao ZX, 2014, BIOMATERIALS, V35, P500, DOI 10.1016/j.biomaterials.2013.09.075; Lin JY, 2013, NEURON, V79, P241, DOI 10.1016/j.neuron.2013.05.022; Lukyanov KA, 2010, PHOTOCH PHOTOBIO SCI, V9, P1301, DOI 10.1039/c0pp00114g; Matsumoto A, 2011, BIOTECHNIQUES, V51, P55, DOI 10.2144/000113705; Matsunaga S, 2012, CELL REP, V1, P299, DOI 10.1016/j.celrep.2012.02.005; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Mishin AS, 2015, CURR OPIN CHEM BIOL, V27, P1, DOI 10.1016/j.cbpa.2015.05.002; Pletnev S, 2009, J BIOL CHEM, V284, P32028, DOI 10.1074/jbc.M109.054973; Qi YCB, 2012, P NATL ACAD SCI USA, V109, P7499, DOI 10.1073/pnas.1204096109; Ryumina AP, 2013, BBA-GEN SUBJECTS, V1830, P5059, DOI 10.1016/j.bbagen.2013.07.015; Sarkisyan KS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00608; Serebrovskaya EO, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.071403; Serebrovskaya EO, 2011, BIOCHEM J, V435, P65, DOI 10.1042/BJ20101217; Shibuya T, 2012, J PHOTOCH PHOTOBIO B, V117, P1, DOI 10.1016/j.jphotobiol.2012.08.005; Shirmanova MV, 2013, J BIOPHOTONICS, V6, P283, DOI 10.1002/jbio.201200056; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Takemoto K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02629; Torra J, 2015, PHOTOCH PHOTOBIO SCI, V14, P280, DOI 10.1039/c4pp00338a; Vartanian JP, 1996, NUCLEIC ACIDS RES, V24, P2627, DOI 10.1093/nar/24.14.2627; Vegh RB, 2014, J PHYS CHEM B, V118, P4527, DOI 10.1021/jp500919a; Vegh RB, 2011, CHEM COMMUN, V47, P4887, DOI 10.1039/c0cc05713d; Williams DC, 2013, CELL REP, V5, P553, DOI 10.1016/j.celrep.2013.09.023; Yan LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131518	39	46	49	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145287	10.1371/journal.pone.0145287	http://dx.doi.org/10.1371/journal.pone.0145287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679300	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400066
J	Zhao, P; Wang, QH; Tian, CM; Kakishima, M				Zhao, Peng; Wang, Qing-Hong; Tian, Cheng-Ming; Kakishima, Makoto			Integrating a Numerical Taxonomic Method and Molecular Phylogeny for Species Delimitation of Melampsora Species (Melampsoraceae, Pucciniales) on Willows in China	PLOS ONE			English	Article							RUST FUNGUS; SALIX; GENERA; LEVEL; NEED	The species in genus Melampsora are the causal agents of leaf rust diseases on willows in natural habitats and plantations. However, the classification and recognition of species diversity are challenging because morphological characteristics are scant and morphological variation in Melampsora on willows has not been thoroughly evaluated. Thus, the taxonomy of Melampsora species on willows remains confused, especially in China where 31 species were reported based on either European or Japanese taxonomic systems. To clarify the species boundaries of Melampsora species on willows in China, we tested two approaches for species delimitation inferred from morphological and molecular variations. Morphological species boundaries were determined based on numerical taxonomic analyses of morphological characteristics in the uredinial and telial stages by cluster analysis and one-way analysis of variance. Phylogenetic species boundaries were delineated based on the generalized mixed Yule-coalescent (GMYC) model analysis of the sequences of the internal transcribed spacer (ITS1 and ITS2) regions including the 5.8S and D1/D2 regions of the large nuclear subunit of the ribosomal RNA gene. Numerical taxonomic analyses of 14 morphological characteristics recognized in the uredinial-telial stages revealed 22 morphological species, whereas the GMYC results recovered 29 phylogenetic species. In total, 17 morphological species were in concordance with the phylogenetic species and 5 morphological species were in concordance with 12 phylogenetic species. Both the morphological and molecular data supported 14 morphological characteristics, including 5 newly recognized characteristics and 9 traditionally emphasized characteristics, as effective for the differentiation of Melampsora species on willows in China. Based on the concordance and discordance of the two species delimitation approaches, we concluded that integrative taxonomy by using both morphological and molecular variations was an effective approach for delimitating Melampsora species on willows in China.	[Zhao, Peng] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan; [Wang, Qing-Hong] China Univ Petr, Beijing Key Lab Oil & Gas Pollut Control, State Key Lab Heavy Oil Proc, Beijing 102249, Peoples R China; [Tian, Cheng-Ming] Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing 100083, Peoples R China; [Kakishima, Makoto] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki 3058572, Japan; [Kakishima, Makoto] Jilin Agr Univ, Chinese Minist Educ Edible & Med Fungi, Engn Res Ctr, Changchun 130118, Jilin Province, Peoples R China	University of Tsukuba; China University of Petroleum; Beijing Forestry University; University of Tsukuba; Jilin Agricultural University	Wang, QH (corresponding author), China Univ Petr, Beijing Key Lab Oil & Gas Pollut Control, State Key Lab Heavy Oil Proc, Beijing 102249, Peoples R China.	wangqhqh@163.com	, peng/AAE-4583-2020		National Natural Science Foundation of China [21306229]; Research Fund for the Doctoral Program of Higher Education of China [20130007120007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China (21306229) and Research Fund for the Doctoral Program of Higher Education of China (20130007120007). Qinghong Wang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime M. Catherine, 2006, Mycoscience, V47, P112, DOI 10.1007/s10267-006-0281-0; [Anonymous], 2014, TRACER V1 6; Arthur J.C., 1920, B TORREY BOT CLUB, V47, P480, DOI 10.2307/2480199; Bagyanarayana G, 2005, RUST DISEASES OF WILLOW AND POPLAR, P29, DOI 10.1079/9780851999999.0029; Bennett C, 2011, MYCOLOGIA, V103, P1004, DOI 10.3852/10-289; Cao ZM, 1999, RUST FUNGI OF QINLIN; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Chatasiri S, 2008, MYCOSCIENCE, V49, P66, DOI 10.1007/s10267-007-0390-4; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cummins GB, 2003, ILLUSTRATED GENERA O; DABINETT PE, 1978, CAN J BOT, V56, P2031, DOI 10.1139/b78-244; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ezard T, 2009, SPECIES LIMITS BY TH; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gonzalez-Garcia S, 2012, SCI TOTAL ENVIRON, V421, P210, DOI 10.1016/j.scitotenv.2012.01.041; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hiratsuka N, 1982, TAXONOMIC REVISION M, V20, P1; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hylander N., 1953, OPERA BOT, V1, P1; Ito S, 1938, MYCOLOGICAL FLORA OF; KAMPFER P, 1991, J GEN MICROBIOL, V137, P1831, DOI 10.1099/00221287-137-8-1831; KIRK PM, 2001, DICT FUNGI; Klebahn H, 1897, Z PFLANZEN KRANKHIET, V7, P129; Klebahn H, 1902, Z PFLANZENKRANKHREIT, V12, P17; Klebahn H, 1914, UREDINEAE, P69; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Kuprevich VF., 1957, CRYPTOGAMIC PLANTS U, P1; Kuzovkina YA, 2005, WATER AIR SOIL POLL, V162, P183, DOI 10.1007/s11270-005-6272-5; Lee Seung Kyu, 1999, Mycoscience, V40, P121, DOI 10.1007/BF02464290; Liang YM., 2006, THESIS U TSUKUBA JAP; Liro J.I., 1908, UREDINEAE FENNICAE F; Liu W., 2005, THESIS; Matsumoto T, 1915, T SAPPORO NATURAL HI, V6, P22; Miyake I., 1913, BOT MAG TOKYO, V27, P37; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padial JM, 2009, ZOOL SCR, V38, P431, DOI 10.1111/j.1463-6409.2008.00381.x; Pei MH, 2005, MYCOL RES, V109, P401, DOI 10.1017/S0953756205002479; Pei MH, 2005, RUST DISEASES OF WILLOW AND POPLAR, P1, DOI 10.1079/9780851999999.0000; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; ROYLE DJ, 1992, BIOMASS BIOENERG, V2, P45, DOI 10.1016/0961-9534(92)90087-7; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schneider O, 1905, WEITERE VERSUCHE SCH, V15, P232; Smith JA, 2004, MYCOLOGIA, V96, P1330, DOI 10.2307/3762149; Spiers AG, 1996, MYCOL RES, V100, P1163, DOI 10.1016/S0953-7562(96)80176-6; Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086; Sydow P, 1915, MONOGRAPHIA UREDINEA; Tai FL, 1979, SYLLOGE FUNGORUM SIN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian Cheng-Ming, 2004, Mycoscience, V45, P56, DOI 10.1007/s10267-003-0150-z; Verwijst T, 1996, SCAND J FOREST RES, V11, P104, DOI 10.1080/02827589609382917; Virtudazo EV, 2001, J GEN PLANT PATHOL, V67, P28, DOI DOI 10.1007/PL00012983; Wahyuno Dono, 2001, Mycoscience, V42, P519, DOI 10.1007/BF02460950; Wang Y.-Z., 1980, Acta Microbiologica Sinica, V20, P16; Wieclaw H, 2013, NORD J BOT, V31, P464, DOI 10.1111/j.1756-1051.2013.00095.x; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Wilson M, 1966, THE BRITISH RUST FUN; ZAMBINO PJ, 1993, MYCOLOGIA, V85, P401, DOI 10.2307/3760702; Zhao P, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-015-1091-6; Zhao P, 2014, MYCOSCIENCE, V55, P390, DOI 10.1016/j.myc.2013.12.005; Zhao P, 2013, MYCOTAXON, V123, P81, DOI 10.5248/123.81; Zheng W., 1983, SYLVA SINICA; Zhuang J. Y., 1989, Acta Mycologica Sinica, V8, P259; Zhuang J. Y., 1994, Mycosystema, V7, P37; Zhuang J. Y., 1986, Acta Mycologica Sinica, V5, P75; Zhuang J. Y., 1983, Acta Mycologica Sinica, V2, P146; Zhuang Jian-yun, 2006, Journal of Fungal Research, V4, P1; Zhuang JianYun, 2002, Journal of Jilin Agricultural University, V24, P5; Zhuang JY, 2003, MYCOSYSTEMA, V22, P107; Zhuang WY, 2005, FUNGI OF NORTHWESTER; Ziller WG, 1974, THE TREE RUSTS OF WE	73	13	13	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144883	10.1371/journal.pone.0144883	http://dx.doi.org/10.1371/journal.pone.0144883			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680416	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400032
J	Chen, QY; Deeb, RS; Ma, YL; Staudt, MR; Crystal, RG; Gross, SS				Chen, Qiuying; Deeb, Ruba S.; Ma, Yuliang; Staudt, Michelle R.; Crystal, Ronald G.; Gross, Steven S.			Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD Smokers	PLOS ONE			English	Article							OBSTRUCTIVE-PULMONARY-DISEASE; SURFACTANT PROTEIN-D; EXHALED BREATH CONDENSATE; INFLAMMATORY BIOMARKERS; LUNG-FUNCTION; POTENTIAL BIOMARKER; ACUTE EXACERBATIONS; PLASMA-FIBRINOGEN; OXIDATIVE STRESS; GENE-EXPRESSION	COPD (chronic obstructive pulmonary disease) is defined by a fixed expiratory airflow obstruction associated with disordered airways and alveolar destruction. COPD is caused by cigarette smoking and is the third greatest cause of mortality in the US. Forced expiratory volume in 1 second (FEV1) is the only validated clinical marker of COPD, but it correlates poorly with clinical features and is not sensitive enough to predict the early onset of disease. Using LC/MS global untargeted metabolite profiling of serum samples from a well-defined cohort of healthy smokers (n = 37), COPD smokers (n = 41) and non-smokers (n = 37), we sought to discover serum metabolic markers with known and/or unknown molecular identities that are associated with early-onset COPD. A total of 1,181 distinct molecular ions were detected in 95% of sera from all study subjects and 23 were found to be differentially-expressed in COPD-smokers vs. healthy-smokers. These 23 putative biomarkers were differentially-correlated with lung function parameters and used to generate a COPD prediction model possessing 87.8% sensitivity and 86.5% specificity. In an independent validation set, this model correctly predicted COPD in 8/10 individuals. These serum biomarkers included myoinositol, glycerophopshoinositol, fumarate, cysteinesulfonic acid, a modified version of fibrinogen peptide B (mFBP), and three doubly-charged peptides with undefined sequence that significantly and positively correlate with mFBP levels. Together, elevated levels of serum mFBP and additional disease-associated biomarkers point to a role for chronic inflammation, thrombosis, and oxidative stress in remodeling of the COPD airways. Serum metabolite biomarkers offer a promising and accessible window for recognition of early-stage COPD.	[Chen, Qiuying; Ma, Yuliang; Gross, Steven S.] Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA; [Deeb, Ruba S.; Staudt, Michelle R.; Crystal, Ronald G.] Weill Cornell Med, Dept Med Genet, New York, NY 10065 USA	Cornell University; Cornell University	Crystal, RG (corresponding author), Weill Cornell Med, Dept Med Genet, 1300 York Ave, New York, NY 10065 USA.	ssgross@med.cornell.edu; geneticmedicine@med.cornell.edu		Staudt, Michelle/0000-0002-3364-0894	NIH [R01HL107882, R01HL1189541, R37HL087062, P20 HL113443]; Family Smoking Prevention and Tobacco Control Act; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113443, R37HL087062, R01HL107882] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Family Smoking Prevention and Tobacco Control Act; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported, in part, by NIH R01HL107882, R01HL1189541, R37HL087062 and P20 HL113443. Research reported in this publication was supported in part by the Family Smoking Prevention and Tobacco Control Act. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration.; We thank C. Hollmann and S. Hyde in the Department of Genetic Medicine for help with the clinical regulatory aspects of these studies. These studies were supported, in part, by NIH R01HL107882, R01HL1189541, R37HL087062 and P20 HL113443. Research reported in this publication was supported in part by the Family Smoking Prevention and Tobacco Control Act. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration.	Akbas F, 2012, EXP LUNG RES, V38, P286, DOI 10.3109/01902148.2012.689088; Allred KF, 2009, J NUTR, V139, P1833, DOI 10.3945/jn.109.108001; Antczak A, 2012, ARCH MED SCI, V8, P277, DOI 10.5114/aoms.2012.28555; Barouchos N, 2015, SCAND J CLIN LAB INV, V75, P126, DOI 10.3109/00365513.2014.992944; Begas E, 2007, BIOMED CHROMATOGR, V21, P190, DOI 10.1002/bmc.736; Bentley AR, 2008, THORAX, V63, P956, DOI 10.1136/thx.2007.086199; BLOMBACK B, 1978, NATURE, V275, P501, DOI 10.1038/275501a0; Bowler RP, 2015, AM J RESP CRIT CARE, V191, P275, DOI 10.1164/rccm.201410-1771OC; Bowler RP, 2012, COPD, V9, P651, DOI 10.3109/15412555.2012.736317; Carolan BJ, 2013, AM J RESP CRIT CARE, V188, P561, DOI 10.1164/rccm.201212-2299OC; Chan KH, 2010, INT J TUBERC LUNG D, V14, P1193; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Csanky E, 2009, ELECTROPHORESIS, V30, P1228, DOI 10.1002/elps.200800722; Dahl M, 2001, AM J RESP CRIT CARE, V164, P1008, DOI 10.1164/ajrccm.164.6.2010067; Dahl M, 2008, AM J RESP CRIT CARE, V177, P1177, DOI 10.1164/rccm.200802-225ED; Deja S, 2014, J PHARMACEUT BIOMED, V100, P369, DOI 10.1016/j.jpba.2014.08.020; Dessi A, 2013, J OBSTET GYNAECOL, V33, P776, DOI 10.3109/01443615.2013.831046; Diaz AA, 2010, CHEST, V138, P880, DOI 10.1378/chest.10-0542; Dickens JA, 2012, COPD, V9, P574, DOI 10.3109/15412555.2012.718926; Dinavahi S S, 2014, Drug Res (Stuttg), V64, P214, DOI 10.1055/s-0033-1355411; Pastor MD, 2013, INT J MOL SCI, V14, P3440, DOI 10.3390/ijms14023440; Duvoix A, 2013, THORAX, V68, P670, DOI 10.1136/thoraxjnl-2012-201871; ECKHARDT T, 1981, J CLIN INVEST, V67, P809, DOI 10.1172/JCI110098; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; El-Deek SE, 2013, MED PRIN PRACT, V22, P469, DOI 10.1159/000349934; Fruchter O, 2015, AM J MED SCI, V349, P29, DOI 10.1097/MAJ.0000000000000332; Fuster Antonia, 2008, Int J Chron Obstruct Pulmon Dis, V3, P149; GIROD S, 1992, PEDIATR PULM, V13, P22, DOI 10.1002/ppul.1950130107; GRYGIEL JJ, 1981, CLIN PHARMACOL THER, V30, P491, DOI 10.1038/clpt.1981.193; Han W, 2009, CANCER PREV RES, V2, P370, DOI 10.1158/1940-6207.CAPR-08-0209; He HY, 2014, CHINESE MED J-PEKING, V127, P1608, DOI 10.3760/cma.j.issn.0366-6999.20132502; Heo JS, 2014, COPD, V11, P152, DOI 10.3109/15412555.2013.828028; Higashimoto Y, 2009, RESP MED, V103, P1231, DOI 10.1016/j.rmed.2009.01.021; Ismailoglu I, 2014, DEV BIOL, V391, P230, DOI 10.1016/j.ydbio.2014.04.005; Jetter A, 2009, EUR J CLIN PHARMACOL, V65, P411, DOI 10.1007/s00228-008-0597-0; Johansson SL, 2014, RESP MED, V108, P1336, DOI 10.1016/j.rmed.2014.06.003; Kirdar S, 2009, SCAND J CLIN LAB INV, V69, P219, DOI 10.1080/00365510802474400; Koutsokera A, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-111; Kurt OK, 2015, INFLAMMATION, V38, P89, DOI 10.1007/s10753-014-0010-3; Liang R, 2013, MOL MED REP, V7, P1470, DOI 10.3892/mmr.2013.1377; Lopez-Campos JL, 2015, PATIENT PREFER ADHER, V9, P95, DOI 10.2147/PPA.S55009; MacNee W, 2013, ANN MED, V45, P291, DOI 10.3109/07853890.2012.732703; Malerba M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/271918; Mannino DM, 2015, CHRON OBSTR PULM DIS, V2, P23, DOI 10.15326/jcopdf.2.1.2014.0138; Markoulis N, 2006, PANMINERVA MED, V48, P209; Marwick John A, 2010, Ther Adv Respir Dis, V4, P19, DOI 10.1177/1753465809352792; Musharraf SG, 2015, SCI REP-UK, V5, DOI 10.1038/srep08607; Ning Wen, 2006, Proc Am Thorac Soc, V3, P466, DOI 10.1513/pats.200603-031MS; Nobakht BF, 2015, BIOMARKERS, V20, P5, DOI 10.3109/1354750X.2014.983167; Paige M, 2011, BIOCHEM BIOPH RES CO, V413, P588, DOI 10.1016/j.bbrc.2011.09.006; Papaioannou AI, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-67; Petersen AMW, 2007, LUNG, V185, P161, DOI 10.1007/s00408-007-9000-7; Pinto-Plata Victor, 2006, Proc Am Thorac Soc, V3, P465, DOI 10.1513/pats.200603-030MS; Polosa R, 2013, INTERN EMERG MED, V8, P567, DOI 10.1007/s11739-011-0636-1; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rana GSJB, 2010, ANAL BIOANAL CHEM, V397, P1809, DOI 10.1007/s00216-010-3742-4; Rosenberg SR, 2012, TRANSL RES, V159, P228, DOI 10.1016/j.trsl.2012.01.019; Rothwell JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093474; Schuetz P, 2015, CLIN CHEM LAB MED, V53, P521, DOI 10.1515/cclm-2014-0748; Scott JA, 2014, INT J MOL SCI, V15, P6062, DOI 10.3390/ijms15046062; SENIOR RM, 1986, J CLIN INVEST, V77, P1014, DOI 10.1172/JCI112353; Shaw JG, 2014, J THORAC DIS, V6, P1532, DOI 10.3978/j.issn.2072-1439.2014.11.33; Sriskantharajah S, 2013, ANN NY ACAD SCI, V1280, P35, DOI 10.1111/nyas.12039; Stockley RA, 2014, INT J CHRONIC OBSTR, V9, P163, DOI 10.2147/COPD.S42362; Suzuki Masaru, 2014, Ann Am Thorac Soc, V11, P1511, DOI 10.1513/AnnalsATS.201408-351OC; TANG BK, 1991, CLIN PHARMACOL THER, V49, P648, DOI 10.1038/clpt.1991.82; Tapson Victor F, 2005, Proc Am Thorac Soc, V2, P71, DOI 10.1513/pats.200407-038MS; Ten Hoeve Arne Lucas, 2012, Tanaffos, V11, P12; Thomsen M, 2013, JAMA-J AM MED ASSOC, V309, P2353, DOI 10.1001/jama.2013.5732; Turino GM, 2011, AM J RESP CRIT CARE, V184, P637, DOI 10.1164/rccm.201103-0450PP; Ubhi BK, 2012, MOL BIOSYST, V8, P3125, DOI 10.1039/c2mb25194a; Undas A, 2009, THROMB HAEMOSTASIS, V102, P1176, DOI 10.1160/TH09-02-0118; Verrills NM, 2011, AM J RESP CRIT CARE, V183, P1633, DOI 10.1164/rccm.201010-1623OC; Vestbo J, 2014, RESP MED, V108, P729, DOI 10.1016/j.rmed.2014.03.002; Wang MY, 2016, CLIN RESPIR J, V10, P104, DOI 10.1111/crj.12194; Wedzicha JA, 2000, THROMB HAEMOSTASIS, V84, P210; Westwood M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-40; Wu HX, 2014, BIOCHEM BIOPH RES CO, V450, P110, DOI 10.1016/j.bbrc.2014.05.073; Zhang J, 2015, RESP CARE, V60, P251, DOI 10.4187/respcare.03519	79	31	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143937	10.1371/journal.pone.0143937	http://dx.doi.org/10.1371/journal.pone.0143937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674646	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700017
J	Choi, HJ; Kim, YJ; Choi, DK; Kim, YS				Choi, Hye-Ji; Kim, Ye-Jin; Choi, Dong-Ki; Kim, Yong-Sung			Engineering of Immunoglobulin Fc Heterodimers Using Yeast Surface-Displayed Combinatorial Fc Library Screening	PLOS ONE			English	Article							BISPECIFIC ANTIBODY; DIRECTED EVOLUTION; IGG ANTIBODIES; CELL-SURFACE; BINDING; GENERATION; EXPRESSION; REVEAL; ALPHA	Immunoglobulin Fc heterodimers, which are useful scaffolds for the generation of bispecific antibodies, have been mostly generated through structure-based rational design methods that introduce asymmetric mutations into the CH3 homodimeric interface to favor heterodimeric Fc formation. Here, we report an approach to generate heterodimeric Fc variants through directed evolution combined with yeast surface display. We developed a combinatorial heterodimeric Fc library display system by mating two haploid yeast cell lines, one haploid cell line displayed an Fc chain library (displayed Fc(CH3A)) with mutations in one CH3 domain (CH3A) on the yeast cell surface, and the other cell line secreted an Fc chain library (secreted Fc(CH3B)) with mutations in the other CH3 domain (CH3B). In the mated cells, secreted Fc(CH3B) is displayed on the cell surface through heterodimerization with the displayed Fc(CH3A), the detection of which enabled us to screen the library for heterodimeric Fc variants. We constructed combinatorial heterodimeric Fc libraries with simultaneous mutations in the homodimer-favoring electrostatic interaction pairs K370-E357/S364 or D399K392/K409 at the CH3 domain interface. High-throughput screening of the libraries using flow cytometry yielded heterodimeric Fc variants with heterodimer-favoring CH3 domain interface mutation pairs, some of them showed high heterodimerization yields (similar to 80-90%) with previously unidentified CH3 domain interface mutation pairs, such as hydrogen bonds and cation-pi interactions. Our study provides a new approach for engineering Fc heterodimers that could be used to engineer other heterodimeric protein-protein interactions through directed evolution combined with yeast surface display.	[Choi, Hye-Ji; Kim, Ye-Jin; Choi, Dong-Ki; Kim, Yong-Sung] Ajou Univ, Dept Mol Sci & Technol, Suwon 16499, South Korea	Ajou University	Kim, YS (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 16499, South Korea.	kimys@ajou.ac.kr		Kim, Yong-Sung/0000-0003-2673-1509	National Research Foundation - Korean government [2014M3C1A3051470, 2013M3A6A4043874, 2013R1A2A2A01005817, 2012-0006687]	National Research Foundation - Korean government(Korean Government)	This work was supported by grants from the Pioneer Research Center Program (2014M3C1A3051470), the Global Frontier Project (2013M3A6A4043874), the Mid-career Researcher Program (2013R1A2A2A01005817), and the Priority Research Center Program (2012-0006687) from the National Research Foundation funded by the Korean government.	Angelini A, 2015, METHODS MOL BIOL, V1319, P3, DOI 10.1007/978-1-4939-2748-7_1; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Baek DS, 2015, BIOCHEM BIOPH RES CO, V463, P414, DOI 10.1016/j.bbrc.2015.05.086; Baek DS, 2014, J MICROBIOL BIOTECHN, V24, P408, DOI 10.4014/jmb.1401.01002; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Choi DK, 2014, MABS-AUSTIN, V6, P1402, DOI 10.4161/mabs.36389; Choi HJ, 2015, MOL IMMUNOL, V65, P377, DOI 10.1016/j.molimm.2015.02.017; Choi HJ, 2013, MOL CANCER THER, V12, P2748, DOI 10.1158/1535-7163.MCT-13-0628; Davis JH, 2010, PROTEIN ENG DES SEL, V23, P195, DOI 10.1093/protein/gzp094; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Elliott JM, 2014, J MOL BIOL, V426, P1947, DOI 10.1016/j.jmb.2014.02.015; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Hu XB, 2009, J BIOL CHEM, V284, P16369, DOI 10.1074/jbc.M109.001743; Jiang W, 2010, P NATL ACAD SCI USA, V107, P13258, DOI 10.1073/pnas.1006344107; Kim MS, 2007, J MOL BIOL, V374, P1374, DOI 10.1016/j.jmb.2007.10.034; Kitazawa T, 2012, NAT MED, V18, P1570, DOI 10.1038/nm.2942; Klein C, 2012, MABS-AUSTIN, V4, P653, DOI 10.4161/mabs.21379; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Lee CH, 2010, PROTEIN EXPRES PURIF, V71, P42, DOI 10.1016/j.pep.2009.12.004; LIPKE PN, 1989, MOL CELL BIOL, V9, P3155, DOI 10.1128/MCB.9.8.3155; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Moore GL, 2011, MABS-AUSTIN, V3, P546, DOI 10.4161/mabs.3.6.18123; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Sampei Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057479; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Spiess C, 2015, MOL IMMUNOL, V67, P95, DOI 10.1016/j.molimm.2015.01.003; Strop P, 2012, J MOL BIOL, V420, P204, DOI 10.1016/j.jmb.2012.04.020; Traxlmayr MW, 2012, BBA-PROTEINS PROTEOM, V1824, P542, DOI 10.1016/j.bbapap.2012.01.006; Von Kreudenstein TS, 2014, METHODS, V65, P77, DOI 10.1016/j.ymeth.2013.10.016; Von Kreudenstein TS, 2013, MABS-AUSTIN, V5, P646, DOI 10.4161/mabs.25632; Wang KC, 2010, J IMMUNOL METHODS, V354, P11, DOI 10.1016/j.jim.2010.01.006; Watt MM, 2013, ACCOUNTS CHEM RES, V46, P955, DOI 10.1021/ar300100g; Weaver-Feldhaus JM, 2004, FEBS LETT, V564, P24, DOI 10.1016/S0014-5793(04)00309-6	34	13	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145349	10.1371/journal.pone.0145349	http://dx.doi.org/10.1371/journal.pone.0145349			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675656	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700120
J	Strumylaite, L; Sharp, SJ; Kregzdyte, R; Poskiene, L; Bogusevicius, A; Pranys, D				Strumylaite, Loreta; Sharp, Stephen J.; Kregzdyte, Rima; Poskiene, Lina; Bogusevicius, Algirdas; Pranys, Darius			The Association of Low-To-Moderate Alcohol Consumption with Breast Cancer Subtypes Defined by Hormone Receptor Status	PLOS ONE			English	Article							RISK-FACTORS; ESTROGEN; ETHANOL; WOMEN; PROLIFERATION; METAANALYSIS; EXPRESSION; ESTRADIOL; ALPHA	Background Alcohol is a well-established risk factor for breast cancer, but pathways involved in alcohol-related breast carcinogenesis are not clearly defined. We examined the association between low-to-moderate alcohol intake and breast cancer subtypes by tumor hormone receptor status. Materials and Methods A hospital-based case-control study was performed in 585 cases and 1,170 controls. Information on alcohol intake and other risk factors was collected via a questionnaire. Logistic regression was used for analyses. All statistical tests were two-sided. Results The odds ratio of breast cancer was 1.75 (95% confidence interval [CI]: 1.21-2.53) in women who consumed <= 5 drinks/week, and 3.13 (95% CI: 1.81-5.43) in women who consumed >5 drinks/week, both compared with non-drinkers for >= 10 years, after adjustment for age and other confounders. The association of alcohol intake with estrogen receptor-positive breast cancer was stronger than with estrogen receptor-negative: the odds ratio per 1 category increase was 2.05 (95% CI: 1.49-2.82) and 1.29 (95% CI: 0.85-1.94) (P-heterogeneity = 0.07). There was no evidence of an interaction between alcohol intake and menopausal status (P = 0.19) in overall group; however, it was significant in estrogen receptor-positive breast cancer (P = 0.04). Conclusions Low-to-moderate alcohol intake is associated with the risk of estrogen receptor-positive breast cancer with the strongest association in postmenopausal women. Since alcohol intake is a modifiable risk factor of breast cancer, every woman should be informed and advised to control alcohol use.	[Strumylaite, Loreta; Kregzdyte, Rima] Lithuanian Univ Hlth Sci, Med Acad, Neurosci Inst, Kaunas, Lithuania; [Sharp, Stephen J.] Univ Cambridge, Inst Metab Sci, Sch Clin Med, MRC Epidemiol Unit, Cambridge, England; [Poskiene, Lina; Pranys, Darius] Lithuanian Univ Hlth Sci, Med Acad, Dept Pathol Anat, Kaunas, Lithuania; [Bogusevicius, Algirdas] Lithuanian Univ Hlth Sci, Dept Surg, Med Acad, Kaunas, Lithuania	Lithuanian University of Health Sciences; University of Cambridge; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences	Strumylaite, L (corresponding author), Lithuanian Univ Hlth Sci, Med Acad, Neurosci Inst, Kaunas, Lithuania.	loreta.strumylaite@lsmuni.lt			Lithuanian State Science and Studies Foundation (at present the Research Council of Lithuania) [T-64/09]	Lithuanian State Science and Studies Foundation (at present the Research Council of Lithuania)(Research Council of Lithuania (LMTLT))	The work was supported by the following: No. T-64/09; The Lithuanian State Science and Studies Foundation (at present the Research Council of Lithuania). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Brown LM, 2010, BREAST CANCER RES TR, V120, P203, DOI 10.1007/s10549-009-0464-4; Cao Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4238; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; DAKO, 1996, REF IMM BREAST CANC, P9; Dallal CM, 2014, CARCINOGENESIS, V35, P346, DOI 10.1093/carcin/bgt367; Deandrea S, 2008, CANCER EPIDEM BIOMAR, V17, P2025, DOI 10.1158/1055-9965.EPI-08-0157; Dorgan JF, 2001, JNCI-J NATL CANCER I, V93, P710, DOI 10.1093/jnci/93.9.710; Etique N, 2004, INT J MOL MED, V13, P149; Fan SJ, 2000, CANCER RES, V60, P5635; Feunekes GIJ, 1999, AM J EPIDEMIOL, V150, P105; FRIEDENREICH CM, 1993, AM J EPIDEMIOL, V137, P512, DOI 10.1093/oxfordjournals.aje.a116704; GAVALER JS, 1987, J STUD ALCOHOL, V48, P295, DOI 10.15288/jsa.1987.48.295; GINSBURG ES, 1995, FERTIL STERIL, V63, P1227, DOI 10.1016/S0015-0282(16)57602-X; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; IARC (International Agency for Research on Cancer), 2010, ALC CONS ETH CARB; Kabat GC, 2011, CANCER CAUSE CONTROL, V22, P775, DOI 10.1007/s10552-011-9750-7; Key J, 2006, CANCER CAUSE CONTROL, V17, P759, DOI 10.1007/s10552-006-0011-0; Key T, 2002, JNCI-J NATL CANCER I, V94, P606, DOI DOI 10.1093/JNCI/94.8.606; Kropp S, 2001, AM J EPIDEMIOL, V154, P624, DOI 10.1093/aje/154.7.624; Lew JQ, 2009, AM J EPIDEMIOL, V170, P308, DOI 10.1093/aje/kwp120; Li CI, 2010, J NATL CANCER I, V102, P1422, DOI 10.1093/jnci/djq316; Li Y, 2009, EUR J CANCER, V45, P843, DOI 10.1016/j.ejca.2008.11.001; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Park SY, 2014, INT J CANCER, V134, P1504, DOI 10.1002/ijc.28476; REICHMAN ME, 1993, J NATL CANCER I, V85, P722, DOI 10.1093/jnci/85.9.722; Romieu I, 2015, INT J CANCER, V137, P1921, DOI 10.1002/ijc.29469; Rosenberg LU, 2006, CANCER EPIDEM BIOMAR, V15, P2482, DOI 10.1158/1055-9965.EPI-06-0489; Sarkola T, 2001, J CLIN ENDOCR METAB, V86, P1981, DOI 10.1210/jc.86.5.1981; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Setiawan VW, 2009, AM J EPIDEMIOL, V169, P1251, DOI 10.1093/aje/kwp036; Singletary KW, 2001, CANCER LETT, V165, P131, DOI 10.1016/S0304-3835(01)00419-0; Strumylaite L, 2013, ASIAN PAC J CANCER P, V14, P2777, DOI 10.7314/APJCP.2013.14.5.2777; Suzuki R, 2005, JNCI-J NATL CANCER I, V97, P1601, DOI 10.1093/jnci/dji341; Suzuki R, 2008, INT J CANCER, V122, P1832, DOI 10.1002/ijc.23184; Suzuki R, 2010, INT J CANCER, V127, P685, DOI 10.1002/ijc.25079; Visvanathan K, 2007, ALCOHOL CLIN EXP RES, V31, P467, DOI 10.1111/j.1530-0277.2006.00334.x; World Health Organization, 2000, INT GUID MON ALC CON; Zhang M, 2011, BRIT J CANCER, V105, P1089, DOI 10.1038/bjc.2011.302; Zhang SMM, 2007, AM J EPIDEMIOL, V165, P667, DOI 10.1093/aje/kwk054	41	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144680	10.1371/journal.pone.0144680	http://dx.doi.org/10.1371/journal.pone.0144680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674340	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700053
J	Wang, LY; Murk, W; DeWan, AT				Wang, Leyao; Murk, William; DeWan, Andrew T.			Genome-Wide Gene by Environment Interaction Analysis Identifies Common SNPs at 17q21.2 that Are Associated with Increased Body Mass Index Only among Asthmatics	PLOS ONE			English	Article							CHILDHOOD ASTHMA; OBESITY; EXPRESSION; KERATIN; RISK; DIFFERENTIATION; POPULATION; DISEASES; CANCER; ORMDL3	Asthmatics have an increased risk of being overweight/obese. Although the underlying mechanisms of this are unclear, genetic factors are believed to play an essential role. To identify common genetic variants that are associated with asthma-related BMI increase, we performed a genome-wide gene by environment (asthma) interaction analysis for the outcome of BMI in the Multi-Ethnic Study of Atherosclerosis (MESA) study (N = 2474 Caucasians, 257 asthmatics), and replicated findings in the Framingham Heart Study (FHS) offspring cohort (N = 1408 Caucasians, 382 asthmatics). The replicable tagging SNP, rs2107212, was further examined in stratified analyses. Seven SNPs clustered in 17q21.2 were identified to be associated with higher BMI among asthmatics (interaction p < 5x10(-7) in MESA and p < 0.05 in FHS). In both MESA and FHS asthmatics, subjects carrying the A allele on rs2107212 had significantly higher odds of obesity than non-carriers, which was not the case for non-asthmatics. We further examined BMI change subsequent to asthma diagnosis over a period of 26 years in FHS and demonstrated greater BMI increase among asthmatics compared to non-asthmatics. Asthmatics carrying the A allele at rs2107212 had significantly greater net BMI increase over the 26-year period compared to non-asthmatics. In this study, we found that common genetic variants on 17q21.2 are associated with postasthma BMI increase among Caucasians. This finding will help elucidate pathways involved in the comorbidity of asthma and obesity.	[Wang, Leyao; Murk, William; DeWan, Andrew T.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT 06520 USA	Yale University	DeWan, AT (corresponding author), Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT 06520 USA.	andrew.dewan@yale.edu		DeWan, Andrew/0000-0002-7679-8704	United States Air Force/AFMC [FA8650-13-2-6371]; NIH/NIAID Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) [1F32AI114097-01A1]; Canadian Institutes of Health Research [DFS - 129311]; National Heart, Lung, and Blood Institute (NHLBI); CTSA [UL1-RR-024156]; U.S. Environmental Protection Agency (EPA) under Science to Achieve Results (STAR) Program [RD831697]; Boston University [N01-HC-25195]; NHLBI [N02-HL-64278];  [N01-HC-95159];  [N01-HC-95160];  [N01-HC-95161];  [N01-HC-95162];  [N01-HC-95163];  [N01-HC-95164];  [N01-HC-95165];  [N01-HC-95166];  [N01-HC-95167];  [N01-HC-95168];  [N01-HC-95169]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI114097] Funding Source: NIH RePORTER	United States Air Force/AFMC; NIH/NIAID Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); U.S. Environmental Protection Agency (EPA) under Science to Achieve Results (STAR) Program; Boston University; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a cooperative agreement from the United States Air Force/AFMC [Award No. FA8650-13-2-6371]. http://www.afmc.af.mil/. Dr. Leyao Wang is supported by the NIH/NIAID Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) [Award No. 1F32AI114097-01A1]. http://www.niaid.nih.gov/. William Murk is supported by a Doctoral Foreign Study Award from the Canadian Institutes of Health Research [Award No. DFS - 129311]. http://www.cihr-irsc.gc.ca/e/37788.html/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169 and CTSA UL1-RR-024156. The Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air) is supported by the U.S. Environmental Protection Agency (EPA) under Science to Achieve Results (STAR) Program Grant # RD831697. The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. SHARe Illumina genotyping was provided under an agreement between Illumina and Boston University. This manuscript was not prepared in collaboration with investigators of the MESA, MESA Air or Framingham Heart Study and does not necessarily reflect the opinions or views of those studies and funding agencies and no official endorsement should be inferred.	Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Birkenkamp-Demtroder K, 2002, CANCER RES, V62, P4352; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279, DOI DOI 10.2105/AJPH.41.3.279; Egan KB, 2015, PEDIATR OBES, V10, P345, DOI 10.1111/ijpo.271; Ford ES, 2005, J ALLERGY CLIN IMMUN, V115, P897, DOI 10.1016/j.jaci.2004.11.050; Gonzalez JR, 2014, AM J HUM GENET, V94, P361, DOI 10.1016/j.ajhg.2014.01.015; Hallstrand TS, 2005, J ALLERGY CLIN IMMUN, V116, P1235, DOI 10.1016/j.jaci.2005.09.016; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Kim SH, 2014, ALLERGY ASTHMA IMMUN, V6, P189, DOI 10.4168/aair.2014.6.3.189; Langbein L, 2007, J INVEST DERMATOL, V127, P1532, DOI 10.1038/sj.jid.5700734; Laprise C, 2014, GENES IMMUN, V15, P247, DOI 10.1038/gene.2014.12; Liffers ST, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-137; Melen E, 2013, CLIN EXP ALLERGY, V43, P463, DOI 10.1111/cea.12054; Melen E, 2010, J ALLERGY CLIN IMMUN, V126, P631, DOI 10.1016/j.jaci.2010.06.030; Meyers DA, 2014, LANCET RESP MED, V2, P405, DOI 10.1016/S2213-2600(14)70012-8; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nahm DH, 2002, AM J RESP CRIT CARE, V165, P1536, DOI 10.1164/rccm.200201-009OC; Nayak AP, 2014, TOXICOL SCI, V140, P327, DOI 10.1093/toxsci/kfu079; Nystad W, 2004, AM J EPIDEMIOL, V160, P969, DOI 10.1093/aje/kwh303; Ono JG, 2014, PEDIATR RES, V75, P165, DOI 10.1038/pr.2013.186; Park JE, 2011, PROTEOMICS, V11, P2777, DOI 10.1002/pmic.201000544; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schwarzer G, 2014, METAMETA ANAL R R PA; Stukus DR, 2015, J ALLERGY CLIN IMMUN, V135, P894, DOI 10.1016/j.jaci.2014.11.002; von Kries R, 2001, ALLERGY, V56, P318, DOI 10.1034/j.1398-9995.2001.00727.x; Wang KJ, 2009, CANCER LETT, V281, P144, DOI 10.1016/j.canlet.2009.02.037; Watanabe Tsuneo, 2013, Rinsho Byori, V61, P19; Winter Y, 2013, VITAM HORM, V91, P29, DOI 10.1016/B978-0-12-407766-9.00002-X; Zhang JS, 2001, GENE CHROMOSOME CANC, V30, P123, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1070>3.0.CO;2-W	33	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144114	10.1371/journal.pone.0144114	http://dx.doi.org/10.1371/journal.pone.0144114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672748	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700025
J	Campos, RC; Hernandez, MIM				Campos, Renata Calixto; Medina Hernandez, Malva Isabel			The Importance of Maize Management on Dung Beetle Communities in Atlantic Forest Fragments	PLOS ONE			English	Article							ARTHROPOD PREDATORS; COLEOPTERA; BIODIVERSITY; SCARABAEIDAE; SECONDARY; CONSERVATION; ASSEMBLAGES; HERBIVORES; PROSPECTS; RICHNESS	Dung beetle community structures changes due to the effects of destruction, fragmentation, isolation and decrease in tropical forest area, and therefore are considered ecological indicators. In order to assess the influence of type of maize cultivated and associated maize management on dung beetle communities in Atlantic Forest fragments surrounded by conventional and transgenic maize were evaluated 40 Atlantic Forest fragments of different sizes, 20 surrounded by GM maize and 20 surrounded by conventional maize, in February 2013 and 2014 in Southern Brazil. After applying a sampling protocol in each fragment (10 pitfall traps baited with human feces or carrion exposed for 48 h), a total of 3454 individuals from 44 species were captured: 1142 individuals from 38 species in GM maize surrounded fragments, and 2312 from 42 species in conventional maize surrounded fragments. Differences in dung beetle communities were found between GM and conventional maize communities. As expected for fragmented areas, the covariance analysis showed a greater species richness in larger fragments under both conditions; however species richness was greater in fragments surrounded by conventional maize. Dung beetle structure in the forest fragments was explained by environmental variables, fragment area, spatial distance and also type of maize (transgenic or conventional) associated with maize management techniques. In Southern Brazil's scenario, the use of GM maize combined with associated agricultural management may be accelerating the loss of diversity in Atlantic Forest areas, and consequently, important ecosystem services provided by dung beetles may be lost.	[Campos, Renata Calixto; Medina Hernandez, Malva Isabel] Univ Fed Santa Catarina, Programa Posgrad Ecol, Dept Ecol & Zool, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Campos, RC (corresponding author), Univ Fed Santa Catarina, Programa Posgrad Ecol, Dept Ecol & Zool, Florianopolis, SC, Brazil.	recalixtocampos@gmail.com	Hernandez, Malva I. M./E-3485-2013	Hernandez, Malva I. M./0000-0002-6820-5980	Genok (Centre for Biosafety/Norway); CAPES (Ministry of Education of Brazil); CNPQ (Science and Technology Ministry of Brazil) [309030/2013-7]	Genok (Centre for Biosafety/Norway); CAPES (Ministry of Education of Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ (Science and Technology Ministry of Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank Genok (Centre for Biosafety/Norway) for project support. RCC thanks CAPES (Ministry of Education of Brazil) for a PhD Grant. MIMH thanks CNPQ (Science and Technology Ministry of Brazil, Proc. 309030/2013-7) for a Productivity Grant.; We would like to thank Dr. Fernando Vaz-de-Mello from Universidade Federal do Mato Grosso/Brazil for confirmation of the dung beetle identification and Dr. Pedro Giovani da Silva and Dr. Eduardo Giehl from Universidade Federal de Santa Catarina/Brazil for helping in data analysis. We are grateful to the farmers for collection permission and Daniel Lira, Moacyr Batilani-Filho, Juliano Bogoni, Georgina Catacora, Leticia Filipini, Victor Michelon Alves and Marcelo Agudelo for helping during fieldwork. We also thank Dr. Rubens Nodari from Universidade Federal de Santa Catarina/Brazil who is the head of the project and GenOk (Centre for Biosafety/Norway) for project support. RCC thanks CAPES (Ministry of Education of Brazil) for a PhD Grant and MIMH thanks CNPQ (Science and Technology Ministry of Brazil, Proc. 309030/2013-7) for a Productivity Grant.	Andresen E, 2007, BIOTROPICA, V39, P141, DOI 10.1111/j.1744-7429.2006.00239.x; Arellano L, 2008, LANDSCAPE ECOL, V23, P69, DOI 10.1007/s10980-007-9165-8; Noriega JA, 2011, J TROP ECOL, V27, P111, DOI 10.1017/S0266467410000581; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barlow J, 2010, J APPL ECOL, V47, P779, DOI 10.1111/j.1365-2664.2010.01825.x; Bogoni JA, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu161; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brower J.E., 1998, FIELD LAB METHODS GE; Campos RC, 2015, ECOL INDIC, V49, P216, DOI 10.1016/j.ecolind.2014.09.043; Campos RC, 2013, REV BRAS ENTOMOL, V57, P47, DOI 10.1590/S0085-56262013000100008; Catarino R, 2015, PLANT BIOTECHNOL J, V13, P601, DOI 10.1111/pbi.12363; Clarke K., 2001, PRIMER V5 USER MANUA; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Culot L, 2013, BIOL CONSERV, V163, P79, DOI 10.1016/j.biocon.2013.04.004; da Silva PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126112; da Silva PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111883; Davis Adrian L. V., 2001, Diversity and Distributions, V7, P161, DOI 10.1111/j.1472-4642.2001.00102.x; Davis AJ, 2001, J APPL ECOL, V38, P593, DOI 10.1046/j.1365-2664.2001.00619.x; Davis ALV, 2005, ENVIRON ENTOMOL, V34, P1081, DOI 10.1603/0046-225X(2005)034[1081:EODOAS]2.0.CO;2; Duan JJ, 2010, BIOL LETTERS, V6, P74, DOI 10.1098/rsbl.2009.0612; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA), 2015, MILH TRANSG MAN PLAT; Estrada A, 1999, AM J PRIMATOL, V48, P253, DOI 10.1002/(SICI)1098-2345(1999)48:4&lt;253::AID-AJP1&gt;3.0.CO;2-D; Favila Mario E., 1997, Acta Zoologica Mexicana Nueva Serie, V72, P1; Filgueiras BKC, 2011, BIOL CONSERV, V144, P362, DOI 10.1016/j.biocon.2010.09.013; Fuck MP, 2009, REV IBEROAM CIENC TE, V12, P9; Galindo-Leal C, 2003, STATE HOTS, P3; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gronsberg I. M., 2011, Food and Nutrition Sciences, V2, P377; Guertler P, 2010, LIVEST SCI, V131, P250, DOI 10.1016/j.livsci.2010.04.010; Halffter G., 1982, The nesting behavior of dung beetles (Scarabaeinae). An ecological and evolutive approach.; Halffter G, 2002, BIOTROPICA, V34, P144, DOI 10.1111/j.1744-7429.2002.tb00250.x; HALFFTER GONZALO, 1966, FOLIA ENTOMOL MEX, V12/14, P1; Halffter Gonzalo, 1993, Biology International, V27, P15; Hanski I., 1991, DUNG BEETLE ECOLOGY; Harwood JD, 2005, MOL ECOL, V14, P2815, DOI 10.1111/j.1365-294X.2005.02611.x; Hernandez MIM, 2014, J INSECT CONSERV, V18, P539, DOI 10.1007/s10841-014-9645-5; Hilbeck A., 2006, BIOPESTIC INT, V2, P1; Hilbeck A, 2008, EUPHYTICA, V164, P903, DOI 10.1007/s10681-008-9666-9; Karam D, 2008, MANUAL MANEJO CONTRO, P659; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leite PF, 1990, GEOGRAFIA BRASIL; Lovei GL, 2009, ENVIRON ENTOMOL, V38, P293, DOI 10.1603/022.038.0201; Lumaret Jean-Pierre, 2005, Acta Zool. Mex, V21, P137; Lumaret JP, 2002, VET RES, V33, P547, DOI 10.1051/vetres:2002038; Lutz B, 2005, J AGR FOOD CHEM, V53, P1453, DOI 10.1021/jf049222x; Martinez IM, 2001, CR ACAD SCI III-VIE, V324, P989, DOI 10.1016/S0764-4469(01)01384-1; Martinez M Imelda, 2009, Acta Zoologica Mexicana Nueva Serie, V25, P673; Martinez-M. Imelda, 1995, Elytron (Barcelona), V9, P5; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; McGeoch MA, 2002, J APPL ECOL, V39, P661, DOI 10.1046/j.1365-2664.2002.00743.x; Hernandez MIM, 2009, REV BRAS ENTOMOL, V53, P607, DOI 10.1590/S0085-56262009000400010; Naranjo S. E., 2009, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V4, P1, DOI 10.1079/PAVSNNR20094011; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nichols E, 2009, OIKOS, V118, P481, DOI 10.1111/j.1600-0706.2009.17268.x; Obrist LB, 2006, ECOL ENTOMOL, V31, P143, DOI 10.1111/j.0307-6946.2006.00762.x; Obrycki JJ, 2001, BIOSCIENCE, V51, P353, DOI 10.1641/0006-3568(2001)051[0353:TICBIT]2.0.CO;2; Pandolfo C, 2002, ATLAS CLIMATICO DIGI; Paul V, 2010, TRANSGENIC RES, V19, P683, DOI 10.1007/s11248-009-9339-z; PECK SB, 1982, CAN J ZOOL, V60, P1624, DOI 10.1139/z82-213; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez-Romero R, 2008, ECOTOX ENVIRON SAFE, V70, P327, DOI 10.1016/j.ecoenv.2007.12.002; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Roslin Tomas, 2011, P220; Simmons L.W., 2011, ECOLOGY EVOLUTION DU, DOI 10.1002/9781444342000; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Tabarelli M, 2010, BIOL CONSERV, V143, P2328, DOI 10.1016/j.biocon.2010.02.005; Then C, 2010, ENVIRON SCI POLLUT R, V17, P791, DOI 10.1007/s11356-009-0208-3; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; Vaz-de-Mello FZ, 2012, ZOOTAXA, V2854, P1; Verdu JR, 2015, SCI REP-UK, V5, DOI 10.1038/srep13912; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Zuur Alain F., 2009, P1; Zwahlen Claudia, 2005, Environmental Biosafety Research, V4, P113, DOI 10.1051/ebr:2005014	79	7	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145000	10.1371/journal.pone.0145000	http://dx.doi.org/10.1371/journal.pone.0145000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694874	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500020
J	Lee, S; Ye, A; Kim, J				Lee, Suman; Ye, An; Kim, Joomyeong			DNA-Binding Motif of the Imprinted Transcription Factor PEG3	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER; GENE; PIK3C3/VPS34; SYSTEM; CELLS; MICE	Peg3 is an imprinted gene that is predicted to encode a DNA-binding zinc finger protein. This was previously demonstrated through Chromatin Immuno Precipitation-based Sequencing experiments. In the current study, we reanalyzed the previous ChIP-Seq results and further characterized the DNA-binding motif of PEG3. According to the results, PEG3 binds to the promoters and enhancers of a subset of genes that are closely associated with the known functions of Peg3. Some of these identified targets include Tufm, Mrpl45, Cry2, Per1, Slc25a29 and Slc38a2. With this set of targets, we derived a DNA-binding motif of PEG3, 5'-GTGGCAGT-3', which also provides a tabulated matrix that can be used for predicting other unknown genomic targets. Among the newly identified targets, we analyzed in detail the two loci, Slc38a2 and Slc38a4, which are known to be involved in neutral amino acid transport. The results indicated that PEG3 likely functions as a transcriptional repressor for these two loci. Overall, the current study provides a set of genomic targets and also redefines the DNA-binding motif for the imprinted transcription factor PEG3.	[Lee, Suman; Ye, An; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu			National Institutes of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097074, R01GM066225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (J.K. R01-GM066225 and R01-GM097074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; Desforges M, 2006, AM J PHYSIOL-CELL PH, V290, pC305, DOI 10.1152/ajpcell.00258.2005; Doi M, 2012, BIOL PHARM BULL, V35, P1385, DOI 10.1248/bpb.b12-00364; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Ezer D, 2014, COMPUT STRUCT BIOTEC, V10, P63, DOI 10.1016/j.csbj.2014.07.005; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; He Hongzhi, 2014, Genomics & Informatics, V12, P105, DOI 10.5808/GI.2014.12.3.105; Jaber N, 2012, AUTOPHAGY, V8, P707, DOI 10.4161/auto.19627; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2008, HUM MOL GENET, V17, P391, DOI 10.1093/hmg/ddm316; Kim J, 2007, GENOMICS, V90, P85, DOI 10.1016/j.ygeno.2007.03.012; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LaSalle JM, 2015, HUM MOL GENET; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Lincoln GA, 2003, J ENDOCRINOL, V179, P1, DOI 10.1677/joe.0.1790001; Perera BPU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119493; Schioth HB, 2013, MOL ASPECTS MED, V34, P571, DOI 10.1016/j.mam.2012.07.012; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Ye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108596; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou XA, 2010, AUTOPHAGY, V6, P798, DOI 10.4161/auto.6.6.12511	32	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145531	10.1371/journal.pone.0145531	http://dx.doi.org/10.1371/journal.pone.0145531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692216	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092300085
J	Li, YX; Wu, X; Jaqueth, J; Zhang, DF; Cui, DH; Li, CH; Hu, GH; Dong, HY; Song, YC; Shi, YS; Wang, TY; Li, BL; Li, Y				Li, Yong-xiang; Wu, Xun; Jaqueth, Jennifer; Zhang, Dengfeng; Cui, Donghui; Li, Chunhui; Hu, Guanghui; Dong, Huaiyu; Song, Yan-chun; Shi, Yun-su; Wang, Tianyu; Li, Bailin; Li, Yu			The Identification of Two Head Smut Resistance-Related QTL in Maize by the Joint Approach of Linkage Mapping and Association Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TRAIT LOCUS QHS2.09; QUANTITATIVE RESISTANCE; SPORISORIUM-REILIANA; LEAF-BLIGHT; MAJOR QTL; PATHOGENS; MARKERS; WEIGHT; TASSEL	Head smut, caused by the fungus Sphacelotheca reiliana (Kuhn) Clint, is a devastating threat to maize production. In this study, QTL mapping of head smut resistance was performed using a recombinant inbred line (RIL) population from a cross between a resistant line "QI319" and a susceptible line "Huangzaosi" (HZS) with a genetic map constructed from genotyping-by-sequencing (GBS) data and composed of 1638 bin markers. Two head smut resistance QTL were identified, located on Chromosome 2 (q2.09HR) and Chromosome 5 (q5.03HR), q2.09HR is co-localized with a previously reported QTL for head smut resistance, and the effect of q5.03HR has been validated in backcross populations. It was also observed that pyramiding the resistant alleles of both QTL enhanced the level of resistance to head smut. A genome-wide association study (GWAS) using 277 diverse inbred lines was processed to validate the mapped QTL and to identify additional head smut resistance associations. A total of 58 associated SNPs were detected, which were distributed in 31 independent regions. SNPs with significant association to head smut resistance were detected within the q2.09HR and q5.03HR regions, confirming the linkage mapping results. It was also observed that both additive and epistastic effects determine the genetic architecture of head smut resistance in maize. As shown in this study, the combined strategy of linkage mapping and association analysis is a powerful approach in QTL dissection for disease resistance in maize.	[Li, Yong-xiang; Wu, Xun; Zhang, Dengfeng; Li, Chunhui; Song, Yan-chun; Shi, Yun-su; Wang, Tianyu; Li, Yu] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Jaqueth, Jennifer; Li, Bailin] DuPont Pioneer, Wilmington, DE 19803 USA; [Cui, Donghui] DuPont Pioneer, Beijing 101309, Peoples R China; [Hu, Guanghui] Heilongjiang Acad Agr Sci, Maize Res Inst, Harbin 150086, Peoples R China; [Dong, Huaiyu] Liaoning Acad Agr Sci, Inst Plant Protect, Shenyang 110161, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; DuPont; Heilongjiang Academy of Agricultural Sciences	Wang, TY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China.	wangtianyu@263.net; liyu03@caas.cn	li, yong/HDN-3885-2022; li, bai/GRJ-4913-2022; li, yongxiang/GPW-6930-2022; li, bz/GVR-7133-2022		DuPont Pioneer; Program of MOST of China; Program of MOA of China [2011CB100105, 201303007, 2013BAD01B02, 2014CB138200, 2014NWB030]; CAAS (Innovation Program)	DuPont Pioneer; Program of MOST of China; Program of MOA of China; CAAS (Innovation Program)	This research was supported by DuPont Pioneer and the Programs of MOST and MOA of China (2011CB100105, 201303007, 2013BAD01B02, 2014CB138200, 2014NWB030) and CAAS (Innovation Program). The funders provided support in the form of salaries for authors but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI A, 1990, J AM SOC HORTIC SCI, V115, P668, DOI 10.21273/JASHS.115.4.668; Bai JK, 1994, J MAIZE SCI, V2, P67; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BERNARDO R, 1992, AGRONOMIE, V12, P303, DOI 10.1051/agro:19920403; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Brown PJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002383; Chen YS, 2008, THEOR APPL GENET, V117, P1241, DOI 10.1007/s00122-008-0858-4; Di H, 2015, EUPHYTICA, V202, P69, DOI 10.1007/s10681-014-1219-9; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Hallauer A.R., 1988, QUANTITATIVE GENETIC; Herzog E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092429; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; [吉海莲 JI Hailian], 2007, [植物遗传资源学报, Journal of Plant Genetic Resources], V8, P132; Jin QiMing, 2003, Journal of Maize Sciences, V11, P86; Jin QM, 2000, J MAIZE SCI, V8, P84; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Li CH, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0187-4; Li CH, 2013, EUPHYTICA, V193, P303, DOI 10.1007/s10681-013-0901-7; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li XH, 2008, FIELD CROP RES, V106, P148, DOI 10.1016/j.fcr.2007.11.008; Liu HJ, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-433, 10.1186/1471-2164-15-25]; Liu RX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049836; Liu ZhiZhai, 2012, Scientia Agricultura Sinica, V45, P2107; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; Lubberstedt T, 1999, THEOR APPL GENET, V99, P593, DOI 10.1007/s001220051273; Ma BY, 1983, CHIN AGRIC SIN, V4, P12; Mei Z. B., 1982, Shanxi Nongye Kexue (Shanxi Agricultural Sciences), P10; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Parlevliet JE, 2002, EUPHYTICA, V124, P147, DOI 10.1023/A:1015601731446; Platt A, 2010, GENETICS, V186, P1045, DOI 10.1534/genetics.110.121665; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; SAS Institute, 2009, SAS SYSTEM FOR WINDO; Shi HL, 2005, CHIN AGRON SIN, V3, P481; Teng WenTao, 2004, Scientia Agricultura Sinica, V37, P1804; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; Wang M, 2012, PLANT SCI, V196, P125, DOI 10.1016/j.plantsci.2012.08.004; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Weng JF, 2012, PHYTOPATHOLOGY, V102, P692, DOI 10.1094/PHYTO-12-11-0330; Wu X, 2014, THEOR APPL GENET, V127, P621, DOI 10.1007/s00122-013-2246-y; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu ML, 1999, PLANT DIS, V83, P390, DOI 10.1094/PDIS.1999.83.4.390; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yu HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017595; Zuo WL, 2015, NAT GENET, V47, P151, DOI 10.1038/ng.3170	47	7	10	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145549	10.1371/journal.pone.0145549	http://dx.doi.org/10.1371/journal.pone.0145549			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689370	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300088
J	Teichenne, J; Morro, M; Casellas, A; Jimenez, V; Tellez, N; Leger, A; Bosch, F; Ayuso, E				Teichenne, Joan; Morro, Meritxell; Casellas, Alba; Jimenez, Veronica; Tellez, Noelia; Leger, Adrien; Bosch, Fatima; Ayuso, Eduard			Identification of miRNAs Involved in Reprogramming Acinar Cells into Insulin Producing Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PANCREATIC EXOCRINE CELLS; TRANSCRIPTION FACTORS; AR42J CELLS; MICRORNA EXPRESSION; SECRETING DUCTS; BETA-CELLS; IN-VITRO; DIFFERENTIATION; LIVER	Reprogramming acinar cells into insulin producing cells using adenoviral (Ad)-mediated delivery of Pdx1, Ngn3 and MafA (PNM) is an innovative approach for the treatment of diabetes. Here, we aimed to investigate the molecular mechanisms involved in this process and in particular, the role of microRNAs. To this end, we performed a comparative study of acinar-to-beta cell reprogramming efficiency in the rat acinar cell line AR42J and its subclone B13 after transduction with Ad-PNM. B13 cells were more efficiently reprogrammed than AR42J cells, which was demonstrated by a strong activation of beta cell markers (Ins1, Ins2, IAPP, NeuroD1 and Pax4). miRNome panels were used to analyze differentially expressed miRNAs in acinar cells under four experimental conditions (i) non-transduced AR42J cells, (ii) non-transduced B13 cells, (iii) B13 cells transduced with Ad-GFP vectors and (iv) B13 cells transduced with Ad-PNM vectors. A total of 59 miRNAs were found to be differentially expressed between non-transduced AR42J and B13 cells. Specifically, the miR-200 family was completely repressed in B13 cells, suggesting that these cells exist in a less differentiated state than AR42J cells and as a consequence they present a greater plasticity. Adeno-viral transduction per se induced dedifferentiation of acinar cells and 11 miRNAs were putatively involved in this process, whereas 8 miRNAs were found to be associated with PNM expression. Of note, Ad-PNM reprogrammed B13 cells presented the same levels of miR-137-3p, miR-135a-5p, miR-204-5p and miR-210-3p of those detected in islets, highlighting their role in the process. In conclusion, this study led to the identification of miRNAs that might be of compelling importance to improve acinar-to-beta cell conversion for the future treatment of diabetes.	[Teichenne, Joan; Morro, Meritxell; Casellas, Alba; Jimenez, Veronica; Bosch, Fatima; Ayuso, Eduard] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Bellaterra, Spain; [Teichenne, Joan; Morro, Meritxell; Casellas, Alba; Jimenez, Veronica; Bosch, Fatima; Ayuso, Eduard] Univ Autonoma Barcelona, Sch Vet Med, Dept Biochem & Mol Biol, Bellaterra, Spain; [Morro, Meritxell; Casellas, Alba; Jimenez, Veronica; Tellez, Noelia; Bosch, Fatima; Ayuso, Eduard] CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain; [Tellez, Noelia] IDIBELL, Bellvitge Biomed Res Inst, Barcelona, Spain; [Leger, Adrien; Ayuso, Eduard] Univ Nantes, Lab Therapie Gen, INSERM, UMR1089, Nantes, France; [Leger, Adrien; Ayuso, Eduard] Atlantic Gene Therapies, Nantes, France	Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Ayuso, E (corresponding author), Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Bellaterra, Spain.	eduard.ayuso@univ-nantes.fr	AYUSO LOPEZ, Eduardo/I-7686-2017; JIMENEZ, VERONICA/AAL-2626-2021; Tellez, Noelia/C-1029-2008; CASELLAS, ALBA/AAG-6719-2020; Morró Larrubia, Meritxell/L-3345-2017	JIMENEZ, VERONICA/0000-0001-9145-9877; Tellez, Noelia/0000-0001-7879-3256; Morró Larrubia, Meritxell/0000-0003-1725-9599; BOSCH, FATIMA/0000-0002-7705-5515; Ayuso, Eduard/0000-0003-0811-2229; CASELLAS, ALBA/0000-0003-0203-4733; Leger, Adrien/0000-0001-8772-6776; Teichenne, Joan/0000-0002-3455-5923	European Foundation for the Study of Diabetes ("Young Investigator Award Innovative Therapies for Type 1 Diabetes" - EFSD/JDRF/Roche); Ministerio de Economia y Competitividad [SAF 2014-54866-R]; Generalitat de Catalunya [2014SGR-1669]; Direccio General de Recerca, Generalitat de Catalunya; Ministerio de Educacion, Cultura y Deporte, Spain; ICREA Academia Award	European Foundation for the Study of Diabetes ("Young Investigator Award Innovative Therapies for Type 1 Diabetes" - EFSD/JDRF/Roche); Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Direccio General de Recerca, Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Educacion, Cultura y Deporte, Spain(Spanish Government); ICREA Academia Award(ICREA)	This work was supported by grants from the European Foundation for the Study of Diabetes ("Young Investigator Award Innovative Therapies for Type 1 Diabetes" sponsored by EFSD/JDRF/Roche) to EA and "Ministerio de Economia y Competitividad (SAF 2014-54866-R) and Generalitat de Catalunya (2014SGR-1669 and ICREA Academia Award) to FB. JT and MM were recipients of predoctoral fellowships from Direccio General de Recerca, Generalitat de Catalunya, and from Ministerio de Educacion, Cultura y Deporte, Spain, respectively.	Akinci E, 2012, BIOCHEM J, V442, P539, DOI 10.1042/BJ20111678; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Banga A, 2014, GENE THER, V21, P19, DOI 10.1038/gt.2013.50; Banga A, 2012, P NATL ACAD SCI USA, V109, P15336, DOI 10.1073/pnas.1201701109; Chen YJ, 2014, CELL REP, V6, P1046, DOI 10.1016/j.celrep.2014.02.013; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; CHRISTOPHE J, 1994, AM J PHYSIOL, V266, pG963, DOI 10.1152/ajpgi.1994.266.6.G963; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; Fairhall EA, 2013, TOXICOL RES-UK, V2, P308, DOI 10.1039/c3tx50030f; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Francis Natalie, 2014, Microrna, V3, P54; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; International Diabetes Federation, DIABETES ATLAS, V9th; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Jimenez V, 2011, DIABETOLOGIA, V54, P1075, DOI 10.1007/s00125-011-2070-3; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaneto H, 2005, DIABETES, V54, P1009, DOI 10.2337/diabetes.54.4.1009; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Klein D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055064; Lahmy R, 2014, MOL BIOL REP, V41, P2055, DOI 10.1007/s11033-014-3054-4; Lan MS, 2014, LIFE SCI, V114, P45, DOI 10.1016/j.lfs.2014.08.001; Li H, 2008, J BIOMED SCI, V15, P487, DOI 10.1007/s11373-008-9233-3; Li WD, 2014, NAT BIOTECHNOL, V32, P1223, DOI 10.1038/nbt.3082; Lima MJ, 2013, DIABETES, V62, P2821, DOI 10.2337/db12-1256; Lima MJ, 2012, MOL CELL ENDOCRINOL, V358, P69, DOI 10.1016/j.mce.2012.02.024; LONGNECKER DS, 1979, CANCER LETT, V7, P197, DOI 10.1016/S0304-3835(79)80080-4; Lu J, 2014, BIOCHEM BIOPH RES CO, V453, P405, DOI 10.1016/j.bbrc.2014.09.095; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Marek CJ, 2003, BIOCHEM J, V370, P763, DOI 10.1042/BJ20021545; Mashima H, 1996, J CLIN INVEST, V97, P1647, DOI 10.1172/JCI118591; Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Miravet S, 2014, METHODS MOL BIOL, V1089, P159, DOI 10.1007/978-1-62703-679-5_12; Morro M, 2014, HUM GENE THER, V25, P824, DOI 10.1089/hum.2013.182; Ogihara T, 2008, ENDOCR J, V55, P691, DOI 10.1507/endocrj.K07E-169; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Strauss WM, 2006, MAMM GENOME, V17, P833, DOI 10.1007/s00335-006-0025-7; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tellez N, 2007, DIABETOLOGIA, V50, P602, DOI 10.1007/s00125-006-0548-1; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang AY, 2007, MOL THER, V15, P255, DOI 10.1038/sj.mt.6300032; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zaldumbide A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048093; Zhang YQ, 2001, DIABETES, V50, pS10, DOI 10.2337/diabetes.50.2007.S10; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	49	4	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145116	10.1371/journal.pone.0145116	http://dx.doi.org/10.1371/journal.pone.0145116			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690959	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300038
J	Xie, SJ; Zhang, XJ; Zhang, JQ; Li, FH; Xiang, JH				Xie, Shijun; Zhang, Xiaojun; Zhang, Jiquan; Li, Fuhua; Xiang, Jianhai			Envelope Proteins of White Spot Syndrome Virus (WSSV) Interact with Litopenaeus vannamei Peritrophin-Like Protein (LvPT)	PLOS ONE			English	Article							STRUCTURAL PROTEINS; PROTEOMIC ANALYSIS; MEMBRANE; WSBV; GENE	White spot syndrome virus (WSSV) is a major pathogen in shrimp cultures. The interactions between viral proteins and their receptors on the surface of cells in a frontier target tissue are crucial for triggering an infection. In this study, a yeast two-hybrid (Y2H) library was constructed using cDNA obtained from the stomach and gut of Litopenaeus vannamei, to ascertain the role of envelope proteins in WSSV infection. For this purpose, VP37 was used as the bait in the Y2H library screening. Forty positive clones were detected after screening. The positive clones were analyzed and discriminated, and two clones belonging to the peritrophin family were subsequently confirmed as genuine positive clones. Sequence analysis revealed that both clones could be considered as the same gene, LV-peritrophin (LvPT). Co-immunoprecipitation confirmed the interaction between LvPT and VP37. Further studies in the Y2H system revealed that LvPT could also interact with other WSSV envelope proteins such as VP32, VP38A, VP39B, and VP41A. The distribution of LvPT in tissues revealed that LvPT was mainly expressed in the stomach than in other tissues. In addition, LvPT was found to be a secretory protein, and its chitin-binding ability was also confirmed.	[Xie, Shijun; Zhang, Xiaojun; Zhang, Jiquan; Li, Fuhua; Xiang, Jianhai] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao 266071, Peoples R China; [Xie, Shijun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiang, JH (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao 266071, Peoples R China.	jhxiang@qdio.ac.cn	zhang, jin/GXV-9154-2022	zhang, Jiquan/0000-0001-5063-339X	National Major Fundamental Research Program (973 program) [2012CB114403]; National High-Tech Research and Development Program (863 program) [2012AA10A404]	National Major Fundamental Research Program (973 program)(National Basic Research Program of China); National High-Tech Research and Development Program (863 program)	This work was financially supported by the National Major Fundamental Research Program (973 program 2012CB114403) and the National High-Tech Research and Development Program (863 program 2012AA10A404).	Bao YY, 2013, FEBS J, V280, P939, DOI 10.1111/febs.12088; Chang YS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010718; Chen KY, 2009, FISH SHELLFISH IMMUN, V27, P460, DOI 10.1016/j.fsi.2009.06.018; Chou HY, 1998, AQUACULTURE, V164, P263, DOI 10.1016/S0044-8486(98)00192-6; Di Leonardo VA, 2005, J FISH DIS, V28, P565, DOI 10.1111/j.1365-2761.2005.00659.x; EISEMAN CH, 1994, INT J PARASITOL, V24, P15, DOI 10.1016/0020-7519(94)90055-8; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Huang CH, 2002, MOL CELL PROTEOMICS, V1, P223, DOI 10.1074/mcp.M100035-MCP200; Kang WK, 2003, ARCH VIROL, V148, P99, DOI 10.1007/s00705-002-0902-7; Liu QH, 2009, LETT APPL MICROBIOL, V48, P44, DOI 10.1111/j.1472-765X.2008.02482.x; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Martin GG, 2006, BIOL BULL-US, V211, P275, DOI 10.2307/4134549; Oidtmann B, 2011, TRANSBOUND EMERG DIS, V58, P469, DOI 10.1111/j.1865-1682.2011.01231.x; Sangsuriya P, 2014, MOL CELL PROTEOMICS, V13, P269, DOI 10.1074/mcp.M113.029199; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; Tsai JM, 2004, J VIROL, V78, P11360, DOI 10.1128/JVI.78.20.11360-11370.2004; van Hulten MCW, 2000, J GEN VIROL, V81, P2525, DOI 10.1099/0022-1317-81-10-2525; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; Wang CH, 1995, DIS AQUAT ORGAN, V23, P239, DOI 10.3354/dao023239; Wang LY, 2013, FISH SHELLFISH IMMUN, V35, P840, DOI 10.1016/j.fsi.2013.06.018; Wang LY, 2012, FISH SHELLFISH IMMUN, V33, P1285, DOI 10.1016/j.fsi.2012.09.014; Wu WL, 2005, VIROLOGY, V332, P578, DOI 10.1016/j.virol.2004.12.011; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Yu Y, 2015, CHIN J OCEANOL LIMN, V33, P1, DOI 10.1007/s00343-014-3232-1; Zhang CC, 2014, J BIOSCIENCES, V39, P63, DOI 10.1007/s12038-013-9411-y	26	30	32	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144922	10.1371/journal.pone.0144922	http://dx.doi.org/10.1371/journal.pone.0144922			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692362	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300026
J	Diaz, E; Poblador-Pou, B; Gimeno-Feliu, LA; Calderon-Larranaga, A; Kumar, BN; Prados-Torres, A				Diaz, Esperanza; Poblador-Pou, Beatriz; Gimeno-Feliu, Luis-Andres; Calderon-Larranaga, Amaia; Kumar, Bernadette N.; Prados-Torres, Alexandra			Multimorbidity and Its Patterns according to Immigrant Origin. A Nationwide Register-Based Study in Norway	PLOS ONE			English	Article							PRIMARY-HEALTH-CARE; RACIAL/ETHNIC VARIATIONS; ALLOSTATIC OVERLOAD; DISEASE CLUSTERS; GENERAL-PRACTICE; SERVICES; BURDEN; POPULATION; EUROPE; BORN	Introduction As the flows of immigrant populations increase worldwide, their heterogeneity becomes apparent with respect to the differences in the prevalence of chronic physical and mental disease. Multimorbidity provides a new framework in understanding chronic diseases holistically as the consequence of environmental, social, and personal risks that contribute to increased vulnerability to a wide variety of illnesses. There is a lack of studies on multimorbidity among immigrants compared to native-born populations. Methodology This nationwide multi-register study in Norway enabled us i) to study the associations between multimorbidity and immigrant origin, accounting for other known risk factors for multimorbidity such as gender, age and socioeconomic levels using logistic regression analyses, and ii) to identify patterns of multimorbidity in Norway for immigrants and Norwegian-born by means of exploratory factor analysis technique. Results Multimorbidity rates were lower for immigrants compared to Norwegian-born individuals, with unadjusted odds ratios (OR) and 95% confidence intervals 0.38 (0.37-0.39) for Eastern Europe, 0.58 (0.57-0.59) for Asia, Africa and Latin America, and 0.67 (0.66-0.68) for Western Europe and North America. Results remained significant after adjusting for socioeconomic factors. Similar multimorbidity disease patterns were observed among Norwegian-born and immigrants, in particular between Norwegian-born and those from Western European and North American countries. However, the complexity of patterns that emerged for the other immigrant groups was greater. Despite differences observed in the development of patterns with age, such as ischemic heart disease among immigrant women, we were unable to detect the systematic development of the multimorbidity patterns among immigrants at younger ages. Conclusions Our study confirms that migrants have lower multimorbidity levels compared to Norwegian-born. The greater complexity of multimorbidity patterns for some immigrant groups requires further investigation. Health care policies and practice will require a holistic approach for specific population groups in order to meet their health needs and to curb and prevent diseases.	[Diaz, Esperanza] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Diaz, Esperanza; Kumar, Bernadette N.] Norwegian Ctr Minor Hlth Res, Oslo, Norway; [Poblador-Pou, Beatriz; Gimeno-Feliu, Luis-Andres; Calderon-Larranaga, Amaia; Prados-Torres, Alexandra] Miguel Servet Univ Hosp, IIS Aragon, Aragon Hlth Sci Inst IACS, EpiChron Res Grp Chron Dis, Zaragoza, Spain; [Poblador-Pou, Beatriz; Calderon-Larranaga, Amaia; Prados-Torres, Alexandra] Carlos III Hlth Inst, Red Invest Serv Salud Enfermedades Cron REDISSEC, Madrid, Spain; [Gimeno-Feliu, Luis-Andres] San Pablo Hlth Ctr, Zaragoza, Spain; [Gimeno-Feliu, Luis-Andres; Prados-Torres, Alexandra] Univ Zaragoza, Zaragoza, Spain; [Kumar, Bernadette N.] Univ Oslo, Inst Hlth & Soc, Oslo, Norway	University of Bergen; Miguel Servet University Hospital; University of Zaragoza; University of Oslo	Diaz, E (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	esperanza.diaz@uib.no	Prados-Torres, Alexandra/P-5818-2017; Gimeno-Feliu, Luis Andrés/E-5390-2016; Calderón-Larrañaga, Amaia/ABC-6828-2021; Poblador-Plou, Beatriz/ABC-7915-2020	Prados-Torres, Alexandra/0000-0002-5704-6056; Gimeno-Feliu, Luis Andrés/0000-0003-2928-6623; Calderón-Larrañaga, Amaia/0000-0001-9064-9222; Poblador-Plou, Beatriz/0000-0002-5119-5093	World University Network grant from the University of Bergen	World University Network grant from the University of Bergen	Dr Gimeno-Feliu from the EpiChron Research Group on Chronic Diseases received a World University Network grant from the University of Bergen that allowed the authors to continue the previously started collaboration between the research groups. Otherwise, the authors received no specific funding for this work.; Dr Gimeno-Feliu from the EpiChron Research Group on Chronic Diseases received a World University Network grant from the University of Bergen that allowed us to continue the previously started collaboration between the research groups.	Adepoju O, 2015, J GEN INTERN MED, V30, P93, DOI 10.1007/s11606-014-3005-8; AE C., 2007, INSULIN, V2, P80, DOI DOI 10.1016/S1557-0843(07)80019-4; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bathia R, 2007, BMC FAMILY PRACTICE, V8; Calderon-Larranaga A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659295; Carlsson L, 2002, INT J HEALTH PLAN M, V17, P269, DOI 10.1002/hpm.674; Cooper B, 2005, EPIDEMIOL PSICHIAT S, V14, P137, DOI 10.1017/S1121189X00006382; de-la-Iglesia-Inigo S, 2013, T ROY SOC TROP MED H, V107, P91, DOI 10.1093/trstmh/trs017; Diaz E, 2015, TROP MED INT HEALTH, V20, P1805, DOI 10.1111/tmi.12615; Diaz E, 2015, DEMENT GERIATR COGN, V39, P321, DOI 10.1159/000375526; Diaz E, 2015, EUR J PUBLIC HEALTH, V25, P72, DOI 10.1093/eurpub/cku123; Diaz E, 2014, SCAND J PRIM HEALTH, V32, P232, DOI 10.3109/02813432.2014.982368; Diaz E, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0623-0; Doamekpor LA, 2015, AM J PUBLIC HEALTH, V105, P591, DOI 10.2105/AJPH.2014.302285; Frese T, 2012, SWISS MED WEEKLY, V142, DOI DOI 10.4414/SMW.2012.13621; Gatta G, 2013, ANN ONCOL, V24, P1660, DOI 10.1093/annonc/mdt030; Grabovschi C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-94; Harrison C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004694; Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363; Information CfH, 2006, INT CLASS PRIM CAR 2; Jatrana S, 2014, SOC SCI MED, V119, P53, DOI 10.1016/j.socscimed.2014.08.008; Jensen NK, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-17; Klinthall M, 2011, ETHNIC HEALTH, V16, P601, DOI 10.1080/13557858.2011.602392; Kreps GL, 2008, PATIENT EDUC COUNS, V71, P328, DOI 10.1016/j.pec.2008.03.001; Kuwornu JP, 2014, CHRON DIS INJ CAN, V34, P218; Le Reste JY, 2013, J AM MED DIR ASSOC, V14, P132, DOI 10.1016/j.jamda.2012.07.017; Lynch CP, 2015, J GEN INTERN MED, V30, P25, DOI 10.1007/s11606-014-2990-y; Lyratzopoulos G, 2012, LANCET ONCOL, V13, P353, DOI 10.1016/S1470-2045(12)70041-4; McDonald JT, 2004, SOC SCI MED, V59, P1613, DOI 10.1016/j.socscimed.2004.02.004; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Mercer SW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4152; MOrk E, 2011, SENIORER NORGE 2010; Morrone A, 2012, EUR J PUBLIC HEALTH, V22, P256, DOI 10.1093/eurpub/ckq144; Nergard TB., 2008, RAPPORT FRA FEM NORS; Norredam M, 2010, EUR J PUBLIC HEALTH, V20, P555, DOI 10.1093/eurpub/ckp195; Nussbaumer-Ochsner Y, 2011, CHEST, V139, P165, DOI 10.1378/chest.10-1252; O'Mahony Joyce Maureen, 2007, Issues Ment Health Nurs, V28, P453; Offidani E, 2012, BRAIN BEHAV IMMUN, V26, P284, DOI 10.1016/j.bbi.2011.09.009; Pfortmueller CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082671; Poblador-Plou B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100375; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Quinones AR, 2011, J GERONTOL B-PSYCHOL, V66, P739, DOI 10.1093/geronb/gbr106; Rabanal KS, 2013, EUR J PREV CARDIOL, V20, P1013, DOI 10.1177/2047487312450539; Rassjo EB, 2013, SEX REPROD HEALTHC, V4, P99, DOI 10.1016/j.srhc.2013.06.001; Razum O, 2000, INT J EPIDEMIOL, V29, P191, DOI 10.1093/ije/29.1.191; Razum O, 2006, INT J EPIDEMIOL, V35, P919, DOI 10.1093/ije/dyl143; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Roberts KC, 2015, HEALTH PROMOT CHRON, V35, DOI 10.24095/hpcdp.35.6.01; Rousseau C, 2008, CAN J PUBLIC HEALTH, V99, P290, DOI 10.1007/BF03403757; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schafer I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1285; Shiroma Paulo R, 2011, J Cult Divers, V18, P3; Sole-Auro A, 2008, INT MIGR REV, V42, P861, DOI 10.1111/j.1747-7379.2008.00150.x; SSB, 2008, COUNTR CIT SOC STAT; Starfield B, 2011, HEALTH POLICY, V103, P3, DOI 10.1016/j.healthpol.2011.09.004; Straiton M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-341; Tomasdottir MOT, 2013, EUR J PERSON CTR HEA, V2, P335; Tran AT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-554; Varvin Sverre, 2009, Tidsskr Nor Laegeforen, V129, P1488, DOI 10.4045/tidsskr.08.0212; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; Viruell-Fuentes EA, 2012, SOC SCI MED, V75, P2099, DOI 10.1016/j.socscimed.2011.12.037; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176	63	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145233	10.1371/journal.pone.0145233	http://dx.doi.org/10.1371/journal.pone.0145233			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9KM	26684188	Green Published, gold, Green Submitted			2022-12-27	WOS:000366725800049
J	Jomoui, W; Fucharoen, G; Sanchaisuriya, K; Nguyen, VH; Fucharoen, S				Jomoui, Wittaya; Fucharoen, Goonnapa; Sanchaisuriya, Kanokwan; Van Hoa Nguyen; Fucharoen, Supan			Hemoglobin Constant Spring among Southeast Asian Populations: Haplotypic Heterogeneities and Phylogenetic Analysis	PLOS ONE			English	Article							NORTHEAST THAILAND; H-DISEASE; HEMATOLOGICAL CHARACTERIZATION; ALPHA-THALASSEMIA; MOLECULAR-BASIS; FEATURES; GENE; VIETNAM; ORIGINS	Background Hemoglobin Constant Spring (Hb CS) is an abnormal Hb caused by a mutation at the termination codon of alpha 2-globin gene found commonly among Southeast Asian and Chinese people. Association of Hb CS with alpha(0)-thalassemia leads to a thalassemia intermedia syndrome commonly encountered in the region. We report chromosome background and addressed genetic origins of Hb CS observed in a large cohort of Hb CS among Southeast Asian populations. Materials and Methods A study was done on 102 Vietnamese (aged 15-49 year-old) and 40 Laotian (aged 18-39 year-old) subjects with Hb CS and results compared with 120 Hb CS genes in Thailand. Hematological parameters were recorded and Hb analysis was performed using capillary electrophoresis. Hb CS mutation and thalassemia genotypes were defined by DNA analysis. Six DNA polymorphisms within a-globin gene cluster including 5' Xba I, Bgl I, Inter-zeta HVR, AccI, RsaI and aPstI 3', were determined using PCR-RFLP assay. Results Nine different genotypes of Hb CS were observed. In contrast to the Thai Hb CS alleles which are mostly linked to haplotype (+-S + + -), most of the Vietnamese and the Laotian Hb CS genes were associated with haplotype (+-M + + -), both of which are different from that of the European Hb CS. Conclusions Hb CS is commonly found in combination with other thalassemias among Southeast Asian populations. Accurate genotyping of the cases requires both hematologic and DNA analyses. At least two independent origins are associated with the Hb CS gene which could indirectly explain the high prevalence of this Hb variant in the region.	[Jomoui, Wittaya] Khon Kaen Univ, Grad Sch, Program Biomed Sci, Khon Kaen, Thailand; [Jomoui, Wittaya; Fucharoen, Goonnapa; Sanchaisuriya, Kanokwan; Fucharoen, Supan] Khon Kaen Univ, Fac Associated Med Sci, Med Diagnost Labs, Ctr Res & Dev, Khon Kaen, Thailand; [Van Hoa Nguyen] Hue Coll Med, Hue, Vietnam; [Van Hoa Nguyen] Hue Coll Pharm, Hue, Vietnam	Khon Kaen University; Khon Kaen University; Hue University; Hue University	Fucharoen, S (corresponding author), Khon Kaen Univ, Fac Associated Med Sci, Med Diagnost Labs, Ctr Res & Dev, Khon Kaen, Thailand.	supan@kku.ac.th	Jomoui, Wittaya/AEU-0406-2022		National Research University Program of Khon Kaen University; Royal Golden Jubilee PhD Program of the Thailand Research Fund (TRF), Thailand [PHD/0210/2553]	National Research University Program of Khon Kaen University; Royal Golden Jubilee PhD Program of the Thailand Research Fund (TRF), Thailand	This work was supported by the National Research University Program of Khon Kaen University and the Office of the Higher Education Commission, Ministry of Education to SF. WJ is supported by the Royal Golden Jubilee PhD Program (PHD/0210/2553) of the Thailand Research Fund (TRF), Thailand.	Boonsa S, 2004, ACTA HAEMATOL-BASEL, V111, P149, DOI 10.1159/000076523; Bunn HF, 1986, HEMOGLOBIN MOL GENET; Chen FE, 2000, NEW ENGL J MED, V343, P544, DOI 10.1056/NEJM200008243430804; Chui DHK, 2003, BLOOD, V101, P791, DOI 10.1182/blood-2002-07-1975; CLEGG JB, 1971, NATURE, V234, P337, DOI 10.1038/234337a0; El-Kalla S, 1998, ACTA HAEMATOL-BASEL, V100, P49, DOI 10.1159/000040863; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; Fucharoen G, 2002, HUM HERED, V53, P18, DOI 10.1159/000048600; Fucharoen S, 2003, HAEMATOLOGICA, V88, P1092; FUCHAROEN S, 1987, HEMOGLOBIN, V11, P65, DOI 10.3109/03630268709036587; FUCHAROEN S, 1990, LANCET, V335, P1527, DOI 10.1016/0140-6736(90)93065-W; Harteveld CL, 2001, HAEMATOLOGICA, V86, P36; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Nguyen HV, 2013, HEMOGLOBIN, V37, P333, DOI 10.3109/03630269.2013.790829; HUNT DM, 1982, BRIT J HAEMATOL, V51, P405, DOI 10.1111/j.1365-2141.1982.tb02796.x; Krause MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037214; Krishnamurti L, 1998, ANN NY ACAD SCI, V850, P415, DOI 10.1111/j.1749-6632.1998.tb10508.x; LAIG M, 1990, HUM GENET, V84, P188; LIU TC, 1994, AM J HEMATOL, V45, P293, DOI 10.1002/ajh.2830450405; Miles KL, 2001, BRIT J HAEMATOL, V113, P694, DOI 10.1046/j.1365-2141.2001.02823.x; Noguera NI, 2000, HAEMATOLOGICA, V85, P667; Sae-Ung N, 2007, ACTA HAEMATOL-BASEL, V117, P78, DOI 10.1159/000096857; Schrier SL, 1997, BLOOD, V89, P1762, DOI 10.1182/blood.V89.5.1762.1762_1762_1769; Singsanan S, 2007, ANN HEMATOL, V86, P665, DOI 10.1007/s00277-007-0310-x; Tritipsombut J, 2012, HEMOGLOBIN, V36, P47, DOI 10.3109/03630269.2011.637149; Nguyen VH, 2014, BLOOD CELL MOL DIS, V52, P161, DOI 10.1016/j.bcmd.2013.12.002; Yamsri S, 2010, PRENATAL DIAG, V30, P540, DOI 10.1002/pd.2514	27	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145230	10.1371/journal.pone.0145230	http://dx.doi.org/10.1371/journal.pone.0145230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683994	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800048
J	Myers, JS; von Lersner, AK; Robbins, CJ; Sang, QXA				Myers, Jennifer S.; von Lersner, Ariana K.; Robbins, Charles J.; Sang, Qing-Xiang Amy			Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IN-SITU HYBRIDIZATION; C-MYC ONCOGENE; TGF-BETA; PROTEIN EXPRESSION; SIGNALING PATHWAY; BREAST-CANCER; RAN-GTPASE; TRANSFORMING GROWTH-FACTOR-BETA-1; RADICAL PROSTATECTOMY	Genomic technologies including microarrays and next-generation sequencing have enabled the generation of molecular signatures of prostate cancer. Lists of differentially expressed genes between malignant and non-malignant states are thought to be fertile sources of putative prostate cancer biomarkers. However such lists of differentially expressed genes can be highly variable for multiple reasons. As such, looking at differential expression in the context of gene sets and pathways has been more robust. Using next-generation genome sequencing data from The Cancer Genome Atlas, differential gene expression between age- and stage- matched human prostate tumors and non-malignant samples was assessed and used to craft a pathway signature of prostate cancer. Up- and down-regulated genes were assigned to pathways composed of curated groups of related genes from multiple databases. The significance of these pathways was then evaluated according to the number of differentially expressed genes found in the pathway and their position within the pathway using Gene Set Enrichment Analysis and Signaling Pathway Impact Analysis. The "transforming growth factor-beta signaling" and "Ran regulation of mitotic spindle formation" pathways were strongly associated with prostate cancer. Several other significant pathways confirm reported findings from microarray data that suggest actin cytoskeleton regulation, cell cycle, mitogen-activated protein kinase signaling, and calcium signaling are also altered in prostate cancer. Thus we have demonstrated feasibility of pathway analysis and identified an underexplored area (Ran) for investigation in prostate cancer pathogenesis.	[Myers, Jennifer S.; von Lersner, Ariana K.; Robbins, Charles J.; Sang, Qing-Xiang Amy] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Sang, Qing-Xiang Amy] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Sang, QXA (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.	qxsang@chem.fsu.edu		Robbins, Charles/0000-0002-3130-7107	Leslie N. Wilson-Delores Auzenne Graduate Assistantship for Minorities; Florida State University Graduate School; Research Experience Program of Women in Math, Science, and Engineering of Florida State University; Florida State University; Endowed Chair Professorship in Cancer Research	Leslie N. Wilson-Delores Auzenne Graduate Assistantship for Minorities; Florida State University Graduate School; Research Experience Program of Women in Math, Science, and Engineering of Florida State University; Florida State University; Endowed Chair Professorship in Cancer Research	This work was in part supported by the Leslie N. Wilson-Delores Auzenne Graduate Assistantship for Minorities awarded to JSM by the Florida State University Graduate School, the Research Experience Program of Women in Math, Science, and Engineering of Florida State University to AKVL, and grants from the Florida State University and an Endowed Chair Professorship in Cancer Research from anonymous donors to QXAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Jinfeng Zhang and Mr. Kaixian Yu in the Departments of Statistics at Florida State University for helpful discussions. This work was in part supported by the Leslie N. Wilson-Delores Auzenne Graduate Assistantship for Minorities awarded to JSM by the Florida State University Graduate School, the Research Experience Program of Women in Math, Science, and Engineering of Florida State University to AKVL, and grants from the Florida State University and an Endowed Chair Professorship in Cancer Research from anonymous donors to QXAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalinkeel R, 2004, CANCER RES, V64, P5311, DOI 10.1158/0008-5472.CAN-2506-2; Aaltomaa S, 1999, PROSTATE, V39, P8; Abe H, 2008, INT J CANCER, V122, P2391, DOI 10.1002/ijc.23400; Abraham G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-277; Adler HL, 1999, J UROLOGY, V161, P182, DOI 10.1016/S0022-5347(01)62092-5; Ahram M, 2002, MOL CARCINOGEN, V33, P9, DOI 10.1002/mc.10019; Aitchison AA, 2008, PROSTATE, V68, P661, DOI 10.1002/pros.20730; Ajiboye S, 2010, BJU INT, V105, P913, DOI 10.1111/j.1464-410X.2009.08999.x; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Akimoto S, 1998, ENDOCR J, V45, P183, DOI 10.1507/endocrj.45.183; Alaiya AA, 2011, INT J ONCOL, V38, P1047, DOI 10.3892/ijo.2011.937; Anees M, 2011, CANCER-AM CANCER SOC, V117, P1172, DOI 10.1002/cncr.25504; Apakama I, 1996, BRIT J CANCER, V74, P1258, DOI 10.1038/bjc.1996.526; Arora R, 2004, CANCER-AM CANCER SOC, V100, P2362, DOI 10.1002/cncr.20243; Azuma K, 2004, CLIN CANCER RES, V10, P6695, DOI 10.1158/1078-0432.CCR-04-0818; Barres V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-272; Basu A, 2012, PROSTATE, V72, P597, DOI 10.1002/pros.21463; Bettuzzi S, 2000, CANCER RES, V60, P1472; Bettuzzi S, 2003, CANCER RES, V63, P3469; Bibikova M, 2007, GENOMICS, V89, P666, DOI 10.1016/j.ygeno.2007.02.005; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Blume-Jensen P, 2015, CLIN CANCER RES, V21, P2591, DOI 10.1158/1078-0432.CCR-14-2603; Bouraoui Y, 2008, CANCER DETECT PREV, V32, P23, DOI 10.1016/j.cdp.2008.02.007; Bubendorf L, 1999, CANCER RES, V59, P803; Bubendorf L, 1996, AM J PATHOL, V148, P1557; BUTTYAN R, 1987, PROSTATE, V11, P327, DOI 10.1002/pros.2990110405; Campa D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016914; Cardillo MR, 2000, ANAL QUANT CYTOL, V22, P1; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Cazares LH, 2002, CLIN CANCER RES, V8, P2541; Chaux A, 2012, MODERN PATHOL, V25, P1543, DOI 10.1038/modpathol.2012.104; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen JJ, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/909525; Chetcuti A, 2001, PROSTATE, V47, P132, DOI 10.1002/pros.1056; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; COLOMBEL M, 1993, AM J PATHOL, V143, P390; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Creighton CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001816; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Dallas SL, 2005, J CELL PHYSIOL, V202, P361, DOI 10.1002/jcp.20147; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Davalieva K, 2015, PROSTATE, V75, P1586, DOI 10.1002/pros.23034; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Diamandis EP, 2014, CLIN CHEM LAB MED, V52, P791, DOI 10.1515/cclm-2014-0317; Diamandis EP, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-87; Dijkstra S, 2014, CLIN BIOCHEM, V47, P889, DOI 10.1016/j.clinbiochem.2013.10.023; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Djonov V, 1997, PROSTATE, V31, P103; Drachenberg DE, 1999, PROSTATE, V41, P127, DOI 10.1002/(SICI)1097-0045(19991001)41:2<127::AID-PROS7>3.0.CO;2-H; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Ernst T, 2002, AM J PATHOL, V160, P2169, DOI 10.1016/S0002-9440(10)61165-0; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; FLEMING WH, 1986, CANCER RES, V46, P1535; Fukuchi M, 2001, MOL BIOL CELL, V12, P1431, DOI 10.1091/mbc.12.5.1431; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; George DJ, 2005, CLIN CANCER RES, V11, P1815, DOI 10.1158/1078-0432.CCR-04-1560; Gerdes MJ, 1998, J HISTOCHEM CYTOCHEM, V46, P379, DOI 10.1177/002215549804600312; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gordanpour A, 2012, PROSTATE CANCER P D, V15, P314, DOI 10.1038/pcan.2012.3; Gotoh A, 1997, J UROLOGY, V158, P636, DOI 10.1016/S0022-5347(01)64574-9; Green MML, 2007, INT J RADIAT ONCOL, V67, P84, DOI 10.1016/j.ijrobp.2006.08.077; Gregg JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-165; Grover SK, 2015, PATHOL ONCOL RES, V21, P651, DOI 10.1007/s12253-014-9870-y; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Harada N, 2008, BIOCHEM BIOPH RES CO, V373, P373, DOI 10.1016/j.bbrc.2008.06.024; Hawksworth D, 2010, PROSTATE CANCER P D, V13, P311, DOI 10.1038/pcan.2010.31; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hobisch A, 2000, J PATHOL, V191, P239, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH633>3.0.CO;2-X; Hoffman RM, 2011, NEW ENGL J MED, V365, P2013, DOI 10.1056/NEJMcp1103642; Hoque MO, 2005, J CLIN ONCOL, V23, P6569, DOI 10.1200/JCO.2005.07.009; Hsiao PW, 1999, J BIOL CHEM, V274, P20229, DOI 10.1074/jbc.274.29.20229; Hu J, 2013, NAT BIOTECHNOL, V31, P522, DOI 10.1038/nbt.2530; Hung KE, 2009, CANCER PREV RES, V2, P224, DOI 10.1158/1940-6207.CAPR-08-0153; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Jenkins RB, 1997, CANCER RES, V57, P524; Jia PL, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S3-S13; Johnson MI, 1998, PROSTATE, V37, P223, DOI 10.1002/(SICI)1097-0045(19981201)37:4<223::AID-PROS3>3.0.CO;2-O; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karnes RJ, 2013, J UROLOGY, V190, P2047, DOI 10.1016/j.juro.2013.06.017; Katayama H, 2008, CELL CYCLE, V7, P2691, DOI 10.4161/cc.7.17.6460; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Khan AP, 2010, MOL CELL PROTEOMICS, V9, P298, DOI 10.1074/mcp.M900159-MCP200; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Kim IY, 1998, CLIN CANCER RES, V4, P1625; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kiprijanovska Sanja, 2014, Int J Proteomics, V2014, P594761, DOI 10.1155/2014/594761; Knezevic D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-690; Koh Cheryl M, 2010, Genes Cancer, V1, P617, DOI 10.1177/1947601910379132; Kremer CL, 2006, PROSTATE, V66, P1203, DOI 10.1002/pros.20410; Kress TR, 2015, NAT REV CANCER, V15, P593, DOI 10.1038/nrc3984; Kurisetty VV, 2008, ONCOGENE, V27, P7139, DOI 10.1038/onc.2008.325; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Latil A, 2003, CLIN CANCER RES, V9, P5477; LaTulippe E, 2002, CANCER RES, V62, P4499; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lee SO, 2003, CLIN CANCER RES, V9, P370; Li P, 2002, AM J PATHOL, V161, P1467, DOI 10.1016/S0002-9440(10)64422-7; Lin BY, 1999, CANCER RES, V59, P4180; Lin JF, 2007, INT J CANCER, V121, P2596, DOI 10.1002/ijc.23016; LIU AJ, 2007, QUANTITATIVE ANAL PA, V8, P853; Liu F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-153; Liu QX, 2013, CANCER RES, V73, P3297, DOI 10.1158/0008-5472.CAN-12-3970; Lotan TL, 2011, CLIN CANCER RES, V17, P6563, DOI 10.1158/1078-0432.CCR-11-1244; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lucas JM, 2014, CANCER DISCOV, V4, P1310, DOI 10.1158/2159-8290.CD-13-1010; Lucas SM, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/640968; Lucia MS, 1998, J CELL PHYSIOL, V175, P184, DOI 10.1002/(SICI)1097-4652(199805)175:2<184::AID-JCP8>3.0.CO;2-K; Luo J, 2001, CANCER RES, V61, P4683; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Mack D, 1997, EUR J CANCER, V33, P317, DOI 10.1016/S0959-8049(96)00402-9; Mahapatra S, 2012, CLIN CANCER RES, V18, P2882, DOI 10.1158/1078-0432.CCR-11-2090; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; Mechergui YB, 2009, INFLAMMATION, V32, P202, DOI 10.1007/s10753-009-9121-7; Meehan KL, 2002, PROSTATE, V50, P54, DOI 10.1002/pros.10032; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Michaelis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019705; Michalaki V, 2004, BRIT J CANCER, V90, P2312, DOI 10.1038/sj.bjc.6601814; Moore JD, 2001, BIOESSAYS, V23, P77, DOI 10.1002/1521-1878(200101)23:1<77::AID-BIES1010>3.3.CO;2-5; Mori R, 2010, PROSTATE, V70, P1692, DOI 10.1002/pros.21204; Moul JW, 1996, SURGERY, V120, P159, DOI 10.1016/S0039-6060(96)80283-2; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Mucci NR, 2000, J NATL CANCER I, V92, P1941, DOI 10.1093/jnci/92.23.1941; Mukherjee R, 2011, BRIT J CANCER, V104, P1920, DOI 10.1038/bjc.2011.163; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nakashima J, 2000, CLIN CANCER RES, V6, P2702; Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7; Nunez C, 2008, HISTOPATHOLOGY, V53, P166, DOI 10.1111/j.1365-2559.2008.03092.x; Omar EA, 2001, PROSTATE, V49, P191, DOI 10.1002/pros.1134; Ouellet V, 2005, ONCOGENE, V24, P4672, DOI 10.1038/sj.onc.1208214; Ouellet V, 2006, INT J CANCER, V119, P599, DOI 10.1002/ijc.21902; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pannu V, 2015, ONCOTARGET, V6, P6076, DOI 10.18632/oncotarget.3475; Park JI, 2003, ONCOGENE, V22, P4314, DOI 10.1038/sj.onc.1206478; Perry KT, 1997, PROSTATE, V33, P133, DOI 10.1002/(SICI)1097-0045(19971001)33:2<133::AID-PROS7>3.0.CO;2-L; Qian DZ, 2009, CLIN CANCER RES, V15, P3135, DOI 10.1158/1078-0432.CCR-08-1982; R Core Team, 2021, R LANGUAGE ENV STAT; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Ravitz MJ, 1997, ADV CANCER RES, V71, P165, DOI 10.1016/S0065-230X(08)60099-8; Reis ST, 2013, CLINICS, V68, P652, DOI 10.6061/clinics/2013(05)12; Remo A, 2016, APPL IMMUNOHISTO M M, V24, P201, DOI 10.1097/PAI.0000000000000171; Revelos K, 2005, IN VIVO, V19, P911; Ricote M, 2004, CANCER-AM CANCER SOC, V100, P1388, DOI 10.1002/cncr.20142; Rigaud J, 2004, PROSTATE, V58, P269, DOI 10.1002/pros.10329; Robey RB, 2015, CARCINOGENESIS, V36, pS203, DOI 10.1093/carcin/bgv037; Royuela M, 1998, GROWTH FACTORS, V16, P101, DOI 10.3109/08977199809002121; Royuela M, 2000, GROWTH FACTORS, V18, P135, DOI 10.3109/08977190009003239; Ruscica M, 2006, ENDOCRINOLOGY, V147, P1466, DOI 10.1210/en.2005-0925; Sanlioglu AD, 2007, J UROLOGY, V177, P359, DOI 10.1016/j.juro.2006.08.087; Sato H, 2006, INT J UROL, V13, P761, DOI 10.1111/j.1442-2042.2006.01399.x; Savli H, 2008, EXP MOL MED, V40, P176, DOI 10.3858/emm.2008.40.2.176; Schroten C, 2012, CANCER IMMUNOL IMMUN, V61, P905, DOI 10.1007/s00262-011-1159-3; Shariat SF, 2004, UROLOGY, V63, P1191, DOI 10.1016/j.urology.2003.12.015; Shariat SF, 2004, CLIN CANCER RES, V10, P1992, DOI 10.1158/1078-0432.CCR-0768-03; Shariat SF, 2001, UROLOGY, V58, P1008, DOI 10.1016/S0090-4295(01)01405-4; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Song CJ, 2015, PROSTATE, V75, P500, DOI 10.1002/pros.22936; Stamey TA, 2001, J UROLOGY, V166, P2171, DOI 10.1016/S0022-5347(05)65528-0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamboli P, 1996, MODERN PATHOL, V9, P1015; Tanenbaum ME, 2009, CURR BIOL, V19, P1703, DOI 10.1016/j.cub.2009.08.027; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Tarca AL, 2013, SPIA SIGNALING PATHW; THOMPSON SJ, 1992, BRIT J UROL, V69, P609, DOI 10.1111/j.1464-410X.1992.tb15632.x; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; TRUONG LD, 1993, HUM PATHOL, V24, P4, DOI 10.1016/0046-8177(93)90055-L; TWILLIE DA, 1995, UROLOGY, V45, P542, DOI 10.1016/S0090-4295(99)80034-X; Ueda K, 2013, J PROTEOME RES, V12, P4497, DOI 10.1021/pr400547s; Vaarala MH, 2001, INT J CANCER, V94, P705, DOI 10.1002/ijc.1526; Vainio Paula, 2012, PLoS One, V7, pe39801, DOI 10.1371/journal.pone.0039801; Vainio P, 2011, ONCOTARGET, V2, P1176; Vainio P, 2011, AM J PATHOL, V178, P525, DOI 10.1016/j.ajpath.2010.10.002; Van der Kwast TH, 2014, VIRCHOWS ARCH, V464, P293, DOI 10.1007/s00428-014-1540-7; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Waalkes S, 2010, ONCOL REP, V23, P1257, DOI 10.3892/or_00000758; Wan YZ, 2010, J INTERF CYTOK RES, V30, P677, DOI 10.1089/jir.2009.0117; Wang Y, 2011, COMPUT BIOL CHEM, V35, P151, DOI 10.1016/j.compbiolchem.2011.04.003; Welsh JB, 2001, CANCER RES, V61, P5974; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; Wise GJ, 2000, J UROLOGY, V164, P722, DOI 10.1016/S0022-5347(05)67289-8; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279; Xu JC, 2000, CANCER RES, V60, P1677; Xu JF, 2005, CANCER EPIDEM BIOMAR, V14, P2563, DOI 10.1158/1055-9965.EPI-05-0356; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zeng L, 2004, HUM PATHOL, V35, P290, DOI 10.1016/j.humpath.2003.11.001; Zhang MS, 2014, DEV CELL, V31, P393, DOI 10.1016/j.devcel.2014.10.014; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365; Zhang M, 2009, BIOINFORMATICS, V25, P1662, DOI 10.1093/bioinformatics/btp295; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao HJ, 2007, J CELL PHYSIOL, V210, P111, DOI 10.1002/jcp.20828; Zhong WD, 2008, CLIN INVEST MED, V31, pE8, DOI 10.25011/cim.v31i1.3136	209	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145322	10.1371/journal.pone.0145322	http://dx.doi.org/10.1371/journal.pone.0145322			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683658	gold, Green Published, Green Submitted			2022-12-27	WOS:000366725800064
J	Mynhardt, S; Maree, S; Pelser, I; Bennett, NC; Bronner, GN; Wilson, JW; Bloomer, P				Mynhardt, Samantha; Maree, Sarita; Pelser, Illona; Bennett, Nigel C.; Bronner, Gary N.; Wilson, John W.; Bloomer, Paulette			Phylogeography of a Morphologically Cryptic Golden Mole Assemblage from South-Eastern Africa	PLOS ONE			English	Article							CHROMOSOMAL EVOLUTION; SPECIES DELIMITATION; GEOGRAPHIC-VARIATION; GENETIC-DIVERGENCE; MITOCHONDRIAL-DNA; DIVERSITY; SEQUENCES; DIVERSIFICATION; LANDSCAPE; CLIMATE	The Greater Maputaland-Pondoland-Albany (GMPA) region of southern Africa was recently designated as a centre of vertebrate endemism. The phylogeography of the vertebrate taxa occupying this region may provide insights into the evolution of faunal endemism in southeastern Africa. Here we investigate the phylogeographic patterns of an understudied small mammal species assemblage (Amblysomus) endemic to the GMPA, to test for cryptic diversity within the genus, and to better understand diversification across the region. We sampled specimens from 50 sites across the distributional range of Amblysomus, with emphasis on the widespread A. hottentotus, to analyse geographic patterns of genetic diversity using mitochondrial DNA (mtDNA) and nuclear intron data. Molecular dating was used to elucidate the evolutionary and phylogeographic history of Amblysomus. Our phylogenetic reconstructions show that A. hottentotus comprises several distinct lineages, or evolutionarily significant units (ESUs), some with restricted geographic ranges and thus worthy of conservation attention. Divergence of the major lineages dated to the early Pliocene, with later radiations in the GMPA during the late-Pliocene to early-Pleistocene. Evolutionary diversification within Amblysomus may have been driven by uplift of the Great Escarpment c. 5-3 million years ago (Ma), habitat changes associated with intensification of the east-west rainfall gradient across South Africa and the influence of subsequent global climatic cycles. These drivers possibly facilitated geographic spread of ancestral lineages, local adaptation and vicariant isolation. Our study adds to growing empirical evidence identifying East and southern Africa as cradles of vertebrate diversity.	[Mynhardt, Samantha; Maree, Sarita; Pelser, Illona; Bloomer, Paulette] Univ Pretoria, Dept Genet, Mol Ecol & Evolut Programme, ZA-0002 Pretoria, South Africa; [Mynhardt, Samantha; Maree, Sarita; Bennett, Nigel C.; Wilson, John W.] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Bronner, Gary N.] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa	University of Pretoria; University of Pretoria; University of Cape Town	Bloomer, P (corresponding author), Univ Pretoria, Dept Genet, Mol Ecol & Evolut Programme, ZA-0002 Pretoria, South Africa.	paulette.bloomer@up.ac.za	Mynhardt, Samantha/N-3213-2019; Wilson, John W./E-9601-2011; Bloomer, Paulette/F-5501-2010; Bennett, Nigel/E-4238-2010; Bronner, Gary/E-9107-2010	Mynhardt, Samantha/0000-0001-9276-8700; Wilson, John W./0000-0002-7230-1449; Bloomer, Paulette/0000-0002-6357-0153; Bennett, Nigel/0000-0001-9748-2947; Bronner, Gary/0000-0002-2279-3094	National Research Foundation [46995]; Department of Science and Technology via the National Research Foundation funds the South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology	National Research Foundation; Department of Science and Technology via the National Research Foundation funds the South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology	This work was supported by National Research Foundation unique grant number 46995 to PB for running expenses and bursary support; Department of Science and Technology via the National Research Foundation funds the South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology held by NCB (running costs and PhD scholarship to S. Mynhardt, postdoctoral scholarship to S. Maree); www.nrf.ac.za. This work is based upon research supported by the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken N, 2004, MOL ECOL, V13, P1423, DOI 10.1111/j.1365-294X.2004.02159.x; [Anonymous], 2005, TERR VERT SPEC DAT; Asher RJ, 2010, PALAEONTOL ELECTRON, V13; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Berthier K, 2005, MOL ECOL, V14, P2861, DOI 10.1111/j.1365-294X.2005.02636.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bininda-Emonds ORP, 2007, EVOL BIOINFORM, V3, P59; Bowie RCK, 2006, MOL PHYLOGENET EVOL, V38, P171, DOI 10.1016/j.ympev.2005.06.001; Bronner GN, 2000, MAMMALIA, V64, P41, DOI 10.1515/mamm.2000.64.1.41; Bronner GN, 1996, MAMMALIA, V60, P707, DOI 10.1515/mamm.1996.60.4.707; Bronner GN, 2015, IUCN RED LIST THREAT; Bronner GN, 2005, MAMMAL SPECIES WORLD, P71; Bronner GN, 1995, SYSTEMATIC REVISION; Bronner GN, 2013, MAMMALS AFRICA, P226; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Broom R., 1941, ANN TRANSVAAL MUS, V20, P215; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; C.E.P.F. Ecosystem Profile, 2010, EC PROF MAP POND ALB; Carr AS, 2012, SO AFRICAN GEOMORPHO, P269; Castillo JA, 2014, MOL ECOL, V23, P843, DOI 10.1111/mec.12650; Ceccarelli FS, 2014, MOL PHYLOGENET EVOL, V80, P125, DOI 10.1016/j.ympev.2014.07.023; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coetzee J. A., 1978, Palaeoecology of Africa; Volume 10, P13; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; Cowling RM, 2009, MOL PHYLOGENET EVOL, V51, P64, DOI 10.1016/j.ympev.2008.05.034; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Demos TC, 2014, MOL PHYLOGENET EVOL, V71, P41, DOI 10.1016/j.ympev.2013.10.014; Diedericks G, 2014, MOL PHYLOGENET EVOL, V71, P234, DOI 10.1016/j.ympev.2013.10.015; Donoghue PCJ, 2007, TRENDS ECOL EVOL, V22, P424, DOI 10.1016/j.tree.2007.05.005; Driver A, 2012, SYNTHESIS REPORT; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, TRACER V 1 5; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dulvy NK, 2009, NATURE, V462, P417, DOI 10.1038/462417a; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; ESRI, 2011, ARCMAP V 10; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faulkes CG, 2004, MOL ECOL, V13, P613, DOI 10.1046/j.1365-294X.2004.02099.x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P325, DOI 10.1023/A:1018356506390; Fjeldsa J, 2012, ANNU REV ECOL EVOL S, V43, P249, DOI 10.1146/annurev-ecolsys-102710-145113; Gilbert C, 2008, CYTOGENET GENOME RES, V121, P110, DOI 10.1159/000125836; Gilbert C, 2006, CHROMOSOME RES, V14, P793, DOI 10.1007/s10577-006-1091-0; GLOBE, 1999, TOP MAP AFR BAS GLOB; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harmse HJ, 1978, BIOGEOGRAPHY ECOLOGY, P71; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HICKMAN GC, 1979, S AFR J ZOOL, V14, P9; Huhndorf MH, 2007, MOL ECOL, V16, P663, DOI 10.1111/j.1365-294X.2007.03153.x; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; LAWES MJ, 1990, J BIOGEOGR, V17, P669, DOI 10.2307/2845148; Linder HP, 2012, J BIOGEOGR, V39, P1189, DOI 10.1111/j.1365-2699.2012.02728.x; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; Lohman DJ, 2010, BIOL CONSERV, V143, P1885, DOI 10.1016/j.biocon.2010.04.042; Lorenzen ED, 2012, MOL ECOL, V21, P3656, DOI 10.1111/j.1365-294X.2012.05650.x; Luyt J, 2004, DEV MICROSATEL UNPUB; Lyons LA, 1997, NAT GENET, V15, P47, DOI 10.1038/ng0197-47; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Maud RR, 2012, SO AFRICAN GEOMORPHO, P7; McCarthy T., 2005, STORY EARTH LIFE SO; Mittermeier Russell A., 2004, P1; Montgelard C, 2012, ACTA OECOL, V42, P50, DOI 10.1016/j.actao.2012.02.001; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Mucina I., 2006, STRELITZIA, V19; Mucina L., 2006, VEGETATION S AFRICA, P349; Nascimento FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061924; Nei M., 2000, MOL EVOLUTION PHYLOG; Nicolas V, 2011, J BIOGEOGR, V38, P191, DOI 10.1111/j.1365-2699.2010.02399.x; Olson LE, 2004, BIOL J LINN SOC, V83, P1, DOI 10.1111/j.1095-8312.2004.00366.x; PALUMBI SR, 1994, MOL BIOL EVOL, V11, P426; Parker PG, 1998, ECOLOGY, V79, P361, DOI 10.1890/0012-9658(1998)079[0361:WMCTUA]2.0.CO;2; Partridge T. C., 1997, VEGETATION SO AFRICA, P5; Partridge TC, 2000, OXFORD MGR GEOL GEOP, P3; Perera SJ, 2011, S AFR J SCI, V107, P49, DOI 10.4102/sajs.v107i7/8.462; Pio DV, 2014, GLOBAL CHANGE BIOL, V20, P1538, DOI 10.1111/gcb.12524; Porat N, 2008, QUATERNARY SCI REV, V27, P1024, DOI 10.1016/j.quascirev.2008.01.017; Rambaut A, 2006, FIGTREE V1 4 2; Roberts A., 1951, MAMMALS S AFRICA; Roberts Austin, 1946, ANN TRANSVAAL MUS, V20, P303; Sambrook J., 2006, COMMONLY USED TECHNI, DOI 10.1101/pdb.prot4455; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seiffert ER, 2010, ACTA PAL POL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steenkamp Y., 2004, HOTSPOTS REVISITED E; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEMPLETON AR, 1992, GENETICS, V132, P619; Tolley KA, 2010, AFR J HERPETOL, V59, P17, DOI 10.1080/04416651003744943; Tyson PD, 2000, OXFORD MGR GEOL GEOP, P371; van Wyk AE., 2001, REGIONS FLORISTIC EN; Venta PJ, 1996, BIOCHEM GENET, V34, P321, DOI 10.1007/BF02399951; Voje KL, 2009, MOL ECOL, V18, P93, DOI 10.1111/j.1365-294X.2008.04002.x; Vrba ES, 2000, OXFORD MGR GEOL GEOP, P277; Waples R. S., 1991, DEFINITION SPECIES E; White F., 1978, Monographiae Biologicae, V31, P463; WILLOWS-MUNRO s, 2008, MOL EVOLUTION AFRICA; Willows-Munro S, 2011, J BIOGEOGR, V38, P1976, DOI 10.1111/j.1365-2699.2011.02543.x; YANG ZB, 1994, J MOL EVOL, V39, P105; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zou FH, 2007, MOL PHYLOGENET EVOL, V44, P165, DOI 10.1016/j.ympev.2006.12.004	106	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144995	10.1371/journal.pone.0144995	http://dx.doi.org/10.1371/journal.pone.0144995			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683828	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800029
J	Smilg, JS; Berger, LR				Smilg, Jacqueline S.; Berger, Lee R.			Discovering Hominins - Application of Medical Computed Tomography (CT) to Fossil-Bearing Rocks from the Site of Malapa, South Africa	PLOS ONE			English	Article							TOOTH ENAMEL THICKNESS; BONE DISTRIBUTION; CORTICAL BONE; MORPHOLOGY; PALEOANTHROPOLOGY; COMMUNICATION; VALIDATION; FEATURES; CRANIUM; BRAIN	In the South African context, computed tomography (CT) has been used applied to individually prepared fossils and small rocks containing fossils, but has not been utilized on large breccia blocks as a means of discovering fossils, and particularly fossil hominins. Previous attempts at CT imaging of rocks from other South African sites for this purpose yielded disappointing results. For this study, 109 fossil-bearing rocks from the site of Malapa, South Africa were scanned with medical CT prior to manual preparation. The resultant images were assessed for accuracy of fossil identification and characterization against the standard of manual preparation. The accurate identification of fossils, including those of early hominins, that were not visible on the surface of individual blocks, is shown to be possible. The discovery of unexpected fossils is reduced, thus lowering the potential that fossils could be damaged through accidental encounter during routine preparation, or even entirely missed. This study should significantly change the way fossil discovery, recovery and preparation is done in the South African context and has potential for application in other palaeontological situations. Medical CT imaging is shown to be reliable, readily available, cost effective and accurate in finding fossils within matrix conglomerates. Improvements in CT equipment and in CT image quality are such that medical CT is now a viable imaging modality for this palaeontological application.	[Smilg, Jacqueline S.] Charlotte Maxeke Johannesburg Acad Hosp, Dept Diagnost Radiol, Johannesburg, South Africa; [Smilg, Jacqueline S.; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Berger, Lee R.] Univ Witwatersrand, Natl Res Fdn, Ctr Excellence Palaeosci, Dept Sci & Technol, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand	Smilg, JS (corresponding author), Charlotte Maxeke Johannesburg Acad Hosp, Dept Diagnost Radiol, Johannesburg, South Africa.	jsmilg@yahoo.com	Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629				Adcock D, 2002, DIGITAL IMAGING; Badawi-Fayad J, 2005, SURG RADIOL ANAT, V27, P536, DOI 10.1007/s00276-005-0041-4; Balzeau A, 2005, J HUM EVOL, V48, P535, DOI 10.1016/j.jhevol.2005.01.002; Balzeau A, 2010, CR PALEVOL, V9, P265, DOI 10.1016/j.crpv.2010.07.006; Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Berger L.R., 2005, HIST MAKULEKA CONCES; Bolliger SA, 2012, RADIOGRAPHICS, V32, P1553, DOI 10.1148/rg.325115742; Bruhl, 1896, ARCH ANAT PHYSL 547, P547; Carpenter K, 2001, J PALEONTOLOGICAL SC, V07, P1; Coleman MN, 2007, AM J PHYS ANTHROPOL, V133, P723, DOI 10.1002/ajpa.20583; CONROY G C, 1991, Palaeontologia Africana, V28, P53; CONROY GC, 1984, SCIENCE, V226, P456, DOI 10.1126/science.226.4673.456; CONROY GC, 1990, SCIENCE, V247, P838, DOI 10.1126/science.2305255; Conroy GC, 1998, SCIENCE, V280, P1730, DOI 10.1126/science.280.5370.1730; Croker SL, 2009, HOMO, V60, P551, DOI 10.1016/j.jchb.2009.07.003; Cunningham JA, 2014, TRENDS ECOL EVOL, V29, P347, DOI 10.1016/j.tree.2014.04.004; DAEGLING DJ, 1991, AM J PHYS ANTHROPOL, V86, P321, DOI 10.1002/ajpa.1330860302; Daniels R, 2011, TECHNLOGIES USED INV; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; du Plessis A, 2013, J ARCHAEOL SCI, V40, P4607, DOI 10.1016/j.jas.2013.07.024; Fairdough I, 2010, CT SCANS OFFER NEW W; Falk D, 2005, SCIENCE, V308, P242, DOI 10.1126/science.1109727; Falk D, 2007, AM J PHYS ANTHROPOL, V134, P529, DOI 10.1002/ajpa.20697; Galik K, 2004, SCIENCE, V305, P1450, DOI 10.1126/science.1098807; GRINE F E, 1991, Palaeontologia Africana, V28, P61; Grine FE, 2004, S AFR J SCI, V100, P389; HAUBITZ B, 1988, PALEOBIOLOGY, V14, P206, DOI 10.1017/S0094837300011921; Hoffmann R, 2014, BIOGEOSCIENCES, V11, P2721, DOI 10.5194/bg-11-2721-2014; Hohenstein P, 2004, BRIT J RADIOL, V77, P420, DOI 10.1259/bjr/27832269; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016; JUNGERS WL, 1979, AM J PHYS ANTHROPOL, V50, P285, DOI 10.1002/ajpa.1330500219; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; Kimpe T, 2007, J DIGIT IMAGING, V20, P422, DOI 10.1007/s10278-006-1052-3; Lemoine M, 1896, CR HEBD ACAD SCI, V123, P764; MANZI G, 2001, RIV ANTROPOL, V79, P61; McLean D, 2001, RADIAT PHYS CHEM, V61, P723, DOI 10.1016/S0969-806X(01)00387-5; Ohman JC, 1997, AM J PHYS ANTHROPOL, V104, P117, DOI 10.1002/(SICI)1096-8644(199709)104:1<117::AID-AJPA8>3.0.CO;2-O; Olejniczak AJ, 2005, S AFR J SCI, V101, P219; PEYTON RL, 1992, GEODERMA, V53, P329, DOI 10.1016/0016-7061(92)90062-C; Plotino G, 2006, J AM DENT ASSOC, V137, P1555, DOI 10.14219/jada.archive.2006.0091; Prossinger Hermann, 2003, Anatomical Record, V273B, P132, DOI 10.1002/ar.b.10022; Rahman Imran A., 2012, Evolution Education and Outreach, V5, P635; RICHTSMEIER JT, 1995, CLEFT PALATE-CRAN J, V32, P217, DOI 10.1597/1545-1569(1995)032<0217:PRAVOT>2.3.CO;2; Ruff Christopher B., 1994, Yearbook of Physical Anthropology, V37, P65; Schoenemann PT, 2007, AM J PHYS ANTHROPOL, V132, P183, DOI 10.1002/ajpa.20499; Schwartz GT, 1996, AM J PHYS ANTHROPOL, V99, P613; Schwartz GT, 1998, J HUM EVOL, V35, P523, DOI 10.1006/jhev.1998.0239; Selden P., 2011, EVOLUTION FOSSIL ECO; Smilg JS, 2010, SHANGH WORLD EXP SEM; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405; Spoor CF, 1993, THESIS; SPOOR F, 1994, NATURE, V369, P645, DOI 10.1038/369645a0; SPOOR F, 1995, J ANAT, V186, P271; Spoor Fred, 1994, Courier Forschungsinstitut Senckenberg, V171, P251; Stewart K, 2009, FAMOUS FOSSIL LUCY S; UNESCO, 2012, WORLD HER LIST; VANNIER MW, 1985, AM J PHYS ANTHROPOL, V67, P299, DOI 10.1002/ajpa.1330670402; Weber GW, 2011, VIRTUAL ANTHROPOLOGY: GUIDE TO A NEW INTERDISCIPLINARY FIELD, P1, DOI 10.1007/978-3-211-49347-2; Willis Paul M.A., 1995, Memoir of the Association of Australasian Palaeontologists, V18, P203; Wu XJ, 2008, CHINESE SCI BULL, V53, P2513, DOI 10.1007/s11434-008-0263-z; Wu XJ, 2009, PROG NAT SCI, V19, P913, DOI 10.1016/j.pnsc.2008.10.009; Zatz LM, 1981, TECHNICAL ASPECTS CO, P3853; Zollikofer C.P.E., 2005, VIRTUAL RECONSTRUCTI	63	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145340	10.1371/journal.pone.0145340	http://dx.doi.org/10.1371/journal.pone.0145340			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684299	Green Published, gold, Green Submitted			2022-12-27	WOS:000366725800068
J	Wang, HP; Zhang, YJ; Zhang, ZL; Mahadevan, S; Deng, Y				Wang, Hongping; Zhang, Yajuan; Zhang, Zili; Mahadevan, Sankaran; Deng, Yong			Physarum Spreader: A New Bio-Inspired Methodology for Identifying Influential Spreaders in Complex Networks	PLOS ONE			English	Article							NODE CENTRALITY; IDENTIFICATION; ALGORITHM	Identifying influential spreaders in networks, which contributes to optimizing the use of available resources and efficient spreading of information, is of great theoretical significance and practical value. A random-walk-based algorithm LeaderRank has been shown as an effective and efficient method in recognizing leaders in social network, which even outperforms the well-known PageRank method. As LeaderRank is initially developed for binary directed networks, further extensions should be studied in weighted networks. In this paper, a generalized algorithm PhysarumSpreader is proposed by combining LeaderRank with a positive feedback mechanism inspired from an amoeboid organism called Physarum Polycephalum. By taking edge weights into consideration and adding the positive feedback mechanism, PhysarumSpreader is applicable in both directed and undirected networks with weights. By taking two real networks for examples, the effectiveness of the proposed method is demonstrated by comparing with other standard centrality measures.	[Wang, Hongping; Zhang, Yajuan; Zhang, Zili; Deng, Yong] Southwest Univ, Sch Comp & Informat Sci, Chongqing, Peoples R China; [Zhang, Zili] Deakin Univ, Sch Informat Technol, Geelong, Vic 3217, Australia; [Mahadevan, Sankaran] Vanderbilt Univ, Civil & Environm Engn Dept, Nashville, TN 37235 USA	Southwest University - China; Deakin University; Vanderbilt University	Deng, Y (corresponding author), Southwest Univ, Sch Comp & Informat Sci, Chongqing, Peoples R China.	ydeng@swu.edu.cn	Wang, Hongping/ABA-6158-2020; Deng, Yong/A-9193-2015	Wang, Hongping/0000-0002-3413-0597; Deng, Yong/0000-0001-9286-2123	National Natural Science Foundation of China [61174022, 61573290, 61503237]; Specialized Research Fund for the Doctoral Program of Higher Education [20131102130002]; R&D Program of China [2012BAH07B01]; National High Technology Research and Development Program of China (863 Program) [2013AA013801]; China State Key Laboratory of Virtual Reality Technology and Systems, Beihang University [BUAA-VR-14KF-02]; General Research Program of the Science - Sichuan Provincial Department of Education [14ZB0322]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); R&D Program of China; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); China State Key Laboratory of Virtual Reality Technology and Systems, Beihang University; General Research Program of the Science - Sichuan Provincial Department of Education	The work is partially supported by National Natural Science Foundation of China (Grant Nos. 61174022, 61573290, 61503237), Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20131102130002), R&D Program of China (2012BAH07B01), National High Technology Research and Development Program of China (863 Program) (Grant No. 2013AA013801), China State Key Laboratory of Virtual Reality Technology and Systems, Beihang University (Grant No. BUAA-VR-14KF-02), the General Research Program of the Science Supported by Sichuan Provincial Department of Education (Grant No. 14ZB0322).; The authors greatly appreciate the reviews' suggestions and the editor's encouragement. The work is partially supported by National High Technology Research and Development Program of China (863 Program) (Grant No. 2013AA013801), National Natural Science Foundation of China (Grant Nos. 61174022, 61573290, 61503237), China State Key Laboratory of Virtual Reality Technology and Systems, Beihang University (Grant No. BUAA-VR-14KF-02).	[Anonymous], 2012, J INFORM COMPUTATION; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Baumgarten W, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/2/026003; Baumgarten W, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046113; Bonacich P, 2001, SOC NETWORKS, V23, P191, DOI 10.1016/S0378-8733(01)00038-7; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chen DB, 2012, PHYSICA A, V391, P1777, DOI 10.1016/j.physa.2011.09.017; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Deng XY, 2014, EXPERT SYST APPL, V41, P156, DOI 10.1016/j.eswa.2013.07.018; Deng Y, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/878024; Deng Y, 2015, APPL INTELL, V43, P530, DOI 10.1007/s10489-015-0661-2; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Douceur JR, 2002, LECT NOTES COMPUT SC, V2429, P251, DOI 10.1007/3-540-45748-8_24; Du YX, 2014, PHYSICA A, V399, P57, DOI 10.1016/j.physa.2013.12.031; Estrada E, 2010, PHYSICA A, V389, P3648, DOI 10.1016/j.physa.2010.03.030; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1991, SOC NETWORKS, V13, P141, DOI 10.1016/0378-8733(91)90017-N; Gao C, 2013, PHYSICA A, V392, P5490, DOI 10.1016/j.physa.2013.06.059; Jiang W, 2015, J INTELL FUZZY SYST, V28, P2343, DOI 10.3233/IFS-151639; Katz L., 1953, PSYCHOMETRIKA, V18, P39, DOI [DOI 10.1007/BF02289026, 10.1007/BF02289026]; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kolaczyk ED, 2009, SOC NETWORKS, V31, P190, DOI 10.1016/j.socnet.2009.02.003; Landherr A, 2010, BUS INFORM SYST ENG+, V2, P371, DOI 10.1007/s12599-010-0127-3; Li Q, 2014, PHYSICA A, V404, P47, DOI 10.1016/j.physa.2014.02.041; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Miyaji T., 2008, INT J PURE APPL MATH, V47, P353; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Nakagaki T, 2001, BIOPHYS CHEM, V92, P47, DOI 10.1016/S0301-4622(01)00179-X; Nakagaki T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.068104; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Pathak PH, 2012, COMPUT COMMUN, V35, P1074, DOI 10.1016/j.comcom.2012.01.023; Pei S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05547; Pei S, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/12/P12002; Qi XQ, 2012, INFORM SCIENCES, V194, P240, DOI 10.1016/j.ins.2011.12.027; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Su XY, 2015, RISK ANAL, V35, P1296, DOI 10.1111/risa.12347; Tero A, 2006, PHYSICA A, V363, P115, DOI 10.1016/j.physa.2006.01.053; Tero A, 2007, J THEOR BIOL, V244, P553, DOI 10.1016/j.jtbi.2006.07.015; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; Wang FH, 2011, J TRANSP GEOGR, V19, P285, DOI 10.1016/j.jtrangeo.2010.01.004; Wang GX, 2008, PROG NAT SCI-MATER, V18, P1043, DOI 10.1016/j.pnsc.2008.03.015; WANG H, 2014, MEDIAT INFLAMM, DOI DOI 10.1155/2014/; Wang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106132; Wang P, 2014, IEEE T BIOMED CIRC S, V8, P87, DOI 10.1109/TBCAS.2014.2303160; Watanabe S, 2011, BIOSYSTEMS, V105, P225, DOI 10.1016/j.biosystems.2011.05.001; Wei DJ, 2013, PHYSICA A, V392, P2564, DOI 10.1016/j.physa.2013.01.054; Yan G, 2005, CHINESE PHYS LETT, V22, P510, DOI 10.1088/0256-307X/22/2/068; Yang R, 2007, PHYS LETT A, V364, P189, DOI 10.1016/j.physleta.2006.12.021; Yong Deng, 2015, Mathematical Problems in Engineering, V2015, DOI 10.1155/2015/212794; Zhang H, 2011, J BIOMED INFORM, V44, P830, DOI 10.1016/j.jbi.2011.05.001; Zhang YJ, 2011, CHIN CONT DECIS CONF, P1440, DOI 10.1109/CCDC.2011.5968418; Zhou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020648; Zio E, 2011, RISK ANAL, V31, P1196, DOI 10.1111/j.1539-6924.2011.01584.x	57	2	2	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145028	10.1371/journal.pone.0145028	http://dx.doi.org/10.1371/journal.pone.0145028			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684194	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800031
J	Jatulan, EO; Rabajante, JF; Banaay, CGB; Fajardo, AC; Jose, EC				Jatulan, Eduardo O.; Rabajante, Jomar F.; Banaay, Charina Gracia B.; Fajardo, Alejandro C., Jr.; Jose, Editha C.			A Mathematical Model of Intra-Colony Spread of American Foulbrood in European Honeybees (Apis mellifera L.)	PLOS ONE			English	Article							LARVAE SUBSP LARVAE; PAENIBACILLUS-LARVAE; BEES	American foulbrood (AFB) is one of the severe infectious diseases of European honeybees (Apis mellifera L.) and other Apis species. This disease is caused by a gram-positive, spore-forming bacterium Paenibacillus larvae. In this paper, a compartmental (SI framework) model is constructed to represent the spread of AFB within a colony. The model is analyzed to determine the long-term fate of the colony once exposed to AFB spores. It was found out that without effective and efficient treatment, AFB infection eventually leads to colony collapse. Furthermore, infection thresholds were predicted based on the stability of the equilibrium states. The number of infected cell combs is one of the factors that drive disease spread. Our results can be used to forecast the transmission timeline of AFB infection and to evaluate the control strategies for minimizing a possible epidemic.	[Jatulan, Eduardo O.; Rabajante, Jomar F.; Jose, Editha C.] Univ Philippines Los Banos, Inst Math Sci & Phys, Laguna, Philippines; [Banaay, Charina Gracia B.; Fajardo, Alejandro C., Jr.] Univ Philippines Los Banos, Inst Biol Sci, Laguna, Philippines; [Jatulan, Eduardo O.; Rabajante, Jomar F.; Banaay, Charina Gracia B.; Fajardo, Alejandro C., Jr.; Jose, Editha C.] Univ Philippines Los Banos, UPLB Bee Program, Laguna, Philippines	University of the Philippines System; University of the Philippines Los Banos; University of the Philippines System; University of the Philippines Los Banos; University of the Philippines System; University of the Philippines Los Banos	Jatulan, EO (corresponding author), Univ Philippines Los Banos, Inst Math Sci & Phys, Laguna, Philippines.	eojatulan@up.edu.ph	Rabajante, Jomar Fajardo/K-3502-2014; Jatulan, Eduardo/ABF-5206-2021; Banaay, Charina Gracia B./AAA-6985-2020	Rabajante, Jomar Fajardo/0000-0002-0655-0893; Jatulan, Eduardo/0000-0003-3558-0757				Alvarado I, 2013, J BACTERIOL, V195, P1005, DOI 10.1128/JB.01958-12; Cervancia C. R., 2013, Philippine Entomologist, V27, P75; Datta S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0650; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Fries I, 2006, VET MICROBIOL, V114, P269, DOI 10.1016/j.vetmic.2005.11.068; Gavina M, 2014, B MATH BIOL, V76, P997, DOI 10.1007/s11538-014-9943-9; Genersch E, 2006, INT J SYST EVOL MICR, V56, P501, DOI 10.1099/ijs.0.63928-0; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; GOODWIN RM, 1994, J APICULT RES, V33, P209, DOI 10.1080/00218839.1994.11100873; Hansen H, 1999, BEE WORLD, V80, P5, DOI 10.1080/0005772X.1999.11099415; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Neuendorf S, 2004, MICROBIOL-SGM, V150, P2381, DOI 10.1099/mic.0.27125-0; Perko L, 2001, DIFFER EQUAT DYN SYS; Sastry S., 1999, NONLINEAR SYSTEM ANA; von der Ohe W., 2003, APIACTA, V38, P137	15	9	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143805	10.1371/journal.pone.0143805	http://dx.doi.org/10.1371/journal.pone.0143805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674357	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700015
J	Murayama, Y; Yoshioka, M; Okada, H; Takata, E; Masujin, K; Iwamaru, Y; Shimozaki, N; Yamamura, T; Yokoyama, T; Mohri, S; Tsutsumi, Y				Murayama, Yuichi; Yoshioka, Miyako; Okada, Hiroyuki; Takata, Eri; Masujin, Kentaro; Iwamaru, Yoshifumi; Shimozaki, Noriko; Yamamura, Tomoaki; Yokoyama, Takashi; Mohri, Shirou; Tsutsumi, Yuji			Subcritical Water Hydrolysis Effectively Reduces the In Vitro Seeding Activity of PrPSc but Fails to Inactivate the Infectivity of Bovine Spongiform Encephalopathy Prions	PLOS ONE			English	Article							MISFOLDING CYCLIC AMPLIFICATION; SUPERCRITICAL WATER; ORGANIC-ACIDS; AMINO-ACIDS; PROTEIN; MEAT; REPLICATION; DISEASE; AGENTS	The global outbreak of bovine spongiform encephalopathy (BSE) has been attributed to the recycling of contaminated meat and bone meals (MBMs) as feed supplements. The use of MBMs has been prohibited in many countries; however, the development of a method for inactivating BSE prions could enable the efficient and safe use of these products as an organic resource. Subcritical water (SCW), which is water heated under pressure to maintain a liquid state at temperatures below the critical temperature (374 degrees C), exhibits strong hydrolytic activity against organic compounds. In this study, we examined the residual in vitro seeding activity of protease-resistant prion protein (PrPSc) and the infectivity of BSE prions after SCW treatments. Spinal cord homogenates prepared from BSE-infected cows were treated with SCW at 230-280 degrees C for 5-7.5 min and used to intracerebrally inoculate transgenic mice overexpressing bovine prion protein. Serial protein misfolding cyclic amplification (sPMCA) analysis detected no PrPSc in the SCW-treated homogenates, and the mice treated with these samples survived for more than 700 days without any signs of disease. However, sPMCA analyses detected PrPSc accumulation in the brains of all inoculated mice. Furthermore, secondary passage mice, which inoculated with brain homogenates derived from a western blotting (WB)-positive primary passage mouse, died after an average of 240 days, similar to mice inoculated with untreated BSE-infected spinal cord homogenates. The PrPSc accumulation and vacuolation typically observed in the brains of BSE-infected mice were confirmed in these secondary passage mice, suggesting that the BSE prions maintained their infectivity after SCW treatment. One late-onset case, as well as asymptomatic but sPMCA-positive cases, were also recognized in secondary passage mice inoculated with brain homogenates from WB-negative but sPMCA-positive primary passage mice. These results indicated that SCW-mediated hydrolysis was insufficient to eliminate the infectivity of BSE prions under the conditions tested.	[Murayama, Yuichi; Yoshioka, Miyako; Okada, Hiroyuki; Masujin, Kentaro; Iwamaru, Yoshifumi; Shimozaki, Noriko; Yamamura, Tomoaki; Yokoyama, Takashi; Mohri, Shirou] Natl Inst Anim Hlth, Influenza Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan; [Yoshioka, Miyako] Natl Inst Anim Hlth, Res Area Pathol & Pathophysiol, Tsukuba, Ibaraki 305, Japan; [Takata, Eri; Tsutsumi, Yuji] Kyushu Univ, Fac Agr, Dept Agroenvironm Sci, Fukuoka, Fukuoka, Japan; [Takata, Eri] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan; [Mohri, Shirou] Tohoku Univ, Grad Sch Med, Dept Neurol Sci, Sendai, Miyagi 980, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Kyushu University; Forestry & Forest Products Research Institute - Japan; Tohoku University	Murayama, Y (corresponding author), Natl Inst Anim Hlth, Influenza Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan.	ymura@affrc.go.jp	Mohri, Shirou/AAK-1281-2020		BSE and other Prion Disease Control Project; Recycling of Bovine Meat and Bone Meal and Inactivation of BSE prion by Sub-critical Water Treatment of the Ministry of Agriculture, Forestry and Fisheries of Japan	BSE and other Prion Disease Control Project; Recycling of Bovine Meat and Bone Meal and Inactivation of BSE prion by Sub-critical Water Treatment of the Ministry of Agriculture, Forestry and Fisheries of Japan	This study was supported by a Grant-in-Aid from the BSE and other Prion Disease Control Project (YM, no grant number) and Recycling of Bovine Meat and Bone Meal and Inactivation of BSE prion by Sub-critical Water Treatment (YT, no grant number) of the Ministry of Agriculture, Forestry and Fisheries of Japan (http://www.maff.go.jp/e/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmoez W, 2013, INT J CHEM REACT ENG, V11, P369, DOI 10.1515/ijcre-2013-0017; de Vos CJ, 2009, RISK ANAL, V29, P541, DOI 10.1111/j.1539-6924.2008.01177.x; Doherr MG, 2007, VACCINE, V25, P5619, DOI 10.1016/j.vaccine.2006.10.059; Fukuda S, 2012, JPN J INFECT DIS, V65, P37; Giles K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000206; Goto M, 1999, IND ENG CHEM RES, V38, P1863, DOI 10.1021/ie980479s; Hayashi HK, 2005, BIOCHEM BIOPH RES CO, V328, P1024, DOI 10.1016/j.bbrc.2005.01.065; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Johnson CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019836; Kabyemela BM, 1999, IND ENG CHEM RES, V38, P2888, DOI 10.1021/ie9806390; Khuwijitjaru P, 2004, CHEM ENG J, V99, P1, DOI 10.1016/j.cej.2003.08.002; Liang X., 2013, J MAT SCI CHEM ENG, V1, P1, DOI [DOI 10.4236/MSCE.2013.15001, 10.4236/msce.2013.15001]; Matsuura Y, 2013, BIOCHEM BIOPH RES CO, V432, P86, DOI 10.1016/j.bbrc.2013.01.081; McLeod AH, 2004, BIOCHEM BIOPH RES CO, V317, P1165, DOI 10.1016/j.bbrc.2004.03.168; Mekonnen TH, 2015, J CHEM TECHNOL BIOT, V90, P476, DOI 10.1002/jctb.4333; Murayama Y, 2006, BIOCHEM BIOPH RES CO, V348, P758, DOI 10.1016/j.bbrc.2006.07.130; Murayama Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013152; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race R, 1998, NATURE, V392, P770, DOI 10.1038/33834; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; Race RE, 2004, J VIROL, V78, P2164, DOI 10.1128/JVI.78.4.2164-2165.2004; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sakudo A, 2011, INT J MOL MED, V27, P483, DOI 10.3892/ijmm.2011.605; Scott MR, 1997, P NATL ACAD SCI USA, V94, P14279, DOI 10.1073/pnas.94.26.14279; Shimizu Y, 2010, MICROBIOL IMMUNOL, V54, P112, DOI 10.1111/j.1348-0421.2009.00190.x; Suyama K, 2007, BIOSCI BIOTECH BIOCH, V71, P2069, DOI 10.1271/bbb.70085; Suyama K, 2007, BIOCHEM BIOPH RES CO, V356, P245, DOI 10.1016/j.bbrc.2007.02.113; Tavakoli O, 2008, SCI TOTAL ENVIRON, V398, P175, DOI 10.1016/j.scitotenv.2008.03.019; Taylor DM, 2001, CONTRIB MICROBIOL, V7, P58; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Wahyudiono, 2013, ENG J-THAIL, V17, P1, DOI 10.4186/ej.2013.17.1.1; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Yoshida H, 2004, J CHEM ENG JPN, V37, P253, DOI 10.1252/jcej.37.253; Yoshida H, 1999, BIOTECHNOL PROGR, V15, P1090, DOI 10.1021/bp9900920; Yoshida H, 2007, WASTE REFINERY SUBCR; Yoshioka M, 2007, J APPL MICROBIOL, V102, P509, DOI 10.1111/j.165-2672.2006.03080.x; Yoshioka M, 2007, BIOSCI BIOTECH BIOCH, V71, P2565, DOI 10.1271/bbb.70257; Yoshioka M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-134; Yoshioka M, 2011, MICROBIOL IMMUNOL, V55, P331, DOI 10.1111/j.1348-0421.2011.00328.x	39	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144761	10.1371/journal.pone.0144761	http://dx.doi.org/10.1371/journal.pone.0144761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675475	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700060
J	Demir, AB; Koc, A				Demir, Ayse Banu; Koc, Ahmet			High-Copy Overexpression Screening Reveals PDR5 as the Main Doxorubicin Resistance Gene in Yeast	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; PLASMA-MEMBRANE; KINASE PRK1P; CELL-LINE; ADRIAMYCIN; TRANSCRIPTION; AMPLIFICATION	Doxorubicin is one of the most potent anticancer drugs used in the treatment of various cancer types. The efficacy of doxorubicin is influenced by the drug resistance mechanisms and its cytotoxicity. In this study, we performed a high-copy screening analysis to find genes that play a role in doxorubicin resistance and found several genes (CUE5, AKL1, CAN1, YHR177W and PDR5) that provide resistance. Among these genes, overexpression of PDR5 provided a remarkable resistance, and deletion of it significantly rendered the tolerance level for the drug. Q-PCR analyses suggested that transcriptional regulation of these genes was not dependent on doxorubicin treatment. Additionally, we profiled the global expression pattern of cells in response to doxorubicin treatment and highlighted the genes and pathways that are important in doxorubicin tolerance/toxicity. Our results suggest that many efflux pumps and DNA metabolism genes are upregulated by the drug and required for doxorubicin tolerance.	[Demir, Ayse Banu; Koc, Ahmet] Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey; [Demir, Ayse Banu] Dokuz Eylul Univ, Inst Oncol, Dept Basic Oncol, Izmir, Turkey	Izmir Institute of Technology; Dokuz Eylul University	Koc, A (corresponding author), Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey.	ahmetkoc@iyte.edu.tr	Demir, Ayse Banu/AAP-8530-2020; KOÇ, AHMET/ABI-3322-2020	Demir, Ayse Banu/0000-0003-4616-8151; KOÇ, AHMET/0000-0003-3484-2137	TUBITAK (Turkey) [114Z701]	TUBITAK (Turkey)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by TUBITAK (Turkey) Grand No. 114Z701 to Ahmet Koc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 1999, CANCER RES, V59, P4237; BALZI E, 1994, J BIOL CHEM, V269, P2206; Bauer BE, 1999, BBA-BIOMEMBRANES, V1461, P217, DOI 10.1016/S0005-2736(99)00160-1; Brown JA, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100043; Cabrito TR, 2011, BIOCHEM J, V440, P195, DOI 10.1042/BJ20110876; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; DECOTTIGNIES A, 1995, J BIOL CHEM, V270, P18150, DOI 10.1074/jbc.270.30.18150; DeRisi J, 2000, FEBS LETT, V470, P156, DOI 10.1016/S0014-5793(00)01294-1; EGNER R, 1995, MOL CELL BIOL, V15, P5879; Furuchi T, 2004, NUCLEIC ACIDS RES, V32, P2578, DOI 10.1093/nar/gkh582; Gao C, 2004, J BIOL CHEM, V279, P42677, DOI 10.1074/jbc.M406363200; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Golin J, 2003, J BIOL CHEM, V278, P5963, DOI 10.1074/jbc.M210908200; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Henry KR, 2003, CURR BIOL, V13, P1564, DOI 10.1016/S0960-9822(03)00579-7; Huang RY, 2007, CANCER RES, V67, P765, DOI 10.1158/0008-5472.CAN-06-2839; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; JOHZUKA K, 1995, GENETICS, V139, P1521; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; Katzmann DJ, 1996, J BIOL CHEM, V271, P23049, DOI 10.1074/jbc.271.38.23049; Kihara A, 2004, MOL BIOL CELL, V15, P4949, DOI 10.1091/mbc.E04-06-0458; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; KULE C, 1994, MOL PHARMACOL, V46, P1234; LEPPERT G, 1990, GENETICS, V125, P13; Lohse MB, 2014, P NATL ACAD SCI USA, V111, P10404, DOI 10.1073/pnas.1410110111; Longhurst TJ, 1996, BRIT J CANCER, V74, P1331, DOI 10.1038/bjc.1996.545; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Maresova L, 2005, MOL MICROBIOL, V55, P588, DOI 10.1111/j.1365-2958.2004.04410.x; Miyahara K, 1996, FEBS LETT, V399, P317, DOI 10.1016/S0014-5793(96)01353-1; Omura S, 1981, Methods Enzymol, V72, P520; Philpott CC, 2002, BIOCHEM SOC T, V30, P698, DOI 10.1042/bst0300698; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Schenk PW, 2003, MOL PHARMACOL, V64, P259, DOI 10.1124/mol.64.2.259; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Shively CA, 2013, GENETICS, V193, P1297, DOI 10.1534/genetics.112.147876; Shukla A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-314; Simunek T, 2009, PHARMACOL REP, V61, P154; SINGH SV, 1989, BIOCHEM PHARMACOL, V38, P3505, DOI 10.1016/0006-2952(89)90121-4; SLOVAK ML, 1995, CANCER RES, V55, P4214; Song Qingxuan, 2012, Cells, V1, P263, DOI 10.3390/cells1030263; SZYBALSKI W, 1952, J BACTERIOL, V64, P489, DOI 10.1128/JB.64.4.489-499.1952; Takahashi T, 2005, J CELL PHYSIOL, V202, P100, DOI 10.1002/jcp.20082; Takahashi T, 2006, CANCER RES, V66, P11932, DOI 10.1158/0008-5472.CAN-06-3220; Takahashi T, 2011, J TOXICOL SCI, V36, P855, DOI 10.2131/jts.36.855; Takahashi T, 2009, J TOXICOL SCI, V34, P703, DOI 10.2131/jts.34.703; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; UEDA K, 1987, J BIOL CHEM, V262, P505; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; Westmoreland TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005830; Withoff S, 1996, ANTICANCER RES, V16, P1867; Xia L, 2007, CANCER RES, V67, P11411, DOI 10.1158/0008-5472.CAN-07-2399; Xiao W, 1998, MOL GEN GENET, V257, P614, DOI 10.1007/s004380050689; YOSHIDA Y, 1991, BIOCHEM SOC T, V19, P778, DOI 10.1042/bst0190778; Zeng GH, 2001, MOL BIOL CELL, V12, P3759, DOI 10.1091/mbc.12.12.3759; Zhu KC, 1999, BIOCHEM BIOPH RES CO, V266, P361, DOI 10.1006/bbrc.1999.1815	58	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145108	10.1371/journal.pone.0145108	http://dx.doi.org/10.1371/journal.pone.0145108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690737	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300036
J	He, JR; Zheng, LM; Zhang, WJ; Lin, YS				He, Jinru; Zheng, Lianming; Zhang, Wenjing; Lin, Yuanshao			Life Cycle Reversal in Aurelia sp.1 (Cnidaria, Scyphozoa)	PLOS ONE			English	Article							ASEXUAL REPRODUCTION RATES; JELLYFISH BLOOMS; GELATINOUS ZOOPLANKTON; TURRITOPSIS-NUTRICULA; COMMON JELLYFISH; AURITA; HYDROZOA; POLYPS; DIFFERENTIATION; METAMORPHOSIS	The genus Aurelia is one of the major contributors to jellyfish blooms in coastal waters, possibly due in part to hydroclimatic and anthropogenic causes, as well as their highly adaptive reproductive traits. Despite the wide plasticity of cnidarian life cycles, especially those recognized in certain Hydroza species, the known modifications of Aurelia life history were mostly restricted to its polyp stage. In this study, we document the formation of polyps directly from the ectoderm of degenerating juvenile medusae, cell masses from medusa tissue fragments, and subumbrella of living medusae. This is the first evidence for back-transformation of sexually mature medusae into polyps in Aurelia sp.1. The resulting reconstruction of the schematic life cycle of Aurelia reveals the underestimated potential of life cycle reversal in scyphozoan medusae, with possible implications for biological and ecological studies.	[He, Jinru; Zheng, Lianming; Zhang, Wenjing] Xiamen Univ, Marine Biodivers & Global Change Res Ctr MBiGC, Xiamen, Peoples R China; [Zheng, Lianming] Xiamen Univ, Fujian Prov Key Lab Coastal Ecol & Environm Studi, Xiamen, Peoples R China; [Zheng, Lianming; Zhang, Wenjing; Lin, Yuanshao] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China; [He, Jinru] Zhejiang Prov Zhoushan Marine Ecol Environm Monit, Zhoushan, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Zheng, LM (corresponding author), Xiamen Univ, Marine Biodivers & Global Change Res Ctr MBiGC, Xiamen, Peoples R China.	zhlm@xmu.edu.cn	Zhang, Wenjing/H-5057-2012; 郑, 连明/GZL-5449-2022; He, Jinru/A-3908-2016	Zhang, Wenjing/0000-0002-2600-5040; He, Jinru/0000-0002-4985-6737	National Natural Science Foundation of China [41006078, J1210050, J1310037]; Public Science and Technology Research Funds Projects of Ocean [201505034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Science and Technology Research Funds Projects of Ocean	This work was supported by the National Natural Science Foundation of China under contract No. 41006078 (LZ), No. J1210050 (LZ) and No. J1310037 (LZ); the Public Science and Technology Research Funds Projects of Ocean under contract No. 201505034 (LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado AS, 2014, CELL, V157, P110, DOI 10.1016/j.cell.2014.02.041; Arai MN, 1997, FUNCTIONAL BIOL SCYP; Bavestrello Giorgio, 1992, Scientia Marina, V56, P137; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Boero F, 2002, REPRO BIOL, V11, P141; Boero F., 1997, P53; Boero F., 1992, SEX ORIGIN EVOL, V6, P59; Bouillon Jean, 2000, Thalassia Salentina, V24, P1; Brodeur RD, 2002, MAR ECOL PROG SER, V233, P89, DOI 10.3354/meps233089; Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7; Carla' EC, 2003, TISSUE CELL, V35, P213, DOI 10.1016/S0040-8166(03)00028-4; CARRE D, 1995, SCI MAR, V59, P193; CHAPMAN DM, 1968, J MAR BIOL ASSOC UK, V48, P187, DOI 10.1017/S0025315400032537; CHAPMAN DM, 1970, J MAR BIOL ASSOC UK, V50, P107, DOI 10.1017/S0025315400000631; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; Condon RH, 2011, P NATL ACAD SCI USA, V108, P10225, DOI 10.1073/pnas.1015782108; COSTELLO JH, 1994, MAR BIOL, V121, P327, DOI 10.1007/BF00346741; Daly M, 2007, ZOOTAXA, P127, DOI 10.11646/zootaxa.1668.1.11; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P11968, DOI 10.1073/pnas.0503811102; De Vito D, 2006, MAR BIOL, V149, P339, DOI 10.1007/s00227-005-0182-3; Dong ZJ, 2010, MAR POLLUT BULL, V60, P954, DOI 10.1016/j.marpolbul.2010.04.022; Duarte CM, 2013, FRONT ECOL ENVIRON, V11, P91, DOI 10.1890/110246; Ender A, 2003, MOL BIOL EVOL, V20, P130, DOI 10.1093/molbev/msg018; Fautin DG, 2002, CAN J ZOOL, V80, P1735, DOI 10.1139/Z02-133; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gibbons MJ, 2013, J PLANKTON RES, V35, P929, DOI 10.1093/plankt/fbt063; Gold DA, 2013, DEV GENES EVOL, V223, P53, DOI 10.1007/s00427-012-0429-1; Hadzi Jovan, 1909, Zoologischer Anzeiger Leipzig, V34; HAMNER WM, 1974, AM ZOOL, V14, P833; He JR, 2015, J MAR BIOL ASSOC UK, V95, P289, DOI 10.1017/S0025315414000836; HIRAI ETURO, 1958, BULL MARINE BIOL STA ASAMUSHI TOHOKU UNIV, V9, P81; Holstein TW, 2014, CURR BIOL, V24, pR159, DOI 10.1016/j.cub.2014.01.003; Jarms G., 1997, P271; Kakinuma Y., 1975, Bulletin Mar Biol Stn Asamushi, V15, P101; Ki JS, 2008, ICES J MAR SCI, V65, P443, DOI 10.1093/icesjms/fsn018; Kubota Shin, 2005, Bulletin of the Biogeographical Society of Japan, V60, P31; Kubota Shin, 2006, Bulletin of the Biogeographical Society of Japan, V61, P85; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; 김동훈, 2013, [The Journal of Korea Robotics Society, 로봇학회 논문지], V8, P51, DOI 10.7746/jkros.2013.8.1.051; Lucas CH, 2014, GLOBAL ECOL BIOGEOGR, V23, P701, DOI 10.1111/geb.12169; Lucas CH, 2012, ADV MAR BIOL, V63, P133, DOI 10.1016/B978-0-12-394282-1.00003-X; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; Makabe R, 2014, J OCEANOGR, V70, P447, DOI 10.1007/s10872-014-0249-1; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miglietta MP, 2007, J ZOOL SYST EVOL RES, V45, P11, DOI 10.1111/j.1439-0469.2006.00379.x; Miller MEC, 2012, J EXP MAR BIOL ECOL, V432, P113, DOI 10.1016/j.jembe.2012.07.015; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; Miranda LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010182; MOLLER H, 1980, MAR BIOL, V60, P123, DOI 10.1007/BF00389155; Piraino S, 1996, BIOL BULL-US, V190, P302, DOI 10.2307/1543022; Piraino S, 2004, CAN J ZOOL, V82, P1748, DOI 10.1139/Z04-174; Purcell JE, 2005, J MAR BIOL ASSOC UK, V85, P461, DOI 10.1017/S0025315405011409; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2007, MAR ECOL PROG SER, V348, P183, DOI 10.3354/meps07056; Purcell JE, 2012, HYDROBIOLOGIA, V690, P169, DOI 10.1007/s10750-012-1047-7; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; RICHMOND RH, 1985, MAR ECOL PROG SER, V22, P181, DOI 10.3354/meps022181; Schiariti A, 2014, MAR ECOL PROG SER, V510, P241, DOI 10.3354/meps10798; Schmich J, 2007, INT J DEV BIOL, V51, P45, DOI 10.1387/ijdb.062152js; Sigerfoos C. P., 1893, Johns Hopkins University Circulars, Vxii, P106; Straehler-Pohl I, 2005, MAR BIOL, V147, P1271, DOI 10.1007/s00227-005-0031-4; Straehler-Pohl Ilka, 2011, Zootaxa, V2755, P36; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thein H, 2012, HYDROBIOLOGIA, V690, P157, DOI 10.1007/s10750-012-1045-9; Uye Siain-Icth, 2008, Plankton & Benthos Research, V3, P125, DOI 10.3800/pbr.3.125; [Вагелли А.А. Vagelli Alejandro A.], 2007, [Зоология беспозвоночных, Invertebrate Zoology, Zoologiya bespozvonochnykh], V4, P111; Xian WW, 2005, SCIENCE, V307, P41	71	17	20	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145314	10.1371/journal.pone.0145314	http://dx.doi.org/10.1371/journal.pone.0145314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690755	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300056
J	Nkuize, M; De Wit, S; Muls, V; Delforge, M; Deyi, VYM; Cadiere, GB; Buset, M				Nkuize, Marcel; De Wit, Stephane; Muls, Vinciane; Delforge, Marc; Deyi, Veronique Y. Miendje; Cadiere, Guy B.; Buset, Michel			HIV-Helicobacter pylori Co-Infection: Antibiotic Resistance, Prevalence, and Risk Factors	PLOS ONE			English	Article							ERADICATION THERAPY; INFECTION; AMOXICILLIN; MANAGEMENT; ENDOSCOPY; PNEUMONIA; DISEASE; ERA	Background Patients infected with human immunodeficiency virus (HIV) are living longer due to the availability of more potent treatments. However, prescription of antibiotics to treat or prevent infections in these patients may increase the likelihood of co-infection with antibiotic-resistant species. Aim To compare antimicrobial susceptibility of Helicobacter pylori (H. pylori) in HIV-positive and HIV-negative patients and assess risk-factors for resistance. Methods We prospectively collected data from consecutive HIV-positive and HIV-negative patients undergoing upper gastrointestinal endoscopy. Patients with H. pylori-positive gastric biopsies who had never received H. pylori treatment were included. Results Of the 353 patients included, 93 were HIV-positive and 260 HIV-negative. Among the HIV-positive patients, 56 (60%) had been infected for < 10 years, the median CD4+ count was 493 cells/mu l and median viral load was 61 copies/mL; 66 (71%) were receiving antiretroviral therapy. HIV-positive patients were more often male (p = 0.009), had a lower body mass index (p<0.0001), and had less frequently received antibiotics during the 12-months prior to the endoscopy (p<0.0001) than HIV-negative patients. HIV-positive patients were more likely to have H. pylori resistant to levofloxacin (p = 0.0004), metronidazole (p = 0.01), or multiple antibiotics (p = 0.006). HIV-positive Black Africans were more likely to have resistant strains than were HIV-negative Black Africans (p = 0.04). Ethnicity and HIV status were independent risk factors for H. pylori resistance in all patients and acquired immune deficiency syndrome (AIDS) and sex were risk factors in HIV-positive patients. Conclusions There was a higher prevalence of primary H. pylori-resistant strains in HIV-positive than in HIV-negative patients. AIDS and sex were predictors of H. pylori resistance in HIV-positive patients.	[Nkuize, Marcel; Muls, Vinciane; Buset, Michel] Univ Libre Bruxelles, CHU St Pierre, Dept Gastroenterol & Hepatol, Brussels, Belgium; [De Wit, Stephane; Delforge, Marc] Univ Libre Bruxelles, CHU St Pierre, Div Infect Dis, Brussels, Belgium; [Deyi, Veronique Y. Miendje] Univ Libre Bruxelles, CHU Brugmann, Dept Microbiol, Brussels, Belgium; [Cadiere, Guy B.] Univ Libre Bruxelles, CHU St Pierre, Dept Digest Surg, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Nkuize, M (corresponding author), Univ Libre Bruxelles, CHU St Pierre, Dept Gastroenterol & Hepatol, Brussels, Belgium.	marcelnkuize@hotmail.com		nkuize, marcel/0000-0002-7708-050X				AliMohamed F, 2002, East Afr Med J, V79, P226; Chiu HM, 2004, J GASTROEN HEPATOL, V19, P423, DOI 10.1111/j.1440-1746.2003.03278.x; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI S, V29, pM100; Collini PJ, 2013, CURR HIV-AIDS REP, V10, P273, DOI 10.1007/s11904-013-0162-z; Collini PJ, 2012, J INFECTION, V64, P131, DOI 10.1016/j.jinf.2011.12.003; De Francesco V, 2010, J GASTROINTEST LIVER, V19, P409; Desroches JJ, 1997, J NUCL MED, V38, P1141; Deyi VYM, 2011, J CLIN MICROBIOL, V49, P2200, DOI 10.1128/JCM.02642-10; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Feikin DR, 2004, LANCET INFECT DIS, V4, P445, DOI 10.1016/S1473-3099(04)01060-6; Fialho ABC, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-13; Figura N, 2012, NEW MICROBIOL, V35, P335; Furuta T, 2001, CLIN PHARMACOL THER, V69, P158, DOI 10.1067/mcp.2001.113959; Graham DY, 2008, NAT CLIN PRACT GASTR, V5, P321, DOI 10.1038/ncpgasthep1138; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Haggerty CL, 2007, CLIN INFECT DIS, V44, P953, DOI 10.1086/512191; Houben MHMG, 1999, ALIMENT PHARM THER, V13, P1047; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; MARANO BJ, 1993, AM J GASTROENTEROL, V88, P687; Megraud F, 2013, GUT, V62, P34, DOI 10.1136/gutjnl-2012-302254; Morris AM, 2000, AM J RESP CRIT CARE, V162, P612, DOI 10.1164/ajrccm.162.2.9912058; Nachega Jean B, 2012, AIDS, V26 Suppl 1, pS39; Ndip RN, 2008, TROP MED INT HEALTH, V13, P848, DOI 10.1111/j.1365-3156.2008.02062.x; Nkuize M, 2010, HIV MED, V11, P412, DOI 10.1111/j.1468-1293.2009.00807.x; Nkuize M, 2012, HELICOBACTER, V17, P153, DOI 10.1111/j.1523-5378.2011.00929.x; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Sachs George, 2011, Curr Gastroenterol Rep, V13, P540, DOI 10.1007/s11894-011-0226-4; Sachs George, 2009, Curr Gastroenterol Rep, V11, P455, DOI 10.1007/s11894-009-0070-y; Saruc M, 2001, BRAZ J MED BIOL RES, V34, P1435, DOI 10.1590/S0100-879X2001001100010; Tanih NF, 2010, SAMJ S AFR MED J, V100, P49; Zuckerman JM, 2004, INFECT DIS CLIN N AM, V18, P621, DOI 10.1016/j.idc.2004.04.010	32	5	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145119	10.1371/journal.pone.0145119	http://dx.doi.org/10.1371/journal.pone.0145119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691198	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092300039
J	Valero, Y; Arizcun, M; Esteban, MA; Bandin, I; Olveira, JG; Patel, S; Cuesta, A; Chaves-Pozo, E				Valero, Yulema; Arizcun, Marta; Angeles Esteban, M.; Bandin, Isabel; Olveira, Jose G.; Patel, Sonal; Cuesta, Alberto; Chaves-Pozo, Elena			Nodavirus Colonizes and Replicates in the Testis of Gilthead Seabream and European Sea Bass Modulating Its Immune and Reproductive Functions	PLOS ONE			English	Article							NERVOUS-NECROSIS-VIRUS; SPARUS-AURATA L.; DICENTRARCHUS-LABRAX; TELEOST FISH; HORIZONTAL TRANSMISSION; VIRAL ENCEPHALOPATHY; SUBGENOMIC RNA3; STAR PROTEIN; BETANODAVIRUS; TESTOSTERONE	Viruses are threatening pathogens for fish aquaculture. Some of them are transmitted through gonad fluids or gametes as occurs with nervous necrosis virus (NNV). In order to be transmitted through the gonad, the virus should colonize and replicate inside some cell types of this tissue and avoid the subsequent immune response locally. However, whether NNV colonizes the gonad, the cell types that are infected, and how the immune response in the gonad is regulated has never been studied. We have demonstrated for the first time the presence and localization of NNV into the testis after an experimental infection in the European sea bass (Dicentrarchus labrax), and in the gilthead seabream (Sparus aurata), a very susceptible and an asymptomatic host fish species, respectively. Thus, we localized in the testis viral RNA in both species using in situ PCR and viral proteins in gilthead seabream by immunohistochemistry, suggesting that males might also transmit the virus. In addition, we were able to isolate infective particles from the testis of both species demonstrating that NNV colonizes and replicates into the testis of both species. Blood contamination of the tissues sampled was discarded by completely fish bleeding, furthermore the in situ PCR and immunocytochemistry techniques never showed staining in blood vessels or cells. Moreover, we also determined how the immune and reproductive functions are affected comparing the effects in the testis with those found in the brain, the main target tissue of the virus. Interestingly, NNV triggered the immune response in the European sea bass but not in the gilthead seabream testis. Regarding reproductive functions, NNV infection alters 17 beta-estradiol and 11-ketotestosterone production and the potential sensitivity of brain and testis to these hormones, whereas there is no disruption of testicular functions according to several reproductive parameters. Moreover, we have also studied the NNV infection of the testis in vitro to assess local responses. Our in vitro results show that the changes observed on the expression of immune and reproductive genes in the testis of both species are different to those observed upon in vivo infections in most of the cases.	[Valero, Yulema; Arizcun, Marta; Chaves-Pozo, Elena] IEO, Ctr Oceanog Murcia, Murcia, Spain; [Angeles Esteban, M.; Cuesta, Alberto] Univ Murcia, Fac Biol, Dept Cell Biol & Histol, Murcia, Spain; [Bandin, Isabel; Olveira, Jose G.] Univ Santiago de Compostela, Inst Acuicultura, Dept Microbiol & Parasitol, Unidad Ictiopatol Patol Viral, Santiago De Compostela, Spain; [Patel, Sonal] Inst Marine Res, N-5024 Bergen, Norway	Spanish Institute of Oceanography; University of Murcia; Universidade de Santiago de Compostela; Institute of Marine Research - Norway	Chaves-Pozo, E (corresponding author), IEO, Ctr Oceanog Murcia, Carretera Azohia S-N, Murcia, Spain.	elena.chaves@mu.ieo.es	Esteban, MA/D-6709-2011; Cuesta, Alberto/B-6372-2008; Arizcun, Marta/ABE-5713-2020; Cuesta, Yulema Valero/H-6694-2015; Bandin, Isabel/K-6542-2014; Chaves-Pozo, Elena/H-5325-2015	Esteban, MA/0000-0002-6264-1458; Cuesta, Alberto/0000-0002-0906-7995; Arizcun, Marta/0000-0001-8514-1854; Cuesta, Yulema Valero/0000-0002-5432-4903; Bandin, Isabel/0000-0002-1947-5933; Chaves-Pozo, Elena/0000-0003-4030-1273	Ministerio de Economia y Competitividad; Instituto Espanol de Ocenaografia; FEDER [AGL2010-20801-C02-01, AGL2010-20801-C02-02, AGL2013-43588-P]; Fundacion Seneca (Grupo de Excelencia de la Region de Murcia) [04538/GERM/06]; Xunta de Galicia [EM2012/005]	Ministerio de Economia y Competitividad(Spanish Government); Instituto Espanol de Ocenaografia; FEDER(European Commission); Fundacion Seneca (Grupo de Excelencia de la Region de Murcia)(Fundacion Seneca); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	Elena Chaves-Pozo thanks the Ministerio de Economia y Competitividad for her Ramon y Cajal's research contract and Yulema Valero thanks the Instituto Espanol de Ocenaografia for her PhD grant. This work was supported by grants of the Ministerio de Economia y Competitividad and FEDER (AGL2010-20801-C02-01, AGL2010-20801-C02-02, AGL2013-43588-P) and Fundacion Seneca (Grupo de Excelencia de la Region de Murcia 04538/GERM/06) and partially by Grant EM2012/005 from Xunta de Galicia.	Aguila S, 2013, MOL IMMUNOL, V53, P218, DOI 10.1016/j.molimm.2012.08.002; Aranguren R, 2002, J FISH DIS, V25, P317, DOI 10.1046/j.1365-2761.2002.00368.x; Arukwe A, 2008, CELL BIOL TOXICOL, V24, P527, DOI 10.1007/s10565-008-9069-7; Blazquez M, 2009, J EXP ZOOL PART B, V312B, P686, DOI 10.1002/jez.b.21286; Breuil G, 2002, J FISH DIS, V25, P697, DOI 10.1046/j.1365-2761.2002.00406.x; BREUIL G, 1991, AQUACULTURE, V97, P109, DOI 10.1016/0044-8486(91)90258-9; Cabas I, 2011, MOL IMMUNOL, V48, P2079, DOI 10.1016/j.molimm.2011.07.001; Castric J, 2001, DIS AQUAT ORGAN, V47, P33, DOI 10.3354/dao047033; Chang YT, 2011, FISH SHELLFISH IMMUN, V30, P1283, DOI 10.1016/j.fsi.2011.03.018; Chaves-Pozo E, 2008, GEN COMP ENDOCR, V156, P531, DOI 10.1016/j.ygcen.2008.03.004; Chaves-Pozo E, 2005, BIOL REPROD, V72, P593, DOI 10.1095/biolreprod.104.036103; Chaves-Pozo E, 2005, J LEUKOCYTE BIOL, V78, P345, DOI 10.1189/jlb.0205120; Chaves-Pozo E, 2007, BIOL REPROD, V76, P142, DOI 10.1095/biolreprod.106.056036; Chaves-Pozo E, 2011, SEX STEROIDS, P199; Chaves-Pozo E, 2012, FISH SHELLFISH IMMUN, V33, P1159, DOI 10.1016/j.fsi.2012.09.002; Chaves-Pozo E, 2010, DEV COMP IMMUNOL, V34, P648, DOI 10.1016/j.dci.2010.01.009; Chen NC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005203; Cuesta A, 2007, FISH SHELLFISH IMMUN, V23, P693, DOI 10.1016/j.fsi.2007.01.015; Deane EE, 2001, COMP BIOCHEM PHYS B, V129, P687, DOI 10.1016/S1096-4959(01)00369-4; Delsert C, 1997, ARCH VIROL, V142, P2359, DOI 10.1007/s007050050248; Diotel N, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00137; Fenner BJ, 2006, J VIROL, V80, P85, DOI 10.1128/JVI.80.1.85-94.2006; Frerichs GN, 1996, J GEN VIROL, V77, P2067, DOI 10.1099/0022-1317-77-9-2067; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Gomez DK, 2004, J FISH DIS, V27, P603, DOI 10.1111/j.1365-2761.2004.00577.x; Gomez Y, 2000, J STEROID BIOCHEM, V74, P143, DOI 10.1016/S0960-0760(00)00099-6; Grotmol S, 1999, DIS AQUAT ORGAN, V36, P95, DOI 10.3354/dao036095; Hedger MP, 2002, J REPROD IMMUNOL, V57, P19, DOI 10.1016/S0165-0378(02)00016-5; Hodneland K, 2011, J FISH DIS, V34, P189, DOI 10.1111/j.1365-2761.2010.01227.x; Hou Y, 1999, FISHERIES SCI, V65, P850, DOI 10.2331/fishsci.65.850; Inoue R, 2003, FEMS MICROBIOL ECOL, V46, P213, DOI 10.1016/S0168-6496(03)00215-0; Iwamoto T, 2005, J GEN VIROL, V86, P2807, DOI 10.1099/vir.0.80902-0; Iwamoto T, 2000, DIS AQUAT ORGAN, V43, P81, DOI 10.3354/dao043081; Kocan RM, 2001, DIS AQUAT ORGAN, V44, P75, DOI 10.3354/dao044075; Korsnes K, 2012, DIS AQUAT ORGAN, V99, P13, DOI 10.3354/dao02454; Kuo HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036183; Liarte S, 2011, DEV COMP IMMUNOL, V35, P840, DOI 10.1016/j.dci.2011.03.015; Liarte S, 2011, DEV COMP IMMUNOL, V35, P19, DOI 10.1016/j.dci.2010.07.007; Liarte S, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-20; Maltese Chiara, 2007, Ittiopatologia, V4, P93; Mezeth KB, 2009, DIS AQUAT ORGAN, V83, P97, DOI 10.3354/dao02015; Migaud H, 2012, GEN COMP ENDOCR, V179, P384, DOI 10.1016/j.ygcen.2012.07.033; Munday BL, 2002, J FISH DIS, V25, P127, DOI 10.1046/j.1365-2761.2002.00350.x; Munoz-Cruz S, 2011, CURR TOP MED CHEM, V11, P1714; Nagai T, 1999, J GEN VIROL, V80, P3019, DOI 10.1099/0022-1317-80-11-3019; NISHIZAWA T, 1994, DIS AQUAT ORGAN, V18, P103, DOI 10.3354/dao018103; NUOVO GJ, 1995, PCR METH APPL, V4, pS151; Olveira JG, 2013, AQUACULTURE, V406, P125, DOI 10.1016/j.aquaculture.2013.05.007; Olveira JG, 2009, J GEN VIROL, V90, P2940, DOI 10.1099/vir.0.013912-0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rodriguez L, 2000, FISH PHYSIOL BIOCHEM, V23, P141, DOI 10.1023/A:1007871604795; Sanchez-Hernandez M, 2013, J STEROID BIOCHEM, V138, P183, DOI 10.1016/j.jsbmb.2013.05.014; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Sinyakov MS, 2011, VIROLOGY, V410, P228, DOI 10.1016/j.virol.2010.11.004; Smail DA, 2008, J FISH DIS, V31, P49, DOI 10.1111/j.1365-2761.2007.00866.x; Sommerset I, 2004, DIS AQUAT ORGAN, V58, P117, DOI 10.3354/dao058117; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Tan C, 2001, J GEN VIROL, V82, P647, DOI 10.1099/0022-1317-82-3-647; Valero Y, 2015, CELL TISSUE RES, V362, P215, DOI 10.1007/s00441-015-2172-1; Valero Y, 2015, J GEN VIROL, V96, P2176, DOI 10.1099/vir.0.000164; Valero Y, 2015, FISH SHELLFISH IMMUN, V44, P203, DOI 10.1016/j.fsi.2015.02.015; Weltzien FA, 2004, COMP BIOCHEM PHYS A, V137, P447, DOI 10.1016/j.cbpb.2003.11.007	63	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145131	10.1371/journal.pone.0145131	http://dx.doi.org/10.1371/journal.pone.0145131			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691348	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300040
J	Dietrich, M; Finocchiaro, N; Olszweski, S; Arens, J; Schmitz-Rode, T; Sachweh, J; Jockenhoevel, S; Cornelissen, CG				Dietrich, Maren; Finocchiaro, Nicole; Olszweski, Sebastian; Arens, Jutta; Schmitz-Rode, Thomas; Sachweh, Joerg; Jockenhoevel, Stefan; Cornelissen, Christian G.			ENDOXY - Development of a Biomimetic Oxygenator-Test-Device	PLOS ONE			English	Article							ENDOTHELIAL-CELL CULTURE; FLUID SHEAR-STRESS; VASCULAR GRAFT; BIOMATERIALS; PROTOCOL; PECAM-1; FLOW	Objective This study focusses on the development of a biomimetic oxygenator test device. Due to limited biocompatibility, current oxygenators do not allow mid- to long-term therapy. Tissue engineering uses autologous cell sources to overcome the immunogenic barriers of biomaterials. Surface coating with endothelial cells might improve hemocompatibility and thus prevent immunogenic reactions of the body. In this study this concept is applied to endothelialise a gas-permeable membrane to develop a biomimetic oxygenator test-device (ENDOXY). Methods ENDOXY-a multifunctional test-system was developed to endothelialise a gas-permeable membrane suitable for cell culture and to test the cell retention under shear stress and to measure gas transfer through it. Results Successful endothelialisation of the membrane was achieved and cells showed characteristic endothelial morphologies. They stained positive for endothelial markers. The number of cells aligned with shear stress and cell retention after blood perfusing experiments was high. Gas transfer is observed via uncoated and endothelialised membranes. Conclusion The study showed promising results with regard to system design, endothelialisation, and cell retention under shear stress conditions. It strongly encourages further research into the system by testing different membrane materials to design a biomimetic membrane surface and pave way for a fully hemocompatible oxygenator.	[Dietrich, Maren; Finocchiaro, Nicole; Olszweski, Sebastian; Schmitz-Rode, Thomas; Sachweh, Joerg; Jockenhoevel, Stefan; Cornelissen, Christian G.] Rhein Westfal TH Aachen, Helmholtz Inst Aachen, Inst Appl Med Engn, Dept Tissue Engn & Text Implants, Aachen, Germany; [Arens, Jutta; Schmitz-Rode, Thomas] Rhein Westfal TH Aachen, Helmholtz Inst Aachen, Inst Appl Med Engn, Dept Cardiovasc Engn, Aachen, Germany; [Cornelissen, Christian G.] RWTH Aachen Univ Hosp, Sect Pneumol, Dept Internal Med, Aachen, Germany	Helmholtz Association; RWTH Aachen University; Helmholtz Association; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital	Jockenhoevel, S (corresponding author), Rhein Westfal TH Aachen, Helmholtz Inst Aachen, Inst Appl Med Engn, Dept Tissue Engn & Text Implants, Aachen, Germany.	jockenhoevel@hia.rwth-aachen.de		Arens, Jutta/0000-0002-9115-0519; Schmitz-Rode, Thomas/0000-0002-1181-2165; Jockenhoevel, Stefan/0000-0003-0584-9444	START research program of the medical faculty of the RWTH Aachen University	START research program of the medical faculty of the RWTH Aachen University	This research was financed by the START research program of the medical faculty of the RWTH Aachen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DEJ, 2011, ANN BIOMED ENG, V39, P2329, DOI 10.1007/s10439-011-0352-z; Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; [Anonymous], European Patent, Patent No. [EP0231572A2, 0231572]; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k; Dusserre N, 2004, ARTERIOSCL THROM VAS, V24, P1796, DOI 10.1161/01.ATV.0000141133.32496.41; Fischer WBH CA HS, 2009, Z HERZ THORAX GEFASS, V23, P293; Flanagan TC., 2009, TISSUE ENG A; Hess C, 2010, TISSUE ENG PT A, V16, P3043, DOI [10.1089/ten.tea.2010.0131, 10.1089/ten.TEA.2010.0131]; HEWETT PW, 1993, IN VITRO CELL DEV-AN, V29A, P823; Howell GJ, 2004, MOL MEMBR BIOL, V21, P413, DOI 10.1080/09687860400011571; IVES CL, 1986, IN VITRO CELL DEV B, V22, P500; Jones CI, 2008, AM J PHYSIOL-CELL PH, V295, pC180, DOI 10.1152/ajpcell.00549.2007; Koch S, 2010, BIOMATERIALS, V31, P4731, DOI 10.1016/j.biomaterials.2010.02.051; LIU SQ, 1994, P NATL ACAD SCI USA, V91, P8782, DOI 10.1073/pnas.91.19.8782; Marin V, 2001, J IMMUNOL METHODS, V254, P183, DOI 10.1016/S0022-1759(01)00408-2; McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; Montoya JP, 1992, ASAIO J, V38, P399; Pearson JD, 1999, BEST PRACT RES CL HA, V12, P329, DOI 10.1053/beha.1999.0028; Polk AA, 2010, BIOTECHNOL BIOENG, V106, P490, DOI 10.1002/bit.22675; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Silbernagel S, 2001, TASCHENATLAS PHYSL, P120; SMEETS EF, 1992, BIOTECH HISTOCHEM, V67, P241, DOI 10.3109/10520299209110072; Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4; Tschoeke B, 2009, TISSUE ENG PT A, V15, P1909, DOI 10.1089/ten.tea.2008.0499; Wegner JA, 1997, J CARDIOTHOR VASC AN, V11, P275, DOI 10.1016/S1053-0770(97)90096-3; West JB, 2003, AM J PHYSIOL-LUNG C, V285, pL501, DOI 10.1152/ajplung.00117.2003; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Yalcin O, 2008, AM J PHYSIOL-HEART C, V294, pH2098, DOI 10.1152/ajpheart.00015.2008; Yazdani SK, 2010, J VASC SURG, V51, P174, DOI 10.1016/j.jvs.2009.08.074	32	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0142961	10.1371/journal.pone.0142961	http://dx.doi.org/10.1371/journal.pone.0142961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682907	Green Submitted, Green Published, gold			2022-12-27	WOS:000366725800004
J	Strzala, T; Kowalczyk, A; Lukaszewicz, E				Strzala, Tomasz; Kowalczyk, Artur; Lukaszewicz, Ewa			Reintroduction of the European Capercaillie from the Capercaillie Breeding Centre in Wisla Forest District: Genetic Assessments of Captive and Reintroduced Populations	PLOS ONE			English	Article							TETRAO-UROGALLUS L.; INFERENCE; SOFTWARE; SEMEN; DIFFERENTIATION; FRAGMENTATION; CONSEQUENCES; PRESERVATION; PHYLOGENIES; DIVERSITY	The Western capercaillie (Tetrao urogallus) is a specific bird species, which, despite its very broad distribution and large global population size, is highly endangered in many Western and Central European countries. According to the species situation, in many countries (including Poland), breeding and reintroduction programmes have been started. One of the most complex and large-scale reintroduction programmes was started in Bory Dolnoslaskie Forest, and the Capercaillie Breeding Centre in Wisla Forest District was used as one of the sources of individuals for reintroduction. As genetic tools provide essential knowledge about species biodiversity, which is crucially important during the breeding process and reintroduction, both captive and reintroduced grouse populations were genetically analysed. We were particularly interested in genetic diversity of the individuals in both populations and the genetic relationship between them, as well as between them and other capercaillie representatives from their current range. To fulfil these goals we determined nine microsatellite loci along with a fragment of the mitochondrial control region. Genetic diversity parameters were moderate to high compared to populations from other Central and Western European countries. Both populations were clustered into three distinct genetic clades based on microsatellites. Phylogenetic analysis placed all mitochondrial haplotypes we revealed in the Eurasian clade. The present results will play an important role as they will help to preserve and maximize genetic diversity in captive populations, and will provide a basis for future monitoring of the reintroduction process.	[Strzala, Tomasz] Wroclaw Univ Environm & Life Sci, Fac Biol, Dept Genet, Wroclaw, Poland; [Kowalczyk, Artur; Lukaszewicz, Ewa] Wroclaw Univ Environm & Life Sci, Fac Biol, Inst Anim Breeding, Div Poultry Breeding, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences	Strzala, T (corresponding author), Wroclaw Univ Environm & Life Sci, Fac Biol, Dept Genet, Wroclaw, Poland.	tomasz.strzala@up.wroc.pl	ŁUKASZEWICZ, EWA T./B-4114-2017; Strzała, Tomasz/P-3357-2019; Kowalczyk, Artur/B-5721-2017; Strzała, Tomasz/F-4578-2011	ŁUKASZEWICZ, EWA T./0000-0002-9505-0056; Strzała, Tomasz/0000-0002-7761-1630; Kowalczyk, Artur/0000-0001-7446-0147; Strzała, Tomasz/0000-0002-7761-1630	National Research Centre [NN 311 081040]; Wroclaw Centre of Biotechnology, programme "The Leading National Research Centre (KNOW) of Wroclaw University of Environmental and Life Sciences"	National Research Centre(National Research Centre (NRC)); Wroclaw Centre of Biotechnology, programme "The Leading National Research Centre (KNOW) of Wroclaw University of Environmental and Life Sciences"	The experiment was supported financially by the National Research Centre, NN 311 081040. The publication was supported by Wroclaw Centre of Biotechnology, programme "The Leading National Research Centre (KNOW) of Wroclaw University of Environmental and Life Sciences for years 2014-2018".	Alda F, 2011, ANIM CONSERV, V14, P249, DOI 10.1111/j.1469-1795.2010.00425.x; [Anonymous], 2001, POLSKA CZERWONA KSIE; Bajc M, 2011, PLOS ONE, P6; Benjamini Y, 1995, J R STAT SOC B; CHAKRABORTY R, 1992, ANN HUM GENET, V56, P45, DOI 10.1111/j.1469-1809.1992.tb01128.x; Criscuolo A, 2011, MOL PHYLOGENET EVOL, V61, P944, DOI 10.1016/j.ympev.2011.08.029; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Olivier D, 2007, CONSERV GENET, V8, P513, DOI 10.1007/s10592-006-9165-2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Glowacinski Z, 1992, POLSKA CZERWONA KSIE, P173; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2006, CONSERV GENET, V7, P991, DOI 10.1007/s10592-006-9134-9; Kowalczyk A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116797; Kowalczyk A, 2012, THERIOGENOLOGY, V77, P899, DOI 10.1016/j.theriogenology.2011.09.015; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liukkonen-Anttila T, 2004, ANN ZOOL FENN, V41, P619; Lukaszewicz ET, 2015, REPROD DOMEST ANIM, V50, P452, DOI 10.1111/rda.12512; Lukaszewicz E, 2011, ORNIS FENNICA, V88, P110; Merta D, 2008, P 1 C PROT FOR GROUS, P224; Merta D, 2013, CZYNNA OCHRONA GLUSZ, P195; Merta Dorota, 2013, Vogelwelt, V134, P65; Moran-Luis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099799; Morin PA, 2010, J HERED, V101, P1, DOI 10.1093/jhered/esp107; Park S, 2008, EXCEL MICROSATELLITE; Piertney SB, 2001, MOL ECOL NOTES, V1, P303, DOI 10.1046/j.1471-8278.2001.00118.x; Pritchard JK, 2000, GENETICS, V155, P945; Regnaut S, 2006, CONSERV GENET, V7, P449, DOI 10.1007/s10592-005-9023-7; Rodriguez-Munoz R, 2007, CONSERV GENET, V8, P659, DOI 10.1007/s10592-006-9212-z; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rutkowski R, 2005, ACTA ORNITHOL, V40, P27, DOI 10.3161/068.040.0108; Rzonca Zenon, 2012, Grouse News, V43, P17; Segelbacher G, 2000, MOL ECOL, V9, P1934, DOI 10.1046/j.1365-294x.2000.0090111934.x; Segelbacher G, 2003, MOL ECOL, V12, P1773, DOI 10.1046/j.1365-294X.2003.01873.x; Segelbacher G, 2002, MOL ECOL, V11, P1669, DOI 10.1046/j.1365-294X.2002.01565.x; Segelbacher G, 2007, J ORNITHOL, P148; Segelbacher G, 2002, THESIS; Segelbacher G, 2008, MOL ECOL, V17, P2356, DOI 10.1111/j.1365-294X.2008.03767.x; Storch I., 2007, GROUSE STATUS SURVEY; Storch Ilse, 2001, BWP Update, V3, P1; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Vazquez JF, 2012, J WILDLIFE MANAGE, V76, P957, DOI 10.1002/jwmg.346; Zurek Z, 2011, STUDIA MAT CENTRUM E, P229; [No title captured]	53	7	8	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145433	10.1371/journal.pone.0145433	http://dx.doi.org/10.1371/journal.pone.0145433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682897	Green Submitted, Green Published, gold			2022-12-27	WOS:000366725800076
J	Yu, RX; Miyamura, N; Okamoto-Uchida, Y; Arima, N; Ishigami-Yuasa, M; Kagechika, H; Nishina, H				Yu, Ruoxing; Miyamura, Norio; Okamoto-Uchida, Yoshimi; Arima, Norie; Ishigami-Yuasa, Mari; Kagechika, Hiroyuki; Nishina, Hiroshi			A Modified Murine Embryonic Stem Cell Test for Evaluating the Teratogenic Effects of Drugs on Early Embryogenesis	PLOS ONE			English	Article							BENZODIAZEPINE USE; IN-VITRO; DEVELOPMENTAL TOXICITY; PRIMITIVE STREAK; PREGNANCY; EMBRYOTOXICITY; MALFORMATIONS; RECEPTORS; BODIES; ASSAY	Mammalian fetal development is easily disrupted by exogenous agents, making it essential to test new drug candidates for embryotoxicity and teratogenicity. To standardize the testing of drugs that might be used to treat pregnant women, the U.S. Food and Drug Administration (FDA) formulated special grade categories, labeled A, B, C, D and X, that define the level of risk associated with the use of a specific drug during pregnancy. Drugs in categories (Cat.) D and X are those with embryotoxic and/ or teratogenic effects on humans and animals. However, which stages of pregnancy are affected by these agents and their molecular mechanisms are unknown. We describe here an embryonic stem cell test (EST) that classifies FDA pregnancy Cat. D and Cat. X drugs into 4 classes based on their differing effects on primitive streak formation. We show that similar to 84% of Cat. D and Cat. X drugs target this period of embryogenesis. Our results demonstrate that our modified EST can identify how a drug affects early embryogenesis, when it acts, and its molecular mechanism. Our test may thus be a useful addition to the drug safety testing armamentarium.	[Yu, Ruoxing; Miyamura, Norio; Okamoto-Uchida, Yoshimi; Arima, Norie; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo 1138510, Japan; [Ishigami-Yuasa, Mari; Kagechika, Hiroyuki] TMDU, Chem Biol Screening Ctr, Tokyo 1010062, Japan; [Ishigami-Yuasa, Mari; Kagechika, Hiroyuki] TMDU, Inst Biomat & Bioengn, Dept Organ & Med Chem, Tokyo 1010062, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Nishina, H (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo 1138510, Japan.	nishina.dbio@mri.tmd.ac.jp		Kagechika, Hiroyuki/0000-0002-6747-1013	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Joint Usage/Research Program of MRI, TMDU; JSPS; A. Advanced Research Networks; MEXT Platform for Drug Discovery, Informatics, and Structural Life Science, Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Joint Usage/Research Program of MRI, TMDU; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); A. Advanced Research Networks; MEXT Platform for Drug Discovery, Informatics, and Structural Life Science, Japan	This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan, and a Joint Usage/Research Program of MRI, TMDU. This work was partly supported by JSPS Core-to-Core Program, A. Advanced Research Networks, and MEXT Platform for Drug Discovery, Informatics, and Structural Life Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank numerous members of the Nishina laboratories for their helpful discussions and critical comments on the manuscript. This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan, and funding by the Joint Usage/Research Program of MRI, TMDU. This work was partly supported by the JSPS Core-to-Core Program, A. Advanced Research Networks, and the MEXT Platform for Drug Discovery, Informatics, and Structural Life Science, Japan.	Arima N, 2013, BIOCHEM BIOPH RES CO, V435, P447, DOI 10.1016/j.bbrc.2013.05.006; Bain PA, 2009, EFFECTIVE MIGRAINE T; Doering PL, 2002, AM J OBSTET GYNECOL, V187, P333, DOI 10.1067/mob.2002.125740; Dolovich LR, 1998, BMJ-BRIT MED J, V317, P839, DOI 10.1136/bmj.317.7162.839; Enato E, 2011, J OBSTET GYNAECOL CA, V33, P46, DOI 10.1016/S1701-2163(16)34772-7; Feibus KB, 2008, J MED TOXICOL, V4, P284, DOI 10.1007/BF03161214; Festag M, 2007, TOXICOL IN VITRO, V21, P1631, DOI 10.1016/j.tiv.2007.06.014; Gilbert-Barness E, 2010, ANN CLIN LAB SCI, V40, P99; Hadjal Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.246; Henderson E, 2011, POSTGRAD MED J, V87, P349, DOI 10.1136/pgmj.2010.103606; Hong EJ, 2013, TOX RESEARCH, V29, P221, DOI 10.5487/TR.2013.29.4.221; Hyoun SC, 2012, BIRTH DEFECTS RES A, V94, P187, DOI 10.1002/bdra.23003; LAEGREID L, 1989, J PEDIATR-US, V114, P126, DOI 10.1016/S0022-3476(89)80619-5; Law R, 2010, CAN FAM PHYSICIAN, V56, P239; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; MCELHATTON PR, 1994, REPROD TOXICOL, V8, P461, DOI 10.1016/0890-6238(94)90029-9; Mikawa T, 2004, DEV DYNAM, V229, P422, DOI 10.1002/dvdy.10458; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; Palmer Jessica A, 2013, Birth Defects Res B Dev Reprod Toxicol, V98, P343, DOI 10.1002/bdrb.21078; Panzica-Kelly JM, 2013, TOXICOL SCI, V131, P447, DOI 10.1093/toxsci/kfs293; Piette D, 2008, NAT PROTOC, V3, P1194, DOI 10.1038/nprot.2008.103; ROSENBERG L, 1983, NEW ENGL J MED, V309, P1282, DOI 10.1056/NEJM198311243092103; Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348; Sevene E, 2012, PEDIATR DRUGS, V14, P43, DOI 10.2165/11591270-000000000-00000; SIEBER SM, 1978, TERATOLOGY, V18, P31, DOI 10.1002/tera.1420180107; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Sogorb MA, 2014, TOXICOL LETT, V230, P356, DOI 10.1016/j.toxlet.2014.01.037; Tan O, 2013, REPROD SCI, V20, P16, DOI 10.1177/1933719112459244; Uhl K, 2002, DRUG SAFETY, V25, P885, DOI 10.2165/00002018-200225120-00006; Wu JZ, 2010, STEM CELLS DEV, V19, P1723, DOI 10.1089/scd.2010.0066; Yap C, 2014, J CELL SCI, V127, P2204, DOI 10.1242/jcs.134502; Zhanel GG, 2004, DRUGS, V64, P63, DOI 10.2165/00003495-200464010-00005	32	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145286	10.1371/journal.pone.0145286	http://dx.doi.org/10.1371/journal.pone.0145286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682887	Green Submitted, Green Published, gold			2022-12-27	WOS:000366725800058
J	Bressler, R; Kreisberg, RB; Bernard, B; Niederhuber, JE; Vockley, JG; Shmulevich, I; Knijnenburg, TA				Bressler, Ryan; Kreisberg, Richard B.; Bernard, Brady; Niederhuber, John E.; Vockley, Joseph G.; Shmulevich, Ilya; Knijnenburg, Theo A.			CloudForest: A Scalable and Efficient Random Forest Implementation for Biological Data	PLOS ONE			English	Article								Random Forest has become a standard data analysis tool in computational biology. However, extensions to existing implementations are often necessary to handle the complexity of biological datasets and their associated research questions. The growing size of these datasets requires high performance implementations. We describe CloudForest, a Random Forest package written in Go, which is particularly well suited for large, heterogeneous, genetic and biomedical datasets. CloudForest includes several extensions, such as dealing with unbalanced classes and missing values. Its flexible design enables users to easily implement additional extensions. CloudForest achieves fast running times by effective use of the CPU cache, optimizing for different classes of features and efficiently multi-threading. https://github.com/ilyalab/CloudForest.	[Bressler, Ryan; Kreisberg, Richard B.; Bernard, Brady; Shmulevich, Ilya; Knijnenburg, Theo A.] Inst Syst Biol, Seattle, WA 98109 USA; [Niederhuber, John E.; Vockley, Joseph G.] Inova Hlth Syst, Inova Translat Med Inst, Falls Church, VA USA; [Niederhuber, John E.; Vockley, Joseph G.] Inova Fairfax Med Ctr, Falls Church, VA USA; [Vockley, Joseph G.] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA	Institute for Systems Biology (ISB); Inova Health System; Inova Fairfax Hospital; Virginia Commonwealth University	Knijnenburg, TA (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	tknijnen@systemsbiology.org			Inova Health System; National Cancer Institute [U24CA143835]; NATIONAL CANCER INSTITUTE [U24CA143835] Funding Source: NIH RePORTER	Inova Health System; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Inova Health System, a non-profit healthcare system in Northern Virginia. Two Inova scientists are coauthors on this manuscript and have provided supervision, interpretation of the results, and contributed to the writing of the manuscript. This work was supported in part by the National Cancer Institute U24CA143835 (RB RBK BB IS TAK).; This work was supported by the Inova Health System, a non-profit healthcare system in Northern Virginia, and the National Cancer Institute U24CA143835.	Bodian DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094554; Boulesteix AL, 2012, WIRES DATA MIN KNOWL, V2, P493, DOI 10.1002/widm.1072; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2004, RF FORTRAN CODE; Breiman L., 2017, CLASSIFICATION REGRE; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Erkkila T., 2013, RF ACE; Freund Y, 1995, COMPUTATIONAL LEARNI, P23, DOI [10.1007/3-540-59119-2_166, DOI 10.1007/3-540-59119-2_166]; Hido S., 2009, STAT ANAL DATA MIN, V2, P412, DOI DOI 10.1002/SAM.10061; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Qi YJ, 2006, PROTEINS, V63, P490, DOI 10.1002/prot.20865; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Tuv E, 2009, J MACH LEARN RES, V10, P1341	15	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144820	10.1371/journal.pone.0144820	http://dx.doi.org/10.1371/journal.pone.0144820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679347	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400027
J	Verdery, AM; Mouw, T; Bauldry, S; Mucha, PJ				Verdery, Ashton M.; Mouw, Ted; Bauldry, Shawn; Mucha, Peter J.			Network Structure and Biased Variance Estimation in Respondent Driven Sampling	PLOS ONE			English	Article							FEMALE SEX WORKERS; RECRUITMENT; POPULATION	This paper explores bias in the estimation of sampling variance in Respondent Driven Sampling (RDS). Prior methodological work on RDS has focused on its problematic assumptions and the biases and inefficiencies of its estimators of the population mean. Nonetheless, researchers have given only slight attention to the topic of estimating sampling variance in RDS, despite the importance of variance estimation for the construction of confidence intervals and hypothesis tests. In this paper, we show that the estimators of RDS sampling variance rely on a critical assumption that the network is First Order Markov (FOM) with respect to the dependent variable of interest. We demonstrate, through intuitive examples, mathematical generalizations, and computational experiments that current RDS variance estimators will always underestimate the population sampling variance of RDS in empirical networks that do not conform to the FOM assumption. Analysis of 215 observed university and school networks from Facebook and Add Health indicates that the FOM assumption is violated in every empirical network we analyze, and that these violations lead to substantially biased RDS estimators of sampling variance. We propose and test two alternative variance estimators that show some promise for reducing biases, but which also illustrate the limits of estimating sampling variance with only partial information on the underlying population social network.	[Verdery, Ashton M.] Penn State Univ, Dept Sociol & Criminol, Populat Res Inst, University Pk, PA 16802 USA; [Verdery, Ashton M.] Penn State Univ, Inst CyberSci, University Pk, PA 16802 USA; [Mouw, Ted] Univ N Carolina, Dept Sociol, Chapel Hill, NC USA; [Bauldry, Shawn] Univ Alabama Birmingham, Dept Sociol, Birmingham, AL 35294 USA; [Mucha, Peter J.] Univ N Carolina, Dept Appl Sci, Chapel Hill, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of North Carolina; University of North Carolina Chapel Hill; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill	Verdery, AM (corresponding author), Penn State Univ, Dept Sociol & Criminol, Populat Res Inst, University Pk, PA 16802 USA.	amv5430@psu.edu	Bauldry, Shawn/ABG-7064-2020		Carolina Population Center [R24 HD050924]; National Science Foundation [DMS-0645369]; National Institute of General Medical Sciences [R21GM099493]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R24HD041025, P01HD031921, T32HD007168, R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM099493] Funding Source: NIH RePORTER	Carolina Population Center; National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to the Carolina Population Center for training (T32 HD007168) and general support (R24 HD050924) and to the Penn State Population Research Institute (R24HD041025). Peter J. Mucha was supported by the National Science Foundation (DMS-0645369) and by Award Number R21GM099493 from the National Institute of General Medical Sciences. This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. No direct support was received from grant P01-HD31921 for this analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mason Porter for providing access to the Facebook data set we use. We also thank participants at the 2012 Hidden and Hard to Reach Populations Conference, Jonathan Daw, and Charles Seguin for helpful comments on earlier drafts. We are grateful to the Carolina Population Center for training (T32 HD007168) and general support (R24 HD050924) and to the Penn State Population Research Institute (R24HD041025). Peter J. Mucha was supported by the National Science Foundation (DMS-0645369) and by Award Number R21GM099493 from the National Institute of General Medical Sciences. This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health website (http://www.cpc.unc.edu/addhealth). No direct support was received from grant P01-HD31921 for this analysis. The content is solely the responsibility of the authors and does not necessarily represent the official views of any aforementioned funding agencies.	Abdul-Quader AS, 2006, J URBAN HEALTH, V83, pI1, DOI 10.1007/s11524-006-9108-8; Bassetti F, 2006, ILLINOIS J MATH, V50, P67, DOI 10.1215/ijm/1258059470; Berchenko Yakir, 2013, ARXIV13043505; Clouston S. P., 2009, CONNECTIONS, V29, P18; Daw J, 2015, SOC SCI MED, V125, P32, DOI 10.1016/j.socscimed.2014.02.047; Gile KJ, 2011, J AM STAT ASS, V106; Gile KJ, 2015, J R STAT SOC A STAT, V178, P241, DOI 10.1111/rssa.12059; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; Gjoka M, 2010, IEEE INFOCOM SER, DOI 10.1109/infcom.2010.5462078; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Goel S, 2009, STAT MED, V28, P2202, DOI 10.1002/sim.3613; Groves RM, 2011, SURVEY METHODOLOGY; Harris KM., 2009, NATL LONGITUDINAL ST; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Kerry SM, 1998, BRIT MED J, V316, P1455, DOI 10.1136/bmj.316.7142.1455; Lawler GF, 1999, LECT CONT PROBABILIT; Lovasz L, 1993, BOLYAI MATH STUD, V1, P9; Lu X, 2013, SOC NETWORKS, V35, P669, DOI 10.1016/j.socnet.2013.10.001; Lu X, 2013, ELECTRON J STAT, V7, P292, DOI 10.1214/13-EJS772; Lu X, 2012, J R STAT SOC A STAT, V175, P191, DOI 10.1111/j.1467-985X.2011.00711.x; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Menger K., 1927, FUND MATH, V10, P96, DOI DOI 10.4064/FM-10-1-96-115; Merli MG, 2015, SOC SCI MED, V125, P79, DOI 10.1016/j.socscimed.2014.04.022; Merli MG, 2014, WORK PAP DUKE NETW A; Moody J, 2003, AM SOCIOL REV, V68, P103, DOI 10.2307/3088904; Moody J.W., 1999, STRUCTURE ADOLESCENT; Mouw T, 2014, SAMPLING HIDDEN POPU; Mouw T, 2012, SOCIOL METHODOL, V42, P206, DOI 10.1177/0081175012461248; Mouw T, 2014, SOC PROBL, V61, P329, DOI 10.1525/sp.2014.12192; National Institutes of Health, REPORTER DAT; Neely WW, 2009, THESIS; Nesterko S, 2015, J STAT COMPUT SIM, V85, P89, DOI 10.1080/00949655.2013.804078; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Racca E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011126; Red V, 2011, SIAM REV, V53, P526, DOI 10.1137/080734315; Reuters Thompson, 2015, WEB SCI; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Snijders T.A., 1997, SIMULATING SOCIAL PH; Tomas A, 2011, ELECTRON J STAT, V5, P899, DOI 10.1214/11-EJS630; Traud AL, 2012, PHYSICA A, V391, P4165, DOI 10.1016/j.physa.2011.12.021; Traud AL, 2009, CHAOS, V19, DOI 10.1063/1.3194108; Verdery AM, 2015, INNOVATIONS RECRUITM; Verdery AM, 2015, EPIDEMIOLOGY, V26, P661, DOI 10.1097/EDE.0000000000000335; Volz E, 2008, J OFF STAT, V24, P79; Wejnert C, 2009, SOCIOL METHODOL, V39, P73, DOI 10.1111/j.1467-9531.2009.01216.x; Yamanis TJ, 2013, SOCIOL METHOD RES, V42, P392, DOI 10.1177/0049124113494576	47	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145296	10.1371/journal.pone.0145296	http://dx.doi.org/10.1371/journal.pone.0145296			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679927	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400069
J	Yan, Z; Liang, HX; Deng, L; Long, H; Chen, H; Chai, WR; Suo, L; Xu, C; Kuang, YP; Wu, LQ; Lu, SS; Lyu, QF				Yan, Zheng; Liang, Hongxing; Deng, Li; Long, Hui; Chen, Hong; Chai, Weiran; Suo, Lun; Xu, Chen; Kuang, Yanping; Wu, Lingqian; Lu, Shengsheng; Lyu, Qifeng			Eight-Shaped Hatching Increases the Risk of Inner Cell Mass Splitting in Extended Mouse Embryo Culture	PLOS ONE			English	Article							MONOZYGOTIC TWINNING RATE; BLASTOCYST STAGE; TWINS; PREGNANCIES; FERTILIZATION	Increased risk of monozygotic twinning (MZT) has been shown to be associated with assisted reproduction techniques, particularly blastocyst culture. Interestingly, inner cell mass (ICM) splitting in human '8'-shaped hatching blastocysts that resulted in MZT was reported. However, the underlying cause of MZT is not known. In this study, we investigated in a mouse model whether in vitro culture leads to ICM splitting and its association with hatching types. Blastocyst hatching was observed in: (i) in vivo developed blastocysts and (ii-iii) in vitro cultured blastocysts following in vivo or in vitro fertilization. We found that '8'-shaped hatching occurred with significantly higher frequency in the two groups of in vitro cultured blastocysts than in the group of in vivo developed blastocysts (24.4% and 20.4% versus 0.8%, respectively; n = 805, P < 0.01). Moreover, Oct4 immunofluorescence staining was performed to identify the ICM in the hatching and hatched blastocysts. Scattered and split distribution of ICM cells was observed around the small zona opening of '8'-shaped hatching blastocysts. This occurred at a high frequency in the in vitro cultured groups. Furthermore, we found more double OCT4-positive masses, suggestive of increased ICM splitting in '8'-shaped hatching and hatched blastocysts than in 'U'-shaped hatching and hatched blastocysts (12.5% versus 1.9%, respectively; n = 838, P < 0.01). Therefore, our results demonstrate that extended in vitro culture can cause high frequencies of '8'-shaped hatching, and '8'-shaped hatching that may disturb ICM herniation leading to increased risk of ICM splitting in mouse blastocysts. These results may provide insights into the increased risk of human MZT after in vitro fertilization and blastocyst transfer.	[Yan, Zheng; Long, Hui; Chen, Hong; Chai, Weiran; Suo, Lun; Kuang, Yanping; Lyu, Qifeng] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Assisted Reprod, Shanghai 200011, Peoples R China; [Liang, Hongxing; Lu, Shengsheng] Guangxi Univ, Guangxi High Educ Key Lab Anim Reprod & Biotechno, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China; [Deng, Li; Wu, Lingqian] Cent S Univ, Xiangya Hosp, Natl Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Xu, Chen; Kuang, Yanping] Shanghai Key Lab Reprod Med, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Guangxi University; Central South University	Wu, LQ (corresponding author), Cent S Univ, Xiangya Hosp, Natl Lab Med Genet, Changsha 410078, Hunan, Peoples R China.	lyuqifeng@126.com; shengshenglu@sina.com; wulingqian@sklmg.edu.cn	Wu, Ling/GZN-2235-2022		Natural Science Foundation of Shanghai, China [15ZR1424900]; National Natural Science Foundation for the Youth of China [81300485]; National Natural Science Foundation of China [31071275, 81571486]	Natural Science Foundation of Shanghai, China(Natural Science Foundation of Shanghai); National Natural Science Foundation for the Youth of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Natural Science Foundation of Shanghai, China (15ZR1424900) URL: http://www.stcsm.gov.cn/, role: design the study, decision to publish, and preparation of the manuscript, the National Natural Science Foundation for the Youth of China (81300485) URL: http://www.nsfc.gov.cn/, role: perform the study, decision to publish, and preparation of the manuscript, and the National Natural Science Foundation of China (31071275, 81571486), URL: http://www.nsfc.gov.cn/, role: design the study, data collection and analysis and preparation of the manuscript.	ALIKANI M, 1994, HUM REPROD, V9, P1318, DOI 10.1093/oxfordjournals.humrep.a138701; Alikani M, 2003, HUM REPROD, V18, P1937, DOI 10.1093/humrep/deg369; Aston KI, 2008, REPRODUCTION, V136, P377, DOI 10.1530/REP-08-0206; Behr B, 2003, FERTIL STERIL, V80, P1502, DOI 10.1016/j.fertnstert.2003.07.001; Behr B, 2000, J ASSIST REPROD GEN, V17, P349, DOI 10.1023/A:1009461213139; Blickstein I, 1999, NEW ENGL J MED, V340, P738, DOI 10.1056/NEJM199903043400916; Blickstein I, 2007, TWIN RES HUM GENET, V10, P394, DOI 10.1375/twin.10.2.394; Bruce AW, 2010, CURR OPIN GENET DEV, V20, P485, DOI 10.1016/j.gde.2010.05.006; CHIDA S, 1990, J IN VITRO FERTIL EM, V7, P177, DOI 10.1007/BF01135685; da Costa ALE, 2001, HUM REPROD, V16, P333, DOI 10.1093/humrep/16.2.333; Derom C, 2006, FERTIL STERIL, V85, P755, DOI 10.1016/j.fertnstert.2005.08.034; DEROM C, 1987, LANCET, V1, P1236; Frankfurter D, 2004, FERTIL STERIL, V82, P483, DOI 10.1016/j.fertnstert.2004.02.105; Haimov-Kochman R, 2009, FERTIL STERIL, V92, DOI 10.1016/j.fertnstert.2009.04.054; Hall JG, 2003, LANCET, V362, P735, DOI 10.1016/S0140-6736(03)14237-7; Harkness UF, 2005, SEMIN PERINATOL, V29, P296, DOI 10.1053/j.semperi.2005.10.001; Hershlag A, 1999, FERTIL STERIL, V71, P144, DOI 10.1016/S0015-0282(98)00402-6; HSU YC, 1980, SCIENCE, V209, P605, DOI 10.1126/science.7190325; Jain JK, 2004, J ASSIST REPROD GEN, V21, P103, DOI 10.1023/B:JARG.0000029493.54929.be; Kawachiya S, 2011, FERTIL STERIL, V95, P2140, DOI 10.1016/j.fertnstert.2010.12.018; Knopman J, 2010, FERTIL STERIL, V94, P502, DOI 10.1016/j.fertnstert.2009.03.064; Landim-Alvarenga FC, 2002, ANIM REPROD SCI, V71, P181, DOI 10.1016/S0378-4320(02)00045-3; MACGILLIVRAY I, 1986, SEMIN PERINATOL, V10, P4; McLaren A, 1995, GENET RES, V66, P195, DOI 10.1017/S0016672300034649; Menezo YJR, 2002, HUM REPROD, V17, P247, DOI 10.1093/humrep/17.1.247; Milki AA, 2003, FERTIL STERIL, V79, P503, DOI 10.1016/S0015-0282(02)04754-4; SCHINZEL AAGL, 1979, J PEDIATR-US, V95, P921, DOI 10.1016/S0022-3476(79)80278-4; Sills E S, 2000, Twin Res, V3, P217, DOI 10.1375/twin.3.4.217; Skiadas CC, 2008, HUM REPROD, V23, P1366, DOI 10.1093/humrep/den045; Slotnick RN, 1996, J ASSIST REPROD GEN, V13, P381, DOI 10.1007/BF02066168; Sparks Amy E, 2012, Methods Mol Biol, V912, P387, DOI 10.1007/978-1-61779-971-6_22; Tarlatzis BC, 2002, FERTIL STERIL, V77, P196, DOI 10.1016/S0015-0282(01)02958-2; Van Langendonckt A, 2000, FERTIL STERIL, V74, P1047, DOI 10.1016/S0015-0282(00)01554-5; Vitthala S, 2009, HUM REPROD UPDATE, V15, P45, DOI 10.1093/humupd/dmn045; Yakin K, 2003, FERTIL STERIL, V79, P1044, DOI 10.1016/S0015-0282(02)04941-5	35	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145172	10.1371/journal.pone.0145172	http://dx.doi.org/10.1371/journal.pone.0145172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680631	Green Submitted, Green Published, gold			2022-12-27	WOS:000366723400053
J	Gaiko-Shcherbak, A; Fabris, G; Dreissen, G; Merkel, R; Hoffmann, B; Noetzel, E				Gaiko-Shcherbak, Aljona; Fabris, Gloria; Dreissen, Georg; Merkel, Rudolf; Hoffmann, Bernd; Noetzel, Erik			The Acinar Cage: Basement Membranes Determine Molecule Exchange and Mechanical Stability of Human Breast Cell Acini	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURE; EPITHELIAL ACINI; FILTRATION BARRIER; IN-VITRO; IV; MORPHOGENESIS; COLLAGEN; BENIGN; MODELS; PERMEABILITY	The biophysical properties of the basement membrane that surrounds human breast glands are poorly understood, but are thought to be decisive for normal organ function and malignancy. Here, we characterize the breast gland basement membrane with a focus on molecule permeation and mechanical stability, both crucial for organ function. We used well-established and nature-mimicking MCF10A acini as 3D cell model for human breast glands, with ether low- or highly-developed basement membrane scaffolds. Semi-quantitative dextran tracer (3 to 40 kDa) experiments allowed us to investigate the basement membrane scaffold as a molecule diffusion barrier in human breast acini in vitro. We demonstrated that molecule permeation correlated positively with macromolecule size and intriguingly also with basement membrane development state, revealing a pore size of at least 9 nm. Notably, an intact collagen IV mesh proved to be essential for this permeation function. Furthermore, we performed ultra-sensitive atomic force microscopy to quantify the response of native breast acini and of decellularized basement membrane shells against mechanical indentation. We found a clear correlation between increasing acinar force resistance and basement membrane formation stage. Most important native acini with highly-developed basement membranes as well as cell-free basement membrane shells could both withstand physiologically relevant loads (<= 20 nN) without loss of structural integrity. In contrast, low-developed basement membranes were significantly softer and more fragile. In conclusion, our study emphasizes the key role of the basement membrane as conductor of acinar molecule influx and mechanical stability of human breast glands, which are fundamental for normal organ function.	[Gaiko-Shcherbak, Aljona; Fabris, Gloria; Dreissen, Georg; Merkel, Rudolf; Hoffmann, Bernd; Noetzel, Erik] Forschungszentrum Julich, Inst Complex Syst ICS7 Biomech, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Noetzel, E (corresponding author), Forschungszentrum Julich, Inst Complex Syst ICS7 Biomech, D-52425 Julich, Germany.	e.noetzel@fz-juelich.de	Hoffmann, Bernd/I-7237-2013; Merkel, Rudolf/G-3647-2013; Noetzel-Reiss, Erik/GYV-0999-2022	Merkel, Rudolf/0000-0003-3178-3282; Noetzel-Reiss, Erik/0000-0003-3163-6848; Gaiko-Shcherbak, Aljona/0000-0001-9097-0825; Hoffmann, Bernd/0000-0002-3803-8835; Dreissen, Georg/0000-0003-2720-660X				Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004; Amsden B, 1998, MACROMOLECULES, V31, P8382, DOI 10.1021/ma980765f; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; CAULFIEL.JP, 1974, J CELL BIOL, V63, P883, DOI 10.1083/jcb.63.3.883; Chipman SD, 2006, INT J NANOMED, V1, P375, DOI 10.2147/nano.2006.1.4.375; DAVIES B, 1993, BRIT J CANCER, V67, P1126, DOI 10.1038/bjc.1993.207; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dong JM, 2013, J SURG RES, V183, P56, DOI 10.1016/j.jss.2012.11.047; FARQUHAR MG, 1975, KIDNEY INT, V8, P197, DOI 10.1038/ki.1975.103; Ferrell N, 2013, BIOPHYS J, V104, P1476, DOI 10.1016/j.bpj.2013.01.062; Gajewska M, 2013, AUTOPHAGY DEV REMODE; Gehrke SH, 1997, ANN NY ACAD SCI, V831, P179; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Halfter W, 2013, CELL ADHES MIGR, V7, P64, DOI 10.4161/cam.22479; Hassiotou F, 2013, CLIN ANAT, V26, P29, DOI 10.1002/ca.22165; Hebner C, 2008, ANNU REV PATHOL-MECH, V3, P313, DOI 10.1146/annurev.pathmechdis.3.121806.151526; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Ikeda K, 2006, AM J PATHOL, V168, P856, DOI 10.2353/ajpath.2006.050384; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Lance A., 2013, J TISSUE ENG REGEN M; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; McKee TD, 2006, CANCER RES, V66, P2509, DOI 10.1158/0008-5472.CAN-05-2242; MONTEAGUDO C, 1990, AM J PATHOL, V136, P585; Muschler J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003202; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nakano S, 1999, LAB INVEST, V79, P281; NATHANSON SD, 1994, ANN SURG ONCOL, V1, P333, DOI 10.1007/BF03187139; OSTROM KM, 1990, PROG FOOD NUTR SCI, V14, P1; PARISH CR, 1992, INT J CANCER, V52, P378, DOI 10.1002/ijc.2910520309; Polyak K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003244; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Singer JW, 2005, J CONTROL RELEASE, V109, P120, DOI 10.1016/j.jconrel.2005.09.033; Taddei I, 2003, J MAMMARY GLAND BIOL, V8, P383, DOI 10.1023/B:JOMG.0000017426.74915.b9; Tang WYY, 2014, CELL REP, V8, P1722, DOI 10.1016/j.celrep.2014.08.026; Underwood JM, 2006, J CELL PHYSIOL, V208, P141, DOI 10.1002/jcp.20639; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13; Wang H, 2013, P NATL ACAD SCI USA, V110, P163, DOI 10.1073/pnas.1201141110; WELLING LW, 1995, NEWS PHYSIOL SCI, V10, P30; YURCHENCO PD, 1992, J CELL BIOL, V117, P1119, DOI 10.1083/jcb.117.5.1119	51	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145174	10.1371/journal.pone.0145174	http://dx.doi.org/10.1371/journal.pone.0145174			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674091	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700110
J	Sharma, G; Johal, AS; Liversidge, HM				Sharma, Geetanjali; Johal, Ama S.; Liversidge, Helen M.			Predicting Agenesis of the Mandibular Second Premolar from Adjacent Teeth	PLOS ONE			English	Article							PERMANENT TEETH; LONDON ATLAS; MINERALIZATION; CHILDREN	Early diagnosis of agenesis of the mandibular second premolar (P2) enhances management of the dental arch in the growing child. The aim of this study was to explore the relationship in the development of the mandibular first molar (M1) and first premolar (P1) at early stages of P2 (second premolar). Specifically, we ask if the likelihood of P2 agenesis can be predicted from adjacent developing teeth. We selected archived dental panoramic radiographs with P2 at crown formation stages (N = 212) and calculated the likelihood of P2 at initial mineralisation stage 'Ci' given the tooth stage of adjacent teeth. Our results show that the probability of observing mandibular P2 at initial mineralisation stage 'Ci' decreased as both the adjacent P1 and M1 matured. The modal stage at P2 'Ci' was P1 'Coc' (cusp outline complete) and M1 'Crc' (crown complete). Initial mineralisation of P2 was observed up to P1 'Crc' and M1 stage 'R1/2' (root half). The chance of observing P2 at least 'Coc' (coalescence of cusps) was considerably greater prior to these threshold stages compared to later stages of P1 and M1. These findings suggest that P2 is highly unlikely to develop if P1 is beyond 'Crc' and M1 is beyond 'R1/2'.	[Sharma, Geetanjali; Johal, Ama S.; Liversidge, Helen M.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England	University of London; Queen Mary University London	Liversidge, HM (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England.	h.m.liversidge@qmul.ac.uk		Liversidge, Helen/0000-0002-7056-9337				AlQahtani SJ, 2014, AM J PHYS ANTHROPOL, V154, P70, DOI 10.1002/ajpa.22473; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; Bicakci AA, 2012, KOREAN J ORTHOD, V42, P94, DOI 10.4041/kjod.2012.42.2.94; CUNAT JJ, 1973, J AM DENT ASSOC, V87, P183, DOI 10.14219/jada.archive.1973.0364; Fass EN, 1971, J DENT CHILD, V37, P494; GARN STANLEY M., 1958, JOUR DENTAL RES, V37, P561, DOI 10.1177/00220345580370032801; Liversidge HM, 2008, ACTA STOMATOL CROAT, V42, P311; Liversidge HM, 2011, ANN HUM BIOL, V38, P702, DOI 10.3109/03014460.2011.609565; LOGAN WILLIAM H. G., 1933, JOUR AMER DENTAL ASSOC, V20, P379; Moorrees CF, 1963, J DENT RES, V42, P490; NIELSEN HG, 1976, SCAND J DENT RES, V84, P109; Nystrom ME, 2007, ACTA ODONTOL SCAND, V65, P36, DOI 10.1080/00016350600965900; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; Rakhshan V, 2013, PROG ORTHOD, V14, DOI 10.1186/2196-1042-14-33; RAVN JJ, 1977, SCAND J DENT RES, V85, P232; Reinquist M, 1969, SWED DENT J, V62, P535; Shackelford LL, 2012, AM J PHYS ANTHROPOL, V147, P227, DOI 10.1002/ajpa.21639; Simpson SW, 1998, J HUM EVOL, V35, P479, DOI 10.1006/jhev.1998.0235	18	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144180	10.1371/journal.pone.0144180	http://dx.doi.org/10.1371/journal.pone.0144180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673218	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700028
J	Curtis, KJ; O'Brien, KA; Tanner, RJ; Polkey, JI; Minnion, M; Feelisch, M; Polkey, MI; Edwards, LM; Hopkinson, NS				Curtis, Katrina J.; O'Brien, Katie A.; Tanner, Rebecca J.; Polkey, Juliet I.; Minnion, Magdalena; Feelisch, Martin; Polkey, Michael I.; Edwards, Lindsay M.; Hopkinson, Nicholas S.			Acute Dietary Nitrate Supplementation and Exercise Performance in COPD: A Double-Blind, Placebo-Controlled, Randomised Controlled Pilot Study	PLOS ONE			English	Article							BLOOD-PRESSURE; INORGANIC NITRATE; O-2 COST; MUSCLE; STANDARDIZATION; VALIDATION; GENERATION; EFFICIENCY; INTENSITY; RESPONSES	Background Dietary nitrate supplementation can enhance exercise performance in healthy people, but it is not clear if it is beneficial in COPD. We investigated the hypotheses that acute nitrate dosing would improve exercise performance and reduce the oxygen cost of submaximal exercise in people with COPD. Methods We performed a double-blind, placebo-controlled, cross-over single dose study. Subjects were randomised to consume either nitrate-rich beetroot juice (containing 12.9mmoles nitrate) or placebo (nitrate-depleted beetroot juice) 3 hours prior to endurance cycle ergometry, performed at 70% of maximal workload assessed by a prior incremental exercise test. After a minimum washout period of 7 days the protocol was repeated with the crossover beverage. Results 21 subjects successfully completed the study (age 68 +/- 7years; BMI 25.2 +/- 5.5kg/m(2); FEV1 percentage predicted 50.1 +/- 21.6%; peak VO2 18.0 +/- 5.9ml/min/kg). Resting diastolic blood pressure fell significantly with nitrate supplementation compared to placebo (-7 +/- 8mmHg nitrate vs. -1 +/- 8mmHg placebo; p = 0.008). Median endurance time did not differ significantly; nitrate 5.65 (3.90-10.40) minutes vs. placebo 6.40 (4.01-9.67) minutes (p = 0.50). However, isotime oxygen consumption (VO2) was lower following nitrate supplementation (16.6 +/- 6.0ml/min/kg nitrate vs. 17.2 +/- 6.0ml/min/kg placebo; p = 0.043), and consequently nitrate supplementation caused a significant lowering of the amplitude of the VO2-percentage isotime curve. Conclusions Acute administration of oral nitrate did not enhance endurance exercise performance; however the observation that beetroot juice caused reduced oxygen consumption at isotime suggests that further investigation of this treatment approach is warranted, perhaps targeting a more hypoxic phenotype.	[Curtis, Katrina J.; Tanner, Rebecca J.; Polkey, Juliet I.; Polkey, Michael I.; Hopkinson, Nicholas S.] Royal Brompton & Harefield NHS Trust, NIHR Resp Biomed Res Unit, London, England; [Curtis, Katrina J.; Tanner, Rebecca J.; Polkey, Juliet I.; Polkey, Michael I.; Hopkinson, Nicholas S.] Univ London Imperial Coll Sci Technol & Med, London, England; [O'Brien, Katie A.; Edwards, Lindsay M.] Kings Coll London, Ctr Human & Aerosp Physiol Sci, London WC2R 2LS, England; [Minnion, Magdalena; Feelisch, Martin] Univ Southampton, Fac Med Clin & Expt Sci, Southampton, Hants, England; [Minnion, Magdalena; Feelisch, Martin] Southampton Gen Hosp, Southampton NIHR Resp Biomed Res Unit, Southampton SO9 4XY, Hants, England	Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Imperial College London; University of London; King's College London; University of Southampton; University of Southampton	Hopkinson, NS (corresponding author), Royal Brompton & Harefield NHS Trust, NIHR Resp Biomed Res Unit, London, England.	n.hopkinson@ic.ac.uk	Feelisch, Martin/C-3042-2008	Feelisch, Martin/0000-0003-2320-1158	National Institute for Health Research Respiratory Disease Biomedical Research Unit at the Royal Brompton; Harefield NHS Foundation Trust; UK Medical Research Council [MR/J000620/1, G1001536]; Imperial College London; MRC [MR/J000620/1, G1001536] Funding Source: UKRI; Medical Research Council [G1001536, MR/J000620/1] Funding Source: researchfish	National Institute for Health Research Respiratory Disease Biomedical Research Unit at the Royal Brompton; Harefield NHS Foundation Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Imperial College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by the National Institute for Health Research Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London who partly funded MIP's salary. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. KJC is funded by the UK Medical Research Council (www.mrc.ac.uk; grant reference MR/J000620/1) and MF acknowledges support from the UK Medical Research Council (G1001536). LME was initially an employee of King's College London, but subsequently moved to work for GSK. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameer F, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000238.pub2; Ashmore T, 2015, FASEB J, V29, P1102, DOI 10.1096/fj.14-263004; Ashmore T, 2014, J PHYSIOL-LONDON, V592, P4715, DOI 10.1113/jphysiol.2014.275263; Bailey SJ, 2010, J APPL PHYSIOL, V109, P135, DOI 10.1152/japplphysiol.00046.2010; Bailey SJ, 2009, J APPL PHYSIOL, V107, P1144, DOI 10.1152/japplphysiol.00722.2009; Bentley R, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12089; Casaburi Richard, 2014, Ann Am Thorac Soc, V11, P1351, DOI 10.1513/AnnalsATS.201404-174OC; EDWARDS RHT, 1977, CLIN SCI MOL MED, V52, P283, DOI 10.1042/cs0520283; Evangelista AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011209; GIBSON GJ, 1993, THE EUROPEAN RESPIRA, V6, P155; Govoni M, 2008, NITRIC OXIDE-BIOL CH, V19, P333, DOI 10.1016/j.niox.2008.08.003; Hill K, 2010, THORAX, V65, P486, DOI 10.1136/thx.2009.128702; Ishii T, 1998, FEBS LETT, V440, P218, DOI 10.1016/S0014-5793(98)01460-4; Jones AM, 2014, SPORTS MED, V44, P35, DOI 10.1007/s40279-014-0149-y; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Jungersten L, 1997, J APPL PHYSIOL, V82, P760, DOI 10.1152/jappl.1997.82.3.760; Kenjale AA, 2011, J APPL PHYSIOL, V110, P1582, DOI 10.1152/japplphysiol.00071.2011; Kerley CP, 2015, NITRIC OXIDE-BIOL CH, V44, P105, DOI 10.1016/j.niox.2014.12.010; Kessler R, 2011, EUR RESPIR J, V37, P264, DOI 10.1183/09031936.00051110; Lansley KE, 2011, J APPL PHYSIOL, V110, P591, DOI 10.1152/japplphysiol.01070.2010; Larsen FJ, 2007, ACTA PHYSIOL, V191, P59, DOI 10.1111/j.1748-1716.2007.01713.x; Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004; Larsen FJ, 2006, NEW ENGL J MED, V355, P2792, DOI 10.1056/NEJMc062800; Leong P, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0057-4; Lundberg JO, 2004, FREE RADICAL BIO MED, V37, P395, DOI 10.1016/j.freeradbiomed.2004.04.027; Lundberg JO, 2010, BIOCHEM BIOPH RES CO, V396, P39, DOI 10.1016/j.bbrc.2010.02.136; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Maltais F, 2005, CHEST, V128, P1168, DOI 10.1378/chest.128.3.1168; Masschelein E, 2012, J APPL PHYSIOL, V113, P736, DOI 10.1152/japplphysiol.01253.2011; McConell GK, 2007, AM J PHYSIOL-REG I, V293, pR821, DOI 10.1152/ajpregu.00796.2006; Meguro M, 2007, CHEST, V132, P456, DOI 10.1378/chest.06-0702; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Murphy M, 2012, J ACAD NUTR DIET, V112, P548, DOI 10.1016/j.jand.2011.12.002; Nikolic SB, 2014, METABOLOMICS, V10, P105, DOI 10.1007/s11306-013-0557-2; O'Donnell DE, 2011, RESP MED, V105, P1030, DOI 10.1016/j.rmed.2011.03.014; Polkey MI, 2000, THORAX, V55, P547, DOI 10.1136/thorax.55.7.547; Porcelli S, 2015, J APPL PHYSIOL, V119, P762; Porcelli S, 2015, MED SCI SPORT EXER, V47, P1643, DOI 10.1249/MSS.0000000000000577; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rassaf T, 2002, FREE RADICAL BIO MED, V33, P1590, DOI 10.1016/S0891-5849(02)01183-8; Seymour JM, 2009, THORAX, V64, P418, DOI 10.1136/thx.2008.103986; Shields GS, 2015, MUSCLE NERVE, V51, P214, DOI 10.1002/mus.24289; Steiner MC, 2002, EUR RESPIR J, V19, P626, DOI 10.1183/09031936.02.00279602; Vanhatalo A, 2010, AM J PHYSIOL-REG I, V299, pR1121, DOI 10.1152/ajpregu.00206.2010; Vogiatzis I, 2009, SCAND J MED SCI SPOR, V19, P364, DOI 10.1111/j.1600-0838.2008.00808.x; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Wylie LJ, 2013, J APPL PHYSIOL, V115, P325, DOI 10.1152/japplphysiol.00372.2013; Ysart G, 1999, FOOD ADDIT CONTAM A, V16, P521, DOI 10.1080/026520399283669	49	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144504	10.1371/journal.pone.0144504	http://dx.doi.org/10.1371/journal.pone.0144504			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698120	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600021
J	Altman, R; Lim, S; Steen, RG; Dasa, V				Altman, Roy; Lim, Sooyeol; Steen, R. Grant; Dasa, Vinod			Hyaluronic Acid Injections Are Associated with Delay of Total Knee Replacement Surgery in Patients with Knee Osteoarthritis: Evidence from a Large US Health Claims Database	PLOS ONE			English	Article							TOTAL JOINT ARTHROPLASTY; INTRAARTICULAR HYALURONAN; TASK-FORCE; MANAGEMENT; RECOMMENDATIONS; HIP; EFFICACY; SAFETY; VISCOSUPPLEMENTATION; GUIDELINES	Background The growing prevalence of osteoarthritis (OA) and the medical costs associated with total knee replacement (TKR) surgery for end-stage OA motivate a search for agents that can delay OA progression. We test a hypothesis that hyaluronic acid (HA) injection is associated with delay of TKR in a dose-dependent manner. Methods and Findings We retrospectively evaluated records in an administrative claims database of similar to 79 million patients, to identify all patients with knee OA who received TKR during a 6-year period. Only patients with continuous plan enrollment from diagnosis until TKR were included, so that complete medical records were available. OA diagnosis was the index event and we evaluated time-to-TKR as a function of the number of HA injections. The database included 182,022 patients with knee OA who had TKR; 50,349 (27.7%) of these patients were classified as HA Users, receiving >= 1 courses of HA prior to TKR, while 131,673 patients (72.3%) were HA Non-users prior to TKR, receiving no HA. Cox proportional hazards modelling shows that TKR risk decreases as a function of the number of HA injection courses, if patient age, gender, and disease comorbidity are used as background covariates. Multiple HA injections are therefore associated with delay of TKR (all, P < 0.0001). Half of HA Non-users had a TKR by 114 days post-diagnosis of knee OA, whereas half of HA Users had a TKR by 484 days post-diagnosis (chi(2) = 19,769; p < 0.0001). Patients who received no HA had a mean time-to-TKR of 0.7 years; with one course of HA, the mean time to TKR was 1.4 years (chi(2) = 13,725; p < 0.0001); patients who received >= 5 courses delayed TKR by 3.6 years (chi(2) = 19,935; p < 0.0001). Conclusions HA injection in patients with knee OA is associated with a dose-dependent increase in time-to-TKR.	[Altman, Roy] Univ Calif Los Angeles, Dept Rheumatol, Los Angeles, CA USA; [Lim, Sooyeol] Seikagaku Corp, North Amer Business Unit, Tokyo, Japan; [Steen, R. Grant] Bioventus LLC, Dept Med Affairs, Durham, NC 27703 USA; [Dasa, Vinod] Louisiana State Univ, Hlth Sci Ctr, Dept Orthopaed, New Orleans, LA USA	University of California System; University of California Los Angeles; Seikagaku Corporation; Smith & Nephew; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Steen, RG (corresponding author), Bioventus LLC, Dept Med Affairs, Durham, NC 27703 USA.	Grant.Steen@bioventusglobal.com		Steen, R. Grant/0000-0003-3386-6575; dasa, vinod/0000-0001-5282-4026	Seikagaku Corporation of Tokyo, Japan; Seikagaku Corporation; Bioventus LLC	Seikagaku Corporation of Tokyo, Japan; Seikagaku Corporation; Bioventus LLC	This research was sponsored by the Seikagaku Corporation of Tokyo, Japan. Sooyeol Lim is employed by Seikagaku Corporation. Seikagaku Corporation provided support in the form of salary for author SL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. R. Grant Steen is employed by Bioventus LLC. Bioventus LLC provided support in the form of salary for author RGS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abbott T, 2013, ARTHRITIS RHEUM-US, V65, pS910; Altman R, 2015, J KNEE SURG, V26; Bagga H, 2006, J RHEUMATOL, V33, P946; Bannuru RR, 2015, ANN INTERN MED, V162, P46, DOI 10.7326/M14-1231; Bannuru RR, 2014, ARTHROSCOPY, V30, P86, DOI 10.1016/j.arthro.2013.10.007; Barrett JP, 2002, CLIN DRUG INVEST, V22, P87, DOI 10.2165/00044011-200222020-00003; Brooks DE, 2014, VETERANS AFFAIRS DEP, P1; Bruyere O, 2014, SEMIN ARTHRITIS RHEU, V44, P253, DOI 10.1016/j.semarthrit.2014.05.014; Charlson ME, 2014, CHARLSON COMORBIDITY; Cianflocco AJ, 2013, POSTGRAD MED, V125, P97, DOI 10.3810/pgm.2013.01.2618; Cram P, 2012, JAMA-J AM MED ASSOC, V308, P1227, DOI 10.1001/2012.jama.11153; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Das Anirban, 2009, J Fam Pract, V58, p281c; Fam H, 2007, BIORHEOLOGY, V44, P59; Fraenkel L, 2014, J RHEUMATOL, V41, P47, DOI 10.3899/jrheum.130762; George LK, 2014, VALUE HEALTH, V17, P605, DOI 10.1016/j.jval.2014.04.004; Ghosh P, 2002, SEMIN ARTHRITIS RHEU, V32, P10, DOI 10.1053/sarh.2002.33720; Health Economics and Outcomes Research, 2013, DAT STAT AN PLAN; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Huddleston JI, 2009, J ARTHROPLASTY, V24, P95, DOI 10.1016/j.arth.2009.05.001; Jevsevar DS, 2013, J AM ACAD ORTHOP SUR, V21, P571, DOI 10.5435/JAAOS-21-09-571; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Khan T, 2014, ACMP NEXUS; Kirksey M, 2012, ANESTH ANALG, V115, P321, DOI 10.1213/ANE.0b013e31825b6824; Kleinberg S, 2011, J BIOMED INFORM, V44, P1102, DOI 10.1016/j.jbi.2011.07.001; Lalmohamed A, 2014, ARTHRITIS RHEUMATOL, V66, P311, DOI 10.1002/art.38232; Losina E, 2015, ARTHRIT CARE RES, V67, P203, DOI 10.1002/acr.22412; Lu N, 2015, ARTHRITIS RHEUMATOL; Malinzak RA, 2009, J ARTHROPLASTY, V24, P84, DOI 10.1016/j.arth.2009.05.016; Mar J, 2013, Rev Esp Cir Ortop Traumatol, V57, P6, DOI 10.1016/j.recot.2012.08.006; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; McArthur BA, 2012, PATIENT PREFER ADHER, V6, P905, DOI 10.2147/PPA.S27783; Meding JB, 2013, BONE JOINT J, V95B, P1484, DOI 10.1302/0301-620X.95B11.32467; Memtsoudis SG, 2013, CLIN ORTHOP RELAT R, V471, P17, DOI [10.1007/s11999-012-2608-9, 10.1007/s11999-012-2682-z]; Moreland LW, 2003, ARTHRITIS RES THER, V5, P54, DOI 10.1186/ar623; MQIC MD, 2013, MED MAN AD OST; National Collaborating Centre for Chronic Conditions N-C, 2008, PHARM MAN OST; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Neustadt DH, 2003, CLIN EXP RHEUMATOL, V21, P307; Newberry SJ, 2014, SYSTEMATIC REV EFFEC, V14; Rasouli MR, 2013, CLIN ORTHOP RELAT R, V471, P3102, DOI 10.1007/s11999-013-2949-z; Ravi B, 2014, BRIT J SPORT MED, V48, P1580, DOI 10.1136/bjsports-2014-f6187rep; Rutjes AWS, 2012, ANN INTERN MED, V157, P180, DOI 10.7326/0003-4819-157-3-201208070-00473; Schairer WW, 2014, CLIN ORTHOP RELAT R, V472, P181, DOI 10.1007/s11999-013-3030-7; Skou ST, 2015, NEW ENGL J MED, V373, P1597, DOI 10.1056/NEJMoa1505467; Slover J, 2012, JAMA-J AM MED ASSOC, V308, P1266, DOI 10.1001/jama.2012.12644; Strand V, 2015, J PAIN RES, V8, P217, DOI 10.2147/JPR.S83076; Turajane Thana, 2009, J Med Assoc Thai, V92 Suppl 6, pS63; Waddell DD, 2007, J MANAGE CARE PHARM, V13, P113, DOI 10.18553/jmcp.2007.13.2.113; Waddell DD, 2014, J KNEE SURG; WILLISOWEN CA, 2010, CLIN ORTHOP RELAT R, V92, P1128, DOI DOI 10.1302/0301-620X.92B8.24333; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	53	71	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145776	10.1371/journal.pone.0145776	http://dx.doi.org/10.1371/journal.pone.0145776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694145	Green Published, gold			2022-12-27	WOS:000367092500075
J	Hansen, GM; Nilsson, M; Nielsen, CH; Holmstrup, P; Helqvist, S; Tolker-Nielsen, T; Givskov, M; Hansen, PR				Hansen, Gorm Mork; Nilsson, Martin; Nielsen, Claus Henrik; Holmstrup, Palle; Helqvist, Steffen; Tolker-Nielsen, Tim; Givskov, Michael; Hansen, Peter Riis			Absence of Bacteria on Coronary Angioplasty Balloons from Unselected Patients: Results with Use of a High Sensitivity Polymerase Chain Reaction Assay	PLOS ONE			English	Article							CHLAMYDIA-PNEUMONIAE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; HELICOBACTER-PYLORI; PERIODONTAL-DISEASE; INFECTIOUS BURDEN; ARTERY-DISEASE; ATHEROSCLEROSIS; METAANALYSIS; TRIAL	Periodontitis is a chronic, bacterially-induced inflammatory disease of the tooth-supporting tissues, which may result in transient bacteremia and a systemic inflammatory response. Periodontitis is associated with coronary artery disease independently of established cardiovascular risk factors, and translocation of bacteria from the oral cavity to the coronary arteries may play a role in the development of coronary artery disease. Very few studies have used angioplasty balloons for in vivo sampling from diseased coronary arteries, and with varying results. Therefore, the aim of this study was to assess if bacterial DNA from primarily oral bacteria could be detected on coronary angioplasty balloons by use of an optimized sampling process combined with an internally validated sensitive polymerase chain reaction (PCR) assay. Coronary angioplasty balloons and control samples from a total of 45 unselected patients with stable angina, unstable angina/non-ST elevation myocardial infarction, and ST-elevation myocardial infarction (n = 15 in each group) were collected and analyzed using a PCR assay with high sensitivity and specificity for 16S rRNA genes of the oral microbiome. Despite elimination of extraction and purification steps, and demonstration of sensitivity levels of 25-125 colony forming units (CFU), we did not detect bacterial DNA from any of the coronary angioplasty balloons. A subsequent questionnaire indicated that the prevalence of periodontitis in the study cohort was at least 39.5%. Although coronary angioplasty balloons are unlikely to be useful for detection of bacteria with current PCR techniques in unselected patients with coronary artery disease, more studies are warranted to determine the extent to which bacteria contribute to atherosclerosis and its clinical manifestations and whether the presence of bacteria in the arteries is a transient phenomenon.	[Hansen, Gorm Mork; Hansen, Peter Riis] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Hansen, Gorm Mork; Nilsson, Martin; Tolker-Nielsen, Tim; Givskov, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Dept Immunol & Microbiol, Costerton Biofilm Ctr, Copenhagen, Denmark; [Nielsen, Claus Henrik] Rigshosp, Dept Infect Dis & Rheumatol, Inst Inflammat Res, DK-2100 Copenhagen, Denmark; [Nielsen, Claus Henrik; Holmstrup, Palle] Univ Copenhagen, Dept Odontol, Fac Hlth & Med Sci, Sect Periodontol, Copenhagen, Denmark; [Helqvist, Steffen] Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Givskov, Michael] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn SCELSE, Singapore 639798, Singapore	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Hansen, GM (corresponding author), Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark.	gorm.moerk.hansen@regionh.dk	Nilsson, Martin/AHH-2943-2022; Hansen, Peter Riis/AAR-7659-2020	Givskov, Michael/0000-0001-5004-8609; Tolker-Nielsen, Tim/0000-0002-9751-474X; Nielsen, Claus Henrik/0000-0001-7543-9016; Mork Hansen, Gorm/0000-0002-6000-8835; Hansen, Peter Riis/0000-0002-9056-535X	University of Copenhagen, Faculty of Health and Medical Sciences [624-0013/12-3000]; Danish Heart Foundation [14-R97-A5031-22857]; Arvid Nilssons Fond; Toyota-Fonden, Denmark [OH/BG-8435]; Danish Medical Research Grant [2013-5480/912523-1]; Aase og Ejnar Danielsens Fond [10-001169]	University of Copenhagen, Faculty of Health and Medical Sciences; Danish Heart Foundation; Arvid Nilssons Fond; Toyota-Fonden, Denmark; Danish Medical Research Grant; Aase og Ejnar Danielsens Fond	This work was supported by grants from University of Copenhagen, Faculty of Health and Medical Sciences (http://www.ku.dk/english; 624-0013/12-3000; Receiver MG); The Danish Heart Foundation (http://www.hjerteforeningen.dk/; 14-R97-A5031-22857; Receiver GMH); Arvid Nilssons Fond (http://arvidnilssonsfond.dk/; Receiver GMH); Toyota-Fonden, Denmark (OH/BG-8435; Receiver GMH); The Danish Medical Research Grant (www.laeger.dk/; 2013-5480/912523-1; Receiver GMH); and Aase og Ejnar Danielsens Fond (http://www.danielsensfond.dk/; 10-001169; Receiver GMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 1999, CIRCULATION, V99, P1540, DOI 10.1161/01.CIR.99.12.1540; Andraws R, 2005, JAMA-J AM MED ASSOC, V293, P2641, DOI 10.1001/jama.293.21.2641; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Belstrom D, 2012, MICROBES INFECT, V14, P411, DOI 10.1016/j.micinf.2011.12.004; Blaizot A, 2009, INT DENT J, V59, P197, DOI 10.1922/IDJ_2114Sixou13; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; D'Aiuto F, 2013, J CLIN PERIODONTOL, V40, pS85, DOI [10.1902/jop.2013.134007, 10.1111/jcpe.12061]; Daus H, 1998, CARDIOLOGY, V90, P83, DOI 10.1159/000006824; Desvarieux M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000254; Dietrich T, 2008, CIRCULATION, V117, P1668, DOI 10.1161/CIRCULATIONAHA.107.711507; Dietrich Thomas, 2013, J Periodontol, V84, pS70, DOI [10.1111/jcpe.12062, 10.1902/jop.2013.134008]; Elkind Mitchell S. V., 2010, Infectious Disorders - Drug Targets, V10, P84; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Geismar K, 2006, J PERIODONTOL, V77, P1547, DOI 10.1902/jop.2006.050405; Grayston JT, 2005, NEW ENGL J MED, V352, P1637, DOI 10.1056/NEJMoa043526; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026; Honarmand Hamidreza, 2013, Interdiscip Perspect Infect Dis, V2013, P941392, DOI 10.1155/2013/941392; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Huws SA, 2007, J MICROBIOL METH, V70, P565, DOI 10.1016/j.mimet.2007.06.013; Jespersen CM, 2006, BRIT MED J, V332, P22, DOI 10.1136/bmj.38666.653600.55; Jolly SS, 2015, NEW ENGL J MED, V372, P1389, DOI 10.1056/NEJMoa1415098; Joshi Rajnish, 2013, N Am J Med Sci, V5, P169, DOI 10.4103/1947-2714.109178; Ketelhuth DFJ, 2015, CIRC J, V79, P924, DOI 10.1253/circj.CJ-15-0167; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Lanter BB, 2014, MBIO, V5, DOI 10.1128/mBio.01206-14; Latsios G, 2004, ACTA CARDIOL, V59, P652, DOI 10.2143/AC.59.6.2005249; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Liu J, 2015, HELICOBACTER, V20, P176, DOI 10.1111/hel.12188; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Maekawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020240; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Ohki T, 2012, AM HEART J, V163, P164, DOI 10.1016/j.ahj.2011.10.012; Ott SJ, 2006, CIRCULATION, V113, P929, DOI 10.1161/CIRCULATIONAHA.105.579979; Pessi T, 2013, CIRCULATION, V127, P1219, DOI 10.1161/CIRCULATIONAHA.112.001254; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Rafferty B, 2011, J INTERN MED, V270, P273, DOI 10.1111/j.1365-2796.2011.02373.x; Ramirez JA, 1996, ANN INTERN MED, V125, P979, DOI 10.7326/0003-4819-125-12-199612150-00008; Rosenfeld ME, 2011, THROMB HAEMOSTASIS, V106, P858, DOI 10.1160/TH11-06-0392; Silva WSE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109761; Sessa R, 2014, WORLD J CLIN CASES, V2, P240, DOI 10.12998/wjcc.v2.i7.240; Suchankova P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076431, 10.1371/journal.pone.0071284]; Tomas I, 2012, J CLIN PERIODONTOL, V39, P213, DOI 10.1111/j.1600-051X.2011.01784.x; Wyplosz B, 2006, J AM COLL CARDIOL, V47, P1229, DOI 10.1016/j.jacc.2005.12.037	47	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145657	10.1371/journal.pone.0145657	http://dx.doi.org/10.1371/journal.pone.0145657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695491	gold, Green Published			2022-12-27	WOS:000367092500065
J	Kovacs, L; Kezer, FL; Bakony, M; Hufnagel, L; Tozser, J; Jurkovich, V				Kovacs, Levente; Kezer, Fruzsina Luca; Bakony, Mikolt; Hufnagel, Levente; Tozser, Janos; Jurkovich, Viktor			Associations between Heart Rate Variability Parameters and Housing- and Individual-Related Variables in Dairy Cows Using Canonical Correspondence Analysis	PLOS ONE			English	Article							CATTLE; MILKING; WELFARE; STRESS; TEMPERAMENT; BEHAVIOR; HABITAT; POSTURE; HUMANS; SYSTEM	We investigated the associations between heart rate variability (HRV) parameters and some housing-and individual-related variables using the canonical correspondence analysis (CCOA) method in lactating Holstein-Friesian dairy cows. We collected a total of 5200 5-min interbeat interval (IBI) samples from 260 animals on five commercial dairy farms [smaller-scale farms with 70 (Farm 1, n = 50) and 80 cows per farm (Farm 2, n = 40), and larger-scale farms with 850 (Farm 3, n = 66), 1900 (Farm 4, n = 60) and 1200 (Farm 5, n = 45) cows. Dependent variables included HRV parameters, which reflect the activity of the autonomic nervous system: heart rate (HR), the root mean square of successive differences (RMSSD) in IBIs, the standard deviation 1 (SD1), the high frequency (HF) component of HRV and the ratio between the low frequency (LF) and the HF parameter (LF/HF). Explanatory variables were group size, space allowance, milking frequency, parity, daily milk yield, body condition score, locomotion score, farm, season and physical activity (lying, lying and rumination, standing, standing and rumination and feeding). Physical activity involved in standing, feeding and in rumination was associated with HRV parameters, indicating a decreasing sympathetic and an increasing vagal tone in the following order: feeding, standing, standing and rumination, lying and rumination, lying. Objects representing summer positioned close to HR and LF and far from SD1, RMSSD and HF indicate a higher sympathetic and a lower vagal activity. Objects representing autumn, spring and winter associated with increasing vagal activity, in this order. Time-domain measures of HRV were associated with most of the housing-and individual-related explanatory variables. Higher HR and lower RMSSD and SD1 were associated with higher group size, milking frequency, parity and milk yield, and low space allowance. Higher parity and milk yield were associated with higher sympathetic activity as well (higher LF/HF), while individuals with lower locomotion scores (lower degree of lameness) were characterized with a higher sympathetic and a lower vagal tone (higher HR and LF/HF and lower RMSSD and SD1). Our findings indicate that the CCOA method is useful in demonstrating associations between HRV and selected explanatory variables. We consider physical activity, space allowance, group size, milking frequency, parity, daily milk yield, locomotion score and season to be the most important variables in further HRV studies on dairy cows.	[Kovacs, Levente; Kezer, Fruzsina Luca] MTA SZIE Large Anim Clin Res Grp, H-2225 Ullo Dora Major, Hungary; [Kovacs, Levente; Kezer, Fruzsina Luca; Tozser, Janos] Szent Istvan Univ, Inst Anim Husb, Fac Agr & Environm Sci, H-2100 Godollo, Hungary; [Bakony, Mikolt] Rumino Vet Bt, H-2030 Erd, Hungary; [Hufnagel, Levente] Szent Istvan Univ, Inst Crop Prod, Fac Agr & Environm Sci, H-2100 Godollo, Hungary; [Jurkovich, Viktor] Szent Istvan Univ, Fac Vet Sci, Dept Anim Hyg Herd Hlth & Vet Ethol, H-1078 Budapest, Hungary	Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences	Kovacs, L (corresponding author), MTA SZIE Large Anim Clin Res Grp, H-2225 Ullo Dora Major, Hungary.	Kovacs.Levente@mkk.szie.hu	Jurkovich, Viktor/AAJ-2114-2020	Bakony, Mikolt/0000-0002-4801-8459; Jurkovich, Viktor/0000-0002-6019-3508	Research Centre of Excellence [9878/2015/FEKUT]	Research Centre of Excellence	This study was supported by the Research Centre of Excellence, grant number: 9878/2015/FEKUT, http://www.nemzetikivalosag.hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Angers B, 1999, MOL ECOL, V8, P1043, DOI 10.1046/j.1365-294x.1999.00669.x; Boddugari K, 2001, J DAIRY SCI, V84, P873, DOI 10.3168/jds.S0022-0302(01)70210-X; Breuer K, 2000, APPL ANIM BEHAV SCI, V66, P273, DOI 10.1016/S0168-1591(99)00097-0; Buck M, 2013, LIVEST SCI, V158, P129, DOI 10.1016/j.livsci.2013.10.011; Camm AJ, 1996, CIRCULATION, V93, P1043; Cooper A, 2005, PLANT ECOL, V181, P255, DOI 10.1007/s11258-005-7149-9; D'Ambrosio JL, 2014, ECOL ENG, V68, P32, DOI 10.1016/j.ecoleng.2014.03.037; Faye B, 1997, PREV VET MED, V32, P171, DOI 10.1016/S0167-5877(97)00017-2; Frondelius L, 2015, PHYSIOL BEHAV, V139, P437, DOI 10.1016/j.physbeh.2014.12.002; Gomes PIA, 2014, J HYDROL, V519, P3615, DOI 10.1016/j.jhydrol.2014.11.009; Greenacre M, 2013, ECOLOGY, V94, P241, DOI 10.1890/11-1730.1; HADY PJ, 1994, J DAIRY SCI, V77, P1543, DOI 10.3168/jds.S0022-0302(94)77095-8; Hagen K, 2005, PHYSIOL BEHAV, V85, P195, DOI 10.1016/j.physbeh.2005.03.019; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Jurkovich V, 2012, MAGY ALLATORVOSOK, V134, P605; Kleiger RE, 2005, ANN NONINVAS ELECTRO, V10, P88, DOI 10.1111/j.1542-474X.2005.10101.x; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Kovacs L, 2015, PHYSIOL BEHAV, V139, P281, DOI 10.1016/j.physbeh.2014.11.039; Kovacs L, 2014, J DAIRY SCI, V97, P6955, DOI 10.3168/jds.2014-8327; Kovacs L, 2014, ANIMAL, V8, P316, DOI 10.1017/S1751731113002140; Kovacs L, 2013, J DAIRY SCI, V96, P7743, DOI 10.3168/jds.2013-7030; Kovacs L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134792; LEBRETON JD, 1991, EURO CH ENV, V2, P85; Legendre P., 2012, NUMERICAL ECOLOGY; Lunardi VO, 2012, ESTUAR COAST SHELF S, V96, P179, DOI 10.1016/j.ecss.2011.11.001; Marler Thomas E, 2013, Commun Integr Biol, V6, pe25924, DOI 10.4161/cib.25924; Mialon MM, 2012, VET J, V194, P55, DOI 10.1016/j.tvjl.2012.02.019; Minero M, 2001, VET REC, V149, P772, DOI 10.1136/vr.149.25.772; Moctezuma C, 2014, J CHEM ECOL, V40, P458, DOI 10.1007/s10886-014-0431-3; Mohr E, 2002, PHYSIOL BEHAV, V75, P251, DOI 10.1016/S0031-9384(01)00651-5; Piccione G, 2005, RES VET SCI, V79, P155, DOI 10.1016/j.rvsc.2004.11.010; Porges SW, 2003, PHYSIOL BEHAV, V79, P503, DOI 10.1016/S0031-9384(03)00156-2; Rao C.R., 1964, SANKHYA A, V26, P329, DOI DOI 10.1214/AOMS/1177704248; Raussi S, 2003, APPL ANIM BEHAV SCI, V80, P245, DOI 10.1016/S0168-1591(02)00213-7; ROBERT P, 1976, ROY STAT SOC C-APP, V25, P257; Rushen J, 1999, J DAIRY SCI, V82, P720, DOI 10.3168/jds.S0022-0302(99)75289-6; Sourial N, 2010, J CLIN EPIDEMIOL, V63, P638, DOI 10.1016/j.jclinepi.2009.08.008; Sprecher DJ, 1997, THERIOGENOLOGY, V47, P1179, DOI 10.1016/S0093-691X(97)00098-8; Sutherland MA, 2012, PHYSIOL BEHAV, V107, P329, DOI 10.1016/j.physbeh.2012.07.013; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Telezhenko E, 2012, J DAIRY SCI, V95, P3064, DOI 10.3168/jds.2011-4953; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERBRAAK CJF, 1998, CANOCO 4; Thayer JF, 1999, ELECTROEN CLIN NEURO, V79, P358; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; von Keyserlingk MAG, 2008, J DAIRY SCI, V91, P1011, DOI 10.3168/jds.2007-0532; Welfare Quality&REG;, 2009, ASS PROT CATTL	51	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145313	10.1371/journal.pone.0145313	http://dx.doi.org/10.1371/journal.pone.0145313			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690578	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300055
J	Eryilmaz, U; Demirci, B; Aksun, S; Boyacioglu, M; Akgullu, C; Ilgenli, TF; Yalinkilinc, HS; Bilgen, M				Eryilmaz, Ufuk; Demirci, Buket; Aksun, Saliha; Boyacioglu, Murat; Akgullu, Cagdas; Ilgenli, Tevfik Fikret; Yalinkilinc, Hande Sultan; Bilgen, Mehmet			S100A1 as a Potential Diagnostic Biomarker for Assessing Cardiotoxicity and Implications for the Chemotherapy of Certain Cancers	PLOS ONE			English	Article							HEART-FAILURE; TROPONIN-I; PREDICTION; MANAGEMENT; THERAPY; FAMILY; DAMAGE; ASSAY	This study examined the value of blood marker S100A1 in detecting cardiotoxicity induced by chemotherapy agents; trastuzumab and lapatinib, in normal rat heart. The rats were divided into three groups: control (n = 8, no treatment), T (n = 8, one time ip treatment with 10mg/kg trastuzumab) and L (n = 8, oral treatment with 100 mg/kg/day lapatinib for 7 days). The activities of oxidative stress parameters Malondialdehyde (MDA), Superoxide dismutase (SOD), Catalase (CAT) and Glutathione (GSH) were measured from the extracted cardiac tissues. The levels of troponinI and S100A1 expressions were measured from blood samples. All biomarkers responded to the treatments as they exhibited alterations from their normative values, validating the chemically induced cardiotoxicity. S100A1 expression attenuated significantly (75%), which made the sensitive detection of cardiotoxicity feasible. Assessment of cardiotoxicity with S100A1 may be a valuable alternative in clinical oncology of cancers in some organs such as breast and prostate, as they do not overexpress it to compete against.	[Eryilmaz, Ufuk; Akgullu, Cagdas] Adnan Menderes Univ, Fac Med, Dept Cardiol, Aydin, Turkey; [Demirci, Buket] Adnan Menderes Univ, Fac Med, Dept Med Pharmacol, Aydin, Turkey; [Aksun, Saliha] Katip Celebi Univ, Fac Med, Dept Med Biochem, Izmir, Turkey; [Boyacioglu, Murat; Yalinkilinc, Hande Sultan] Adnan Menderes Univ, Fac Vet Med, Dept Pharmacol & Toxicol, Aydin, Turkey; [Ilgenli, Tevfik Fikret] Konya Selcuklu Private Hosp, Dept Cardiol, Konya, Turkey; [Bilgen, Mehmet] Adnan Menderes Univ, Fac Med, Dept Biophys, Aydin, Turkey	Adnan Menderes University; Adnan Menderes University; Izmir Katip Celebi University; Adnan Menderes University; Private Konya Hospital; Selcuklu Hospital; Adnan Menderes University	Eryilmaz, U (corresponding author), Adnan Menderes Univ, Fac Med, Dept Cardiol, Aydin, Turkey.	drufukeryilmaz@gmail.com	DEMIRCI, BUKET/C-1006-2018; aksun, saliha/S-1742-2019; SAHINER, Hande Sultan/GOK-0902-2022; Sahiner, Hande Sultan/O-9777-2015	DEMIRCI, BUKET/0000-0002-3442-5061; SAHINER, Hande Sultan/0000-0003-2811-3579; Sahiner, Hande Sultan/0000-0003-2811-3579; AKSUN, SALIHA/0000-0002-7991-1645	Scientific and Technological Research Council of Turkey [TUBITAK 1001-113E177]	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	M. Bilgen is funded by the Scientific and Technological Research Council of Turkey (Research Grant TUBITAK 1001-113E177). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Babar T, 2014, CURR PHARM DESIGN, V20, P4911; Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; Baykara M, 2015, DIAGN INTERV RADIOL, V21, P317, DOI 10.5152/dir.2015.14075; Bielecka-Dabrowa A, 2015, INT J MOL SCI, V16, P10715, DOI 10.3390/ijms160510715; Cardinale D, 2002, ANN ONCOL, V13, P710, DOI 10.1093/annonc/mdf170; Chen HY, 2014, AM J CANCER RES, V4, P89; Willis BC, 2015, AM J PHYSIOL-HEART C, V308, pH467, DOI 10.1152/ajpheart.00734.2013; Conway A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1407-6; de Boer RA, 2015, EUR J HEART FAIL, V17, P559, DOI 10.1002/ejhf.273; De Buyzere M, 2015, CLIN CHIM ACTA, V443, P1, DOI 10.1016/j.cca.2015.01.015; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Duarte-Costa S, 2014, PHYSIOL RES, V63, P669, DOI 10.33549/physiolres.932712; Ewer MS, 2010, J CLIN ONCOL, V28, P3901, DOI 10.1200/JCO.2010.30.6274; Gimenez MR, 2015, EXPERT REV MOL DIAGN, V15, P547, DOI 10.1586/14737159.2015.1010519; Gupta S, 2007, PROG CARDIOVASC DIS, V50, P151, DOI 10.1016/j.pcad.2007.01.002; Ji YF, 2014, INT J MOL MED, V33, P769, DOI 10.3892/ijmm.2014.1633; Lazo M, 2015, J HEPATOL, V62, P841, DOI 10.1016/j.jhep.2014.11.024; Li YB, 2015, J PROTEOME RES, V14, P2437, DOI 10.1021/pr501116c; Mallick A, 2015, REV ESP CARDIOL, V68, P514, DOI 10.1016/j.rec.2015.02.009; Morris PG, 2013, CANCER-AM CANCER SOC, V119, P3943, DOI 10.1002/cncr.28284; Morris PG, 2011, CLIN CANCER RES, V17, P3490, DOI 10.1158/1078-0432.CCR-10-1359; Most P, 2001, P NATL ACAD SCI USA, V98, P13889, DOI 10.1073/pnas.241393598; Most P, 2006, CIRCULATION, V114, P1258, DOI 10.1161/CIRCULATIONAHA.106.622415; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Omland T, 2015, CLIN CHIM ACTA, V443, P78, DOI 10.1016/j.cca.2014.08.016; Pouleur AC, 2015, CLIN CHIM ACTA, V443, P9, DOI 10.1016/j.cca.2014.10.046; Salama SM, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/137083; Salama SM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-279; Sawaya H, 2012, CIRC-CARDIOVASC IMAG, V5, P596, DOI 10.1161/CIRCIMAGING.112.973321; Sendur MAN, 2013, CURR MED RES OPIN, V29, P1015, DOI 10.1185/03007995.2013.807232; Singh Dhssraj, 2015, Curr Heart Fail Rep, V12, P255, DOI 10.1007/s11897-015-0258-4; Stevens PL, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0603-y; SUN Y, 1988, CLIN CHEM, V34, P497; Tian S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00277; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; van Boxtel W, 2015, BIOMARKERS, V20, P143, DOI 10.3109/1354750X.2015.1040839; van Hasselt JGC, 2011, CLIN PHARMACOL THER, V90, P126, DOI 10.1038/clpt.2011.74; Wright Nathan T, 2009, Curr Chem Biol, V3, P138; Wu AHB, 2015, AM HEART J, V169, P674, DOI 10.1016/j.ahj.2015.01.016	40	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145418	10.1371/journal.pone.0145418	http://dx.doi.org/10.1371/journal.pone.0145418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682543	Green Submitted, gold, Green Published			2022-12-27	WOS:000366725800074
J	Kanobe, C; McCarville, MT; O'Neal, ME; Tylka, GL; MacIntosh, GC				Kanobe, Charles; McCarville, Michael T.; O'Neal, Matthew E.; Tylka, Gregory L.; MacIntosh, Gustavo C.			Soybean Aphid Infestation Induces Changes in Fatty Acid Metabolism in Soybean	PLOS ONE			English	Article							HETERODERA-GLYCINES; HYDROPEROXIDE LYASE; DESATURASE GENES; PLANT DEFENSES; HOST-PLANT; ARABIDOPSIS; HEMIPTERA; EXPRESSION; RESPONSES; NEMATODE	The soybean aphid (Aphis glycines Matsumura) is one of the most important insect pests of soybeans in the North- central region of the US. It has been hypothesized that aphids avoid effective defenses by inhibition of jasmonate- regulated plant responses. Given the role fatty acids play in jasmonate- induced plant defenses, we analyzed the fatty acid profile of soybean leaves and seeds from aphid-infested plants. Aphid infestation reduced levels of polyunsaturated fatty acids in leaves with a concomitant increase in palmitic acid. In seeds, a reduction in polyunsaturated fatty acids was associated with an increase in stearic acid and oleic acid. Soybean plants challenged with the brown stem rot fungus or with soybean cyst nematodes did not present changes in fatty acid levels in leaves or seeds, indicating that the changes induced by aphids are not a general response to pests. One of the polyunsaturated fatty acids, linolenic acid, is the precursor of jasmonate; thus, these changes in fatty acid metabolism may be examples of " metabolic hijacking" by the aphid to avoid the induction of effective defenses. Based on the changes in fatty acid levels observed in seeds and leaves, we hypothesize that aphids potentially induce interference in the fatty acid desaturation pathway, likely reducing FAD2 and FAD6 activity that leads to a reduction in polyunsaturated fatty acids. Our data support the idea that aphids block jasmonate- dependent defenses by reduction of the hormone precursor.	[Kanobe, Charles; MacIntosh, Gustavo C.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [McCarville, Michael T.; O'Neal, Matthew E.] Iowa State Univ, Dept Entomol, Ames, IA USA; [Tylka, Gregory L.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	MacIntosh, GC (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	gustavo@iastate.edu		MacIntosh, Gustavo/0000-0003-1350-1229	Iowa Soybean Association; soybean checkoff	Iowa Soybean Association; soybean checkoff	This research was supported in part by the Iowa Soybean Association and the soybean checkoff through a grant to GCM, MEO and GLT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghoram K, 2006, CROP SCI, V46, P2453, DOI 10.2135/cropsci2006.04.0218; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; Avila CA, 2013, MOL PLANT MICROBE IN, V26, P977, DOI 10.1094/MPMI-01-13-0031-R; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bate NJ, 1998, PLANT PHYSIOL, V117, P1393, DOI 10.1104/pp.117.4.1393; Bilyeu KD, 2003, CROP SCI, V43, P1833, DOI 10.2135/cropsci2003.1833; Botella MA, 1996, PLANT PHYSIOL, V112, P1201, DOI 10.1104/pp.112.3.1201; BROWSE J, 1989, PLANT PHYSIOL, V90, P522, DOI 10.1104/pp.90.2.522; Chehab EW, 2007, J INTEGR PLANT BIOL, V49, P43, DOI 10.1111/j.1744-7909.2006.00405.x; Chi XY, 2011, PLANT MOL BIOL REP, V29, P769, DOI 10.1007/s11105-010-0284-z; Chiozza MV, 2010, ENVIRON ENTOMOL, V39, P856, DOI 10.1603/EN09338; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; Conconi A, 1996, PLANT PHYSIOL, V111, P797, DOI 10.1104/pp.111.3.797; Creelman Robert A, 2002, Arabidopsis Book, V1, pe0012, DOI 10.1199/tab.0012; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dixon AF G, 1998, APHID ECOLOGY; Elzinga DA, 2013, CURR OPIN PLANT BIOL, V16, P451, DOI 10.1016/j.pbi.2013.06.018; ERICKSON EA, 1988, J HERED, V79, P465, DOI 10.1093/oxfordjournals.jhered.a110552; FEHR W. R., 1977, STAGES SOYBEAN DEV; Fehr WR, 2007, CROP SCI, V47, pS72, DOI 10.2135/cropsci2007.04.0004IPBS; Gheysen G, 2011, CURR OPIN PLANT BIOL, V14, P415, DOI 10.1016/j.pbi.2011.03.012; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; Hammond E. G., 1991, MOD METHOD PLANT, V12, P321, DOI DOI 10.1007/978-3-642-84023-4_; HAMMOND EG, 1984, BIOTECHNOLOGY OILS F, P89; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Heldt H.-W., 2005, PLANT BIOCH; Heppard EP, 1996, PLANT PHYSIOL, V110, P311, DOI 10.1104/pp.110.1.311; Hildebrand D., 2011, PLANT METABOLISM BIO, P27, DOI DOI 10.1002/9781119991311.CH2; Hill CB, 2009, CROP SCI, V49, P1193, DOI 10.2135/cropsci2008.09.0561; Hill J. H., 2001, Plant Disease, V85, P561, DOI 10.1094/PDIS.2001.85.5.561C; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; Impullitti AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098311; Li Y, 2008, NEW PHYTOL, V179, P185, DOI 10.1111/j.1469-8137.2008.02443.x; Louis J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00213; Louis J, 2010, PLANT J, V64, P800, DOI 10.1111/j.1365-313X.2010.04378.x; Louis J, 2010, MOL PLANT MICROBE IN, V23, P618, DOI 10.1094/MPMI-23-5-0618; Lygin AV, 2010, PHYTOPATHOLOGY, V100, P897, DOI 10.1094/PHYTO-100-9-0897; Mantelin S, 2015, ADV BOT RES, V73, P325, DOI 10.1016/bs.abr.2014.12.011; McCarville MT, 2012, ENTOMOL EXP APPL, V143, P55, DOI 10.1111/j.1570-7458.2012.01227.x; McCarville MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086415; McCarville MT, 2012, CROP PROT, V42, P210, DOI 10.1016/j.cropro.2012.05.022; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; Miyara SB, 2015, ADV BOT RES, V73, P139, DOI 10.1016/bs.abr.2014.12.004; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Myers SW, 2005, J ECON ENTOMOL, V98, P113, DOI 10.1603/0022-0493-98.1.113; Nafie E., 2008, J APPL SCI RES, V4, P2046; Niblack TL, 2006, ANNU REV PHYTOPATHOL, V44, P283, DOI 10.1146/annurev.phyto.43.040204.140218; Ragsdale DW, 2007, J ECON ENTOMOL, V100, P1258, DOI 10.1603/0022-0493(2007)100[1258:ETFSAH]2.0.CO;2; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Ragsdale DW, 2004, ANN ENTOMOL SOC AM, V97, P204, DOI 10.1603/0013-8746(2004)097[0204:SABINA]2.0.CO;2; Sandhu D, 2007, J AM OIL CHEM SOC, V84, P229, DOI 10.1007/s11746-007-1037-5; Schmid KM., 2002, BIOCH LIPIDS LIPOPRO, P93; Studham ME, 2013, MOL PLANT MICROBE IN, V26, P116, DOI 10.1094/MPMI-05-12-0124-FI; Studham Matthew E, 2012, BMC Res Notes, V5, P392; Thiex NJ, 2003, J AOAC INT, V86, P899; Tooker JF, 2009, MOL PLANT MICROBE IN, V22, P551, DOI 10.1094/MPMI-22-5-0551; Upchurch RG, 2010, J AM OIL CHEM SOC, V87, P857, DOI 10.1007/s11746-010-1576-z; Vancanneyt G, 2001, P NATL ACAD SCI USA, V98, P8139, DOI 10.1073/pnas.141079498; Varenhorst AJ, 2015, ENVIRON ENTOMOL, V44, P658, DOI 10.1093/ee/nvv051; Varenhorst AJ, 2015, ARTHROPOD-PLANT INTE, V9, P457, DOI 10.1007/s11829-015-9395-7; Wallis JG, 2002, PROG LIPID RES, V41, P254, DOI 10.1016/S0163-7827(01)00027-3; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Workneh F, 1999, PHYTOPATHOLOGY, V89, P204, DOI 10.1094/PHYTO.1999.89.3.204; Wrather JA, 2006, J NEMATOL, V38, P173; YADAV NS, 1993, PLANT PHYSIOL, V103, P467, DOI 10.1104/pp.103.2.467; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhu JW, 2005, J CHEM ECOL, V31, P1733, DOI 10.1007/s10886-005-5923-8; Zhuang H, 1996, PLANT PHYSIOL, V111, P805, DOI 10.1104/pp.111.3.805	68	13	13	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145660	10.1371/journal.pone.0145660	http://dx.doi.org/10.1371/journal.pone.0145660			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684003	gold, Green Published, Green Submitted			2022-12-27	WOS:000366725800084
J	Watanabe, A; Gold, MEL; Brusatte, SL; Benson, RBJ; Choiniere, J; Davidson, A; Norell, MA				Watanabe, Akinobu; Gold, Maria Eugenia Leone; Brusatte, Stephen L.; Benson, Roger B. J.; Choiniere, Jonah; Davidson, Amy; Norell, Mark A.			Vertebral Pneumaticity in the Ornithomimosaur Archaeornithomimus (Dinosauria: Theropoda) Revealed by Computed Tomography Imaging and Reappraisal of Axial Pneumaticity in Ornithomimosauria	PLOS ONE			English	Article							POSTCRANIAL SKELETAL PNEUMATICITY; AIR-SACS; GIANT ORNITHOMIMOSAUR; PNEUMATIZATION; EVOLUTION; RECONSTRUCTION; ORIGIN	Among extant vertebrates, pneumatization of postcranial bones is unique to birds, with few known exceptions in other groups. Through reduction in bone mass, this feature is thought to benefit flight capacity in modern birds, but its prevalence in non-avian dinosaurs of variable sizes has generated competing hypotheses on the initial adaptive significance of postcranial pneumaticity. To better understand the evolutionary history of postcranial pneumaticity, studies have surveyed its distribution among non-avian dinosaurs. Nevertheless, the degree of pneumaticity in the basal coelurosaurian group Ornithomimosauria remains poorly known, despite their potential to greatly enhance our understanding of the early evolution of pneumatic bones along the lineage leading to birds. Historically, the identification of postcranial pneumaticity in non-avian dinosaurs has been based on examination of external morphology, and few studies thus far have focused on the internal architecture of pneumatic structures inside the bones. Here, we describe the vertebral pneumaticity of the ornithomimosaur Archaeornithomimus with the aid of X-ray computed tomography (CT) imaging. Complementary examination of external and internal osteology reveals (1) highly pneumatized cervical vertebrae with an elaborate configuration of interconnected chambers within the neural arch and the centrum; (2) anterior dorsal vertebrae with pneumatic chambers inside the neural arch; (3) apneumatic sacral vertebrae; and (4) a subset of proximal caudal vertebrae with limited pneumatic invasion into the neural arch. Comparisons with other theropod dinosaurs suggest that ornithomimosaurs primitively exhibited a plesio-morphic theropod condition for axial pneumaticity that was extended among later taxa, such as Archaeornithomimus and large bodied Deinocheirus. This finding corroborates the notion that evolutionary increases in vertebral pneumaticity occurred in parallel among independent lineages of bird-line archosaurs. Beyond providing a comprehensive view of vertebral pneumaticity in a non-avian coelurosaur, this study demonstrates the utility and need of CT imaging for further clarifying the early evolutionary history of postcranial pneumaticity.	[Watanabe, Akinobu; Gold, Maria Eugenia Leone; Davidson, Amy; Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Watanabe, Akinobu; Gold, Maria Eugenia Leone; Norell, Mark A.] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA; [Brusatte, Stephen L.] Univ Edinburgh, Sch GeoSci, Edinburgh EH8 9YL, Midlothian, Scotland; [Benson, Roger B. J.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; [Benson, Roger B. J.; Choiniere, Jonah] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Benson, Roger B. J.; Choiniere, Jonah] Univ Witwatersrand, DST NRF Ctr Excellence Palaeosci, Johannesburg, South Africa	American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); University of Edinburgh; University of Oxford; University of Witwatersrand; University of Witwatersrand	Watanabe, A (corresponding author), Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA.	awatanabe@amnh.org	Watanabe, Akinobu/ABE-2244-2021		Richard Gilder Graduate School at the American Museum of Natural History; NSF Graduate Research Fellowship; NSF [DEB 1110357]; Columbia University; Royal Society Research Grant [RG130018]; Marie Curie Career Integration Grant [FP7-PEOPLE-2013-CIG 630652]; Department of Science and Technology and National Research Foundation of South Africa Centre of Excellence in Palaeosciences; Friedel Sellschop Award through the University of the Witwatersrand; Palaeontological Scientific Trust; Scatterlings of Africa Programmes; National Research Foundation of South Africa Incentive Funding for Rated Researchers; American Museum of Natural History Division of Paleontology	Richard Gilder Graduate School at the American Museum of Natural History; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Columbia University; Royal Society Research Grant(Royal Society of London); Marie Curie Career Integration Grant; Department of Science and Technology and National Research Foundation of South Africa Centre of Excellence in Palaeosciences; Friedel Sellschop Award through the University of the Witwatersrand; Palaeontological Scientific Trust; Scatterlings of Africa Programmes; National Research Foundation of South Africa Incentive Funding for Rated Researchers; American Museum of Natural History Division of Paleontology	This study was funded by the Richard Gilder Graduate School at the American Museum of Natural History (AW, MELG), Kalbfleisch Fellowship and Gerstner Scholarship (JNC) administered by the Richard Gilder Graduate School at the American Museum of Natural History; NSF Graduate Research Fellowship (SLB, AW), NSF DEB 1110357 (SLB), Columbia University (SLB), Royal Society Research Grant RG130018 (SLB), Marie Curie Career Integration Grant FP7-PEOPLE-2013-CIG 630652 (SLB), Department of Science and Technology and National Research Foundation of South Africa Centre of Excellence in Palaeosciences grants in aid of research (JNC), Friedel Sellschop Award through the University of the Witwatersrand (JNC), Palaeontological Scientific Trust (PAST) and its Scatterlings of Africa Programmes (JNC), National Research Foundation of South Africa Incentive Funding for Rated Researchers (JNC), and the American Museum of Natural History Division of Paleontology (AW, MELG, SLB, JC, AD, MAN).	Bellairs A.D., 1960, BIOL COMP PHYSL BIRD, V1, P241, DOI DOI 10.1016/B978-1-4832-3142-6.50012-4; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Benson RBJ, 2012, BIOL REV, V87, P168, DOI 10.1111/j.1469-185X.2011.00190.x; Britt B., 1997, ENCY DINOSAURS, P590; Britt BB, 1998, NATURE, V395, P374, DOI 10.1038/26469; Britt BB, 1993, THESIS; Brusatte SL, 2014, CURR BIOL, V24, P2386, DOI 10.1016/j.cub.2014.08.034; Butler RJ, 2009, BIOL LETTERS, V5, P557, DOI 10.1098/rsbl.2009.0139; Choiniere JN, 2012, J AFR EARTH SCI, V71-72, P1, DOI 10.1016/j.jafrearsci.2012.05.005; Christiansen P, 2000, P ROY SOC B-BIOL SCI, V267, P2501, DOI 10.1098/rspb.2000.1311; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Crisp E., 1857, P ZOOL SOC LOND, V25, P215, DOI [10.1111/j.1096-3642.1857.tb01229.x, DOI 10.1111/J.1096-3642.1857.TB01229.X]; CURREY JD, 1985, J ZOOL, V206, P453; CURRIE PJ, 1993, CRETACEOUS RES, V14, P127, DOI 10.1006/cres.1993.1011; De Klerk WJ, 2000, J VERTEBR PALEONTOL, V20, P324, DOI 10.1671/0272-4634(2000)020[0324:ANCDFT]2.0.CO;2; Duncker H.-R., 1971, ADV ANAT EMBRYOL CEL, V45, P1; DUNCKER HR, 1989, LIFE SCI R, V45, P147; Fajardo RJ, 2007, J ANAT, V211, P138, DOI 10.1111/j.1469-7580.2007.00749.x; Farmer CG, 2006, RESP PHYSIOL NEUROBI, V154, P89, DOI 10.1016/j.resp.2006.04.014; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gold MEL, 2013, AM MUS NOVIT, P1; HOGG DA, 1984, J ANAT, V139, P105; HOGG DA, 1984, J ANAT, V138, P617; Hunter J, 1774, PHILOS T ROY SOC LON, V64, P205; Janensch W., 1947, PALAEONTOGRAPHICA S, V7, P1; Ji Q, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)420<0001:AEODAI>2.0.CO;2; King A. S., 1966, International Review of General and Experimental Zoology, V2, P171; KING A. S., 1956, BRIT VET JOUR, V112, P279; KING A. S., 1957, ACTA ANAT, V31, P220; KING AS, 1979, FORM FUNCTION BIRDS; Kobayashi Y, 2005, CAN J EARTH SCI, V42, P1501, DOI 10.1139/E05-044; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; Lee YN, 2014, NATURE, V515, P257, DOI 10.1038/nature13874; MAGNUSSEN H, 1979, RESP PHYSL, V27, P129; Makovicky P. J., 2011, LIVING DINOSAURS EVO, P9, DOI DOI 10.1002/9781119990475.CH1; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P137; Makovicky PJ, 2010, P ROY SOC B-BIOL SCI, V277, P191, DOI 10.1098/rspb.2009.0236; Martin EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097159; McLelland J., 1989, P221; Nysten M., 1962, ANN MUSEE ROYAL AFRI, V8, P187; O'Connor PM, 2007, J VERTEBR PALEONTOL, V27, P127; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; O'Connor PM, 2004, J MORPHOL, V261, P141, DOI 10.1002/jmor.10190; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; O'Connor PM, 2009, J EXPT ZOOLOGY A, V311A, P504, DOI [10.1002/jez.548, DOI 10.1002/JEZ.548]; Osmolska H., 1972, Palaeontologia Polonica, VNo. 27, P103; PEREZMORENO BP, 1994, NATURE, V370, P363, DOI 10.1038/370363a0; Ruben JA, 2003, PHYSIOL BIOCHEM ZOOL, V76, P141, DOI 10.1086/375425; Scheid P., 1989, P369; Scheid P., 1982, MODEL COMP GAS EXCHA; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Smith D., 1990, Journal of Vertebrate Paleontology, V10, P255; Taylor MP, 2007, PALAEONTOLOGY, V50, P1547, DOI 10.1111/j.1475-4983.2007.00728.x; Watanabe A, 2013, J VERTEBR PALEONTOL, V33, P1169, DOI 10.1080/02724634.2013.770750; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wedel MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078213; Wedel MJ, 2006, INTEGR ZOOL, V1, P80, DOI 10.1111/j.1749-4877.2006.00019.x; Wedel MJ, 2009, J EXP ZOOL PART A, V311A, P611, DOI 10.1002/jez.513; Wedel MJ, 2000, ACTA PALAEONTOL POL, V45, P343; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Welty J. C., 1982, LIFE BIRDS; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Xu X, 2014, SCIENCE, V346, P1341, DOI 10.1126/science.1253293	65	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145168	10.1371/journal.pone.0145168	http://dx.doi.org/10.1371/journal.pone.0145168			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682888	Green Published, gold, Green Submitted			2022-12-27	WOS:000366725800040
J	Soleymani, A; Pennekamp, F; Petchey, OL; Weibel, R				Soleymani, Ali; Pennekamp, Frank; Petchey, Owen L.; Weibel, Robert			Developing and Integrating Advanced Movement Features Improves Automated Classification of Ciliate Species	PLOS ONE			English	Article							CROSS-SCALE ANALYSIS; IMAGE-ANALYSIS; BEHAVIOR; PROTOZOA; SYSTEM; TAXONOMY; ECOLOGY; MODELS; TIME; FOOD	Recent advances in tracking technologies such as GPS or video tracking systems describe the movement paths of individuals in unprecedented details and are increasingly used in different fields, including ecology. However, extracting information from raw movement data requires advanced analysis techniques, for instance to infer behaviors expressed during a certain period of the recorded trajectory, or gender or species identity in case data is obtained from remote tracking. In this paper, we address how different movement features affect the ability to automatically classify the species identity, using a dataset of unicellular microbes (i.e., ciliates). Previously, morphological attributes and simple movement metrics, such as speed, were used for classifying ciliate species. Here, we demonstrate that adding advanced movement features, in particular such based on discrete wavelet transform, to morphological features can improve classification. These results may have practical applications in automated monitoring of waste water facilities as well as environmental monitoring of aquatic systems.	[Soleymani, Ali; Weibel, Robert] Univ Zurich, Dept Geog, Zurich, Switzerland; [Pennekamp, Frank; Petchey, Owen L.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Petchey, Owen L.] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Soleymani, A (corresponding author), Univ Zurich, Dept Geog, Zurich, Switzerland.	ali.soleymani@geo.uzh.ch	Pennekamp, Frank/ABD-3597-2020; Petchey, Owen/D-8851-2011	Pennekamp, Frank/0000-0003-0679-1045; Petchey, Owen/0000-0002-7724-1633; Weibel, Robert/0000-0002-2425-0077	University of Zurich; University of Zurich Research Priority Program on 'Global Change and Biodiversity' (URPP GCB)	University of Zurich; University of Zurich Research Priority Program on 'Global Change and Biodiversity' (URPP GCB)	AS and FP were supported by the University of Zurich. Contributions of OLP were supported by the University of Zurich Research Priority Program on 'Global Change and Biodiversity' (URPP GCB).	Altermatt F, 2015, METHODS ECOL EVOL, V6, P218, DOI 10.1111/2041-210X.12312; Amaral AL, 2008, ANAL BIOANAL CHEM, V391, P1321, DOI 10.1007/s00216-008-1845-y; Amaral AL, 2004, ENVIRONMETRICS, V15, P381, DOI 10.1002/env.652; Amer M., 2011, 2011 IEEE International Conference on Computer Vision Workshops (ICCV Workshops), P1488, DOI 10.1109/ICCVW.2011.6130426; Bell JL, 2008, J PLANKTON RES, V30, P1351, DOI 10.1093/plankt/fbn092; Beyer HL, 2013, METHODS ECOL EVOL, V4, P433, DOI 10.1111/2041-210X.12026; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Chang YC, 2011, HYDROBIOLOGIA, V666, P223, DOI 10.1007/s10750-010-0548-5; Chen MR, 2012, J EXP MAR BIOL ECOL, V422, P14, DOI 10.1016/j.jembe.2012.04.005; Conradt L, 2000, P ROY SOC B-BIOL SCI, V267, P1505, DOI 10.1098/rspb.2000.1171; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; de Weerd N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129030; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Demsar U, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0032-y; Dodge S, 2009, COMPUT ENVIRON URBAN, V33, P419, DOI 10.1016/j.compenvurbsys.2009.07.008; Dodge S, 2008, INFORM VISUAL, V7, P240, DOI 10.1057/palgrave.ivs.9500182; Dray S, 2010, ECOL RES, V25, P673, DOI 10.1007/s11284-010-0701-7; Fagan WF, 2013, ECOL LETT, V16, P1316, DOI 10.1111/ele.12165; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fenchel T, 1999, PROTIST, V150, P325, DOI 10.1016/S1434-4610(99)70033-7; Finlay BJ, 2004, PHILOS T R SOC B, V359, P599, DOI 10.1098/rstb.2003.1450; Gaucherel C., 2011, Computational Ecology and Software, V1, P69; Ginoris YP, 2007, WATER RES, V41, P2581, DOI 10.1016/j.watres.2007.02.006; Guler I, 2005, J NEUROSCI METH, V148, P113, DOI 10.1016/j.jneumeth.2005.04.013; Gurarie E, 2015, J ANIM ECOL; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hennessey TM, 2012, METHOD CELL BIOL, V109, P393, DOI [10.1016/B978-0-12-395967-9.00015-3, 10.1016/B978-0-12-385967-9.00015-3]; Joo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077686; Jordan D, 2013, P NATL ACAD SCI USA, V110, P14018, DOI 10.1073/pnas.1308282110; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Laube P, 2011, T GIS, V15, P401, DOI 10.1111/j.1467-9671.2011.01256.x; Li X., 2014, AM J GEOGR INF SYST, V3, P63; Long JA, 2013, INT J GEOGR INF SCI, V27, P292, DOI 10.1080/13658816.2012.682578; Lynn D., 2011, CILIATED PROTOZOA CH; MALLAT SG, 1989, IEEE T ACOUST SPEECH, V37, P2091, DOI 10.1109/29.45554; Mallat SG, 1989, IEEE T PATTERN ANAL, VI, P1604; March D, 2010, MAR ECOL PROG SER, V400, P195, DOI 10.3354/meps08410; Mesquita DP, 2013, ANAL CHIM ACTA, V802, P14, DOI 10.1016/j.aca.2013.09.016; Nams VO, 2014, ECOL LETT, V17, P1228, DOI 10.1111/ele.12328; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Pennekamp F, 2015, ECOL EVOL, V5, P2584, DOI 10.1002/ece3.1529; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Riotte-Lambert L, 2013, J THEOR BIOL, V317, P238, DOI 10.1016/j.jtbi.2012.10.026; Soleymani A, 2014, J SPAT INT SCI, P1, DOI 10.5311/JOSIS.2014.8.162; Subasi A, 2007, EXPERT SYST APPL, V32, P1084, DOI 10.1016/j.eswa.2006.02.005; Sur M, 2014, ECOL INFORM, V20, P47, DOI 10.1016/j.ecoinf.2014.01.007; Webb SL, 2009, J MAMMAL, V90, P1210, DOI 10.1644/08-MAMM-A-278.1; Wittemyer G, 2008, P NATL ACAD SCI USA, V105, P19108, DOI 10.1073/pnas.0801744105	51	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145345	10.1371/journal.pone.0145345	http://dx.doi.org/10.1371/journal.pone.0145345			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680591	Green Accepted, Green Published, gold			2022-12-27	WOS:000366723400072
J	Chu, JJ; Khan, MH; Jahn, HJ; Kraemer, A				Chu, Janet Junqing; Khan, Mobarak Hossain; Jahn, Heiko J.; Kraemer, Alexander			Only-Child Status in Relation to Perceived Stress and Studying-Related Life Satisfaction among University Students in China: A Comparison with International Students	PLOS ONE			English	Article							PERSONALITY; HEALTH; EVENTS	Objectives University students in general face multiple challenges, which may affect their levels of perceived stress and life satisfaction. Chinese students currently face specific strains due to the One-Child Policy (OCP). The aim of this study was to assess (1) whether the levels of perceived stress and studying-related life satisfaction are associated with only-child (OC) status after controlling for demographic and socio-economic characteristics and (2) whether these associations differ between Chinese and international students. Materials and Methods A cross-sectional health survey based on a self-administrated standardised questionnaire was conducted among 1,843 (1,543 Chinese, 300 international) students at two Chinese universities in 2010-2011. Cohen's Perceived Stress Scale (PSS-14) and Stock and Kraemer's Studying-related Life Satisfaction Scale were used to measure perceived stress and studying-related life satisfaction respectively. Multivariable logistic regression analyses were used to examine the associations of OC status with perceived stress and studying-related life satisfaction by sex for Chinese students and international students separately. Results The Chinese non-only-children (NOCs) were more likely to come from small cities. Multivariable regression models indicate that the Chinese NOCs were more stressed than OCs (OR = 1.39, 1.11-1.74) with a stronger association in men (OR = 1.48, 1.08-2.02) than women (OR = 1.26, 0.89-1.77). NOCs were also more dissatisfied than their OC fellows in the Chinese subsample (OR = 1.37, 1.09-1.73). Among international students, no associations between OC status and perceived stress or studying-related life satisfaction were found. Conclusions To promote equality between OCs and NOCs at Chinese universities, the causes of more stress and less studying-related life satisfaction among NOCs compared to OCs need further exploration.	[Chu, Janet Junqing; Khan, Mobarak Hossain; Jahn, Heiko J.; Kraemer, Alexander] Univ Bielefeld, Dept Publ Hlth Med, Sch Publ Hlth, D-33502 Bielefeld, Germany	University of Bielefeld	Chu, JJ (corresponding author), Univ Bielefeld, Dept Publ Hlth Med, Sch Publ Hlth, POB 10 02 91, D-33502 Bielefeld, Germany.	janet_junqing.chu@uni-bielefeld.de	Kraemer, Alexander/F-8832-2016	Kraemer, Alexander/0000-0003-2774-7860; Jahn, Heiko J./0000-0001-5915-5283	Deutsche Forschungsgemeinschaft; Open Access Publication Funds of Bielefeld University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Funds of Bielefeld University	The authors acknowledge support of the publication fee by Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University.	Ash C, 2001, SCHOOL PSYCHOL INT, V22, P320, DOI 10.1177/0143034301223008; Belmont L, 1976, ANN M SOC LIF HIST R; BLAKE J, 1981, POPUL DEV REV, V7, P43, DOI 10.2307/1972763; BLAKE J, 1974, DEMOGRAPHY, V11, P25, DOI 10.2307/2060697; Cameron L, 2013, SCIENCE, V339, P953, DOI 10.1126/science.1230221; Chan CLW, 2002, J ASSIST REPROD GEN, V19, P426, DOI 10.1023/A:1016815807703; China's National Bureau of Statistics, 2010 POP CENS; Chow HPH, 2005, SOC INDIC RES, V70, P139, DOI 10.1007/s11205-004-7526-0; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Deckro GR, 2002, J AM COLL HEALTH, V50, P281, DOI 10.1080/07448480209603446; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; El Ansari W, 2010, INT J ENV RES PUB HE, V7, P509, DOI 10.3390/ijerph7020509; FALBO T, 1989, J BIOSOC SCI, V21, P483, DOI 10.1017/S0021932000018228; Foubert J., 1998, J COLL U STUDENT HOU, V21, P41; Gilman R, 2006, J YOUTH ADOLESCENCE, V35, P311, DOI 10.1007/s10964-006-9036-7; GOETTING A, 1986, J MARRIAGE FAM, V48, P703, DOI 10.2307/352563; JIAO SL, 1986, CHILD DEV, V57, P357, DOI 10.2307/1130591; KEMPTON T, 1991, J CLIN CHILD PSYCHOL, V20, P434, DOI 10.1207/s15374424jccp2004_12; KING M, 1992, SOCIOL ANAL, V53, P37, DOI 10.2307/3711626; Kitzmann KM, 2002, J SOC PERS RELAT, V19, P299, DOI 10.1177/0265407502193001; Kong F, 2012, PERS INDIV DIFFER, V53, P1039, DOI 10.1016/j.paid.2012.07.032; Kwan YK, 2009, CHILD INDIC RES, V2, P375, DOI 10.1007/s12187-009-9041-y; LARSEN U, 1990, EUR J POPUL, V6, P257, DOI 10.1007/BF01796621; Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004; Li JH, 2003, RURAL SOCIOL, V68, P87; Liu CY, 2005, ADOLESCENCE, V40, P831; Maslen G, 2012, WORLDWIDE STUDENT NU; Matheny KB, 2002, INT J STRESS MANAGE, V9, P81, DOI 10.1023/A:1014902719664; Meier S, 2007, GESUNDHEITSFORDERUNG, P29; Meier S., 2007, NRW GESUNDHEITSSURVE; Mikolajczyk RT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-215; Milwertz Cecilia Nathansen, 1997, ACCEPTING POPULATION; MOE (Ministry of Education of the People's Republic of China), 2012 NAT ED DEV STAT; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Polit DF, 1982, EFFECTS FAMILY SIZE; Qian XiaoLei, 2008, Journal of International Development, V20, P132, DOI 10.1002/jid.1396; Sam DL, 2001, SOC INDIC RES, V53, P315, DOI 10.1023/A:1007108614571; Shah M, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-2; Shao Y, 2013, PERS INDIV DIFFER, V54, P536, DOI 10.1016/j.paid.2012.11.001; Stock C, 2001, GESUNDHEITSWESEN, V63, pS56; Suldo SM, 2004, SCHOOL PSYCHOL QUART, V19, P93, DOI 10.1521/scpq.19.2.93.33313; Sun YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027140; Vahey DC, 2004, MED CARE, V42, P57, DOI 10.1097/01.mlr.0000109126.50398.5a; Wang W, 2002, PSYCHIAT RES, V109, P37, DOI 10.1016/S0165-1781(01)00361-4; Wardle J, 2004, INT J BEHAV MED, V11, P27, DOI 10.1207/s15327558ijbm1101_4; White T., 2006, CHINAS LONGEST CAMPA; Williams SM, 2005, J VET MED EDUC, V32, P201, DOI 10.3138/jvme.32.2.201	47	16	16	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144947	10.1371/journal.pone.0144947	http://dx.doi.org/10.1371/journal.pone.0144947			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JH	26675032	gold, Green Submitted, Green Published			2022-12-27	WOS:000366722700077
J	Sapey-Triomphe, LA; Heckemann, RA; Boublay, N; Dorey, JM; Henaff, MA; Rouch, I; Padovan, C; Hammers, A; Krolak-Salmon, P				Sapey-Triomphe, Laurie-Anne; Heckemann, Rolf A.; Boublay, Nawele; Dorey, Jean-Michel; Henaff, Marie-Anne; Rouch, Isabelle; Padovan, Catherine; Hammers, Alexander; Krolak-Salmon, Pierre		Alzheimers Dis Neuroimaging Initia	Neuroanatomical Correlates of Recognizing Face Expressions in Mild Stages of Alzheimer's Disease	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; EMOTION RECOGNITION; FACIAL EXPRESSIONS; ELDERLY SUBJECTS; UP-REGULATION; HUMAN BRAIN; DISGUST; DIAGNOSIS; MEMORY; REGIONS	Early Alzheimer's disease can involve social disinvestment, possibly as a consequence of impairment of nonverbal communication skills. This study explores whether patients with Alzheimer's disease at the mild cognitive impairment or mild dementia stage have impaired recognition of emotions in facial expressions, and describes neuroanatomical correlates of emotion processing impairment. As part of the ongoing PACO study (personality, Alzheimer's disease and behaviour), 39 patients with Alzheimer's disease at the mild cognitive impairment or mild dementia stage and 39 matched controls completed tests involving discrimination of four basic emotions-happiness, fear, anger, and disgust-on photographs of faces. In patients, automatic volumetry of 83 brain regions was performed on structural magnetic resonance images using MAPER (multi-atlas propagation with enhanced registration). From the literature, we identified for each of the four basic emotions one brain region thought to be primarily associated with the function of recognizing that emotion. We hypothesized that the volume of each of these regions would be correlated with subjects' performance in recognizing the associated emotion. Patients showed deficits of basic emotion recognition, and these impairments were correlated with the volumes of the expected regions of interest. Unexpectedly, most of these correlations were negative: better emotional facial recognition was associated with lower brain volume. In particular, recognition of fear was negatively correlated with the volume of amygdala, disgust with pallidum, and happiness with fusiform gyrus. Recognition impairment in mild stages of Alzheimer's disease for a given emotion was thus associated with less visible atrophy of functionally responsible brain structures within the patient group. Possible explanations for this counterintuitive result include neuroinflammation, regional beta-amyloid deposition, or transient overcompensation during early stages of Alzheimer's disease.	[Sapey-Triomphe, Laurie-Anne; Heckemann, Rolf A.; Hammers, Alexander] CERMEP Imagerie Vivant, Neurodis Fdn, Lyon, France; [Sapey-Triomphe, Laurie-Anne; Henaff, Marie-Anne; Padovan, Catherine; Krolak-Salmon, Pierre] CNRS, UMR 5292, Lyon Neurosci Res Ctr, Brain Dynam & Cognit,INSERM,U1028, Lyon, France; [Sapey-Triomphe, Laurie-Anne] Ecole Normale Super Lyon, F-69364 Lyon, France; [Heckemann, Rolf A.] Univ Gothenburg, Sahlgrenska Univ Hosp, MedTech West, Gothenburg, Sweden; [Heckemann, Rolf A.] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, London, England; [Boublay, Nawele; Dorey, Jean-Michel; Rouch, Isabelle; Krolak-Salmon, Pierre] Hosp Civils Lyon, Clin & Res Memory Ctr Lyon, Hop Charpennes, Lyon, France; [Boublay, Nawele] Hosp Civils Lyon, Dept Med Informat & Res Evaluat, Lyon, France; [Boublay, Nawele; Krolak-Salmon, Pierre] Univ Lyon 1, F-69000 Lyon, France; [Dorey, Jean-Michel; Padovan, Catherine] Ctr Hosp Le Vinatier, Pole Est, Bron, France; [Hammers, Alexander] Kings Coll London, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Ecole Normale Superieure de Lyon (ENS de LYON); Sahlgrenska University Hospital; University of Gothenburg; Imperial College London; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of London; King's College London	Heckemann, RA (corresponding author), MedTech West, Roda Straket 10B, S-41345 Gothenburg, Sweden.	rolf.heckemann@medtechwest.se	krolak-salmon, pierre/AAV-2152-2020; Heckemann, Rolf Andreas/H-9022-2019; Hammers, Alexander/D-9982-2015	Heckemann, Rolf Andreas/0000-0003-3582-3683; Hammers, Alexander/0000-0001-9530-4848	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; National Hospital-Based Clinical Research Program (PHRC); AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd.; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Hospital-Based Clinical Research Program (PHRC); AbbVie, Alzheimer's Association(AbbVie); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); EuroImmun; F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The PACO project (PI: Prof. Pierre Krolak-Salmon) was financed by a grant from the French Ministry of Health via the Hospital Programme for Clinicial Research (Le programme hospitalier de recherche clinique). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd. and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosi ty; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PACO is financed by the National Hospital-Based Clinical Research Program (PHRC). We would like to thank all study participants and their carers for their time.; One part of the data used in preparation of this article was obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wpcontent/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf. Datacollection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-20012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Adalbert R, 2013, NEUROPATH APPL NEURO, V39, P90, DOI 10.1111/j.1365-2990.2012.01308.x; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Albert MS, 2011, NEUROBIOL AGING, V32, pS58, DOI 10.1016/j.neurobiolaging.2011.09.010; Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Bediou B, 2005, CAN J PSYCHIAT, V50, P525, DOI 10.1177/070674370505000905; Bediou B, 2009, J GERIATR PSYCH NEUR, V22, P130, DOI 10.1177/0891988709332939; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bussiere T, 2002, NEUROSCIENCE, V112, P75, DOI 10.1016/S0306-4522(02)00056-8; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Chetelat G, 2003, NEUROIMAGE, V18, P525, DOI 10.1016/S1053-8119(02)00026-5; DeKosky ST, 2002, ANN NEUROL, V51, P145, DOI 10.1002/ana.10069; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Hargrave R, 2002, J NEUROPSYCH CLIN N, V14, P64, DOI 10.1176/jnp.14.1.64; Heckemann RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129211; Heckemann RA, 2011, NEUROIMAGE, V56, P2024, DOI 10.1016/j.neuroimage.2011.03.014; Heckemann RA, 2010, NEUROIMAGE, V51, P221, DOI 10.1016/j.neuroimage.2010.01.072; Henry JD, 2008, NEUROPSYCHOLOGIA, V46, P1363, DOI 10.1016/j.neuropsychologia.2007.12.012; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Keihaninejad S, 2010, NEUROIMAGE, V50, P1427, DOI 10.1016/j.neuroimage.2010.01.064; Kohler CG, 2005, AM J GERIAT PSYCHIAT, V13, P926, DOI 10.1176/appi.ajgp.13.11.926; Krolak-Salmon P, 2006, REV NEUROL-FRANCE, V162, P1047, DOI 10.1016/S0035-3787(06)75117-7; Krolak-Salmon P, 2003, ANN NEUROL, V53, P446, DOI 10.1002/ana.10502; Kumfor F, 2014, BRAIN, V137, P3061, DOI 10.1093/brain/awu246; LAAKSO MP, 1995, J NEURAL TRANSM-PARK, V9, P73, DOI 10.1007/BF02252964; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; McCade D, 2011, DEMENT GERIATR COGN, V32, P257, DOI 10.1159/000335009; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Perrin M, 2012, J ALZHEIMERS DIS, V29, P817, DOI 10.3233/JAD-2012-111490; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Putcha D, 2011, J NEUROSCI, V31, P17680, DOI 10.1523/JNEUROSCI.4740-11.2011; Sapey-Triomphe LA, 2015, PACO BASELINE MR BRA, DOI [10.6084/m9.figshare.1534657, DOI 10.6084/M9.FIGSHARE.1534657]; Spoletini I, 2008, AM J GERIAT PSYCHIAT, V16, P389, DOI 10.1097/JGP.0b013e318165dbce; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Teng E, 2007, DEMENT GERIATR COGN, V23, P271, DOI 10.1159/000100829; Truchot L, 2007, NEUROLOGY, V69, P1012, DOI 10.1212/01.wnl.0000271377.52421.4a; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Weiss EM, 2008, AM J GERIAT PSYCHIAT, V16, P974, DOI 10.1097/JGP.0b013e318186bd53; Whitwell JL, 2007, ARCH NEUROL-CHICAGO, V64, P1130, DOI 10.1001/archneur.64.8.1130; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Willis M, 2011, J NEURAL TRANSM, V118, P727, DOI 10.1007/s00702-011-0648-z	54	29	31	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143586	10.1371/journal.pone.0143586	http://dx.doi.org/10.1371/journal.pone.0143586			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673928	Green Submitted, gold, Green Published			2022-12-27	WOS:000366722700012
J	Keravis, T; Favot, L; Abusnina, AA; Anton, A; Justiniano, H; Soleti, R; Alibrahim, EA; Simard, G; Andriantsitohaina, R; Lugnier, C				Keravis, Therese; Favot, Laure; Abusnina, Abdurrazag A.; Anton, Anita; Justiniano, Helene; Soleti, Raffaella; Alibrahim, Eid Alabed; Simard, Gilles; Andriantsitohaina, Ramaroson; Lugnier, Claire			Delphinidin Inhibits Tumor Growth by Acting on VEGF Signalling in Endothelial Cells	PLOS ONE			English	Article							RED WINE POLYPHENOLS; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; PROTEIN-KINASE-C; DIETARY ANTHOCYANIDIN; RAT AORTA; ACTIVATION; PDE4; ANGIOGENESIS; MECHANISMS; PATHWAY	The vasculoprotective properties of delphinidin are driven mainly by its action on endothelial cells. Moreover, delphinidin displays anti-angiogenic properties in both in vitro and in vivo angiogenesis models and thereby might prevent the development of tumors associated with excessive vascularization. This study was aimed to test the effect of delphinidin on melanoma-induced tumor growth with emphasis on its molecular mechanism on endothelial cells. Delphinidin treatment significantly decreased in vivo tumor growth induced by B16-F10 melanoma cell xenograft in mice. In vitro, delphinidin was not able to inhibit VEGFR2-mediated B16-F10 melanoma cell proliferation but it specifically reduced basal and VEGFR2-mediated endothelial cell proliferation. The anti-proliferative effect of delphinidin was reversed either by the MEK1/2 MAP kinase inhibitor, U-0126, or the PI3K inhibitor, LY-294002. VEGF-induced proliferation was reduced either by U-0126 or LY-294002. Under these conditions, delphinidin failed to decrease further endothelial cell proliferation. Delphinidin prevented VEGF-induced phosphorylation of ERK1/2 and p38 MAPK and decreased the expression of the transcription factors, CREB and ATF1. Finally, delphinidin was more potent in inhibiting in vitro cyclic nucleotide phosphodiesterases (PDEs), PDE1 and PDE2, compared to PDE3-PDE5. Altogether delphinidin reduced tumor growth of melanoma cell in vivo by acting specifically on endothelial cell proliferation. The mechanism implies an association between inhibition of VEGF-induced proliferation via VEGFR2 signalling, MAPK, PI3K and at transcription level on CREB/ATF1 factors, and the inhibition of PDE2. In conjunction with our previous studies, we demonstrate that delphinidin is a promising compound to prevent pathologies associated with generation of vascular network in tumorigenesis.	[Keravis, Therese; Favot, Laure; Abusnina, Abdurrazag A.; Anton, Anita; Justiniano, Helene; Lugnier, Claire] Univ Strasbourg, Lab Biophoton & Pharmacol, CNRS, UMR 7213, Illkirch Graffenstaden, France; [Soleti, Raffaella; Alibrahim, Eid Alabed; Simard, Gilles; Andriantsitohaina, Ramaroson] Univ Angers, INSERM, LUNAM, U1063, Angers, France; [Simard, Gilles; Andriantsitohaina, Ramaroson] CHU Angers, Angers, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Lugnier, C (corresponding author), Univ Strasbourg, Lab Biophoton & Pharmacol, CNRS, UMR 7213, Illkirch Graffenstaden, France.	claire.lugnier@unistra.fr	SOLETI, RAFFAELLA/ABB-5455-2020; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018; lugnier, claire/AAF-3911-2020; Laforge, Laure Favot/AGW-2729-2022; soleti, raffaella/AAC-1678-2021	SOLETI, RAFFAELLA/0000-0002-0271-0490; andriantsitohaina, ramaroson/0000-0002-4770-3585; Lugnier, Claire/0000-0002-0850-1331	French Centre National de la Recherche Scientifique; INSERM; University of Strasbourg; University of Angers; APRIFEL/Ligue Contre le Cancer, France; Libyan Higher Education Ministry	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Strasbourg; University of Angers; APRIFEL/Ligue Contre le Cancer, France; Libyan Higher Education Ministry	This work was supported in part by the French Centre National de la Recherche Scientifique, the INSERM, the University of Strasbourg, the University of Angers and APRIFEL/Ligue Contre le Cancer, France. Dr. Abdurazzag Abusnina was supported by a fellowship from the Libyan Higher Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusnina A, 2015, THROMB HAEMOSTASIS, V113, P319, DOI 10.1160/TH14-05-0454; Abusnina A, 2011, MOL NUTR FOOD RES, V55, P1677, DOI 10.1002/mnfr.201100307; Alvarez E, 2006, BRIT J PHARMACOL, V147, P269, DOI 10.1038/sj.bjp.0706507; Andriambeloson E, 1998, J NUTR, V128, P2324, DOI 10.1093/jn/128.12.2324; Andriantsitohaina R, 2012, BRIT J NUTR, V108, P1532, DOI 10.1017/S0007114512003406; Arranz S, 2012, NUTRIENTS, V4, P759, DOI 10.3390/nu4070759; Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com; Campos-Toimil M, 2008, BRIT J PHARMACOL, V154, P82, DOI 10.1038/bjp.2008.56; Chalopin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008554; Clere Nicolas, 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P62; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dent Paul, 2014, Cancer Biol Ther, V15, P245, DOI 10.4161/cbt.27541; Duluc L, 2014, INT J BIOCHEM CELL B, V53, P9, DOI 10.1016/j.biocel.2014.03.030; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Favot L, 2004, THROMB HAEMOSTASIS, V92, P634, DOI 10.1160/TH03-12-0768; Favot L, 2003, CARDIOVASC RES, V59, P479, DOI 10.1016/S0008-6363(03)00433-4; Favot L, 2003, THROMB HAEMOSTASIS, V90, P334, DOI 10.1160/TH03-02-0084; Geoffroy V, 1999, EUR J BIOCHEM, V259, P892, DOI 10.1046/j.1432-1327.1999.00123.x; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Goncalves RL, 2009, EUR J PHARMACOL, V620, P78, DOI 10.1016/j.ejphar.2009.08.008; Gustin JA, 2004, AM J PHYSIOL-CELL PH, V286, pC547, DOI 10.1152/ajpcell.00332.2002; Ilan N, 1998, J CELL SCI, V111, P3621; Keravis T., 2006, CYCLIC NUCLEOTIDE PH, P417; Keravis Therese, 2005, V307, P63; Keravis T, 2012, BRIT J PHARMACOL, V165, P1288, DOI 10.1111/j.1476-5381.2011.01729.x; Kubo K, 2005, J MED CHEM, V48, P1359, DOI 10.1021/jm030427r; Lamy S, 2006, CARCINOGENESIS, V27, P989, DOI 10.1093/carcin/bgi279; Lamy S, 2008, CARCINOGENESIS, V29, P1033, DOI 10.1093/carcin/bgn070; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Lugnier C, 2001, FASEB J, V15, pA211; LUGNIER C, 1986, BIOCHEM PHARMACOL, V35, P1743, DOI 10.1016/0006-2952(86)90333-3; Martin S, 2003, BIOCHEM PHARMACOL, V65, P669, DOI 10.1016/S0006-2952(02)01568-X; Martin S, 2002, BRIT J PHARMACOL, V135, P1579, DOI 10.1038/sj.bjp.0704603; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Pal HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077270; Sassone-Corsi P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011148; Soleti R, 2009, CARCINOGENESIS, V30, P580, DOI 10.1093/carcin/bgp030; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang Z, 2015, SEM CANC BI IN PRESS; Xu CS, 2013, SCI WORLD J, DOI 10.1155/2013/417413; Xu H, 2008, CARDIOVASC RES, V78, P349, DOI 10.1093/cvr/cvm085; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6	43	20	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145291	10.1371/journal.pone.0145291	http://dx.doi.org/10.1371/journal.pone.0145291			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694325	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092500036
J	Perumal, V; Hashim, U; Gopinath, SCB; Haarindraprasad, R; Liu, WW; Poopalan, P; Balakrishnan, SR; Thivina, V; Ruslinda, AR				Perumal, Veeradasan; Hashim, Uda; Gopinath, Subash C. B.; Haarindraprasad, R.; Liu, Wei-Wen; Poopalan, P.; Balakrishnan, S. R.; Thivina, V.; Ruslinda, A. R.			Thickness Dependent Nanostructural, Morphological, Optical and Impedometric Analyses of Zinc Oxide-Gold Hybrids: Nanoparticle to Thin Film	PLOS ONE			English	Article							ZNO NANORODS; ENHANCED PHOTOLUMINESCENCE; ELECTRICAL-PROPERTIES; REFRACTIVE-INDEX; TEMPERATURE; EMISSION; FABRICATION; NETWORKS; GROWTH; MECHANISMS	The creation of an appropriate thin film is important for the development of novel sensing surfaces, which will ultimately enhance the properties and output of high-performance sensors. In this study, we have fabricated and characterized zinc oxide (ZnO) thin films on silicon substrates, which were hybridized with gold nanoparticles (AuNPs) to obtain ZnO-Au-x (x = 10, 20, 30, 40 and 50 nm) hybrid structures with different thicknesses. Nanoscale imaging by field emission scanning electron microscopy revealed increasing film uniformity and coverage with the Au deposition thickness. Transmission electron microscopy analysis indicated that the AuNPs exhibit an increasing average diameter (5-10 nm). The face center cubic Au were found to co-exist with wurtzite ZnO nanostructure. Atomic force microscopy observations revealed that as the Au content increased, the overall crystallite size increased, which was supported by X-ray diffraction measurements. The structural characterizations indicated that the Au on the ZnO crystal lattice exists without any impurities in a preferred orientation (002). When the ZnO thickness increased from 10 to 40 nm, transmittance and an optical bandgap value decreased. Interestingly, with 50 nm thickness, the band gap value was increased, which might be due to the Burstein-Moss effect. Photoluminescence studies revealed that the overall structural defect (green emission) improved significantly as the Au deposition increased. The impedance measurements shows a decreasing value of impedance arc with increasing Au thicknesses (0 to 40 nm). In contrast, the 50 nm AuNP impedance arc shows an increased value compared to lower sputtering thicknesses, which indicated the presence of larger sized AuNPs that form a continuous film, and its ohmic characteristics changed to rectifying characteristics. This improved hybrid thin film (ZnO/Au) is suitable for a wide range of sensing applications.	[Perumal, Veeradasan; Hashim, Uda; Gopinath, Subash C. B.; Haarindraprasad, R.; Liu, Wei-Wen; Balakrishnan, S. R.; Thivina, V.; Ruslinda, A. R.] Univ Malaysia Perlis, Inst Nano Elect Engn INEE, Biomed Nano Diagnost Res Grp, Kangar, Perlis, Malaysia; [Hashim, Uda; Poopalan, P.] Univ Malaysia Perlis, Sch Microelect Engn, Kuala Perlis, Perlis, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Sch Bioproc Engn, Arau, Perlis, Malaysia	Universiti Malaysia Perlis; Universiti Malaysia Perlis; Universiti Malaysia Perlis	Hashim, U (corresponding author), Univ Malaysia Perlis, Inst Nano Elect Engn INEE, Biomed Nano Diagnost Res Grp, Kangar, Perlis, Malaysia.	uda@unimap.edu.my	Balakrishnan, Sharma Rao/G-4561-2015; Rahim, Ruslinda A/AAR-5069-2020; Balakrishnan, Sharma Rao/AAP-2889-2021; Gopinath, Subash/D-2953-2015; LIU, WEI WEN/D-2098-2015; A.Rahim, Ruslinda/K-7078-2014	Balakrishnan, Sharma Rao/0000-0002-6796-2277; Rahim, Ruslinda A/0000-0001-8549-0077; Balakrishnan, Sharma Rao/0000-0002-6796-2277; Gopinath, Subash/0000-0002-8347-4687; LIU, WEI WEN/0000-0002-7632-9078; A.Rahim, Ruslinda/0000-0002-3511-9509; Perumal, Veeradasan/0000-0003-4492-0282; POOPALAN, PRABAKARAN/0000-0003-1698-0632	Universiti Malaysia Perlis (UniMAP); Ministry of Higher Education Malaysia through MTUN-COE [9016-00004]	Universiti Malaysia Perlis (UniMAP); Ministry of Higher Education Malaysia through MTUN-COE	The authors would like to thank Universiti Malaysia Perlis (UniMAP), and Ministry of Higher Education Malaysia for the financial support through MTUN-COE grant 9016-00004 to conduct the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Douri Y, 2013, PROCEDIA ENGINEER, V53, P400, DOI 10.1016/j.proeng.2013.02.052; Alaeddin AS, 2010, J KOREAN PHYS SOC, V57, P1449, DOI [10.3938/jkps.57.1449, DOI 10.3938/JKPS.57.1449]; Antoine TE, 2012, ANTIVIR RES, V96, P363, DOI 10.1016/j.antiviral.2012.09.020; Arshad M, 2015, J LUMIN, V161, P275, DOI 10.1016/j.jlumin.2014.12.016; Balakrishnan SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137891; Balakrishnan SR, 2016, BIOSENS BIOELECTRON, V84, P44, DOI 10.1016/j.bios.2015.10.075; Balakrishnan SR, 2014, SENSOR ACTUAT A-PHYS, V220, P101, DOI 10.1016/j.sna.2014.09.027; Chen Y, 2012, J PHYS CHEM SOLIDS, V73, P1259, DOI 10.1016/j.jpcs.2012.06.007; Cheng CW, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3323091; Cheng C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04181; Deki S, 1996, J MATER CHEM, V6, P1879, DOI 10.1039/jm9960601879; Dhara S, 2011, J APPL PHYS, V110, DOI 10.1063/1.3671023; Fabbri F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05158; Foo KL, 2016, MICROSYST TECHNOL, V22, P903, DOI 10.1007/s00542-015-2572-x; Foo KL, 2014, CERAM INT, V40, P753, DOI 10.1016/j.ceramint.2013.06.065; Fujimaki M, 2010, OPT EXPRESS, V18, P15732, DOI 10.1364/OE.18.015732; Gedamu D, 2014, ADV MATER, V26, P1541, DOI 10.1002/adma.201304363; GHOSH DK, 1984, INFRARED PHYS, V24, P43, DOI 10.1016/0020-0891(84)90046-0; Gogurla N, 2014, SCI REP-UK, V4, DOI 10.1038/srep06483; Gopinath SCB, 2008, ACS NANO, V2, P1885, DOI 10.1021/nn800285p; Gopinath SCB, 2012, ANALYST, V137, P3520, DOI 10.1039/c2an35159e; Gopinath SCB, 2011, SENSOR ACTUAT B-CHEM, V155, P239, DOI 10.1016/j.snb.2010.11.054; Guo J, 2014, SENSOR ACTUAT B-CHEM, V199, P339, DOI 10.1016/j.snb.2014.04.010; Haarindraprasad R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132755; HERVE PJL, 1995, J APPL PHYS, V77, P5476, DOI 10.1063/1.359248; Hosseini ZS, 2015, J ALLOY COMPD, V628, P222, DOI 10.1016/j.jallcom.2014.12.163; Jain PK, 2007, NANO TODAY, V2, P18, DOI 10.1016/S1748-0132(07)70016-6; Jiang RB, 2014, ADV MATER, V26, P5274, DOI 10.1002/adma.201400203; Jin X, 2013, ADV MATER, V25, P1342, DOI 10.1002/adma.201203849; Jin ZW, 2014, SCI REP-UK, V4, DOI 10.1038/srep04268; Joseph B, 1999, B MATER SCI, V22, P921, DOI 10.1007/BF02745554; Kahraman S, 2013, J CRYST GROWTH, V363, P86, DOI 10.1016/j.jcrysgro.2012.10.018; Kang DJ, 2005, THIN SOLID FILMS, V475, P160, DOI 10.1016/j.tsf.2004.07.029; Kashif M, 2013, CERAM INT, V39, P6461, DOI 10.1016/j.ceramint.2013.01.075; Kashif M, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-68; Khoa NT, 2015, ACS APPL MATER INTER, V7, P3524, DOI 10.1021/acsami.5b00152; Kim WM, 2013, THIN SOLID FILMS, V531, P430, DOI 10.1016/j.tsf.2013.01.078; Kumar M, 2016, PLASMONICS, V11, P261, DOI 10.1007/s11468-015-0044-x; Kumar M, 2015, SCRIPTA MATER, V105, P46, DOI 10.1016/j.scriptamat.2015.04.030; Kumar M, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4922732; Kumar M, 2014, PLASMONICS, V9, P129, DOI 10.1007/s11468-013-9605-z; Kumar M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3555593; Kumar M, 2010, PHYSICA E, V43, P470, DOI 10.1016/j.physe.2010.08.031; Kumar M, 2009, PHYS STATUS SOLIDI B, V246, P2232, DOI 10.1002/pssb.200844464; Kumar R, 2015, TALANTA, V137, P204, DOI 10.1016/j.talanta.2015.01.039; Lai CW, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1954883; Lakshmipriya T, 2013, LANGMUIR, V29, P15107, DOI 10.1021/la4027283; Li XH, 2009, OPT EXPRESS, V17, P8735, DOI 10.1364/OE.17.008735; Lim ZZJ, 2011, ACTA PHARMACOL SIN, V32, P983, DOI 10.1038/aps.2011.82; Lin HY, 2006, OPT EXPRESS, V14, P2372, DOI 10.1364/OE.14.002372; Lin JH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06967; Mishra YK, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2838302; Mishra YK, 2007, J OPT A-PURE APPL OP, V9, pS410, DOI 10.1088/1464-4258/9/9/S21; Mishra YK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752469; Mishra YK, 2015, ACS APPL MATER INTER, V7, P14303, DOI 10.1021/acsami.5b02816; Mishra YK, 2014, KONA POWDER PART J, P92; Mishra YK, 2011, ANTIVIR RES, V92, P305, DOI 10.1016/j.antiviral.2011.08.017; Mohapatra S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2894187; Mohapatra S., 2013, ADV MAT LETT, V4, P444, DOI [DOI 10.5185/AMLETT.2012.IB.111, 10.5185/amlett.2012.ib.111]; Naseri N, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/10/105405; Naseri N, 2010, THIN SOLID FILMS, V518, P2250, DOI 10.1016/j.tsf.2009.08.001; Nomura K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3855; Notes S, 1979, PHYS STATUS SOLIDI, V93, pK115; Nour ES, 2015, AIP ADV, V5, DOI 10.1063/1.4927510; Ozga K, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/18/185709; Park S, 2014, J LUMIN, V147, P5, DOI 10.1016/j.jlumin.2013.10.044; PERUMAL V, 2013, RSM 2013 IEEE REG S, P33, DOI DOI 10.1109/RSM.2013.6706466; Perumal V, 2016, BIOSENS BIOELECTRON, V78, P14, DOI 10.1016/j.bios.2015.10.083; Perumal V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12231; Perumal V, 2014, J APPL BIOMED, V12, P1, DOI 10.1016/j.jab.2013.02.001; Rouhi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123433; Sahu D, 2014, OPT MATER, V36, P1402, DOI 10.1016/j.optmat.2014.03.041; Saif AA, 2011, SOLID STATE ELECTRON, V62, P25, DOI 10.1016/j.sse.2011.03.004; Saif AA, 2011, J ALLOY COMPD, V509, P7210, DOI 10.1016/j.jallcom.2011.04.068; Sangpour P, 2007, APPL SURF SCI, V253, P7438, DOI 10.1016/j.apsusc.2007.03.050; Shan GY, 2008, J COLLOID INTERF SCI, V326, P392, DOI 10.1016/j.jcis.2008.06.027; Shao DL, 2012, NANO LETT, V12, P5840, DOI 10.1021/nl3031955; Shi XH, 2014, MICROCHIM ACTA, V181, P1, DOI 10.1007/s00604-013-1069-5; Shinde SS, 2013, J ALLOY COMPD, V551, P688, DOI 10.1016/j.jallcom.2012.11.057; Song JZ, 2015, ANGEW CHEM INT EDIT, V54, P9760, DOI 10.1002/anie.201501233; Song JZ, 2015, ANGEW CHEM INT EDIT, V54, P462, DOI 10.1002/anie.201408621; Srivastava S, 2015, J ALLOY COMPD, V644, P597, DOI 10.1016/j.jallcom.2015.04.220; Strunk J, 2009, APPL CATAL A-GEN, V359, P121, DOI 10.1016/j.apcata.2009.02.030; Su L, 2015, CERAM INT, V41, P2673, DOI 10.1016/j.ceramint.2014.10.081; Sun YG, 2003, ANALYST, V128, P686, DOI 10.1039/b212437h; Tan ST, 2005, J APPL PHYS, V98, DOI 10.1063/1.1940137; Tarwal NL, 2013, SENSOR ACTUAT A-PHYS, V199, P67, DOI 10.1016/j.sna.2013.05.003; Tarwal NL, 2012, ELECTROCHIM ACTA, V72, P32, DOI 10.1016/j.electacta.2012.03.135; UNDERWOOD S, 1994, LANGMUIR, V10, P3427, DOI 10.1021/la00022a011; Upadhyayula VKK, 2012, ANAL CHIM ACTA, V715, P1, DOI 10.1016/j.aca.2011.12.008; Wang FH, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-97; Wang XH, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-109; Wang X, 2007, J PHYS CHEM C, V111, P3836, DOI 10.1021/jp064118z; Wu AP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08858; Wu JJ, 2006, APPL CATAL B-ENVIRON, V66, P51, DOI 10.1016/j.apcatb.2006.02.013; Xu JP, 2013, MAT SCI SEMICON PROC, V16, P732, DOI 10.1016/j.mssp.2012.12.016; Xu Y, 2014, J ALLOY COMPD, V585, P479, DOI 10.1016/j.jallcom.2013.09.199; Yuan YJ, 2011, OPT ENG, V50, DOI 10.1117/1.3554392; Zeng HB, 2010, ADV FUNCT MATER, V20, P561, DOI 10.1002/adfm.200901884; Zhang XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04596	100	25	25	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144964	10.1371/journal.pone.0144964	http://dx.doi.org/10.1371/journal.pone.0144964			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694656	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092500018
J	Dobbins, GC; Ugai, H; Curiel, DT; Gillespie, GY				Dobbins, G. Clement; Ugai, Hideyo; Curiel, David T.; Gillespie, G. Yancey			A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic Agents	PLOS ONE			English	Article							GENE-TRANSFER EFFICIENCY; MALIGNANT GLIOMA; OVARIAN-CANCER; IN-VIVO; CELLS; PROTEIN; VIROTHERAPY; GENERATION; INFECTION; RECEPTOR	Studies have demonstrated that oncolytic adenoviruses based on a 24 base pair deletion in the viral E1A gene (D24) may be promising therapeutics for treating a number of cancer types. In order to increase the therapeutic potential of these oncolytic viruses, a novel conditionally replicating adenovirus targeting multiple receptors upregulated on tumors was generated by incorporating an Ad5/3 fiber with a carboxyl terminus RGD ligand. The virus displayed full cytopathic effect in all tumor lines assayed at low titers with improved cytotoxicity over Ad5-RGD D24, Ad5/3 D24 and an HSV oncolytic virus. The virus was then engineered to deliver immunotherapeutic agents such as GM-CSF while maintaining enhanced heterogenic oncolysis.	[Dobbins, G. Clement] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Dobbins, G. Clement; Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA; [Ugai, Hideyo] Washington Univ, Sch Med, Dept Radiat Oncol, Div Canc Biol, St Louis, MO USA; [Curiel, David T.] Washington Univ, Sch Med, Dept Radiat Oncol, Biol Therapeut Ctr, St Louis, MO USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Washington University (WUSTL)	Dobbins, GC (corresponding author), Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA.	gclemd@uab.edu; yancey@uab.edu	Ugai, Hideyo/K-4920-2017	Ugai, Hideyo/0000-0002-9121-8480; Gillespie, George/0000-0001-6436-9542	National Institutes of Health [T32-NS048039]; American Cancer Society [PF-12-143-01-CCE]; Susan G. Komen for the Cure [KG100194]; UAB/UMN SPORE in Pancreatic Cancer [5P50 CA101955-07]; UAB Brain Tumor SPORE [5P20 CA151129-03, P01 CA071933]; NATIONAL CANCER INSTITUTE [P50CA101955, P01CA071933, P20CA151129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); UAB/UMN SPORE in Pancreatic Cancer; UAB Brain Tumor SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the following grants: T32-NS048039 from the National Institutes of Health and PF-12-143-01-CCE from the American Cancer Society (G.C.D); Susan G. Komen for the Cure KG100194 (D.T.C., H.U.); UAB/UMN SPORE in Pancreatic Cancer 5P50 CA101955-07 (D.T.C.); UAB Brain Tumor SPORE 5P20 CA151129-03 (G.Y.G.) and P01 CA071933 (G.Y.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano M, 2008, BIOL-TARGETS THER, V2, P13; Bauerschmitz GJ, 2002, INT J ONCOL, V21, P1161; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; BERK AJ, 1986, ANNU REV GENET, V20, P45, DOI 10.1146/annurev.ge.20.120186.000401; BIGNER DD, 1981, J NEUROPATH EXP NEUR, V40, P201, DOI 10.1097/00005072-198105000-00001; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Fukuda K, 2003, CANCER RES, V63, P4434; Gill BJ, 2014, P NATL ACAD SCI USA, V111, P12550, DOI 10.1073/pnas.1405839111; Heise C, 2000, NAT MED, V6, P1134, DOI 10.1038/80474; Horwitz MS, 2004, J GENE MED, V6, pS172, DOI 10.1002/jgm.495; Jiang H, 2011, J VIROL, V85, P4720, DOI 10.1128/JVI.02032-10; Kanerva A, 2002, CLIN CANCER RES, V8, P275; Kim KH, 2011, HUM GENE THER, V22, P821, DOI 10.1089/hum.2010.180; Kimball KJ, 2010, CLIN CANCER RES, V16, P5277, DOI 10.1158/1078-0432.CCR-10-0791; Kimball KJ, 2009, MOL IMAGING, V8, P264, DOI 10.2310/7290.2009.00025; Koski A, 2015, MOL THER, V23, P1641, DOI 10.1038/mt.2015.125; Koski A, 2010, MOL THER, V18, P1874, DOI 10.1038/mt.2010.161; Krasnykh VN, 1996, J VIROL, V70, P6839, DOI 10.1128/JVI.70.10.6839-6846.1996; Lenaerts L, 2008, REV MED VIROL, V18, P357, DOI 10.1002/rmv.589; Li EG, 1998, J VIROL, V72, P2055, DOI 10.1128/JVI.72.3.2055-2061.1998; Liu YP, 2014, GYNECOL ONCOL, V132, P722, DOI 10.1016/j.ygyno.2014.01.009; Lu ZZ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003718; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Megison ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086843; Meulenbroek RA, 2004, MOL THER, V9, P617, DOI 10.1016/j.ymthe.2004.01.012; Miller CR, 1998, CANCER RES, V58, P5738; Parker JN, 2000, P NATL ACAD SCI USA, V97, P2208, DOI 10.1073/pnas.040557897; Pesonen S, 2011, MOL PHARMACEUT, V8, P12, DOI 10.1021/mp100219n; Pol J, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28694; Rein Daniel T, 2006, Future Oncol, V2, P137, DOI 10.2217/14796694.2.1.137; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Sauthoff H, 2004, MOL THER, V10, P749, DOI 10.1016/j.ymthe.2004.07.014; Senzer NN, 2009, J CLIN ONCOL, V27, P5763, DOI 10.1200/JCO.2009.24.3675; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Suzuki K, 2001, CLIN CANCER RES, V7, P120; Tollefson AE, 1996, J VIROL, V70, P2296, DOI 10.1128/JVI.70.4.2296-2306.1996; Tyler MA, 2006, MOL CANCER THER, V5, P2408, DOI 10.1158/1535-7163.MCT-06-0187; Ugai H, 2005, BIOCHEM BIOPH RES CO, V331, P1053, DOI 10.1016/j.bbrc.2005.03.227; Ugai H, 2007, J MOL BIOL, V366, P1142, DOI 10.1016/j.jmb.2006.11.090; Ugai H, 2010, J MOL BIOL, V395, P55, DOI 10.1016/j.jmb.2009.10.034; Ulasov IV, 2007, J NEUROSURG, V107, P617, DOI 10.3171/JNS-07/09/0617; Volk AL, 2003, CANCER BIOL THER, V2, P511, DOI 10.4161/cbt.2.5.440; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Young AM, 2012, MOL THER, V20, P1676, DOI 10.1038/mt.2012.116; Zheng CY, 2000, NAT BIOTECHNOL, V18, P176, DOI 10.1038/72628; Zhu ZB, 2007, INT J ONCOL, V31, P1213	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145272	10.1371/journal.pone.0145272	http://dx.doi.org/10.1371/journal.pone.0145272			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689910	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300052
J	Silal, SP; Little, F; Barnes, KI; White, LJ				Silal, Sheetal Prakash; Little, Francesca; Barnes, Karen Irma; White, Lisa Jane			Hitting a Moving Target: A Model for Malaria Elimination in the Presence of Population Movement	PLOS ONE			English	Article							SOUTH-AFRICA; PLASMODIUM-FALCIPARUM; MPUMALANGA PROVINCE; MATHEMATICAL-MODELS; TRANSMISSION; MOZAMBIQUE; SPREAD	South Africa is committed to eliminating malaria with a goal of zero local transmission by 2018. Malaria elimination strategies may be unsuccessful if they focus only on vector biology, and ignore the mobility patterns of humans, particularly where the majority of infections are imported. In the first study in Mpumalanga Province in South Africa designed for this purpose, a metapopulation model is developed to assess the impact of their proposed elimination-focused policy interventions. A stochastic, non-linear, ordinary-differential equation model is fitted to malaria data from Mpumalanga and neighbouring Maputo Province in Mozambique. Further scaling-up of vector control is predicted to lead to a minimal reduction in local infections, while mass drug administration and focal screening and treatment at the Mpumalanga-Maputo border are predicted to have only a short-lived impact. Source reduction in Maputo Province is predicted to generate large reductions in local infections through stemming imported infections. The mathematical model predicts malaria elimination to be possible only when imported infections are treated before entry or eliminated at the source suggesting that a regionally focused strategy appears needed, for achieving malaria elimination in Mpumalanga and South Africa.	[Silal, Sheetal Prakash; Little, Francesca] Univ Cape Town, Dept Stat Sci, ZA-7700 Rondebosch, South Africa; [Barnes, Karen Irma] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Observatory, South Africa; [White, Lisa Jane] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [White, Lisa Jane] Univ Oxford, Nuffield Dept Clin Med, Churchill Hosp, Ctr Trop Med, Oxford, England	University of Cape Town; University of Cape Town; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Silal, SP (corresponding author), Univ Cape Town, Dept Stat Sci, ZA-7700 Rondebosch, South Africa.	Sheetal.Silal@uct.ac.za	White, Lisa/AAC-9396-2020; Silal, Sheetal/AAB-1873-2020	White, Lisa/0000-0002-6523-185X; Silal, Sheetal/0000-0002-3007-5383; Little, Francesca/0000-0002-5917-9928	National Research Foundation of South Africa under the Thuthuka Grant Programme [80617]; National Research Foundation in South Africa; Wellcome Trust	National Research Foundation of South Africa under the Thuthuka Grant Programme; National Research Foundation in South Africa(National Research Foundation - South Africa); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the National Research Foundation of South Africa under the Thuthuka Grant Programme (Grant number: 80617; http://www.nrf.ac.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Malaria Elimination Programme of the Department of Health in Mpumalanga, South Africa for the provision of data and are particularly grateful to Aaron Mabuza and Gerdalize Kok from the Malaria Elimination Programme for their valuable input. This material is based upon work supported financially by the National Research Foundation in South Africa. We are grateful to the National Research Foundation in South Africa for financial support. Any opinion, findings and conclusions or recommendations expressed in this material are those of the authors and therefore the NRF does not accept any liability in regard thereto. Mahidol-Oxford Tropical Medicine Research Unit is funded by the Wellcome Trust.	ANDERSON R M, 1991; [Anonymous], 2011, TECHNICAL REPORT; [Anonymous], 2014, LUBOMBO SPATIAL DEV; Ariey F, 2003, INFECT GENET EVOL, V2, P185, DOI 10.1016/S1567-1348(02)00099-0; Arino J, 2012, J MATH BIOL, V64, P423, DOI 10.1007/s00285-011-0418-4; Auger P, 2008, MATH BIOSCI, V216, P123, DOI 10.1016/j.mbs.2008.08.010; Blumberg L, 2007, SAMJ S AFR MED J, V97, P1193; Castillo-Riquelme M, 2008, TROP MED INT HEALTH, V13, P108, DOI 10.1111/j.1365-3156.2007.01979.x; Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0; Cleveland R.B., 1990, J OFF STAT, V6; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; Collins WE, 1999, AM J TROP MED HYG, V61, P4, DOI 10.4269/tropmed.1999.61-04; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Crowell V, 2012, EPIDEMICS-NETH, V4, P1, DOI 10.1016/j.epidem.2011.10.003; Department of Home Affairs, 2005, TECHNICAL REPORT; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Espinal C, 1992, ENFOQUE INTEGRAL SAL, P429; Executive Office of the President, 2013, TECHNICAL REPORT; EYLES DON E., 1951, JOUR NATL MALARIA SOC, V10, P327; Govere JM, 2001, S AFR J SCI, V97, P55; Griffin JT, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms4136, DOI 10.1038/NC0MMS4136]; Hall BF, 2009, J INFECT DIS, V200, P1639, DOI 10.1086/646611; Hlongwana KW, 2011, AFRICAN J PRIMARY HL, V3; JEFFERY GM, 1955, AM J TROP MED HYG, V4, P781, DOI 10.4269/ajtmh.1955.4.781; Kennedy J., 1995, P ICNN 95 INT C NEUR, V4, P1942; Koella JC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-3; Le Menach A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-23; Makanga M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S5; Mandal S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-202; MILLER M. J., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P152, DOI 10.1016/0035-9203(58)90036-1; Montosi E, 2012, HYDROL EARTH SYST SC, V16, P2759, DOI 10.5194/hess-16-2759-2012; Moonasar D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-294; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Ngomane L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-19; Oluwagbemi OO, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068040, DOI 10.1371/J0URNAL.P0NE.0068040]; President&rsquo;s Malaria Initiative, 2013, TECHNICAL REPORT; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Rodriguez DJ, 2001, B MATH BIOL, V63, P547, DOI 10.1006/bulm.2001.0231; Sharp B, 2001, TECHNICAL REPORT; Sharp BL, 1996, S AFR MED J, V86, P83; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Silal SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076640; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Statistics South Africa, 2012, CENS 2011 MUN REP MP; Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107; Thomson D, 1911, THE LEUCOCYTES IN MA; White LJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-212; World Health Organization, 2007, TECHNICAL REPORT; Zacarias OP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-79; Zambrano-Bigiarini M, 2013, HYDROPSO PARTICLE SW; Zambrano-Bigiarini M, 2013, ENVIRON MODELL SOFTW, V43, P5, DOI 10.1016/j.envsoft.2013.01.004; Zorom M, 2012, J APPL MATH, DOI 10.1155/2012/854723	52	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144990	10.1371/journal.pone.0144990	http://dx.doi.org/10.1371/journal.pone.0144990			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689547	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092300029
J	Wan, M; Huang, W; Zhang, JM; Zhao, XD; Tan, RS; Wan, XF; Zhong, L				Wan, Min; Huang, Wei; Zhang, Jun-Mei; Zhao, Xiaodan; Tan, Ru San; Wan, Xiaofeng; Zhong, Liang			Variational Reconstruction of Left Cardiac Structure from CMR Images	PLOS ONE			English	Article							REGIONAL WALL CURVEDNESS; SURFACE RECONSTRUCTION; SHAPE RECONSTRUCTION; VENTRICULAR-FUNCTION; HEART; MODEL; SEGMENTATION; RESTORATION; SIMULATION; STRESS	Cardiovascular Disease (CVD), accounting for 17% of overall deaths in the USA, is the leading cause of death over the world. Advances in medical imaging techniques make the quantitative assessment of both the anatomy and function of heart possible. The cardiac modeling is an invariable prerequisite for quantitative analysis. In this study, a novel method is proposed to reconstruct the left cardiac structure from multi-planed cardiac magnetic resonance (CMR) images and contours. Routine CMR examination was performed to acquire both long axis and short axis images. Trained technologists delineated the endocardial contours. Multiple sets of two dimensional contours were projected into the three dimensional patient-based coordinate system and registered to each other. The union of the registered point sets was applied a variational surface reconstruction algorithm based on Delaunay triangulation and graph-cuts. The resulting triangulated surfaces were further post-processed. Quantitative evaluation on our method was performed via computing the overlapping ratio between the reconstructed model and the manually delineated long axis contours, which validates our method. We envisage that this method could be used by radiographers and cardiologists to diagnose and assess cardiac function in patients with diverse heart diseases.	[Wan, Min; Huang, Wei; Wan, Xiaofeng] Nanchang Univ, Nanchang 330031, Jiangxi, Peoples R China; [Zhang, Jun-Mei; Zhao, Xiaodan; Tan, Ru San; Zhong, Liang] Natl Heart Ctr Singapore, Singapore 169609, Singapore; [Zhang, Jun-Mei; Tan, Ru San; Zhong, Liang] Duke NUS Grad Med Sch Singapore, Singapore 169857, Singapore	Nanchang University; National Heart Centre Singapore; National University of Singapore	Wan, M (corresponding author), Nanchang Univ, Nanchang 330031, Jiangxi, Peoples R China.	wanmin1983@gmail.com; zhong.liang@nhcs.com.sg		Tan, Ru San/0000-0003-2086-6517; Zhang, Jun-Mei/0000-0002-2257-1803; zhao, xiaodan/0000-0003-1469-8027; ZHONG, LIANG/0000-0003-3608-4173	National Natural Science Foundation of China [NSFC 61562060]; National Research Foundation [NRF2011NRF-POC001-068]; National Medical Research Council [NMRC/EDG/1037/2011]; Biomedical Research Council Research Grant [14/1/32/24/002]; Goh Cardiovascular Research Grant [Duke-NUS-GCR/2013/0009]; SERC Biomedical Engineering Programme [1211480003, 1321480012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council Research Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Goh Cardiovascular Research Grant; SERC Biomedical Engineering Programme	This work was supported by National Natural Science Foundation of China (NSFC 61562060), http://www.nsfc.gov.cn, M.W., study design; National Research Foundation (NRF2011NRF-POC001-068), http://www.nrf.gov.sg, R.S.T., study design; the National Medical Research Council (NMRC/EDG/1037/2011), http://www.nmrc.gov.sg, L.Z., data collection; Biomedical Research Council Research Grant (14/1/32/24/002), http://www.a-star.edu.sg/About-A-STAR/Biomedical-Research-Council.aspx, L.Z., data collection; the Goh Cardiovascular Research Grant (Duke-NUS-GCR/2013/0009), https://www.nhcs.com.sg/aboutnhc/awards/Pages/Home.aspx, L.Z., data analysis; and SERC Biomedical Engineering Programme Grants 1211480003 and 1321480012, http://www.a-star.edu.sg/Research/Funding-Opportunities/Grants-Sponsorship/SERC-Biomedical-Engineering-Programme-BEP.aspx, R.S.T, preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (NSFC 61562060), National Research Foundation (NRF2011NRF-POC001-068), the National Medical Research Council (NMRC/EDG/1037/2011), Biomedical Research Council Research Grant (14/1/32/24/002), the Goh Cardiovascular Research Grant (Duke-NUS-GCR/2013/0009) and SERC Biomedical Engineering Programme Grants 1211480003 and 1321480012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj CL, 1996, GRAPH MODEL IM PROC, V58, P524, DOI 10.1006/gmip.1996.0044; Bardinet E, 1996, Med Image Anal, V1, P129, DOI 10.1016/S1361-8415(96)80009-0; Barr A. H., 1981, IEEE Computer Graphics and Applications, V1, P11, DOI 10.1109/MCG.1981.1673799; Bereg S, 2004, P 9 ACM S SOL MOD AP, P303; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; BOISSONNAT JD, 1988, COMPUT VISION GRAPH, V44, P1, DOI 10.1016/S0734-189X(88)80028-8; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; CAUVIN JC, 1993, COMPUT MED IMAG GRAP, V17, P345, DOI 10.1016/0895-6111(93)90027-K; CHEN CW, 1995, COMPUT MED IMAG GRAP, V19, P85, DOI 10.1016/0895-6111(94)00041-7; Ecabert O, 2006, PROC SPIE, V6144, DOI 10.1117/12.652105; Ector J, 2005, CIRCULATION, V112, P3769, DOI 10.1161/CIRCULATIONAHA.105.565002; Frangi AF, 2002, IEEE T MED IMAGING, V21, P1151, DOI 10.1109/TMI.2002.804426; Frangi AF, 2001, IEEE T MED IMAGING, V20, P2, DOI 10.1109/42.906421; Khalafvand SS, 2014, INT J NUMER METH BIO, V30, P1044, DOI 10.1002/cnm.2643; Khalafvand SS, 2012, COMPUT BIOL MED, V42, P863, DOI 10.1016/j.compbiomed.2012.06.010; Khalafvand SS, 2011, COMPUT METHOD BIOMEC, V14, P113, DOI 10.1080/10255842.2010.493515; Khalafvand SS, 2015, SUBMITTED TO COMP MA; Lim CW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093747, DOI 10.1371/J0URNAL.P0NE.0093747]; Lorenz C, 2006, MED IMAGE ANAL, V10, P657, DOI 10.1016/j.media.2006.03.004; Lotjonen J, 2004, MED IMAGE ANAL, V8, P371, DOI 10.1016/j.media.2004.06.013; METAXAS D, 1993, IEEE T PATTERN ANAL, V15, P580, DOI 10.1109/34.216727; Oliva JM, 1996, COMPUT GRAPH FORUM, V15, pC397, DOI 10.1111/1467-8659.1530397; Su B, 2015, NUMERICAL MODELING O; Su BY, 2014, COMPUT METH PROG BIO, V113, P474, DOI 10.1016/j.cmpb.2013.11.009; Swingen C, 2003, INT J CARDIOVAS IMAG, V19, P325, DOI 10.1023/A:1025450211508; Tan ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068615; Teo SK, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0006; Vadakkumpadan F, 2010, WIRES SYST BIOL MED, V2, P489, DOI 10.1002/wsbm.76; van Assen HC, 2006, MED IMAGE ANAL, V10, P286, DOI 10.1016/j.media.2005.12.001; Nguyen VT, 2015, COMPUT METHOD BIOMEC, V18, P401, DOI 10.1080/10255842.2013.803534; Vollmer J, 1999, COMPUT GRAPH FORUM, V18, pC131, DOI 10.1111/1467-8659.00334; Wan M, 2011, INT J NUMER METH ENG, V85, P206, DOI 10.1002/nme.2965; Wang DS, 2006, COMPUT METHOD APPL M, V195, P5621, DOI 10.1016/j.cma.2005.10.028; Wang DS, 2006, INT J NUMER METH ENG, V65, P734, DOI 10.1002/nme.1465; Zhao HK, 2001, IEEE WORKSHOP ON VARIATIONAL AND LEVEL SET METHODS IN COMPUTER VISION, PROCEEDINGS, P194, DOI 10.1109/VLSM.2001.938900; Zheng YF, 2008, IEEE T MED IMAGING, V27, P1668, DOI 10.1109/TMI.2008.2004421; Zhong L, 2011, AM J PHYSIOL-HEART C, V300, pH1653, DOI 10.1152/ajpheart.00021.2011; Zhong L, 2012, AM J PHYSIOL-HEART C, V302, pH1306, DOI 10.1152/ajpheart.00679.2011; Zhong L, 2011, MED ENG PHYS, V33, P1120, DOI 10.1016/j.medengphy.2011.05.003; Zhong L, 2009, AM J PHYSIOL-HEART C, V296, pH573, DOI 10.1152/ajpheart.00525.2008	40	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145570	10.1371/journal.pone.0145570	http://dx.doi.org/10.1371/journal.pone.0145570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689551	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092300089
J	Akther, H; Agersted, MD; Olesen, J				Akther, Hasna; Agersted, Mette Dalgaard; Olesen, Jorgen			Naupliar and Metanaupliar Development of Thysanoessa raschii (Malacostraca, Euphausiacea) from Godthabsfjord, Greenland, with a Reinstatement of the Ancestral Status of the Free-Living Nauplius in Malacostracan Evolution	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; LARVAL DEVELOPMENT; JAPANESE CONCHOSTRACANS; POSTEMBRYONIC DEVELOPMENT; CRUSTACEA; BRANCHIOPODA; PHYLOGENY; LAEVICAUDATA; SPINICAUDATA; CIRRIPEDIA	The presence of a characteristic crustacean larval type, the nauplius, in many crustacean taxa has often been considered one of the few uniting characters of the Crustacea. WithinMalacostraca, the largest crustacean group, nauplii are only present in two taxa, Euphauciacea (krill) and Decapoda Dendrobranchiata. The presence of nauplii in these two taxa has traditionally been considered a retained primitive characteristic, but free-living nauplii have also been suggested to have reappeared a couple of times from direct developing ancestors duringmalacostracan evolution. Based on a re-study of Thysanoessa raschii (Euphausiacea) using preserved material collected in Greenland, we readdress this important controversy in crustacean evolution, and, in the process, redescribe the naupliar and metanaupliar development of T. raschii. In contrast tomost previous studies of euphausiid development, we recognize three (not two) naupliar (= ortho-naupliar) stages (N1-N3) followed by a metanauplius (MN). While there are many morphological changes between nauplius 1 and 2 (e.g., appearance of long caudal setae), the changes between nauplius 2 and 3 are few but distinct. They involve the size of some caudal spines (largest in N3) and the setation of the antennal endopod (an extra seta in N3). A wider comparison between free-living nauplii of both Malacostraca and nonMalacostraca revealed similarities between nauplii in many taxa both at the general level (e.g., the gradual development and number of appendages) and at the more detailed level (e.g., unclear segmentation of naupliar appendages, caudal setation, presence of frontal filaments). We recognize these similarities as homologies and therefore suggest that free-living nauplii were part of the ancestral malacostracan type of development. The derived morphology (e.g., lack of feeding structures, no fully formed gut, high content of yolk) of both euphausiid and dendrobranchiate nauplii is evidently related to their non-feeding (lecithotrophic) status.	[Akther, Hasna; Olesen, Jorgen] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark; [Akther, Hasna; Agersted, Mette Dalgaard] Tech Univ Denmark, Sect Oceanog & Climate, Natl Inst Aquat Resources, Charlottenlund, Denmark	University of Copenhagen; Technical University of Denmark	Olesen, J (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark.	jolesen@snm.ku.dk	Agersted, Mette Dalgaard/AFW-0709-2022; Illife, Thomas/R-2252-2017; Olesen, Jørgen/A-3353-2013	Illife, Thomas/0000-0002-4342-5960; Olesen, Jørgen/0000-0001-9582-7083; Olesen, Jes/0000-0002-6712-2702	Danish Centre for Marine Research, DCH; European Union [ENV.2010.2.2.1-1, 264933]; Greenland Climate Research Centre [6505]; Carlsberg grant	Danish Centre for Marine Research, DCH; European Union(European Commission); Greenland Climate Research Centre; Carlsberg grant	Field work of the project BOFYGO was funded by a grant from the Danish Centre for Marine Research, DCH to Torkel Gissel Nielsen; the research received funding from the European Union Seventh Framework Programme project EURO-BASIN (ENV.2010.2.2.1-1) under grant agreement no 264933; support was provided by the Greenland Climate Research Centre (project 6505); microscopic equipment was supported by a Carlsberg grant to JO.; Torkel Gissel Nielsen (DTU Aqua) is thanked for donating the samples used in the work to the Natural History Museum of Denmark. Russell Hopcroft (University of Alaska Fairbanks) is thanked for permission to use his photo of an adult Thysanoessa raschii in Fig 1. The field work of the project BOFYGO was funded by a grant from the Danish Centre for Marine Research, DCH to Torkel Gissel Nielsen. The research leading to these results has received funding from the European Union Seventh Framework Programme project EURO-BASIN (ENV.2010.2.2.1-1) under grant agreement no 264933 and the Greenland Climate Research Centre (project 6505). Light microscopy equipment used in the project was supported by a Carlsberg grant to JO.	Agersted MD, 2014, J PLANKTON RES, V36, P800, DOI 10.1093/plankt/fbt139; ANDERSON D. T., 1967, AUST J ZOOL, V15, P47, DOI 10.1071/ZO9670047; Anderson D. T., 1973, EMBRYOLOGY PHYLOGENY; Chan BKK, 2014, ATLAS OF CRUSTACEAN LARVAE, P116; Choi JH, 2001, FISH B-NOAA, V99, P275; COLLIS SA, 1994, ACTA ZOOL-STOCKHOLM, V75, P297, DOI 10.1111/j.1463-6395.1994.tb00966.x; DAHMS HU, 1989, POLAR BIOL, V10, P221; Dahms HU, 2000, HYDROBIOLOGIA, V417, P91, DOI 10.1023/A:1003886818724; Dunger W., 1993, LEHRBUCH SPEZIELLEN, P1031; Einarsson Hermann, 1945, DANA REPT, V27, P1; Ferrari FD, 2013, CRUSTACEANA, V86, P632, DOI 10.1163/15685403-00003190; Ferrari FD, 2011, CRUSTACEANA, V84, P869, DOI 10.1163/001121611X579745; Fraser F. C., 1936, Discovery Reports Cambridge, V14, P1; Fritsch M, 2013, ZOOMORPHOLOGY, V132, P163, DOI 10.1007/s00435-012-0173-0; Glenner H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-21; Gomez-Gutierrez J, 2002, J PLANKTON RES, V24, P1265, DOI 10.1093/plankt/24.12.1265; GURNEY R, 1942, LARVAE DECAPOD CRUST; Haug C, 2012, PALAEONTOL ELECTRON, V15, P1; Haug C, 2014, CONTRIB ZOOL, V83, P185, DOI 10.1163/18759866-08303003; Haug JT, 2011, J CRUSTACEAN BIOL, V31, P668, DOI 10.1651/11-3481.1; Haug JT, 2010, EARTH ENV SCI T R SO, V100, P311, DOI 10.1017/S1755691010008145; Heath H, 1924, J MORPHOL, V38, P453, DOI 10.1002/jmor.1050380402; HIROTA Y, 1984, MAR BIOL, V81, P311, DOI 10.1007/BF00393226; Jenner RA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-21; Jia ZN, 2014, POLAR BIOL, V37, P165, DOI 10.1007/s00300-013-1420-7; Jirikowski GJ, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-76; Kiernan DA, 2006, EVOL DEV, V8, P537, DOI 10.1111/j.1525-142X.2006.00126.x; KNIGHT MD, 1975, FISH B-NOAA, V73, P145; Koenemann S, 2009, DEV GENES EVOL, V219, P131, DOI 10.1007/s00427-009-0273-0; Lebour M. V., 1924, Journal of the Marine Biol Society Plymouth, V13, P402; LEBOUR MARIE V., 1926, JOUR MARINE BIOL ASSOC, V14, P1; Maas Andreas, 2003, Fossils and Strata, V49, P1; MACDONALD R9DERICK, 1928, JOUR MARINE BIOL ASSOC, V15, P57; MACDONALD RODERICK, 1927, JOUR MARINE BIOL ASSOC, V14, P785; MARSCHALL HP, 1984, POLAR BIOL, V2, P245, DOI 10.1007/BF00263631; Martin JW, 2014, ATLAS OF CRUSTACEAN LARVAE, P220; Martin JW, 2014, ATLAS OF CRUSTACEAN LARVAE, P8; Martin JW, 2014, ATLAS OF CRUSTACEAN LARVAE, P1; Maruzzo D, 2009, ARTHROPOD STRUCT DEV, V38, P163, DOI 10.1016/j.asd.2008.09.001; Mauchline J., 1971, Fiches Ident Zooplancton, VNo. 135/137,1971, P1; Mauchline J, 1969, Adv. mar. Biol., V7, P1; Mauchline J., 1980, ADV MAR BIOL, P3; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Moller OS, 2008, ARTHROPOD STRUCT DEV, V37, P333, DOI 10.1016/j.asd.2007.12.002; Moller OS, 2004, ZOOMORPHOLOGY, V123, P107, DOI 10.1007/s00435-003-0093-0; MULLER KJ, 1988, FOSSILS STRATA, V23, P1; Nijhout H.F., 1994, INSECT HORMONES; Olesen, 2001, BIOL SKRIFTER, V53, P1; Olesen J, 2005, J MORPHOL, V264, P131, DOI 10.1002/jmor.10202; Olesen J, 2004, ARTHROPOD STRUCT DEV, V33, P453, DOI 10.1016/j.asd.2004.07.001; Olesen J, 2003, J MORPHOL, V256, P235, DOI 10.1002/jmor.10043; Olesen J, 2003, ACTA ZOOL-STOCKHOLM, V84, P41, DOI 10.1046/j.1463-6395.2003.00129.x; Olesen J, 2000, ZOOMORPHOLOGY, V120, P47, DOI 10.1007/s004350000024; Olesen J, 2015, PLOS ONE, P1; Olesen J., 2013, FUNCTIONAL MORPHOLOG, P103; Olesen J, 2014, ATLAS OF CRUSTACEAN LARVAE, P138; Olesen J, 2014, ATLAS OF CRUSTACEAN LARVAE, P90; Olesen J, 2014, ATLAS OF CRUSTACEAN LARVAE, P84; Olesen J, 2013, J MORPHOL, V274, P229, DOI 10.1002/jmor.20101; Olesen J, 2011, ARTHROPOD STRUCT DEV, V40, P449, DOI 10.1016/j.asd.2011.04.002; RCore Team, 2020, R LANG ENV STAT COMP; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Richter S, 2001, J ZOOL SYST EVOL RES, V39, P113; Riisgaard K, 2014, MAR ECOL PROG SER, V500, P67, DOI 10.3354/meps10706; Sars GO, 1898, ARCH MATH NATURVID, V20, P1; Scholtz G, 2000, J ZOOL SYST EVOL RES, V38, P175, DOI 10.1046/j.1439-0469.2000.383151.x; Scholtz Gerhard, 2013, P63; Scourfield D. J., 1940, Proceedings of the Linnean Society of London, V152, P290; Semmler H, 2009, ARTHROPOD STRUCT DEV, V38, P135, DOI 10.1016/j.asd.2008.09.003; Shen X, 2015, ACTA OCEANOL SIN, V34, P84, DOI 10.1007/s13131-015-0583-1; Siegel Volker, 2000, Fish and Aquatic Resources Series, V6, P103; Stegner MEJ, 2015, ZOOMORPHOLOGY; STRATHMANN RR, 1994, AM ZOOL, V34, P502; SUH HL, 1993, MAR BIOL, V115, P625, DOI 10.1007/BF00349370; Swalethorp R, 2014, J PLANKTON RES; Tarling GT, 2010, ADV MAR BIOL, P57; Teglhus F, DISTRIBUTION S UNPUB; Vicente CS, 2014, ATLAS OF CRUSTACEAN LARVAE, P199; WALOSSEK D, 1990, LETHAIA, V23, P409, DOI 10.1111/j.1502-3931.1990.tb01373.x; Walossek D., 1998, Systematics Association Special Volume Series, V55, P139; WALOSSEK D, 1993, LETHAIA, V26, P7, DOI 10.1111/j.1502-3931.1993.tb01504.x; Zhang XG, 2007, NATURE, V449, P595, DOI 10.1038/nature06138; Zhang XG, 2010, CURR BIOL, V20, P1075, DOI 10.1016/j.cub.2010.04.026	83	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0141955	10.1371/journal.pone.0141955	http://dx.doi.org/10.1371/journal.pone.0141955			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682744	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800003
J	He, DL; Wang, Q; Wang, K; Yang, PF				He, Dongli; Wang, Qiong; Wang, Kun; Yang, Pingfang			Genome-Wide Dissection of the MicroRNA Expression Profile in Rice Embryo during Early Stages of Seed Germination	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; COMPUTATIONAL IDENTIFICATION; TRANSCRIPTION FACTORS; PROTEOMIC ANALYSIS; STRESS CONDITIONS; ALEURONE CELLS; MESSENGER-RNA; PROTEIN; GENES; REVEALS	The first 24 hours after imbibition (HAI) is pivotal for rice seed germination, during which embryo cells switch from a quiescent state to a metabolically active state rapidly. MicroRNAs (miRNAs) have increasingly been shown to play important roles in rice development. Nevertheless, limited knowledge about miRNA regulation has been obtained in the early stages of rice seed germination. In this study, the small RNAs (sRNAs) from embryos of 0, 12, and 24 HAI rice seeds were sequenced to investigate the composition and expression patterns of miRNAs. The bioinformatics analysis identified 289 miRNA loci, including 59 known and 230 novel miRNAs, and 35 selected miRNAs were confirmed by stem-loop real-time RT-PCR. Expression analysis revealed that the dry and imbibed seeds have unique miRNA expression patterns compared with other tissues, particularly for the dry seeds. Using three methods, Mireap, psRNATarget and degradome analyses, 1197 potential target genes of identified miRNAs involved in various molecular functions were predicted. Among these target genes, 39 had significantly negative correlations with their corresponding miRNAs as inferred from published transcriptome data, and 6 inversely expressed miRNA-target pairs were confirmed by 5'-RACE assay. Our work provides an inventory of miRNA expression profiles and miRNA-target interactions in rice embryos, and lays a foundation for further studies of miRNA-mediated regulation in initial seed germination.	[He, Dongli; Wang, Qiong; Yang, Pingfang] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan 430074, Peoples R China; [Wang, Qiong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wang, Kun] Wuhan Univ, Coll Iife Sci, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan University	Yang, PF (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan 430074, Peoples R China.	yangpf@wbgcas.cn		He, Dongli/0000-0002-5510-7556	National Science Foundation of China [31101213, 31271805]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the the National Science Foundation of China (31101213 and 31271805), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Azevedo C, 2006, EMBO J, V25, P2007, DOI 10.1038/sj.emboj.7601084; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Braun JE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012328; Curaba J, 2014, J EXP BOT, V65, P1425, DOI 10.1093/jxb/eru002; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Eckardt NA, 2013, PLANT CELL, V25, P2382, DOI 10.1105/tpc.113.250713; Gallagher M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01281; Galland M, 2014, MOL CELL PROTEOMICS, V13, P252, DOI 10.1074/mcp.M113.032227; Groszmann M, 2011, P NATL ACAD SCI USA, V108, P2617, DOI 10.1073/pnas.1019217108; Han C, 2014, PLANT CELL PHYSIOL, V55, P1826, DOI 10.1093/pcp/pcu114; Han C, 2014, J PROTEOME RES, V13, P1766, DOI 10.1021/pr401295c; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; He DL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00246; He DL, 2011, J INTEGR PLANT BIOL, V53, P835, DOI 10.1111/j.1744-7909.2011.01074.x; He DL, 2011, PROTEOMICS, V11, P2693, DOI 10.1002/pmic.201000598; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Holdsworth MJ, 2008, TRENDS PLANT SCI, V13, P7, DOI 10.1016/j.tplants.2007.11.002; Howell KA, 2006, PLANT MOL BIOL, V60, P201, DOI 10.1007/s11103-005-3688-7; Howell KA, 2007, J BIOL CHEM, V282, P15619, DOI 10.1074/jbc.M609866200; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Iwakawa H, 2013, MOL CELL, V52, P591, DOI 10.1016/j.molcel.2013.10.033; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jossier M, 2009, PLANT J, V59, P316, DOI 10.1111/j.1365-313X.2009.03871.x; Kanegae H, 2005, PLANT PHYSIOL BIOCH, V43, P669, DOI 10.1016/j.plaphy.2005.06.004; Kim JY, 2010, PLANT CELL PHYSIOL, V51, P1079, DOI 10.1093/pcp/pcq072; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/BF02191820; Koyama T, 2010, PLANT CELL, V22, P3574, DOI 10.1105/tpc.110.075598; Lewis SM, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni189; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Ma XX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-510; Meyers BC, 2007, CONSTRUCTION SMALL R, V43, P110; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Nonogaki H, 2010, PLANT CELL PHYSIOL, V51, P1840, DOI 10.1093/pcp/pcq154; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang HJ, 2013, SHOCK, V39, P480, DOI 10.1097/SHK.0b013e3182940cb8; WANG L, 2011, INT SYST APPL ISA 20, V2011, P1, DOI DOI 10.1145/2072298.2071964; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Watanabe KA, 2014, GENOMICS, V103, P122, DOI 10.1016/j.ygeno.2013.10.007; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xu XH, 2009, THEOR APPL GENET, V119, P75, DOI 10.1007/s00122-009-1018-1; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yang GD, 2012, J GENET, V91, P313, DOI 10.1007/s12041-012-0199-6; Yang PF, 2007, PROTEOMICS, V7, P3358, DOI 10.1002/pmic.200700207; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7	60	22	23	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145424	10.1371/journal.pone.0145424	http://dx.doi.org/10.1371/journal.pone.0145424			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26681181	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400074
J	Sarr, FD; Niang, M; Thiam, D; Dia, N; Badiane, A; Ndao, AB; Sokhna, C; Spiegel, A; Richard, V				Sarr, Fatoumata Diene; Niang, Mbayame; Thiam, Diamilatou; Dia, Ndongo; Badiane, Abdoulaye; Ndao, A. B.; Sokhna, Cheikh; Spiegel, Andre; Richard, Vincent			Acute Febrile Illness and Influenza Disease Burden in a Rural Cohort Dedicated to Malaria in Senegal, 2012-2013	PLOS ONE			English	Article							SENTINEL SURVEILLANCE; SEASONAL INFLUENZA; VIRAL ETIOLOGY; GLOBAL BURDEN; EPIDEMIOLOGY; CHILDREN; AFRICA; PNEUMONIA; MORTALITY; KENYA	Background African populations are considered to be particularly vulnerable to fever illnesses, including malaria, and acute respiratory disease, owing to limited resources and overcrowding. However, the overall burden of influenza in this context is poorly defined and incidence data for African countries are scarce. We therefore studied the fever syndrome incidence and more specifically influenza incidence in a cohort of inhabitants of Dielmo and Ndiop in Sokone district, Senegal. Methods Daily febrile-illness data were prospectively obtained from January 2012 to December 2013 from the cohort of the villages of Dielmo and Ndiop, initially dedicated to the study of malaria. Nasopharyngeal swabs were collected from, and malaria diagnosis tests (thick blood smears) carried out on, every febrile individual during clinical visits; reverse transcriptase- polymerase chain reaction was used to identify influenza viruses in the samples. Binomial negative regression analysis was used to study the relationship between the monthly incidence rate and various covariates. Results In Dielmo and Ndiop, the incidence ofmalaria has decreased, but fever syndromes remain frequent. Among the 1036 inhabitants included in the cohort, a total of 1,129 episodes of fever were reported. Influenza was present all year round with peaks in October-December 2012 and August 2013. The fever, ILI and influenza incidence density rates differed significantly between age groups. At both sites, the adjusted incidence relative risks for fever syndromes and ILI were significantly higher in the [6-24 months) than other age groups: 7.3 (95% CI: [5.7-9.3]) and 16.1 (95% CI: [11.1-23.3]) respectively. The adjusted incidence relative risk for influenza was significantly higher for the [0-6 months) than other age groups: 9.9 (95% CI: [2.9-33.6]). At both sites, incidence density rates were lowest among adults > = 50 years. Conclusions In this rural setting in Senegal, influenza was most frequent among the youngest children. Preventive strategies targeting this population should be implemented.	[Sarr, Fatoumata Diene; Thiam, Diamilatou; Badiane, Abdoulaye; Spiegel, Andre; Richard, Vincent] Inst Pasteur, Epidemiol Unit, Dakar, Senegal; [Niang, Mbayame; Dia, Ndongo] Inst Pasteur, Virol Unit, Dakar, Senegal; [Ndao, A. B.] Minist Hlth, Hlth Dist Sokone, Sokone, Senegal; [Sokhna, Cheikh] Inst Rech Dev, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Institut de Recherche pour le Developpement (IRD)	Richard, V (corresponding author), Inst Pasteur, Epidemiol Unit, Dakar, Senegal.	vrichard@pasteur.sn		Vincent, RICHARD/0000-0002-6961-1753	Department of Health and Human Service via the International Network of Pasteur Institutes [IDSEP 110011-01-00]; Pasteur Institute of Dakar; Institut pour la recherche et le developpement (IRD)	Department of Health and Human Service via the International Network of Pasteur Institutes; Pasteur Institute of Dakar; Institut pour la recherche et le developpement (IRD)	This work was supported by the Department of Health and Human Service (Grant Number: IDSEP 110011-01-00) via the International Network of Pasteur Institutes, the Pasteur Institute of Dakar and the Institut pour la recherche et le developpement (IRD) via the support of the Dielmo and Ndiop research programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], MALARIA J; Dia N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093227; Dosseh A, 2000, AM J TROP MED HYG, V62, P639, DOI 10.4269/ajtmh.2000.62.639; Freitas FTM, 2013, EPIDEMIOL INFECT, V141, P1731, DOI 10.1017/S0950268812002221; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Guinovart C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-36; Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530; Katz MA, 2012, J INFECT DIS, V206, pS1, DOI 10.1093/infdis/jis548; Lekana-Douki SE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-373; Li CK, 2006, PUBLIC HEALTH, V120, P517, DOI 10.1016/j.puhe.2006.03.004; Monto AS, 2004, INT CONGR SER, V1263, P3, DOI 10.1016/j.ics.2004.02.049; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Niang MN, 2012, J INFECT DIS, V206, pS129, DOI 10.1093/infdis/jis576; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; Nyatanyi T, 2012, J INFECT DIS, V206, pS74, DOI 10.1093/infdis/jis574; Onyango CO, 2012, J INFECT DIS, V206, pS61, DOI 10.1093/infdis/jis536; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Rajatonirina S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072839; Rajatonirina S, 2012, B WORLD HEALTH ORGAN, V90, P385, DOI 10.2471/BLT.11.097816; Randrianasolo L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-31; Schoub Barry D, 2010, Expert Rev Respir Med, V4, P167, DOI 10.1586/ers.10.10; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Steffen C, 2011, VACCINE, V29, P363, DOI 10.1016/j.vaccine.2010.11.029; Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI 10.1016/S1473-3099(14)70712-1; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Yazdanbakhsh M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000182; [No title captured]	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0143999	10.1371/journal.pone.0143999	http://dx.doi.org/10.1371/journal.pone.0143999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679177	gold, Green Published, Green Submitted			2022-12-27	WOS:000366723400006
J	Au, HK; Chang, JH; Wu, YC; Kuo, YC; Chen, YH; Lee, WC; Chang, TS; Lan, PC; Kuo, HC; Lee, KL; Lee, MT; Tzeng, CR; Huang, YH				Au, Heng-Kien; Chang, Jui-Hung; Wu, Yu-Chih; Kuo, Yung-Che; Chen, Yu-Hsi; Lee, Wei-Chin; Chang, Te-Sheng; Lan, Pei-Chi; Kuo, Hung-Chih; Lee, Kha-Liang; Lee, Mei-Tsu; Tzeng, Chii-Ruey; Huang, Yen-Hua			TGF-beta I Regulates Cell Migration through Pluripotent Transcription Factor OCT4 in Endometriosis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; STEM-CELLS; MENSTRUAL DISSEMINATION; SIGNALING PATHWAY; PERITONEAL-FLUID; EXPRESSION; CANCER; WOMEN; EMT	Transforming growth factor (TGF-beta)/TGF-beta receptor signal is known to promote cell migration. Up-regulation of TGF-beta in serum/peritoneal fluid and increased levels of pluripotent transcription factor OCT4 in endometriotic tissues are frequently observed in patients with endometriosis. However, the mechanisms underlying how TGF-beta/TGF-beta receptor and OCT4 affect endometriotic cell migration still remain largely unknown. Therefore, endometriotic tissue with high cell migratory capacity were collected from patients with adenomyotic myometrium (n = 23) and chocolate cyst (n = 24); and endometrial tissue with low cell migratory capacity in normal endometrium or hyperplastic endometrium (n = 8) were collected as the controls. We found the mRNA levels of TGF-beta receptor I (TGF-beta RI) and OCT4 were significantly higher in the high-migratory ectopic endometriotic tissues than those of the low-migratory normal or hyperplastic endometrium. Positive correlations between TGF-beta RI and OCT4, and either TGF-beta RI or OCT4 with migration-related genes (SNAIL, SLUG and TWIST) regarding the mRNA levels were observed in human endometriotic tissues. TGF-beta I dose-dependently increased the gene and protein levels of OCT4, SNAIL and N-Cadherin (N-CAD) and silencing of endogenous OCT4 significantly suppressed the TGF-beta I-induced expressions of N-CAD and SNAIL in primary human endometriotic stromal cells and human endometrial carcinoma cell lines RL95-2 and HEC1A. Furthermore, TGF-beta I significantly increased the migration ability of endometriotic cells and silencing of OCT4 dramatically suppressed the TGF-beta I-induced cell migration activity evidenced by wound-closure assay, transwell assay, and confocal image of F-actin cellular distribution. In conclusion, the present findings demonstrate that the niche TGF-beta plays a critical role in initiating expressions of pluripotent transcription factor OCT4 which may contribute to the ectopic endometrial growth by stimulating endometrial cell migration. These findings would be useful for developing therapeutic strategies targeting TGF-beta-OCT4 signaling to prevent endometriosis in the future.	[Chang, Jui-Hung; Wu, Yu-Chih; Kuo, Yung-Che; Chen, Yu-Hsi; Lee, Wei-Chin; Chang, Te-Sheng; Lan, Pei-Chi; Lee, Kha-Liang; Lee, Mei-Tsu; Huang, Yen-Hua] Taipei Med Univ, Dept Biochem & Mol Cell Biol, Sch Med, Coll Med, Taipei, Taiwan; [Lee, Wei-Chin; Lee, Kha-Liang; Huang, Yen-Hua] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Wu, Yu-Chih; Lan, Pei-Chi; Huang, Yen-Hua] Taipei Med Univ, Ctr Cell Therapy & Regenerat Med, Taipei, Taiwan; [Au, Heng-Kien] Taipei Med Univ, Sch Med, Dept Obstet & Gynecol, Coll Med, Taipei, Taiwan; [Au, Heng-Kien; Tzeng, Chii-Ruey] Taipei Med Univ, Taipei Med Univ Hosp, Ctr Reprod Med, Taipei, Taiwan; [Au, Heng-Kien; Tzeng, Chii-Ruey] Taipei Med Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chang, Te-Sheng] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Chiayi, Taiwan; [Kuo, Hung-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Ctr Comprehens Canc, Taipei, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, PhD Program Translat Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Chang Gung Memorial Hospital; Academia Sinica - Taiwan; Taipei Medical University; Taipei Medical University	Huang, YH (corresponding author), Taipei Med Univ, Dept Biochem & Mol Cell Biol, Sch Med, Coll Med, Taipei, Taiwan.	rita1204@tmu.edu.tw	Kuo, Hung-Chih/H-7810-2014	Kuo, Hung-Chih/0000-0003-1336-1203; Kuo, Yung-Che/0000-0002-9425-7389; Wu, Yu-Chih/0000-0001-5781-2665; Huang, Yen-Hua/0000-0001-6020-9998	National Science Council, Taiwan [NSC (100-102)-2321-B-038-003, NSC101-2314-B-182A-028, NSC102-2628-B-038-008-MY3]; Ministry of Science and Technology, Taiwan [MOST 103-2321-B-038-011]; Health and Welfare Surcharge of Tobacco Products [MOHW104-TDU-B-212-124-001]; Taipei Medical University [TMUTOP103002-9]; Taipei Medical University Hospital [100TMU-TMUH-13, 102TMU-TMUH-13, 103TMU-TMUH-05]; Chang Gung Memorial Hospital [CMRPG680311, CMRPG690411, CMRPG6A0471, CMRPG6B0381, CMRPG6B0382]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Health and Welfare Surcharge of Tobacco Products; Taipei Medical University; Taipei Medical University Hospital; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from the National Science Council, Taiwan (NSC (100-102)-2321-B-038-003, NSC101-2314-B-182A-028, and NSC102-2628-B-038-008-MY3) (http://www.most.gov.tw/), Ministry of Science and Technology, Taiwan (MOST 103-2321-B-038-011) (http://www.most.gov.tw/), Health and Welfare Surcharge of Tobacco Products (MOHW104-TDU-B-212-124-001) (http://www.mohw.gov.tw/EN/Ministry/Index.aspx), Taipei Medical University (TMUTOP103002-9) (http://www.tmu.edu.tw/english/main.php), and Taipei Medical University Hospital (100TMU-TMUH-13, 102TMU-TMUH-13, 103TMU-TMUH-05) (http://www.tmuh.org.tw/tmuh_en/index.php), and Chang Gung Memorial Hospital (CMRPG680311, CMRPG690411, CMRPG6A0471, CMRPG6B0381 and CMRPG6B0382) (https://www.cgmh.org.tw/eng2002/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Chan RWS, 2011, AM J PATHOL, V178, P2832, DOI 10.1016/j.ajpath.2011.02.025; Chang JH, 2013, FERTIL STERIL, V99, P1332, DOI 10.1016/j.fertnstert.2012.11.033; Chang TS, 2015, CLIN CANCER RES, V21, P201, DOI 10.1158/1078-0432.CCR-13-3274; Chen YJ, 2010, J PATHOL, V222, P261, DOI 10.1002/path.2761; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Duangkumpha K, 2014, TUMOR BIOL, V35, P9667, DOI 10.1007/s13277-014-2246-9; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Forte A, 2009, MOL MED, V15, P392, DOI 10.2119/molmed.2009.00068; Fuxe J, 2012, SEMIN CANCER BIOL, V22, P455, DOI 10.1016/j.semcancer.2012.05.004; Gargett CE, 2007, HUM REPROD UPDATE, V13, P87, DOI 10.1093/humupd/dml045; Gargett CE, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.05.004; Gotte M, 2011, FERTIL STERIL, V95, P338, DOI 10.1016/j.fertnstert.2010.08.006; Gruenwald P, 1942, AM J OBSTET GYNECOL, V44, P470, DOI 10.1016/S0002-9378(42)90484-8; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Huang HP, 2011, J BIOL CHEM, V286, P33520, DOI 10.1074/jbc.M111.256164; Huang YH, 2014, MOL HUM REPROD, V20, P1, DOI 10.1093/molehr/gau016; Huang YH, 2009, FASEB J, V23, P2076, DOI 10.1096/fj.08-121939; Hull ML, 2012, AM J PATHOL, V180, P880, DOI 10.1016/j.ajpath.2011.11.013; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jung JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028068; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Karoubi G, 2010, J SURG ONCOL, V102, P689, DOI 10.1002/jso.21665; Kristensen DM, 2010, MOL HUM REPROD, V16, P835, DOI 10.1093/molehr/gaq008; Kupker W, 1998, HUM REPROD UPDATE, V4, P719, DOI 10.1093/humupd/4.5.719; Lebovic DI, 2001, FERTIL STERIL, V75, P1, DOI 10.1016/S0015-0282(00)01630-7; Ling TY, 2006, P NATL ACAD SCI USA, V103, P9530, DOI 10.1073/pnas.0510232103; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Figueira PGM, 2011, ANN NY ACAD SCI, V1221, P10, DOI 10.1111/j.1749-6632.2011.05969.x; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Moustakas A, 2012, SEMIN CANCER BIOL, V22, P446, DOI 10.1016/j.semcancer.2012.04.002; Nilsson Eric E, 2002, Reprod Biomed Online, V5, P254; Omwandho COA, 2010, HUM REPROD, V25, P101, DOI 10.1093/humrep/dep382; OOSTERLYNCK DJ, 1994, OBSTET GYNECOL, V83, P287; Pacchiarotti A, 2011, FERTIL STERIL, V95, P1171, DOI 10.1016/j.fertnstert.2010.10.029; Padykula HA, 1991, ANN N Y ACAD SCI, V622, P47, DOI 10.1111/j.1749-6632.1991.tb37849.x; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Pizzo A, 2002, GYNECOL OBSTET INVES, V54, P82, DOI 10.1159/000067717; Russell WW, 1899, J HOPKINS HOSP B, V10, P8; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; Sampson JA, 1927, AM J PATHOL, V3, P93; Sampson JA, 1925, AM J OBSTET GYNECOL, V10, P649, DOI 10.1016/S0002-9378(25)90629-1; Sasson IE, 2008, ANN NY ACAD SCI, V1127, P106, DOI 10.1196/annals.1434.014; Silveira CGT, 2012, HUM REPROD, V27, P3187, DOI 10.1093/humrep/des282; Simoens S, 2012, HUM REPROD, V27, P1292, DOI 10.1093/humrep/des073; Sotomayor P, 2009, PROSTATE, V69, P401, DOI 10.1002/pros.20895; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Vassiliadis S, 2005, Clin Dev Immunol, V12, P125, DOI 10.1080/17402520500125484; Wu YJ, 2011, CANCER-AM CANCER SOC, V117, P3989, DOI 10.1002/cncr.25944; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang WCV, 2004, BEST PRACT RES CL OB, V18, P305, DOI 10.1016/j.bpobgyn.2004.03.003	55	25	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145256	10.1371/journal.pone.0145256	http://dx.doi.org/10.1371/journal.pone.0145256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675296	Green Submitted, gold, Green Published			2022-12-27	WOS:000366722700118
J	Evans, AT; Peters, E; Strasser, AA; Emery, LF; Sheerin, KM; Romer, D				Evans, Abigail T.; Peters, Ellen; Strasser, Andrew A.; Emery, Lydia F.; Sheerin, Kaitlin M.; Romer, Daniel			Graphic Warning Labels Elicit Affective and Thoughtful Responses from Smokers: Results of a Randomized Clinical Trial	PLOS ONE			English	Article							COVARIANCE STRUCTURE-ANALYSIS; HEALTH WARNINGS; UNITED-STATES; CIGARETTE; IMPACT; SMOKING; PERCEPTION; MEDIATION; KNOWLEDGE; BLINDNESS	Objective Observational research suggests that placing graphic images on cigarette warning labels can reduce smoking rates, but field studies lack experimental control. Our primary objective was to determine the psychological processes set in motion by naturalistic exposure to graphic vs. text-only warnings in a randomized clinical trial involving exposure to modified cigarette packs over a 4-week period. Theories of graphic-warning impact were tested by examining affect toward smoking, credibility of warning information, risk perceptions, quit intentions, warning label memory, and smoking risk knowledge. Methods Adults who smoked between 5 and 40 cigarettes daily (N = 293; mean age = 33.7), did not have a contra-indicated medical condition, and did not intend to quit were recruited from Philadelphia, PA and Columbus, OH. Smokers were randomly assigned to receive their own brand of cigarettes for four weeks in one of three warning conditions: text only, graphic images plus text, or graphic images with elaborated text. Results Data from 244 participants who completed the trial were analyzed in structural-equation models. The presence of graphic images (compared to text-only) caused more negative affect toward smoking, a process that indirectly influenced risk perceptions and quit intentions (e.g., image->negative affect->risk perception->quit intention). Negative affect from graphic images also enhanced warning credibility including through increased scrutiny of the warnings, a process that also indirectly affected risk perceptions and quit intentions (e.g., image->negative affect->risk scrutiny->warning credibility->risk perception->quit intention). Unexpectedly, elaborated text reduced warning credibility. Finally, graphic warnings increased warning-information recall and indirectly increased smoking-risk knowledge at the end of the trial and one month later. Conclusions In the first naturalistic clinical trial conducted, graphic warning labels are more effective than text-only warnings in encouraging smokers to consider quitting and in educating them about smoking's risks. Negative affective reactions to smoking, thinking about risks, and perceptions of credibility are mediators of their impact.	[Evans, Abigail T.; Peters, Ellen] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Strasser, Andrew A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Emery, Lydia F.] Northwestern Univ, Dept Psychol, Evanston, IL USA; [Sheerin, Kaitlin M.] Univ Missouri, Dept Psychol Sci, Columbia, MO USA; [Romer, Daniel] Univ Penn, Annenberg Publ Policy Ctr, Philadelphia, PA 19104 USA	University System of Ohio; Ohio State University; University of Pennsylvania; Pennsylvania Medicine; Northwestern University; University of Missouri System; University of Missouri Columbia; University of Pennsylvania	Evans, AT (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.	Evans.1339@osu.edu			National Cancer Institute [P50CA180908, R01CA157824]; FDA Center for Tobacco Products (CTP); NATIONAL CANCER INSTITUTE [R01CA157824, P50CA180908] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FDA Center for Tobacco Products (CTP)(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by grants number P50CA180908 and R01CA157824 from the National Cancer Institute and FDA Center for Tobacco Products (CTP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration.	Andrews JC, 2014, J MARKETING RES, V51, P165, DOI 10.1509/jmr.13.0092; BEM DJ, 1967, PSYCHOL REV, V74, P183, DOI 10.1037/h0024835; BENTHIN A, 1993, J ADOLESCENCE, V16, P153, DOI 10.1006/jado.1993.1014; BIENER L, 1991, HEALTH PSYCHOL, V10, P360, DOI 10.1037/0278-6133.10.5.360; Brewer NT, 2015, TOB CONTROL; Cameron LD, 2015, TOB CONTROL, V24, pE14, DOI 10.1136/tobaccocontrol-2012-050645; Canadian Cancer Society, 2014, CIG PACK HLTH WARN I; Cantrell J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052206; Centers for Disease Control and Prevention, 2014, SMOK TOB US FAST FAC; CHOU CP, 1991, BRIT J MATH STAT PSY, V44, P347, DOI 10.1111/j.2044-8317.1991.tb00966.x; Emery LF, 2014, NICOTINE TOB RES, V16, P263, DOI 10.1093/ntr/ntt124; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Food and Drug Administration HHS, 2011, Fed Regist, V76, P36628; Frederick S, 1999, WELL BEING FDN HEDON, P302; Hall MG, 2015, 36 ANN M SOC BEH MED; Hammond D, 2004, AM J PUBLIC HEALTH, V94, P1442, DOI 10.2105/AJPH.94.8.1442; Hammond D, 2007, AM J PREV MED, V32, P202, DOI 10.1016/j.amepre.2006.11.011; Hammond D, 2013, NICOTINE TOB RES, V15, P93, DOI 10.1093/ntr/nts094; HAUGTVEDT CP, 1992, J PERS SOC PSYCHOL, V63, P308, DOI 10.1037/0022-3514.63.2.308; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kees J, 2010, J PUBLIC POLICY MARK, V29, P265, DOI 10.1509/jppm.29.2.265; Kennedy RD, 2012, CLIN EXP OPTOM, V95, P590, DOI 10.1111/j.1444-0938.2012.00789.x; Kennedy RD, 2011, OPTOMETRY, V82, P310, DOI 10.1016/j.optm.2010.10.014; Kensinger EA, 2006, PSYCHON B REV, V13, P757, DOI 10.3758/BF03193993; Kensinger EA, 2009, EMOT REV, V1, P99, DOI 10.1177/1754073908100432; Laney C, 2004, MEM COGNITION, V32, P1149, DOI 10.3758/BF03196888; LEVIE WH, 1982, ECTJ-EDUC COMMUN TEC, V30, P195; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; Mather M, 2011, PERSPECT PSYCHOL SCI, V6, P114, DOI 10.1177/1745691611400234; McQueen A, 2015, NICOTINE TOB RES, V17, P784, DOI 10.1093/ntr/ntu339; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Noar SM, 2015, TOB CONTROL; Peters E, 2007, NICOTINE TOB RES, V9, P473, DOI 10.1080/14622200701239639; Peters E, 2006, CONSTRUCTION OF PREFERENCE, P454, DOI 10.1017/CBO9780511618031.025; Peters E, 2006, J COMMUN, V56, pS140, DOI 10.1111/j.1460-2466.2006.00287.x; PETTY RE, 1983, J CONSUM RES, V10, P135, DOI 10.1086/208954; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reimer RA, 2010, PSYCHOL HEALTH, V25, P943, DOI 10.1080/08870440902935913; Romer D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054937; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; SIVACEK J, 1982, J PERS SOC PSYCHOL, V43, P210, DOI 10.1037/0022-3514.43.2.210; Slovic P, 2000, J BEHAV DECIS MAKING, V13, P273, DOI 10.1002/(SICI)1099-0771(200004/06)13:2<273::AID-BDM338>3.0.CO;2-G; Slovic P., 2001, SMOKING RISK PERCEPT, DOI 10.4135/9781452232652; Slovic P., 2002, J SOCIO-ECON, V31, P329, DOI [10.1016/S1053-5357(02)00174-9, DOI 10.1016/S1053-5357(02)00174-9]; StataCorp, 2011, STAT STAT SOFTW REL; Strasser AA, 2009, EXP CLIN PSYCHOPHARM, V17, P405, DOI 10.1037/a0017649; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; Ullman S., 2001, USING MULTIVARIATE S, P653; Wang AL, 2015, TOB CONTROL, V24, P225, DOI 10.1136/tobaccocontrol-2014-051993; Weinstein ND, 2004, NICOTINE TOB RES, V6, P349, DOI 10.1080/14622200410001676459; Wilson TD, 2008, PERSPECT PSYCHOL SCI, V3, P370, DOI 10.1111/j.1745-6924.2008.00085.x; Yong HH, 2014, HEALTH PSYCHOL, V33, P1410, DOI 10.1037/hea0000056; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257	56	93	93	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0142879	10.1371/journal.pone.0142879	http://dx.doi.org/10.1371/journal.pone.0142879			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JH	26672982	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700006
J	Levy, E; Kornowski, R; Gavrieli, R; Fratty, I; Greenberg, G; Waldman, M; Birk, E; Shainberg, A; Akirov, A; Miskin, R; Hochhauser, E				Levy, Esther; Kornowski, Ran; Gavrieli, Reut; Fratty, Ilana; Greenberg, Gabriel; Waldman, Maayan; Birk, Einat; Shainberg, Asher; Akirov, Amit; Miskin, Ruth; Hochhauser, Edith			Long-Lived alpha MUPA Mice Show Attenuation of Cardiac Aging and Leptin-Dependent Cardioprotection	PLOS ONE			English	Article							TERM CALORIC RESTRICTION; CIRCADIAN-RHYTHMS; NITRIC-OXIDE; BODY-WEIGHT; HEART; ADIPONECTIN; DYSFUNCTION; PROTECTS; EXPRESSION; APOPTOSIS	alpha MUPA transgenic mice spontaneously consume less food compared with their wild type (WT) ancestors due to endogenously increased levels of the satiety hormone leptin. aMUPA mice share many benefits with mice under caloric restriction (CR) including an extended life span. To understand mechanisms linked to cardiac aging, we explored the response of aMUPA hearts to ischemic conditions at the age of 6, 18, or 24 months. Mice were subjected to myocardial infarction (MI) in vivo and to ischemia/reperfusion ex vivo. Compared to WT mice, aMUPA showed functional and histological advantages under all experimental conditions. At 24 months, none of the WT mice survived the first ischemic day while aMUPA mice demonstrated 50% survival after 7 ischemic days. Leptin, an adipokine decreasing under CR, was consistently similar to 60% higher in aMUPA sera at baseline. Leptin levels gradually increased in both genotypes 24h post MI but were doubled in aMUPA. Pretreatment with leptin neutralizing antibodies or with inhibitors of leptin signaling (AG-490 and Wortmannin) abrogated the aMUPA benefits. The antibodies also reduced phosphorylation of the leptin signaling components STAT3 and AKT specifically in the aMUPA myocardium. aMUPA mice did not show elevation in adiponectin, an adipokine previously implicated in CR-induced cardioprotection. WT mice treated for short-term CR exhibited cardioprotection similar to that of aMUPA, however, along with increased adiponectin at baseline. Collectively, the results demonstrate a life-long increased ischemic tolerance in aMUPA mice, indicating the attenuation of cardiac aging. aMUPA cardioprotection is mediated through endogenous leptin, suggesting a protective pathway distinct from that elicited under CR.	[Levy, Esther; Gavrieli, Reut; Fratty, Ilana; Waldman, Maayan; Akirov, Amit; Hochhauser, Edith] Tel Aviv Univ, Felsenstein Med Res Ctr, Cardiac Res Lab, Petah Tiqwa, Israel; [Kornowski, Ran; Greenberg, Gabriel] Rabin Med Ctr, Dept Cardiol, Petah Tiqwa, Israel; [Gavrieli, Reut; Fratty, Ilana; Shainberg, Asher] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Birk, Einat] Tel Aviv Univ, Dept Cardiol, Petah Tiqwa, Israel; [Birk, Einat] Tel Aviv Univ, Schneider Childrens Med Ctr, Petah Tiqwa, Israel; [Miskin, Ruth] Weizmann Inst Sci, IL-76100 Rehovot, Israel	Tel Aviv University; Rabin Medical Center; Bar Ilan University; Tel Aviv University; Tel Aviv University; Weizmann Institute of Science	Hochhauser, E (corresponding author), Tel Aviv Univ, Felsenstein Med Res Ctr, Cardiac Res Lab, Petah Tiqwa, Israel.	hochhaus@post.tau.ac.il	Akirov, Amit/GYV-5697-2022; Waldman, Maayan/G-5369-2015	Waldman, Maayan/0000-0002-6204-6974	Israel Science Foundation (ISF) [834/09]; Young Investigator Support Grant at Rabin Medical Center to Amit Akirov	Israel Science Foundation (ISF)(Israel Science Foundation); Young Investigator Support Grant at Rabin Medical Center to Amit Akirov	This study was supported by the Israel Science Foundation (ISF) grant No. 834/09, awarded to me and The Young Investigator Support Grant at Rabin Medical Center to Amit Akirov.	Ahmet I, 2011, J MOL CELL CARDIOL, V51, P263, DOI 10.1016/j.yjmcc.2011.04.015; Barouch LA, 2003, CIRCULATION, V108, P754, DOI 10.1161/01.CIR.0000083716.82622.FD; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Boengler K, 2008, CIRC RES, V102, P131, DOI 10.1161/CIRCRESAHA.107.164699; Boengler K, 2011, ANTIOXID REDOX SIGN, V14, P863, DOI 10.1089/ars.2010.3309; Boengler K, 2009, CARDIOVASC RES, V83, P247, DOI 10.1093/cvr/cvp033; Broderick TL, 2002, MOL CELL BIOCHEM, V233, P119, DOI 10.1023/A:1015506327849; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Chandrasekar B, 2001, AM J PHYSIOL-HEART C, V280, pH2094, DOI 10.1152/ajpheart.2001.280.5.H2094; Chapnik N, 2013, J ENDOCRINOL, V217, P283, DOI 10.1530/JOE-13-0033; Chatham JC, 2013, J MOL CELL CARDIOL, V55, P139, DOI 10.1016/j.yjmcc.2012.06.016; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Edwards AG, 2010, MECH AGEING DEV, V131, P739, DOI 10.1016/j.mad.2010.09.007; Fallach R, 2010, J MOL CELL CARDIOL, V48, P1236, DOI 10.1016/j.yjmcc.2010.02.020; Froy O, 2010, INT J OBES LOND, V35, P226; Froy O, 2007, PROG NEUROBIOL, V82, P142, DOI 10.1016/j.pneurobio.2007.03.002; Froy O, 2010, AGING-US, V2, P7, DOI 10.18632/aging.100116; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Gonzalez AA, 2004, AM J PHYSIOL-ENDOC M, V287, pE1032, DOI 10.1152/ajpendo.00172.2004; Gutman R, 2011, EXP GERONTOL, V46, P606, DOI 10.1016/j.exger.2011.02.015; Han XF, 2012, J NUTR BIOCHEM, V23, P1592, DOI 10.1016/j.jnutbio.2011.11.002; Harlan SM, 2013, MOL METAB, V2, P69, DOI 10.1016/j.molmet.2013.03.004; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Karmazyn M, 2008, CARDIOVASC RES, V79, P279, DOI 10.1093/cvr/cvn115; Konstantinides S, 2004, ARTERIOSCL THROM VAS, V24, P2196, DOI 10.1161/01.ATV.0000146531.79402.9a; Lee B, 2014, REV ENDOCR METAB DIS, V15, P149, DOI 10.1007/s11154-013-9283-3; Long PG, 2002, MECH AGEING DEV, V123, P1411, DOI 10.1016/S0047-6374(02)00068-4; Matsui H, 2007, LIFE SCI, V80, P672, DOI 10.1016/j.lfs.2006.10.027; McGaffin KR, 2008, CARDIOVASC RES, V77, P54, DOI 10.1093/cvr/cvm023; McGaffin KR, 2011, CARDIOVASC RES, V89, P60, DOI 10.1093/cvr/cvq288; McGaffin KR, 2009, CARDIOVASC RES, V83, P313, DOI 10.1093/cvr/cvp071; Miskin R, 2005, MECH AGEING DEV, V126, P255, DOI 10.1016/j.mad.2004.08.018; Miskin R, 1997, J GERONTOL A-BIOL, V52, pB118, DOI 10.1093/gerona/52A.2.B118; MISKIN R, 1990, EUR J BIOCHEM, V190, P31, DOI 10.1111/j.1432-1033.1990.tb15541.x; Rico L, 2005, ENDOCRINOLOGY, V146, P4167, DOI 10.1210/en.2005-0156; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Shinmura K, 2005, J MOL CELL CARDIOL, V39, P285, DOI 10.1016/j.yjmcc.2005.03.010; Shinmura K, 2007, CIRCULATION, V116, P2809, DOI 10.1161/CIRCULATIONAHA.107.725697; Shinmura K, 2008, AM J PHYSIOL-HEART C, V295, pH2348, DOI 10.1152/ajpheart.00602.2008; Smith CCT, 2006, BRIT J PHARMACOL, V149, P5, DOI 10.1038/sj.bjp.0706834; Smith CCT, 2011, PHARMACOL THERAPEUT, V129, P206, DOI 10.1016/j.pharmthera.2010.09.003; Smith CCT, 2010, AM J PHYSIOL-HEART C, V299, pH1265, DOI 10.1152/ajpheart.00092.2010; Smith RM, 2004, CARDIOVASC RES, V63, P611, DOI 10.1016/j.cardiores.2004.06.019; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Steckler R, 2015, J GERONOTOL IN PRESS; Tahergorabi Zoya, 2015, Adv Biomed Res, V4, P79, DOI 10.4103/2277-9175.156526; Tirosh O, 2005, MECH AGEING DEV, V126, P1262, DOI 10.1016/j.mad.2005.07.003; van den Borne SWM, 2009, CARDIOVASC RES, V84, P273, DOI 10.1093/cvr/cvp207; Waldman M, 2013, BIOCHEM PHARMACOL, V85, P1626, DOI 10.1016/j.bcp.2013.03.014; Weiss EP, 2011, AM J PHYSIOL-HEART C, V301, pH1205, DOI 10.1152/ajpheart.00685.2011; Wojtovich AP, 2012, EXP GERONTOL, V47, P1, DOI 10.1016/j.exger.2011.11.001; Yanai H, 2015, AGING-US, V7, P167, DOI 10.18632/aging.100726; Zhu M, 2004, EXP GERONTOL, V39, P1049, DOI 10.1016/j.exger.2004.03.024	56	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144593	10.1371/journal.pone.0144593	http://dx.doi.org/10.1371/journal.pone.0144593			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673217	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700046
J	Naro, A; Russo, M; Leo, A; Rifici, C; Pollicino, P; Bramanti, P; Calabro, RS				Naro, Antonino; Russo, Margherita; Leo, Antonino; Rifici, Carmela; Pollicino, Patrizia; Bramanti, Placido; Calabro, Rocco Salvatore			Cortical Responsiveness to Nociceptive Stimuli in Patients with Chronic Disorders of Consciousness: Do C-Fiber Laser Evoked Potentials Have a Role?	PLOS ONE			English	Article							COMA RECOVERY SCALE; BRAIN POTENTIALS; A-DELTA; SURFACE-AREAS; PAIN; HYPERALGESIA; GUIDELINES; RESPONSES; PATHWAYS; NOVELTY	It has been shown that the presence of Ad-fiber laser evoked potentials (Ad-LEP) in patients suffering from chronic disorders of consciousness (DOC), such as vegetative state (VS) and minimally conscious state (MCS), may be the expression of a residual cortical pain arousal. Interestingly, the study of C-fiber LEP (C-LEP) could be useful in the assessment of cortical pain arousal in the DOC individuals who lack of A delta-LEP. To this end, we enrolled 38 DOC patients following post-anoxic or post-traumatic brain injury, who met the international criteria for VS and MCS diagnosis. Each subject was clinically evaluated, through the coma recovery scale-revised (CRS-R) and the nociceptive coma scale-revised (NCS-R), and electrophysiologically tested by means of a solid-state laser for A delta-LEP and C-LEP. VS individuals showed increased latencies and reduced amplitudes of both the A delta-LEP and C-LEP components in comparison to MCS patients. Although nearly all of the patients had both the LEP components, some VS individuals showed only the C-LEP ones. Notably, such patients had a similar NCS-R score to those having both the LEP components. Hence, we could hypothesize that C-LEP generators may be rearranged or partially spared in order to still guarantee cortical pain arousal when A delta-LEP generators are damaged. Therefore, the residual presence of C-LEP should be assessed when A delta-LEP are missing, since a potential pain experience should be still present in some patients, so to properly initiate, or adapt, the most appropriate pain treatment.	[Naro, Antonino; Russo, Margherita; Leo, Antonino; Rifici, Carmela; Pollicino, Patrizia; Bramanti, Placido; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy	IRCCS Bonino Pulejo	Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy.	salbro77@tiscali.it	calabro, rocco salvatore/L-9570-2019; Calabrò, Rocco S/K-7520-2016; Bramanti, Placido/K-5117-2016; Leo, Antonino/K-7529-2016; Leo, Antonino/ABI-7198-2020; Rifici, Carmela/ABH-4398-2020	calabro, rocco salvatore/0000-0002-8566-3166; Leo, Antonino/0000-0003-4163-5830; Leo, Antonino/0000-0003-4163-5830; 				ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BENNETT GJ, 1994, TXB PAIN; Boly M, 2005, NEUROPSYCHOL REHABIL, V15, P283, DOI 10.1080/09602010443000371; Bragard D, 1996, NEUROSCI LETT, V209, P81, DOI 10.1016/0304-3940(96)12604-5; BROMM B, 1983, PFLUG ARCH EUR J PHY, V399, P155, DOI 10.1007/BF00663913; CAMPBELL JN, 1983, J NEUROPHYSIOL, V49, P98, DOI 10.1152/jn.1983.49.1.98; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Cruccu G, 2008, CLIN NEUROPHYSIOL, V119, P1705, DOI 10.1016/j.clinph.2008.03.016; Cruccu G, 2003, BRAIN, V126, P2246, DOI 10.1093/brain/awg227; Cruccu G, 2010, EUR J NEUROL, V17, P1010, DOI 10.1111/j.1468-1331.2010.02969.x; de Tommaso M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00017; de Tommaso M, 2013, BRAIN INJURY, V27, P962, DOI 10.3109/02699052.2013.775507; Di Perri C, 2013, NEUROLOGY, V81, P1417, DOI 10.1212/WNL.0b013e3182a43b78; Garcia-Larrea L, 2003, NEUROPHYSIOL CLIN, V33, P279, DOI 10.1016/j.neucli.2003.10.008; Garcia-Larrea L, 2002, BRAIN, V125, P2766, DOI 10.1093/brain/awf275; GEISSER S, 1958, ANN MATH STAT, V29, P885, DOI 10.1214/aoms/1177706545; Gerrard P, 2014, ARCH PHYS MED REHAB, V95, P2335, DOI 10.1016/j.apmr.2014.06.018; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Hu L, 2014, J NEUROSCI, V34, P11439, DOI 10.1523/JNEUROSCI.1355-14.2014; Iannetti GD, 2008, J NEUROPHYSIOL, V100, P815, DOI 10.1152/jn.00097.2008; Iannetti GD, 2004, CLIN NEUROPHYSIOL, V115, P2629, DOI 10.1016/j.clinph.2004.05.023; Iannetti GD, 2003, J NEUROPHYSIOL, V89, P562, DOI 10.1152/jn.00393.2002; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kassubek J, 2003, J NEUROL SCI, V212, P85, DOI 10.1016/S0022-510X(03)00106-0; LAMOTTE RH, 1983, J NEUROPHYSIOL, V50, P1; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Lenz FA, 1991, PAIN CENTRAL NERVOU; Letham B, 2011, J NEUROSCI METH, V194, P374, DOI 10.1016/j.jneumeth.2010.10.016; Magerl W, 1999, PAIN, V82, P127, DOI 10.1016/S0304-3959(99)00061-5; Montagna W, 1959, P BROWN U S BIOL SKI; Mouraux A, 2006, Suppl Clin Neurophysiol, V59, P197; Mouraux A, 2009, J NEUROPHYSIOL, V101, P3258, DOI 10.1152/jn.91181.2008; Opsommer E, 2001, CLIN NEUROPHYSIOL, V112, P1868, DOI 10.1016/S1388-2457(01)00622-8; Opsommer E, 1999, NEUROPHYSIOL CLIN, V29, P411, DOI 10.1016/S0987-7053(00)87265-2; Perchet C, 2008, CLIN NEUROPHYSIOL, V119, P2615, DOI 10.1016/j.clinph.2008.06.021; Plaghki L, 2003, NEUROPHYSIOL CLIN, V33, P269, DOI 10.1016/j.neucli.2003.10.003; Ronga I, 2013, J NEUROPHYSIOL, V109, P692, DOI 10.1152/jn.00464.2012; Spiegel J, 2000, CLIN NEUROPHYSIOL, V111, P725, DOI 10.1016/S1388-2457(99)00297-7; Treede RD, 2003, NEUROPHYSIOL CLIN, V33, P303, DOI 10.1016/j.neucli.2003.10.009; Treede RD, 1998, PAIN FORUM, V7, P191, DOI 10.1016/S1082-3174(98)80005-6; Truini A, 2008, PAIN, V140, P405, DOI 10.1016/j.pain.2008.08.018; Valeriani M, 2002, NEUROSCI LETT, V329, P329, DOI 10.1016/S0304-3940(02)00671-7; Vogt BA, 2000, PROG BRAIN RES, V122, P223; Wang AL, 2010, J NEUROPHYSIOL, V104, P2116, DOI 10.1152/jn.01088.2009; Weng HR, 2000, NEUROSCIENCE, V101, P393, DOI 10.1016/S0306-4522(00)00368-7; Wu Q, 1999, PAIN, V80, P209, DOI 10.1016/S0304-3959(98)00206-1; Zanatta P, 2012, MINERVA ANESTESIOL, V78, P749	48	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144713	10.1371/journal.pone.0144713	http://dx.doi.org/10.1371/journal.pone.0144713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674634	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700055
J	Wang, DC; Shanina, I; Toyofuku, WM; Horwitz, MS; Scott, MD				Wang, Duncheng; Shanina, Iryna; Toyofuku, Wendy M.; Horwitz, Marc S.; Scott, Mark D.			Inhibition of Autoimmune Diabetes in NOD Mice by miRNA Therapy	PLOS ONE			English	Article							REGULATORY T-CELLS; METHOXYPOLY(ETHYLENE GLYCOL); ISLET TRANSPLANTATION; DENDRITIC CELLS; TH17 CELLS; IMMUNOCAMOUFLAGE; PREVENTION; INDUCTION; RECOGNITION; EFFICACY	Autoimmune destruction of the pancreatic islets in Type 1 diabetes is mediated by both increased proinflammatory (Teff) and decreased regulatory (Treg) T lymphocytes resulting in a significant decrease in the Treg: Teff ratio. The non-obese diabetic (NOD) mouse is an excellent in vivo model for testing potential therapeutics for attenuating the decrease in the Treg: Teff ratio and inhibiting disease pathogenesis. Here we show for the first time that a bioreactor manufactured therapeutic consisting of a complex of miRNA species (denoted as TA1) can effectively reset the NOD immune system from a proinflammatory to a tolerogenic state thus preventing or delaying autoimmune diabetes. Treatment of NOD mice with TA1 resulted in a systemic broad-spectrum upregulation of tolerogenic T cell subsets with a parallel downregulation of Teff subsets yielding a dramatic increase in the Treg: Teff ratio. Moreover, the murine-derived TA1 was highly effective in the inhibition of allorecognition of HLA-disparate human PBMC. TA1 demonstrated dose-responsiveness and exhibited equivalent or better inhibition of allorecognition driven proliferation than etanercept (a soluble TNF receptor). These findings demonstrate that miRNA-based therapeutics can effectively attenuate or arrest autoimmune disease processes and may be of significant utility in a broad range of autoimmune diseases including Type 1 diabetes.	[Wang, Duncheng; Toyofuku, Wendy M.; Scott, Mark D.] Canadian Blood Serv, Ctr Innovat, Ottawa, ON, Canada; [Wang, Duncheng; Toyofuku, Wendy M.; Scott, Mark D.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada; [Shanina, Iryna; Horwitz, Marc S.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Scott, Mark D.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	Canadian Blood Services; University of British Columbia; University of British Columbia; University of British Columbia	Scott, MD (corresponding author), Canadian Blood Serv, Ctr Innovat, Ottawa, ON, Canada.	mdscott@mail.ubc.ca		Wang, Duncheng/0000-0002-2085-9512	Canadian Institutes of Health Research [123317]; Canadian Blood Services; Health Canada; Canada Foundation for Innovation; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Blood Services; Health Canada; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by grants from the Canadian Institutes of Health Research (Grant No. 123317; MDS), Canadian Blood Services (MDS) and Health Canada (MDS). The views expressed herein do not necessarily represent the view of the federal government of Canada. We thank the Canada Foundation for Innovation and the Michael Smith Foundation for Health Research for infrastructure funding at the University of British Columbia Centre for Blood Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Balasa B, 1997, J IMMUNOL, V159, P4620; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bhardwaj Arun, 2010, Mol Cell Pharmacol, V2, P213; Braicu C, 2013, CURR MED CHEM; Chen AM, 2003, J BIOMED MATER RES A, V67A, P626, DOI 10.1002/jbm.a.10146; Chen AM, 2001, BIODRUGS, V15, P833, DOI 10.2165/00063030-200115120-00005; Chen AM, 2006, ARTIF CELL BLOOD SUB, V34, P305, DOI 10.1080/10731190600683845; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cortes JR, 2014, J AUTOIMMUN, V55, P51, DOI 10.1016/j.jaut.2014.05.007; Creusot RJ, 2010, MOL THER, V18, P2112, DOI 10.1038/mt.2010.146; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaudreau S, 2007, J IMMUNOL, V179, P3638, DOI 10.4049/jimmunol.179.6.3638; Gregori S, 2003, J IMMUNOL, V171, P4040, DOI 10.4049/jimmunol.171.8.4040; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kriegel MA, 2012, P NATL ACAD SCI USA, V109, P3457, DOI 10.1073/pnas.1115308109; Kyluik-Price DL, 2014, BIOMATERIALS, V35, P412, DOI 10.1016/j.biomaterials.2013.09.016; Le Y, 2010, ACTA BIOMATER, V6, P2631, DOI 10.1016/j.actbio.2010.01.031; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin MS, 2011, IMMUNOL RES, V50, P213, DOI 10.1007/s12026-011-8215-0; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Luo XR, 2010, IMMUNITY, V32, P488, DOI 10.1016/j.immuni.2010.04.002; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; Murad KL, 1999, BLOOD, V94, P2135; Nielsen LB, 2012, EXP DIABETES RES, V2012, DOI DOI 10.1155/2012/896362; Nishio J, 2010, J EXP MED, V207, P1879, DOI 10.1084/jem.20100205; Noorchashm H, 1997, DIABETOLOGIA, V40, pB50, DOI 10.1007/BF03168187; Richer MJ, 2008, DIABETES, V57, P1302, DOI 10.2337/db07-1460; Richer MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031153; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shen EX, 2011, CELL BIOL INT, V35, P705, DOI 10.1042/CBI20100528; Tang XY, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/345347; Thayer TC, 2010, ENDOCRIN METAB CLIN, V39, P541, DOI 10.1016/j.ecl.2010.05.001; Thomas David, 2005, Rev Diabet Stud, V2, P9, DOI 10.1900/RDS.2005.2.9; Tritt M, 2008, DIABETES, V57, P113, DOI 10.2337/db06-1700; Wang DC, 2012, BIOMATERIALS, V33, P3002, DOI 10.1016/j.biomaterials.2011.12.041; Wang DC, 2011, BIOMATERIALS, V32, P9494, DOI 10.1016/j.biomaterials.2011.08.061; Wei B, 2010, CELL MOL IMMUNOL, V7, P175, DOI 10.1038/cmi.2010.19; Yang H, 2012, TRANSPLANTATION, V93, P580, DOI 10.1097/TP.0b013e318244dd67; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415	53	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145179	10.1371/journal.pone.0145179	http://dx.doi.org/10.1371/journal.pone.0145179			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674203	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700111
J	Weijerman, M; Fulton, EA; Kaplan, IC; Gorton, R; Leemans, R; Mooij, WM; Brainard, RE				Weijerman, Mariska; Fulton, Elizabeth A.; Kaplan, Isaac C.; Gorton, Rebecca; Leemans, Rik; Mooij, Wolf M.; Brainard, Russell E.			An Integrated Coral Reef Ecosystem Model to Support Resource Management under a Changing Climate	PLOS ONE			English	Article							GREAT-BARRIER-REEF; REGION-WIDE DECLINES; OCEAN ACIDIFICATION; MARINE ECOSYSTEMS; FISHES; IMPACTS; RECOVERY; FUTURE; DISTURBANCE; RESPONSES	Millions of people rely on the ecosystem services provided by coral reefs, but sustaining these benefits requires an understanding of how reefs and their biotic communities are affected by local human-induced disturbances and global climate change. Ecosystembased management that explicitly considers the indirect and cumulative effects of multiple disturbances has been recommended and adopted in policies in many places around the globe. Ecosystem models give insight into complex reef dynamics and their responses to multiple disturbances and are useful tools to support planning and implementation of ecosystem-based management. We adapted the Atlantis Ecosystem Model to incorporate key dynamics for a coral reef ecosystem around Guam in the tropical western Pacific. We used this model to quantify the effects of predicted climate and ocean changes and current levels of current land-based sources of pollution (LBSP) and fishing. We used the following six ecosystem metrics as indicators of ecosystem state, resilience and harvest potential: 1) ratio of calcifying to non-calcifying benthic groups, 2) trophic level of the community, 3) biomass of apex predators, 4) biomass of herbivorous fishes, 5) total biomass of living groups and 6) the end-to-start ratio of exploited fish groups. Simulation tests of the effects of each of the three drivers separately suggest that by mid-century climate change will have the largest overall effect on this suite of ecosystem metrics due to substantial negative effects on coral cover. The effects of fishing were also important, negatively influencing five out of the six metrics. Moreover, LBSP exacerbates this effect for all metrics but not quite as badly as would be expected under additive assumptions, although the magnitude of the effects of LBSP are sensitive to uncertainty associated with primary productivity. Over longer time spans (i.e., 65 year simulations), climate change impacts have a slight positive interaction with other drivers, generally meaning that declines in ecosystem metrics are not as steep as the sum of individual effects of the drivers. These analyses offer one way to quantify impacts and interactions of particular stressors in an ecosystem context and so provide guidance to managers. For example, the model showed that improving water quality, rather than prohibiting fishing, extended the timescales over which corals can maintain high abundance by at least 5-8 years. This result, in turn, provides more scope for corals to adapt or for resilient species to become established and for local and global management efforts to reduce or reverse stressors.	[Weijerman, Mariska] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Weijerman, Mariska; Leemans, Rik] Wageningen Univ, Environm Syst Anal Grp, NL-6700 AP Wageningen, Netherlands; [Weijerman, Mariska; Brainard, Russell E.] NOAA Fisheries, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Fulton, Elizabeth A.; Gorton, Rebecca] CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia; [Kaplan, Isaac C.] NOAA Fisheries, NW Fisheries Sci Ctr, Seattle, WA USA; [Mooij, Wolf M.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Mooij, Wolf M.] Wageningen Univ, Aquat Ecol & Water Qual Management Grp, NL-6700 AP Wageningen, Netherlands	University of Hawaii System; University of Hawaii Manoa; Wageningen University & Research; National Oceanic Atmospheric Admin (NOAA) - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Oceanic Atmospheric Admin (NOAA) - USA; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research	Weijerman, M (corresponding author), Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.	mariska.weijerman@noaa.gov	Mooij, Wolf M/C-2677-2008; Leemans, Rik/A-1548-2009; Fulton, Beth/AAJ-1398-2021; Fulton, Beth/A-2871-2008; KNAW, NIOO-KNAW/A-4320-2012	Mooij, Wolf M/0000-0001-5586-8200; Leemans, Rik/0000-0002-4001-6301; Fulton, Beth/0000-0002-5904-7917; Fulton, Beth/0000-0002-5904-7917; KNAW, NIOO-KNAW/0000-0002-3835-159X; Gorton, Rebecca/0000-0002-5290-3506	NOAA Coral Reef Conservation Program; NOAA Office of Habitat	NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA Office of Habitat	MW received funding from the NOAA Coral Reef Conservation Program (http://coralreef.noaa.gov/) and from NOAA Office of Habitat (http://www.habitat.noaa.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided to MW by the NOAA Coral Reef Conservation Program and NOAA Office of Habitat. We would like to thank Ivor Williams, John Rooney, Jeff Polovina and anonymous reviewers for their improvements to the manuscript. The scientific results and conclusions, and any views or opinions expressed herein, are those of the authors and do not necessarily reflect those of NOAA or the Department of Commerce.	Aeby GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016887; Ainsworth CH, 2008, ECOL MODEL, V214, P361, DOI 10.1016/j.ecolmodel.2008.02.039; Ainsworth CH, 2011, ICES J MAR SCI, V68, P1217, DOI 10.1093/icesjms/fsr043; Ainsworth CH, 2014, GLOBAL CHANGE BIOLOG; Ainsworth CH, 2011, ATLANTIS MODEL DEVEL; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Balmford A, 2005, ECOL LETT, V8, P1218, DOI 10.1111/j.1461-0248.2005.00814.x; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Baskett ML, 2009, ECOL APPL, V19, P3, DOI 10.1890/08-0139.1; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; Bellwood DR, 2011, PROCEEDINGS OF THE R; Brand E, 2007, NOAA TECHNICAL MEMOR; Carriger JF, 2013, COAST MANAGE, V41, P19, DOI 10.1080/08920753.2012.747814; Castruccio FS, 2013, J GEOPHYS RES-OCEANS, V118, P6123, DOI 10.1002/2013JC009196; Christensen V., 2008, LEN OCE FUTS PROJ, P235; Coker DJ, 2014, REV FISH BIOL FISHER, V24, P89, DOI 10.1007/s11160-013-9319-5; DeMartini EE, 2007, B MAR SCI, V81, P139; Edwards HJ, 2011, GLOBAL CHANGE BIOL, V17, P2033, DOI 10.1111/j.1365-2486.2010.02366.x; Enochs I, 2008, PROCEEDINGS 11TH INT; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; Fulton EA, 2007, ALTERNATIVE MANAGEME; Fulton EA, 2001, THE EFFECTS OF MODEL; Fulton EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084242; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Fung T, 2009, LOCAL SCALE MODELS O; Gesch D., 2007, DIGITAL ELEVATION MO, P99; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Green A.L., 2009, MONITORING FUNCTIONA; Griffith GP, 2012, CONSERV BIOL, V26, P1145, DOI 10.1111/j.1523-1739.2012.01937.x; Heenan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079604; Hoeke RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018038; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Horne P, 2010, TECHNICAL MEMO NMFS, P140; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jackson JBC, 2014, STATUS AND TRENDS OF; Jennings S, 1996, AMBIO, V25, P44; Kaplan IC, 2013, FISH FISH, V14, P515, DOI 10.1111/j.1467-2979.2012.00484.x; Kaplan IC, 2012, PROG OCEANOGR, V102, P5, DOI 10.1016/j.pocean.2012.03.009; Kaplan IC, 2010, CAN J FISH AQUAT SCI, V67, P1968, DOI 10.1139/F10-118; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; Kirby RR, 2009, ECOSYSTEMS, V12, P548, DOI 10.1007/s10021-009-9241-9; Link JS, 2010, PROG OCEANOGR, V87, P214, DOI 10.1016/j.pocean.2010.09.020; Logan CA, 2014, GLOBAL CHANGE BIOL, V20, P125, DOI 10.1111/gcb.12390; Loh T-L, 2015, PEERJ PREPRINTS, P2167; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2014, CURR OPIN ENV SUST, V7, P59, DOI 10.1016/j.cosust.2013.11.028; McClanahan TR, 2014, MAR ECOL PROG SER, V497, P13, DOI 10.3354/meps10605; Melbourne-Thomas J, 2011, ECOL SOC, V16, DOI 10.5751/ES-04208-160323; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Nystrom M, 2012, ECOSYSTEMS, V15, P695, DOI 10.1007/s10021-012-9530-6; Ortiz JC, 2014, NAT CLIM CHANGE, V4, P1090, DOI 10.1038/NCLIMATE2439; Paddack MJ, 2006, CORAL REEFS, V25, P461, DOI 10.1007/s00338-006-0112-y; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pequignet AC, 2011, CORAL REEFS, V30, P71, DOI 10.1007/s00338-011-0719-5; Plaganyi EE, 2007, FAO FISHERIES TECHNI, V477, P126; Principe P., 2012, QUANTIFYING CORAL RE; Riegl B, 2013, ECOL EVOL, V3, P1050, DOI 10.1002/ece3.519; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Sebastian CR, 2013, ECOL MODEL, V263, P326, DOI 10.1016/j.ecolmodel.2013.05.012; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Stocker T. F., 2013, CONTRIBUTION OF WORK; Storlazzi CD, 2014, 20141130 US GEOL SUR, DOI [10.3133/ofr20141130, DOI 10.3133/OFR20141130:]; Stow CA, 2009, J MARINE SYST, V76, P4, DOI 10.1016/j.jmarsys.2008.03.011; Thompson AA, 2010, CORAL REEFS, V29, P637, DOI 10.1007/s00338-009-0562-0; Travers M, 2007, PROG OCEANOGR, V75, P751, DOI 10.1016/j.pocean.2007.08.001; Vetter O, 2010, JOURNAL OF GEOPHYSIC, V115; Wang X, 2008, BIOGEOSCIENCES, V5, P3869; Weijerman M, 2014, NOAA TECH MEMO NOAA; Weijerman M, FISHERIES BULLETIN I; Weijerman M, 2015, PROGRESS IN OCEANOGR; Weijerman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063797; Williams GJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3069; Williams I, 2011, NOAA TECH MEMO NOAA; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wolanski E, 2004, J MARINE SYST, V46, P133, DOI 10.1016/j.jmarsys.2003.11.018; Yee SH, 2014, ECOLOGICAL EC	87	30	30	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144165	10.1371/journal.pone.0144165	http://dx.doi.org/10.1371/journal.pone.0144165			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672983	gold, Green Submitted, Green Published			2022-12-27	WOS:000366722700026
J	Dreber, H; Reynisdottir, S; Angelin, B; Hemmingsson, E				Dreber, Helena; Reynisdottir, Signy; Angelin, Bo; Hemmingsson, Erik			Who is the Treatment-Seeking Young Adult with Severe Obesity: A Comprehensive Characterization with Emphasis on Mental Health	PLOS ONE			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; BARIATRIC SURGERY; PSYCHOLOGICAL OUTCOMES; PSYCHOSOCIAL STATUS; CONSTRUCT-VALIDITY; HOSPITAL ANXIETY; GASTRIC BYPASS; UNITED-STATES; SELF-ESTEEM	Objective To characterize treatment-seeking young adults (16-25 years) with severe obesity, particularly mental health problems. Study Design and Participants Cross-sectional study of 165 participants (132 women, 33 men) with BMI >= 35 kg/m(2) or >= 30 kg/m(2) with comorbidities, enrolling in a multidisciplinary obesity treatment program. Method Data collection at admission of present and life-time health issues including symptomatology of anxiety, depression (Hospital Anxiety and Depression Scale) and attention-deficit/hyperactivity disorder (Adult ADHD Self-Report scale); self-esteem (Rosenberg Self-Esteem Scale), suicide attempts, health-related quality of life (Short Form-36 Health Survey), psychosocial functioning related to obesity (Obesity-related Problems Scale), cardiorespiratory fitness (Astrand's bicycle ergometer test), somatic and psychiatric comorbidities, cardiometabolic risk factors, and micronutritional status. We used multiple regression analysis to identify variables independently associated with present anxiety and depressive symptomatology. Results Mean body mass index was 39.2 kg/m(2) (SD = 5.2). We found evidence of poor mental health, including present psychiatric diagnoses (29%), symptomatology of anxiety (47%), depression (27%) and attention-deficit/hyperactivity disorder (37%); low self-esteem (42%), attempted suicide (12%), and low quality of life (physical component score = 46, SD = 11.2; mental component score = 36, SD = 13.9, P<0.001 for difference). Variables independently associated with present anxiety symptomatology (R-2 = 0.33, P<0.001) included low selfesteem (P<0.001) and pain (P = 0.003), whereas present depressive symptomatology (R-2 = 0.38, P<0.001) was independently associated with low self-esteem (P<0.001), low cardiorespiratory fitness (P = 0.009) and obesity-related problems (P = 0.018). The prevalence of type 2 diabetes was 3%, and hypertension 2%. Insulin resistance was present in 82%, lipid abnormality in 62%, and poor cardiorespiratory fitness in 92%. Forty-eight percent had at least one micronutritional deficiency, vitamin D being the most common (35%). Conclusion A wide range of health issues, including quite severe mental health problems, was prevalent in treatment-seeking young adults with severe obesity. These are likely to constitute a major treatment challenge, including options relating to bariatric surgery.	[Dreber, Helena; Reynisdottir, Signy; Hemmingsson, Erik] Karolinska Inst, Dept Med, Karolinska Univ Hosp, Obes Ctr, Stockholm, Sweden; [Angelin, Bo] Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Dreber, H (corresponding author), Karolinska Inst, Dept Med, Karolinska Univ Hosp, Obes Ctr, Stockholm, Sweden.	helena.dreber@ki.se		Hemmingsson, Erik/0000-0001-7335-3796				Abdollahi A, 2015, PSYCHOL HEALTH MED, V20, P205, DOI 10.1080/13548506.2014.913799; Adler Lenard A, 2006, Ann Clin Psychiatry, V18, P145, DOI 10.1080/10401230600801077; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Ambwani S, 2013, SURG OBES RELAT DIS, V9, P300, DOI 10.1016/j.soard.2011.06.019; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2005, ALKOHOL HALSA KUNSKA; Araghi MH, 2013, SLEEP, V36, P1859, DOI 10.5665/sleep.3216; ASTRAND I, 1960, Acta Physiol Scand Suppl, V49, P1; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; Britz B, 2000, INT J OBESITY, V24, P1707, DOI 10.1038/sj.ijo.0801449; Broder-Fingert S, 2014, ACAD PEDIATR, V14, P408, DOI 10.1016/j.acap.2014.04.004; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cortese S, 2013, PEDIATRICS, V131, pE1731, DOI 10.1542/peds.2012-0540; Eriksson EH, 1950, CHILDHOOD SOC; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Fortuna RJ, 2009, ANN INTERN MED, V151, P379, DOI 10.7326/0003-4819-151-6-200909150-00002; Freeman B, 2016, HEALTH PROMOT INT, V31, P954, DOI 10.1093/heapro/dav081; Gokee-LaRose J, 2009, INT J OBESITY, V33, P1374, DOI 10.1038/ijo.2009.185; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; GRAY DS, 1991, J CLIN EPIDEMIOL, V44, P545, DOI 10.1016/0895-4356(91)90218-X; Herget S, 2014, OBESITY FACTS, V7, P233, DOI 10.1159/000365793; Holm L, 2010, INT STAT KLASSIFIKAT; Ibrahim AK, 2013, J PSYCHIATR RES, V47, P391, DOI 10.1016/j.jpsychires.2012.11.015; Jarvholm K, 2015, OBESITY, V23, P1966, DOI 10.1002/oby.21188; Jarvholm K, 2012, OBESITY, V20, P318, DOI 10.1038/oby.2011.310; Jorngarden A, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-91; Karlsson J, 2003, INT J OBESITY, V27, P617, DOI 10.1038/sj.ijo.0802272; Karmali S, 2013, OBES SURG, V23, P1922, DOI 10.1007/s11695-013-1070-4; KECKLUND G, 1992, J SLEEP RES, V1, P30, DOI 10.1111/j.1365-2869.1992.tb00005.x; Kelly AS, 2013, CIRCULATION, V128, P1689, DOI 10.1161/CIR.0b013e3182a5cfb3; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kim RJ, 2008, OBES SURG, V18, P27, DOI 10.1007/s11695-007-9285-x; LaRose JG, DIFFERENCES MOTIVATI; Lee H, 2011, J ADOLESCENT HEALTH, V49, P601, DOI 10.1016/j.jadohealth.2011.04.019; Leeb RebeccaT., 2008, CHILD MALTREATMENT; Lennerz BS, 2014, INT J OBESITY, V38, P334, DOI 10.1038/ijo.2013.182; Lillis J, 2009, ANN BEHAV MED, V37, P58, DOI 10.1007/s12160-009-9083-x; Martin-Albo J, 2007, SPAN J PSYCHOL, V10, P458, DOI 10.1017/S1138741600006727; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Michalsky MP, 2015, JAMA PEDIATR, V169, P438, DOI 10.1001/jamapediatrics.2014.3690; Nelson MC, 2008, OBESITY, V16, P2205, DOI 10.1038/oby.2008.365; Neovius M, 2008, INT J OBESITY, V32, P832, DOI 10.1038/sj.ijo.0803784; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nordin M, 2013, SLEEP BIOL RHYTHMS, V11, P216, DOI 10.1111/sbr.12024; Norman M, 2015, LAKARTIDNINGEN, P112; Olbers T, 2012, INT J OBESITY, V36, P1388, DOI 10.1038/ijo.2012.160; Peterhansel C, 2013, OBES REV, V14, P369, DOI 10.1111/obr.12014; Preiss K, 2013, OBES REV, V14, P906, DOI 10.1111/obr.12052; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Rosenberg M, 1989, SOC ADOLESCENT SELF; Salawi HA, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-154; Salmi P, 2013, PSYKISK OHALSA BLAND; Skinner AC, 2015, NEW ENGL J MED, V373, P1307, DOI 10.1056/NEJMoa1502821; Skinner AC, 2014, JAMA PEDIATR, V168, P561, DOI 10.1001/jamapediatrics.2014.21; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Svensson A, 2011, HALSOENKAT 2010 TEKN, P9; Svensson PA, 2013, OBESITY, V21, P2444, DOI 10.1002/oby.20397; Sysko R, 2013, CLIN OBES, V3, P62, DOI 10.1111/cob.12019; Thibault R, 2016, CLIN NUTR, V35, P12, DOI 10.1016/j.clnu.2015.02.012; Titchener K, 2015, EAT BEHAV, V16, P13, DOI 10.1016/j.eatbeh.2014.10.005; Twenge JM, 2001, PERS SOC PSYCHOL REV, V5, P321, DOI 10.1207/S15327957PSPR0504_3; Ul-Haq Z, 2013, J PEDIATR-US, V162, P280, DOI 10.1016/j.jpeds.2012.07.049; Wabitsch M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-789; Ware J., 1993, SF 36 HLTH SURVEY MA; White D, 1999, BRIT J PSYCHIAT, V175, P452, DOI 10.1192/bjp.175.5.452; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wilkins D, 2008, GENDER ACCESS HLTH S; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zeller MH, 2013, OBESITY, V21, P1039, DOI 10.1002/oby.20084	73	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145273	10.1371/journal.pone.0145273	http://dx.doi.org/10.1371/journal.pone.0145273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SH	26694031	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092500034
J	Reine, TM; Vuong, TT; Rutkovskiy, A; Meen, AJ; Vaage, J; Jenssen, TG; Kolset, SO				Reine, Trine M.; Vuong, Tram T.; Rutkovskiy, Arkady; Meen, Astri J.; Vaage, Jarle; Jenssen, Trond G.; Kolset, Svein O.			Serglycin in Quiescent and Proliferating Primary Endothelial Cells	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; INFLAMMATORY STIMULI; HYPOXIC REGULATION; GROWTH-FACTOR; CORE PROTEIN; EXPRESSION; ANGIOGENESIS; SECRETION; BINDING; GRANULE	Proteoglycans are fundamental components of the endothelial barrier, but the functions of the proteoglycan serglycin in endothelium are less described. Our aim was to describe the roles of serglycin in processes relevant for endothelial dysfunction. Primary human umbilical vein endothelial cells (HUVEC) were cultured in vitro and the expression of proteoglycans was investigated. Dense cell cultures representing the quiescent endothelium coating the vasculature was compared to sparse activated cell cultures, relevant for diabetes, cancer and cardiovascular disease. Secretion of 35S-proteoglycans increased in sparse cultures, and we showed that serglycin is a major component of the cell-density sensitive proteoglycan population. In contrast to the other proteoglycans, serglycin expression and secretion was higher in proliferating compared to quiescent HUVEC. RNAi silencing of serglycin inhibited proliferation and wound healing, and serglycin expression and secretion was augmented by hypoxia, mechanical strain and IL-1 beta induced inflammation. Notably, the secretion of the angiogenic chemokine CCL2 resulting from IL-1 beta activation, was increased in serglycin knockdown cells, while angiopoietin was not affected. Both serglycin and CCL2 were secreted predominantly to the apical side of polarized HUVEC, and serglycin and CCL2 co-localized both in perinuclear areas and in vesicles. These results suggest functions for serglycin in endothelial cells trough interactions with partnermolecules, in biological processes with relevance for diabetic complications, cardiovascular disease and cancer development.	[Reine, Trine M.; Vuong, Tram T.; Meen, Astri J.; Kolset, Svein O.] Univ Oslo, Inst Basic Med Sci, Dept Nutr, N-0316 Oslo, Norway; [Rutkovskiy, Arkady] Univ Oslo, Inst Basic Med Sci, Dept Physiol, N-0316 Oslo, Norway; [Rutkovskiy, Arkady; Vaage, Jarle] Univ Oslo, Inst Clin Med, Dept Emergency & Intens Care, N-0316 Oslo, Norway; [Reine, Trine M.; Jenssen, Trond G.] Univ Oslo, Rikshosp, Dept Organ Transplantat, Sect Renal Dis,Oslo Univ Hosp, N-0027 Oslo, Norway; [Reine, Trine M.; Jenssen, Trond G.] UiT Arctic Univ Norway, Metab & Renal Res Grp, Tromso, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; UiT The Arctic University of Tromso	Reine, TM (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Nutr, Box 1046, N-0316 Oslo, Norway.	t.m.reine@medisin.uio.no	Vaage, Jarle/H-9079-2016	Vaage, Jarle/0000-0002-8747-5193	South Eastern Norway Regional Health Authority; Throne Holst Foundation; Nansen Foundation; Jahre Foundation; Norwegian Diabetes Association	South Eastern Norway Regional Health Authority; Throne Holst Foundation; Nansen Foundation; Jahre Foundation; Norwegian Diabetes Association	The research leading to these results received funding from The South Eastern Norway Regional Health Authority, The Throne Holst Foundation, The Nansen Foundation, and The Jahre Foundation and The Norwegian Diabetes Association.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Asplund A, 2010, GLYCOBIOLOGY, V20, P33, DOI 10.1093/glycob/cwp139; Azcutia V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010091; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Chow MT, 2014, CANCER IMMUNOL RES, V2, P1125, DOI 10.1158/2326-6066.CIR-14-0160; Cines DB, 1998, BLOOD, V91, P3527; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Dudley AC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006536; Friden V, 2011, KIDNEY INT, V79, P1322, DOI 10.1038/ki.2011.58; Garcia-Olivas R, 2003, HISTOCHEM CELL BIOL, V120, P371, DOI 10.1007/s00418-003-0576-6; Gharagozlian S, 2006, EUR J NUTR, V45, P369, DOI 10.1007/s00394-006-0608-9; Gharagozlian S, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-7; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; Hagerling C, 2015, TRENDS CELL BIOL, V25, P214, DOI 10.1016/j.tcb.2014.11.001; Hamilton A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126688; Herder C, 2015, TRENDS ENDOCRIN MET, V26, P551, DOI 10.1016/j.tem.2015.08.001; Hjorth M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12473; Hoh BL, 2011, CIRCULATION, V124, P2243, DOI 10.1161/CIRCULATIONAHA.111.036061; HUMPHRIES DE, 1986, J CELL PHYSIOL, V126, P249, DOI 10.1002/jcp.1041260214; Imoto-Tsubakimoto H, 2013, BIOCHEM BIOPH RES CO, V432, P105, DOI 10.1016/j.bbrc.2013.01.078; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kaji T, 2000, J BIOL CHEM, V275, P1463, DOI 10.1074/jbc.275.2.1463; Keleg S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100178; Khoo CP, 2011, TISSUE ENG PART C-ME, V17, P895, DOI [10.1089/ten.tec.2011.0150, 10.1089/ten.TEC.2011.0150]; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Kim JA, 2012, HEART FAIL CLIN, V8, P589, DOI 10.1016/j.hfc.2012.06.012; Kinsella MG, 1997, J BIOL CHEM, V272, P318; Kolset SO, 1996, J LEUKOCYTE BIOL, V59, P545, DOI 10.1002/jlb.59.4.545; Kolset SO, 2011, J IMMUNOL, V187, P4927, DOI 10.4049/jimmunol.1100806; Korpetinou A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/690721; Korpetinou A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078157; Kuchler AM, 2008, AM J PATHOL, V173, P1229, DOI 10.2353/ajpath.2008.080014; Li S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104107; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; Liu SH, 2013, J PATHOL, V230, P215, DOI 10.1002/path.4045; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024; Meen AJ, 2011, J BIOL CHEM, V286, P2636, DOI 10.1074/jbc.M110.151944; Melo FR, 2011, J BIOL CHEM, V286, P5423, DOI 10.1074/jbc.M110.176461; MERTENS G, 1992, J BIOL CHEM, V267, P20435; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; Niemann CU, 2007, LEUKEMIA, V21, P2406, DOI 10.1038/sj.leu.2404975; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Obika M, 2014, J HISTOCHEM CYTOCHEM, V62, P34, DOI 10.1369/0022155413507727; Oynebraten I, 2005, J IMMUNOL, V175, P5358, DOI 10.4049/jimmunol.175.8.5358; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Purushothaman A, 2014, J BIOL CHEM, V289, P5499, DOI 10.1074/jbc.M113.532143; Reine TM, 2014, BBA-GEN SUBJECTS, V1840, P2498, DOI 10.1016/j.bbagen.2014.02.002; Reine TM, 2012, GLYCOCONJUGATE J, V29, P67, DOI 10.1007/s10719-011-9365-y; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Salmon AHJ, 2012, J PATHOL, V226, P562, DOI 10.1002/path.3964; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Solomon SD, 2014, THE COCHRANE DATABAS, V8, DOI [10.1002/14651858.CD005139, DOI 10.1002/14651858.CD005139]; STEVENS RL, 1985, J BIOL CHEM, V260, P4194; Suffee N, 2012, ANGIOGENESIS, V15, P727, DOI 10.1007/s10456-012-9285-x; Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4; Tsidulko AY, 2015, ONCOTARGET, DOI 10.18632/oncotarget.5984; UHLINHANSEN L, 1988, J BIOL CHEM, V263, P2526; van den Oever IAM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/792393; Vuong TT, 2015, J HISTOCHEM CYTOCHEM, V63, P280, DOI 10.1369/0022155415568995; Weber KSC, 1999, ARTERIOSCL THROM VAS, V19, P2085, DOI 10.1161/01.ATV.19.9.2085; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wernersson S, 2009, J LEUKOCYTE BIOL, V85, P401, DOI 10.1189/jlb.1008670; Werth BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014830; Woulfe DS, 2008, BLOOD, V111, P3458, DOI 10.1182/blood-2007-07-104703; Zernichow L, 2006, J BIOL CHEM, V281, P26792, DOI 10.1074/jbc.M512889200	72	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145584	10.1371/journal.pone.0145584	http://dx.doi.org/10.1371/journal.pone.0145584			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694746	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500059
J	Reppe, S; Wang, YP; Thompson, WK; McEvoy, LK; Schork, AJ; Zuber, V; LeBlanc, M; Bettella, F; Mills, IG; Desikan, RS; Djurovic, S; Gautvik, KM; Dale, AM; Andreassen, OA				Reppe, Sjur; Wang, Yunpeng; Thompson, Wesley K.; McEvoy, Linda K.; Schork, Andrew J.; Zuber, Verena; LeBlanc, Marissa; Bettella, Francesco; Mills, Ian G.; Desikan, Rahul S.; Djurovic, Srdjan; Gautvik, Kaare M.; Dale, Anders M.; Andreassen, Ole A.		GEFOS Consortium	Genetic Sharing with Cardiovascular Disease Risk Factors and Diabetes Reveals Novel Bone Mineral Density Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; NUCLEAR FACTOR; COMMON VARIANTS; NATIONAL-HEALTH; FRACTURE RISK; OSTEOPOROSIS; METAANALYSIS; PLEIOTROPY; INSULIN	Bone Mineral Density (BMD) is a highly heritable trait, but genome-wide association studies have identified few genetic risk factors. Epidemiological studies suggest associations between BMD and several traits and diseases, but the nature of the suggestive comorbidity is still unknown. We used a novel genetic pleiotropy-informed conditional False Discovery Rate (FDR) method to identify single nucleotide polymorphisms (SNPs) associated with BMD by leveraging cardiovascular disease (CVD) associated disorders and metabolic traits. By conditioning on SNPs associated with the CVD-related phenotypes, type 1 diabetes, type 2 diabetes, systolic blood pressure, diastolic blood pressure, high density lipoprotein, low density lipoprotein, triglycerides and waist hip ratio, we identified 65 novel independent BMD loci (26 with femoral neck BMD and 47 with lumbar spine BMD) at conditional FDR < 0.01. Many of the loci were confirmed in genetic expression studies. Genes validated at the mRNA levels were characteristic for the osteoblast/osteocyte lineage, Wnt signaling pathway and bone metabolism. The results provide new insight into genetic mechanisms of variability in BMD, and a better understanding of the genetic underpinnings of clinical comorbidity.	[Reppe, Sjur; Gautvik, Kaare M.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Reppe, Sjur; Gautvik, Kaare M.] Lovisenberg Diakonale Hosp, Oslo, Norway; [Reppe, Sjur; Gautvik, Kaare M.] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Wang, Yunpeng; Zuber, Verena; Bettella, Francesco; Djurovic, Srdjan; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway; [Wang, Yunpeng; Zuber, Verena; Bettella, Francesco; Djurovic, Srdjan; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Wang, Yunpeng; Thompson, Wesley K.; Dale, Anders M.; Andreassen, Ole A.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Wang, Yunpeng; Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [McEvoy, Linda K.; Schork, Andrew J.; Desikan, Rahul S.; Dale, Anders M.] Univ Calif San Diego, Multimodal Imaging Lab, La Jolla, CA 92093 USA; [McEvoy, Linda K.; Desikan, Rahul S.; Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Schork, Andrew J.] Univ Calif San Diego, Cognit Sci Grad Program, La Jolla, CA 92093 USA; [LeBlanc, Marissa] Univ Oslo, Inst Clin Med, Dept Clin Mol Biol, Oslo, Norway; [LeBlanc, Marissa] Univ Oslo, Oslo Ctr Biostat & Epidemiol, Dept Biostat, Oslo, Norway; [Mills, Ian G.] Univ Oslo, Ctr Mol Med Norway NCMM, Prostate Canc Res Grp, Oslo, Norway; [Mills, Ian G.] Oslo Univ Hosp, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Andreassen, OA (corresponding author), Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway.	o.a.andreassen@medisin.uio.no	Garcia-Giralt, Natalia/AAA-7588-2021; Mills, Ian/AAK-9292-2020; Aulchenko, Yurii/M-8270-2013; Brown, Matthew A/E-5749-2010; Urreizti, Roser/M-6402-2014; Andreassen, Ole A./AAY-7531-2020; Balcells, Susana/C-5222-2017; Wang, Yunpeng/W-8871-2018; Kemp, John P./R-3091-2018; Aspelund, Thor/C-5983-2008; Evans, David/H-6325-2013; /G-9410-2011; Luben, Robert/H-5519-2015; Duncan, Emma/L-1224-2013; Smith, Albert Vernon/K-5150-2015	Garcia-Giralt, Natalia/0000-0001-6507-0147; Mills, Ian/0000-0001-5347-5083; Aulchenko, Yurii/0000-0002-7899-1575; Brown, Matthew A/0000-0003-0538-8211; Urreizti, Roser/0000-0003-3617-7134; Balcells, Susana/0000-0003-1211-1907; Wang, Yunpeng/0000-0001-9831-1090; Kemp, John P./0000-0002-9105-2249; Aspelund, Thor/0000-0002-7998-5433; Leslie, William/0000-0002-1056-1691; brandi, maria luisa/0000-0002-8741-0592; Williams, Frances/0000-0002-2998-2744; Djurovic, Srdjan/0000-0002-8140-8061; Shuldiner, Alan/0000-0001-9921-4305; Reid, Ian/0000-0001-6021-5458; Zarrabeitia, Maria T./0000-0002-2836-7766; Raychaudhuri, Soumya/0000-0002-1901-8265; Amin, Najaf/0000-0002-8944-1771; van Schoor, Natasja/0000-0002-0870-0795; Wilson, Scott/0000-0002-0357-1373; Evans, David/0000-0003-0663-4621; Cauley, Jane A/0000-0003-0752-4408; Center, Jacqueline/0000-0002-5278-4527; Minster, Ryan/0000-0001-7382-6717; Nogues, Xavier/0000-0002-5537-1859; /0000-0002-5608-1589; Koromila, Theodora/0000-0001-5504-1369; Mitchell, Braxton/0000-0003-4920-4744; Ohlsson, Claes/0000-0002-9633-2805; Luben, Robert/0000-0002-5088-6343; Zuber, Verena/0000-0001-9827-1877; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Duncan, Emma/0000-0002-8143-4403; Smith, Albert Vernon/0000-0003-1942-5845; Styrkarsdottir, Unnur/0000-0001-8146-8278; marc, janja/0000-0001-6013-9758; /0000-0001-7061-6837; Kammerer, Candace M/0000-0002-2841-4761; Kahonen, Mika/0000-0002-4510-7341	Research Council of Norway [183782/V50]; South East Norway Health Authority [2010-074, 52009/8029]; National Institutes of Health [T32 EB005970, RC2DA029475, R01HD061414]; Robert J. Glushko and Pamela Samuelson Graduate Fellowship; 6th EU framework program [LSHM-CT-2003-502941]; Oslo University Hospital, Ullevaal [52009/8029]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA029475] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); South East Norway Health Authority; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert J. Glushko and Pamela Samuelson Graduate Fellowship; 6th EU framework program(European Commission); Oslo University Hospital, Ullevaal; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Research Council of Norway [grant number 183782/V50 to OAA]; the South East Norway Health Authority [grant number 2010-074 to OAA and 52009/8029 to KMG]; the National Institutes of Health [grant number T32 EB005970 to RSD, RC2DA029475 and R01HD061414 to AJS]; the Robert J. Glushko and Pamela Samuelson Graduate Fellowship to AJS; the 6th EU framework program [grant number LSHM-CT-2003-502941 to KMG and SR]; and Oslo University Hospital, Ullevaal [grant number 52009/8029 to KMG]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert-Bicknell CL, 2012, BONE, V50, P525, DOI 10.1016/j.bone.2011.07.002; Andreassen OA, 2014, INT J EPIDEMIOL, V43, P1205, DOI 10.1093/ije/dyu090; Andreassen OA, 2014, HYPERTENSION, V63, P819, DOI 10.1161/HYPERTENSIONAHA.113.02077; Andreassen OA, 2013, AM J HUM GENET, V92, P197, DOI 10.1016/j.ajhg.2013.01.001; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Billings LK, 2012, DIABETES, V61, P2176, DOI 10.2337/db11-1515; Buizert PJ, 2009, J BONE MINER RES, V24, P1103, DOI [10.1359/JBMR.081262, 10.1359/jbmr.081262]; Compston J, 2010, RADIOL CLIN N AM, V48, P477, DOI 10.1016/j.rcl.2010.02.010; Dallas SL, 2012, METHODS MOL BIOL, V816, P425, DOI 10.1007/978-1-61779-415-5_26; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fitzpatrick DJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1300-3; Fromigue O, 2010, J BIOL CHEM, V285, P25251, DOI 10.1074/jbc.M110.110502; Garg M K, 2014, Indian J Endocrinol Metab, V18, P325, DOI 10.4103/2230-8210.131165; Ge YQ, 2008, AM J PHYSIOL-RENAL, V295, pF1635, DOI 10.1152/ajprenal.90279.2008; Goettsch C, 2011, DIABETOLOGIA, V54, P2690, DOI 10.1007/s00125-011-2219-0; Gupta M, 2011, J BONE MINER RES, V26, P1261, DOI 10.1002/jbmr.333; Jackuliak P, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/820615; Janicka A, 2007, J CLIN ENDOCR METAB, V92, P143, DOI 10.1210/jc.2006-0794; Jemtland R, 2011, J BONE MINER RES, V26, P1793, DOI 10.1002/jbmr.396; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kado DM, 2000, J BONE MINER RES, V15, P1974, DOI 10.1359/jbmr.2000.15.10.1974; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kaplan S, 2010, J WOMENS HEALTH, V19, P1209, DOI 10.1089/jwh.2009.1587; Khan TS, 2015, J OSTEOPOROS, V2015, DOI 10.1155/2015/174186; Kim CJ, 2009, CLIN ENDOCRINOL, V71, P18, DOI 10.1111/j.1365-2265.2008.03452.x; Kim T, 2013, J BONE MINER METAB, V31, P652, DOI 10.1007/s00774-013-0459-4; Kim YH, 2013, ENDOCR J, V60, P1179, DOI 10.1507/endocrj.EJ13-0224; Lawlor DA, 2012, J CLIN ENDOCR METAB, V97, P2068, DOI 10.1210/jc.2011-2721; Lee HT, 2015, CLIN EXP HYPERTENS, V37, P212, DOI 10.3109/10641963.2014.933971; Li S, 2015, CLIN ENDOCRINOL, V82, P53, DOI 10.1111/cen.12616; Lin DY, 2009, AM J HUM GENET, V85, P862, DOI 10.1016/j.ajhg.2009.11.001; Liu J, 2013, BONE, V54, P151, DOI 10.1016/j.bone.2013.01.044; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Oei L, 2013, DIABETES CARE, V36, P1619, DOI 10.2337/dc12-1188; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Reppe S, 2007, AM J PHYSIOL-ENDOC M, V292, pE1465, DOI 10.1152/ajpendo.00487.2006; Reppe S, 2010, BONE, V46, P604, DOI 10.1016/j.bone.2009.11.007; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Saidak Z, 2012, AGING CELL, V11, P467, DOI 10.1111/j.1474-9726.2012.00804.x; Sayers A, 2012, J BONE MINER RES, V27, P610, DOI 10.1002/jbmr.1467; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Strait KA, 2010, J BIOL CHEM, V285, P28520, DOI 10.1074/jbc.M110.153189; Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yazici S, 2011, ARCH MED SCI, V7, P264, DOI 10.5114/aoms.2011.22077; Zillikens MC, 2010, CALCIFIED TISSUE INT, V86, P116, DOI 10.1007/s00223-009-9319-6	53	14	16	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144531	10.1371/journal.pone.0144531	http://dx.doi.org/10.1371/journal.pone.0144531			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695485	Green Published, gold			2022-12-27	WOS:000367092500005
J	Muller, A; Stellmacher, A; Freitag, CE; Landgraf, P; Dieterich, DC				Mueller, Anke; Stellmacher, Anne; Freitag, Christine E.; Landgraf, Peter; Dieterich, Daniela C.			Monitoring Astrocytic Proteome Dynamics by Cell Type-Specific Protein Labeling	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; NEWLY SYNTHESIZED PROTEINS; ACID TAGGING BONCAT; SYNAPTIC PLASTICITY; TRANSLATIONAL CONTROL; CALCIUM OSCILLATIONS; ESCHERICHIA-COLI; MAMMALIAN-CELLS; IN-VIVO; BRAIN	The ability of the nervous system to undergo long-term plasticity is based on changes in cellular and synaptic proteomes. While many studies have explored dynamic alterations in neuronal proteomes during plasticity, there has been less attention paid to the astrocytic counterpart. Indeed, progress in identifying cell type-specific proteomes is limited owing to technical difficulties. Here, we present a cell type-specific metabolic tagging technique for a mammalian coculture model based on the bioorthogonal amino acid azidonorleucine and the mutated Mus musculus methionyl-tRNA synthetase(L274G) enabling azidonorleucine introduction into de novo synthesized proteins. Azidonorleucine incorporation resulted in cell type-specific protein labeling and retained neuronal or astrocytic cell viability. Furthermore, we were able to label astrocytic de novo synthesized proteins and identified both Connexin-43 and 60S ribosomal protein L10a upregulated upon treatment with Brain-derived neurotrophic factor in astrocytes of a neuron-glia coculture. Taken together, we demonstrate the successful dissociation of astrocytic from neuronal proteomes by cell type-specific metabolic labeling offering new possibilities for the analyses of cell type-specific proteome dynamics.	[Mueller, Anke; Stellmacher, Anne; Landgraf, Peter; Dieterich, Daniela C.] Univ Magdeburg, Inst Pharmacol & Toxicol, Neural Plast & Commun, D-39106 Magdeburg, Germany; [Freitag, Christine E.; Dieterich, Daniela C.] Leibniz Inst Neurobiol, Res Grp Neural, Magdeburg, Germany; [Dieterich, Daniela C.] Ctr Behav Brain Sci, Magdeburg, Germany	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN)	Dieterich, DC (corresponding author), Univ Magdeburg, Inst Pharmacol & Toxicol, Neural Plast & Commun, D-39106 Magdeburg, Germany.	daniela.dieterich@med.ovgu.de		Dieterich, Daniela C./0000-0002-9880-1214	German Research Foundation (DFG) [DI 1512/1-1, SPP 1172/1757, DI 1512/2-1, DI 1512/5-1, GU230/6-1, SFB 779 TPB09]; Leibniz Society PAKT grant (LGS SynaptoGenetics)	German Research Foundation (DFG)(German Research Foundation (DFG)); Leibniz Society PAKT grant (LGS SynaptoGenetics)	This work was supported by the German Research Foundation (DFG; Emmy Noether Program (DI 1512/1-1), SPP 1172/1757 (DI 1512/2-1 & 5-1, German-Israeli DIP grant (GU230/6-1), SFB 779 TPB09 to D.C.D), a Leibniz Society PAKT grant (LGS SynaptoGenetics) to D.C.D.	Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Buffington SA, 2014, ANNU REV NEUROSCI, V37, P17, DOI 10.1146/annurev-neuro-071013-014100; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Chever O, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0596; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; Dieck ST, 2015, NAT METHODS, V12, P411, DOI [10.1038/nmeth.3319, 10.1038/NMETH.3319]; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Dieterich DC, 2010, CURR OPIN NEUROBIOL, V20, P623, DOI 10.1016/j.conb.2010.06.011; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Erdmann I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8521; Goudriaan A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00012; Greco TM, 2010, J PROTEOME RES, V9, P2764, DOI 10.1021/pr100134n; Habas A, 2013, P NATL ACAD SCI USA, V110, P18291, DOI 10.1073/pnas.1208764110; Han D, 2014, PROTEOMICS, V14, P1604, DOI 10.1002/pmic.201300495; Harada C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1190; Hinz FI, 2012, ACS CHEM NEUROSCI, V3, P40, DOI 10.1021/cn2000876; Hodas JJL, 2012, PROTEOMICS, V12, P2464, DOI 10.1002/pmic.201200112; Jones EV, 2011, J NEUROSCI, V31, P4154, DOI 10.1523/JNEUROSCI.4757-10.2011; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kawamura M, 2011, CELL CALCIUM, V49, P249, DOI 10.1016/j.ceca.2011.02.009; Koulakoff A, 2008, GLIA, V56, P1299, DOI 10.1002/glia.20698; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; Lange SC, 2012, NEUROCHEM RES, V37, P2569, DOI 10.1007/s11064-012-0868-0; Leal G, 2015, BRAIN RES, V1621, P82, DOI 10.1016/j.brainres.2014.10.019; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Link AJ, 2006, P NATL ACAD SCI USA, V103, P10180, DOI 10.1073/pnas.0601167103; Link AJ, 2003, J AM CHEM SOC, V125, P11164, DOI 10.1021/ja036765z; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Ngo JT, 2013, P NATL ACAD SCI USA, V110, P4992, DOI 10.1073/pnas.1216375110; Ngo JT, 2009, NAT CHEM BIOL, V5, P715, DOI 10.1038/nchembio.200; Niehues S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8520; Ohira K, 2007, EUR J NEUROSCI, V25, P406, DOI 10.1111/j.1460-9568.2007.05282.x; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; PASTI L, 1995, J BIOL CHEM, V270, P15203, DOI 10.1074/jbc.270.25.15203; Perea G, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/1ncel.2014.00378, 10.3389/fncel.2014.00378]; Pfrieger FW, 2012, GLIA, V60, P681, DOI 10.1002/glia.22283; Pirttimaki TM, 2011, J NEUROSCI, V31, P7637, DOI 10.1523/JNEUROSCI.5783-10.2011; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Rouach N, 2000, J CELL BIOL, V149, P1513, DOI 10.1083/jcb.149.7.1513; Santello M, 2012, ADV EXP MED BIOL, V970, P307, DOI 10.1007/978-3-7091-0932-8_14; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tanrikulu IC, 2009, P NATL ACAD SCI USA, V106, P15285, DOI 10.1073/pnas.0905735106; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Xie AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049637; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Ye YY, 2011, NEUROSCI LETT, V503, P15, DOI 10.1016/j.neulet.2011.07.055; Yoon BC, 2012, CELL, V148, P752, DOI 10.1016/j.cell.2011.11.064; Yuet KP, 2015, P NATL ACAD SCI USA, V112, P2705, DOI 10.1073/pnas.1421567112	52	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145451	10.1371/journal.pone.0145451	http://dx.doi.org/10.1371/journal.pone.0145451			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690742	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300076
J	Vidovic, MMC; Gornitz, N; Muller, KR; Ratsch, G; Kloft, M				Vidovic, Marina M. -C.; Goernitz, Nico; Mueller, Klaus-Robert; Raetsch, Gunnar; Kloft, Marius			SVM2Motif-Reconstructing Overlapping DNA Sequence Motifs by Mimicking an SVM Predictor	PLOS ONE			English	Article								Identifying discriminative motifs underlying the functionality and evolution of organisms is a major challenge in computational biology. Machine learning approaches such as support vector machines (SVMs) achieve state-of-the-art performances in genomic discrimination tasks, but-due to its black-box character-motifs underlying its decision function are largely unknown. As a remedy, positional oligomer importance matrices (POIMs) allow us to visualize the significance of position-specific subsequences. Although being a major step towards the explanation of trained SVM models, they suffer from the fact that their size grows exponentially in the length of the motif, which renders their manual inspection feasible only for comparably small motif sizes, typically k <= 5. In this work, we extend the work on positional oligomer importance matrices, by presenting a new machine-learning methodology, entitled motifPOIM, to extract the truly relevant motifs-regardless of their length and complexity-underlying the predictions of a trained SVM model. Our framework thereby considers the motifs as free parameters in a probabilistic model, a task which can be phrased as a non-convex optimization problem. The exponential dependence of the POIM size on the oligomer length poses a major numerical challenge, which we address by an efficient optimization framework that allows us to find possibly overlapping motifs consisting of up to hundreds of nucleotides. We demonstrate the efficacy of our approach on a synthetic data set as well as a real-world human splice site data set.	[Vidovic, Marina M. -C.; Goernitz, Nico; Mueller, Klaus-Robert] Tech Univ Berlin, Machine Learning Grp, Berlin, Germany; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul 136713, South Korea; [Raetsch, Gunnar] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Kloft, Marius] Humboldt Univ, Dept Comp Sci, D-10099 Berlin, Germany	Technical University of Berlin; Korea University; Memorial Sloan Kettering Cancer Center; Humboldt University of Berlin	Vidovic, MMC (corresponding author), Tech Univ Berlin, Machine Learning Grp, Berlin, Germany.	marina.vidovic@tu-berlin.de; klaus-robert.mueller@tu-berlin.de; ratschg@mskcc.org; kloft@hu-berlin.de	Mueller, Klaus-Robert/Y-3547-2019; Rätsch, Gunnar/O-5914-2017	Mueller, Klaus-Robert/0000-0002-3861-7685; Rätsch, Gunnar/0000-0001-5486-8532	German Research Foundation [KL 2698/1-1, KL 2698/2-1]; BMBF ALICE II grant [01IB15001B]; German Research Foundation through the grant DFG [MU 987/6-1, RA 1894/1-1]; National Research Foundation of Korea - Ministry of Education, Science, and Technology in the BK21 program; German Ministry for Education and Research as Berlin Big Data Center BBDC [01IS14013A]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); BMBF ALICE II grant(Federal Ministry of Education & Research (BMBF)); German Research Foundation through the grant DFG(German Research Foundation (DFG)); National Research Foundation of Korea - Ministry of Education, Science, and Technology in the BK21 program; German Ministry for Education and Research as Berlin Big Data Center BBDC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MK acknowledges support by the German Research Foundation (http://www.dfg.de/en/) through the grant KL 2698/1-1 and KL 2698/2-1. MMCV and NG were supported by BMBF (http://www.bmbf.de) ALICE II grant 01IB15001B. The authors also acknowledge the support by the German Research Foundation through the grant DFG MU 987/6-1 and RA 1894/1-1. KRM is thankful for partial funding by the National Research Foundation of Korea (http://www.nrf.re.kr/nrf_eng_cms/) funded by the Ministry of Education, Science, and Technology in the BK21 program and the German Ministry for Education and Research (http://www.bmbf.de/en/) as Berlin Big Data Center BBDC, funding mark 01IS14013A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We greatly thank Sebastian Schultheiss, Soren Sonnenburg, Christian Widmer, Manu Setty, Alexander Zien and Christina Leslie for interesting discussions and helpful comments. MK acknowledges support by the German Research Foundation through the grant KL 2698/1-1 and KL 2698/2-1. MMCV and NG were supported by BMBF ALICE II grant 01IB15001B. We also acknowledge the support by the German Research Foundation through the grant DFG MU 987/6-1 and RA 1894/1-1. KRM thanks for partial funding by the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology in the BK21 program and the German Ministry for Education and Research as Berlin Big Data Center BBDC, funding mark 01IS14013A.	Abeel T, 2009, BIOINFORMATICS, DOI [10.1093/bioinformatics/btp191, DOI 10.1093/BI0INF0RMATICS/BTP191]; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Baehrens D, 2010, J MACH LEARN RES, V11, P1803; Bailey T.L., 1994, FITTING A MIXTURE MO; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cortes C., 2013, ADV NEURAL INFORM PR, P2760; Gornitz N, 2009, LECT NOTES ARTIF INT, V5781, P407, DOI 10.1007/978-3-642-04180-8_44; Gorntiz N, 2015, PR MACH LEARN RES, V37, P1833; Gornitz N., 2009, P 2 ACM WORKSH SEC A, P47, DOI 10.1145/1654988.1655002; Hansen K, 2011, MOL INFORM, V30, P817, DOI 10.1002/minf.201100059; Kloft M., 2011, ADV NEURAL INFORM PR, V24, P2438; Kloft M., 2008, P 1 ACM WORKSH WORKS, P71; Kloft M, 2011, J MACH LEARN RES, V12, P953; Kloft M, 2010, LECT NOTES ARTIF INT, V6322, P66, DOI 10.1007/978-3-642-15883-4_5; LESLIE C, 2002, P PSB, V7, P566; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; Marius K., 2009, NIPS, P997; Montavon G, 2013, IEEE SIGNAL PROC MAG, V30, P62, DOI 10.1109/MSP.2013.2249294; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Nakajima S, 2009, PROCEEDINGS OF THE 1, V24; Ratsch G, 2007, PLOS COMPUT BIOL, V3, P313, DOI 10.1371/journal.pcbi.0030020; Ratsch G., 2004, KERNEL METHODS COMPU, P277; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sandelin Albin, 2003, Functional & Integrative Genomics, V3, P125, DOI 10.1007/s10142-003-0086-6; Scholkopf B., 2002, LEARNING WITH KERNEL; Sonnenburg S, 2002, LECT NOTES COMPUT SC, V2415, P329; Sonnenburg S, 2010, P 27 INT C MACH LEAR, P999; Sonnenburg S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S10-S7; Sonnenburg S, 2008, BIOINFORMATICS, V24, pI6, DOI 10.1093/bioinformatics/btn170; Sonnenburg S, 2006, BIOINFORMATICS, V22, pE472, DOI 10.1093/bioinformatics/btl250; Sonnenburg S, 2006, J MACH LEARN RES, V7, P1531; Sonnenburg S, 2010, J MACH LEARN RES, V11, P1799; Zeller G, 2013, ARXIV PREPRINT ARXIV; Zien A, 2000, BIOINFORMATICS, V16, P799, DOI 10.1093/bioinformatics/16.9.799; Zien A, 2007, COMPUTING POSITIONAL, P2	38	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144782	10.1371/journal.pone.0144782	http://dx.doi.org/10.1371/journal.pone.0144782			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690911	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092300017
J	Xia, ZQ; Zhang, J; Xue, YK; Sun, GQ; Jin, Z				Xia, Zhi-Qiang; Zhang, Juan; Xue, Ya-Kui; Sun, Gui-Quan; Jin, Zhen			Modeling the Transmission of Middle East Respirator Syndrome Corona Virus in the Republic of Korea	PLOS ONE			English	Article							MERS-COV; DYNAMICS; OUTBREAK; LESSONS; DISEASE	The 2015 epidemic of Middle East respiratory syndrome (MERS) in the Republic of Korea has been the largest outbreak outside Middle East. This epidemic had caused 185 laboratory-confirmed cases and 36 deaths in the Republic of Korea until September 2, 2015, which attracted public's attention. Based on the detailed data of patients released by World Health Organization (WHO) and actual propagation of the epidemic, we construct two dynamical models to simulate the propagation processes from May 20 to June 8 and from June 9 to July 10, 2015, respectively and find that the basic reproduction number R-0 reaches up to 4.422. The numerical analysis shows that the reasons of the outbreak spread quickly are lack of self-protection sense and targeted control measures. Through partial correction analysis, the parameters a1 and. have strong correlations with R-0, i.e., the infectivity and proportion of the asymptomatic infected cases have much influence on the spread of disease. By sensitivity analysis, strengthening self-protection ability of susceptible and quickly isolating or monitoring close contacts are effective measures to control the disease.	[Xia, Zhi-Qiang; Xue, Ya-Kui] North Univ China, Dept Math, Taiyuan 030051, Shanxi, Peoples R China; [Xia, Zhi-Qiang; Zhang, Juan; Sun, Gui-Quan; Jin, Zhen] Shanxi Univ, Complex Syst Res Ctr, Taiyuan 030006, Shanxi, Peoples R China	North University of China; Shanxi University	Xue, YK (corresponding author), North Univ China, Dept Math, Taiyuan 030051, Shanxi, Peoples R China.	xyk5152@163.com; gquansun@126.com; jinzhn@263.net	jin, zhen/B-6563-2015; Sun, Gui-Quan/Y-3606-2019; Sun, Gui-Quan/AAE-7769-2019	jin, zhen/0000-0002-9763-707X; Sun, Gui-Quan/0000-0002-1831-1603; 	National Natural Science Foundation of China [11501338, 11171314, 11331009, 11301490]; 131 Talents of Shanxi University; Top Young Academic Leaders of Higher Learning Institutions of Shanxi Province; International Exchange Program of Postdoctor in Fudan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 131 Talents of Shanxi University; Top Young Academic Leaders of Higher Learning Institutions of Shanxi Province; International Exchange Program of Postdoctor in Fudan University	The research is funded by the National Natural Science Foundation of China (under grants 11501338, 11171314, 11331009, and 11301490), 131 Talents of Shanxi University, Top Young Academic Leaders of Higher Learning Institutions of Shanxi Province, and International Exchange Program of Postdoctor in Fudan University.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Cauchemez S, 2013, EUROSURVEILLANCE, V18, P18; Chowell G, 2014, EPIDEMICS-NETH, V9, P40, DOI 10.1016/j.epidem.2014.09.011; Cowling BJ, 2015, EUROPEAN COMMUNICABL, V20; Drosten C, 2013, LANCET INFECT DIS, V13, P727, DOI 10.1016/S1473-3099(13)70159-2; Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3; Ferguson NM, 2014, LANCET INFECT DIS, V14, P93, DOI 10.1016/S1473-3099(13)70691-1; Jansen A, 2015, WEST PAC SURVEILL RE, V6, P68, DOI [10.5365/WPSAR.2015.6.3.002, 10.5365/wpsar.2015.6.3.002]; Khan A, 2015, J INFECT DEV COUNTR, V9, P543, DOI 10.3855/jidc.7278; Lee SS, 2015, INT J INFECT DIS, V38, P65, DOI 10.1016/j.ijid.2015.07.014; Li MT, 2014, MATH BIOSCI ENG, V11, P1115, DOI 10.3934/mbe.2014.11.1115; Lim PL, 2015, T ROY SOC TROP MED H, V109, P541, DOI 10.1093/trstmh/trv064; Lovecraft H P, 2013, LANCET, V382, P694; Memish ZA, 2015, TRAVEL MED INFECT DI, V13, P311, DOI 10.1016/j.tmaid.2015.06.012; Mizumoto K, 2015, INT J INFECT DIS, V39, P7, DOI 10.1016/j.ijid.2015.08.005; Nishiura H, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES2015.20.27.21181; Rivers C, MODELING EMERGING IN; Sharif-Yakan A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004457; Su S, 2015, LANCET, V385, P2349, DOI 10.1016/S0140-6736(15)60859-5; Wang Z, 2015, PHYS LIFE REV, V15, P1, DOI 10.1016/j.plrev.2015.07.006; Wang Z, 2015, PHYS LIFE REV, V14, P1, DOI 10.1016/j.plrev.2015.04.033; Wang Z, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60270-7; World Health Organization, 2015, INVESTIGATION OF CAS; World Health Organization, 2015, CLINICAL MANAGEMENT; Xia S, 2014, VIRUS RES, V194, P200, DOI 10.1016/j.virusres.2014.10.007; Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108592; Zhang RongHua, 2015, Journal of Applied Virology, V4, P30	29	32	32	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144778	10.1371/journal.pone.0144778	http://dx.doi.org/10.1371/journal.pone.0144778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690750	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300016
J	Sanabria-Urban, S; Song, HJ; Oyama, K; Gonzalez-Rodriguez, A; Serrano-Meneses, MA; del Castillo, RC				Sanabria-Urban, Salomon; Song, Hojun; Oyama, Ken; Gonzalez-Rodriguez, Antonio; Serrano-Meneses, Martin A.; Cueva del Castillo, Raul			Body Size Adaptations to Altitudinal Climatic Variation in Neotropical Grasshoppers of the Genus Sphenarium (Orthoptera: Pyrgomorphidae)	PLOS ONE			English	Article							LIFE-HISTORY VARIATION; SEXUAL SELECTION; PURPURASCENS ORTHOPTERA; ONTOGENIC PERSPECTIVE; CORRELATED RESPONSE; RENSCHS RULE; DIMORPHISM; INSECTS; EVOLUTION; INFERENCE	Altitudinal clines in body size can result from the effects of natural and sexual selection on growth rates and developing times in seasonal environments. Short growing and reproductive seasons constrain the body size that adults can attain and their reproductive success. Little is known about the effects of altitudinal climatic variation on the diversification of Neotropical insects. In central Mexico, in addition to altitude, highly heterogeneous topography generates diverse climates that can occur even at the same latitude. Altitudinal variation and heterogeneous topography open an opportunity to test the relative impact of climatic variation on body size adaptations. In this study, we investigated the relationship between altitudinal climatic variation and body size, and the divergence rates of sexual size dimorphism (SSD) in Neotropical grasshoppers of the genus Sphenarium using a phylogenetic comparative approach. In order to distinguish the relative impact of natural and sexual selection on the diversification of the group, we also tracked the altitudinal distribution of the species and trends of both body size and SSD on the phylogeny of Sphenarium. The correlative evidence suggests no relationship between altitude and body size. However, larger species were associated with places having a warmer winter season in which the temporal window for development and reproduction can be longer. Nonetheless, the largest species were also associated with highly seasonal environments. Moreover, large body size and high levels of SSD have evolved independently several times throughout the history of the group and male body size has experienced a greater evolutionary divergence than females. These lines of evidence suggest that natural selection, associated with seasonality and sexual selection, on maturation time and body size could have enhanced the diversification of this insect group.	[Sanabria-Urban, Salomon; Cueva del Castillo, Raul] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, UBIPRO, Lab Ecol, AP 314, Mexico City 54090, DF, Mexico; [Song, Hojun] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Oyama, Ken; Gonzalez-Rodriguez, Antonio] UNAM, Inst Invest Ecosistemas & Sustentabilidad, Morelia 58190, Michoacan, Mexico; [Serrano-Meneses, Martin A.] Univ Autonoma Tlaxcala, Ctr Tlaxcala Biol Conducta, Lab Biol Evolut, Tlaxcala 90062, Mexico	Universidad Nacional Autonoma de Mexico; Texas A&M University System; Texas A&M University College Station; Universidad Nacional Autonoma de Mexico	del Castillo, RC (corresponding author), Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, UBIPRO, Lab Ecol, AP 314, Mexico City 54090, DF, Mexico.	rcueva@ecologia.unam.mx	Cueva del Castillo, Raul/D-3800-2018; Serrano-Meneses, Martin Alejandro/V-6601-2019	Cueva del Castillo, Raul/0000-0002-6385-0729; Serrano-Meneses, Martin Alejandro/0000-0002-0163-4983; Sanabria-Urban, Salomon/0000-0002-4079-498X	Universidad Nacional Autonoma de Mexico, Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IN 220214]; Consejo Nacional de Ciencia y Tecnologia, Ciencia Basica [57009]; PAPIIT-UNAM [IN220214]; CONACyT [57009, 262893]; NSF [IOS-1253493]	Universidad Nacional Autonoma de Mexico, Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica; Consejo Nacional de Ciencia y Tecnologia, Ciencia Basica; PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NSF(National Science Foundation (NSF))	This work was supported by the following sources of funding: Universidad Nacional Autonoma de Mexico, Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica: IN 220214; Consejo Nacional de Ciencia y Tecnologia, Ciencia Basica 57009.r We thank O. Tellez-Valdez, M. Arenas-Navarro and W. Ramirez-Toro for their support with the geographic information systems, E. Aguilar for her support in the laboratory and A. Blanco, A. Diaz-De la Vega, A. Pingarroni, F. A. Rivera-Ortiz, P. Gomez-Ruiz, R. Marino-Perez, P. Fontana and V. Jimenez-Arcos for their support in the field work. We thank E. Marino-Pedraza, M. F. O'brien and J. D. Weintraub for the facilities provided to review the museum type specimens. We thank Enio Cano for the facilities provided to obtain samples from Guatemala. Thanks also to Derek A. Woller for reviewing and editing the English of this manuscript. Matthias Foellmer, Matjaz Kuntner and an anonymous reviewer made valuable suggestions to improve the quality of the manuscript. This research was partially supported by the following projects: PAPIIT-UNAM IN220214, CONACyT-57009, and NSF IOS-1253493. S. Sanabria-Urban is a doctoral student from Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) and received fellowship 262893 from CONACYT.	Abrams PA, 1996, AM NAT, V147, P381, DOI 10.1086/285857; [Anonymous], 2014, TRACER V1 6; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Berner D, 2007, FUNCT ECOL, V21, P505, DOI 10.1111/j.1365-2435.2007.01253.x; Berner D, 2006, J ANIM ECOL, V75, P130, DOI 10.1111/j.1365-2656.2005.01028.x; Berner D, 2004, ECOGRAPHY, V27, P733, DOI 10.1111/j.0906-7590.2005.04012.x; Blanckenhorn WU, 2007, AM NAT, V169, P245, DOI 10.1086/510597; Blanckenhorn WU, 2004, INTEGR COMP BIOL, V44, P413, DOI 10.1093/icb/44.6.413; Blanckenhorn WU, 1997, OECOLOGIA, V109, P342, DOI 10.1007/s004420050092; Blanckenhorn WU, 2007, SEX SIZE GENDER ROLE, P278; Boyle WK, 1974, REVISION GENUS SPHEN; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Brandt R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020040; Cano-Santana Z., 2009, BIODIVERSIDAD ECOSIS, P337; CHEVERUD JM, 1985, EVOLUTION, V39, P1335, DOI 10.1111/j.1558-5646.1985.tb05699.x; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Cuervo-Robayo AP, 2014, INT J CLIMATOL, V34, P2427, DOI 10.1002/joc.3848; CUEVA D, 2003, J INSECT BEHAV, V16, P503, DOI DOI 10.1023/A:1027303323242; Dale J, 2007, P ROY SOC B-BIOL SCI, V274, P2971, DOI 10.1098/rspb.2007.1043; del Castillo RC, 1999, ECOL ENTOMOL, V24, P146, DOI 10.1046/j.1365-2311.1999.00188.x; del Castillo RC, 2002, OIKOS, V96, P217, DOI 10.1034/j.1600-0706.2002.960203.x; Del Castillo RC, 1999, EVOLUTION, V53, P209, DOI 10.1111/j.1558-5646.1999.tb05346.x; Descamps M., 1975, Folia Ent Mex, VNo. 31-32, P3; DINGLE H, 1990, OECOLOGIA, V84, P199, DOI 10.1007/BF00318272; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eades DC, 2015, ORTHOPTERA SPECIES F; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fairburn Daphne J., 2007, P1; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Foellmer MW, 2007, SEX SIZE GENDER ROLE, P278; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hagen SB, 2007, ECOGRAPHY, V30, P299, DOI [10.1111/j.2007.0906-7590.04981.x, 10.1111/j.0906-7590.2007.04981.x]; Harvey P, 1991, OXFORD SERIES ECOLOG; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Horne CR, 2015, ECOL LETT, V18, P327, DOI 10.1111/ele.12413; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Jones KE, 1997, FUNCT ECOL, V11, P751, DOI 10.1046/j.1365-2435.1997.00149.x; Karl I, 2008, OIKOS, V117, P778, DOI 10.1111/j.0030-1299.2008.16522.x; Kevan D.K.M., 1978, Revista de la Sociedad Entomologica Argentina, V36, P3; KEVAN D. KEITH McE., 1964, PROC ACAD NATUR SCI PHILA, V116, P231; Krasnov B, 1996, J ARID ENVIRON, V34, P477, DOI 10.1006/jare.1996.0126; Laiolo P, 2013, J EVOLUTION BIOL, V26, P2171, DOI 10.1111/jeb.12213; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Lehmann Gerund U. C., 2008, Journal of Orthoptera Research, V17, P165, DOI 10.1665/1082-6467-17.2.165; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Lugo-Olguin SD, 2007, ANN ENTOMOL SOC AM, V100, P591, DOI 10.1603/0013-8746(2007)100[591:MMFFAA]2.0.CO;2; Maddison, 2018, MESQUITE MODULAR SYS; Marques-Mayaudon C, 1962, AN I BIOL U MEX, V33, P247; Marquez C., 1965, AN I BIOL UNAM Z, V39, P107; Marquez M C., 1965, Anales del Instituto de Biologia Universidad de Mexico, V35, P87; McLean MJ, 2013, EVOL BIOL, V40, P141, DOI 10.1007/s11692-012-9197-0; Morbey YE, 2013, J THEOR BIOL, V339, P93, DOI 10.1016/j.jtbi.2013.05.009; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Moya-Larano J, 2002, EVOLUTION, V56, P420, DOI 10.1111/j.0014-3820.2002.tb01351.x; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; O'Donnell M.S., 2012, US GEOLOGICAL SURVEY, V691, P10, DOI [DOI 10.3133/DS691, 10.1016/j.mimet.2011.04.001]; Orme D, 2013, R PACKAGE VERSION 0; Oyama K, 1994, ESTUDIOS INTERACCION, P301; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PEREZ DE, 1995, ANN ENTOMOL SOC AM, V88, P31, DOI 10.1093/aesa/88.1.31; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poissant J, 2010, EVOLUTION, V64, P97, DOI 10.1111/j.1558-5646.2009.00793.x; R Core Team, 2021, R LANGUAGE ENV STAT; Raihani G, 2006, ANIM BEHAV, V71, P833, DOI 10.1016/j.anbehav.2005.06.013; Reeve JP, 1996, EVOLUTION, V50, P1927, DOI [10.2307/2410751, 10.1111/j.1558-5646.1996.tb03580.x]; Rensch B., 1950, Bonner Zoologische Beitraege, V1, P58; ROFF D, 1980, OECOLOGIA, V45, P202, DOI 10.1007/BF00346461; Serrano Limon G., 1989, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V59, P139; Serrano-Meneses MA, 2007, ANIM BEHAV, V73, P987, DOI 10.1016/j.anbehav.2006.08.012; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sokal R. R., 1981, BIOMETRY; Sol D, 2014, P NATL ACAD SCI USA, V111, pE534, DOI 10.1073/pnas.1320729111; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Song HJ, 2009, INSECT SYST EVOL, V40, P159, DOI 10.1163/187631209X424571; Sorensen JG, 2005, J EVOLUTION BIOL, V18, P829, DOI 10.1111/j.1420-9101.2004.00876.x; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Svenson GJ, 2004, SYST ENTOMOL, V29, P359, DOI 10.1111/j.0307-6970.2004.00240.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatarnic NJ, 2013, INVERTEBR SYST, V27, P307, DOI 10.1071/IS12072; Thornhill R., 1983, pi; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Webb TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000897; Whitman Douglas W., 2008, Journal of Orthoptera Research, V17, P117, DOI 10.1665/1082-6467-17.2.117; WIKLUND C, 1991, OIKOS, V60, P373, DOI 10.2307/3545080; Wiklund C, 1988, AM NATURALIST, P132, DOI 10.1086/284779; Yom-Tov Y, 2006, OECOLOGIA, V148, P213, DOI 10.1007/s00442-006-0364-9	93	16	16	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145248	10.1371/journal.pone.0145248	http://dx.doi.org/10.1371/journal.pone.0145248			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684616	Green Published, gold, Green Submitted			2022-12-27	WOS:000366725800052
J	Agossa, FR; Gnanguenon, V; Anagonou, R; Azondekon, R; Aizoun, N; Sovi, A; Oke-Agbo, F; Sezonlin, M; Akogbeto, MC				Agossa, Fiacre R.; Gnanguenon, Virgile; Anagonou, Rodrigue; Azondekon, Roseric; Aizoun, Nazaire; Sovi, Arthur; Oke-Agbo, Frederic; Sezonlin, Michel; Akogbeto, Martin C.			Impact of Insecticide Resistance on the Effectiveness of Pyrethroid-Based Malaria Vectors Control Tools in Benin: Decreased Toxicity and Repellent Effect	PLOS ONE			English	Article							ANOPHELES-GAMBIAE-S.L.; TREATED NETS; BENDIOCARB; TRANSMISSION; POPULATIONS; EFFICACY	Since the first evidence of pyrethroids resistance in 1999 in Benin, mutations have rapidly increased in mosquitoes and it is now difficult to design a study including a control area where malaria vectors are fully susceptible. Few studies have assessed the after effect of resistance on the success of pyrethroid based prevention methods in mosquito populations. We therefore assessed the impact of resistance on the effectiveness of pyrethroids based indoor residual spraying (IRS) in semi-field conditions and long lasting insecticidal nets (LLINs) in laboratory conditions. The results observed showed low repulsion and low toxicity of pyrethroids compounds in the test populations. The toxicity of pyrethroids used in IRS was significantly low with An. gambiae s.l (< 46%) but high for other predominant species such as Mansonia africana (93% to 97%). There were significant differences in terms of the repellent effect expressed as exophily and deterrence compared to the untreated huts (P<0.001). Furthermore, mortality was 23.71% for OlyseNet (R) and 39.06% for PermaNet (R). However, with laboratory susceptible "Kisumu", mortality was 100% for both nets suggesting a resistance within the wild mosquito populations. Thus treatment with pyrethroids at World Health Organization recommended dose will not be effective at reducing malaria in the coming years. Therefore it is necessary to study how insecticide resistance decreases the efficacy of particular pyrethroids used in pyrethroid-based vector control so that a targeted approach can be adopted.	[Agossa, Fiacre R.; Gnanguenon, Virgile; Anagonou, Rodrigue; Azondekon, Roseric; Aizoun, Nazaire; Sovi, Arthur; Oke-Agbo, Frederic; Akogbeto, Martin C.] CREC, Cotonou, Benin; [Sezonlin, Michel; Akogbeto, Martin C.] FAST UAC, Lab Evolut Biodiversite Arthropodes & Assainissem, Abomey Calavi, Benin	Entomological Research Center of Cotonou (CREC); University of Abomey Calavi	Agossa, FR (corresponding author), CREC, Cotonou, Benin.	rofargossa@yahoo.fr		SOVI, ARTHUR/0000-0003-1294-2129; Azondekon, Roseric/0000-0001-9155-4153	Tagros under grant Tagros/CREC/; Tagros	Tagros under grant Tagros/CREC/; Tagros	The research leading to these results was financially supported by Tagros under grant Tagros/CREC/June 12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Tagros which funded this study. We acknowledge all volunteers from Malanville for participating and facilitating this study. We are also grateful to Simon MCollins for language editing.	Agossa FR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-193; Agossa FR, 2014, T ROY SOC TROP MED H, V108, P84, DOI 10.1093/trstmh/trt117; Aikpon R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-192; Akogbeto M, 1999, B SOC PATHOL EXOT, V92, P123; Akogbeto M, 2011, AM J TROP MED HYG, V85, P586, DOI 10.4269/ajtmh.2011.10-0668; Akogbeto MC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-22; Akogbeto MC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-204; Alonso PL, 2011, PLOS MED, V8, DOI DOI 10.1371/J0URNA; [Anonymous], 2010, TECHNICAL REPORT; [Anonymous], 2010, VCC DEV NEW PUBL HLT; [Anonymous], 1985, INT GUIDING PRINCIPL; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Djegbe I, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-409; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Gnanguenon V, 2013, BMC PUBLIC HEALTH, V13, P1; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; LAURENCE B. R., 1960, BULL ENT RES, V51, P491, DOI 10.1017/S0007485300055127; Malima RC, 2008, MALARIA J, V7, P6; Moore SJ, 2007, TROP MED INT HEALTH, V12, P532, DOI 10.1111/j.1365-3156.2006.01811.x; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Padonou GG, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-72; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Sovi A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-319; Stanczyk NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054438; Ughasi J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-89; WHO, 2013, TEST PROC INS RES MA	29	15	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145207	10.1371/journal.pone.0145207	http://dx.doi.org/10.1371/journal.pone.0145207			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674643	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700114
J	Alves, J; Madureira, P; Baltazar, MT; Barros, L; Oliveira, L; Dinis-Oliveira, RJ; Andrade, EB; Ribeiro, A; Vieira, LM; Trieu-Cuot, P; Duarte, JA; Carvalho, F; Ferreira, P				Alves, Joana; Madureira, Pedro; Baltazar, Maria Teresa; Barros, Leandro; Oliveira, Liliana; Dinis-Oliveira, Ricardo Jorge; Andrade, Elva Bonifacio; Ribeiro, Adlia; Vieira, Luis Mira; Trieu-Cuot, Patrick; Duarte, Jose Alberto; Carvalho, Felix; Ferreira, Paula			A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice	PLOS ONE			English	Article							NONPREGNANT ADULTS; DISEASE; PROTEINS; SURFACE; PREVENTION; SEROTYPES; TOXICITY; MARKERS; HUMANS; RATS	Group B Streptococcus (GBS), a commensal organism, can turn into a life-threatening pathogen in neonates and elderly, or in adults with severe underlying diseases such as diabetes. We developed a vaccine targeting the GBS glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a glycolytic enzyme detected at the bacterial surface, which was proven to be effective in a neonatal mouse model of infection. Since this bacterium has emerged as an important pathogen in non-pregnant adults, here we investigated whether this vaccine also confers protection in an adult susceptible and in a diabetic mouse model of infection. For immunoprotection studies, sham or immunized adult mice were infected with GBS serotype Ia and V strains, the two most prevalent serotypes isolated in adults. Sham and vaccinated mice were also rendered diabetic and infected with a serotype V GBS strain. For toxicological (pre-clinical) studies, adult mice were vaccinated three times, with three concentrations of recombinant GAPDH adjuvanted with Allydrogel, and the toxicity parameters were evaluated twenty-four hours after the last immunization. For the stability tests, the vaccine formulations were maintained at 4 degrees C for 6 and 12 months prior immunization. The results showed that all tested doses of the vaccine, including the stability study formulations, were immunogenic and that the vaccine was innocuous. The organs (brain, blood, heart, and liver) of vaccinated susceptible or diabetic adult mice were significantly less colonized compared to those of control mice. Altogether, these results demonstrate that the GAPDH-based vaccine is safe and stable and protects susceptible and diabetic adult mice against GBS infections. It is therefore a promising candidate as a global vaccine to prevent GBS-induced neonatal and adult diseases.	[Alves, Joana; Madureira, Pedro; Barros, Leandro; Oliveira, Liliana; Andrade, Elva Bonifacio; Ribeiro, Adlia; Vieira, Luis Mira; Ferreira, Paula] Univ Porto, ICBAS, P-4100 Porto, Portugal; [Alves, Joana; Madureira, Pedro; Oliveira, Liliana; Andrade, Elva Bonifacio; Ribeiro, Adlia; Ferreira, Paula] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Porto, Portugal; [Alves, Joana; Madureira, Pedro; Oliveira, Liliana; Andrade, Elva Bonifacio; Ribeiro, Adlia; Ferreira, Paula] Univ Porto, IBMC, P-4100 Porto, Portugal; [Baltazar, Maria Teresa; Dinis-Oliveira, Ricardo Jorge; Carvalho, Felix] Univ Porto, Fac Farm, REQUIMTE, Toxicol Lab, P-4100 Porto, Portugal; [Dinis-Oliveira, Ricardo Jorge] Univ Porto, Fac Med, Dept Legal Med & Forens Sci, P-4100 Porto, Portugal; [Dinis-Oliveira, Ricardo Jorge] CRL, Inst Res & Adv Training Hlth Sci & Technol, Adv Inst Hlth Sci, IINFACTS,Dept Sci,North ISCS N,CESPU, Gandra, Portugal; [Trieu-Cuot, Patrick] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, CNRS, ERL 3526, Paris, France; [Duarte, Jose Alberto] Univ Porto, Fac Desporto, CIAFEL, P-4100 Porto, Portugal	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade do Porto	Ferreira, P (corresponding author), Univ Porto, ICBAS, Rua Campo Alegre 823, P-4100 Porto, Portugal.	pauferr@icbas.up.pt	Duarte, Jose Alberto/F-1443-2013; Oliveira, Liliana/AAX-9115-2021; Andrade, Elva Bonifácio/K-3096-2013; Carvalho, Félix/D-4914-2013; Oliveira, Liliana/K-5859-2013; Dinis-Oliveira, Ricardo Jorge/D-9186-2013; Madureira, Pedro/D-2174-2013; Alves, Joana EV/J-6866-2013; Ferreira da Silva, Paula/J-6149-2013	Duarte, Jose Alberto/0000-0003-4756-5917; Oliveira, Liliana/0000-0001-5222-7600; Andrade, Elva Bonifácio/0000-0002-1941-580X; Carvalho, Félix/0000-0003-3858-3494; Oliveira, Liliana/0000-0001-5222-7600; Dinis-Oliveira, Ricardo Jorge/0000-0001-7430-6297; Madureira, Pedro/0000-0003-4078-800X; Alves, Joana EV/0000-0003-3131-9834; TRIEU-CUOT, Patrick/0000-0002-2768-9587; Barros, Leandro/0000-0002-7339-9994; Ferreira da Silva, Paula/0000-0001-8639-9224	European Regional Development Fund (FEDER) through the Operational Competitiveness Program (COMPETE) under Project FCOMP [01-0124-FEDER-015841]; National funds from the Foundation for Science and Technology (FCT) [PTDC/SAU - MIC/111387/2009, RFH/BD/77232/2011, SFRH/BPD/88137/2012]	European Regional Development Fund (FEDER) through the Operational Competitiveness Program (COMPETE) under Project FCOMP; National funds from the Foundation for Science and Technology (FCT)	This work was supported by funds from European Regional Development Fund (FEDER) through the Operational Competitiveness Program (COMPETE) under Project FCOMP [01-0124-FEDER-015841] and National funds from the Foundation for Science and Technology (FCT) [PTDC/SAU - MIC/111387/2009, RFH/BD/77232/2011 to JA and SFRH/BPD/88137/2012 to PM].	BAKER CJ, 1976, NEW ENGL J MED, V294, P753, DOI 10.1056/NEJM197604012941404; BAKER CJ, 1985, REV INFECT DIS, V7, P458; Barrow P, 2012, J PHARMACOL TOX MET, V65, P58, DOI 10.1016/j.vascn.2011.12.001; Bellais S, 2012, J INFECT DIS, V206, P1745, DOI 10.1093/infdis/jis605; Bergseng H, 2008, EUR J CLIN MICROBIOL, V27, P1193, DOI 10.1007/s10096-008-0565-8; BERNARD A, 1995, TOXICOL LETT, V77, P145, DOI 10.1016/0378-4274(95)03284-3; Black S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005451; Blancas D, 2004, EUR J CLIN MICROBIOL, V23, P168, DOI 10.1007/s10096-003-1098-9; Bozbas H, 2006, CLIN MED RES, V4, P79, DOI 10.3121/cmr.4.1.79; Chen DX, 2013, J PHARM SCI-US, V102, P29, DOI 10.1002/jps.23352; Da Cunha V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5544; Dinis M, 2009, J INFECT DIS, V199, P116, DOI 10.1086/594372; Dinis-Oliveira RJ, 2007, FREE RADICAL BIO MED, V42, P1017, DOI 10.1016/j.freeradbiomed.2006.12.031; Domingo P, 1997, CLIN INFECT DIS, V25, P1180, DOI 10.1086/516094; Edwards MS, 2008, HUM VACCINES, V4, P444, DOI 10.4161/hv.4.6.6507; FABINY DL, 1971, CLIN CHEM, V17, P696; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Feng YJ, 2009, J INFECT DIS, V200, P1583, DOI 10.1086/644602; Forster R, 2012, J PHARMACOL TOX MET, V66, P1, DOI 10.1016/j.vascn.2012.04.003; Hayashi K, 2006, BIOL PHARM BULL, V29, P1110, DOI 10.1248/bpb.29.1110; Henningham A, 2012, J MOL MED, V90, P1197, DOI 10.1007/s00109-012-0897-9; Hill SA, 2009, FEMS MICROBIOL REV, V33, P521, DOI 10.1111/j.1574-6976.2009.00171.x; JACKSON LA, 1995, ANN INTERN MED, V123, P415, DOI 10.7326/0003-4819-123-6-199509150-00003; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; Jordan HT, 2008, PEDIATR INFECT DIS J, V27, P1057, DOI 10.1097/INF.0b013e318180b3b9; Kim SB, 1998, NEPHROL DIAL TRANSPL, V13, P2053, DOI 10.1093/ndt/13.8.2053; Knezevic I, 2009, BIOLOGICALS, V37, P357, DOI 10.1016/j.biologicals.2009.08.004; Lachenauer CS, 1999, J INFECT DIS, V179, P1030, DOI 10.1086/314666; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Madureira P, 2007, J IMMUNOL, V178, P1379, DOI 10.4049/jimmunol.178.3.1379; Madureira P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002363; Magalhaes V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063244; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Martins ER, 2012, J CLIN MICROBIOL, V50, P1219, DOI 10.1128/JCM.05488-11; Matull WR, 2006, J CLIN PATHOL, V59, P340, DOI 10.1136/jcp.2002.002923; Obianime A W, 2009, Niger J Physiol Sci, V24, P177; Oliveira L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029963; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Palmeiro JK, 2011, VACCINE, V29, P3729, DOI 10.1016/j.vaccine.2011.02.102; Persson E, 2004, CLIN MICROBIOL INFEC, V10, P791, DOI 10.1111/j.1469-0691.2004.00931.x; Sambola A, 2002, CLIN INFECT DIS, V34, P1576, DOI 10.1086/340538; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Seifert KN, 2003, CAN J MICROBIOL, V49, P350, DOI 10.1139/W03-042; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; TALKE H, 1965, KLIN WOCHENSCHR, V43, P174, DOI 10.1007/BF01484513; Tazi A, 2011, CLIN MICROBIOL INFEC, V17, P1587, DOI 10.1111/j.1469-0691.2011.03628.x; Watterson C, 2009, TOXICOL PATHOL, V37, P28, DOI 10.1177/0192623308329286; Zeissig S, 2014, NAT IMMUNOL, V15, P307, DOI 10.1038/ni.2847	49	9	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144196	10.1371/journal.pone.0144196	http://dx.doi.org/10.1371/journal.pone.0144196			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673420	Green Published, gold			2022-12-27	WOS:000366722700029
J	Fan, GX; Guan, XF; Sun, Q; Hu, AN; Zhu, YJ; Gu, GF; Zhang, HL; He, SS				Fan, Guoxin; Guan, Xiaofei; Sun, Qi; Hu, Annan; Zhu, Yanjie; Gu, Guangfei; Zhang, Hailong; He, Shisheng			Puncture Reduction in Percutaneous Transforaminal Endoscopic Discectomy with HE's Lumbar LOcation (HELLO) System: A Cadaver Study	PLOS ONE			English	Article							OPERATING-ROOM PERSONNEL; RADIATION-EXPOSURE; INTERBODY FUSION; SPINAL SURGERY; STENOSIS	Background Percutaneous transforaminal endoscopic discectomy (PTED) usually requires numerous punctures under X-ray fluoroscopy. Repeated puncture will lead to more radiation exposure and reduce the beginners' confidence. Objective This cadaver study aimed to investigate the efficacy of HE's Lumbar Location (HELLO) system in puncture reduction of PTED. Study design Cadaver study. Setting Comparative groups. Methods HELLO system consists of self-made surface locator and puncture locator. One senior surgeon conducted the puncture procedure of PTED on the left side of 20 cadavers at L4/L5 and L5/S1 level with the assistance of HELLO system (Group A). Additionally, the senior surgeon conducted the puncture procedure of PTED on the right side of the cadavers at L4/L5 and L5/S1 level with traditional methods (Group B). On the other hand, an inexperienced surgeon conducted the puncture procedure of PTED on the left side of the cadavers at L4/L5 and L5/S1 level with the assistance of our HELLO system (Group C). Results At L4/L5 level, there was significant difference in puncture times between Group A and Group B (P<0.001), but no significant difference was observed between Group A and Group C (P = 0.811). Similarly at L5/S1 level, there was significant difference in puncture times between Group A and Group B (P<0.001), but no significant difference was observed between Group A and Group C (P = 0.981). At L4/L5 level, there was significant difference in fluoroscopy time between Group A and Group B (P<0.001), but no significant difference was observed between Group A and Group C (P = 0.290). Similarly at L5/S1 level, there was significant difference in fluoroscopy time between Group A and Group B (P<0.001), but no significant difference was observed between Group A and Group C (P = 0.523). As for radiation exposure, HELLO system reduced 39%-45% radiation dosage when comparing Group A and Group B, but there was no significant difference in radiation exposure between Group A and Group C whatever at L4/L5 level or L5/S1 level (P>0.05). There was no difference in location time between Group A and Group B or Group A and Group C either at L4/L5 level or L5/S1 level (P>0.05). Limitations Small-sample preclinical study. Conclusion HELLO system was effective in reducing puncture times, fluoroscopy time and radiation exposure, as well as the difficulty of learning PTED. (2015-RES-127)	[Fan, Guoxin; Guan, Xiaofei; Sun, Qi; Hu, Annan; Zhu, Yanjie; Gu, Guangfei; Zhang, Hailong; He, Shisheng] Tongji Univ, Sch Med, Dept Orthoped, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China	Tongji University	He, SS (corresponding author), Tongji Univ, Sch Med, Dept Orthoped, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.	tjhss7418@foxmail.com			National College Students' Innovative Project-Tongji University [1500107108]	National College Students' Innovative Project-Tongji University	This study was supported by the National College Students' Innovative Project-Tongji University (1500107108).	Abdullah KG, 2012, SPINE, V37, pE1074, DOI 10.1097/BRS.0b013e31825786d8; Ahn Y, 2014, EXPERT REV MED DEVIC, V11, P605, DOI 10.1586/17434440.2014.940314; Ahn Y, 2013, SPINE, V38, P617, DOI 10.1097/BRS.0b013e318275ca58; Ahn Y, 2012, EXPERT REV MED DEVIC, V9, P361, DOI [10.1586/erd.12.23, 10.1586/ERD.12.23]; Fan GX, 2015, J PEDIATR ORTHOPED, V35, pE37, DOI 10.1097/BPO.0000000000000279; Fan GX, 2015, J SPINAL DISORD TECH, V28, pE173, DOI 10.1097/BSD.0000000000000210; Fan GX, 2015, SPINE J, V15, P797, DOI 10.1016/j.spinee.2014.09.034; Fan GX, 2014, J SPINAL DISORD TECH, V27, P448, DOI 10.1097/BSD.0000000000000083; Gu G, 2013, J SPINAL DISORD TECH; Gu GF, 2013, J SPINAL DISORD TECH, V26, pE277, DOI 10.1097/BSD.0b013e31828677d8; Kafadar A, 2006, MINIM INVAS NEUROSUR, V49, P74, DOI 10.1055/s-2006-932184; Moses ZB, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.5.FOCUS13150; Mulconrey DS, 2013, J SPINAL DISORD TECH; Nellensteijn J, 2010, EUR SPINE J, V19, P879, DOI 10.1007/s00586-009-1272-6; Nellensteijn J, 2010, EUR SPINE J, V19, P181, DOI 10.1007/s00586-009-1155-x; Tabaraee E, 2013, SPINE, V38, P1953, DOI 10.1097/BRS.0b013e3182a51d1e; Taher F, 2013, SPINE, V38, P1386, DOI 10.1097/BRS.0b013e31828705ad; Zhang L, 2014, MINIM INVASIV THER, V23, P173, DOI 10.3109/13645706.2013.870914	18	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144939	10.1371/journal.pone.0144939	http://dx.doi.org/10.1371/journal.pone.0144939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674640	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700075
J	Boa, ISF; Porto, ML; Pereira, ACH; Ramos, JPL; Scherer, R; Oliveira, JP; Nogueira, BV; Meyrelles, SS; Vasquez, EC; Endringer, DC; Pereira, TMC				Fonte Boa, Igor Santos; Porto, Marcella Leite; Hertel Pereira, Ana Claudia; Louzada Ramos, Jean Pierre; Scherer, Rodrigo; Oliveira, Jairo Pinto; Nogueira, Breno Valentim; Meyrelles, Silvana Santos; Vasquez, Elisardo Corral; Endringer, Denise Coutinho; Costa Pereira, Thiago Melo			Resin from Virola oleifera Protects Against Radiocontrast-Induced Nephropathy in Mice	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CONTRAST-INDUCED NEPHROPATHY; OXIDATIVE STRESS; RENOVASCULAR HYPERTENSION; ASCORBIC-ACID; NITRIC-OXIDE; RISK-FACTORS; DNA-DAMAGE; PREVENTION; MEDIA	Contrast-induced nephropathy (CIN) is an iatrogenic medical event for which there is not yet a successful therapy. Increasing evidence in rodents has suggested that this disease is associated with renal tubular and vascular injury that is triggered directly by oxidative stress. In the present study, we evaluated whether the antioxidant resin from Virola oleifera (RV) could attenuate renal damage in an experimental mouse model of CIN. Adult male Swiss mice were divided into six groups and pre-treated orally with RV (10, 100 and 300 mg/kg), N-acetylcysteine (200 mg/kg) or vehicle for 5 days before the induction of CIN and Control group. Renal function was assessed by measuring plasma creatinine and urea levels. Additionally, renal oxidative stress and apoptosis/cell viability were determined with flow cytometry. Finally, kidney tissues were sectioned for histopathological examination. In this CIN model, pre-treatment with RV improved renal function, lowered the mortality rate, and reduced oxidative stress and apoptosis in both the medulla and cortex renal cells in a dose-dependent manner. Moreover, the RV treatment had beneficial effects on kidney histopathology that were superior to the standard treatment with N-acetylcysteine. These data suggest that because of its antioxidative and antiapoptotic effects and its ability to preserve renal function, resin from Virola oleifera may have potential as a new therapeutic approach for preventing CIN.	[Fonte Boa, Igor Santos; Hertel Pereira, Ana Claudia; Louzada Ramos, Jean Pierre; Scherer, Rodrigo; Vasquez, Elisardo Corral; Endringer, Denise Coutinho; Costa Pereira, Thiago Melo] Vila Velha Univ UVV, Pharmaceut Sci Grad Program, Vila Velha, ES, Brazil; [Porto, Marcella Leite; Meyrelles, Silvana Santos; Vasquez, Elisardo Corral] Univ Fed Espirito Santo, Hlth Sci Ctr, Lab Translat Physiol, Vitoria, Brazil; [Oliveira, Jairo Pinto; Nogueira, Breno Valentim] Univ Fed Espirito Santo, Dept Morphol, Hlth Sci Ctr, Vitoria, Brazil; [Endringer, Denise Coutinho; Costa Pereira, Thiago Melo] Fed Inst Educ Sci & Technol IFES, Vila Velha, ES, Brazil	Centro Universitario Vila Velha; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Instituto Federal do Espirito Santo (IFES)	Pereira, TMC (corresponding author), Vila Velha Univ UVV, Pharmaceut Sci Grad Program, Vila Velha, ES, Brazil.	pereiratmc@gmail.com	Endringer, Denise C/N-7520-2017; OLIVEIRA, JAIRO/I-7147-2019; Meyrelles, Silvana/GPW-5312-2022; Endringer, Denise/AAB-5156-2021; Scherer, Rodrigo/J-8594-2012; NOGUEIRA, BRENO/X-7418-2019; Vasquez, Elisardo C/D-5885-2012; NOGUEIRA, BRENO VALENTIM/O-7459-2016	Endringer, Denise C/0000-0001-9396-2097; OLIVEIRA, JAIRO/0000-0001-7595-1183; Meyrelles, Silvana/0000-0003-0167-4093; Endringer, Denise/0000-0001-9396-2097; Scherer, Rodrigo/0000-0001-7656-0248; NOGUEIRA, BRENO/0000-0002-2199-0635; Vasquez, Elisardo C/0000-0002-7169-5634; NOGUEIRA, BRENO VALENTIM/0000-0002-2199-0635	National Council for the Development of Science and Technology (CNPq) [445080/2014-0]; State Agency for the Development of Science and Technology (FAPES) [60619392/2012, 61581321/2013]	National Council for the Development of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State Agency for the Development of Science and Technology (FAPES)	This study was supported by the National Council for the Development of Science and Technology (CNPq, 445080/2014-0 Grant, http://carloschagas.cnpq.br/) and the State Agency for the Development of Science and Technology (FAPES, 60619392/2012 and 61581321/2013 Grants, http://www.fapes.es.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Council for the Development of Science and Technology (CNPq, 445080/2014-0 Grant) and the State Agency for the Development of Science and Technology (FAPES- 60619392/2012 and 61581321/2013 Grants). We are grateful to Dr. Rogerio Piontkowski, Arthur Lourensute Porto and Tommasi Laboratory analysis for use of their facilities and the Laboratory of Cellular Ultrastructure Carlos Alberto Redins (LUCCAR) for technical assistance and use of the microscope.	AGMON Y, 1994, J CLIN INVEST, V94, P1069, DOI 10.1172/JCI117421; Andreucci M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/362725; Baliano A. P., 2015, Ethnobotany Research and Applications, V14, P155; Barrett BJ, 2006, NEW ENGL J MED, V354, P379, DOI 10.1056/NEJMcp050801; BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330; Billings FT, 2008, AM J PHYSIOL-RENAL, V295, pF741, DOI 10.1152/ajprenal.90244.2008; Brune B, 2003, KIDNEY INT, V63, pS22; Bunel V, 2015, TOXICOL IN VITRO, V29, P458, DOI 10.1016/j.tiv.2014.12.017; Carvalho AAV, 2010, PHYTOTHER RES, V24, P113, DOI 10.1002/ptr.2882; Cheng CW, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/161235; Colbay M, 2010, EXP TOXICOL PATHOL, V62, P81, DOI 10.1016/j.etp.2009.02.119; Colombo AF, 2010, BRAZ J BIOL, V70, P697, DOI 10.1590/S1519-69842010000400002; Curtis LM, 2007, KIDNEY INT, V72, P907, DOI 10.1038/sj.ki.5002530; Dias AT, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-35; Domitrovic R, 2014, FOOD CHEM TOXICOL, V66, P321, DOI 10.1016/j.fct.2014.02.002; Duan SB, 2013, RENAL FAILURE, V35, P150, DOI 10.3109/0886022X.2012.741650; FERNANDES AMAP, 1993, PHYTOCHEMISTRY, V32, P1567, DOI 10.1016/0031-9422(93)85181-P; Goldenberg I, 2005, CAN MED ASSOC J, V172, P1461, DOI 10.1503/cmaj.1040847; Goldfarb S, 2009, MAYO CLIN PROC, V84, P170, DOI 10.1016/S0025-6196(11)60825-2; Gomes IBS, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00247; Gomes IBS, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-184; Grassi D, 2010, NUTRIENTS, V2, P889, DOI 10.3390/nu2080889; Gurm HS, 2012, JACC-CARDIOVASC INTE, V5, P98, DOI 10.1016/j.jcin.2011.09.019; Heyman SN, 2010, INVEST RADIOL, V45, P188, DOI 10.1097/RLI.0b013e3181d2eed8; Hizoh I, 2002, INVEST RADIOL, V37, P428, DOI 10.1097/00004424-200208000-00003; Itoh Y, 2005, J PHARMACOL SCI, V97, P473, DOI 10.1254/jphs.CRJ05002X; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Karami M, 2014, IRAN J BASIC MED SCI, V17, P69; Khan AM, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.163; Kinaci MK, 2012, EXP THER MED, V3, P249, DOI 10.3892/etm.2011.382; Kongkham S, 2013, NEFROLOGIA, V33, P116, DOI 10.3265/Nefrologia.pre2012.Nov.11736; Kwak KH, 2014, EXP THER MED, V7, P508, DOI 10.3892/etm.2013.1440; Lauver DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113598; Lee HT, 2006, AM J PHYSIOL-RENAL, V290, pF1367, DOI 10.1152/ajprenal.00347.2005; Liu SS, 2013, AM J PHYSIOL-RENAL, V305, pF1533, DOI 10.1152/ajprenal.00656.2012; Lopez-Novoa JM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-13; McCullough PA, 2013, J AM COLL CARDIOL, V62, P2176, DOI 10.1016/j.jacc.2013.07.066; Michael A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249810; Milaneze B., 2014, BMC P, V8, pP29, DOI [10.1186/1753-6561-8-S4-P29, DOI 10.1186/1753-6561-8-S4-P29]; Nogueira BV, 2012, CELL PHYSIOL BIOCHEM, V29, P143, DOI 10.1159/000337595; Rua EDO, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0105-z; Osthoff M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/962695; Pashkow FJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/514623; Pattharanitima P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/236930; Persson PB, 2005, KIDNEY INT, V68, P14, DOI 10.1111/j.1523-1755.2005.00377.x; Poljsak B, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/956792; Scherer R, 2009, FOOD CHEM, V112, P654, DOI 10.1016/j.foodchem.2008.06.026; Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Singh JP, 2014, J SURG RES, V187, P631, DOI 10.1016/j.jss.2013.11.1088; Spargias K, 2004, CIRCULATION, V110, P2837, DOI 10.1161/01.CIR.0000146396.19081.73; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Tonini CL, 2013, INT J MOL SCI, V14, P3325, DOI 10.3390/ijms14023325; Wu HL, 2007, J AM SOC NEPHROL, V18, P1180, DOI 10.1681/ASN.2006060622; Yokomaku Y, 2008, J AM SOC NEPHROL, V19, P321, DOI 10.1681/ASN.2007040481; Zager RA, 2003, KIDNEY INT, V64, P128, DOI 10.1046/j.1523-1755.2003.00059.x	56	13	14	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144329	10.1371/journal.pone.0144329	http://dx.doi.org/10.1371/journal.pone.0144329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674346	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700035
J	Luo, WM; Kong, J; Gong, Y; Liu, XQ; Yang, RX; Zhao, YX				Luo, Wei-min; Kong, Jing; Gong, Yan; Liu, Xiao-qiong; Yang, Rui-xue; Zhao, Yu-xia			Tongxinluo Protects against Hypertensive Kidney Injury in Spontaneously-Hypertensive Rats by Inhibiting Oxidative Stress and Activating Forkhead Box O1 Signaling	PLOS ONE			English	Article							GINSENOSIDE RG1; MESENCHYMAL TRANSITION; RENAL STRUCTURE; BLOOD-PRESSURE; TRANSCRIPTION; PODOCYTES; DISEASE; INFLAMMATION; MARKERS; DAMAGE	Hypertension is an independent risk factor for the progression of chronic renal failure, and oxidative stress plays a critical role in hypertensive renal damage. Forkbox O1(FoxO1) signaling protects cells against oxidative stress and may be a useful target for treating oxidative stress-induced hypertension. Tongxinluo is a traditional Chinese medicine with cardioprotective and renoprotective functions. Therefore, this study aimed to determine the effects of Tongxinluo in hypertensive renal damage in spontaneously hypertensive rats (SHRs) and elucidate the possible involvement of oxidative stress and FoxO1 signaling in its molecular mechanisms. SHRs treated with Tongxinluo for 12 weeks showed a reduction in systolic blood pressure. In addition to increasing creatinine clearance, Tongxinluo decreased urinary albumin excretion, oxidative stress injury markers including malondialdehyde and protein carbonyls, and expression of nicotinamide adenine dinucleotide phosphate oxidase subunits and its activity in SHR kidneys. While decreasing phosphorylation of FoxO1, Tongxinluo also inhibited the phosphorylation of extracellular signal-regulated kinase1/2 and p38 and enhanced manganese superoxide dismutase and catalase activities in SHR kidneys. Furthermore, histology revealed attenuation of glomerulosclerosis and renal podocyte injury, while Tongxinluo decreased the expression of alpha-smooth muscle actin, extracellular matrixprotein, transforming growth factor beta 1 and small mothers against decapentaplegic homolog 3, and improved tubulointerstitial fibrosis in SHR kidneys. Finally, Tongxinluo inhibited inflammatory cell infiltration as well as expression of tumor necrosis factor-a and interleukin-6. In conclusion, Tongxinluo protected SHRs against hypertension-induced renal injury by exerting antioxidant, antifibrotic, and anti-inflammatory activities. Moreover, the underlying mechanisms of these effects may involve inhibition of oxidative stress and functional activation of FoxO1 signaling.	[Luo, Wei-min; Kong, Jing] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Shandong, Peoples R China; [Luo, Wei-min; Zhao, Yu-xia] Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan, Shandong, Peoples R China; [Gong, Yan] Jinan Hosp Infect Dis, Dept Magnet Resonance Imaging, Jinan, Shandong, Peoples R China; [Liu, Xiao-qiong; Yang, Rui-xue] Shandong Univ, Qilu Hosp, Dept Cardiol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Zhao, YX (corresponding author), Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan, Shandong, Peoples R China.	yxzhao@sdu.edu.cn		Luo, Weimin/0000-0002-3403-4183	National 973 Basic Research Program of China [2012CB518603]; National Natural Science Foundation of China [30873325, 81100103, 81173251, 81302939]; Shandong Province Medical Science and Technology Development Plan [2014WS0147]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Medical Science and Technology Development Plan	This work was supported by the National 973 Basic Research Program of China, www.973.gov.cn (no. 2012CB518603 to YXZ), the National Natural Science Foundation of China, www.nsfc.gov.cn (30873325, 81100103, 81173251, 81302939 to YXZ), and the Shandong Province Medical Science and Technology Development Plan, www.sdwsjs.gov.cn (2014WS0147 to RXY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2012, ANTIOXID REDOX SIGN, V16, P139, DOI 10.1089/ars.2011.3967; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Biswas SK, 2007, FREE RADICAL RES, V41, P216, DOI 10.1080/10715760601059672; Boccitto M, 2011, CURR DRUG TARGETS, V12, P1303, DOI 10.2174/138945011796150316; Cao HB, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-84; Chandran G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/608512; Cifarelli V, 2012, MOL ENDOCRINOL, V26, P1213, DOI 10.1210/me.2011-1276; Crews DC, 2010, HYPERTENSION, V55, P1102, DOI 10.1161/HYPERTENSIONAHA.110.150722; Daehn I, 2014, J CLIN INVEST, V124, P1608, DOI 10.1172/JCI71195; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; Dounousi E, 2006, AM J KIDNEY DIS, V48, P752, DOI 10.1053/j.ajkd.2006.08.015; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Erejuwa OO, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/374037; Guo F, 2016, J CELL BIOCHEM, V117, P74, DOI 10.1002/jcb.25249; HASSENKHODJA R, 1992, J CARDIOVASC SURG, V33, P199; Heijnen BFJ, 2014, HYPERTENS RES, V37, P100, DOI 10.1038/hr.2013.99; Joshi S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/462361; Jung YA, 2009, BIOCHEM BIOPH RES CO, V386, P757, DOI 10.1016/j.bbrc.2009.06.124; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; LEE LK, 1995, J CLIN INVEST, V96, P953, DOI 10.1172/JCI118143; Liu C, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0347-4; Ludikhuize J, 2007, ARTHRITIS RHEUM-US, V56, P2180, DOI 10.1002/art.22653; Ma LY, 2015, EUR HEART J SUPPL, V17, pB5, DOI 10.1093/eurheartj/suv020; Ma LJ, 2005, J AM SOC NEPHROL, V16, P966, DOI 10.1681/ASN.2004060492; Maiese K, 2009, CLIN SCI, V116, P191, DOI 10.1042/CS20080113; Mao N, 2014, ACTA PHARMACOL SIN, V35, P513, DOI 10.1038/aps.2013.187; Olzinski AR, 2005, CARDIOVASC RES, V66, P170, DOI 10.1016/j.cardiores.2004.12.021; Palm F, 2011, AM J PHYSIOL-REG I, V301, pR1229, DOI 10.1152/ajpregu.00720.2010; Palmer SC, 2015, LANCET, V385, P2047, DOI 10.1016/S0140-6736(14)62459-4; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Ponugoti B, 2012, EXP DIABETES RES, DOI 10.1155/2012/939751; Reiser J, 2014, NAT REV NEPHROL, V10, P104, DOI 10.1038/nrneph.2013.274; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Shao D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4315; Sun Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080859; Wang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098047; Wang J, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/187979; Wang JY, 2014, AM J PHYSIOL-RENAL, V306, pF486, DOI 10.1152/ajprenal.00528.2013; Xie XS, 2010, PHYTOTHER RES, V24, P1581, DOI 10.1002/ptr.3190; Xie XS, 2009, CHIN J INTEGR MED, V15, P133, DOI 10.1007/s11655-009-0133-9; Xie XS, 2009, J ETHNOPHARMACOL, V122, P35, DOI 10.1016/j.jep.2008.11.020; Zhang L, 2009, AM J PHYSIOL-HEART C, V297, pH2004, DOI 10.1152/ajpheart.00208.2009; Zhang MH, 2013, PLANTA MED, V79, P1319, DOI 10.1055/s-0033-1350649; Zhang MH, 2011, J ETHNOPHARMACOL, V137, P99, DOI 10.1016/j.jep.2011.04.045; Zhang WR, 2012, HYPERTENSION, V59, P136, DOI 10.1161/HYPERTENSIONAHA.111.173328	46	22	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145130	10.1371/journal.pone.0145130	http://dx.doi.org/10.1371/journal.pone.0145130			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673167	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700104
J	Sircar, G; Saha, B; Mandal, RS; Pandey, N; Saha, S; Bhattacharya, SG				Sircar, Gaurab; Saha, Bodhisattwa; Mandal, Rahul Shubhra; Pandey, Naren; Saha, Sudipto; Bhattacharya, Swati Gupta			Purification, Cloning and Immuno-Biochemical Characterization of a Fungal Aspartic Protease Allergen Rhi o 1 from the Airborne Mold Rhizopus oryzae	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS; SEQUENCES; PROTEINS; BLA-G-2; MODEL	Background Fungal allergy is considered as serious health problem worldwide and is increasing at an alarming rate in the industrialized areas. Rhizopus oyzae is a ubiquitously present airborne pathogenic mold and an important source of inhalant allergens for the atopic population of India. Here, we report the biochemical and immunological features of its 44 kDa sero-reactive aspartic protease allergen, which is given the official designation 'Rhi o 1'. Method The natural Rhi o 1 was purified by sequential column chromatography and its amino acid sequence was determined by mass spectrometry and N-terminal sequencing. Based on its amino acid sequence, the cDNA sequence was identified, cloned and expressed to produce recombinant Rhi o 1. The allergenic activity of rRhi o 1 was assessed by means of its IgE reactivity and histamine release ability. The biochemical property of Rhi o 1 was studied by enzyme assay. IgE-inhibition experiments were performed to identify its cross-reactivity with the German cockroach aspartic protease allergen Bla g 2. For precise characterization of the cross-reactive epitope, we used anti-Bla g 2 monoclonal antibodies for their antigenic specificity towards Rhi o 1. A homology based model of Rhi o 1 was built and mapping of the cross-reactive conformational epitope was done using certain in silico structural studies. Results The purified natural nRhi o 1 was identified as an endopeptidase. The full length allergen cDNA was expressed and purified as recombinant rRhi o 1. Purified rRhi o 1 displayed complete allergenicity similar to the native nRhi o 1. It was recognized by the serum IgE of the selected mold allergy patients and efficiently induced histamine release from the sensitized PBMC cells. This allergen was identified as an active aspartic protease functional in low pH. The Rhi o 1 showed cross reactivity with the cockroach allergen Bla g 2, as it can inhibit IgE binding to rBla g 2 up to certain level. The rBla g 2 was also found to cross-stimulate histamine release from the effector cells sensitized with anti-Rhi o 1 serum IgE. This cross-reactivity was found to be mediated by a common mAb4C3 recognizable conformational epitope. Bioinformatic studies revealed high degree of structural resemblances between the 4C3 binding sites of both the allergens. Conclusion/Significance The present study reports for the first time anew fungal aspartic protease allergen designated as Rhi o 1, which triggers IgE-mediated sensitization leading to various allergic diseases. Here we have characterized the recombinant Rhi o 1 and its immunological features including cross-reactive epitope information that will facilitate the component-resolved diagnosis of mold allergy.	[Sircar, Gaurab; Saha, Bodhisattwa; Bhattacharya, Swati Gupta] Bose Inst, Div Plant Biol, Kolkata 700009, W Bengal, India; [Mandal, Rahul Shubhra] Natl Inst Cholera & Enter Dis, Biomed Informat Ctr, Kolkata 700010, W Bengal, India; [Pandey, Naren] Belle Vue Clin, Dept Allergy & Asthma, Kolkata 700001, W Bengal, India; [Saha, Sudipto] Bose Inst, Bioinformat Ctr, Kolkata 700054, W Bengal, India	Department of Science & Technology (India); Bose Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Department of Science & Technology (India); Bose Institute	Bhattacharya, SG (corresponding author), Bose Inst, Div Plant Biol, Main Campus,93-1 Acharya Prafulla Chandra Rd, Kolkata 700009, W Bengal, India.	swati@jcbose.ac.in	Saha, Sudipto/AAF-1034-2020	Mandal, Rahul/0000-0001-8939-3362; Sircar, Gaurab/0000-0002-9067-4564	Council of Scientific and Industrial Research [03/015(0414)/2011-EMR-I]; University Grant Commission [F.2-8/2002 (SA-I)]; Indian Council of Medical Research [2013-1551G]; DBT [BT/RLF/Re-entry/11/2011]; Dept. of Science and Technology, Govt. of India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission(University Grants Commission, India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); DBT(Department of Biotechnology (DBT) India); Dept. of Science and Technology, Govt. of India(Department of Science & Technology (India))	GS, BS and RSM recieved PhD fellowships from Council of Scientific and Industrial Research (Grant No. 03/015(0414)/2011-EMR-I), University Grant Commission (Grant No. F.2-8/2002 (SA-I)) and Indian Council of Medical Research (extramural project grant number - IRIS ID: 2013-1551G), respectively. SS is a recipient of Ramalingaswamy re-entry scientist fellow from DBT (BT/RLF/Re-entry/11/2011). Dept. of Science and Technology, Govt. of India has provided financial support for infrastructural facility to pursue this research in Bose Institute.	Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; ARRUDA LK, 1995, J BIOL CHEM, V270, P19563, DOI 10.1074/jbc.270.33.19563; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brenke R, 2012, BIOINFORMATICS, V28, P2608, DOI 10.1093/bioinformatics/bts493; Chapman MD, 2007, J ALLERGY CLIN IMMUN, V119, P414, DOI 10.1016/j.jaci.2006.11.001; Chen JC, 2011, J BIOL CHEM, V286, P26667, DOI 10.1074/jbc.M110.193987; Chowdhary A, 2014, CRIT REV MICROBIOL, V40, P30, DOI 10.3109/1040841X.2012.754401; Crameri R, 1998, INT ARCH ALLERGY IMM, V115, P99, DOI 10.1159/000023889; Devars du Mayne Marie, 2015, Ear Nose Throat J, V94, pE17; Glesner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022223; Green B. J., 2011, J ALLERGY; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HEYMANN PW, 1986, J IMMUNOL, V137, P2841; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HORNER WE, 1995, CLIN MICROBIOL REV, V8, P161, DOI 10.1128/CMR.8.2.161; Hox V, 2014, ALLERGY, V69, P282, DOI 10.1111/all.12347; Kasera R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063063; Kauffman Henk F, 2006, Clin Mol Allergy, V4, P5, DOI 10.1186/1476-7961-4-5; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee MF, 2012, ANN ALLERG ASTHMA IM, V108, P243, DOI 10.1016/j.anai.2012.01.014; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Li M, 2011, J IMMUNOL, V186, P333, DOI 10.4049/jimmunol.1002318; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Mayerhofer M., 2014, ACID PROTEASE PRODUC; Nawange SR, 2012, MYCOPATHOLOGIA, V174, P171, DOI 10.1007/s11046-012-9532-0; Norbaeck D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088303; Pomes A, 2014, METHODS, V66, P75, DOI 10.1016/j.ymeth.2013.07.036; Pomes A, 2010, INT ARCH ALLERGY IMM, V152, P1, DOI 10.1159/000260078; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Sharma R, 2011, ALLERGY RHINOL, V2, P21, DOI 10.2500/ar.2011.2.0005; Shen HD, 1999, CLIN EXP ALLERGY, V29, P642, DOI 10.1046/j.1365-2222.1999.00509.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sicherer SH, 2001, J ALLERGY CLIN IMMUN, V108, P881, DOI 10.1067/mai.2001.118515; Singh B, 2010, J PROTEOME RES, V9, P5517, DOI 10.1021/pr100604x; Sircar G, 2012, J PROTEOMICS, V77, P455, DOI 10.1016/j.jprot.2012.09.023; Smolenski G, 1997, MICROBIOL-SGM, V143, P349, DOI 10.1099/00221287-143-2-349; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Valenta R, 2010, ANNU REV IMMUNOL, V28, P211, DOI 10.1146/annurev-immunol-030409-101218; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wunschmann S, 2005, J ALLERGY CLIN IMMUN, V116, P140, DOI 10.1016/j.jaci.2005.04.024	42	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144547	10.1371/journal.pone.0144547	http://dx.doi.org/10.1371/journal.pone.0144547			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672984	gold, Green Submitted, Green Published			2022-12-27	WOS:000366722700044
J	Wang, M; Xie, TT; Chang, ZY; Wang, L; Xie, XY; Kou, YH; Xu, HX; Gao, XL				Wang, Mei; Xie, Tingting; Chang, Zhanying; Wang, Ling; Xie, Xiangyun; Kou, Yaohong; Xu, Hongxia; Gao, Xiaoli			A New Type of Liquid Silymarin Proliposome Containing Bile Salts: Its Preparation and Improved Hepatoprotective Effects	PLOS ONE			English	Article							IMPROVED ORAL DELIVERY; IN-VITRO EVALUATION; LIPOSOMES; BIOAVAILABILITY; SYSTEM; FORMULATION; LIPIDS; MODEL	Silymarin, a known extract, is used in the treatment of liver diseases with various origins, but its current administration form cannot target the liver because of its poor oral bioavailability. A new type of oral silymarin proliposome aimed at improving silymarin's poor bioavailability and hepatoprotective effects, is introduced in this work. Silymarin-loaded liquid proliposome were prepared using a simple dissolving process. The morphology, particle size, zeta potential, and entrapment efficiency of the silymarin liposomes were analysed. The everted gut sac transport model was used to measure the intestinal transport of liposomes. The liposomal hepatoprotective activity was evaluated in three types of experimental hepatitis animal models. After staining with haematoxylin and eosin, the livers were microscopically examined to analyse any pathological changes. The prepared silymarin proliposome formed silymarin liposomes with a multilayer liposome structure and improved intestinal transport. In an injured liver, the silymarin liposomes produced a stronger hepatoprotective effect through a significant decrease in both the aminotransferase and MDA levels and a significant increase in the SOD and GSH-PX levels compared to orally administered silymarin tablets. This effect was also confirmed histopathologically. In a word, incorporation of silymarin into a liposomal carrier system increased intestinal absorption and showed better hepatoprotective effects compared to silymarin tablets.	[Wang, Mei; Chang, Zhanying; Wang, Ling; Xie, Xiangyun; Kou, Yaohong; Xu, Hongxia; Gao, Xiaoli] Xinjiang Med Univ, Coll Pharm, Dept Pharmaceut, Urumqi, Peoples R China; [Xie, Tingting] Peoples Liberat Army Gen Hosp, Dept Pharmaceut Care, Beijing, Peoples R China	Xinjiang Medical University; Chinese People's Liberation Army General Hospital	Gao, XL (corresponding author), Xinjiang Med Univ, Coll Pharm, Dept Pharmaceut, Urumqi, Peoples R China.	Xli_g@sina.com						Alam MA, 2012, J PHARM PHARMACOL, V64, P326, DOI 10.1111/j.2042-7158.2011.01391.x; BARZAGHI N, 1990, EUR J DRUG METAB PH, V15, P333, DOI 10.1007/BF03190223; Cao X, 2012, ACTA BIOMATER, V8, P2104, DOI 10.1016/j.actbio.2012.02.011; Chen YP, 2009, INT J PHARMACEUT, V376, P153, DOI 10.1016/j.ijpharm.2009.04.022; Chu C, 2011, ACTA PHARMACOL SIN, V32, P973, DOI 10.1038/aps.2011.25; El-Samaligy MS, 2006, INT J PHARMACEUT, V319, P121, DOI 10.1016/j.ijpharm.2006.04.023; Elmowafy M, 2013, EUR J PHARM SCI, V50, P161, DOI 10.1016/j.ejps.2013.06.012; Gao Xiao-li, 2005, Yaoxue Xuebao, V40, P1139; Ghosh A, 2012, J PHARM SCI TECHNOL, V2, P348; Hildebrand A, 2003, COLLOID SURFACE B, V32, P335, DOI 10.1016/j.colsurfb.2003.08.001; Hiremath PS, 2009, INT J PHARMACEUT, V380, P96, DOI 10.1016/j.ijpharm.2009.07.008; Karn PR, 2013, NANOMEDICINE-UK, V8, P1529, DOI [10.2217/NNM.13.131, 10.2217/nnm.13.131]; Kossena GA, 2003, J PHARM SCI-US, V92, P634, DOI 10.1002/jps.10329; Kumar N, 2014, PHARMACOL REP, V66, P788, DOI 10.1016/j.pharep.2014.04.007; Li XR, 2010, AAPS PHARMSCITECH, V11, P672, DOI 10.1208/s12249-010-9432-x; Liu L., 2007, ASIAN J PHARM SCI, V2, P150; Maherani B, 2011, CURR NANOSCI, V7, P436, DOI 10.2174/157341311795542453; Niu M, 2011, EUR J PHARM BIOPHARM, V81, P265; Parveen R, 2011, INT J PHARMACEUT, V413, P245, DOI 10.1016/j.ijpharm.2011.04.041; Porter CJH, 2007, NAT REV DRUG DISCOV, V6, P231, DOI 10.1038/nrd2197; Potluri P, 2006, DRUG DELIV, V13, P227, DOI 10.1080/10717540500395007; Rao S, 2014, J CONTROL RELEASE, V193, P174, DOI 10.1016/j.jconrel.2014.05.013; Shaji J, 2013, INT J PHARM BIO SCI, V4, P150; Sonali D, 2010, ACTA PHARMACEUT, V60, P427, DOI 10.2478/v10007-010-0038-3; Sun CD, 2013, AAPS PHARMSCITECH, V14, P332, DOI 10.1208/s12249-013-9924-6; Theodosiou E, 2014, PHYTOCHEM REV, V13, P1, DOI 10.1007/s11101-013-9285-5; Wagner A, 2011, LIPOSOME TECHNOLOGY; Wang J, 2005, J CHIN MED IND, V36, P707; Wang M, 2011, CHIN J NEW DRUGS, V20, P75; Wu W, 2006, EUR J PHARM BIOPHARM, V63, P288, DOI 10.1016/j.ejpb.2005.12.005; Zhang Y, 2010, RESOURCES, V18, P239	31	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143625	10.1371/journal.pone.0143625	http://dx.doi.org/10.1371/journal.pone.0143625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674103	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700013
J	Wang, XC; Blanchard, J; Grundke-Iqbal, I; Iqbal, K				Wang, Xiaochuan; Blanchard, Julie; Grundke-Iqbal, Inge; Iqbal, Khalid			Memantine Attenuates Alzheimer's Disease-Like Pathology and Cognitive Impairment	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; GLYCOGEN-SYNTHASE KINASE-3-BETA; PAIRED HELICAL FILAMENTS; TAU-PHOSPHORYLATION; NEUROBLASTOMA-CELLS; SYNAPTIC PLASTICITY; TRANSGENIC MICE; NMDA RECEPTORS; UP-REGULATION; BETA PEPTIDE	Deficiency of protein phosphatase-2A is a key event in Alzheimer's disease. An endogenous inhibitor of protein phosphatase-2A, inhibitor-1, I-1(PP2A), which inhibits the phosphatase activity by interacting with its catalytic subunit protein phosphatase-2Ac, is known to be upregulated in Alzheimer's disease brain. In the present study, we overexpressed I-1(PP2A) by intracerebroventricular injection with adeno-associated virus vector-1-I-1(PP2A) in Wistar rats. The I-1(PP2A) rats showed a decrease in brain protein phosphatase-2A activity, abnormal hyperphosphorylation of tau, neurodegeneration, an increase in the level of activated glycogen synthase kinase-3beta, enhanced expression of intraneuronal amyloid-beta and spatial reference memory deficit; littermates treated identically but with vector only, i.e., adenoassociated virus vector-1-enhanced GFP, served as a control. Treatment with memantine, a noncompetitive NMDA receptor antagonist which is an approved drug for treatment of Alzheimer's disease, rescued protein phosphatase-2A activity by decreasing its demethylation at Leu309 selectively and attenuated Alzheimer's disease-like pathology and cognitive impairment in adeno-associated virus vector-1-I-1(PP2A) rats. These findings provide new clues into the possible mechanism of the beneficial therapeutic effect of memantine in Alzheimer's disease patients.	[Wang, Xiaochuan; Blanchard, Julie; Grundke-Iqbal, Inge; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Wang, Xiaochuan] Huazhong Univ Sci & Technol, Dept Pathophysiol, Key Lab Neurol Dis, Natl Educ Minist,Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Institute for Basic Research in Developmental Disabilities; Huazhong University of Science & Technology	Iqbal, K (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, Inge Grundke Iqbal Res Floor, Staten Isl, NY 10314 USA.	khalid.iqbal.ibr@gmail.com			National Institutes of Health [AG019158, TW008744]; FOGARTY INTERNATIONAL CENTER [R03TW008744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this work came from AG019158, National Institutes of Health, www.nih.gov; and TW008744, National Institutes of Health, www.nih.gov.	Alley GM, 2010, J NEUROSCI RES, V88, P143, DOI 10.1002/jnr.22172; An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Bennecib M, 2000, ALZHEIMERS REP, V3, P295; Bennecib M, 2001, FEBS LETT, V490, P15, DOI 10.1016/S0014-5793(01)02127-5; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Chen S, 2008, J BIOL CHEM, V283, P10513, DOI 10.1074/jbc.M709852200; Cheng LY, 2000, NEUROCHEM RES, V25, P107, DOI 10.1023/A:1007547701518; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Farokhnia M, 2014, HUM PSYCHOPHARM CLIN, V29, P351, DOI 10.1002/hup.2412; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; Gantier R, 2000, NEUROSCI LETT, V283, P217, DOI 10.1016/S0304-3940(00)00949-6; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GRUNDKEIQBAL I, 1988, MOL BRAIN RES, V4, P43, DOI 10.1016/0169-328X(88)90017-4; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Harkany T, 2000, EUR J NEUROSCI, V12, P2735, DOI 10.1046/j.1460-9568.2000.00164.x; HASEGAWA M, 1993, J NEUROCHEM, V60, P2068, DOI 10.1111/j.1471-4159.1993.tb03491.x; Henckaerts E, 2009, P NATL ACAD SCI USA, V106, P7571, DOI 10.1073/pnas.0806821106; Hernandez F, 2010, MOL CELL BIOCHEM, V344, P211, DOI 10.1007/s11010-010-0544-0; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Iqbal K, 2010, ALZHEIMERS DEMENT, V6, P420, DOI 10.1016/j.jalz.2010.04.006; Katayose Y, 2000, J BIOL CHEM, V275, P9209, DOI 10.1074/jbc.275.13.9209; Kins S, 2003, AM J PATHOL, V163, P833, DOI 10.1016/S0002-9440(10)63444-X; Korenov M, 2009, J NEUROSCI METH, V177, P108, DOI 10.1016/j.jneumeth.2008.09.027; Kwiecien RA, 2011, ARCH BIOCHEM BIOPHYS, V510, P35, DOI 10.1016/j.abb.2011.03.007; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Liang L, 2004, FEBS LETT, V566, P261, DOI 10.1016/j.febslet.2004.04.047; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Lupp A, 2003, EXP TOXICOL PATHOL, V54, P441, DOI 10.1078/0940-2993-00280; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Miguel-Hidalgo JJ, 2002, BRAIN RES, V958, P210, DOI 10.1016/S0006-8993(02)03731-9; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mount C, 2006, NAT MED, V12, P780, DOI 10.1038/nm0706-780; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Planel E, 2001, J BIOL CHEM, V276, P34298, DOI 10.1074/jbc.M102780200; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Ray B, 2010, NEUROSCI LETT, V470, P1, DOI 10.1016/j.neulet.2009.11.016; Schmitt F, 2007, EXPERT OPIN DRUG MET, V3, P135, DOI 10.1517/17425255.3.1.135; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Song MS, 2008, EUR J NEUROSCI, V28, P1989, DOI 10.1111/j.1460-9568.2008.06498.x; Sonkusare SK, 2005, PHARMACOL RES, V51, P1, DOI 10.1016/j.phrs.2004.05.005; Szatmari E, 2005, J BIOL CHEM, V280, P37526, DOI 10.1074/jbc.M502699200; Tanaka T, 1998, FEBS LETT, V426, P248, DOI 10.1016/S0014-5793(98)00346-9; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; Tremblay R, 2000, J NEUROSCI, V20, P7183; Tsujio I, 2005, FEBS LETT, V579, P363, DOI 10.1016/j.febslet.2004.11.097; Tu SC, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-48; Wang XC, 2010, FASEB J, V24, P4420, DOI 10.1096/fj.10-158477; Wang YX, 2015, NEUROBIOL AGING, V36, P188, DOI 10.1016/j.neurobiolaging.2014.07.035; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729; Zadori D, 2014, J ALZHEIMERS DIS, V42, pS177, DOI 10.3233/JAD-132621; Zhou XW, 2008, NEUROBIOL DIS, V31, P386, DOI 10.1016/j.nbd.2008.05.013; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	63	11	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145441	10.1371/journal.pone.0145441	http://dx.doi.org/10.1371/journal.pone.0145441			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26697860	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092600080
J	Kuper, H; Nyapera, V; Evans, J; Munyendo, D; Zuurmond, M; Frison, S; Mwenda, V; Otieno, D; Kisia, J				Kuper, Hannah; Nyapera, Velma; Evans, Jennifer; Munyendo, David; Zuurmond, Maria; Frison, Severine; Mwenda, Victoria; Otieno, David; Kisia, James			Malnutrition and Childhood Disability in Turkana, Kenya: Results from a Case-Control Study	PLOS ONE			English	Article							DISABLED-CHILDREN; CEREBRAL-PALSY; NUTRITION; COUNTRIES; AFRICA	Background Children with disabilities may be particularly vulnerable to malnutrition, as a result of exclusions and feeding difficulties. However, there is limited evidence currently available on this subject. Methods A population-based case-control study was conducted in Turkana County, Kenya, between July and August 2013. Key informants in the community identified children aged 6 months to 10 years who they believed may have a disability. These children were screened by a questionnaire (UNICEF-Washington Group) and assessed by a paediatrician to confirm whether they had a disability and the type. Two controls without disabilities were selected per case: A sibling control (sibling nearest in age) and a neighbourhood control (nearest neighbour within one year of age). The caregiver completed a questionnaire on behalf of the child (e.g. information on feeding, poverty, illness, education), and anthropometric measures were taken. We undertook multivariable logistic and linear regression analyses to estimate the relationship between disability and malnutrition. Results The study included 311 cases with disabilities, 196 sibling controls and 300 neighbour controls. Children with disabilities were more likely to report a range of feeding difficulties. They were 1.6-2.9 times more likely to have malnutrition in comparison to neighbour controls or family controls, including general malnutrition (low weight for age), stunting (low height for age), low body mass index (BMI) or low mid upper arm circumference (MUAC) for age. Children with disabilities were almost twice as likely to have wasting (low weight for height) in comparison to neighbour controls (OR = 1.9, 95% CI 1.1-3.2), but this difference was not apparent compared with siblings (OR = 1.5, 95% CI 0.8-2.7). Children with disabilities also faced other exclusions. For instance those aged 5+ were much more likely not to attend school than neighbour controls (OR = 8.5, 95% CI 4.3-16.9). Conclusions Children with disabilities were particularly vulnerable to malnutrition, even within this area of food insecurity and widespread malnutrition. Efforts need to be made to include children with disabilities within food supplementation programmes, and school based programmes alone may be inadequate to meet this need. Exclusion of children with disabilities from education is also a priority area to be addressed.	[Kuper, Hannah; Zuurmond, Maria] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London WC1, England; [Nyapera, Velma; Mwenda, Victoria; Otieno, David; Kisia, James] Kenya Red Cross Soc, Nairobi, Kenya; [Evans, Jennifer] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Munyendo, David] CBM Kenya, Nairobi, Kenya; [Frison, Severine] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Kuper, H (corresponding author), London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London WC1, England.	hannah.kuper@lshtm.ac.uk	Evans, Jennifer/F-4672-2012	Evans, Jennifer/0000-0002-6137-2030	Christoffel Blinden Mission (CBM)	Christoffel Blinden Mission (CBM)	This work was supported by a grant from Christoffel Blinden Mission (CBM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Colver A, 2014, LANCET, V383, P1240, DOI 10.1016/S0140-6736(13)61835-8; Gladstone M, 2014, SEMIN PEDIATR NEUROL, V21, P50, DOI 10.1016/j.spen.2014.01.002; Gottlieb CA, 2009, LANCET, V374, P1831, DOI 10.1016/S0140-6736(09)61871-7; Groce N, 2014, PAEDIATR INT CHILD H, V34, P308, DOI 10.1179/2046905514Y.0000000156; Grosh M., 2000, DESIGNING HOUSEHOLD; Kenya National Bureau of Statistics, 2009, KEN POP HOUS CENS; Kerac M, 2014, SEMIN PEDIATR NEUROL, V21, P42, DOI 10.1016/j.spen.2014.01.003; Kett M, 2009, LANCET, V374, P1801, DOI 10.1016/S0140-6736(09)62024-9; Kuper H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107300; Mactaggart I, 2013, KEY INFORMANT CHILD; Murthy GVS, 2014, ARCH DIS CHILD, V99, P1103, DOI 10.1136/archdischild-2014-305937; OCHA (United Nations Office for the Coordination of Humanitarian Affairs), 2012, TURK NUTR MORT SURV; Ochola S., 2011, TURKANA NUTR SURVEY; Socrates C, 2000, INT J REHABIL RES, V23, P177, DOI 10.1097/00004356-200023030-00007; Tomlinson M, 2009, LANCET, V374, P1857, DOI 10.1016/S0140-6736(09)61910-3; Tompsett J, 1999, EUR J CLIN NUTR, V53, P915, DOI 10.1038/sj.ejcn.1600850; UN, 1989, CONV RIGHTS CHILD; UNICEF, 2014, THE STATE OF THE WOR; United Nations Convention on the Rights of Persons with Disabilities (UNCRPD), 2006, CONV RIGHTS PERS DIS; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2006, WHO CHILD GROWTH STA; Wu L, 2010, J HEALTH POPUL NUTR, V28, P585, DOI 10.3329/jhpn.v28i6.6607; Yousafzai AK, 2003, BRIT J NUTR, V90, P1097, DOI 10.1079/BJN2003991; Yousafzai AK, 2003, INT J REHABIL RES, V26, P33, DOI 10.1097/00004356-200303000-00004; Yousafzai AK, 2014, ARCH DIS CHILD, V0, P1	26	28	28	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144926	10.1371/journal.pone.0144926	http://dx.doi.org/10.1371/journal.pone.0144926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689213	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300027
J	de Oliveira, DN; Christofoletti, RA; Barreto, RE				de Oliveira, Diogo Nunes; Christofoletti, Ronaldo Adriano; Barreto, Rodrigo Egydio			Feeding Behavior of a Crab According to Cheliped Number	PLOS ONE			English	Article							CALLINECTES-SAPIDUS RATHBUN; BLUE-CRAB; CARCINUS-MAENAS; PORCELAIN CRABS; CAUDAL AUTOTOMY; CANCER-PAGURUS; FIDDLER-CRAB; REGENERATION; COSTS; MECHANISM	Cheliped loss through autotomy is a common reflexive response in decapod crustaceans. Cheliped loss has direct and indirect effects on feeding behavior which can affect population dynamics and the role of species in the community. In this study, we assessed the impact of autotomy (0, 1, or 2 cheliped loss) on feeding behavior in the crab Pachygrapsus transversus, an omnivorous and abundant species that inhabits subtropical intertidal rocky shores along the South Atlantic Ocean. Autotomy altered crab feeding patterns and foraging behavior; however, the time spent foraging on animal prey or algae was not affected. These results indicate a plasticity of feeding behavior in P. transversus, allowing them to maintain feeding when injured.	[de Oliveira, Diogo Nunes] Univ Estadual Paulista, Inst Biociencias IBB UNESP, BR-18618970 Sao Paulo, Brazil; [Christofoletti, Ronaldo Adriano] Univ Fed Sao Paulo, Inst Mar, Santos, SP, Brazil; [Barreto, Rodrigo Egydio] Univ Estadual Paulista, Inst Biociencias, Dept Fisiol, BR-18618970 Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Estadual Paulista	Barreto, RE (corresponding author), Univ Estadual Paulista, Inst Biociencias, Dept Fisiol, Rubiao Jr S-N, BR-18618970 Sao Paulo, Brazil.	rebarreto@yahoo.com	Christofoletti, Ronaldo A./D-3266-2012; Barreto, Rodrigo E/A-3440-2013	Christofoletti, Ronaldo A./0000-0002-2168-9527; Barreto, Rodrigo E/0000-0002-4611-0059	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/58436-8, 06/00559-4, 06/60237-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) due scholarship to DNO (07/58436-8) and research funds granted to RAC (06/00559-4 and 06/60237-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BJ, 2007, FUNCT ECOL, V21, P154, DOI 10.1111/j.1365-2435.2006.01219.x; ARNOLD EN, 1984, J NAT HIST, V18, P127, DOI 10.1080/00222938400770131; Bateman PW, 2009, J ZOOL, V277, P1, DOI 10.1111/j.1469-7998.2008.00484.x; BENNETT D B, 1973, Journal of Experimental Marine Biology and Ecology, V13, P45, DOI 10.1016/0022-0981(73)90045-2; Brock RE, 1998, BIOL BULL, V194, P53, DOI 10.2307/1542513; Christofoletti RA, 2010, MAR ECOL PROG SER, V420, P125, DOI 10.3354/meps08880; COEN LD, 1988, OECOLOGIA, V75, P198, DOI 10.1007/BF00378597; Davis JLD, 2005, J CRUSTACEAN BIOL, V25, P655, DOI 10.1651/C-2586.1; Endler J.A., 1986, P109; Fleming PA, 2007, BIOL REV, V82, P481, DOI 10.1111/j.1469-185X.2007.00020.x; Flynn PST, 2015, J SEA RES, V103, P113, DOI 10.1016/j.seares.2015.07.002; FORMANOWICZ DR, 1990, ANIM BEHAV, V40, P400, DOI 10.1016/S0003-3472(05)80936-4; HARRIS RN, 1989, AM NAT, V134, P835, DOI 10.1086/285016; Hiatt R. W., 1948, Pacific Science, V2, P135; HINES AH, 1990, MAR ECOL PROG SER, V67, P105, DOI 10.3354/meps067105; JUANES F, 1990, ECOLOGY, V71, P744, DOI 10.2307/1940327; Juanes F, 1995, J EXP MAR BIOL ECOL, V193, P197, DOI 10.1016/0022-0981(95)00118-2; Knope ML, 2014, MAR ECOL-EVOL PERSP, V35, P471, DOI 10.1111/maec.12103; LAWTON P, 1989, MAR ECOL PROG SER, V52, P169, DOI 10.3354/meps052169; Maginnis TL, 2015, MAR FRESHW BEHAV PHY, V48, P241, DOI 10.1080/10236244.2015.1041241; Maginnis TL, 2006, BEHAV ECOL, V17, P857, DOI 10.1093/beheco/arl010; MCVEAN A, 1974, J EXP BIOL, V60, P423; McVean A, 1982, BIOL CRUSTACEA, P107; Naya DE, 2007, COMP BIOCHEM PHYS A, V146, P189, DOI 10.1016/j.cbpa.2006.10.014; Patterson L, 2009, APPL ANIM BEHAV SCI, V116, P302, DOI 10.1016/j.applanim.2008.08.007; Reaney LT, 2008, ANIM BEHAV, V75, P1473, DOI 10.1016/j.anbehav.2007.09.021; Savage T, 1978, FLA MAR RES PUBL, V32, P23; SKINNER DM, 1970, SCIENCE, V169, P383, DOI 10.1126/science.169.3943.383; SMITH LD, 1991, BIOL BULL, V180, P416, DOI 10.2307/1542342; SMITH LD, 1991, J EXP MAR BIOL ECOL, V151, P245; SMITH LD, 1990, B MAR SCI, V46, P23; SMITH LD, 1992, OECOLOGIA, V89, P494, DOI 10.1007/BF00317155; Wasson K, 2002, BEHAV ECOL, V13, P481, DOI 10.1093/beheco/13.4.481; Wood FD, 1932, J EXP ZOOL, V62, P1, DOI 10.1002/jez.1400620102; Woodland WNF, 1920, Q J MICROSC SCI, V65, P63	35	15	16	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145121	10.1371/journal.pone.0145121	http://dx.doi.org/10.1371/journal.pone.0145121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682546	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800038
J	Li, X; Qiu, WL; Morrow, J; Demeo, DL; Weiss, ST; Fu, YJ; Wang, XG				Li, Xuan; Qiu, Weiliang; Morrow, Jarrett; Demeo, Dawn L.; Weiss, Scott T.; Fu, Yuejiao; Wang, Xiaogang			A Comparative Study of Tests for Homogeneity of Variances with Application to DNA Methylation Data	PLOS ONE			English	Article							DIFFERENTIAL VARIABILITY; EPIGENETIC VARIATION; CANCER; CELLS; RISK	Variable DNA methylation has been associated with cancers and complex diseases. Researchers have identified many DNA methylation markers that have different mean methylation levels between diseased subjects and normal subjects. Recently, researchers found that DNA methylation markers with different variabilities between subject groups could also have biological meaning. In this article, we aimed to help researchers choose the right test of equal variance in DNA methylation data analysis. We performed systematic simulation studies and a real data analysis to compare the performances of 7 equal-variance tests, including 2 tests recently proposed in the DNA methylation analysis literature. Our results showed that the Brown-Forsythe test and trimmed-mean-based Levene's test had good performance in testing for equality of variance in our simulation studies and real data analyses. Our results also showed that outlier profiles could be biologically very important.	[Li, Xuan; Fu, Yuejiao; Wang, Xiaogang] York Univ, Dept Math & Stat, Toronto, ON M3J 1P3, Canada; [Qiu, Weiliang; Morrow, Jarrett; Demeo, Dawn L.; Weiss, Scott T.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA	York University - Canada; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Qiu, WL (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med, 181 Longwood Ave, Boston, MA 02115 USA.	stwxq@channing.harvard.edu		Fu, Yuejiao/0000-0001-8606-570X; Morrow, Jarrett/0000-0002-5670-5865	National Institutes of Health [R01 HL111108, R01 HL089438, R01 HL089897, P01 HL105339, P01 HL114501, R01 HL097144]; Natural Sciences and Engineering Research Council of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114501, R01HL089438, R01HL089897, R01HL097144, R01HL111108, P01HL105339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health [R01 HL111108 to D.L.D., R01 HL089438 to D.L.D., R01 HL089897 to D.L.D., P01 HL105339 to D.L.D., P01 HL114501 to D.L.D., R01 HL097144 to S.T.W.], and Natural Sciences and Engineering Research Council of Canada discovery grant (to X.W., to Y.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Surin, 2013, Pac Symp Biocomput, P69; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CONOVER WJ, 1981, TECHNOMETRICS, V23, P351, DOI 10.2307/1268225; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Issa JP, 2011, NAT GENET, V43, P724, DOI 10.1038/ng.897; Jaffe AE, 2012, BIOSTATISTICS, V13, P166, DOI 10.1093/biostatistics/kxr013; Phipson B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0465-4; R Core Team, 2014, R FDN STAT COMP; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Teschendorff AE, 2012, GENOME MED, V4, DOI 10.1186/gm323; Teschendorff AE, 2012, BIOINFORMATICS, V28, P1487, DOI 10.1093/bioinformatics/bts170; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109	16	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145295	10.1371/journal.pone.0145295	http://dx.doi.org/10.1371/journal.pone.0145295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683022	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800059
J	Podleschny, M; Grund, A; Berger, H; Rollwitz, E; Borchers, A				Podleschny, Martina; Grund, Anita; Berger, Hanna; Rollwitz, Erik; Borchers, Annette			A PTK7/Ror2 Co-Receptor Complex Affects Xenopus Neural Crest Migration	PLOS ONE			English	Article							TYROSINE KINASE ROR2; PLANAR CELL POLARITY; SIGNALING ACTIVITY; RECEPTOR; PTK7; EXPRESSION; CANCER; ACTIVATION; PATHWAY; GROWTH	Neural crest cells are a highly migratory pluripotent cell population that generates a wide array of different cell types and failure in their migration can result in severe birth defects and malformation syndromes. Neural crest migration is controlled by various means including chemotaxis, repellent guidance cues and cell-cell interaction. Non-canonical Wnt PCP (planar cell polarity) signaling has previously been shown to control cell-contact mediated neural crest cell guidance. PTK7 (protein tyrosine kinase 7) is a transmembrane pseudokinase and a known regulator of Wnt/PCP signaling, which is expressed in Xenopus neural crest cells and required for their migration. PTK7 functions as a Wnt co-receptor; however, it remains unclear by which means PTK7 affects neural crest migration. Expressing fluorescently labeled proteins in Xenopus neural crest cells we find that PTK7 co-localizes with the Ror2 Wnt-receptor. Further, co-immunoprecipitation experiments demonstrate that PTK7 interacts with Ror2. The PTK7/Ror2 interaction is likely relevant for neural crest migration, because Ror2 expression can rescue the PTK7 loss of function migration defect. Live cell imaging of explanted neural crest cells shows that PTK7 loss of function affects the formation of cell protrusions as well as cell motility. Co-expression of Ror2 can rescue these defects. In vivo analysis demonstrates that a kinase dead Ror2 mutant cannot rescue PTK7 loss of function. Thus, our data suggest that Ror2 can substitute for PTK7 and that the signaling function of its kinase domain is required for this effect.	[Podleschny, Martina; Grund, Anita; Berger, Hanna; Rollwitz, Erik; Borchers, Annette] Univ Marburg, Fac Biol, Mol Embryol, D-35043 Marburg, Germany	Philipps University Marburg	Borchers, A (corresponding author), Univ Marburg, Fac Biol, Mol Embryol, D-35043 Marburg, Germany.	borchers@uni-marburg.de	Borchers, Annette/AAF-8126-2021	Borchers, Annette/0000-0002-2524-5384	Deutsche Forschungsgemeinschaft [BO 1978/42]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft, grant number BO 1978/42. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; ABERCROMBIE M, 1954, EXP CELL RES, V6, P293, DOI 10.1016/0014-4827(54)90176-7; Andreeva A, 2014, DEV CELL, V29, P20, DOI 10.1016/j.devcel.2014.02.008; Ataseven B, 2014, ONCOTARGETS THER, V7, P1723, DOI 10.2147/OTT.S62676; Axelrod Jeffrey D, 2002, ScientificWorldJournal, V2, P434; Banerjee S, 2011, DEVELOPMENT, V138, P3287, DOI 10.1242/dev.067306; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; Becker SFS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085717; Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153; Bin-Nun N, 2014, DEVELOPMENT, V141, P410, DOI 10.1242/dev.095984; Bolande RP, 1997, PEDIATR PATHOL LAB M, V17, P1, DOI 10.1080/107710497174994; Borchers A, 2001, DEVELOPMENT, V128, P3049; Borchers A, 2000, DEV GENES EVOL, V210, P217, DOI 10.1007/s004270050307; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Carmona-Fontaine C, 2011, DEV CELL, V21, P1026, DOI 10.1016/j.devcel.2011.10.012; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Chen R, 2014, CANCER RES, V74, P2892, DOI 10.1158/0008-5472.CAN-13-2775; Clay MR, 2013, DEVELOPMENT, V140, P3198, DOI 10.1242/dev.095448; de Melker AA, 2004, DEV DYNAM, V230, P708, DOI 10.1002/dvdy.20091; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Feike AC, 2010, BIOCH BIOPHYS RES CO; Gartner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084472; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Golubkov VS, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-15; Golubkov VS, 2010, J BIOL CHEM; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hayes M, 2013, DEVELOPMENT, V140, P1807, DOI 10.1242/dev.090183; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Jin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090247; Kani S, 2004, J BIOL CHEM, V279, P50102, DOI 10.1074/jbc.M409039200; Kashef J, 2009, GENE DEV, V23, P1393, DOI 10.1101/gad.519409; Kim SH, 1998, DEVELOPMENT, V125, P4681; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Kobayashi M, 2009, ORAL SURG ORAL MED O, V107, P398, DOI 10.1016/j.tripleo.2008.08.018; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.3.CO;2-B; Kuriyama S, 2008, PHILOS T R SOC LON B; Lara E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-170; Linnemannstons K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004443; Liu Q, 2014, NEUROONCOLOGY; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; Mayor R, 2014, BIOCHEM J, V457, P19, DOI 10.1042/BJ20131182; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Miller MA, 2000, DEV BIOL, V224, P286, DOI 10.1006/dbio.2000.9786; Morioka K, 2009, CANCER SCI, V100, P1227, DOI 10.1111/j.1349-7006.2009.01165.x; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Ohkawara B, 2011, DEV DYNAM, V240, P188, DOI 10.1002/dvdy.22500; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Ossipova O, 2011, DEVELOPMENT, V138, P5441, DOI 10.1242/dev.067280; Paudyal A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-87; Peradziryi H, 2012, ARCH BIOCHEM BIOPHYS, V524, P71, DOI 10.1016/j.abb.2011.12.019; Peradziryi H, 2011, EMBO J, V30, P3729, DOI 10.1038/emboj.2011.236; Powell DR, 2013, WIRES SYST BIOL MED, V5, P511, DOI 10.1002/wsbm.1224; Prebet T, 2010, BLOOD; Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Sammar M, 2004, GENES CELLS, V9, P1227, DOI 10.1111/j.1365-2443.2004.00799.x; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Snider TN, 2014, BIRTH DEFECTS RES C, V102, P324, DOI 10.1002/bdrc.21075; Theveneau E, 2013, CELL MOL LIFE SCI, V70, P3481, DOI 10.1007/s00018-012-1251-7; Theveneau E, 2013, NAT CELL BIOL, V15, P763, DOI 10.1038/ncb2772; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Theveneau Eric, 2010, Small GTPases, V1, P113, DOI 10.4161/sgtp.1.2.13673; Theveneau E, 2011, GENESIS, V49, P164, DOI 10.1002/dvg.20700; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Ulmer B, 2013, CELL REP, V3, P615, DOI 10.1016/j.celrep.2013.02.015; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Winkel A, 2008, CELL SIGNAL, V20, P2134, DOI 10.1016/j.cellsig.2008.08.009; Witte F, 2010, FASEB J, V24, P2417, DOI 10.1096/fj.09-150615; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Yamada M, 2010, DEV DYNAM, V239, P941, DOI 10.1002/dvdy.22212; Yamamoto H, 2007, GENES CELLS, V12, P1215, DOI 10.1111/j.1365-2443.2007.01128.x; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Yen WW, 2009, DEVELOPMENT, V136, P2039, DOI 10.1242/dev.030601; Zhang DC, 2014, BIRTH DEFECTS RES C, V102, P275, DOI 10.1002/bdrc.21081; Zhang HT, 2014, INT J MOL SCI, V15, P11665, DOI 10.3390/ijms150711665	95	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145169	10.1371/journal.pone.0145169	http://dx.doi.org/10.1371/journal.pone.0145169			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680417	gold, Green Published, Green Submitted			2022-12-27	WOS:000366723400052
J	Tyack, PL; Calambokidis, J; Friedlaender, A; Goldbogen, J; Southall, B				Tyack, Peter L.; Calambokidis, John; Friedlaender, Ari; Goldbogen, Jeremy; Southall, Brandon			Formal Comment on Schorr GS, Falcone EA, Moretti DJ, Andrews RD (2014) First Long-Term Behavioral Records from Cuvier's Beaked Whales (Ziphius cavirostris) Reveal Record-Breaking Dives. PLoS ONE 9(3): e92633. doi:10.1371/journal.pone.0092633	PLOS ONE			English	Editorial Material									[Tyack, Peter L.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland; [Tyack, Peter L.] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Calambokidis, John] Cascadia Res, Olympia, WA USA; [Friedlaender, Ari] Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Newport, OR 97365 USA; [Goldbogen, Jeremy] Stanford Univ, Dept Biol, Pacific Grove, CA USA; [Southall, Brandon] Southall Environm Associates Inc, Aptos, CA USA	University of St Andrews; University of St Andrews; Oregon State University; Stanford University	Tyack, PL (corresponding author), Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland.	plt@st-andrews.ac.uk	Tyack, Peter/AAC-4513-2019	Tyack, Peter/0000-0002-8409-4790; Goldbogen, Jeremy/0000-0002-4170-7294				DeRuiter SL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0223; Falcone E A, 2013, DISTRIBUTION DEMOGRA; Schorr GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092633; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009	4	21	23	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0142287	10.1371/journal.pone.0142287	http://dx.doi.org/10.1371/journal.pone.0142287			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678487	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400001
J	Xue, P; Gao, L; Xiao, S; Zhang, GP; Xiao, MY; Zhang, QY; Zheng, X; Cai, Y; Jin, CH; Yang, JH; Wu, SW; Lu, XB				Xue, Ping; Gao, Lin; Xiao, Sha; Zhang, Guopei; Xiao, Mingyang; Zhang, Qianye; Zheng, Xiao; Cai, Yuan; Jin, Cuihong; Yang, Jinghua; Wu, Shengwen; Lu, Xiaobo			Genetic Polymorphisms in XRCC1, CD3EAP, PPP1R13L, XPB, XPC, and XPF and the Risk of Chronic Benzene Poisoning in a Chinese Occupational Population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; OXIDATIVE DNA-DAMAGE; BONE-MARROW; CHROMOSOME 19Q13.2-3; BREAST-CANCER; LUNG-CANCER; REPAIR; ERCC1; SUSCEPTIBILITY; ASSOCIATION	Objectives Individual variations in the capacity of DNA repair machinery to relieve benzene-induced DNA damage may be the key to developing chronic benzene poisoning (CBP), an increasingly prevalent occupational disease in China. ERCC1 (Excision repair cross complementation group 1) is located on chromosome 19q13.2-3 and participates in the crucial steps of Nucleotide Excision Repair (NER); moreover, we determined that one of its polymorphisms, ERCC1 rs11615, is a biomarker for CBP susceptibility in our previous report. Our aim is to further explore the deeper association between some genetic variations related to ERCC1 polymorphisms and CBP risk. Methods Nine single nucleotide polymorphisms (SNPs) of XRCC1 (X-ray repair cross-complementing 1), CD3EAP (CD3e molecule, epsilon associated protein), PPP1R13L (protein phosphatase 1, regulatory subunit 13 like), XPB (Xeroderma pigmentosum group B), XPC (Xeroderma pigmentosum group C) and XPF (Xeroderma pigmentosum group F) were genotyped by the Snapshot and TaqMan-MGB (R) probe techniques, in a study involving 102 CBP patients and 204 controls. The potential interactions between these SNPs and lifestyle factors, such as smoking and drinking, were assessed using a stratified analysis. Results An XRCC1 allele, rs25487, was related to a higher risk of CBP (P<0.001) even after stratifying for potential confounders. Carriers of the TT genotype of XRCC1 rs1799782 who were alcohol drinkers (OR = 8.000; 95% CI: 1.316-48.645; P = 0.022), male (OR = 9.333; 95% CI: 1.593-54.672; P = 0.019), and had an exposure of <= 12 years (OR = 2.612; 95% CI: 1.048-6.510; P = 0.035) had an increased risk of CBP. However, the T allele in PPP1R13L rs1005165 (P<0.05) and the GA allele in CD3EAP rs967591 (OR = 0.162; 95% CI: 0039 +/- 0.666; P = 0.037) decreased the risk of CBP in men. The haplotype analysis of XRCC1 indicated that XRCC1 rs25487(A), rs25489(G) and rs1799782(T) (OR = 15.469; 95% CI: 5.536-43.225; P<0.001) were associated with a high risk of CBP. Conclusions The findings showed that the rs25487 and rs1799782 polymorphisms of XRCC1 may contribute to an individual's susceptibility to CBP and may be used as valid biomarkers. Overall, the genes on chromosome 19q13.2-3 may have a special significance in the development of CBP in occupationally exposed Chinese populations.	[Xue, Ping; Gao, Lin; Xiao, Sha; Zhang, Guopei; Xiao, Mingyang; Zhang, Qianye; Zheng, Xiao; Cai, Yuan; Jin, Cuihong; Yang, Jinghua; Wu, Shengwen; Lu, Xiaobo] China Med Univ, Sch Publ Hlth, Dept Toxicol, Shenyang 110001, Liaoning, Peoples R China; [Gao, Lin] Shenyang Ninth Peoples Hosp, Poisoning Dept, Shenyang 110001, Liaoning, Peoples R China	China Medical University	Lu, XB (corresponding author), China Med Univ, Sch Publ Hlth, Dept Toxicol, Shenyang 110001, Liaoning, Peoples R China.	xiaobo-lu@163.com			National Natural Science Foundation of China [81273118]; Shenyang Technology Specific Foundation [F12-193-9-17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenyang Technology Specific Foundation	This study was supported by National Natural Science Foundation of China (No. 81273118) and Shenyang Technology Specific Foundation (No. F12-193-9-17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin DP, 2001, INT J TOXICOL, V20, P69; Andreoli C, 1997, MUTAT RES-FUND MOL M, V377, P95, DOI 10.1016/S0027-5107(97)00065-1; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Capleton AC, 2005, CHEM-BIOL INTERACT, V153, P43, DOI 10.1016/j.cbi.2005.03.007; Chae YS, 2013, J CANCER RES CLIN, V139, P465, DOI 10.1007/s00432-012-1346-4; Chanvaivit S, 2007, MUTAT RES-GEN TOX EN, V626, P79, DOI 10.1016/j.mrgentox.2006.09.007; Chen SQ, 2002, CARCINOGENESIS, V23, P1321, DOI 10.1093/CARCIN/23.8.1321; Ding PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092083; Faiola B, 2004, MUTAT RES-FUND MOL M, V549, P195, DOI 10.1016/j.mrfmmm.2003.12.022; Fracasso ME, 2010, TOXICOL LETT, V192, P22, DOI 10.1016/j.toxlet.2009.04.028; Hosgood HD, 2009, OCCUP ENVIRON MED, V66, P848, DOI 10.1136/oem.2008.044024; Huang J, 2007, INT J GYNECOL CANCER, V17, P668, DOI 10.1111/j.1525-1438.2007.00840.x; Jeon HS, 2013, CLIN CANCER RES, V19, P4185, DOI 10.1158/1078-0432.CCR-12-2792; Jiang HL, 2013, TUMOR BIOL, V34, P3417, DOI 10.1007/s13277-013-0914-9; Kim SY, 2004, PHARMACOGENETICS, V14, P453, DOI 10.1097/01.fpc.0000114751.08559.7b; KOLACHANA P, 1993, CANCER RES, V53, P1023; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Lan Q, 2004, SCIENCE, V306, P1774, DOI 10.1126/science.1102443; Lee EB, 2010, ANN SURG ONCOL, V17, P2608, DOI 10.1245/s10434-010-1082-4; Leng SG, 2005, CANCER EPIDEM BIOMAR, V14, P1295, DOI 10.1158/1055-9965.EPI-04-0690; LI YB, 1995, CHEM-BIOL INTERACT, V94, P101, DOI 10.1016/0009-2797(94)03326-4; Lu AL, 2001, CELL BIOCHEM BIOPHYS, V35, P141, DOI 10.1385/CBB:35:2:141; Maffei F, 2009, MUTAT RES, V583, P1; Nexo BA, 2003, CARCINOGENESIS, V24, P899, DOI 10.1093/carcin/bgg043; Nexo BA, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-56; Recio L, 2005, CHEM-BIOL INTERACT, V153, P159, DOI 10.1016/j.cbi.2005.03.020; Rodriguez B, 2010, TOXICOL LETT, V193, P26, DOI 10.1016/j.toxlet.2009.12.005; SEATON MJ, 1994, CARCINOGENESIS, V15, P1799, DOI 10.1093/carcin/15.9.1799; Shen M, 2006, CARCINOGENESIS, V27, P2083, DOI 10.1093/carcin/bgl061; Skjelbred CF, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-175; Stern MC, 2001, CANCER EPIDEM BIOMAR, V10, P125; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Vogel U, 2004, MUTAT RES-FUND MOL M, V546, P65, DOI 10.1016/j.mrfmmm.2003.11.001; Vogel U, 2007, CANCER LETT, V247, P159, DOI 10.1016/j.canlet.2006.04.001; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Xiao S, 2013, MUTAT RES-GEN TOX EN, V751, P52, DOI 10.1016/j.mrgentox.2012.11.002; Xing DY, 2002, INT J CANCER, V100, P600, DOI 10.1002/ijc.10528; Yin JY, 2012, LUNG CANCER, V76, P286, DOI 10.1016/j.lungcan.2012.01.001; Yin JY, 2002, CANCER EPIDEM BIOMAR, V11, P1449; Zhang ZB, 2005, CANCER EPIDEM BIOMAR, V14, P2614, DOI 10.1158/1055-9965.EPI-05-0143	40	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144458	10.1371/journal.pone.0144458	http://dx.doi.org/10.1371/journal.pone.0144458			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26681190	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400015
J	Hashimoto, Y; Kondo, C; Katunuma, N				Hashimoto, Yoko; Kondo, Chihiro; Katunuma, Nobuhiko			An Active 32-kDa Cathepsin L Is Secreted Directly from HT 1080 Fibrosarcoma Cells and Not via Lysosomal Exocytosis	PLOS ONE			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; DIPLOCOCCUS-PNEUMONIAE; TUMOR MICROENVIRONMENT; CARBOHYDRATE MOIETIES; MOLECULAR-MASS; PROCATHEPSIN-L; CANCER-CELLS; ENZYMES; INHIBITION; ACTIVATION	Cathepsin L [EC 3.4.22.15] is secreted via lysosomal exocytosis by several types of cancer cells, including prostate and breast cancer cells. We previously reported that human cultured fibrosarcoma ( HT 1080) cells secrete cathepsin L into the medium; this secreted cathepsin is 10-times more active than intracellular cathepsin. This increased activity was attributed to the presence of a 32-kDa cathepsin L in the medium. The aim of this study was to examine how this active 32-kDa cathepsin L is secreted into the medium. To this end, we compared the secreted active 32-kDa cathepsin L with lysosomal cathepsin L by using a novel gelatin zymography technique that employs leupeptin. We also examined the glycosylation and phosphorylation status of the proteins by using the enzymes endoglycosidase H [EC 3.2.1.96] and alkaline phosphatase [EC 3.1.3.1]. Strong active bands corresponding to the 32-kDa and 34-kDa cathepsin L forms were detected in the medium and lysosomes, respectively. The cell extract exhibited strong active bands for both forms. Moreover, both forms were adsorbed onto a concanavalin A-agarose column. The core protein domain of both forms had the same molecular mass of 30 kDa. The 32-kDa cathepsin L was phosphorylated, while the 34-kDa lysosomal form was dephosphorylated, perhaps because of the lysosomal marker enzyme, acid phosphatase. These results suggest that the active 32-kDa form does not enter the lysosomes. In conclusion, our results indicate that the active 32-kDa cathepsin L is secreted directly from the HT 1080 cells and not via lysosomal exocytosis.	[Hashimoto, Yoko; Kondo, Chihiro] Aichi Gakuin Univ, Sch Dent, Dept Biochem, Nagoya, Aichi 464, Japan; [Katunuma, Nobuhiko] Tokushima Bunri Univ, Inst Hlth Sci, Tokushima, Japan	Aichi Gakuin University; Tokushima Bunri University	Hashimoto, Y (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Biochem, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	yokuteku@dpc.agu.ac.jp			Aichi-Gakuin University Annual Fund	Aichi-Gakuin University Annual Fund	This work was supported by Aichi-Gakuin University Annual Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NW, 2000, TRENDS CELL BIOL, V10, P316, DOI 10.1016/S0962-8924(00)01794-3; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; ARAKAWA M, 1974, J BIOCHEM, V76, P307, DOI 10.1093/oxfordjournals.jbchem.a130572; Castino R, 2003, J MOL RECOGNIT, V16, P337, DOI 10.1002/jmr.643; DONG JM, 1990, J BIOL CHEM, V265, P4210; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Ghosh P, 2003, J CELL BIOL, V163, P755, DOI 10.1083/jcb.200308038; Gillies Robert J., 1999, Neoplasia (New York), V1, P197, DOI 10.1038/sj.neo.7900037; HARA K, 1988, FEBS LETT, V231, P229, DOI 10.1016/0014-5793(88)80737-3; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P334, DOI 10.1006/bbrc.2001.4787; Hashimoto Y, 2006, CANCER BIOTHER RADIO, V21, P217, DOI 10.1089/cbr.2006.21.217; INUBUSHI T, 1994, J BIOCHEM-TOKYO, V116, P282, DOI 10.1093/oxfordjournals.jbchem.a124520; ISHIDOH K, 1987, FEBS LETT, V223, P69, DOI 10.1016/0014-5793(87)80511-2; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Katunuma N, 1999, FEBS LETT, V458, P6, DOI 10.1016/S0014-5793(99)01107-2; KOIDE N, 1974, J BIOL CHEM, V249, P4897; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; Kuliawat R, 1997, J CELL BIOL, V137, P595, DOI 10.1083/jcb.137.3.595; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; LANG L, 1984, J BIOL CHEM, V259, P4663; LAZZARINO D, 1990, J BIOL CHEM, V265, P11864; Linebaugh BE, 1999, EUR J BIOCHEM, V264, P100, DOI 10.1046/j.1432-1327.1999.00582.x; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045910; Lunt SJ, 2009, CLIN EXP METASTAS, V26, P19, DOI 10.1007/s10585-008-9182-2; MASON RW, 1992, BIOCHEM BIOPH RES CO, V189, P1659, DOI 10.1016/0006-291X(92)90268-P; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; MURAMATS.T, 1971, J BIOL CHEM, V246, P5534; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V261, P64, DOI 10.1016/0003-9861(88)90104-X; NOVIKOFF ALEX B., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P179, DOI 10.1083/jcb.2.4.179; Ohkubo K, 2003, ENDOCR J, V50, P9, DOI 10.1507/endocrj.50.9; Podgorski I, 2003, BIOCHEM SOC SYMP, V70, P263, DOI 10.1042/bss0700263; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Rohn WM, 2000, J CELL SCI, V113, P2093; ROTHMAN JE, 1987, CELL, V50, P521, DOI 10.1016/0092-8674(87)90024-9; Samie MA, 2014, J LIPID RES, V55, P995, DOI 10.1194/jlr.R046896; SMITH SM, 1989, BIOCHEM J, V262, P931, DOI 10.1042/bj2620931; Sudhan DR, 2013, CLIN EXP METASTAS, V30, P891, DOI 10.1007/s10585-013-9590-9; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; TURK B, 1993, BIOCHEMISTRY-US, V32, P375, DOI 10.1021/bi00052a046; UMEZAWA H, 1970, J ANTIBIOT, V23, P425, DOI 10.7164/antibiotics.23.425	41	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145067	10.1371/journal.pone.0145067	http://dx.doi.org/10.1371/journal.pone.0145067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674348	Green Submitted, gold, Green Published			2022-12-27	WOS:000366722700092
J	Huang, RE; Ye, WM; Ren, XL; Zhao, ZY				Huang, Ren-E; Ye, Weimin; Ren, Xiaoliang; Zhao, Zhongying			Morphological and Molecular Characterization of Phasmarhabditis huizhouensis sp nov (Nematoda: Rhabditidae), a New Rhabditid Nematode from South China	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; HERMAPHRODITA NEMATODA; TERRESTRIAL MOLLUSKS; PARASITE; DNA; ANGIOSTOMATIDAE; PHYLOGENY; SLUGS; SECERNENTEA; AGENT	The genus Phasmarhabditis is an economically important group of rhabditid nematodes, to which the well-known slug-parasite P. hermaphrodita belongs. Despite the commercial use of Phasmarhabditis species as an attractive and promising approach for pest control, the taxonomy and systematics of this group of rhabditids are poorly understood, largely because of the lack of diagnostic morphological features and DNA sequences for distinguishing species or inferring phylogenetic relationship. During a nematode sampling effort for identifying free-living relatives of Caenorhabditis elegans in Huizhou City, Guangdong, China, a novel species belonging to the genus Phasmarhabditis was isolated from rotting leaves. Detailed morphology of the gonochoristic P. huizhouensis sp. nov. was described and illustrated. The adult female has a robust body, a relatively short and wide buccal capsule conjoined by a rhabditiform pharynx. Females are characterized by a short cupola-shaped tail end bearing a slender pointed tip, with the junction flanked by a pair of 'rod-like' phasmids. Males have an open peloderan bursa that is supported by 9 pairs of genital papillae and 1 terminal pair of phasmids. P. huizhouensis sp. nov. is morphologically very similar to the type species Phasmarhabditis papillosa but is distinguishable by its male caudal traits. The new species is readily differentiated from other taxa in the genus by its female tail shape. Molecular phylogenetic inferences based on small subunit (SSU) and the D2-D3 domain of large subunit (LSU) ribosomal DNA genes reveal that P. huizhouensis sp. nov. forms a unique branch in both phylogenies which is genetically related to P. hermaphrodita and other parasites such as Angiostoma spp. The host associations of P. huizhouensis sp. nov. and its ability to parasitize slugs are unknown.	[Huang, Ren-E] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Huang, Ren-E; Ren, Xiaoliang; Zhao, Zhongying] Hong Kong Baptist Univ, Dept Biol, Fac Sci, Hong Kong, Hong Kong, Peoples R China; [Ye, Weimin] North Carolina Dept Agr & Consumer Serv, Div Agron, Nematode Assay Sect, Raleigh, NC USA	Tsinghua University; Hong Kong Baptist University	Huang, RE (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	renehuang2014@126.com; zyzhao@hkbu.edu.hk	Zhao, Zhongying/C-3261-2015		National Natural Science Foundation of China [31201700]; Early Career Scheme (ECS) of the Research Grants Council (RGC) of Hong Kong [HKBU263512]; General Research Fund (GRF) of the Research Grants Council (RGC) of Hong Kong [HKBU12103314]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Early Career Scheme (ECS) of the Research Grants Council (RGC) of Hong Kong; General Research Fund (GRF) of the Research Grants Council (RGC) of Hong Kong	This study was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (Grant No. 31201700) to REH, and by the Early Career Scheme (ECS) and General Research Fund (GRF) of the Research Grants Council (RGC) of Hong Kong (http://www.ugc.edu.hk/eng/rgc/) (Grant No. HKBU263512 and HKBU12103314 respectively) to ZZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy I., 1976, EVOLUTION BASIS SYST; Andrassy I., 1983, TAXONOMIC REV SUBORD; Azzam Karima M., 2003, Journal of the Egyptian German Society of Zoology, V42, P79; Barriere Antoine, 2006, WormBook, P1; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bonaparte CLJL, 1838, ICONOGRAPHIA TAUNA I, VII; De Ley IT, 2014, NEMATOLOGY, V16, P1129, DOI 10.1163/15685411-00002838; deMan J.G, 1880, TIJDSCHRIFT NEDERLAN, V5, P1; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Haber M, 2005, MOL BIOL EVOL, V22, P160, DOI 10.1093/molbev/msh264; Hooper DJ, 1999, NEMATOLOGY, V1, P173, DOI 10.1163/156854199508144; Huang RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110957; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ivanova ES, 2010, J HELMINTHOL, V84, P297, DOI 10.1017/S0022149X09990678; Ivanova ES, 2013, RUSS J NEMATOL, V21, P41; Ivanova ES, 2009, SYST PARASITOL, V74, P113, DOI 10.1007/s11230-009-9200-z; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Mengert H., 1953, Zeitschrift fuer Morphologie und Oekologie der Tiere, V41, P311, DOI 10.1007/BF00407426; MORAND S, 1990, SYST PARASITOL, V15, P127, DOI 10.1007/BF00009990; Nadler SA, 1998, MOL PHYLOGENET EVOL, V10, P221, DOI 10.1006/mpev.1998.0514; Nadler SA, 2003, INT J PARASITOL, V33, P1115, DOI 10.1016/S0020-7519(03)00134-6; POINAR GO, 1993, FUND APPL NEMATOL, V16, P333; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rae R. G., 2006, Aspects of Applied Biology, P211; Rae R, 2007, PEST MANAG SCI, V63, P1153, DOI 10.1002/ps.1424; da Silva NRR, 2010, NEMATOLOGY, V12, P661, DOI 10.1163/138855410X500073; Ross JL, 2012, J HELMINTHOL, V86, P215, DOI 10.1017/S0022149X11000277; Ross JL, 2011, SYST PARASITOL, V79, P71, DOI 10.1007/s11230-011-9294-y; Ross JL, 2010, MOL PHYLOGENET EVOL, V55, P738, DOI 10.1016/j.ympev.2010.01.026; Ross JL, 2010, BIOL INVASIONS, V12, P603, DOI 10.1007/s10530-009-9467-7; Ryss AY, 2003, ZOOSYSTEMATICA ROSSI, V11, P257; Sanchez-Herraiz MJ, 2000, HERPETOLOGICA, V56, P105; STOCK SP, 1991, MEM I OSWALDO CRUZ, V86, P219, DOI 10.1590/S0074-02761991000200011; Sudhaus W., 2011, Journal of Nematode Morphology and Systematics, V14, P113; Sudhaus W, 2001, J NEMATOL, V33, P1; Sudhaus W., 1976, Zoologica Stuttg, V43, P1; Thomas WK, 1997, J NEMATOL, V29, P250; WILSON MJ, 1993, BIOCONTROL SCI TECHN, V3, P503, DOI 10.1080/09583159309355306; Wilson MJ, 2004, APPL SOIL ECOL, V26, P179, DOI 10.1016/j.apsoil.2004.01.005; WILSON MJ, 1995, FUND APPL NEMATOL, V18, P159; Zaborski ER, 2001, J INVERTEBR PATHOL, V77, P284, DOI 10.1006/jipa.2001.5024	41	23	25	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144386	10.1371/journal.pone.0144386	http://dx.doi.org/10.1371/journal.pone.0144386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674768	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700038
J	Maier, O; Schroder, C; Forkert, ND; Martinetz, T; Handels, H				Maier, Oskar; Schroeder, Christoph; Forkert, Nils Daniel; Martinetz, Thomas; Handels, Heinz			Classifiers for Ischemic Stroke Lesion Segmentation: A Comparison Study	PLOS ONE			English	Article							IMPACT	Motivation Ischemic stroke, triggered by an obstruction in the cerebral blood supply, leads to infarction of the affected brain tissue. An accurate and reproducible automatic segmentation is of high interest, since the lesion volume is an important end-point for clinical trials. However, various factors, such as the high variance in lesion shape, location and appearance, render it a difficult task. Methods In this article, nine classification methods (e.g. Generalized Linear Models, Random Decision Forests and Convolutional Neural Networks) are evaluated and compared with each other using 37 multiparametric MRI datasets of ischemic stroke patients in the sub-acute phase in terms of their accuracy and reliability for ischemic stroke lesion segmentation. Within this context, a multi-spectral classification approach is compared against mono-spectral classification performance using only FLAIR MRI datasets and two sets of expert segmentations are used for inter-observer agreement evaluation. Results and Conclusion The results of this study reveal that high-level machine learning methods lead to significantly better segmentation results compared to the rather simple classification methods, pointing towards a difficult non-linear problem. The overall best segmentation results were achieved by a Random Decision Forest and a Convolutional Neural Networks classification approach, even outperforming all previously published results. However, none of the methods tested in this work are capable of achieving results in the range of the human observer agreement and the automatic ischemic stroke lesion segmentation remains a complicated problem that needs to be explored in more detail to improve the segmentation results.	[Maier, Oskar; Handels, Heinz] Med Univ Lubeck, Inst Med Informat, D-23538 Lubeck, Germany; [Maier, Oskar] Med Univ Lubeck, Grad Sch Comp Med & Live Sci, D-23538 Lubeck, Germany; [Schroeder, Christoph; Martinetz, Thomas] Med Univ Lubeck, Inst Neuro & Bioinformat, D-23538 Lubeck, Germany; [Forkert, Nils Daniel] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Forkert, Nils Daniel] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Lubeck; University of Lubeck; University of Lubeck; University of Calgary; University of Calgary	Maier, O (corresponding author), Med Univ Lubeck, Inst Med Informat, D-23538 Lubeck, Germany.	maier@imi.uni-luebeck.de	Handels, Heinz/E-3858-2010; Forkert, Nils Daniel/K-6273-2012	Forkert, Nils Daniel/0000-0003-2556-3224; Maier, Oskar/0000-0003-3441-9902; Handels, Heinz/0000-0002-3499-4328; Schroder-Dering, Christoph/0000-0003-0722-9222	Graduate School for Computing in Medicine and Life Sciences, Universitat zu Lubeck, Lubeck, Germany	Graduate School for Computing in Medicine and Life Sciences, Universitat zu Lubeck, Lubeck, Germany	OM holds a scholarship of the Graduate School for Computing in Medicine and Life Sciences, Universitat zu Lubeck, Lubeck, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Chyzhyk D, 2015, NEUROCOMPUTING, V150, P26, DOI 10.1016/j.neucom.2014.01.077; Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Criminisi A., 2013, DECISION FORESTCOM; Forbes F, 2010, I S BIOMED IMAGING, P69, DOI 10.1109/ISBI.2010.5490413; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Geoffrey E Hinton, 2012, ARXIV; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Goodfellow IJ, 2013, PREPRINT; Hevia-Montiel N, 2007, P ANN INT IEEE EMBS, P2102, DOI 10.1109/IEMBS.2007.4352736; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Jia Y.Q., 2014, PREPRINT; Kaesemann P, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00254; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Machner B, 2014, STROKE, V45, P2465, DOI 10.1161/STROKEAHA.114.006059; Machner B, 2012, NEUROPSYCHOLOGIA, V50, P2415, DOI 10.1016/j.neuropsychologia.2012.06.012; Maier O, 2014, PROC SPIE, V9035, DOI 10.1117/12.2043494; Maier O, 2015, J NEUROSCI METH, V240, P89, DOI 10.1016/j.jneumeth.2014.11.011; Mitra J, 2014, NEUROIMAGE, V98, P324, DOI 10.1016/j.neuroimage.2014.04.056; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rekik I, 2012, NEUROIMAGE-CLIN, V1, P164, DOI 10.1016/j.nicl.2012.10.003; Rish I., 2001, IJCAI 2001 WORKSH EM, V3, P41, DOI DOI 10.1039/B104835J; Seghier ML, 2008, NEUROIMAGE, V41, P1253, DOI 10.1016/j.neuroimage.2008.03.028; Szegedy Christian, 2014, ARXIV; von der Gablentz J, 2012, THESIS; Wilke M, 2011, NEUROIMAGE, V56, P2038, DOI 10.1016/j.neuroimage.2011.04.014; Zhang JQ, 2004, 18TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS, VOL 1 (LONG PAPERS), PROCEEDINGS, P562	33	100	104	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145118	10.1371/journal.pone.0145118	http://dx.doi.org/10.1371/journal.pone.0145118			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672989	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700103
J	Sandrock, I; Zietara, N; Lyszkiewicz, M; Oberdorfer, L; Witzlau, K; Krueger, A; Prinz, I				Sandrock, Inga; Zietara, Natalia; Lyszkiewicz, Marcin; Oberdoerfer, Linda; Witzlau, Katrin; Krueger, Andreas; Prinz, Immo			MicroRNA-181a/b-1 Is Not Required for Innate gamma delta NKT Effector Cell Development	PLOS ONE			English	Article							T-CELLS; ALPHA-BETA; LIMITED DIVERSITY; SELECTION; REPERTOIRE; EXPRESSION; STRENGTH; SUBSET; TRANSCRIPTION; IL-17A	Thymic development of alpha beta T lymphocytes into invariant natural killer (NK) T cells depends on their selection via agonistic lipid antigen presented by CD1d. If successful, newly selected NKT cells gain effector functions already in the thymus. Some gamma delta T cell subsets also acquire effector functions in the thymus. However, it is not clear whether agonistic TCR stimulation is involved in thymic gamma delta T cell selection and development. Here we combine two genetic models to address this question. MiR-181a/b-1(-/-) mice, which show impaired agonistic T cell selection of invariant alpha beta NKT cells, were crossed to Tcrd-H2BeGFP reporter mice to monitor selection, intra-thymic expansion and differentiation of gamma delta T cells. We found that miR-181a/b-1-deficiency had no effect on numbers of thymic gamma delta T cell or on their differentiation towards an IL-17- or IFN-gamma-producing effector phenotype. Also, the composition of peripheral lymph node gamma delta T cells was not affected by miR-181a/b-1-deficiency. Dendritic epidermal gamma delta T cells were normally present in knock-out animals. However, we observed elevated frequencies and numbers of gamma delta NKT cells in the liver, possibly because gamma delta NKT cells can expand and replace missing alpha beta NKT cells in peripheral niches. In summary, we investigated the role of miR-181a/b-1 for selection, intrathymic development and homeostasis of gamma delta T cells. We conclude that miR-181a/b-1-dependent modulation of T cell selection is not critically required for innate development of gamma delta NKT cells or of any other gamma delta T cell subtypes.	[Sandrock, Inga; Zietara, Natalia; Lyszkiewicz, Marcin; Oberdoerfer, Linda; Witzlau, Katrin; Krueger, Andreas; Prinz, Immo] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany	Hannover Medical School	Sandrock, I (corresponding author), Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany.	Sandrock.Inga@mh-hannover.de	Prinz, Immo/A-3026-2010; Krueger, Andreas/M-9769-2019; Krueger, Andreas/B-9427-2009	Prinz, Immo/0000-0002-8789-9578; Krueger, Andreas/0000-0001-7873-7334; Krueger, Andreas/0000-0001-7873-7334; Zietara, Natalia/0000-0002-4597-6731	Braukmann-Wittenberg-Herz-Stiftung; German Research Foundation (DFG); DFG [PR727/4-1, PR727/5-1, SFB900-B8, KR2320/3-1, SFB738-A7]; Ministry For Science and Culture of Lower Saxony through the Georg-Christoph-Lichtenberg Scholarship scheme	Braukmann-Wittenberg-Herz-Stiftung; German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Ministry For Science and Culture of Lower Saxony through the Georg-Christoph-Lichtenberg Scholarship scheme	Assistance was provided by the Cell Sorting Core Facility of the Hannover Medical School, supported in part by Braukmann-Wittenberg-Herz-Stiftung and German Research Foundation (DFG). The work was supported by grants from the DFG (PR727/4-1; PR727/5-1; and SFB900-B8 to I.P. and cluster of excellence EXC62-2 "REBIRTH", KR2320/3-1 and SFB738-A7 to A.K.). I.S. was supported in part by the Ministry For Science and Culture of Lower Saxony through the Georg-Christoph-Lichtenberg Scholarship scheme.; Assistance was provided by the Cell Sorting Core Facility of the Hannover Medical School, supported in part by Braukmann-Wittenberg-Herz-Stiftung and German Research Foundation (DFG). The allophycocyanin-conjugated CD1d tetramer loaded with PBS-57, an analog of alpha GalCer, as well as unloaded CD1d tetramer were kindly provided by the National Institutes of Health Tetramer Facility at Emory University. The work was supported by grants from the DFG (PR727/4-1; PR727/5-1; and SFB900-B8 to I.P. and cluster of excellence EXC62-2 "REBIRTH", KR2320/3-1 and SFB738-A7 to A.K.). I.S. was a scholar of Hannover Biomedical Research School (HBRS/DEWIN).	Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; ARASE H, 1995, J EXP MED, V182, P891, DOI 10.1084/jem.182.3.891; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; Azuara V, 1998, EUR J IMMUNOL, V28, P3456, DOI 10.1002/(SICI)1521-4141(199811)28:11&lt;3456::AID-IMMU3456&gt;3.0.CO;2-F; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chennupati V, 2010, J IMMUNOL, V185, P5160, DOI 10.4049/jimmunol.1001652; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Fragoso R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002855; Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474; Gerber DJ, 1999, J IMMUNOL, V163, P3076; Grigoriadou K, 2002, J IMMUNOL, V169, P3736, DOI 10.4049/jimmunol.169.7.3736; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; HAVRAN WL, 1989, P NATL ACAD SCI USA, V86, P4185, DOI 10.1073/pnas.86.11.4185; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; ITOHARA S, 1990, NATURE, V343, P754, DOI 10.1038/343754a0; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kirigin FF, 2012, J IMMUNOL, V188, P3257, DOI 10.4049/jimmunol.1103175; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Li J, 2013, J IMMUNOL, V191, P5052, DOI 10.4049/jimmunol.1301252; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Pang DJ, 2012, IMMUNOLOGY, V136, P283, DOI 10.1111/j.1365-2567.2012.03582.x; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; Pereira P, 2013, J IMMUNOL, V191, P1716, DOI 10.4049/jimmunol.1203168; Pereira P, 2012, EUR J IMMUNOL, V42, P1272, DOI 10.1002/eji.201142109; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Prinz I, 2013, EUR J IMMUNOL, V43, P1988, DOI 10.1002/eji.201343759; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Roark CL, 2004, J LEUKOCYTE BIOL, V75, P68, DOI 10.1189/jlb.0703326; Shibata K, 2008, J IMMUNOL, V181, P5940, DOI 10.4049/jimmunol.181.9.5940; Shibata K, 2014, J IMMUNOL, V192, P2210, DOI 10.4049/jimmunol.1302145; Shibata K, 2011, BLOOD, V118, P586, DOI 10.1182/blood-2011-02-334995; Simonian PL, 2009, J IMMUNOL, V182, P6540, DOI 10.4049/jimmunol.0900013; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Turchinovich G, 2011, TRENDS IMMUNOL, V32, P567, DOI 10.1016/j.it.2011.09.005; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008; Zietara N, 2013, P NATL ACAD SCI USA, V110, P7407, DOI 10.1073/pnas.1221984110	49	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145010	10.1371/journal.pone.0145010	http://dx.doi.org/10.1371/journal.pone.0145010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673421	gold, Green Submitted, Green Published			2022-12-27	WOS:000366722700086
J	Cox, F; Baart, M; Huizingh, J; Tolboom, J; Dekking, L; Goudsmit, J; Saeland, E; Radosevic, K				Cox, Freek; Baart, Matthijs; Huizingh, Jeroen; Tolboom, Jeroen; Dekking, Liesbeth; Goudsmit, Jaap; Saeland, Eirikur; Radosevic, Katarina			Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells	PLOS ONE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; MONOCLONAL-ANTIBODIES; HETEROSUBTYPIC IMMUNITY; VIRAL NEURAMINIDASE; A VIRUSES; CORRELATE; HEMAGGLUTININ; EFFICACY; ECTODOMAIN; CHALLENGE	Background It remains important to develop the next generation of influenza vaccines that can provide protection against vaccine mismatched strains and to be prepared for potential pandemic outbreaks. To achieve this, the understanding of the immunological parameters that mediate such broad protection is crucial. Method In the current study we assessed the contribution of humoral and cellular immune responses to heterosubtypic protection against H5N1 induced by a Matrix-M (MM) adjuvanted seasonal influenza vaccine by serum transfer and T-cell depletion studies. Results We demonstrate that the heterosubtypic protection against H5N1 induced by MM adjuvanted vaccine is partially mediated by antibodies. The serum contained both H5N1 cross-reactive hemagglutinin (HA)- and neuraminidase (NA)-specific antibodies but with limited virus neutralizing and no hemagglutination inhibiting activity. The cross-reactive antibodies induced antibody-dependent cellular cytotoxicity (ADCC) in vitro, suggesting a role for the Fc part of the antibodies in protection against H5N1. Besides H5N1 specific antibody responses, cross-reactive HA- and NA-specific T-cell responses were induced by the adjuvanted vaccine. T-cell depletion experiments demonstrated that both CD4(+) and CD8(+) T cells contribute to protection. Conclusion Our study demonstrates that cross-protection against H5N1 induced by MM adjuvanted seasonal virosomal influenza vaccine requires both the humoral and cellular arm of the immune system.	[Cox, Freek; Baart, Matthijs; Huizingh, Jeroen; Tolboom, Jeroen; Dekking, Liesbeth; Goudsmit, Jaap; Saeland, Eirikur; Radosevic, Katarina] Pharmaceut Co Johnson & Johnson, Janssen Res & Dev, Ctr Excellence, Janssen Prevent Ctr, Leiden, Netherlands	Johnson & Johnson; Janssen Pharmaceuticals	Saeland, E (corresponding author), Pharmaceut Co Johnson & Johnson, Janssen Res & Dev, Infect Dis & Vaccines Therapeut Area, Leiden, Netherlands.	Esaeland@its.jnj.com						Alberini I, 2009, VACCINE, V27, P5998, DOI 10.1016/j.vaccine.2009.07.079; Altenburg AF, 2014, VACCINE; Altenburg AF, 2015, VACCINE, V33, P500, DOI 10.1016/j.vaccine.2014.11.054; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Cheng ZJ, 2014, J IMMUNOL METHODS, V414, P69, DOI 10.1016/j.jim.2014.07.010; Co MDT, 2009, VACCINE, V27, P319, DOI 10.1016/j.vaccine.2008.09.092; Cox F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135723; Cox RJ, 2011, VACCINE, V29, P8049, DOI 10.1016/j.vaccine.2011.08.042; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Doucet JD, 2011, J GEN VIROL, V92, P1162, DOI 10.1099/vir.0.029777-0; Doyle TM, ANTIVIRAL RES; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Fu TM, 2009, VIROLOGY, V385, P218, DOI 10.1016/j.virol.2008.11.035; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Guo HL, 2011, J VIROL, V85, P448, DOI 10.1128/JVI.01812-10; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Hannoun C, 2013, EXPERT REV VACCINES, V12, P1085, DOI 10.1586/14760584.2013.824709; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Jegaskanda S, 2014, J INFECT DIS; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Johansson BE, 2011, EXPERT REV VACCINES, V10, P1683, DOI [10.1586/erv.11.130, 10.1586/ERV.11.130]; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; LIANG SH, 1994, J IMMUNOL, V152, P1653; Marshall NB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/954602; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Mischler R, 2002, VACCINE, V20, pB17, DOI 10.1016/S0264-410X(02)00512-1; Moise L, 2013, HUM VACC IMMUNOTHER, V9, P2060, DOI 10.4161/hv.26511; Pedersen G, 2011, INFLUENZA OTHER RESP, V5, P426, DOI 10.1111/j.1750-2659.2011.00256.x; Pedersen GK, 2012, J INFECT DIS, V206, P158, DOI 10.1093/infdis/jis330; Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Radosevic K, 2008, VACCINE, V26, P3640, DOI 10.1016/j.vaccine.2008.04.071; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Rockman S, 2013, J VIROL, V87, P3053, DOI 10.1128/JVI.02434-12; Roos A, 2015, VACCINE, P7; Sambhara S, 1998, J INFECT DIS, V177, P1266, DOI 10.1086/515285; Sambhara S, 2001, CELL IMMUNOL, V211, P143, DOI 10.1006/cimm.2001.1835; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Schotsaert M, 2013, MUCOSAL IMMUNOL, V6, P276, DOI 10.1038/mi.2012.69; Slutter B, 2013, IMMUNITY, V39, P939, DOI 10.1016/j.immuni.2013.09.013; Sridhar S, 2013, NAT MED; Temperton NJ, 2007, INFLUENZA OTHER RESP, V1, P105, DOI 10.1111/j.1750-2659.2007.00016.x; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Verbist KC, 2011, J IMMUNOL, V186, P6667, DOI 10.4049/jimmunol.1004022; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wohlbold TJ, 2014, VIRUSES-BASEL, V6, P2465, DOI 10.3390/v6062465; Wood JM, 2003, VACCINE, V21, P1786, DOI 10.1016/S0264-410X(03)00073-2	56	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145243	10.1371/journal.pone.0145243	http://dx.doi.org/10.1371/journal.pone.0145243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696245	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092500029
J	Rocha, JMD; Pinto, MP; Boubli, JP; Grelle, CEV				de Almeida Rocha, Juliana Monteiro; Pinto, Miriam Plaza; Boubli, Jean Philippe; Viveiros Grelle, Carlos Eduardo			The Role of Competition in Structuring Primate Communities under Different Productivity Regimes in the Amazon	PLOS ONE			English	Article							FOXS ASSEMBLY RULE; FUNCTIONAL-GROUPS; RAIN-FOREST; NULL MODEL; RIVER; PATTERNS; BRAZIL; ECOLOGY; VEGETATION; EVOLUTION	The factors responsible for the formation of Amazonian primate communities are not well understood. Here we investigated the influence of interspecific competition in the assembly of these communities, specifically whether they follow an assembly rule known as "favored states". According to this rule, interspecific competition influences final species composition, resulting in functional groups that are equally represented in the community. We compiled presence-absence data for primate species at 39 Amazonian sites in Brazil, contrasting two regions with distinct productivity regimes: the eutrophic Jurua River basin and the oligotrophic Negro River basin. We tested two hypotheses: that interspecific competition is a mechanism that influences the structure of Amazonian primate communities, and that competition has had a greater influence on the structure of primate communities in regions with low productivity, where resources are more limited. We used null models to test the statistical significance of the results, and found a non-random pattern compatible with the favored states rule in the two regions. Our findings suggest that interspecific competition is an important force driving primate community assembly regardless of productivity regimes.	[de Almeida Rocha, Juliana Monteiro] Univ Estadual Santa Cruz, Programa Posgrad Ecol & Conservacao Biodiversidad, Ilheus, Brazil; [Pinto, Miriam Plaza] Univ Fed Rio Grande do Norte, Dept Ecol, BR-59072970 Natal, RN, Brazil; [Boubli, Jean Philippe] Univ Salford, Sch Environm & Life Sci, Salford M5 4WT, Lancs, England; [Viveiros Grelle, Carlos Eduardo] Univ Fed Rio de Janeiro, Dept Ecol, Rio De Janeiro, Brazil	Universidade Estadual de Santa Cruz; Universidade Federal do Rio Grande do Norte; University of Salford; Universidade Federal do Rio de Janeiro	Rocha, JMD (corresponding author), Univ Estadual Santa Cruz, Programa Posgrad Ecol & Conservacao Biodiversidad, Ilheus, Brazil.	almeidarocha.jm@gmail.com	Pinto, Míriam Plaza/B-8000-2013; Grelle, Carlos EV/A-9687-2017	Pinto, Míriam Plaza/0000-0002-4030-5015; boubli, Jean/0000-0002-5833-9264	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) fellowship; FAPERJ fellowship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) productivity fellowship; Louis Leakey Foundation; National Geographic Society; National Science Foundation; New York Zoological Society; World Wildlife Fund for Nature	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) fellowship(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ fellowship(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) productivity fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Louis Leakey Foundation; National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); New York Zoological Society; World Wildlife Fund for Nature	JM was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) fellowship; MP by FAPERJ fellowship, and CEV by Grelle by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) productivity fellowship. JP field work on Negro River region was supported by the Sustainable Development of the Brazilian Biodiversity Program (PROBIO/MMA/BIRD/GEF/CNPq), the Zoological Society of San Diego and the University of Auckland. Field work in Pico da Neblina National Park was funded by grants from the Louis Leakey Foundation, National Geographic Society, National Science Foundation, New York Zoological Society and World Wildlife Fund for Nature. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2007, ECOLOGY, V88, P1292, DOI 10.1890/06-0697; [Anonymous], 2012, OCCASIONAL PAPERS CO; AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; AYRES JM, 1993, MATAS VARZEA MAMIRAU; Beaudrot L, 2013, AM J PRIMATOL, V75, P170, DOI 10.1002/ajp.22095; Benchimol M, 2014, AM J PRIMATOL, V76, P289, DOI 10.1002/ajp.22233; Booth BD, 2004, ECOLOGICAL ASSEMBLY, P206; Boubli J, 2009, INT J PRIMATOL, V30, P217, DOI 10.1007/s10764-009-9335-4; Boubli JP, 2008, INT J PRIMATOL, V29, P723, DOI 10.1007/s10764-008-9248-7; Boubli JP, 2015, MOL PHYLOGENET EVOL, V82, P400, DOI 10.1016/j.ympev.2014.09.005; Boubli Jean Phillipe, 1997, Neotropical Primates, V5, P113; Brinkmann WLF, 1989, TROPICAL RAINFORES B, P99; Cody M, 2004, ECOLOGICAL ASSEMBLY, P165; Colwell R.K., 1984, P344; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; DAYAN T, 1994, AM NAT, V143, P462, DOI 10.1086/285613; DECKER BS, 1994, INT J PRIMATOL, V15, P703, DOI 10.1007/BF02737428; Diamond J.M., 1975, P342; DIAMOND JM, 1982, OECOLOGIA, V52, P64, DOI 10.1007/BF00349013; FONSECA GAB, 1996, OCCASIONAL PAPERS CO, V4, P1; Fox BJ, 1987, EVOL ECOL, V1, P201, DOI 10.1007/BF02067551; FOX BJ, 1992, J MAMMAL, V73, P491, DOI 10.2307/1382015; FOX BJ, 1993, OIKOS, V67, P358, DOI 10.2307/3545483; FOX BJ, 1989, SPECIAL PUBLICATION, V28, P91; Franzinelli E, 2002, GEOMORPHOLOGY, V44, P259, DOI 10.1016/S0169-555X(01)00178-7; Furch K., 1989, Mineral nutrients in tropical forest and savanna ecosystems., P189; Ganzhorn JU, 1997, J ZOOL, V241, P533, DOI 10.1111/j.1469-7998.1997.tb04845.x; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Grelle CEV, 2005, ORYX, V39, P347, DOI 10.1017/S0030605305000700; Grelle CEV, 2002, BIOL CONSERV, V108, P101, DOI 10.1016/S0006-3207(02)00094-0; Haugaasen T, 2009, PRIMATES, V50, P239, DOI 10.1007/s10329-009-0135-4; Hawes JE, 2014, OIKOS, V123, P365, DOI 10.1111/j.1600-0706.2013.00745.x; IRION G, 1978, NATURWISSENSCHAFTEN, V65, P515, DOI 10.1007/BF00439791; Iron G, 1978, NATURWISSENSCHAFTEN, V65, P515; IUCN, IUCN RED LIST THREAT; JANSON CH, 1988, BEHAVIOUR, V105, P53, DOI 10.1163/156853988X00449; Kamilar JM, 2011, AM J PHYS ANTHROPOL, V144, P131, DOI 10.1002/ajpa.21380; Keddy P, 2004, ECOLOGICAL ASSEMBLY, P1; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; KELT DA, 1995, ECOLOGY, V76, P1283, DOI 10.2307/1940935; Klinge H, 1979, HEATLANDS RELATED A, V9A, P483; Latrubesse EM, 2002, GEOMORPHOLOGY, V44, P241, DOI 10.1016/S0169-555X(01)00177-5; McCay TS, 2004, OIKOS, V107, P141, DOI 10.1111/j.0030-1299.2004.13244.x; MEADE RH, 1991, ENVIRON GEOL WATER S, V18, P105, DOI 10.1007/BF01704664; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Peres C.A., 1999, MAMMALS NEOTROPICS, V3, P564; Peres CA, 1997, J TROP ECOL, V13, P259; Pimenta Flavio Eduardo, 2005, Neotropical Primates, V13, P23, DOI 10.1896/1413-4705.13.2.23; PRANCE GT, 1979, BRITTONIA, V31, P26, DOI 10.2307/2806669; Prance GT, 1989, TROPICAL RAINFORES B, P99; PUHAKKA M, 1992, J BIOGEOGR, V19, P651, DOI 10.2307/2845707; R Development Core Team, R LANG ENV STAT COMP; RASANEN ME, 1987, SCIENCE, V238, P1398, DOI 10.1126/science.238.4832.1398; Rylands A. B., 2012, International Zoo Yearbook, V46, P11, DOI 10.1111/j.1748-1090.2011.00152.x; Schreier BM, 2009, BIOTROPICA, V41, P283, DOI 10.1111/j.1744-7429.2008.00486.x; Simberloff Daniel, 1999, P58, DOI 10.1017/CBO9780511542237.003; SOINI P, 1982, FOLIA PRIMATOL, V39, P1, DOI 10.1159/000156066; Stone L, 1996, AM NAT, V148, P997, DOI 10.1086/285968; Terborgh J., 1991, Habitat structure: the physical arrangement of objects in space, based on a symposium held at the Chinsegut Hill Conference Center, University of South Florida, in May 1988., P28; Von Holle B, 2004, OIKOS, V105, P551, DOI 10.1111/j.0030-1299.2004.12597.x; WEIHER E, 1995, OIKOS, V74, P159, DOI 10.2307/3545686; WILSON JB, 1989, OECOLOGIA, V80, P263, DOI 10.1007/BF00380161	63	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145699	10.1371/journal.pone.0145699	http://dx.doi.org/10.1371/journal.pone.0145699			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696089	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500069
J	Feng, DD; Li, Q; Yu, H; Zhao, XL; Kong, LF				Feng, Dandan; Li, Qi; Yu, Hong; Zhao, Xuelin; Kong, Lingfeng			Comparative Transcriptome Analysis of the Pacific Oyster Crassostrea gigas Characterized by Shell Colors: Identification of Genetic Bases Potentially Involved in Pigmentation	PLOS ONE			English	Article							ABC TRANSPORTER; EXPRESSION DATA; DROSOPHILA; ENDOSOMES; CHOLESTEROL; PROTEIN; FAMILY; WHITE; MELANOGENESIS; LOCALIZATION	Background Shell color polymorphisms of Mollusca have contributed to development of evolutionary biology and population genetics, while the genetic bases and molecular mechanisms underlying shell pigmentation are poorly understood. The Pacific oyster (Crassostrea gigas) is one of the most important farmed oysters worldwide. Through successive family selection, four shell color variants (white, golden, black and partially pigmented) of C. gigas have been developed. To elucidate the genetic mechanisms of shell coloration in C. gigas and facilitate the selection of elite oyster lines with desired coloration patterns, differentially expressed genes (DEGs) were identified among the four shell color variants by RNA-seq. Results Digital gene expression generated over fifteen million reads per sample, producing expression data for 28,027 genes. A total number of 2,645 DEGs were identified from pair-wise comparisons, of which 432, 91, 43 and 39 genes specially were up-regulated in white, black, golden and partially pigmented shell of C. gigas, respectively. Three genes of Abca1, Abca3 and Abcb1 which belong to the ATP-binding cassette (ABC) transporters superfamilies were significantly associated with white shell formation. A tyrosinase transcript (CGI_10008737) represented consistent up-regulated pattern with golden coloration. We proposed that white shell variant of C. gigas could employ "endocytosis" to down-regulate notch level and to prevent shell pigmentation. Conclusion This study discovered some potential shell coloration genes and related molecular mechanisms by the RNA-seq, which would provide foundational information to further study on shell coloration and assist in selective breeding in C. gigas.	[Feng, Dandan; Li, Qi; Yu, Hong; Zhao, Xuelin; Kong, Lingfeng] Ocean Univ China, Minist Educ, Key Lab Mariculture, Qingdao, Peoples R China	Ocean University of China	Li, Q (corresponding author), Ocean Univ China, Minist Educ, Key Lab Mariculture, Qingdao, Peoples R China.	qili66@ouc.edu.cn	Kong, Lingfeng/AAG-2473-2019; Kong, Lingfeng/AAJ-3402-2021; Feng, Dandan/X-7524-2019	Kong, Lingfeng/0000-0001-5263-1697; 	National Natural Science Foundation of China [31372524]; Shandong Seed Project; Shandong Province [2014GHY115002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Seed Project; Shandong Province	This study was supported by the grants from National Natural Science Foundation of China (31372524), Shandong Seed Project and Shandong Province (2014GHY115002).	Aguilera F, 2014, ACTA BIOMATER, V10, P3855, DOI 10.1016/j.actbio.2014.03.031; Anders S., 2010, HTSEQ ANAL HIGH THRO; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bai ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053617; Bandaranayake WM, 2006, NAT PROD REP, V23, P223, DOI 10.1039/b307612c; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chang Y.Q., 2007, ACT ECOL SIN, V27, P1146; Chen KG, 2009, PIGM CELL MELANOMA R, V22, P740, DOI 10.1111/j.1755-148X.2009.00630.x; Chen P, 2014, INVEST OPHTH VIS SCI, V55, P8031, DOI 10.1167/iovs.14-14098; Croucher PJP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-862; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Ding J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116406; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Evans S, 2009, AQUACULTURE, V286, P211, DOI 10.1016/j.aquaculture.2008.09.022; Fan RW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-389; Feng LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092567; Food and Agriculture Organization (FAO), 2014, FISH AQ STAT 2012; Gazzin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016165; Ge JL, 2015, MAR BIOTECHNOL, V17, P655, DOI 10.1007/s10126-015-9652-x; Ge JL, 2014, AQUACULTURE, V434, P249, DOI 10.1016/j.aquaculture.2014.08.027; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Goldsmith Marian R., 1995, P21, DOI 10.1017/CBO9780511529931.003; Hirosaki K, 2002, J INVEST DERMATOL, V119, P475, DOI 10.1046/j.1523-1747.2002.01832.x; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Kanehisa M, 2008, KEGG FOR LINKING GEN; Kang JH, 2013, ASIAN AUSTRAL J ANIM, V26, P1659, DOI 10.5713/ajas.2013.13562; Kim D. G., 2012, TOPHAT2 PARALLEL MAP; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Komoto N, 2009, INSECT BIOCHEM MOLEC, V39, P152, DOI 10.1016/j.ibmb.2008.10.003; Kramer H, 2002, TRAFFIC, V3, P87, DOI 10.1034/j.1600-0854.2002.030201.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; Li ZF, 2015, INSECT BIOCHEM MOLEC, V62, P211, DOI 10.1016/j.ibmb.2014.11.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackenzie SM, 2000, GENETICA, V108, P239, DOI 10.1023/A:1004115718597; Mao X, 2005, BIOINFORMATICS; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Morgan T., 1910, EXP BIOL MED, V8, P17, DOI [DOI 10.3181/00379727-8-12, 10.3181/00379727-8-12]; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OGAWA K, 1995, MOL BIOL CELL, V6, P685, DOI 10.1091/mbc.6.6.685; Peralta S, 2009, MECH DEVELOP, V126, P256, DOI 10.1016/j.mod.2008.10.011; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Renault T, 2011, DEV COMP IMMUNOL, V35, P725, DOI 10.1016/j.dci.2011.02.004; Richards PM, 2013, MOL ECOL, V22, P3077, DOI 10.1111/mec.12262; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schallreuter KU, 2009, EXP DERMATOL, V18, P680, DOI 10.1111/j.1600-0625.2009.00850.x; Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9; Sun XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122967; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takeuchi K, 2005, ZOOL SCI, V22, P723, DOI 10.2108/zsj.22.723; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; True JR, 1999, CURR BIOL, V9, P1382, DOI 10.1016/S0960-9822(00)80083-4; Truschel ST, 2009, TRAFFIC, V10, P1318, DOI 10.1111/j.1600-0854.2009.00955.x; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; VERHECKEN A, 1989, ANN SOC ROY ZOOL BEL, V119, P181; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yue X, 2015, MAR BIOTECHNOL, V17, P364, DOI 10.1007/s10126-015-9625-0; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	66	64	68	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145257	10.1371/journal.pone.0145257	http://dx.doi.org/10.1371/journal.pone.0145257			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26693729	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092500032
J	Guthrie, KM; Vargas, S; Shaw, JG; Rosen, RK; van den Berg, JJ; Kiser, PF; Buckheit, K; Bregman, D; Thompson, L; Jensen, K; Johnson, T; Buckheit, RW				Guthrie, Kate Morrow; Vargas, Sara; Shaw, Julia G.; Rosen, Rochelle K.; van den Berg, Jacob J.; Kiser, Patrick F.; Buckheit, Karen; Bregman, Dana; Thompson, Lara; Jensen, Kathleen; Johnson, Todd; Buckheit, Robert W.			The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development	PLOS ONE			English	Article							CONTRACEPTIVE VAGINAL RING; CYCLE CONTROL; CLINICAL-EXPERIENCE; HIV-INFECTION; ACCEPTABILITY; EFFICACY; NUVARING(R); TOLERABILITY; TECHNOLOGY; ADOLESCENT	Intravaginal rings (IVRs) are currently under investigation as devices for the delivery of agents to protect against the sexual transmission of HIV and STIs, as well as pregnancy. To assist product developers in creating highly acceptable rings, we sought to identify characteristics that intravaginal ring users consider when making decisions about ring use or nonuse. We conducted four semi-structured focus groups with 21 women (aged 18-45) who reported using an IVR in the past 12 months. Participants manipulated four prototype rings in their hands, discussed ring materials, dimensionality, and "behavior," and shared perceptions and appraisals. Five salient ring characteristics were identified: 1) appearance of the rings' surfaces, 2) tactile sensations of the cylinder material, 3) materials properties, 4) diameter of the cylinder, and 5) ring circumference. Pliability (or flexibility) was generally considered the most important mechanical property. Several ring properties (e.g., porousness, dimensionality) were associated with perceptions of efficacy. Women also revealed user behaviors that may impact the effectiveness of certain drugs, such as removing, rinsing and re-inserting the ring while bathing, and removing the ring during sexual encounters. As product developers explore IVRs as prevention delivery systems, it is critical to balance product materials and dimensions with use parameters to optimize drug delivery and the user experience. It is also critical to consider how user behaviors (e.g., removing the ring) might impact drug delivery.	[Guthrie, Kate Morrow; Vargas, Sara; Shaw, Julia G.; Rosen, Rochelle K.; van den Berg, Jacob J.; Bregman, Dana; Thompson, Lara; Jensen, Kathleen] Miriam Hosp, Ctr Behav & Prevent Med, Providence, RI 02906 USA; [Guthrie, Kate Morrow; Vargas, Sara; van den Berg, Jacob J.] Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Providence, RI 02912 USA; [Guthrie, Kate Morrow; Rosen, Rochelle K.] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA; [Kiser, Patrick F.; Johnson, Todd] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Buckheit, Karen; Buckheit, Robert W.] ImQuest BioSci, Frederick, MD USA	Lifespan Health Rhode Island; Miriam Hospital; Brown University; Brown University; Utah System of Higher Education; University of Utah	Guthrie, KM (corresponding author), Miriam Hosp, Ctr Behav & Prevent Med, Providence, RI 02906 USA.	kate.guthrie@lifespan.org	Kiser, Patrick F/C-2843-2014	Kiser, Patrick F/0000-0002-3868-7122; Vargas, Sara/0000-0003-2934-4766	National Institutes of Health/National Institutes of Allergy and Infectious Diseases (NIH/NIAID); NIH; ImQuest BioSciences, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD062645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077289] Funding Source: NIH RePORTER	National Institutes of Health/National Institutes of Allergy and Infectious Diseases (NIH/NIAID); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ImQuest BioSciences, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Institutes of Health/National Institutes of Allergy and Infectious Diseases (NIH/NIAID). The NIH/NIAID did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of the grant award (which contributed to authors' salaries and research materials). ImQuest BioSciences, Inc., was the institution that received the funding from NIH, headed by Principal Investigator RWB and Co-Investigator KB. ImQuest BioSciences, Inc., provided support in the form of salaries for authors KB and RWB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barreiros FA, 2010, CONTRACEPTION, V81, P223, DOI 10.1016/j.contraception.2009.10.007; Bayer R, 1997, J ACQ IMMUN DEF SYND, V14, pS22, DOI 10.1097/00042560-199700002-00005; Brache V, 2010, CONTRACEPTION, V82, P418, DOI 10.1016/j.contraception.2010.04.012; Brucker C, 2008, EUR J CONTRACEP REPR, V13, P31, DOI 10.1080/13625180701577122; Dieben TOM, 2002, OBSTET GYNECOL, V100, P585, DOI 10.1016/S0029-7844(02)02124-5; Epstein LB, 2008, J ADOLESCENT HEALTH, V43, P64, DOI 10.1016/j.jadohealth.2007.12.007; Gilliam ML, 2010, OBSTET GYNECOL, V115, P503, DOI 10.1097/AOG.0b013e3181cf45dc; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Highleyman L, 2014, VAGINAL RING MAY BE; Holt BY, 2013, MULTIPURPOSE PREVENT; International Partnership for Microbicides, 2014, RING STUD 2014; Johnson TJ, 2012, ANTIMICROB AGENTS CH, V56, P6272, DOI 10.1128/AAC.01431-12; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Kerns J, 2011, CONTRACEPTION, V83, P107, DOI 10.1016/j.contraception.2010.07.008; Kiser PF, 2012, AIDS REV, V14, P62; Lopez LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003552.pub4; Malcolm RK, 2010, ANTIVIR RES, V88, pS30, DOI 10.1016/j.antiviral.2010.09.003; Merki-Feld GS, 2007, EUR J CONTRACEP REPR, V12, P240, DOI 10.1080/13625180701440180; Microbicide Trials Network, 2014, MTN 020 MULT RAND DO; Microbicide Trials Network, 2014, ASPIRE PHAS 3 TRIAL; Miller L, 2005, OBSTET GYNECOL, V106, P473, DOI 10.1097/01.AOG.0000175144.08035.74; Montgomery ET, 2012, AIDS BEHAV, V16, P1787, DOI 10.1007/s10461-012-0248-4; Morrow KM, 2014, ARCH SEX BEHAV, V43, P1459, DOI 10.1007/s10508-013-0235-5; Morrow KM, 2014, AIDS RES HUM RETROV, V30, P78, DOI [10.1089/aid.2013.0099, 10.1089/AID.2013.0099]; Morrow KM, 2014, INT HIV R4P RES PREV; National Research Council, 2008, METH CHALL BIOM HIV; Novak A, 2003, CONTRACEPTION, V67, P187, DOI 10.1016/S0010-7824(02)00514-0; Rosen RK, 2015, CONTRACEPTION; Roumen FJME, 2001, HUM REPROD, V16, P469, DOI 10.1093/humrep/16.3.469; Roumen FJME, 1999, CONTRACEPTION, V59, P59, DOI 10.1016/S0010-7824(98)00145-0; Sahota J, 1999, ADV CONTRACEPT, V15, P313, DOI 10.1023/A:1006748626008; Sanchez S, 1997, ACCEPTABILITY USERS; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Smith DJ, 2008, J WOMENS HEALTH, V17, P1025, DOI 10.1089/jwh.2007.0529; Stewart FH, 2007, J PEDIATR ADOL GYNEC, V20, P345, DOI 10.1016/j.jpag.2007.06.001; Tolley EE, 2013, ANTIVIR RES, V100, pS54, DOI 10.1016/j.antiviral.2013.09.029; UN Population Fund, 2014, DEADL GAP M UNM NEED; UN Population Fund, 2014, SEX TRANSM INF BREAK; UNAIDS, 2014, GLOB REP UNAIDS REP; Veres S, 2004, OBSTET GYNECOL, V104, P555, DOI 10.1097/01.AOG.0000136082.59644.13; Weisberg E, 1997, CONTRACEPTION, V56, P233, DOI 10.1016/S0010-7824(97)00133-9; Wieder DR, 2010, INT J WOMENS HEALTH, V2, P401, DOI 10.2147/IJWH.S6162	42	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145642	10.1371/journal.pone.0145642	http://dx.doi.org/10.1371/journal.pone.0145642			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SH	26695431	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092500064
J	Sakamoto, A; Akiyama, Y; Shimada, S; Zhu, WG; Yuasa, Y; Tanaka, S				Sakamoto, Ayuna; Akiyama, Yoshimitsu; Shimada, Shu; Zhu, Wei-Guo; Yuasa, Yasuhito; Tanaka, Shinji			DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; PROMOTER METHYLATION; COLORECTAL-CANCER; DIFFUSE-TYPE; TRANSCRIPTION FACTORS; HISTONE METHYLATION; SP1 EXPRESSION; GENE-MUTATIONS; CPG ISLAND	Twist1 overexpression is frequently observed in various cancers including gastric cancer (GC). Although DNA methylation of the Twist1 gene has been reported in cancer cells, the mechanisms underlying transcriptional activation remain uncertain. In this study, we first examined epigenetic alterations of the Twist1 using Twist1 transcription-positive and - negative cell lines that are derived from our established diffuse-type GC mouse model. Treatment with a DNA demethylation agent 5-aza-dC re-activated Twist1 expression in Twist1 expression-negative GC cells. According to methylation-specific PCR and bisulfite sequencing analysis, methylation at the CpG-rich region within Twist1 coding exon 1, rather than its promoter region, was tightly linked to transcriptional silencing of the Twist1 expression in mouse GC cells. Chromatin immunoprecipitation assays revealed that active histone mark H3K4me3 was enriched in Twist1 expression-positive cells, and inactive histone mark H3K9me3 was enriched in Twist1 expression-negative cells. The expression levels of Suv39h1 and Suv39h2, histone methyltransferases for H3K9me3, were inversely correlated with Twist1 expression, and knockdown of Suv39h1 or Suv39h2 induced Twist1 expression. Moreover, Sp1 transcription factor bound to the exon 1 CpG-rich region in Twist1 expression-positive cell lines, and Twist1 expression was diminished by mithramycin, which that interferes with Sp1 binding to CpG-rich regulatory sequences. Our studies suggested that the Twist1 transcription in GC cells might be regulated through potential cooperation of DNA methylation, histone modification in complex with Sp1 binding to CpG-rich regions within the exon 1 region.	[Sakamoto, Ayuna; Akiyama, Yoshimitsu; Shimada, Shu; Yuasa, Yasuhito; Tanaka, Shinji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan; [Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China	Tokyo Medical & Dental University (TMDU); Peking University	Tanaka, S (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan.	yakiyama.monc@tmd.ac.jp; tanaka.monc@tmd.ac.jp		Zhu, Wei-Guo/0000-0001-8385-6581	Japan Society for the Promotion of Science (JSPS) [AA005]; Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED [15Ack0106017h0002];  [24590444];  [25253081]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); ; 	This work was supported by Grants-in-Aid for Scientific Research (C) (24590444) and (A) (25253081), and the A3 Foresight Program (AA005) from the Japan Society for the Promotion of Science (JSPS), and the Practical Research for Innovative Cancer Control (15Ack0106017h0002) from Japan Agency for Medical Research and Development, AMED; https://kaken.nii.ac.jp/d/r/30253420.ja.html, https://kaken.nii.ac.jp/d/r/80262187.ja.html.	Barnes RM, 2009, INT J DEV BIOL, V53, P909, DOI 10.1387/ijdb.082747rb; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; BECKER KF, 1994, CANCER RES, V54, P3845; Benlhabib H, 2011, MOL CELL BIOL, V31, P1949, DOI 10.1128/MCB.01063-10; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Cai LS, 2014, ONCOL REP, V31, P2593, DOI 10.3892/or.2014.3135; Chen RP, 2014, ONCOL REP, V31, P1211, DOI 10.3892/or.2014.2972; Choi ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep07162; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Dong C, 2013, ONCOGENE, V32, P1351, DOI 10.1038/onc.2012.169; Douglas DB, 2004, CANCER RES, V64, P1611, DOI 10.1158/0008-5472.CAN-0318-2; Erfurth FE, 2008, P NATL ACAD SCI USA, V105, P7517, DOI 10.1073/pnas.0800090105; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Ezponda T, 2013, ONCOGENE, V32, P2882, DOI 10.1038/onc.2012.297; Gong MZ, 2012, J CELL BIOCHEM, V113, P329, DOI 10.1002/jcb.23359; Gort EH, 2008, CANCER EPIDEM BIOMAR, V17, P3325, DOI 10.1158/1055-9965.EPI-08-0472; Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kang GH, 2008, LAB INVEST, V88, P161, DOI 10.1038/labinvest.3700707; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kwon MJ, 2013, HUM PATHOL, V44, P1722, DOI 10.1016/j.humpath.2013.03.004; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Mulero-Navarro S, 2006, CARCINOGENESIS, V27, P1099, DOI 10.1093/carcin/bgi344; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Ohkuma M, 2007, BIOCHEM BIOPH RES CO, V352, P925, DOI 10.1016/j.bbrc.2006.11.114; Okada T, 2010, GENE CHROMOSOME CANC, V49, P452, DOI 10.1002/gcc.20755; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; RANZANI GN, 1995, CANCER EPIDEM BIOMAR, V4, P223; Rao X, 2013, ONCOGENE, V32, P4519, DOI 10.1038/onc.2012.474; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Ruppenthal RD, 2011, PATHOL ONCOL RES, V17, P867, DOI 10.1007/s12253-011-9395-6; Shimada S, 2012, GUT, V61, P344, DOI 10.1136/gutjnl-2011-300050; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; Sone K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6691; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Takahashi Tsunehiro, 2013, Cancers (Basel), V5, P48, DOI 10.3390/cancers5010048; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; Tian HP, 2015, J BIOL CHEM, V290, P19173, DOI 10.1074/jbc.M114.636126; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; van Engeland M, 2003, CANCER RES, V63, P3133; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Vuillemenot BR, 2004, CARCINOGENESIS, V25, P623, DOI 10.1093/carcin/bgh038; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141; Zhang YQ, 2007, PATHOLOGY, V39, P470, DOI 10.1080/00313020701570053; Zheng JB, 2001, NUCLEIC ACIDS RES, V29, P4070, DOI 10.1093/nar/29.19.4070; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003	53	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145630	10.1371/journal.pone.0145630	http://dx.doi.org/10.1371/journal.pone.0145630			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695186	Green Published, gold			2022-12-27	WOS:000367092500063
J	de Sousa, GF; Lima, MD; Custodio, DF; Freitas, VM; Monteiro, G				de Sousa, Graziele Fonseca; Lima, Maira de Assis; Custodio, Debora Fernandes; Freitas, Vanessa Morais; Monteiro, Gisele			Chemogenomic Study of Carboplatin in Saccharomyces cerevisiae: Inhibition of the NEDDylation Process Overcomes Cellular Resistance Mediated by HuR and Cullin Proteins	PLOS ONE			English	Article							EPITHELIAL OVARIAN-CARCINOMA; CANCER CELLS; EXPRESSION; PROGNOSIS; MLN4924; ERCC5; YEAST	The use of carboplatin in cancer chemotherapy is limited by the emergence of drug resistance. To understand the molecular basis for this resistance, a chemogenomic screen was performed in 53 yeast mutants that had previously presented strong sensitivity to this widely used anticancer agent. Thirty-four mutants were responsive to carboplatin, and from these, 21 genes were selected for further studies because they have human homologues. Sixty percent of these yeast genes possessed human homologues which encoded proteins that interact with cullin scaffolds of ubiquitin ligases, or whose mRNA are under the regulation of Human antigen R (HuR) protein. Both HuR and cullin proteins are regulated through NED-Dylation post-translational modification, and so our results indicate that inhibition of this process should sensitise resistant tumour cells to carboplatin. We showed that treatment of a tumour cell line with MLN4924, a NEDDylation inhibitor, overcame the resistance to carboplatin. Our data suggest that inhibition of NEDDylation may be a useful strategy to resensitise tumour cells in patients that have acquired carboplatin resistance.	[de Sousa, Graziele Fonseca; Custodio, Debora Fernandes; Monteiro, Gisele] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Tecnol Bioquim Farmaceut, Sao Paulo, Brazil; [Lima, Maira de Assis; Freitas, Vanessa Morais] Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular Desenvolvimento, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Monteiro, G (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Tecnol Bioquim Farmaceut, Sao Paulo, Brazil.	smgisele@usp.br	Freitas, Vanessa M/D-7897-2012; Monteiro, Gisele/E-5897-2012	Freitas, Vanessa M/0000-0001-9613-8626; Monteiro, Gisele/0000-0002-3385-047X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/04173-1, 2009/01303-1, 2015/07749-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by GFS received grant by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - grant number 2011/04173-1 to GFS, and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - grant numbers 2009/01303-1 and 2015/07749-2 to GM. DFC, MAL and VMF received no specific funding for this work.	Arnoldo A, 2014, GENOME MED, V6, DOI 10.1186/gm549; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Brody JR, 2011, WIRES RNA, V2, P435, DOI 10.1002/wrna.62; Chen XJ, 2014, ARCH GYNECOL OBSTET, V290, P525, DOI 10.1007/s00404-014-3216-6; Dolan ME, 2004, CANCER RES, V64, P4353, DOI 10.1158/0008-5472.CAN-04-0340; Embade N, 2012, HEPATOLOGY, V55, P1237, DOI 10.1002/hep.24795; Frede J, 2013, EUR J CANCER, V49, P2331, DOI 10.1016/j.ejca.2013.03.016; He CY, 2013, ANTI-CANCER DRUG, V24, P300, DOI 10.1097/CAD.0b013e32835bd6ce; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Huang YT, 2015, SCI REP-UK, V5, DOI 10.1038/srep12484; Jazaeri AA, 2013, MOL CANCER THER, V12, P1958, DOI 10.1158/1535-7163.MCT-12-1028; Lal S, 2014, CANCER RES, V74, P1128, DOI 10.1158/0008-5472.CAN-13-1915; Navarro FJ, 2012, CURR OPIN CELL BIOL, V24, P833, DOI 10.1016/j.ceb.2012.10.015; Nawrocki ST, 2013, CLIN CANCER RES, V19, P3577, DOI 10.1158/1078-0432.CCR-12-3212; Osterberg L, 2005, CANCER GENET CYTOGEN, V163, P144, DOI 10.1016/j.cancergencyto.2005.06.023; Osterberg L, 2009, CYTOGENET GENOME RES, V125, P8, DOI 10.1159/000218744; Peters D, 2005, MOL CANCER THER, V4, P1605, DOI 10.1158/1535-7163.MCT-04-0311; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; Walsh CS, 2008, J CLIN ONCOL, V26, P2952, DOI 10.1200/JCO.2007.13.5806; Yasuno T, 1999, ANTICANCER RES, V19, P4049; Yoshihara K, 2009, CANCER SCI, V100, P1421, DOI 10.1111/j.1349-7006.2009.01204.x; Zhao YC, 2014, ANTIOXID REDOX SIGN, V21, P2383, DOI 10.1089/ars.2013.5795	23	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145377	10.1371/journal.pone.0145377	http://dx.doi.org/10.1371/journal.pone.0145377			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692264	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300065
J	Ito, Y; Yamanishi, M; Ikeuchi, A; Imamura, C; Matsuyama, T				Ito, Yoichiro; Yamanishi, Mamoru; Ikeuchi, Akinori; Imamura, Chie; Matsuyama, Takashi			Combinatorial Screening for Transgenic Yeasts with High Cellulase Activities in Combination with a Tunable Expression System	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; TERMINATOR REGIONS; ETHANOL-PRODUCTION; PROTEIN YIELD; PROMOTERS; HYDROLYSIS; PATHWAY; GENE; ACTIVATOR	Combinatorial screening used together with a broad library of gene expression cassettes is expected to produce a powerful tool for the optimization of the simultaneous expression of multiple enzymes. Recently, we proposed a highly tunable protein expression system that utilized multiple genome-integrated target genes to fine-tune enzyme expression in yeast cells. This tunable system included a library of expression cassettes each composed of three gene-expression control elements that in different combinations produced a wide range of protein expression levels. In this study, four gene expression cassettes with graded protein expression levels were applied to the expression of three cellulases: cellobiohydrolase 1, cellobiohydrolase 2, and endoglucanase 2. After combinatorial screening for transgenic yeasts simultaneously secreting these three cellulases, we obtained strains with higher cellulase expressions than a strain harboring three cellulase-expression constructs within one high-performance gene expression cassette. These results show that our method will be of broad use throughout the field of metabolic engineering.	[Ito, Yoichiro; Yamanishi, Mamoru; Matsuyama, Takashi] Toyota Cent Res & Dev Labs Inc, Matsuyama Res Grp, Nagakute, Aichi 48011, Japan; [Ikeuchi, Akinori; Imamura, Chie] Toyota Cent Res & Dev Labs Inc, Biotechnol Lab, Nagakute, Aichi 48011, Japan	Toyota Central R&D Labs Inc; Toyota Central R&D Labs Inc	Ito, Y (corresponding author), Technol Res Assoc Highly Efficient Gene Design, Kobe, Hyogo, Japan.	yito@dragon.kobe-u.ac.jp; e1215@mosk.tytlabs.co.jp		Matsuyama, Takashi/0000-0001-7834-9358	JSPS [15K07378]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by a JSPS Grant-in-Aid for Scientific Research (C) (Grant Number 15K07378 (TM)). All authors were employed by TOYOTA Central Research and Development Laboratories Incorporation at the time of the study. The specific contributions of each author are listed in the Author Contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Blazeck J, 2013, BIOTECHNOL J, V8, P46, DOI 10.1002/biot.201200120; Borodina I, 2014, BIOTECHNOL J, V9, P609, DOI 10.1002/biot.201300445; BRENT R, 1985, CELL, V43, P729, DOI 10.1016/0092-8674(85)90246-6; Cobb RE, 2012, CURR OPIN CHEM BIOL, V16, P285, DOI 10.1016/j.cbpa.2012.05.186; Coleman DJ, 2007, ANAL BIOCHEM, V371, P146, DOI 10.1016/j.ab.2007.08.027; Da Silva NA, 2012, FEMS YEAST RES, V12, P197, DOI 10.1111/j.1567-1364.2011.00769.x; Du J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks549; HOHMANN S, 1991, J BACTERIOL, V173, P7963, DOI 10.1128/jb.173.24.7963-7969.1991; Ilmen M, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-30; Ito Y, 2013, PROTEIN ENG DES SEL, V26, P73, DOI 10.1093/protein/gzs072; Ito Y, 2015, ACS SYNTH BIOL, V4, P12, DOI 10.1021/sb500096y; Ito Y, 2013, J BIOTECHNOL, V168, P486, DOI 10.1016/j.jbiotec.2013.09.024; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kim B, 2013, APPL ENVIRON MICROB, V79, P931, DOI 10.1128/AEM.02736-12; Kim IK, 2012, FEMS YEAST RES, V12, P228, DOI 10.1111/j.1567-1364.2011.00779.x; Kitagawa T, 2011, J BIOTECHNOL, V151, P194, DOI 10.1016/j.jbiotec.2010.12.002; Kung Y, 2012, ACS SYNTH BIOL, V1, P498, DOI 10.1021/sb300074k; Liao HH, 2011, BIOTECHNOL J, V6, P1409, DOI 10.1002/biot.201100157; Lu CF, 2007, APPL ENVIRON MICROB, V73, P6072, DOI 10.1128/AEM.00955-07; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Matsuyama T, 2011, J BIOSCI BIOENG, V111, P175, DOI 10.1016/j.jbiosc.2010.09.014; Olson DG, 2012, CURR OPIN BIOTECH, V23, P396, DOI 10.1016/j.copbio.2011.11.026; Partow S, 2010, YEAST, V27, P955, DOI 10.1002/yea.1806; SALOHEIMO M, 1988, GENE, V63, P11, DOI 10.1016/0378-1119(88)90541-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Siddiqui MS, 2012, FEMS YEAST RES, V12, P144, DOI 10.1111/j.1567-1364.2011.00774.x; Sun J, 2012, BIOTECHNOL BIOENG, V109, P2082, DOI 10.1002/bit.24481; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Suzuki H, 2012, J BIOTECHNOL, V157, P64, DOI 10.1016/j.jbiotec.2011.11.015; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; Tsai SL, 2010, APPL ENVIRON MICROB, V76, P7514, DOI 10.1128/AEM.01777-10; Vogl T, 2014, ACS SYNTH BIOL, V3, P188, DOI 10.1021/sb400091p; Wen F, 2010, APPL ENVIRON MICROB, V76, P1251, DOI 10.1128/AEM.01687-09; Xu Q, 2009, CURR OPIN BIOTECH, V20, P364, DOI 10.1016/j.copbio.2009.05.006; Yamada R, 2013, BIOTECHNOL ADV, V31, P754, DOI 10.1016/j.biotechadv.2013.02.007; Yamada R, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-32; Yamanishi M, 2013, ACS SYNTH BIOL, V2, P337, DOI 10.1021/sb300116y; Yamanishi M, 2012, ACS SYNTH BIOL, V1, P172, DOI 10.1021/sb200017p; Yamanishi M, 2011, BIOSCI BIOTECH BIOCH, V75, P2234, DOI 10.1271/bbb.110246; Yanase S, 2010, BIOTECHNOL J, V5, P449, DOI 10.1002/biot.200900291; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282	44	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144870	10.1371/journal.pone.0144870	http://dx.doi.org/10.1371/journal.pone.0144870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692026	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092300024
J	Schrauwen, JTC; Karanasos, A; van Ditzhuijzen, NS; Aben, JP; van der Steen, AFW; Wentzel, JJ; Gijsen, FJH				Schrauwen, Jelle T. C.; Karanasos, Antonios; van Ditzhuijzen, Nienke S.; Aben, Jean-Paul; van der Steen, Antonius F. W.; Wentzel, Jolanda J.; Gijsen, Frank J. H.			Influence of the Accuracy of Angiography-Based Reconstructions on Velocity and Wall Shear Stress Computations in Coronary Bifurcations: A Phantom Study	PLOS ONE			English	Article							INTRAVASCULAR ULTRASOUND; 3-DIMENSIONAL RECONSTRUCTION; ATHEROSCLEROTIC PLAQUE; BLOOD-FLOW; ARTERIES; METHODOLOGY; VALIDATION; LESIONS; PROGRESSION; PATTERNS	Introduction Wall shear stress (WSS) plays a key role in the onset and progression of atherosclerosis in human coronary arteries. Especially sites with low and oscillating WSS near bifurcations have a higher propensity to develop atherosclerosis. WSS computations in coronary bifurcations can be performed in angiography-based 3D reconstructions. It is essential to evaluate how reconstruction errors influence WSS computations in mildly-diseased coronary bifurcations. In mildly-diseased lesions WSS could potentially provide more insight in plaque progression. Materials Methods Four Plexiglas phantom models of coronary bifurcations were imaged with bi-plane angiography. The lumens were segmented by two clinically experienced readers. Based on the segmentations 3D models were generated. This resulted in three models per phantom: one gold-standard from the phantom model itself, and one from each reader. Steady-state and transient simulations were performed with computational fluid dynamics to compute the WSS. A similarity index and a noninferiority test were used to compare the WSS in the phantoms and their reconstructions. The margin for this test was based on the resolution constraints of angiography. Results The reconstruction errors were similar to previously reported data; in seven out of eight reconstructions less than 0.10 mm. WSS in the regions proximal and far distal of the stenosis showed a good agreement. However, the low WSS areas directly distal of the stenosis showed some disagreement between the phantoms and the readers. This was due to small deviations in the reconstruction of the stenosis that caused differences in the resulting jet, and consequently the size and location of the low WSS area. Discussion This study showed that WSS can accurately be computed within angiography-based 3D reconstructions of coronary arteries with early stage atherosclerosis. Qualitatively, there was a good agreement between the phantoms and the readers. Quantitatively, the low WSS regions directly distal to the stenosis were sensitive to small reconstruction errors.	[Schrauwen, Jelle T. C.; van der Steen, Antonius F. W.; Wentzel, Jolanda J.; Gijsen, Frank J. H.] Erasmus MC, Thoraxctr, Dept Biomed Engn, Rotterdam, Netherlands; [Karanasos, Antonios; van Ditzhuijzen, Nienke S.] Erasmus MC, Thoraxctr, Dept Cardiol, Rotterdam, Netherlands; [Aben, Jean-Paul] Pie Med Imaging, Maastricht, Netherlands; [van der Steen, Antonius F. W.] Delft Univ Technol, Dept Imaging Phys, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology	Gijsen, FJH (corresponding author), Erasmus MC, Thoraxctr, Dept Biomed Engn, Rotterdam, Netherlands.	f.gijsen@erasmusmc.nl	Karanasos, Antonios/AAQ-7739-2020	Karanasos, Antonios/0000-0001-8052-6739	Stichting technische wetenschappen [11635]	Stichting technische wetenschappen	This work was supported by Stichting technische wetenschappen, Grant number: 11635 and Progamme name: Cardiovascular Risk Management by Advanced Medical Image Analysis. (URLs: http://stw.nl/en/; http://www.stw.nl/nl/programmas/cardiovascular-risk-management-advanced-medical-image-analysis-carisma). The funder provided support in the form of salaries for authors JS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Bourantas CV, 2014, INT J CARDIOVAS IMAG, V30, P485, DOI 10.1007/s10554-014-0374-3; Bourantas CV, 2013, EUROINTERVENTION, V9, P582, DOI 10.4244/EIJV9I5A94; Bovendeerd PHM, 2006, ANN BIOMED ENG, V34, P1833, DOI 10.1007/s10439-006-9189-2; Caro CG, 1996, P ROY SOC A-MATH PHY, V452, P185, DOI 10.1098/rspa.1996.0011; Chen MCY, 2005, ASAIO J, V51, P313, DOI 10.1097/01.mat.0000169117.07070.fb; CHO YI, 1991, BIORHEOLOGY, V28, P241; Cicha I, 2011, STROKE, V42, P3502, DOI 10.1161/STROKEAHA.111.627265; Corban MT, 2014, ATHEROSCLEROSIS, V232, P271, DOI 10.1016/j.atherosclerosis.2013.11.049; De Santis G, 2010, MED BIOL ENG COMPUT, V48, P371, DOI 10.1007/s11517-010-0583-4; Feldman CL, 2002, AM HEART J, V143, P931, DOI 10.1067/mhj.2002.123118; Fujii K, 2006, AM J CARDIOL, V98, P429, DOI 10.1016/j.amjcard.2006.03.020; Fukumoto Y, 2008, J AM COLL CARDIOL, V51, P645, DOI 10.1016/j.jacc.2007.10.030; Gijsen F, 2013, J BIOMECH, V46, P240, DOI 10.1016/j.jbiomech.2012.11.006; Gijsen FJH, 2008, AM J PHYSIOL-HEART C, V295, pH1608, DOI 10.1152/ajpheart.01081.2007; Girasis C, 2013, EUROINTERVENTION, V8, P1451, DOI 10.4244/EIJV8I12A219; Girasis C, 2011, CATHETER CARDIO INTE, V77, P790, DOI 10.1002/ccd.22704; Goubergrits L, 2008, INT J CARDIOVAS IMAG, V24, P411, DOI 10.1007/s10554-007-9275-z; Goubergrits L, 2009, ANN BIOMED ENG, V37, P682, DOI 10.1007/s10439-009-9656-7; Grigioni M, 2005, J BIOMECH, V38, P1375, DOI 10.1016/j.jbiomech.2004.06.028; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; Johnston BM, 2006, J BIOMECH, V39, P1116, DOI 10.1016/j.jbiomech.2005.01.034; Lee SW, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127252; Leter EM, 2004, INT J RADIAT ONCOL, V58, P278, DOI 10.1016/j.ijrobp.2003.08.017; Morbiducci U, 2009, ANN BIOMED ENG, V37, P516, DOI 10.1007/s10439-008-9609-6; Myers JG, 2001, ANN BIOMED ENG, V29, P109, DOI 10.1114/1.1349703; Nakazawa G, 2010, J AM COLL CARDIOL, V55, P1679, DOI 10.1016/j.jacc.2010.01.021; Newby DE, 2010, HEART, V96, P1247, DOI 10.1136/hrt.2009.175141; Onuma Y, 2011, EUROINTERVENTION, V7, P629, DOI 10.4244/EIJV7I5A100; Peiffer V, 2013, CARDIOVASC RES, V99, P242, DOI 10.1093/cvr/cvt044; Pijls N.H.J., 2000, CORONARY PRESSURE, V2nd; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; Schrauwen JTC, 2015, ANN BIOMED ENG, V43, P59, DOI 10.1007/s10439-014-1090-9; Schrauwen JTC, 2015, J BIOMECH IN PRESS; Slager CJ, 2005, NAT CLIN PRACT CARD, V2, P401, DOI 10.1038/ncpcardio0274; Slager CJ, 2000, CIRCULATION, V102, P511; Stone PH, 2012, CIRCULATION, V126, P172, DOI 10.1161/CIRCULATIONAHA.112.096438; Tu SX, 2011, INT J CARDIOVAS IMAG, V27, P197, DOI 10.1007/s10554-011-9809-2; van der Giessen AG, 2011, J BIOMECH, V44, P1089, DOI 10.1016/j.jbiomech.2011.01.036; Van Langenhove G, 2000, Circulation, V102, pE22; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8; Wellnhofer E, 2009, ATHEROSCLEROSIS, V202, P483, DOI 10.1016/j.atherosclerosis.2008.05.044; Wellnhofer E, 1999, INT J CARDIAC IMAG, V15, P339, DOI 10.1023/A:1006322609072; Wellnhofer E, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-39; Wellnhofer E, 2010, ATHEROSCLEROSIS, V213, P475, DOI 10.1016/j.atherosclerosis.2010.09.007; Wentzel JJ, 2005, J BIOMECH, V38, P1551, DOI 10.1016/j.jbiomech.2004.06.022; Wentzel JJ, 2012, CARDIOVASC RES, V96, P234, DOI 10.1093/cvr/cvs217; Zeng DH, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2937744	48	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145114	10.1371/journal.pone.0145114	http://dx.doi.org/10.1371/journal.pone.0145114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690897	gold, Green Submitted, Green Published			2022-12-27	WOS:000367092300037
J	Arias, CA; Betancur, MCT; Pinzon, MA; Arango, DC; Taffur, CAC; Prada, EC				Arias Arias, Carolina; Tamayo Betancur, Maria Carolina; Alejandro Pinzon, Miguel; Cardona Arango, Doris; Capataz Taffur, Cesar Antonio; Correa Prada, Edgar			Differences in the Clinical Outcome of Osteomyelitis by Treating Specialty: Orthopedics or Infectology	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; INFECTIONS; MANAGEMENT; DIAGNOSIS; CONSULTATION; OXACILLIN; RIFAMPIN; ADULTS	Osteomyelitis is a heterogeneous infection with regard to etiology and treatment, and currently no single management protocol exists. Management of the condition is typically an interdisciplinary approach between orthopedics and infectious disease; however, the orthopedist is often the person who manages treatment. The aim of the study was to determine differences in the outcome of osteomyelitis according to its treating specialty and to identify factors associated with the recurrence of the disease. An ambispective cohort study of 129 patients with osteomyelitis was conducted and the proportions for qualitative variables and central tendency and dispersion measures for quantitative variables were calculated; the latter were tested for normality using the Shapiro-Wilk test. A bivariate analysis was conducted with measures of association based on the chi square test and crude relative risk. A logistic regression model was applied and statistical significance was set at p < 0.05, including the model of relevant clinical variables that fit the Hosmer-Lemeshow test. We found that 70% of patients were treated either by orthopedics or infectious disease. Patients who were treated by an orthopedist alone presented a greater risk of relapse or reinfection (RR = 4.6; 95% CI 2.3;8.9). Risk factors of osteomyelitis recurrence as determined in the regression model included the following: age of 57 years or older (RR = 1.3; 95% 0.3;5.2), long bones (RR = 1.9; 95% CI 0.5;7.1), fracture (RR = 5.0; 95% CI 0.4;51.4), monotherapy (RR = 3.0; 95% CI 0.6;14.5), receiving less than 4 weeks of antibiotics (RR = 1.5; 95% CI 0.2;10.1), inadequate treatment (RR = 3.1; 95% CI 0.4;20.1), and receiving orthopedics treatment (RR = 5.5; 95% CI 1.6;18.2). Most patients evaluated jointly by orthopedics and infectious disease received adequate treatment for osteomyelitis and had fewer relapses.	[Arias Arias, Carolina; Tamayo Betancur, Maria Carolina; Cardona Arango, Doris] Univ CES, Dept Epidemiol, Medellin, Antioquia, Colombia; [Alejandro Pinzon, Miguel] Clin Medellin, Dept Infect Dis, Medellin, Antioquia, Colombia; [Capataz Taffur, Cesar Antonio] Fdn Clin Norte, Dept Infect Dis, Bello, Antioquia, Colombia; [Correa Prada, Edgar] Nueva Clin Sagrado Corazon, Dept Orthoped, Medellin, Antioquia, Colombia		Pinzon, MA (corresponding author), Clin Medellin, Dept Infect Dis, Medellin, Antioquia, Colombia.	alejandropinzon01@yahoo.es						Conterno LO, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004439.pub3; Forsberg JA, 2011, J AM ACAD ORTHOP SUR, V19, pS8, DOI 10.5435/00124635-201102001-00003; Hassan Azza M, 2009, EGYPT J MED MICROBIO, V18, P55; Hatzenbuehler J, 2011, AM FAM PHYSICIAN, V84, P1027; Honda H, 2010, AM J MED, V123, P631, DOI 10.1016/j.amjmed.2010.01.015; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; Jorge LS, 2010, BRAZ J INFECT DIS, V14, P310, DOI 10.1590/S1413-86702010000300020; KINDSFATER K, 1995, J ORTHOP TRAUMA, V9, P121, DOI 10.1097/00005131-199504000-00006; Lazzarini L, 2005, INT J INFECT DIS, V9, P127, DOI 10.1016/j.ijid.2004.09.009; Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406; MADER JT, 1992, CLIN INFECT DIS, V15, pS155, DOI 10.1093/clind/15.Supplement_1.S155; McHenry MC, 2002, CLIN INFECT DIS, V34, P1342, DOI 10.1086/340102; NORDEN CW, 1986, SOUTHERN MED J, V79, P947, DOI 10.1097/00007611-198608000-00008; NORRBY SR, 1993, J ANTIMICROB CHEMOTH, V31, P41, DOI 10.1093/jac/31.suppl_D.41; Rieg S, 2009, J INFECTION, V59, P232, DOI 10.1016/j.jinf.2009.07.015; Salvana Jose, 2005, Conn Med, V69, P195; Sanders J, 2013, ORTHOPEDICS, V36, P368, DOI 10.3928/01477447-20130426-07; Schmitt S, 2014, CLIN INFECT DIS, V58, P22, DOI 10.1093/cid/cit610; SHEFTEL TG, 1986, ANTIMICROB AGENTS CH, V29, P112, DOI 10.1128/AAC.29.1.112; Takakura S, 2006, INFECT CONT HOSP EP, V27, P964, DOI 10.1086/504934; Tice AD, 2003, J ANTIMICROB CHEMOTH, V51, P1261, DOI 10.1093/jac/dkg186; Uckay I, 2009, J INFECTION, V58, P205, DOI 10.1016/j.jinf.2009.01.012; VANDERAUWERA P, 1985, ANTIMICROB AGENTS CH, V28, P467, DOI 10.1128/AAC.28.4.467; WALDVOGEL FA, 1970, NEW ENGL J MED, V283, P822; Wieland BW, 2012, CLIN INFECT DIS, V54, P585, DOI 10.1093/cid/cir857; Zuluaga AF, 2006, ARCH INTERN MED, V166, P95, DOI 10.1001/archinte.166.1.95	26	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144736	10.1371/journal.pone.0144736	http://dx.doi.org/10.1371/journal.pone.0144736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678551	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400022
J	Shen, RZ; Achenbach, J; Shen, Y; Palaia, J; Rahkola, JT; Nick, HJ; Smythies, LE; McConnell, M; Fowler, MG; Smith, PD; Janoff, EN				Shen, Ruizhong; Achenbach, Jenna; Shen, Yue; Palaia, Jana; Rahkola, Jeremy T.; Nick, Heidi J.; Smythies, Lesley E.; McConnell, Michelle; Fowler, Mary G.; Smith, Phillip D.; Janoff, Edward N.			Mother-to-Child HIV-1 Transmission Events Are Differentially Impacted by Breast Milk and Its Components from HIV-1-Infected Women	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-ASSOCIATED HIV-1; TYPE-1 TRANSCYTOSIS; EPITHELIAL-CELLS; DENDRITIC CELLS; SECRETORY IGA; POSITIVE MOTHERS; FED INFANTS; R5 HIV-1; INFECTION	Breast milk is a vehicle of infection and source of protection in post-natal mother-to-child HIV-1 transmission (MTCT). Understanding the mechanism by which breast milk limits vertical transmission will provide critical insight into the design of preventive and therapeutic approaches to interrupt HIV-1 mucosal transmission. However, characterization of the inhibitory activity of breast milk in human intestinal mucosa, the portal of entry in postnatal MTCT, has been constrained by the limited availability of primary mucosal target cells and tissues to recapitulate mucosal transmission ex vivo. Here, we characterized the impact of skimmed breast milk, breast milk antibodies (Igs) and non-Ig components from HIV-1-infected Ugandan women on the major events of HIV-1 mucosal transmission using primary human intestinal cells and tissues. HIV-1-specific IgG antibodies and non-Ig components in breast milk inhibited the uptake of Ugandan HIV-1 isolates by primary human intestinal epithelial cells, viral replication in and transport of HIV-1-bearing dendritic cells through the human intestinal mucosa. Breast milk HIV-1-specific IgG and IgA, as well as innate factors, blocked the uptake and transport of HIV-1 through intestinal mucosa. Thus, breast milk components have distinct and complementary effects in reducing HIV-1 uptake, transport through and replication in the intestinal mucosa and, therefore, likely contribute to preventing postnatal HIV-1 transmission. Our data suggests that a successful preventive or therapeutic approach would require multiple immune factors acting at multiple steps in the HIV-1 mucosal transmission process.	[Shen, Ruizhong; Nick, Heidi J.; Smythies, Lesley E.; Smith, Phillip D.] Univ Alabama Birmingham, Dept Med, Div Gastroenterol, Birmingham, AL 35294 USA; [Achenbach, Jenna; Palaia, Jana; Rahkola, Jeremy T.; Janoff, Edward N.] Univ Colorado Denver, Mucosal & Vaccine Res Program Colorado MAVRC, Aurora, CO 80045 USA; [Shen, Yue] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Rahkola, Jeremy T.; Janoff, Edward N.] Denver Vet Affairs Med Ctr, Denver, CO USA; [McConnell, Michelle] Ctr Dis Control & Prevent, Atlanta, GA USA; [Fowler, Mary G.] Makerere Univ Johns Hopkins Univ Res Collaborat, Kampala, Uganda; [Smith, Phillip D.] Vet Affairs Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Auburn University System; Auburn University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Centers for Disease Control & Prevention - USA; Makerere University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Janoff, EN (corresponding author), Univ Colorado Denver, Mucosal & Vaccine Res Program Colorado MAVRC, Aurora, CO 80045 USA.	rshen@uab.edu; Edward.Janoff@ucdenver.edu		NICK, HEIDI/0000-0002-7853-6302	National Institutes of Health [AI093151, AI106395, AI083127, DK064400, AI41361, HD059527, AI083615]; UAB Center for AIDS Research (CFAR); Comprehensive Cancer Center Pilot Grant Program; amfAR; Foundation for AIDS Research [108015-49-RGRL]; Elisabeth Glaser Pediatric AIDS Foundations [MV-00-9-900-01432-0-00]; Research Service of the Veterans Administration; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI106395, R56AI093151, R21AI083615, R01AI097265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Center for AIDS Research (CFAR); Comprehensive Cancer Center Pilot Grant Program; amfAR; Foundation for AIDS Research; Elisabeth Glaser Pediatric AIDS Foundations; Research Service of the Veterans Administration; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health grants AI093151 and AI106395 (RS), AI083127 and DK064400 (PDS), AI41361, HD059527 and AI083615 (ENJ); UAB Center for AIDS Research (CFAR) and Comprehensive Cancer Center Pilot Grant Program (RS); amfAR, the Foundation for AIDS Research 108015-49-RGRL (PDS); the Elisabeth Glaser Pediatric AIDS Foundations MV-00-9-900-01432-0-00 (ENJ); and the Research Service of the Veterans Administration (PDS and ENJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizire J, 2012, JAIDS-J ACQ IMM DEF, V60, P483, DOI 10.1097/QAI.0b013e318246bf9e; Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Baroncelli S, 2008, AIDS, V22, P1515, DOI 10.1097/QAD.0b013e3282fd6e0c; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; Bomsel M, 2003, NAT REV MOL CELL BIO, V4, P57, DOI 10.1038/nrm1005; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Cavarelli M, 2013, EMBO MOL MED, V5, P776, DOI 10.1002/emmm.201202232; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; DUNN DT, 1992, LANCET, V340, P585, DOI 10.1016/0140-6736(92)92115-V; Fouda GG, 2011, J VIROL, V85, P9555, DOI 10.1128/JVI.05174-11; Fowler MG, 2007, AM J OBSTET GYNECOL, V197, pS3, DOI 10.1016/j.ajog.2007.06.048; Friedman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037648; HARMSEN MC, 1995, J INFECT DIS, V172, P380, DOI 10.1093/infdis/172.2.380; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hocini H, 1997, AIDS RES HUM RETROV, V13, P1179, DOI 10.1089/aid.1997.13.1179; Hocini H, 2001, J VIROL, V75, P5370, DOI 10.1128/JVI.75.11.5370-5374.2001; Humphrey JH, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6580; Koulinska IN, 2006, JAIDS-J ACQ IMM DEF, V41, P93, DOI 10.1097/01.qai.0000179424.19413.24; Kuhn L, 2005, JAIDS-J ACQ IMM DEF, V39, P138; Kuhn L, 2006, J PEDIATR-US, V149, P611, DOI 10.1016/j.jpeds.2006.06.017; Leroy V, 1998, LANCET, V352, P597, DOI 10.1016/S0140-6736(98)01419-6; Lewis P, 1998, J INFECT DIS, V177, P34, DOI 10.1086/513816; Lohman BL, 2003, J INFECT DIS, V188, P1666, DOI 10.1086/379374; Lyimo MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043815; Lyimo MA, 2009, JAIDS-J ACQ IMM DEF, V51, P117, DOI 10.1097/QAI.0b013e3181a3908d; Mantis NJ, 2007, J IMMUNOL, V179, P3144, DOI 10.4049/jimmunol.179.5.3144; Matoba N, 2004, P NATL ACAD SCI USA, V101, P13584, DOI 10.1073/pnas.0405297101; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Palaia JM, 2014, J INFECTION, V68, P264, DOI 10.1016/j.jinf.2013.11.002; Pollakis G, 2011, CURR OPIN HIV AIDS, V6, P341, DOI 10.1097/COH.0b013e3283499e11; Pollara J, 2015, J VIROL, V89, P9952, DOI 10.1128/JVI.01560-15; Rousseau CM, 2004, J INFECT DIS, V190, P1880, DOI 10.1086/425076; Saeland E, 2009, MOL IMMUNOL, V46, P2309, DOI 10.1016/j.molimm.2009.03.025; Shapiro RL, 2007, J INFECT DIS, V196, P562, DOI 10.1086/519847; Shen RZ, 2014, J VIROL, V88, P14258, DOI 10.1128/JVI.02164-14; Shen RZ, 2014, J VIROL, V88, P7683, DOI 10.1128/JVI.00766-14; Shen RZ, 2014, AM J REPROD IMMUNOL, V71, P608, DOI 10.1111/aji.12244; Shen RZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002060; Shen RZ, 2011, AM J REPROD IMMUNOL, V65, P261, DOI 10.1111/j.1600-0897.2010.00939.x; Shen RZ, 2010, J LEUKOCYTE BIOL, V87, P663, DOI 10.1189/jlb.0909605; Shen RZ, 2010, J IMMUNOL, V184, P3648, DOI 10.4049/jimmunol.0903346; Shen R, 2009, J VIROL, V83, P3258, DOI 10.1128/JVI.01796-08; Smith MM, 2000, NUTR REV, V58, P333, DOI 10.1111/j.1753-4887.2000.tb01830.x; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; Van de Perre P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003327; VANDEPERRE P, 1993, LANCET, V341, P914, DOI 10.1016/0140-6736(93)91210-D; Wahl A, 2015, J VIROL, V89, P10868, DOI 10.1128/JVI.01702-15; Wahl A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002732; Walter J, 2009, J INFECT DIS, V200, P1498, DOI 10.1086/644603; Wolbank S, 2003, J VIROL, V77, P4095, DOI 10.1128/JVI.77.7.4095-4103.2003	54	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145150	10.1371/journal.pone.0145150	http://dx.doi.org/10.1371/journal.pone.0145150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680219	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400051
J	Taki, S; Kamada, H; Inoue, M; Nagano, K; Mukai, Y; Higashisaka, K; Yoshioka, Y; Tsutsumi, Y; Tsunoda, S				Taki, Shintaro; Kamada, Haruhiko; Inoue, Masaki; Nagano, Kazuya; Mukai, Yohei; Higashisaka, Kazuma; Yoshioka, Yasuo; Tsutsumi, Yasuo; Tsunoda, Shin-ichi			A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODY; GROWTH-FACTOR RECEPTOR; TRASTUZUMAB RESISTANCE; LEUKEMIA; LYMPHOMA; POTENT; CELLS; INTERLEUKIN-2; BLINATUMOMAB; CYTOTOXICITY	Ephrin receptor A10 (EphA10), a transmembrane receptor that binds to ephrin, is a newly identified breast cancer marker protein that has also been detected in HER2-negative tissue. In this study, we report creation of a novel bispecific antibody (BsAb) binding both EphA10 and CD3, thereby forming a bridge between antigens expressed on both tumor and immune cells and promoting recognition of tumor cells by immune cells and redirection of cytotoxic T cells (CTL). This BsAb (EphA10/CD3) was expressed in supernatants of BsAb gene-transfected cells asmonomeric and dimeric molecules. Redirected T-cell lysis was observed when monomeric and dimeric BsAb were added to EphA10-overexpressing tumor cells in vitro. Furthermore, dimeric BsAb (EphA10/CD3) was more cytotoxic than monomeric BsAb, with efficient tumor cell lysis elicited by lower concentrations (<= 10(-1) mu g/mL) and a lower effector to target (E/T) cell ratio (E/T = 2.5). Dimeric BsAb (EphA10/CD3) also showed significant antitumor effects in human xenograft mouse models. Together, these results revealed opportunities to redirect the activity of CTL towards tumor cells that express EphA10 using the BsAb (EphA10/CD3), which could be tested in future clinical trials as a novel and potent therapeutic for breast cancer tumors.	[Taki, Shintaro; Kamada, Haruhiko; Inoue, Masaki; Tsunoda, Shin-ichi] Natl Inst Biomed Innovat Hlth & Nutr, Lab Biopharmaceut Res, Ibaraki, Osaka, Japan; [Taki, Shintaro; Nagano, Kazuya; Higashisaka, Kazuma; Yoshioka, Yasuo; Tsutsumi, Yasuo; Tsunoda, Shin-ichi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan; [Kamada, Haruhiko; Yoshioka, Yasuo; Tsutsumi, Yasuo; Tsunoda, Shin-ichi] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka, Japan; [Mukai, Yohei; Yoshioka, Yasuo; Tsutsumi, Yasuo; Tsunoda, Shin-ichi] Natl Inst Biomed Innovat Hlth & Nutr, Ctr Drug Design Res, Ibaraki, Osaka, Japan	Osaka University; Osaka University	Tsunoda, S (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Lab Biopharmaceut Res, 7-6-8 Saito Asagi, Ibaraki, Osaka, Japan.	tsunoda@nibio.go.jp		Tsunoda, Shin-ichi/0000-0003-3299-2182	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS); Health Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan; Project for Development of Innovative Research on Cancer Therapeutics, the Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS; Grants-in-Aid for Scientific Research [15K12550] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan; Project for Development of Innovative Research on Cancer Therapeutics, the Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grants-in-Aid for Scientific Research and a Project for the Development of Innovative Research on Cancer Therapeutics from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and from the Japan Society for the Promotion of Science (JSPS) (S. Taki, H. Kamada, S. Tsunoda). This study was also supported in part by Health Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan (H. Kamada, S. Tsunoda).; This study was supported in part by Grants-in-Aid for Scientific Research from the Project for Development of Innovative Research on Cancer Therapeutics, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and from the JSPS. This study was also supported in part by Health Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan.	Asano R, 2011, J BIOL CHEM, V286, P1812, DOI 10.1074/jbc.M110.172957; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brischwein K, 2006, MOL IMMUNOL, V43, P1129, DOI 10.1016/j.molimm.2005.07.034; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Crown J, 2012, ANN ONCOL, V23, P56, DOI 10.1093/annonc/mds196; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Dreier T, 2002, INT J CANCER, V100, P690, DOI 10.1002/ijc.10557; Flieger D, 2000, CANCER IMMUNOL IMMUN, V49, P441, DOI 10.1007/s002620000130; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fury MG, 2008, CANCER IMMUNOL IMMUN, V57, P155, DOI 10.1007/s00262-007-0357-5; Gogineni K, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3064; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Hammond SA, 2007, CANCER RES, V67, P3927, DOI 10.1158/0008-5472.CAN-06-2760; Hartmann F, 1997, BLOOD, V89, P2042, DOI 10.1182/blood.V89.6.2042; Hoffman LM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00063; Imai S, 2011, BIOMATERIALS, V32, P162, DOI 10.1016/j.biomaterials.2010.09.030; Jager M, 2009, CANCER RES, V69, P4270, DOI 10.1158/0008-5472.CAN-08-2861; James ND, 2001, BRIT J CANCER, V85, P152, DOI 10.1054/bjoc.2001.1878; Kandouz M, 2012, CANCER METAST REV, V31, P353, DOI 10.1007/s10555-012-9352-1; Kipriyanov SM, 1999, J MOL BIOL, V293, P41, DOI 10.1006/jmbi.1999.3156; Klee GG, 2000, ARCH PATHOL LAB MED, V124, P921; Koene HR, 1997, BLOOD, V90, P1109, DOI 10.1182/blood.V90.3.1109.1109_1109_1114; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Loffler A, 2000, BLOOD, V95, P2098, DOI 10.1182/blood.V95.6.2098; Maloney DG, 1997, BLOOD, V90, P2188; Nagano K, 2014, J CONTROL RELEASE, V189, P72, DOI 10.1016/j.jconrel.2014.06.010; Nagano K, 2014, BIOCHEM BIOPH RES CO, V450, P545, DOI 10.1016/j.bbrc.2014.06.007; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nagorsen D, 2009, LEUKEMIA LYMPHOMA, V50, P886, DOI 10.1080/10428190902943077; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Niwa R, 2004, CANCER RES, V64, P2127, DOI 10.1158/0008-5472.CAN-03-2068; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Reslan L, 2009, MABS-AUSTIN, V1, P222, DOI 10.4161/mabs.1.3.8292; Reusch U, 2014, MABS-AUSTIN, V6, P727, DOI 10.4161/mabs.28591; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Seidman AD, 2008, J CLIN ONCOL, V26, P1642, DOI 10.1200/JCO.2007.11.6699; SHEPARD HM, 1991, J CLIN IMMUNOL, V11, P117, DOI 10.1007/BF00918679; Spector NL, 2009, J CLIN ONCOL, V27, P5838, DOI 10.1200/JCO.2009.22.1507; Todorovska A, 2001, J IMMUNOL METHODS, V248, P47, DOI 10.1016/S0022-1759(00)00342-2; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Xu QL, 1997, J MOL MED-JMM, V75, P576, DOI 10.1007/s001090050142; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhang T, 2011, CANCER RES, V71, P2066, DOI 10.1158/0008-5472.CAN-10-3200	47	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144712	10.1371/journal.pone.0144712	http://dx.doi.org/10.1371/journal.pone.0144712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678395	Green Submitted, Green Published, gold			2022-12-27	WOS:000366723400020
J	Botto-Menezes, C; dos Santos, MCS; Simplicio, JL; de Medeiros, JM; Gomes, KCB; Costa, ICD; Batista-Silva, E; do Nascimento, CT; Chagas, ECD; Sardinha, JFJ; de Santana, FS; Brock, M; Bardaj, A; Martinez-Espinosa, FE				Botto-Menezes, Camila; Silva dos Santos, Monica Caroline; Simplicio, Janiceia Lopes; de Medeiros, Jandira Menezes; Barroso Gomes, Kelly Cristina; de Carvalho Costa, Isabel Cristina; Batista-Silva, Eva; do Nascimento, Cristiana Teixeira; da Silva Chagas, Eda Cristina; Jardim Sardinha, Jose Felipe; de Santana Filho, Franklin Simoes; Brock, Marianna; Bardaj, Azucena; Martinez-Espinosa, Flor Ernestina			Plasmodium vivax Malaria in Pregnant Women in the Brazilian Amazon and the Risk Factors Associated with Prematurity and Low Birth Weight: A Descriptive Study	PLOS ONE			English	Article							EPIDEMIOLOGY; FALCIPARUM; CONSEQUENCES; INFECTIONS; OUTCOMES; BURDEN; AREA	Introduction Plasmodium vivax is the most prevalent malaria species in the American region. Brazil accounts for the higher number of the malaria cases reported in pregnant women in the Americas. This study aims to describe the characteristics of pregnant women with malaria in an endemic area of the Brazilian Amazon and the risk factors associated with prematurity and low birth weight (LBW). Methods/Principal Findings Between December 2005 and March 2008, 503 pregnant women with malaria that attended a tertiary health centre were enrolled and followed up until delivery and reported a total of 1016 malaria episodes. More than half of study women (54%) were between 20-29 years old, and almost a third were adolescents. The prevalence of anaemia at enrolment was 59%. Most women (286/503) reported more than one malaria episode and most malaria episodes (84.5%, 846/1001) were due to P. vivax infection. Among women with only P. vivax malaria, the risk of preterm birth and low birth weight decreased in multigravidae (OR, 0.36 [95% CI, 0.16-0.82]; p = 0.015 and OR 0.24 [95% CI, 0.10-0.58]; p = 0.001, respectively). The risk of preterm birth decreased with higher maternal age (OR 0.43 [95% CI, 0.19-0.95]; p = 0.037) and among those women who reported higher antenatal care (ANC) attendance (OR, 0.32 [95% CI, 0.15-0.70]; p = 0.005). Conclusion This study shows that P. vivax is the prevailing species among pregnant women with malaria in the region and shows that vivax clinical malaria may represent harmful consequences for the health of the mother and their offsprings particularly on specific groups such as adolescents, primigravidae and those women with lower ANC attendance.	[Botto-Menezes, Camila; Brock, Marianna] Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil; [Botto-Menezes, Camila; Silva dos Santos, Monica Caroline; Simplicio, Janiceia Lopes; de Medeiros, Jandira Menezes; Barroso Gomes, Kelly Cristina; de Carvalho Costa, Isabel Cristina; de Santana Filho, Franklin Simoes] Univ Fed Amazonas, Manaus, Amazonas, Brazil; [Batista-Silva, Eva; do Nascimento, Cristiana Teixeira; da Silva Chagas, Eda Cristina; Jardim Sardinha, Jose Felipe; de Santana Filho, Franklin Simoes; Martinez-Espinosa, Flor Ernestina] Fundacao Med Trop Dr Heitor Vieira Dourado FMT HV, Manaus, Amazonas, Brazil; [Bardaj, Azucena] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Martinez-Espinosa, Flor Ernestina] Ctr Pesquisas Leonidas & Maria Deane Fiocruz Amaz, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; Universidade Federal de Amazonas; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Fundacao Oswaldo Cruz	Botto-Menezes, C (corresponding author), Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil.	camila.chabm@gmail.com	Bardají, Azucena/AAE-9145-2019; Alonso, Azucena Bardají/V-5978-2018	Alonso, Azucena Bardají/0000-0002-5135-0540	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM), Regional Scientific Development Program [DCR/2005]; European Union Seventh Framework Programme (FP7) [201588]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM), Regional Scientific Development Program; European Union Seventh Framework Programme (FP7)	The study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and by the Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM), Regional Scientific Development Program (DCR/2005) conferred to FEME in 2005. AB received support from the European Union Seventh Framework Programme (FP7/2007-2013) under the grant agreement 201588.	Akanbi O M, 2009, East Afr J Public Health, V6, P63; [Anonymous], 2010, GUIA PRAT TRAT MAL B; [Anonymous], PORT SAUD; [Anonymous], DAT SIST INF NASC VI; [Anonymous], SIST INF VIG EP; [Anonymous], REP SIT MAL AM; [Anonymous], THESIS; [Anonymous], SIST INF NASC VIV SI; Brutus L, 2013, EMERG INFECT DIS, V19, P1605, DOI 10.3201/eid1910.130308; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Cottrell G, 2007, AM J TROP MED HYG, V76, P849, DOI 10.4269/ajtmh.2007.76.849; Costa Carolina Marinho da, 2009, Acta Amaz., V39, P901, DOI 10.1590/S0044-59672009000400018; Chagas ECD, 2009, REV PANAM SALUD PUBL, V26, P203, DOI 10.1590/S1020-49892009000900003; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Fernando SD, 2011, ASIAN PAC J TROP MED, V4, P330, DOI 10.1016/S1995-7645(11)60098-9; de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386; Galappaththy GNL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004389.pub3; Gama BE, 2011, MEM I OSWALDO CRUZ, V106, P159, DOI 10.1590/S0074-02762011000900020; Gomez E, 2009, INVEST CLIN, V50, P455; Karunaweera ND, 2003, TRENDS PARASITOL, V19, P188, DOI 10.1016/S1471-4922(03)00036-9; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; McGready R, 2004, AM J TROP MED HYG, V70, P398, DOI 10.4269/ajtmh.2004.70.398; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Okoko BJ, 2003, ACTA TROP, V87, P193, DOI 10.1016/S0001-706X(03)00097-4; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Pedreira CE, 2011, AN ACAD BRAS CIENC, V83, P619, DOI 10.1590/S0001-37652011005000008; Poespoprodjo JR, 2008, CLIN INFECT DIS, V46, P1374, DOI 10.1086/586743; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Rodriguez-Morales AJ, 2006, AM J TROP MED HYG, V74, P755, DOI 10.4269/ajtmh.2006.74.755; Singh N, 1999, B WORLD HEALTH ORGAN, V77, P567; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Tobon-Castano A, 2011, REV SOC BRAS MED TRO, V44, P364, DOI 10.1590/S0037-86822011005000030; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Villegas L, 2007, TROP MED INT HEALTH, V12, P209, DOI [10.1111/j.1365-3165.2006.01778.x, 10.1111/j.1365-3156.2006.01778.x]; WHO, 2012, WORLD MALARIA REPORT 2012, P1	37	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144399	10.1371/journal.pone.0144399	http://dx.doi.org/10.1371/journal.pone.0144399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675007	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700039
J	Depont, F; Berenbaum, F; Filippi, J; Le Maitre, M; Nataf, H; Paul, C; Peyrin-Biroulet, L; Thibout, E				Depont, Fanny; Berenbaum, Francis; Filippi, Jerome; Le Maitre, Michel; Nataf, Henri; Paul, Carle; Peyrin-Biroulet, Laurent; Thibout, Emmanuel			Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; RHEUMATOID-ARTHRITIS; MEDICATION ADHERENCE; PREDICTIVE-VALIDITY; ULCERATIVE-COLITIS; EDUCATION; HEALTH; NONADHERENCE; DISEASES; THERAPY	Background In patients with immune-mediated inflammatory disorders, poor adherence to medication is associated with increased healthcare costs, decreased patient satisfaction, reduced quality of life and unfavorable treatment outcomes. Objective To determine the impact of different interventions on medication adherence in patients with immune-mediated inflammatory disorders. Design Systematic review. Data sources MEDLINE, EMBASE and Cochrane Library. Study eligibility criteria for selecting studies Included studies were clinical trials and observational studies in adult outpatients treated for psoriasis, Crohn's disease, ulcerative colitis, rheumatoid arthritis, spondyloarthritis, psoriatic arthritis or multiple sclerosis. Study appraisal and synthesis methods Intervention approaches were classified into four categories: educational, behavioral, cognitive behavioral, and multicomponent interventions. The risk of bias/study limitations of each study was assessed using the GRADE system. Results Fifteen studies (14 clinical trials and one observational study) met eligibility criteria and enrolled a total of 1958 patients. Forty percent of the studies (6/15) was conducted in patients with inflammatory bowel disease, half (7/15) in rheumatoid arthritis patients, one in psoriasis patients and one in multiple sclerosis patients. Seven out of 15 interventions were classified as multicomponent, four as educational, two as behavioral and two as cognitive behavioral. Nine studies, of which five were multicomponent interventions, had no serious limitations according to GRADE criteria. Nine out of 15 interventions showed an improvement of adherence: three multicomponent interventions in inflammatory bowel disease; one intervention of each category in rheumatoid arthritis; one multicomponent in psoriasis and one multicomponent in multiple sclerosis. Conclusion The assessment of interventions designed for increasing medication adherence in IMID is rare in the literature and their methodological quality may be improved in upcoming studies. Nonetheless, multicomponent interventions showed the strongest evidence for promoting adherence in patients with IMID.	[Depont, Fanny] SC Partners, Paris, France; [Berenbaum, Francis] Univ Paris 06, AP HP, Univ Sorbonne, UMRS 938,DHU i2B,Dept Rheumatol,St Antoine Hosp, Paris, France; [Filippi, Jerome] Archet 2 Hosp, Dept Gastroenterol, Nice, France; [Nataf, Henri] Francois Quesnay Hosp, Mantes LA Jolie, France; [Paul, Carle] Paul Sabatier Univ, Dept Dermatol, Toulouse, France; [Peyrin-Biroulet, Laurent] Univ Lorraine, INSERM, U954, Vandoeuvre Les Nancy, France; [Peyrin-Biroulet, Laurent] Univ Lorraine, Dept Gastroenterol, Vandoeuvre Les Nancy, France; [Thibout, Emmanuel] AbbVie, Rungis, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Nice; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universite de Lorraine; AbbVie	Depont, F (corresponding author), SC Partners, Paris, France.	fanny.depont@sc-partners.eu	Hu, James W./B-2063-2008; Berenbaum, Francis/AAO-5690-2020	Berenbaum, Francis/0000-0001-8252-7815; Paul, Carle/0000-0003-0165-5263; peyrin-biroulet, laurent/0000-0003-2536-6618	AbbVie	AbbVie(AbbVie)	Financial support was provided by AbbVie to SC Partners, a commercial company, for the selection of publications and data analysis, and to FB, JF, MLM, HN, CP and LBP for their participation to scientific boards. The design and study conduct were approved by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication. The specific roles of authors are articulated in the "author contributions" section. This financial support had no impact on the selection of publications, data analysis or the publication process.	Anastats, 2014, TEL UT EX 2014; Augustin M, 2011, DERMATOLOGY, V222, P363, DOI 10.1159/000329026; Balato N, 2013, BRIT J DERMATOL, V168, P201, DOI 10.1111/j.1365-2133.2012.11205.x; Berger BA, 2005, J AM PHARM ASSOC, V45, P466, DOI 10.1331/1544345054475469; Brus HLM, 1998, ANN RHEUM DIS, V57, P146, DOI 10.1136/ard.57.3.146; Cook PF, 2010, PATIENT EDUC COUNS, V81, P182, DOI 10.1016/j.pec.2009.12.010; Cramer JA, 2008, INT J CLIN PRACT, V62, P76, DOI 10.1111/j.1742-1241.2007.01630.x; Cross RK, 2012, INFLAMM BOWEL DIS, V18, P1018, DOI 10.1002/ibd.21795; Culig Josip, 2014, Coll Antropol, V38, P55; El Miedany Y, 2012, CLIN EXP RHEUMATOL, V30, P899; El Miedany Y, 2012, RHEUMATOL INT, V32, P3061, DOI 10.1007/s00296-011-2098-1; Elkjaer M, 2010, GUT, V59, P1652, DOI 10.1136/gut.2010.220160; Evers AWM, 2002, PAIN, V100, P141, DOI 10.1016/S0304-3959(02)00274-9; Greenley RN, 2013, INFLAMM BOWEL DIS, V19, P1534, DOI 10.1097/MIB.0b013e3182813482; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Haynes RB, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub2; Hess LM, 2006, ANN PHARMACOTHER, V40, P1280, DOI 10.1345/aph.1H018; Hill J, 2001, ANN RHEUM DIS, V60, P869; Hill J, 2005, MUSCULOSKELET CARE, V3, P61, DOI 10.1002/msc.27; Homer D, 2009, MUSCULOSKELET CARE, V7, P78, DOI 10.1002/msc.141; Kane S, 2008, DIGEST DIS SCI, V53, P1020, DOI 10.1007/s10620-007-9968-0; Laysa S. M., 2003, J AM PHARM ASSOC, V51, P90, DOI DOI 10.1331/JAPHA.2011.09154]; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Makela MJ, 2013, RESP MED, V107, P1481, DOI 10.1016/j.rmed.2013.04.005; McGough James J, 2009, Psychiatry (Edgmont), V6, P21; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Moshkovska T, 2011, INFLAMM BOWEL DIS, V17, P1874, DOI 10.1002/ibd.21570; Moss AC, 2010, J CROHNS COLITIS, V4, P171, DOI 10.1016/j.crohns.2009.10.002; National Collaborating Centre for Primary Care National Institute for Health and Clinical Excellence, 2009, MED ADH INV PAT DEC; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; SabatU E., 2003, ADHERENCE LONG TERM; Thorneloe RJ, 2013, BRIT J DERMATOL, V168, P20, DOI 10.1111/bjd.12039; van den Bemt BJF, 2011, SCAND J RHEUMATOL, V40, P192, DOI 10.3109/03009742.2010.517214; Viswanathan M, 2012, ANN INTERN MED, V157, P785, DOI 10.7326/0003-4819-157-11-201212040-00538; Waters BM, 2005, CAN J GASTROENTEROL, V19, P235, DOI 10.1155/2005/250504; Williams JP, 2002, AM J MANAG CARE, V8, pS664; Williams JP, 2002, AM J MANAG CARE, V8, pS82	38	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145076	10.1371/journal.pone.0145076	http://dx.doi.org/10.1371/journal.pone.0145076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674526	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700093
J	Kalani, R; Liotta, EM; Prabhakaran, S				Kalani, Rizwan; Liotta, Eric M.; Prabhakaran, Shyam			Diagnostic Yield of Universal Urine Toxicology Screening in an Unselected Cohort of Stroke Patients	PLOS ONE			English	Article							HEALTH-CARE PROFESSIONALS; ISCHEMIC-STROKE; ABUSE; COCAINE; VASOCONSTRICTION; HEMORRHAGE; CANNABIS	Background Illicit drug use increases the risk of cerebrovascular events by a variety of mechanisms. A recent report suggested that universal urine toxicology (UTox) screening of patients with stroke may be warranted. We aimed to evaluate the diagnostic yield of urine drug screening among unselected patients admitted with acute stroke or transient ischemic attack (TIA). Methods Using a single-center prospective study design, we evaluated consecutive patients with acute ischemic stroke, TIA, intracerebral hemorrhage (ICH), or subarachnoid hemorrhage (SAH) over one year. Urine samples were collected within 48 hours of admission and analyzed for common classes of abused drugs. Prevalence of positive UTox screening was determined. We evaluated whether baseline demographics and clinical factors were associated with UTox results. Results Of 483 eligible patients (acute ischemic stroke 66.4%; TIA 18.8%; ICH 7.7%; SAH 7.0%), 414 (85.7%) completed UTox screening. The mean (standard deviation) age was 65.1 (15.6) years, 52.7% were male, and 64.3% were Caucasian. Twenty-two (4.6%) patients had positive screening-cannabinoids were detected in 13 cases (3.1%), cocaine in 5 cases (1.2%), amphetamines in 1 case, and phencyclidine in 1 case. The highest yield (14.1%) was observed in patients < 60 years old with history of tobacco use while it was < 5% in the remaining subgroups (p<0.01). Conclusions Consistent with current guidelines, a selective approach to UTox screening should be pursued in acute stroke evaluation. The highest diagnostic yield is likely to be for cannabinoids and cocaine testing in younger patients with a history of concurrent tobacco use.	[Kalani, Rizwan] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Liotta, Eric M.; Prabhakaran, Shyam] Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA	University of Washington; University of Washington Seattle; Northwestern University	Kalani, R (corresponding author), Univ Washington, Dept Neurol, Seattle, WA 98195 USA.	rkalani517@gmail.com						Abuse S., 2013, NSDUH SER H, V46; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Barber PA, 2013, STROKE, V44, P2327, DOI 10.1161/STROKEAHA.113.001562; BOYKO OB, 1987, J NEUROSURG, V67, P446, DOI 10.3171/jns.1987.67.3.0446; Brust JCM, 1997, NEUROL CLIN, V15, P945; Burke James F, 2014, Continuum (Minneap Minn), V20, P436, DOI 10.1212/01.CON.0000446112.05291.35; Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5; Ducros A, 2007, BRAIN, V130, P3091, DOI 10.1093/brain/awm256; Gorodetzky CW, 1977, HDB EXPT PHARM, V45, P319; Ho EL, 2009, NEUROCRIT CARE, V10, P295, DOI 10.1007/s12028-008-9177-5; JACOBS IG, 1989, RADIOLOGY, V170, P223, DOI 10.1148/radiology.170.1.2909100; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; KAKU DA, 1990, ANN INTERN MED, V113, P821, DOI 10.7326/0003-4819-113-11-821; McGee SM, 2004, AM J FOREN MED PATH, V25, P334, DOI 10.1097/01.paf.0000137206.16785.2f; Petitti DB, 1998, EPIDEMIOLOGY, V9, P596, DOI 10.1097/00001648-199811000-00005; ROTHROCK JF, 1988, NEUROLOGY, V38, P589, DOI 10.1212/WNL.38.4.589; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Silver B, 2013, NEUROLOGY, V80, P1702, DOI 10.1212/WNL.0b013e318293e2fe; SLOAN MA, 1992, STROKE, V23, P427, DOI 10.1161/01.STR.23.3.427; Treadwell SD, 2007, POSTGRAD MED J, V83, P389, DOI 10.1136/pgmj.2006.055970; UNODC, WORLD DRUG REP 2013; WILSON JF, 1994, ANN CLIN BIOCHEM, V31, P335, DOI 10.1177/000456329403100405; Wolff V, 2011, STROKE, V42, P1778, DOI 10.1161/STROKEAHA.110.610915	23	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144772	10.1371/journal.pone.0144772	http://dx.doi.org/10.1371/journal.pone.0144772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675665	gold, Green Published			2022-12-27	WOS:000366722700061
J	Lee, YT; de Vasconcellos, JF; Byrnes, C; Kaushal, M; Rabel, A; Tumburu, L; Allwardt, JM; Miller, JL				Lee, Y. Terry; de Vasconcellos, Jaira F.; Byrnes, Colleen; Kaushal, Megha; Rabel, Antoinette; Tumburu, Laxminath; Allwardt, Joshua M.; Miller, Jeffery L.			Erythroid-Specific Expression of LIN28A Is Sufficient for Robust Gamma-Globin Gene and Protein Expression in Adult Erythroblasts	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LIN-28; FETAL; DIFFERENTIATION; IDENTIFICATION; HEMOGLOBIN; EKLF/KLF1; PROMOTER; CELLS; AGE	Increasing fetal hemoglobin (HbF) levels in adult humans remains an active area in hematologic research. Here we explored erythroid-specific LIN28A expression for its effect in regulating gamma-globin gene expression and HbF levels in cultured adult erythroblasts. For this purpose, lentiviral transduction vectors were produced with LIN28A expression driven by erythroid-specific gene promoter regions of the human KLF1 or SPTA1 genes. Transgene expression of LIN28A with a linked puromycin resistance marker was restricted to the erythroid lineage as demonstrated by selective survival of erythroid colonies (greater than 95% of all colonies). Erythroblast LIN28A over-expression (LIN28A-OE) did not significantly affect proliferation or inhibit differentiation. Greater than 70% suppression of total let-7 microRNA levels was confirmed in LIN28A-OE cells. Increases in gamma-globin mRNA and protein expression with HbF levels reaching 30-40% were achieved. These data suggest that erythroblast targeting of LIN28A expression is sufficient for increasing fetal hemoglobin expression in adult human erythroblasts.	[Lee, Y. Terry; de Vasconcellos, Jaira F.; Byrnes, Colleen; Kaushal, Megha; Rabel, Antoinette; Tumburu, Laxminath; Allwardt, Joshua M.; Miller, Jeffery L.] NIDDK, Mol Genom & Therapeut Sect, Mol Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Miller, JL (corresponding author), NIDDK, Mol Genom & Therapeut Sect, Mol Med Branch, NIH, Bethesda, MD 20892 USA.	jm7f@nih.gov		Ferreira de Vasconcellos, Jaira/0000-0001-5011-4493	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025101, ZIADK025100, ZIADK025098] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases supported this work.	BENNETT V, 1989, BIOCHIM BIOPHYS ACTA, V988, P107, DOI 10.1016/0304-4157(89)90006-3; Bhanu NV, 2005, BLOOD, V105, P387, DOI 10.1182/blood-2004-04-1599; Boulanger L, 2002, J BIOL CHEM, V277, P41563, DOI 10.1074/jbc.M208184200; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Davoodian N, 2014, J PHYSIOL BIOCHEM, V70, P781, DOI 10.1007/s13105-014-0346-z; de Vasconcellos JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106924; Goh SH, 2005, BLOOD, V106, P1466, DOI 10.1182/blood-2005-03-0948; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Kropp J, 2015, BIOCHEM J, V466, P85, DOI 10.1042/BJ20141175; Lee YT, 2013, BLOOD, V122, P1034, DOI 10.1182/blood-2012-12-472308; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; MARCHESI V. T., 1968, SCIENCE, V159, P203, DOI 10.1126/science.159.3811.203; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noh SJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-98; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Sripichai O, 2009, BLOOD, V114, P2299, DOI 10.1182/blood-2009-05-219386; Stefani G, 2015, NOVEL MECH LIN 28 RE; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Tewari R, 1998, EMBO J, V17, P2334, DOI 10.1093/emboj/17.8.2334; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Wojda U, 2002, BLOOD, V99, P3005, DOI 10.1182/blood.V99.8.3005.h8003005_3005_3013; Wolgast LR, 2011, AM J CLIN PATHOL, V136, P300, DOI 10.1309/AJCPSA5RNM9IGFJF; Wolny Marcin, 2012, Postepy Biochem, V58, P245; Wong EY, 2004, J BIOL CHEM, V279, P55024, DOI 10.1074/jbc.M408886200; Yien YY, 2013, MOL CELL BIOL, V33, P4, DOI 10.1128/MCB.01058-12; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	36	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144977	10.1371/journal.pone.0144977	http://dx.doi.org/10.1371/journal.pone.0144977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675483	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700079
J	Mainini, F; Larsen, DS; Webster, GA; Young, SL; Eccles, MR				Mainini, Francesco; Larsen, David S.; Webster, Gill A.; Young, Sarah L.; Eccles, Michael R.			Bridging Small Molecules to Modified Bacterial Microparticles Using a Disulphide Linkage: MIS416 as a Cargo Delivery System	PLOS ONE			English	Article							RECOGNITION; RELEASE; SIRNA; PEG	MIS416 is an intact minimal cell wall skeleton derived from Proprionibacterium acnes that is phagocytosed by antigen presenting cells, including dendritic cells (DCs). This property allows MIS416 to be exploited as a vehicle for the delivery of peptide antigens or other molecules (for example, nucleic acids) to DCs. We previously showed that covalent (non-cleavable) conjugation of OVA, a model antigen derived from ovalbumin, to MIS416 enhanced immune responses in DCs in vivo, compared to unconjugated MIS416 and OVA. Intracellular trafficking promotes the lysosomal degradation of MIS416, leading to the destruction of MIS416 plus the associated cargos conjugated to MIS416. However, lysosomal degradation of cargo may not be desired for some MIS416 conjugates. Here we have investigated whether a cleavable linkage could facilitate release of the cargo in the cytoplasm of DCs to avoid lysosomal degradation. DCs were treated in vitro with disulfide-containing conjugates, and as hypothesised faster release of SIINFEKL peptide in the cytoplasm of DCs was observed with the inclusion of a disulfide bond between MIS416 and cargo. The inclusion of a cleavable disulfide bond in the conjugates did not significantly alter the amount of SIINFEKL antigens presented on MHC I molecules on DCs as compared with conjugates without a disulfide bond. However, the conjugates containing disulfide-linkages performed either slightly better (p<0.05) than, or the same as conjugates without a disulfide bond with respect to in vitro OT-1 T-cell proliferation induced by the presentation of SIINFEKL antigens on DCs, or DC activation studies, respectively. However, disulfide-containing conjugates were less effective than conjugates without a disulfide bond in in vivo cytotoxicity assays. In conclusion, inclusion of a disulfide bond in MIS416-peptide conjugates was associated with efficient release of peptides in the cytoplasm of DCs, an important consideration for MIS416-mediated delivery of degradation-sensitive cargoes. However, treatment of DCs with disulfide-containing conjugates did not significantly alter the presentation of peptide antigens on MHC class I molecules to T-cells, or greatly enhance antigen-associated T-cell proliferation in vitro.	[Mainini, Francesco; Young, Sarah L.; Eccles, Michael R.] Univ Otago, Dept Pathol, Dunedin, New Zealand; [Larsen, David S.] Univ Otago, Dept Chem, Dunedin, New Zealand; [Webster, Gill A.] Innate Immunotherapeut Ltd, Auckland, New Zealand; [Young, Sarah L.; Eccles, Michael R.] Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand	University of Otago; University of Otago; University of Auckland	Eccles, MR (corresponding author), Univ Otago, Dept Pathol, Dunedin, New Zealand.	michael.eccles@otago.ac.nz	Mainini, Francesco/AAN-1958-2020; Eccles, Michael Roger/AAF-7878-2020	Mainini, Francesco/0000-0001-7743-952X; Eccles, Michael Roger/0000-0002-6824-8761; Young, Sarah/0000-0003-0374-2221	Cancer Society of New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery [MWC14]; Otago Medical Research Foundation [AG303]; Innate Immunotherapeutics Limited	Cancer Society of New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery; Otago Medical Research Foundation; Innate Immunotherapeutics Limited	This research was supported by a Cancer Society of New Zealand (www.cancernz.org.nz) PhD Fellowship to FM, and grants from the Maurice Wilkins Centre for Molecular Biodiscovery (www.mauricewilkinscentre.org.nz; MWC14), and the Otago Medical Research Foundation (www.omrf.org.nz; AG303) to MRE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. With regard to the commercial affiliation of Innate Immunotherapeutics Limited, this organization provided support in the form of salary for the author [GAW], 270 Great King Street, Dunedin 9054, New Zealand Tel: +64 0 34797880; Fax: +64 3 479 7866, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all the authors are articulated in the 'author contributions section'.	Breunig M, 2008, J CONTROL RELEASE, V130, P57, DOI 10.1016/j.jconrel.2008.05.016; Chu TC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl388; Ferrand J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00344; Geng Q, 2012, BIOCONJUGATE CHEM, V23, P1200, DOI 10.1021/bc300020f; Girvan RC, 2011, VACCINE, V29, P545, DOI 10.1016/j.vaccine.2010.10.040; Gonciarz-Swiatek M, 2006, MOL IMMUNOL, V43, P1993, DOI 10.1016/j.molimm.2005.11.012; He XB, 2013, ACTA BIOCH BIOPH SIN, V45, P241, DOI 10.1093/abbs/gms122; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Kurihara A, 1999, CANCER RES, V59, P6159; Li CJ, 2012, J BIOTECHNOL, V162, P283, DOI 10.1016/j.jbiotec.2012.09.008; Lin C, 2009, EXPERT OPIN DRUG DEL, V6, P421, DOI [10.1517/17425240902878010, 10.1517/17425240902878010 ]; Liu ZY, 2013, BIOMATERIALS, V34, P3870, DOI 10.1016/j.biomaterials.2013.02.003; MYERS DE, 1989, J IMMUNOL METHODS, V121, P129, DOI 10.1016/0022-1759(89)90428-6; Namgung R, 2012, SMALL, V8, P3209, DOI 10.1002/smll.201200496; Ogawa K, 2013, PLOS ONE, V8; WEAVER CT, 1988, P NATL ACAD SCI USA, V85, P8181, DOI 10.1073/pnas.85.21.8181	16	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145403	10.1371/journal.pone.0145403	http://dx.doi.org/10.1371/journal.pone.0145403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695183	gold, Green Submitted, Green Published			2022-12-27	WOS:000367092500043
J	Plank, MW; Maltby, S; Tay, HL; Stewart, J; Eyers, F; Hansbro, PM; Foster, PS				Plank, Maximilian W. Z.; Maltby, Steven; Tay, Hock L.; Stewart, Jessica; Eyers, Fiona; Hansbro, Philip M.; Foster, Paul S.			MicroRNA Expression Is Altered in an Ovalbumin-Induced Asthma Model and Targeting miR-155 with Antagomirs Reveals Cellular Specificity	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GLUCOCORTICOID RECEPTOR-ALPHA; OBSTRUCTIVE PULMONARY-DISEASE; ALLERGIC AIRWAY INFLAMMATION; IN-VIVO; DOWN-REGULATION; CORTICOSTEROID RESISTANCE; SYNOVIAL FIBROBLASTS; RHEUMATOID-ARTHRITIS	MicroRNAs are post-transcriptional regulators of gene expression that are differentially regulated during development and in inflammatory diseases. A role for miRNAs in allergic asthma is emerging and further investigation is required to determine whether they may serve as potential therapeutic targets. We profiled miRNA expression in murine lungs from an ovalbumin-induced allergic airways disease model, and compared expression to animals receiving dexamethasone treatment and non-allergic controls. Our analysis identified 29 miRNAs that were significantly altered during allergic inflammation. Target prediction analysis revealed novel genes with altered expression in allergic airways disease and suggests synergistic miRNA regulation of target mRNAs. To assess the impacts of one induced miRNA on pathology, we targeted miR-155-5p using a specific antagomir. Antagomir administration successfully reduced miR-155-5p expression with high specificity, but failed to alter the disease phenotype. Interestingly, further investigation revealed that antagomir delivery has variable efficacy across different immune cell types, effectively targeting myeloid cell populations, but exhibiting poor uptake in lymphocytes. Our findings demonstrate that antagomir-based targeting of miRNA function in the lung is highly specific, but highlights cell-specificity as a key limitation to be considered for antagomir-based strategies as therapeutics.	[Plank, Maximilian W. Z.] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2300, Australia; Hunter Med Res Inst, Callaghan, NSW 2300, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Plank, MW (corresponding author), Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2300, Australia.	Maximilian.Plank@newcastle.edu.au; Paul.Foster@newcastle.edu.au	Hansbro, Phil/G-7486-2013; Foster, Paul/G-5057-2013	Hansbro, Phil/0000-0002-4741-3035; Barnes, Jessica/0000-0002-5386-4123; , Paul/0000-0002-0827-8299; Maltby, Steven/0000-0003-1240-5964	National Health and Medical Research Council; Canadian Institutes of Health Research; University of Newcastle	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Newcastle	PF received funding from the National Health and Medical Research Council. SM received funding from the Canadian Institutes of Health Research and the University of Newcastle.	Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Baillat D, 2009, MOL CELL BIOL, V29, P4144, DOI 10.1128/MCB.00380-09; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Collison A, 2011, J ALLERGY CLIN IMMUN, V128, P160, DOI 10.1016/j.jaci.2011.04.005; Collison A, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-29; Comer BS, 2015, AM J RESP CELL MOL, V52, P438, DOI 10.1165/rcmb.2014-0129OC; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Daubeuf F, 2013, J BIOL CHEM, V288, P11865, DOI 10.1074/jbc.M112.449348; Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Foster PS, 2013, IMMUNOL REV, V253, P198, DOI 10.1111/imr.12058; Fulci V, 2010, HUM IMMUNOL, V71, P206, DOI 10.1016/j.humimm.2009.11.008; Garbacki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016509; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Gonzalo JA, 2000, J IMMUNOL, V165, P499, DOI 10.4049/jimmunol.165.1.499; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Guan HB, 2013, EUR J IMMUNOL, V43, P104, DOI 10.1002/eji.201242702; Holt PG, 2009, ADV IMMUNOL, V104, P51, DOI 10.1016/S0065-2776(08)04003-0; Jiang Q, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-194; Kim SR, 2007, J IMMUNOL, V179, P6820, DOI 10.4049/jimmunol.179.10.6820; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Kumar R, 2012, CELL MICROBIOL, V14, P1620, DOI 10.1111/j.1462-5822.2012.01827.x; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Kwak YG, 2003, J CLIN INVEST, V111, P1083, DOI 10.1172/JCI200316440; Lazzaretti D, 2009, RNA, V15, P1059, DOI 10.1261/rna.1606309; Ledderose C, 2012, CRIT CARE MED, V40, P2745, DOI 10.1097/CCM.0b013e31825b8ebc; Lee KS, 2005, FASEB J, V19, P1033, DOI 10.1096/fj.04-3309fje; Lee KS, 2006, MOL PHARMACOL, V69, P1829, DOI 10.1124/mol.106.022228; Lee Y, 2011, DEV CELL, V21, P746, DOI 10.1016/j.devcel.2011.08.017; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Linnstaedt SD, 2010, J VIROL, V84, P11670, DOI 10.1128/JVI.01248-10; Liu SH, 2011, BIOCHEM BIOPH RES CO, V414, P618, DOI 10.1016/j.bbrc.2011.09.131; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; Lv M, 2012, LEUKEMIA, V26, P769, DOI 10.1038/leu.2011.273; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Makinde T, 2007, IMMUNOL CELL BIOL, V85, P348, DOI 10.1038/sj.icb.7100044; Malik R, 2008, J INVEST ALLERG CLIN, V18, P106; Malmhall C, 2014, J ALLERGY CLIN IMMUN, V133, P1429, DOI 10.1016/j.jaci.2013.11.008; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Neuhofer W, 2010, CURR GENOMICS, V11, P584, DOI 10.2174/138920210793360961; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Oertli M, 2011, J IMMUNOL, V187, P3578, DOI 10.4049/jimmunol.1101772; Okoye IS, 2014, P NATL ACAD SCI USA, V111, pE3081, DOI 10.1073/pnas.1406322111; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Plank M, 2013, CLIN EXP ALLERGY, V43, P981, DOI [10.1111/cea.12135, 10.1111/cea.12170]; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Qin HB, 2012, INFLAMMATION, V35, P1595, DOI 10.1007/s10753-012-9474-1; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Riester A, 2012, ENDOCRINOLOGY, V153, P212, DOI 10.1210/en.2011-1285; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Solberg OD, 2012, AM J RESP CRIT CARE, V186, P965, DOI 10.1164/rccm.201201-0027OC; Sonkoly E, 2010, J ALLERGY CLIN IMMUN, V126, P581, DOI 10.1016/j.jaci.2010.05.045; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Suojalehto H, 2013, INT FORUM ALLERGY RH, V3, P612, DOI 10.1002/alr.21179; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tolgyesi G, 2009, INT IMMUNOL, V21, P967, DOI 10.1093/intimm/dxp063; Trenkmann M, 2013, ARTHRITIS RHEUM-US, V65, P916, DOI 10.1002/art.37834; Uchida S, 2008, EUR J NEUROSCI, V27, P2250, DOI 10.1111/j.1460-9568.2008.06218.x; van Solingen C, 2009, J CELL MOL MED, V13, P1577, DOI 10.1111/j.1582-4934.2008.00613.x; Vo NK, 2010, P NATL ACAD SCI USA, V107, P19231, DOI 10.1073/pnas.1013162107; Vreugdenhil E, 2009, ENDOCRINOLOGY, V150, P2220, DOI 10.1210/en.2008-1335; Wechsler ME, 2014, AM J MED, V127, P1049, DOI 10.1016/j.amjmed.2014.05.006; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Wilson JA, 2014, CURR OPIN VIROL, V7, P11, DOI 10.1016/j.coviro.2014.03.005; Witkos TM, 2011, CURR MOL MED, V11, P93; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Yang M, 2010, CLIN EXP ALLERGY, V40, P163, DOI 10.1111/j.1365-2222.2009.03393.x; Yin QY, 2010, J VIROL, V84, P6318, DOI 10.1128/JVI.00635-10; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009; Zwiers A, 2012, J IMMUNOL, V188, P1573, DOI 10.4049/jimmunol.1101494	93	51	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144810	10.1371/journal.pone.0144810	http://dx.doi.org/10.1371/journal.pone.0144810			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26693910	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092500013
J	Dasgupta, S; Fishman, MA; Mahallati, H; Castro, LM; Tashima, AK; Ferro, ES; Fricker, LD				Dasgupta, Sayani; Fishman, Michael A.; Mahallati, Hana; Castro, Leandro M.; Tashima, Alexandre K.; Ferro, Emer S.; Fricker, Lloyd D.			Reduced Levels of Proteasome Products in a Mouse Striatal Cell Model of Huntington's Disease	PLOS ONE			English	Article							FACTOR-KAPPA-B; INHIBITOR PS-341; QUANTITATIVE PEPTIDOMICS; INTRACELLULAR PEPTIDES; EXPANDED POLYGLUTAMINE; INCLUSION-BODIES; SYSTEM; DEGRADATION; ACTIVATION; NUCLEAR	Huntington's disease is the result of a long polyglutamine tract in the gene encoding huntingtin protein, which in turn causes a large number of cellular changes and ultimately results in neurodegeneration of striatal neurons. Although many theories have been proposed, the precise mechanism by which the polyglutamine expansion causes cellular changes is not certain. Some evidence supports the hypothesis that the long polyglutamine tract inhibits the proteasome, a multiprotein complex involved in protein degradation. However, other studies report normal proteasome function in cells expressing long polyglutamine tracts. The controversy may be due to the methods used to examine proteasome activity in each of the previous studies. In the present study, we measured proteasome function by examining levels of endogenous peptides that are products of proteasome cleavage. Peptide levels were compared among mouse striatal cell lines expressing either 7 glutamines (STHdh(Q7/Q7)) or 111 glutamines in the huntingtin protein, either heterozygous (STHdh(Q7/Q111)) or homozygous (STHdh(Q111/Q111)). Both of the cell lines expressing huntingtin with 111 glutamines showed a large reduction in nearly all of the peptides detected in the cells, relative to levels of these peptides in cells homozygous for 7 glutamines. Treatment of STHdh(Q7/Q7) cells with proteasome inhibitors epoxomicin or bortezomib also caused a large reduction in most of these peptides, suggesting that they are products of proteasome-mediated cleavage of cellular proteins. Taken together, these results support the hypothesis that proteasome function is impaired by the expression of huntingtin protein containing long polyglutamine tracts.	[Dasgupta, Sayani; Fishman, Michael A.; Mahallati, Hana; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Castro, Leandro M.] Sao Paulo State Univ UNESP, BR-11330900 Sao Vicente, SP, Brazil; [Tashima, Alexandre K.] Univ Fed Sao Paulo, Dept Biochem, Escola Paulista Med, BR-04023901 Sao Paulo, SP, Brazil; [Ferro, Emer S.] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, BR-05508000 Sao Paulo, SP, Brazil; [Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lloyd.fricker@einstein.yu.edu	Castro, Leandro/O-6762-2019; Tashima, Alexandre Keiji/B-8228-2015; Ferro, Emer S/D-3908-2012; Castro, Leandro/ABI-5520-2020; Castro, Leandro M/E-5654-2014	Castro, Leandro/0000-0002-7156-2006; Tashima, Alexandre Keiji/0000-0002-1332-8895; Ferro, Emer S/0000-0003-1651-9192; Castro, Leandro/0000-0002-7156-2006; Dasgupta, Sayani/0000-0003-4782-7956	US National Institutes of Health [R01-DA004494]; Financiadora de Estudos e Projetos (FINEP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/19321-9]; Brazilian National Research Council (CNPq) [400944/2014-6, 445363/2014-2]; CNPq research fellowship [303135/2011-5]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM104547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq research fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was primarily funded by a grant from the US National Institutes of Health R01-DA004494 to LDF. Mass spectrometry was supported by grants from Financiadora de Estudos e Projetos (FINEP) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2012/19321-9 to AKT), and Brazilian National Research Council (CNPq) grants 400944/2014-6 and 445363/2014-2 to ESF. ESF is supported by a CNPq research fellowship (303135/2011-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arastu-Kapur S, 2011, CLIN CANCER RES, V17, P2734, DOI 10.1158/1078-0432.CCR-10-1950; Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Churchill EN, 2009, TRENDS ENDOCRIN MET, V20, P25, DOI 10.1016/j.tem.2008.10.002; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Crawford LJA, 2006, CANCER RES, V66, P6379, DOI 10.1158/0008-5472.CAN-06-0605; Cunha FM, 2008, J BIOL CHEM, V283, P24448, DOI 10.1074/jbc.M801252200; Cusack JC, 2001, CANCER RES, V61, P3535; Das E, 2015, DELAYED CELL CYCLE P; Dasgupta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103604; de Araujo CB, 2014, J BIOL CHEM, V289, P16711, DOI 10.1074/jbc.M113.537118; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Diaz-Hernandez M, 2006, J NEUROCHEM, V98, P1585, DOI 10.1111/j.1471-4159.2006.03968.x; Ding QX, 2002, J BIOL CHEM, V277, P13935, DOI 10.1074/jbc.M107706200; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Ferro E. S., 2014, EUPA OPEN PROTEOMICS, V3, P143, DOI [10.1016/j.euprot.2014.02.009, DOI 10.1016/J.EUPROT.2014.02.009]; Fricker LD, 2006, MASS SPECTROM REV, V25, P327, DOI 10.1002/mas.20079; Fricker LD, 2012, J PROTEOME RES, V11, P1981, DOI 10.1021/pr2012076; Fricker LD, 2010, MOL BIOSYST, V6, P1355, DOI 10.1039/c003317k; Gelman JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053263; Gelman JS, 2012, METHODS MOL BIOL, V829, P487, DOI 10.1007/978-1-61779-458-2_31; Gelman JS, 2011, J PROTEOME RES, V10, P1583, DOI 10.1021/pr100952f; Ghatak S, 2015, BIOCHEM BIOPH RES CO, V459, P509, DOI 10.1016/j.bbrc.2015.02.137; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Grisham MB, 1999, METHOD ENZYMOL, V300, P345; Groner B, 2012, BIOENGINEERED, V3, P320, DOI 10.4161/bioe.21272; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Hideshima T, 2001, CANCER RES, V61, P3071; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Hunter JM, 2007, J NEUROSCI RES, V85, P1774, DOI 10.1002/jnr.21287; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Juenemann K, 2013, J BIOL CHEM, V288, P27068, DOI 10.1074/jbc.M113.486076; Kalogeris TJ, 1999, AM J PHYSIOL-CELL PH, V276, pC856, DOI 10.1152/ajpcell.1999.276.4.C856; Khan LA, 2006, J NEUROCHEM, V98, P576, DOI 10.1111/j.1471-4159.2006.03895.x; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kniepert A, 2014, TRENDS BIOCHEM SCI, V39, P17, DOI 10.1016/j.tibs.2013.10.004; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Labbadia J, 2013, TRENDS BIOCHEM SCI, V38, P378, DOI 10.1016/j.tibs.2013.05.003; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; London N, 2013, CURR OPIN STRUC BIOL, V23, P894, DOI 10.1016/j.sbi.2013.07.006; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; Maynard CJ, 2009, P NATL ACAD SCI USA, V106, P13986, DOI 10.1073/pnas.0906463106; Michalik A, 2004, NEUROBIOL DIS, V16, P202, DOI 10.1016/j.nbd.2003.12.020; Milner E, 2013, MOL CELL PROTEOMICS, V12, P1853, DOI 10.1074/mcp.M112.026013; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Navon A, 2009, J BIOL CHEM, V284, P33713, DOI 10.1074/jbc.R109.018481; Ortega Z, 2007, CELL MOL LIFE SCI, V64, P2245, DOI 10.1007/s00018-007-7222-8; Ortega Z, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmol.2014.00077, 10.3389/fnmo1.2014.00077]; Pickering AM, 2012, PROG MOL BIOL TRANSL, V109, P227, DOI 10.1016/B978-0-12-397863-9.00006-7; Pickering AM, 2012, ARCH BIOCHEM BIOPHYS, V523, P181, DOI 10.1016/j.abb.2012.04.018; Plotkin JL, 2015, CURR OPIN NEUROBIOL, V33, P53, DOI 10.1016/j.conb.2015.01.020; Quintanilla RA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-45; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rousseau E, 2009, J BIOL CHEM, V284, P1917, DOI 10.1074/jbc.M806256200; Rubinstein M, 2009, BIOPOLYMERS, V91, P505, DOI 10.1002/bip.21164; Russo LC, 2012, PROTEOMICS, V12, P2641, DOI 10.1002/pmic.201200032; Schipper-Krom S, 2014, FEBS LETT, V588, P151, DOI 10.1016/j.febslet.2013.11.023; Schipper-Krom S, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/837015; Schrader M., 2014, EUPA OPEN PROTEOM, V3, P171, DOI [10.1016/j.euprot.2014.02.014, DOI 10.1016/J.EUPROT.2014.02.014]; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; Sillerud LO, 2005, CURR PROTEIN PEPT SC, V6, P151, DOI 10.2174/1389203053545462; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Swanson CJ, 2014, J BIOL CHEM, V289, P25460, DOI 10.1074/jbc.R114.583906; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Wardman J, 2011, METHODS MOL BIOL, V768, P307, DOI 10.1007/978-1-61779-204-5_17; Zhang RJ, 2002, ANAL CHEM, V74, P3662, DOI 10.1021/ac025614w	77	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145333	10.1371/journal.pone.0145333	http://dx.doi.org/10.1371/journal.pone.0145333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691307	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300059
J	Cheatham, MA; Edge, RM; Homma, K; Leserman, EL; Dallos, P; Zheng, J				Cheatham, Mary Ann; Edge, Roxanne M.; Homma, Kazuaki; Leserman, Emily L.; Dallos, Peter; Zheng, Jing			Prestin-Dependence of Outer Hair Cell Survival and Partial Rescue of Outer Hair Cell Loss in Prestin(V499G/Y501H) Knockin Mice	PLOS ONE			English	Article							INDUCED HEARING-LOSS; DEVELOPMENTAL EXPRESSION; COCHLEAR FUNCTION; MOTOR PROTEIN; D-METHIONINE; MOUSE; ELECTROMOTILITY; THRESHOLD; OTOTOXICITY; MECHANISMS	A knockin (KI) mouse expressing mutated prestin(V499G/Y501H) (499 prestin) was created to study cochlear amplification. Recordings from isolated outer hair cells (OHC) in this mutant showed vastly reduced electromotility and, as a consequence, reduced hearing sensitivity. Although 499 prestin OHCs were normal in stiffness and longer than OHCs lacking prestin, accelerated OHC death was unexpectedly observed relative to that documented in prestin knockout (KO) mice. These observations imply an additional role of prestin in OHC maintenance besides its known requirement for mammalian cochlear amplification. In order to gain mechanistic insights into prestin-associated OHC loss, we implemented several interventions to improve survival. First, 499 prestin KI's were backcrossed to Bak KO mice, which lack the mitochondrial pro-apoptotic gene Bak. Because oxidative stress is implicated in OHC death, another group of 499 prestin KI mice was fed the antioxidant diet, Protandim. 499 KI mice were also backcrossed onto the FVB murine strain, which retains excellent high-frequency hearing well into adulthood, to reduce the compounding effect of age-related hearing loss associated with the original 499 prestin KIs. Finally, a compound heterozygous (chet) mouse expressing one copy of 499 prestin and one copy of KO prestin was also created to reduce quantities of 499 prestin protein. Results show reduction in OHC death in chets, and in 499 prestin KIs on the FVB background, but only a slight improvement in OHC survival for mice receiving Protandim. We also report that improved OHC survival in 499 prestin KIs had little effect on hearing phenotype, reaffirming the original contention about the essential role of prestin's motor function in cochlear amplification.	[Cheatham, Mary Ann; Edge, Roxanne M.; Leserman, Emily L.; Dallos, Peter] Northwestern Univ, Knowles Hearing Ctr, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA; [Homma, Kazuaki; Zheng, Jing] Northwestern Univ, Feinberg Sch Med, Knowles Hearing Ctr, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA; [Dallos, Peter] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University	Cheatham, MA (corresponding author), Northwestern Univ, Knowles Hearing Ctr, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA.	m-cheatham@northwestern.edu	Dallos, Peter/Q-9360-2019; Zheng, Jing/F-5273-2017	Dallos, Peter/0000-0002-9731-6591; Zheng, Jing/0000-0003-2790-1143	Knowles Hearing Center; NIDCD [DC000089, DC010633, DC011813]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [RC1DC010633, R01DC000089, R56DC011813, R01DC011813] Funding Source: NIH RePORTER	Knowles Hearing Center; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Knowles Hearing Center, and NIDCD grants DC000089, DC010633 and DC011813. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Work supported by The Hugh Knowles Center and NIDCD grants DC000089 and DC010633 and DC011813.	Abe T, 2007, J MEMBRANE BIOL, V215, P49, DOI 10.1007/s00232-007-9004-5; Campbell KCM, 2007, HEARING RES, V226, P92, DOI 10.1016/j.heares.2006.11.012; Cheatham M, 2012, ABS ASS RES OTOLARYN, V48; Cheatham MA, 2007, AUDIOL NEURO-OTOL, V12, P378, DOI 10.1159/000106481; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; Cheatham MA, 2005, J PHYSIOL-LONDON, V569, P229, DOI 10.1113/jphysiol.2005.093518; Cheatham MA, 2014, J NEUROSCI, V34, P10325, DOI 10.1523/JNEUROSCI.1256-14.2014; Coffin AB, 2013, JARO-J ASSOC RES OTO, V14, P645, DOI 10.1007/s10162-013-0404-1; Corbacella E, 2004, HEARING RES, V197, P11, DOI 10.1016/j.heares.2004.03.012; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Fujimoto C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/582849; Furness DN, 2015, CELL TISSUE RES, V361, P387, DOI 10.1007/s00441-015-2113-z; Gao JG, 2007, P NATL ACAD SCI USA, V104, P12542, DOI 10.1073/pnas.0700356104; Gao SS, 2014, J NEUROPHYSIOL, V112, P1192, DOI 10.1152/jn.00306.2014; HE DZZ, 1994, HEARING RES, V78, P77, DOI 10.1016/0378-5955(94)90046-9; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Homma K, 2013, J BIOL CHEM, V288, P2452, DOI 10.1074/jbc.M112.411579; Huynh HM, 2006, ABS ASSOC RES OTOLAR, V142; KIANG NYS, 1986, HEARING RES, V22, P171; Le Prell CG, 2007, FREE RADICAL BIO MED, V42, P1454, DOI 10.1016/j.freeradbiomed.2007.02.008; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Liu JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005284; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Rabbitt RD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000444; ROBERTSON D, 1979, PFLUG ARCH EUR J PHY, V380, P7, DOI 10.1007/BF00582605; RYAN A, 1975, NATURE, V253, P44, DOI 10.1038/253044a0; Sha SH, 2000, HEARING RES, V142, P34, DOI 10.1016/S0378-5955(00)00003-4; Sodhi JS, 2004, J MOL BIOL, V342, P307, DOI 10.1016/j.jmb.2004.07.019; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Souter M, 1995, HEARING RES, V91, P43, DOI 10.1016/0378-5955(95)00163-8; Viberg A, 2004, HEARING RES, V197, P1, DOI 10.1016/j.heares.2004.04.016; Weddell TD, 2011, CURR BIOL, V21, pR682, DOI 10.1016/j.cub.2011.08.001; Wei X, 2005, NEUROSCIENCE, V131, P513, DOI 10.1016/j.neuroscience.2004.11.014; Wilson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108276; Wong ACY, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00058; Wu XD, 2004, MOL BRAIN RES, V126, P30, DOI 10.1016/j.molbrainres.2004.03.020; Yamashita T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045453; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2005, J CELL SCI, V118, P2987, DOI 10.1242/jcs.02431; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	42	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145428	10.1371/journal.pone.0145428	http://dx.doi.org/10.1371/journal.pone.0145428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682723	Green Submitted, gold, Green Published			2022-12-27	WOS:000366725800075
J	Curnoe, D; Ji, XP; Liu, W; Bao, ZD; Tacon, PSC; Ren, L				Curnoe, Darren; Ji, Xueping; Liu, Wu; Bao, Zhende; Tacon, Paul S. C.; Ren, Liang			A Hominin Femur with Archaic Affinities from the Late Pleistocene of Southwest China	PLOS ONE			English	Article							MODERN HUMANS; EARLY HOMO; YUNNAN; SIZE; MORPHOLOGY; SEQUENCE; HISTORY; GENOME; SITE; BODY	The number of Late Pleistocene hominin species and the timing of their extinction are issues receiving renewed attention following genomic evidence for interbreeding between the ancestors of some living humans and archaic taxa. Yet, major gaps in the fossil record and uncertainties surrounding the age of key fossils have meant that these questions remain poorly understood. Here we describe and compare a highly unusual femur from Late Pleistocene sediments at Maludong (Yunnan), Southwest China, recovered along with cranial remains that exhibit a mixture of anatomically modern human and archaic traits. Our studies show that the Maludong femur has affinities to archaic hominins, especially Lower Pleistocene femora. However, the scarcity of later Middle and Late Pleistocene archaic remains in East Asia makes an assessment of systematically relevant character states difficult, warranting caution in assigning the specimen to a species at this time. The Maludong fossil probably samples an archaic population that survived until around 14,000 years ago in the biogeographically complex region of Southwest China.	[Curnoe, Darren] Univ New S Wales, Sch Biol Earth & Environm Sci, Palaeontol Geobiol & Earth Arch Res Ctr, Sydney, NSW, Australia; [Ji, Xueping] Yunnan Inst Cultural Rel & Archaeol, Kunming, Yunnan, Peoples R China; [Liu, Wu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Bao, Zhende; Ren, Liang] Mengzi Inst Cultural Rel, Mengzi, Yunnan, Peoples R China; [Tacon, Paul S. C.] Griffith Univ, Sch Humanities, Pl Evolut & Rock Art Heritage Unit, Nathan, Qld 4111, Australia	University of New South Wales Sydney; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Griffith University	Curnoe, D (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Palaeontol Geobiol & Earth Arch Res Ctr, Sydney, NSW, Australia.	d.curnoe@unsw.edu.au; jxpchina@foxmail.com		Curnoe, Darren/0000-0001-8622-4141; Tacon, Paul/0000-0002-0280-4366	Australian Research Council [DP0877603, FT120100168]; Yunnan Institute of Cultural Relics and Archaeology [A-201301]; University of New South Wales; Griffith University	Australian Research Council(Australian Research Council); Yunnan Institute of Cultural Relics and Archaeology; University of New South Wales; Griffith University(Griffith University)	The authors wish to thank the Australian Research Council (grants DP0877603 & FT120100168), the Yunnan Institute of Cultural Relics and Archaeology (Key Project Grant A-201301), and the University of New South Wales and Griffith University for funding this research.	Argue D, 2009, J HUM EVOL, V57, P623, DOI 10.1016/j.jhevol.2009.05.002; Barnosky AD, 2008, P NATL ACAD SCI USA, V105, P11543, DOI 10.1073/pnas.0801918105; Barton RNE, 2009, QUATERNARY SCI REV, V28, P1914, DOI 10.1016/j.quascirev.2009.03.010; Bromham L, 2007, BIOL LETTERS, V3, P398, DOI 10.1098/rsbl.2007.0113; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Cooper A, 2013, SCIENCE, V342, P321, DOI 10.1126/science.1244869; Curnoe D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12408; Curnoe D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031918; Gordon AD, 2008, P NATL ACAD SCI USA, V105, P4650, DOI 10.1073/pnas.0710041105; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; GRINE FE, 1995, AM J PHYS ANTHROPOL, V97, P151, DOI 10.1002/ajpa.1330970207; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Holt BM, 2003, AM J PHYS ANTHROPOL, V122, P200, DOI 10.1002/ajpa.10256; Ji XP, 2013, CHINESE SCI BULL, V58, P4472, DOI 10.1007/s11434-013-6026-5; Jungers WL, 2009, J HUM EVOL, V57, P538, DOI 10.1016/j.jhevol.2008.08.014; KENNEDY GE, 1983, J HUM EVOL, V12, P587, DOI 10.1016/S0047-2484(83)80001-3; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krzywinski M, 2014, NAT METHODS, V11, P119, DOI 10.1038/nmeth.2813; Li R, 2015, SCI REP-UK, V5, DOI 10.1038/srep09396; LI XW, 1986, J BIOGEOGR, V13, P367, DOI 10.2307/2844964; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; Martin R., 1928, LEHRBUCH ANTHR; MCHENRY HM, 1991, AM J PHYS ANTHROPOL, V85, P149, DOI 10.1002/ajpa.1330850204; McHenry HM, 2000, ANNU REV ANTHROPOL, V29, P125, DOI 10.1146/annurev.anthro.29.1.125; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Pinhasi R, 2011, P NATL ACAD SCI USA, V108, P8611, DOI 10.1073/pnas.1018938108; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Roberts RG, 2009, J HUM EVOL, V57, P484, DOI 10.1016/j.jhevol.2009.01.003; Ruff CB, 1999, AM J PHYS ANTHROPOL, V109, P509, DOI 10.1002/(SICI)1096-8644(199908)109:4<509::AID-AJPA7>3.0.CO;2-X; Ruff CB, 2000, J HUM EVOL, V38, P269, DOI 10.1006/jhev.1999.0322; RUFF CB, 1995, AM J PHYS ANTHROPOL, V98, P527, DOI 10.1002/ajpa.1330980412; Ruff CB, 2015, J HUM EVOL, V80, P147, DOI 10.1016/j.jhevol.2014.12.004; Shen GJ, 2014, QUAT GEOCHRONOL, V23, P56, DOI 10.1016/j.quageo.2014.06.004; Stewart JR, 2012, SCIENCE, V335, P1317, DOI 10.1126/science.1215627; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; TRINKAUS E, 1984, AM J PHYS ANTHROPOL, V64, P137, DOI 10.1002/ajpa.1330640206; TRINKAUS E, 1976, Zeitschrift fuer Morphologie und Anthropologie, V67, P291; Trinkaus E, 2007, P NATL ACAD SCI USA, V104, P7367, DOI 10.1073/pnas.0702214104; Trinkaus E, 2006, CURR ANTHROPOL, V47, P597, DOI 10.1086/504165; Trinkaus Erik, 2012, Paleoanthropology, V2012, P13; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Weston EM, 2009, NATURE, V459, P85, DOI 10.1038/nature07922; WOLPOFF MH, 1978, AM J PHYS ANTHROPOL, V48, P143, DOI 10.1002/ajpa.1330480203; Wu X.Z., 1995, HUMAN EVOLUTION CHIN; Wu XJ, 2014, P NATL ACAD SCI USA, V111, P10509, DOI 10.1073/pnas.1410735111; Wu XJ, 2014, CR PALEVOL, V13, P333, DOI 10.1016/j.crpv.2013.10.002; Wu XZ, 2004, QUATERN INT, V117, P131, DOI 10.1016/S1040-6182(03)00123-X; Xing S, 2015, AM J PHYS ANTHROPOL, V156, P224, DOI 10.1002/ajpa.22641; Zhu H, 2006, BIOTROPICA, V38, P310, DOI 10.1111/j.1744-7429.2006.00147.x	52	15	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0143332	10.1371/journal.pone.0143332	http://dx.doi.org/10.1371/journal.pone.0143332			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678851	gold, Green Published, Green Submitted			2022-12-27	WOS:000366723400004
J	Niu, YZ; Pan, DB; Shi, DF; Bai, QF; Liu, HX; Yao, XJ				Niu, Yuzhen; Pan, Dabo; Shi, Danfeng; Bai, Qifeng; Liu, Huanxiang; Yao, Xiaojun			Influence of Chirality of Crizotinib on Its MTH1 Protein Inhibitory Activity: Insight from Molecular Dynamics Simulations and Binding Free Energy Calculations	PLOS ONE			English	Article							COMPUTER-SIMULATIONS; RESP METHODOLOGY; FORCE-FIELD; MMGBSA; DECOMPOSITION; CONVERGENCE; COMPLEXES; MECHANICS; STRATEGY; MODEL	As a promising target for the treatment of lung cancer, the MutT Homolog 1 (MTH1) protein can be inhibited by crizotinib. A recent work shows that the inhibitory potency of (S)-crizotinib against MTH1 is about 20 times over that of (R)-crizotinib. But the detailed molecular mechanism remains unclear. In this study, molecular dynamics (MD) simulations and free energy calculations were used to elucidate the mechanism about the effect of chirality of crizotinib on the inhibitory activity against MTH1. The binding free energy of (S)-crizotinib predicted by the Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) and Adaptive biasing force (ABF) methodologies is much lower than that of (R)-crizotinib, which is consistent with the experimental data. The analysis of the individual energy terms suggests that the van der Waals interactions are important for distinguishing the binding of (S)crizotinib and (R)-crizotinib. The binding free energy decomposition analysis illustrated that residues Tyr7, Phe27, Phe72 and Trp117 were important for the selective binding of (S)-crizotinib to MTH1. The adaptive biasing force (ABF) method was further employed to elucidate the unbinding process of (S)-crizotinib and (R)-crizotinib from the binding pocket of MTH1. ABF simulation results suggest that the reaction coordinates of the (S)-crizotinib from the binding pocket is different from (R)-crizotinib. The results from our study can reveal the details about the effect of chirality on the inhibition activity of crizotinib to MTH1 and provide valuable information for the design of more potent inhibitors.	[Niu, Yuzhen; Pan, Dabo; Shi, Danfeng; Bai, Qifeng; Yao, Xiaojun] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Niu, Yuzhen; Pan, Dabo; Shi, Danfeng; Bai, Qifeng; Yao, Xiaojun] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China; [Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Yao, Xiaojun] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China; [Liu, Huanxiang] Separating Sci Inst Lanzhou, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Lanzhou University	Yao, XJ (corresponding author), Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.	xjyao@lzu.edu.cn	Bai, Qifeng/A-2950-2019	Bai, Qifeng/0000-0001-7296-6187; Liu, Huanxiang/0000-0002-9284-3667	National Natural Science Foundation of China [21475054]; Fundamental Research Funds for the Central Universities [lzujbky-2014-191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 21475054) and the Fundamental Research Funds for the Central Universities (Grant No. lzujbky-2014-191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (Grant No. 21475054) and the Fundamental Research Funds for the Central Universities (Grant No. lzujbky-2014-191).	Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bello M, 2014, BIOPOLYMERS, V101, P1010, DOI 10.1002/bip.22483; Case D.A., 2002, RIGIDITY THEO APP FU, P329; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CASE DA, 1994, CURR OPIN STRUC BIOL, V4, P285, DOI 10.1016/S0959-440X(94)90321-2; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darve E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829861; Deng YQ, 2009, J PHYS CHEM B, V113, P2234, DOI 10.1021/jp807701h; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Faller CE, 2013, J PHYS CHEM B, V117, P518, DOI 10.1021/jp309741j; Fox T, 1998, J PHYS CHEM B, V102, P8070, DOI 10.1021/jp9717655; Frisch G. W. T. M. J., 2009, GAUSSIAN 09; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Gaillard T, 2014, J COMPUT CHEM, V35, P1371, DOI 10.1002/jcc.23637; GEORGE P, 1976, TETRAHEDRON, V32, P317, DOI 10.1016/0040-4020(76)80043-9; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Gumbart JC, 2013, J CHEM THEORY COMPUT, V9, P794, DOI 10.1021/ct3008099; Hou TJ, 2008, J MOL BIOL, V376, P1201, DOI 10.1016/j.jmb.2007.12.054; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kennedy CH, 2003, FREE RADICAL BIO MED, V34, P1447, DOI 10.1016/S0891-5849(03)00176-X; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Martin HSC, 2014, J COMPUT CHEM, V35, P692, DOI 10.1002/jcc.23525; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Patel A, 2015, ONCOGENE, V34, P2586, DOI 10.1038/onc.2014.195; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; prime, 2008, PRIM VERS 2 0; Rai Priyamvada, 2012, Small GTPases, V3, P120, DOI 10.4161/sgtp.19556; Rodriguez-Gomez D, 2004, J CHEM PHYS, V120, P3563, DOI 10.1063/1.1642607; Romo TD, 2011, J CHEM THEORY COMPUT, V7, P2464, DOI 10.1021/ct2002754; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Srivastava HK, 2013, J BIOMOL STRUCT DYN, V31, P522, DOI 10.1080/07391102.2012.703071; Sun H., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1007/S00704-013-1033-7; Sun HY, 2014, PHYS CHEM CHEM PHYS, V16, P16719, DOI 10.1039/c4cp01388c; Sun HY, 2013, J CHEM INF MODEL, V53, P2376, DOI 10.1021/ci400188q; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Svensson LM, 2011, FEBS LETT, V585, P2617, DOI 10.1016/j.febslet.2011.07.017; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; Ylilauri M, 2013, J CHEM INF MODEL, V53, P2626, DOI 10.1021/ci4002475	48	17	18	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145219	10.1371/journal.pone.0145219	http://dx.doi.org/10.1371/journal.pone.0145219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26677850	gold, Green Submitted, Green Published			2022-12-27	WOS:000366723400057
J	Paris, RM; Petrovas, C; Ferrando-Martinez, S; Moysi, E; Boswell, KL; Archer, E; Yamamoto, T; Ambrozak, D; Casazza, JP; Haubrich, R; Connors, M; Ake, J; Kim, JH; Koup, RA				Paris, Robert M.; Petrovas, Constantinos; Ferrando-Martinez, Sara; Moysi, Eirini; Boswell, Kristin L.; Archer, Eva; Yamamoto, Takuya; Ambrozak, David; Casazza, Joseph P.; Haubrich, Richard; Connors, Mark; Ake, Julie; Kim, Jerome H.; Koup, Richard A.			Selective Loss of Early Differentiated, Highly Functional PD1(high) CD4 T Cells with HIV Progression	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; DISEASE PROGRESSION; SPARING REGIMENS; TELOMERE LENGTH; IN-VIVO; PD-1; EXHAUSTION; CTLA-4; LYMPHOCYTES; DYSFUNCTION	The role of PD-1 expression on CD4 T cells during HIV infection is not well understood. Here, we describe the differential expression of PD-1 in CD127(high) CD4 T cells within the early/intermediate differentiated (EI) (CD27(high)CD45RA(low)) T cell population among uninfected and HIV-infected subjects, with higher expression associated with decreased viral replication (HIV-1 viral load). A significant loss of circulating PD-1(high)CTLA-4(low) CD4 T cells was found specifically in the CD127(high)CD27(high)CD45RA(low) compartment, while initiation of antiretroviral treatment, particularly in subjects with advanced disease, reversed these dynamics. Increased HIV-1 Gag DNA was also found in PD-1(high) compared to PD-1(low) ED CD4 T cells. In line with an increased susceptibility to HIV infection, PD-1 expression in this CD4 T cell subset was associated with increased activation and expression of the HIV co-receptor, CCR5. Rather than exhaustion, this population produced more IFN-g, MIP1-a, IL-4, IL-10, and IL-17a compared to PD-1(low) EI CD4 T cells. In line with our previous findings, PD-1(high) EI CD4 T cells were also characterized by a high expression of CCR7, CXCR5 and CCR6, a phenotype associated with increased in vitro B cell help. Our data show that expression of PD-1 on early-differentiated CD4 T cells may represent a population that is highly functional, more susceptible to HIV infection and selectively lost in chronic HIV infection.	[Paris, Robert M.; Petrovas, Constantinos; Ferrando-Martinez, Sara; Moysi, Eirini; Boswell, Kristin L.; Archer, Eva; Yamamoto, Takuya; Ambrozak, David; Casazza, Joseph P.; Koup, Richard A.] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Moysi, Eirini] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Paris, Robert M.; Ake, Julie] US Mil HIV Res Program, Silver Spring, MD USA; [Haubrich, Richard] Univ Calif San Diego, Div Infect Dis, Antiviral Res Ctr, San Diego, CA 92103 USA; [Connors, Mark] NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Miami; Walter Reed Army Institute of Research (WRAIR); University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); International Vaccine Institute	Petrovas, C (corresponding author), NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	petrovasc@mail.nih.gov	Yamamoto, Takuya/L-2642-2013	Yamamoto, Takuya/0000-0003-3753-1211; Moysi, Eirini/0000-0002-2070-2902	Intramural Research Program of the Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health [AI064086]; University of California San Diego Center for AIDS Research [AI36214]; San Diego AIDS Clinical Trial Group [CTU AI69432]; U.S. Army Medical Research and Material Command (USAMRMC) [Y1-AI-2642-12]; National Institutes of Allergy and Infectious Diseases [Y1-AI-2642-12]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI064086, U01AI069432, ZIAAI001090, UM1AI069432, ZIAAI000855, N01AI002642, P30AI036214] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health; University of California San Diego Center for AIDS Research; San Diego AIDS Clinical Trial Group; U.S. Army Medical Research and Material Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health (AI064086; RH), the University of California San Diego Center for AIDS Research (AI36214; RH), and the San Diego AIDS Clinical Trial Group (CTU AI69432; RH). The work was also supported in part by an Interagency Agreement Y1-AI-2642-12 between the U.S. Army Medical Research and Material Command (USAMRMC) and the National Institutes of Allergy and Infectious Diseases and by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD).	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Birx DL, 2000, J INFECT DIS, V181, P881, DOI 10.1086/315308; Boswell KL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003853; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Colle JH, 2006, JAIDS-J ACQ IMM DEF, V42, P277, DOI 10.1097/01.qai.0000214823.11034.4e; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Hathcock KS, 2003, J IMMUNOL, V170, P147, DOI 10.4049/jimmunol.170.1.147; Haubrich RH, 2009, AIDS, V23, P1109, DOI 10.1097/QAD.0b013e32832b4377; Hong JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060186; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kinter AL, 2008, J IMMUNOL, V181, P6738, DOI 10.4049/jimmunol.181.10.6738; Klatt NR, 2010, CURR OPIN HIV AIDS, V5, P135, DOI 10.1097/COH.0b013e3283364846; Kulpa DA, 2013, SEMIN IMMUNOL, V25, P219, DOI 10.1016/j.smim.2013.02.002; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Perreau M, 2012, J EXP MED; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Salek-Ardakani S, 2013, NAT IMMUNOL, V14, P531, DOI 10.1038/ni.2619; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Weng NP, 1998, IMMUNITY, V9, P151, DOI 10.1016/S1074-7613(00)80597-X; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zaunders JJ, 2006, J VIROL, V80, P10162, DOI 10.1128/JVI.00249-06	36	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144767	10.1371/journal.pone.0144767	http://dx.doi.org/10.1371/journal.pone.0144767			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678998	gold, Green Published, Green Submitted			2022-12-27	WOS:000366723400025
J	Cha, S; Park, AY; Kang, C				Cha, Seongwon; Park, Ah Yeon; Kang, Changsoo			A Genome-Wide Association Study Uncovers a Genetic Locus Associated with Thoracic-to-Hip Ratio in Koreans	PLOS ONE			English	Article							RISK; CIRCUMFERENCE; VISUALIZATION; METAANALYSIS; POPULATION; GLUCOSE; NIDDM	The thoracic-to-hip circumference ratio (THR) is an anthropometric marker recently described as a predictor of type 2 diabetes. In this study, we performed a genome-wide association study (GWAS) followed by confirmatory analyses to identify genetic markers associated with THR. A total of 7,240 Korean subjects (4,988 for the discovery stage and 2,252 for the confirmatory analyses) were recruited for this study, and genome-wide single nucleotide polymorphism (SNP) genotyping of the initial 4,988 individuals was performed using Affymetrix Human SNP array 5.0. Linear regression analysis was then performed to adjust for the effects of age, sex, and current diabetes medication status on the THR of the study subjects. In the initial discovery stage, there was a statistically nominal association between minor alleles of SNP markers on chromosomes 4, 8, 10, and 12, and THR changes (p < 5.0 x 10(-6)). The subsequent confirmatory analyses of these markers, however, only detected a significant association between two SNPs in the HECTD4 gene and decreased THRs. Notably, this association was detected in male (rs11066280: p = 1.14 x 10(-2); rs2074356: p = 1.10 x 10(-2)), but not in female subjects. Meanwhile, the combined results from the two analyses (initial and confirmatory) indicated that minor alleles of these two intronic variants exhibited a significant genome-wide association with decreased THR in the male subjects (n = 3,155; rs11066280: effect size = -0.008624, p = 6.19 x 10(-9); rs2074356: effect size = -0.008762, p = 1.89 x 10(-8)). Furthermore, minor alleles of these two SNPs exhibited protective effects on patients' risks for developing type 2 diabetes. In conclusion, we have identified two genetic variations in HECTD4 that are associated with THR, particularly in men.	[Cha, Seongwon; Park, Ah Yeon] Korea Inst Oriental Med, Mibyeong Res Ctr, Daejeon 34054, South Korea; [Kang, Changsoo] Sungshin Womens Univ, Dept Biol, Seoul 01133, South Korea; [Kang, Changsoo] Sungshin Womens Univ, Res Inst Basic Sci, Coll Nat Sci, Seoul 01133, South Korea	Korea Institute of Oriental Medicine (KIOM); Sungshin Women's University; Sungshin Women's University	Kang, C (corresponding author), Sungshin Womens Univ, Dept Biol, Seoul 01133, South Korea.	ckang@sungshin.ac.kr	Cha, Seongwon/A-2377-2012	Cha, Seongwon/0000-0001-9012-8718	Korea Center for Disease Control and Prevention [4851-307, KBP-2014-16, KBP-2014-063, 4845-301, 4851-302]; Korea Institute of Oriental Medicine (KIOM) [K15090]; Bio&Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea [2006- 2005173, I-1210/002-002-03]	Korea Center for Disease Control and Prevention; Korea Institute of Oriental Medicine (KIOM); Bio&Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea	This study was provided with biospecimens and data from the Korean Genome Analysis Project (4845-301), the Korean Genome and Epidemiology Study (4851-302), and Korea Biobank Project (4851-307, KBP-2014-16, KBP-2014-063) that were supported by the Korea Center for Disease Control and Prevention, and was also supported by the research program of the Korea Institute of Oriental Medicine (KIOM) (K15090) and by the Bio&Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2006- 2005173, I-1210/002-002-03), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cha SW, 2008, OBESITY, V16, P2185, DOI 10.1038/oby.2008.314; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Pham DD, 2013, INTEGR MED RES, V2, P1, DOI 10.1016/j.imr.2013.01.001; Pham DD, 2014, DIABETES RES CLIN PR, V104, P273, DOI 10.1016/j.diabres.2013.12.022; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Jeong S, 2011, J BIOTECHNOL, V154, P321, DOI 10.1016/j.jbiotec.2011.05.017; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kraja AT, 2014, MOL GENET METAB, V112, P317, DOI 10.1016/j.ymgme.2014.04.007; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Stevens J, 2001, OBES RES, V9, P696, DOI 10.1038/oby.2001.94; Wang SL, 1997, DIABETOLOGIA, V40, P1431, DOI 10.1007/s001250050846; Yoo Keun-Young, 2005, Asian Pac J Cancer Prev, V6, P238; Yoon D, 2012, HUM GENET, V131, P1009, DOI 10.1007/s00439-011-1102-x	22	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145220	10.1371/journal.pone.0145220	http://dx.doi.org/10.1371/journal.pone.0145220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675016	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700116
J	Huoponen, S; Blom, M				Huoponen, Saara; Blom, Marja			A Systematic Review of the Cost-Effectiveness of Biologics for the Treatment of Inflammatory Bowel Diseases	PLOS ONE			English	Review							EVIDENCE-BASED CONSENSUS; SCHEDULED MAINTENANCE TREATMENT; SEVERE CROHNS-DISEASE; QUALITY-OF-LIFE; ECONOMIC-EVALUATION; UTILITY ANALYSIS; INFLIXIMAB; MANAGEMENT; ADALIMUMAB; STRATEGIES	Background Biologics are used for the treatment of inflammatory bowel diseases, Crohn's disease and ulcerative colitis refractory to conventional treatment. In order to allocate healthcare spending efficiently, costly biologics for inflammatory bowel diseases are an important target for cost-effectiveness analyses. The aim of this study was to systemically review all published literature on the cost-effectiveness of biologics for inflammatory bowel diseases and to evaluate the methodological quality of cost-effectiveness analyses. Methods A literature search was performed using Medline (Ovid), Cochrane Library, and SCOPUS. All cost-utility analyses comparing biologics with conventional medical treatment, another biologic treatment, placebo, or surgery for the treatment of inflammatory bowel diseases in adults were included in this review. All costs were converted to the 2014 euro. The methodological quality of the included studies was assessed by Drummond's, Philips', and the Consolidated Health Economic Evaluation Reporting Standards checklist. Results Altogether, 25 studies were included in the review. Among the patients refractory to conventional medical treatment, the incremental cost-effectiveness ratio ranged from dominance to 549,335 (sic)/Quality-Adjusted Life Year compared to the incremental cost-effectiveness ratio associated with conventional medical treatment. When comparing biologics with another biologic treatment, the incremental cost-effectiveness ratio ranged from dominance to 24,012,483 (sic)/Quality-Adjusted Life Year. A study including both direct and indirect costs produced more favorable incremental cost-effectiveness ratios than those produced by studies including only direct costs. Conclusions With a threshold of 35,000 (sic)/Quality-Adjusted Life Year, biologics seem to be cost-effective for the induction treatment of active and severe inflammatory bowel disease. Between biologics, the cost-effectiveness remains unclear.	[Huoponen, Saara; Blom, Marja] Univ Helsinki, Fac Pharm, Helsinki, Finland	University of Helsinki	Huoponen, S (corresponding author), Univ Helsinki, Fac Pharm, Helsinki, Finland.	saara.huoponen@helsinki.fi						Ananthakrishnan AN, 2012, DIGEST DIS SCI, V57, P472, DOI 10.1007/s10620-011-1896-3; Ananthakrishnan AN, 2011, AM J GASTROENTEROL, V106, P2009, DOI 10.1038/ajg.2011.237; [Anonymous], 2012, AHRQ PUBLICATION; Arseneau KO, 2001, GASTROENTEROLOGY, V120, P1640, DOI 10.1053/gast.2001.24884; Arseneau KO, 2006, CLIN GASTROENTEROL H, V4, P1135, DOI 10.1016/j.cgh.2006.05.003; Assasi N, 2009, 120 CADTH; Blackhouse G, 2012, J CROHNS COLITIS, V6, P77, DOI 10.1016/j.crohns.2011.07.007; Bodger K, 2009, ALIMENT PHARM THER, V30, P265, DOI 10.1111/j.1365-2036.2009.04033.x; Bryan S, 2008, INFLIXIMAB TREATMENT, P1; Burisch J, 2013, J CROHNS COLITIS, V7, P322, DOI 10.1016/j.crohns.2013.01.010; Buxton MJ, 2007, VALUE HEALTH, V10, P214, DOI 10.1111/j.1524-4733.2007.00171.x; Casellas F, 2005, INFLAMM BOWEL DIS, V11, P488, DOI 10.1097/01.MIB.0000159661.55028.56; Chaudhary Mohammad A, 2013, Biol Ther, V3, P45; Clark W, 2004, HEALTH TECHNOL ASSES, V8, P1; Craig D., 2007, NHS EC EVALUATION DA; Danese S, 2015, NAT REV GASTRO HEPAT, V12, P537, DOI 10.1038/nrgastro.2015.135; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Dignass A, 2012, J CROHNS COLITIS, V6, P965, DOI 10.1016/j.crohns.2012.09.003; Dignass A, 2012, J CROHNS COLITIS, V6, P991, DOI 10.1016/j.crohns.2012.09.002; Doherty GA, 2012, INFLAMM BOWEL DIS, V18, P1608, DOI 10.1002/ibd.21904; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Dretzke J, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15060; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF., 2005, METHODS EC EVALUATIO, P55; European Central Bank, 2015, BIL EXCH RAT; European Medicines Agency, 2015, DAT EUR PUBL ASS REP; European Network for Health Technology Assessment (EUnetHTA), 2013, CRIT CHOIC CHOIC MOS; Fleurence R, 2006, J RHEUMATOL, V33, P2124; Ford AC, 2011, AM J GASTROENTEROL, V106, P644, DOI 10.1038/ajg.2011.73; Frolkis AD, 2013, GASTROENTEROLOGY, V145, P996, DOI 10.1053/j.gastro.2013.07.041; Gold MR, 1996, COST EFFECTIVENESS H, P82; Gregor JC, 1997, INFLAMM BOWEL DIS, V3, P265, DOI 10.1002/ibd.3780030405; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Hyde C, 2007, INFLIXIMAB ULCERATIV, P1; Jaisson-Hot I, 2004, INT J TECHNOL ASSESS, V20, P274, DOI 10.1017/S0266462304001084; Kaplan GG, 2007, ALIMENT PHARM THER, V26, P1509, DOI 10.1111/j.1365-2036.2007.03548.x; Kaplan R.M., 1982, HEALTH PSYCHOL, V1, P61, DOI [DOI 10.1037/0278-6133.1.1.61, 10.1037/0278-6133.1.1.61]; Lawson M, 2006, COCHRANE DATABA SE S, P1; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Lichtenstein GR, 2004, AM J GASTROENTEROL, V99, P91, DOI 10.1046/j.1572-0241.2003.04010.x; Lindsay J, 2008, ALIMENT PHARM THER, V28, P76, DOI 10.1111/j.1365-2036.2008.03709.x; Loftus EV, 2009, EUR J GASTROEN HEPAT, V21, P1302, DOI 10.1097/MEG.0b013e32832a8d71; Luce BR, 1996, COST EFFECTIVENESS H, P176; Lv RX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086692; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Marchetti M, 2013, EUR J HEALTH ECON, V14, P853, DOI 10.1007/s10198-012-0430-7; Marshall JK, 2002, 24 CCOHTA; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; Odes S, 2006, GASTROENTEROLOGY, V131, P719, DOI 10.1053/j.gastro.2006.05.052; Official Statistics of Finland, 2014, VAL MON 1860 2014 DA; Oresland T, 2015, J CROHNS COLITIS, V9, P4, DOI 10.1016/j.crohns.2014.08.012; Organization. W. H, 2015, COST EFF THRESH; Philips Z, 2004, HEALTH TECHNOL ASSES, V8, P1; Punekar YS, 2010, EUR J HEALTH ECON, V11, P67, DOI 10.1007/s10198-009-0199-5; Rocchi A, 2008, VALUE HEALTH, V11, P771, DOI 10.1111/j.1524-4733.2007.00298.x; Saito S, 2013, J CROHNS COLITIS, V7, P167, DOI 10.1016/j.crohns.2012.04.007; Shemilt I, 2008, COCHRANE HDB SYSTEMA, P447; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Tang DH, 2013, INFLAMM BOWEL DIS, V19, P2673, DOI 10.1097/MIB.0b013e3182916046; Tang DH, 2012, PHARMACOTHERAPY, V32, P515, DOI 10.1002/j.1875-9114.2011.01053.x; Torrance GW., 1996, COST EFFECTIVENESS H, P54; Tsai HH, 2008, ALIMENT PHARM THER, V28, P1230, DOI 10.1111/j.1365-2036.2008.03839.x; U.S. Food and Drug Administration, 2015, DAT DRUGS FDA APPR D; Ung V, 2014, CLIN GASTROENTEROL H, V12, P1871, DOI 10.1016/j.cgh.2014.03.012; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; van der Valk ME, 2014, GUT, V63, P72, DOI 10.1136/gutjnl-2012-303376; Xie Feng, 2009, Cost Eff Resour Alloc, V7, P20, DOI 10.1186/1478-7547-7-20; Yu AP, 2009, PHARMACOECONOMICS, V27, P609, DOI 10.2165/11312710-000000000-00000	69	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145087	10.1371/journal.pone.0145087	http://dx.doi.org/10.1371/journal.pone.0145087			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675292	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700098
J	Marcos, E; Cos, I; Girard, B; Verschure, PFMJ				Marcos, Encarni; Cos, Ignasi; Girard, Benoit; Verschure, Paul F. M. J.			Motor Cost Influences Perceptual Decisions	PLOS ONE			English	Article							DORSAL PREMOTOR CORTEX; PRIOR PROBABILITY; PARIETAL CORTEX; TIME; TASK; PERFORMANCE; NEURONS; MOTION; BRAIN; MODEL	Perceptual decision making has been widely studied using tasks in which subjects are asked to discriminate a visual stimulus and instructed to report their decision with a movement. In these studies, performance is measured by assessing the accuracy of the participants' choices as a function of the ambiguity of the visual stimulus. Typically, the reporting movement is considered as a mere means of reporting the decision with no influence on the decision-making process. However, recent studies have shown that even subtle differences of biomechanical costs between movements may influence how we select between them. Here we investigated whether this purely motor cost could also influence decisions in a perceptual discrimination task in detriment of accuracy. In other words, are perceptual decisions only dependent on the visual stimulus and entirely orthogonal to motor costs? Here we show the results of a psychophysical experiment in which human subjects were presented with a random dot motion discrimination task and asked to report the perceived motion direction using movements of different biomechanical cost. We found that the pattern of decisions exhibited a significant bias towards the movement of lower cost, even when this bias reduced performance accuracy. This strongly suggests that motor costs influence decision making in visual discrimination tasks for which its contribution is neither instructed nor beneficial.	[Marcos, Encarni; Verschure, Paul F. M. J.] Univ Pompeu Fabra, Lab Synthet Percept Emot & Cognit Syst SPECS, Barcelona 08018, Spain; [Cos, Ignasi; Girard, Benoit] Univ Paris 06, Sorbonne Univ, ISIR, UMR7222, F-75005 Paris, France; [Cos, Ignasi; Girard, Benoit] CNRS, ISIR, UMR 7222, F-75005 Paris, France; [Verschure, Paul F. M. J.] Inst Catalana Recercai Estudis Avancats ICREA, Barcelona 08010, Spain	Pompeu Fabra University; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; ICREA	Verschure, PFMJ (corresponding author), Univ Pompeu Fabra, Lab Synthet Percept Emot & Cognit Syst SPECS, Roc Boronat 138, Barcelona 08018, Spain.	paul.verschure@upf.edu	Girard, Benoît/C-2374-2009; Cos, Ignasi/AAA-6031-2019; Marcos, Encarni/AAE-4144-2019	Girard, Benoît/0000-0002-8117-7064; Cos, Ignasi/0000-0002-4639-1444; Marcos, Encarni/0000-0001-6518-4734	EU [FP7-ICT-270108, FP7-ICT-270212, ERC-341196]; Ville de Paris HABOT-Project grant; ICREA Funding Source: Custom	EU(European Commission); Ville de Paris HABOT-Project grant; ICREA(ICREA)	This work was supported by the EU FP7 framework under grant agreements no FP7-ICT-270108 - Goal-Leaders, FP7-ICT-270212 - eSMC and ERC-341196 - CDAC (PV) and Ville de Paris HABOT-Project grant (IC & BG).	BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Burk D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092681; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cos I, 2012, J NEUROPHYSIOL, V108, P1764, DOI 10.1152/jn.00081.2012; Cos I, 2011, J NEUROPHYSIOL, V105, P3022, DOI 10.1152/jn.00975.2010; Dounskaia N, 2011, J NEUROPHYSIOL, V105, P999, DOI 10.1152/jn.00630.2010; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hanks TD, 2011, J NEUROSCI, V31, P6339, DOI 10.1523/JNEUROSCI.5613-10.2011; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Lepora NF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004110; Marcos E, 2013, NEURON, V78, P249, DOI 10.1016/j.neuron.2013.02.006; Mirabella G, 2011, J NEUROPHYSIOL, V106, P1454, DOI 10.1152/jn.00995.2010; Mulder MJ, 2012, J NEUROSCI, V32, P2335, DOI 10.1523/JNEUROSCI.4156-11.2012; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Roitman JD, 2002, J NEUROSCI, V22, P9475; Sabes PN, 1997, J NEUROSCI, V17, P7119; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Verschure PFMJ, 2003, NATURE, V425, P620, DOI 10.1038/nature02024; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wolpert D, 2012, CURR OPIN NEUROBIOL, V22, P1, DOI [10.1016/j.conb.2012.01.004, DOI 10.1016/J.CONB.2012.01.004]	24	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144841	10.1371/journal.pone.0144841	http://dx.doi.org/10.1371/journal.pone.0144841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673222	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700066
J	Ruel-Bergeron, JC; Stevens, GA; Sugimoto, JD; Roos, FF; Ezzati, M; Black, RE; Kraemer, K				Ruel-Bergeron, Julie C.; Stevens, Gretchen A.; Sugimoto, Jonathan D.; Roos, Franz F.; Ezzati, Majid; Black, Robert E.; Kraemer, Klaus			Global Update and Trends of Hidden Hunger, 1995-2011: The Hidden Hunger Index	PLOS ONE			English	Article							LOW-INCOME; DEFICIENCY; COUNTRIES; ANEMIA	Background Deficiencies in essential vitamins and minerals-also termed hidden hunger-are pervasive and hold negative consequences for the cognitive and physical development of children. Methods This analysis evaluates the change in hidden hunger over time in the form of one composite indicator-the Hidden Hunger Index (HHI)-using an unweighted average of prevalence estimates from the Nutrition Impact Model Study for anemia due to iron deficiency, vitamin A deficiency, and stunting (used as a proxy indicator for zinc deficiency). Net changes from 1995-2011 and population weighted regional means for various time periods are measured. Findings Globally, hidden hunger improved (-6.7 net change in HHI) from 1995-2011. Africa was the only region to see a deterioration in hidden hunger (+1.9) over the studied time period; East Asia and the Pacific performed exceptionally well (-13.0), while other regions improved only slightly. Improvements in HHI were mostly due to reductions in zinc and vitamin A deficiencies, while anemia due to iron deficiency persisted and even increased. Interpretation This analysis is critical for informing and tracking the impact of policy and programmatic efforts to reduce micronutrient deficiencies, to advance the global nutrition agenda, and to achieve the Millennium Development Goals (MDGs). However, there remains an unmet need to invest in gathering frequent, nationally representative, high-quality micronutrient data as we renew our efforts to scale up nutrition, and as we enter the post-2015 development agenda.	[Ruel-Bergeron, Julie C.; Black, Robert E.; Kraemer, Klaus] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Stevens, Gretchen A.] WHO, Dept Hlth Stat & Informat Serv, CH-1211 Geneva, Switzerland; [Sugimoto, Jonathan D.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Roos, Franz F.] DSM Nutr Prod, Kaiseraugst, Switzerland; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Environm & Global Hlth Res Grp, London, England; [Kraemer, Klaus] Sight & Life, Kaiseraugst, Switzerland	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; Fred Hutchinson Cancer Center; DSM NV; Imperial College London	Ruel-Bergeron, JC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	jruelbe1@jhu.edu		Sugimoto, Jonathan/0000-0002-1761-328X	Sight and Life	Sight and Life	Preparation of this manuscript was funded by Sight and Life. There was no additional funding involved in the study design, data collection, analysis, or decision to publish. The funder provided support in the form of salaries for authors [JRB, FR, KK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The preparation of this manuscript was funded by Sight and Life. The estimation of micronutrient deficiencies (iron-amenable anemia, vitamin A, and stunting) was developed and commissioned by the WHO; these estimates are published elsewhere.	[Anonymous], 2014, VIT MIN NUTR INF SYS; [Anonymous], 2014, BRIT BROADCAST CORPO; [Anonymous], HUNGER NUTR COMMITME; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; de Benoist B, 2007, FOOD NUTR BULL, V28, pS480, DOI 10.1177/15648265070283S306; De-Regil Luz M, 2011, COCHRANE DATABASE SY; Hotz C., 2004, Food and Nutrition Bulletin, V25, pS94; Lintelo DT, 2013, HUNGER NUTR COMMITME; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; Mayo-Wilson E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009384.pub2; Muthayya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067860; Pasricha SR, 2013, BLOOD, V121, P2607, DOI 10.1182/blood-2012-09-453522; Stevens GA, LANCET UNPUB; Stevens GA, 2013, LANCET, V1, P16, DOI DOI 10.1016/S2214-109X(13)70001-9; Stevens GA, 2015, LANCET GLOB HEALTH, V3, pE528, DOI 10.1016/S2214-109X(15)00039-X; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Tulchinsky TH, 2010, PUBLIC HEALTH REV, V32, P243, DOI 10.1007/BF03391600; UNDP-United Nations Development Programme, 2014, HUM DEV REP SUST HUM; United Nations Development Programme (UNDP), 2014, HUM DEV REP 2013 RIS; United Nations Viet Nam, 2012, VIET NAM MDGS ACH MD; United Nations' Department of Economic and Social Affairs, WORLD POP PROSP 2012; von Grebmer K., 2014, SYNOPSIS 2014 GLOBAL; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 2012, GLOB DAT IMPL NUTR A; World Health Organization (WHO), 2014, WHO GLOB DAT CHILD G	27	42	44	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143497	10.1371/journal.pone.0143497	http://dx.doi.org/10.1371/journal.pone.0143497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673631	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700010
J	Sanchez-Sevilla, JF; Horvath, A; Botella, MA; Gaston, A; Folta, K; Kilian, A; Denoyes, B; Amaya, I				Sanchez-Sevilla, Jose F.; Horvath, Aniko; Botella, Miguel A.; Gaston, Amelia; Folta, Kevin; Kilian, Andrzej; Denoyes, Beatrice; Amaya, Iraida			Diversity Arrays Technology (DArT) Marker Platforms for Diversity Analysis and Linkage Mapping in a Complex Crop, the Octoploid Cultivated Strawberry (Fragaria x ananassa)	PLOS ONE			English	Article							GENETIC DIVERSITY; SNP DISCOVERY; POPULATION; MAP; GENOME; MICROSATELLITE; SOFTWARE; SSR; IDENTIFICATION; INFERENCE	Cultivated strawberry (Fragaria x ananassa) is a genetically complex allo-octoploid crop with 28 pairs of chromosomes (2n = 8x = 56) for which a genome sequence is not yet available. The diploid Fragaria vesca is considered the donor species of one of the octoploid subgenomes and its available genome sequence can be used as a reference for genomic studies. A wide number of strawberry cultivars are stored in ex situ germplasm collections worldwide but a number of previous studies have addressed the genetic diversity present within a limited number of these collections. Here, we report the development and application of two platforms based on the implementation of Diversity Array Technology (DArT) markers for high-throughput genotyping in strawberry. The first DArT microarray was used to evaluate the genetic diversity of 62 strawberry cultivars that represent a wide range of variation based on phenotype, geographical and temporal origin and pedigrees. A total of 603 DArT markers were used to evaluate the diversity and structure of the population and their cluster analyses revealed that these markers were highly efficient in classifying the accessions in groups based on historical, geographical and pedigree-based cues. The second DArTseq platform took benefit of the complexity reduction method optimized for strawberry and the development of next generation sequencing technologies. The strawberry DArTseq was used to generate a total of 9,386 SNP markers in the previously developed '232' x '1392' mapping population, of which, 4,242 high quality markers were further selected to saturate this map after several filtering steps. The high-throughput platforms here developed for genotyping strawberry will facilitate genome-wide characterizations of large accessions sets and complement other available options.	[Sanchez-Sevilla, Jose F.; Amaya, Iraida] Ctr Churriana, Inst Andaluz Invest & Formac Agr & Pesquera IFAPA, Malaga 29140, Spain; [Horvath, Aniko; Gaston, Amelia; Denoyes, Beatrice] INRA, UMR BFP 1332, F-33140 Villenave Dornon, France; [Horvath, Aniko; Gaston, Amelia; Denoyes, Beatrice] Univ Bordeaux, UMR NFP 1332, F-33140 Villenave Dornon, France; [Botella, Miguel A.] Univ Malaga, Dept Bioquim & Biol Mol, Inst Hortofruticultura Subtrop & Mediterranea IHS, E-29071 Malaga, Spain; [Folta, Kevin; Amaya, Iraida] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Kilian, Andrzej] Univ Canberra, Divers Arrays Technol Pty Ltd, Bruce, ACT 2617, Australia	INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); State University System of Florida; University of Florida; University of Canberra	Amaya, I (corresponding author), Ctr Churriana, Inst Andaluz Invest & Formac Agr & Pesquera IFAPA, Malaga 29140, Spain.	iraida.amaya@juntadeandalucia.es	Botella, Miguel A/B-5734-2012; Amaya, Iraida/C-3709-2016; Sánchez Sevilla, José Federico/L-3279-2013; GASTON, AMELIA/R-8691-2016	Botella, Miguel A/0000-0002-8867-1831; Amaya, Iraida/0000-0002-4612-8902; Sánchez Sevilla, José Federico/0000-0002-6690-7196; Gaston, Amelia/0000-0001-9974-8083; Denoyes, Beatrice/0000-0002-0369-9609; Kilian, Andrzej/0000-0002-2730-7462	Spanish Ministry of Economy and Competitivity; FEDER [AGL2012-40066]; EUBerry Project (EU FP7) [KBBE-2010-4, 265942]; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme [IOF Flavor 328052]	Spanish Ministry of Economy and Competitivity(Spanish Government); FEDER(European Commission); EUBerry Project (EU FP7); Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme	This work was supported by the Spanish Ministry of Economy and Competitivity and FEDER (grant number AGL2012-40066), the EUBerry Project (EU FP7 KBBE-2010-4 Grant Agreement number 265942) and by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme to IA (IOF Flavor 328052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Amil-Ruiz F, 2011, PLANT CELL PHYSIOL, V52, P1873, DOI 10.1093/pcp/pcr136; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bassil NV, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1310-1; Bombarely A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-503; Bringhurst R. S., 1984, Iowa State Journal of Research, V58, P371; Chambers A, 2013, MOL BREEDING, V31, P615, DOI 10.1007/s11032-012-9819-3; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Cruz VMV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064062; DALE A, 1990, HORTSCIENCE, V25, P1341, DOI 10.21273/HORTSCI.25.11.1341; Darrow GM, 1966, STRAWBERRY HIST BREE; Davik J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137746; Davis T. M., 2007, GENOME MAPPING MOL B, P189, DOI DOI 10.1007/978-3-540-34533-6_8; Debnath SC, 2008, CAN J PLANT SCI, V88, P313, DOI 10.4141/CJPS07088; Degani C, 2001, EUPHYTICA, V117, P1, DOI 10.1023/A:1004008408435; Delourme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-120; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Durstewitz G, 2010, GENOME, V53, P948, DOI 10.1139/G10-079; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Galletta G. J., 1990, SMALL FRUIT CROP MAN, P83; Garcia AAF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03399; Govan CL, 2008, MOL BREEDING, V22, P649, DOI 10.1007/s11032-008-9206-2; Grant OM, 2012, ENVIRON EXP BOT, V76, P7, DOI 10.1016/j.envexpbot.2011.09.013; Grant OM, 2010, ENVIRON EXP BOT, V68, P264, DOI 10.1016/j.envexpbot.2010.01.008; Hancock J.F., 1999, STRAWBERRIES, P25; Hancock JF, 2008, STRAWBERRIES, P393, DOI [10.1007/978-1-4020-6907-9_13, DOI 10.1007/978-1-4020-6907-9_13]; Heller-Uszynska K, 2011, MOL BREEDING, V28, P37, DOI 10.1007/s11032-010-9460-y; Horvath A, 2011, ANN APPL BIOL, V159, P358, DOI 10.1111/j.1744-7348.2011.00503.x; Isobe SN, 2013, DNA RES, V20, P79, DOI 10.1093/dnares/dss035; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Gil-Ariza DJ, 2009, J AM SOC HORTIC SCI, V134, P337, DOI 10.21273/JASHS.134.3.337; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lerceteau-Kohler E, 2012, THEOR APPL GENET, V124, P1059, DOI 10.1007/s00122-011-1769-3; Lerceteau-Kohler E, 2003, THEOR APPL GENET, V107, P619, DOI 10.1007/s00122-003-1300-6; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petroli CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044684; PHYLIP J F., 2004, PHYLIP PHYLOGENY INF; Pritchard JK, 2000, GENETICS, V155, P945; Raman H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101673; Raman H, 2010, CROP PASTURE SCI, V61, P222, DOI 10.1071/CP09093; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousseau-Gueutin M, 2009, MOL PHYLOGENET EVOL, V51, P515, DOI 10.1016/j.ympev.2008.12.024; Rousseau-Gueutin M, 2008, GENETICS, V179, P2045, DOI 10.1534/genetics.107.083840; Salentijn EMJ, 2003, PHYSIOL PLANTARUM, V118, P571, DOI 10.1034/j.1399-3054.2003.00138.x; Sanchez-Sevilla JF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-218; Sansaloni CP, 2011, BMC P S7, V5, P54, DOI [10.1186/1753-6561-5-S7-P54, DOI 10.1186/1753-6561-5-S7-P54]; Sargent DJ, 2008, GENOME, V51, P120, DOI [10.1139/G07-107, 10.1139/g07-107]; Sargent DJ, 2012, THEOR APPL GENET, V124, P1229, DOI 10.1007/s00122-011-1782-6; Sargent DJ, 2006, THEOR APPL GENET, V112, P1349, DOI 10.1007/s00122-006-0237-y; Sargent DJ, 2004, THEOR APPL GENET, V109, P1385, DOI 10.1007/s00122-004-1767-9; Sargent DJ, 2015, PLANT SCI; Schouten HJ, 2012, MOL BREEDING, V29, P645, DOI 10.1007/s11032-011-9579-5; Schwieterman ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088446; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Simko I, 2012, PLANT SCI, V184, P54, DOI 10.1016/j.plantsci.2011.12.009; SJULIN TM, 1987, J AM SOC HORTIC SCI, V112, P375; Sugimoto T, 2005, PLANT BREEDING, V124, P498, DOI 10.1111/j.1439-0523.2005.01144.x; Tennessen JA, 2014, GENOME BIOL EVOL, V6, P3295, DOI 10.1093/gbe/evu261; Tinker NA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-39; Troggio M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067407; Tyrka M, 2002, EUPHYTICA, V125, P273, DOI 10.1023/A:1015892313900; Ulrich D, 2013, J APPL BOT FOOD QUAL, V86, P37, DOI 10.5073/JABFQ.2013.086.006; Vallarino JG, 2015, NEW PHYTOL, V208, P482, DOI 10.1111/nph.13463; van Dijk T, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-55; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Wilhelm S, 1974, HIST STRAWBERRY ANCI; Zorrilla-Fontanesi Y, 2012, PLANT PHYSIOL, V159, P851, DOI 10.1104/pp.111.188318; Zorrilla-Fontanesi Y, 2011, THEOR APPL GENET, V123, P755, DOI 10.1007/s00122-011-1624-6; Zorrilla-Fontanesi Y, 2011, MOL BREEDING, V27, P137, DOI 10.1007/s11032-010-9417-1	82	49	52	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144960	10.1371/journal.pone.0144960	http://dx.doi.org/10.1371/journal.pone.0144960			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675207	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700078
J	Wang, J; Jian, HJ; Wei, LJ; Qu, CM; Xu, XF; Lu, K; Qian, W; Li, JN; Li, MT; Liu, LZ				Wang, Jia; Jian, Hongju; Wei, Lijuan; Qu, Cunmin; Xu, Xinfu; Lu, Kun; Qian, Wei; Li, Jiana; Li, Maoteng; Liu, Liezhao			Genome-Wide Analysis of Seed Acid Detergent Lignin (ADL) and Hull Content in Rapeseed (Brassica napus L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; OILSEED RAPE; MAJOR QTL; PHENOLIC-COMPOUNDS; CROP PLANTS; SSR MARKERS; ASSOCIATION; QUALITY; GENE; COLOR	A stable yellow-seeded variety is the breeding goal for obtaining the ideal rapeseed (Brassica napus L.) plant, and the amount of acid detergent lignin (ADL) in the seeds and the hull content (HC) are often used as yellow-seeded rapeseed screening indices. In this study, a genome-wide association analysis of 520 accessions was performed using the Q + K model with a total of 31,839 single-nucleotide polymorphism (SNP) sites. As a result, three significant associations on the B. napus chromosomes A05, A09, and C05 were detected for seed ADL content. The peak SNPs were within 9.27, 14.22, and 20.86 kb of the key genes BnaA. PAL4, BnaA. CAD2/BnaA. CAD3, and BnaC. CCR1, respectively. Further analyses were performed on the major locus of A05, which was also detected in the seed HC examination. A comparison of our genome-wide association study (GWAS) results and previous linkage mappings revealed a common chromosomal region on A09, which indicates that GWAS can be used as a powerful complementary strategy for dissecting complex traits in B. napus. Genomic selection (GS) utilizing the significant SNP markers based on the GWAS results exhibited increased predictive ability, indicating that the predictive ability of a given model can be substantially improved by using GWAS and GS.	[Wang, Jia; Jian, Hongju; Wei, Lijuan; Qu, Cunmin; Xu, Xinfu; Lu, Kun; Qian, Wei; Li, Jiana; Liu, Liezhao] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China; [Li, Maoteng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Inst Resource Biol & Biotechnol, Wuhan 430074, Peoples R China	Southwest University - China; Huazhong University of Science & Technology	Liu, LZ (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China.	liezhao2003@126.com	Lu, Kun/C-2597-2008	Lu, Kun/0000-0003-1370-8633	National Natural Science Foundation of China [31171584]; National Natural Science Foundation of China (CN) [31371655]; 973 Program [2015CB150201]; Contributed reagents/analysis tools and Earmarked Fund for Modern Agro-industry Technology Research System [CARS-13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China (CN)(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Contributed reagents/analysis tools and Earmarked Fund for Modern Agro-industry Technology Research System	Funding provided by National Natural Science Foundation of China, (31171584), pr. Liezhao Liu, Conceived and designed the experiments, analyzed the data, National Natural Science Foundation of China (CN), (31371655), pr. Liezhao Liu, 973 Program, (2015CB150201), Pr. Wei Qian, Contributed reagents/analysis tools and Earmarked Fund for Modern Agro-industry Technology Research System, (CARS-13), pr. Jiana Li, Contributed reagents/materials.	Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Angelovici R, 2013, PLANT CELL, V25, P4827, DOI 10.1105/tpc.113.119370; Badani AG, 2006, GENOME, V49, P1499, DOI 10.1139/G06-091; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cai DF, 2014, THEOR APPL GENET, V127, P85, DOI 10.1007/s00122-013-2203-9; Cavanagh C, 2008, CURR OPIN PLANT BIOL, V11, P215, DOI 10.1016/j.pbi.2008.01.002; Dimov Z, 2012, PLANT BREEDING, V131, P361, DOI 10.1111/j.1439-0523.2012.01951.x; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fomeju BF, 2014, BMC GENOMICS, P15; Fritsche S, 2012, FRONT PLANT SCI, P3; Fu FY, 2007, GENOME, V50, P840, DOI 10.1139/G07-068; Gebhardt C, 2004, MOL BREEDING, V13, P93, DOI 10.1023/B:MOLB.0000012878.89855.df; Hasan M, 2008, THEOR APPL GENET, V116, P1035, DOI 10.1007/s00122-008-0733-3; Honsdorf N, 2010, GENOME, V53, P899, DOI 10.1139/G10-049; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jestin C, 2011, MOL BREEDING, V27, P271, DOI 10.1007/s11032-010-9429-x; Jin MengYang, 2007, Scientia Agricultura Sinica, V40, P677; Li F, 2014, DNA RES, V21, P355, DOI 10.1093/dnares/dsu002; Liang YL, 2002, CHINESE J OIL CROP S, V24, P13; Liu HF, 2014, AGR TECHNOLOGY, V34, P22; Liu LZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083052; Liu LZ, 2012, THEOR APPL GENET, V124, P1573, DOI 10.1007/s00122-012-1811-0; Lund M. S., 2009, BMC P S1, V3, pS1, DOI DOI 10.1186/1753-6561-3-S1-S1; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Nuzhdin SV, 2012, TRENDS GENET, V28, P421, DOI 10.1016/j.tig.2012.06.003; Ochodzki P, 2003, 11 INT RAP C COP 6 1, P5; Olsen HG, 2011, ANIM GENET, V42, P466, DOI 10.1111/j.1365-2052.2011.02179.x; Pauli D, 2014, PLANT GENOME, P7; Qu CM, 2013, J EXP BOT, V64, P2885, DOI 10.1093/jxb/ert148; Raman H, 2014, PLOS ONE, P9; RAMAN H, 2014, SCIENCE, V9, P16207, DOI DOI 10.1126/SCIENCE.1253435; Ravel C, 2007, EUPHYTICA, V158, P331, DOI 10.1007/s10681-006-9288-z; Rezaeizad A, 2011, EUPHYTICA, V177, P335, DOI 10.1007/s10681-010-0231-y; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Seren U, 2012, PLANT CELL, V24, P4793, DOI 10.1105/tpc.112.108068; SIMBAYA J, 1995, J AGR FOOD CHEM, V43, P2062, DOI 10.1021/jf00056a020; Slavov GT, 2014, NEW PHYTOL, V201, P1227, DOI 10.1111/nph.12621; Snowdon RJ, 2010, GENOME, V53, P917, DOI 10.1139/G10-052; Stein A, 2013, PLANT BREEDING, V132, P382, DOI 10.1111/pbr.12073; Stracke S, 2009, THEOR APPL GENET, V118, P259, DOI 10.1007/s00122-008-0896-y; Stringam GR, 1974, P 4 INT RAP C, V2, P99; Wang NA, 2011, J EXP BOT, V62, P5641, DOI 10.1093/jxb/err249; Wang X.R., 2012, PLOS ONE, P7, DOI [DOI 10.1371/J0URNAL.P0NE.0040084, 10.1371/journal.pone.0040084]; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wittkop B, 2009, EUPHYTICA, V170, P131, DOI 10.1007/s10681-009-9940-5; Xiao YJ, 2012, THEOR APPL GENET, V125, P437, DOI 10.1007/s00122-012-1843-5; Yan XY, 2009, EUPHYTICA, V170, P355, DOI 10.1007/s10681-009-0006-5; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zou J, 2010, GENOME, V53, P908, DOI 10.1139/G10-075	53	18	20	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145045	10.1371/journal.pone.0145045	http://dx.doi.org/10.1371/journal.pone.0145045			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673885	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700089
J	Zimik, S; Nayak, AR; Pandit, R				Zimik, Soling; Nayak, Alok Ranjan; Pandit, Rahul			A Computational Study of the Factors Influencing the PVC-Triggering Ability of a Cluster of Early Afterdepolarization-Capable Myocytes	PLOS ONE			English	Article							HUMAN VENTRICULAR TISSUE; HEART-FAILURE; CARDIAC FIBROBLASTS; CELLULAR BASIS; CANINE HEARTS; DE-POINTES; M-CELLS; ARRHYTHMIAS; FIBROSIS; FIBRILLATION	Premature ventricular complexes (PVCs), which are abnormal impulse propagations in cardiac tissue, can develop because of various reasons including early afterdepolarizations (EADs). We show how a cluster of EAD-generating cells (EAD clump) can lead to PVCs in a model of cardiac tissue, and also investigate the factors that assist such clumps in triggering PVCs. In particular, we study, through computer simulations, the effects of the following factors on the PVC-triggering ability of an EAD clump: (1) the repolarization reserve (RR) of the EAD cells; (2) the size of the EAD clump; (3) the coupling strength between the EAD cells in the clump; and (4) the presence of fibroblasts in the EAD clump. We find that, although a low value of RR is necessary to generate EADs and hence PVCs, a very low value of RR leads to low-amplitude EAD oscillations that decay with time and do not lead to PVCs. We demonstrate that a certain threshold size of the EAD clump, or a reduction in the coupling strength between the EAD cells, in the clump, is required to trigger PVCs. We illustrate how randomly distributed inexcitable obstacles, which we use to model collagen deposits, affect PVC-triggering by an EAD clump. We show that the gap-junctional coupling of fibroblasts with myocytes can either assist or impede the PVC-triggering ability of an EAD clump, depending on the resting membrane potential of the fibroblasts and the coupling strength between the myocyte and fibroblasts. We also find that the triggering of PVCs by an EAD clump depends sensitively on factors like the pacing cycle length and the distribution pattern of the fibroblasts.	[Zimik, Soling; Nayak, Alok Ranjan; Pandit, Rahul] Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India; [Nayak, Alok Ranjan] Indian Inst Sci, Robert Bosch Ctr Cyber Phys Syst, Bangalore 560012, Karnataka, India; [Pandit, Rahul] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Bosch; Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Pandit, R (corresponding author), Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India.	rahul@physics.iisc.ernet.in	Nayak, Alok/E-2979-2016; Nayak, Alok Ranjan/AAF-1119-2020	Nayak, Alok/0000-0003-0102-0778; 	Department of Science and Technology (DST), India; University Grants Commission (UGC), India; Council for Scientific and Industrial Research (CSIR), India; Robert Bosch Centre for Cyber Physical Systems	Department of Science and Technology (DST), India(Department of Science & Technology (India)); University Grants Commission (UGC), India(University Grants Commission, India); Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Robert Bosch Centre for Cyber Physical Systems	This study was supported by research grants from the Department of Science and Technology (DST), India and the University Grants Commission (UGC), India. Soling Zimik is supported by research fellowships from the Council for Scientific and Industrial Research (CSIR), India. Alok Ranjan Nayak is supported by the Robert Bosch Centre for Cyber Physical Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; Akar FG, 2002, CIRCULATION, V105, P1247, DOI 10.1161/hc1002.105231; ANTZELEVITCH C, 1991, CIRC RES, V69, P1427, DOI 10.1161/01.RES.69.6.1427; Bansch D, 2003, CIRCULATION, V108, P3011, DOI 10.1161/01.CIR.0000103701.30662.5C; Biernacka A, 2011, AGING DIS, V2, P158; Bueno-Orovio A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0352; Calvo D, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1133, DOI 10.1161/CIRCEP.114.002717; de Jong S, 2011, J CARDIOVASC PHARM, V57, P630, DOI 10.1097/FJC.0b013e318207a35f; de Lange E, 2012, BIOPHYS J, V103, P365, DOI 10.1016/j.bpj.2012.06.007; Defauw A, 2014, AM J PHYSIOL-HEART C, V307, pH1456, DOI 10.1152/ajpheart.00410.2014; Elshrif MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084401; Fast VG, 1996, CIRC RES, V79, P115, DOI 10.1161/01.RES.79.1.115; Feld Y, 2002, CIRCULATION, V105, P522, DOI 10.1161/hc0402.102661; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; GRAY RA, 1995, SCIENCE, V270, P1222, DOI 10.1126/science.270.5239.1222; Greisas A, 2012, IEEE T BIO-MED ENG, V59, P1398, DOI 10.1109/TBME.2012.2188291; Haissaguerre M, 2002, LANCET, V359, P677, DOI 10.1016/S0140-6736(02)07807-8; Jacquemet V, 2007, EUROPACE, V9, P29, DOI 10.1093/europace/eum207; JANSE MJ, 1980, CIRC RES, V47, P151, DOI 10.1161/01.RES.47.2.151; Kapur NK, 2012, CIRCULATION, V125, P2728, DOI 10.1161/CIRCULATIONAHA.111.080002; Li GR, 2002, AM J PHYSIOL-HEART C, V283, pH1031, DOI 10.1152/ajpheart.00105.2002; Li GR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007307; MacCannell KA, 2007, BIOPHYS J, V92, P4121, DOI 10.1529/biophysj.106.101410; Majumder R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045040; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; Morita N, 2009, AM J PHYSIOL-HEART C, V297, pH1594, DOI 10.1152/ajpheart.00579.2009; Nayak AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00207; Nayak AR, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032720; Nayak AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072950; Nguyen TP, 2014, J MOL CELL CARDIOL, V70, P83, DOI 10.1016/j.yjmcc.2013.10.018; Nguyen TP, 2012, CARDIOVASC RES, V93, P242, DOI 10.1093/cvr/cvr292; Nuss HB, 1999, AM J PHYSIOL-HEART C, V277, pH80, DOI 10.1152/ajpheart.1999.277.1.H80; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Passini E, 2016, J MOL CELL CARDIOL, V96, P72, DOI 10.1016/j.yjmcc.2015.09.003; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; POLLARD AE, 1992, CRIT REV BIOMED ENG, V20, P171; Qu ZL, 2013, CARDIOVASC RES, V99, P6, DOI 10.1093/cvr/cvt104; Rohr S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P442, DOI 10.1161/CIRCEP.110.957647; ROOK MB, 1992, AM J PHYSIOL, V263, pC959, DOI 10.1152/ajpcell.1992.263.5.C959; Saiz J, 1999, IEEE T BIO-MED ENG, V46, P138, DOI 10.1109/10.740876; Sato D, 2009, P NATL ACAD SCI USA, V106, P2983, DOI 10.1073/pnas.0809148106; Shajahan TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004738; Shajahan TK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011929; Shibukawa Y, 2005, BIOPHYS J, V88, P3924, DOI 10.1529/biophysj.104.054429; Solhjoo S, 2015, PLOS ONE, V78, P90, DOI DOI 10.1016/J.YJMCC.2014.09.024; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Ten Tusscher KHWJ, 2007, EUROPACE, V9, P38, DOI 10.1093/europace/eum206; Tran DX, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258103; Vandersickel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084595; Veldkamp MW, 2001, EUR HEART J, V22, P955, DOI 10.1053/euhj.2000.2499; Volders PGA, 2000, CARDIOVASC RES, V46, P376, DOI 10.1016/S0008-6363(00)00022-5; WEBER KT, 1993, CARDIOVASC RES, V27, P341, DOI 10.1093/cvr/27.3.341; Wiegerinck RF, 2008, HEART RHYTHM, V5, P1178, DOI 10.1016/j.hrthm.2008.04.026; WINFREE AT, 1994, SCIENCE, V266, P1003, DOI 10.1126/science.7973648; Xie YF, 2010, BIOPHYS J, V99, P1408, DOI 10.1016/j.bpj.2010.06.042; Xie YF, 2009, AM J PHYSIOL-HEART C, V297, pH775, DOI 10.1152/ajpheart.00341.2009; Zhao ZH, 2012, CARDIOVASC RES, V95, P308, DOI 10.1093/cvr/cvs183; Zimik S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130632; Zlochiver S, 2008, BIOPHYS J, V95, P4469, DOI 10.1529/biophysj.108.136473	59	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144979	10.1371/journal.pone.0144979	http://dx.doi.org/10.1371/journal.pone.0144979			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675670	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000366722700080
J	Shin, HC; Ju, DH; Jeon, BS; Choi, O; Kim, HW; Um, Y; Lee, DH; Sang, BI				Shin, Hyun Chul; Ju, Dong-Hun; Jeon, Byoung Seung; Choi, Okkyoung; Kim, Hyun Wook; Um, Youngsoon; Lee, Dong-Hoon; Sang, Byoung-In			Analysis of the Microbial Community in an Acidic Hollow-Fiber Membrane Biofilm Reactor (Hf-MBfR) Used for the Biological Conversion of Carbon Dioxide to Methane	PLOS ONE			English	Article							SP-NOV; METHANOTHERMOBACTER-MARBURGENSIS; HYDROGENOTROPHIC METHANOGENESIS; ANAEROBIC OXIDATION; CONTINUOUS-CULTURE; CATTLE MANURE; SPOROMUSA; PERFORMANCE; BACTERIA; WASTE	Hydrogenotrophic methanogens can use gaseous substrates, such as H-2 and CO2, in CH4 production. H-2 gas is used to reduce CO2. We have successfully operated a hollow-fiber membrane biofilm reactor (Hf-MBfR) for stable and continuous CH4 production from CO2 and H-2. CO2 and H-2 were diffused into the culture medium through the membrane without bubble formation in the Hf-MBfR, which was operated at pH 4.5-5.5 over 70 days. Focusing on the presence of hydrogenotrophic methanogens, we analyzed the structure of the microbial community in the reactor. Denaturing gradient gel electrophoresis (DGGE) was conducted with bacterial and archaeal 16S rDNA primers. Real-time qPCR was used to track changes in the community composition of methanogens over the course of operation. Finally, the microbial community and its diversity at the time of maximum CH4 production were analyzed by pyrosequencing methods. Genus Methanobacterium, related to hydrogenotrophic methanogens, dominated the microbial community, but acetate consumption by bacteria, such as unclassified Clostridium sp., restricted the development of acetoclastic methanogens in the acidic CH4 production process. The results show that acidic operation of a CH4 production reactor without any pH adjustment inhibited acetogenic growth and enriched the hydrogenotrophic methanogens, decreasing the growth of acetoclastic methanogens.	[Shin, Hyun Chul; Ju, Dong-Hun; Um, Youngsoon] Korea Inst Sci & Technol, Clean Energy Res Ctr, Natl Agenda Res Div, Seoul, South Korea; [Shin, Hyun Chul; Kim, Hyun Wook; Lee, Dong-Hoon] Univ Seoul, Dept Environm Engn, Seoul, South Korea; [Jeon, Byoung Seung; Sang, Byoung-In] Hanyang Univ, Dept Chem Engn, Seoul 133791, South Korea; [Choi, Okkyoung] Hanyang Univ, Res Inst Ind Sci, Seoul 133791, South Korea	Korea Institute of Science & Technology (KIST); University of Seoul; Hanyang University; Hanyang University	Choi, O (corresponding author), Hanyang Univ, Res Inst Ind Sci, Seoul 133791, South Korea.	okgii77@hanmail.net; biosang@hanyang.ac.kr	Sang, Byoung-In/T-2817-2017; Kim, Hyunook/C-9316-2012	Sang, Byoung-In/0000-0001-7972-6709; Kim, Hyunook/0000-0003-1256-480X	research fund of Korea Ministry of Environment as "Converging Technology Project" [202-101-006]; Korea Ministry of Environment (MOE) as "Algae monitoring and removed to utilized R&D substantiation Project" [2015001790002]	research fund of Korea Ministry of Environment as "Converging Technology Project"; Korea Ministry of Environment (MOE) as "Algae monitoring and removed to utilized R&D substantiation Project"	This work was supported by the research fund of Korea Ministry of Environment as "Converging Technology Project (202-101-006)"; Korea Ministry of Environment (MOE) as "Algae monitoring and removed to utilized R&D substantiation Project (2015001790002)".	Ahmadian A, 2006, CLIN CHIM ACTA, V363, P83, DOI 10.1016/j.cccn.2005.04.038; Ahring BK, 2001, WATER RES, V35, P2446, DOI 10.1016/S0043-1354(00)00526-1; Baker RW, 2008, IND ENG CHEM RES, V47, P2109, DOI 10.1021/ie071083w; BREZNAK JA, 1988, ARCH MICROBIOL, V150, P282, DOI 10.1007/BF00407793; CHARTRAIN M, 1986, APPL ENVIRON MICROB, V51, P180, DOI 10.1128/AEM.51.1.180-187.1986; Chen CL, 2008, WATER RES, V42, P1963, DOI 10.1016/j.watres.2007.11.037; Cuzin N, 2001, INT J SYST EVOL MICR, V51, P489, DOI 10.1099/00207713-51-2-489; DEHNING I, 1989, ARCH MICROBIOL, V151, P421, DOI 10.1007/BF00416601; Dollhopf SL, 2001, APPL MICROBIOL BIOT, V56, P531, DOI 10.1007/s002530100612; FERRY JG, 1974, INT J SYST BACTERIOL, V24, P465, DOI 10.1099/00207713-24-4-465; Goevert D, 2009, APPL ENVIRON MICROB, V75, P2605, DOI 10.1128/AEM.02680-08; Haroon MF, 2013, NATURE, V500, P567, DOI 10.1038/nature12375; HERMANN M, 1987, INT J SYST BACTERIOL, V37, P93, DOI 10.1099/00207713-37-2-93; Horn MA, 2003, APPL ENVIRON MICROB, V69, P74, DOI 10.1128/AEM.69.1.74-83.2003; Huang WH, 2015, CHEMOSPHERE, V140, P40, DOI 10.1016/j.chemosphere.2014.10.047; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hwang K, 2008, APPL MICROBIOL BIOT, V80, P269, DOI 10.1007/s00253-008-1544-9; Joulian C, 1998, FEMS MICROBIOL ECOL, V25, P135, DOI 10.1016/S0168-6496(97)00090-1; Ju DH, 2008, DESALINATION, V234, P409, DOI 10.1016/j.desal.2007.09.111; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kim S, 2014, PROCESS BIOCHEM, V49, P301, DOI 10.1016/j.procbio.2013.10.022; Kotelnikova S, 1998, INT J SYST BACTERIOL, V48, P357, DOI 10.1099/00207713-48-2-357; Kotsyurbenko OR, 2007, APPL ENVIRON MICROB, V73, P2344, DOI 10.1128/AEM.02413-06; Lebuhn M, 2003, WATER SCI TECHNOL, V48, P97, DOI 10.2166/wst.2003.0230; Lee S, 2015, BIOSCI BIOTECH BIOCH, V79, P1378, DOI 10.1080/09168451.2015.1018122; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Ma K, 2005, INT J SYST EVOL MICR, V55, P325, DOI 10.1099/ijs.0.63254-0; McKeown RM, 2009, ISME J, V3, P1231, DOI 10.1038/ismej.2009.67; MOLLER B, 1984, ARCH MICROBIOL, V139, P388, DOI 10.1007/BF00408385; Nandi R, 1998, CRIT REV MICROBIOL, V24, P61, DOI 10.1080/10408419891294181; NISHIMURA N, 1992, J FERMENT BIOENG, V73, P477, DOI 10.1016/0922-338X(92)90141-G; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Pap B, 2015, BIORESOURCE TECHNOL, V177, P375, DOI 10.1016/j.biortech.2014.11.021; PATEL GB, 1990, INT J SYST BACTERIOL, V40, P79, DOI 10.1099/00207713-40-1-79; Pope PB, 2013, 3 BIOTECH, V3, P407, DOI 10.1007/s13205-012-0097-x; Rittmann S, 2012, BIOMASS BIOENERG, V36, P293, DOI 10.1016/j.biombioe.2011.10.038; Rittmann S, 2015, CRIT REV BIOTECHNOL, V35, P141, DOI 10.3109/07388551.2013.820685; Sakai S, 2009, APPL ENVIRON MICROB, V75, P4892, DOI 10.1128/AEM.02835-08; Scherer PA, 2000, WATER SCI TECHNOL, V41, P83, DOI 10.2166/wst.2000.0059; Seifert AH, 2014, APPL ENERG, V132, P155, DOI 10.1016/j.apenergy.2014.07.002; Seifert AH, 2013, BIORESOURCE TECHNOL, V136, P747, DOI 10.1016/j.biortech.2013.03.119; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Smith JM, 2007, APPL ENVIRON MICROB, V73, P4135, DOI 10.1128/AEM.02557-06; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Thauer RK, 2011, CURR OPIN MICROBIOL, V14, P292, DOI 10.1016/j.mib.2011.03.003; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; White D, 2000, PHYSL BIOCH PROKARYO; Xu H, 2015, ENVIRON TECHNOL, V36, P529, DOI 10.1080/09593330.2014.979886; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; ZEHNDER AJB, 1979, J BACTERIOL, V137, P420, DOI 10.1128/JB.137.1.420-432.1979	50	4	4	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144999	10.1371/journal.pone.0144999	http://dx.doi.org/10.1371/journal.pone.0144999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694756	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500019
J	Deng, XB; Mohandass, D; Katabuchi, M; Hughes, AC; Roubik, DW				Deng, Xiaobao; Mohandass, Dharmalingam; Katabuchi, Masatoshi; Hughes, Alice C.; Roubik, David W.			Impact of Striped-Squirrel Nectar-Robbing Behaviour on Gender Fitness in Alpinia roxburghii Sweet (Zingiberaceae)	PLOS ONE			English	Article							BLEPHAROCALYX ZINGIBERACEAE; REPRODUCTIVE FITNESS; IPOMOPSIS-AGGREGATA; POLLINATOR BEHAVIOR; BUMBLE BEES; PLANT; ROBBERS; POLLEN; CONSEQUENCES; SUCCESS	Nectar-robbing has the potential to strongly affect male and female reproductive fitness of plants. One example of nectar theft is that shown by striped-squirrels (Tamiops swinhoei) on a number of ginger species, including Alpinia roxburghii and A. kwangsiensis (Zingiberaceae). In this study, we used a fluorescent dye as a pollen analogue, and measured fruit and seed output, to test the effect of squirrel nectar-robbing on A. roxburghii reproductive fitness. Pollen transfer between robbed and unrobbed flowers was assessed by comparing 60 randomly established plots containing robbed and unrobbed flowers. The frequency of squirrel robbing visits and broken styles were recorded from a number of flowers for five consecutive days. Two bee species (Bombus eximius and Apis cerana), were the primary pollinators, and their visitation frequency was recorded for six consecutive days. The results showed that fluorescent powder from unrobbed flowers was dispersed further, and to a greater number of flowers than that placed on robbed flowers. Additionally, robbing flowers caused significant damage to reproductive organs, resulting in lower fruit and seed sets in robbed than in unrobbed flowers and influencing both male and female fitness. The frequency of the primary pollinator visits (B. eximius) was significantly higher for unrobbed plants than for robbed plants. The present study clearly shows the negative impact of squirrel robbing on A. roxburghii male reproductive fitness and neutral impact on female reproductive fitness.	[Deng, Xiaobao; Mohandass, Dharmalingam; Roubik, David W.] Chinese Acad Sci, XTBG, Key Lab Trop Forest Ecol, Mengla County 666303, Yunnan, Peoples R China; [Katabuchi, Masatoshi] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Hughes, Alice C.] Chinese Acad Sci, XTBG, Ctr Integrat Conservat, Mengla County 666303, Yunnan, Peoples R China; [Roubik, David W.] Smithsonian Trop Res Inst, Balboa 03092, Ancon, Panama	Chinese Academy of Sciences; State University System of Florida; University of Florida; Chinese Academy of Sciences; Smithsonian Institution; Smithsonian Tropical Research Institute	Mohandass, D (corresponding author), Chinese Acad Sci, XTBG, Key Lab Trop Forest Ecol, Mengla County 666303, Yunnan, Peoples R China.	dmohandass997@yahoo.com	Katabuchi, Masatoshi/P-3768-2018; Mohandass, Dharmalingam/AAT-4750-2020; hughes, Alice/HCH-3838-2022	Katabuchi, Masatoshi/0000-0001-9900-9029; Mohandass, Dharmalingam/0000-0002-0949-6589; hughes, Alice/0000-0002-4899-3158	National Science Foundation of China [30470271, 31061160188-03, 31200173]; Chinese Academy of Sciences Research Fellowship for International Young Scientist Researchers [119103KP11]; Xishuangbanna Station for Tropical Rain Forest Ecosystem Studies; Caiyonghe National Park of Chinese Forestry Administration	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Research Fellowship for International Young Scientist Researchers; Xishuangbanna Station for Tropical Rain Forest Ecosystem Studies; Caiyonghe National Park of Chinese Forestry Administration	This research was supported by the National Science Foundation of China Grant No. 30470271 and 31061160188-03, awarded to Xiao-bao Deng, who conducted the experiment in the field. The publication was also supported by the National Natural Science Foundation of China Grant. No. 31200173, awarded to D. Mohandass, who helped write this paper. The study was partially supported by Chinese Academy of Sciences Research Fellowship for International Young Scientist Researchers (119103KP11), awarded to M. Katabuchi, who performed the statistical analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Xishuangbanna Station for Tropical Rain Forest Ecosystem Studies and Caiyonghe National Park of Chinese Forestry Administration for allowing us to use their facilities and for their support of our fieldwork. We are thankful to Prof. Qing-Jun Li who provided logistic support and facilities for writing this paper. We are also thankful to two anonymous reviewers for helpful comments on the manuscript. Our sincere thanks go to Mr. Kingsly Chuo Beng and Mr. Mason J. Campbell for useful English corrections in the final version. We are also grateful to Dr. Michael Breed for his insightful suggestions pertaining to the field experiment, and for obtaining fluorescence powder from Colorado University, USA. We thank Chun Li, Donghua Zhou and Congjian Luo for their assistance in the fieldwork conducted during the flowering seasons.	Arizmendi MC, 1996, FUNCT ECOL, V10, P119, DOI 10.2307/2390270; Burkle LA, 2007, AM J BOT, V94, P1935, DOI 10.3732/ajb.94.12.1935; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Castro S, 2008, PLANT ECOL, V199, P201, DOI 10.1007/s11258-008-9424-z; Darwin C, 1877, EFFECTS CROSS SELF F; Deng XB, 2004, BIOTROPICA, V36, P633, DOI 10.1646/1603; Deng XiaoBao, 2005, Acta Phytoecologica Sinica, V29, P274; FRITZ RS, 1981, OECOLOGIA, V50, P316, DOI 10.1007/BF00344969; Galen C, 1999, OIKOS, V85, P426, DOI 10.2307/3546692; Gelman A., 2004, BAYESIAN DATA ANAL; Gonzalez-Gomez PL, 2005, BIOTROPICA, V37, P693, DOI 10.1111/j.1744-7429.2005.00088.x; HIGASHI S, 1988, ECOL ENTOMOL, V13, P411, DOI 10.1111/j.1365-2311.1988.tb00373.x; HODGES CM, 1985, ECOLOGY, V66, P179, DOI 10.2307/1941318; Huang WJ, 1995, RODENTS CHINA, P76; INOUYE DW, 1980, ECOLOGY, V61, P1251, DOI 10.2307/1936841; Irwin RE, 2000, ECOLOGY, V81, P2637, DOI 10.1890/0012-9658(2000)081[2637:CONRFR]2.0.CO;2; Irwin RE, 2006, AM J BOT, V93, P64, DOI 10.3732/ajb.93.1.64; Irwin RE, 1998, OECOLOGIA, V116, P519, DOI 10.1007/s004420050617; Irwin RE, 2010, ANNU REV ECOL EVOL S, V41, P271, DOI 10.1146/annurev.ecolsys.110308.120330; Irwin RE, 2008, ECOLOGY, V89, P3093, DOI 10.1890/08-0081.1; JENSEN TS, 1985, OIKOS, V44, P149, DOI 10.2307/3544056; Li QJ, 2001, NATURE, V410, P432, DOI 10.1038/35068635; Maloof JE, 2001, AM J BOT, V88, P1960, DOI 10.2307/3558423; Maloof JE, 2000, ECOLOGY, V81, P2651, DOI 10.1890/0012-9658(2000)081[2651:ANRCOM]2.0.CO;2; Maruyama PK, 2015, OECOLOGIA, V178, P783, DOI 10.1007/s00442-015-3275-9; Mayer C, 2014, EVOL ECOL, V28, P669, DOI 10.1007/s10682-014-9696-9; Momose K, 1998, AM J BOT, V85, P1477, DOI 10.2307/2446404; Morris WF, 1996, ECOLOGY, V77, P1451, DOI 10.2307/2265542; NEWTON SD, 1983, J APICULT RES, V22, P124, DOI 10.1080/00218839.1983.11100573; PYKE GH, 1982, ECOLOGY, V63, P555, DOI 10.2307/1938970; R Core Team, 2021, R LANGUAGE ENV STAT; REDDY TB, 1992, CURR SCI INDIA, V62, P690; Renner SS, 2001, TRENDS ECOL EVOL, V16, P595, DOI 10.1016/S0169-5347(01)02280-7; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; ROUBIK DW, 1982, ECOLOGY, V63, P354, DOI 10.2307/1938953; ROUBIK DW, 1985, OECOLOGIA, V66, P161, DOI 10.1007/BF00379850; Spielgelhalter D, 2003, WINBUGS USER MANUAL; Stout JC, 2000, ACTA OECOL, V21, P277, DOI 10.1016/S1146-609X(00)01085-7; Sun S, 2007, ANN BOT-LONDON, V99, P661, DOI 10.1093/aob/mcl292; Tandon R, 2003, ANN BOT-LONDON, V92, P715, DOI 10.1093/aob/mcg193; Temeles EJ, 2002, INT J PLANT SCI, V163, P803, DOI 10.1086/342033; THOMSON JD, 1986, J ECOL, V74, P329, DOI 10.2307/2260258; THOMSON JD, 1980, OECOLOGIA, V46, P68, DOI 10.1007/BF00346968; Traveset A, 1998, FUNCT ECOL, V12, P459, DOI 10.1046/j.1365-2435.1998.00212.x; WASER NM, 1982, ECOLOGY, V63, P1168, DOI 10.2307/1937253; Zhang L, 2003, PLANT SYST EVOL, V241, P67, DOI 10.1007/s00606-003-0021-2; Zhang YW, 2009, J EVOLUTION BIOL, V22, P527, DOI 10.1111/j.1420-9101.2008.01669.x; Zhang YW, 2007, PLANT ECOL, V193, P1, DOI 10.1007/s11258-006-9244-y; Zhang YW, 2014, J ECOL, V102, P229, DOI 10.1111/1365-2745.12166; ZIMMERMAN M, 1985, AM MIDL NAT, V113, P84, DOI 10.2307/2425350	51	1	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144585	10.1371/journal.pone.0144585	http://dx.doi.org/10.1371/journal.pone.0144585			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689684	gold, Green Published			2022-12-27	WOS:000367092300010
J	Nelson, A; Wassmann, R; Sander, BO; Palao, LK				Nelson, Andrew; Wassmann, Reiner; Sander, Bjoern Ole; Palao, Leo Kris			Climate-Determined Suitability of the Water Saving Technology "Alternate Wetting and Drying" in Rice Systems: A Scalable Methodology demonstrated for a Province in the Philippines	PLOS ONE			English	Article							MANAGEMENT; IRRIGATION; TRENDS; ASIA	70% of the world's freshwater is used for irrigated agriculture and demand is expected to increase to meet future food security requirements. In Asia, rice accounts for the largest proportion of irrigated water use and reducing or conserving water in rice systems has been a long standing goal in agricultural research. The Alternate Wetting and Drying (AWD) technique has been developed to reduce water use by up to 30% compared to the continuously flooded conditions typically found in rice systems, while not impacting yield. AWD also reduces methane emissions produced by anaerobic archae and hence has applications for reducing water use and greenhouse gas emissions. Although AWD is being promoted across Asia, there have been no attempts to estimate the suitable area for this promising technology on a large scale. We present and demonstrate a spatial and temporal climate suitability assessment method for AWD that can be widely applied across rice systems in Asia. We use a simple water balance model and easily available spatial and temporal information on rice area, rice seasonality, rainfall, potential evapotranspiration and soil percolation rates to assess the suitable area per season. We apply the model to Cagayan province in the Philippines and conduct a sensitivity analysis to account for uncertainties in soil percolation and suitability classification. As expected, the entire dry season is climatically suitable for AWD for all scenarios. A further 60% of the wet season area is found suitable contradicting general perceptions that AWD would not be feasible in the wet season and showing that spatial and temporal assessments are necessary to explore the full potential of AWD.	[Nelson, Andrew] Univ Twente, Fac Geoinformat & Earth Observat ITC, NL-7500 AE Enschede, Netherlands; [Wassmann, Reiner; Sander, Bjoern Ole; Palao, Leo Kris] Int Rice Res Inst, Los Banos 4031, Philippines	University of Twente; CGIAR; International Rice Research Institute (IRRI)	Nelson, A (corresponding author), Univ Twente, Fac Geoinformat & Earth Observat ITC, NL-7500 AE Enschede, Netherlands.	a.nelson@utwente.nl	Nelson, Andy/G-3649-2012	Nelson, Andy/0000-0002-7249-3778	CGIAR Research Program on Rice: Global Rice Science Partnership (GRISP); CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS); Climate and Clean Air Coalition (CCAC)	CGIAR Research Program on Rice: Global Rice Science Partnership (GRISP)(CGIAR); CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS)(CGIAR); Climate and Clean Air Coalition (CCAC)	AN, RW, and LKP received support from The CGIAR Research Program on Rice: Global Rice Science Partnership (GRISP), http://www.grisp.net/main/summary. BOS received support from The CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS), https://ccafs.cgiar.org/. BOS received support from Climate and Clean Air Coalition (CCAC), http://www.ccacoalition.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 1985, REFERENCE CROP EVAPO; [Anonymous], 2006, CARBON LAND WATER GL; Aureus M, 2009, RICE TODAY, V8, P16; Bouman B. A. M., 2001, International Rice Research Notes, V26, P17; Bouman B.A.M., 2007, WATER MANAGEMENT IRR, P53; Dawe D, 2005, PLANT PROD SCI, V8, P221, DOI 10.1626/pps.8.221; Doll P, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000355; Food and Agriculture Organization (FAO), 2013, AQUASTAT; Frenken K., 2012, IRRIGATION WATER REQ; GRiSP (Global Rice Science Partnership). (, 2013, RICE ALMANAC, V4th edition; Hijmans R., 2012, GLOBAL ADM AREAS DAT; Humphreys E, 2005, PLANT PROD SCI, V8, P242, DOI 10.1626/pps.8.242; IRRI PhilRice, 2013, MAPP RIC PHIL; Khan S, 2006, AGR WATER MANAGE, V80, P87, DOI 10.1016/j.agwat.2005.07.006; Lampayan RM, 2015, FIELD CROP RES, V170, P95, DOI 10.1016/j.fcr.2014.10.013; Molle F., 2004, EVOLUTION IRRIGATION, P1; MONDAL MK, 1993, AGR WATER MANAGE, V23, P11, DOI 10.1016/0378-3774(93)90017-5; NOAA, 2015, GLOB SURF SUMM DAY G; PSA, 2012, 2010 CENS POP HOUS P; Richards M, 2014, ALTERNATE WETTING DR; Rosegrant MW, 2009, ANNU REV ENV RESOUR, V34, P205, DOI 10.1146/annurev.environ.030308.090351; Sakaguchi A, 2014, AGR WATER MANAGE, V137, P116, DOI [10.1016/j.agwat.2014.01.009, 10.1016/j.agwat.2014.01.099]; Sander BO, 2014, GEODERMA, V235, P355, DOI 10.1016/j.geoderma.2014.07.020; Searchinger T, 2015, WETTING DRYING REDUC; SIOPONGCO JDL, 2013, ALTERNATE WETTING DR; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; TUONG TP, 1994, SOIL SCI SOC AM J, V58, P1794, DOI 10.2136/sssaj1994.03615995005800060031x; UNFCCC, 2011, AMS 3 AU METH EM RED; UNFCCC, 2015, ASB0008 STAND BAS ME; Uprety, 2017, TECHNOLOGIES CLIMATE; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wada Y, 2011, HYDROL EARTH SYST SC, V15, P3785, DOI 10.5194/hess-15-3785-2011; WOPEREIS MCS, 1992, SOIL TILL RES, V24, P199, DOI 10.1016/0167-1987(92)90087-R; Xiao XM, 2006, REMOTE SENS ENVIRON, V100, P95, DOI 10.1016/j.rse.2005.10.004	36	24	24	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145268	10.1371/journal.pone.0145268	http://dx.doi.org/10.1371/journal.pone.0145268			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689778	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092300051
J	Weehuizen, TAF; Prior, JL; van der Vaart, TW; Ngugi, SA; Nepogodiev, SA; Field, RA; Kager, LM; van't Veer, C; de Vos, AF; Wiersinga, WJ				Weehuizen, Tassili A. F.; Prior, Joann L.; van der Vaart, Thomas W.; Ngugi, Sarah A.; Nepogodiev, Sergey A.; Field, Robert A.; Kager, Liesbeth M.; van't Veer, Cornelis; de Vos, Alex F.; Wiersinga, W. Joost			Differential Toll-Like Receptor-Signalling of Burkholderia pseudomallei Lipopolysaccharide in Murine and Human Models	PLOS ONE			English	Article							ANTIGENIC POLYSACCHARIDE MOIETY; SUBTRACTIVE HYBRIDIZATION; CAPSULAR POLYSACCHARIDE; HOST-DEFENSE; LIPID-A; LPS; DIVERSITY; EPIDEMIOLOGY; MELIOIDOSIS; RECOGNITION	The Gram-negative bacterium Burkholderia pseudomallei causes melioidosis and is a CDC category B bioterrorism agent. Toll-like receptor (TLR)-2 impairs host defense during pulmonary B. pseudomallei infection while TLR4 only has limited impact. We investigated the role of TLRs in B. pseudomallei-lipopolysaccharide (LPS) induced inflammation. Purified B. pseudomallei-LPS activated only TLR2-transfected-HEK-cells during short stimulation but both HEK-TLR2 and HEK-TLR4-cells after 24 h. In human blood, an additive effect of TLR2 on TLR4-mediated signalling induced by B. pseudomallei-LPS was observed. In contrast, murine peritoneal macrophages recognized B. pseudomallei-LPS solely through TLR4. Intranasal inoculation of B. pseudomallei-LPS showed that both TLR4-knockout((-/-)) and TLR2x4(-/-), but not TLR2(-/-) mice, displayed diminished cytokine responses and neutrophil influx compared to wild-type controls. These data suggest that B. pseudomallei-LPS signalling occurs solely through murine TLR4, while in human models TLR2 plays an additional role, highlighting important differences between specificity of human and murine models that may have important consequences for B. pseudomallei-LPS sensing by TLRs and subsequent susceptibility to melioidosis.	[Weehuizen, Tassili A. F.; van der Vaart, Thomas W.; Kager, Liesbeth M.; van't Veer, Cornelis; de Vos, Alex F.; Wiersinga, W. Joost] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Weehuizen, Tassili A. F.; van der Vaart, Thomas W.; Kager, Liesbeth M.; van't Veer, Cornelis; de Vos, Alex F.; Wiersinga, W. Joost] Univ Amsterdam, Acad Med Ctr, CEMM, NL-1105 AZ Amsterdam, Netherlands; [Prior, Joann L.; Ngugi, Sarah A.] Def Sci & Technol Lab, Salisbury, Wilts, England; [Nepogodiev, Sergey A.; Field, Robert A.] John Innes Ctr, Colney, Herts, England; [Wiersinga, W. Joost] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Defence Science & Technology Laboratory; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Amsterdam; Academic Medical Center Amsterdam	Weehuizen, TAF (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.a.weehuizen@amc.uva.nl; w.j.wiersinga@amc.uva.nl	van der Vaart, Thomas/AFQ-1712-2022	van der Vaart, Thomas/0000-0002-5873-0474; Wiersinga, Willem/0000-0003-2277-1343; Field, Rob/0000-0001-8574-0275	Netherlands Organisation for Health Research and Development / ZonMW [90700424]; Netherlands Organization for Scientific Research [91610008]; BBSRC [BBS/E/J/000C0618] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0618] Funding Source: researchfish	Netherlands Organisation for Health Research and Development / ZonMW(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Netherlands Organisation for Health Research and Development / ZonMW; grant number 90700424 and the Netherlands Organization for Scientific Research; grant number: 91610008.	Anas AA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010183; Anuntagool N, 2006, AM J TROP MED HYG, V74, P348, DOI 10.4269/ajtmh.2006.74.348; Anuntagool N, 2000, Southeast Asian J Trop Med Public Health, V31 Suppl 1, P146; Arjcharoen S, 2007, INFECT IMMUN, V75, P4298, DOI 10.1128/IAI.00285-07; Brett PJ, 2007, MOL MICROBIOL, V63, P379, DOI 10.1111/j.1365-2958.2006.05519.x; Burtnick MN, 1999, ANTIMICROB AGENTS CH, V43, P2648, DOI 10.1128/AAC.43.11.2648; Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X; Centers for Disease Control and Prevention (CDC) Department of Health and Human Services (HHS), 2012, Fed Regist, V77, P61083; Chan JK, 2012, J CLIN INVEST, V122, P2711, DOI 10.1172/JCI62423; Chantratita N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081617; Charuchaimontri C, 1999, CLIN INFECT DIS, V29, P813, DOI 10.1086/520441; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Darveau RP, 1998, CURR OPIN MICROBIOL, V1, P36, DOI 10.1016/S1369-5274(98)80140-9; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; DeShazer D, 2004, J BACTERIOL, V186, P3938, DOI 10.1128/JB.186.12.3938-3950.2004; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; Goris MGA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018279; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Ho M, 1997, INFECT IMMUN, V65, P3648, DOI 10.1128/IAI.65.9.3648-3653.1997; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; JOHNSON KG, 1976, CAN J MICROBIOL, V22, P29, DOI 10.1139/m76-004; Lee HK, 2002, J IMMUNOL, V168, P4012, DOI 10.4049/jimmunol.168.8.4012; Lindner B, 2000, METH MOL B, V145, P311; Matsuura M, 1996, FEMS MICROBIOL LETT, V137, P79, DOI 10.1111/j.1574-6968.1996.tb08086.x; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Meumann EM, 2012, CLIN INFECT DIS, V54, P362, DOI 10.1093/cid/cir808; Mulye M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002988; Munford RS, 2008, INFECT IMMUN, V76, P454, DOI 10.1128/IAI.00939-07; Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Novem V, 2009, CLIN VACCINE IMMUNOL, V16, P1420, DOI 10.1128/CVI.00472-08; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pristovsek P, 1999, J MED CHEM, V42, P4604, DOI 10.1021/jm991031b; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Rehli M, 2002, TRENDS IMMUNOL, V23, P375, DOI 10.1016/S1471-4906(02)02259-7; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Seydel U, 2000, CHEM IMMUNOL, V74, P5; Simpson AJH, 2000, J INFECT DIS, V181, P1014, DOI 10.1086/315306; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Tuanyok A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001453; van 't Veer C, 2011, J BIOL CHEM, V286, P36603, DOI 10.1074/jbc.M110.189126; WARREN HS, 1985, ANTIMICROB AGENTS CH, V28, P107, DOI 10.1128/AAC.28.1.107; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Weshphal O. JK, 1974, METHODS CARBOHYDRATE, V5, P83; West TE, 2012, GENES IMMUN, V13, P38, DOI 10.1038/gene.2011.49; West TE, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-46; Wiersinga WJ, 2008, J INFECT DIS, V198, P1388, DOI 10.1086/592220; Wiersinga WJ, 2007, PLOS MED, V4, P1268, DOI 10.1371/journal.pmed.0040248; Wiersinga WJ, 2007, J INFECT DIS, V196, P1707, DOI 10.1086/522141; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wiersinga WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003494; Woodman ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052276; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82	56	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145397	10.1371/journal.pone.0145397	http://dx.doi.org/10.1371/journal.pone.0145397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689559	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092300069
J	Dubey, M; Ram, U; Ram, F				Dubey, Manisha; Ram, Usha; Ram, Faujdar			Threshold Levels of Infant and Under-Five Mortality for Crossover between Life Expectancies at Ages Zero, One and Five in India: A Decomposition Analysis	PLOS ONE			English	Article							SEX-RATIO; LONGEVITY; BIRTH	Objectives Under the prevailing conditions of imbalanced life table and historic gender discrimination in India, our study examines crossover between life expectancies at ages zero, one and five years for India and quantifies the relative share of infant and under-five mortality towards this crossover. Methods We estimate threshold levels of infant and under-five mortality required for crossover using age specific death rates during 1981-2009 for 16 Indian states by sex (comprising of India's 90% population in 2011). Kitagawa decomposition equations were used to analyse relative share of infant and under-five mortality towards crossover. Findings India experienced crossover between life expectancies at ages zero and five in 2004 for menand in 2009 for women; eleven and nine Indian states have experienced this crossover for men and women, respectively. Men usually experienced crossover four years earlier than the women. Improvements in mortality below ages five have mostly contributed towards this crossover. Life expectancy at age one exceeds that at age zero for both men and women in India except for Kerala (the only state to experience this crossover in 2000 for men and 1999 for women). Conclusions For India, using life expectancy at age zero and under-five mortality rate together may be more meaningful to measure overall health of its people until the crossover. Delayed crossover for women, despite higher life expectancy at birth than for men reiterates that Indian women are still disadvantaged and hence use of life expectancies at ages zero, one and five become important for India. Greater programmatic efforts to control leading causes of death during the first month and 1-59 months in high child mortality areas can help India to attain this crossover early.	[Dubey, Manisha; Ram, Faujdar] IIPS, Bombay, Maharashtra, India; [Ram, Usha] IIPS, Dept Publ Hlth & Mortal Studies, Bombay, Maharashtra, India	International Institute for Population Sciences; International Institute for Population Sciences	Dubey, M (corresponding author), IIPS, Bombay, Maharashtra, India.	manikvdlw@gmail.com	Ram, Usha/AAS-4140-2020	Ram, Usha/0000-0001-6722-7347; Dubey, Manisha/0000-0003-2879-903X				[Anonymous], FIN POP TOT; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Bhat PN., 1998, DEMOGRAPHY INDIA, V27, P23; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P119, DOI 10.1080/00324720215930; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P23, DOI 10.1080/00324720213798; Bhutta Z.A., 2008, LANCET, V371, P417, DOI [10.1016/S0140-6736(07)61693-6, DOI 10.1016/S0140-6736(07)61693-6]; Canudas-Romo V, 2011, DEMOGR RES, V24, P113, DOI 10.4054/DemRes.2011.24.4; Cheung SLK, 2005, DEMOGRAPHY, V42, P243, DOI 10.1353/dem.2005.0012; COALE AJ, 1986, POP STUD-J DEMOG, V40, P389, DOI 10.1080/0032472031000142316; Coale AJ, 2013, STUDIES POPULATION; Cutler D, 2003, PERSPECTIVES EC AGIN; Dubey M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005386; Fadel SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140448; Guillot M, 2002, POP STUD-J DEMOG, V56, P51, DOI 10.1080/00324720213795; Jha P, 2006, LANCET, V367, P211, DOI 10.1016/S0140-6736(06)67930-0; Jha P, 2011, LANCET, V377, P1921, DOI 10.1016/S0140-6736(11)60649-1; Kannisto V., 2001, POPULATION ENGLISH S, P159; Kintner HJ, 2004, LIFE TABLE METHODS M; KITAGAWA EM, 1955, J AM STAT ASSOC, V50, P1168, DOI 10.2307/2281213; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mohanty SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026857; MURRAY CJL, 1988, INT J EPIDEMIOL, V17, P122, DOI 10.1093/ije/17.1.122; NAM CB, 1995, SOC BIOL, V42, P133; ORGI, SAMPL REG SYST STAT; ORGI, 2015, CAUS DEATH IND 2004; ORGI, 2012, SRS BAS ABR LIF TABL; Pearl R, 1922, THE BIOL OF DEATH; Preston S, 2000, DEMOGRAPHY MEASURING; Ram U, 2015, LANCET GLOB IN PRESS; Ram U, 2013, LANCET GLOB HEALTH, V1, pE219, DOI 10.1016/S2214-109X(13)70073-1; Robine JM, 2006, INT STUD POPUL, V4, P7; Saikia N, 2010, HAS CHILD MORTALITY; Saikia N, 2011, POP STUD-J DEMOG, V65, P73, DOI 10.1080/00324728.2010.534642; UN, 2013, MORTPAK WIND VERS 4; United Nations. Department of International Economic and Social Affairs. Population Division, 1982, Popul Bull UN, P54; VAUPEL JW, 1986, POP STUD-J DEMOG, V40, P147, DOI 10.1080/0032472031000141896; Wilmoth JR, 2000, EXP GERONTOL, V35, P1111, DOI 10.1016/S0531-5565(00)00194-7; World Bank, 2015, LIF EXP BIRTH MAL YE; World-Bank, 2015, LIF EXP BIRTH FEM YE; Yadav AK, 2011, EXAMINATION IN PRESS	41	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0143764	10.1371/journal.pone.0143764	http://dx.doi.org/10.1371/journal.pone.0143764			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9KM	26683617	Green Submitted, Green Published, gold			2022-12-27	WOS:000366725800009
J	Alves, SP; Raundrup, K; Cabo, A; Bessa, RJB; Almeida, AM				Alves, Susana P.; Raundrup, Katrine; Cabo, Angelo; Bessa, Rui J. B.; Almeida, Andre M.			Fatty Acid Composition of Muscle, Adipose Tissue and Liver from Muskoxen (Ovibos moschatus) Living in West Greenland	PLOS ONE			English	Article							BRANCHED-CHAIN; INTRAMUSCULAR FAT; ANGUJAARTORFIUP NUNAA; NUTRITIONAL QUALITY; TRANS-18/1 ISOMERS; SEASONAL-VARIATION; BODY-COMPOSITION; BEEF; MEAT; TRIGLYCERIDES	Information about lipid content and fatty acid (FA) composition of muskoxen (Ovibos moschatos) edible tissues is very limited in comparison to other meat sources. Thus, this work aims to present the first in-depth characterization of the FA profile of meat, subcutaneous adipose tissue and liver of muskoxen living in West Greenland. Furthermore, we aim to evaluate the effect of sex in the FA composition of these edible tissues. Samples from muscle (Longissimus dorsi), subcutaneous adipose tissue and liver were collected from female and male muskoxen, which were delivered at the butchery in Kangerlussuaq (West Greenland) during the winter hunting season. The lipid content of muscle, adipose tissue and liver averaged 284, 846 and 173 mg/g of dry tissue, respectively. This large lipid contents confirms that in late winter, when forage availability is scarce, muskoxen from West Greenland still have high fat reserves, demonstrating that they are well adapted to seasonal feed restriction. A detailed characterization of FA and dimethylacetal composition of muskoxen muscle, subcutaneous adipose tissue and liver showed that there are little differences on FA composition between sexes. Nevertheless, the 18:1cis-9 was the most abundant FA in muscle and adipose tissue, reaching 43% of total FA in muscle. The high content of 18:1cis-9 suggests that it can be selectively stored in muskoxen tissues. Regarding the nutritional composition of muskoxen edible tissues, they are not a good source of polyunsaturated FA; however, they may contribute to a higher fat intake. Information about the FA composition of muskoxen meat and liver is scarce, so this work can contribute to the characterization of the nutritional fat properties of muskoxen edible tissues and can be also useful to update food composition databases.	[Alves, Susana P.; Cabo, Angelo; Bessa, Rui J. B.; Almeida, Andre M.] Univ Lisbon, FMV, CIISA, P-1699 Lisbon, Portugal; [Raundrup, Katrine] Greenland Inst Nat Resources, Nuuk, Greenland; [Almeida, Andre M.] IBET, Oeiras, Portugal	Universidade de Lisboa; Greenland Institute of Natural Resources	Alves, SP (corresponding author), Univ Lisbon, FMV, CIISA, P-1699 Lisbon, Portugal.	susanaalves@fmv.ulisboa.pt	Alves, Susana P/C-1447-2008; Almeida, Andre/I-4369-2013; Bessa, Rui J. B./B-8006-2008; Alves, Susana/Q-3889-2019	Alves, Susana P/0000-0002-3171-9566; Almeida, Andre/0000-0002-7810-3988; Bessa, Rui J. B./0000-0003-4109-3488; Alves, Susana/0000-0002-3171-9566	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/76836/2011]; FCT [PTDC/CVT/120122/2010, UID/CVT/00276/2013]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	SPA was supported by Fundacao para a Ciencia e a Tecnologia (FCT) (www.fct.pt) through grant SFRH/BPD/76836/2011. The work was also supported by FCT through grants PTDC/CVT/120122/2010 and UID/CVT/00276/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMCZEWSKI JZ, 1994, CAN J ANIM SCI, V74, P305, DOI 10.4141/cjas94-042; Adamczewski JZ, 1997, J ZOOL, V241, P245, DOI 10.1111/j.1469-7998.1997.tb01956.x; Adamczewski JZ, 1995, CAN J ZOOL, V73, P2021, DOI 10.1139/z95-238; Aldai N, 2011, ANIMAL, V5, P1643, DOI 10.1017/S1751731111000607; Aldai N, 2013, EUR J LIPID SCI TECH, V115, P1378, DOI 10.1002/ejlt.201300072; Alfaia CPM, 2009, FOOD CHEM, V114, P939, DOI 10.1016/j.foodchem.2008.10.041; Alves SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077313; Becker W, 2008, SCAND J NUTR, V48, P10, DOI [10.3402/fnr.v48i4.1633, DOI 10.3402/FNR.V48I4.1633]; Bell A W, 1979, Prog Lipid Res, V18, P117, DOI 10.1016/0163-7827(79)90013-4; Berthelot V, 2001, SMALL RUMINANT RES, V41, P29, DOI 10.1016/S0921-4488(01)00190-0; Bessa RJB, 2007, EUR J LIPID SCI TECH, V109, P868, DOI 10.1002/ejlt.200600311; Bessa RJB, 2015, EUR J LIPID SCI TECH, V117, P1325, DOI 10.1002/ejlt.201400468; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Cappelen J, 2015, 1508 DAN MET I; Costa ASH, 2012, INT J BIOL SCI, V8, P214, DOI 10.7150/ijbs.8.214; Cruz-Hernandez C, 2004, J AOAC INT, V87, P545; Cuyler C, 2009, 75 GREENL I NAT RES; Dugan MER, 2007, LIPIDS, V42, P509, DOI 10.1007/s11745-007-3051-7; DUNCAN WRH, 1978, BRIT J NUTR, V40, P29, DOI 10.1079/BJN19780092; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; Enser M, 1998, MEAT SCI, V49, P329, DOI 10.1016/S0309-1740(97)00144-7; Enser M, 1998, MEAT SCI, V49, P321, DOI 10.1016/S0309-1740(97)00143-5; FAO, 2010, FATS FATT AC HUM NUT; FOLCH J, 1957, J BIOL CHEM, V226, P497; FORCHHAMMER MC, 1995, CAN J ZOOL, V73, P1344, DOI 10.1139/z95-158; GARTON GA, 1971, J SCI FOOD AGR, V22, P29, DOI 10.1002/jsfa.2740220110; GARTON GA, 1972, BRIT J NUTR, V28, P409, DOI 10.1079/BJN19720050; GARTON GA, 1971, CAN J ZOOLOG, V49, P1159, DOI 10.1139/z71-176; Hassan AA, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.17997; Hills Foods, 2015, WILD ARCT MUSK; Hocquette JF, 2010, ANIMAL, V4, P303, DOI 10.1017/S1751731109991091; Hocquette JF, 1999, REPROD NUTR DEV, V39, P27, DOI 10.1051/rnd:19990102; Hoffman LC, 2006, MEAT SCI, V74, P197, DOI 10.1016/j.meatsci.2006.04.005; HORNING MG, 1961, J BIOL CHEM, V236, P669; Howe P, 2006, NUTRITION, V22, P47, DOI 10.1016/j.nut.2005.05.009; Jeronimo E, 2010, ANIM FEED SCI TECH, V158, P136, DOI 10.1016/j.anifeedsci.2010.04.010; Jorgensen B. V., 2001, 0018 DAN MET I; Kelley NS, 2007, J NUTR, V137, P2599, DOI 10.1093/jn/137.12.2599; Kim SC, 2007, J ANIM SCI, V85, P706, DOI 10.2527/jas.2006-289; Kraft J, 2008, J AGR FOOD CHEM, V56, P4775, DOI 10.1021/jf8001813; Kuhnlein HV, 2002, J FOOD COMPOS ANAL, V15, P545, DOI 10.1016/S0889-1575(02)91066-5; Mapiye C, 2012, MEAT SCI, V92, P210, DOI 10.1016/j.meatsci.2012.03.016; National Health and Medical Research Council, 2006, NUTR REF VAL AUSTR N; Nellemann C, 1997, CAN J ZOOL, V75, P1129, DOI 10.1139/z97-135; Nunavut Development Corporation, 2015, NUN MUSK; Olesen Carsten Riis, 1993, Rangifer, V13, P27; Park Y, 2007, FOOD RES INT, V40, P311, DOI 10.1016/j.foodres.2006.11.002; Pedersen CB, 2000, ARCTIC, V53, P18; Pestana JM, 2012, J SCI FOOD AGR, V92, P2428, DOI 10.1002/jsfa.5648; Pestana JM, 2012, EUR FOOD RES TECHNOL, V234, P187, DOI 10.1007/s00217-011-1625-3; Pestana JM, 2012, MEAT SCI, V90, P819, DOI 10.1016/j.meatsci.2011.11.023; RACLOT T, 1993, J LIPID RES, V34, P1515; Raclot T, 2003, PROG LIPID RES, V42, P257, DOI 10.1016/S0163-7827(02)00066-8; Raghavan M, 2014, QUATERNARY SCI REV, V102, P192, DOI 10.1016/j.quascirev.2014.08.001; Ran-Ressler RR, 2011, LIPIDS, V46, P569, DOI 10.1007/s11745-011-3530-8; Robinson JG, 2006, AM J CARDIOL, V98, p39I, DOI 10.1016/j.amjcard.2005.12.026; Rosa HJD, 2014, J ANIM SCI, V92, P3701, DOI 10.2527/jas.2013-6982; Rowell JE, 2001, J ANIM SCI, V79, P1670; SCAIFE JR, 1978, BIOCHEM J, V176, P799, DOI 10.1042/bj1760799; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Simopoulos Artemis P., 1999, Annals of Nutrition and Metabolism, V43, P127, DOI 10.1159/000012777; Soppela P, 2002, COMP BIOCHEM PHYS A, V132, P403, DOI 10.1016/S1095-6433(02)00040-5; STAALAND H, 1992, Rangifer, V12, P105; STURDIVANT CA, 1992, MEAT SCI, V32, P449, DOI 10.1016/0309-1740(92)90086-J; Tajik Hossein, 2012, Vet Res Forum, V3, P275; THING H, 1987, HOLARCTIC ECOL, V10, P95; US Department of Agriculture ARS, 2014, USDA NAT NUTR DAT ST; Vlaeminck B, 2006, ANIM FEED SCI TECH, V131, P389, DOI 10.1016/j.anifeedsci.2006.06.017; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Yurawecz MP, 1998, LIPIDS, V33, P803, DOI 10.1007/s11745-998-0273-z	70	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145241	10.1371/journal.pone.0145241	http://dx.doi.org/10.1371/journal.pone.0145241			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678792	Green Submitted, Green Published, gold			2022-12-27	WOS:000366723400063
J	Gothard, D; Smith, EL; Kanczler, JM; Black, CR; Wells, JA; Roberts, CA; White, LJ; Qutachi, O; Peto, H; Rashidi, H; Rojo, L; Stevens, MM; El Haj, AJ; Rose, FRAJ; Shakesheff, KM; Oreffo, ROC				Gothard, David; Smith, Emma L.; Kanczler, Janos M.; Black, Cameron R.; Wells, Julia A.; Roberts, Carol A.; White, Lisa J.; Qutachi, Omar; Peto, Heather; Rashidi, Hassan; Rojo, Luis; Stevens, Molly M.; El Haj, Alicia J.; Rose, Felicity R. A. J.; Shakesheff, Kevin M.; Oreffo, Richard O. C.			In Vivo Assessment of Bone Regeneration in Alginate/Bone ECM Hydrogels with Incorporated Skeletal Stem Cells and Single Growth Factors	PLOS ONE			English	Article							FACTOR-RELEASING HYDROGELS; EXTRACELLULAR-MATRIX; CHONDROGENIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; MECHANICAL-PROPERTIES; GRAFT SUBSTITUTES; COLLAGEN HYDROGEL; FACTOR DELIVERY; TISSUE-REPAIR	The current study has investigated the use of decellularised, demineralised bone extracellular matrix (ECM) hydrogel constructs for in vivo tissue mineralisation and bone formation. Stro-1-enriched human bone marrow stromal cells were incorporated together with select growth factors including VEGF, TGF-beta 3, BMP-2, PTHrP and VitD3, to augment bone formation, and mixed with alginate for structural support. Growth factors were delivered through fast (non-osteogenic factors) and slow (osteogenic factors) release PLGA microparticles. Constructs of 5 mm length were implanted in vivo for 28 days within mice. Dense tissue assessed by micro-CT correlated with histologically assessed mineralised bone formation in all constructs. Exogenous growth factor addition did not enhance bone formation further compared to alginate/bone ECM (ALG/ECM) hydrogels alone. UV irradiation reduced bone formation through degradation of intrinsic growth factors within the bone ECM component and possibly also ECM cross-linking. BMP-2 and VitD3 rescued osteogenic induction. ALG/ECM hydrogels appeared highly osteoinductive and delivery of angiogenic or chondrogenic growth factors led to altered bone formation. All constructs demonstrated extensive host tissue invasion and vascularisation aiding integration and implant longevity. The proposed hydrogel system functioned without the need for growth factor incorporation or an exogenous inducible cell source. Optimal growth factor concentrations and spatiotemporal release profiles require further assessment, as the bone ECM component may suffer batch variability between donor materials. In summary, ALG/ECM hydrogels provide a versatile biomaterial scaffold for utilisation within regenerative medicine which may be tailored, ultimately, to form the tissue of choice through incorporation of select growth factors.	[Gothard, David; Smith, Emma L.; Kanczler, Janos M.; Black, Cameron R.; Wells, Julia A.; Roberts, Carol A.; Oreffo, Richard O. C.] Univ Southampton, Bone & Joint Res Grp, Ctr Human Dev Stem Cells & Regenerat, Inst Dev Sci, Southampton SO16 6YD, Hants, England; [White, Lisa J.; Qutachi, Omar; Peto, Heather; Rashidi, Hassan; Rose, Felicity R. A. J.; Shakesheff, Kevin M.] Univ Nottingham, Wolfson Ctr Stem Cells Tissue Engn & Modelling, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Shakesheff, Kevin M.] Locate Therapeut Ltd, MediCity, Nottingham NG90 6BH, England; [Rojo, Luis; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Royal Sch Mines, Dept Mat, London SW7 2AZ, England; [Rojo, Luis; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London SW7 2AZ, England; [Rojo, Luis; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England; [Rojo, Luis] Guys Hosp, Biomat Biomimet Biophoton Res Div, Kings Coll London, Inst Dent, London SE1 9RT, England; [El Haj, Alicia J.] Keele Univ, Inst Sci & Technol Med, Guy Hilton Res Ctr, Keele ST4 7BQ, Staffs, England	University of Southampton; University of Nottingham; Imperial College London; Imperial College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Keele University	Gothard, D (corresponding author), Univ Southampton, Bone & Joint Res Grp, Ctr Human Dev Stem Cells & Regenerat, Inst Dev Sci, Southampton SO16 6YD, Hants, England.	D.Gothard@soton.ac.uk; roco@soton.ac.uk	White, Lisa/AAM-9012-2021; Rojo, Luis/B-3073-2009; Shakesheff, Kevin/AAR-6603-2021; Shakesheff, Kevin M/O-6371-2018; Rashidi, Hassan/N-9313-2014; Qutachi, Omar/AAD-7332-2019; Oreffo, Richard/A-4615-2011	Rojo, Luis/0000-0001-6334-6736; Shakesheff, Kevin M/0000-0003-3236-2439; Rashidi, Hassan/0000-0001-8078-6688; Qutachi, Omar/0000-0002-5026-7358; Kanczler, Janos/0000-0001-7249-0414; Rose, Felicity/0000-0001-6640-8840; Wells, Julia Anne/0000-0001-8272-0236; Stevens, Molly/0000-0002-7335-266X; White, Lisa/0000-0003-0571-999X; El Haj, Alicia/0000-0003-3544-5678; Oreffo, Richard/0000-0001-5995-6726	BBSRC (sLOLA grant) [BB/G010579/1]; BBSRC [BB/G010579/1, BB/G010617/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G010579/1, BB/G010617/1] Funding Source: researchfish	BBSRC (sLOLA grant); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC (sLOLA grant BB/G010579/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Mr Douglas Dunlop and colleagues at the Southampton General Hospital for provision of adult human bone marrow samples. We would also like to thank Dr Jens Madsen for his help with statistical analysis. Research funding from the BBSRC (sLOLA BB/G010579/1) is gratefully acknowledged.	Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501; Ambikaipalan A, 2013, CURR STEM CELL RES T, V8, P210, DOI 10.2174/1574888X11308030005; Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7; Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Baroli B, 2007, J PHARM SCI-US, V96, P2197, DOI 10.1002/jps.20873; Basmanav FB, 2008, BIOMATERIALS, V29, P4195, DOI 10.1016/j.biomaterials.2008.07.017; Bhakta G, 2013, ACTA BIOMATER, V9, P9098, DOI 10.1016/j.actbio.2013.07.008; Bhakta G, 2012, BIOMATERIALS, V33, P6113, DOI 10.1016/j.biomaterials.2012.05.030; Bonfield W, 2006, PHILOS T R SOC A, V364, P227, DOI 10.1098/rsta.2005.1692; Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828; BRADLEY CM, 1992, AUST NZ J SURG, V62, P39, DOI 10.1111/j.1445-2197.1992.tb05352.x; Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040; Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131; Buttermann GR, 2008, SPINE J, V8, P426, DOI 10.1016/j.spinee.2006.12.006; Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011; Chiarello E, 2013, AGING CLIN EXP RES, V25, pS101, DOI 10.1007/s40520-013-0088-8; Coyac BR, 2013, J DENT RES, V92, P648, DOI 10.1177/0022034513488599; Dadsetan M, 2008, BIOMATERIALS, V29, P2193, DOI 10.1016/j.biomaterials.2008.01.006; Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024; Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175; Flausse A, 2013, J BIOMED MATER RES A, V101, P3211, DOI 10.1002/jbm.a.34629; Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]; Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014; Gothard D, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414551763; Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007; Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008; He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v; Howard D, 2008, J ANAT, V213, P66, DOI 10.1111/j.1469-7580.2008.00878.x; Jakob F, 2013, MATURITAS, V75, P118, DOI 10.1016/j.maturitas.2013.03.004; Johnson TD, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494015; Kanczler JA, 2008, BIOMATERIALS, V29, P1892, DOI 10.1016/j.biomaterials.2007.12.031; Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3; Kim J, 2013, J KOREAN SOC ATMOS E, V29, P1, DOI 10.5572/KOSAE.2013.29.1.001; Kirby GTS, 2011, POLYMERS-BASEL, V3, P571, DOI 10.3390/polym3010571; Kisiel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078551; Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074; Kuhls Rainer, 2001, Cell and Tissue Banking, V2, P143, DOI 10.1023/A:1020173119669; Laschke MW, 2008, J BIOMED MATER RES A, V85A, P397, DOI 10.1002/jbm.a.31503; Lee CSD, 2010, BIOMATERIALS, V31, P4926, DOI 10.1016/j.biomaterials.2010.03.001; LEO WJ, 1990, BIOTECHNOL PROGR, V6, P51, DOI 10.1021/bp00001a008; Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062; Ma K, 2012, ACTA BIOMATER, V8, P3754, DOI 10.1016/j.actbio.2012.06.028; Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220; Markel DC, 2012, J INFLAMM RES, V5, P13, DOI 10.2147/JIR.S21411; Marsh D, 1998, CLIN ORTHOP RELAT R, pS22; Mladenov KV, 2010, EUR SPINE J, V19, pS135, DOI 10.1007/s00586-009-1179-2; Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x; Nakasone S, 2013, CLIN ORTHOP RELAT R, V471, P1926, DOI 10.1007/s11999-013-2833-x; Nukavarapu SP, 2013, BIOTECHNOL ADV, V31, P706, DOI 10.1016/j.biotechadv.2012.11.004; Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863; Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016; Rabie A B, 1999, Aust Orthod J, V15, P269; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519; Rutledge K, 2014, TISSUE ENG PART C-ME, V20, P865, DOI [10.1089/ten.tec.2013.0411, 10.1089/ten.TEC.2013.0411]; Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084; Silva NA, 2013, BIOCHIMIE, V95, P2314, DOI 10.1016/j.biochi.2013.08.016; Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304; Smith EL, 2014, ACTA BIOMATER, V10, P4186, DOI 10.1016/j.actbio.2014.06.011; Smith EL, 2014, ACTA BIOMATER, V10, P4197, DOI 10.1016/j.actbio.2014.05.025; Stoppel WL, 2014, J BIOMED MATER RES B, V102, P877, DOI 10.1002/jbm.b.33070; Suarez-Gonzalez D, 2013, TISSUE ENG A; Tabata Y, 2003, TISSUE ENG, V9, pS5, DOI 10.1089/10763270360696941; Taghavi CE, 2010, SPINE, V35, P1144, DOI 10.1097/BRS.0b013e3181bb5203; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; TULI SM, 1978, J BONE JOINT SURG BR, V60, P116, DOI 10.1302/0301-620X.60B1.342532; Wang JC, 2007, EUR SPINE J, V16, P1233, DOI 10.1007/s00586-006-0282-x; Wenger MPE, 2007, BIOPHYS J, V93, P1255, DOI 10.1529/biophysj.106.103192; White LJ, 2013, MAT SCI ENG C-MATER, V33, P2578, DOI 10.1016/j.msec.2013.02.020; Williams EL, 2013, METHODS MOL BIOL, V1035, P67, DOI 10.1007/978-1-62703-508-8_7; Yan TQ, 2013, J SURG RES; Zhang L, 2012, J BIOMED MATER RES A, V100A, P2717, DOI 10.1002/jbm.a.34194; Zheng L, 2010, J BIOMED MATER RES A, V93A, P783, DOI 10.1002/jbm.a.32588	76	51	53	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145080	10.1371/journal.pone.0145080	http://dx.doi.org/10.1371/journal.pone.0145080			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675008	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000366722700096
J	Kim, TY; Shin, JS; Lee, J; Lee, YJ; Kim, MR; Ahn, YJ; Park, KB; Hwang, DS; Ha, IH				Kim, Tae-Yoon; Shin, Joon-Shik; Lee, Jinho; Lee, Yoon Jae; Kim, Me-Riong; Ahn, Yong-Jun; Park, Ki Byung; Hwang, Deok-Sang; Ha, In-Hyuk			Gender Difference in Associations between Chronic Temporomandibular Disorders and General Quality of Life in Koreans: A Cross-Sectional Study	PLOS ONE			English	Article							PAIN-DYSFUNCTION SYNDROME; CLINICAL PAIN; JOINT PAIN; SYMPTOMS; HEADACHE; DEPRESSION; ADOLESCENTS; PREVALENCE; CHILDREN; ANXIETY	Background Chronic temporomandibular disorder (TMD) is known to have strong correlations with psychological factors and to display gender disparity. However, while chronic TMD is known to affect quality of life, large-scale studies investigating the influence on quality of life by gender are scarce. Methods This cross-sectional study assessed the data of 17,198 participants aged >= 19 years who completed chronic TMD and EuroQol-5 Dimension sections in the 4th Korean National Health and Nutrition Examination Survey (2007-2009). We adjusted for covariates (health behavior, sociodemographic factors) in regression analysis for complex sampling design to calculate regression coefficients and 95% CIs for gender difference in the association between chronic TMD and quality of life. We also evaluated which covariates of somatic health, mental health, health behavior, and sociodemographic factors weakened the relationship between TMD and EQ-5D. Results Prevalence of chronic TMD was 1.6% (men 1.3%, women 1.8%), and chronic TMD persisted to negatively impact quality of life even after adjusting for confounding variables. Low sociodemographic factors and health behavior had a negative effect on quality of life. Somatic health and mental health were most affected by chronic TMD. As for quality of life, women were affected to a greater extent than men by TMD. Women were more affected by osteoarthritis and general mental health (stress, depressive symptoms, and thoughts of suicide), and men by employment. Conclusions These results imply that chronic diseases and psychological factors are important in chronic TMD, and that there may be physiological and pathological gender differences in TMD.	[Kim, Tae-Yoon; Shin, Joon-Shik; Lee, Jinho; Lee, Yoon Jae; Kim, Me-Riong; Ahn, Yong-Jun; Park, Ki Byung; Ha, In-Hyuk] Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea; [Hwang, Deok-Sang] Kyung Hee Univ, Dept Korean Med Obstet & Gynecol, Seoul, South Korea	Kyung Hee University	Ha, IH (corresponding author), Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea.	hanihata@gmail.com	Lee, Yoon Jae/ABA-8808-2020	Lee, Yoon Jae/0000-0002-1532-0942; Shin, Joon-Shik/0000-0001-5488-3273; HA, IN-HYUK/0000-0002-5020-6723; Lee, Jinho/0000-0003-0672-6892	Jaseng Medical Foundation	Jaseng Medical Foundation	The authors received no specific funding for this work. However, this work was supported by Jaseng Medical Foundation. Jaseng Medical Foundation had no involvement in study design, data collection, analysis and interpretation, manuscript writing, nor decision for manuscript publication. The authors thank Jaseng Medical Foundation for their support.	Aggarwal V, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008456.pub2; Ballegaard V, 2008, CEPHALALGIA, V28, P832, DOI 10.1111/j.1468-2982.2008.01597.x; BEATON RD, 1991, J PROSTHET DENT, V65, P289, DOI 10.1016/0022-3913(91)90177-X; Berkley K., 1997, BEHAV BRAIN SCI, V20, P1; Bonjardim LR, 2005, INT J PROSTHODONT, V18, P347; Christidis N, 2014, J HEADACHE PAIN, V15; Ciancaglini R, 2001, J DENT, V29, P93, DOI 10.1016/S0300-5712(00)00042-7; CLARK GT, 1987, J AM DENT ASSOC, V115, P251, DOI 10.14219/jada.archive.1987.0231; Dao TTT, 1998, J PROSTHET DENT, V79, P663, DOI 10.1016/S0022-3913(98)70073-3; De Laat A, 1998, Clin Oral Investig, V2, P54, DOI 10.1007/s007840050045; Dick B, 2007, CANADIAN J ANESTHESI, V54, P44579; DWORKIN SF, 1990, J AM DENT ASSOC, V120, P273, DOI 10.14219/jada.archive.1990.0043; DWORKIN SF, 1994, J PROSTHET DENT, V72, P29, DOI 10.1016/0022-3913(94)90213-5; Dworkin SF, 2006, TMDS EVIDENCE BASED, P203; Fillingim RB, 1999, PAIN, V83, P419, DOI 10.1016/S0304-3959(99)00128-1; GALE EN, 1989, J PROSTHET DENT, V61, P235, DOI 10.1016/0022-3913(89)90381-8; Gatchel RJ, 1996, J AM DENT ASSOC, V127, P1365, DOI 10.14219/jada.archive.1996.0450; Giannakopoulos NN, 2010, J DENT, V38, P369, DOI 10.1016/j.jdent.2010.01.003; Glaros AG, 2007, CEPHALALGIA, V27, P542, DOI 10.1111/j.1468-2982.2007.01325.x; Goncalves DAG, 2010, HEADACHE, V50, P231, DOI 10.1111/j.1526-4610.2009.01511.x; GRECO CM, 1998, FUNCTIONAL SOMATIC S, P127; Group EQ, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9; Korszun A, 1998, ORAL SURG ORAL MED O, V86, P416, DOI 10.1016/S1079-2104(98)90366-3; LeResche L, 1997, CRIT REV ORAL BIOL M, V8, P291, DOI 10.1177/10454411970080030401; LeResche L, 1997, PAIN, V69, P153, DOI 10.1016/S0304-3959(96)03230-7; Manfredini D, 2004, J ORAL REHABIL, V31, P933, DOI 10.1111/j.1365-2842.2004.01335.x; McNeill C, 1997, J PROSTHET DENT, V77, P510, DOI 10.1016/S0022-3913(97)70145-8; Ministry of Health and Welfare, KOR CTR DIS CONTR PR; Morris S, 1997, BRIT DENT J, V182, P255, DOI 10.1038/sj.bdj.4809362; Murray Heather, 1996, Journal of Orofacial Pain, V10, P316; Naito Mariko, 2006, J Oral Sci, V48, P1, DOI 10.2334/josnusd.48.1; Nam HS., 2007, EQ 5D KOREAN VALUATI; Nilsson IM, 2006, J OROFAC PAIN, V20, P138; Ojima K, 2007, BIOPSYCHOSOC MED, V1, DOI 10.1186/1751-0759-1-3; Pinelli C, 2007, CLIN ORAL INVEST, V11, P431, DOI 10.1007/s00784-007-0133-0; Plesh O, 2011, J OROFAC PAIN, V25, P190; Rantala MAI, 2003, ACTA ODONTOL SCAND, V61, P217, DOI 10.1080/00016350310004089; Reisine S T, 1989, Community Dent Health, V6, P257; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Rodrigues JH, 2012, PHYSIOTHER RES INT, V17, DOI 10.1002/pri.508; Scher AI, 2008, HEADACHE, V48, P16, DOI 10.1111/j.1526-4610.2007.00970.x; SCHNURR RF, 1991, ORAL SURG ORAL MED O, V72, P550, DOI 10.1016/0030-4220(91)90492-U; Sherman J J, 2001, Curr Pain Headache Rep, V5, P421, DOI 10.1007/s11916-001-0053-7; Sipila K, 2001, CRANIO, V19, P183, DOI 10.1080/08869634.2001.11746168; Sonmez H, 2001, J ORAL REHABIL, V28, P280, DOI 10.1111/j.1365-2842.2001.tb01678.x; Thilander B, 2002, ANGLE ORTHOD, V72, P146; Tjakkes GHE, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-46; Turp JC, 1998, J DENT RES, V77, P1465, DOI 10.1177/00220345980770061101; TVERSKY J, 1991, ORAL SURG ORAL MED O, V71, P696, DOI 10.1016/0030-4220(91)90276-I; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6; Vanderas A P, 2002, Int J Paediatr Dent, V12, P336, DOI 10.1046/j.1365-263X.2002.00380.x; Vanderas AP, 2001, CRANIO, V19, P123, DOI 10.1080/08869634.2001.11746161; VONKORFF M, 1988, PAIN, V32, P173, DOI 10.1016/0304-3959(88)90066-8; Wanman Anders, 1995, Journal of Orofacial Pain, V9, P235; Weingarten TN, 2009, PAIN, V147, P67, DOI 10.1016/j.pain.2009.08.021; Wiesinger B, 2007, PAIN, V131, P311, DOI 10.1016/j.pain.2007.03.018; Wolfe F, 2005, J RHEUMATOL, V32, P2421; Yap AUJ, 2002, J PROSTHET DENT, V88, P479, DOI 10.1067/mpr.2002.129375; ZACH GA, 1991, J PROSTHET DENT, V66, P810, DOI 10.1016/0022-3913(91)90423-T	59	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145002	10.1371/journal.pone.0145002	http://dx.doi.org/10.1371/journal.pone.0145002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673219	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700085
J	Linhares, MM; Affonso, RJ; Viana, LD; Silva, SRM; Denadai, MVA; de Toledo, SRC; Matos, D				Linhares, Marcelo Moura; Affonso, Renato Jose, Jr.; Viana, Luciano de Souza; Morini Silva, Sandra Regina; Araujo Denadai, Marcos Vinicius; Caminada de Toledo, Silvia Regina; Matos, Delcio			Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival	PLOS ONE			English	Article							COLON-CARCINOMA CELLS; EXTRACELLULAR-MATRIX; TUMOR PROGRESSION; OSTEOPONTIN; FIBRONECTIN; METASTASES; MIGRATION; OVEREXPRESSION; ACTIVATION; PREDICTION	Objective To evaluate the relationship between the expression profiles of 84 extracellular matrix (ECM) genes and the prognosis of patients with colorectal cancer (CRC). Methods This retrospective study included 114 patients with stage I-IV CRC who underwent primary tumour resection. Quantitative real-time PCR and immunohistochemistry assays were conducted using primary tumour samples. Kaplan-Meier survival curves were also generated to identify differences in global survival (GS) and disease-free survival (DFS) for the hypoor hyperexpression status of each marker. The log-rank test was used to verify whether the differences were significant. Stepwise Cox regression models were also used to identify the risk factors associated with GS and DFS in a multivariate mode, and then were used to score the risk of death associated with each marker, either independently or in association. Results In the univariate analyses, significant differences in GS in relation to the expression profiles of ITGAV (p = 0.001), ITGA3 (p = 0.002), ITGA6 (p = 0.001), SPARC (p = 0.036), MMP9 (p = 0.034), and MMP16 (p = 0.038) were observed. For DFS, significant differences were observed in associated with ITGAV (p = 0.004) and ITGA3 (p = 0.001). However, only the ITGAV and ITGA6 gene markers for GS (hazard ratio (HR) = 3.209, 95% confidence interval (CI) = 1.412-7.293, p = 0.005 and HR = 3.105, 95% CI = 1.367-7.055, p = 0.007, respectively), and ITGA3 for DFS (HR = 3.806, 95% CI = 1.573-9.209, p = 0.003), remained in the final Cox regression models. A scoring system was developed to evaluate the risk of patient death based on the number of markers for the components of the final GS model. Scores of 0, 1, or 2 were associated with the following mean survival rates [CI]: 47.162 [44.613-49.711], 39.717 [35.471-43.964], 30.197 [24.030-36.327], respectively. Conclusions Multivariate mathematical models demonstrated an association between hyperexpression of the ITGAV and ITGA6 integrins and GS, and also between the ITGA3 integrin and DFS, in patients with colorectal tumours. A risk scoring system based on detected hyperexpression of 0, 1, or 2 markers (e.g., ITGAV and/or ITGA6) was also found to accurately correlate with the GS curves generated for the present cohort.	[Linhares, Marcelo Moura; Affonso, Renato Jose, Jr.; Viana, Luciano de Souza; Morini Silva, Sandra Regina; Araujo Denadai, Marcos Vinicius; Matos, Delcio] Fed Univ Sao Paulo UNIFESP, Escola Paulista Med, Postgrad Program Interdisciplinary Surg Sci, Sao Paulo, Brazil; [Affonso, Renato Jose, Jr.; Viana, Luciano de Souza; Morini Silva, Sandra Regina] Hosp Canc Barretos Fundacao Pio XII, Barretos, Brazil; [Caminada de Toledo, Silvia Regina] Fed Univ Sao Paulo UNIFESP, Mol Biol Lab, EPM, GRAACC, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Hospital de Cancer de Barretos; Universidade Federal de Sao Paulo (UNIFESP)	Linhares, MM (corresponding author), Fed Univ Sao Paulo UNIFESP, Escola Paulista Med, Postgrad Program Interdisciplinary Surg Sci, Sao Paulo, Brazil.	mlinhares@unifesp.br	Linhares, Marcelo Moura/Y-5137-2019; de Souza Viana, Luciano/S-8179-2019; Linhares, Marcelo Moura/Y-5137-2019	Linhares, Marcelo Moura/0000-0002-9540-5937; Linhares, Marcelo Moura/0000-0001-9562-0058	CAPES (Coordination for the Improvement of Higher Level -or Education-Personnel - Brazilian Government); Fundacao Pio XII, Barretos - Brazil	CAPES (Coordination for the Improvement of Higher Level -or Education-Personnel - Brazilian Government); Fundacao Pio XII, Barretos - Brazil	This work was supported by CAPES (Coordination for the Improvement of Higher Level -or Education-Personnel - Brazilian Government) and Fundacao Pio XII, Barretos - Brazil.	AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Davidson B, 2003, CANCER METAST REV, V22, P103, DOI 10.1023/A:1022272204045; Denadai MVA, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-16; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Devita Govindan R., 2012, DEVITA HELLMAN ROSEN; Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695; Galamb O, 2009, CELL ONCOL, V31, P19, DOI 10.3233/CLO-2009-0458; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Ha SY, 2014, J CLIN PATHOL, V67, P576, DOI 10.1136/jclinpath-2013-202163; Instituto Nacional de Cancer, 2011, EST 2012 INC CANC BR; Karmakar S, 2003, CANCER LETT, V196, P217, DOI 10.1016/S0304-3835(03)00208-8; Kemperman H, 1997, EXP CELL RES, V234, P156, DOI 10.1006/excr.1997.3599; Koehler A, 2004, J PATHOL, V204, P65, DOI 10.1002/path.1606; Koivisto L, 2000, EXP CELL RES, V255, P10, DOI 10.1006/excr.1999.4769; Kwon HC, 2004, DIS COLON RECTUM, V47, P141, DOI 10.1007/s10350-003-0032-7; LODISH H, 2003, MOL CELL BIOL; Lustosa SA, 2014, SCI WORLD J, V4, P1; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Meeh PF, 2009, NEOPLASIA, V11, P1074, DOI 10.1593/neo.09808; Meyerhardt J., 2007, COLORECTAL CANC; NIP J, 1992, J CLIN INVEST, V90, P1406, DOI 10.1172/JCI116007; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Ohtaka K, 1996, BIOCHEM BIOPH RES CO, V220, P346, DOI 10.1006/bbrc.1996.0408; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Vassos N, 2014, INT J CLIN EXP PATHO, V7, P288; Viana LD, 2013, ONCOLOGY-BASEL, V84, P81, DOI 10.1159/000343436; Vonlaufen A, 2001, MODERN PATHOL, V14, P1126, DOI 10.1038/modpathol.3880447; Waisberg J, 2014, ANTICANCER RES, V34, P5599; Watanabe T, 2009, DIS COLON RECTUM, V52, P1941, DOI 10.1007/DCR.0b013e3181b53684; World Health Organization, 2011, GLOB HLTH OBS DAT RE; Yeatman TJ, 2003, CLIN EXP METASTAS, V20, P85, DOI 10.1023/A:1022502805474; Zhang CH, 2012, INT J CANCER, V130, P2685, DOI 10.1002/ijc.26301; Zutter MM, 1998, J MAMMARY GLAND BIOL, V3, P191, DOI 10.1023/A:1018798907544	36	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144333	10.1371/journal.pone.0144333	http://dx.doi.org/10.1371/journal.pone.0144333			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674523	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700036
J	Nader, AM; Jelenic, P; Soulieres, I				Nader, Anne-Marie; Jelenic, Patricia; Soulieres, Isabelle			Discrepancy between WISC-III and WISC-IV Cognitive Profile in Autism Spectrum: What Does It Reveal about Autistic Cognition?	PLOS ONE			English	Article							WECHSLER INTELLIGENCE SCALE; HIGH-FUNCTIONING AUTISM; LONG-TERM STABILITY; ASPERGER-SYNDROME; CHILDREN-3RD EDITION; DEVELOPMENTAL DISORDER; PROCESSING SPEED; FOLLOW-UP; AGE; LEVEL	The cognitive profile and measured intellectual level vary according to assessment tools in children on the autism spectrum, much more so than in typically developing children. The recent inclusion of intellectual functioning in the diagnostic process for autism spectrum disorders leads to the crucial question on how to assess intelligence in autism, especially as some tests and subtests seem more sensitive to certain neurodevelopmental conditions. Our first aim was to examine the cognitive profile on the current version of the most widely used test, the Wechsler Intelligence Scales for Children (WISC-IV), for a homogenous subgroup of children on the autism spectrum, i.e. corresponding to DSM-IV diagnosis of "autism". The second aim was to compare cognitive profiles obtained on the third edition versus 4th edition of WISC, in order to verify whether the WISC-IV yields a more distinctive cognitive profile in autistic children. The third aim was to examine the impact of the WISC-IV on the cognitive profile of another subgroup, children with Asperger's Syndrome. 51 autistic, 15 Asperger and 42 typically developing children completed the WISC-IV and were individually matched to children who completed the WISC-III. Divergent WISC-IV profiles were observed despite no significant intelligence quotient difference between groups. Autistic children scored significantly higher on the Perceptual Reasoning Index than on the Verbal Comprehension Index, a discrepancy that nearly tripled in comparison to WISC-III results. Asperger children scored higher on the VCI than on other indexes, with the lowest score found on the Processing Speed Index. WISC-IV cognitive profiles were consistent with, but more pronounced than WISC-III profiles. Cognitive profiles are a valuable diagnostic tool for differential diagnosis, keeping in mind that children on the autism spectrum might be more sensitive to the choice of subtests used to assess intelligence.	[Nader, Anne-Marie; Soulieres, Isabelle] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [Jelenic, Patricia; Soulieres, Isabelle] Riviere des Prairies Hosp, Res Ctr, Inst Univ Sante Mentale Montreal, Montreal, PQ, Canada	University of Quebec; University of Quebec Montreal; Universite de Montreal	Soulieres, I (corresponding author), Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada.	soulieres.isabelle@uqam.ca			Fonds de recherche du Quebec - Sante	Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	ANM is funded by a graduate award from Fonds de recherche du Quebec - Sante. IS is funded by a career award from Fonds de recherche du Quebec - Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th, DOI [DOI 10.1176/APPI.BOOKS.9780890425596, DOI 10.1016/B978-0-12-809324-5.05530-9]; Ankenman K, 2014, AJIDD-AM J INTELLECT, V119, P84, DOI 10.1352/1944-7558-119.1.84; Barbeau EB, 2012, J ABNORMAL PSYCHOL; Barbeau EB, 2013, J ABNORM PSYCHOL, V122, P295, DOI 10.1037/a0029984; Barnhill G., 2000, FOCUS AUTISM OTHER D, V15, P146, DOI [10.1177/10883576020170030201, DOI 10.1177/108835760001500303, 10.1177/108835760001500303]; Black DO, 2009, J AUTISM DEV DISORD, V39, P1613, DOI 10.1007/s10803-009-0795-3; Canivez GL, 2001, SCHOOL PSYCHOL REV, V30, P438; Canivez GL, 1999, J PSYCHOEDUC ASSESS, V17, P300, DOI 10.1177/073428299901700401; Caron MJ, 2006, BRAIN, V129, P1789, DOI 10.1093/brain/awl072; Cederlund M, 2008, J AUTISM DEV DISORD, V38, P72, DOI 10.1007/s10803-007-0364-6; Charman T, 2005, J CHILD PSYCHOL PSYC, V46, P500, DOI 10.1111/j.1469-7610.2004.00377.x; Charman T, 2011, PSYCHOL MED, V41, P619, DOI 10.1017/S0033291710000991; Charman T, 2011, BRAIN RES, V1380, P10, DOI 10.1016/j.brainres.2010.10.075; Dawson M, 2007, PSYCHOL SCI, V18, P657, DOI 10.1111/j.1467-9280.2007.01954.x; de Bruin EI, 2006, J ABNORM CHILD PSYCH, V34, P263, DOI 10.1007/s10802-005-9018-3; Eaves LC, 1996, J AUTISM DEV DISORD, V26, P557, DOI 10.1007/BF02172276; Ehlers S, 1997, J CHILD PSYCHOL PSYC, V38, P207, DOI 10.1111/j.1469-7610.1997.tb01855.x; EHLERS S, 1993, J CHILD PSYCHOL PSYC, V34, P1327, DOI 10.1111/j.1469-7610.1993.tb02094.x; Flanagan D.P., 2009, ESSENTIALS WISC 4 AS; Fountain C, 2012, PEDIATRICS, V129, pE1112, DOI 10.1542/peds.2011-1601; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Ghaziuddin M, 1996, J AUTISM DEV DISORD, V26, P585, DOI 10.1007/BF02172348; Ghaziuddin M, 2004, J AUTISM DEV DISORD, V34, P279, DOI 10.1023/B:JADD.0000029550.19098.77; Gilchrist A, 2001, J CHILD PSYCHOL PSYC, V42, P227, DOI 10.1111/1469-7610.00714; Green D, 2002, J CHILD PSYCHOL PSYC, V43, P655, DOI 10.1111/1469-7610.00054; Grondhuis SN, 2013, AJIDD-AM J INTELLECT, V118, P44, DOI 10.1352/1944-7558-118.1.44; HAPPE FGE, 1994, J CHILD PSYCHOL PSYC, V35, P1461, DOI 10.1111/j.1469-7610.1994.tb01287.x; Hobson Peter., 2002, CRADLE THOUGHT EXPLO; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; Jansiewicz EM, 2006, J AUTISM DEV DISORD, V36, P613, DOI 10.1007/s10803-006-0109-y; Joseph RM, 2002, J CHILD PSYCHOL PSYC, V43, P807, DOI 10.1111/1469-7610.00092; Just MA, 2012, NEUROSCI BIOBEHAV R, V36, P1292, DOI 10.1016/j.neubiorev.2012.02.007; Kaufman A.S., 2006, J PSYCHOEDUC ASSESS, V24, P278, DOI [DOI 10.1177/0734282906288389, 10.1177/0734282906288389]; KLIN A, 1995, J CHILD PSYCHOL PSYC, V36, P1127, DOI 10.1111/j.1469-7610.1995.tb01361.x; Koyama T, 2007, PSYCHIAT CLIN NEUROS, V61, P99, DOI 10.1111/j.1440-1819.2007.01617.x; Koyama T, 2008, PSYCHIAT CLIN NEUROS, V62, P691, DOI 10.1111/j.1440-1819.2008.01871.x; Koyama T, 2009, J AUTISM DEV DISORD, V39, P135, DOI 10.1007/s10803-008-0610-6; Lincoln AJ, 1995, ASSESSMENT INTERPRET, P89; LORD C, 1989, J AUTISM DEV DISORD, V19, P483, DOI 10.1007/BF02212853; MANJIVIONA J, 1995, J AUTISM DEV DISORD, V25, P23, DOI 10.1007/BF02178165; Mayes SD, 2004, CLIN NEUROPSYCHOL, V18, P559, DOI 10.1080/13854040490888530; Mayes SD, 2008, J AUTISM DEV DISORD, V38, P428, DOI 10.1007/s10803-007-0410-4; Nader A-M, 2014, J AUTISM DEV DISORD, P1; Oliveras-Rentas RE, 2012, J AUTISM DEV DISORD, V42, P655, DOI 10.1007/s10803-011-1289-7; Ozonoff S., 2000, AUTISM, V4, P29, DOI DOI 10.1177/1362361300041003; RUTTER M, 1978, J AUTISM CHILD SCHIZ, V8, P139, DOI 10.1007/BF01537863; Sahyoun CP, 2010, NEUROPSYCHOLOGIA, V48, P86, DOI 10.1016/j.neuropsychologia.2009.08.013; Samson F, 2012, HUM BRAIN MAPP, V33, P1553, DOI 10.1002/hbm.21307; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Siegel DJ, 1996, J AUTISM DEV DISORD, V26, P389, DOI 10.1007/BF02172825; Sigman M, 2005, J AUTISM DEV DISORD, V35, P15, DOI 10.1007/s10803-004-1027-5; Sinzig J, 2009, J ATTENTION DISORDER; Soulieres I, 2011, NEUROPSYCHOLOGIA, V49, P848, DOI 10.1016/j.neuropsychologia.2011.01.027; Soulieres I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025372; Soulieres I, 2009, HUM BRAIN MAPP, V30, P4082, DOI 10.1002/hbm.20831; Stevens MC, 2000, J AM ACAD CHILD PSY, V39, P346, DOI 10.1097/00004583-200003000-00017; Stevenson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059329; Sturm H, 2004, DEV MED CHILD NEUROL, V46, P444, DOI 10.1017/S0012162204000738; SZATMARI P, 1995, J AM ACAD CHILD PSY, V34, P1662, DOI 10.1097/00004583-199512000-00017; SZATMARI P, 1990, J AM ACAD CHILD PSY, V29, P130, DOI 10.1097/00004583-199001000-00021; Thaler NS, 2013, J ATTEN DISORD, V17, P291, DOI 10.1177/1087054711428806; Turner LM, 2006, AUTISM, V10, P243, DOI 10.1177/1362361306063296; Vivanti G, 2013, AUST PSYCHOL, V48, P258, DOI 10.1111/ap.12008; Wallace GL, 2009, J AUTISM DEV DISORD, V39, P809, DOI 10.1007/s10803-008-0684-1; Wechsler D, 2005, WECHSLER INTELLIGENC; Wechsler D., 1991, WISC 3 WECHSLER INTE; Zander E, 2010, PSYCHOL ASSESSMENT, V22, P213, DOI 10.1037/a0018335	67	30	32	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144645	10.1371/journal.pone.0144645	http://dx.doi.org/10.1371/journal.pone.0144645			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JH	26673881	Green Submitted, gold, Green Published			2022-12-27	WOS:000366722700050
J	Segnani, C; Ippolito, C; Antonioli, L; Pellegrini, C; Blandizzi, C; Dolfi, A; Bernardini, N				Segnani, Cristina; Ippolito, Chiara; Antonioli, Luca; Pellegrini, Carolina; Blandizzi, Corrado; Dolfi, Amelio; Bernardini, Nunzia			Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon	PLOS ONE			English	Article							PULMONARY-FIBROSIS; IMAGE-ANALYSIS; MODEL; QUANTIFICATION; PENTOXIFYLLINE	Collagen detection in histological sections and its quantitative estimation by computer-aided image analysis represent important procedures to assess tissue localization and distribution of connective fibers. Different histochemical approaches have been proposed to detect and quantify collagen deposition in paraffin slices with different degrees of satisfaction. The present study was performed to compare the qualitative and quantitative efficiency of three histochemical methods available for collagen staining in paraffin sections of colon. van Gieson, Sirius Red and Sirius Red/Fast Green stainings were carried out for collagen detection and quantitative estimation by morphometric image analysis in colonic specimens from normal rats or animals with 2,4-dinitrobenzenesulfonic acid (DNBS) induced colitis. Haematoxylin/eosin staining was carried out to assess tissue morphology and histopathological lesions. Among the three investigated methods, Sirius Red/Fast Green staining allowed to best highlight well-defined red-stained collagen fibers and to obtain the highest quantitative results by morphometric image analysis in both normal and inflamed colon. Collagen fibers, which stood out against the green-stained non-collagen components, could be clearly appreciated, even in their thinner networks, within all layers of normal or inflamed colonic wall. The present study provides evidence that, as compared with Sirius Red alone or van Gieson staining, the Sirius Red/Fast Green method is the most sensitive, in terms of both qualitative and quantitative evaluation of collagen fibers, in paraffin sections of both normal and inflamed colon.	[Segnani, Cristina; Ippolito, Chiara; Dolfi, Amelio; Bernardini, Nunzia] Univ Pisa, Dept Clin & Expt Med, Unit Histol & Med Embryol, Pisa, Italy; [Antonioli, Luca; Pellegrini, Carolina; Blandizzi, Corrado] Univ Pisa, Div Pharmacol, Dept Clin & Expt Med, Pisa, Italy	University of Pisa; University of Pisa	Bernardini, N (corresponding author), Univ Pisa, Dept Clin & Expt Med, Unit Histol & Med Embryol, Pisa, Italy.	nunzia.bernardini@med.unipi.it	Blandizzi, Corrado/AAB-8736-2019; Bernardini, Nunzia/AAC-4602-2021; Pellegrini, Carolina/ABE-3462-2021	Pellegrini, Carolina/0000-0003-2644-5430; BERNARDINI, NUNZIA/0000-0001-9061-9402; Ippolito, Chiara/0000-0001-8671-313X; BLANDIZZI, CORRADO/0000-0001-9927-5386	Interdepartmental Center for Research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa, Italy	Interdepartmental Center for Research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa, Italy	This work was supported by an institutional research grant issued by the Interdepartmental Center for Research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa, Italy.	Alexakis C, 2004, GUT, V53, P85, DOI 10.1136/gut.53.1.85; Antonioli L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116253; Burke JP, 2007, AM J GASTROENTEROL, V102, P439, DOI 10.1111/j.1572-0241.2006.01010.x; Caravan P, 2013, AM J RESP CELL MOL, V49, P1120, DOI 10.1165/rcmb.2013-0039OC; Encarnacion MMD, 2004, AM J TRANSPLANT, V4, P248, DOI 10.1046/j.1600-6143.2003.00311.x; Fiocchi C, 2011, AM J PHYSIOL-GASTR L, V300, pG677, DOI 10.1152/ajpgi.00104.2011; Fornai M, 2006, J PHARMACOL EXP THER, V317, P938, DOI 10.1124/jpet.105.098350; Garcia-Tsao G, 2010, HEPATOLOGY, V51, P1445, DOI 10.1002/hep.23478; Garewal H, 2003, DIGEST DIS SCI, V48, P197, DOI 10.1023/A:1021871423154; GASCONBARRE M, 1989, J HISTOCHEM CYTOCHEM, V37, P377, DOI 10.1177/37.3.2465335; Geboes KP, 2000, ACTA GASTRO-ENT BELG, V63, P371; Hadi AM, 2011, CELL ONCOL, V34, P343, DOI 10.1007/s13402-011-0035-7; Haller ST, 2014, AM J HYPERTENS, V27, P603, DOI 10.1093/ajh/hpt169; Huang Y, 2013, LIVER INT, V33, P1249, DOI 10.1111/liv.12184; Ippolito C, 2015, J CELL MOL MED, V19, P485, DOI 10.1111/jcmm.12428; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480; Marlow SL, 2006, EXP MOL PATHOL, V80, P54, DOI 10.1016/j.yexmp.2005.04.006; Martinez-Galan L, 2010, ARCH BRONCONEUMOL, V46, P20, DOI 10.1016/j.arbres.2009.10.006; Pape L, 2003, TRANSPLANTATION, V76, P955, DOI 10.1097/01.TP.0000078899.62040.E5; Peterson TC, 1997, ALIMENT PHARM THERAP, V11, P575, DOI 10.1046/j.1365-2036.1997.00188.x; Peterson TC, 2011, EUR J PHARMACOL, V662, P47, DOI 10.1016/j.ejphar.2011.04.030; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; PUCHTLER H, 1973, BEITR PATHOL, V150, P174, DOI 10.1016/S0005-8165(73)80016-2; Rabau MY, 1995, EXP MOL PATHOL, V62, P160, DOI 10.1006/exmp.1995.1017; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; San-Miguel B, 2010, J NUTR, V140, P1065, DOI 10.3945/jn.110.121525; Standish RA, 2006, GUT, V55, P569, DOI 10.1136/gut.2005.084475; Street JM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12088; Sweat F, 1964, ARCH PATHOL, P7869; Tamiolakis D, 2002, Clin Exp Obstet Gynecol, V29, P135; Thoua NM, 2012, RHEUMATOLOGY, V51, P1989, DOI 10.1093/rheumatology/kes191; Vogel B, 2015, METHODSX, V2, P124, DOI 10.1016/j.mex.2015.02.007; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278	35	67	68	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144630	10.1371/journal.pone.0144630	http://dx.doi.org/10.1371/journal.pone.0144630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673752	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700049
J	Grosser, S; Burridge, CP; Peucker, AJ; Waters, JM				Grosser, Stefanie; Burridge, Christopher P.; Peucker, Amanda J.; Waters, Jonathan M.			Coalescent Modelling Suggests Recent Secondary-Contact of Cryptic Penguin Species	PLOS ONE			English	Article							EUDYPTULA-MINOR; POPULATION-STRUCTURE; SARCOPHILUS-HARRISII; MITOCHONDRIAL-DNA; BLUE-PENGUIN; DIVERGENCE; SOFTWARE; TIME; MARKERS; DIVERSITY	Molecular genetic analyses present powerful tools for elucidating demographic and biogeographic histories of taxa. Here we present genetic evidence showing a dynamic history for two cryptic lineages within Eudyptula, the world's smallest penguin. Specifically, we use a suite of genetic markers to reveal that two congeneric taxa ('Australia' and 'New Zealand') co-occur in southern New Zealand, with only low levels of hybridization. Coalescent modelling suggests that the Australian little penguin only recently expanded into southern New Zealand. Analyses conducted under time-dependent molecular evolutionary rates lend support to the hypothesis of recent anthropogenic turnover, consistent with shifts detected in several other New Zealand coastal vertebrate taxa. This apparent turnover event highlights the dynamic nature of the region's coastal ecosystem.	[Grosser, Stefanie; Waters, Jonathan M.] Univ Otago, Dept Zool, Allan Wilson Ctr, Dunedin, New Zealand; [Burridge, Christopher P.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Peucker, Amanda J.] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia	University of Otago; University of Tasmania; Deakin University	Grosser, S (corresponding author), Univ Otago, Dept Anat, Allan Wilson Ctr, Dunedin, New Zealand.	grost309@student.otago.ac.nz	Burridge, Christopher/J-2653-2012; Waters, Jon/B-4983-2009; Burridge, Chris/L-4392-2019	Burridge, Christopher/0000-0002-8185-6091; Waters, Jon/0000-0002-1514-7916; 	Allan Wilson Centre, Marsden [UoO1112]	Allan Wilson Centre, Marsden(Royal Society of New ZealandMarsden Fund (NZ))	Funding was provided by the Allan Wilson Centre, Marsden Contract UoO1112, and SG received a University of Otago Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2014, J ORNITHOL, V155, P101, DOI 10.1007/s10336-013-0992-x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson EC, 2002, GENETICS, V160, P1217; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Avise J, 2004, MOL MARKERS NATURAL; Banks J, 2006, POLAR BIOL, V30, P61, DOI 10.1007/s00300-006-0160-3; Banks Jonathan C., 2002, Notornis, V49, P29; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boessenkool S, 2009, P ROY SOC B-BIOL SCI, V276, P815, DOI 10.1098/rspb.2008.1246; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Burridge CP, 2003, NEW ZEAL J MAR FRESH, V37, P223, DOI 10.1080/00288330.2003.9517160; Chiswell SM, 2003, MAR ECOL PROG SER, V247, P173, DOI 10.3354/meps247173; Collins CJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0097; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; Cullen JM, 2009, MAR ECOL PROG SER, V378, P269, DOI 10.3354/meps07881; Daniel TA, 2007, ANIM BEHAV, V74, P1241, DOI 10.1016/j.anbehav.2007.01.029; DANN P, 1992, EMU, V91, P263, DOI 10.1071/MU9910263; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Emerson BC, 2015, MOL ECOL, V24, P702, DOI 10.1111/mec.13070; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Feinberg JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108213; Forster JR, 1781, COMMENT PHYS SOC REG, V3, P135; GALES R, 1985, EMU, V85, P127, DOI 10.1071/MU9850127; Geller JB, 1999, CONSERV BIOL, V13, P661, DOI 10.1046/j.1523-1739.1999.97470.x; Grosser S, 2015, CONSERV GENET RESOUR; Grosser S, 2015, CONSERV GENET RESOUR, V7, P143, DOI 10.1007/s12686-014-0313-6; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hofreiter M, 2007, CURR BIOL, V17, pR122, DOI 10.1016/j.cub.2007.01.026; Holdaway RN, 2001, NEW ZEAL J ZOOL, V28, P119, DOI 10.1080/03014223.2001.9518262; Holder MT, 2001, SYST BIOL, V50, P978, DOI 10.1080/106351501753462911; Hrbek T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083623; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jouventin P, 2006, MOL ECOL, V15, P3413, DOI 10.1111/j.1365-294X.2006.03028.x; Kinsky F.C., 1976, Records nat Mus NZ, V1, P105; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Macey S, 2015, NZ J ZOOL, DOI [10.1080/03014223.2014.995107, DOI 10.1080/03014223.2014.995107]; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; MARCHANT S, 1990, HDB AUSTR NZ ANTARTI, V1; Mathews G. M., 1911, BIRDS AUSTR; MEREDITH MAM, 1988, HEREDITY, V60, P69, DOI 10.1038/hdy.1988.11; MICKELSON MJ, 1992, EMU, V91, P355, DOI 10.1071/MU9910355; Millar CD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000209; Miller W, 2011, P NATL ACAD SCI USA, V108, P12348, DOI 10.1073/pnas.1102838108; Miyazaki M, 2015, ACTA ETHOL, V18, P227, DOI 10.1007/s10211-014-0193-5; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Pemberton David, 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P13; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Peucker AJ, 2009, AUK, V126, P397, DOI 10.1525/auk.2009.08055; Pritchard JK, 2000, GENETICS, V155, P945; Prychitko TM, 1997, MOL PHYLOGENET EVOL, V8, P193, DOI 10.1006/mpev.1997.0420; Robertson HA, 2013, NZ CLASSIFICATION SE, V4, P11; Roeder AD, 2002, CONSERV GENET, V3, P341, DOI 10.1023/A:1019982009059; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Slack KE, 2003, GENE, V302, P43, DOI 10.1016/S0378111902010533; Slatkin M, 1996, GENET RES, V68, P259, DOI 10.1017/S0016672300034236; Smith I, 2013, J ROY SOC NEW ZEAL, V43, P1, DOI 10.1080/03036758.2011.574709; Stahel C., 1987, LITTLE PENGUIN FAIRY; Stephens JF, 1826, GENERAL ZOOL, V13, P68; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stevenson Caryn, 2007, Marine Ornithology, V35, P71; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Waters JM, 2013, TRENDS ECOL EVOL, V28, P78, DOI 10.1016/j.tree.2012.08.024; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Wilmshurst JM, 2008, P NATL ACAD SCI USA, V105, P7676, DOI 10.1073/pnas.0801507105; Zavodna M, 2008, EXP PARASITOL, V120, P57, DOI 10.1016/j.exppara.2008.04.021	80	37	37	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144966	10.1371/journal.pone.0144966	http://dx.doi.org/10.1371/journal.pone.0144966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26675310	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900158
J	Ahn, JM; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW				Ahn, Jem Ma; Sinn, Dong Hyun; Gwak, Geum-Youn; Paik, Yong-Han; Choi, Moon Seok; Lee, Joon Hyeok; Koh, Kwang Cheol; Paik, Seung Woon			Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels	PLOS ONE			English	Article							SURFACE-ANTIGEN; NATURAL-HISTORY; LEVELS HELP; CARRIERS; DISEASE	Objectives We investigated whether long-term clinical outcomes such as disease progression or inactive hepatitis B virus (HBV) carrier state can be predicted by baseline factors in hepatitis B e antigen (HBeAg)-negative HBV infected patients with an elevated viral load. Methods A retrospective cohort of 527 HBeAg-negative chronic HBV infected patients with an elevated viral load (HBV DNA >= 2,000 IU/ml) was assessed for disease progression defined by the development of hepatocellular carcinoma (HCC) or cirrhotic complication, as well as becoming an inactive carrier. Results During a median 3.6 years of follow-up, disease progression was detected in 46 patients (40 with HCC, 6 with cirrhotic complication), and 31 of 309 non-cirrhotic patients became inactive carriers. Older age, male gender, cirrhosis, high HBV DNA levels at baseline, and short antiviral therapy duration were independent risk factors for HCC. Low HBV DNA and quantitative hepatitis B surface antigen (qHBsAg) levels were independent predictors for becoming inactive carriers in patients without cirrhosis. In non-cirrhotic patients with both low qHBsAg and HBV DNA levels, the 5-year cumulative incidence of an inactive carrier was 39.8%, while that of disease progression was 1.6%. Conclusion HBeAg negative patients without cirrhosis can be closely monitored for becoming an inactive carrier when both HBV DNA and qHBsAg levels are low, as the risk of disease progression is low while incidence of an inactive carrier is high.	[Ahn, Jem Ma; Sinn, Dong Hyun; Gwak, Geum-Youn; Paik, Yong-Han; Choi, Moon Seok; Lee, Joon Hyeok; Koh, Kwang Cheol; Paik, Seung Woon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Ahn, Jem Ma] Korea Univ, Sch Med, Dept Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Korea University Medicine (KU Medicine)	Sinn, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.	sinndhn@hanmail.net						Bae SH, 2005, J KOREAN MED SCI, V20, P816, DOI 10.3346/jkms.2005.20.5.816; Brunetto MR, 2010, GASTROENTEROLOGY, V139, P483, DOI 10.1053/j.gastro.2010.04.052; Brunetto MR, 2010, J HEPATOL, V52, P475, DOI 10.1016/j.jhep.2009.12.020; Chan HLY, 2010, HEPATOLOGY, V52, P1232, DOI 10.1002/hep.23803; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; KASL, 2012, CLIN MOL HEPATOL, V18, P109, DOI 10.3350/cmh.2012.18.2.109; Kawanaka M, 2014, LIVER CANCER, V3, P41, DOI 10.1159/000343857; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Nguyen T, 2009, HEPATOL INT, V3, pS5, DOI 10.1007/s12072-009-9149-7; Nguyen T, 2010, J HEPATOL, V52, P508, DOI 10.1016/j.jhep.2010.01.007; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Park Joong Won, 2004, Korean J Hepatol, V10, P88; Pollicino T, 2012, HEPATOLOGY, V56, P434, DOI 10.1002/hep.25592; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Tseng TC, 2015, ALIMENT PHARM THER, V41, P949, DOI 10.1111/apt.13170; Tseng TC, 2013, HEPATOLOGY, V57, P441, DOI 10.1002/hep.26041; Tseng TC, 2012, GASTROENTEROLOGY, V142, P1140, DOI 10.1053/j.gastro.2012.02.007; Udell JA, 2012, JAMA-J AM MED ASSOC, V307, P832, DOI 10.1001/jama.2012.186; Yang JD, 2011, CLIN GASTROENTEROL H, V9, P64, DOI 10.1016/j.cgh.2010.08.019	19	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144777	10.1371/journal.pone.0144777	http://dx.doi.org/10.1371/journal.pone.0144777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696302	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092500010
J	Choudhury, AR; Novic, M				Choudhury, Amrita Roy; Novic, Marjana			Pred beta TM: A Novel beta-Transmembrane Region Prediction Algorithm	PLOS ONE			English	Article							BARREL MEMBRANE-PROTEINS; DATA-BANK; IDENTIFICATION; TOPOLOGY	Predicting the transmembrane regions is an important aspect of understanding the structures and architecture of different beta-barrel membrane proteins. Despite significant efforts, currently available beta-transmembrane region predictors are still limited in terms of prediction accuracy, especially in precision. Here, we describe Pred beta TM, a transmembrane region prediction algorithm for beta-barrel proteins. Using amino acid pair frequency information in known beta-transmembrane protein sequences, we have trained a support vector machine classifier to predict beta-transmembrane segments. Position-specific amino acid preference data is incorporated in the final prediction. The predictor does not incorporate evolutionary profile information explicitly, but is based on sequence patterns generated implicitly by encoding the protein segments using amino acid adjacency matrix. With a benchmark set of 35 beta-transmembrane proteins, Pred beta TM shows a sensitivity and precision of 83.71% and 72.98%, respectively. The segment overlap score is 82.19%. In comparison with other state-of-art methods, Pred beta TM provides a higher precision and segment overlap without compromising with sensitivity. Further, we applied Pred beta TM to analyze the beta-barrel membrane proteins without defined transmembrane regions and the uncharacterized protein sequences in eight bacterial genomes and predict possible beta-transmembrane proteins. Pred beta TM can be freely accessed on the web at http://transpred.ki.si/.	[Choudhury, Amrita Roy; Novic, Marjana] Natl Inst Chem, Lab Chemometr, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia	Choudhury, AR (corresponding author), Natl Inst Chem, Lab Chemometr, Ljubljana, Slovenia.	amrita.roychoudhury@ki.si			Ministry of Higher Education, Science and Technology of the Republic of Slovenia [P1-017, J1-2151]; European Regional Development Fund (Cross-border Collaboration Italy-Slovenia, TRANS2CARE strategic project)	Ministry of Higher Education, Science and Technology of the Republic of Slovenia; European Regional Development Fund (Cross-border Collaboration Italy-Slovenia, TRANS2CARE strategic project)	This work is supported by the Ministry of Higher Education, Science and Technology of the Republic of Slovenia [P1-017, J1-2151], as well as by the European Regional Development Fund (Cross-border Collaboration Italy-Slovenia 2007-2013, TRANS2CARE strategic project). Funding for open access charge: Ministry of Higher Education, Science and Technology of the Republic of Slovenia.	Bagos PG, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-7; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Gromiha MM, 2005, NUCLEIC ACIDS RES, V33, pW164, DOI 10.1093/nar/gki367; Jacoboni I, 2001, PROTEIN SCI, V10, P779, DOI 10.1110/ps.37201; Kaur G, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-28; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Lu W, 2014, J BACTERIOL, V196, P1073, DOI 10.1128/JB.01021-13; Natt NK, 2004, PROTEINS, V56, P11, DOI 10.1002/prot.20092; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Randall A, 2008, BIOINFORMATICS, V24, P513, DOI 10.1093/bioinformatics/btm548; Randic M, 2008, SAR QSAR ENVIRON RES, V19, P339, DOI 10.1080/10629360802085082; Roy Choudhury A, 2012, INT J CHEM MODEL, V4, P205; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Stewart L, 2014, PATHOG DIS, V71, P20, DOI 10.1111/2049-632X.12107; Tusnady GE, 2008, NUCLEIC ACIDS RES, V36, pD234, DOI 10.1093/nar/gkm751; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wimley WC, 2002, PROTEIN SCI, V11, P301, DOI 10.1110/ps.29402; Wright MS, 2014, MBIO, V5, DOI 10.1128/mBio.00963-13; Zhang W, 2014, ENVIRON MICROBIOL, V16, P963, DOI 10.1111/1462-2920.12234; Zupan J, 1997, CHEMOMETR INTELL LAB, V38, P1, DOI 10.1016/S0169-7439(97)00030-0	24	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145564	10.1371/journal.pone.0145564	http://dx.doi.org/10.1371/journal.pone.0145564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694538	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500057
J	Jia, SJ; Zhang, T; Xiong, Z; Pan, WM; Liu, J; Sun, W				Jia, Shuaijun; Zhang, Ting; Xiong, Zhuo; Pan, Weimin; Liu, Jian; Sun, Wei			In Vivo Evaluation of a Novel Oriented Scaffold-BMSC Construct for Enhancing Full-Thickness Articular Cartilage Repair in a Rabbit Model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MECHANICAL-PROPERTIES; OSTEOCHONDRAL REPAIR; GROWTH-FACTOR; REGENERATION; COLLAGEN; MATRIX; MICROFRACTURE; IMPLANTATION; DEFECTS	Tissue engineering (TE) has been proven usefulness in cartilage defect repair. For effective cartilage repair, the structural orientation of the cartilage scaffold should mimic that of native articular cartilage, as this orientation is closely linked to cartilage mechanical functions. Using thermal-induced phase separation (TIPS) technology, we have fabricated an oriented cartilage extracellular matrix (ECM)-derived scaffold with a Young's modulus value 3 times higher than that of a random scaffold. In this study, we test the effectiveness of bone mesenchymal stem cell (BMSC)-scaffold constructs (cell-oriented and random) in repairing full-thickness articular cartilage defects in rabbits. While histological and immunohistochemical analyses revealed efficient cartilage regeneration and cartilaginous matrix secretion at 6 and 12 weeks after transplantation in both groups, the biochemical properties (levels of DNA, GAG, and collagen) and biomechanical values in the oriented scaffold group were higher than that in random group at early time points after implantation. While these differences were not evident at 24 weeks, the biochemical and biomechanical properties of the regenerated cartilage in the oriented scaffold-BMSC construct group were similar to that of native cartilage. These results demonstrate that an oriented scaffold, in combination with differentiated BMSCs can successfully repair full-thickness articular cartilage defects in rabbits, and produce cartilage enhanced biomechanical properties.	[Jia, Shuaijun; Zhang, Ting; Xiong, Zhuo; Sun, Wei] Tsinghua Univ, Dept Mech Engn, Biomfg Engn Res Inst, Beijing 100084, Peoples R China; [Jia, Shuaijun] Armed Police Force, Shannxi Hosp, Dept Orthopaed, Xian, Shannxi, Peoples R China; [Pan, Weimin] Xian Phys Educ Univ, Dept Human Movement Studies, Xian, Shannxi, Peoples R China; [Liu, Jian] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710032, Shannxi, Peoples R China; [Sun, Wei] Drexel Univ, Dept Mech Engn, Philadelphia, PA 19104 USA	Tsinghua University; Xi'an Physical Education University; Air Force Military Medical University; Drexel University	Sun, W (corresponding author), Tsinghua Univ, Dept Mech Engn, Biomfg Engn Res Inst, Beijing 100084, Peoples R China.	sunweidrexl@mail.tsinghua.edu.cn			National Natural Science Foundation of China [31070860, 50675108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (Nos. 31070860 and 50675108)(http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basser PJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P207, DOI 10.1006/abbi.1997.0507; Bi L, 2011, J MATER SCI-MATER M, V22, P51, DOI 10.1007/s10856-010-4177-3; Brochhausen C, 2013, J BIOMED MATER RES A, V101, P2374, DOI 10.1002/jbm.a.34538; Caminal M, 2014, BIOTECHNOL LETT, V36, P2143, DOI 10.1007/s10529-014-1585-3; Chang CH, 2014, J BIOMED MATER RES A, V102, P2248, DOI 10.1002/jbm.a.34897; Chen PF, 2015, BIOMATERIALS, V39, P114, DOI 10.1016/j.biomaterials.2014.10.049; Dai WD, 2010, BIOMATERIALS, V31, P2141, DOI 10.1016/j.biomaterials.2009.11.070; Hoenig E, 2011, TISSUE ENG PT A, V17, P1401, DOI [10.1089/ten.TEA.2010.0395, 10.1089/ten.tea.2010.0395]; Huang X, 2007, BIOMATERIALS, V28, P3091, DOI 10.1016/j.biomaterials.2007.03.017; Hwang YS, 2010, TISSUE ENG PT A, V16, P3033, DOI [10.1089/ten.tea.2010.0045, 10.1089/ten.TEA.2010.0045]; Ishihara K, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0098-z; Jia SJ, 2012, J BIOSCI BIOENG, V113, P647, DOI 10.1016/j.jbiosc.2011.12.009; Kang HJ, 2014, J TISSUE ENG REGEN M, V8, P442, DOI 10.1002/term.1538; Kreuz PC, 2006, OSTEOARTHR CARTILAGE, V14, P1119, DOI 10.1016/j.joca.2006.05.003; Levett PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113216; Li C, 2012, J BIOMAT SCI-POLYM E, V23, P405, DOI 10.1163/092050610X551970; Little CJ, 2011, TISSUE ENG PART B-RE, V17, P213, DOI [10.1089/ten.TEB.2010.0572, 10.1089/ten.teb.2010.0572]; Liu S, 2015, J BIOMED MATER RES A, V103, P581, DOI 10.1002/jbm.a.35206; Liu XD, 2014, J BIOMED MATER RES B, V102, P1407, DOI 10.1002/jbm.b.33119; Luo ZW, 2015, BIOMATERIALS, V52, P463, DOI 10.1016/j.biomaterials.2015.01.001; Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309; Mow VC, 1999, CLIN ORTHOP RELAT R, pS204, DOI 10.1097/00003086-199910001-00021; POOLE AR, 1982, J CELL BIOL, V93, P921, DOI 10.1083/jcb.93.3.921; SETTON LA, 1993, J BIOMECH, V26, P581, DOI 10.1016/0021-9290(93)90019-B; Silva MMCG, 2006, BIOMATERIALS, V27, P5909, DOI 10.1016/j.biomaterials.2006.08.010; Steck E, 2010, TISSUE ENG PT A, V16, P3697, DOI 10.1089/ten.TEA.2009.0817; Sutherland AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121966; Van den Borne MPJ, 2007, OSTEOARTHR CARTILAGE, V15, P1397, DOI 10.1016/j.joca.2007.05.005; Wise JK, 2009, TISSUE ENG PT A, V15, P913, DOI 10.1089/ten.tea.2008.0109; Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041; Yang F, 2006, BIOMATERIALS, V27, P4923, DOI 10.1016/j.biomaterials.2006.05.028; Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037; Zhang WJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/746138; Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0	34	31	33	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145667	10.1371/journal.pone.0145667	http://dx.doi.org/10.1371/journal.pone.0145667			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695629	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092500066
J	Baranyai, T; Herczeg, K; Onodi, Z; Voszka, I; Modos, K; Marton, N; Nagy, G; Mager, I; Wood, MJ; El Andaloussi, S; Palinkas, Z; Kumar, V; Nagy, P; Kittel, A; Buzas, EI; Ferdinandy, P; Giricz, Z				Baranyai, Tamas; Herczeg, Kata; Onodi, Zsofia; Voszka, Istvan; Modos, Karoly; Marton, Nikolett; Nagy, Gyoergy; Maeger, Imre; Wood, Matthew J.; El Andaloussi, Samir; Palinkas, Zoltan; Kumar, Vikas; Nagy, Pater; Kittel, Agnes; Buzas, Edit Iren; Ferdinandy, Peter; Giricz, Zoltan			Isolation of Exosomes from Blood Plasma: Qualitative and Quantitative Comparison of Ultracentrifugation and Size Exclusion Chromatography Methods	PLOS ONE			English	Article							EXTRACELLULAR VESICLES; HEART	Background Exosomes are emerging targets for biomedical research. However, suitable methods for the isolation of blood plasma-derived exosomes without impurities have not yet been described. Aim Therefore, we investigated the efficiency and purity of exosomes isolated with potentially suitable methods; differential ultracentrifugation (UC) and size exclusion chromatography (SEC). Methods and Results Exosomes were isolated from rat and human blood plasma by various UC and SEC conditions. Efficiency was investigated at serial UC of the supernatant, while in case of SEC by comparing the content of exosomal markers of various fractions. Purity was assessed based on the presence of albumin. We found that the diameter of the majority of isolated particles fell into the size range of exosomes, however, albumin was also present in the preparations, when 1h UC at 4 degrees C was applied. Furthermore, with this method only a minor fraction of total exosomes could be isolated from blood as deduced from the constant amount of exosomal markers CD63 and TSG101 detected after serial UC of rat blood plasma samples. By using UC for longer time or with shorter sedimentation distance at 4 degrees C, or UC performed at 37 degrees C, exosomal yield increased, but albumin impurity was still observed in the isolates, as assessed by transmission electron microscopy, dynamic light scattering and immunoblotting against CD63, TSG101 and albumin. Efficiency and purity were not different in case of using further diluted samples. By using SEC with different columns, we have found that although a minor fraction of exosomes can be isolated without significant albumin content on Sepharose CL-4B or Sephacryl S-400 columns, but not on Sepharose 2B columns, the majority of exosomes co-eluted with albumin. Conclusion Here we show that it is feasible to isolate exosomes from blood plasma by SEC without significant albumin contamination albeit with low vesicle yield.	[Baranyai, Tamas; Onodi, Zsofia; Ferdinandy, Peter; Giricz, Zoltan] Semmelweis Univ, Dept Pharmacol & Pharmacotherapy, H-1085 Budapest, Hungary; [Herczeg, Kata; Voszka, Istvan; Modos, Karoly] Semmelweis Univ, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary; [Marton, Nikolett; Nagy, Gyoergy; Buzas, Edit Iren] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary; [Nagy, Gyoergy] Polyclin Hosp Bros St John God, Dept Rheumatol, Budapest, Hungary; [Maeger, Imre; Wood, Matthew J.; El Andaloussi, Samir] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Maeger, Imre] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia; [El Andaloussi, Samir] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Palinkas, Zoltan; Nagy, Pater] Natl Inst Oncol, Dept Mol Immunol & Toxicol, Budapest, Hungary; [Kumar, Vikas] NCBS, Ctr Cellular & Mol Platforms, Bangalore, Karnataka, India; [Kittel, Agnes] Hungarian Acad Sci, Inst Expt Med, Dept Pharmacol, Budapest, Hungary; [Ferdinandy, Peter] Pharmahungary Grp, Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University; University of Oxford; University of Tartu; Karolinska Institutet; National Institute of Oncology Hungary; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Pharmahungary Group	Giricz, Z (corresponding author), Semmelweis Univ, Dept Pharmacol & Pharmacotherapy, H-1085 Budapest, Hungary.	giricz.zoltan@med.semmelweis-univ.hu	Onódi, Zsófia/Q-3346-2017; Nagy, György/W-6254-2019; Wood, Matthew/HDN-1469-2022; Giricz, Zoltán/B-6990-2008; Onódi, Zsófia/AAT-1950-2021; Ferdinandy, Péter/H-9181-2019; Nagy, Peter/C-6768-2008	Onódi, Zsófia/0000-0002-3746-8016; Nagy, György/0000-0003-1198-3228; Giricz, Zoltán/0000-0003-2036-8665; Onódi, Zsófia/0000-0002-3746-8016; Kittel, Agnes/0000-0002-6888-7731; Marton, Nikolett/0000-0002-7351-6361; Wood, Matthew/0000-0002-5436-6011; Mager, Imre/0000-0003-2242-7227; Nagy, Peter/0000-0003-3393-235X	Hungarian Scientific Research Fund [OTKA PD 109051, OTKA NK 84043, OTKA NK 111958, OTKA K 109843]; Marie Curie Networks for Initial Training-ITN-FP7-PEOPLE-ITN [PITN-GA-2011-289033]; COST Action [BM1202 ME-HAD]; Hungarian Academy of Sciences; Estonian Research Council [PUT618]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Marie Curie Networks for Initial Training-ITN-FP7-PEOPLE-ITN; COST Action(European Cooperation in Science and Technology (COST)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Estonian Research Council(Estonian Research Council)	This work was supported by the Hungarian Scientific Research Fund (OTKA PD 109051, OTKA NK 84043, OTKA NK 111958, OTKA K 109843) and the following grants: Marie Curie Networks for Initial Training-ITN-FP7-PEOPLE-2011-ITN, PITN-GA-2011-289033 and COST Action BM1202 ME-HAD. P.N. and Z.G. hold a "Janos Bolyai Fellowship" from the Hungarian Academy of Sciences. I.M. is supported by the Estonian Research Council Grant PUT618.	Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Boing AN, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23430; Giricz Z, 2014, J MOL CELL CARDIOL, V68, P75, DOI 10.1016/j.yjmcc.2014.01.004; Gyorgy B, 2014, THROMB RES, V133, P285, DOI 10.1016/j.thromres.2013.11.010; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005; Kalra H, 2013, PROTEOMICS, V13, P3354, DOI 10.1002/pmic.201300282; Lobb RJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27031; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Momen-Heravi F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00162; Muller L, 2014, J IMMUNOL METHODS, V411, P55, DOI 10.1016/j.jim.2014.06.007; Nordin JZ, 2015, NANOMED-NANOTECHNOL, V11, P879, DOI 10.1016/j.nano.2015.01.003; Ong SG, 2014, CIRCULATION, V130, pS60, DOI 10.1161/CIRCULATIONAHA.113.007917; Osteikoetxea X, 2015, ORG BIOMOL CHEM, V13, P9775, DOI 10.1039/c5ob01451d; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Shelke GV, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24783; Shet AS, 2003, BLOOD, V102, P2678, DOI 10.1182/blood-2003-03-0693; Taylor DD, 2015, METHODS, V87, P3, DOI 10.1016/j.ymeth.2015.02.019; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; Wang XH, 2014, J MOL CELL CARDIOL, V74, P139, DOI 10.1016/j.yjmcc.2014.05.001; Welton JL, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27269; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360	25	367	380	8	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145686	10.1371/journal.pone.0145686	http://dx.doi.org/10.1371/journal.pone.0145686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690353	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000367092300094
J	Choveau, FS; Zhang, J; Bierbower, SM; Sharma, R; Shapiro, MS				Choveau, Frank S.; Zhang, Jie; Bierbower, Sonya M.; Sharma, Ramaswamy; Shapiro, Mark S.			The Role of the Carboxyl Terminus Helix C-D Linker in Regulating KCNQ3 K+ Current Amplitudes by Controlling Channel Trafficking	PLOS ONE			English	Article							SURFACE EXPRESSION; POTASSIUM CHANNELS; DETERMINANTS; DOMAIN; SIGNAL; MOTIF; IDENTIFICATION; DEACTIVATION; SENSITIVITY; SELECTIVITY	In the central and peripheral nervous system, the assembly of KCNQ3 with KCNQ2 as mostly heteromers, but also homomers, underlies "M-type" currents, a slowly-activating voltage-gated K+ current that plays a dominant role in neuronal excitability. KCNQ3 homomers yield much smaller currents compared to KCNQ2 or KCNQ4 homomers and KCNQ2/3 heteromers. This smaller current has been suggested to result either from divergent channel surface expression or from a pore that is more unstable in KCNQ3. Channel surface expression has been shown to be governed by the distal part of the C-terminus in which helices C and D are critical for channel trafficking and assembly. A sequence alignment of this region in KCNQ channels shows that KCNQ3 possesses a longer linker between helix C and D compared to the other KCNQ subunits. Here, we investigate the role of the extra residues of this linker on KCNQ channel expression. Deletion of these residues increased KCNQ3 current amplitudes. Total internal reflection fluorescence imaging and plasma membrane protein assays suggest that the increase in current is due to a higher surface expression of the channels. Conversely, introduction of the extra residues into the linker between helices C and D of KCNQ4 reduced current amplitudes by decreasing the number of KCNQ4 channels at the plasma membrane. Confocal imaging suggests a higher fraction of channels, which possess the extra residues of helix C-D linker, were retained within the endoplasmic reticulum. Such retention does not appear to lead to protein accumulation and activation of the unfolded protein response that regulates protein folding and maintains endoplasmic reticulum homeostasis. Taken together, we conclude that extra helix C-D linker residues play a role in KCNQ3 current amplitudes by controlling the exit of the channel from the endoplasmic reticulum.	[Choveau, Frank S.; Zhang, Jie; Bierbower, Sonya M.; Shapiro, Mark S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Sharma, Ramaswamy] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Shapiro, MS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.	shapirom@uthscsa.edu	Choveau, Frank/AFI-6500-2022; Choveau, Frank/AAF-3858-2022		National Institutes of Health [R01 NS150305, R56 NS153503]; UTHSCSA; NIH-NCI (CTRC at UTHSCSA) [P30 CA54174]; NIH-NIA [P01AG19316]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UTHSCSA; NIH-NCI (CTRC at UTHSCSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants R01 NS150305 and R56 NS153503 to M.S.S.; We thank Drs. Nikita Gamper and James D. Lechleiter for their constructive discussions. We thank Pamela Reed for her assistance with biochemistry assays and Exing Wang for his assistance with confocal imaging. All the confocal experiments were performed at the Core Optical Imaging Facility which is supported by UTHSCSA, NIH-NCI P30 CA54174 (CTRC at UTHSCSA) and NIH-NIA P01AG19316.	Alaimo A, 2009, J BIOL CHEM, V284, P20668, DOI 10.1074/jbc.M109.019539; ALMERS W, 1980, J GEN PHYSIOL, V75, P61, DOI 10.1085/jgp.75.1.61; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Gomez-Posada JC, 2010, J NEUROSCI, V30, P9316, DOI 10.1523/JNEUROSCI.0851-10.2010; Chakrapani S, 2011, NAT STRUCT MOL BIOL, V18, P67, DOI 10.1038/nsmb.1968; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; Choveau FS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00397; Choveau FS, 2012, BIOPHYS J, V102, P2499, DOI 10.1016/j.bpj.2012.04.019; Choveau FS, 2012, BIOPHYS J, V102, P2489, DOI 10.1016/j.bpj.2012.04.018; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cordero-Morales JF, 2011, BIOPHYS J, V100, P2387, DOI 10.1016/j.bpj.2011.01.073; Dahimene S, 2006, CIRC RES, V99, P1076, DOI 10.1161/01.RES.0000250262.12219.95; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; Hardt B, 2003, GLYCOBIOLOGY, V13, P159, DOI 10.1093/glycob/cwg013; Hernandez CC, 2009, J GEN PHYSIOL, V134, P437, DOI 10.1085/jgp.200910313; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Li Y, 2004, J NEUROSCI, V24, P5079, DOI 10.1523/JNEUROSCI.0882-04.2004; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; London B, 1997, CIRC RES, V81, P870; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Maljevic S, 2003, J PHYSIOL-LONDON, V548, P353, DOI 10.1113/jphysiol.2003.040980; MANDERS EMM, 1992, J CELL SCI, V103, P857; Manganas LN, 2001, P NATL ACAD SCI USA, V98, P14055, DOI 10.1073/pnas.241403898; Martinez-Marmol R, 2013, J CELL SCI, V126, P5681, DOI 10.1242/jcs.134825; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Nakajo K, 2008, J PHYSIOL-LONDON, V586, P2827, DOI 10.1113/jphysiol.2007.148601; Pahl HL, 1996, J CELL BIOL, V132, P511, DOI 10.1083/jcb.132.4.511; Pan N, 2009, CELL SIGNAL, V21, P349, DOI 10.1016/j.cellsig.2008.11.006; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; Seebohm G, 2005, J PHYSIOL-LONDON, V563, P359, DOI 10.1113/jphysiol.2004.080887; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Shim J, 2004, MOL BIOL CELL, V15, P4818, DOI 10.1091/mbc.E04-02-0108; Valiyaveetil FI, 2006, SCIENCE, V314, P1004, DOI 10.1126/science.1133415; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918; Zaika O, 2008, BIOPHYS J, V95, P5121, DOI 10.1529/biophysj.108.137604; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zhu J, 2005, BIOCHEM J, V388, P355, DOI 10.1042/BJ20041447; Zhu J, 2003, J BIOL CHEM, V278, P25558, DOI 10.1074/jbc.M207984200	57	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145367	10.1371/journal.pone.0145367	http://dx.doi.org/10.1371/journal.pone.0145367			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692086	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092300064
J	Felber, K; Elks, PM; Lecca, M; Roehl, HH				Felber, Katharina; Elks, Philip M.; Lecca, Maria; Roehl, Henry H.			Expression of osterix Is Regulated by FGF and Wnt/beta-Catenin Signalling during Osteoblast Differentiation	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; TRANSCRIPTION FACTOR OSTERIX; BONE-FORMATION; GENE-EXPRESSION; RETINOIC ACID; MAP-KINASE; ZEBRAFISH DEVELOPMENT; ALKALINE-PHOSPHATASE; MESODERM INDUCTION	Osteoblast differentiation from mesenchymal cells is regulated by multiple signalling pathways. Here we have analysed the roles of Fibroblast Growth Factor (FGF) and canonical Wingless-type MMTV integration site (Wnt/beta-Catenin) signalling pathways on zebrafish osteogenesis. We have used transgenic and chemical interference approaches to manipulate these pathways and have found that both pathways are required for osteoblast differentiation in vivo. Our analysis of bone markers suggests that these pathways act at the same stage of differentiation to initiate expression of the osteoblast master regulatory gene osterix (osx). We use two independent approaches that suggest that osx is a direct target of these pathways. Firstly, we manipulate signalling and show that osx gene expression responds with similar kinetics to that of known transcriptional targets of the FGF and Wnt pathways. Secondly, we have performed ChIP with transcription factors for both pathways and our data suggest that a genomic region in the first intron of osx mediates transcriptional activation. Based upon these data, we propose that FGF and Wnt/beta-Catenin pathways act in part by directing transcription of osx to promote osteoblast differentiation at sites of bone formation.	[Roehl, Henry H.] Univ Sheffield, Bateson Ctr, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield	Roehl, HH (corresponding author), Univ Sheffield, Bateson Ctr, Sheffield S10 2TN, S Yorkshire, England.	h.roehl@sheffield.ac.uk			Wellcome Trust UK [072346/Z/03/Z]; Cancer Research UK [C11413/A4072]; Medical Research Council UK [MR/J001457/1]; MRC [MR/J001457/1] Funding Source: UKRI; Medical Research Council [MR/J001457/1] Funding Source: researchfish	Wellcome Trust UK(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the following grant sponsors: HHR: Wellcome Trust UK, 072346/Z/03/Z; Cancer Research UK, C11413/A4072; and Medical Research Council UK, MR/J001457/1.	Ambrosetti D, 2008, MOL CELL BIOL, V28, P4759, DOI 10.1128/MCB.01849-07; Avaron F, 2006, DEV DYNAM, V235, P478, DOI 10.1002/dvdy.20619; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Christen B, 1999, DEVELOPMENT, V126, P119; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; DeLaurier A, 2010, GENESIS, V48, P505, DOI 10.1002/dvg.20639; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Felber K, 2011, MECH DEVELOP, V128, P141, DOI 10.1016/j.mod.2010.11.006; Flores MV, 2004, GENE EXPR PATTERNS, V4, P573, DOI 10.1016/j.modgep.2004.01.016; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hammond CL, 2009, DEVELOPMENT, V136, P3991, DOI 10.1242/dev.042150; Hartmann C, 2007, MOL CELLS, V24, P177; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Huycke TR, 2012, DEVELOPMENT, V139, P2371, DOI 10.1242/dev.079806; Huysseune A., 2000, P307, DOI 10.1016/B978-012529650-2/50024-X; Jackson RA, 2006, GENE, V379, P79, DOI 10.1016/j.gene.2006.04.028; Jeon E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043982; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; LABONNE C, 1995, DEVELOPMENT, V121, P1475; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Laue K, 2008, DEVELOPMENT, V135, P3775, DOI 10.1242/dev.021238; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lerner UH, 2015, J INTERN MED, V277, P630, DOI 10.1111/joim.12368; Li N, 2010, DEVELOPMENT, V137, P389, DOI 10.1242/dev.044164; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Milat F, 2009, MOL CELL ENDOCRINOL, V310, P52, DOI 10.1016/j.mce.2009.06.002; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pinto JP, 2005, J BONE MINER RES, V20, P1440, DOI 10.1359/JBMR.050318; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Renn J, 2009, DEV DYNAM, V238, P241, DOI 10.1002/dvdy.21836; RODAN SB, 1989, J BIOL CHEM, V264, P19934; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Sawada A, 2001, DEVELOPMENT, V128, P4873; Shimizu-Sasaki K, 2001, J BIOL CHEM, V276, P5459, DOI 10.1074/jbc.M008971200; Simon MA, 2000, CELL, V103, P13, DOI 10.1016/S0092-8674(00)00100-8; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Stevens JR, 2010, J BONE MINER RES, V25, P2138, DOI 10.1002/jbmr.118; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Su N, 2008, FRONT BIOSCI-LANDMRK, V13, P2842, DOI 10.2741/2890; Tan SH, 2014, P NATL ACAD SCI USA, V111, pE5262, DOI 10.1073/pnas.1420463111; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; van der Meulen T, 2005, BBA-GENE STRUCT EXPR, V1729, P105, DOI 10.1016/j.bbaexp.2005.03.008; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Witten PE, 2009, BIOL REV, V84, P315, DOI 10.1111/j.1469-185X.2009.00077.x; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang X, 2002, BIOCHEM BIOPH RES CO, V290, P526, DOI 10.1006/bbrc.2001.6217	66	33	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144982	10.1371/journal.pone.0144982	http://dx.doi.org/10.1371/journal.pone.0144982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689368	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300028
J	Segers, FJJ; Meijer, M; Houbraken, J; Samson, RA; Wosten, HAB; Dijksterhuis, J				Segers, Frank J. J.; Meijer, Martin; Houbraken, Jos; Samson, Robert A.; Wosten, Han A. B.; Dijksterhuis, Jan			Xerotolerant Cladosporium sphaerospermum Are Predominant on Indoor Surfaces Compared to Other Cladosporium Species	PLOS ONE			English	Article							MOLECULAR DIAGNOSTICS; PHYLLOPLANE FUNGI; ALLERGEN; HEALTH; TEMPERATURE; ASPERGILLUS; TOLERANCE; AIRBORNE; ASTHMA; MOLDS	Indoor fungi are a major cause of cosmetic and structural damage of buildings worldwide and prolonged exposure of these fungi poses a health risk. Aspergillus, Penicillium and Cladosporium species are the most predominant fungi in indoor environments. Cladosporium species predominate under ambient conditions. A total of 123 Cladosporium isolates originating from indoor air and indoor surfaces of archives, industrial factories, laboratories, and other buildings from four continents were identified by sequencing the internal transcribed spacer (ITS), and a part of the translation elongation factor 1 alpha gene (TEF) and actin gene (ACT). Species from the Cladosporium sphaerospermum species complex were most predominant representing 44.7% of all isolates, while the Cladosporium cladosporioides and Cladosporium herbarum species complexes represented 33.3% and 22.0%, respectively. The contribution of the C. sphaerospermum species complex was 23.1% and 58.2% in the indoor air and isolates from indoor surfaces, respectively. Isolates from this species complex showed growth at lower water activity (>= 0.82) when compared to species from the C. cladosporioides and C. herbarum species complexes (>= 0.85). Together, these data indicate that xerotolerance provide the C. sphaerospermum species complex advantage in colonizing indoor surfaces. As a consequence, C. sphaerospermum are proposed to be the most predominant fungus at these locations under ambient conditions. Findings are discussed in relation to the specificity of allergy test, as the current species of Cladosporium used to develop these tests are not the predominant indoor species.	[Segers, Frank J. J.; Meijer, Martin; Houbraken, Jos; Samson, Robert A.; Dijksterhuis, Jan] CBS KNAW Fungal Biodivers Ctr, Appl & Ind Mycol, NL-3584 CT Utrecht, Netherlands; [Wosten, Han A. B.] Univ Utrecht, Microbiol, NL-3584 CH Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Utrecht University	Dijksterhuis, J (corresponding author), CBS KNAW Fungal Biodivers Ctr, Appl & Ind Mycol, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	j.dijksterhuis@cbs.knaw.nl	Houbraken, Jos/AAE-7955-2019; Dijksterhuis, Jan/K-5945-2014; Dijksterhuis, Jan/AAQ-3652-2020; Samson, Robert/ABE-6704-2020; Wösten, Han AB/K-2769-2016	Houbraken, Jos/0000-0003-4893-4438; Dijksterhuis, Jan/0000-0002-2649-1704; Dijksterhuis, Jan/0000-0002-2649-1704; Wösten, Han AB/0000-0002-0399-3648; Samson, Robert A./0000-0002-2979-3097	Dutch Technology Foundation STW, Netherlands Organization for Scientific Research (NWO); Ministry of Economic Affairs [11117]; Alfred Sloan foundation	Dutch Technology Foundation STW, Netherlands Organization for Scientific Research (NWO)(Technologiestichting STWNetherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs; Alfred Sloan foundation(Alfred P. Sloan Foundation)	This research was supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO), and which is partly funded by the Ministry of Economic Affairs. Project number 11117 http://www.stw.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO), and which is partly funded by the Ministry of Economic Affairs. A part of the isolates were obtained during the experiments of the IMBOL project and we would also like to thank the Alfred Sloan foundation for their support. We received several indoor isolates from the Technical University of Denmark (DTU) and thank Birgitte Andersen for this contribution to the collection. We thank Marina van Houten for technical assistance.	Adams RI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078866, 10.1371/journal.pone.0067861]; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Andersen B, 2011, APPL ENVIRON MICROB, V77, P4180, DOI 10.1128/AEM.02513-10; Bensch K, 2012, STUD MYCOL, P1, DOI 10.3114/sim0003; Bensch K, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.67.01; Bonnefoy X, 2007, INT J ENVIRON POLLUT, V30, P411, DOI 10.1504/IJEP.2007.014819; Bonnefoy XR, 2003, AM J PUBLIC HEALTH, V93, P1559, DOI 10.2105/AJPH.93.9.1559; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Chauhan D, 2010, P NATL A SCI INDIA B, V80, P254; de Hoog GS, 1998, MYCOSES, V41, P183, DOI 10.1111/j.1439-0507.1998.tb00321.x; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Flannigan B., 2001, MICROORGANISMS HOME, DOI [10.1201/9780203302934, DOI 10.1201/9780203302934]; FRADKIN A, 1987, JAPCA J AIR WASTE MA, V37, P51, DOI 10.1080/08940630.1987.10466201; de Ana SG, 2006, J INVEST ALLERG CLIN, V16, P357; Gunde-Cimerman N, 2003, PHYS CHEM EARTH, V28, P1273, DOI 10.1016/j.pce.2003.08.056; Heinzerling Lucie, 2013, Clin Transl Allergy, V3, P3, DOI 10.1186/2045-7022-3-3; HORNER WE, 1995, CLIN MICROBIOL REV, V8, P161, DOI 10.1128/CMR.8.2.161; Horner WE, 2004, APPL ENVIRON MICROB, V70, P6394, DOI 10.1128/AEM.70.11.6394-6400.2004; Houbraken J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.70.01; Katoh K, 2012, BIOINFORMATICS, V28, P3144, DOI 10.1093/bioinformatics/bts578; LI DW, 1995, MYCOLOGIA, V87, P190, DOI 10.2307/3760904; Mari A, 2009, CURR ALLERGY ASTHM R, V9, P376, DOI 10.1007/s11882-009-0055-9; Matheson MC, 2005, CLIN EXP ALLERGY, V35, P907, DOI 10.1111/j.1365-2222.2005.02272.x; McGinnis MR, 2007, MED MYCOL, V45, P1, DOI 10.1080/13693780600928495; Moody SA, 1999, MYCOL RES, V103, P1469, DOI 10.1017/S0953756299008783; Ng KP, 2012, EUKARYOT CELL, V11, P705, DOI 10.1128/EC.00081-12; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; PARK D, 1982, T BRIT MYCOL SOC, V79, P174, DOI 10.1016/S0007-1536(82)80212-X; Pasanen P, 1997, ENVIRON INT, V23, P425, DOI 10.1016/S0160-4120(97)00027-5; Pinar G, 2013, INT BIODETER BIODEGR, V84, P388, DOI 10.1016/j.ibiod.2012.02.008; Poll V, 2009, MOL IMMUNOL, V46, P1360, DOI 10.1016/j.molimm.2008.11.017; Polizzi V, 2009, J ENVIRON MONITOR, V11, P1849, DOI 10.1039/b906856b; Reboux G, 2010, REV FR ALLERGOL, V50, P611, DOI 10.1016/j.reval.2010.03.009; Samson RA, 2010, FOOD INDOOR FUNGI; Samson RA, 2011, FUNDAMENTALS OF MOLD GROWTH IN INDOOR ENVIRONMENTS AND STRATEGIES FOR HEALTHY LIVING, P101; Schubert K, 2007, STUD MYCOL, P105, DOI 10.3114/sim.2007.58.05; Simon-Nobbe B, 2006, J BIOL CHEM, V281, P16354, DOI 10.1074/jbc.M513638200; Sterflinger K, 1998, ANTON LEEUW INT J G, V74, P271, DOI 10.1023/A:1001753131034; Sterflinger K, 2012, ENVIRON MICROBIOL, V14, P559, DOI 10.1111/j.1462-2920.2011.02584.x; Sundell J, 2004, INDOOR AIR, V14, P51, DOI 10.1111/j.1600-0668.2004.00273.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van den Ende AHGG, 1999, STUD MYCOL, P151; Zalar P, 2007, STUD MYCOL, P157, DOI 10.3114/sim.2007.58.06	45	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145415	10.1371/journal.pone.0145415	http://dx.doi.org/10.1371/journal.pone.0145415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690349	gold, Green Submitted, Green Published			2022-12-27	WOS:000367092300074
J	Thakore-Shah, K; Koleilat, T; Jan, M; John, A; Pyle, AD				Thakore-Shah, Kaushali; Koleilat, Tasneem; Jan, Majib; John, Alan; Pyle, April D.			REST/NRSF Knockdown Alters Survival, Lineage Differentiation and Signaling in Human Embryonic Stem Cells	PLOS ONE			English	Article							TARGET GENES; NEURONAL GENES; IN-VIVO; REST NRSF; TRANSCRIPTION; REPRESSOR; PROTEIN; PLURIPOTENCY; NEUROGENESIS; EXPRESSION	REST (RE1 silencing transcription factor), also known as NRSF (neuron-restrictive silencer factor), is a well-known transcriptional repressor of neural genes in non-neural tissues and stem cells. Dysregulation of REST activity is thought to play a role in diverse diseases including epilepsy, cancer, Down's syndrome and Huntington's disease. The role of REST/NRSF in control of human embryonic stem cell (hESC) fate has never been examined. To evaluate the role of REST in hESCs we developed an inducible REST knockdown system and examined both growth and differentiation over short and long term culture. Interestingly, we have found that altering REST levels in multiple hESC lines does not result in loss of self-renewal but instead leads to increased survival. During differentiation, REST knockdown resulted in increased MAPK/ERK and WNT signaling and increased expression of mesendoderm differentiation markers. Therefore we have uncovered a new role for REST in regulation of growth and early differentiation decisions in human embryonic stem cells.	[Thakore-Shah, Kaushali; Pyle, April D.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Koleilat, Tasneem; Jan, Majib] Calif State Univ Northridge, Northridge, CA 91325 USA; [John, Alan; Pyle, April D.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Pyle, April D.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; California State University System; California State University Northridge; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Pyle, AD (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	apyle@mednet.ucla.edu			California Institute for Regenerative Medicine (CIRM) Bridges to Stem Cell Research Program; UCLA Jonsson Comprehensive Cancer Center (JCCC) grant; National Institutes of Health [P01GM081621]; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research (BSCRC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM) Bridges to Stem Cell Research Program; UCLA Jonsson Comprehensive Cancer Center (JCCC) grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research (BSCRC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TK and MJ were supported by the California Institute for Regenerative Medicine (CIRM) Bridges to Stem Cell Research Program. This work was supported in part by the UCLA Jonsson Comprehensive Cancer Center (JCCC) grant to ADP. ADP was also supported by the National Institutes of Health through grant P01GM081621, and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research (BSCRC).	Alva JA, 2011, STEM CELLS, V29, P1952, DOI 10.1002/stem.748; Aoki H, 2012, DEVELOPMENT, V139, P667, DOI 10.1242/dev.072272; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; Bingham AJ, 2007, MOL CELL BIOL, V27, P4082, DOI 10.1128/MCB.00269-07; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Buckley NJ, 2009, NATURE, V457, pE5, DOI 10.1038/nature07784; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Coulson J.M., 2005, CURR BIOL, V15, P666; Damoiseaux R, 2009, STEM CELLS, V27, P533, DOI 10.1634/stemcells.2008-0596; Duhamel S, 2012, CANCER RES, V72, P626, DOI 10.1158/0008-5472.CAN-11-2126; Fazeli A, 2011, INT J DEV BIOL, V55, P175, DOI 10.1387/ijdb.103177af; Formisano L, 2007, P NATL ACAD SCI USA, V104, P4170, DOI 10.1073/pnas.0611704104; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Jones FS, 1999, BIOESSAYS, V21, P372, DOI 10.1002/(SICI)1521-1878(199905)21:5<372::AID-BIES3>3.0.CO;2-3; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Lunyak VV, 2005, CELL, V121, P499, DOI 10.1016/j.cell.2005.05.003; Majumder S, 2006, CELL CYCLE, V5, P1929, DOI 10.4161/cc.5.17.2982; Pereira LA, 2012, STEM CELL RES, V8, P165, DOI 10.1016/j.scr.2011.09.007; Satoh J, 2013, BIOINFORM BIOL INSIG, V7, P357, DOI 10.4137/BBI.S13279; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Singh S. K., 2008, NATURE; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Wagoner MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000979; Weissman AM, 2008, CANCER CELL, V13, P381, DOI 10.1016/j.ccr.2008.04.011; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Yamada Y, 2010, CELL STEM CELL, V6, P10, DOI 10.1016/j.stem.2009.12.003; Zeng XM, 2004, RESTOR NEUROL NEUROS, V22, P421; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145280	10.1371/journal.pone.0145280	http://dx.doi.org/10.1371/journal.pone.0145280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690059	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092300053
J	Tulstrup, MVL; Christensen, EG; Carvalho, V; Linninge, C; Ahrne, S; Hojberg, O; Licht, TR; Bahl, MI				Tulstrup, Monica Vera-Lise; Christensen, Ellen Gerd; Carvalho, Vera; Linninge, Caroline; Ahrne, Siv; Hojberg, Ole; Licht, Tine Rask; Bahl, Martin Iain			Antibiotic Treatment Affects Intestinal Permeability and Gut Microbial Composition in Wistar Rats Dependent on Antibiotic Class	PLOS ONE			English	Article							EPITHELIAL BARRIER FUNCTION; ELECTRICAL-RESISTANCE; TIGHT; BUTYRATE; MODEL; MICE; BIFIDOBACTERIA; COLONIZATION; INFLAMMATION; FERMENTATION	Antibiotics are frequently administered orally to treat bacterial infections not necessarily related to the gastrointestinal system. This has adverse effects on the commensal gut microbial community, as it disrupts the intricate balance between specific bacterial groups within this ecosystem, potentially leading to dysbiosis. We hypothesized that modulation of community composition and function induced by antibiotics affects intestinal integrity depending on the antibiotic administered. To address this a total of 60 Wistar rats (housed in pairs with 6 cages per group) were dosed by oral gavage with either amoxicillin (AMX), cefotaxime (CTX), vancomycin (VAN), metronidazole (MTZ), or water (CON) daily for 10-11 days. Bacterial composition, alpha diversity and caecum short chain fatty acid levels were significantly affected by AMX, CTX and VAN, and varied among antibiotic treatments. A general decrease in diversity and an increase in the relative abundance of Proteobacteria was observed for all three antibiotics. Additionally, the relative abundance of Bifidobacteriaceae was increased in the CTX group and both Lactobacillaceae and Verrucomicrobiaceae were increased in the VAN group compared to the CON group. No changes in microbiota composition or function were observed following MTZ treatment. Intestinal permeability to 4 kDa FITC-dextran decreased after CTX and VAN treatment and increased following MTZ treatment. Plasma haptoglobin levels were increased by both AMX and CTX but no changes in expression of host tight junction genes were found in any treatment group. A strong correlation between the level of caecal succinate, the relative abundance of Clostridiaceae 1 family in the caecum, and the level of acute phase protein haptoglobin in blood plasma was observed. In conclusion, antibiotic-induced changes in microbiota may be linked to alterations in intestinal permeability, although the specific interactions remain to be elucidated as changes in permeability did not always result from major changes in microbiota and vice versa.	[Tulstrup, Monica Vera-Lise; Christensen, Ellen Gerd; Carvalho, Vera; Licht, Tine Rask; Bahl, Martin Iain] Tech Univ Denmark, Natl Food Inst, Div Diet Dis prevent & Toxicol, Soborg, Denmark; [Linninge, Caroline; Ahrne, Siv] Lund Univ, Dept Food Technol Engn & Nutr, Lund, Sweden; [Hojberg, Ole] Aarhus Univ, Dept Anim Sci, Tjele, Denmark	Technical University of Denmark; Lund University; Aarhus University	Bahl, MI (corresponding author), Tech Univ Denmark, Natl Food Inst, Div Diet Dis prevent & Toxicol, Soborg, Denmark.	mbah@food.dtu.dk		Tulstrup, Monica Vera-Lise/0000-0002-2568-3982; Bahl, Martin Iain/0000-0003-1579-8038; Licht, Tine Rask/0000-0002-6399-9574	Danish Council for Independent Research, Technology and Production Sciences [DFF-1335-00092]; Royal Physiographic Society of Lund	Danish Council for Independent Research, Technology and Production Sciences(Det Frie Forskningsrad (DFF)); Royal Physiographic Society of Lund	The present work was funded by a grant from the Danish Council for Independent Research, Technology and Production Sciences (DFF-133500092) and The Royal Physiographic Society of Lund.	Anderson RC, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-316; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Bergmann KR, 2013, AM J PATHOL, V182, P1595, DOI 10.1016/j.ajpath.2013.01.013; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Canibe N, 2007, J ANIM SCI, V85, P2959, DOI 10.2527/jas.2006-744; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Christensen Ellen Gerd, 2014, BMC Res Notes, V7, P660, DOI 10.1186/1756-0500-7-660; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Commane DM, 2005, NUTR CANCER, V51, P102, DOI 10.1207/s15327914nc5101_14; Dubourg G, 2013, INT J ANTIMICROB AG, V41, P149, DOI 10.1016/j.ijantimicag.2012.10.012; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Perez-Cobas AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080201; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fak F, 2008, AM J PHYSIOL-GASTR L, V294, pG148, DOI 10.1152/ajpgi.00023.2007; Ferreyra JA, 2014, CELL HOST MICROBE, V16, P770, DOI 10.1016/j.chom.2014.11.003; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hviid A, 2011, GUT, V60, P49, DOI 10.1136/gut.2010.219683; JENSEN MT, 1995, ANIM SCI, V61, P293, DOI 10.1017/S1357729800013837; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Jiang PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044929; John LJ, 2011, ANTIOXID REDOX SIGN, V15, P1255, DOI 10.1089/ars.2011.3892; Kanauchi O, 1999, J GASTROEN HEPATOL, V14, P880, DOI 10.1046/j.1440-1746.1999.01971.x; Klingberg TD, 2005, APPL ENVIRON MICROB, V71, P7528, DOI 10.1128/AEM.71.11.7528-7530.2005; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Lofmark S, 2010, CLIN INFECT DIS, V50, pS16, DOI 10.1086/647939; Lopez P, 2012, FOOD RES INT, V46, P99, DOI 10.1016/j.foodres.2011.11.020; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Maccaferri S, 2010, J ANTIMICROB CHEMOTH, V65, P2556, DOI 10.1093/jac/dkq345; Macfarlane S, 2014, ENVIRON MICROBIOL, V16, P919, DOI 10.1111/1462-2920.12399; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Nejrup RG, 2015, BR J NUTR, P1; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Putaala H, 2008, RES MICROBIOL, V159, P692, DOI 10.1016/j.resmic.2008.08.002; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Schroedl W, 2014, SCAND J IMMUNOL, V79, P299, DOI 10.1111/sji.12161; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Wang HB, 2012, DIGEST DIS SCI, V57, P3126, DOI 10.1007/s10620-012-2259-4; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Zhang YC, 2014, TOXICOL APPL PHARM, V277, P138, DOI 10.1016/j.taap.2014.03.009	47	132	137	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144854	10.1371/journal.pone.0144854	http://dx.doi.org/10.1371/journal.pone.0144854			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691591	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092300021
J	Matula, P; Maska, M; Sorokin, DV; Matula, P; Ortiz-de-Solorzano, C; Kozubek, M				Matula, Pavel; Maska, Martin; Sorokin, Dmitry V.; Matula, Petr; Ortiz-de-Solorzano, Carlos; Kozubek, Michal			Cell Tracking Accuracy Measurement Based on Comparison of Acyclic Oriented Graphs	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY IMAGES; LINEAGE CONSTRUCTION; MANUAL VALIDATION; LEVEL SETS; SEGMENTATION; MIGRATION; SYSTEM	Tracking motile cells in time-lapse series is challenging and is required in many biomedical applications. Cell tracks can be mathematically represented as acyclic oriented graphs. Their vertices describe the spatio-temporal locations of individual cells, whereas the edges represent temporal relationships between them. Such a representation maintains the knowledge of all important cellular events within a captured field of view, such as migration, division, death, and transit through the field of view. The increasing number of cell tracking algorithms calls for comparison of their performance. However, the lack of a standardized cell tracking accuracy measure makes the comparison impracticable. This paper defines and evaluates an accuracy measure for objective and systematic benchmarking of cell tracking algorithms. The measure assumes the existence of a ground-truth reference, and assesses how difficult it is to transform a computed graph into the reference one. The difficulty is measured as a weighted sum of the lowest number of graph operations, such as split, delete, and add a vertex and delete, add, and alter the semantics of an edge, needed to make the graphs identical. The measure behavior is extensively analyzed based on the tracking results provided by the participants of the first Cell Tracking Challenge hosted by the 2013 IEEE International Symposium on Biomedical Imaging. We demonstrate the robustness and stability of the measure against small changes in the choice of weights for diverse cell tracking algorithms and fluorescence microscopy datasets. As the measure penalizes all possible errors in the tracking results and is easy to compute, it may especially help developers and analysts to tune their algorithms according to their needs.	[Matula, Pavel; Maska, Martin; Sorokin, Dmitry V.; Matula, Petr; Kozubek, Michal] Masaryk Univ, Fac Informat, Ctr Biomed Image Anal, Brno, Czech Republic; [Matula, Pavel] Acad Sci Czech Republic, Inst Biophys, Dept Mol Cytol & Cytometry, CS-61265 Brno, Czech Republic; [Ortiz-de-Solorzano, Carlos] Univ Navarra, Canc Imaging Lab, Ctr Appl Med Res, E-31080 Pamplona, Spain	Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of Navarra	Matula, P (corresponding author), Bot 68a, Brno 60200, Czech Republic.	pam@fi.muni.cz	Matula, Petr/L-2119-2013; Sorokin, Dmitry V./J-1764-2016; Kozubek, Michal/G-8939-2013; Matula, Pavel/AAN-9794-2021; Matula, Pavel/G-2141-2014; Ortiz-de-Solorzano, Carlos/G-3278-2010; Maška, Martin/J-3302-2013	Matula, Petr/0000-0003-4125-1597; Sorokin, Dmitry V./0000-0003-3299-2545; Kozubek, Michal/0000-0001-7902-589X; Matula, Pavel/0000-0001-9797-4853; Matula, Pavel/0000-0001-9797-4853; Ortiz-de-Solorzano, Carlos/0000-0001-8720-0205; Maška, Martin/0000-0003-3544-6494	Czech Science Foundation [GA14-22461S, 13-07822S]; European Social Fund; Czech Ministry of Education [CZ.1.07/2.3.00/30.0009, CZ.1.07/2.3.00/30.0030]; Spanish Ministry of Economy and Competitiveness [DPI2012-38090-C03-02]	Czech Science Foundation(Grant Agency of the Czech Republic); European Social Fund(European Social Fund (ESF)); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the Czech Science Foundation (GA14-22461S to Petr Matula and 13-07822S to Pavel Matula), the European Social Fund and the Czech Ministry of Education (CZ.1.07/2.3.00/30.0009 to MM, CZ.1.07/2.3.00/30.0030 to DVS), and the Spanish Ministry of Economy and Competitiveness (DPI2012-38090-C03-02 to COS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kofahi O, 2006, CELL CYCLE, V5, P327, DOI 10.4161/cc.5.3.2426; Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Bergeest JP, 2012, MED IMAGE ANAL, V16, P1436, DOI 10.1016/j.media.2012.05.012; Chenouard N, 2014, NAT METHODS, V11, P281, DOI 10.1038/nmeth.2808; Degerman J, 2009, J MICROSC-OXFORD, V233, P178, DOI 10.1111/j.1365-2818.2008.03108.x; Dufour A, 2011, IEEE T IMAGE PROCESS, V20, P1925, DOI 10.1109/TIP.2010.2099125; Dzyubachyk O, 2010, IEEE T MED IMAGING, V29, P852, DOI 10.1109/TMI.2009.2038693; Harder N, 2015, CYTOM PART A, V87A, P524, DOI 10.1002/cyto.a.22632; Huth J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-24; Kan A, 2011, J MICROSC-OXFORD, V244, P194, DOI 10.1111/j.1365-2818.2011.03529.x; Kan A, 2015, PATTERN RECOGN LETT, V53, P38, DOI 10.1016/j.patrec.2014.11.005; Kan A, 2013, PATTERN RECOGN, V46, P2849, DOI 10.1016/j.patcog.2013.04.007; Kasturi R, 2009, IEEE T PATTERN ANAL, V31, P319, DOI 10.1109/TPAMI.2008.57; Li FH, 2010, IEEE T MED IMAGING, V29, P96, DOI 10.1109/TMI.2009.2027813; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Magnusson KEG, 2015, IEEE T MED IMAGING, V34, P911, DOI 10.1109/TMI.2014.2370951; Maska M, 2014, BIOINFORMATICS, V30, P1609, DOI 10.1093/bioinformatics/btu080; Maska M, 2013, IEEE T MED IMAGING, V32, P995, DOI 10.1109/TMI.2013.2243463; Meijering E, 2009, SEMIN CELL DEV BIOL, V20, P894, DOI 10.1016/j.semcdb.2009.07.004; Padfield D, 2011, MED IMAGE ANAL, V15, P650, DOI 10.1016/j.media.2010.07.006; Padfield D, 2009, MED IMAGE ANAL, V13, P143, DOI 10.1016/j.media.2008.06.018; Smal I, 2008, IEEE T MED IMAGING, V27, P789, DOI 10.1109/TMI.2008.916964; Stegmaier J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090036; Svoboda D, 2012, P 9 INT C IM AN REC, P473; Svoboda D, 2009, CYTOM PART A, V75A, P494, DOI 10.1002/cyto.a.20714; Winter M, 2011, NAT PROTOC, V6, P1942, DOI 10.1038/nprot.2011.422; Zimmer C, 2006, IEEE SIGNAL PROC MAG, V23, P54, DOI 10.1109/MSP.2006.1628878	27	36	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144959	10.1371/journal.pone.0144959	http://dx.doi.org/10.1371/journal.pone.0144959			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683608	Green Published, gold, Green Submitted			2022-12-27	WOS:000366725800027
J	Miller, CB; Kyle, SD; Gordon, CJ; Espie, CA; Grunstein, RR; Mullins, AE; Postnova, S; Bartlett, DJ				Miller, Christopher B.; Kyle, Simon D.; Gordon, Christopher J.; Espie, Colin A.; Grunstein, Ronald R.; Mullins, Anna E.; Postnova, Svetlana; Bartlett, Delwyn J.			Physiological Markers of Arousal Change with Psychological Treatment for Insomnia: A Preliminary Investigation	PLOS ONE			English	Article							SLEEP RESTRICTION THERAPY; HEAT-LOSS; TEMPERATURE; PHASE; INITIATION; TIME	Objectives The aim of this preliminary study was to evaluate if Sleep Restriction Therapy for insomnia is associated with modifications to physiological arousal, indexed through overnight measures of plasma cortisol concentrations and core body temperature. Methods In a pre-to-post open label study design, eleven patients with chronic and severe Psychophysiological Insomnia underwent 5 weeks of Sleep Restriction Therapy. Results Eight (73%) patients out of 11 consented completed therapy and showed a decrease in insomnia severity pre-to-post treatment (mean (SD): 18.1 (2.8) versus 8.4 (4.8); p =.001). Six patients were analyzed with pre-to-post overnight measures of temperature and cortisol. Contrary to our hypothesis, significantly higher levels of plasma cortisol concentrations were found during the early morning at post-treatment compared to baseline (p < .01), while no change was observed in the pre-sleep phase or early part of the night. Core body temperature during sleep was however reduced significantly (overall mean [95% CI]: 36.54 (degrees C) [36.3, 36.8] versus 36.45 [36.2, 36.7]; p < .05). Conclusions Sleep Restriction Therapy therefore was associated with increased early morning cortisol concentrations and decreased core body temperature, supporting the premise of physiological changes in functioning after effective therapy. Future work should evaluate change in physiological variables associated with clinical treatment response.	[Miller, Christopher B.; Gordon, Christopher J.; Grunstein, Ronald R.; Mullins, Anna E.; Bartlett, Delwyn J.] Univ Sydney, NeuroSleep & Woolcock Inst Med Res, CIRUS, Sydney, NSW 2006, Australia; [Kyle, Simon D.; Espie, Colin A.] Univ Oxford, Nuffield Dept Clin Neurosci, Sleep & Circadian Neurosci Inst, Oxford, England; [Gordon, Christopher J.] Univ Sydney, Sydney Nursing Sch, Sydney, NSW 2006, Australia; [Grunstein, Ronald R.] Sydney Local Hlth Dist, RPAH, Dept Resp & Sleep Med, Sydney, NSW, Australia; [Postnova, Svetlana] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Oxford; University of Sydney; University of Sydney	Miller, CB (corresponding author), Univ Sydney, NeuroSleep & Woolcock Inst Med Res, CIRUS, Sydney, NSW 2006, Australia.	chris.miller@sydney.edu.au	Miller, Christopher/E-6752-2013	Miller, Christopher/0000-0002-2936-7717; Kyle, Simon/0000-0002-9581-5311; Espie, Colin/0000-0002-1294-8734; Postnova, Svetlana/0000-0002-1224-0779; Mullins, Anna/0000-0002-5143-6977	National Health and Medical Research Council (NHMRC, Australia) Centres for Integrated Research and Understanding of Sleep (CIRUS) [571421, 1060992]; Sackler Institute of Psychobiological Research (University of Glasgow Sleep Centre, Scotland, UK); Chief Scientist Office (Scotland, UK) [CZG/2/503]	National Health and Medical Research Council (NHMRC, Australia) Centres for Integrated Research and Understanding of Sleep (CIRUS)(National Health and Medical Research Council (NHMRC) of Australia); Sackler Institute of Psychobiological Research (University of Glasgow Sleep Centre, Scotland, UK); Chief Scientist Office (Scotland, UK)	This research was supported by the National Health and Medical Research Council (NHMRC, Australia) Centres for Integrated Research and Understanding of Sleep (CIRUS) 571421 & NeuroSleep 1060992; the Sackler Institute of Psychobiological Research (University of Glasgow Sleep Centre, Scotland, UK); and the Chief Scientist Office (Scotland, UK) CZG/2/503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM K, 1986, J PSYCHIAT RES, V20, P301, DOI 10.1016/0022-3956(86)90033-6; Backhaus J, 2004, PSYCHONEUROENDOCRINO, V29, P1184, DOI 10.1016/j.psyneuen.2004.01.010; BONNET MH, 1995, SLEEP, V18, P581, DOI 10.1093/sleep/18.7.581; Bonnet MH, 2010, SLEEP MED REV, V14, P9, DOI 10.1016/j.smrv.2009.05.002; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conroy Deirdre A, 2005, J Circadian Rhythms, V3, P3, DOI 10.1186/1740-3391-3-3; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; Fries E, 2009, INT J PSYCHOPHYSIOL, V72, P67, DOI 10.1016/j.ijpsycho.2008.03.014; Gradisar M, 2006, AM J PHYSIOL-REG I, V290, pR1115, DOI 10.1152/ajpregu.00266.2005; Iber C, 2007, AASM MANUAL SCORING; Krauchi K, 2007, SLEEP MED REV, V11, P439, DOI 10.1016/j.smrv.2007.07.001; KRAVITZ RL, 1993, ARCH INTERN MED, V153, P1869, DOI 10.1001/archinte.153.16.1869; Kyle SD, 2015, SLEEP MED REV, V23, P83, DOI 10.1016/j.smrv.2015.02.003; Kyle SD, 2014, SLEEP, V37, P229, DOI 10.5665/sleep.3386; Kyle SD, 2011, SLEEP MED, V12, P735, DOI 10.1016/j.sleep.2011.03.016; Lack LC, 2008, SLEEP MED REV, V12, P307, DOI 10.1016/j.smrv.2008.02.003; Lushington K, 2000, SLEEP, V23, P504; Miller CB, 2014, SLEEP MED REV, V18, P415, DOI 10.1016/j.smrv.2014.01.006; Miller CB, 2013, J SLEEP RES, V22, P266, DOI 10.1111/jsr.12024; MONROE LJ, 1967, J ABNORM PSYCHOL, V72, P255, DOI 10.1037/h0024563; Morin CM., 1993, INSOMNIA PSYCHOL ASS; Neff LM, 2014, CLIN STUDIES OBESITY, pSAT; O'Brien C, 1998, MED SCI SPORT EXER, V30, P468, DOI 10.1097/00005768-199803000-00020; Perlis M., 2011, PRINCIPLES PRACTICE, V5, P850, DOI [10.1016/B978-1-4160-6645-3.00078-5, DOI 10.1016/B978-1-4160-6645-3.00078-5]; Riemann D, 2015, LANCET NEUROL, V14, P547, DOI 10.1016/S1474-4422(15)00021-6; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Rodenbeck A, 2003, PSYCHOPHARMACOLOGY, V170, P423, DOI 10.1007/s00213-003-1565-0; Romeijn N, 2012, SLEEP, V35, P1673, DOI 10.5665/sleep.2242; SPIELMAN AJ, 1987, SLEEP, V10, P45; Spielman AJ., 1991, VARIED NATURE INSOMN, P1, DOI DOI 10.1007/978-1-4757-9586-8_1; Spielman AJ, 2010, MED PSYCHIATRY, P277; Stephenson LA, 1999, J APPL PHYSIOL, V86, P22, DOI 10.1152/jappl.1999.86.1.22; Vallieres Annie, 2013, Sleep Disord, V2013, P726372, DOI 10.1155/2013/726372; van den Heuvel C, 2006, SLEEP, V29, P1174, DOI 10.1093/sleep/29.9.1174; Van Dongen HPA, 1998, CHRONOBIOL INT, V15, P623, DOI 10.3109/07420529808993198; Vgontzas AN, 2013, SLEEP MED REV, V17, P241, DOI 10.1016/j.smrv.2012.09.005; Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P3787, DOI 10.1210/jc.86.8.3787; Vollenweider S, 2008, AM J PHYSIOL-REG I, V294, pR630, DOI 10.1152/ajpregu.00609.2007; YANOVSKI JA, 1993, JAMA-J AM MED ASSOC, V269, P2232, DOI 10.1001/jama.269.17.2232	40	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145317	10.1371/journal.pone.0145317	http://dx.doi.org/10.1371/journal.pone.0145317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9KM	26683607	Green Published, gold			2022-12-27	WOS:000366725800063
J	Sammarco, PW; Porter, SA; Genazzio, M; Sinclair, J				Sammarco, Paul W.; Porter, Scott A.; Genazzio, Melissa; Sinclair, James			Success in Competition for Space in Two Invasive Coral Species in the western Atlantic - Tubastraea micranthus and T-coccinea	PLOS ONE			English	Article							GULF-OF-MEXICO; INTERSPECIFIC AGGRESSION; NORTHERN GULF; SPONGE/CORAL INTERACTIONS; SCLERACTINIAN CORALS; EXPANSION; OVERGROWTH; DISPERSAL; OCTOCORALLIA; COMMUNITIES	Invasion success by an alien species is dependent upon rate of reproduction, growth, mortality, physical characteristics of the environment, and successful competition for resources with native species. For sessile, epibenthic marine species, one critical resource is space. We examined competitive success in two invasive Indo-Pacific corals involved in competition for space in the northern Gulf of Mexico-Tubastraea coccinea and T. micranthus-on up to 13 offshore oil/gas platforms south of the Mississippi River. Still-capture photos of thousands of overgrowth interactions between the target corals and other sessile epibenthic fauna were analyzed from ROV videos collected at 8-183 m depth. T. micranthus was observed overgrowing >90% of all sessile epibenthic species which it encountered. Frequencies of competitive success varied significantly between platforms. T. coccinea was competitively superior to all competitors pooled, at the 60% level. There was little variability between T. coccinea populations. T. coccinea encountered the following species most frequently-the encrusting sponges Xestospongia sp. (with the commensal Parazoanthus catenularis), X. carbonaria, Dictyonella funicularis, Mycale carmigropila, Phorbas amaranthus, and Haliclona vansoesti- and was found to be, on average, competitively superior to them. Both T. micranthus and T. coccinea appear to be good competitors for space against these species in the northern Gulf of Mexico. Competitive success in T. micranthus was highest in the NE part of the study area, and lowest in the SW area near the Mississippi River plume. T. coccinea's competitive success peaked in the SW study area. This suggests that variation in competitive success both within and between populations of these species may be due to differences in local environmental factors.	[Sammarco, Paul W.; Porter, Scott A.; Genazzio, Melissa] Louisiana Univ Marine Consortium LUMCON, Chauvin, LA 70344 USA; [Sammarco, Paul W.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Porter, Scott A.] EcoLog Environm Inc, Houma, LA 70361 USA; [Genazzio, Melissa] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28409 USA; [Sinclair, James] Bur Safety & Environm Enforcement, US Dept Interior, New Orleans, LA 70123 USA	Louisiana State University System; Louisiana State University; University of North Carolina; University of North Carolina Wilmington; United States Department of the Interior	Sammarco, PW (corresponding author), Louisiana Univ Marine Consortium LUMCON, 8124 Hwy 56, Chauvin, LA 70344 USA.	psammarco@lumcon.edu		Genazzio, Melissa A/0000-0002-0901-0331	U.S. Department of the Interior, Bureau of Ocean Energy Management (BOEM), Environmental Studies Program [M10AC20006]; US Dept. Interior, Minerals Management Service[MMS]/Bureau of Ocean Energy Management [BOEM/BSEE]; BOEM	U.S. Department of the Interior, Bureau of Ocean Energy Management (BOEM), Environmental Studies Program; US Dept. Interior, Minerals Management Service[MMS]/Bureau of Ocean Energy Management [BOEM/BSEE]; BOEM	This study was funded by the U.S. Department of the Interior, Bureau of Ocean Energy Management (BOEM), Environmental Studies Program through Interagency Agreement M10AC20006. PWS and SAP received the funding. Please note that the fourth author is a representative of the funding agency which supported this study (US Dept. Interior, Minerals Management Service[MMS]/Bureau of Ocean Energy Management [BOEM/BSEE]). This study was not part of a research "grant", but of a "cooperative research agreement" and a collaboration between my laboratory and this agency. Co-author Scott A. Porter is employed by EcoLogic Environmental, Inc. He is the proprietor and sole employee. EcoLogic Environmental, Inc. provided support in the form of salary for author SAP. SAP played a role in the study design, data collection and analysis, decision to publish and preparation of the manuscript. The specific role of this author is articulated in the 'authoor contributions' section.; We would like to express our hearty thanks to the many folks who provided us with assistance in the field and the laboratory: R/V Acadiana, LUMCON-C. Sevin, T. Widgeon, M. Wike; M/V Fling, Freeport, TX-B. Allen, K. Bush, K. Dies, M. McReynold, B. Oldham, M. Spurgeon, J. Tyler; US Air Force/NASA-D. Perrenod; ARACAR-John Blitch; LUMCON-D. Beltz (statistical analyses); Others-M. Gaskill. This study was funded by the U.S. Department of the Interior, Bureau of Ocean Energy Management (BOEM), Environmental Studies Program through Cooperative Agreement M10AC20006. We extend our thanks to BOEM for funding the study, administered through the Louisiana State University Coastal Marine Institute (CMI) program, under the direction of L. Rouse and S. Welsh.	Aerts LAM, 1998, MAR ECOL PROG SER, V175, P241, DOI 10.3354/meps175241; Aerts LAM, 1997, MAR ECOL PROG SER, V148, P125, DOI 10.3354/meps148125; Alamaru A, 2009, CORAL REEFS, V28, P865, DOI 10.1007/s00338-009-0507-7; ALINO PM, 1992, MAR ECOL PROG SER, V81, P129, DOI 10.3354/meps081129; Belote RT, 2004, NEW PHYTOL, V161, P827, DOI 10.1111/j.1469-8137.2004.00977.x; BEST MA, 1986, MAR BIOL, V93, P371, DOI 10.1007/BF00401104; BUSS LW, 1979, NATURE, V281, P475, DOI 10.1038/281475a0; Cairns Stephen D., 2000, Uitgaven Natuurwetenschappelijke Studiekring voor het Caraibisch Gebied, V143, P1; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Chadwick NE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P347, DOI 10.1007/978-94-007-0114-4_20; Coll J. C., 1992, 3 S SUR SUBST NAT IN, P227; COLL JC, 1989, CHEM SCRIPTA, V29, P383; Collin R, 2005, CARIBB J SCI, V41, P638; de Paula AF, 2004, B MAR SCI, V74, P175; Diez JM, 2008, ECOL LETT, V11, P674, DOI 10.1111/j.1461-0248.2008.01178.x; Dussuncao C, 2009, MIT PUBLICATION, V09-32; Engelhardt K.A.M., 2011, ENCY BIOL INVASIONS, P209; Fenner D, 2004, CORAL REEFS, V23, P505, DOI 10.1007/s00338-004-0422-x; Fenner D, 2001, B MAR SCI, V69, P1175; Gallaway BJ, 1981, 10BS8287 FWS OFF BIO; Griffiths RW, 1991, J SHELLFISH RES, V10, P1; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hennessey SM, 2014, J EXP MAR BIOL ECOL, V459, P144, DOI 10.1016/j.jembe.2014.05.021; Humann P., 2002, REEF CORAL IDENTIFIC; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; Johnson LE, 1996, ECOLOGY, V77, P1686, DOI 10.2307/2265774; LaJeunesse TC, 2005, CORAL REEFS, V24, P157, DOI 10.1007/s00338-004-0436-4; LANG J, 1973, B MAR SCI, V23, P260; LANG J, 1971, B MAR SCI, V21, P952; Lang JC, 1973, COMMUNICATION; LEWBEL GS, 1987, MAR ENVIRON RES, V21, P199, DOI 10.1016/0141-1136(87)90066-3; MAC ARTHUR ROBERT H., 1967; MacArthur R.H., 1972, pvii; Mangla S, 2011, PLANT ECOL, V212, P531, DOI 10.1007/s11258-011-9909-z; MCINTOSH AR, 1992, J FISH BIOL, V41, P63, DOI 10.1111/j.1095-8649.1992.tb03170.x; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; PORTER JW, 1988, BIOL BULL, V175, P230, DOI 10.2307/1541563; Preston DL, 2012, ECOLOGY, V93, P1254, DOI 10.1890/11-1821.1; Qasem J.R., 2001, J CROP PRODUCTION, V4, P43; Rejmanek M, 1996, ECOL STU AN, V122, P153; Rice EL, 1984, ALLELOPATHY PHYSL EC; RICHARDSON CA, 1979, MAR BIOL, V55, P181, DOI 10.1007/BF00396816; ROHLF F. J., 1996, BIOMSTAT WINDOWS STA; Rohlf FJ, 1981, STAT TABLES; Russell-Hunter W. D., 1968, BIOL LOWER INVERTEBR; Sammarco P.W., 1983, Coral Reefs, V1, P173, DOI 10.1007/BF00571194; Sammarco Paul W., 2013, Management of Biological Invasions, V4, P291; Sammarco PW, 2014, MAR ECOL PROG SER, V495, P161, DOI 10.3354/meps10576; Sammarco PW, 2012, J EXP MAR BIOL ECOL, V436, P36, DOI 10.1016/j.jembe.2012.08.009; Sammarco PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030144; Sammarco PW, 2010, AQUAT INVASIONS, V5, P131, DOI 10.3391/ai.2010.5.2.02; SAMMARCO PW, 1992, MAR ECOL PROG SER, V88, P93, DOI 10.3354/meps088093; SAMMARCO PW, 1980, J EXP MAR BIOL ECOL, V45, P245, DOI 10.1016/0022-0981(80)90061-1; SAMMARCO PW, 1982, J EXP MAR BIOL ECOL, V61, P31, DOI 10.1016/0022-0981(82)90020-X; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; Sammarco PW, 1982, THE REEF AND MAN, V1, P525; Secord D, 2003, BIOL INVASIONS, V5, P117, DOI 10.1023/A:1024054909052; Shearer T, 2008, 2008 OC SCI M WAT GL; SHEPPARD CRC, 1979, MAR ECOL PROG SER, V1, P237, DOI 10.3354/meps001237; Silva AG, 2011, AQUAT INVASIONS, V6, pS105, DOI 10.3391/ai.2011.6.S1.024; Sokal R. R, 1981, BIOMETRY; Sokal Robert R., 1969, BIOMETRY; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Stachowicz JJ, 2002, ECOLOGY, V83, P2575; Suchanek TH, 2002, SPONGES IMPORTANT SP; Thomsen MS, 2007, BIOL INVASIONS, V9, P499, DOI 10.1007/s10530-006-9043-3; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; WAHLE CM, 1980, SCIENCE, V209, P689, DOI 10.1126/science.209.4457.689; Wang JT, 2012, ZOOL STUD, V51, P150; Wonham MJ, 2000, MAR BIOL, V136, P1111, DOI 10.1007/s002270000303; Zea S, 2009, SPONGE GUIDE PICTURE	72	19	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144581	10.1371/journal.pone.0144581	http://dx.doi.org/10.1371/journal.pone.0144581			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684321	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800014
J	Thompson, AF; Crowe, ME; Lieven, CJ; Levin, LA				Thompson, Alex F.; Crowe, Megan E.; Lieven, Christopher J.; Levin, Leonard A.			Induction of Neuronal Morphology in the 661W Cone Photoreceptor Cell Line with Staurosporine	PLOS ONE			English	Article							MEDIATED DEATH; RGC-5; DIFFERENTIATION; APOPTOSIS; GLUTAMATE; TUMORS	Purpose RGC-5 cells undergo differentiation into a neuronal phenotype with low concentrations of staurosporine. Although the RGC-5 cell line was initially thought to be of retinal ganglion cell origin, recent evidence suggests that the RGC-5 line could have been the result of contamination with 661W mouse cone photoreceptor cells. This raised the possibility that a cone photoreceptor cell line could be multipotent and could be differentiated to a neuronal phenotype. Methods 661W and RGC-5 cells, non-neuronal retinal astrocytes, retinal endothelial cells, retinal pericytes, M21 melanoma cells, K562 chronic myelogenous leukemia cells, and Daudi Burkitt lymphoma cells, were differentiated with staurosporine. The resulting morphology was quantitated using NeuronJ with respect to neurite counts and topology. Results Treatment with staurosporine induced similar-appearing morphological differentiation in both 661W and RGC-5 cells. The following measures were not significantly different between 661W and RGC-5 cells: number of neurites per cell, total neurite field length, number of neurite branch points, and cell viability. Neuronal-like differentiation was not observed in the other cell lines tested. Conclusions 661W and RGC-5 cells have virtually identical and distinctive morphology when differentiated with low concentrations of staurosporine. This result demonstrates that a retinal neuronal precursor cell with cone photoreceptor lineage can be differentiated to express a neuronal morphology.	[Thompson, Alex F.; Crowe, Megan E.; Lieven, Christopher J.; Levin, Leonard A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA; [Levin, Leonard A.] McGill Univ, Dept Ophthalmol, Montreal, PQ H3A 2T5, Canada	University of Wisconsin System; University of Wisconsin Madison; McGill University	Levin, LA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA.	lalevin@wisc.edu		Thompson, Alex/0000-0003-4316-7532	National Eye Institute NIH [R21 EY017970, R21 EY025074, P30EY016665]; Retina Research Foundation; Research to Prevent Blindness, Inc.; NIH; NATIONAL EYE INSTITUTE [R21EY017970, R21EY025074, P30EY016665] Funding Source: NIH RePORTER	National Eye Institute NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Retina Research Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Eye Institute NIH R21 EY017970, R21 EY025074, and P30EY016665 (Core Grant), Retina Research Foundation (LAL), and an unrestricted departmental grant from Research to Prevent Blindness, Inc.; NIH R21 EY017970, R21 EY025074, and P30EY016665, Retina Research Foundation, and an unrestricted departmental grant from Research to Prevent Blindness, Inc. LAL is Canada Research Chair of Ophthalmology and Visual Sciences.	Al-Ubaidi MR, 2014, EXP EYE RES, V119, P115, DOI 10.1016/j.exer.2013.10.012; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; Boatright JH, 2013, MOL VIS, V19, P1848; BUMOL TF, 1982, P NATL ACAD SCI-BIOL, V79, P1245, DOI 10.1073/pnas.79.4.1245; Burugula B, 2011, INVEST OPHTH VIS SCI, V52, P4263, DOI 10.1167/iovs.10-7103; Fragoso MA, 2011, CELL MOL NEUROBIOL, V31, P163, DOI 10.1007/s10571-010-9603-z; Frassetto LJ, 2006, INVEST OPHTH VIS SCI, V47, P427, DOI 10.1167/iovs.05-0340; Ganapathy PS, 2010, CURR EYE RES, V35, P80, DOI 10.3109/02713680903421194; Harper MM, 2009, EXP EYE RES, V89, P538, DOI 10.1016/j.exer.2009.05.013; Kheirkhah A, 2013, INVEST OPHTH VIS SCI, V54; KLEIN E, 1968, CANCER RES, V28, P1300; Krishnamoorthy RR, 2013, INVEST OPHTH VIS SCI, V54, P5712, DOI 10.1167/iovs.13-12085; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kritis AA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00091; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; Lieven CJ, 2007, EXP EYE RES, V85, P678, DOI 10.1016/j.exer.2007.08.001; Lin S, 2009, MOL VIS, V15, P26; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Nieto PS, 2010, NEUROCHEM INT, V57, P216, DOI 10.1016/j.neuint.2010.05.013; Rock N, 2008, EXP EYE RES, V86, P492, DOI 10.1016/j.exer.2007.12.006; Scheef E, 2005, MOL VIS, V11, P613; Scheef EA, 2009, AM J PHYSIOL-CELL PH, V296, pC724, DOI 10.1152/ajpcell.00409.2008; Schnichels S, 2012, NEUROCHEM INT, V60, P581, DOI 10.1016/j.neuint.2012.02.017; Schultheiss M, 2012, GRAEF ARCH CLIN EXP, V250, P1221, DOI 10.1007/s00417-011-1906-3; Sheedlo HJ, 2007, IN VITRO CELL DEV-AN, V43, P361, DOI 10.1007/s11626-007-9051-3; Shi H, 2015, APOPTOSIS, V20, P433, DOI 10.1007/s10495-015-1091-7; Su XJ, 2003, MOL VIS, V9, P171; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Thompson AF, 2010, NEUROCHEM INT, V56, P554, DOI 10.1016/j.neuint.2009.12.018; Tsuruma K, 2012, J PHARMACOL SCI, V118, P351, DOI 10.1254/jphs.11110FP; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Wood JPM, 2010, INVEST OPHTH VIS SCI, V51, P3774, DOI 10.1167/iovs.09-4305; Yang MH, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/901329	33	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145270	10.1371/journal.pone.0145270	http://dx.doi.org/10.1371/journal.pone.0145270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684837	Green Submitted, gold, Green Published			2022-12-27	WOS:000366725800055
J	Nozhenko, Y; Asnani-Kishnani, M; Rodriguez, AM; Palou, A				Nozhenko, Yuriy; Asnani-Kishnani, Madhu; Rodriguez, Ana M.; Palou, Andreu			Milk Leptin Surge and Biological Rhythms of Leptin and Other Regulatory Proteins in Breastmilk	PLOS ONE			English	Article							GESTATIONAL CALORIE RESTRICTION; LACTATING MOTHERS; SERUM LEPTIN; FOOD-INTAKE; PLASMA ADIPONECTIN; CIRCADIAN-RHYTHM; PREVENTS OBESITY; LIPID-METABOLISM; ENERGY-BALANCE; DIURNAL RHYTHM	A significant number of chronic diseases are linked to perinatal nutrition, and prevention may be associated to naturally occurring components of breast milk. One key hormone in breast milk is leptin, related with the protection from obesity in the adulthood, thus knowing its changes through the day or lactation is crucial. We aimed to investigate the daily rhythms in the milk levels of leptin, together with other two related hormones, ghrelin and adiponectin, during lactation (days 5, 10 and 15) in rat dams, and the relation with morphometric parameters (dams and pups). Summarizing the main results, the existence of biological rhythms, but not daily and maybe circasemidian, was confirmed for the three hormones at the earliest period of lactation. The correlations performed generally showed a possible dependence of milk hormone levels on plasma levels at the early phase of lactation, while with the progression of lactation this dependence may fade and the hormone levels are suggested to be more dependent on mammary gland production/maturation. There was also a correlation between milk leptin and adiponectin levels, especially in the first half of lactation, suggesting a possible parallel regulation. Interestingly, we describe a milk leptin surge around the mid of lactation (at day 10) which may be related with pup's growth (males and females) and with the well-known (in the literature) plasma leptin surge in pups. All this knowledge may be crucial for future applications in the development of formula milk and in relation with the role of leptin surge during lactation.	[Rodriguez, Ana M.] UIB, Lab Mol Biol Nutr & Biotechnol Nutrigen, Palma De Mallorca, Balearic Island, Spain; CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Palma De Mallorca, Balearic Island, Spain	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Rodriguez, AM (corresponding author), UIB, Lab Mol Biol Nutr & Biotechnol Nutrigen, Palma De Mallorca, Balearic Island, Spain.	amrodriguez@uib.es	Palou, Andreu/K-9881-2014; Guerrero, Ana M. Rodriguez/H-6678-2015	Palou, Andreu/0000-0002-0295-4452; Guerrero, Ana M. Rodriguez/0000-0002-1559-6279	Spanish Government (project EPIMILK) [AGL2012-33692]; "Agencia Espanola de Cooperacion y Desarrollo" of the Spanish Ministry of Foreign Affairs and Cooperation; University of the Balearic Islands	Spanish Government (project EPIMILK); "Agencia Espanola de Cooperacion y Desarrollo" of the Spanish Ministry of Foreign Affairs and Cooperation; University of the Balearic Islands	This work was supported by the Spanish Government (project EPIMILK, AGL2012-33692, Principal Investigator AP). YN received a grant by "Agencia Espanola de Cooperacion y Desarrollo" of the Spanish Ministry of Foreign Affairs and Cooperation (http://www.aecid.es/es). MA received a grant by the University of the Balearic Islands (www.uib.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Spanish Government (project EPIMILK, AGL2012-33692, Principal Investigator AP). YN was granted by "Agencia Espanola de Cooperacion y Desarrollo" of the Spanish Ministry of Foreign Affairs and Cooperation (http://www.aecid.es/es). MA was granted by the University of the Balearic Islands (www.uib.es).	Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Bautista CJ, 2008, PEDIATR RES, V63, P358, DOI 10.1203/01.pdr.0000304938.78998.21; Bonnet M, 2002, J ANIM SCI, V80, P723; Bronsky J, 2011, J PEDIATR GASTR NUTR, V52, P474, DOI 10.1097/MPG.0b013e3182062fcc; Butte NF, 1997, J CLIN ENDOCR METAB, V82, P585, DOI 10.1210/jc.82.2.585; Casabiell X, 1997, J CLIN ENDOCR METAB, V82, P4270, DOI 10.1210/jc.82.12.4270; Cheung WW, 2012, ISRN ENDOCRINOL, V2012, P536905, DOI [DOI 10.5402/2012/536905, 10.5402/2012/536905]; Contreras C, 2013, HORM METAB RES, V45, P935, DOI 10.1055/s-0033-1351281; CRAMER CP, 1990, DEV PSYCHOBIOL, V23, P479, DOI 10.1002/dev.420230604; Cretenet G, 2010, CELL METAB, V11, P47, DOI 10.1016/j.cmet.2009.11.002; Cripps RL, 2005, CLIN SCI, V109, P1, DOI 10.1042/CS20040367; Cubero J, 2005, NEUROENDOCRINOL LETT, V26, P657; De Vriese C, 2010, NUTRITION, V26, P579, DOI 10.1016/j.nut.2009.09.013; Devaskar SU, 1997, BIOCHEM BIOPH RES CO, V238, P44, DOI 10.1006/bbrc.1997.7237; Eilers E, 2011, EARLY HUM DEV, V87, P415, DOI 10.1016/j.earlhumdev.2011.03.004; Eriksson L, 1998, ACTA VET SCAND, V39, P301; Fernandez-Twinn DS, 2010, ANN NY ACAD SCI, V1212, P78, DOI 10.1111/j.1749-6632.2010.05798.x; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Ilcol YO, 2007, ACTA PAEDIATR, V96, P1632, DOI 10.1111/j.1651-2227.2007.00493.x; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; Kierson JA, 2006, ACTA PAEDIATR, V95, P991, DOI 10.1080/08035250600669769; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Konieczna J, 2015, INT J OBESITY, V39, P959, DOI 10.1038/ijo.2015.22; Konieczna J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09088; Martin LJ, 2006, AM J CLIN NUTR, V83, P1106, DOI 10.1093/ajcn/83.5.1106; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; Miralles O, 2006, OBESITY, V14, P1371, DOI 10.1038/oby.2006.155; Oliver P, 2002, DEV DYNAM, V223, P148, DOI 10.1002/dvdy.1233; Ozarda Y, 2012, CLIN BIOCHEM, V45, P298, DOI 10.1016/j.clinbiochem.2011.12.022; Palou A, 2009, APPETITE, V52, P249, DOI 10.1016/j.appet.2008.09.013; Pickavance L, 1998, BIOCHEM BIOPH RES CO, V248, P196, DOI 10.1006/bbrc.1998.8934; Pico C, 2007, INT J OBESITY, V31, P1199, DOI 10.1038/sj.ijo.0803585; Priego T, 2010, INT J OBESITY, V34, P809, DOI 10.1038/ijo.2010.18; Rayner DV, 1997, AM J PHYSIOL-REG I, V273, pR446, DOI 10.1152/ajpregu.1997.273.1.R446; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; RODGERS CT, 1995, LAB ANIM, V29, P450, DOI 10.1258/002367795780739980; Ryan AS, 2003, DIABETES CARE, V26, P2383, DOI 10.2337/diacare.26.8.2383; Sanchez CL, 2009, NUTR NEUROSCI, V12, P2, DOI 10.1179/147683009X388922; Sanchez J, 2005, ENDOCRINOLOGY, V146, P2575, DOI 10.1210/en.2005-0112; Sanchez J, 2004, PFLUG ARCH EUR J PHY, V448, P500, DOI 10.1007/s00424-004-1283-4; Savino F, 2013, CELL MOL BIOL, V59, P89, DOI 10.1170/T950; Savino F, 2012, ACTA PAEDIATR, V101, P1058, DOI 10.1111/j.1651-2227.2012.02744.x; Savino F, 2010, EUR J CLIN NUTR, V64, P972, DOI 10.1038/ejcn.2010.105; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Smith-Kirwin SM, 1998, J CLIN ENDOCR METAB, V83, P1810, DOI 10.1210/jc.83.5.1810; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Varela L, 2011, J MOL ENDOCRINOL, V46, pR43, DOI 10.1677/JME-10-0068; Yildiz BO, 2004, P NATL ACAD SCI USA, V101, P10434, DOI 10.1073/pnas.0403465101; Zhou YH, 2005, GENE EXPR PATTERNS, V5, P711, DOI 10.1016/j.modgep.2005.02.002	50	23	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145376	10.1371/journal.pone.0145376	http://dx.doi.org/10.1371/journal.pone.0145376			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680765	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400073
J	Hommes, TJ; van Lieshout, MH; van't Veer, C; Florquin, S; Bootsma, HJ; Hermans, PW; de Vos, AF; van der Poll, T				Hommes, Tijmen J.; van Lieshout, Miriam H.; van't Veer, Cornelis; Florquin, Sandrine; Bootsma, Hester J.; Hermans, Peter W.; de Vos, Alex F.; van der Poll, Tom			Role of Nucleotide-Binding Oligomerization Domain-Containing (NOD) 2 in Host Defense during Pneumococcal Pneumonia	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; IMMUNE-RESPONSE; INNATE; INFECTION; PEPTIDOGLYCAN; COLONIZATION; RECOGNITION; MECHANISMS; RECEPTORS	Streptococcus (S.) pneumoniae is the most common causative pathogen in community-acquired pneumonia. Nucleotide-binding oligomerization domain-containing (NOD) 2 is a pattern recognition receptor located in the cytosol of myeloid cells that is able to detect peptidoglycan fragments of S. pneumoniae. We here aimed to investigate the role of NOD2 in the host response during pneumococcal pneumonia. Phagocytosis of S. pneumoniae was studied in NOD2 deficient (Nod2(-/-)) and wild-type (Wt) alveolar macrophages and neutrophils in vitro. In subsequent in vivo experiments Nod2(-/-) and Wt mice were inoculated with serotype 2 S. pneumoniae (D39), an isogenic capsule locus deletion mutant (D39 Delta cps) or serotype 3 S. pneumoniae (6303) via the airways, and bacterial growth and dissemination and the lung inflammatory response were evaluated. Nod2(-/-) alveolar macrophages and blood neutrophils displayed a reduced capacity to internalize pneumococci in vitro. During pneumonia caused by S. pneumoniae D39 Nod2(-/-) mice were indistinguishable from Wt mice with regard to bacterial loads in lungs and distant organs, lung pathology and neutrophil recruitment. While Nod2(-/-) and Wt mice also had similar bacterial loads after infection with the more virulent S. pneumoniae 6303 strain, Nod2(-/-) mice displayed a reduced bacterial clearance of the normally avirulent unencapsulated D39 Delta cps strain. These results suggest that NOD2 does not contribute to host defense during pneumococcal pneumonia and that the pneumococcal capsule impairs recognition of S. pneumoniae by NOD2.	[Hommes, Tijmen J.; van Lieshout, Miriam H.; van't Veer, Cornelis; de Vos, Alex F.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Hommes, Tijmen J.; van Lieshout, Miriam H.; van't Veer, Cornelis; de Vos, Alex F.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun, NL-1105 AZ Amsterdam, Netherlands; [Florquin, Sandrine] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Bootsma, Hester J.; Hermans, Peter W.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam	Hommes, TJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.j.hommes@amc.nl	Hermans, Peter W.M./H-8042-2014	Florquin, Sandrine/0000-0002-9676-1722	AMC Graduate School from the University of Amsterdam	AMC Graduate School from the University of Amsterdam	This work was supported by a grant (PhD scholarship) from the AMC Graduate School from the University of Amsterdam (https://www.amc.nl/web/Onderwijs/PhD-6/AMC-Graduate-School/About-the-AMC-Graduate-School.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender JM, 2010, PEDIATR INFECT DIS J, V29, P712, DOI 10.1097/INF.0b013e3181db03a7; Berrington WR, 2010, EUR J IMMUNOL, V40, P3519, DOI 10.1002/eji.201040518; Bootsma HJ, 2007, INFECT IMMUN, V75, P5489, DOI 10.1128/IAI.01823-06; Burgos J, 2011, CLIN INFECT DIS, V53, P254, DOI 10.1093/cid/cir354; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; de Vos AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118181; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Dessing MC, 2007, AM J RESP CRIT CARE, V175, P604, DOI 10.1164/rccm.200606-824OC; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Hommes TJ, 2014, J PATHOL, V233, P357, DOI 10.1002/path.4361; Hong JS, 2011, J IMMUNOL, V186, P6427, DOI 10.4049/jimmunol.1003449; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kapetanovic R, 2010, MICROBES INFECT, V12, P759, DOI 10.1016/j.micinf.2010.05.003; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Lammers AJ, 2011, IMMUNOBIOLOGY, V216, P863, DOI 10.1016/j.imbio.2011.02.004; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Sorbara MT, 2011, IMMUNOL REV, V243, P40, DOI 10.1111/j.1600-065X.2011.01047.x; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Vissers M, 2014, INFECT IMMUN, V82, P4952, DOI 10.1128/IAI.02150-14; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Wiersinga WJ, 2007, PLOS MED, V4, P1268, DOI 10.1371/journal.pmed.0040248; Yu JG, 2011, J CLIN MICROBIOL, V49, P534, DOI 10.1128/JCM.01827-10	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145138	10.1371/journal.pone.0145138	http://dx.doi.org/10.1371/journal.pone.0145138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673231	Green Submitted, gold, Green Published			2022-12-27	WOS:000366722700105
J	Jarukanont, D; Arredondo, IB; Femat, R; Garcia, ME				Jarukanont, Daungruthai; Bonifas Arredondo, Imelda; Femat, Ricardo; Garcia, Martin E.			Vesicle Motion during Sustained Exocytosis in Chromaffin Cells: Numerical Model Based on Amperometric Measurements	PLOS ONE			English	Article							SINGLE SECRETORY GRANULES; MEDIATED MEMBRANE-FUSION; DENSE-CORE VESICLES; SYNAPTIC VESICLES; NEUROTRANSMITTER RELEASE; FLUORESCENCE MICROSCOPY; REGULATED EXOCYTOSIS; PLASMA-MEMBRANE; SNARE COMPLEX; CALCIUM	Chromaffin cells release catecholamines by exocytosis, a process that includes vesicle docking, priming and fusion. Although all these steps have been intensively studied, some aspects of their mechanisms, particularly those regarding vesicle transport to the active sites situated at the membrane, are still unclear. In this work, we show that it is possible to extract information on vesicle motion in Chromaffin cells from the combination of Langevin simulations and amperometric measurements. We developed a numerical model based on Langevin simulations of vesicle motion towards the cell membrane and on the statistical analysis of vesicle arrival times. We also performed amperometric experiments in bovine-adrenal Chromaffin cells under Ba2+ stimulation to capture neurotransmitter releases during sustained exocytosis. In the sustained phase, each amperometric peak can be related to a single release from a new vesicle arriving at the active site. The amperometric signal can then be mapped into a spike-series of release events. We normalized the spike-series resulting from the current peaks using a time-rescaling transformation, thus making signals coming from different cells comparable. We discuss why the obtained spike-series may contain information about the motion of all vesicles leading to release of catecholamines. We show that the release statistics in our experiments considerably deviate from Poisson processes. Moreover, the interspike-time probability is reasonably well described by two-parameter gamma distributions. In order to interpret this result we computed the vesicles' arrival statistics from our Langevin simulations. As expected, assuming purely diffusive vesicle motion we obtain Poisson statistics. However, if we assume that all vesicles are guided toward the membrane by an attractive harmonic potential, simulations also lead to gamma distributions of the interspike-time probability, in remarkably good agreement with experiment. We also show that including the fusion-time statistics in our model does not produce any significant changes on the results. These findings indicate that the motion of the whole ensemble of vesicles towards the membrane is directed and reflected in the amperometric signals. Our results confirm the conclusions of previous imaging studies performed on single vesicles that vesicles' motion underneath plasma membranes is not purely random, but biased towards the membrane.	[Jarukanont, Daungruthai; Garcia, Martin E.] Univ Kassel, Inst Phys, D-34125 Kassel, Germany; [Jarukanont, Daungruthai; Garcia, Martin E.] Univ Kassel, Ctr Interdisciplinary Nanostruct Sci & Technol CI, D-34125 Kassel, Germany; [Bonifas Arredondo, Imelda; Femat, Ricardo] IPICYT, Div Matemat Aplicadas, San Luis Potosi, Mexico	Universitat Kassel; Universitat Kassel; Instituto Potosino Investigacion Cientifica y Tecnologica	Femat, R (corresponding author), IPICYT, Div Matemat Aplicadas, Camino Presa San Jose 2055,Lomas 4A Secc, San Luis Potosi, Mexico.	rfemat@ipicyt.edu.mx; garcia@physik.uni-kassel.de	Garcia, Martin E/D-2697-2009; Femat, Ricardo/HGF-0751-2022					Abeles M., 1982, LOCAL CORTICAL CIRCU, V6; Allersma MW, 2004, MOL BIOL CELL, V15, P4658, DOI 10.1091/mbc.E04-02-0149; Amatore C, 2003, CHEMPHYSCHEM, V4, P147, DOI 10.1002/cphc.200390024; Artalejo CR, 2002, P NATL ACAD SCI USA, V99, P6358, DOI 10.1073/pnas.082658499; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Becherer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000505; Becherer U, 2006, CELL TISSUE RES, V326, P393, DOI 10.1007/s00441-006-0243-z; Bhalla A, 2005, MOL BIOL CELL, V16, P4755, DOI 10.1091/mbc.E05-04-0277; Brown EN, 2002, NEURAL COMPUT, V14, P325, DOI 10.1162/08997660252741149; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chou T, 2014, ARXIV PREPRINT ARXIV; Chow RH, 1996, NEURON, V16, P369, DOI 10.1016/S0896-6273(00)80054-9; de Wit H, 2010, HISTOCHEM CELL BIOL, V134, P103, DOI 10.1007/s00418-010-0719-5; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; Draper NR, 2014, APPLIED REGRESSION A; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Evanko D, 2005, NAT METHODS, V2, P650, DOI 10.1038/nmeth0905-650; Finnegan JM, 1996, J NEUROCHEM, V66, P1914; Gandasi NR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4914; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; GERSTEIN GL, 1960, BIOPHYS J, V1, P15, DOI 10.1016/S0006-3495(60)86872-5; Graczyk A, 2013, FRONTIERS ENDOCRINOL, V4, DOI [10.3389/fendo.2013.00147, DOI 10.3389/FENDO.2013.00147]; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; HELDMAN E, 1989, J BIOL CHEM, V264, P7914; Henkel AW, 1996, J NEUROSCI, V16, P3960; Holt M, 2004, CURR BIOL, V14, P173, DOI 10.1016/j.cub.2003.12.053; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Hugo S, 2013, J NEUROSCI, V 33, P17123, DOI 10.1523/JNEUROSCI.1589-13.2013; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Jones E., 2001, SCIPY OPEN SOURCE SC; Kasai H, 2012, PHYSIOL REV, V92, P1915, DOI 10.1152/physrev.00007.2012; Kasai K, 2008, TRAFFIC, V9, P1191, DOI 10.1111/j.1600-0854.2008.00744.x; Keating DJ, 2008, HUM MOL GENET, V17, P1020, DOI 10.1093/hmg/ddm374; Kroese D. P., 2012, REV COMPUT STAT, V4, P48, DOI DOI 10.1002/WICS.194; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Liu DF, 2011, IMMUNOL CELL BIOL, V89, P728, DOI 10.1038/icb.2010.167; LIVETT BG, 1984, PHYSIOL REV, V64, P1103, DOI 10.1152/physrev.1984.64.4.1103; Maucort G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087242; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Mosharov EV, 2005, NAT METHODS, V2, P651, DOI 10.1038/nmeth782; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Pillow JW., 2009, NIPS, P1473; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; PRZYWARA DA, 1993, P NATL ACAD SCI USA, V90, P557, DOI 10.1073/pnas.90.2.557; Reichl L.E., 2009, MODERN COURSE STAT P; Rickman C, 2004, J BIOL CHEM, V279, P644, DOI 10.1074/jbc.M310879200; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Sagiv A, 2012, ONCOGENE, V32, P1971, DOI [10.1038/onc.2012.206, DOI 10.1038/ONC.2012.206]; Sakaba T, 2006, J NEUROSCI, V26, P5863, DOI 10.1523/JNEUROSCI.0182-06.2006; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Stevens DR, 2011, FRONTIERS IN SYNAPTI, P3, DOI [10.3389/fnsyn.2011.00002, DOI 10.3389/FNSYN.2011.00002]; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takahashi N, 2010, CELL METAB, V12, P19, DOI 10.1016/j.cmet.2010.05.013; Trifaro JM, 1997, NEUROCHEM RES, V22, P831, DOI 10.1023/A:1022087910902; Tukey J.W., EXPLORATORY DATA ANA; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; van Lengerich B, 2013, BIOPHYS J, V105, P409, DOI 10.1016/j.bpj.2013.05.056; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Verhulst P. F., 1838, QUETELET, V10, P113; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; WINKELMANN R, 1995, J BUS ECON STAT, V13, P467, DOI 10.2307/1392392; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498; Zikich D, 2008, J NEUROSCI, V28, P1949, DOI 10.1523/JNEUROSCI.5096-07.2008	77	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144045	10.1371/journal.pone.0144045	http://dx.doi.org/10.1371/journal.pone.0144045			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675312	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700021
J	Kurtagic, E; Rich, CB; Buczek-Thomas, JA; Nugent, MA				Kurtagic, Elma; Rich, Celeste B.; Buczek-Thomas, Jo Ann; Nugent, Matthew A.			Neutrophil Elastase-Generated Fragment of Vascular Endothelial Growth Factor-A Stimulates Macrophage and Endothelial Progenitor Cell Migration	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FACTOR VEGF FAMILY; MAINTENANCE PROGRAM; EMPHYSEMA; ANGIOGENESIS; LUNG; RECEPTORS; GENE; INVOLVEMENT; HOMEOSTASIS	Elastase released from neutrophils as part of the innate immune system has been implicated in chronic diseases such as emphysema and cardiovascular disease. We have previously shown that neutrophil elastase targets vascular endothelial growth factor-A (VEGF) for partial degradation to generate a fragment of VEGF (VEGFf) that has distinct activities. Namely, VEGFf binds to VEGF receptor 1 but not to VEGF receptor 2 and shows altered signaling compared to intact VEGF. In the present study we investigated the chemotactic function of VEGF and VEGFf released from cells by neutrophil elastase. We found that endothelial cells migrated in response to intact VEGF but not VEGFf whereas RAW 264.7 macrophages/monocytes and embryonic endothelial progenitor cells were stimulated to migrate by either VEGF or VEGFf. To investigate the role of elastase-mediated release of VEGF from cells/extracellular matrices, a co-culture system was established. High or low VEGF producing cells were co-cultured with macrophages, endothelial or endothelial progenitor cells and treated with neutrophil elastase. Elastase treatment stimulated macrophage and endothelial progenitor cell migration with the response being greater with the high VEGF expressing cells. However, elastase treatment led to decreased endothelial cell migration due to VEGF cleavage to VEGF fragment. These findings suggest that the tissue response to NE-mediated injury might involve the generation of diffusible VEGF fragments that stimulate inflammatory cell recruitment.	[Kurtagic, Elma; Rich, Celeste B.; Buczek-Thomas, Jo Ann; Nugent, Matthew A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Nugent, Matthew A.] Univ Massachusetts, Dept Biol Sci, Lowell, MA USA	Boston University; University of Massachusetts System; University of Massachusetts Lowell	Nugent, MA (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	matthew_nugent@uml.edu	Nugent, Matthew/GSI-5872-2022		National Institutes of Health grant [HL088672]; BrightFocus Foundation grant [M2012014]; NIH grant [HL088672]	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus Foundation grant(BrightFocus Foundation); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by National Institutes of Health grant HL088672 to MAN [http://www.nih.gov/] and BrightFocus Foundation grant M2012014 to MAN [http://www.brightfocus.org/].; We thank Dr. Antonis Hatzopoulos at Vanderbilt University for providing eEPCs and advice on their use. This study was funded in part by NIH grant HL088672 (MAN), and grant M2012014 from the BrightFocus Foundation (MAN).	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Barbera JA, 2011, EUR RESPIR J, V37, P752, DOI 10.1183/09031936.00154610; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Belgore F, 2004, J CLIN PATHOL, V57, P266, DOI 10.1136/jcp.2003.012419; Buczek-Thomas JA, 1999, J BIOL CHEM, V274, P25167, DOI 10.1074/jbc.274.35.25167; Buczek-Thomas JA, 2002, J CELL PHYSIOL, V192, P294, DOI 10.1002/jcp.10135; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Dinbergs ID, 1996, J BIOL CHEM, V271, P29822, DOI 10.1074/jbc.271.47.29822; Dollery CM, 2003, CIRCULATION, V107, P2829, DOI 10.1161/01.CIR.0000072792.65250.4A; Dor Y, 2001, AM J PHYSIOL-CELL PH, V280, pC1367, DOI 10.1152/ajpcell.2001.280.6.C1367; FARIS B, 1992, MATRIX, V12, P185, DOI 10.1016/S0934-8832(11)80060-0; Foley CJ, 2014, ONCOGENE, V33, P2264, DOI 10.1038/onc.2013.157; Forsten-Williams K, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-170; Fu YN, 2011, J HISTOCHEM CYTOCHEM, V59, P463, DOI 10.1369/0022155411401748; Gillis S, 1997, SEMIN HEMATOL, V34, P336; Gooptu B, 2009, EUR RESPIR J, V34, P475, DOI 10.1183/09031936.00096508; Handsley MM, 2005, INT J CANCER, V115, P849, DOI 10.1002/ijc.20945; Hatzopoulos AK, 1998, DEVELOPMENT, V125, P1457; Holmes DIR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-209; Inoue M, 1998, CIRCULATION, V98, P2108, DOI 10.1161/01.CIR.98.20.2108; Kalka C, 2000, ANN THORAC SURG, V70, P829, DOI 10.1016/S0003-4975(00)01633-7; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kupatt C, 2005, FASEB J, V19, P1576, DOI 10.1096/fj.04-3282fje; Kurtagic E, 2009, AM J PHYSIOL-LUNG C, V296, pL534, DOI 10.1152/ajplung.90505.2008; Madonna R, 2015, VASC PHARMACOL, V67-69, P2, DOI 10.1016/j.vph.2015.02.018; Marino F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124565; Mobius-Winkler S, 2009, CYTOM PART A, V75A, P25, DOI 10.1002/cyto.a.20669; Pearson JD, 2010, MICROVASC RES, V79, P162, DOI 10.1016/j.mvr.2009.12.004; Peinado VI, 2006, AM J RESP CELL MOL, V34, P257, DOI 10.1165/rcmb.2005-0255OC; Peinado VI, 2008, CHEST, V134, P808, DOI 10.1378/chest.08-0820; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; RISAU W, 1988, DEVELOPMENT, V102, P471; Robinson CJ, 2001, J CELL SCI, V114, P853; Shapiro SD, 2003, EUR RESPIR J, V22, p30S, DOI 10.1183/09031936.03.00000903a; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Tuder RM, 2008, CURR OPIN PHARMACOL, V8, P255, DOI 10.1016/j.coph.2008.03.003; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P673, DOI 10.1513/pats.200605-124SF; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; Wei JW, 2004, CANCER CELL, V5, P477, DOI 10.1016/S1535-6108(04)00116-3; Winkler Tilo, 2011, Critical Reviews in Biomedical Engineering, V39, P263, DOI 10.1615/CritRevBiomedEng.v39.i4.20; WOLFE BL, 1993, J BIOL CHEM, V268, P12418	45	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145115	10.1371/journal.pone.0145115	http://dx.doi.org/10.1371/journal.pone.0145115			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672607	Green Submitted, gold, Green Published			2022-12-27	WOS:000366722700101
J	Huang, HH; Lin, YT; Chen, WC; Huang, YW; Chen, SJ; Yang, TC				Huang, Hsin-Hui; Lin, Yi-Tsung; Chen, Wei-Ching; Huang, Yi-Wei; Chen, Shiang-Jiuun; Yang, Tsuey-Ching			Expression and Functions of CreD, an Inner Membrane Protein in Stenotrophomonas maltophilia	PLOS ONE			English	Article							L2 BETA-LACTAMASES; GENE-EXPRESSION; GROWTH; L1; INDUCTION; REGULATOR	CreBC is a highly conserved two-component regulatory system (TCS) in several gram-negative bacteria, including Escherichia coli, Aeromonas spp., Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. CreD is a conserved gene that encodes a predicted innermembrane protein and is located near the creBC loci. Activation of CreBC increases creD expression; therefore, creD expression is generally used as a measure of CreBC activation in E. coli, Aeromonas spp., and P. aeruginosa systems. In this article, we aim to elucidate the expression of creD and further to investigate its functions in S. maltophilia. In spite of a short intergenic region of 81 bp between creBC and creD, creD is expressed separately from the adjacent creBC operon and from a promoter immediately upstream of creD (P-creD) in S. maltophilia. We found that the promoter activity of PcreD is negatively regulated by the creBC TCS, positively regulated by the bacterial culture density, and not affected by beta-lactams. Furthermore, creD expression is not significantly altered in the presence of the phosphor-mimic variant of CreB, CreB(D55E), which mimics activated CreB. The functions of CreD of S. maltophilia were assessed by comparison among the following: wild-type KJ; the creD isogenic mutant, KJ Delta CreD; and the complementary strain, KJ Delta CreD(pCreD). The mutant lacking creD had cell division defects and aberrations in cell envelope integrity, which then triggered the sigma(E)-mediated envelope stress response. Thus, the results indicated that CreD plays a critical role in the maintenance of envelope integrity.	[Huang, Hsin-Hui; Chen, Wei-Ching; Huang, Yi-Wei; Yang, Tsuey-Ching] Natl Yang Ming Univ, Dept Biotechnol, Taipei 112, Taiwan; [Huang, Hsin-Hui; Chen, Wei-Ching; Huang, Yi-Wei; Yang, Tsuey-Ching] Natl Yang Ming Univ, Lab Sci Med, Taipei 112, Taiwan; [Lin, Yi-Tsung] Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan; [Lin, Yi-Tsung] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chen, Shiang-Jiuun] Natl Taiwan Univ, Coll Life Sci, Inst Ecol & Evolutionary Biol & TechComm 5, Dept Life Sci, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University	Yang, TC (corresponding author), Natl Yang Ming Univ, Dept Biotechnol, Taipei 112, Taiwan.	tcyang@ym.edu.tw	Huang, Yi-Wei/K-9717-2019		Ministry of Science and Technology of Taiwan [MOST 104-2320-B-010-023-MY3]; Professor Tsuei-Chu Mong Merit Scholarship. [40419001]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Professor Tsuei-Chu Mong Merit Scholarship.	This work was supported by grant MOST 104-2320-B-010-023-MY3 from Ministry of Science and Technology of Taiwan and grant 40419001 from Professor Tsuei-Chu Mong Merit Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant MOST 104-2320-B-010-023-MY3 from Ministry of Science and Technology of Taiwan and grant 40419001 from Professor Tsuei-Chu Mong Merit Scholarship.	Alksne LE, 1997, J BACTERIOL, V179, P2006, DOI 10.1128/jb.179.6.2006-2013.1997; Avison MB, 2001, J BIOL CHEM, V276, P26955, DOI 10.1074/jbc.M011186200; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Cariss SJL, 2008, J BACTERIOL, V190, P3930, DOI 10.1128/JB.00108-08; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; DRURY LS, 1988, MOL MICROBIOL, V2, P109, DOI 10.1111/j.1365-2958.1988.tb00012.x; Elofsson A, 2007, ANNU REV BIOCHEM, V76, P125, DOI 10.1146/annurev.biochem.76.052705.163539; Hayden JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001573; Hu RM, 2008, ANTIMICROB AGENTS CH, V52, P1198, DOI 10.1128/AAC.00682-07; Hu RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051053; Huang Y, ANTIMICROB AGENTS CH; Huang YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111784; KLOSE KE, 1993, J MOL BIOL, V232, P67, DOI 10.1006/jmbi.1993.1370; Li XZ, 2002, ANTIMICROB AGENTS CH, V46, P333, DOI 10.1128/AAC.46.2.333-343.2002; Lin CW, 2011, J ANTIMICROB CHEMOTH, V66, P2033, DOI 10.1093/jac/dkr276; Lin CW, 2009, RES MICROBIOL, V160, P152, DOI 10.1016/j.resmic.2008.11.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moya B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000353; Niumsup P, 2003, J ANTIMICROB CHEMOTH, V51, P1351, DOI 10.1093/jac/dkg247; Olaitan AO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00643; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tayler AE, 2010, MICROBIOL-SGM, V156, P2327, DOI 10.1099/mic.0.035220-0; Yang TC, 2009, ANTIMICROB AGENTS CH, V53, P2902, DOI 10.1128/AAC.01513-08; Zamorano L, 2014, ANTIMICROB AGENTS CH, V58, P5084, DOI 10.1128/AAC.02556-14	24	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145009	10.1371/journal.pone.0145009	http://dx.doi.org/10.1371/journal.pone.0145009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698119	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600041
J	Chen, YE; Goodwin, BK				Chen, Ying-Erh; Goodwin, Barry K.			Policy Design of Multi-Year Crop Insurance Contracts with Partial Payments	PLOS ONE			English	Article							RISK; MARKETS; DEMAND	Current crop insurance is designed to mitigate monetary fluctuations resulting from yield losses for a specific year. However, yield realization tendency can vary from year to year and may depend on the correlation of yield realizations across years. When the current single-year Yield Protection (YP) and Area Risk Protection Insurance (ARPI) contracts are extended to multiple periods, actuarially fair premium rate is expected to decrease as poor yield realizations in a year can be offset by another year's better yield realizations. In this study, we first use simulations to demonstrate how significant premium savings are possible when coverage is based on the sum of yields across years rather than on a year-by-year basis. We then describe the design of a multi-year framework of crop insurance and model the insurance using a copula approach. Insurance terms are extended to more than a year and the premium, liability, and indemnity are determined by a multi-year term. Moreover, partial payment is provided at the end of each term to offset the possibility of significant loss in a single term. County-level data obtained from the U.S. Department of Agriculture are used to demonstrate the implementations of the proposed multi-year crop insurance. The proposed multi-year plan would benefit farmers by offering insurance guarantees across years for significantly lower costs.	[Chen, Ying-Erh] Tamkang Univ, Dept Insurance, New Taipei 25137, Taiwan; [Goodwin, Barry K.] N Carolina State Univ, Dept Agr & Resource Econ, Raleigh, NC 27695 USA; [Goodwin, Barry K.] N Carolina State Univ, Dept Econ, Raleigh, NC 27695 USA	Tamkang University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Chen, YE (corresponding author), Tamkang Univ, Dept Insurance, New Taipei 25137, Taiwan.	143553@mail.tku.edu.tw			National Science Council in Taiwan [NSC-102-2410-H-032-095]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by NSC-102-2410-H-032-095 from National Science Council in Taiwan (http://www.most.gov.tw/).	Arrow KJ, 1985, EC AGENCY; Babcock BA, 1996, AM J AGR ECON, V78, P416, DOI 10.2307/1243713; BORGES RB, 1994, AM J AGR ECON, V76, P809, DOI 10.2307/1243742; BOTTS RR, 1958, J FARM ECON, V40, P733, DOI 10.2307/1235383; CHAMBERS RG, 1989, AM J AGR ECON, V71, P604, DOI 10.2307/1242016; Coble KH, 1996, AM J AGR ECON, V78, P439, DOI 10.2307/1243715; Gallagher P, 1987, AM J AGR ECON, V69, P798; Gardner BL, 1986, EXPERIENCE CROP INSU; Goodwin BK, 2015, AM J AGR ECON, V97, P879, DOI 10.1093/ajae/aau086; Goodwin BK, 2009, AM J AGR ECON, V91, P19, DOI 10.1111/j.1467-8276.2008.01187.x; Kleindorfer PR, 2012, J RISK UNCERTAINTY, V45, P51, DOI 10.1007/s11166-012-9148-2; Maynard T, 2012, GENEVA PAP R I-ISS P, V37, P318, DOI 10.1057/gpp.2012.10; Miranda MJ, 1997, AM J AGR ECON, V79, P206, DOI 10.2307/1243954; Nelson C. H., 1990, North Central Journal of Agricultural Economics, V12, P71, DOI 10.2307/1349359; Okhrin O, 2013, J RISK INSUR, V80, P351, DOI 10.1111/j.1539-6975.2012.01476.x; Osipenko M, 2015, AGRIC FINANCE REV, V75, P92, DOI 10.1108/AFR-12-2014-0043; ROGERSON WP, 1985, ECONOMETRICA, V53, P1357, DOI 10.2307/1913212; SKEES JR, 1986, AM J AGR ECON, V68, P653, DOI 10.2307/1241549; Tejeda HA, 2008, AM AGR EC ASS ANN M; Vedenov D, 2008, AM AGR EC ASS ANN M; Woodard JD, 2010, APPL ECON PERSPECT P, V32, P472, DOI 10.1093/aepp/ppq014	21	2	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145384	10.1371/journal.pone.0145384	http://dx.doi.org/10.1371/journal.pone.0145384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SH	26695074	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092500042
J	Jensen, SS; Fomsgaard, A; Borggren, M; Tingstedt, JL; Gerstoft, J; Kronborg, G; Rasmussen, LD; Pedersen, C; Karlsson, I				Jensen, Sanne Skov; Fomsgaard, Anders; Borggren, Marie; Tingstedt, Jeanette Linnea; Gerstoft, Jan; Kronborg, Gitte; Rasmussen, Line Dahlerup; Pedersen, Court; Karlsson, Ingrid			HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) - Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART)	PLOS ONE			English	Article							INFECTION; RESPONSES; ACTIVATION; EXPRESSION; SUBSETS; VACCINE; CD27; CRYOPRESERVATION; RECONSTITUTION; PROGRESSION	Understanding alterations in HIV-specific immune responses during antiretroviral therapy (ART), such as antibody-dependent cellular cytotoxicity (ADCC), is important in the development of novel strategies to control HIV-1 infection. This study included 53 HIV-1 positive individuals. We evaluated the ability of effector cells and antibodies to mediate ADCC separately and in combination using the ADCC-PanToxiLux assay. The ability of the peripheral blood mononuclear cells (PBMCs) to mediate ADCC was significantly higher in individuals who had been treated with ART before seroconversion, compared to the individuals initiating ART at a low CD4(+) T cell count (<350 cells/mu l blood) and the ART-naive individuals. The frequency of CD16 expressing natural killer (NK) cells correlated with both the duration of ART and Granzyme B (GzB) activity. In contrast, the plasma titer of antibodies mediating ADCC declined during ART. These findings suggest improved cytotoxic function of the NK cells if initiating ART early during infection, while the levels of ADCC mediating antibodies declined during ART.	[Jensen, Sanne Skov; Fomsgaard, Anders; Borggren, Marie; Tingstedt, Jeanette Linnea; Karlsson, Ingrid] Statens Serum Inst, Virus Res & Dev Lab, Dept Microbial Diagnost & Virol, DK-2300 Copenhagen, Denmark; [Jensen, Sanne Skov; Rasmussen, Line Dahlerup; Pedersen, Court] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Jensen, Sanne Skov; Fomsgaard, Anders] Univ Southern Denmark, Inst Clin, Infect Dis Res Unit, Odense, Denmark; [Gerstoft, Jan] Copenhagen Univ Hosp, Dept Infect Dis, Viroimmunol Res Unit, Copenhagen, Denmark; [Kronborg, Gitte] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark	Statens Serum Institut; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Copenhagen; University of Copenhagen	Karlsson, I (corresponding author), Statens Serum Inst, Virus Res & Dev Lab, Dept Microbial Diagnost & Virol, DK-2300 Copenhagen, Denmark.	iks@ssi.dk		Fomsgaard, Anders/0000-0003-4304-0603; Tingstedt, Jeanette Linnea/0000-0001-6005-0518	Danish AIDS foundation; Region of Southern Denmark	Danish AIDS foundation; Region of Southern Denmark	This work was supported by the Danish AIDS foundation and scholarship support from the Region of Southern Denmark (SSJ).	Berhanu D, 2003, J IMMUNOL METHODS, V279, P199, DOI 10.1016/S0022-1759(03)00186-8; Borggren M, 2013, VACCINES, V1, P305, DOI 10.3390/vaccines1030305; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; Chehimi J, 2007, J IMMUNOL, V179, P2642, DOI 10.4049/jimmunol.179.4.2642; Chung AW, 2011, JAIDS-J ACQ IMM DEF, V58, P127, DOI 10.1097/QAI.0b013e31822c62b9; Chung AW, 2009, J IMMUNOL, V182, P1202, DOI 10.4049/jimmunol.182.2.1202; Clements-Mann ML, 1998, J INFECT DIS, V177, P1230, DOI 10.1086/515288; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Costantini A, 2003, J IMMUNOL METHODS, V278, P145, DOI 10.1016/S0022-1759(03)00202-3; De Maria A, 2003, EUR J IMMUNOL, V33, P2410, DOI 10.1002/eji.200324141; Focosi D, 2010, J LEUKOCYTE BIOL, V87, P107, DOI 10.1189/jlb.0809566; Goepfert PA, 2007, VACCINE, V25, P510, DOI 10.1016/j.vaccine.2006.07.050; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hong HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044820; HOWELL DN, 1985, J IMMUNOL, V134, P971; Jensen SS, 2015, JAIDS-J ACQ IMM DEF, V68, P103, DOI 10.1097/QAI.0000000000000429; Karnasuta C, 2005, VACCINE, V23, P2522, DOI 10.1016/j.vaccine.2004.10.028; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kottilil S, 2006, J IMMUNOL, V176, P1107, DOI 10.4049/jimmunol.176.2.1107; Lafeuillade A, 2012, CURR HIV-AIDS REP, V9, P121, DOI 10.1007/s11904-012-0115-y; Lambotte O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074855; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Madhavi V, 2015, J INFECT DIS, V211, P529, DOI 10.1093/infdis/jiu486; Madhavi V, 2014, AIDS, V28, P1859, DOI 10.1097/QAD.0000000000000310; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Milush JM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-158; Montaldo E, 2013, CYTOM PART A, V83A, P702, DOI 10.1002/cyto.a.22302; Opravil M, 2002, AIDS, V16, P1371, DOI 10.1097/00002030-200207050-00009; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Parsons MS, 2014, J IMMUNOL, V192, P308, DOI 10.4049/jimmunol.1301247; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; Shete A, 2013, J IMMUNOASS IMMUNOCH, V34, P333, DOI 10.1080/15321819.2012.741087; Silva A, 2008, INT IMMUNOL, V20, P625, DOI 10.1093/intimm/dxn022; Smalls-Mantey A, 2012, J VIROL, V86, P8672, DOI 10.1128/JVI.00287-12; Titanji K, 2008, IMMUNOLOGY, V123, P164, DOI 10.1111/j.1365-2567.2007.02657.x; Vossen MTM, 2008, J IMMUNOL, V180, P3739, DOI 10.4049/jimmunol.180.6.3739; Weber K, 2000, IMMUNOBIOLOGY, V202, P172, DOI 10.1016/S0171-2985(00)80063-7; Wren LH, 2013, IMMUNOLOGY, V138, P116, DOI 10.1111/imm.12016	40	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145249	10.1371/journal.pone.0145249	http://dx.doi.org/10.1371/journal.pone.0145249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696395	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500030
J	Nevin, PE; Pfeiffer, J; Kibira, SPS; Lubinga, SJ; Mukose, A; Babigumira, JB				Nevin, Paul E.; Pfeiffer, James; Kibira, Simon P. S.; Lubinga, Solomon J.; Mukose, Aggrey; Babigumira, Joseph B.			Perceptions of HIV and Safe Male Circumcision in High HIV Prevalence Fishing Communities on Lake Victoria, Uganda	PLOS ONE			English	Article							MEDICAL MALE CIRCUMCISION; RISK-FACTORS; PREVENTION; BARRIERS; RAKAI; MEN; KNOWLEDGE; BEHAVIOR; KISUMU	Background In 2010, the Uganda Ministry of Health introduced its Safe Male Circumcision (SMC) strategy for HIV prevention with the goal of providing 4.2 million voluntary medical male circumcisions by 2015. Fishing communities, where HIV prevalence is approximately 3-5 times higher than the national average, have been identified as a key population needing targeted HIV prevention services by the National HIV Prevention Strategy. This study aimed to understand perceptions of HIV and identify potential barriers and facilitators to SMC in fishing communities along Lake Victoria. Methods We conducted 8 focus group discussions, stratified by sex and age, with 67 purposefully sampled participants in 4 communities in Kalangala District, Uganda. Results There was universal knowledge of the availability of SMC services, but males reported high uptake in the community while females indicated that it is low. Improved hygiene, disease prevention, and improved sexual performance and desirability were reported facilitators. Barriers included a perceived increase in SMC recipients' physiological libido, post-surgical abstinence, lost income during convalescence, and lengthier recovery due to occupational hazards. Both males and females reported concerns about spousal fidelity during post-SMC abstinence. Reported misconceptions and community-held cultural beliefs include fear that foreskins are sold after their removal, the belief that a SMC recipient's first sexual partner after the procedure should not be his spouse, and the belief that vaginal fluids aid circumcision wound healing. Conclusions Previous outreach efforts have effectively reached these remote communities, where availability and health benefits of SMC are widely understood. However, community-specific intervention strategies are needed to address the barriers identified in this study. We recommend the development of targeted counseling, outreach, and communication strategies to address barriers, misconceptions, and community-held beliefs. Interventions should also incorporate female partners into the SMC decision-making process and develop compensation strategies to address lost income during SMC recovery.	[Nevin, Paul E.; Pfeiffer, James] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA 98195 USA; [Nevin, Paul E.; Pfeiffer, James] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98195 USA; [Pfeiffer, James] Hlth Alliance Int, Seattle, WA USA; [Pfeiffer, James] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Kibira, Simon P. S.] Makerere Univ, Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda; [Lubinga, Solomon J.; Babigumira, Joseph B.] Univ Washington, Sch Med, Dept Global Hlth, Global Med Program, Seattle, WA USA; [Lubinga, Solomon J.; Babigumira, Joseph B.] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Global Med Program, Seattle, WA 98195 USA; [Lubinga, Solomon J.; Babigumira, Joseph B.] Univ Washington, Sch Pharm, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; [Mukose, Aggrey] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Makerere University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Makerere University	Nevin, PE (corresponding author), Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA 98195 USA.	penevin@uw.edu	Babigumira, Joseph/T-4208-2019; Lubinga, Solomon James/AAD-6637-2019; Lubinga, Solomon James/B-6590-2018	Lubinga, Solomon James/0000-0003-0539-9156; Lubinga, Solomon James/0000-0003-0539-9156; Kibira, Simon Peter Sebina/0000-0002-7385-423X	National Institutes of Health [P30AI027757]; University of Washington School of Public Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington School of Public Health(University of Washington); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JBB received award number P30AI027757 from the National Institutes of Health (http://www.nih.gov/). JBB also received an emerging challenges pilot grant from the University of Washington School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiki G, 2011, SEX TRANSM INFECT, V87, P511, DOI 10.1136/sti.2010.046805; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Evens E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098221; George G, 2014, AJAR-AFR J AIDS RES, V13, P179, DOI 10.2989/16085906.2014.943253; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Herman-Roloff A, 2012, AIDS BEHAV, V16, P1173, DOI 10.1007/s10461-011-0073-1; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019814; Hewett PC, 2012, AIDS, V26, P749, DOI 10.1097/QAD.0b013e32835097ff; Jones D, 2014, AIDS BEHAV, V18, P278, DOI 10.1007/s10461-013-0530-0; Kalichman S, 2007, PLOS MED, V4, P597, DOI 10.1371/journal.pmed.0040138; Kissling E, 2005, AIDS, V19, P1939, DOI 10.1097/01.aids.0000191925.54679.94; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kiwanuka N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094932; Kiwanuka N, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18621; Kong XR, 2014, AIDS BEHAV, V18, P880, DOI 10.1007/s10461-014-0740-0; Kwena ZA, 2010, INT J STD AIDS, V21, P708, DOI 10.1258/ijsa.2010.010160; Lanham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044825; Maibvise C, 2014, AJAR-AFR J AIDS RES, V13, P281, DOI 10.2989/16085906.2014.952652; Miles M. B., 2019, SAGE, DOI DOI 10.1080/1034912X.2016.1228856; Opio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070770; Patton M. Q., 1990, QUALITATIVE EVALUATI; Plotkin M, 2013, GLOB HEALTH-SCI PRAC, V1, P108, DOI 10.9745/GHSP-D-12-00037; Seeley JA, 2005, AIDS CARE, V17, P688, DOI 10.1080/09540120412331336698; Seeley J, 2012, SEX TRANSM DIS, V39, P433, DOI 10.1097/OLQ.0b013e318251555d; Skolnik L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1119; Smolak A, 2014, AIDS CARE, V26, P282, DOI 10.1080/09540121.2013.824541; Ssekubugu R, 2013, QUAL HEALTH RES, V23, P795, DOI 10.1177/1049732313482189; Tumwesigye NM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1069; UBOS, 2014, NATL POPULATION HOUS; Uganda AIDS Commission, 2014, DISTR HIV AIDS SUPP; Uganda AIDS Commission, 2014, HIV AIDS UG COUNTR P; Uganda AIDS Commission, 2014, CONS MIDT REV REP NA; Uganda AIDS Commission, 2011, NAT HIV PREV STRAT 2; Uganda Ministry of Health, 2011, SAF MAL CIRC HIV PRE; Uganda Ministry of Health, 2010, SAF MAL CIRC POL; Uganda Ministry of Health, 2012, UG AIDS IND SURV 201; Uganda Ministry of Health, 2010, SAF MAL CIRC HIV PRE; Uganda Ministry of Health, 2012, UND SAF MAL CIRC; Westercamp N, 2014, AIDS BEHAV, V18, P1764, DOI 10.1007/s10461-014-0846-4	41	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145543	10.1371/journal.pone.0145543	http://dx.doi.org/10.1371/journal.pone.0145543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SF	26689212	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092300087
J	Ngwe, MFSN; Omokolo, DN; Joly, S				Ngwe, Marie Florence Sandrine Ngo; Omokolo, Denis Ndoumou; Joly, Simon			Evolution and Phylogenetic Diversity of Yam Species (Dioscorea spp.): Implication for Conservation and Agricultural Practices	PLOS ONE			English	Article							ROTUNDATA COMPLEX; BIODIVERSITY; CHLOROPLAST; PERSPECTIVE; MIGRATION	Yams (Dioscorea spp.) consist of approximately 600 species. Presently, these species are threatened by genetic erosion due to many factors such as pest attacks and farming practices. In parallel, complex taxonomic boundaries in this genus makes it more challenging to properly address the genetic diversity of yam and manage its germplasm. As a first step toward evaluating and preserving the genetic diversity yam species, we use a phylogenetic diversity (PD) approach that has the advantage to investigate phylogenetic relationships and test hypotheses of species monophyly while alleviating to the problem of ploidy variation within and among species. The Bayesian phylogenetic analysis of 62 accessions from 7 species from three regions of Cameroon showed that most Dioscorea sections were monophyletic, but species within sections were generally non-monophyletic. The wild species D. praehensilis and cultivated D. cayenensis were the species with the highest PD. At the opposite, D. esculenta has a low PD and future studies should focus on this species to properly address its conservation status. We also show that wild species show a stronger genetic structure than cultivated species, which potentially reflects the management of the yam germplasm by farmers. These findings show that phylogenetic diversity is a promising approach for an initial investigation of genetic diversity in a crop consisting of closely related species.	[Ngwe, Marie Florence Sandrine Ngo; Omokolo, Denis Ndoumou] Univ Yaounde I, Higher Teachers Training Coll, Lab Plant Physiol, Yaounde, Cameroon; [Joly, Simon] Montreal Bot Garden, Inst Rech Biol Vegetale, Montreal, PQ H1X 2B2, Canada; [Joly, Simon] Univ Montreal, Montreal, PQ H1X 2B2, Canada; [Ngwe, Marie Florence Sandrine Ngo] Inst Agr Res Development CEREFEN, Meyomessala, Cameroon	University of Yaounde I; Universite de Montreal; Universite de Montreal	Ngwe, MFSN (corresponding author), Univ Yaounde I, Higher Teachers Training Coll, Lab Plant Physiol, POB 47, Yaounde, Cameroon.	florencengongwe@yahoo.fr		Joly, Simon/0000-0002-0865-8267	L'Oreal-UNESCO	L'Oreal-UNESCO	This work was funded by the L'Oreal-UNESCO for Women in Science [grant to NNMFS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Asahina H, 2010, J NAT MED-TOKYO, V64, P133, DOI 10.1007/s11418-009-0379-8; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; BIRKY CW, 1989, GENETICS, V121, P613; Bivand R, 2015, TOOLS READING HANDLI; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Burkill IH, 1960, SOCIETY, V56, P319; Cadotte MW, 2013, P NATL ACAD SCI USA, V110, P8996, DOI 10.1073/pnas.1301685110; Couto RS, 2014, PHYTOTAXA, V163, P229, DOI 10.11646/phytotaxa.163.4.3; Croxton MD, 2011, INVAS PLANT SCI MANA, V1, P32; Dansi A., 2013, International Journal of Biological and Chemical Sciences, V7, P60; Dansi A, 2001, EUPHYTICA, V119, P301, DOI 10.1023/A:1017510402681; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond A. J., 2009, GENEIOUS V 4 7; Dumont R, 2005, COLLECTION REPERES, P119; Dumont R, 1994, IGNAMES CAMEROUN; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engler A, 1924, PFLANZENREICH, V4, P253; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Faith DP, 2010, CURR OPIN ENV SUST, V2, P66, DOI 10.1016/j.cosust.2010.04.002; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faith DP, 2006, EVOL BIOINFORM ONLIN, V2, P70; FIDA, 2003, RAPP PREEV PNDRT, VI; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gerritsen H., 2014, MAPPLOTS DATA VISUAL; Girma G, 2012, INT J CONSERV SCI, V3, P199; Girma G, 2014, THEOR APPL GENET, V127, P1783, DOI 10.1007/s00122-014-2339-2; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Huber, 1998, DIOSCOREACEAE FAMILI, VIII, P216; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Islam Md. Tariqul, 2008, Plant Tissue Culture & Biotechnology, V18, P25; IUCN (World Conservation Union), 2001, IUCN RED LIST CAT VE; Joly S, 2015, METHODS ECOL EVOL, V6, P938, DOI 10.1111/2041-210X.12343; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Koonjul PK, 1999, NUCLEIC ACIDS RES, V27, P915, DOI 10.1093/nar/27.3.915; Lee A.C., 2014, BERKELEY SCI J, V18; Levy F, 1999, HEREDITY, V82, P422, DOI 10.1038/sj.hdy.6885000; Mi XC, 2012, AM NAT, V180, pE17, DOI 10.1086/665999; Miege J., 1948, 28 ANN B 313 314 NOV, V313-314, P509; Mignouna HD, 2003, GENET RESOUR CROP EV, V50, P519, DOI 10.1023/A:1023990618128; Mignouna HD, 2002, GENET RESOUR CROP EV, V49, P21, DOI 10.1023/A:1013805813522; Mishler BD, 2009, TAXON, V58, P61, DOI 10.1002/tax.581009; MOOERS AO, 2005, PHYLOGENY CONSERVATI; Moritz CC, 2013, MOL ECOL, V22, P5969, DOI 10.1111/mec.12565; Ngo Ngwe MFS, 2014, J PLANT BREEDING GEN, V02, P87; NIXON KC, 1990, CLADISTICS, V6, P211, DOI 10.1111/j.1096-0031.1990.tb00541.x; Norman P. E., 2012, International Journal of Agronomy and Plant Production, V3, P265; OKSANEN FJ, 2013, R PACKAGE VERSION 2; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Primack RB., 2012, PRIMER CONSERVATION, V5th; Purvis A, 2005, PHYLOGENY CONSERVATI; R. Core Team, 2013, R LANGUAGE ENV STAT; Ronquist F, 2010, MRBAYES 3 1 MANUEL; Sautour M, 2007, J NAT MED, V61, P91, DOI 10.1007/s11418-006-0126-3; Scarcelli N, 2006, GENET RESOUR CROP EV, V53, P121, DOI 10.1007/s10722-004-1950-5; Scarcelli N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019954; Sesay L, 2013, SKY J AGR RES, V2, P1; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shorthouse DP, 2010, SIMPLEMAPPR ONLINE T; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Siquiera VBMS, 2011, AM J BOT, P144; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thrall PH, 2011, EVOL APPL, V4, P200, DOI 10.1111/j.1752-4571.2010.00179.x; Ting CT, 2000, FLORA IN CHINA; Tortoe C, 2012, AFR J FOOD SCI TECHN, V3, P59; Tostain S, 2010, IGNAMES MALGACHES RE, P23; Wilkin P, 2005, SYST BOT, V30, P736, DOI 10.1600/036364405775097879; Wilkin Paul, 2008, Kew Bulletin, V63, P113, DOI 10.1007/s12225-007-9000-z; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106; Gao X, 2008, J SYST EVOL, V46, P315, DOI 10.3724/SP.J.1002.2008.08007; Yan QQ, 2014, GENET MOL RES, V13, P1514, DOI 10.4238/2014.March.12.3; Zoundjihekpon J., 1993, THESIS	73	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145364	10.1371/journal.pone.0145364	http://dx.doi.org/10.1371/journal.pone.0145364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691919	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092300063
J	Tian, T; McLachlan, GJ; Dieters, MJ; Basford, KE				Tian, Ting; McLachlan, Geoffrey J.; Dieters, Mark J.; Basford, Kaye E.			Application of Multiple Imputation for Missing Values in Three-Way Three-Mode Multi-Environment Trial Data	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; COMPONENT ANALYSIS; VARIETY TRIALS; GENOTYPE	It is a common occurrence in plant breeding programs to observe missing values in three-way three-mode multi-environment trial (MET) data. We proposed modifications of models for estimating missing observations for these data arrays, and developed a novel approach in terms of hierarchical clustering. Multiple imputation (MI) was used in four ways, multiple agglomerative hierarchical clustering, normal distribution model, normal regression model, and predictive mean match. The later three models used both Bayesian analysis and non-Bayesian analysis, while the first approach used a clustering procedure with randomly selected attributes and assigned real values from the nearest neighbour to the one with missing observations. Different proportions of data entries in six complete datasets were randomly selected to be missing and the MI methods were compared based on the efficiency and accuracy of estimating those values. The results indicated that the models using Bayesian analysis had slightly higher accuracy of estimation performance than those using non-Bayesian analysis but they were more time-consuming. However, the novel approach of multiple agglomerative hierarchical clustering demonstrated the overall best performances.	[Tian, Ting; Dieters, Mark J.; Basford, Kaye E.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [McLachlan, Geoffrey J.] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Tian, T (corresponding author), Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia.	t.tian2@uq.edu.au	McLachlan, Geoffrey J/A-1491-2008; Basford, Kaye/T-9578-2019	McLachlan, Geoffrey J/0000-0002-5921-3145; Basford, Kaye/0000-0003-0955-4504	Monsanto Company	Monsanto Company	The funding for the PhD scholarship for Ms Ting Tian came from Monsanto Company, but there is no employment, patents, products in development, marketed products or any restrictions whatsoever on the research work reported in this manuscript. Unrestricted funding for a scholarship was the requirement for independent consultancy work by Professor Kaye Basford for Monsanto Company. She has no patents, products in development, or marketed products associated with that company. There are no competing interests in relation to the research being reported in this manuscript. This competing interests statement does not alter or impact on the authors' adherence to PLOS ONE policies on sharing data and materials.	[Anonymous], 2001, MISSING DATA; Basford KE, 1997, J STAT PLAN INFER, V57, P93, DOI 10.1016/S0378-3758(96)00038-9; BASFORD KE, 1990, THEOR APPL GENET, V79, P225, DOI 10.1007/BF00225956; Box G. E. P., 2011, BAYESIAN INFERENCE S; de la Vega AJ, 2002, FIELD CROP RES, V78, P165, DOI 10.1016/S0378-4290(02)00123-5; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gilmour A., 2006, ASREML USER GUIDE RE; Kiers HAL, 2000, J CHEMOMETR, V14, P105, DOI 10.1002/1099-128X(200005/06)14:3<105::AID-CEM582>3.0.CO;2-I; Kim C.J., 1999, STATE SPACE MODELS R; Krishnan T, 1998, STAT MED, V17, P1187, DOI DOI 10.1002/(SICI)1097-0258(19980530)17:10<1187::AID-SIM849>3.0.CO;2-A; Kroonenberg PM, 2012, CURR ANAL CHEM, V8, P224; KROONENBERG PM, 1995, EUPHYTICA, V84, P31, DOI 10.1007/BF01677554; KROONENBERG PM, 1989, EUPHYTICA, V44, P109, DOI 10.1007/BF00022605; Little R. J. A., 1987, STAT ANAL; LITTLE RJA, 1988, J BUS ECON STAT, V6, P287, DOI 10.2307/1391878; Oba S, 2003, BIOINFORMATICS, V19, P2088, DOI 10.1093/bioinformatics/btg287; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; RUBIN DB, 1986, J BUS ECON STAT, V4, P87, DOI 10.2307/1391390; Rubin DB, 2004, MULTIPLE IMPUTATION; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Soullier N, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-79; Steele Russell J, 2010, Stat Methodol, V7, P351; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	29	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144370	10.1371/journal.pone.0144370	http://dx.doi.org/10.1371/journal.pone.0144370			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689369	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300008
J	Cao, ZB; Li, YS; Chen, Z; Wang, H; Zhang, ML; Zhou, NR; Wu, RH; Ling, YH; Fang, FG; Li, N; Zhang, YH				Cao, Zubing; Li, Yunsheng; Chen, Zhen; Wang, Heng; Zhang, Meiling; Zhou, Naru; Wu, Ronghua; Ling, Yinghui; Fang, Fugui; Li, Ning; Zhang, Yunhai			Genome-Wide Dynamic Profiling of Histone Methylation during Nuclear Transfer-Mediated Porcine Somatic Cell Reprogramming	PLOS ONE			English	Article							BOVINE PREIMPLANTATION DEVELOPMENT; IN-VITRO DEVELOPMENT; DNA METHYLATION; EMBRYONIC-DEVELOPMENT; MAMMALIAN DEVELOPMENT; GENE-EXPRESSION; MOUSE EMBRYOS; PLURIPOTENCY; ACTIVATION; MONOMETHYLATION	The low full-term developmental efficiency of porcine somatic cell nuclear transfer (SCNT) embryos is mainly attributed to imperfect epigenetic reprogramming in the early embryos. However, dynamic expression patterns of histone methylation involved in epigenetic reprogramming progression during porcine SCNT embryo early development remain to be unknown. In this study, we characterized and compared the expression patterns of multiple histone methylation markers including transcriptionally repressive (H3K9me2, H3K9me3, H3K27me2, H3K27me3, H4K20me2 and H4K20me3) and active modifications (H3K4me2, H3K4me3, H3K36me2, H3K36me3, H3K79me2 and H3K79me3) in SCNT early embryos from different developmental stages with that from in vitro fertilization (IVF) counterparts. We found that the expression level of H3K9me2, H3K9me3 and H4K20me3 of SCNT embryos from 1-cell to 4-cell stages was significantly higher than that in the IVF embryos. We also detected a symmetric distribution pattern of H3K9me2 between inner cell mass (ICM) and trophectoderm (TE) in SCNT blastocysts. The expression level of H3K9me2 in both lineages from SCNT expanded blastocyst onwards was significantly higher than that in IVF counterparts. The expression level of H4K20me2 was significantly lower in SCNT embryos from morula to blastocyst stage compared with IVF embryos. However, no aberrant dynamic reprogramming of H3K27me2/3 occurred during early developmental stages of SCNT embryos. The expression of H3K4me3 was higher in SCNT embryos at 4-cell stage than that of IVF embryos. H3K4me2 expression in SCNT embryos from 8-cell stage to blastocyst stage was lower than that in the IVF embryos. Dynamic patterns of other active histone methylation markers were similar between SCNT and IVF embryos. Taken together, histone methylation exhibited developmentally stage-specific abnormal expression patterns in porcine SCNT early embryos.	[Cao, Zubing; Li, Yunsheng; Chen, Zhen; Wang, Heng; Zhang, Meiling; Zhou, Naru; Wu, Ronghua; Ling, Yinghui; Fang, Fugui; Zhang, Yunhai] Anhui Agr Univ, Coll Anim Sci & Technol, Anhui Prov Lab Local Livestock & Poultry Genet Re, Hefei, Anhui, Peoples R China; [Cao, Zubing; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	Anhui Agricultural University; China Agricultural University	Li, N (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	ninglcau@cau.edu.cn; yunhaizhang@ahau.edu.cn	Zhang, Yunhai/O-4453-2014	Zhang, Yunhai/0000-0001-9721-5910	National Natural Science Foundation of China [31272442]; Genetically Modified Organisms Technology Major Project [2014ZX08006-01B]; "973" National Key Basic Research Program of China [2011CBA01001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms Technology Major Project; "973" National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by the grants from the National Natural Science Foundation of China (31272442), Genetically Modified Organisms Technology Major Project (2014ZX08006-01B) and"973" National Key Basic Research Program of China (2011CBA01001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaujean N, 2004, BIOL REPROD, V71, P185, DOI 10.1095/biolreprod.103.026559; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Canovas S, 2012, P NATL ACAD SCI USA, V109, P2400, DOI 10.1073/pnas.1119112109; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; Deshmukh RS, 2011, EPIGENETICS-US, V6, P177, DOI 10.4161/epi.6.2.13519; Diao YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100205; Fu L, 2012, THERIOGENOLOGY, V78, P1929, DOI 10.1016/j.theriogenology.2012.07.017; Gao Y, 2010, MOL REPROD DEV, V77, P540, DOI 10.1002/mrd.21180; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Huan YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129803; Huang JJ, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.122762; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; Mallol A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120033; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Ohgane J, 2001, GENESIS, V30, P45, DOI 10.1002/gene.1031; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Ooga M, 2008, BIOL REPROD, V78, P413, DOI 10.1095/biolreprod.107.063453; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Ross PJ, 2008, REPRODUCTION, V136, P777, DOI 10.1530/REP-08-0045; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Sega MF, 2007, MOL REPROD DEV, V74, P2, DOI 10.1002/mrd.20599; Shao GB, 2008, J REPROD DEVELOP, V54, P233, DOI 10.1262/jrd.19173; Shao GB, 2008, IN VITRO CELL DEV-AN, V44, P115, DOI 10.1007/s11626-008-9082-4; Shi W, 2004, BIOL REPROD, V71, P340, DOI 10.1095/biolreprod.103.024554; Song YR, 2014, PROTEIN CELL, V5, P382, DOI 10.1007/s13238-014-0034-3; Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112; Zhang AJ, 2012, FERTIL STERIL, V98, P1009, DOI 10.1016/j.fertnstert.2012.06.034; Zhang K, 2007, J REPROD DEVELOP, V53, P647, DOI 10.1262/jrd.18140; Zhang M, 2009, J BIOL CHEM, V284, P24981, DOI 10.1074/jbc.M109.011973; Zhang YH, 2007, CLONING STEM CELLS, V9, P357, DOI 10.1089/clo.2006.0090	40	39	42	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144897	10.1371/journal.pone.0144897	http://dx.doi.org/10.1371/journal.pone.0144897			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683029	gold, Green Submitted, Green Published			2022-12-27	WOS:000366725800023
J	Shukla, SK; Cook, D; Meyer, J; Vernon, SD; Le, T; Clevidence, D; Robertson, CE; Schrodi, SJ; Yale, S; Frank, DN				Shukla, Sanjay K.; Cook, Dane; Meyer, Jacob; Vernon, Suzanne D.; Le, Thao; Clevidence, Derek; Robertson, Charles E.; Schrodi, Steven J.; Yale, Steven; Frank, Daniel N.			Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)	PLOS ONE			English	Article							GRAM-NEGATIVE ENTEROBACTERIA; NITROSATIVE STRESS; SYNDROME CFS; INFLAMMATORY PATHWAYS; LEAKY GUT; LPS; NORMALIZATION; TRANSLOCATION; RESPONSES; SYMPTOMS	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disease characterized by intense and debilitating fatigue not due to physical activity that has persisted for at least 6 months, post-exertional malaise, unrefreshing sleep, and accompanied by a number of secondary symptoms, including sore throat, memory and concentration impairment, headache, and muscle/joint pain. In patients with post-exertional malaise, significant worsening of symptoms occurs following physical exertion and exercise challenge serves as a useful method for identifying biomarkers for exertion intolerance. Evidence suggests that intestinal dysbiosis and systemic responses to gut microorganisms may play a role in the symptomology of ME/CFS. As such, we hypothesized that post-exertion worsening of ME/CFS symptoms could be due to increased bacterial translocation from the intestine into the systemic circulation. To test this hypothesis, we collected symptom reports and blood and stool samples from ten clinically characterized ME/CFS patients and ten matched healthy controls before and 15 minutes, 48 hours, and 72 hours after a maximal exercise challenge. Microbiomes of blood and stool samples were examined. Stool sample microbiomes differed between ME/CFS patients and healthy controls in the abundance of several major bacterial phyla. Following maximal exercise challenge, there was an increase in relative abundance of 6 of the 9 major bacterial phyla/genera in ME/CFS patients from baseline to 72 hours post-exercise compared to only 2 of the 9 phyla/genera in controls (p = 0.005). There was also a significant difference in clearance of specific bacterial phyla from blood following exercise with high levels of bacterial sequences maintained at 72 hours post-exercise in ME/CFS patients versus clearance in the controls. These results provide evidence for a systemic effect of an altered gut microbiome in ME/CFS patients compared to controls. Upon exercise challenge, there were significant changes in the abundance of major bacterial phyla in the gut in ME/CFS patients not observed in healthy controls. In addition, compared to controls clearance of bacteria from the blood was delayed in ME/CFS patients following exercise. These findings suggest a role for an altered gut microbiome and increased bacterial translocation following exercise in ME/CFS patients that may account for the profound post-exertional malaise experienced by ME/CFS patients.	[Shukla, Sanjay K.; Le, Thao; Schrodi, Steven J.] Marshfield Clin Res Fdn, Marshfield, WI 54449 USA; [Cook, Dane; Meyer, Jacob] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Cook, Dane; Clevidence, Derek] Univ Wisconsin, Madison, WI USA; [Vernon, Suzanne D.] Bateman Horne Ctr Excellence, Salt Lake City, UT USA; [Robertson, Charles E.; Frank, Daniel N.] Univ Colorado Denver, Aurora, CO USA; [Yale, Steven] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Marshfield Clinic	Shukla, SK (corresponding author), Marshfield Clin Res Fdn, Marshfield, WI 54449 USA.	shukla.sanjay@mcrf.mfldclin.edu	Meyer, Jacob/AAD-8057-2020; Schrodi, Steven J./O-4288-2019	Meyer, Jacob/0000-0003-3180-5728; Schrodi, Steven J./0000-0003-2304-8528; ROBERTSON, CHARLES/0000-0002-4136-4121	CFIDS Association of America; Marshfield Clinic Research Foundation	CFIDS Association of America; Marshfield Clinic Research Foundation	This study was funded from a grant from The CFIDS Association of America to SKS and donors to the Marshfield Clinic Research Foundation. The funding agency has no role in the study design or in the preparation of the manuscript.	Benitez-Paez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057782; Centers for Disease Control and Prevention, CHRONIC FATIGUE SYND; Clarke SF, 2014, GUT, V63, P1913, DOI 10.1136/gutjnl-2013-306541; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cook DB, 2012, MED SCI SPORT EXER, V44, P1186, DOI 10.1249/MSS.0b013e3182417b9a; Cook DB, 2003, MED SCI SPORT EXER, V35, P563, DOI 10.1249/01.MSS.0000058360.61448.6C; Maranduba CMD, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/931574; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Frank DN, 2012, JAIDS-J ACQ IMM DEF, V60, P299, DOI 10.1097/QAI.0b013e31824e4bdb; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Fremont M, 2013, ANAEROBE, V22, P50, DOI 10.1016/j.anaerobe.2013.06.002; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Ianiro G, 2014, CURR DRUG TARGETS, V15, P762, DOI 10.2174/1389450115666140606111402; Jason Leonard A, 2008, Dyn Med, V7, P6, DOI 10.1186/1476-5918-7-6; Krebs NF, 2013, J PEDIATR-US, V163, P416, DOI 10.1016/j.jpeds.2013.01.024; Lakhan SE, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-79; Lambert JE, 2015, APPL PHYSIOL NUTR ME, V40, P749, DOI 10.1139/apnm-2014-0452; Lee TH, 2000, GASTROINTEST ENDOSC, V52, P223, DOI 10.1067/mge.2000.107718; Li E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026284; Light AR, 2009, J PAIN, V10, P1099, DOI 10.1016/j.jpain.2009.06.003; Maes M, 2007, NEUROENDOCRINOL LETT, V28, P739; Maes M, 2007, J AFFECT DISORDERS, V99, P237, DOI 10.1016/j.jad.2006.08.021; Maes M, 2014, NEUROENDOCRINOL LETT, V35, P445; Maes M, 2013, J AFFECT DISORDERS, V150, P223, DOI 10.1016/j.jad.2013.03.029; Maes M, 2012, PSYCHIAT RES, V200, P754, DOI 10.1016/j.psychres.2012.03.031; Maes M, 2012, J AFFECT DISORDERS, V136, P909, DOI 10.1016/j.jad.2011.09.010; Maes M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-35; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P902; Maes M, 2009, CURR OPIN PSYCHIATR, V22, P75, DOI 10.1097/YCO.0b013e32831a4728; Mayer EA, 2015, J CLIN INVEST, V125, P926, DOI 10.1172/JCI76304; McNair D. M, 1992, PROFILE MOOD STATES; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Meyer JD, 2013, FATIGUE, V1, P190, DOI 10.1080/21641846.2013.838444; Mika A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125889; Morris G, 2016, MOL NEUROBIOL, V53, P4638, DOI 10.1007/s12035-015-9392-y; Morris G, 2014, CURR NEUROPHARMACOL, V12, P168, DOI 10.2174/1570159X11666131120224653; Morris G, 2014, MOL NEUROBIOL, V49, P741, DOI 10.1007/s12035-013-8553-0; Morris G, 2014, METAB BRAIN DIS, V29, P19, DOI 10.1007/s11011-013-9435-x; Morris G, 2013, METAB BRAIN DIS, V28, P523, DOI 10.1007/s11011-012-9324-8; Morris G, 2013, NEUROENDOCRINOL LETT, V34, P185; Natelson BH, 2002, CLIN DIAGN LAB IMMUN, V9, P747, DOI 10.1128/CDLI.9.4.747-752.2002; Nijs J, 2014, EXERC IMMUNOL REV, V20, P94; O'Connor PJ, 2006, NUTR REV, V64, pS7, DOI 10.1111/j.1753-4887.2006.tb00256.x; O'Sullivan O, 2015, GUT MICROBES, V6, P131, DOI 10.1080/19490976.2015.1011875; Proal AD, 2013, IMMUNOL RES, V56, P398, DOI 10.1007/s12026-013-8413-z; Ramakrishnan VR, 2015, J ALLERGY CLIN IMMUN; Rao AV, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-6; Reynolds Kenneth J, 2004, Cost Eff Resour Alloc, V2, P4, DOI 10.1186/1478-7547-2-4; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Shukla SK, 2015, TRENDS MOL MED; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Solomon Laura, 2003, Health Qual Life Outcomes, V1, P48, DOI 10.1186/1477-7525-1-48; Wagner BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020296; Wagner Dieter, 2005, Popul Health Metr, V3, P8, DOI 10.1186/1478-7954-3-8; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; West CE, 2015, J ALLERGY CLIN IMMUN, V135, P3, DOI 10.1016/j.jaci.2014.11.012	57	64	71	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145453	10.1371/journal.pone.0145453	http://dx.doi.org/10.1371/journal.pone.0145453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683192	Green Submitted, Green Published, gold			2022-12-27	WOS:000366725800078
J	Wang, JQ				Wang, Jiaqiu			Resilience of Self-Organised and Top-Down Planned Cities-A Case Study on London and Beijing Street Networks	PLOS ONE			English	Article							ATTACK TOLERANCE; URBAN; PERCOLATION; CENTRALITY; INTERNET; PATTERNS; ERROR	The success or failure of the street network depends on its reliability. In this article, using resilience analysis, the author studies how the shape and appearance of street networks in self-organised and top-down planned cities influences urban transport. Considering London and Beijing as proxies for self-organised and top-down planned cities, the structural properties of London and Beijing networks first are investigated based on their primal and dual representations of planar graphs. The robustness of street networks then is evaluated in primal space and dual space by deactivating road links under random and intentional attack scenarios. The results show that the reliability of London street network differs from that of Beijing, which seems to rely more on its architecture and connectivity. It is found that top-down planned Beijing with its higher average degree in the dual space and assortativity in the primal space is more robust than self-organised London using the measures of maximum and second largest cluster size and network efficiency. The article offers an insight, from a network perspective, into the reliability of street patterns in self-organised and top-down planned city systems.	[Wang, Jiaqiu] UCL, CASA, London, England	University of London; University College London	Wang, JQ (corresponding author), UCL, CASA, London, England.	jiaqiu.wang@ucl.ac.uk			European Research Council (ERC) [249393-ERC-2009-AdG]; EPSRC [EP/G060983/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G060983/1] Funding Source: researchfish	European Research Council (ERC)(European Research Council (ERC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by European Research Council (ERC) - 249393-ERC-2009-AdG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JQW acknowledges the support of ERC grant no. 249393-ERC-2009-AdG. JQW thanks Robin Morphet for his helpful discussions.	Al-Shameri W.F.H., 2012, INT J CONT MATH SCI, V7, P413; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Barthelemy M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02153; Barthelemy M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.138702; Batty M., 2013, NEW SCI CITIES; Batty M, 2013, ENVIRON PLANN B, V40, P571, DOI 10.1068/b4004ed; Berche B, 2009, EUR PHYS J B, V71, P125, DOI 10.1140/epjb/e2009-00291-3; Buhl J, 2006, EUR PHYS J B, V49, P513, DOI 10.1140/epjb/e2006-00085-1; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cardillo A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066107; Chan SHY, 2011, EUR PHYS J B, V84, P563, DOI 10.1140/epjb/e2011-10889-3; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Courtat T, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036106; Crucitti P, 2004, PHYSICA A, V340, P388, DOI 10.1016/j.physa.2004.04.031; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gudmundsson A, 2013, SCI REPORTS, P3; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Hu MB, 2008, EUR PHYS J B, V63, P127, DOI 10.1140/epjb/e2008-00219-5; Hu MB, 2009, PHYS LETT A, V373, P2007, DOI 10.1016/j.physleta.2009.04.014; Iyer SV, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053532, 10.1371/journal.pone.0059613]; Jiang B, 2004, ENVIRON PLANN B, V31, P151, DOI 10.1068/b306; Latora V, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/188; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Levinson D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029721; Li DQ, 2015, P NATL ACAD SCI USA, V112, P669, DOI 10.1073/pnas.1419185112; Li DQ, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/68004; Louf R, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0924; Lu YM, 2004, ENVIRON PLANN B, V31, P895, DOI 10.1068/b3163; Marshall, 2004, STREETS AND PATTERNS; Masucci AP, 2009, EUR PHYS J B, V71, P259, DOI 10.1140/epjb/e2009-00290-4; Masucci A.P., 2015, ARXIV150407380; Masucci AP, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012805; Masucci AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069469; Masucci AP, 2013, 189 CASA; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Porta S, 2006, PHYSICA A, V369, P853, DOI 10.1016/j.physa.2005.12.063; Portugali J, 2009, ENCY COMPLEXITY SYST, P7953; Rui YK, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2012-30235-7; Samaniego H, 2008, J TRANSP LAND USE, V1; Southworth M, 2003, STREETS SHAPING TOWN; Strano E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00296; Wang J., 2007, P 6 INT SPAC SYNT S; Xie F, 2007, GEOGR ANAL, V39, P336, DOI 10.1111/j.1538-4632.2007.00707.x; Yang T., 2004, ROBOT MECH TOPOLOGY	46	13	14	6	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0141736	10.1371/journal.pone.0141736	http://dx.doi.org/10.1371/journal.pone.0141736			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682551	Green Submitted, Green Published, gold			2022-12-27	WOS:000366725800002
J	Zhang, YJ; Wang, W; Yang, HL; Li, Y; Kang, XY; Wang, XR; Yang, ZL				Zhang, Yuan-Jie; Wang, Wei; Yang, Hai-Ling; Li, Yue; Kang, Xiang-Yang; Wang, Xiao-Ru; Yang, Zhi-Ling			Molecular Properties and Functional Divergence of the Dehydroascorbate Reductase Gene Family in Lower and Higher Plants	PLOS ONE			English	Article							ENHANCED TOLERANCE; GLUTATHIONE; EXPRESSION; INCREASES; TRANSPORT; ASCORBATE; PROTEINS; OZONE	Dehydroascorbate reductase (DHAR), which reduces oxidized ascorbate, is important for maintaining an appropriate ascorbate redox state in plant cells. To date, genome-wide molecular characterization of DHARs has only been conducted in bryophytes (Physcomitrella patens) and eudicots (e.g. Arabidopsis thaliana). In this study, to gain a general understanding of the molecular properties and functional divergence of the DHARs in land plants, we further conducted a comprehensive analysis of DHARs from the lycophyte Selaginella moellendorffii, gymnosperm Picea abies and monocot Zea mays. DHARs were present as a small gene family in all of the land plants we examined, with gene numbers ranging from two to four. All the plants contained cytosolic and chloroplastic DHARs, indicating dehydroascorbate (DHA) can be directly reduced in the cytoplasm and chloroplast by DHARs in all the plants. A novel vacuolar DHAR was found in Z. mays, indicating DHA may also be reduced in the vacuole by DHARs in Z. mays. The DHARs within each species showed extensive functional divergence in their gene structures, subcellular localizations, and enzymatic characteristics. This study provides new insights into the molecular characteristics and functional divergence of DHARs in land plants.	[Zhang, Yuan-Jie; Wang, Wei; Yang, Hai-Ling; Li, Yue; Kang, Xiang-Yang; Wang, Xiao-Ru; Yang, Zhi-Ling] Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China	Beijing Forestry University	Yang, ZL (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.	yang_zhiling@yahoo.com	Wang, Xiao-Ru/H-6811-2012	Wang, Xiao-Ru/0000-0002-6150-7046	Natural Science Foundation of China (NSFC) [31270641]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Natural Science Foundation of China (NSFC 31270641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boruc J, 2010, PLANT PHYSIOL, V152, P553, DOI 10.1104/pp.109.148643; Byun SA, 2013, GENOME BIOL EVOL, V5, P2402, DOI 10.1093/gbe/evt183; Chen Z, 2004, PLANT CELL, V16, P1143, DOI 10.1105/tpc.021584; Chen Z, 2006, PLANT PHYSIOL, V142, P775, DOI 10.1104/pp.106.085506; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Eltayeb AE, 2006, PHYSIOL PLANTARUM, V127, P57, DOI 10.1111/j.1399-3054.2006.00624.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Horemans N, 2000, PLANT PHYSIOL BIOCH, V38, P531, DOI 10.1016/S0981-9428(00)00782-8; KERK NM, 1995, DEVELOPMENT, V121, P2825; Kim YS, 2014, J AGRON CROP SCI, V200, P444, DOI 10.1111/jac.12078; Kim YS, 2013, PLANTA, V237, P1613, DOI 10.1007/s00425-013-1862-8; Liu YJ, 2013, PLANT PHYSIOL, V161, P773, DOI 10.1104/pp.112.205815; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; RAUTENKRANZ AAF, 1994, PLANT PHYSIOL, V106, P187, DOI 10.1104/pp.106.1.187; Takahama Umeo, 2004, Phytochemistry Reviews, V3, P207, DOI 10.1023/B:PHYT.0000047805.08470.e3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang ZX, 2013, MOL BIOL REP, V40, P5105, DOI 10.1007/s11033-013-2612-5; Yamasaki H, 1999, PLANT CELL PHYSIOL, V40, P640, DOI 10.1093/oxfordjournals.pcp.a029587; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshida S, 2006, PLANT CELL PHYSIOL, V47, P304, DOI 10.1093/pcp/pci246; Yuen WK, 2001, COMP BIOCHEM PHYS A, V129, P631, DOI 10.1016/S1095-6433(01)00327-0	21	9	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145038	10.1371/journal.pone.0145038	http://dx.doi.org/10.1371/journal.pone.0145038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684301	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800032
J	Freyler, K; Gollhofer, A; Colin, R; Bruderlin, U; Ritzmann, R				Freyler, Kathrin; Gollhofer, Albert; Colin, Ralf; Bruederlin, Uli; Ritzmann, Ramona			Reactive Balance Control in Response to Perturbation in Unilateral Stance: Interaction Effects of Direction, Displacement and Velocity on Compensatory Neuromuscular and Kinematic Responses	PLOS ONE			English	Article							POSTURAL RESPONSES; STRETCH REFLEX; SUDDEN TORQUES; CENTRAL SET; PLATFORM; ADAPTATION; CONTRIBUTE; MOVEMENTS; INSIGHTS; MUSCLES	Unexpected sudden perturbations challenge postural equilibrium and require reactive compensation. This study aimed to assess interaction effects of the direction, displacement and velocity of perturbations on electromyographic (EMG) activity, centre of pressure (COP) displacement and joint kinematics to detect neuromuscular characteristics (phasic and segmental) and kinematic strategies of compensatory reactions in an unilateral balance paradigm. In 20 subjects, COP displacement and velocity, ankle, knee and hip joint excursions and EMG during short (SLR), medium (MLR) and long latency response (LLR) of four shank and five thigh muscles were analysed during random surface translations varying in direction (anterior-posterior (sagittal plane), medial-lateral (frontal plane)), displacement (2 vs. 3cm) and velocity (0.11 vs. 0.18m/s) of perturbation when balancing on one leg on a movable platform. Phases: SLR and MLR were scaled to increased velocity (P<0.05); LLR was scaled to increased displacement (P<0.05). Segments: phasic interrelationships were accompanied by segmental distinctions: distal muscles were used for fast compensation in SLR (P<0.05) and proximal muscles to stabilise in LLR (P<0.05). Kinematics: ankle joints compensated for both increasing displacement and velocity in all directions (P<0.05), whereas knee joint deflections were particularly sensitive to increasing displacement in the sagittal (P<0.05) and hip joint deflections to increasing velocity in the frontal plane (P<0.05). COP measures increased with increasing perturbation velocity and displacement (P<0.05). Interaction effects indicate that compensatory responses are based on complex processes, including different postural strategies characterised by phasic and segmental specifications, precisely adjusted to the type of balance disturbance. To regain balance after surface translation, muscles of the distal segment govern the quick regain of equilibrium; the muscles of the proximal limb serve as delayed stabilisers after a balance disturbance. Further, a kinematic distinction regarding the compensation for balance disturbance indicated different plane- and segment-specific sensitivities with respect to the determinants displacement and velocity.	[Freyler, Kathrin; Gollhofer, Albert; Ritzmann, Ramona] Univ Freiburg, Dept Sport & Sport Sci, D-79106 Freiburg, Germany; [Colin, Ralf; Bruederlin, Uli] Univ Appl Sci, Dept Mechatron, Esslingen, Germany	University of Freiburg	Freyler, K (corresponding author), Univ Freiburg, Dept Sport & Sport Sci, Hugstetter Str 55, D-79106 Freiburg, Germany.	kathrin.freyler@sport.uni-freiburg.de	Gollhofer, Albert/ABF-5766-2020; Albert, Gollhofer/V-3291-2019		German Aerospace Center [DLR 50WB1120]; German Ministry of Economy and Technology (ZIM Project) [KF2168712RR2]; Albert-Ludwigs-University Freiburg	German Aerospace Center(Helmholtz AssociationGerman Aerospace Centre (DLR)); German Ministry of Economy and Technology (ZIM Project); Albert-Ludwigs-University Freiburg	This study was funded by the German Aerospace Center (DLR 50WB1120) and German Ministry of Economy and Technology (ZIM Project KF2168712RR2). The article processing charge was funded by the open access publication fund of the Albert-Ludwigs-University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bhatt T, 2009, J NEUROPHYSIOL, V101, P948, DOI 10.1152/jn.91004.2008; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Boeer J, 2010, SPORTVERLETZ SPORTSC, V24, P40, DOI 10.1055/s-0029-1245184; Boeer J, 2010, J GERIATR PHYS THER, V33, P10, DOI 10.1097/JPT.0b013e3181d0720e; Brown LA, 2001, GAIT POSTURE, V14, P256, DOI 10.1016/S0966-6362(01)00131-X; Chomiak Taylor, 2015, J Clin Med Res, V7, P182, DOI 10.14740/jocmr1878w; d'Avella A, 2008, J NEUROPHYSIOL, V100, P1433, DOI 10.1152/jn.01377.2007; Di Giulio I, 2013, J APPL PHYSIOL, V114, P1717, DOI 10.1152/japplphysiol.01299.2012; DIENER HC, 1985, ELECTROEN CLIN NEURO, V60, P407, DOI 10.1016/0013-4694(85)91014-4; DIENER HC, 1988, J NEUROPHYSIOL, V59, P1888, DOI 10.1152/jn.1988.59.6.1888; DIENER HC, 1984, EXP BRAIN RES, V56, P126; DIETZ V, 1988, NEUROSCI LETT, V94, P82, DOI 10.1016/0304-3940(88)90274-1; DIETZ V, 1985, EXP BRAIN RES, V57, P348; DIETZ V, 1991, NEUROSCI LETT, V126, P71, DOI 10.1016/0304-3940(91)90374-3; DIETZ V, 1992, PHYSIOL REV, V72, P33, DOI 10.1152/physrev.1992.72.1.33; DIETZ V, 1989, J NEUROPHYSIOL, V62, P680, DOI 10.1152/jn.1989.62.3.680; Giboin L, 2015, HUMAN MOVEMENT SCI, P4422; GOLLHOFER A, 1993, EUR J APPL PHYSIOL, V66, P415, DOI 10.1007/BF00599614; GOLLHOFER A, 1989, NEUROSCI LETT, V105, P73, DOI 10.1016/0304-3940(89)90014-1; GOTTLIEB GL, 1979, J NEUROPHYSIOL, V42, P91, DOI 10.1152/jn.1979.42.1.91; GOTTLIEB GL, 1981, J NEUROPHYSIOL, V46, P179, DOI 10.1152/jn.1981.46.1.179; Grey MJ, 2001, J PHYSIOL-LONDON, V534, P925, DOI 10.1111/j.1469-7793.2001.00925.x; Henry SM, 1998, J NEUROPHYSIOL, V80, P1939, DOI 10.1152/jn.1998.80.4.1939; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Honeycutt CF, 2012, J NEUROPHYSIOL, V108, P1253, DOI 10.1152/jn.00929.2011; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479, DOI 10.1152/jn.1994.72.2.479; Horak FB, 1997, PHYS THER, V77, P517, DOI 10.1093/ptj/77.5.517; HORAK FB, 1989, J NEUROPHYSIOL, V62, P841, DOI 10.1152/jn.1989.62.4.841; HUGHES MA, 1995, CLIN BIOMECH, V10, P318, DOI 10.1016/0268-0033(94)00001-N; Jacobs JV, 2007, J NEURAL TRANSM, V114, P1339, DOI 10.1007/s00702-007-0657-0; Labanca L, 2015, EUR J APPL PHYSIOL, V115, P1441, DOI 10.1007/s00421-015-3126-8; da Costa PHL, 2013, GAIT POSTURE, V37, P419, DOI 10.1016/j.gaitpost.2012.08.015; Mergner T, 1998, BRAIN RES REV, V28, P118, DOI 10.1016/S0165-0173(98)00032-0; MOORE SP, 1988, EXP BRAIN RES, V73, P648, DOI 10.1007/BF00406624; Murnaghan CD, 2013, HUM MOVEMENT SCI, V32, P857, DOI 10.1016/j.humov.2013.07.002; NARDONE A, 1990, EXP BRAIN RES, V80, P323; NASHNER LM, 1977, EXP BRAIN RES, V30, P13; Nijhuis LBO, 2007, J NEUROPHYSIOL, V98, P3047, DOI 10.1152/jn.01303.2006; Richardson JK, 1996, ARCH PHYS MED REHAB, V77, P1152, DOI 10.1016/S0003-9993(96)90139-2; Rinalduzzi S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/434683; Ritzmann R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128400; Roelants M, 2006, J STRENGTH COND RES, V20, P124, DOI 10.1519/R-16674.1; Runge CF, 1999, GAIT POSTURE, V10, P161, DOI 10.1016/S0966-6362(99)00032-6; Strang AJ, 2011, EUR J APPL PHYSIOL, V111, P1485, DOI 10.1007/s00421-010-1770-6; Taube W, 2006, J APPL PHYSIOL, V101, P420, DOI 10.1152/japplphysiol.01447.2005; Tokuno CD, 2006, EXP BRAIN RES, V174, P19, DOI 10.1007/s00221-006-0414-x; Wiley ME, 1998, DEV MED CHILD NEUROL, V40, P100, DOI 10.1111/j.1469-8749.1998.tb15369.x; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9	49	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144529	10.1371/journal.pone.0144529	http://dx.doi.org/10.1371/journal.pone.0144529			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678061	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400018
J	Kasaie, P; Mathema, B; Kelton, WD; Azman, AS; Pennington, J; Dowdy, DW				Kasaie, Parastu; Mathema, Barun; Kelton, W. David; Azman, Andrew S.; Pennington, Jeff; Dowdy, David W.			A Novel Tool Improves Existing Estimates of Recent Tuberculosis Transmission in Settings of Sparse Data Collection	PLOS ONE			English	Article							NEW-YORK-CITY; MOLECULAR EPIDEMIOLOGY; LATENT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; SOUTH-AFRICA; INFECTION; RISK; PROPORTION; PATTERNS; DISEASE	In any setting, a proportion of incident active tuberculosis (TB) reflects recent transmission ("recent transmission proportion"), whereas the remainder represents reactivation. Appropriately estimating the recent transmission proportion has important implications for local TB control, but existing approaches have known biases, especially where data are incomplete. We constructed a stochastic individual-based model of a TB epidemic and designed a set of simulations (derivation set) to develop two regression-based tools for estimating the recent transmission proportion from five inputs: underlying TB incidence, sampling coverage, study duration, clustered proportion of observed cases, and proportion of observed clusters in the sample. We tested these tools on a set of unrelated simulations (validation set), and compared their performance against that of the traditional 'n-1' approach. In the validation set, the regression tools reduced the absolute estimation bias (difference between estimated and true recent transmission proportion) in the 'n-1' technique by a median [interquartile range] of 60% [9%, 82%] and 69% [30%, 87%]. The bias in the 'n-1' model was highly sensitive to underlying levels of study coverage and duration, and substantially underestimated the recent transmission proportion in settings of incomplete data coverage. By contrast, the regression models' performance was more consistent across different epidemiological settings and study characteristics. We provide one of these regression models as a user-friendly, web-based tool. Novel tools can improve our ability to estimate the recent TB transmission proportion from data that are observable (or estimable) by public health practitioners with limited available molecular data.	[Kasaie, Parastu; Azman, Andrew S.; Pennington, Jeff; Dowdy, David W.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Mathema, Barun] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Kelton, W. David] Univ Cincinnati, Dept Operat Business Analyt & Informat Syst, Cincinnati, OH USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University; University System of Ohio; University of Cincinnati	Dowdy, DW (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	ddowdy@jhsph.edu	Kasaie, Parastu/AAD-1960-2021	Mathema, Barun/0000-0003-2772-479X; Azman, Andrew/0000-0001-8662-9077	Johns Hopkins University Center for AIDS Research, an NIH [P30AI094189]; NIH; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC; NIGMS; NIDDK; OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Johns Hopkins University Center for AIDS Research, an NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by B. Frank and Kathleen Polk Assistant Professorship in Epidemiology, Johns Hopkins Bloomberg School of Public Health [DWD, ASA, PK]. This research was funded in part by a 2015 developmental grant from the Johns Hopkins University Center for AIDS Research, an NIH funded program (P30AI094189), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, NIGMS, NIDDK, and OAR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; Anderson LF, 2014, LANCET INFECT DIS, V14, P406, DOI 10.1016/S1473-3099(14)70022-2; Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Azman AS, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0216-0; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Benedetti A, 2010, AM J EPIDEMIOL, V172, P318, DOI 10.1093/aje/kwq124; Bishai WR, 1998, JAMA-J AM MED ASSOC, V280, P1679, DOI 10.1001/jama.280.19.1679; Driver CR, 2007, EPIDEMIOL INFECT, V135, P634, DOI 10.1017/S0950268806007278; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; GENEWEIN A, 1993, LANCET, V342, P841, DOI 10.1016/0140-6736(93)92698-S; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; Glynn JR, 1999, INT J TUBERC LUNG D, V3, P1055; Glynn JR, 1999, AM J EPIDEMIOL, V149, P366, DOI 10.1093/oxfordjournals.aje.a009822; Golub JE, 2008, JAIDS-J ACQ IMM DEF, V49, P532, DOI 10.1097/QAI.0b013e31818d5c1c; Grabowski MK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001610; Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166; Hollm-Delgado MG, 2009, SOC SCI MED, V69, P747, DOI 10.1016/j.socscimed.2009.06.043; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Houben RMGJ, 2009, TROP MED INT HEALTH, V14, P892, DOI 10.1111/j.1365-3156.2009.02316.x; Houben RMGJ, 2014, AM J EPIDEMIOL; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Kasaie P, 2014, BETTER N 1 MODEL EST; Kasaie P, 2014, WINT SIMUL C PROC, P1469, DOI 10.1109/WSC.2014.7020000; Kouyos RD, 2014, INT J EPIDEMIOL; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Mahony AA, 2013, MED J AUSTRALIA, V198, P210, DOI 10.5694/mja12.10556; Mathema B, 2014, ANN AM THORAC SOC; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; MCKENNA MT, 1995, NEW ENGL J MED, V332, P1071, DOI 10.1056/NEJM199504203321606; Meissner JS, 2012, AM J RESP CRIT CARE, V185; Middelkoop K, 2015, J INFECT DIS, V211, P53, DOI 10.1093/infdis/jiu403; Moonan PK, 2012, EMERG INFECT DIS, V18, P458, DOI 10.3201/eid1803.111107; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Murray M, 2002, EMERG INFECT DIS, V8, P363, DOI 10.3201/eid0804.000444; Murray M, 2002, P NATL ACAD SCI USA, V99, P1538, DOI 10.1073/pnas.022618299; Murray M, 2002, AM J EPIDEMIOL, V155, P565, DOI 10.1093/aje/155.6.565; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Sanchez MA, 1997, AM J EPIDEMIOL, V145, P1127; Schurch AC, 2012, INFECT GENET EVOL, V12, P602, DOI 10.1016/j.meegid.2011.08.032; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; SUTHERLAND I, 1982, TUBERCLE, V63, P255, DOI 10.1016/S0041-3879(82)80013-5; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; van Deutekom H, 2004, AM J RESP CRIT CARE, V169, P806, DOI 10.1164/rccm.200306-856OC; van Soolingen D, 1999, J INFECT DIS, V180, P726, DOI 10.1086/314930; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Vynnycky E, 2001, EPIDEMIOL INFECT, V126, P43, DOI 10.1017/S095026880100499X; World Health Organization, 2013, GLOB TB REP; World Health Organization, 2013, WHO TB BURD EST	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144137	10.1371/journal.pone.0144137	http://dx.doi.org/10.1371/journal.pone.0144137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679499	gold, Green Submitted, Green Published			2022-12-27	WOS:000366723400008
J	Saxena, MK; Taylor, C; Billot, L; Bompoint, S; Gowardman, J; Roberts, JA; Lipman, J; Myburgh, J				Saxena, Manoj K.; Taylor, Colman; Billot, Laurent; Bompoint, Severine; Gowardman, John; Roberts, Jason A.; Lipman, Jeffery; Myburgh, John			The Effect of Paracetamol on Core Body Temperature in Acute Traumatic Brain Injury: A Randomised, Controlled Clinical Trial	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ACUTE ISCHEMIC-STROKE; DOUBLE-BLIND; INTENSIVE-CARE; ACETAMINOPHEN; HYPERTHERMIA; HYPOTHERMIA; MANAGEMENT; MORTALITY; MULTICENTER	Background Strategies to prevent pyrexia in patients with acute neurological injury may reduce secondary neuronal damage. The aim of this study was to determine the safety and efficacy of the routine administration of 6 grams/day of intravenous paracetamol in reducing body temperature following severe traumatic brain injury, compared to placebo. Methods A multicentre, randomised, blind, placebo-controlled clinical trial in adult patients with traumatic brain injury (TBI). Patients were randomised to receive an intravenous infusion of either 1g of paracetamol or 0.9% sodium chloride (saline) every 4 hours for 72 hours. The primary outcome was the mean difference in core temperature during the study intervention period. Results Forty-one patients were included in this study: 21 were allocated to paracetamol and 20 to saline. The median (interquartile range) number of doses of study drug was 18 (17-18) in the paracetamol group and 18 (16-18) in the saline group (P = 0.85). From randomisation until 4 hours after the last dose of study treatment, there were 2798 temperature measurements (median 73 [67-76] per patient). The mean +/- standard deviation temperature was 37.4 +/- 0.5 degrees C in the paracetamol group and 37.7 +/- 0.4 degrees C in the saline group (absolute difference -0.3 degrees C; 95% confidence interval -0.6 to 0.0; P = 0.09). There were no significant differences in the use of physical cooling, or episodes of hypotension or hepatic abnormalities, between the two groups. Conclusion The routine administration of 6g/day of intravenous paracetamol did not significantly reduce core body temperature in patients with TBI.	[Saxena, Manoj K.; Taylor, Colman; Myburgh, John] George Inst Global Hlth, Div Crit Care, Sydney, NSW, Australia; [Saxena, Manoj K.; Taylor, Colman; Myburgh, John] George Inst Global Hlth, Trauma Div, Sydney, NSW, Australia; [Saxena, Manoj K.; Myburgh, John] Univ New S Wales, St George Hosp, Sch Clin, Dept Intens Care Med, Sydney, NSW 2052, Australia; [Taylor, Colman; Billot, Laurent] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Billot, Laurent; Bompoint, Severine] George Inst Global Hlth, Div Stat, Sydney, NSW, Australia; [Gowardman, John; Roberts, Jason A.; Lipman, Jeffery] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia; [Gowardman, John; Roberts, Jason A.; Lipman, Jeffery] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia; [Lipman, Jeffery] Queensland Univ Technol, Fac Hlth, Brisbane, Qld 4001, Australia	George Institute for Global Health; University of Sydney; George Institute for Global Health; University of Sydney; St George Hospital; University of New South Wales Sydney; University of Sydney; George Institute for Global Health; University of Sydney; Royal Brisbane & Women's Hospital; University of Queensland; Queensland University of Technology (QUT)	Saxena, MK (corresponding author), George Inst Global Hlth, Div Crit Care, Sydney, NSW, Australia.	m.saxena@georgeinstitute.org.au	Lipman, Jeffrey/G-2211-2010; Billot, Laurent/Y-1241-2019; Roberts, Jason A/F-6272-2010	Lipman, Jeffrey/0000-0002-5965-9876; Billot, Laurent/0000-0002-4975-9793; Roberts, Jason A/0000-0001-6218-435X; Bompoint, Severine/0000-0001-5226-4321; Saxena, Manoj/0000-0002-0385-6731; Myburgh, John/0000-0003-4088-7016	Australia and New Zealand College of Anaesthetists; St. George Medical research Foundation	Australia and New Zealand College of Anaesthetists; St. George Medical research Foundation	This work was supported by: Project grant from the Australia and New Zealand College of Anaesthetists (MS JM JG JL); Unrestricted grant from the St. George Medical research Foundation (The Honda-St. George Critical Care and Trauma Fellowship) (MS JM). The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, and approval of the manuscript.	Adelson PD, 2013, THE LANCET NEUROLOGY; Andrews P. J., 2015, N ENGL J MED; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Brain Trauma F, 2008, J NEUROTRAUM, V25, P276; Brain Trauma F, 2007, J NEUROTRAUM, V24, pS21; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Brown JM, 2008, CHILD NERV SYST, V24, P477, DOI 10.1007/s00381-007-0517-0; Daly FFS, 2004, ANN EMERG MED, V44, P393, DOI 10.1016/j.annemergmed.2004.05.005; den Hertog HM, 2009, LANCET NEUROL, V8, P434, DOI 10.1016/S1474-4422(09)70051-1; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Dippel DWJ, 2003, BMC CARDIOVASC DISOR, V3, DOI 10.1186/1471-2261-3-2; Dippel DWJ, 2001, STROKE, V32, P1607, DOI 10.1161/01.STR.32.7.1607; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Heyland DK, 1996, INTENS CARE MED, V22, P1339, DOI 10.1007/BF01709548; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jefferies S, 2012, CRIT CARE RESUSC, V14, P74; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Maekawa T, 2014, J NEUROTRAUMA; Marion DW, 2004, CRIT CARE MED, V32, pS43, DOI 10.1097/01.CCM.0000110731.69637.16; Mullins ME, 2011, NEUROCRIT CARE, V15, P375, DOI 10.1007/s12028-011-9533-8; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; PERUCCA E, 1979, BRIT J CLIN PHARMACO, V7, P201, DOI 10.1111/j.1365-2125.1979.tb00922.x; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Ridder IR, 2013, INT J; Sacho RH, 2008, BRIT J NEUROSURG, V22, P497, DOI 10.1080/02688690802245558; Saxena M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006811.pub3; Saxena M, 2015, INTENS CARE MED, V41, P823, DOI 10.1007/s00134-015-3676-6; Saxena MK, 2015, CRIT CARE RESUSC, V17, P129; Saxena MK, 2013, CRIT CARE RESUSC, V15, P110; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; van der Jagt M, 2015, INTENS CARE MED, V41, P1129, DOI 10.1007/s00134-015-3844-8; Wang Y, 2000, STROKE, V31, P404, DOI 10.1161/01.STR.31.2.404; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Young P, 2015, N ENGL J MED	39	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144740	10.1371/journal.pone.0144740	http://dx.doi.org/10.1371/journal.pone.0144740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678710	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400023
J	Broell, F; Taggart, CT				Broell, Franziska; Taggart, Christopher T.			Scaling in Free-Swimming Fish and Implications for Measuring Size-at-Time in the Wild	PLOS ONE			English	Article							SAITHE POLLACHIUS-VIRENS; ACCELERATION DATA-LOGGER; TAIL BEAT; ACIPENSER-BREVIROSTRUM; SHORTNOSE STURGEON; STROKE FREQUENCY; SPEED; OTOLITHS; KINEMATICS; BEHAVIOR	This study was motivated by the need to measure size-at-age, and thus growth rate, in fish in the wild. We postulated that this could be achieved using accelerometer tags based first on early isometric scaling models that hypothesize that similar animals should move at the same speed with a stroke frequency that scales with length-(1), and second on observations that the speed of primarily air-breathing free-swimming animals, presumably swimming 'efficiently',is independent of size, confirming that stroke frequency scales as length-(1). However, such scaling relations between size and swimming parameters for fish remain mostly theoretical. Based on free-swimming saithe and sturgeon tagged with accelerometers, we introduce a species-specific scaling relationship between dominant tail beat frequency (TBF) and fork length. Dominant TBF was proportional to length-(1) ( r(2) = 0.73, n = 40), and estimated swimming speed within species was independent of length. Similar scaling relations accrued in relation to body mass(-0.29). We demonstrate that the dominant TBF can be used to estimate size-at-time and that accelerometer tags with onboard processing may be able to provide size-at-time estimates among free-swimming fish and thus the estimation of growth rate (change in size-at-time) in the wild.	[Broell, Franziska; Taggart, Christopher T.] Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4R2, Canada	Dalhousie University	Broell, F (corresponding author), Dalhousie Univ, Dept Oceanog, 1355 Oxford St, Halifax, NS B3H 4R2, Canada.	franziskabroell@dal.ca			OTN Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) [NETGP 375118 - 08]	OTN Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by OTN Canada (oceantrackingnetwork.org) - Natural Sciences and Engineering Research Council of Canada (NSERC Strategic Network Grant; NETGP 375118 - 08) funding to CTT and FB.	Aitken A. C., 1936, P ROY SOC EDINB, V55, P42, DOI [10.1017/s0370164600014346, DOI 10.1017/S0370164600014346]; [Anonymous], MATLAB R2012A NAT; BAINBRIDGE R, 1958, J EXP BIOL, V35, P109; BAINBRIDGE RICHARD, 1961, SYMPOSIA ZOOL SOC LONDON, V5, P13; Broell F, 2013, J EXP BIOL, V216, P1255, DOI 10.1242/jeb.077396; Burnham KP, 2002, J APPL STAT, V29, P245, DOI 10.1080/02664760120108755; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Cargnelli LM, 1999, NMFSNE131 NOAA; Chattopadhyay S, 2006, P NATL ACAD SCI USA, V103, P13712, DOI 10.1073/pnas.0602043103; Cheng JY, 1998, PHILOS T ROY SOC B, V353, P981, DOI 10.1098/rstb.1998.0262; Christiansen P, 1999, J MORPHOL, V239, P167, DOI 10.1002/(SICI)1097-4687(199902)239:2<167::AID-JMOR5>3.3.CO;2-#; DADSWELL MJ, 1979, CAN J ZOOL, V57, P2186, DOI 10.1139/z79-287; Deslauriers D, 2012, CAN J ZOOL, V90, P345, DOI 10.1139/Z2012-004; Domenici P, 1997, J EXP BIOL, V200, P1165; Faust MD, 2013, J FISH WILDL MANAG, V4, P332, DOI 10.3996/062013-JFWM-041; Gazzola M, 2014, NAT PHYS, V10, P758, DOI 10.1038/NPHYS3078; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Gray J., 1968, ANIMAL LOCOMOTION; HESS F, 1984, J EXP BIOL, V109, P229; Hill A. V., 1950, Science Progress London, V38, P209; Kawabe R, 2003, FISHERIES SCI, V69, P959, DOI 10.1046/j.1444-2906.2003.00713.x; Kawabe R, 2003, FISHERIES SCI, V69, P3, DOI 10.1046/j.1444-2906.2003.00581.x; KEDEM B, 1986, P IEEE, V74, P1477, DOI 10.1109/PROC.1986.13663; Kohannim S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1073; LONG JH, 1995, ENVIRON BIOL FISH, V44, P199, DOI 10.1007/BF00005916; Motani R, 2002, NATURE, V415, P309, DOI 10.1038/415309a; Neuheimer AB, 2007, CAN J FISH AQUAT SCI, V64, P375, DOI 10.1139/F07-003; Noda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079392; PANFILI J, 1992, J FISH BIOL, V41, P201, DOI 10.1111/j.1095-8649.1992.tb02650.x; PANNELLA G, 1971, SCIENCE, V173, P1124, DOI 10.1126/science.173.4002.1124; Pedley T.J, 1977, SCALE EFFECTS ANIMAL; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robinson MP, 2002, J ZOOL, V256, P449, DOI 10.1017/S0952836902000493; Sardenne F, 2015, FISH RES, V163, P44, DOI 10.1016/j.fishres.2014.03.008; Sato K, 2007, P R SOC B, V274, P471, DOI 10.1098/rspb.2006.0005; Sato K, 2010, P R SOC B, V277, P707, DOI 10.1098/rspb.2009.1515; Sato K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005400; STASKO AB, 1976, J FISH RES BOARD CAN, V33, P2596, DOI 10.1139/f76-305; Stein, 2000, DIGIT SIGNAL PROCESS; Steinhausen MF, 2005, MAR BIOL, V148, P197, DOI 10.1007/s00227-005-0055-9; Taylor GK, 2014, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780198566373.001.0001; Toro E, 2003, J EXP BIOL, V206, P2641, DOI 10.1242/jeb.00473; Tsuda Y, 2006, ECOL FRESHW FISH, V15, P264, DOI 10.1111/j.1600-0633.2006.00147.x; van Ginneken V, 2005, J EXP BIOL, V208, P1329, DOI 10.1242/jeb.01524; van Leeuwen JL, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0479; Videler J.J., 1991, Reviews in Fish Biology and Fisheries, V1, P23, DOI 10.1007/BF00042660; VIDELER JJ, 1984, J EXP BIOL, V109, P209; Watanabe Y, 2008, J ZOOL, V275, P381, DOI 10.1111/j.1469-7998.2008.00451.x; Webb P.W., 1975, B FISH RES BOARD CAN, V190, P1, DOI DOI 10.1002/RRA.1371; WEBB PW, 1986, CAN J ZOOL, V64, P2137, DOI 10.1139/z86-328; Webb PW, 1976, FISH PHYSL, V7; Wu T. Y.-T., 1971, ADV APPL MECH, V11, P1	55	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144875	10.1371/journal.pone.0144875	http://dx.doi.org/10.1371/journal.pone.0144875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673777	Green Submitted, gold, Green Published			2022-12-27	WOS:000366722700069
J	Bruggeman, DJ				Bruggeman, Douglas J.			The Value of Learning about Natural History in Biodiversity Markets	PLOS ONE			English	Article							RED-COCKADED WOODPECKER; HABITAT FRAGMENTATION; POPULATION-DYNAMICS; DISPERSAL; MODELS; RESISTANCE; INDEXES; RISK	Markets for biodiversity have generated much controversy because of the often unstated and untested assumptions included in transactions rules. Simple trading rules are favored to reduce transaction costs, but others have argued that this leads to markets that favor development and erode biodiversity. Here, I describe how embracing complexity and uncertainty within a tradable credit system for the Red-cockaded Woodpecker (Picoides borealis) creates opportunities to achieve financial and conservation goals simultaneously. Reversing the effects of habitat fragmentation is one of the main reasons for developing markets. I include uncertainty in habitat fragmentation effects by evaluating market transactions using five alternative dispersal models that were able to approximate observed patterns of occupancy and movement. Further, because dispersal habitat is often not included in market transactions, I contrast how changes in breeding versus dispersal habitat affect credit values. I use an individually-based, spatially-explicit population model for the Red-cockaded Woodpecker (Picoides borealis) to predict spatial-and temporal-influences of landscape change on species occurrence and genetic diversity. Results indicated that the probability of no net loss of abundance and genetic diversity responded differently to the transient dynamics in breeding and dispersal habitat. Trades that do not violate the abundance cap may simultaneously violate the cap for the erosion of genetic diversity. To highlight how economic incentives may help reduce uncertainty, I demonstrate tradeoffs between the value of tradable credits and the value of information needed to predict the influence of habitat trades on population viability. For the trade with the greatest uncertainty regarding the change in habitat fragmentation, I estimate that the value of using 13-years of data to reduce uncertainty in dispersal behaviors is $6.2 million. Future guidance for biodiversity markets should at least encourage the use of spatially-and temporally-explicit techniques that include population genetic estimates and the influence of uncertainty.	[Bruggeman, Douglas J.] Ecol Serv & Markets Inc, Marshall, NC 28753 USA		Bruggeman, DJ (corresponding author), Ecol Serv & Markets Inc, Marshall, NC 28753 USA.	dougbrugg@gmail.com			Ecological Services and Markets, Inc. (ESaM)	Ecological Services and Markets, Inc. (ESaM)	Ecological Services and Markets, Inc. (ESaM;esmarkets.com) funded this study. ESaM had sole responsibility for study design, analysis, decision to publish, and preparation of the manuscript.	Armsworth PR, 2006, P NATL ACAD SCI USA, V103, P5403, DOI 10.1073/pnas.0505278103; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Bouzat JL, 2000, GENETICA, V110, P109, DOI 10.1023/A:1017985522650; Bruggeman DJ, 2005, ENVIRON MANAGE, V36, P518, DOI 10.1007/s00267-004-0239-y; Bruggeman DJ, 2014, DEV ADAPTIVE MANAGEM; Bruggeman DJ, 2008, ENVIRON MANAGE, V42, P591, DOI 10.1007/s00267-008-9179-2; Bruggeman DJ, 2014, LANDSCAPE ECOL, V29, P639, DOI 10.1007/s10980-014-0011-5; Bruggeman DJ, 2010, MOL ECOL, V19, P3679, DOI 10.1111/j.1365-294X.2010.04659.x; Bruggeman DJ, 2009, LANDSCAPE ECOL, V24, P775, DOI 10.1007/s10980-009-9351-y; Clemen R.T, 2001, MAKING HARD DECISION; Cosentino BJ, 2012, P ROY SOC B-BIOL SCI, V279, P1575, DOI 10.1098/rspb.2011.1880; Cushman SA, 2012, LANDSCAPE ECOL, V27, P369, DOI 10.1007/s10980-011-9693-0; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Fox J, 2005, CONSERV BIOL, V19, P996, DOI 10.1111/j.1523-1739.2005.00231.x; Goss-Custard JD, 2006, ECOL APPL, V16, P2215, DOI 10.1890/1051-0761(2006)016[2215:TOABIM]2.0.CO;2; Grantham HS, 2009, ECOL LETT, V12, P293, DOI 10.1111/j.1461-0248.2009.01287.x; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Horan RD, 2005, J ECON BEHAV ORGAN, V58, P1, DOI 10.1016/j.jebo.2004.03.009; Jepsen JU, 2005, ECOL MODEL, V181, P445, DOI 10.1016/j.ecolmodel.2003.11.019; Jones CA, 1997, CONTEMP ECON POLICY, V15, P111, DOI 10.1111/j.1465-7287.1997.tb00494.x; Kesler DC, 2010, BEHAV ECOL, V21, P1337, DOI 10.1093/beheco/arq158; Letcher BH, 1998, BIOL CONSERV, V86, P1, DOI 10.1016/S0006-3207(98)00019-6; Lewis DJ, 2009, AM J AGR ECON, V91, P1080, DOI 10.1111/j.1467-8276.2009.01310.x; Lindenmayer DB, 2007, TRENDS ECOL EVOL, V22, P127, DOI 10.1016/j.tree.2006.11.006; Loomis JB, 1996, ECOL ECON, V18, P197, DOI 10.1016/0921-8009(96)00029-8; Mac Nally R, 2000, BIOL CONSERV, V95, P7, DOI 10.1016/S0006-3207(00)00017-3; Madsen B., 2010, STATE BIODIVERSITY M; Manly BFJ, 1986, RANDOMIZATION BOOTST; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Maron M, 2012, BIOL CONSERV, V155, P141, DOI 10.1016/j.biocon.2012.06.003; Meffe GK, 1996, BIODIVERSITY MANAGED; Minor ES, 2007, ECOL APPL, V17, P1771, DOI 10.1890/06-1073.1; Moilanen A, 2009, RESTOR ECOL, V17, P470, DOI 10.1111/j.1526-100X.2008.00382.x; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Obama B., 2015, PRESIDENTIAL MEMORAN; Parkhurst GM, 2002, ECOL ECON, V41, P305, DOI 10.1016/S0921-8009(02)00036-8; Parkhurst GM, 2008, AM J AGR ECON, V90, P1192, DOI 10.1111/j.1467-8276.2008.01203.x; Polasky S, 2014, P NATL ACAD SCI USA, V111, P6248, DOI 10.1073/pnas.1404484111; Reed DH, 2004, ANIM CONSERV, V7, P181, DOI 10.1017/S1367943004001313; Ruckelshaus M, 1997, CONSERV BIOL, V11, P1298, DOI 10.1046/j.1523-1739.1997.96151.x; Runge CA, 2014, FRONT ECOL ENVIRON, V12, P395, DOI 10.1890/130237; Schlaifer R., 1961, APPL STAT DECISION T; Sugg DW, 1996, TRENDS ECOL EVOL, V11, P338, DOI 10.1016/0169-5347(96)20050-3; Thomas CD, 1999, J ANIM ECOL, V68, P647, DOI 10.1046/j.1365-2656.1999.00330.x; TIETENBERG T, 2004, TRADABLE PERMITS APP; Trainor AM, 2013, LANDSCAPE ECOL, V28, P755, DOI 10.1007/s10980-013-9861-5; U.S. Fish and Wildlife Service, 2003, REC PLAN RED COCK WO; Walker S, 2009, CONSERV LETT, V2, P149, DOI 10.1111/j.1755-263X.2009.00061.x; Walters C., 1986, ADAPTIVE MANAGEMENT; Walters JR, 2002, J WILDLIFE MANAGE, V66, P1064, DOI 10.2307/3802938; WALTERS JR, 1988, ETHOLOGY, V78, P275; Walters JR, 2011, DECISION SUPPORT SYS; Wennergren U, 1995, OIKOS, V74, P349, DOI 10.2307/3545979; Wiegand T, 2004, BIODIVERS CONSERV, V13, P53, DOI 10.1023/B:BIOC.0000004313.86836.ab; Wiegand T, 1999, AM NAT, V154, P605, DOI 10.1086/303272; Wilhere GF, 2002, CONSERV BIOL, V16, P20, DOI 10.1046/j.1523-1739.2002.00350.x; Williams BK, 2012, ADAPTOVE MANAGEMENT; Williams KJ, 2012, ECOL ECON, V81, P48, DOI 10.1016/j.ecolecon.2012.07.005; Winfree R, 2005, AM NAT, V165, P707, DOI 10.1086/430009; With KA, 1999, CONSERV BIOL, V13, P314, DOI 10.1046/j.1523-1739.1999.013002314.x; Yokota F, 2004, MED DECIS MAKING, V24, P287, DOI 10.1177/0272989X04263157	63	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144047	10.1371/journal.pone.0144047	http://dx.doi.org/10.1371/journal.pone.0144047			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JH	26675488	gold, Green Submitted, Green Published			2022-12-27	WOS:000366722700022
J	Salinas, RP; Flores, RMO; Distel, JS; Aguilera, MO; Colombo, MI; Beron, W				Salinas, Romina P.; Ortiz Flores, Rodolfo M.; Distel, Jesus S.; Aguilera, Milton O.; Colombo, Maria I.; Beron, Walter			Coxiella burnetii Phagocytosis Is Regulated by GTPases of the Rho Family and the RhoA Effectors mDia1 and ROCK	PLOS ONE			English	Article							FC-GAMMA-R; RECEPTOR-MEDIATED PHAGOCYTOSIS; DIAPHANOUS-RELATED FORMINS; ARP2/3 COMPLEX; MYOSIN-II; ALPHA(V)BETA(3) INTEGRIN; SALMONELLA INVASION; DISTINCT MECHANISMS; BACTERIAL PATHOGENS; ACTIN CYTOSKELETON	The GTPases belonging to the Rho family control the actin cytoskeleton rearrangements needed for particle internalization during phagocytosis. ROCK and mDia1 are downstream effectors of RhoA, a GTPase involved in that process. Coxiella burnetii, the etiologic agent of Q fever, is internalized by the host's cells in an actin-dependent manner. Nevertheless, the molecular mechanism involved in this process has been poorly characterized. This work analyzes the role of different GTPases of the Rho family and some downstream effectors in the internalization of C. burnetii by phagocytic and non-phagocytic cells. The internalization of C. burnetii into HeLa and RAW cells was significantly inhibited when the cells were treated with Clostridium difficile Toxin B which irreversibly inactivates members of the Rho family. In addition, the internalization was reduced in HeLa cells that overexpressed the dominant negative mutants of RhoA, Rac1 or Cdc42 or that were knocked down for the Rho GTPases. The pharmacological inhibition or the knocking down of ROCK diminished bacterium internalization. Moreover, C. burnetii was less efficiently internalized in HeLa cells overexpressing mDia1-N1, a dominant negative mutant of mDia1, while the overexpression of the constitutively active mutant mDia1-Delta N3 increased bacteria uptake. Interestingly, when HeLa and RAW cells were infected, RhoA, Rac1 and mDia1 were recruited to membrane cell fractions. Our results suggest that the GTPases of the Rho family play an important role in C. burnetii phagocytosis in both HeLa and RAW cells. Additionally, we present evidence that ROCK and mDia1, which are downstream effectors of RhoA, are involved in that process.	[Salinas, Romina P.; Ortiz Flores, Rodolfo M.; Distel, Jesus S.; Aguilera, Milton O.; Colombo, Maria I.; Beron, Walter] Univ Nacl Cuyo, Inst Histol & Embriol, Fac Ciencias Med, CONICET, RA-5500 Mendoza, Argentina	University Nacional Cuyo Mendoza	Beron, W (corresponding author), Univ Nacl Cuyo, Inst Histol & Embriol, Fac Ciencias Med, CONICET, RA-5500 Mendoza, Argentina.	wberon@fcm.uncu.edu.ar	Ortiz Flores, Rodolfo Matias/ABA-5380-2021	Ortiz Flores, Rodolfo Matias/0000-0003-4509-0161; Distel, Jesus Sebastian/0000-0003-4589-5314	CONICET (Consejo Nacional de Investigacion Cientifica y Tecnica) (PIP); ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnologica) [PICT-2012-2425]; SECTyP (Secretaria de Ciencia, Tecnica y Postgrado); Universidad Nacional de Cuyo	CONICET (Consejo Nacional de Investigacion Cientifica y Tecnica) (PIP); ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnologica)(ANPCyT); SECTyP (Secretaria de Ciencia, Tecnica y Postgrado); Universidad Nacional de Cuyo	This work was supported by grants from CONICET (Consejo Nacional de Investigacion Cientifica y Tecnica) (PIP 2010-2012), ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnologica) (PICT-2012-2425) and SECTyP (Secretaria de Ciencia, Tecnica y Postgrado) (2013-2015), Universidad Nacional de Cuyo, to WB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aguilera M, 2009, INFECT IMMUN, V77, P4609, DOI 10.1128/IAI.00301-09; Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Alix E, 2011, J CELL BIOL, V195, P943, DOI 10.1083/jcb.201105019; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Alonso A, 2004, INT MICROBIOL, V7, P181; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; BACA OG, 1983, MICROBIOL REV, V47, P127, DOI 10.1128/MMBR.47.2.127-149.1983; BACA OG, 1993, ACTA VIROL, V37, P143; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Beron W, 2002, INFECT IMMUN, V70, P5816, DOI 10.1128/IAI.70.10.5816-5821.2002; Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; Bierne H, 2005, J CELL SCI, V118, P1537, DOI 10.1242/jcs.02285; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Billker O, 2002, EMBO J, V21, P560, DOI 10.1093/emboj/21.4.560; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Burnham CAD, 2007, FEMS MICROBIOL LETT, V272, P8, DOI 10.1111/j.1574-6968.2007.00768.x; Capo C, 1999, J IMMUNOL, V163, P6078; Carabeo RA, 2004, TRAFFIC, V5, P418, DOI 10.1111/j.1398-9219.2004.00184.x; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chi XJ, 2013, INT J MOL SCI, V14, P7089, DOI 10.3390/ijms14047089; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Cossart P, 2010, CURR OPIN CELL BIOL, V22, P547, DOI 10.1016/j.ceb.2010.05.006; Cougoule C, 2006, J BIOL CHEM, V281, P8756, DOI 10.1074/jbc.M513731200; Croise Pauline, 2014, Small GTPases, V5, pe29469, DOI 10.4161/sgtp.29469; Dellacasagrande J, 2000, INFECT IMMUN, V68, P5673, DOI 10.1128/IAI.68.10.5673-5678.2000; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Duman JG, 2015, NEUROSCI LETT, V601, P4, DOI 10.1016/j.neulet.2015.05.034; Fairn GD, 2012, TRENDS IMMUNOL, V33, P397, DOI 10.1016/j.it.2012.03.003; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Firat-Karalar EN, 2011, CURR OPIN CELL BIOL, V23, P4, DOI 10.1016/j.ceb.2010.10.007; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Fox R, 2007, EMBO J, V26, P505, DOI 10.1038/sj.emboj.7601522; Frampton AR, 2007, J VIROL, V81, P10879, DOI 10.1128/JVI.00504-07; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Genth H, 2006, FEBS LETT, V580, P3565, DOI 10.1016/j.febslet.2006.04.100; Goh WI, 2012, J BIOL CHEM, V287, P4702, DOI 10.1074/jbc.M111.305102; Gourlay CW, 2005, BIOCHEM SOC T, V33, P1260, DOI 10.1042/BST0331260; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; Hackam DJ, 1997, J EXP MED, V186, P955, DOI 10.1084/jem.186.6.955; Hanisch J, 2011, CELL HOST MICROBE, V9, P273, DOI 10.1016/j.chom.2011.03.009; Haglund CM, 2010, NAT CELL BIOL, V12, P1057, DOI 10.1038/ncb2109; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heindl JE, 2010, INFECT IMMUN, V78, P193, DOI 10.1128/IAI.00252-09; Hodgson L., 2010, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb1411s46, DOI 10.1002/0471143030.CB1411S46]; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Howe D, 2000, INFECT IMMUN, V68, P3815, DOI 10.1128/IAI.68.7.3815-3821.2000; Hussain SK, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00137; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; KAPLAN G, 1977, SCAND J IMMUNOL, V6, P797, DOI 10.1111/j.1365-3083.1977.tb02153.x; Khan NA, 2003, MICROB PATHOGENESIS, V35, P35, DOI 10.1016/S0882-4010(03)00090-1; Kim JG, 2012, J BIOL CHEM, V287, P5145, DOI 10.1074/jbc.M111.257634; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; Lemichez E, 2013, EXP CELL RES, V319, P2329, DOI 10.1016/j.yexcr.2013.04.021; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Matas OB, 2005, EUR J CELL BIOL, V84, P699, DOI 10.1016/j.ejcb.2005.05.001; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; May RC, 2001, J CELL SCI, V114, P1061; McDonough JA, 2013, MBIO, V4, DOI 10.1128/mBio.00606-12; Meconi S, 1998, INFECT IMMUN, V66, P5527, DOI 10.1128/IAI.66.11.5527-5533.1998; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Michaelson D, 2006, METHOD ENZYMOL, V406, P296, DOI 10.1016/S0076-6879(06)06022-8; Newton HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054566; Niedergang F, 2005, CURR TOP MICROBIOL, V291, P43; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Patel JC, 2008, METHOD ENZYMOL, V439, P145, DOI 10.1016/S0076-6879(07)00411-9; Patel JC, 2000, METHOD ENZYMOL, V325, P462; Pertz O, 2004, J CELL SCI, V117, P1313, DOI 10.1242/jcs.01117; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Pizarro-Cerda J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010009; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Rosales EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039348; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Subtil A, 2004, J CELL SCI, V117, P3923, DOI 10.1242/jcs.01247; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P89, DOI 10.1016/S0962-8924(00)88956-4; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; Tierrez A, 2005, CELL MICROBIOL, V7, P901, DOI 10.1111/j.1462-5822.2005.00540.x; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Truong D, 2013, CELL MICROBIOL, V15, P2051, DOI 10.1111/cmi.12173; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; van Schaik EJ, 2013, NAT REV MICROBIOL, V11, P561, DOI 10.1038/nrmicro3049; Voth DE, 2007, CELL MICROBIOL, V9, P829, DOI 10.1111/j.1462-5822.2007.00901.x; Waag DM, 2007, VACCINE, V25, P7288, DOI 10.1016/j.vaccine.2007.08.002; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Woldehiwet Z, 2004, RES VET SCI, V77, P93, DOI 10.1016/j.rvsc.2003.09.001; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043	103	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145211	10.1371/journal.pone.0145211	http://dx.doi.org/10.1371/journal.pone.0145211			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674774	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700115
J	Senter, P; Robins, JH				Senter, Phil; Robins, James H.			Resting Orientations of Dinosaur Scapulae and Forelimbs: A Numerical Analysis, with Implications for Reconstructions and Museum Mounts	PLOS ONE			English	Article							THEROPOD DINOSAUR; STRUTHIOMIMUS; SPECIMEN; SKELETON; FURCULA; ANATOMY; POSTURE; CHINA	The inclination of the scapular blade and the resting pose of the forelimb in dinosaurs differ among reconstructions and among skeletal mounts. For most dinosaurian taxa, no attempt has previously been made to quantify the correct resting positions of these elements. Here, we used data from skeletons preserved in articulation to quantify the resting orientations of the scapula and forelimb in dinosaurs. Specimens were included in the study only if they were preserved lying on their sides; for each specimen the angle between forelimb bones at a given joint was included in the analysis only if the joint was preserved in articulation. Using correlation analyses of the angles between the long axis of the sacrum, the first dorsal centrum, and the scapular blade in theropods and Eoraptor, we found that vertebral hyperextension does not influence scapular orientation in saurischians. Among examined taxa, the long axis of the scapular blade was found to be most horizontal in bipedal saurischians, most vertical in basal ornithopods, and intermediate in hadrosauroids. We found that in bipedal dinosaurs other than theropods with semilunate carpals, the resting orientation of the elbow is close to a right angle and the resting orientation of the wrist is such that the hand exhibits only slight ulnar deviation from the antebrachium. In theropods with semilunate carpals the elbow and wrist are more flexed at rest, with the elbow at a strongly acute angle and with the wrist approximately at a right angle. The results of our study have important implications for correct orientations of bones in reconstructions and skeletal mounts. Here, we provide recommendations on bone orientations based on our results.	[Senter, Phil] Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC 28301 USA; [Robins, James H.] SE Missouri State Univ, Dept Biol, Cape Girardeau, MO 63701 USA	University of North Carolina; Fayetteville State University	Senter, P (corresponding author), Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC 28301 USA.	psenter@uncfsu.edu						ACHENBACH J, 2003, NATL GEOGR, V203, P2; [Anonymous], 1997, AUDUBON, V99; Bakker RT., 1987, DINOSAURS PAST PRESE, V1, P38; Bonaparte Jose F., 1995, Ameghiniana, V32, P341; Bonnan MF, 2007, SPEC PAP PALAEONTOL, P139; Brown B, 1917, B AM MUS NAT HIST, V37, P281; Brown B, 1916, B AM MUS NAT HIST, V35, P709; Brown B, 1913, AM MUS J, V8, P138; Brown B, 1937, AM MUS NOVIT, V955, P1; Carpenter Kenneth, 2002, Senckenbergiana Lethaea, V82, P59; Carpenter Kenneth, 2001, P90; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Chure DJ, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P283; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; Cutler A, 2011, J VERTEBR PALEONTOL, V31, P95; Czerkas Stephen A., 2002, Dinosaur Museum Journal, V1, P97; Dal Sasso C, 1998, NATURE, V392, P383; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; Elzanowski A, 2001, ACTA PALAEONTOL POL, V46, P519; Faux CM, 2007, PALEOBIOLOGY, V33, P201, DOI 10.1666/06015.1; Galton P.M., 1976, Postilla, VNo. 69, P1; Galton P.M., 1983, Geologica et Palaeontologica, V17, P207; Gambaryan P., 1974, HOW MAMMALS RUN; Garstka William R., 1997, P385; Gatton P. M., 1970, J. Paleont., V44, P464; Gilmore C. W., 1905, Proceedings United States Museum, Vxxix, P433; Gilmore C.W., 1915, P US NATL MUS, V49, P591, DOI DOI 10.5479/SI.00963801.49-2127.591; Gishlick AD, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P301; Glut D., 1972, DINOSAUR DICT; Glut D. F., 1997, DINOSAURS ENCY; Godefroit Pascal, 2013, Nature Communications, V4, P1; Godefroit P, 2013, NATURE, V498, P359, DOI 10.1038/nature12168; Hatcher J. B., 1907, MONOGRAPHS US GEOLOG, VXLIX, DOI DOI 10.5962/BHL.TITLE.60500; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hwang Sunny H., 2004, Journal of Systematic Palaeontology, V2, P13, DOI 10.1017/S1477201903001081; JENKINS FA, 1983, J MORPHOL, V175, P195, DOI 10.1002/jmor.1051750207; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji Qiang, 2005, Dizhi Tongbao, V24, P197; JOHNSON RE, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P205; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; Kobayashi Y, 1999, NATURE, V402, P480, DOI 10.1038/44999; Lanzendorf J.J., 2000, DINOSAUR IMAGERY SCI; Larson P, 2005, LIFE O PAST, P247; Larson P, 2004, REX APPEAL; Lu JC, 2005, LIFE O PAST, P256; LULL RICHARD SWANN, 1933, MEM PEABODY MUS NAT HIST, V3, P1; Mallison H, 2010, ACTA PALAEONTOL POL, V55, P433, DOI 10.4202/app.2009.0075; Matthew WD, 1923, AM MUS NOVIT, V89, P1, DOI [10.5281/zenodo.4715537, DOI 10.5281/ZENODO.4715537]; Newman B. H., 1970, Biol. J. Linn. Soc., V2, P119, DOI 10.1111/j.1095-8312.1970.tb01707.x; NICHOLLS EL, 1985, PALAEONTOLOGY, V28, P643; Norell Mark A., 1999, American Museum Novitates, V3282, P1; O'Connor J, 2011, P NATL ACAD SCI USA, V108, P19662, DOI 10.1073/pnas.1117727108; OSBORN HENRY FAIRFIELD, 1933, AMER MUS NOVITATES, V654, P1; Osborn HF, 1916, B AM MUS NAT HIST, V35, P733; OSTROM J H, 1978, Zitteliana, V4, P73; PARKS WA, 1920, U TORONTO STUDIES GE, V11, P1; PARKS WA, 1922, U TORONTO STUDIES GE, V13, P1; Paul G., 1988, PREDATORY DINOSAURS; Paul GS, 2000, PALEOBIOLOGY, V26, P450, DOI 10.1666/0094-8373(2000)026<0450:FPINDI>2.0.CO;2; Paul GS, 1987, DINOSAURS PAST PRESE, V2, P4; PETERSON JA, 1984, J ZOOL, V202, P1; Peyer K, 2006, J VERTEBR PALEONTOL, V26, P879, DOI 10.1671/0272-4634(2006)26[879:AROCFT]2.0.CO;2; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Senter P, 2005, PALEOBIOLOGY, V31, P373, DOI 10.1666/0094-8373(2005)031[0373:FITSFO]2.0.CO;2; Senter P, 2005, J ZOOL, V266, P307, DOI 10.1017/S0952836905006989; Senter P, 2007, J ZOOL, V273, P305, DOI 10.1111/j.1469-7998.2007.00329.x; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Senter P, 2006, J VERTEBR PALEONTOL, V26, P897, DOI 10.1671/0272-4634(2006)26[897:COFFBD]2.0.CO;2; Senter Phil, 2006, Paleobios, V26, P7; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; Simpson G. G., 1960, QUANTITATIVE ZOOLOGY; STERNBERG C. M., 1940, JOUR PALEONTOL, V14, P481; STERNBERG C. M., 1933, CANADIAN FIELD NATURALIST, V47, P79; Tykoski RS, 2002, J VERTEBR PALEONTOL, V22, P728, DOI 10.1671/0272-4634(2002)022[0728:AFITCT]2.0.CO;2; Vargas-Peixoto D, 2015, J S AM EARTH SCI, V61, P129, DOI 10.1016/j.jsames.2014.09.024; Varricchio DJ, 2008, ACTA PALAEONTOL POL, V53, P567, DOI 10.4202/app.2008.0402; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; Wellnhofer P., 1974, Palaeontographica Abt A, V147, P169; Wellnhofer Peter, 1992, Natural History Museum of Los Angeles County Science Series, V36, P3; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2012, NATURE, V484, P92, DOI 10.1038/nature10906; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Xu X, 2009, P NATL ACAD SCI USA, V106, P832, DOI 10.1073/pnas.0810055106; Zar, 2011, BIOSTAT ANAL; Zhou Z, 2000, VERTEBR PALAS, V38, P111; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P241	87	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144036	10.1371/journal.pone.0144036	http://dx.doi.org/10.1371/journal.pone.0144036			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675035	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700019
J	Zhang, J; Yin, BJ; Xie, YH; Li, J; Yang, ZB; Zhang, GG				Zhang, Jie; Yin, Binjie; Xie, Yuhuai; Li, Jing; Yang, Zaibin; Zhang, Guiguo			Legume-Cereal Intercropping Improves Forage Yield, Quality and Degradability	PLOS ONE			English	Article							ALFALFA STEM TISSUES; CROP-LIVESTOCK SYSTEMS; VITRO GAS-PRODUCTION; PERENNIAL RYEGRASS; RUMINAL DEGRADATION; FED DIETS; RUMEN; CORN; MIXTURES; CLOVER	Intercropping legume with cereal is an extensively applied planting pattern in crop cultivation. However, forage potential and the degradability of harvested mixtures from intercropping system remain unclear. To investigate the feasibility of applying an intercropping system as a forage supply source to ruminants, two consecutive experiments (experiments 1 and 2) involving a field cultivation trial and a subsequent in vivo degradable experiment were conducted to determine the forage production performance and the ruminally degradable characteristics of a harvested mixture from an alfalfa/corn-rye intercropping system. In experiment 1, the intercropping system was established by alternating alfalfa and corn or rye with a row ratio of 5:2. Dry matter (DM) and nutrient yields were determined. In experiment 2, forages harvested from the different treatments were used as feedstuff to identify nutrient degradation kinetics and distribution of components between the rapidly degradable (a), potentially degradable (b) and the degradation rate constant (c) of 'b' fraction by in sacco method in Small-Tail Han wether Sheep. The intercropping system of alfalfa and corn-rye provided higher forage production performance with net increases of 9.52% and 34.81% in DM yield, 42.13% and 16.74% in crude protein (CP) yield, 25.94% and 69.99% in degradable DM yield, and 16.96% and 5.50% in degradable CP yield than rotation and alfalfa sole cropping systems, respectively. In addition, the harvest mixture from intercropping system also had greater 'a' fraction, 'b' fraction, 'c' values, and effective degradability (E value) of DM and CP than corn or rye hay harvested from rotation system. After 48-h exposure to rumen microbes, intercropping harvest materials were degraded to a higher extent than separately degraded crop stems from the sole system as indicated by visual microscopic examination with more tissues disappeared. Thus, the intercropping of alfalfa and corn-rye exhibited a greater forage production potential, and could be applied as forage supply source for ruminants. The improved effective degradability of harvest mixture material could be attributed to greater degradable components involving the rapidly degradable fractions (a), potentially degradable (b) fractions, and degradable rate constant (c), than that of corn and rye hay.	[Zhang, Jie; Yin, Binjie; Xie, Yuhuai; Yang, Zaibin; Zhang, Guiguo] Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China; [Li, Jing; Zhang, Guiguo] Peking Univ, Coll Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China	Shandong Agricultural University; Peking University	Zhang, GG (corresponding author), Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China.	zhanggg@sdau.edu.cn	Xie, Yuhuai/ACE-2095-2022	Xie, Yuhuai/0000-0001-7280-7098	Special Fund for Agro-scientific Research in the Public Interest of China [201403047]; Awarding Fund for Outstanding Young Scientists of Shandong Province [BS2013NY007]; Shandong Province Special Fund of Native Sheep Varieties Protecting Project	Special Fund for Agro-scientific Research in the Public Interest of China; Awarding Fund for Outstanding Young Scientists of Shandong Province; Shandong Province Special Fund of Native Sheep Varieties Protecting Project	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest of China (project no. 201403047), the Awarding Fund for Outstanding Young Scientists of Shandong Province (project no. BS2013NY007), and the Shandong Province Special Fund of Native Sheep Varieties Protecting Project.	Abbeddou S, 2011, SMALL RUMINANT RES, V96, P126, DOI 10.1016/j.smallrumres.2010.11.017; Anil L, 1998, GRASS FORAGE SCI, V53, P301, DOI 10.1046/j.1365-2494.1998.00144.x; Carruthers K, 2000, EUR J AGRON, V12, P103, DOI 10.1016/S1161-0301(99)00051-9; Cho AS, 2012, ANIM SCI J, V83, P650, DOI 10.1111/j.1740-0929.2011.01003.x; Da Silva Michele Simili, 2014, ANIM FEED SCI TECH, V5, P17; Dixon RM, 1999, AUST J AGR RES, V50, P757, DOI 10.1071/AR98165; EASTIN EF, 1978, ANAL BIOCHEM, V85, P591, DOI 10.1016/0003-2697(78)90259-2; Eguienta YK, 2002, CROP LIVESTOCK INTER, P221; Elgersma A, 1998, GRASS FORAGE SCI, V53, P353, DOI 10.1046/j.1365-2494.1998.00151.x; Engels FM, 2005, ANIM FEED SCI TECH, V120, P309, DOI 10.1016/j.anifeedsci.2005.03.003; Engels FM, 1998, ANN BOT-LONDON, V82, P561, DOI 10.1006/anbo.1998.0705; Erice G, 2010, J PLANT PHYSIOL, V167, P114, DOI 10.1016/j.jplph.2009.07.016; Halmemies-Beauchet-Filleau A, 2013, J DAIRY SCI, V96, P5882, DOI 10.3168/jds.2013-6872; Jiang D, 2012, RENEW SUST ENERG REV, V16, P1377, DOI 10.1016/j.rser.2011.12.012; Jung HG, 2006, CROP SCI, V46, P1801, DOI 10.2135/cropsci2006.02-0086; JUNG HG, 1995, J ANIM SCI, V73, P2774; Jung HG, 2001, NETH J AGR SCI, V49, P3, DOI 10.1016/S1573-5214(01)80012-9; King C, 2014, GRASS FORAGE SCI, V69, P64, DOI 10.1111/gfs.12032; Lauriault LM, 2004, AGRON J, V96, P352, DOI 10.2134/agronj2004.0352; Lenne JM, 2006, OUTLOOK AGR, V35, P167, DOI 10.5367/000000006778536765; Li L, 2003, NUTR CYCL AGROECOSYS, V65, P61, DOI 10.1023/A:1021885032241; Li L, 1999, PLANT SOIL, V212, P105, DOI 10.1023/A:1004656205144; Li L, 2001, FIELD CROP RES, V71, P123, DOI 10.1016/S0378-4290(01)00156-3; Lopez S, 1999, J ANIM SCI, V77, P1875; Metzler-Zebeli BU, 2012, J SCI FOOD AGR, V92, P2479, DOI 10.1002/jsfa.5656; Niderkorn V, 2011, J ANIM SCI, V89, P1138, DOI 10.2527/jas.2010-2819; Niderkorn V, 2009, ANIMAL, V3, P951, DOI 10.1017/S1751731109004261; ORSKOV ER, 1979, J AGR SCI, V92, P499, DOI 10.1017/S0021859600063048; Ross SM, 2004, AGRON J, V96, P1013, DOI 10.2134/agronj2004.1013; Russelle MP, 2007, AGRON J, V99, P325, DOI 10.2134/agronj2006.0139; Sleugh B, 2000, AGRON J, V92, P24, DOI 10.2134/agronj2000.92124x; Strydhorst SM, 2008, AGRON J, V100, P182, DOI 10.2134/agronj2007.0197; Sulc RM, 2007, AGRON J, V99, P335, DOI 10.2134/agronj2006.0086; Sun B., 2014, PLOS ONE, P1; Sun XZ, 2010, ANIM FEED SCI TECH, V155, P172, DOI 10.1016/j.anifeedsci.2009.12.004; Terramoccia S, 2000, LIVEST PROD SCI, V65, P185, DOI 10.1016/S0301-6226(99)00155-4; Zhang GG, 2012, J APPL POULTRY RES, V21, P216, DOI 10.3382/japr.2010-00288; Zhang GG, 2013, J AGR SCI, V5, P129; Zhang GG, 2011, FIELD CROP RES, V124, P66, DOI 10.1016/j.fcr.2011.06.006	39	25	28	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144813	10.1371/journal.pone.0144813	http://dx.doi.org/10.1371/journal.pone.0144813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672990	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700064
J	Carpenter-Thompson, JR; Schmidt, S; McAuley, E; Husain, FT				Carpenter-Thompson, Jake R.; Schmidt, Sara; McAuley, Edward; Husain, Fatima T.			Increased Frontal Response May Underlie Decreased Tinnitus Severity	PLOS ONE			English	Article							QUALITY-OF-LIFE; BECK DEPRESSION INVENTORY; PHYSICAL-ACTIVITY; OLDER-ADULTS; PSYCHIATRIC OUTPATIENTS; ANXIETY INVENTORY; FMRI; TIME; SUFFERERS; VALIDITY	Objectives The overall goal of the study was to identify functional and behavioral differences between individuals with higher tinnitus distress and individuals with lower tinnitus distress. Subsequent exploratory analyses were conducted to investigate the role physical activity may have on the observed results between high and low distress groups. The purpose of the experiment was to identify brain regions to be targeted in future intervention studies for tinnitus. Design A total of 32 individuals with varying levels of tinnitus severity were recruited from the Urbana-Champaign area. Volunteers were divided into higher tinnitus distress (HD) and lower tinnitus distress (LD) groups. Note that these groups also significantly differed based on physical activity level and were subsequently stratified into higher and lower physical activity level subgroups for exploratory analysis. While in a functional magnetic resonance imaging (fMRI) scanner, subjects listened to affective sounds classified as pleasant, neutral or unpleasant from the International Affective Digital Sounds database. Results The HD group recruited amygdala and parahippocampus to a greater extent than the LD group when listening to affective sounds. The LD group engaged frontal regions to a greater extent when listening to the affective stimuli compared to the HD group. Both higher physical activity level subgroups recruited more frontal regions, and both lower levels of physical activity subgroups recruited more limbic regions respectively. Conclusion Individuals with lower tinnitus distress may utilize frontal regions to better control their emotional response to affective sounds. Our analysis also suggests physical activity may contribute to lower tinnitus severity and greater engagement of the frontal cortices. We suggest that future intervention studies focus on changes in the function of limbic and frontal regions when evaluating the efficacy of treatment. Additionally, we recommend further investigation concerning the impact of physical activity level on tinnitus distress.	[Carpenter-Thompson, Jake R.; Schmidt, Sara; Husain, Fatima T.] Univ Illinois, Neurosci Program, Champaign, IL 61820 USA; [Carpenter-Thompson, Jake R.] Univ Illinois, Med Scholars Program, Champaign, IL USA; [Husain, Fatima T.] Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL USA; [Carpenter-Thompson, Jake R.; Schmidt, Sara; McAuley, Edward; Husain, Fatima T.] Univ Illinois, Beckman Inst, Champaign, IL USA; [McAuley, Edward] Univ Illinois, Dept Kinesiol & Community Hlth, Champaign, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Husain, FT (corresponding author), Univ Illinois, Neurosci Program, Champaign, IL 61820 USA.	husainf@acnlab.com			American Tinnitus Association [392]; Center on Health, Aging, and Disability at University of Illinois Urbana-Champaign	American Tinnitus Association; Center on Health, Aging, and Disability at University of Illinois Urbana-Champaign	This work was supported by Grant #392 "Effects of Exercise on Tinnitus Severity" from the American Tinnitus Association, https://www.ata.org/, and by "Understanding the Role of Physical Fitness in Mitigating Tinnitus Severity: An fMRI Study" from the Center on Health, Aging, and Disability at University of Illinois Urbana-Champaign, http://chad.illinois.edu/.	AINSWORTH BE, 1992, J ADOLESCENT HEALTH, V13, P606, DOI 10.1016/1054-139X(92)90375-L; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; Bartels H, 2008, EAR HEARING, V29, P947, DOI 10.1097/AUD.0b013e3181888f83; Beck A.T., 1990, BECK SCALE SUICIDE I; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Bradley M. M., 2007, B3 U FLOR; Brown SG, 2006, AM J PREV MED, V30, P131, DOI 10.1016/j.amepre.2005.10.007; Carpenter-Thompson JR, 2015, EAR HEARING; Carpenter-Thompson JR, 2015, NEURAL PLASTICITY, V2015; Carpenter-Thompson JR, 2014, BRAIN RES; Courneya K, 1996, ONCOLOGY NURSING FOR; De Ridder D, 2006, ACTA OTO-LARYNGOL, V126, P50, DOI 10.1080/03655230600895580; De Ridder D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024273; Dolcos F, 2011, J COGN PSYCHOL, V23, P669, DOI 10.1080/20445911.2011.594433; Elavsky S, 2005, ANN BEHAV MED, V30, P138, DOI 10.1207/s15324796abm3002_6; FYDRICH T, 1992, J ANXIETY DISORD, V6, P55, DOI 10.1016/0887-6185(92)90026-4; Gaab N, 2003, NEUROIMAGE, V19, P1417, DOI 10.1016/S1053-8119(03)00224-6; Gillison FB, 2006, HEALTH EDUC RES, V21, P836, DOI 10.1093/her/cyl139; Giraud AL, 1999, NEUROREPORT, V10, P1, DOI 10.1097/00001756-199901180-00001; Godin G, 1997, MED SCI SPORTS EXERC, V29, P36, DOI DOI 10.1097/00005768-199706001-00009; Golm D, 2013, HEARING RES, V295, P87, DOI 10.1016/j.heares.2012.03.003; HALFORD JBS, 1991, J PSYCHOSOM RES, V35, P383, DOI 10.1016/0022-3999(91)90033-K; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Haller S, 2010, EUR RADIOL, V20, P696, DOI 10.1007/s00330-009-1595-z; Husain FT, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00010; Husain FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026639; Jacques PS, 2010, NEUROBIOL AGING, V31, P315, DOI 10.1016/j.neurobiolaging.2008.03.012; Jastreboff P J, 2000, J Am Acad Audiol, V11, P162; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; Kraus KS, 2012, HEARING RES, V288, P34, DOI 10.1016/j.heares.2012.02.009; Kumar S, 2012, J NEUROSCI, V32, P14184, DOI 10.1523/JNEUROSCI.1759-12.2012; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Langguth B, 2007, PROG BRAIN RES, V166, P221, DOI 10.1016/S0079-6123(07)66020-8; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; McAuley E, 2004, BRAIN BEHAV IMMUN, V18, P214, DOI 10.1016/j.bbi.2003.12.007; Meikle MB, 2012, EAR HEARING, V33, P153, DOI 10.1097/AUD.0b013e31822f67c0; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Mirz F, 2000, NEUROREPORT, V11, P633, DOI 10.1097/00001756-200002280-00039; Motl RW, 2005, PREV MED, V40, P735, DOI 10.1016/j.ypmed.2004.09.016; Newman CW, 1998, J AM ACAD AUDIOLOGY, V9; Phan KL, 2003, BIOL PSYCHIAT, V53, P211, DOI 10.1016/S0006-3223(02)01485-3; Plewnia C, 2007, HUM BRAIN MAPP, V28, P238, DOI 10.1002/hbm.20270; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Reyes SA, 2002, HEARING RES, V171, P43, DOI 10.1016/S0378-5955(02)00346-5; Schmidt SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076488; Searchfield G, 2011, EVAL HEALTH PROF; Sindhusake D, 2003, INT J AUDIOL, V42, P289, DOI 10.3109/14992020309078348; St Jacques PL, 2009, PSYCHOL SCI, V20, P74, DOI 10.1111/j.1467-9280.2008.02258.x; STEER RA, 1993, J ANXIETY DISORD, V7, P195, DOI 10.1016/0887-6185(93)90002-3; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Suh MR, 2002, RENAL FAILURE, V24, P337; TYLER RS, 1983, J SPEECH HEAR DISORD, V48, P150, DOI 10.1044/jshd.4802.150; Unterrainer Josef, 2003, Int Tinnitus J, V9, P130; Vanneste S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088253; Vanneste S, 2011, EUR J NEUROSCI, V34, P718, DOI 10.1111/j.1460-9568.2011.07793.x; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029	57	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144419	10.1371/journal.pone.0144419	http://dx.doi.org/10.1371/journal.pone.0144419			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26675290	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900047
J	Xiao, YH; Wu, YH; Sun, KP; Wang, H; Zhang, B; Song, SH; Du, ZL; Jiang, TL; Shi, LM; Wang, L; Lin, AQ; Yue, XK; Li, CJ; Chen, TT; Feng, J				Xiao, Yanhong; Wu, Yonghua; Sun, Keping; Wang, Hui; Zhang, Bing; Song, Shuhui; Du, Zhenglin; Jiang, Tinglei; Shi, Limin; Wang, Lei; Lin, Aiqing; Yue, Xinke; Li, Chenji; Chen, Tingting; Feng, Jiang			Differential Expression of Hepatic Genes of the Greater Horseshoe Bat (Rhinolophus ferrumequinum) between the Summer Active and Winter Torpid States	PLOS ONE			English	Article							HIBERNATING GROUND-SQUIRRELS; RNA-SEQ DATA; BURROWS-WHEELER TRANSFORM; BEARS URSUS-AMERICANUS; MAMMALIAN HIBERNATION; LIPID-METABOLISM; SEASONAL-CHANGES; READ ALIGNMENT; IMMUNE-SYSTEM; LIVER	Hibernation is one type of torpor, a hypometabolic state in heterothermic mammals, which can be used as an energy-conservation strategy in response to harsh environments, e.g. limited food resource. The liver, in particular, plays a crucial role in adaptive metabolic adjustment during hibernation. Studies on ground squirrels and bears reveal that many genes involved in metabolism are differentially expressed during hibernation. Especially, the genes involved in carbohydrate catabolism are down-regulated during hibernation, while genes responsible for lipid beta-oxidation are up-regulated. However, there is little transcriptional evidence to suggest physiological changes to the liver during hibernation in the greater horseshoe bat, a representative heterothermic bat. In this study, we explored the transcriptional changes in the livers of active and torpid greater horseshoe bats using the Illumina HiSeq 2000 platform. A total of 1358 genes were identified as differentially expressed during torpor. In the functional analyses, differentially expressed genes were mainly involved in metabolic depression, shifts in the fuel utilization, immune function and response to stresses. Our findings provide a comprehensive evidence of differential gene expression in the livers of greater horseshoe bats during active and torpid states and highlight potential evidence for physiological adaptations that occur in the liver during hibernation.	[Xiao, Yanhong; Sun, Keping; Wang, Hui; Jiang, Tinglei; Wang, Lei; Lin, Aiqing; Yue, Xinke; Feng, Jiang] NE Normal Univ, Jilin Prov Key Lab Anim Resource Conservat & Util, Changchun, Peoples R China; [Xiao, Yanhong; Sun, Keping; Wang, Hui; Jiang, Tinglei; Wang, Lei; Lin, Aiqing; Yue, Xinke; Feng, Jiang] NE Normal Univ, Key Lab Wetland Ecol & Vegetat Restorat Natl Envi, Changchun, Peoples R China; [Wu, Yonghua] NE Normal Univ, Sch Life Sci, Changchun, Peoples R China; [Zhang, Bing; Song, Shuhui; Du, Zhenglin; Li, Chenji; Chen, Tingting] Chinese Acad Sci, Beijing Inst Genom, Core Genom Facil, Beijing, Peoples R China; [Shi, Limin] Yunnan Normal Univ, Sch Life Sci, Kunming, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Yunnan Normal University	Wu, YH (corresponding author), NE Normal Univ, Sch Life Sci, Changchun, Peoples R China.	wuyh442@nenu.edu.cn; fengj@nenu.edu.cn	Jiang, Tinglei/GQQ-9485-2022		National Natural Science Foundation of China [91131003, 31270414]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China. The grant numbers were 91131003 (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list) and 31270414 (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLQUIST DA, 1984, J COMP PHYSIOL B, V155, P75, DOI 10.1007/BF00688794; Andrews MT, 2004, BIOCHEM SOC T, V32, P1021, DOI 10.1042/BST0321021; [Anonymous], 1999, WALKERS MAMMALS WORL; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ATANASSOV CL, 1995, COMP BIOCHEM PHYS C, V112, P93, DOI 10.1016/0742-8413(95)00000-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boss O, 1997, FEBS LETT, V412, P111, DOI 10.1016/S0014-5793(97)00755-2; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; Burton M, 2002, INT WILDLIFE ENCY; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen JP, 2008, COMP BIOCHEM PHYS B, V149, P388, DOI 10.1016/j.cbpb.2007.10.011; Csorba G., 2003, HORSESHOE BATS WORLD; Dave KR, 2012, COMP BIOCHEM PHYS B, V162, P1, DOI 10.1016/j.cbpb.2012.01.008; Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003; Fedorov VB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-171; Fedorov VB, 2009, PHYSIOL GENOMICS, V37, P108, DOI 10.1152/physiolgenomics.90398.2008; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; GALLETTI G, 1972, ACTA ANAT, V83, P593; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Geiser F., 2011, ENCY LIFE SCI, P1; Geiser F, 2013, CURR BIOL, V23, pR188, DOI 10.1016/j.cub.2013.01.062; Gobin S, 2003, J BIOL CHEM, V278, P50428, DOI 10.1074/jbc.M310130200; Hampton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027021; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; HOFMANN GE, 1995, J EXP BIOL, V198, P1509; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Kandror O, 1997, P NATL ACAD SCI USA, V94, P4978, DOI 10.1073/pnas.94.10.4978; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kurtz CC, 2007, DEV COMP IMMUNOL, V31, P415, DOI 10.1016/j.dci.2006.07.003; Lei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107746; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louet JF, 2001, BIOCHEM SOC T, V29, P310, DOI 10.1042/0300-5127:0290310; Moore MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058976; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x; Novoselova E, 2004, DOKLADY BIOL SCI; Park KJ, 2000, FUNCT ECOL, V14, P580, DOI 10.1046/j.1365-2435.2000.00460.x; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Prendergast BJ, 2002, AM J PHYSIOL-REG I, V282, pR1054, DOI 10.1152/ajpregu.00562.2001; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Ransome R., 1990, NATURAL HIST HIBERNA; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Roots C, 2006, HIBERNATION; Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376; Ruf T, 2015, BIOL REV, V90, P891, DOI 10.1111/brv.12137; Seim I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3212; Shimozuru M, 2012, COMP BIOCHEM PHYS B, V163, P254, DOI 10.1016/j.cbpb.2012.06.007; Shivatcheva T, 1987, FOLIA BIOL-PRAGUE, V36, P213; Smith-Unna RD, 2015, BIORXIV; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; South F.E., 1967, MAMMALIAN HIBERNATIO, P305; SRERE HK, 1992, P NATL ACAD SCI USA, V89, P7119, DOI 10.1073/pnas.89.15.7119; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; van Breukelen F, 2015, PHYSIOLOGY, V30, P273, DOI 10.1152/physiol.00010.2015; vanBreukelen F, 2002, J COMP PHYSIOL B, V172, P269, DOI 10.1007/s00360-002-0252-5; Wang LCH, 1996, HDB PHYSL ENV PHYSL; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Williams DR, 2005, PHYSIOL GENOMICS, V24, P13, DOI 10.1152/physiolgenomics.00301.2004; Yan J, 2008, PHYSIOL GENOMICS, V32, P170, DOI 10.1152/physiolgenomics.00075.2007; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhao WM, 2011, BIOINFORMATICS, V27, P3076, DOI 10.1093/bioinformatics/btr504; Zhou HJ, 2004, ARCH BIOCHEM BIOPHYS, V422, P23, DOI 10.1016/j.abb.2003.11.019	68	11	11	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145702	10.1371/journal.pone.0145702	http://dx.doi.org/10.1371/journal.pone.0145702			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698122	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600121
J	Baker, T; Schell, CO; Lugazia, E; Blixt, J; Mulungu, M; Castegren, M; Eriksen, J; Konrad, D				Baker, Tim; Schell, Carl Otto; Lugazia, Edwin; Blixt, Jonas; Mulungu, Moses; Castegren, Markus; Eriksen, Jaran; Konrad, David			Vital Signs Directed Therapy: Improving Care in an Intensive Care Unit in a Low-Income Country	PLOS ONE			English	Article							EARLY WARNING SCORE; SEVERE SEPSIS; CARDIAC ARRESTS; SEPTIC SHOCK; MORTALITY; EMERGENCY; PATIENT; SERVICES; RISK; CHALLENGES	Background Global Critical Care is attracting increasing attention. At several million deaths per year, the worldwide burden of critical illness is greater than generally appreciated. Low income countries (LICs) have a disproportionally greater share of critical illness, and yet critical care facilities are scarce in such settings. Routines utilizing abnormal vital signs to identify critical illness and trigger medical interventions have become common in high-income countries but have not been investigated in LICs. The aim of the study was to assess whether the introduction of a vital signs directed therapy protocol improved acute care and reduced mortality in an Intensive Care Unit (ICU) in Tanzania. Methods and Findings Prospective, before-and-after interventional study in the ICU of a university hospital in Tanzania. A context-appropriate protocol that defined danger levels of severely abnormal vital signs and stipulated acute treatment responses was implemented in a four week period using sensitisation, training, job aids, supervision and feedback. Acute treatment of danger signs at admission and during care in the ICU and in-hospital mortality were compared pre and post-implementation using regression models. Danger signs from 447 patients were included: 269 pre-implementation and 178 post-implementation. Acute treatment of danger signs was higher post-implementation (at admission: 72.9% vs 23.1%, p<0.001; in ICU: 16.6% vs 2.9%, p<0.001). A danger sign was five times more likely to be treated post-implementation (Prevalence Ratio (PR) 4.9 (2.9-8.3)). Intravenous fluids were given in response to 35.0% of hypotensive episodes post-implementation, as compared to 4.1% pre-implementation (PR 6.4 (2.5-16.2)). In patients admitted with hypotension, mortality was lower post-implementation (69.2% vs 92.3% p = 0.02) giving a numbers-needed-to-treat of 4.3. Overall in-hospital mortality rates were unchanged (49.4% vs 49.8%, p = 0.94). Conclusion The introduction of a vital signs directed therapy protocol improved the acute treatment of abnormal vital signs in an ICU in a low-income country. Mortality rates were reduced for patients with hypotension at admission but not for all patients.	[Baker, Tim; Blixt, Jonas; Castegren, Markus; Konrad, David] Karolinska Univ Hosp, Dept Anaesthesia Intens Care & Surg Serv, Stockholm, Sweden; [Baker, Tim; Schell, Carl Otto] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth Hlth Syst & Policy, Stockholm, Sweden; [Baker, Tim; Blixt, Jonas; Konrad, David] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Schell, Carl Otto; Eriksen, Jaran] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden; [Schell, Carl Otto] Nykoping Hosp, Sormland Cty Council, Dept Internal Med, Nykoping, Sweden; [Lugazia, Edwin] Muhimbili Univ Hlth & Allied Sci, Dept Anaesthesia & Intens Care, Dar Es Salaam, Tanzania; [Mulungu, Moses] Muhimbili Natl Hosp, Dept Anaesthesia & Intens Care, Dar Es Salaam, Tanzania; [Eriksen, Jaran] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Lab Med,Div Clin Pharmacol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Uppsala University; Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Karolinska University Hospital	Baker, T (corresponding author), Karolinska Univ Hosp, Dept Anaesthesia Intens Care & Surg Serv, Stockholm, Sweden.	tim.baker@ki.se	Castegren, Markus/AAF-2620-2019	Castegren, Markus/0000-0002-9292-0298; Schell, Carl Otto/0000-0002-7904-1336; Baker, Tim/0000-0001-8727-7018; Eriksen, Jaran/0000-0003-1146-5615	Olof Norlander Stipend; Association of Anaesthetists of Great Britain and Ireland; Laerdal Foundation; Karolinska Institutet Travel Grant; Swedish Society for Medical Research; Swedish Association for Anaesthesia and Intensive Care; Muhimbili University of Health AMP; Allied Sciences; MKAIC; Life Support Foundation	Olof Norlander Stipend; Association of Anaesthetists of Great Britain and Ireland; Laerdal Foundation; Karolinska Institutet Travel Grant; Swedish Society for Medical Research; Swedish Association for Anaesthesia and Intensive Care; Muhimbili University of Health AMP; Allied Sciences; MKAIC; Life Support Foundation	TB received grants for the study from the Olof Norlander Stipend, the Association of Anaesthetists of Great Britain and Ireland, the Laerdal Foundation, the Karolinska Institutet Travel Grant, the Swedish Society for Medical Research and the Swedish Association for Anaesthesia and Intensive Care. The funding sources had no role in the design, conduct or reporting of the study.r Thank you to the Executive Director, the Director of Surgical Services, the Head of Department of Anaesthesia ad Intensive Care and the administration at Muhimbili National Hospital for their active support for this study. Thank you to Muhimbili University of Health & Allied Sciences, Life Support Foundation and MKAIC for their support. Thank you to Agness Laizer, Erasto Kalinga, Nazahed Richards, Elizabeth Stephens, Ulrica Mickelsson, Lotta Forars, Martin Dunser and Tim Stephens for their involvement in the expert group and to the research nurses for their hard work and dedication to the project. Thank you to Anna Batelsson and Erik Dahlen for assistance with data input and management and to Gaetano Marrone for invaluable statistical consultancy.	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Andrews B, 2014, CRIT CARE MED, V42, P2315, DOI 10.1097/CCM.0000000000000541; Ayieko P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001018; Baelani I, 2011, CRIT CARE, V15, DOI 10.1186/cc9410; Baker T, 2015, CRIT CARE MED, V43, P2171, DOI 10.1097/CCM.0000000000001194; Baker T, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-140; Baker T, 2009, TROP MED INT HEALTH, V14, P143, DOI 10.1111/j.1365-3156.2008.02202.x; Bleyer AJ, 2011, RESUSCITATION, V82, P1387, DOI 10.1016/j.resuscitation.2011.06.033; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Castellanos-Ortega A, 2010, CRIT CARE MED, V38, P1036, DOI 10.1097/CCM.0b013e3181d455b6; Chaudoir SR, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-22; Cheng AC, 2008, PLOS MED, V5, P1173, DOI 10.1371/journal.pmed.0050175; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dunser MW, 2012, INTENS CARE MED, V38, P557, DOI [10.1007/s00134-012-2468-5, 10.1007/s00134-012-2521-4]; Dunser MW, 2006, CRIT CARE MED, V34, P1234, DOI 10.1097/01.CCM.0000208360.70835.87; Figo Safe Motherhood And Newborn H, 2009, INT J GYNECOL OBSTET, V105, P74, DOI 10.1016/j.ijgo.2008.11.007; Flottorp SA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-35; Fowler RA, 2014, AM J RESP CRIT CARE, V190, P733, DOI 10.1164/rccm.201408-1514CP; Goldhill DR, 1999, ANAESTHESIA, V54, P853; Gosselin RA, 2006, WORLD J SURG, V30, P505, DOI 10.1007/s00268-005-0609-5; Gosselin RA, 2008, WORLD J SURG, V32, P2450, DOI 10.1007/s00268-008-9708-4; Hirshon JM, 2013, B WORLD HEALTH ORGAN, V91, P386, DOI 10.2471/BLT.12.112664; Howell MD, 2012, CRIT CARE MED, V40, P2562, DOI 10.1097/CCM.0b013e318259007b; Jacob ST, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-107; Jacob ST, 2012, CRIT CARE MED, V40, P2050, DOI 10.1097/CCM.0b013e31824e65d7; Kause J, 2004, RESUSCITATION, V62, P275, DOI 10.1016/j.resuscitation.2004.05.016; Konrad D, 2010, INTENS CARE MED, V36, P100, DOI 10.1007/s00134-009-1634-x; Kwizera Arthur, 2012, BMC Res Notes, V5, P475, DOI 10.1186/1756-0500-5-475; Lavy C, 2011, WORLD J SURG, V35, P262, DOI 10.1007/s00268-010-0885-6; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Marik PE, 2012, CURR PHARM DESIGN, V18, P6215; McCord C, 2003, INT J GYNECOL OBSTET, V81, P83, DOI 10.1016/S0020-7292(03)00072-9; Meara JG, 2015, LANCET; Mock C, 2005, CURR OPIN CRIT CARE, V11, P568, DOI 10.1097/01.ccx.0000186373.49320.65; Murthy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116949; Osorio-Guzman M, 2015, SALUD PUBLICA MEXICO, V57, P112; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Requejo JH, 2011, CURR OPIN OBSTET GYN, V23, P465, DOI 10.1097/GCO.0b013e32834cdc9b; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Riviello ED, 2014, CRIT CARE MED, V42, P2439, DOI 10.1097/CCM.0000000000000591; Riviello ED, 2011, CRIT CARE MED, V39, P860, DOI 10.1097/CCM.0b013e318206d6d5; Rylance J, 2009, T ROY SOC TROP MED H, V103, P790, DOI 10.1016/j.trstmh.2009.05.004; Savu A, 2010, STAT MED, V29, P2269, DOI 10.1002/sim.3989; Schell Carl Otto, 2015, BMC Res Notes, V8, P313, DOI 10.1186/s13104-015-1275-9; Smith GB, 2013, RESUSCITATION, V84, P465, DOI 10.1016/j.resuscitation.2012.12.016; Stafford RE, 2014, GLOB HEART, V9, P319, DOI 10.1016/j.gheart.2014.08.005; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; Winters BD, 2013, ANN INTERN MED, V158, P417, DOI 10.7326/0003-4819-158-5-201303051-00009; World Health Organization, 2015, PUBLIC HLTH IMPLICAT; [No title captured]; [No title captured]; [No title captured]; [No title captured]	53	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144801	10.1371/journal.pone.0144801	http://dx.doi.org/10.1371/journal.pone.0144801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26693728	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500012
J	Li, FG; Zhou, CP; Weng, QJ; Li, M; Yu, XL; Guo, Y; Wang, Y; Zhang, XH; Gan, SM				Li, Fagen; Zhou, Changpin; Weng, Qijie; Li, Mei; Yu, Xiaoli; Guo, Yong; Wang, Yu; Zhang, Xiaohong; Gan, Siming			Comparative Genomics Analyses Reveal Extensive Chromosome Colinearity and Novel Quantitative Trait Loci in Eucalyptus	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; MICROSATELLITE LOCI; DART MARKERS; DENSITY; GROWTH; TERETICORNIS; CONSTRUCTION; DIVERSITY; STABILITY; UROPHYLLA	Dense genetic maps, along with quantitative trait loci (QTLs) detected on such maps, are powerful tools for genomics and molecular breeding studies. In the important woody genus Eucalyptus, the recent release of E. grandis genome sequence allows for sequence-based genomic comparison and searching for positional candidate genes within QTL regions. Here, dense genetic maps were constructed for E. urophylla and E. tereticornis using genomic simple sequence repeats (SSR), expressed sequence tag (EST) derived SSR, EST-derived cleaved amplified polymorphic sequence (EST-CAPS), and diversity arrays technology (DArT) markers. The E. urophylla and E. tereticornis maps comprised 700 and 585 markers across 11 linkage groups, totaling at 1,208.2 and 1,241.4 cM in length, respectively. Extensive synteny and colinearity were observed as compared to three earlier DArT-based eucalypt maps (two maps with E. grandis x E. urophylla and one map of E. globulus) and with the E. grandis genome sequence. Fifty-three QTLs for growth (10-56 months of age) and wood density (56 months) were identified in 22 discrete regions on both maps, in which only one colocalizaiton was found between growth and wood density. Novel QTLs were revealed as compared with those previously detected on DArT-based maps for similar ages in Eucalyptus. Eleven to 585 positional candidate genes were obained for a 56-month-old QTL through aligning QTL confidence interval with the E. grandis genome. These results will assist in comparative genomics studies, targeted gene characterization, and marker-assisted selection in Eucalyptus and the related taxa.	[Li, Fagen; Gan, Siming] Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Beijing 100091, Peoples R China; [Li, Fagen; Zhou, Changpin; Weng, Qijie; Li, Mei; Yu, Xiaoli; Guo, Yong; Wang, Yu; Zhang, Xiaohong; Gan, Siming] Chinese Acad Forestry, Res Inst Trop Forestry, Guangzhou 510520, Guangdong, Peoples R China	Chinese Academy of Forestry; State Key Laboratory of Tree Genetics & Breeding, CAF; Chinese Academy of Forestry; Research Institute of Tropical Forestry, CAF	Gan, SM (corresponding author), Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Xiangshan Rd, Beijing 100091, Peoples R China.	siming.gan@ritf.ac.cn	LI, Fagen/GYJ-2407-2022		Ministry of Science and Technology of China [2012CB114505, 2011AA100202]; National Natural Science Foundation of China [31100485]; Ministry of Finance of China [RITFYWZX201103, RITFYWZX201403]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Finance of China	This work was supported by the Ministry of Science and Technology of China (2012CB114505 and 2011AA100202 to SG, URL: http://www.most.gov.cn/), the National Natural Science Foundation of China (31100485 to FL, URL: http://www.nsfc.gov.cn/), and the Ministry of Finance of China (RITFYWZX201103 and RITFYWZX201403 to FL, URL: http://www.mof.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2006, TRENDS PLANT SCI, V11, P344, DOI 10.1016/j.tplants.2006.05.008; Bartholome J, 2015, NEW PHYTOL, V206, P1283, DOI 10.1111/nph.13150; Bartholome J, 2015, NEW PHYTOL, V206, P1437, DOI 10.1111/nph.13301; Bartholome J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-120; Beavis William D., 1998, P145; Bourquin V, 2002, PLANT CELL, V14, P3073, DOI 10.1105/tpc.007773; Brondani RPV, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-20; Bundock PC, 2008, TREE GENET GENOMES, V4, P85, DOI 10.1007/s11295-007-0090-4; Byrne M, 1996, AUST J BOT, V44, P331, DOI 10.1071/BT9960331; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Chen MS, 2002, PLANT CELL, V14, P537, DOI 10.1105/tpc.010485; Devey ME, 2004, THEOR APPL GENET, V108, P516, DOI 10.1007/s00122-003-1471-1; Drost DR, 2009, PLANT J, V58, P1054, DOI 10.1111/j.1365-313X.2009.03828.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fabbrini F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-47; Freeman JS, 2013, NEW PHYTOL, V198, P1121, DOI 10.1111/nph.12237; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gao ZY, 2013, P NATL ACAD SCI USA, V110, P14492, DOI 10.1073/pnas.1306579110; Gion JM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-301; Glaubitz JC, 2001, GENOME, V44, P1041, DOI 10.1139/gen-44-6-1041; GRATTAPAGLIA D, 1994, CAN J FOREST RES, V24, P1074, DOI 10.1139/x94-142; Grattapaglia D, 1996, GENETICS, V144, P1205; Grattapaglia D, 2008, NEW PHYTOL, V179, P911, DOI 10.1111/j.1469-8137.2008.02503.x; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; Grattapaglia D, 2009, CURR OPIN PLANT BIOL, V12, P148, DOI 10.1016/j.pbi.2008.12.008; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; He X, 2011, SILVAE GENET, V60, P92, DOI 10.1515/sg-2011-0013; He XD, 2012, AM J BOT, V99, pE134, DOI 10.3732/ajb.1100442; Hudson CJ, 2012, TREE GENET GENOMES, V8, P339, DOI 10.1007/s11295-011-0444-9; Kachroo P, 2001, P NATL ACAD SCI USA, V98, P9448, DOI 10.1073/pnas.151258398; Kang BY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-515; King J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-437; Kullan ARK, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-60; Kullan ARK, 2012, TREE GENET GENOMES, V8, P163, DOI 10.1007/s11295-011-0430-2; Li F, 2011, SILVAE GENET, V60, P18, DOI 10.1515/sg-2011-0003; Martinez-Garcia PJ, 2013, TREE GENET GENOMES, V9, P1529, DOI 10.1007/s11295-013-0646-4; Miura K, 2011, TRENDS PLANT SCI, V16, P319, DOI 10.1016/j.tplants.2011.02.009; Monclus R, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-173; Moriguchi Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-95; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Neves LG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-189; Novaes E, 2009, NEW PHYTOL, V182, P878, DOI 10.1111/j.1469-8137.2009.02785.x; Ottewell KM, 2005, J HERED, V96, P445, DOI 10.1093/jhered/esi057; Pelgas B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-145; Petroli CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044684; Raman H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-277; Ranjan P, 2010, BIOENERG RES, V3, P172, DOI 10.1007/s12155-009-9060-z; Silva OB, 2015, NEW PHYTOL, V206, P1527, DOI 10.1111/nph.13322; Steane DA, 2002, AUST SYST BOT, V15, P49, DOI 10.1071/SB00039; Steane DA, 2001, SILVAE GENET, V50, P89; Vannini C, 2012, J EXP BOT, V63, P3137, DOI 10.1093/jxb/ers031; Wagner TA, 2001, PLANT CELL, V13, P303, DOI 10.1105/tpc.13.2.303; Weng Q, 2014, SILVAE GENET, V63, P15, DOI 10.1515/sg-2014-0003; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Wight CP, 2003, GENOME, V46, P28, DOI [10.1139/g02-099, 10.1139/G02-099]; Wingler A, 2000, PLANT PHYSIOL, V124, P105, DOI 10.1104/pp.124.1.105; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Yu X, 2012, SILVAE GENET, V61, P247, DOI 10.1515/sg-2012-0031; Zhou C, 2010, MOL PLANT BREED, V8, pe1, DOI [10.5376/mpb.cn.2010.08.0001, DOI 10.5376/MPB.CN.2010.08.0001]; Zhou CP, 2014, MOL BREEDING, V33, P221, DOI 10.1007/s11032-013-9923-z	61	9	12	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145144	10.1371/journal.pone.0145144	http://dx.doi.org/10.1371/journal.pone.0145144			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695430	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092500024
J	Liu, F; Adi, D; Xie, X; Li, XM; Fu, ZY; Shan, CF; Huang, Y; Chen, BD; Gai, MT; Gao, XM; Ma, YT; Yang, YN				Liu, Fen; Adi, Dilare; Xie, Xiang; Li, Xiao-Mei; Fu, Zhen-Yan; Shan, Chun-Fang; Huang, Ying; Chen, Bang-Dang; Gai, Min-Tao; Gao, Xiao-Ming; Ma, Yi-Tong; Yang, Yi-Ning			Prevalence of Isolated Diastolic Hypertension and Associated Risk Factors among Different Ethnicity Groups in Xinjiang, China	PLOS ONE			English	Article							ISOLATED SYSTOLIC HYPERTENSION; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; PULSE PRESSURE; GLOBAL BURDEN; PREDICTORS; SUBTYPES; PROGNOSIS; PROVINCE	Objectives Little is known about isolated diastolic hypertension (IDH) among different ethnicity groups. We aimed to investigate the prevalence and risk factors for IDH among the major ethnicity population i.e. Han, Uygur and Kazakh in Xinjiang, northwestern part of China. Methods In total, 14,618 adult participants (7,799 males, 6,819 females) were recruited from the Cardiovascular Risk Survey conducted during 2007 and 2010. Blood pressure, body mass index and standard lipid profile and fasting glucose level from plasma were measured. Results The overall prevalence of IDH was 10.8% in the Han, 4.5% in the Uygur and 8.7% in the Kazakh populations. When stratified by gender, IDH prevalence was 9.8% in men and 6.8% in women (P<0.001). The prevalence of IDH also varied significantly with age and it was highest in those aged 35-44 yrs old (9.7%) and lowest in those over 75 yrs old (4.1%, P<0.001). Multivariate logistic regression analysis showed that overweight (OR = 1.179, 95% CI: 1.015-1.369) or obesity (OR = 1.202, 95% CI: 1.015-1.424), smoking (OR = 1.362, 95% CI: 1.156-1.604) and high total cholesterol (TC) hyperlipidemia (OR = 1.237, 95% CI: 1.074-1.423) were significantly associated with a higher prevalence of IDH. Identified risk factors for IDH differed among ethnicity groups with male gender, young age (35-44 yrs old), more coffee or tea consumption and high TC hyperlipidemia in the Han; smoking and often coffee or tea consumption in the Uygur and male gender and overweight or obesity in the Kazakh populations. Conclusions IDH prevalence in the Han population is higher than that in the Uygur and Kazak populations in Xinjiang, northwestern part of China. Male gender, middle age, overweight or obesity, smoking and high TC hyperlipidemia appear to be relevant risk factors of IDH in adults. Different ethnicity background had different sets of risk factors for IDH.	[Liu, Fen; Xie, Xiang; Chen, Bang-Dang; Gai, Min-Tao; Gao, Xiao-Ming; Ma, Yi-Tong; Yang, Yi-Ning] Xinjiang Med Univ, Affiliated Hosp 1, Clin Med Res Inst, Xin Jiang Key Lab Cardiovasc Dis, Urumqi, Peoples R China; [Liu, Fen; Adi, Dilare; Xie, Xiang; Li, Xiao-Mei; Fu, Zhen-Yan; Shan, Chun-Fang; Huang, Ying; Chen, Bang-Dang; Gai, Min-Tao; Ma, Yi-Tong; Yang, Yi-Ning] Xingjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Gao, Xiao-Ming] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Xinjiang Medical University; Baker Heart and Diabetes Institute	Gao, XM (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Clin Med Res Inst, Xin Jiang Key Lab Cardiovasc Dis, Urumqi, Peoples R China.	xiaomng.gao@bakeridi.edu.au; myt_xj@sina.com; yangyn5126@163.com	xie, xiang/AAG-2128-2021		Key Laboratory of Xinjiang Uygur Autonomous Region [2014KL011]	Key Laboratory of Xinjiang Uygur Autonomous Region	This work was supported financially by the special funded project, Key Laboratory of Xinjiang Uygur Autonomous Region (No. 2014KL011).	Adeoye AM, 2014, INT J HYPERTENS, V2014, DOI 10.1155/2014/295916; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; [Anonymous], 2002, WORLD HLTH REP, P12; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Franklin SS, 2001, HYPERTENSION, V37, P869, DOI 10.1161/01.HYP.37.3.869; Franklin SS, 2005, CIRCULATION, V111, P1121, DOI 10.1161/01.CIR.0000157159.39889.EC; Franklin SS, 2006, J HYPERTENS, V24, P2009, DOI 10.1097/01.hjh.0000244950.72664.02; Franklin SS, 2009, CIRCULATION, V119, P243, DOI 10.1161/CIRCULATIONAHA.108.797936; Grebla RC, 2010, J HYPERTENS, V28, P15, DOI 10.1097/HJH.0b013e328331b7ff; Hozawa A, 2000, ARCH INTERN MED, V160, P3301, DOI 10.1001/archinte.160.21.3301; Huang JF, 2004, AM J HYPERTENS, V17, P955, DOI 10.1016/j.amjhyper.2004.06.007; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kelly TN, 2008, CIRCULATION, V118, P1558, DOI 10.1161/CIRCULATIONAHA.107.723593; Li Y, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0489-x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu F, 2014, BLOOD PRESSURE, V23, P154, DOI 10.3109/08037051.2013.838827; Liu Li-Sheng, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P579; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; McEniery CM, 2005, HYPERTENSION, V46, P221, DOI 10.1161/01.HYP.0000165310.84801.e0; McManus RJ, 2012, BMJ-BRIT MED J, V13, P344; Midha Tanu, 2012, Indian Heart J, V64, P374, DOI 10.1016/j.ihj.2012.06.007; Niiranen TJ, 2014, J HYPERTENS, V32, P518, DOI 10.1097/HJH.0000000000000070; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Rehill N, 2006, BRIT J CLIN PHARMACO, V61, P767, DOI 10.1111/j.1365-2125.2006.02630.x; Strandberg TE, 2002, J HYPERTENS, V20, P399, DOI 10.1097/00004872-200203000-00014; Wang YC, 2015, INT J ENV RES PUB HE, V12, P4395, DOI 10.3390/ijerph120404395; World Health Organization Study Group Diabetes mellitus, 1985, WHO TECH REP SER, V727, P1; Wu HL, 2009, AM J HYPERTENS, V22, P1287, DOI 10.1038/ajh.2009.189; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015181; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Xie X, 2009, CLIN APPL THROMB-HEM, V15, P574, DOI 10.1177/1076029608329581; Yang TO, 2015, AM J CLIN NUTR, V101, P570, DOI 10.3945/ajcn.113.081836; Yeh CJ, 2001, J FORMOS MED ASSOC, V100, P668; Zhang RB, 2000, AM J HYPERTENS, V13, P1308, DOI 10.1016/S0895-7061(00)01254-1; 卓朗, 2006, [高血压杂志, Chinese Journal of Hypertension], V14, P307	36	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145325	10.1371/journal.pone.0145325	http://dx.doi.org/10.1371/journal.pone.0145325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694755	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092500039
J	Wang, Z; Zhao, SM; Zhao, LM; Chen, XQ; Zeng, GZ; Tan, NH				Wang, Zhe; Zhao, Si-Meng; Zhao, Li-Mei; Chen, Xiao-Qiang; Zeng, Guang-Zhi; Tan, Ning-Hua			Rubipodanin A, the First Natural N-Desmonomethyl Rubiaceae-Type Cyclopeptide from Rubia podantha, Indicating an Important Role of the N-9-Methyl Group in the Conformation and Bioactivity	PLOS ONE			English	Article							ANTITUMOR CYCLIC HEXAPEPTIDES; CYTOTOXIC BICYCLIC HEXAPEPTIDES; BREAST-CANCER CELLS; RA-VII; CORDIFOLIA; DEOXYBOUVARDIN; IDENTIFICATION; RUBIYUNNANINS; PHARMACOPHORE; YUNNANENSIS	One new cyclic hexapeptide named rubipodanin A (1), which is the first identified natural N-desmonomethyl Rubiaceae-type cyclopeptide, together with six known Rubiaceae-type cyclopeptides (2-7) were obtained using the TLC cyclopeptide protosite detection method with ninhydrin from the roots and rhizomes of Rubia podantha. The cyclopeptide structures were elucidated by extensive spectroscopic analysis, including 1D-NMR, 2D-NMR, IR, UV and MS. The solution conformation and biological activities of 1 and RA-V (4) were evaluated, and the results demonstrated that the N-9-methyl group plays a vital role in the maintenance of the conformation and bioactivity.	[Wang, Zhe; Zhao, Si-Meng; Zhao, Li-Mei; Chen, Xiao-Qiang; Zeng, Guang-Zhi; Tan, Ning-Hua] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Peoples R China; [Tan, Ning-Hua] China Pharmaceut Univ, Dept Nat Med Chem, Nanjing 210009, Jiangsu, Peoples R China; [Tan, Ning-Hua] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China; [Wang, Zhe] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; China Pharmaceutical University; China Pharmaceutical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zeng, GZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Peoples R China.	gzh_zeng@mail.kib.ac.cn; nhtan@mail.kib.ac.cn			National Basic Research Program of China [2013CB127505]; Foundation of Chinese Academy of Sciences (Hundred Talents Program) [XDA09030301-4]; National Natural Science Foundation of China [U1032602, 91013002, 31470428]; National New Drug Innovation Major Project of China [2011ZX09307-002-02]; Natural Science Foundation of Yunnan Province [2012GA003]	National Basic Research Program of China(National Basic Research Program of China); Foundation of Chinese Academy of Sciences (Hundred Talents Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National New Drug Innovation Major Project of China; Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This work was supported by the National Basic Research Program of China (2013CB127505), the Foundation of Chinese Academy of Sciences (Hundred Talents Program, XDA09030301-4), the National Natural Science Foundation of China (U1032602, 91013002, 31470428), the National New Drug Innovation Major Project of China (2011ZX09307-002-02), and the Natural Science Foundation of Yunnan Province (2012GA003).	AEBI JD, 1990, J MED CHEM, V33, P999, DOI 10.1021/jm00165a018; Bik-San C, 2015, SCIENCE, V347, pS45; BOGER DL, 1994, J AM CHEM SOC, V116, P8544, DOI 10.1021/ja00098a015; BOGER DL, 1992, J ORG CHEM, V57, P1319, DOI 10.1021/jo00031a001; BOGER DL, 1993, J AM CHEM SOC, V115, P3420, DOI 10.1021/ja00062a004; BOGER DL, 1995, J AM CHEM SOC, V117, P7364, DOI 10.1021/ja00133a010; Fan JT, 2010, TETRAHEDRON LETT, V51, P6810, DOI 10.1016/j.tetlet.2010.07.066; Fan JT, 2010, BIOORGAN MED CHEM, V18, P8226, DOI 10.1016/j.bmc.2010.10.019; Fang XY, 2013, TOXICOL APPL PHARM, V267, P95, DOI 10.1016/j.taap.2012.12.010; Fujiwara H, 2004, CANCER LETT, V209, P223, DOI 10.1016/j.canlet.2003.12.022; Hitotsuyanagi Y, 2012, PHYTOCHEM LETT, V5, P335, DOI 10.1016/j.phytol.2012.02.014; Hitotsuyanagi Y, 2012, CHEM-EUR J, V18, P2839, DOI 10.1002/chem.201103185; Huang MB, 2014, TETRAHEDRON, V70, P7627, DOI 10.1016/j.tet.2014.07.105; ITOKAWA H, 1983, CHEM PHARM BULL, V31, P1424; ITOKAWA H, 1986, CHEM PHARM BULL, V34, P3762; JOLAD SD, 1977, J AM CHEM SOC, V99, P8040, DOI 10.1021/ja00466a043; Kuang Bin, 2012, Zhongguo Zhong Yao Za Zhi, V37, P2563; Lee JE, 2008, CHEM PHARM BULL, V56, P730, DOI 10.1248/cpb.56.730; Lee JE, 2008, TETRAHEDRON, V64, P4117, DOI 10.1016/j.tet.2008.01.094; Lee JE, 2008, BIOORG MED CHEM LETT, V18, P808, DOI 10.1016/j.bmcl.2007.11.030; Leung HW, 2015, BBA-MOL CELL RES, V1853, P1827, DOI 10.1016/j.bbamcr.2015.04.020; Liu NN, 2014, TETRAHEDRON, V70, P6630, DOI 10.1016/j.tet.2014.06.108; MORITA H, 1993, CHEM PHARM BULL, V41, P781, DOI 10.1248/cpb.41.781; MORITA H, 1992, CHEM PHARM BULL, V40, P1352, DOI 10.1248/cpb.40.1352; Morita H, 2010, HETEROCYCLES, V80, P739, DOI 10.3987/REV-09-SR(S)7; Otrubova K, 2008, J MED CHEM, V51, P530, DOI 10.1021/jm070731a; Tan NH, 2006, CHEM REV, V106, P840, DOI 10.1021/cr040699h; Tao J, 2003, CHEM PHARM BULL, V51, P654, DOI 10.1248/cpb.51.654; Yan H, 2009, EUR J MED CHEM, V44, P3425, DOI 10.1016/j.ejmech.2009.02.005; Yue GGL, 2011, BRIT J PHARMACOL, V164, P1883, DOI 10.1111/j.1476-5381.2011.01458.x; Zeng GZ, 2009, PHYTOTHER RES, V23, P885, DOI 10.1002/ptr.2671; Zhao SM, 2011, CHIMIA, V65, P952, DOI 10.2533/chimia.2011.952; Zhao SM, 2014, ORG LETT, V16, P5576, DOI 10.1021/ol502603f; Zhou T, 2000, CHINESE SCI BULL, V45, P1825	34	18	18	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144950	10.1371/journal.pone.0144950	http://dx.doi.org/10.1371/journal.pone.0144950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694544	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500017
J	Cho, IJ; Chang, HJ; Chung, H; Lee, SE; Shim, CY; Hong, GR; Ha, JW; Chung, N				Cho, In-Jeong; Chang, Hyuk-Jae; Chung, Hyemoon; Lee, Sang-Eun; Shim, Chi Young; Hong, Geu-Ru; Ha, Jong-Won; Chung, Namsik			Differential Impact of Constrictive Physiology after Pericardiocentesis in Malignancy Patients with Pericardial Effusion	PLOS ONE			English	Article							CARDIAC-TAMPONADE; DIAGNOSTIC-VALUE; OUTCOMES; MANAGEMENT; CANCER; ECHOCARDIOGRAPHY; DRAINAGE; DISEASE	Background Echocardiographic signs of constrictive physiology (CP) after pericardiocentesis are frequently observed in malignancy patients. The purpose of the current study was to explore whether features of CP after pericardiocentesis have prognostic impact in malignancy patients with pericardial effusion (PE). Methods We retrospectively reviewed 467 consecutive patients who underwent pericardiocentesis at our institution from January 2006 to May 2014. Among them, 205 patients with advanced malignancy who underwent comprehensive echocardiography after the procedure comprised the study population. Co-primary end points were all-cause mortality (ACM) and repeated drainage (RD) for PE. Patients were divided into four subgroups according to cytologic result for malignant cells and CP (positive cytology with negative CP, both positive, both negative, and negative cytology with positive CP). Results CP after pericardiocentesis was present in 106 patients (50%) at median 4 days after the procedure. During median follow-up of 208 days, ACM and RD occurred in 162 patients (79%) and 29 patients (14%), respectively. Cox regression analysis revealed that independent predictors for ACM were male gender and positive cytology (all, p < 0.05). For RD, predictors were positive cytology, the absence of cardiac tamponade, and negative CP after pericardiocentesis (all, p < 0.05). When the patients were divided into four subgroups, patients with negative cytology and positive CP demonstrated the most favorable survival (hazard ratio [HR]: 0.39, p = 0.005) and the lowest RD rates (HR: 0.07, p = 0.012). Conclusion CP after pericardiocentesis is common, but does not always imply poor survival or the need for RD in patients with advanced malignancies. On the contrary, the presence of CP in patients with negative cytology conferred the most favorable survival and the lowest rate of RD. Comprehensive echocardiographic evaluation for CP after pericardiocentesis would be helpful for predicting prognosis in patients with advanced malignancies.	[Cho, In-Jeong; Chang, Hyuk-Jae; Chung, Hyemoon; Lee, Sang-Eun; Shim, Chi Young; Hong, Geu-Ru; Ha, Jong-Won; Chung, Namsik] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol,Severance Hosp, Seoul, South Korea; [Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Chang, HJ (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol,Severance Hosp, Seoul, South Korea.	hjchang@yuhs.ac	Shim, Chi Young/AAK-1057-2021	Shim, Chi Young/0000-0002-6136-0136; Lee, Sang-Eun/0000-0001-6645-4038; Chang, Hyuk-Jae/0000-0002-6139-7545; Hong, Geu-Ru/0000-0003-4981-3304; Ha, Jong-Won/0000-0002-8260-2958	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [2012027176]	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP)	This research was supported by Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP) (No. 2012027176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyarajah V, 2007, TEX HEART I J, V34, P347; CAMPBELL PT, 1992, CHEST, V101, P938, DOI 10.1378/chest.101.4.938; Cosyns B, 2014, EUR HEART J CARDIOVA, V23; Cullinane CA, 2004, CHEST, V125, P1328, DOI 10.1378/chest.125.4.1328; Dal-Bianco JP, 2009, J AM SOC ECHOCARDIOG, V22, P24, DOI 10.1016/j.echo.2008.11.004; Ha JW, 2002, J AM SOC ECHOCARDIOG, V15, P1468, DOI 10.1067/mje.2002.127452; HANCOCK EW, 1980, AM HEART J, V100, P917, DOI 10.1016/0002-8703(80)90074-5; Im E, 2013, J AM COLL CARDIOL, V61, P2110, DOI 10.1016/j.jacc.2013.02.033; Laham RJ, 1996, HEART, V75, P67, DOI 10.1136/hrt.75.1.67; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Merce J, 1999, AM HEART J, V138, P759, DOI 10.1016/S0002-8703(99)70193-6; Patel N, 2013, AM J CARDIOL, V112, P1235, DOI 10.1016/j.amjcard.2013.05.066; POSNER MR, 1981, AM J MED, V71, P407, DOI 10.1016/0002-9343(81)90168-6; Rafique AM, 2011, AM J CARDIOL, V108, P1820, DOI 10.1016/j.amjcard.2011.07.057; Sagrista-Sauleda J, 2004, NEW ENGL J MED, V350, P469, DOI 10.1056/NEJMoa035630; SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792; Talreja DR, 2003, CIRCULATION, V108, P1852, DOI 10.1161/01.CIR.0000087606.18453.FD; Tsang TSM, 2000, MAYO CLIN PROC, V75, P248; Tsang TSM, 2002, MAYO CLIN PROC, V77, P429; VAITKUS PT, 1994, JAMA-J AM MED ASSOC, V272, P59, DOI 10.1001/jama.272.1.59; Wang HJ, 2002, CHEST, V122, P893, DOI 10.1378/chest.122.3.893; Wang ZJ, 2003, RADIOGRAPHICS, V23, pS167, DOI 10.1148/rg.23si035504; WILKES JD, 1995, CANCER, V76, P1377, DOI 10.1002/1097-0142(19951015)76:8<1377::AID-CNCR2820760813>3.0.CO;2-M	23	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145461	10.1371/journal.pone.0145461	http://dx.doi.org/10.1371/journal.pone.0145461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691279	gold, Green Submitted, Green Published			2022-12-27	WOS:000367092300079
J	Fielding, JE; Kelly, HA; Glass, K				Fielding, James E.; Kelly, Heath A.; Glass, Kathryn			Transmission of the First Influenza A(H1N1) pdm09 Pandemic Wave in Australia Was Driven by Undetected Infections: Pandemic Response Implications	PLOS ONE			English	Article							H1N1 2009 INFLUENZA; VIRAL LOAD; REAL-TIME; VIRUS; EPIDEMIOLOGY; SURVEILLANCE	Background During the first wave of influenza A(H1N1)pdm09 in Victoria, Australia the rapid increase in notified cases and the high proportion with relatively mild symptoms suggested that community transmission was established before cases were identified. This lead to the hypothesis that those with low-level infections were the main drivers of the pandemic. Methods A deterministic susceptible-infected-recovered model was constructed to describe the first pandemic wave in a population structured by disease severity levels of asymptomatic, low-level symptoms, moderate symptoms and severe symptoms requiring hospitalisation. The model incorporated mixing, infectivity and duration of infectiousness parameters to calculate subgroup-specific reproduction numbers for each severity level. Results With stratum-specific effective reproduction numbers of 1.82 and 1.32 respectively, those with low-level symptoms, and those with asymptomatic infections were responsible for most of the transmission. The effective reproduction numbers for infections resulting in moderate symptoms and hospitalisation were less than one. Sensitivity analyses confirmed the importance of parameters relating to asymptomatic individuals and those with low-level symptoms. Conclusions Transmission of influenza A(H1N1) pdm09 was largely driven by those invisible to the health system. This has implications for control measures-such as distribution of antivirals to cases and contacts and quarantine/isolation-that rely on detection of infected cases. Pandemic plans need to incorporate milder scenarios, with a graded approach to implementation of control measures.	[Fielding, James E.; Kelly, Heath A.] Victorian Infect Dis Reference Lab, North Melbourne, Vic, Australia; [Fielding, James E.; Kelly, Heath A.; Glass, Kathryn] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Fielding, James E.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Parkville, Vic 3052, Australia	Victorian Infectious Diseases Reference Laboratory; Australian National University; University of Melbourne	Fielding, JE (corresponding author), Victorian Infect Dis Reference Lab, North Melbourne, Vic, Australia.	james.fielding@mh.org.au		Glass, Kathryn/0000-0001-5905-1310; Fielding, James/0000-0003-2995-9576				Amato-Gauci A, 2011, EURO SURVEILL, V16, P19903; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P173; Australian Government Department of Health and Ageing, 2009, REV AUSTR HLTH SECT; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Centers for Disease Control and Prevention, FLUVIEW 2009 2010 IN; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Dalton CB, 2013, EMERG INFECT DIS, V19, P1863, DOI 10.3201/eid1911.121878; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Denholm JT, 2010, MED J AUSTRALIA, V192, P84, DOI 10.5694/j.1326-5377.2010.tb03424.x; Duchamp MB, 2010, CLIN MICROBIOL INFEC, V16, P317, DOI 10.1111/j.1469-0691.2010.03169.x; Fielding JE, 2009, EUROSURVEILLANCE, V14, P37; Fielding JE, 2014, INFLUENZA OTHER RESP, V8, P142, DOI 10.1111/irv.12216; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Glass K, 2012, EPIDEMIOLOGY, V23, P86, DOI 10.1097/EDE.0b013e31823a44a5; Gu Y, 2011, EMERG INFECT DIS, V17, P1737, DOI 10.3201/eid1709.101411; Jackson ML, 2011, CLIN INFECT DIS, V53, P455, DOI 10.1093/cid/cir437; Kay M, 2011, EMERG INFECT DIS, V17, P639, DOI 10.3201/eid1704.100866; Kelly HA, 2011, VACCINE, V29, P6419, DOI 10.1016/j.vaccine.2011.03.055; Kelly HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011341; Khaokham CB, 2013, INFLUENZA OTHER RESP; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Killingley B, 2010, HEALTH TECHNOL ASSES, V14, P237, DOI 10.3310/hta14460-04; Lambert SB, 2010, MED J AUSTRALIA, V193, P43, DOI 10.5694/j.1326-5377.2010.tb03741.x; Lester R, 2009, VICTORIAN INFECT DIS, V12, P43; Loeb M, 2012, J INFECT DIS, V206, P1078, DOI 10.1093/infdis/jis450; Looker C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013702, DOI 10.1371/J0URNAL.P0NE.0013702]; McVernon J, 2010, EURO SURVEILL, V15, pii; Meschi S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-140; Muscatello DJ, 2011, EMERG INFECT DIS, V17, P1240, DOI 10.3201/eid1707.101173; Pang XH, 2011, EMERG INFECT DIS, V17, P1824, DOI 10.3201/eid1710.101344; Poeppl W, 2012, J MED VIROL, V84, P1331, DOI 10.1002/jmv.23337; Suess T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051653; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Turner RB., 2010, PRINCIPLES PRACTICE, P809; Van Kerkhove MD, 2011, INFLUENZA OTHER RESP, V5, P375, DOI 10.1111/j.1750-2659.2011.00241.x; Wu JY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1018; Wu UI, 2012, INFLUENZA OTHER RESP, V6, P367, DOI 10.1111/j.1750-2659.2011.00300.x; Yan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045898	40	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144331	10.1371/journal.pone.0144331	http://dx.doi.org/10.1371/journal.pone.0144331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692335	Green Published, gold			2022-12-27	WOS:000367092300006
J	Sun, DL; Harris, N; Walther, G; Baiocchi, M				Sun, Dennis L.; Harris, Naftali; Walther, Guenther; Baiocchi, Michael			Peer Assessment Enhances Student Learning: The Results of a Matched Randomized Crossover Experiment in a College Statistics Class	PLOS ONE			English	Article							ACHIEVEMENT GAP; FEEDBACK; SCIENCE	Feedback has a powerful influence on learning, but it is also expensive to provide. In large classes it may even be impossible for instructors to provide individualized feedback. Peer assessment is one way to provide personalized feedback that scales to large classes. Besides these obvious logistical benefits, it has been conjectured that students also learn from the practice of peer assessment. However, this has never been conclusively demonstrated. Using an online educational platform that we developed, we conducted an in-class matched-set, randomized crossover experiment with high power to detect small effects. We establish that peer assessment causes a small but significant gain in student achievement. Our study also demonstrates the potential of web-based platforms to facilitate the design of high-quality experiments to identify small effects that were previously not detectable.	[Sun, Dennis L.] Calif Polytech State Univ San Luis Obispo, Dept Stat, San Luis Obispo, CA 93407 USA; [Harris, Naftali; Walther, Guenther; Baiocchi, Michael] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Baiocchi, Michael] Stanford Sch Med, Prevent Res Ctr, Stanford, CA 94305 USA	California State University System; California Polytechnic State University San Luis Obispo; Stanford University; Stanford University	Sun, DL (corresponding author), Calif Polytech State Univ San Luis Obispo, Dept Stat, San Luis Obispo, CA 93407 USA.	dsun09@calpoly.edu; baiocchi@stanford.edu			Stanford University; Agency for Health Research Quality [KHS022192A]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K99HS022192, R00HS022192] Funding Source: NIH RePORTER	Stanford University(Stanford University); Agency for Health Research Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Stanford University supplied a grant to fund the development of our online homework platform (< $10,000USD). This platform is being used on an ongoing basis by the department, separately from the study. A grant from the Agency for Health Research & Quality provided support for some of Professor Baiocchi's time (KHS022192A).	BANGERTDROWNS RL, 1991, REV EDUC RES, V61, P213, DOI 10.2307/1170535; Bloom BS, 1984, ED RES, V136, P4, DOI DOI 10.3102/0013189X013006004; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Falchikov N, 2000, REV EDUC RES, V70, P287, DOI 10.3102/00346543070003287; Falchikov N., 2005, IMPROVING ASSESSMENT; Freeman S, 2010, CBE-LIFE SCI EDUC, V9, P482, DOI 10.1187/cbe.10-03-0017; Gerdeman RD, 2007, J COLL SCI TEACH, V36, P5; Haak DC, 2011, SCIENCE, V332, P1213, DOI 10.1126/science.1204820; Hattie J, 2007, POWER FEEDBACK REV E, V77, P1; KULIK JA, 1988, REV EDUC RES, V58, P79, DOI 10.3102/00346543058001079; Kulkarni C, 2013, ACM T COMPUT-HUM INT, V20, DOI 10.1145/2505057; Leacock C, 2003, COMPUT HUMANITIES, V37, P389, DOI 10.1023/A:1025779619903; Linn MC, 2014, SCIENCE, V344, P155, DOI 10.1126/science.1245980; Miyake A, 2010, SCIENCE, V330, P1234, DOI 10.1126/science.1195996; Sadler PM, 2006, EDUC ASSESS, V11, P1, DOI 10.1207/s15326977ea1101_1; Tinapple D, 2013, B IEEE TECH COM LEAR, V15, P1; Topping K, 1998, REV EDUC RES, V68, P249, DOI 10.3102/00346543068003249; Topping K, 2009, THEOR PRACT, V48, P20, DOI 10.1080/00405840802577569; von Ahn L, 2008, SCIENCE, V321, P1465, DOI 10.1126/science.1160379	19	10	10	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0143177	10.1371/journal.pone.0143177	http://dx.doi.org/10.1371/journal.pone.0143177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9KM	26683053	Green Published, gold, Green Submitted			2022-12-27	WOS:000366725800005
J	Wang, HS; Iwasaki, M; Haiman, CA; Kono, S; Wilkens, LR; Keku, TO; Berndt, SI; Tsugane, S; Le Marchand, L				Wang, Hansong; Iwasaki, Motoki; Haiman, Christopher A.; Kono, Suminori; Wilkens, Lynne R.; Keku, Temitope O.; Berndt, Sonja I.; Tsugane, Shoichiro; Le Marchand, Loic			Interaction between Red Meat Intake and NAT2 Genotype in Increasing the Risk of Colorectal Cancer in Japanese and African Americans	PLOS ONE			English	Article							HETEROCYCLIC AMINE INTAKE; GENOME-WIDE ASSOCIATION; COLON-CANCER; CYTOCHROME-P450 1A2; CONSUMPTION; SMOKING; POLYMORPHISMS; POPULATIONS; N-ACETYLTRANSFERASE-2; SUSCEPTIBILITY	Heterocyclic aromatic amines formed in cooked meat may be an underlying mechanism for the red meat-colorectal cancer (CRC) association. These compounds require bioactivaction by N-acetyltransferase 2 (NAT2). An interaction effect between red meat consumption and NAT2 in increasing CRC risk has been inconsistently reported in whites. We investigated this interaction in two populations in which the high-activity rapid NAT2 phenotype is 10- and 2-fold more common than in whites. We meta-analyzed four studies of Japanese (2,217 cases, 3,788 controls) and three studies of African Americans (527 cases, 4,527 controls). NAT2 phenotype was inferred from an optimized seven-SNP genotyping panel. Processed and total red meat intakes were associated with an increased CRC risk in Japanese and in both ethnic groups combined (P's <= 0.002). We observed an interaction between processed meat intake and NAT2 in Japanese (P = 0.04), African Americans (P = 0.02), and in both groups combined (P = 0.006). The association of processed meat with CRC was strongest among individuals with the rapid NAT2 phenotype (combined analysis, OR for highest vs. lowest quartile: 1.62, 95% CI: 1.28-2.05; P-trend = 8.0x10(-5)), intermediate among those with the intermediate NAT2 phenotype (1.29, 95% CI: 1.05-1.59; P-trend = 0.05) and null among those with the slow phenotype (P-trend = 0.45). A similar interaction was found for NAT2 and total red meat (P-interaction = 0.03). Our findings support a role for NAT2 in modifying the association between red meat consumption and CRC in Japanese and African Americans.	[Wang, Hansong; Wilkens, Lynne R.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Iwasaki, Motoki; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan; [Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Haiman, Christopher A.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Kono, Suminori] Kyushu Univ, Grad Sch Med Sci, Dept Prevent Med, Fukuoka 812, Japan; [Keku, Temitope O.] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA; [Berndt, Sonja I.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA	Cancer Research Center of Hawaii; University of Hawaii System; National Cancer Center - Japan; University of Southern California; University of Southern California; Kyushu University; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Le Marchand, L (corresponding author), Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA.	loic@cc.hawaii.edu	Berndt, Sonja I/J-8423-2016; Tsugane, Shoichiro/A-2424-2015	Tsugane, Shoichiro/0000-0003-4105-2774	National Institutes of Health [R01 CA126895, CA126895-S01, U01 CA164973, CA63464, CA54281, CA1326792, CA148085, HG004726, P30 DK 034987, R01 CA66635]; Department of Defense Breast Cancer Research Program Era of Hope Scholar Award [W81XWH-08-1-0383]; National Cancer Center Research and Development Fund; Ministry of Health, Labor and Welfare of Japan; NATIONAL CANCER INSTITUTE [P30CA071789, U01CA164973, R37CA054281, R01CA126895, RC2CA148085, R01CA063464, R01CA054281, P30CA016086, R01CA066635, U01CA063464] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program Era of Hope Scholar Award(United States Department of Defense); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The colorectal cancer GWAS in Japanese and African Americans was supported by grants from the National Institutes of Health (R01 CA126895 and CA126895-S01). The Multiethnic Cohort Study is supported by the National Institutes of Health (U01 CA164973). The genotyping of African American male and female controls was supported by the National Institutes of Health (CA63464, CA54281, CA1326792, CA148085 and HG004726); and a Department of Defense Breast Cancer Research Program Era of Hope Scholar Award [W81XWH-08-1-0383 to CAH]. JPHC was supported by the National Cancer Center Research and Development Fund (since 2011) and a Grant-in-Aid for Cancer Research (from 1989 to 2010) from the Ministry of Health, Labor and Welfare of Japan. The UNC study was supported the National Institutes of Health (P30 DK 034987 and R01 CA66635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DD, 2011, OBES REV, V12, pe472, DOI 10.1111/j.1467-789X.2010.00785.x; Alexander DD, 2010, EUR J CANCER PREV, V19, P328, DOI 10.1097/CEJ.0b013e32833b48fa; Ananthakrishnan AN, 2015, CANCER EPIDEM BIOMAR, V24, P198, DOI 10.1158/1055-9965.EPI-14-0897; Barrett JH, 2003, CARCINOGENESIS, V24, P275, DOI 10.1093/carcin/24.2.275; Brockton N, 2000, AM J EPIDEMIOL, V151, P846; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Budhathoki S, 2015, CANCER EPIDEM BIOMAR, V24, P613, DOI 10.1158/1055-9965.EPI-14-1051; BUTLER MA, 1992, PHARMACOGENETICS, V2, P116, DOI 10.1097/00008571-199206000-00003; Chan AT, 2005, INT J CANCER, V115, P648, DOI 10.1002/ijc.20890; Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Deitz AC, 2004, CANCER EPIDEM BIOMAR, V13, P1543; Doll MA, 2001, ANAL BIOCHEM, V288, P106, DOI 10.1006/abio.2000.4892; ELLARD GA, 1976, CLIN PHARMACOL THER, V19, P610; Forman D, 2013, IARC SCI PUBLICATION, VX, P164; Garcia-Closas M, 2011, PHARMACOGENET GENOM, V21, P231, DOI 10.1097/FPC.0b013e32833e1b54; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kampman E, 1999, CANCER EPIDEM BIOMAR, V8, P15; Kono S, 2004, EUR J CANCER PREV, V13, P127, DOI 10.1097/00008469-200404000-00006; Larsson SC, 2006, INT J CANCER, V119, P2657, DOI 10.1002/ijc.22170; Lilla C, 2006, CANCER EPIDEM BIOMAR, V15, P99, DOI 10.1158/1055-9965.EPI-05-0618; Liu JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042797; Miller BA, 1996, RACIAL ETHNIC PATTER; Murtaugh MA, 2004, J NUTR, V134, P776, DOI 10.1093/jn/134.4.776; Nothlings U, 2009, CANCER EPIDEM BIOMAR, V18, P2098, DOI 10.1158/1055-9965.EPI-08-1218; Ognjanovic S, 2006, CANCER CAUSE CONTROL, V17, P1175, DOI 10.1007/s10552-006-0061-3; Sabbagh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018507; SUGIMURA T, 1983, CANCER RES, V43, P2415; Takachi R, 2011, ASIA PAC J CLIN NUTR, V20, P603; Turesky RJ, 2013, CANCER EPIDEM BIOMAR, V22, P356, DOI 10.1158/1055-9965.EPI-12-1206; Voutsinas J, 2013, GUT, V62, P416, DOI 10.1136/gutjnl-2011-300665; Wang HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5613; Wang HS, 2013, HUM MOL GENET, V22, P5048, DOI 10.1093/hmg/ddt337; Welfare MR, 1997, CARCINOGENESIS, V18, P1351, DOI 10.1093/carcin/18.7.1351; Williams CD, 2010, NUTR CANCER, V62, P701, DOI 10.1080/01635581003605938; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Zhang L, 2012, IET WIREL SENS SYST, V2, P40, DOI 10.1049/iet-wss.2011.0012	36	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144955	10.1371/journal.pone.0144955	http://dx.doi.org/10.1371/journal.pone.0144955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683305	gold, Green Published			2022-12-27	WOS:000366725800025
J	Chouchou, F; Chauny, JM; Rainville, P; Lavigne, GJ				Chouchou, Florian; Chauny, Jean-Marc; Rainville, Pierre; Lavigne, Gilles J.			Selective REM Sleep Deprivation Improves Expectation-Related Placebo Analgesia	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; INDIVIDUAL-DIFFERENCES; CLONIDINE; PAIN; RESPONSES; BRAIN; REWARD; HUMANS; SUPPRESSION; EXPERIENCE	The placebo effect is a neurobiological and psychophysiological process known to influence perceived pain relief. Optimization of placebo analgesia may contribute to the clinical efficacy and effectiveness of medication for acute and chronic pain management. We know that the placebo effect operates through two main mechanisms, expectations and learning, which is also influenced by sleep. Moreover, a recent study suggested that rapid eye movement (REM) sleep is associated with modulation of expectation-mediated placebo analgesia. We examined placebo analgesia following pharmacological REM sleep deprivation and we tested the hypothesis that relief expectations and placebo analgesia would be improved by experimental REM sleep deprivation in healthy volunteers. Following an adaptive night in a sleep laboratory, 26 healthy volunteers underwent classical experimental placebo analgesic conditioning in the evening combined with pharmacological REM sleep deprivation (clonidine: 13 volunteers or inert control pill: 13 volunteers). Medication was administered in a double-blind manner at bedtime, and placebo analgesia was tested in the morning. Results revealed that 1) placebo analgesia improved with REM sleep deprivation; 2) pain relief expectations did not differ between REM sleep deprivation and control groups; and 3) REM sleep moderated the relationship between pain relief expectations and placebo analgesia. These results support the putative role of REM sleep in modulating placebo analgesia. The mechanisms involved in these improvements in placebo analgesia and pain relief following selective REM sleep deprivation should be further investigated.	[Chouchou, Florian; Rainville, Pierre; Lavigne, Gilles J.] Univ Montreal, Fac Med Dent, Montreal, PQ H3C 3J7, Canada; [Chouchou, Florian; Rainville, Pierre; Lavigne, Gilles J.] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Chouchou, Florian; Lavigne, Gilles J.] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Chauny, Jean-Marc; Lavigne, Gilles J.] Hop Sacre Coeur, Emergency Dept, Montreal, PQ H4J 1C5, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Lavigne, GJ (corresponding author), Univ Montreal, Fac Med Dent, Montreal, PQ H3C 3J7, Canada.	gilles.lavigne@umontreal.ca	Rainville, Pierre/M-5480-2015; Chouchou, Florian/AAS-5499-2021	Rainville, Pierre/0000-0001-9801-757X; 	Network for Oral and Bone Health Research (Quebec, Canada); Rhone-Alpes Region (France)	Network for Oral and Bone Health Research (Quebec, Canada); Rhone-Alpes Region (France)(Region Auvergne-Rhone-Alpes)	GJL holds a Canada Research Chair on Pain, Sleep and Traumatic Injuries. FC received a grant from the Network for Oral and Bone Health Research (Quebec, Canada) and from the Rhone-Alpes Region (France).	Atlas Lauren Y, 2014, Handb Exp Pharmacol, V225, P37, DOI 10.1007/978-3-662-44519-8_3; AUTRET A, 1976, CR ACAD SCI D NAT, V283, P955; Azevedo E, 2011, PAIN, V152, P2052, DOI 10.1016/j.pain.2011.04.032; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 2014, NEURON, V84, P623, DOI 10.1016/j.neuron.2014.10.023; Benedict C, 2012, J CLIN ENDOCR METAB, V97, pE443, DOI 10.1210/jc.2011-2759; Chouchou F, 2014, SLEEP MED REV, V18, P273, DOI 10.1016/j.smrv.2013.07.002; Clement O, 2012, J NEUROSCI, V32, P16763, DOI 10.1523/JNEUROSCI.1885-12.2012; Colloca L, 2008, PAIN, V139, P306, DOI 10.1016/j.pain.2008.04.021; Drummond SPA, 1999, NEUROREPORT, V10, P3745, DOI 10.1097/00001756-199912160-00004; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Gentili A, 1996, EUR J CLIN PHARMACOL, V50, P463, DOI 10.1007/s002280050141; Geuter S, 2013, NEUROIMAGE, V67, P227, DOI 10.1016/j.neuroimage.2012.11.029; GILLBERG M, 1994, SLEEP, V17, P236, DOI 10.1093/sleep/17.3.236; Gujar N, 2011, J NEUROSCI, V31, P4466, DOI 10.1523/JNEUROSCI.3220-10.2011; Hanlon EC, 2005, BEHAV BRAIN RES, V163, P58, DOI 10.1016/j.bbr.2005.04.017; Hauck M, 2006, EUR J PAIN, V10, P757, DOI 10.1016/j.ejpain.2005.12.003; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; HORNE JA, 1988, SLEEP, V11, P528, DOI 10.1093/sleep/11.6.528; Huynh N, 2006, SLEEP, V29, P307, DOI 10.1093/sleep/29.3.307; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Klinger R, 2014, PAIN, V155, P1055, DOI 10.1016/j.pain.2013.12.007; Laverdure-Dupont D, 2010, REV NEUROSCIENCE, V21, P381; Laverdure-Dupont D, 2009, J NEUROSCI, V29, P11745, DOI 10.1523/JNEUROSCI.1224-09.2009; Loh S, 2004, BEHAV RES METH INS C, V36, P339, DOI 10.3758/BF03195580; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Marshall AJ, 2014, J NEUROSCI, V34, P11754, DOI 10.1523/JNEUROSCI.0478-14.2014; Mckenna BS, 2007, J SLEEP RES, V16, P245, DOI 10.1111/j.1365-2869.2007.00591.x; Mitchell A, 2005, CARDIOVASC DRUG THER, V19, P49, DOI 10.1007/s10557-005-6890-6; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; Pace-Schott E.F., 2015, PSYCHOL B; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; PORCHET HC, 1990, LIFE SCI, V46, P991, DOI 10.1016/0024-3205(90)90022-J; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Price DD, 1999, PAIN, V83, P147, DOI 10.1016/S0304-3959(99)00081-0; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Spoormaker VI, 2014, EXP BRAIN RES, V232, P1547, DOI 10.1007/s00221-014-3831-2; Spoormaker VI, 2012, HUM BRAIN MAPP, V33, P2362, DOI 10.1002/hbm.21369; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; Venkatraman V, 2007, SLEEP, V30, P603, DOI 10.1093/sleep/30.5.603; Wager TD, 2011, J NEUROSCI, V31, P439, DOI 10.1523/JNEUROSCI.3420-10.2011; Watts A, 2012, J NEUROSCI, V32, P13411, DOI 10.1523/JNEUROSCI.0170-12.2012; Wong MM, 2009, SLEEP MED, V10, P787, DOI 10.1016/j.sleep.2008.06.015; Wu JC, 2006, NEUROPSYCHOPHARMACOL, V31, P2783, DOI 10.1038/sj.npp.1301166; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007	50	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144992	10.1371/journal.pone.0144992	http://dx.doi.org/10.1371/journal.pone.0144992			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678391	Green Submitted, Green Published, gold			2022-12-27	WOS:000366723400040
J	Pan, SC; Chen, YC; Wang, JY; Sheng, WH; Lin, HH; Fang, CT; Chang, SC				Pan, Sung-Ching; Chen, Yee-Chun; Wang, Jann-Yuan; Sheng, Wang-Huei; Lin, Hsien-Ho; Fang, Chi-Tai; Chang, Shan-Chwen			Tuberculosis in Healthcare Workers: A Matched Cohort Study in Taiwan	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INCREASED RISK; TRANSMISSION; INFECTION; DIAGNOSIS; MORTALITY; DISEASES; WORKING; STAFF	Background Proportional mortality ratio data indicate that healthcare workers (HCWs) have an elevated tuberculosis (TB) mortality. Whether this is caused by an increased TB incidence, a worse TB treatment outcome, or a combination of effects, remains unclear. To elucidate the hazard components of occupational TB, we assessed TB incidence and TB treatment outcome among HCWs in Taiwan. Methods We compared the incidence of active TB among HCWs at a major medical center in Taiwan with that of Taiwan general population in 2004-2012. We also compared the TB treatment outcome of HCWs with that of age/sex-matched non-HCW patients treated at the same hospital, as well as that of nationally registered TB patients. Results The standardized TB incidence ratio of the HCWs was 1.9 (95% confidence interval [CI]: 1.2-2.9), compared with the general population. HCWs with pulmonary TB (n = 30) were less likely to have underlying diseases, delay in diagnosis, delay in treatment, or side effects of treatment, compared with age/sex-matched non-HCW TB patients (n = 120) (all Ps<0.05). The TB treatment outcome of HCWs was significantly better than that of non-HCW patients (TB-related mortality: 0.0% vs. 5.8%, P = 0.008, Mantel-Haenszel test). The standardized TB-related mortality rate was 1.08%[ 95% CI: 0.96% - 1.20%] for all of the nationally registered TB patients in Taiwan. Conclusions HCWs are at increased risk of active TB, compared with general population. To mitigate this occupational hazard, more efforts need to be directed towards the prevention of nosocomial TB transmission. Healthy worker effect, more rapid diagnosis, and less delay in treatment contribute to a lower TB-related mortality in HCWs.	[Pan, Sung-Ching; Lin, Hsien-Ho; Fang, Chi-Tai] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Pan, Sung-Ching; Chen, Yee-Chun; Wang, Jann-Yuan; Sheng, Wang-Huei; Fang, Chi-Tai; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chen, Yee-Chun; Chang, Shan-Chwen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Fang, CT (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	fangct@ntu.edu.tw; hsienho@gmail.com	Fang, Chi-Tai/P-2908-2016; Chen, Yee-Chun/AGW-7535-2022	Fang, Chi-Tai/0000-0002-7380-1699; Chen, Yee-Chun/0000-0002-1816-9010; WANG, JANN-YUAN/0000-0003-3406-366X; SHENG, WANG-HUEI/0000-0002-5605-7853; PAN, SUNG-CHING/0000-0003-3154-6690; LIN, HSIEN-HO/0000-0002-7481-6016; CHANG, SHAN-CHWEN/0000-0001-6505-4139				Alonso-Echanove J, 2001, CLIN INFECT DIS, V33, P589, DOI 10.1086/321892; [Anonymous], 2007, AD TOX TABL IN PRESS; [Anonymous], STAT COMM DIS SURV R; Babus V, 1997, INT J TUBERC LUNG D, V1, P254; Bang KM, 2005, INT J TUBERC LUNG D, V9, P437; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P14; Centers for Disease Control R.O.C. (Taiwan), 2012, EP TB TAIW; Centers for Disease Control R.O.C. (Taiwan), 2013, TAIW GUID TB DIAGN T; Centers for Disease Control R. O. C. (Taiwan), 2014, TAIW TUB CONTR REP 2; Centers for Disease Control Taiwan, 2015, HIV STAT TAIP; Chan PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057719; Chiang CY, 2005, INT J TUBERC LUNG D, V9, P1006; Chien JY, 2015, CLIN MICROBIOL INFEC, V21, P59, DOI 10.1016/j.cmi.2014.08.008; Chou M, 2004, MMWR-MORBID MORTAL W, V51, P321; Cuhadaroglu C, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-14; Dimitrova B, 2005, INT J TUBERC LUNG D, V9, P43; El-Sadr WM, 2008, SEMIN RESP CRIT CARE, V29, P525, DOI 10.1055/s-0028-1085703; Eyob G, 2002, INT J TUBERC LUNG D, V6, P85; Harries AD, 1999, T ROY SOC TROP MED H, V93, P32, DOI 10.1016/S0035-9203(99)90170-0; Holty JEC, 2009, CURR OPIN ORGAN TRAN, V14, P613, DOI 10.1097/MOT.0b013e3283324dfc; Hosoglu S, 2005, AM J INFECT CONTROL, V33, P23, DOI 10.1016/j.ajic.2004.07.013; Jarand J, 2010, TROP MED INT HEALTH, V15, P1179, DOI 10.1111/j.1365-3156.2010.02590.x; Kawatsu Lisa, 2014, Kekkaku, V89, P547; Kilinc O, 2002, RESP MED, V96, P506, DOI 10.1053/rmed.2002.1315; Kruuner A, 2001, INT J TUBERC LUNG D, V5, P170; Lash TL, 2008, MODERN EPIDEMIOLOGY, P267; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037978; Liu YC, 2010, INT J TUBERC LUNG D, V14, P72; McKenna MT, 1996, AM J RESP CRIT CARE, V154, P587, DOI 10.1164/ajrccm.154.3.8810591; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pleszewski B, 1998, INT J TUBERC LUNG D, V2, P898; Rao KG, 2004, INT J TUBERC LUNG D, V8, P1392; SEPKOWITZ KA, 1995, CLIN INFECT DIS, V21, P1098, DOI 10.1093/clinids/21.5.1098; Skodric V, 2000, INT J TUBERC LUNG D, V4, P827; Statistics Do, 2014, ABR LIF TABL TAIW MI; Taki Hisashi, 2008, Kekkaku, V83, P497; vanDeutekom H, 1997, CLIN INFECT DIS, V25, P1071, DOI 10.1086/516072; Vasankari T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-291; Virenfeldt J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004818; Wang FD, 2006, INFECT CONT HOSP EP, V27, P510, DOI 10.1086/503639; Wilkinson D, 1998, T ROY SOC TROP MED H, V92, P500, DOI 10.1016/S0035-9203(98)90889-6; World Health Organization, 2008, WHOHTMTB2008392	44	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145047	10.1371/journal.pone.0145047	http://dx.doi.org/10.1371/journal.pone.0145047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679188	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400046
J	Smirni, D; Turriziani, P; Mangano, GR; Cipolotti, L; Oliveri, M				Smirni, Daniela; Turriziani, Patrizia; Mangano, Giuseppa Renata; Cipolotti, Lisa; Oliveri, Massimiliano			Modulating Memory Performance in Healthy Subjects with Transcranial Direct Current Stimulation Over the Right Dorsolateral Prefrontal Cortex	PLOS ONE			English	Article							LONG-TERM-MEMORY; NONINVASIVE BRAIN-STIMULATION; VERBAL EPISODIC MEMORY; MAGNETIC STIMULATION; RECOGNITION MEMORY; ALZHEIMERS-DISEASE; INHIBITORY CONTROL; FRONTAL-CORTEX; OLDER-ADULTS; RETRIEVAL	Objective The role of the Dorsolateral Prefrontal Cortex (DLPFC) in recognition memory has been well documented in lesion, neuroimaging and repetitive Transcranial Magnetic Stimulation (rTMS) studies. The aim of the present study was to investigate the effects of transcranial Direct Current Stimulation (tDCS) over the left and the right DLPFC during the delay interval of a non-verbal recognition memory task. Method 36 right-handed young healthy subjects participated in the study. The experimental task was an Italian version of Recognition Memory Test for unknown faces. Study included two experiments: in a first experiment, each subject underwent one session of sham tDCS and one session of left or right cathodal tDCS; in a second experiment each subject underwent one session of sham tDCS and one session of left or right anodal tDCS. Results Cathodal tDCS over the right DLPFC significantly improved non verbal recognition memory performance, while cathodal tDCS over the left DLPFC had no effect. Anodal tDCS of both the left and right DLPFC did not modify non verbal recognition memory performance. Conclusion Complementing the majority of previous studies, reporting long term memory facilitations following left prefrontal anodal tDCS, the present findings show that cathodal tDCS of the right DLPFC can also improve recognition memory in healthy subjects.	[Smirni, Daniela; Turriziani, Patrizia; Mangano, Giuseppa Renata; Cipolotti, Lisa; Oliveri, Massimiliano] Univ Palermo, Dipartimento Sci Psicol Pedag & Formaz, Palermo, Italy; [Smirni, Daniela; Turriziani, Patrizia; Mangano, Giuseppa Renata; Cipolotti, Lisa; Oliveri, Massimiliano] NeuroTeam Life & Sci, Palermo, Italy; [Cipolotti, Lisa] Natl Hosp Neurol & Neurosurg, Dept Neuropsychol, London WC1N 3BG, England; [Oliveri, Massimiliano] IRCCS Fdn SantaLucia, Rome, Italy	University of Palermo; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Smirni, D (corresponding author), Univ Palermo, Dipartimento Sci Psicol Pedag & Formaz, Palermo, Italy.	daniela.smirni@unipa.it	Smirni, Daniela/R-3445-2019; Oliveri, Massimiliano/HDO-5602-2022	Smirni, Daniela/0000-0002-4410-2047; Turriziani, Patrizia/0000-0003-4802-280X; cipolotti, lisa/0000-0001-5838-3647				Acevedo A, 2007, J GERIATR PSYCH NEUR, V20, P239, DOI 10.1177/0891988707308808; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Bestmann S, 2003, NEUROIMAGE, V20, P1685, DOI 10.1016/j.neuroimage.2003.07.028; Bilek E, 2013, J NEUROSCI, V33, P7050, DOI 10.1523/JNEUROSCI.3081-12.2013; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Boggio PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004959; Boggio PS, 2012, BRAIN STIMUL, V5, P223, DOI 10.1016/j.brs.2011.06.006; Boggio PS, 2011, NEUROPSYCHOL REHABIL, V21, P703, DOI 10.1080/09602011.2011.617943; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Chi RP, 2010, BRAIN RES, V1353, P168, DOI 10.1016/j.brainres.2010.07.062; Cipolotti L, 2008, NEUROPSYCHOLOGIA, V46, P2745, DOI 10.1016/j.neuropsychologia.2008.05.009; Cipolotti L, 2001, NEUROPSYCHOLOGIA, V39, P151, DOI 10.1016/S0028-3932(00)00103-2; Cotelli M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00038; De Neys W, 2008, PSYCHOL SCI, V19, P483, DOI 10.1111/j.1467-9280.2008.02113.x; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Floel A, 2004, CEREB CORTEX, V14, P404, DOI 10.1093/cercor/bhh002; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Hammer A, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-72; Jacobs HIL, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00344; Jacobson TK, 2013, J NEUROPHYSIOL, V109, P1852, DOI 10.1152/jn.00409.2012; Javadi AH, 2013, BRAIN STIMUL, V6, P668, DOI 10.1016/j.brs.2012.10.007; Javadi AH, 2012, BRAIN STIMUL, V5, P468, DOI 10.1016/j.brs.2011.08.003; Javadi AH, 2012, BRAIN STIMUL, V5, P231, DOI 10.1016/j.brs.2011.06.007; Juan CH, 2012, BRAIN STIMUL, V5, P63, DOI 10.1016/j.brs.2012.03.012; Kamida T, 2011, BEHAV BRAIN RES, V217, P99, DOI 10.1016/j.bbr.2010.08.050; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kincses TZ, 2004, NEUROPSYCHOLOGIA, V42, P113, DOI 10.1016/S0028-3932(03)00124-6; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Manenti R, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00049; Manenti R, 2012, BRAIN STIMUL, V5, P103, DOI 10.1016/j.brs.2012.03.004; McDermott KB, 1999, J COGNITIVE NEUROSCI, V11, P631, DOI 10.1162/089892999563698; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Oliveri M, 1999, BRAIN, V122, P1731, DOI 10.1093/brain/122.9.1731; Penolazzi B, 2014, J NEUROSCI, V34, P6606, DOI 10.1523/JNEUROSCI.0349-14.2014; Penolazzi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010623; Pisoni A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123085; Rossi S, 2001, NAT NEUROSCI, V4, P948, DOI 10.1038/nn0901-948; Rounis E, 2006, J NEUROSCI, V26, P9629, DOI 10.1523/JNEUROSCI.2657-06.2006; Sandrini M, 2003, J COGNITIVE NEUROSCI, V15, P855, DOI 10.1162/089892903322370771; Sandrini M, 2013, CURR BIOL, V23, P2181, DOI 10.1016/j.cub.2013.08.045; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Smirni D., 2010, G ITAL PSICOL, V1, P227; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Turriziani P, 2008, BEHAV NEUROL, V19, P23, DOI 10.1155/2008/568057; Turriziani P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00062; Turriziani P, 2010, NEUROIMAGE, V52, P348, DOI 10.1016/j.neuroimage.2010.04.007; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107; Wagner AD, 1998, BRAIN, V121, P1985, DOI 10.1093/brain/121.10.1985; Warrington E.K., 1984, RECOGNITION MEMORY T; Warrington EK, 1996, CAMDEN MEMORY TEST; Wermke M, 2008, EUR J NUCL MED MOL I, V35, pS12, DOI 10.1007/s00259-007-0698-5; Williams JA, 2010, PHYS THER, V90, P398, DOI 10.2522/ptj.20090075; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Zwissler B, 2014, J NEUROSCI, V34, P4022, DOI 10.1523/JNEUROSCI.5407-13.2014	62	36	37	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144838	10.1371/journal.pone.0144838	http://dx.doi.org/10.1371/journal.pone.0144838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679936	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400030
J	Ulfsdotter, M; Lindberg, L; Mansdotter, A				Ulfsdotter, Malin; Lindberg, Lene; Mansdotter, Anna			A Cost-Effectiveness Analysis of the Swedish Universal Parenting Program All Children in Focus	PLOS ONE			English	Article							QUALITY-OF-LIFE; FRIENDLY PILOT VERSION; HEALTH PROMOTION; CONDUCT DISORDER; EQ-5D; PREVENTION; BEHAVIOR; EUROQOL; TRIAL	Objective There are few health economic evaluations of parenting programs with quality-adjusted lifeyears (QALYs) as the outcome measure. The objective of this study was, therefore, to conduct a cost-effectiveness analysis of the universal parenting program All Children in Focus (ABC). The goals were to estimate the costs of program implementation, investigate the health effects of the program, and examine its cost-effectiveness. Methods A cost-effectiveness analysis was conducted. Costs included setup costs and operating costs. A parent proxy Visual Analog Scale was used to measure QALYs in children, whereas the General Health Questionnaire-12 was used for parents. A societal perspective was adopted, and the incremental cost-effectiveness ratio was calculated. To account for uncertainty in the estimate, the probability of cost-effectiveness was investigated, and sensitivity analyses were used to account for the uncertainty in cost data. Results The cost was (sic)326.3 per parent, of which (sic)53.7 represented setup costs under the assumption that group leaders on average run 10 groups, and (sic)272.6 was the operating costs. For health effects, the QALY gain was 0.0042 per child and 0.0027 per parent. These gains resulted in an incremental cost-effectiveness ratio for the base case of (sic)47 290 per gained QALY. The sensitivity analyses resulted in ratios from (sic)41 739 to (sic)55 072. With the common Swedish threshold value of (sic)55 000 per QALY, the probability of the ABC program being cost-effective was 50.8 percent. Conclusion Our analysis of the ABC program demonstrates cost-effectiveness ratios below or just above the QALY threshold in Sweden. However, due to great uncertainty about the data, the health economic rationale for implementation should be further studied considering a longer time perspective, effects on siblings, and validated measuring techniques, before full scale implementation.	[Ulfsdotter, Malin] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lindberg, Lene; Mansdotter, Anna] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Ulfsdotter, M (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	malin.ulfsdotter@ki.se			National Institute of Public Health [HFA 2010/90]	National Institute of Public Health	The trial was funded by the former National Institute of Public Health (today called the Public Health Agency of Sweden), grant number: HFA 2010/90, grant recipient: LL, URL: http://www.folkhalsomyndigheten.se/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002020.pub3; Bonin EM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-803; Brazier John, 2003, Expert Rev Pharmacoecon Outcomes Res, V3, P293, DOI 10.1586/14737167.3.3.293; Briggs A, 1998, HEALTH ECON, V7, P723, DOI 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.3.CO;2-F; BROOKS RG, 1991, HEALTH POLICY, V18, P37, DOI 10.1016/0168-8510(91)90142-K; Brouwer WBF, 1998, INT J TECHNOL ASSESS, V14, P505, DOI 10.1017/S026646230001148X; Burstrom K, 2011, EUR J PUBLIC HEALTH, V21, P178, DOI 10.1093/eurpub/ckq042; Burstrom K, 2011, EUR J PUBLIC HEALTH, V21, P171, DOI 10.1093/eurpub/ckq037; Charles JM, 2011, CHILD CARE HLTH DEV, V37, P462, DOI 10.1111/j.1365-2214.2011.01217.x; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Dretzke J, 2005, HEALTH TECHNOL ASSES, V9, pIII; Dretzke Janine, 2009, Child Adolesc Psychiatry Ment Health, V3, P7, DOI 10.1186/1753-2000-3-7; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Edwards RT, 2007, BRIT MED J, V334, P682, DOI 10.1136/bmj.39126.699421.55; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Fenwick E, 2005, BRIT J PSYCHIAT, V187, P106, DOI 10.1192/bjp.187.2.106; Fenwick E, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-52; Furlong M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008225.pub2; Gerdtham U, 2012, MALMO STAD; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Hagberg Lars Axel, 2010, Cost Eff Resour Alloc, V8, P9, DOI 10.1186/1478-7547-8-9; HATZIANDREU EI, 1988, AM J PUBLIC HEALTH, V78, P1417, DOI 10.2105/AJPH.78.11.1417; Johannesson M, 1991, Scand J Prim Health Care, V9, P155, DOI 10.3109/02813439109018511; Lindberg L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-688; Mihalopoulos C, 2007, AUST NZ J PSYCHIAT, V41, P239, DOI 10.1080/00048670601172723; Muntz Rachel, 2004, J Ment Health Policy Econ, V7, P177; National Institute for Health and Clinical Excellence, 2015, GUIDE TO THE METHODS; O'Neill D, 2013, EUR J HEALTH ECON, V14, P85, DOI 10.1007/s10198-011-0342-y; Parkin D, 2006, HEALTH ECON, V15, P653, DOI 10.1002/hec.1086; Patterson J, 2005, CHILD CARE HLTH DEV, V31, P53, DOI 10.1111/j.1365-2214.2005.00479.x; Piquero AR, 2009, J EXP CRIMINOL, V5, P83, DOI 10.1007/s11292-009-9072-x; Polsky D, 2015, EC EVALUATION CLIN T; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; Sampaio F, 2014, BMC HLTH SERV RES S2, V14, P107; Sendi Pedram, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P1, DOI 10.1586/14737167.4.1.1; Serrano-Aguilar P, 2009, EPIDEMIOL PSICHIAT S, V18, P229, DOI 10.1017/S1121189X00000518; Simkiss DE, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002851; Stevens M, 2014, CHILD FAM SOC WORK, V19, P109, DOI 10.1111/j.1365-2206.2012.00888.x; Sun S, 2012, SCAND J PUBLIC HEALT, V40, P115, DOI 10.1177/1403494811435493; Thorrington D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135672; Torrance GW, 2001, MED DECIS MAKING, V21, P329, DOI 10.1177/02729890122062622; Ulfsdotter M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1083; Ungar W. J., 2010, EC EVALUATION CHILD; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Weare K, 2011, HEALTH PROMOT INT, V26, pI29, DOI 10.1093/heapro/dar075	46	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145201	10.1371/journal.pone.0145201	http://dx.doi.org/10.1371/journal.pone.0145201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JO	26681349	gold, Green Published, Green Submitted			2022-12-27	WOS:000366723400056
J	Chen, T; Lin, JF; Wang, W; Fleming, J; Chen, L; Wang, YX; Li, HC; Guo, HX; Zhou, J; Chen, XX; Chen, YH; Liao, QH; Shu, Y; Tan, YJ; Yu, ML; Li, GZ; Zhou, L; Zhong, Q; Bi, LJ; Guo, LN; Zhao, MG				Chen, Tao; Lin, Jinfei; Wang, Wei; Fleming, Joy; Chen, Liang; Wang, Yunxia; Li, Haicheng; Guo, Huixin; Zhou, Jie; Chen, Xunxun; Chen, Yuhui; Liao, Qinghua; Shu, Yang; Tan, Yaoju; Yu, Meiling; Li, Guozhou; Zhou, Lin; Zhong, Qiu; Bi, Lijun; Guo, Lina; Zhao, Meigui			Cytokine and Antibody Based Diagnostic Algorithms for Sputum Culture-Positive Pulmonary Tuberculosis	PLOS ONE			English	Article							16-KDA MYCOBACTERIAL ANTIGENS; HUMORAL IMMUNE-RESPONSE; LATENT TUBERCULOSIS; EPITHELIAL-CELLS; PROTEIN; IDENTIFICATION; INFECTION; IL-8; SERODIAGNOSIS; RECRUITMENT	Background Tuberculosis (TB) is one of the most serious infectious diseases globally and has high mortality rates. A variety of diagnostic tests are available, yet none are wholly reliable. Serum cytokines, although significantly and frequently induced by different diseases and thus good biomarkers for disease diagnosis and prognosis, are not sufficiently disease-specific. TB-specific antibody detection, on the other hand, has been reported to be highly specific but not sufficiently sensitive. In this study, our aim was to improve the sensitivity and specificity of TB diagnosis by combining detection of TB-related cytokines and TB-specific antibodies in peripheral blood samples. Methods TB-related serum cytokines were screened using a human cytokine array. TB-related cytokines and TB-specific antibodies were detected in parallel with microarray technology. The diagnostic performance of the new protocol for active TB was systematically compared with other traditional methods. Results Here, we show that cytokines I-309, IL-8 and MIG are capable of distinguishing patients with active TB from healthy controls, patients with latent TB infection, and those with a range of other pulmonary diseases, and that these cytokines, and their presence alongside antibodies for TB-specific antigens Ag14-16kDa, Ag32kDa, Ag38kDa and Ag85B, are specific markers for active TB. The diagnostic protocol for active TB developed here, which combines the detection of three TB-related cytokines and TB-specific antibodies, is highly sensitive (91.03%), specific (90.77%) and accurate (90.87%). Conclusions Our results show that combining detection of TB-related cytokines and TB-specific antibodies significantly enhances diagnostic accuracy for active TB, providing greater accuracy than conventional diagnostic methods such as interferon gamma release assays (IGRAs), TB antibody Colloidal Gold Assays and microbiological culture, and suggest that this diagnostic protocol has potential for clinical application.	[Chen, Tao; Lin, Jinfei; Chen, Liang; Li, Haicheng; Guo, Huixin; Chen, Xunxun; Chen, Yuhui; Liao, Qinghua; Shu, Yang; Zhou, Lin; Zhong, Qiu] Ctr TB Control Guangdong Prov, Guangzhou 510630, Guangdong, Peoples R China; [Fleming, Joy; Bi, Lijun] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Wang, Wei; Zhou, Jie] Foshan Fourth Peoples Hosp, Foshan 528000, Peoples R China; [Wang, Yunxia; Zhao, Meigui] Baoan Chron Dis Prevent & Cure Hosp, Shenzhen 518102, Peoples R China; [Tan, Yaoju] Guangzhou Chest Hosp, Guangzhou 510095, Guangdong, Peoples R China; [Yu, Meiling] Chinese Med Hosp Huangpu Dist, Guangzhou 510700, Guangdong, Peoples R China; [Guo, Lina] GuangDong Prov Hosp Chinese Med, Guangzhou 510120, Guangdong, Peoples R China; [Li, Guozhou] Chron Dis Control & Prevent Stn Dongguan, Dongguan 523008, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Guangzhou University of Chinese Medicine	Zhou, L (corresponding author), Ctr TB Control Guangdong Prov, Guangzhou 510630, Guangdong, Peoples R China.	zhoulinpaper@163.com; zhongqiu@vip.163.com; blj@sun5.ibp.ac.cn; guolinapaper@163.com; bazmg@126.com		CHEN, Xunxun/0000-0002-9481-4819	National Science and Technology Key Project [2012ZX10004903, 2013ZX10003001-001-002, 2014ZX10003002-003]	National Science and Technology Key Project	This study was funded by grants from the National Science and Technology Key Project: (2012ZX10004903, 2013ZX10003001-001-002, and 2014ZX10003002-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramo C, 2006, MICROBES INFECT, V8, P45, DOI 10.1016/j.micinf.2005.05.019; Anbarasu D, 2013, CYTOKINE, V61, P747, DOI 10.1016/j.cyto.2012.12.031; Andersson M, 2012, INNATE IMMUN-LONDON, V18, P531, DOI 10.1177/1753425911426591; Anochie Philip Ifesinachi, 2012, Germs, V2, P110, DOI 10.11599/germs.2012.1021; Armand M, 2014, J INFECTION, V68, P62, DOI 10.1016/j.jinf.2013.08.005; Bai XY, 2011, TUBERCULOSIS, V91, P26, DOI 10.1016/j.tube.2010.11.005; Beck ST, 2005, BRAZ J MED BIOL RES, V38, P587, DOI 10.1590/S0100-879X2005000400013; Boggaram V, 2013, J BIOL CHEM, V288, P25500, DOI 10.1074/jbc.M112.448217; Borgstrom E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043438; Campbell IA, 2006, BRIT MED J, V332, P1194, DOI 10.1136/bmj.332.7551.1194; DAS S, 1992, CLIN EXP IMMUNOL, V89, P402; DEBRUYN J, 1990, TROP MED PARASITOL, V41, P331; Demkow U, 2002, INT J TUBERC LUNG D, V6, P1023; Dorman SE, 2010, CLIN INFECT DIS, V50, pS173, DOI 10.1086/651488; Essone PN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102584; Fae KC, 2013, INFLAMMATION, V36, P800, DOI 10.1007/s10753-013-9606-2; Frahm M, 2011, TUBERCULOSIS, V91, P250, DOI 10.1016/j.tube.2011.02.006; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Greco S, 2006, THORAX, V61, P783, DOI 10.1136/thx.2005.054908; Guerra-Laso JM, 2015, IMMUNOLOGY, V144, P291, DOI 10.1111/imm.12371; He Xiu-yun, 2009, Zhonghua Jie He He Hu Xi Za Zhi, V32, P581; He Xiuyun, 2000, Zhonghua Jiehe He Huxi Zazhi, V23, P485; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Houghton RL, 2002, CLIN DIAGN LAB IMMUN, V9, P883, DOI 10.1128/CDLI.9.4.883-891.2002; Hur YG, 2014, CLIN VACCINE IMMUNOL, V21, P133, DOI 10.1128/CVI.00620-13; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; Kunduracioglu A, 2013, MIKROBIYOL BUL, V47, P417; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Lalvani A, 2010, BRIT MED BULL, V93, P69, DOI 10.1093/bmb/ldp039; Lange C, 2010, RESPIROLOGY, V15, P220, DOI 10.1111/j.1440-1843.2009.01692.x; Lee JS, 2008, RESPIROLOGY, V13, P432, DOI 10.1111/j.1440-1843.2008.01243.x; LEE KS, 1995, AM J ROENTGENOL, V164, P1361, DOI 10.2214/ajr.164.6.7754873; Lyashchenko K, 1998, INFECT IMMUN, V66, P3936, DOI 10.1128/IAI.66.8.3936-3940.1998; Nabeshima Shigeki, 2005, Journal of Infection and Chemotherapy, V11, P256, DOI 10.1007/s10156-005-0398-7; Pai Madhukar, 2013, J Indian Med Assoc, V111, P332; Phunpae P, 2014, DIAGN MICR INFEC DIS, V78, P242, DOI 10.1016/j.diagmicrobio.2013.11.028; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Raja A, 2008, DIAGN MICR INFEC DIS, V60, P361, DOI 10.1016/j.diagmicrobio.2007.11.006; Samanich KM, 1998, J INFECT DIS, V178, P1534, DOI 10.1086/314438; SCHOREY JS, 1995, INFECT IMMUN, V63, P2652, DOI 10.1128/IAI.63.7.2652-2657.1995; Senol G, 2009, PEDIATR PULM, V44, P839, DOI 10.1002/ppul.20901; Shalit I, 2006, J ANTIMICROB CHEMOTH, V57, P230, DOI 10.1093/jac/dki441; Siddiqui KF, 2011, CRIT REV MICROBIOL, V37, P349, DOI 10.3109/1040841X.2011.606425; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; Tsujimura Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106807; Venkataraman P, 1998, INDIAN J MED RES, V108, P120; Wang XJ, 2012, TUBERCULOSIS, V92, P513, DOI 10.1016/j.tube.2012.06.005; Weldingh K, 2005, J CLIN MICROBIOL, V43, P57, DOI 10.1128/JCM.43.1.57-65.2005; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992; Wu XQ, 2010, CLIN CHIM ACTA, V411, P1520, DOI 10.1016/j.cca.2010.06.014; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	52	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144705	10.1371/journal.pone.0144705	http://dx.doi.org/10.1371/journal.pone.0144705			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674517	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700054
J	Zhang, ZR; Yu, H; Jiang, SS; Liao, JM; Lu, TL; Wang, LF; Zhang, D; Yue, WH				Zhang, Zhengrong; Yu, Hao; Jiang, Sisi; Liao, Jinmin; Lu, Tianlan; Wang, Lifang; Zhang, Dai; Yue, Weihua			Evidence for Association of Cell Adhesion Molecules Pathway and NLGN1 Polymorphisms with Schizophrenia in Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; BIPOLAR DISORDER; NEUROLIGIN 1; HUMAN BRAIN; RISK; METAANALYSIS; IDENTIFICATION; PSYCHOSIS; SYNAPSES	Multiple risk variants of schizophrenia have been identified by Genome-wide association studies (GWAS). As a complement for GWAS, previous pathway-based analysis has indicated that cell adhesion molecules (CAMs) pathway might be involved in the pathogenesis of schizophrenia. However, less replication studies have been reported. Our objective was to investigate the association between CAMs pathway and schizophrenia in the Chinese Han population. We first performed a pathway analysis utilizing our previous GWAS data. The CAMs pathway (hsa04514) was significantly associated with schizophrenia using hybrid gene set-based test (P = 1.03x10(-10)) and hypergeometric test (P = 5.04x10(-6)). Moreover, 12 genes (HLA-A, HLA-C, HLA-DOB, HLA-DPB1, HLA-DQA2, HLA-DRB1, MPZ, CD276, NLGN1, NRCAM, CLDN1 and ICAM3) were modestly significantly associated with schizophrenia (P<0.01). Then, we selected one promising gene neuroligin 1 (NLGN1) to further investigate the association between eight significant SNPs and schizophrenia in an independent sample (1814 schizophrenia cases and 1487 healthy controls). Our study showed that seven SNPs of NLGN1 and two haplotype blocks were significantly associated with schizophrenia. This association was confirmed by the results of combined analysis. Among them, SNP rs9835385 had the most significant association with schizophrenia (P = 2.83x10(-7)). Furthermore, in silico analysis we demonstrated that NLGN1 is preferentially expressed in human brain and SNP rs1488547 was related to the expression level. We validated the association of CAMs pathway with schizophrenia in pathway-level and identified one susceptibility gene NLGN1. Further investigation of the roles of CAMs pathway in the pathogenesis of schizophrenia is warranted.	[Zhang, Zhengrong; Jiang, Sisi; Liao, Jinmin; Lu, Tianlan; Wang, Lifang; Zhang, Dai; Yue, Weihua] Peking Univ, Inst Mental Hlth, Hosp 6, Beijing 100871, Peoples R China; [Zhang, Zhengrong; Jiang, Sisi; Liao, Jinmin; Lu, Tianlan; Wang, Lifang; Zhang, Dai; Yue, Weihua] Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing 100871, Peoples R China; [Zhang, Zhengrong; Jiang, Sisi; Liao, Jinmin; Lu, Tianlan; Wang, Lifang; Zhang, Dai; Yue, Weihua] Peking Univ, Natl Clin Res Ctr Mental Disorders, Beijing 100871, Peoples R China; [Yu, Hao] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Yu, Hao; Zhang, Dai] Tsinghua Univ Peking Univ Joint Ctr Life Sci, Beijing, Peoples R China; [Zhang, Dai] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Tsinghua University; Peking University	Zhang, D (corresponding author), Peking Univ, Inst Mental Hlth, Hosp 6, Beijing 100871, Peoples R China.	daizhang@bjmu.edu.cn; dryue@bjmu.edu.cn	Yu, Hao/GYD-8698-2022	Yu, Hao/0000-0002-9785-8489	National Key Technology R&D Program of China [2015BAI13B01]; National Natural Science Foundation of China [81222017, 91232305, 81361120395, 81221002]; Program for New Century Excellent Talents in University [NCET-120008]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Key Technology R&D Program of China (2015BAI13B01), National Natural Science Foundation of China (81222017, 91232305, 81361120395, and 81221002), Program for New Century Excellent Talents in University (NCET-120008).; We extend our gratitude to all subjects who participated in this study. This work was supported by grants from the National Natural Science Foundation of China (81222017, 91232305, 81361120395, and 81221002), National Key Technology R&D Program of China (2015BAI13B01), and Program for New Century Excellent Talents in University (NCET-120008).	Aberg KA, 2013, JAMA PSYCHIAT, V70, P573, DOI 10.1001/jamapsychiatry.2013.288; ANDREASEN NC, 1995, LANCET, V346, P477, DOI 10.1016/S0140-6736(95)91325-4; Andreassen O. A, 2014, MOL PSYCHIAT; Askland K, 2012, HUM GENET, V131, P373, DOI 10.1007/s00439-011-1082-x; Bacanu SA, 2014, MOL PSYCHIATR, V19, P276, DOI 10.1038/mp.2013.33; Benita Y, 2010, BLOOD, V115, P5376, DOI 10.1182/blood-2010-01-263855; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bray NJ, 2008, SCHIZOPHRENIA BULL, V34, P412, DOI 10.1093/schbul/sbn013; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Bundy H, 2011, ACTA PSYCHIAT SCAND, V123, P98, DOI 10.1111/j.1600-0447.2010.01623.x; Choi YB, 2011, NEURON, V70, P468, DOI 10.1016/j.neuron.2011.03.020; Corvin A, 2014, BIOL PSYCHIAT, V75, P276, DOI 10.1016/j.biopsych.2013.09.018; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Eaton WW, 2006, AM J PSYCHIAT, V163, P521, DOI 10.1176/appi.ajp.163.3.521; Elangbam CS, 1997, VET PATHOL, V34, P61, DOI 10.1177/030098589703400113; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Giusti-Rodriguez P, 2013, J CLIN INVEST, V123, P4557, DOI 10.1172/JCI66031; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hargreaves A, 2014, PSYCHOL MED, V44, P2177, DOI 10.1017/S0033291713002663; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Honer WG, 1997, NEUROSCIENCE, V78, P99, DOI 10.1016/S0306-4522(96)00489-7; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Lewis CM, 2010, AM J PSYCHIAT; Li MX, 2012, AM J HUM GENET, V91, P478, DOI 10.1016/j.ajhg.2012.08.004; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Mighdoll MI, 2015, SCHIZOPHR RES, V161, P85, DOI 10.1016/j.schres.2014.09.040; Millson A, 2012, AM J MED GENET A, V158A, P159, DOI 10.1002/ajmg.a.34349; Mowry BJ, 2013, MOL PSYCHIATR, V18, P38, DOI 10.1038/mp.2012.34; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Reissner C, 2008, P NATL ACAD SCI USA, V105, P15124, DOI 10.1073/pnas.0801639105; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Sakurai T, 2012, MOL CELL NEUROSCI, V49, P351, DOI 10.1016/j.mcn.2011.12.002; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Singh S, 2014, GENE, V535, P97, DOI 10.1016/j.gene.2013.09.110; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Sun CC, 2011, HUM MOL GENET, V20, P3042, DOI 10.1093/hmg/ddr208; Sun YV, 2012, HUM GENET, V131, P1677, DOI 10.1007/s00439-012-1198-7; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Vawter MP, 1999, MOL PSYCHIATR, V4, P467, DOI 10.1038/sj.mp.4000547; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wright JW, 2002, PEPTIDES, V23, P221, DOI 10.1016/S0196-9781(01)00599-X; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yang XF, 2014, PROTEIN CELL, V5, P420, DOI 10.1007/s13238-014-0054-z; Yu H, 2014, PROG NEURO-PSYCHOPH, V51, P140, DOI 10.1016/j.pnpbp.2014.01.006; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Yue WH, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-7; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	58	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144719	10.1371/journal.pone.0144719	http://dx.doi.org/10.1371/journal.pone.0144719			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674772	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700056
J	Wagner, RG; Ibinda, F; Tollman, S; Lindholm, L; Newton, CR; Bertram, MY				Wagner, Ryan G.; Ibinda, Fredrick; Tollman, Stephen; Lindholm, Lars; Newton, Charles R.; Bertram, Melanie Y.			Differing Methods and Definitions Influence DALY estimates: Using Population-Based Data to Calculate the Burden of Convulsive Epilepsy in Rural South Africa	PLOS ONE			English	Article							ADJUSTED LIFE YEARS; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; COST-EFFECTIVENESS; MEASURING HEALTH; DISABILITY; DISEASE; PREVALENCE; MORTALITY; INJURIES	Background The disability adjusted life year (DALY) is a composite measure of disease burden that includes both morbidity and mortality, and is relevant to conditions such as epilepsy that can limit productive functioning. The 2010 Global Burden of Disease (GBD) study introduced a number of new methods and definitions, including a prevalence-based approach and revised disability weights to calculate morbidity and new standard life expectancies to calculate premature mortality. We used these approaches, and local, population-based data, to estimate the burden of convulsive epilepsy in rural South Africa. Methods & Findings Comprehensive prevalence, incidence and mortality data on convulsive epilepsy were collected within the Agincourt sub-district in rural northeastern South Africa between 2008 and 2012. We estimated DALYs using both prevalence- and incidence-based approaches for calculating years of life lived with disability. Additionally, we explored how changing the disease model by varying the disability weights influenced DALY estimates. Using the prevalence- based approach, convulsive epilepsy in Agincourt resulted in 332 DALYs (95% uncertainty interval (UI): 216-455) and 4.1 DALYs per 1,000 individuals (95% UI: 2.7-5.7) annually. Of this, 26% was due to morbidity while 74% was due to premature mortality. DALYs increased by 10% when using the incidence-based method. Varying the disability weight from 0.072 (treated epilepsy, seizure free) to 0.657 (severe epilepsy) caused years lived with disability to increase from 18 (95%UI: 16-19) to 161 (95%UI: 143-170). Conclusions DALY estimates are influenced by both the methods applied and population parameters used in the calculation. Irrespective of method, a significant burden of epilepsy is due to premature mortality in rural South Africa, with a lower burden than rural Kenya. Researchers and national policymakers should carefully interrogate the methods and data used to calculate DALYs as this will influence policy priorities and resource allocation.	[Wagner, Ryan G.; Ibinda, Fredrick; Tollman, Stephen; Newton, Charles R.] INDEPTH Network, Studies Epidemiol Epilepsy Demog Surveillance Sys, Accra, Ghana; [Wagner, Ryan G.; Tollman, Stephen] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Wagner, Ryan G.; Tollman, Stephen; Lindholm, Lars] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, Umea, Sweden; [Ibinda, Fredrick; Newton, Charles R.] Ctr Geog Med Res Coast, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Newton, Charles R.] UCL, Inst Child Hlth, Neurosci Unit, London, England; [Newton, Charles R.] Univ Oxford, Dept Psychiat, Oxford, England; [Bertram, Melanie Y.] WHO, CH-1211 Geneva, Switzerland	INDEPTH Network; University of Witwatersrand; Umea University; University of London; University College London; University of Oxford; World Health Organization	Wagner, RG (corresponding author), INDEPTH Network, Studies Epidemiol Epilepsy Demog Surveillance Sys, Accra, Ghana.	Ryan.wagner@wits.ac.za	Newton, Charles RJC/B-7578-2014; Wagner, Ryan G/AFK-7323-2022	Newton, Charles RJC/0000-0002-6999-5507; Wagner, Ryan G/0000-0003-2741-3676; Tollman, Stephen/0000-0003-0744-7588	EU Marie-Curie International Research Staff Exchange Scheme [295168]; Wellcome Trust, UK [083744, 058893/Z/99/A, 069683/Z/02/Z, 085477/Z/08/Z]; University of the Witwatersrand; South African Medical Research Council; National Institute on Aging (NIA) of the National Institutes of Health (NIH)	EU Marie-Curie International Research Staff Exchange Scheme; Wellcome Trust, UK(Wellcome Trust); University of the Witwatersrand; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute on Aging (NIA) of the National Institutes of Health (NIH)	RGW gratefully acknowledges the EU Marie-Curie International Research Staff Exchange Scheme (http://ec.europa.eu/research/mariecurieactions/about-mca/actions/irses/index_en.htm) (grant no. 295168) that allowed him to undertake this work. CRN is funded by the Wellcome Trust, UK (083744)(www.wellcome.ac.uk). The Agincourt HDSS is funded by the Wellcome Trust, UK (grants 058893/Z/99/A; 069683/Z/02/Z; 085477/Z/08/Z), with important contributions from the University of the Witwatersrand, the South African Medical Research Council, and National Institute on Aging (NIA) of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO JM, 1992, BIOMETRICS, V48, P587, DOI 10.2307/2532312; Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; Arnesen T, 2000, LEPROSY REV, V71, P123; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Bharucha N, 2008, EPILEPSY COMPREHENSI, P89; Canty A, 1997, BOOTSTRAP R S PLUS F; Chisholm D, 2005, EPILEPSIA, V46, P751, DOI 10.1111/j.1528-1167.2005.52704.x; COCKERELL OC, 1995, J NEUROL NEUROSUR PS, V58, P570, DOI 10.1136/jnnp.58.5.570; Davison AC, 1997, BOOTSTRAP METHODS TH; de Boer HM, 2008, EPILEPSY BEHAV, V12, P540, DOI 10.1016/j.yebeh.2007.12.019; Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P571, DOI 10.1007/s00038-014-0553-y; Ding D, 2006, EPILEPSIA, V47, P2032, DOI 10.1111/j.1528-1167.2006.00802.x; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Grosse SD, 2009, PUBLIC HEALTH REP, V124, P197, DOI 10.1177/003335490912400206; Ibinda F, 2014, EPILEPSIA, V55, P1626, DOI 10.1111/epi.12741; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; KLEINMAN A, 1995, SOC SCI MED, V40, P1319, DOI 10.1016/0277-9536(94)00254-Q; Langfitt J, 2002, EPILEPSIA, V43, P17, DOI 10.1046/j.1528-1157.43.s.4.4.x; Leonardi M, 2002, EPILEPSIA, V43, P21, DOI 10.1046/j.1528-1157.43.s.6.11.x; Lhatoo SD, 2005, EPILEPSIA, V46, P36, DOI 10.1111/j.1528-1167.2005.00406.x; Mbuba CK, 2008, EPILEPSIA, V49, P1491, DOI 10.1111/j.1528-1167.2008.01693.x; Mont D, 2007, LANCET, V369, P1658, DOI 10.1016/S0140-6736(07)60752-1; Murray C, 1994, B WORLD HEALTH ORGAN, V72; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Ngugi AK, 2013, LANCET NEUROL, V4422, P1; Ngugi AK, 2014, NEUROLOGY, V82, P582, DOI 10.1212/WNL.0000000000000123; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Reidpath DD, 2003, HEALTH POLICY PLANN, V18, P351, DOI 10.1093/heapol/czg043; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Schroeder SA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-19; The R Development Core Team, 2008, R LANGUAGE ENV STAT, P1; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wagner RG, 2009, PARASITE IMMUNOL, V31, P697, DOI 10.1111/j.1365-3024.2009.01128.x; Wagner RG, 2015, PLOS ONE, DOI [10.1371/jounal.pone.0129097, DOI 10.1371/J0URNAL.P0NE.0129097]; Wagner RG, 2014, EPILEPSY RES, V108, P782, DOI 10.1016/j.eplepsyres.2014.01.004	41	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145300	10.1371/journal.pone.0145300	http://dx.doi.org/10.1371/journal.pone.0145300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26697856	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600060
J	Zhou, X; Peng, W; Xu, Z; Yang, B				Zhou, Xing; Peng, Wei; Xu, Zhen; Yang, Bo			Hardness Analysis and Empirical Studies of the Relations among Robustness, Topology and Flow in Dynamic Networks	PLOS ONE			English	Article							ATTACK TOLERANCE; NODES; ERROR	Network robustness is the ability of a network to maintain performance after disruption, thus it is an important index for network designers to refer to. Every actual network has its own topology structure, flow magnitude (scale) and flow distribution. How the robustness relates to these factors still remains unresolved. To analyze the relations, we first established a robustness problem model, studied the hardness of a special case of the model, and generated a lot of representative network instances. We conducted experiments on these instances, deleting 5% to 50% edges on each instance and found that the robustness of a network has an approximate linearity to its structural entropy and flow entropy, when the correlation coefficient between the structure and flow is fixed. We also found that robustness is unlikely to have a relation to the flow scale and edge scale in our model. The empirical studies thus can provide a way of quickly estimating the robustness of real-world networks by using the regression coefficients we obtained during the experiments. We conducted computation on a real-world dataset and got favorable results, which exhibited the effectiveness of the estimation.	[Zhou, Xing; Peng, Wei; Xu, Zhen; Yang, Bo] Natl Univ Def Technol, Natl Lab Parallel & Distributed Proc, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Zhou, X (corresponding author), Natl Univ Def Technol, Natl Lab Parallel & Distributed Proc, Changsha, Hunan, Peoples R China.	zhouxing@nudt.edu.cn	zhou, xt/GWZ-9212-2022		 [61272010];  [61271252]	; 	This work was supported by 61272010, 61271252, http://www.nsfc.gov.cn/publish/portal1/, WP, a research project of NUDT, www.nudt.edu.cn, WP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Arulselvan A, 2009, COMPUT OPER RES, V36, P2193, DOI 10.1016/j.cor.2008.08.016; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Chen ZQ, 2015, APPL MATH COMPUT, V265, P983, DOI 10.1016/j.amc.2015.06.003; Chen ZQ, 2015, ENTROPY-SWITZ, V17, P3710, DOI 10.3390/e17063710; Chen ZQ, 2014, ENTROPY-SWITZ, V16, P5416, DOI 10.3390/e16105416; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Cohen R., 2010, COMPLEX NETWORKS STR; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; Du D.-Z., 2011, DESIGN ANAL APPROXIM, V62; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Gomory R.E., 1958, B AM MATH SOC, V64, P275, DOI DOI 10.1090/S0002-9904-1958-10224-4; Gurobi Optimization I, 2015, GUR OPT REF MAN; Herrmann HJ, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01027; Li RQ, 2015, CHAOS SOLITON FRACT, V80, P109, DOI 10.1016/j.chaos.2015.06.022; Matisziw TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039788; Myung YS, 2004, EUR J OPER RES, V156, P579, DOI 10.1016/S0377-2217(03)00135-8; Shen YL, 2013, IEEE ACM T NETWORK, V21, P963, DOI 10.1109/TNET.2012.2215882; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Sun S, 2007, PHYSICA A, V373, P851, DOI 10.1016/j.physa.2006.05.049; Sun SW, 2015, APPL MATH COMPUT, V252, P249, DOI 10.1016/j.amc.2014.12.044; Tanizawa T, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046109; Valente A, 2004, PHYS REV A, V92; Walteros Jose L., 2012, Experimental Algorithms. Proceedings 11th International Symposium, SEA 2012, P393, DOI 10.1007/978-3-642-30850-5_34; Walteros JL., 2012, APPL MATH INFORMATIC, Vvol 71, P9; Wu J., 2008, UNIFYING THEMES COMP, P66; Wu J, 2010, CHINESE PHYS LETT, V27, DOI 10.1088/0256-307X/27/7/078902; Wu ZX, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026106; Yuan X, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032122; Zeng A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066130	30	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145421	10.1371/journal.pone.0145421	http://dx.doi.org/10.1371/journal.pone.0145421			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695517	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500045
J	Gu, CG; Xu, JS; Rohling, J; Yang, HJ; Liu, ZH				Gu, Changgui; Xu, Jinshan; Rohling, Jos; Yang, Huijie; Liu, Zonghua			Noise Induces Oscillation and Synchronization of the Circadian Neurons	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; DIM LIGHT; CLOCK; RHYTHMS; MECHANISM; ILLUMINATION; NETWORK; PERIOD; NIGHT; CYCLE	The principle clock of mammals, named suprachiasmatic nucleus (SCN), coordinates the circadian rhythms of behavioral and physiological activity to the external 24 h light-dark cycle. In the absence of the daily cycle, the SCN acts as an endogenous clock that regulates the similar to 24h rhythm of activity. Experimental and theoretical studies usually take the light-dark cycle as a main external influence, and often ignore light pollution as an external influence. However, in modern society, the light pollution such as induced by electrical lighting influences the circadian clock. In the present study, we examined the effect of external noise (light pollution) on the collective behavior of coupled circadian oscillators under constant darkness using a Goodwin model. We found that the external noise plays distinct roles in the network behavior of neurons for weak or strong coupling between the neurons. In the case of strong coupling, the noise reduces the synchronization and the period of the SCN network. Interestingly, in the case of weak coupling, the noise induces a circadian rhythm in the SCN network which is absent in noise-free condition. In addition, the noise increases the synchronization and decreases the period of the SCN network. Our findings may shed new light on the impact of the external noise on the collective behavior of SCN neurons.	[Gu, Changgui; Yang, Huijie] Univ Shanghai Sci & Technol, Sch Business, Shanghai, Peoples R China; [Xu, Jinshan] Zhejiang Univ Technol, Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Rohling, Jos] Leiden Univ, Med Ctr, Neurophysiol Lab, Dept Mol Cell Biol, Leiden, Netherlands; [Liu, Zonghua] E China Normal Univ, Dept Phys, Shanghai 200062, Peoples R China	University of Shanghai for Science & Technology; Zhejiang University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; East China Normal University	Gu, CG (corresponding author), Univ Shanghai Sci & Technol, Sch Business, Shanghai, Peoples R China.	gu_changgui@163.com	Rohling, Jos/AAC-3516-2022	Rohling, Jos H T/0000-0001-5721-2715	Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning [QD2015016]; National Science Foundation of China [11505114, 11405145]; Natural Science Foundation of Zhejiang Province [LQ14A050002]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, National Science Foundation of China [10975099]; innovation Program of Shanghai Municipal Education Commission [13YZ072]	Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, National Science Foundation of China; innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	CG is supported by The Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (QD2015016) [http://www.shmec.gov.cn/] and National Science Foundation of China (11505114) [http://www.nsfc.gov.cn/]. JX is supported by Natural Science Foundation of Zhejiang Province (LQ14A050002) [http://www.zjnsf.gov.cn/] and National Science Foundation of China (11405145) [http://www.nsfc.gov.cn/]. HY is supported by The Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning [http://www.shmec.gov.cn/], National Science Foundation of China (10975099) [http://www.nsfc.gov.cn/] and the innovation Program of Shanghai Municipal Education Commission under Grant No. 13YZ072.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Bernard S, 2007, PLOS COMPUT BIOL, V3, P667, DOI 10.1371/journal.pcbi.0030068; CAMPBELL SS, 1993, SLEEP, V16, P638; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; DORRSCHEIDT GJ, 1975, J MATH BIOL, V2, P107; Evans JA, 2009, CURR BIOL, V19, pR156, DOI 10.1016/j.cub.2009.01.023; Farajnia S, 2012, J NEUROSCI, V32, P5891, DOI 10.1523/JNEUROSCI.0469-12.2012; Fonken LK, 2013, J BIOL RHYTHM, V28, P262, DOI 10.1177/0748730413493862; Gorman MR, 2006, CHRONOBIOL INT, V23, P245, DOI 10.1080/07420520500521905; Gu CG, 2014, J BIOL RHYTHM, V29, P16, DOI 10.1177/0748730413516752; Gu CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036900; Gu CG, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046224; Gu CG, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.030904; Guckenheimer J., 1983, NONLINEAR OSCILLATOR; Halberg F., 1990, CYCLES NATURE INTRO; HERZEL H, 1995, PHYS REV E, V52, P3238, DOI 10.1103/PhysRevE.52.3238; Hirota T, 2004, ZOOL SCI, V21, P359, DOI 10.2108/zsj.21.359; Honma S, 2004, NEUROSCI LETT, V358, P173, DOI 10.1016/j.neulet.2004.01.022; Kloeden P. E., 1992, APPL MATH NEW YORK, V23, DOI [10.1007/978-3-662-12616-5, DOI 10.1007/978-3-662-12616-5]; Ko CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000513; Liang XM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031916; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Locke JCW, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-22; Middleton B, 1996, J SLEEP RES, V5, P69, DOI 10.1046/j.1365-2869.1996.d01-67.x; Ruoff P, 1999, J BIOL RHYTHM, V14, P469, DOI 10.1177/074873099129001037; Ueda HR, 2002, J THEOR BIOL, V216, P501, DOI 10.1006/jtbi.2002.3000; Ullner E, 2009, BIOPHYS J, V96, P3573, DOI 10.1016/j.bpj.2009.02.031; Vansteensel MJ, 2003, CURR BIOL, V13, P1538, DOI 10.1016/S0960-9822(03)00560-8; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Xu JS, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041903; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yi M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.012902	34	17	17	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145360	10.1371/journal.pone.0145360	http://dx.doi.org/10.1371/journal.pone.0145360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691765	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092300062
J	Mahmood, A; Pulakat, L				Mahmood, Abuzar; Pulakat, Lakshmi			Differential Effects of beta-Blockers, Angiotensin II Receptor Blockers, and a Novel AT2R Agonist NP-6A4 on Stress Response of Nutrient-Starved Cardiovascular Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; REAL-TIME; CARDIOMYOCYTE APOPTOSIS; MYOCARDIAL-INFARCTION; LABEL-FREE; HEART; MECHANISMS; INHIBITION; NEBIVOLOL; AUTOPHAGY	In order to determine differences in cardiovascular cell response during nutrient stress to different cardiovascular protective drugs, we investigated cell responses of serum starved mouse cardiomyocyte HL-1 cells and primary cultures of human coronary artery vascular smooth muscles (hCAVSMCs) to treatment with beta-blockers (atenolol, metoprolol, carvedilol, nebivolol, 3 mu M each), AT1R blocker losartan (1 mu M) and AT2R agonists (CGP42112A and novel agonist NP-6A4, 300nM each). Treatment with nebivolol, carvedilol, metoprolol and atenolol suppressed Cell Index (CI) of serum-starved HL-1 cells (<= 17%, <= 8%, <= 15% and <= 15% respectively) as measured by the Xcelligence Real-Time Cell Analyzer (RTCA). Conversely, CI was increased by Ang II (>= 9.6%), CGP42112A (>= 14%), and NP-6A4 (>= 25%) respectively and this effect was blocked by AT2R antagonist PD123319, but not by AT1R antagonist losartan. Thus, the CI signature for each drug could be unique. MTS cell proliferation assay showed that NP-6A4, but not other drugs, increased viability (>= 20%) of HL-1 and hCAVSMCs. Wheat Germ Agglutinin (WGA) staining showed that nebivolol was most effective in reducing cell sizes of HL-1 and hCAVSMCs. Myeloid Cell Leukemia 1 (MCL-1) is a protein critical for cardiovascular cell survival and implicated in cell adhesion. beta-blockers significantly suppressed and NP-6A4 increased MCL-1 expression in HL-1 and hCAVSMCs as determined by immunofluorescence. Thus, reduction in cell size and/or MCL-1 expression might underlie beta-blocker-induced reduction in CI of HL-1. Conversely, increase in cell viability and MCL-1 expression by NP-6A4 through AT2R could have resulted in NP-6A4 mediated increase in CI of HL-1. These data show for the first time that activation of the AT2R-MCL-1 axis by NP-6A4 in nutrient-stressed mouse and human cardiovascular cells (mouse HL-1 cells and primary cultures of hCAVSMCs) might underlie improved survival of cells treated by NP-6A4 compared to other drugs tested in this study.	[Mahmood, Abuzar; Pulakat, Lakshmi] Univ Missouri, Dept Med, Columbia, MO 65211 USA; [Pulakat, Lakshmi] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA; [Mahmood, Abuzar; Pulakat, Lakshmi] Harry S Truman Mem Vet Affairs Hosp, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital	Pulakat, L (corresponding author), Univ Missouri, Dept Med, Columbia, MO 65211 USA.	pulakatl@health.missouri.edu			Life Science Mission Enhancement Fund from UM-Columbia; NIH NHLBI [1R01HL118376-01]; Novopyxis; Missouri Foundation for Veteran's Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118376] Funding Source: NIH RePORTER	Life Science Mission Enhancement Fund from UM-Columbia; NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Novopyxis; Missouri Foundation for Veteran's Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by the Life Science Mission Enhancement Fund from UM-Columbia (LP), as well as research grants from NIH NHLBI 1R01HL118376-01 (LP), Novopyxis (LP) and Missouri Foundation for Veteran's Medical Research (LP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2013, CARDIOVASC DRUG THER, V27, P155, DOI 10.1007/s10557-012-6392-2; Altarche-Xifro W, 2009, STEM CELLS, V27, P2488, DOI 10.1002/stem.171; Amann U, 2014, CLIN RES CARDIOL, V103, P655, DOI 10.1007/s00392-014-0688-0; [Anonymous], 2015, LEAD CAUS DEATH; Arnold N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103284; Badalzadeh R, 2015, J PHYSIOL SCI, V65, P201, DOI 10.1007/s12576-015-0365-8; Blessberger H, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004476.pub2, 10.1002/14651858.CD004476.pub3]; Brunt KR, 2009, EXP BIOL MED, V234, P582, DOI 10.3181/0810-RM-312; Erickson CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071980; Falcon BL, 2005, HYPERTENSION, V45, P692, DOI 10.1161/01.HYP.0000154254.89733.29; Gatica D, 2015, CIRC RES, V116, P456, DOI 10.1161/CIRCRESAHA.114.303788; Grimm Christine, 2010, GMS Health Technol Assess, V6, pDoc03, DOI 10.3205/hta000081; Gul R, 2015, OBESITY, V23, P2251, DOI 10.1002/oby.21227; Gul R, 2012, CARDIORENAL MED, V2, P268, DOI 10.1159/000343456; Gul R, 2012, CARDIORENAL MED, V2, P225, DOI 10.1159/000339565; Gupta S, 2008, CARDIOVASC THER, V26, P189, DOI 10.1111/j.1755-5922.2008.00054.x; Hashem SI, 2015, STEM CELLS, V33, P2343, DOI 10.1002/stem.2015; Ibe JCF, 2013, AM J RESP CELL MOL, V49, P609, DOI 10.1165/rcmb.2012-0446OC; Kajstura J, 1997, J MOL CELL CARDIOL, V29, P859, DOI 10.1006/jmcc.1996.0333; Ke N, 2015, METHODS MOL BIOL, V1272, P215, DOI 10.1007/978-1-4939-2336-6_15; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Keating GM, 2003, DRUGS, V63, P1697, DOI 10.2165/00003495-200363160-00006; Knowle D, 2001, PEPTIDES, V22, P2145, DOI 10.1016/S0196-9781(01)00553-8; Kumar V, 2002, FEBS LETT, V532, P379, DOI 10.1016/S0014-5793(02)03713-4; Ladage D, 2010, J CARDIOVASC PHARM, V56, P275, DOI 10.1097/FJC.0b013e3181eb4ff2; Ludwig M, 2012, CAN J PHYSIOL PHARM, V90, P287, DOI [10.1139/Y11-108, 10.1139/y11-108]; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Mangat R, 2006, AM J PHYSIOL-HEART C, V291, pH854, DOI 10.1152/ajpheart.01205.2005; Ong SB, 2015, J MOL CELL CARDIOL, V78, P23, DOI 10.1016/j.yjmcc.2014.11.005; Parenti A, 2000, J PHARMACOL EXP THER, V292, P698; Perciavalle RM, 2012, NAT CELL BIOL, V14, P575, DOI 10.1038/ncb2488; Pulakat L, 2002, FEBS LETT, V524, P73, DOI 10.1016/S0014-5793(02)03005-3; Ramis G, 2013, BIOMED MICRODEVICES, V15, P985, DOI 10.1007/s10544-013-9790-8; Rinkenberger JL, 2000, GENE DEV, V14, P23; Sato M, 2000, CIRCULATION, V102, P346; Solaini G, 2010, BBA-BIOENERGETICS, V1797, P1171, DOI 10.1016/j.bbabio.2010.02.011; Strauss MH, 2006, CIRCULATION, V114, P838, DOI 10.1161/CIRCULATIONAHA.105.594986; Su Q, 2013, EXP CLIN CARDIOL, V18, P161; Sugino H, 2001, HYPERTENSION, V37, P1394, DOI 10.1161/01.HYP.37.6.1394; Thomas RL, 2013, GENE DEV, V27, P1365, DOI 10.1101/gad.215871.113; Thompson PL, 2013, CURR OPIN CARDIOL, V28, P399, DOI 10.1097/HCO.0b013e328361e97a; Troncoso R, 2012, CARDIOVASC RES, V93, P320, DOI 10.1093/cvr/cvr321; Vardeny O, 2011, AM J CARDIOL, V107, P1705, DOI 10.1016/j.amjcard.2011.01.064; Wang X, 2013, GENE DEV, V27, P1351, DOI 10.1101/gad.215855.113; Wang YY, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0820-1; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; World Health Organization, 2014, TOP 10 CAUS DEATH; Xiao L, 2013, AM J PHYSIOL-CELL PH, V304, pC1073, DOI 10.1152/ajpcell.00364.2012; Yang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085785; Zhang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098179	50	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144824	10.1371/journal.pone.0144824	http://dx.doi.org/10.1371/journal.pone.0144824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691397	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092300020
J	Sisler, JD; Morgan, M; Raje, V; Grande, RC; Derecka, M; Meier, J; Cantwell, M; Szczepanek, K; Korzun, WJ; Lesnefsky, EJ; Harris, TE; Croniger, CM; Larner, AC				Sisler, Jennifer D.; Morgan, Magdalena; Raje, Vidisha; Grande, Rebecca C.; Derecka, Marta; Meier, Jeremy; Cantwell, Marc; Szczepanek, Karol; Korzun, William J.; Lesnefsky, Edward J.; Harris, Thurl E.; Croniger, Colleen M.; Larner, Andrew C.			The Signal Transducer and Activator of Transcription 1 (STAT1) Inhibits Mitochondrial Biogenesis in Liver and Fatty Acid Oxidation in Adipocytes	PLOS ONE			English	Article							EXPRESSION; RESISTANCE; GLUCOSE; GAMMA	The transcription factor STAT1 plays a central role in orchestrating responses to various pathogens by activating the transcription of nuclear-encoded genes that mediate the antiviral, the antigrowth, and immune surveillance effects of interferons and other cytokines. In addition to regulating gene expression, we report that STAT1(-/-) mice display increased energy expenditure and paradoxically decreased release of triglycerides from white adipose tissue (WAT). Liver mitochondria from STAT1(-/-) mice show both defects in coupling of the electron transport chain (ETC) and increased numbers of mitochondria. Consistent with elevated numbers of mitochondria, STAT1(-/-) mice expressed increased amounts of PGC1 alpha, a master regulator of mitochondrial biogenesis. STAT1 binds to the PGC1 alpha promoter in fed mice but not in fasted animals, suggesting that STAT1 inhibited transcription of PGC1 alpha. Since STAT1(-/-) mice utilized more lipids we examined white adipose tissue (WAT) stores. Contrary to expectations, fasted STAT1(-/-) mice did not lose lipid from WAT. beta-adrenergic stimulation of glycerol release from isolated STAT1(-/-) WAT was decreased, while activation of hormone sensitive lipase was not changed. These findings suggest that STAT1(-/-) adipose tissue does not release glycerol and that free fatty acids (FFA) re-esterify back to triglycerides, thus maintaining fat mass in fasted STAT1(-/-) mice.	[Sisler, Jennifer D.; Morgan, Magdalena; Raje, Vidisha; Derecka, Marta; Meier, Jeremy; Cantwell, Marc; Szczepanek, Karol; Lesnefsky, Edward J.; Larner, Andrew C.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Sisler, Jennifer D.; Morgan, Magdalena; Raje, Vidisha; Derecka, Marta; Meier, Jeremy; Cantwell, Marc; Szczepanek, Karol; Lesnefsky, Edward J.; Larner, Andrew C.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Grande, Rebecca C.; Harris, Thurl E.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; [Szczepanek, Karol; Lesnefsky, Edward J.] McGuire Dept Vet Affairs Med Ctr, Med Serv, Richmond, VA 23249 USA; [Korzun, William J.] Virginia Commonwealth Univ, Dept Clin Chem, Richmond, VA 23298 USA; [Croniger, Colleen M.] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Lesnefsky, Edward J.] Virginia Commonwealth Univ, Dept Internal Med, Div Cardiol, Richmond, VA 23298 USA; [Lesnefsky, Edward J.] Virginia Commonwealth Univ, Pauley Heart Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Virginia; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; Case Western Reserve University; Virginia Commonwealth University; Virginia Commonwealth University	Larner, AC (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	alarner@vcu.edu		Derecka, Marta/0000-0001-6265-9781; Raje, Vidisha/0000-0003-1808-6511	NIH [1R01 DK099732, 1R01GM101677-01A1]; NIH NINDS Center [5P30NS047463]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099732, R01DK101946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NINDS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants 1R01 DK099732 and 1R01GM101677-01A1 to Andrew Larner. Microscopy was performed at the VCU Dept. of Anatomy and Neurobiology Microscopy Facility, supported, in part, with funding from NIH NINDS Center core grant 5P30NS047463.	Bederman IR, 2009, J BIOL CHEM, V284, P6101, DOI 10.1074/jbc.M808668200; Bell EL, 2005, MITOCHONDRION, V5, P322, DOI 10.1016/j.mito.2005.06.005; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Cheon H, 2013, EMBO J, V32, P2751, DOI 10.1038/emboj.2013.203; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; Dominy J.E., 2013, COLD SPRING HARBOR P, V5; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McPherson PAC, 2012, J PHYSIOL BIOCHEM, V68, P141, DOI 10.1007/s13105-011-0112-4; Meier JA, 2014, SEMIN IMMUNOL, V26, P20, DOI 10.1016/j.smim.2013.12.005; Millward CA, 2009, MAMM GENOME, V20, P71, DOI 10.1007/s00335-008-9165-2; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Palikaras K, 2014, EXP GERONTOL, V56, P182, DOI 10.1016/j.exger.2014.01.021; Pitroda SP, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-68; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Sawada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014006; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stephens JM, 1996, J BIOL CHEM, V271, P10441, DOI 10.1074/jbc.271.18.10441; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; Todoric J, 2011, DIABETES, V60, P1668, DOI 10.2337/db10-1628; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41	28	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144444	10.1371/journal.pone.0144444	http://dx.doi.org/10.1371/journal.pone.0144444			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689548	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092300009
J	Mittal, A; Pachter, L; Nelson, JL; Kjaergaard, H; Smed, MK; Gildengorin, VL; Zoffmann, V; Hetland, ML; Jewell, NP; Olsen, J; Jawaheer, D				Mittal, Anuradha; Pachter, Lior; Nelson, J. Lee; Kjaergaard, Hanne; Smed, Mette Kiel; Gildengorin, Virginia L.; Zoffmann, Vibeke; Hetland, Merete Lund; Jewell, Nicholas P.; Olsen, Jorn; Jawaheer, Damini			Pregnancy-Induced Changes in Systemic Gene Expression among Healthy Women and Women with Rheumatoid Arthritis	PLOS ONE			English	Article							RNA-SEQ; DISEASE-ACTIVITY; MATERNAL PLASMA; BLOOD; ACTIVATION; POSTPARTUM; NATIONWIDE; CELLS; ONSET; TERM	Background Pregnancy induces drastic biological changes systemically, and has a beneficial effect on some autoimmune conditions such as rheumatoid arthritis (RA). However, specific systemic changes that occur as a result of pregnancy have not been thoroughly examined in healthy women or women with RA. The goal of this study was to identify genes with expression patterns associated with pregnancy, compared to pre-pregnancy as baseline and determine whether those associations are modified by presence of RA. Results In our RNA sequencing (RNA-seq) dataset from 5 healthy women and 20 women with RA, normalized expression levels of 4,710 genes were significantly associated with pregnancy status (pre-pregnancy, first, second and third trimesters) over time, irrespective of presence of RA (False Discovery Rate (FDR)-adjusted p value<0.05). These genes were enriched in pathways spanning multiple systems, as would be expected during pregnancy. A subset of these genes (n = 256) showed greater than two-fold change in expression during pregnancy compared to baseline levels, with distinct temporal trends through pregnancy. Another 98 genes involved in various biological processes including immune regulation exhibited expression patterns that were differentially associated with pregnancy in the presence or absence of RA. Conclusions Our findings support the hypothesis that the maternal immune system plays an active role during pregnancy, and also provide insight into other systemic changes that occur in the maternal transcriptome during pregnancy compared to the pre-pregnancy state. Only a small proportion of genes modulated by pregnancy were influenced by presence of RA in our data.	[Mittal, Anuradha; Gildengorin, Virginia L.; Jawaheer, Damini] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Nelson, J. Lee] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Nelson, J. Lee] Univ Washington, Seattle, WA 98195 USA; [Kjaergaard, Hanne; Smed, Mette Kiel; Zoffmann, Vibeke] Rigshosp, Juliane Marie Ctr, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Hetland, Merete Lund] Rigshosp, DANBIO Registry, DK-2100 Copenhagen, Denmark; [Hetland, Merete Lund] Rigshosp, Ctr Rheumatol & Spine Dis VRR, Copenhagen Ctr Arthrit Res, DK-2100 Copenhagen, Denmark; [Hetland, Merete Lund] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Jewell, Nicholas P.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; [Olsen, Jorn] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Berkeley; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; Aarhus University	Jawaheer, D (corresponding author), Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA.	djawaheer@chori.org	Zoffmann, Vibeke/X-7192-2019; Hetland, Merete L/AAE-5297-2019; Jawaheer, Damini/AFR-8556-2022	Hetland, Merete L/0000-0003-4229-6818; Jawaheer, Damini/0000-0003-4954-874X; Pachter, Lior/0000-0002-9164-6231	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), USA [R21AR057931]; Gigtforeningen, Denmark [R87-A1477-B512]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057931] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), USA; Gigtforeningen, Denmark; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by funds from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, http://www.niams.nih.gov/), USA (grant R21AR057931); and Gigtforeningen (https://www.gigtforeningen.dk/), Denmark (grant R87-A1477-B512). Author DJ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KM, 2004, JAMA-J AM MED ASSOC, V291, P1127, DOI 10.1001/jama.291.9.1127; Amino N, 1999, THYROID, V9, P705, DOI 10.1089/thy.1999.9.705; ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315; Barrett JH, 1999, ARTHRITIS RHEUM, V42, P1219, DOI 10.1002/1529-0131(199906)42:6<1219::AID-ANR19>3.0.CO;2-G; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; De Man YA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1241, DOI 10.1002/art.24003; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Gomez-Lopez N, 2014, CELL MOL IMMUNOL, V11, P571, DOI 10.1038/cmi.2014.46; Guthrie KA, 2010, ARTHRITIS RHEUM-US, V62, P1842, DOI 10.1002/art.27459; Haupl T, 2008, RHEUMATOLOGY, V47, P19, DOI 10.1093/rheumatology/ken157; Haupl T, 2008, ARTHRITIS RHEUM, V58, P2981, DOI 10.1002/art.23907; Hench PS, 1938, MAYO CLIN P, V13, P161; Heung MMS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005858; Julia A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007556; Kim TH, 2014, JOINT BONE SPINE, V81, P325, DOI 10.1016/j.jbspin.2014.01.013; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LANSINK M, 1993, CLIN EXP RHEUMATOL, V11, P171; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Luppi P, 2002, AM J REPROD IMMUNOL, V47, P72, DOI 10.1034/j.1600-0897.2002.1o041.x; Lyons TR, 2009, J MAMMARY GLAND BIOL, V14, P87, DOI 10.1007/s10911-009-9119-7; Matjila M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063574; Mikheev AM, 2008, REPROD SCI, V15, P866, DOI 10.1177/1933719108322425; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; NELSON JL, 1993, NEW ENGL J MED, V329, P466, DOI 10.1056/NEJM199308123290704; Nelson JL, 1997, RHEUM DIS CLIN N AM, V23, P195, DOI 10.1016/S0889-857X(05)70323-9; O'Hara MW, 2014, BEST PRACT RES CL OB, V28, P3, DOI 10.1016/j.bpobgyn.2013.09.002; OKA M, 1953, ANN RHEUM DIS, V12, P227, DOI 10.1136/ard.12.3.227; POSER S, 1983, NEUROLOGY, V33, P1422, DOI 10.1212/WNL.33.11.1422; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Scrandis DA, 2007, THESCIENTIFICWORLDJO, V7, P1670, DOI 10.1100/tsw.2007.207; SILMAN A, 1992, ARTHRITIS RHEUM, V35, P152, DOI 10.1002/art.1780350205; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tat SK, 2008, ARTHRITIS RHEUM-US, V58, P3820, DOI 10.1002/art.24029; Tsui NBY, 2014, CLIN CHEM, V60, P954, DOI 10.1373/clinchem.2014.221648; Wang Y, 2001, PLACENTA, V22, P560, DOI 10.1053/plac.2001.0691; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weix J, 2013, TRANSL RES, V161, P505, DOI 10.1016/j.trsl.2013.02.007; Weix J, 2012, ARTHRITIS RHEUM-US, V64, P2095, DOI 10.1002/art.34375; Winn VD, 2007, ENDOCRINOLOGY, V148, P1059, DOI 10.1210/en.2006-0683; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	46	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145204	10.1371/journal.pone.0145204	http://dx.doi.org/10.1371/journal.pone.0145204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683605	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000366725800045
J	Thirumurthy, H; Hayashi, K; Linnemayr, S; Vreeman, RC; Levin, IP; Bangsberg, DR; Brewer, NT				Thirumurthy, Harsha; Hayashi, Kami; Linnemayr, Sebastian; Vreeman, Rachel C.; Levin, Irwin P.; Bangsberg, David R.; Brewer, Noel T.			Time Preferences Predict Mortality among HIV-Infected Adults Receiving Antiretroviral Therapy in Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CIGARETTE SMOKERS; ALCOHOL; ADHERENCE; FUTURE	Background Identifying characteristics of HIV-infected adults likely to have poor treatment outcomes can be useful for targeting interventions efficiently. Research in economics and psychology suggests that individuals' intertemporal time preferences, which indicate the extent to which they trade-off immediate vs. future cost and benefits, can influence various health behaviors. While there is empirical support for the association between time preferences and various non-HIV health behaviors and outcomes, the extent to which time preferences predict outcomes of those receiving antiretroviral therapy (ART) has not been examined previously. Methods HIV-infected adults initiating ART were enrolled at a health facility in Kenya. Participants' time preferences were measured at enrollment and used to classify them as having either a low or high discount rate for future benefits. At 48 weeks, we assessed mortality and ART adherence, as measured by Medication Event Monitoring System (MEMS). Logistic regression models adjusting for socio-economic characteristics and risk factors were used to determine the association between time preferences and mortality as well as MEMS adherence >= 90%. Results Overall, 44% (96/220) of participants were classified as having high discount rates. Participants with high discount rates had significantly higher 48-week mortality than participants with low discount rates (9.3% vs. 3.1%; adjusted odds ratio 3.84; 95% CI 1.03, 14.50). MEMS adherence >= 90% was similar for participants with high vs. low discount rates (42.3% vs. 49.6%, AOR 0.70; 95% CI 0.40, 1.25). Conclusion High discount rates were associated with significantly higher risk of mortality among HIV-infected patients initiating ART. Greater use of time preference measures may improve identification of patients at risk of poor clinical outcomes. More research is needed to further identify mechanisms of action and also to build upon and test the generalizability of this finding.	[Thirumurthy, Harsha] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA; [Thirumurthy, Harsha] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Hayashi, Kami; Brewer, Noel T.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA; [Linnemayr, Sebastian] RAND Corp, Santa Monica, CA USA; [Vreeman, Rachel C.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Vreeman, Rachel C.] Acad Model Providing Access Healthcare, Eldoret, Kenya; [Levin, Irwin P.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Bangsberg, David R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Global Hlth, Boston, MA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; RAND Corporation; Indiana University System; Indiana University Bloomington; University of Iowa; Harvard University; Harvard Medical School; Massachusetts General Hospital	Thirumurthy, H (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA.	harsha@unc.edu	Brewer, Noel T/C-4375-2008	Brewer, Noel T/0000-0003-2241-7002; Thirumurthy, Harsha/0000-0002-3308-7603	World Bank Research Group - Bank Netherlands Partnership Program (BNPP) [7142349, 7144565]; United States Agency for International Development, President's Emergency Plan for AIDS Relief (PEPFAR); National Institute of Child Health & Human Development [K01HD061605]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD061605, P2CHD050924] Funding Source: NIH RePORTER	World Bank Research Group - Bank Netherlands Partnership Program (BNPP); United States Agency for International Development, President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The World Bank Research Group provided financial support for this project under contracts 7142349 and 7144565 funded by the Bank Netherlands Partnership Program (BNPP). This research was also supported in part by a grant to the USAID-Academic Model Providing Access to Healthcare Partnership from the United States Agency for International Development as part of the President's Emergency Plan for AIDS Relief (PEPFAR). H. Thirumurthy received support from the National Institute of Child Health & Human Development (K01HD061605).	Axon RN, 2009, J AM SOC HYPERTENS, V3, P35, DOI 10.1016/j.jash.2008.08.005; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Baker F, 2003, J ABNORM PSYCHOL, V112, P382, DOI 10.1037/0021-843X.112.3.382; Bickel WK, 2008, DRUG ALCOHOL DEPEN, V96, P256, DOI 10.1016/j.drugalcdep.2008.03.009; Boulle A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001718; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brandt S, 2013, PEDIATRICS, V131, pE1204, DOI 10.1542/peds.2011-2982; Chapman GB, 2005, HEALTH PSYCHOL, V24, pS41, DOI 10.1037/0278-6133.24.4.S41; Chapman GB, 2001, J EXP PSYCHOL-APPL, V7, P235, DOI 10.1037//1076-898X.7.3.235; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Galarraga O, 2013, AIDS BEHAV, V17, P2283, DOI 10.1007/s10461-013-0415-2; Gyrd-Hansen Dorte, 2002, Eur J Health Econ, V3, P10, DOI 10.1007/s10198-002-0098-5; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; MacKillop J, 2015, AIDS BEHAV, V19, P450, DOI 10.1007/s10461-014-0909-6; MacKillop J, 2011, PSYCHOPHARMACOLOGY, V216, P305, DOI 10.1007/s00213-011-2229-0; MacKillop J, 2010, J ABNORM PSYCHOL, V119, P106, DOI 10.1037/a0017513; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; Odum Amy L, 2002, Nicotine Tob Res, V4, P295, DOI 10.1080/14622200210141257; Petry NM, 2001, PSYCHOPHARMACOLOGY, V154, P243, DOI 10.1007/s002130000638; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Siedner MJ, 2013, AIDS, V27, P1503, DOI 10.1097/QAD.0b013e32835fd873; Smith PK, 2005, ECON HUM BIOL, V3, P259, DOI 10.1016/j.ehb.2005.05.001; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea	26	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145245	10.1371/journal.pone.0145245	http://dx.doi.org/10.1371/journal.pone.0145245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684298	Green Published, gold			2022-12-27	WOS:000366725800050
J	Jiang, XX; Fei, XW; Zhao, L; Ye, XL; Xin, LB; Qu, Y; Xu, KH; Wu, RJ; Lin, J				Jiang, Xiu Xiu; Fei, Xiang Wei; Zhao, Li; Ye, Xiao Lei; Xin, Liao Bin; Qu, Yang; Xu, Kai Hong; Wu, Rui Jin; Lin, Jun			Aquaporin 5 Plays a Role in Estrogen-Induced Ectopic Implantation of Endometrial Stromal Cells in Endometriosis	PLOS ONE			English	Article							WATER CHANNEL DISEASES; MOLECULAR-MECHANISMS; DRUG DEVELOPMENT; BREAST-CANCER; LUNG-CANCER; EXPRESSION; AQP5; PROLIFERATION; IDENTIFICATION; ACTIVATION	Aquaporin 5 (AQP5) participates in the migration of endometrial cells. Elucidation of the molecular mechanisms associated with AQP5-mediated, migration of endometrial cells may contribute to a better understanding of endometriosis. Our objectives included identifying the estrogen-response element (ERE) in the promoter region of the AQP5 gene, and, investigating the effects of AQP5 on ectopic implantation of endometrial cells. Luciferase reporter assays and electrophoretic mobility shift assay (EMSA) identified the ERE-like motif in the promoter region of the AQP5 gene. After blocking and up-regulating estradiol (E-2) levels, we analysed the expression of AQP5 in endometrial stromal (ES) cells. After blocking E-2/or phosphatidylinositol 3 kinase(PI3K), we analysed the role of AQP5 in signaling pathways. We constructed an AQP5, shRNA, lentiviral vector to knock out the AQP5 gene in ES cells. After knock-out of the AQP5 gene, we studied the role of AQP5 in cell invasion, proliferation, and the formation of ectopic endometrial implants in female mice. We identified an estrogen-response element in the promoter region of the AQP5 gene. Estradiol (E-2) increased AQP5 expression in a dose-dependent fashion, that was blocked by ICI182,780(an estrogen receptor inhibitor). E-2 activated PI3K/protein kinase B(AKT) pathway (PI3K/AKT), that, in turn, increased AQP5 expression. LY294002(PI3K inhibitor) attenuated estrogen-enhanced, AQP5 expression. Knock-out of the AQP5 gene with AQP5 shRNA lentiviral vector significantly inhibited E-2-enhanced invasion, proliferation of ES cells and formation of ectopic implants. Estrogen induces AQP5 expression by activating ERE in the promoter region of the AQP5gene, activates the PI3K/AKT pathway, and, promotes endometrial cell invasion and proliferation. These results provide new insights into some of the mechanisms that may underpin the development of deposits of ectopic endometrium.	[Jiang, Xiu Xiu; Zhao, Li; Xu, Kai Hong; Wu, Rui Jin; Lin, Jun] Zhejiang Univ, Sch Med, Womens Hosp, Dept Gynecol, Hangzhou 310006, Zhejiang, Peoples R China; [Fei, Xiang Wei; Qu, Yang] Zhejiang Univ, Sch Med, Womens Hosp, Dept Lab, Hangzhou 310006, Zhejiang, Peoples R China; [Ye, Xiao Lei] Ningbo Univ, Sch Med, Dept Lab, Ningbo 315000, Zhejiang, Peoples R China; [Xin, Liao Bin] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gynecol, Hangzhou 310006, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Ningbo University; Zhejiang University	Xu, KH (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Dept Gynecol, Hangzhou 310006, Zhejiang, Peoples R China.	xukh@zju.edu.cn; wurj@zju.edu.cn; janet418@sina.com.cn			Zhejiang Province Natural Science Foundation of China [LY12H04009]; National Natural Science Foundation of China [81170546, 81401179]	Zhejiang Province Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by: 1. The Zhejiang Province Natural Science Foundation of China (grant number: LY12H04009). Xiu xiu Jiang received the funding; http://www.zjnsf.gov.cn. 2. The National Natural Science Foundation of China (grant numbers: 81170546). Jun Lin received the funding, http://www.nsfc.gov.cn. 3. The National Natural Science Foundation of China (grant number: 81401179). Xiu Xiu Jiang received the funding, http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002162; Chen FL, 2014, PLASMID, V76, P24, DOI 10.1016/j.plasmid.2014.08.004; Gresz V, 2001, AM J PHYSIOL-GASTR L, V281, pG247, DOI 10.1152/ajpgi.2001.281.1.G247; Huang YH, 2013, TUMOR BIOL, V34, P1743, DOI 10.1007/s13277-013-0712-4; Jiang XX, 2012, ONCOL LETT, V4, P257, DOI 10.3892/ol.2012.738; Jiang XX, 2010, FERTIL STERIL, V94, P1229, DOI 10.1016/j.fertnstert.2009.08.053; Kim SO, 2012, WORLD J UROL, V30, P207, DOI 10.1007/s00345-011-0674-3; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Kobayashi M, 2006, GENES CELLS, V11, P1133, DOI 10.1111/j.1365-2443.2006.01009.x; Lee SJ, 2014, ANN SURG ONCOL, V21, P375, DOI 10.1245/s10434-013-3317-7; Li JP, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-284; Li X, 2012, ZHONGGUO ZHONG YAO Z, V37, P1640; Lindsay LA, 2006, REPRODUCTION, V131, P369, DOI 10.1530/rep.1.00914; Lonetti A, 2014, LEUKEMIA, V28, P1196, DOI 10.1038/leu.2013.369; Morishita Y, 2004, J PHARMACOL SCI, V96, P276, DOI 10.1254/jphs.FMJ04004X7; Noda Y, 2004, J PHARMACOL SCI, V96, P249, DOI 10.1254/jphs.FMJ04004X2; O'Brien JE, 2006, J BIOL CHEM, V281, P26683, DOI 10.1074/jbc.M601522200; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908; Saglam O, 2007, CLIN COLORECTAL CANC, V6, P652, DOI 10.3816/CCC.2007.n.034; Sakamoto Y, 2014, BIOCHEM BIOPH RES CO, V448, P355, DOI 10.1016/j.bbrc.2014.04.047; Shan T, 2014, ONCOL REP, V32, P1564, DOI 10.3892/or.2014.3377; Shi XM, 2014, TUMOR BIOL, V35, P7035, DOI 10.1007/s13277-014-1956-3; Shi ZH, 2012, J SURG ONCOL, V106, P267, DOI 10.1002/jso.22155; Skowronski MT, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-109; Woo J, 2008, CANCER LETT, V264, P54, DOI 10.1016/j.canlet.2008.01.029; Xin Liao-bing, 2015, Zhejiang Da Xue Xue Bao Yi Xue Ban, V44, P285; Yan CX, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0078-2; Zhang ZQ, 2010, J PATHOL, V221, P210, DOI 10.1002/path.2702; Zou LB, 2011, J CLIN ENDOCR METAB, V96, pE1399, DOI 10.1210/jc.2011-0426	30	18	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145290	10.1371/journal.pone.0145290	http://dx.doi.org/10.1371/journal.pone.0145290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679484	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400067
J	Sepulveda, AJ; Tercek, MT; Al-Chokhachy, R; Ray, AM; Thoma, DP; Hossack, BR; Pederson, GT; Rodman, AW; Olliff, T				Sepulveda, Adam J.; Tercek, Michael T.; Al-Chokhachy, Robert; Ray, Andrew M.; Thoma, David P.; Hossack, Blake R.; Pederson, Gregory T.; Rodman, Ann W.; Olliff, Tom			The Shifting Climate Portfolio of the Greater Yellowstone Area	PLOS ONE			English	Article							CONSERVATION; MANAGEMENT; VULNERABILITY; SNOWPACK; TRENDS; VARIABILITY; ADAPTATION; EXTREMES; IMPACTS	Knowledge of climatic variability at small spatial extents (< 50 km) is needed to assess vulnerabilities of biological reserves to climate change. We used empirical and modeled weather station data to test if climate change has increased the synchrony of surface air temperatures among 50 sites within the Greater Yellowstone Area (GYA) of the interior western United States. This important biological reserve is the largest protected area in the Lower 48 states and provides critical habitat for some of the world's most iconic wildlife. We focused our analyses on temporal shifts and shape changes in the annual distributions of seasonal minimum and maximum air temperatures among valley-bottom and higher elevation sites from 1948-2012. We documented consistent patterns of warming since 1948 at all 50 sites, with the most pronounced changes occurring during the Winter and Summer when minimum and maximum temperature distributions increased. These shifts indicate more hot temperatures and less cold temperatures would be expected across the GYA. Though the shifting statistical distributions indicate warming, little change in the shape of the temperature distributions across sites since 1948 suggest the GYA has maintained a diverse portfolio of temperatures within a year. Spatial heterogeneity in temperatures is likely maintained by the GYA's physiographic complexity and its large size, which encompasses multiple climate zones that respond differently to synoptic drivers. Having a diverse portfolio of temperatures may help biological reserves spread the extinction risk posed by climate change.	[Sepulveda, Adam J.; Al-Chokhachy, Robert; Pederson, Gregory T.] US Geol Survey, Northern Rocky Mt Sci Ctr, Bozeman, MT 59715 USA; [Tercek, Michael T.] Walking Shadow Ecol, Gardiner, MT 59030 USA; [Ray, Andrew M.; Thoma, David P.] Natl Pk Serv, Greater Yellowstone Inventory & Monitory Network, Bozeman, MT 59715 USA; [Hossack, Blake R.] US Geol Survey, Aldo Leopold Wilderness Res Inst, Missoula, MT 59801 USA; [Rodman, Ann W.] Natl Pk Serv, Yellowstone Ctr Resources, Yellowstone Np, WY 82190 USA; [Olliff, Tom] Natl Pk Serv, Intermountain Reg Landscape Conservat & Climate C, Bozeman, MT 59715 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Department of the Interior	Sepulveda, AJ (corresponding author), US Geol Survey, Northern Rocky Mt Sci Ctr, 2327 Univ Way,Suite 2, Bozeman, MT 59715 USA.	asepulveda@usgs.gov			U.S. Geological Survey's National Park Monitoring Project program; Walking Shadow Ecology	U.S. Geological Survey's National Park Monitoring Project program; Walking Shadow Ecology	Funding for this research was provided by the U.S. Geological Survey's National Park Monitoring Project program. Walking Shadow Ecology provided support in the form of salary for author MTT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Abatzoglou JT, 2011, INT J CLIMATOL, V31, P1135, DOI 10.1002/joc.2137; Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Al-Chokhachy R, 2013, GLOBAL CHANGE BIOL, V19, DOI 10.1111/gcb.12262; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Bell J, 2012, J HYDROL ENG, V17, P521, DOI 10.1061/(ASCE)HE.1943-5584.0000469; Case MJ, 2015, BIOL CONSERV, V187, P127, DOI 10.1016/j.biocon.2015.04.013; Cliff A. D., 1981, SPATIAL PROCESSES MO; Daly C, 2006, INT J CLIMATOL, V26, P707, DOI 10.1002/joc.1322; Den Boer P. J., 1968, Acta Biotheoretica, V18, P165; Diffenbaugh NS, 2005, P NATL ACAD SCI USA, V102, P15774, DOI 10.1073/pnas.0506042102; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Field C, 2012, MANAGING RISKS EXTRE; Figge F, 2004, BIODIVERS CONSERV, V13, P827, DOI 10.1023/B:BIOC.0000011729.93889.34; Grimm NB, 2013, FRONT ECOL ENVIRON, V11, P474, DOI 10.1890/120282; Hamlet AF, 2007, EFFECTS 20 CENTURY W, P43; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hartmann D., 2013, CLIMATE CHANGE 2013; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hobbs RJ, 2010, FRONT ECOL ENVIRON, V8, P483, DOI 10.1890/090089; Intergovernmental Panel on Climate Change (IPCC), 2014, CLIMATE CHANGE 201 A; Isaac V, 2012, J CLIMATE, V25, P3599, DOI 10.1175/JCLI-D-11-00003.1; Kapnick S, 2012, CLIM DYNAM, V38, P1885, DOI 10.1007/s00382-011-1089-y; Keiter R. B., 1994, GREATER YELLOWSTONE; Knowles N, 2006, J CLIMATE, V19, P4545, DOI 10.1175/JCLI3850.1; Lambeck RJ, 1997, CONSERV BIOL, V11, P849, DOI 10.1046/j.1523-1739.1997.96319.x; Lawler JJ, 2009, ANN NY ACAD SCI, V1162, P79, DOI 10.1111/j.1749-6632.2009.04147.x; Leadley P., 2010, BIODIVERSITY SCENARI; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Logan JA, 2010, ECOL APPL, V20, P895, DOI 10.1890/09-0655.1; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Lundquist JD, 2007, J GEOPHYS RES-ATMOS, P112; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; McGuire CR, 2012, ELEVATION DEPENDENT; Menne MJ, 2009, J CLIMATE, V22, P1700, DOI 10.1175/2008JCLI2263.1; Noss RF, 2002, CONSERV BIOL, V16, P895, DOI 10.1046/j.1523-1739.2002.01405.x; Oyler JW, 2015, INT J CLIMATOL, V35, P2258, DOI 10.1002/joc.4127; Oyler JW, 2015, GEOPHYS RES LETT, V42, P153, DOI 10.1002/2014GL062803; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Parry M. L., 2007, CLIMATE CHANGE 2007; Pederson GT, 2013, GEOPHYS RES LETT, V40, P1811, DOI 10.1002/grl.50424; Pederson GT, 2011, SCIENCE, V333, P332, DOI 10.1126/science.1201570; Pederson GT, 2011, J CLIMATE, V24, P1666, DOI 10.1175/2010JCLI3729.1; Pederson GT, 2010, CLIMATIC CHANGE, V98, P133, DOI 10.1007/s10584-009-9642-y; Raimondo S, 2004, ECOL ENTOMOL, V29, P96, DOI 10.1111/j.0307-6946.2004.00579.x; Regonda SK, 2005, J CLIMATE, V18, P372, DOI 10.1175/JCLI-3272.1; ROMME WH, 1989, BIOSCIENCE, V39, P695, DOI 10.2307/1311000; Schindler DE, 2015, FRONT ECOL ENVIRON, V13, P257, DOI 10.1890/140275; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Shafer SL, 2005, UNDERSTANDING SPATIL, P21; Shinker JJ, 2010, EARTH INTERACT, V14, DOI 10.1175/2010EI323.1; Sitas N, 2009, ANIM CONSERV, V12, P231, DOI 10.1111/j.1469-1795.2009.00244.x; Smith B, 2000, CLIMATIC CHANGE, V45, P223, DOI 10.1023/A:1005661622966; Thibault KM, 2008, P NATL ACAD SCI USA, V105, P3410, DOI 10.1073/pnas.0712282105; Thompson RM, 2013, ECOL LETT, V16, P799, DOI 10.1111/ele.12095; Thornton PK, 2014, GLOBAL CHANGE BIOL, V20, P3313, DOI 10.1111/gcb.12581; Viviroli D, 2011, HYDROL EARTH SYST SC, V15, P471, DOI 10.5194/hess-15-471-2011; Watters JV, 2003, BIOL CONSERV, V112, P435, DOI 10.1016/S0006-3207(02)00343-9; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; WHITLOCK C, 1993, QUATERNARY RES, V39, P231, DOI 10.1006/qres.1993.1026; You QL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032669; Yue S, 2002, J HYDROL, V259, P254, DOI 10.1016/S0022-1694(01)00594-7	65	25	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145060	10.1371/journal.pone.0145060	http://dx.doi.org/10.1371/journal.pone.0145060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674185	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700091
J	Wang, K; Guo, WX; Li, N; Gao, CF; Shi, J; Tang, YF; Shen, F; Wu, MC; Liu, SR; Cheng, SQ				Wang, Kang; Guo, Wei Xing; Li, Nan; Gao, Chun Fang; Shi, Jie; Tang, Yu Fu; Shen, Feng; Wu, Meng Chao; Liu, Shan Rong; Cheng, Shu Qun			Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma	PLOS ONE			English	Article							LONG NONCODING RNA; OPERATING CHARACTERISTIC CURVES; ALPHA-FETOPROTEIN; HEPATITIS-B; PROSTATE-CANCER; HIGH EXPRESSION; NUCLEIC-ACIDS; URINE TEST; CELL; METASTASIS	Background Hepatocellular carcinoma (HCC) is a common malignancy that has a poor prognosis because there is lack of methods for early diagnosis. We aimed to utilize two serum long non-coding RNAs (lncRNAs), uc001ncr and AX800134, to diagnose hepatitis B virus (HBV)-positive HCC. Methods lncRNA microarrays were utilized to measure the differential expression of lncRNAs between tumor tissues and corresponding non-tumor tissues in HBV-positive hapatocellular carcinoma. uc001ncr and AX800134 were selected as candidate lncRNAs and detected in three independent cohorts containing a total of 684 participants (healthy individuals and chronic HBV patients and HBV-positive HCC patients) who were recruited between March 2011 and December 2012. A logistic regression model was constructed using a training cohort (n = 353) and validated using an independent cohort (n = 181). The area under the receiver operating characteristic curve (AUC) was utilized to evaluate the diagnostic accuracy. Results We determined that a panel based on the expression of uc001ncr and AX800134 accurately diagnosed HBV-positive HCC (AUC values of 0.9494 and 0.9491 for the training and validation cohorts, respectively). The diagnostic performance of the panel remained high in patients with AFP <= 400 ng/ml (AUC values of 0.9371 and 0.9527 for the training and validation cohorts, respectively). The panel also diagnosed early HCC (AUC values of 0.9450 and 0.9564 for the training and validation cohorts, respectively). Conclusion Our results indicated that the serum expression of uc001ncr and AX800134 has potential as novel potential biomarker for the diagnosis of HCC, especially in patients with AFP <= 400 ng/ml or early-stage disease (BCLC 0+A).	[Wang, Kang; Guo, Wei Xing; Li, Nan; Gao, Chun Fang; Shi, Jie; Tang, Yu Fu; Shen, Feng; Wu, Meng Chao; Cheng, Shu Qun] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Liu, Shan Rong] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Liu, SR (corresponding author), Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China.	liushanrong@hotmail.com; chengshuqun@aliyun.com	SHI, JIE/GXG-3394-2022; Shen, Feng/GSD-2508-2022; cheng, sq/GPT-4112-2022		grants of the Science Fund for Creative Research Groups [81221061]; Chang Jiang Scholars Program; Shanghai Science and Technology Committee [134119a0200, 10JC1417600]; State Key Project on Infections Diseases of China [2012zx10002016016003]; China National Funds for Distinguished Young Scientists [81125018]; New Excellent Talents Program of Shanghai Municipal Health Bureau [XBR2011025]; New Excellent Talents Program of Shanghai Science and Technology Committee [10XD1405800]; National Natural Science Foundation [81101831]; Excellent Young Scholar Program of SMMU [20111010B]; Natural Science Foundation of Shanghai, China [12ZR1439600]	grants of the Science Fund for Creative Research Groups; Chang Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); State Key Project on Infections Diseases of China; China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); New Excellent Talents Program of Shanghai Municipal Health Bureau; New Excellent Talents Program of Shanghai Science and Technology Committee; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Excellent Young Scholar Program of SMMU; Natural Science Foundation of Shanghai, China(Natural Science Foundation of Shanghai)	This work was supported by the grants of the Science Fund for Creative Research Groups (No. 81221061); Chang Jiang Scholars Program (2012); Shanghai Science and Technology Committee (No. 134119a0200); The State Key Project on Infections Diseases of China (2012zx10002016016003); The China National Funds for Distinguished Young Scientists (No. 81125018); The New Excellent Talents Program of Shanghai Municipal Health Bureau (No. XBR2011025); The New Excellent Talents Program of Shanghai Science and Technology Committee (No. 10XD1405800); Shanghai Science and Technology Committee (No. 10JC1417600); The National Natural Science Foundation (No. 81101831); Excellent Young Scholar Program of SMMU (No. 20111010B); and Project supported by the Natural Science Foundation of Shanghai, China (No. 12ZR1439600).	AKEYAMA T, 1972, NEW ENGL J MED, V287, P989; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DIBISCEGLIE AM, 1989, CANCER, V64, P2117, DOI 10.1002/1097-0142(19891115)64:10<2117::AID-CNCR2820641024>3.0.CO;2-7; Dong L, 2015, INT J CANCER, V137, P1128, DOI 10.1002/ijc.29484; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Fradet YF, 2004, UROLOGY, V64, P311, DOI 10.1016/j.urology.2004.03.052; Fu WM, 2015, J HEPATOL, V26; Guo S, 2015, INT J CLIN EXP PATHO, V8, P5395; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hu XD, 2016, TUMOR BIOL, V37, P3497, DOI 10.1007/s13277-015-4023-9; Huang JF, 2013, HEPATOLOGY, V57, P1882, DOI 10.1002/hep.26195; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Johnson P J, 2001, Clin Liver Dis, V5, P145, DOI 10.1016/S1089-3261(05)70158-6; Kapranov P, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-149; LEANDRO G, 1989, ONCOLOGY-BASEL, V46, P381; Lee GL, 2011, NAT REV UROL, V8, P123, DOI 10.1038/nrurol.2011.10; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Matouk IJ, 2009, EUR J GASTROEN HEPAT, V21, P688, DOI 10.1097/MEG.0b013e328306a3a2; Orozco AF, 2010, CYTOM PART A, V77A, P502, DOI 10.1002/cyto.a.20886; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Poon Ronnie Tung-Ping, 2004, Liver Transpl, V10, pS39, DOI 10.1002/lt.20040; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Reis Eduardo M., 2012, Frontiers in Genetics, V3, P32, DOI 10.3389/fgene.2012.00032; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shappell Scott B, 2008, Rev Urol, V10, P44; SIMONETTI RG, 1991, DIGEST DIS SCI, V36, P962, DOI 10.1007/BF01297149; Takahashi K, 2014, HEPATOLOGY, V60, P744, DOI 10.1002/hep.27043; TAKETA K, 1990, HEPATOLOGY, V12, P1420, DOI 10.1002/hep.1840120625; Tantai JC, 2015, INT J CLIN EXP PATHO, V8, P7887; Tinzl M, 2004, EUR UROL, V46, P182, DOI 10.1016/j.eururo.2004.06.004; Tong YK, 2006, CLIN CHIM ACTA, V363, P187, DOI 10.1016/j.cccn.2005.05.048; Trevisani F, 2001, J HEPATOL, V34, P570, DOI 10.1016/S0168-8278(00)00053-2; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang T, 2015, ONCOTARGET, DOI 10.18632/oncotarget.6304; Xu N, 2015, TUMOR BIOL, V36, P7659, DOI 10.1007/s13277-015-3469-0; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	47	42	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144934	10.1371/journal.pone.0144934	http://dx.doi.org/10.1371/journal.pone.0144934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674525	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700074
J	Wei, X; Zhang, SH; Cao, D; Zhao, MY; Zhang, Q; Zhao, J; Yang, T; Pei, ML; Wang, L; Li, Y; Yang, XF				Wei, Xing; Zhang, Shaohua; Cao, Di; Zhao, Minyi; Zhang, Qian; Zhao, Juan; Yang, Ting; Pei, Meili; Wang, Li; Li, Yang; Yang, Xiaofeng			Aberrant Hypermethylation of SALL3 with HPV Involvement Contributes to the Carcinogenesis of Cervical Cancer	PLOS ONE			English	Article							METHYLATION; ACTIVATION; GENES; CPG	Objective This study aimed to investigate the methylation status of the promoter region of spalt-like transcription factor 3 (SALL3) and the expression of SALL3 in cervical cancer to explore the function of this gene in cervical cancer carcinogenesis. Methods The methylation status of SALL3 was detected by methylation-specific PCR, and SALL3 gene expression was assessed by real-time quantitative PCR in the cervical cancer cell lines, SiHa, HeLa and C33A, as well as in cervical cancer tissue samples (n = 23), matched pericarcinomatous tissue samples (n = 23) and normal cervix tissue samples (n = 17). MTT was used to measure the cell viability and proliferation capacity of SiHa and HeLa cells. Results The SALL3 promoter was completely methylated in SiHa cells, unmethylated in C33A cells and partially methylated in HeLa cells. After treatment of SiHa and HeLa cells with 5 mu M and 10 mu M of 5-Azacytidine (5-Aza), respectively, the methylation level of the SALL3 promoter decreased and observed increase in the degree of unmethylation in a dose-dependent manner. Moreover, the relative expression of SALL3 mRNA increased as the concentration of 5-Aza increased in SiHa (p<0.05) and HeLa (p<0.05) cells. This above-mentioned increase in SALL3 mRNA in SiHa cells was more remarkable than that observed in HeLa cells. Cell proliferation capacity also decreased after administration of 5-Aza to SiHa and HeLa cells (p<0.05). Methylation of the SALL3 promoter was observed in 15 of 23 (65.21%) cervical cancer tissue samples, 15 of 23 (65.21%) matched pericarcinomatous tissue samples and 5 of 17 (29.41%) normal cervical tissue samples (p<0.05). SALL3 mRNA expression was significantly lower in cervical cancer and pericarcinomatous tissues compared with normal cervical tissues (p<0.05). In all cervix tissue samples, HPV infection was positively associated with hypermethylation of the promoter region of SALL3 (p<0.05, r = 0.408), and the expression of SALL3 mRNA in HPV-positive tissues was lower than that in HPV-negative tissues (p<0.05). Conclusion The aberrant hypermethylation of SALL3 together with HPV involvement inactivated its function as a tumor suppressor and contributed to carcinogenesis in cervical cancer.	[Wei, Xing; Cao, Di; Zhao, Minyi; Zhang, Qian; Zhao, Juan; Yang, Ting; Pei, Meili; Li, Yang; Yang, Xiaofeng] Xi An Jiao Tong Univ, Dept Gynecol & Obstet, Affiliated Hosp 1, Sch Med, Xian 710061, Peoples R China; [Zhang, Shaohua] Xian Med Coll, Dept Gynecol & Obstet, Affiliated Hosp, Xian 710077, Peoples R China; [Wang, Li] Xi An Jiao Tong Univ, Ctr Maternal & Child Hlth Care, Affiliated Hosp 1, Sch Med, Xian 710061, Peoples R China	Xi'an Jiaotong University; Xi'an Medical University; Xi'an Jiaotong University	Yang, XF (corresponding author), Xi An Jiao Tong Univ, Dept Gynecol & Obstet, Affiliated Hosp 1, Sch Med, 277 West Yanta Rd, Xian 710061, Peoples R China.	yxf73@163.com	li, yong/HDN-3885-2022; Li, Yuan/GXV-1310-2022; Li, Yang/GWM-7879-2022		National Natural Science Foundation of China [81472428]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a National Natural Science Foundation of China (No. 81472428).	[Anonymous], 2015, NCCN CLINICAL PRACTI; Bishop KS, 2015, NUTRIENTS, V7, P922, DOI 10.3390/nu7020922; Chai L, 2011, TRANSFUSION, V51, p87S, DOI 10.1111/j.1537-2995.2011.03371.x; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06; Ennaifer Emna, 2014, Tunis Med, V92, P253; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Guo X, 2015, NATURE, V517, P640, DOI 10.1038/nature13899; Ji J, 2010, HUM PATHOL, V41, P1438, DOI 10.1016/j.humpath.2009.11.021; Ji J, 2010, GYNECOL ONCOL, V117, P103, DOI 10.1016/j.ygyno.2009.12.020; Kim ST, 2014, CANCER GENOM PROTEOM, V11, P259; Kohlhase J, 1999, GENOMICS, V62, P216, DOI 10.1006/geno.1999.6005; Kojima T, 2013, BIOSCI BIOTECH BIOCH, V77, P1035, DOI 10.1271/bbb.121017; Kroeze LI, 2015, BBA-REV CANCER, V1855, P144, DOI 10.1016/j.bbcan.2015.01.001; Lee HS, 2015, ONCOL LETT, V9, P1691, DOI 10.3892/ol.2015.2917; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Munoz N, 2014, SALUD PUBLICA MEXICO, V56, P431; Parrish M, 2004, MOL CELL BIOL, V24, P7102, DOI 10.1128/MCB.24.16.7102-7112.2004; Pirek D, 2015, SEX TRANSM INFECT, V91, P440, DOI 10.1136/sextrans-2014-051642; Roossink F, 2012, CELL ONCOL, V35, P231, DOI 10.1007/s13402-012-0091-7; Schutze DM, 2015, EPIGENETICS-US, V10, P73, DOI 10.4161/15592294.2014.990787; Shikauchi Y, 2009, MOL CELL BIOL, V29, P1944, DOI 10.1128/MCB.00840-08; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Van Kriekinge G, 2014, VACCINE, V32, P733, DOI 10.1016/j.vaccine.2013.11.049; Wu LP, 2008, MOL CELL BIOL, V28, P3219, DOI 10.1128/MCB.01516-07; Yang XX, 2012, WORLD J GASTROENTERO, V18, P2719, DOI 10.3748/wjg.v18.i21.2719; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861; Zhang CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120361; Zhu X, 2015, BREAST CANCER RES TR, V150, P479, DOI 10.1007/s10549-015-3338-y	28	26	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145700	10.1371/journal.pone.0145700	http://dx.doi.org/10.1371/journal.pone.0145700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26697877	gold, Green Published			2022-12-27	WOS:000367092600120
J	Brandt, AR; Sun, YC; Bharadwaj, S; Livingston, D; Tan, E; Gordon, D				Brandt, Adam R.; Sun, Yuchi; Bharadwaj, Sharad; Livingston, David; Tan, Eugene; Gordon, Deborah			Energy Return on Investment (EROI) for Forty Global Oilfields Using a Detailed Engineering-Based Model of Oil Production	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; NET ENERGY; UNITED-STATES; INFORMATION GAPS; FUELS; EXTRACTION; EFFICIENCY; UNCERTAINTY; QUALITY; YIELD	Studies of the energy return on investment (EROI) for oil production generally rely on aggregated statistics for large regions or countries. In order to better understand the drivers of the energy productivity of oil production, we use a novel approach that applies a detailed field-level engineering model of oil and gas production to estimate energy requirements of drilling, producing, processing, and transporting crude oil. We examine 40 global oilfields, utilizing detailed data for each field from hundreds of technical and scientific data sources. Resulting net energy return (NER) ratios for studied oil fields range from approximate to 2 to approximate to 100 MJ crude oil produced per MJ of total fuels consumed. External energy return (EER) ratios, which compare energy produced to energy consumed from external sources, exceed 1000: 1 for fields that are largely self-sufficient. The lowest energy returns are found to come from thermally-enhanced oil recovery technologies. Results are generally insensitive to reasonable ranges of assumptions explored in sensitivity analysis. Fields with very large associated gas production are sensitive to assumptions about surface fluids processing due to the shifts in energy consumed under different gas treatment configurations. This model does not currently include energy invested in building oilfield capital equipment (e.g., drilling rigs), nor does it include other indirect energy uses such as labor or services.	[Brandt, Adam R.; Sun, Yuchi; Bharadwaj, Sharad] Stanford Univ, Dept Energy Resources Engn, Stanford, CA 94035 USA; [Livingston, David; Tan, Eugene; Gordon, Deborah] Carnegie Endowment Int Peace, Washington, DC 20036 USA	Stanford University	Brandt, AR (corresponding author), Stanford Univ, Dept Energy Resources Engn, 367 Panama St, Stanford, CA 94035 USA.	abrandt@stanford.edu			Oil-Climate Index project of Carnegie Endowment for International Peace; Blue Moon Fund; Oak Foundation; William and Flora Hewlett Foundation; Climate Works Foundation; Rockefeller Family Fund	Oil-Climate Index project of Carnegie Endowment for International Peace; Blue Moon Fund; Oak Foundation; William and Flora Hewlett Foundation; Climate Works Foundation; Rockefeller Family Fund	This research was supported by the Oil-Climate Index project of the Carnegie Endowment for International Peace, with support from the Blue Moon Fund, Oak Foundation, William and Flora Hewlett Foundation, Climate Works Foundation and the Rockefeller Family Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Oil-Climate Index co-authors Joule Bergerson and John Koomey contributed significantly to the broader effort on which this work is based. This research was supported by the Oil-Climate Index project of the Carnegie Endowment for International Peace, with support from the Blue Moon Fund, Oak Foundation, William and Flora Hewlett Foundation, Climate Works Foundation and the Rockefeller Family Fund.	Abella JP, 2012, ENVIRON SCI TECHNOL, V46, P13037, DOI 10.1021/es3018682; Air and Waste Management Association, 2012, 105 A WMA ANN C; Brandt AR, 2008, ENVIRON SCI TECHNOL, V42, P7489, DOI 10.1021/es800531f; Brandt AR, 2015, ENVIRON SCI TECHNOL, V49, P679, DOI 10.1021/es505376t; Brandt AR, 2013, ENERGY, V62, P235, DOI 10.1016/j.energy.2013.09.054; Brandt AR, 2013, ENERGY, V55, P693, DOI 10.1016/j.energy.2013.03.080; Brandt AR, 2011, SUSTAINABILITY-BASEL, V3, P1833, DOI 10.3390/su3101833; Brandt AR, 2011, ENERGIES, V4, P1211, DOI 10.3390/en4081211; Brandt AR, 2009, ENERG FUEL, V23, P6253, DOI 10.1021/ef900678d; Cleveland CJ, 2005, ENERGY, V30, P769, DOI 10.1016/j.energy.2004.05.023; CLEVELAND CJ, 1992, ECOL ECON, V6, P139; Cleveland CJ, 2006, NET ENERGY ANAL; Dale M, 2011, ENERG POLICY, V39, P7095, DOI 10.1016/j.enpol.2011.08.021; El-Houjeiri H. M., 2014, OIL PRODUCTION GREEN; El-Houjeiri HM, 2013, ENVIRON SCI TECHNOL, V47, P5998, DOI 10.1021/es304570m; Gagnon N, 2009, ENERGIES, V2, P490, DOI 10.3390/en20300490; Gerdes K., 2009, DOENETL20091362; Gerdes KJ, 2009, CONSIDERATION CRUDE; Gordon D., 2015, KNOW YOUR OIL CREATI; Grandell L, 2011, SUSTAINABILITY-BASEL, V3, P2050, DOI 10.3390/su3112050; Guilford MC, 2011, SUSTAINABILITY-BASEL, V3, P1866, DOI 10.3390/su3101866; Hall C.A., 1986, ENERGY RESOURCE QUAL; HALL CAS, 1981, SCIENCE, V211, P576, DOI 10.1126/science.211.4482.576; Hall CAS, 2014, ENERG POLICY, V64, P141, DOI 10.1016/j.enpol.2013.05.049; Herweyer MC, 2008, THE OIL DRUM; Hubbert MK, 1956, SHELL DEV CO PUBLICA, V95; Hubbert MK, 1958, M SO DISTR DIV PROD, V128; Kavanaugh M., 2015, FINANCIAL TIMES; Keesom W, 2009, LIFE CYCLE ASSESSMEN; Kong ZY, 2015, ENERGIES, V8, P786, DOI 10.3390/en8020786; Kopits S., 2014, OIL EC GROWTH SUPPLY; Murphy DJ, 2011, SUSTAINABILITY-BASEL, V3, P1888, DOI 10.3390/su3101888; Norgaard R., 1971, THESIS; Poisson A, 2013, ENERGIES, V6, P5940, DOI 10.3390/en6115940; Vafi K, 2014, ENVIRON SCI TECHNOL, V48, P12978, DOI 10.1021/es501847p; Vafi K, 2014, ENVIRON SCI TECHNOL, V48, P10511, DOI 10.1021/es502107s; Wang MQ, 2013, GREET MODEL 1 2013; Wang MQ, 2014, GREET MODEL 1 2014	38	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144141	10.1371/journal.pone.0144141	http://dx.doi.org/10.1371/journal.pone.0144141			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SH	26695068	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092500002
J	Habuka, M; Fagerberg, L; Hallstrom, BM; Ponten, F; Yamamoto, T; Uhlen, M				Habuka, Masato; Fagerberg, Linn; Hallstrom, Bjorn M.; Ponten, Fredrik; Yamamoto, Tadashi; Uhlen, Mathias			The Urinary Bladder Transcriptome and Proteome Defined by Transcriptomics and Antibody-Based Profiling	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; RNA-SEQ; EXPRESSION; UROTHELIUM; UROPLAKINS; GREMLIN; BIOLOGY; TRACT; SHH	To understand functions and diseases of urinary bladder, it is important to define its molecular constituents and their roles in urinary bladder biology. Here, we performed genome-wide deep RNA sequencing analysis of human urinary bladder samples and identified genes upregulated in the urinary bladder by comparing the transcriptome data to those of all other major human tissue types. 90 protein-coding genes were elevated in the urinary bladder, either with enhanced expression uniquely in the urinary bladder or elevated expression together with at least one other tissue (group enriched). We further examined the localization of these proteins by immunohistochemistry and tissue microarrays and 20 of these 90 proteins were localized to the whole urothelium with a majority not yet described in the context of the urinary bladder. Four additional proteins were found specifically in the umbrella cells (Uroplakin 1a, 2, 3a, and 3b), and three in the intermediate/basal cells (KRT17, PCP4L1 and ATP1A4). 61 of the 90 elevated genes have not been previously described in the context of urinary bladder and the corresponding proteins are interesting targets for more in-depth studies. In summary, an integrated omics approach using transcriptomics and antibody-based profiling has been used to define a comprehensive list of proteins elevated in the urinary bladder.	[Habuka, Masato; Fagerberg, Linn; Hallstrom, Bjorn M.; Uhlen, Mathias] KTH Royal Inst Technol, Sci Life Lab, SE-17121 Stockholm, Sweden; [Ponten, Fredrik] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden; [Habuka, Masato; Yamamoto, Tadashi] Niigata Univ, Sch Med & Dent, Inst Nephrol, Dept Struct Pathol, Niigata 9518510, Japan; [Uhlen, Mathias] KTH Royal Inst Technol, Dept Prote, SE-10691 Stockholm, Sweden	Royal Institute of Technology; Uppsala University; Niigata University; Royal Institute of Technology	Uhlen, M (corresponding author), KTH Royal Inst Technol, Sci Life Lab, SE-17121 Stockholm, Sweden.	mathias.uhlen@scilifelab.se	Uhlen, Mathias/AAV-8746-2021; Uhlen, Mathias/B-3262-2016	Uhlen, Mathias/0000-0002-4858-8056; Fagerberg, Linn/0000-0003-0198-7137	Knut and Alice Wallenberg Foundation; Stockholm County Council	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Stockholm County Council(Stockholm County Council)	Funding was provided by the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/en) and by the Stockholm County Council (http://www.forskningsstod.sll.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Cao M, 2008, PEDIATR RES, V64, P352, DOI 10.1203/PDR.0b013e318180e4c9; Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019; Chung SS, 2013, IN VITRO CELL DEV-AN, V49, P746, DOI 10.1007/s11626-013-9662-9; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gamer LW, 2005, DEV BIOL, V285, P156, DOI 10.1016/j.ydbio.2005.06.012; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Higgins JPT, 2007, AM J SURG PATHOL, V31, P673, DOI 10.1097/01.pas.0000213438.01278.5f; Jenkins D, 2007, KIDNEY INT, V71, P195, DOI 10.1038/sj.ki.5002053; Jimenez T, 2011, BIOL REPROD, V84, P153, DOI 10.1095/biolreprod.110.087064; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kampf C, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-103; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kong KL, 2010, CANCER RES, V70, P8832, DOI 10.1158/0008-5472.CAN-10-0779; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Morgan MAJ, 2012, J NEUROCHEM, V121, P843, DOI 10.1111/j.1471-4159.2012.07745.x; N'Dow J, 2000, J UROLOGY, V164, P1398, DOI 10.1016/S0022-5347(05)67206-0; Nissim S, 2006, DEV BIOL, V299, P12, DOI 10.1016/j.ydbio.2006.05.026; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheth R, 2013, DEVELOPMENT, V140, P2130, DOI 10.1242/dev.089409; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Yamany T, 2014, CURR OPIN ORGAN TRAN, V19, P323, DOI 10.1097/MOT.0000000000000084; Yang MH, 2011, BIOCHEM BIOPH RES CO, V411, P714, DOI 10.1016/j.bbrc.2011.07.010; Yang YF, 2008, DIS ESOPHAGUS, V21, P395, DOI 10.1111/j.1442-2050.2007.00789.x; Ying SB, 2009, J DERMATOL SCI, V53, P2, DOI 10.1016/j.jdermsci.2008.09.009; Zhang SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091466; Zhu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028223	35	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145301	10.1371/journal.pone.0145301	http://dx.doi.org/10.1371/journal.pone.0145301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694548	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092500037
J	Kohli, M; Wang, LG; Xie, F; Sicotte, H; Yin, P; Dehm, SM; Hart, SN; Vedell, PT; Barman, P; Qin, R; Mahoney, DW; Carlson, RE; Eckel-Passow, JE; Atwell, TD; Eiken, PW; McMenomy, BP; Wieben, ED; Jha, G; Jimenez, RE; Weinshilboum, R; Wang, LW				Kohli, Manish; Wang, Liguo; Xie, Fang; Sicotte, Hugues; Yin, Ping; Dehm, Scott M.; Hart, Steven N.; Vedell, Peter T.; Barman, Poulami; Qin, Rui; Mahoney, Douglas W.; Carlson, Rachel E.; Eckel-Passow, Jeanette E.; Atwell, Thomas D.; Eiken, Patrick W.; McMenomy, Brendan P.; Wieben, Eric D.; Jha, Gautam; Jimenez, Rafael E.; Weinshilboum, Richard; Wang, Liewei			Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy	PLOS ONE			English	Article							CANCER; EVOLUTION; MODELS	Developing patient derived models from individual tumors that capture the biological heterogeneity and mutation landscape in advanced prostate cancer is challenging, but essential for understanding tumor progression and delivery of personalized therapy in metastatic castrate resistant prostate cancer stage. To demonstrate the feasibility of developing patient derived xenograft models in this stage, we present a case study wherein xenografts were derived from cancer metastases in a patient progressing on androgen deprivation therapy and prior to initiating pre-chemotherapy enzalutamide treatment. Tissue biopsies from a metastatic rib lesion were obtained for sequencing before and after initiating enzalutamide treatment over a twelve-week period and also implanted subcutaneously as well as under the renal capsule in immuno-deficient mice. The genome and transcriptome landscapes of xenografts and the original patient tumor tissues were compared by performing whole exome and transcriptome sequencing of the metastatic tumor tissues and the xenografts at both time points. After comparing the somatic mutations, copy number variations, gene fusions and gene expression we found that the patient's genomic and transcriptomic alterations were preserved in the patient derived xenografts with high fidelity. These xenograft models provide an opportunity for predicting efficacy of existing and potentially novel drugs that is based on individual metastatic tumor expression signature and molecular pharmacology for delivery of precision medicine.	[Kohli, Manish; Yin, Ping] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Wang, Liguo; Sicotte, Hugues; Hart, Steven N.; Vedell, Peter T.; Barman, Poulami; Qin, Rui; Mahoney, Douglas W.; Carlson, Rachel E.; Eckel-Passow, Jeanette E.] Mayo Clin, Dept Hlth Sci, Div Biomed Stat & Informat, Rochester, MN USA; Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Dehm, Scott M.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Atwell, Thomas D.; Eiken, Patrick W.; McMenomy, Brendan P.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Wieben, Eric D.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Jha, Gautam] Univ Minnesota, Div Hematol Oncol, Minneapolis, MN USA; [Jimenez, Rafael E.] Mayo Clin, Dept Pathol & Lab Med, Rochester, MN USA; [Xie, Fang; Weinshilboum, Richard; Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic	Kohli, M (corresponding author), Mayo Clin, Dept Oncol, Rochester, MN 55905 USA.	kohli.manish@mayo.edu; wang.liguo@mayo.edu	Barman, Poulami/ABG-1426-2020; Kohli, Manish/AAN-8862-2021; Hart, Steven/AAI-4761-2021; Jimenez, Rafael/AAG-9814-2020	Barman, Poulami/0000-0002-4604-9868; Hart, Steven/0000-0001-7714-2734; Wang, Liguo/0000-0003-2072-4826	National Institutes of Health [R01CA174777]; Minnesota Partnership for Biotechnology and Medical Genomics grant [14.37]; Mayo Clinic Centre for Individualized Medicine; Mayo Clinic Schulze Cancer for Novel Therapeutics in Cancer Research; Pharmacogenomics Research Network; NATIONAL CANCER INSTITUTE [R01CA174777, P30CA015083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership for Biotechnology and Medical Genomics grant; Mayo Clinic Centre for Individualized Medicine; Mayo Clinic Schulze Cancer for Novel Therapeutics in Cancer Research; Pharmacogenomics Research Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by National Institutes of Health grant R01CA174777 (to S. M. D.), http://projectreporter.nih.gov/project_info_details.cfm?aid=8826081&icde=25365178&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC, Minnesota Partnership for Biotechnology and Medical Genomics grant #14.37 (to M. K. and S. M. D.), http://minnesotapartnership.info/2015/04/minnesotapartnership-awards-six-new-research-grants/ and Private and philanthropy funding sources: i) The study is funded in part by the Mayo Clinic Centre for Individualized Medicine; ii) A. T. Suharya and Ghan D. H.; iii) Joseph and Gail Gassner; iv) Mayo Clinic Schulze Cancer for Novel Therapeutics in Cancer Research. v) Pharmacogenomics Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study is supported by the Mayo Clinic Centre for Individualized Medicine and the Pharmacogenomics Research Network (PGRN). This work was also supported by NIH grant R01CA174777 (to S.M.D.)	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Barbieri CE, 2013, EUR UROL, V64, P567, DOI 10.1016/j.eururo.2013.05.029; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Beltran H, 2014, CLIN CANCER RES, V20, P2846, DOI 10.1158/1078-0432.CCR-13-3309; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Corey E, 2003, PROSTATE, V56, P110, DOI 10.1002/pros.10235; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Kalari KR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-224; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Lawrence MG, 2013, NAT PROTOC, V8, P836, DOI 10.1038/nprot.2013.043; Li Y, 2012, ONCOGENE, V31, P4759, DOI 10.1038/onc.2011.637; Lin D, 2014, ASIAN J ANDROL, V16, P407, DOI 10.4103/1008-682X.125394; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nicholson TM, 2013, JOVE-J VIS EXP, DOI 10.3791/50574; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pritchyk KM, 2002, LARYNGOSCOPE, V112, P1598, DOI 10.1097/00005537-200209000-00012; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Roth A, 2012, BIOINFORMATICS; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Spiotto Michael T, 2013, J Oral Maxillofac Res, V4, pe1, DOI 10.5037/jomr.2013.4101; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Allen EM, 2014, PROSTATE CANCER P D, V17, P23, DOI 10.1038/pcan.2013.37; Wang C, 2014, BIOINFORMATICS; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317	35	17	17	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145176	10.1371/journal.pone.0145176	http://dx.doi.org/10.1371/journal.pone.0145176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695660	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500026
J	Rehm, C; Wurmthaler, LA; Li, YH; Frickey, T; Hartig, JS				Rehm, Charlotte; Wurmthaler, Lena A.; Li, Yuanhao; Frickey, Tancred; Hartig, Joerg S.			Investigation of a Quadruplex-Forming Repeat Sequence Highly Enriched in Xanthomonas and Nostoc sp.	PLOS ONE			English	Article							NON-B DNA; INDUCED GENETIC INSTABILITY; I-MOTIF; ESCHERICHIA-COLI; NEISSERIA-GONORRHOEAE; PROKARYOTIC GENOMES; ANTIGENIC VARIATION; PROMOTER REGION; TANDEM REPEATS; BACTERIAL ADAPTATION	In prokaryotes simple sequence repeats (SSRs) with unit sizes of 1-5 nucleotides (nt) are causative for phase and antigenic variation. Although an increased abundance of heptameric repeats was noticed in bacteria, reports about SSRs of 6-9 nt are rare. In particular G-rich repeat sequences with the propensity to fold into G-quadruplex (G4) structures have received little attention. In silico analysis of prokaryotic genomes show putative G4 forming sequences to be abundant. This report focuses on a surprisingly enriched G-rich repeat of the type GGGNATC in Xanthomonas and cyanobacteria such as Nostoc. We studied in detail the genomes of Xanthomonas campestris pv. campestris ATCC 33913 (Xcc), Xanthomonas axonopodis pv. citri str. 306 (Xac), and Nostoc sp. strain PCC7120 (Ana). In all three organisms repeats are spread all over the genome with an over-representation in non-coding regions. Extensive variation of the number of repetitive units was observed with repeat numbers ranging from two up to 26 units. However a clear preference for four units was detected. The strong bias for four units coincides with the requirement of four consecutive G-tracts for G4 formation. Evidence for G4 formation of the consensus repeat sequences was found in biophysical studies utilizing CD spectroscopy. The G-rich repeats are preferably located between aligned open reading frames (ORFs) and are under-represented in coding regions or between divergent ORFs. The G-rich repeats are preferentially located within a distance of 50 bp upstream of an ORF on the anti-sense strand or within 50 bp from the stop codon on the sense strand. Analysis of whole transcriptome sequence data showed that the majority of repeat sequences are transcribed. The genetic loci in the vicinity of repeat regions show increased genomic stability. In conclusion, we introduce and characterize a special class of highly abundant and wide-spread quadruplex-forming repeat sequences in bacteria.	[Rehm, Charlotte; Wurmthaler, Lena A.; Hartig, Joerg S.] Univ Konstanz, Dept Chem, D-78457 Constance, Germany; [Rehm, Charlotte; Wurmthaler, Lena A.; Hartig, Joerg S.] Univ Konstanz, Konstanz Res Sch Chem Biol KoRS CB, D-78457 Constance, Germany; [Li, Yuanhao; Frickey, Tancred] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Konstanz; University of Konstanz; University of Konstanz	Hartig, JS (corresponding author), Univ Konstanz, Dept Chem, Univ Str 10, D-78457 Constance, Germany.	joerg.hartig@uni-konstanz.de			China Scholarship Council; Konstanz Research School Chemical Biology; SFB 969	China Scholarship Council(China Scholarship Council); Konstanz Research School Chemical Biology; SFB 969	We thank the members of the Hartig group for helpful discussions. Yuanhao Li thanks the China Scholarship Council for financial support. Jorg S. Hartig thanks the Konstanz Research School Chemical Biology and the SFB 969 for financial support.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beaume N, 2013, NUCLEIC ACIDS RES, V41, P76, DOI 10.1093/nar/gks1071; Benabou S, 2014, BBA-GEN SUBJECTS, V1840, P41, DOI 10.1016/j.bbagen.2013.08.028; Bichara M, 2006, MUTAT RES-FUND MOL M, V598, P144, DOI 10.1016/j.mrfmmm.2006.01.020; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bolger AM, 2014, BIOINFORMATICS; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cahoon LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003074; Cahoon LA, 2011, MOL MICROBIOL, V81, P1136, DOI 10.1111/j.1365-2958.2011.07773.x; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Choi J, 2011, CHEM SOC REV, V40, P5893, DOI 10.1039/c1cs15153c; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Collin D, 1998, J AM CHEM SOC, V120, P4069, DOI 10.1021/ja973346r; CORREIA FF, 1988, J BIOL CHEM, V263, P12194; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Day HA, 2014, BIOORGAN MED CHEM, V22, P4407, DOI 10.1016/j.bmc.2014.05.047; Delihas N, 2011, GENOME BIOL EVOL, V3, P959, DOI 10.1093/gbe/evr077; Du XJ, 2013, NUCLEIC ACIDS RES, V41, P5965, DOI 10.1093/nar/gkt308; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Endoh T, 2013, ANAL CHEM, V85, P11435, DOI 10.1021/ac402497x; Endoh T, 2013, ANGEW CHEM INT EDIT, V52, P5522, DOI 10.1002/anie.201300058; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gur-Arie R, 2000, GENOME RES, V10, P62; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Han XG, 1998, J MOL BIOL, V278, P949, DOI 10.1006/jmbi.1998.1740; Hannan AJ, 2010, DISCOV MED, V10, P314; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; Holder Isabelle T, CHEM BIOL; Holder Isabelle T, 2014, CHEM BIOL, V21, P1511; HTUN H, 1989, SCIENCE, V243, P1571, DOI 10.1126/science.2648571; Huang YJ, 2014, DNA RES, V21, P285, DOI 10.1093/dnares/dst057; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Jalan N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-551; Joachimi A, 2009, BIOORGAN MED CHEM, V17, P6811, DOI 10.1016/j.bmc.2009.08.043; JOHNSTON BH, 1992, METHOD ENZYMOL, V211, P127; Joukhadar Reem, 2012, BMC Res Notes, V5, P556, DOI 10.1186/1756-0500-5-556; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Kassai-Jager E, 2008, GENE, V410, P18, DOI 10.1016/j.gene.2007.11.006; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lacroix L, 1996, BIOCHEMISTRY-US, V35, P8715, DOI 10.1021/bi960107s; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lin WH, 2012, NUCLEIC ACIDS RES, V40, P2399, DOI 10.1093/nar/gkr1078; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MALFOY B, 1986, NUCLEIC ACIDS RES, V14, P3197, DOI 10.1093/nar/14.8.3197; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; MAZEL D, 1990, J BACTERIOL, V172, P2755, DOI 10.1128/jb.172.5.2755-2761.1990; McLuckie KIE, 2011, J AM CHEM SOC, V133, P2658, DOI 10.1021/ja109474c; MERGNY JL, 1995, J AM CHEM SOC, V117, P8887, DOI 10.1021/ja00140a001; MIRKIN SM, 1994, ANNU REV BIOPH BIOM, V23, P541, DOI 10.1146/annurev.bb.23.060194.002545; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Mrazek J, 2006, MOL BIOL EVOL, V23, P1370, DOI 10.1093/molbev/msk023; Mrazek J, 2007, P NATL ACAD SCI USA, V104, P8472, DOI 10.1073/pnas.0702412104; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Schlotterer C, 2006, J EVOLUTION BIOL, V19, P1671, DOI 10.1111/j.1420-9101.2006.01108.x; Shabala L, 2009, ENVIRON MICROBIOL, V11, P137, DOI 10.1111/j.1462-2920.2008.01748.x; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; SWANSON RV, 1992, J BACTERIOL, V174, P2640, DOI 10.1128/jb.174.8.2640-2647.1992; Tobes R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-62; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; van Belkum A, 1999, RES MICROBIOL, V150, P617, DOI 10.1016/S0923-2508(99)00129-1; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; VANHAM SM, 1993, CELL, V73, P1187, DOI 10.1016/0092-8674(93)90647-9; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang GL, 2006, MUTAT RES-FUND MOL M, V598, P103, DOI 10.1016/j.mrfmmm.2006.01.019; Wang GL, 2014, DNA REPAIR, V19, P143, DOI 10.1016/j.dnarep.2014.03.017; Wang GL, 2009, MOL CARCINOGEN, V48, P286, DOI 10.1002/mc.20508; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Wieland M, 2007, CHEM BIOL, V14, P757, DOI 10.1016/j.chembiol.2007.06.005; Xu Y, 2006, NUCLEIC ACIDS RES, V34, P949, DOI 10.1093/nar/gkj485; Yadav VK, 2008, NUCLEIC ACIDS RES, V36, pD381, DOI 10.1093/nar/gkm781; Yang J, 2003, GENE, V322, P85, DOI 10.1016/j.gene.2003.09.017; Zhou K, 2014, FEMS MICROBIOL REV, V38, P119, DOI 10.1111/1574-6976.12036	85	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144275	10.1371/journal.pone.0144275	http://dx.doi.org/10.1371/journal.pone.0144275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695179	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092500003
J	Puig, MS; Zapata, LP; Puigcerver, L; Iglesias, NE; Garcia, CS; Romeo, A; Crespillo, JC; Super, H				Sole Puig, Maria; Perez Zapata, Laura; Puigcerver, Laura; Esperalba Iglesias, Neus; Sanchez Garcia, Carmen; Romeo, August; Canete Crespillo, Josep; Super, Hans			Attention-Related Eye Vergence Measured in Children with Attention Deficit Hyperactivity Disorder	PLOS ONE			English	Article							CONVERGENCE INSUFFICIENCY; BINOCULAR COORDINATION; MOVEMENTS; MICROSACCADES; DISPARITY; NEURONS; ABNORMALITIES; CORTEX; GAZE; AREA	Recent evidence shows a novel role for eye vergence in orienting attention in adult subjects. Here we investigated whether such modulation in eye vergence by attention is present in children and whether it is altered in children with ADHD compared to control subjects. We therefore measured the angle of eye vergence in children previously diagnosed with ADHD while performing a cue task and compared the results to those from agematched controls. We observed a strong modulation in the angle of vergence in the control group and a weak modulation in the ADHD group. In addition, in the control group the modulation in eye vergence was different between the informative cue and uninformative cue condition. This difference was less noticeable in the ADHD group. Our study supports the observation of deficient binocular vision in ADHD children. We argue that the observed disruption in vergence modulation in ADHD children is manifest of altered cognitive processing of sensory information. Our work may provide new insights into attention disorders, like ADHD.	[Sole Puig, Maria; Perez Zapata, Laura; Puigcerver, Laura; Romeo, August; Super, Hans] Univ Barcelona, Fac Psychol, Dept Basic Psychol, Barcelona, Spain; [Sole Puig, Maria; Perez Zapata, Laura; Puigcerver, Laura; Romeo, August; Super, Hans] Hosp St Joan de Deu HSJD, Barcelona, Spain; [Esperalba Iglesias, Neus; Sanchez Garcia, Carmen; Canete Crespillo, Josep] Consorci Sanitari Maresme CSdM, Dept Mental Hlth, Mataro, Spain; [Super, Hans] Inst Brain Cognit & Behav IR3C, Barcelona, Spain; [Super, Hans] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	University of Barcelona; University of Barcelona; ICREA	Super, H (corresponding author), Univ Barcelona, Fac Psychol, Dept Basic Psychol, Barcelona, Spain.	hans.super@icrea.cat	CAÑETE, JOSE/H-6715-2014; Puigcerver, Laura/I-1114-2015	CAÑETE, JOSE/0000-0002-1368-6801; Puigcerver, Laura/0000-0002-6443-5869; Super, Hans/0000-0001-9328-0096; Sole Puig, Maria/0000-0002-4331-3432	Spanish Ministry of Education and Science (MICINN) [PSI2010-18139, SAF2009-10367]; Catalan government (AGAUR) [2009-SGR-308]; ICREA Funding Source: Custom	Spanish Ministry of Education and Science (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan government (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); ICREA(ICREA)	This work was supported by grants to HS (PSI2010-18139 & SAF2009-10367) from the Spanish Ministry of Education and Science (MICINN) and (2009-SGR-308) from the Catalan government (AGAUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JA, 2004, DEV NEUROPSYCHOL, V26, P627, DOI 10.1207/s15326942dn2602_6; Alvarez TL, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00050; Arnsten AF, 2006, TRENDS COGN SCI, V10, P124; Awh E, 2006, EXP BRAIN RES, V152, P444; Bisley JW, 2011, J PHYSIOL-LONDON, V589, P49, DOI 10.1113/jphysiol.2010.192666; Blythe HI, 2006, VISION RES, V46, P3898, DOI 10.1016/j.visres.2006.06.006; Borsting E, 2011, OPTOMETRY VISION SCI, V88; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Borsting Eric, 2005, Optometry, V76, P588, DOI 10.1016/j.optm.2005.07.007; Bucci MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033458; Bucci MP, 2006, VISION RES, V46, P457, DOI 10.1016/j.visres.2005.05.004; Bush G, 2011, BIOL PSYCHIAT, V69, P1160, DOI 10.1016/j.biopsych.2011.01.022; Chaturvedi V, 2000, EXP BRAIN RES, V132, P72, DOI 10.1007/s002219900221; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P157, DOI 10.1113/jphysiol.1988.sp017284; Coubard OA, 2013, EUR J NEUROSCI, V38, P3384, DOI 10.1111/ejn.12356; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; Cumming BG, 2002, NATURE, V418, P633, DOI 10.1038/nature00909; DAUM KM, 1984, AM J OPTOM PHYS OPT, V61, P16; de Zeeuw P, 2012, HUM BRAIN MAPP, V33, P1941, DOI 10.1002/hbm.21335; di Michele F, 2005, INT J PSYCHOPHYSIOL, V58, P81, DOI 10.1016/j.ijpsycho.2005.03.011; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; Fried M, 2014, VISION RES, V101, P62, DOI 10.1016/j.visres.2014.05.004; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Gamlin PDR, 2002, ANN NY ACAD SCI, V956, P264, DOI 10.1111/j.1749-6632.2002.tb02825.x; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; Granet DB, 2005, STRABISMUS, V13, P163, DOI 10.1080/09273970500455436; Hafed ZM, 2002, VISION RES, V42, P2533, DOI 10.1016/S0042-6989(02)00263-8; Heller D, 1999, CURRENT OCULOMOTOR RESEARCH, P341; Johnston BA, 2014, HUM BRAIN MAPP, V35, P5179, DOI 10.1002/hbm.22542; JUDGE SJ, 1986, J NEUROPHYSIOL, V55, P915, DOI 10.1152/jn.1986.55.5.915; Kara P, 2009, NATURE, V458, P627, DOI 10.1038/nature07721; Kiorpes L, 2013, J VISION, V13, P469, DOI [10.1167/13.9.469, DOI 10.1167/13.9.469]; Kirkby JA, 2008, PSYCHOL BULL, V134, P742, DOI 10.1037/a0012979; Kirkby JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027105; Ko HK, 2010, NAT NEUROSCI, V13, P1549, DOI 10.1038/nn.2663; Krain AL, 2006, CLIN PSYCHOL REV, V26, P433, DOI 10.1016/j.cpr.2006.01.005; Kuntsi J, 2006, PSYCHOL MED, V36, P1613, DOI 10.1017/S0033291706008580; Leth-Steensen C, 2000, ACTA PSYCHOL, V104, P167, DOI 10.1016/S0001-6918(00)00019-6; Liversedge SP, 2006, VISION RES, V46, P2363, DOI 10.1016/j.visres.2006.01.013; Marran LF, 2006, OPTOMETRY VISION SCI, V83, P281, DOI 10.1097/01.opx.0000216097.78951.7b; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Masson GS, 1997, NATURE, V389, P283, DOI 10.1038/38496; MAYS LE, 1984, J NEUROPHYSIOL, V51, P1091, DOI 10.1152/jn.1984.51.5.1091; Mezer E, 2012, EUR J OPHTHALMOL, V22, P931, DOI 10.5301/ejo.5000145; Mostofsky SH, 2001, NEUROLOGY, V57, P423, DOI 10.1212/WNL.57.3.423; Munoz DP, 2003, J NEUROPHYSIOL, V90, P503, DOI 10.1152/jn.00192.2003; NICE Clinical Guidelines, 2009, BRIT PSYCH SOC ROYAL, V72; Nitta T, 2008, PROG BRAIN RES, V171, P173, DOI 10.1016/S0079-6123(08)00623-7; Zapata LP, 2013, VISION RES, V86, P15, DOI 10.1016/j.visres.2013.04.005; Poltavski DV, 2012, VISION RES, V63, P1, DOI 10.1016/j.visres.2012.04.017; Prado C, 2007, VISION RES, V47, P2521, DOI 10.1016/j.visres.2007.06.001; Rommelse NNJ, 2008, BRAIN COGNITION, V68, P391, DOI 10.1016/j.bandc.2008.08.025; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P1169, DOI 10.1097/OPX.0b013e3181baad13; Rouse MW, 1999, OPTOMETRY VISION SCI, V76, P643, DOI 10.1097/00006324-199909000-00022; Rucci M, 2003, J VISION, V3, P852, DOI 10.1167/3.11.18; Seassau M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00085; Puig MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052955; Soliva Juan Carlos, 2011, Expert Opin Med Diagn, V5, P307, DOI 10.1517/17530059.2011.577413; Super H, 2003, J NEUROSCI, V23, P3407; Super H, 2001, CEREB CORTEX, V11, P1101, DOI 10.1093/cercor/11.12.1101; Super H, 2014, J VISION, V14, P9; Super H, 2007, NEUROPSYCHOLOGIA, V45, P3329, DOI 10.1016/j.neuropsychologia.2007.07.001; Suzuki S, 2004, NEUROSCI RES, V49, P39, DOI 10.1016/j.neures.2004.01.009; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; van der Togt C, 2006, CEREB CORTEX, V16, P136, DOI 10.1093/cercor/bhi093; Versino M, 1996, BRAIN, V119, P1933, DOI 10.1093/brain/119.6.1933; Williams MA, 2008, NAT NEUROSCI, V11, P1439, DOI 10.1038/nn.2218	69	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145281	10.1371/journal.pone.0145281	http://dx.doi.org/10.1371/journal.pone.0145281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694162	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500035
J	Wang, XG; Sun, J; Hu, JH				Wang, Xuguo; Sun, Jun; Hu, JinHong			IMQ Induced K14-VEGF Mouse: A Stable and Long-Term Mouse Model of Psoriasis-Like Inflammation	PLOS ONE			English	Article							DENDRITIC CELLS; SKIN INFLAMMATION; PLAQUE-FORMATION; T-CELLS; VEGF; IDENTIFICATION; LYMPHOCYTES; RECEPTOR; DENSITY; IL-23	An imiquimod (IMQ) induced wild type (WT) mouse can mimic some features of psoriasis, such as thickened skin, abnormal keratinocyte-related proteins, infiltration of inflammatory cells and pro-inflammatory cytokines. This model is a prevalent model that is widely used in the study of psoriasis. However, skin inflammation decreases during the eighth day when IMQ is given to WT mice, which may result in false results when evaluating the pharmacodynamics effects of a drug. To extend the timeliness and inherit the advantages of this model, we applied IMQ to the skin of 8-week-old homozygous K14-VEGF mice to investigate whether IMQ can prolong mice ear inflammation. In our experiments, we found that, compared to the IMQ induced WT mice model, the IMQ induced K14-VEGF mice have serious skin inflammation, even on the fourteenth day. We also evaluated the stability of skin inflammation at days 8, 10, and 13, and the inflammatory situation remained stable in the skin. This research intends to improve the existing model, and we hypothesize that the IMQ induced K14-VEGF mouse will become a practical mouse model in psoriasis research.	[Wang, Xuguo; Hu, JinHong] Second Mil Med Univ, Changhai Hosp, Dept Pharm, Shanghai, Peoples R China; [Sun, Jun] Jinan Mil Area, Gen Hosp, Dept Pharm, Jinan, Shandong, Peoples R China	Naval Medical University	Hu, JH (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Pharm, Shanghai, Peoples R China.	wxh201309@126.com						Beutner KR, 1998, J AM ACAD DERMATOL, V38, P230, DOI 10.1016/S0190-9622(98)70243-9; Brenner D, 2007, BLOOD, V110, P3968, DOI 10.1182/blood-2007-01-071167; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; El Malki K, 2013, J INVEST DERMATOL, V133, P441, DOI 10.1038/jid.2012.318; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Kim TG, 2014, J INVEST DERMATOL, V134, P1462, DOI 10.1038/jid.2013.534; Lindroos J, 2011, J INVEST DERMATOL, V131, P1110, DOI 10.1038/jid.2010.432; Micali G, 2010, INT J DERMATOL, V49, P249, DOI 10.1111/j.1365-4632.2009.04287.x; Moniaga CS, 2011, J DERMATOL SCI, V61, P79, DOI 10.1016/j.jdermsci.2010.11.005; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nordlind K, 2008, EXP DERMATOL, V17, P301, DOI 10.1111/j.1600-0625.2007.00670.x; Palamara F, 2004, J IMMUNOL, V173, P3051, DOI 10.4049/jimmunol.173.5.3051; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Steinmann A, 2000, J AM ACAD DERMATOL, V43, P555, DOI 10.1067/mjd.2000.107954; Sun J.-P., 2013, ELECT J DIFFERENTIAL, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0067078; Suzuki T, 2014, J DERMATOL SCI, V74, P116, DOI 10.1016/j.jdermsci.2013.12.013; Taneda K, 2011, BRIT J DERMATOL, V165, P277, DOI 10.1111/j.1365-2133.2011.10347.x; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Uribe-Herranz M, 2013, J INVEST DERMATOL, V133, P1541, DOI 10.1038/jid.2012.512; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wagner EF, 2010, NAT REV RHEUMATOL, V6, P704, DOI 10.1038/nrrheum.2010.157; Walter A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2566; Wary Kishore K, 2003, Mol Cancer, V2, P25, DOI 10.1186/1476-4598-2-25; Witte E, 2014, J INVEST DERMATOL, V134, P2757, DOI 10.1038/jid.2014.308; Wohn C, 2013, P NATL ACAD SCI USA, V110, P10723, DOI 10.1073/pnas.1307569110; Wolk K, 2003, J BIOL CHEM, V278, P18030, DOI 10.1074/jbc.M207714200; Wu Jason K, 2004, Australas J Dermatol, V45, P47, DOI 10.1111/j.1440-0960.2004.00030.x; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Zaba LC, 2009, J INVEST DERMATOL, V129, P302, DOI 10.1038/jid.2008.225	33	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145498	10.1371/journal.pone.0145498	http://dx.doi.org/10.1371/journal.pone.0145498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691862	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300083
J	Lacour, G; Chanaud, L; L'Ambert, G; Hance, T				Lacour, Guillaume; Chanaud, Lionel; L'Ambert, Gregory; Hance, Thierry			Seasonal Synchronization of Diapause Phases in Aedes albopictus (Diptera: Culicidae)	PLOS ONE			English	Article							CHIKUNGUNYA VIRUS; RANGE EXPANSION; TEMPERATURE; POPULATIONS; DENGUE; EVOLUTION; MOSQUITO; SKUSE; OVIPOSITION; PHOTOPERIOD	In temperate areas, population dynamics of the invasive Asian tiger mosquito Aedes albopictus are strongly affected by winter. The work we present here analyzes the adaptive synchronization of the diapause process in the wintry generation of A. albopictus, where the egg stage is exposed to adverse winter conditions. The seasonal pattern of egg laying activity of a French Mediterranean population of the Asian tiger mosquito was monitored weekly for 2 years with ovitraps. The field diapause incidence and the critical photoperiod (CPP, i.e. the maternal day length inducing diapause in 50% of the eggs), were determined by hatching experiments on the collected eggs. The period of diapause termination was estimated by a field survey of the first hatchings for both years. The CPP is equal to 13.5 hours of light and occurs in the field on the 25th of August. Thus, it is on September 11th, 17 days after the CPP, that 50% of the eggs are in a prediapause stage in the field. The egg diapause rate increases rapidly during September, whereas the mean number of eggs laid decreases sharply after mid-September. Surprisingly, after having reached a peak of 95% at the end of September, from mid-October the diapause incidence declined and stayed below 50%. Indeed, both years the diapause initiates before the rapid decrease of the environmental temperature. This leaves a sufficient period of time to the complete development of one generation of A. albopictus with effective induction of diapause in the laid eggs. The very first larvae hatched were sampled both years in the first half of March. With 20 to 26 weeks in the egg stage and about 7 weeks in the larval stages, the first annual generation spends a long time in immature stages. On a practical point of view, this long development time represents a wide window for eggs and larvae control in early spring.	[Lacour, Guillaume; Chanaud, Lionel; L'Ambert, Gregory] EID Mediterranee, Montpellier, France; [Lacour, Guillaume; Hance, Thierry] Catholic Univ Louvain, Earth & Life Inst, Ctr Rech Biodiversite, Louvain, Belgium	Universite Catholique Louvain	Lacour, G (corresponding author), EID Mediterranee, Montpellier, France.	glacour@eid-med.org	Lacour, Guillaume/AAQ-5935-2021	Lacour, Guillaume/0000-0002-9588-6064	EID Mediterranee; French ministry in charge of health, Direction Generale de la Sante (DGS)	EID Mediterranee; French ministry in charge of health, Direction Generale de la Sante (DGS)	This work was supported by EID Mediterranee and the French ministry in charge of health, Direction Generale de la Sante (DGS).r The authors are grateful to the EID Mediterranee (EID) staff for helping to provide mosquito egg samples, Myriam Cros for the map and Nathalie Barras for English revision. This work was supported by EID Mediterranee and the French ministry in charge of health, Direction Generale de la Sante (DGS). This paper is number BRC343 of the Biodiversity Research Centre.	Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340; Andreadis TG, 2010, J AM MOSQUITO CONTR, V26, P257, DOI 10.2987/10-6004.1; [Anonymous], 2015, EURO SURVEILL; Bean DW, 2012, EVOL APPL, V5, P511, DOI 10.1111/j.1752-4571.2012.00262.x; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338; Bueno-Mari R, 2015, J VECTOR DIS, V52, P175; Caminade C, 2012, J R SOC INTERFACE; Claeys C, 2013, INT REV SOC RES, V3, P151, DOI DOI 10.1515/IRSR-2013-0015; Collantes Francisco, 2014, Anales de Biologia, V36, P71, DOI 10.6018/analesbio.36.12; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Delaunay P, 2007, Med Trop (Mars), V67, P310; Denlinger DL, 2014, ANNU REV ENTOMOL, V59, P73, DOI 10.1146/annurev-ento-011613-162023; Dieng H, 2012, INT J BIOMETEOROL, V56, P113, DOI 10.1007/s00484-011-0402-0; European Center for Disease Control and Prevention, 2013, ENV RISK MAPP AED AL; Fonseca DM, 2015, J MED ENTOMOL, V52, P705, DOI 10.1093/jme/tjv060; Fontenille D, 2007, ECOL CONT VECTOR-BOR, V1, P169; Giatropoulos A, 2012, J MED ENTOMOL, V49, P262, DOI 10.1603/ME11096; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Giron S., 2015, Bulletin Epidemiologique Hebdomadaire, P217; Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Halstead S. B., 2008, Dengue; Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kuno G, 2012, J MED ENTOMOL, V49, P1163, DOI 10.1603/ME12022; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Lacour G, 2014, J INSECT PHYSIOL, V71, P87, DOI 10.1016/j.jinsphys.2014.10.008; Lounibos LP, 2011, J AM MOSQUITO CONTR, V27, P433, DOI 10.2987/11-6164.1; Lounibos LP, 2003, ANN ENTOMOL SOC AM, V96, P512, DOI 10.1603/0013-8746(2003)096[0512:AEOPDI]2.0.CO;2; Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661; MCNAMARA JM, 1994, J THEOR BIOL, V168, P201, DOI 10.1006/jtbi.1994.1099; Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2; MITCHELL CJ, 1995, J VECTOR ECOL, V20, P44; Mogi M, 2012, J MED ENTOMOL, V49, P1233, DOI 10.1603/ME12104; Musolin DL, 2012, ENTOMOL REV, V92, P715, DOI DOI 10.1134/S0013873812070019; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; POZZA GLD, 1994, J AM MOSQUITO CONTR, V10, P589; PUMPUNI CB, 1992, J AM MOSQUITO CONTR, V8, P223; Pumpuni CB, 1989, FACTORS INFLUENCING; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098; Romi R, 2006, J AM MOSQUITO CONTR, V22, P149, DOI 10.2987/8756-971X(2006)22[149:CAAOOF]2.0.CO;2; Sinegre G, 1974, THESIS, P280; Tauber M.J., 1986, SEASONAL ADAPTATIONS, P411; Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100; Toma L, 2003, J AM MOSQUITO CONTR, V19, P19; Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698; TRPIS M, 1970, CAN J ZOOLOG, V48, P892, DOI 10.1139/z70-158; Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x; Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709; Velo E, 2012, 18 E SOVE C 2012 OCT; Vinogradova E.B., 2007, DIAPAUSE AQUATIC INV, P83, DOI DOI 10.1007/978-1-4020-5680-2_5; Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100; [No title captured]	56	29	30	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145311	10.1371/journal.pone.0145311	http://dx.doi.org/10.1371/journal.pone.0145311			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683460	Green Submitted, Green Published, gold			2022-12-27	WOS:000366725800062
J	Xing, JY; Song, GP; Deng, JP; Jiang, LZ; Xiong, P; Yang, BJ; Liu, SS				Xing, Jie-yu; Song, Gao-peng; Deng, Jun-peng; Jiang, Ling-zhi; Xiong, Ping; Yang, Bin-jie; Liu, Shan-shan			Antitumor Effects and Mechanism of Novel Emodin Rhamnoside Derivatives against Human Cancer Cells In Vitro	PLOS ONE			English	Article							INDUCED APOPTOSIS; DOWN-REGULATION; GENE-EXPRESSION; SCC-4 CELLS; INHIBITION; GEMCITABINE; GLYCOSIDES; MIGRATION; INVASION; DEATH	A series of novel anthracene L-rhamnopyranosides compounds were designed and synthesized and their anti-proliferative activities on cancer cell lines were investigated. We found that one derivative S-8 (EM-d-Rha) strongly inhibited cell proliferation of a panel of different human cancer cell lines including A549, HepG2, OVCAR-3, HeLa and K562 and SGC-790 cell lines, and displayed IC50 values in low micro-molar ranges, which are ten folds more effective than emodin. In addition, we found EM-d-Rha (3-(2 '',3 ''-Di-O-acetyl-alpha-L-rhamnopyranosyl-(1 -> 4)-2',3'-di-O-acetyl-alpha-L-rhamnopyranosyl)-emodin) substantially induced cellular apoptosis of HepG2 and OVCAR-3 cells in the early growth stage. Furthermore, EM-d-Rha led to the decrease of mitochondrial transmembrane potential, and up-regulated the express of cells apoptosis factors in a concentration-and time-dependent manner. The results indicated the EM-d-Rha may inhibit the growth and proliferation of HepG2 cells through the pathway of apoptosis induction, and the possible molecular mechanism may due to the activation of intrinsic apoptotic signal pathway.	[Xing, Jie-yu; Song, Gao-peng; Xiong, Ping; Yang, Bin-jie; Liu, Shan-shan] South China Agr Univ, Dept Pharmaceut Engn, Guangzhou, Guangdong, Peoples R China; [Deng, Jun-peng] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Jiang, Ling-zhi] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen, Guangdong, Peoples R China	South China Agricultural University; Oklahoma State University System; Oklahoma State University - Stillwater; Shenzhen University	Jiang, LZ (corresponding author), Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen, Guangdong, Peoples R China.	jlz2004@szu.edu.cn; xp0000542003@scau.edu.cn			Major Program of Science and Technology Program of Guangzhou, China [11C32100704]; Reserch Project of Chinese Medicine Administration of Guangdong province, China [2010276]; Natural Science Foundation for Youths, China [B020602]	Major Program of Science and Technology Program of Guangzhou, China; Reserch Project of Chinese Medicine Administration of Guangdong province, China; Natural Science Foundation for Youths, China	This work was supported by the Major Program of Science and Technology Program of Guangzhou (PX, 11C32100704), China, Reserch Project of Chinese Medicine Administration of Guangdong province(px, 2010276), China and the Natural Science Foundation for Youths (GPS & PX, B020602), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carter GT, 2011, NAT PROD REP, V28, P1783, DOI 10.1039/c1np00033k; Cha TL, 2005, CANCER RES, V65, P2287, DOI 10.1158/0008-5472.CAN-04-3250; Chen H, 2011, ONCOL REP, V25, P1253, DOI 10.3892/or.2011.1174; Chen YY, 2010, INT J ONCOL, V36, P1113; Chun-Guang W, 2010, EUR J PHARMACOL, V627, P33, DOI 10.1016/j.ejphar.2009.10.035; Damodharan U, 2011, APPL BIOCHEM BIOTECH, V165, P1245, DOI 10.1007/s12010-011-9342-8; Han YM, 2012, BIOORG MED CHEM LETT, V22, P323, DOI 10.1016/j.bmcl.2011.11.008; [何林 He Lin], 2011, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V33, P2370; Hsu CM, 2010, BIOCHEM BIOPH RES CO, V392, P473, DOI 10.1016/j.bbrc.2009.10.153; Huang ZW, 2008, ARCH PHARM RES, V31, P742, DOI 10.1007/s12272-001-1221-6; Huang ZW, 2009, CANCER DETECT PREV, V32, P286, DOI 10.1016/j.cdp.2008.12.003; Kaneshiro T, 2006, EUR J PHARMACOL, V553, P46, DOI 10.1016/j.ejphar.2006.09.026; Kim R, 2002, CANCER CHEMOTH PHARM, V50, P343, DOI 10.1007/s00280-002-0522-7; Ko JC, 2010, LUNG CANCER, V69, P155, DOI 10.1016/j.lungcan.2009.10.013; Ko JC, 2010, BIOCHEM PHARMACOL, V79, P655, DOI 10.1016/j.bcp.2009.09.024; Lai JM, 2009, EUR J PHARMACOL, V623, P1, DOI 10.1016/j.ejphar.2009.08.031; Li J, 2015, J CANCER RES CLIN, V141, P283, DOI 10.1007/s00432-014-1820-2; Li P., 2004, CELL, V116, pS59; Li XX, 2013, STEM CELLS DEV, V22, P554, DOI 10.1089/scd.2011.0709; Li XX, 2012, BIOCHEM BIOPH RES CO, V419, P728, DOI 10.1016/j.bbrc.2012.02.090; LIN CN, 1991, PHYTOCHEMISTRY, V30, P3103, DOI 10.1016/S0031-9422(00)98262-1; LIN CN, 1990, PHYTOCHEMISTRY, V29, P3903, DOI 10.1016/0031-9422(90)85356-K; Lin SY, 2009, ANTICANCER RES, V29, P327; Liu A, 2011, ONCOL REP, V26, P81, DOI 10.3892/or.2011.1257; Liu DL, 2012, INT J ONCOL, V40, P1049, DOI 10.3892/ijo.2011.1285; Liu JX, 2012, ONCOL REP, V28, P1991, DOI 10.3892/or.2012.2042; Ma YS, 2012, FOOD CHEM TOXICOL, V50, P1271, DOI 10.1016/j.fct.2012.01.033; Mai LP, 2001, J NAT PROD, V64, P1162, DOI 10.1021/np010030v; Manu KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057015; Muto A, 2007, MOL CANCER THER, V6, P987, DOI 10.1158/1535-7163.MCT-06-0605; Ok S, 2012, IMMUNOPHARM IMMUNOT, V34, P768, DOI 10.3109/08923973.2012.654494; RAO JUM, 1986, J NAT PROD, V49, P343, DOI 10.1021/np50044a028; Ricci JE, 2003, CELL DEATH DIFFER, V10, P488, DOI 10.1038/sj.cdd.4401225; Song GP, 2010, BIOORGAN MED CHEM, V18, P5183, DOI 10.1016/j.bmc.2010.05.064; Su YT, 2005, BIOCHEM PHARMACOL, V70, P229, DOI 10.1016/j.bcp.2005.04.026; Subramaniam A, 2013, APOPTOSIS, V18, P1175, DOI 10.1007/s10495-013-0851-5; Teich L, 2004, BIOORGAN MED CHEM, V12, P5961, DOI 10.1016/j.bmc.2004.08.024; WAGNER H, 1974, Z NATURFORSCH C, VC 29, P204; Wang SP, 2012, INT J PHARMACEUT, V430, P238, DOI 10.1016/j.ijpharm.2012.03.027; Wang W, 2010, BIOCHEM PHARMACOL, V79, P1134, DOI 10.1016/j.bcp.2009.12.006; Wang WF, 2013, MED CHEM, V9, P545, DOI 10.2174/1573406411309040008; Wang XD, 2007, BIOL PHARM BULL, V30, P1113, DOI 10.1248/bpb.30.1113; Wang Xin-hua, 2004, Yaoxue Xuebao, V39, P254; Wang YX, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-71; Xie QC, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-377; Yan YY, 2014, J BUON, V19, P650; Yan YY, 2008, MOL CANCER THER, V7, P1688, DOI 10.1158/1535-7163.MCT-07-2362; Yi J, 2008, NEOPLASIA, V10, P41, DOI 10.1593/neo.07754; Yim H, 1999, PLANTA MED, V65, P9, DOI 10.1055/s-1999-13953; Zhang W, 2013, INT J ONCOL, V42, P1189, DOI 10.3892/ijo.2013.1839	50	22	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144781	10.1371/journal.pone.0144781	http://dx.doi.org/10.1371/journal.pone.0144781			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682731	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800021
J	Kim, TH; Joung, JY; Kang, M; Choi, SK; Kim, K; Jang, JY; Cho, YY; Min, YK; Chung, JH; Kim, SW				Kim, Tae Hyuk; Joung, Ji Young; Kang, Mira; Choi, Sun Kyu; Kim, Kyunga; Jang, Ju Young; Cho, Yoon Young; Min, Yong-Ki; Chung, Jae Hoon; Kim, Sun Wook			A Modest Protective Effect of Thyrotropin against Bone Loss Is Associated with Plasma Triiodothyronine Levels	PLOS ONE			English	Article							SUBCLINICAL THYROID-DYSFUNCTION; TYPE-2 IODOTHYRONINE DEIODINASE; MINERAL DENSITY; POSTMENOPAUSAL WOMEN; INCREASED RISK; HIP FRACTURE; NORMAL RANGE; TSH; HYPERTHYROIDISM; METAANALYSIS	Background The independent skeletal effect of thyrotropin (thyroid stimulating hormone, TSH) has been suggested in animal studies. However, clinical data on the association between bone loss and variations in TSH levels is inconsistent. This study aimed to investigate the relationship between TSH levels and bone mineral density (BMD). Methods We conducted a cross-sectional study with 37,431 subjects (33,052 cases with euthyroidism and 4,379 cases with subclinical thyroid dysfunction) aged over 35 years. We performed thyroid function tests and measured BMD at the lumbar spine, femur neck, and total hip. Results Levels of TSH and T3 were positively correlated in women (r = 0.076, P = 0.001) and uncorrelated in men. In both men and women, TSH levels correlated positively and T3 levels correlated negatively with BMD at all skeletal sites in age and body mass index adjusted analyses. BMD increased steadily with TSH levels from the subclinical hyperthyroid to subclinical hypothyroid range in subjects with T3 levels in the highest tertile (119.5-200.0 ng/dL), but was no longer significant in subjects with lower plasma T3 levels. Conclusions The variations in TSH levels within the euthyroid and subclinical range were positively correlated with BMD in healthy men and women. The negative effect of T3 on BMD appears to be compensated for by increased TSH in subjects with plasma T3 levels in the upper normal range.	[Kim, Tae Hyuk; Joung, Ji Young; Jang, Ju Young; Cho, Yoon Young; Min, Yong-Ki; Chung, Jae Hoon; Kim, Sun Wook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea; [Kang, Mira] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Hlth Promot, Seoul, South Korea; [Choi, Sun Kyu; Kim, Kyunga] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Biostat & Clin Epidemiol Ctr,Res Inst Future Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea.	swkimmd@skku.edu	Kim, Tae Hyuk/B-9921-2013; KIM, SUN WOOK/I-9389-2017	Kim, Tae Hyuk/0000-0002-7975-2437; choe, seongyu/0000-0001-8827-7060	Samsung Medical Center grant [CRP1500078]	Samsung Medical Center grant(Samsung)	This study was supported by Samsung Medical Center grant [#CRP1500078]. All authors are employed by a not-for-profit organization, Samsung Medical Center, Seoul, Korea. The organization provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SM, 2014, CLIN ENDOCRINOL, V81, P633, DOI 10.1111/cen.12538; Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Asvold BO, 2007, ARCH INTERN MED, V167, P1428, DOI 10.1001/archinte.167.13.1428; Baliram R, 2012, J CLIN INVEST, V122, P3737, DOI 10.1172/JCI63948; Bassett JHD, 2010, P NATL ACAD SCI USA, V107, P7604, DOI 10.1073/pnas.0911346107; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Blum MR, 2015, JAMA-J AM MED ASSOC, V313, P2055, DOI 10.1001/jama.2015.5161; Brennan SL, 2009, J BONE MINER RES, V24, P809, DOI [10.1359/JBMR.081243, 10.1359/jbmr.081243]; de Lloyd A, 2010, J ENDOCRINOL, V204, P13, DOI 10.1677/JOE-09-0262; Faber J, 1998, CLIN ENDOCRINOL, V48, P285; FABER J, 1994, EUR J ENDOCRINOL, V130, P350, DOI 10.1530/eje.0.1300350; Garin MC, 2014, J CLIN ENDOCR METAB, V99, P2657, DOI 10.1210/jc.2014-1051; Grimnes G, 2008, THYROID, V18, P1147, DOI 10.1089/thy.2008.0158; Kim KM, 2014, J CLIN ENDOCR METAB, V99, P2409, DOI 10.1210/jc.2014-1006; Kim TH, 2013, J CLIN ENDOCR METAB, V98, P3420, DOI 10.1210/jc.2013-1607; Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841; Leader A, 2014, J CLIN ENDOCR METAB, V99, P2665, DOI 10.1210/jc.2013-2474; LEE MS, 1990, J CLIN ENDOCR METAB, V70, P766, DOI 10.1210/jcem-70-3-766; Lin JD, 2011, ENDOCR RES, V36, P1, DOI 10.3109/07435800.2010.514877; Morimura T, 2005, ENDOCRINOLOGY, V146, P2077, DOI 10.1210/en.2004-1432; MOSEKILDE L, 1990, ENDOCRIN METAB CLIN, V19, P35, DOI 10.1016/S0889-8529(18)30338-4; MOSEKILDE L, 1978, ACTA ENDOCRINOL-COP, V87, P751, DOI 10.1530/acta.0.0870751; MUDDE AH, 1994, CLIN ENDOCRINOL, V41, P421, DOI 10.1111/j.1365-2265.1994.tb02571.x; Murphy E, 2010, J CLIN ENDOCR METAB, V95, P3173, DOI 10.1210/jc.2009-2630; Sampath TK, 2007, J BONE MINER RES, V22, P849, DOI 10.1359/JBMR.070302; Sun L, 2008, P NATL ACAD SCI USA, V105, P4289, DOI 10.1073/pnas.0712395105; Wirth CD, 2014, ANN INTERN MED, V161, P189, DOI 10.7326/M14-0125	28	6	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145292	10.1371/journal.pone.0145292	http://dx.doi.org/10.1371/journal.pone.0145292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679692	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400068
J	Belo, VS; Werneck, GL; da Silva, ES; Barbosa, DS; Struchiner, CJ				Belo, Vincius Silva; Werneck, Guilherme Loureiro; da Silva, Eduardo Sergio; Barbosa, David Soeiro; Struchiner, Claudio Jose			Population Estimation Methods for Free-Ranging Dogs: A Systematic Review	PLOS ONE			English	Review							JOLLY-SEBER MODEL; STRAY DOGS; CANINE POPULATIONS; ABUNDANCE; SIZE; PARAMETERS; MANAGEMENT; DYNAMICS; ECOLOGY; DENSITY	The understanding of the structure of free-roaming dog populations is of extreme importance for the planning and monitoring of populational control strategies and animal welfare. The methods used to estimate the abundance of this group of dogs are more complex than the ones used with domiciled owned dogs. In this systematic review, we analyze the techniques and the results obtained in studies that seek to estimate the size of free-ranging dog populations. Twenty-six studies were reviewed regarding the quality of execution and their capacity to generate valid estimates. Seven of the eight publications that take a simple count of the animal population did not consider the different probabilities of animal detection; only one study used methods based on distances; twelve relied on capture-recapture models for closed populations without considering heterogeneities in capture probabilities; six studies applied their own methods with different potential and limitations. Potential sources of bias in the studies were related to the inadequate description or implementation of animal capturing or viewing procedures and to inadequacies in the identification and registration of dogs. Thus, there was a predominance of estimates with low validity. Abundance and density estimates carried high variability, and all studies identified a greater number of male dogs. We point to enhancements necessary for the implementation of future studies and to potential updates and revisions to the recommendations of the World Health Organization with respect to the estimation of free-ranging dog populations.	[Belo, Vincius Silva; Barbosa, David Soeiro; Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Dept Endemias Samuel Pessoa, Rio De Janeiro, RJ, Brazil; [Werneck, Guilherme Loureiro] Univ Estado Rio de Janeiro, Dept Epidemiol, Inst Med Social, BR-20550011 Rio De Janeiro, Brazil; [Belo, Vincius Silva; da Silva, Eduardo Sergio] Univ Fed Sao Joao del Rei, Divinopolis, MG, Brazil	Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Universidade Federal de Sao Joao del-Rei	Belo, VS (corresponding author), Fundacao Oswaldo Cruz, Dept Endemias Samuel Pessoa, Rio De Janeiro, RJ, Brazil.	viniciusbelo4@hotmail.com	Werneck, Guilherme/A-2841-2013; Struchiner, Claudio Jose/HGB-9492-2022; Silva, Eduardo Sergio/B-3777-2018; Belo, Vinícius Silva/AAP-6532-2020; Struchiner, Claudio J/M-9360-2013; Silva, Eduardo/N-7254-2019	Werneck, Guilherme/0000-0003-1169-1436; Belo, Vinícius Silva/0000-0003-0183-1175; Struchiner, Claudio J/0000-0003-2114-847X; Silva, Eduardo/0000-0001-7409-9216				Aiyedun J. O., 2012, Sokoto Journal of Veterinary Sciences, V10, P22, DOI 10.4314/sokjvs.v10i1.5; Alves AJS, 2013, CONTINUOUS ED J VET, V11, P32; Amaku M, 2010, MATH POPUL STUD, V17, P69, DOI 10.1080/08898481003689452; Amstrup SC, 2005, HANDBOOK OF CAPTURE-RECAPTURE ANALYSIS, P1; ARTOIS M, 1986, COMP IMMUNOL MICROB, V9, P4; Ashe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075228; Beck A.M., 1973, ECOLOGY STRAY DOGS S; Belo VS, 2013, VET PARASITOL, V195, P1, DOI 10.1016/j.vetpar.2013.03.010; Belsare AV, 2013, PREV VET MED, V111, P139, DOI 10.1016/j.prevetmed.2013.04.003; BERMAN M, 1983, APPL ANIM ETHOL, V10, P5, DOI 10.1016/0304-3762(83)90107-4; Borchers D, 2012, J ORNITHOL, V152, pS435, DOI 10.1007/s10336-010-0583-z; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; BULLOCK JA, 1969, J ZOOL, V159, P167; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Childs JE, 1998, PREV VET MED, V33, P207, DOI 10.1016/S0167-5877(97)00039-1; Cormack R., 2002, INT ENCY SOCIAL BEHA, P11809; Cowen L, 2006, BIOMETRICS, V62, P699, DOI 10.1111/j.1541-0420.2006.00523.x; Dalla Villa P, 2010, PREV VET MED, V97, P58, DOI 10.1016/j.prevetmed.2010.07.001; DANIELS TJ, 1989, J MAMMAL, V70, P754, DOI 10.2307/1381709; de Little Siobhan C., 2007, BMC Ecology, V7, P3, DOI 10.1186/1472-6785-7-3; Dias RA, 2013, PREV VET MED, V110, P263, DOI 10.1016/j.prevetmed.2012.12.002; Downes MJ, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-121; Faleke O. O., 2003, Nigerian Journal of Animal Production, V30, P242; Fei SY, 2012, ENVIRON ECOL STAT, V19, P485, DOI 10.1007/s10651-012-0197-0; Fernandez FAZ., 1995, BRASILIENSIS ECOLOGY, V2; FONT E, 1987, APPL ANIM BEHAV SCI, V17, P319, DOI 10.1016/0168-1591(87)90155-9; Gsell AS, 2012, BMC VET RES, V8, P1, DOI 10.1186/1746-6148-8-236; Guthlin D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094537; Guilloux AGA., 2011, THESIS; Hiby LR, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-46; Hogasen HR, 2013, PREV VET MED, V112, P401, DOI 10.1016/j.prevetmed.2013.07.010; Hossain M, 2013, PREV VET MED, V111, P134, DOI 10.1016/j.prevetmed.2013.03.008; Huggins R, 2007, STAT PROBABIL LETT, V77, P649, DOI 10.1016/j.spl.2006.09.012; Ibarra L, 2006, AVANCES CIENCIAS VET, V21, P33, DOI DOI 10.5354/0719-5273.2010.3953; Ivanter EV, 2008, RUSS J ECOL+, V39, P105, DOI 10.1134/S1067413608020057; Johnson HE, 2010, J APPL ECOL, V47, P1083, DOI 10.1111/j.1365-2664.2010.01846.x; Kalati K, 2010, STREET DOG POPULATIO; Kato M, 2003, ACTA MED OKAYAMA, V57, P261; Kendall WL, 2002, ECOLOGY, V83, P3276; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kirkeby C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061269; Lunney M, 2011, PREV VET MED, V102, P315, DOI 10.1016/j.prevetmed.2011.07.017; Manning JA, 2010, METHODS ECOL EVOL, V1, P389, DOI 10.1111/j.2041-210X.2010.00041.x; MARGAWANI KR, 1995, VET REC, V137, P486, DOI 10.1136/vr.137.19.486; Garcia RDM, 2012, REV PANAM SALUD PUBL, V32, P140, DOI 10.1590/S1020-49892012000800008; Massei G, 2013, THERIOGENOLOGY, V80, P829, DOI 10.1016/j.theriogenology.2013.07.016; Matos Marina Ruiz de, 2002, Cad. Saúde Pública, V18, P1423, DOI 10.1590/S0102-311X2002000500035; Matter HC, 2000, ACTA TROP, V75, P95, DOI 10.1016/S0001-706X(99)00085-6; McClintock BT, 2009, ECOLOGY, V90, P313, DOI 10.1890/08-0973.1; McClintock BT, 2009, MODELING DEMOGRAPHIC; McDonald TL, 2003, WILDLIFE SOC B, V31, P814; Mills L. S., 2007, CONSERVATION WILDLIF; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; Oli MK, 2020, ECOLOGY, V101, DOI 10.1002/ecy.2969; Pal SK, 2001, ACTA THERIOL, V46, P69, DOI 10.1007/BF03192418; Pledger S, 2003, BIOMETRICS, V59, P786, DOI 10.1111/j.0006-341X.2003.00092.x; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Punjabi GA, 2012, TROP CONSERV SCI, V5, P510, DOI 10.1177/194008291200500408; Reece JF, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-6; Royle JA, 2009, J APPL ECOL, V46, P118, DOI 10.1111/j.1365-2664.2008.01578.x; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Sawaya MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034777; Schumacher FX, 1942, J TENN ACAD SCI, V17, P228; Schwarz CJ, 2001, J AGR BIOL ENVIR ST, V6, P195, DOI 10.1198/108571101750524706; Schwarz CJ, 1999, STAT SCI, V14, P427; Serafini CAV, 2008, ZOONOSES PUBLIC HLTH, V55, P402, DOI 10.1111/j.1863-2378.2008.01171.x; Shimozako AJ, 2008, PHOTOGRAPHIC CAPTURE; Skrzypczak U., 2010, WILDLIFE PHOTOGRAPHY; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Sutherland WJ, 2006, ECOLOGICAL CENSUS TECHNIQUES: A HANDBOOK, 2ND EDITION, P1, DOI 10.2277/ 0521606365; Tenzin, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001391; Torres PC, 2010, BRAZ J BIOL, V70, P987, DOI 10.1590/S1519-69842010000500010; Totton SC, 2010, PREV VET MED, V97, P51, DOI 10.1016/j.prevetmed.2010.07.009; Tung MengChih, 2010, Journal of the Chinese Society of Animal Science, V39, P175; Ugbomoiko Uade Samuel, 2008, BMC Vet Res, V4, P49, DOI 10.1186/1746-6148-4-49; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Vial F, 2011, AFR J ECOL, V49, P91, DOI 10.1111/j.1365-2028.2010.01233.x; White GC, 2009, RADIO TRACKING ANIMA; Willians BK, 2002, ANAL MANAGEMENT ANIM; World Health Organization/World Society for the Protection of Animals, 1990, GUID DOG POP MAN	81	23	24	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144830	10.1371/journal.pone.0144830	http://dx.doi.org/10.1371/journal.pone.0144830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673165	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700065
J	Garcia, N; Feranec, RS; Passey, BH; Cerling, TE; Arsuaga, JL				Garcia, Nuria; Feranec, Robert S.; Passey, Benjamin H.; Cerling, Thure E.; Luis Arsuaga, Juan			Exploring the Potential of Laser Ablation Carbon Isotope Analysis for Examining Ecology during the Ontogeny of Middle Pleistocene Hominins from Sima de los Huesos (Northern Spain)	PLOS ONE			English	Article							INTRA-TOOTH VARIATION; STABLE CARBON; DIETARY HABITS; FOSSIL MAMMALS; ENAMEL; ATAPUERCA; COLLAGEN; BONE; DISCRIMINATION; SEQUENCE	Laser ablation of tooth enamel was used to analyze stable carbon isotope compositions of teeth of hominins, red deer, and bears from middle Pleistocene sites in the Sierra de Atapuerca in northern Spain, to investigate the possibility that this technique could be used as an additional tool to identify periods of physiological change that are not detectable as changes in tooth morphology. Most of the specimens were found to have minimal intratooth variation in carbon isotopes (< 2.3 parts per thousand), suggesting isotopically uniform diets through time and revealing no obvious periods of physiological change. However, one of the two sampled hominin teeth displayed a temporal carbon isotope shift (3.2 parts per thousand) that was significantly greater than observed for co-occurring specimens. The delta C-13 value of this individual averaged about -16 parts per thousand early in life, and -13 parts per thousand later in life. This isotopic change occurred on the canine crown about 4.2 mm from the root, which corresponds to an approximate age of two to four years old in modern humans. Our dataset is perforce small owing to the precious nature of hominid teeth, but it demonstrates the potential utility of the intra-tooth isotope profile method for extracting ontogenetic histories of human ancestors.	[Garcia, Nuria; Luis Arsuaga, Juan] Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, E-28040 Madrid, Spain; [Garcia, Nuria; Luis Arsuaga, Juan] Ctr Mixto UCM ISCIII Evoluc & Comportamiento Huma, Madrid 28029, Spain; [Feranec, Robert S.] New York State Museum & Sci Serv, Res & Collect Div, Cultural Educ Ctr 3140, Albany, NY 12230 USA; [Passey, Benjamin H.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Cerling, Thure E.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA	Complutense University of Madrid; Complutense University of Madrid; UCM-ISCIII Center for Human Evolution & Behavior; Johns Hopkins University; Utah System of Higher Education; University of Utah	Arsuaga, JL (corresponding author), Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, Ciudad Univ, E-28040 Madrid, Spain.	jlarsuaga@isciii.es		Cerling, Thure/0000-0002-3590-294X; Arsuaga, Juan Luis/0000-0001-5361-2295	Ministerio de Ciencia e Innovacion [CGL2009-12703-C03-03]; Programa (convocatoria) de Estancias de Doctores y Tecnologos Extranjeros en la Universidad Complutense-Grupo Santander (Madrid, Spain); NY State Museum	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Programa (convocatoria) de Estancias de Doctores y Tecnologos Extranjeros en la Universidad Complutense-Grupo Santander (Madrid, Spain); NY State Museum	Funding for this project was provided by the Ministerio de Ciencia e Innovacion (CGL2009-12703-C03-03), Programa (convocatoria 2010) de Estancias de Doctores y Tecnologos Extranjeros en la Universidad Complutense-Grupo Santander (Madrid, Spain), and the NY State Museum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kelley Feranec for help with figures, Rebeca Garcia (Laboratory of Human Evolution, University of Burgos) for SEM microscope pictures, and Rolf Quam and two anonymous reviewers for helpful comments and criticisms that improved this manuscript. Funding for this project was provided by the Ministerio de Ciencia e Innovacion (CGL2009-12703-C03-03), Programa (convocatoria 2010) de Estancias de Doctores y Tecnologos Extranjeros en la Universidad Complutense-Grupo Santander (Madrid, Spain), and the NY State Museum.	Anderson D L, 1976, J Forensic Sci, V21, P191; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Balaisse M, 2001, J ARCHAEOL SCI, V28, P235, DOI 10.1006/jasc.1999.0535; Balasse M, 2002, J ARCHAEOL SCI, V29, P853, DOI 10.1006/jasc.2001.0725; Bescos GC, 2001, ANTHROPOLOGIE, V105, P115; Bischoff JL, 2007, J ARCHAEOL SCI, V34, P763, DOI 10.1016/j.jas.2006.08.003; Bischoff JL, 1997, J HUM EVOL, V33, P129, DOI 10.1006/jhev.1997.0130; Bocherens H, 1997, QUATERNARY RES, V48, P370, DOI 10.1006/qres.1997.1927; BOCHERENS H, 1994, PALAEOGEOGR PALAEOCL, V107, P213, DOI 10.1016/0031-0182(94)90095-7; Bocherens H., 1991, Bulletin du Musee d'Anthropologie Prehistorique de Monaco, V34, P29; Bocherens H, 2001, J HUM EVOL, V40, P497, DOI 10.1006/jhev.2000.0452; BOCHERENS H, 1991, J HUM EVOL, V20, P481, DOI 10.1016/0047-2484(91)90021-M; Bocherens Herve, 2003, Deinsea, V9, P57; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Cerling TE, 1996, PALAEOGEOGR PALAEOCL, V126, P173, DOI 10.1016/S0031-0182(96)00078-8; Cerling TE, 2004, OECOLOGIA, V138, P5, DOI 10.1007/s00442-003-1375-4; Codron J, 2005, J ARCHAEOL SCI, V32, P1757, DOI 10.1016/j.jas.2005.06.006; COLLINS RP, 1985, VEGETATIO, V64, P121; CONSTANDSEWESTERMANN TS, 1984, P K NED AKAD B PHYS, V87, P139; Cuenca-Bescos G, 2010, QUATERN INT, V212, P109, DOI 10.1016/j.quaint.2009.06.007; CuencaBescos G, 1997, J HUM EVOL, V33, P175, DOI 10.1006/jhev.1997.0153; Cunha E, 2004, AM J PHYS ANTHROPOL, V125, P220, DOI 10.1002/ajpa.10402; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; DECASTRO JMB, 1995, AM J PHYS ANTHROPOL, V96, P301, DOI 10.1002/ajpa.1330960307; Demuro M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110169; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DeSantis LRG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005750; Dettwyler Katherine A., 1995, BREASTFEEDING, P39, DOI [10.4324/9781315081984-2, DOI 10.4324/9781315081984-2]; Drucker D, 2003, PALAEOGEOGR PALAEOCL, V195, P375, DOI 10.1016/S0031-0182(03)00366-3; EHLERINGER JR, 1993, ANNU REV ECOL SYST, V24, P411, DOI 10.1146/annurev.es.24.110193.002211; EHLERINGER JR, 1991, TRENDS ECOL EVOL, V6, P95, DOI 10.1016/0169-5347(91)90183-X; Falgueres C, 1999, J HUM EVOL, V37, P343, DOI 10.1006/jhev.1999.0326; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Feranec R, 2010, PALAEOGEOGR PALAEOCL, V297, P263, DOI 10.1016/j.palaeo.2010.08.006; Feranec RS, 2007, PALAEOGEOGR PALAEOCL, V252, P575, DOI 10.1016/j.palaeo.2007.05.012; Feranec RS, 2009, PALAEOGEOGR PALAEOCL, V271, P153, DOI 10.1016/j.palaeo.2008.10.005; Feranec RS, 2006, PALEOBIOLOGY, V32, P191, DOI 10.1666/05006.1; Fricke HC, 1996, PALAEOGEOGR PALAEOCL, V126, P91, DOI 10.1016/S0031-0182(96)00072-7; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P279, DOI 10.1002/ajpa.20249; Garcia Garcia N, 2003, OSOS OTROS CARNIVORO; Garcia N, 1997, J HUM EVOL, V33, P155, DOI 10.1006/jhev.1997.0154; Garcia NG, 2009, J ARCHAEOL SCI, V36, P1142, DOI 10.1016/j.jas.2008.12.018; Garcia N, 2011, QUATERNARY SCI REV, V30, P1413, DOI 10.1016/j.quascirev.2010.11.008; GARTEN CT, 1992, OECOLOGIA, V90, P1, DOI 10.1007/BF00317801; Harris EF, 2002, DENT ANTHR J, V16, P15, DOI 10.26575/daj.v16i1.165; Heaton THE, 1999, J ARCHAEOL SCI, V26, P637, DOI 10.1006/jasc.1998.0381; Henry AG, 2012, NATURE, V487, P90, DOI 10.1038/nature11185; Iacumin P, 2000, PALAEOGEOGR PALAEOCL, V163, P33, DOI 10.1016/S0031-0182(00)00141-3; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Kohn MJ, 2004, GEOCHIM COSMOCHIM AC, V68, P403, DOI 10.1016/S0016-7037(03)00443-5; KRUEGER HW, 1991, J ARCHAEOL SCI, V18, P355, DOI 10.1016/0305-4403(91)90071-V; Lee-Thorp J, 2003, J ANTHROPOL ARCHAEOL, V22, P208, DOI 10.1016/S0278-4165(03)00035-7; Arsuaga JL, 2010, P NATL ACAD SCI USA, V107, P8910, DOI 10.1073/pnas.0914614107; Macfadden BJ, 1996, J VERTEBR PALEONTOL, V16, P103, DOI 10.1080/02724634.1996.10011288; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; MOLE S, 1994, OECOLOGIA, V97, P316, DOI 10.1007/BF00317320; Monson R.K., 1999, C4 PLANT BIOL, P339; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Palmqvist P, 2003, PALEOBIOLOGY, V29, P205, DOI 10.1666/0094-8373(2003)029<0205:PROALP>2.0.CO;2; Passey BH, 2006, CHEM GEOL, V235, P238, DOI 10.1016/j.chemgeo.2006.07.002; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Passey BH, 2002, GEOCHIM COSMOCHIM AC, V66, P3225, DOI 10.1016/S0016-7037(02)00933-X; Pettitt PB, 2000, WORLD ARCHAEOL, V31, P351, DOI 10.1080/713781494; Richards MP, 2008, P NATL ACAD SCI USA, V105, P600, DOI 10.1073/pnas.0711063105; Richards MP, 2000, P NATL ACAD SCI USA, V97, P7663, DOI 10.1073/pnas.120178997; Richards MP, 2002, AM J PHYS ANTHROPOL, V119, P205, DOI 10.1002/ajpa.10124; Rozzi FVR, 2004, NATURE, V428, P936, DOI 10.1038/nature02428; SCHOENINGER MJ, 1982, NATURE, V297, P577, DOI 10.1038/297577a0; Sellen DW, 2001, HUM NATURE-INT BIOS, V12, P47, DOI 10.1007/s12110-001-1013-y; Sellen DW, 2001, J NUTR, V131, P2707, DOI 10.1093/jn/131.10.2707; TIESZEN LL, 1979, OECOLOGIA, V37, P351, DOI 10.1007/BF00347911; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; VOGEL JC, 1978, S AFR J SCI, V74, P298; WANG Y, 1994, PALAEOGEOGR PALAEOCL, V107, P281, DOI 10.1016/0031-0182(94)90100-7; Williams JS, 2005, AM J PHYS ANTHROPOL, V128, P781, DOI 10.1002/ajpa.20229; WOOD JW, 1992, CURR ANTHROPOL, V33, P343, DOI 10.1086/204084; Wright LE, 1998, AM J PHYS ANTHROPOL, V106, P1; Zazzo A, 2005, GEOCHIM COSMOCHIM AC, V69, P3631, DOI 10.1016/j.gca.2005.02.031; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P1, DOI 10.1016/S0016-7037(03)00278-3	81	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0142895	10.1371/journal.pone.0142895	http://dx.doi.org/10.1371/journal.pone.0142895			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673156	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700007
J	Smyslova, P; Popa, I; Lycka, A; Tejral, G; Hlavac, J				Smyslova, Petra; Popa, Igor; Lycka, Antonin; Tejral, Gracian; Hlavac, Jan			Non-Catalyzed Click Reactions of ADIBO Derivatives with 5-Methyluridine Azides and Conformational Study of the Resulting Triazoles	PLOS ONE			English	Article							COPPER-FREE CLICK; ALKYNE CYCLOADDITION; CHEMISTRY; NANOPARTICLES; NUCLEOSIDES; PROTEIN	Copper-free click reactions between a dibenzoazocine derivative and azides derived from 5-methyluridine were investigated. The non-catalyzed reaction yielded both regioisomers in an approximately equivalent ratio. The NMR spectra of each regioisomer revealed conformational isomery. The ratio of isomers was dependent on the type of regioisomer and the type of solvent. The synthesis of various analogs, a detailed NMR study and computational modeling provided evidence that the isomery was dependent on the interaction of the azocine and pyrimidine parts.	[Smyslova, Petra; Popa, Igor; Hlavac, Jan] Inst Mol & Translat Med, Olomouc, Czech Republic; [Smyslova, Petra; Hlavac, Jan] Palacky Univ, Fac Sci, Dept Organ Chem, CR-77147 Olomouc, Czech Republic; [Lycka, Antonin] Univ Hradec Kralove, Fac Sci, Hradec Kralove, Czech Republic; [Tejral, Gracian] Charles Univ Prague, Inst Biophys, Fac Med 2, Prague 5, Czech Republic; [Tejral, Gracian] Acad Sci Czech Republic, Inst Expt Med, Lab Tissue Engn, Prague 4, Czech Republic	Palacky University Olomouc; University of Hradec Kralove; Charles University Prague; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Hlavac, J (corresponding author), Inst Mol & Translat Med, Olomouc, Czech Republic.	hlavac@orgchem.upol.cz		Lycka, Antonin/0000-0002-8911-5044	Ministry of Education, Youth and Sport of the Czech Republic [IGA_PrF_2015_007]; Technological Agency CR [TE01020028]; European Social Fund [CZ.1.07/2.3.00/20.0009]; National Program of sustainability [LO1304]; MetaCentrum [LM2010005]	Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Technological Agency CR; European Social Fund(European Social Fund (ESF)); National Program of sustainability; MetaCentrum	The research in this project was supported by the Ministry of Education, Youth and Sport of the Czech Republic (project IGA_PrF_2015_007), Technological Agency CR (project TE01020028) and by the European Social Fund (CZ.1.07/2.3.00/20.0009). The infrastructure of this project (Institute of Molecular and Translation Medicine) was supported by the National Program of sustainability (project LO1304). Computational resources were provided by the MetaCentrum under the program LM2010005 and the CERIT-SC under the program Centre CERIT Scientific Cloud, part of the Operational Program Research and Development for Innovations, Reg. no. CZ.1.05/3.2.00/08.0144.	Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f; Arumugam S, 2014, J ORG CHEM, V79, P2702, DOI 10.1021/jo500143v; Baskin JM, 2010, ALDRICHIM ACTA, V43, P15; Bostic HE, 2012, CHEM COMMUN, V48, P1431, DOI 10.1039/c1cc14415d; Carpenter RD, 2011, ACS MED CHEM LETT, V2, P885, DOI 10.1021/ml200187j; Carroll L, 2013, ORG BIOMOL CHEM, V11, P5772, DOI 10.1039/c3ob40897c; Cheng ZL, 2011, BIOCONJUGATE CHEM, V22, P2021, DOI 10.1021/bc200214g; Chiacchio U, 2003, TETRAHEDRON, V59, P4733, DOI 10.1016/S0040-4020(03)00689-6; Debets MF, 2010, CHEM COMMUN, V46, P97, DOI 10.1039/b917797c; Frisch G. W., 2013, GAUSSIAN 09; Garland W, 2009, WO patent, Patent No. 2009114325; Hausner SH, 2013, NUCL MED BIOL, V40, P233, DOI 10.1016/j.nucmedbio.2012.10.007; Holstein JM, 2014, CHEM COMMUN, V50, P4478, DOI 10.1039/c4cc01549e; Jang S, 2012, BIOCONJUGATE CHEM, V23, P2256, DOI 10.1021/bc300364z; Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g; Kim HL, 2015, ACS MED CHEM LETT, V6, P402, DOI 10.1021/ml500464f; Lee S B, 2013, ANGEW CHEM INT ED, V52; Lee S, 2014, BIOCONJUGATE CHEM, V25, P601, DOI 10.1021/bc500020g; Li GQ, 2014, MOL PHARMACEUT, V11, P3938, DOI 10.1021/mp500354x; Prim D, 2013, MOLECULES, V18, P9833, DOI 10.3390/molecules18089833; Rajaganesh R, 2011, CARBOHYD RES, V346, P2327, DOI 10.1016/j.carres.2011.07.024; Reschke ML, 2014, BBA-PROTEINS PROTEOM, V1844, P2182, DOI 10.1016/j.bbapap.2014.07.017; Satpati D, 2014, J RADIOANAL NUCL CH, V302, P765, DOI 10.1007/s10967-014-3197-8; Smyslova P., 2012, PREPARATION REACTIVI; Soerensen R S, 2013, ENZYMATIC LIGATION O, V7, P8098, DOI [10.1021/nn403386f, DOI 10.1021/NN403386F]; Starke F, 2010, ARKIVOC, P350, DOI 10.3998/ark.5550190.0011.b28; Wang CF, 2015, BIOMATERIALS, V48, P108, DOI 10.1016/j.biomaterials.2015.01.008; Wang XX, 2014, RSC ADV, V4, P43087, DOI 10.1039/c4ra07574a; WITTIG G, 1961, CHEM BER-RECL, V94, P3260, DOI 10.1002/cber.19610941213; Wittmann JG, 2008, STRUCTURE, V16, P82, DOI 10.1016/j.str.2007.10.020; Zayas J, 2015, BIOCONJUGATE CHEM, V26, P1519, DOI 10.1021/acs.bioconjchem.5b00300; Zhao MX, 2014, J AM CHEM SOC, V136, P15319, DOI 10.1021/ja508083g; Zhou QH, 2013, J AM CHEM SOC, V135, P12994, DOI 10.1021/ja407739y	33	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144613	10.1371/journal.pone.0144613	http://dx.doi.org/10.1371/journal.pone.0144613			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673606	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700048
J	Zere, TR; Vakulskas, CA; Leng, YY; Pannuri, A; Potts, AH; Dias, R; Tang, DJ; Kolaczkowski, B; Georgellis, D; Ahmer, BMM; Romeo, T				Zere, Tesfalem R.; Vakulskas, Christopher A.; Leng, Yuanyuan; Pannuri, Archana; Potts, Anastasia H.; Dias, Raquel; Tang, Dongjie; Kolaczkowski, Bryan; Georgellis, Dimitris; Ahmer, Brian M. M.; Romeo, Tony			Genomic Targets and Features of BarA-UvrY (-SirA) Signal Transduction Systems	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; ESCHERICHIA-COLI; TRANSCRIPTION INITIATION; GENE-EXPRESSION; TRANSLATIONAL REPRESSION; REGULATORY SYSTEM; CHROMOSOMAL GENES; FLHDC EXPRESSION; CSRA; RNA	The two-component signal transduction system BarA-UvrY of Escherichia coli and its orthologs globally regulate metabolism, motility, biofilm formation, stress resistance, virulence of pathogens and quorum sensing by activating the transcription of genes for regulatory sRNAs, e.g. CsrB and CsrC in E. coli. These sRNAs act by sequestering the RNA binding protein CsrA (RsmA) away from lower affinity mRNA targets. In this study, we used ChIP-exo to identify, at single nucleotide resolution, genomic sites for UvrY (SirA) binding in E. coli and Salmonella enterica. The csrB and csrC genes were the strongest targets of cross-linking, which required UvrY phosphorylation by the BarA sensor kinase. Crosslinking occurred at two sites, an inverted repeat sequence far upstream of the promoter and a site near the -35 sequence. DNAse I footprinting revealed specific binding of UvrY in vitro only to the upstream site, indicative of additional binding requirements and/or indirect binding to the downstream site. Additional genes, including cspA, encoding the cold-shock RNA-binding protein CspA, showed weaker crosslinking and modest or negligible regulation by UvrY. We conclude that the global effects of UvrY/SirA on gene expression are primarily mediated by activating csrB and csrC transcription. We also used in vivo crosslinking and other experimental approaches to reveal new features of csrB/csrC regulation by the DeaD and SrmB RNA helicases, IHF, ppGpp and DksA. Finally, the phylogenetic distribution of BarA-UvrY was analyzed and found to be uniquely characteristic of gamma-Proteobacteria and strongly anti-correlated with fliW, which encodes a protein that binds to CsrA and antagonizes its activity in Bacillus subtilis. We propose that BarA-UvrY and orthologous TCS transcribe sRNA antagonists of CsrA throughout the gamma-Proteobacteria, but rarely or never perform this function in other species.	[Zere, Tesfalem R.; Vakulskas, Christopher A.; Leng, Yuanyuan; Pannuri, Archana; Potts, Anastasia H.; Dias, Raquel; Tang, Dongjie; Kolaczkowski, Bryan; Romeo, Tony] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Georgellis, Dimitris] Univ Nacl Autonoma Mexico, Dept Genet Mol, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Ahmer, Brian M. M.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	State University System of Florida; University of Florida; Universidad Nacional Autonoma de Mexico; University System of Ohio; Ohio State University	Romeo, T (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	tromeo@ufl.edu	Ahmer, Brian M. M./F-2228-2010; Georgellis, Dimitris/U-2517-2017	Ahmer, Brian M. M./0000-0002-4267-7322; Georgellis, Dimitris/0000-0002-6114-795X; Vakulskas, Christopher/0000-0001-8510-4332	National Institute of General Medical Sciences [R01GM059969]; National Institute of Allergy and Infectious Diseases; University of Florida Foundation, Inc.; Guangxi Scholarship Fund of Guangxi Education Department; Consejo Nacional de Ciencia y Tecnologia [178033]; Direccion General Asuntos del Personal Academico; Universidad Nacional Autonoma de Mexico [IN209215]; National Institute of Allergy and Infectious Diseases [F32AI100322, R01AI097116]; National Institutes of Health [R01GM059969, F32AI100322, R01AI097116]; DGAPA-UNAM [IN209215]; University of Florida Alumni Graduate Fellowship; Guangxi Scholarship Fund of Guangxi Education Department, PR China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097116, F32AI100322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059969] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Florida Foundation, Inc.(University of Florida); Guangxi Scholarship Fund of Guangxi Education Department; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General Asuntos del Personal Academico; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); University of Florida Alumni Graduate Fellowship(University of Florida); Guangxi Scholarship Fund of Guangxi Education Department, PR China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences, Award Number: R01GM059969 to TR, the National Institute of Allergy and Infectious Diseases to TR, the University of Florida Foundation, Inc., Award Number: Alumni Graduate Fellowships Fund to TRZ, Guangxi Scholarship Fund of Guangxi Education Department to DT, the Consejo Nacional de Ciencia y Tecnologia, Award Number: 178033 to DG, the Direccion General Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico, Award Number: IN209215 to DG, the National Institute of Allergy and Infectious Diseases Award Number: F32AI100322 to CAV, and the National Institute of Allergy and Infectious Diseases Award Number: R01AI097116 to BMMA and TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; These studies were supported in part by the National Institutes of Health (R01AI097116, R01GM059969, F32AI100322), the Consejo Nacional de Ciencia y Tecnologia (178033), the DGAPA-UNAM (IN209215), a University of Florida Alumni Graduate Fellowship (T.Z.) and the Guangxi Scholarship Fund of Guangxi Education Department, PR China (D.T.).	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Altier C, 2000, MOL MICROBIOL, V35, P635, DOI 10.1046/j.1365-2958.2000.01734.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Broberg M, 2014, APPL ENVIRON MICROB, V80, P1972, DOI 10.1128/AEM.03829-13; Camacho MI, 2015, J BACTERIOL, V197, P983, DOI 10.1128/JB.02325-14; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dessimoz C, 2012, BIOINFORMATICS, V28, P900, DOI 10.1093/bioinformatics/bts050; Dias R, 2014, J BIOINF COMPUT BIOL, V12, DOI 10.1142/S0219720014500139; Edwards AN, 2011, MOL MICROBIOL, V80, P1561, DOI 10.1111/j.1365-2958.2011.07663.x; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Chavez RG, 2010, J BACTERIOL, V192, P2009, DOI 10.1128/JB.01685-09; Goodier RI, 2001, J BACTERIOL, V183, P2249, DOI 10.1128/JB.183.7.2249-2258.2001; GOOSEN N, 1995, MOL MICROBIOL, V16, P1, DOI 10.1111/j.1365-2958.1995.tb02386.x; Hammer BK, 2002, MOL MICROBIOL, V44, P107, DOI 10.1046/j.1365-2958.2002.02884.x; Huang Y, 2008, J BACTERIOL, V190, P4233, DOI 10.1128/JB.00205-08; Humair B, 2010, APPL ENVIRON MICROB, V76, P1497, DOI 10.1128/AEM.02014-09; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Krin E, 2008, ENVIRON MICROBIOL, V10, P1118, DOI 10.1111/j.1462-2920.2007.01528.x; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Lee DJ, 2012, ANNU REV MICROBIOL, V66, P125, DOI 10.1146/annurev-micro-092611-150012; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liu MY, 1997, J BIOL CHEM, V272, P17502, DOI 10.1074/jbc.272.28.17502; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Martinez LC, 2014, J BACTERIOL, V196, P325, DOI 10.1128/JB.00806-13; Martinez LC, 2011, MOL MICROBIOL, V80, P1637, DOI 10.1111/j.1365-2958.2011.07674.x; Mercante J, 2006, J BIOL CHEM, V281, P31832, DOI 10.1074/jbc.M606057200; Mercante J, 2009, J MOL BIOL, V392, P511, DOI 10.1016/j.jmb.2009.07.034; Mrazek J, 2008, BIOINFORMATICS, V24, P1041, DOI 10.1093/bioinformatics/btn077; Mukherjee S, 2011, MOL MICROBIOL, V82, P447, DOI 10.1111/j.1365-2958.2011.07822.x; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; Pannuri A, 2012, J BACTERIOL, V194, P79, DOI 10.1128/JB.06209-11; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Pernestig AK, 2001, J BIOL CHEM, V276, P225, DOI 10.1074/jbc.M001550200; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Prieto AI, 2012, NUCLEIC ACIDS RES, V40, P3524, DOI 10.1093/nar/gkr1236; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; RICHET E, 1991, CELL, V66, P1185, DOI 10.1016/0092-8674(91)90041-V; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Sahu SN, 2003, MOL CELL BIOCHEM, V253, P167, DOI 10.1023/A:1026028930203; SCHRODER I, 1993, J BIOL CHEM, V268, P771; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Teif VB, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/41/414105; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; Vakulskas CA, 2014, MOL MICROBIOL, V92, P945, DOI 10.1111/mmi.12606; Wade JT, 2007, MOL MICROBIOL, V65, P21, DOI 10.1111/j.1365-2958.2007.05781.x; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; Wong SM, 1998, INFECT IMMUN, V66, P5854, DOI 10.1128/IAI.66.12.5854-5861.1998; Yakhnin AV, 2013, MOL MICROBIOL, V87, P851, DOI 10.1111/mmi.12136; Yakhnin H, 2007, MOL MICROBIOL, V64, P1605, DOI 10.1111/j.1365-2958.2007.05765.x; Yakhnin H, 2011, J BACTERIOL, V193, P6162, DOI 10.1128/JB.05975-11; Yakhnin H, 2011, MOL MICROBIOL, V81, P689, DOI 10.1111/j.1365-2958.2011.07723.x	68	59	60	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145035	10.1371/journal.pone.0145035	http://dx.doi.org/10.1371/journal.pone.0145035			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673755	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700088
J	Ahmad, A; Wani, MY; Khan, A; Manzoor, N; Molepo, J				Ahmad, Aijaz; Wani, Mohmmad Younus; Khan, Amber; Manzoor, Nikhat; Molepo, Julitha			Synergistic Interactions of Eugenol-tosylate and Its Congeners with Fluconazole against Candida albicans	PLOS ONE			English	Article							ERGOSTEROL BIOSYNTHESIS PATHWAY; ERG11 GENE; DRUG-RESISTANCE; UP-REGULATION; AZOLES; MUTATIONS	We previously reported the antifungal properties of a monoterpene phenol "Eugenol" against different Candida strains and have observed that the addition of methyl group to eugenol drastically increased its antimicrobial potency. Based on the results and the importance of medicinal synthetic chemistry, we synthesized eugenol-tosylate and its congeners (E1-E6) and tested their antifungal activity against different clinical fluconazole (FLC)-susceptible and FLC-resistant C. albicans isolates alone and in combination with FLC by determining fractional inhibitory concentration indices (FICIs) and isobolograms calculated from microdilution assays. Minimum inhibitory concentration (MIC) results confirmed that all the tested C. albicans strains were variably susceptible to the semi-synthetic derivatives E1-E6, with MIC values ranging from 1-62 mu g/ml. The test compounds in combination with FLC exhibited either synergy (36%), additive (41%) or indifferent (23%) interactions, however, no antagonistic interactions were observed. The MICs of FLC decreased 2-9 fold when used in combination with the test compounds. Like their precursor eugenol, all the derivatives showed significant impairment of ergosterol biosynthesis in all C. albicans strains coupled with down regulation of the important ergosterol biosynthesis pathway gene-ERG11. The results were further validated by docking studies, which revealed that the inhibitors snugly fitting the active site of the target enzyme, mimicking fluconazole, may well explain their excellent inhibitory activity. Our results suggest that these compounds have a great potential as antifungals, which can be used as chemosensitizing agents with the known antifungal drugs.	[Ahmad, Aijaz; Molepo, Julitha] Univ Witwatersrand, Fac Hlth Sci, Sch Oral Hlth Sci, Dept Oral Biol Sci, Johannesburg, South Africa; [Wani, Mohmmad Younus] Univ Coimbra, Dept Quim, FCTUC, Coimbra, Portugal; [Khan, Amber] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Johannesburg, South Africa; [Manzoor, Nikhat] Taibah Univ, Coll Appl Med Sci, Al Madinah Al Munawarah, KSA, Saudi Arabia; [Manzoor, Nikhat] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, Delhi, India	University of Witwatersrand; Universidade de Coimbra; University of Witwatersrand; Taibah University; Jamia Millia Islamia	Manzoor, N (corresponding author), Taibah Univ, Coll Appl Med Sci, Al Madinah Al Munawarah, KSA, Saudi Arabia.	nikhatmanzoor@yahoo.co.in; Julitha.molepo@wits.ac.za	Wani, Mohammad Younus/E-3909-2018; Wani, Mohmmad Younus/AAJ-5016-2020	Wani, Mohammad Younus/0000-0002-1838-1337; Wani, Mohmmad Younus/0000-0002-1838-1337; Manzoor, Nikhat/0000-0002-6850-6142; Ahmad, Aijaz/0000-0003-2845-0727	Faculty Research Committee Individual Research Grant [001254 84511025121105]	Faculty Research Committee Individual Research Grant	AA and JM are highly thankful to Faculty Research Committee Individual Research Grants/No. 001254 84511025121105 for finical support. Funding agency has no role in the study design or any other experimental work.	Ahmad A, 2011, EUR J CLIN MICROBIOL, V30, P41, DOI 10.1007/s10096-010-1050-8; Ahmad A, 2014, MOLECULES, V19, P2896, DOI 10.3390/molecules19032896; Ahmad A, 2013, EUR J PHARM SCI, V48, P80, DOI 10.1016/j.ejps.2012.09.016; Ahmad A, 2010, J MED MICROBIOL, V59, P1178, DOI 10.1099/jmm.0.020693-0; Ahmad A, 2010, MICROB PATHOGENESIS, V48, P35, DOI 10.1016/j.micpath.2009.10.001; Borecka-Melkusova S, 2009, MYCOSES, V52, P118, DOI 10.1111/j.1439-0507.2008.01550.x; Bozic DD, 2014, INDIAN J MED RES, V140, P130; Canuto MM, 2002, LANCET INFECT DIS, V2, P550, DOI 10.1016/S1473-3099(02)00371-7; Ceita GD, 2014, GENET MOL BIOL, V37, P683, DOI [10.1590/S1415-47572014005000017, 10.1590/S1415-47572014000500011]; CLSI, 2008, M27A3 CLSI; Dai LL, 2015, MEDCHEMCOMM, V6, P147, DOI 10.1039/c4md00266k; Darvishi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076028; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eddouzi J, 2013, ANTIMICROB AGENTS CH, V57, P3182, DOI 10.1128/AAC.00555-13; Eloff JN, 1998, J ETHNOPHARMACOL, V60, P1, DOI 10.1016/S0378-8741(97)00123-2; Hemaiswarya S, 2009, PHYTOMEDICINE, V16, P997, DOI 10.1016/j.phymed.2009.04.006; Henry KW, 2000, ANTIMICROB AGENTS CH, V44, P2693, DOI 10.1128/AAC.44.10.2693-2700.2000; Hof H, 2008, DRUG RESIST UPDATE, V11, P25, DOI 10.1016/j.drup.2008.01.001; Jeu L, 2003, CLIN THER, V25, P1321, DOI 10.1016/S0149-2918(03)80126-1; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Levy JW, 2015, J MOL GRAPH MODEL, V56, P43, DOI 10.1016/j.jmgm.2014.11.013; Manastir L, 2011, MYCOSES, V54, P99, DOI 10.1111/j.1439-0507.2009.01766.x; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Prasad R, 2005, INT REV CYTOL, V242, P215; Sanglard D, 2003, ANTIMICROB AGENTS CH, V47, P2404, DOI 10.1128/AAC.47.8.2404-2412.2003; Sgherri C, 2014, BBA-BIOMEMBRANES, V1838, P465, DOI 10.1016/j.bbamem.2013.10.015; SHIMOKAWA O, 1989, BIOCHIM BIOPHYS ACTA, V1003, P15, DOI 10.1016/0005-2760(89)90092-1; Sousa MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089939; Tavakoli M, 2010, DARU, V18, P276; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ulrich-Merzenich G.S., 2014, SYNERGY, V1, P59, DOI [10.1016/j.synres.2014.07.011, DOI 10.1016/J.SYNRES.2014.07.011]; van Vuuren S, 2011, PLANTA MED, V77, P1168, DOI 10.1055/s-0030-1250736; Volkamer A, 2012, J CHEM INF MODEL, V52, P360, DOI 10.1021/ci200454v; Warrilow AG, 2013, ANTIMICROB AGENTS CH, V57, P1352, DOI 10.1128/AAC.02067-12; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Zhang HZ, 2014, SCI CHINA CHEM, V57, P807, DOI 10.1007/s11426-014-5087-x; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	38	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145053	10.1371/journal.pone.0145053	http://dx.doi.org/10.1371/journal.pone.0145053			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694966	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092500021
J	Ayuso, M; Fernandez, A; Nunez, Y; Benitez, R; Isabel, B; Barragan, C; Fernandez, AI; Rey, AI; Medrano, JF; Canovas, A; Gonzalez-Bulnes, A; Lopez-Bote, C; Ovilo, C				Ayuso, Miriam; Fernandez, Almudena; Nunez, Yolanda; Benitez, Rita; Isabel, Beatriz; Barragan, Carmen; Isabel Fernandez, Ana; Isabel Rey, Ana; Medrano, Juan F.; Canovas, Angela; Gonzalez-Bulnes, Antonio; Lopez-Bote, Clemente; Ovilo, Cristina			Comparative Analysis of Muscle Transcriptome between Pig Genotypes Identifies Genes and Regulatory Mechanisms Associated to Growth, Fatness and Metabolism	PLOS ONE			English	Article							FAMILIAL COMBINED HYPERLIPIDEMIA; MEAT QUALITY TRAITS; DIFFERENTIALLY EXPRESSED GENES; RING FINGER PROTEIN-1; RNA-SEQ; FATTY-ACIDS; BODY-COMPOSITION; IBERIAN PIGS; LARGE WHITE; TISSUE	Iberian ham production includes both purebred (IB) and Duroc-crossbred (IBxDU) Iberian pigs, which show important differences in meat quality and production traits, such as muscle growth and fatness. This experiment was conducted to investigate gene expression differences, transcriptional regulation and genetic polymorphisms that could be associated with the observed phenotypic differences between IB and IBxDU pigs. Nine IB and 10 IBxDU pigs were slaughtered at birth. Morphometric measures and blood samples were obtained and samples from Biceps femoris muscle were employed for compositional and transcriptome analysis by RNA-Seq technology. Phenotypic differences were evident at this early age, including greater body size and weight in IBxDU and greater Biceps femoris intramuscular fat and plasma cholesterol content in IB newborns. We detected 149 differentially expressed genes between IB and IBxDU neonates (p < 0.01 and Fold-Change > 1. 5). Several were related to adipose and muscle tissues development (DLK1, FGF21 or UBC). The functional interpretation of the transcriptomic differences revealed enrichment of functions and pathways related to lipid metabolism in IB and to cellular and muscle growth in IBxDU pigs. Protein catabolism, cholesterol biosynthesis and immune system were functions enriched in both genotypes. We identified transcription factors potentially affecting the observed gene expression differences. Some of them have known functions on adipogenesis (CEBPA, EGRs), lipid metabolism (PPARGC1B)and myogenesis (FOXOs, MEF2D, MYOD1), which suggest a key role in the meat quality differences existing between IB and IBxDU hams. We also identified several polymorphisms showing differential segregation between IB and IBxDU pigs. Among them, non-synonymous variants were detected in several transcription factors as PPARGC1B and TRIM63 genes, which could be associated to altered gene function. Taken together, these results provide information about candidate genes, metabolic pathways and genetic polymorphisms potentially involved in phenotypic differences between IB and IBxDU pigs associated to meat quality and production traits.	[Ayuso, Miriam; Isabel, Beatriz; Isabel Rey, Ana; Lopez-Bote, Clemente] Univ Complutense, Fac Vet, Dept Anim Prod, E-28040 Madrid, Spain; [Fernandez, Almudena; Nunez, Yolanda; Benitez, Rita; Barragan, Carmen; Isabel Fernandez, Ana; Ovilo, Cristina] INIA, Dept Mejora Genet Anim, Madrid, Spain; [Gonzalez-Bulnes, Antonio] Comparat Physiol Lab SGIT INIA, Madrid, Spain; [Medrano, Juan F.; Canovas, Angela] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	Complutense University of Madrid; University of California System; University of California Davis	Ovilo, C (corresponding author), INIA, Dept Mejora Genet Anim, Madrid, Spain.	ovilo@inia.es	Cánovas, Angela/AAG-6282-2020; Hernando, Miriam Ayuso/AAY-3751-2020; Fernández, Ana Isabel/J-3265-2012; Redondo, Beatriz Isabel/F-8662-2016; ayuso, miriam/GPX-8386-2022; Muñoz, Almudena Fernández/AAB-4608-2019; Ovilo, Cristina/N-9931-2014; Benítez, Rita/AAL-6381-2020; MUÑOZ, ANA ISABEL REY/G-9894-2016; Gonzalez-Bulnes, Antonio/K-7691-2015; Lopez-Bote, Clemente/F-5103-2014; bote, clemente lopez/AAQ-6503-2021	Fernández, Ana Isabel/0000-0002-1509-5191; Redondo, Beatriz Isabel/0000-0001-6593-9500; ayuso, miriam/0000-0001-6045-394X; Muñoz, Almudena Fernández/0000-0002-4495-9366; Ovilo, Cristina/0000-0002-5738-8435; MUÑOZ, ANA ISABEL REY/0000-0003-4403-9225; Gonzalez-Bulnes, Antonio/0000-0002-0917-4475; Lopez-Bote, Clemente/0000-0002-6839-8057; BENITEZ, RITA/0000-0001-7459-2836	Spanish Ministry of Science and Innovation [AGL2010-21991-C03]; Ministry of Economy and Competitiveness [AGL2013-48121-C3]; FEDER; Ministry of Science and Innovation [BES-2011-045136]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Economy and Competitiveness; FEDER(European Commission); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The experimental work was supported by funds from the Spanish Ministry of Science and Innovation (project AGL2010-21991-C03) and the Ministry of Economy and Competitiveness (project AGL2013-48121-C3), co-funded by FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Miriam Ayuso is granted by the Ministry of Science and Innovation (BES-2011-045136).; We are grateful to the staff of "S. A. T Vallehermoso" and to De la Torre, I for technical support. The experimental work was supported by funds from the Spanish Ministry of Science and Innovation (project AGL2010-21991-C03) and the Ministry of Economy and Competitiveness (project AGL2013-48121-C3),co-funded by FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Miriam Ayuso is granted by the Ministry of Science and Innovation (BES-2011-045136).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen DL, 2007, AM J PHYSL CELL PHYS, V292; Almudevar Anthony, 2006, NeuroRx, V3, P384, DOI 10.1016/j.nurx.2006.05.037; Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Annayev Y, 2014, J BIOL CHEM, V289, P5013, DOI 10.1074/jbc.M113.534651; Astiz S, 2014, EXP PHYSIOL, V99, P1241, DOI 10.1113/expphysiol.2014.081455; Ayuso M, 2015, J ANIMAL SCI; BECKER BA, 1993, J ANIM SCI, V71, P2073, DOI 10.2527/1993.7182073x; Bergman IM, 2010, IMMUNOGENETICS, V62, P49, DOI 10.1007/s00251-009-0409-4; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Boyle KB, 2009, CELL DEATH DIFFER, V16, P782, DOI 10.1038/cdd.2009.11; Bredt DS, 2003, J CELL SCI, V116, P9, DOI 10.1242/jcs.00183; Butler AA, 2001, ANNU REV PHYSIOL, V63, P141, DOI 10.1146/annurev.physiol.63.1.141; Cagnazzo M, 2006, J ANIM SCI, V84, P1; Canovas A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05297; Chang KC, 2003, MEAT SCI, V64, P93, DOI 10.1016/S0309-1740(02)00208-5; Chen SN, 2012, CIRC RES, V111, P907, DOI 10.1161/CIRCRESAHA.112.270207; COLEMAN RA, 1984, BIOCHEM J, V217, P391, DOI 10.1042/bj2170391; D'Andrea M, 2011, ANIM GENET, V42, P501, DOI 10.1111/j.1365-2052.2010.02164.x; Damon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033763; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Demmerle J, 2013, CHROMOSOME RES, V21, P765, DOI 10.1007/s10577-013-9381-9; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; Esteve-Codina A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-552; Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516; Fan B, 2010, MEAT SCI, V84, P645, DOI 10.1016/j.meatsci.2009.10.025; Fernandez-Figares I, 2007, LIVEST SCI, V110, P73, DOI 10.1016/j.livsci.2006.10.002; Fonken LK, 2014, ENDOCR REV, V35, P648, DOI 10.1210/er.2013-1051; Franks PW, 2014, DIABETOLOGIA, V57, P485, DOI 10.1007/s00125-013-3133-4; Frateschi S, 2012, AM J PATHOL, V181, P605, DOI 10.1016/j.ajpath.2012.05.007; Fuentes V, 2014, MEAT SCI, V96, P737, DOI 10.1016/j.meatsci.2013.10.010; Gerfault V, 1999, GEN COMP ENDOCR, V114, P396, DOI 10.1006/gcen.1999.7271; Ghosh M, 2015, ANIM GENET, V46, P255, DOI 10.1111/age.12281; Gonzalez-Bulnes A, 2012, GEN COMP ENDOCR, V176, P94, DOI 10.1016/j.ygcen.2011.12.038; Granucci F, 2003, BLOOD, V102, P2940, DOI 10.1182/blood-2002-12-3651; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gupta D, 2013, J BIOL CHEM, V288, P25440, DOI 10.1074/jbc.M113.486852; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hakuno F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025655; Hamam D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.462; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Herault F, 2014, LONGISSIMUS SEMIMEMB; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Herrera E, 2002, PLACENTA, V23, pS9, DOI 10.1053/plac.2002.0771; Hudson NJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-356; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Iwasaki S, 2013, CELLS TISSUES ORGANS, V198, P66, DOI 10.1159/000351462; Jacobs K, 2006, CYTOGENET GENOME RES, V112, P106, DOI 10.1159/000087521; Jaitovich A, 2015, J BIOL CHEM, V290, P9183, DOI 10.1074/jbc.M114.625715; Johnson AD, 2008, PHARMACOGENET GENOM, V18, P781, DOI 10.1097/FPC.0b013e3283050107; Kabir SM, 2014, ADIPOCYTE, V3, P97, DOI 10.4161/adip.28110; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; KARLSSON A, 1993, J ANIM SCI, V71, P930, DOI 10.2527/1993.714930x; Kim NK, 2010, MAMM GENOME, V21, P307, DOI 10.1007/s00335-010-9264-8; Koc M, 2015, BIOCHEM BIOPH RES CO, V460, P684, DOI 10.1016/j.bbrc.2015.03.090; Lee SH, 2014, CIRC RES, V115, P215, DOI 10.1161/CIRCRESAHA.115.303142; Lefaucheur L, 2011, J ANIM SCI, V89, P996, DOI 10.2527/jas.2010-3493; Li WZ, 2012, RES VET SCI, V93, P1190, DOI 10.1016/j.rvsc.2012.06.006; Lin HQ, 2010, CHEM-BIOL INTERACT, V187, P120, DOI 10.1016/j.cbi.2010.03.054; Lopez-Bote CJ, 1998, MEAT SCI, V49, pS17, DOI 10.1016/S0309-1740(98)00072-2; LopezBote C, 1997, ANIM SCI, V64, P177, DOI 10.1017/S1357729800015691; Luo XL, 2015, MOL MED REP, V11, P4032, DOI 10.3892/mmr.2015.3263; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mata P, 2014, ATEN PRIM, V46, P440, DOI 10.1016/j.aprim.2014.04.013; Merbitz-Zahradnik T, 2015, FEBS LETT; Miron M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-333; Moinard C, 2015, J NUTR; Munoz G, 2009, J ANIM SCI, V87, P459, DOI 10.2527/jas.2008-1127; Murgiano L, 2010, J PROTEOME RES, V9, P6450, DOI 10.1021/pr100693h; Nabeshima Y, 1993, MYOGENIN GENE DISRUP; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nishizawa S, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.71; Ovilo C, 2005, GENET RES, V85, P57, DOI 10.1017/S0016672305007330; Ovilo C, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-413, 10.1186/s12863-014-0148-x]; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; Palinski W, 2009, CIRC RES, V104, P569, DOI 10.1161/CIRCRESAHA.109.194191; Patel PS, 2013, J OBES, V2013, DOI 10.1155/2013/616193; Perez-Enciso M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-89; Perez-Montarelo D, 2014, PHYSIOL GENOMICS, V46, P195, DOI 10.1152/physiolgenomics.00151.2013; Posey AD, 2014, DEV BIOL, V387, P179, DOI 10.1016/j.ydbio.2014.01.004; Puig-Oliveras A, 2014, DIFFERENCES MUSCLE T; Pushpakom SP, 2013, PHARMACOGENET GENOM, V23, P438, DOI 10.1097/FPC.0b013e328362cfc6; Qian X, 2014, OMICS, V18, P98, DOI 10.1089/omi.2013.0110; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Ribas F, 2014, BIOCHEM J, V463, P191, DOI 10.1042/BJ20140403; Rivera-Ferre MG, 2005, J NUTR, V135, P469, DOI 10.1093/jn/135.3.469; Robina A, 2013, SPAN J AGRIC RES, V11, P1057, DOI 10.5424/sjar/2013114-4637; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ropka-Molik K, 2014, ANIM GENET, V45, P674, DOI 10.1111/age.12184; Segura J, 2014, FOOD CHEM, V145, P821, DOI 10.1016/j.foodchem.2013.08.131; Sepe A, 2011, GERONTOLOGY, V57, P66, DOI 10.1159/000279755; Serrano MP, 2008, MEAT SCI, V78, P420, DOI 10.1016/j.meatsci.2007.07.006; Shi XZ, 2012, J CELL SCI, V125, P5329, DOI 10.1242/jcs.105239; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Sutherland MA, 2005, J ANIM SCI, V83, P2087; SZABO AJ, 1973, AM J OBSTET GYNECOL, V115, P263, DOI 10.1016/0002-9378(73)90296-2; Te Pas MF, 2011, J LIFE SCI, V5, P598; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Torres-Rovira L, 2012, SCI WORLD J, DOI 10.1100/2012/510149; Torres-Rovira L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066728; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uzun A, 2007, NUCLEIC ACIDS RES, V35, pW384, DOI 10.1093/nar/gkm232; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Ventanas S, 2006, MEAT SCI, V73, P651, DOI 10.1016/j.meatsci.2006.03.009; Verardo LL, 2013, J ANIM BREED GENET, V130, P372, DOI 10.1111/jbg.12006; Veum VL, 2012, INT J OBESITY, V36, P1195, DOI 10.1038/ijo.2011.240; Villegas R, 2014, ANN HUM GENET, V78, P23, DOI 10.1111/ahg.12044; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; WABITSCH M, 1995, METABOLISM, V44, P45, DOI 10.1016/0026-0495(95)90220-1; Wadsack C, 2007, AM J PHYSIOL-ENDOC M, V292, pE476, DOI 10.1152/ajpendo.00547.2005; Wallberg-Henriksson H, 2001, MOL MEMBR BIOL, V18, P205; Wang YH, 2010, CLIN LIPIDOL, V5, P109, DOI 10.2217/CLP.09.80; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wickramasinghe S, 2014, LIVEST SCI, V166, P206, DOI 10.1016/j.livsci.2014.06.015; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Woollett LA, 2001, CURR OPIN LIPIDOL, V12, P305, DOI 10.1097/00041433-200106000-00010; Xing K, 2015, INTEGRATION TRANSCRI; Yasuhara K, 2011, J APPL PHYSIOL, V111, P1142, DOI 10.1152/japplphysiol.00471.2011; Zhang GH, 2014, BIOCHEM CELL BIOL, V92, P259, DOI 10.1139/bcb-2014-0019; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]; Zhao YQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1580-7; Zheng Z, 2010, WORLD J HEPATOL, V2, P203, DOI 10.4254/wjh.v2.i6.203	126	62	66	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145162	10.1371/journal.pone.0145162	http://dx.doi.org/10.1371/journal.pone.0145162			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695515	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092500025
J	Heger, Z; Michalek, P; Guran, R; Havelkova, B; Kominkova, M; Cernei, N; Richtera, L; Beklova, M; Adam, V; Kizek, R				Heger, Zbynek; Michalek, Petr; Guran, Roman; Havelkova, Barbora; Kominkova, Marketa; Cernei, Natalia; Richtera, Lukas; Beklova, Miroslava; Adam, Vojtech; Kizek, Rene			Exposure to 17 beta-Oestradiol Induces Oxidative Stress in the Non-Oestrogen Receptor Invertebrate Species Eisenia fetida	PLOS ONE			English	Article							DISRUPTING COMPOUNDS; METALLOTHIONEIN; WATER; PHARMACEUTICALS; CONTAMINANTS; EXPRESSION; HORMONES; SOILS; OLIGOCHAETA; POLLUTANTS	Background The environmental impacts of various substances on all levels of organisms are under investigation. Among these substances, endocrine-disrupting compounds (EDCs) present a threat, although the environmental significance of these compounds remains largely unknown. To shed some light on this field, we assessed the effects of 17 beta-oestradiol on the growth, reproduction and formation of free radicals in Eisenia fetida. Methodology/Principal Findings Although the observed effects on growth and survival were relatively weak, a strong impact on reproduction was observed (50.70% inhibition in 100 mu g/kg of E-2). We further demonstrated that the exposure of the earthworm Eisenia fetida to a contaminant of emerging concern, 17 beta-oestradiol (E2), significantly affected the molecules involved in antioxidant defence. Exposure to E2 results in the production of reactive oxygen species (ROS) and the stimulation of antioxidant systems (metallothionein and reduced oxidized glutathione ratio) but not phytochelatins at both the mRNA and translated protein levels. Matrix-assisted laser desorption/ionization (MALDI)-imaging revealed the subcuticular bioaccumulation of oestradiol- 3,4-quinone, altering the levels of local antioxidants in a time-dependent manner. Conclusions/Significance The present study illustrates that although most invertebrates do not possess oestrogen receptors, these organisms can be affected by oestrogen hormones, likely reflecting free diffusion into the cellular microenvironment with subsequent degradation to molecules that undergo redox cycling, producing ROS, thereby increasing environmental contamination that also perilously affects keystone animals, forming lower trophic levels.	[Heger, Zbynek; Michalek, Petr; Guran, Roman; Kominkova, Marketa; Cernei, Natalia; Richtera, Lukas; Adam, Vojtech; Kizek, Rene] Mendel Univ Brno, Dept Chem & Biochem, CZ-61300 Brno, Czech Republic; [Heger, Zbynek; Michalek, Petr; Guran, Roman; Kominkova, Marketa; Cernei, Natalia; Richtera, Lukas; Beklova, Miroslava; Adam, Vojtech; Kizek, Rene] Brno Univ Technol, Cent European Inst Technol, CZ-61600 Brno, Czech Republic; [Heger, Zbynek; Havelkova, Barbora; Beklova, Miroslava] Univ Vet & Pharmaceut Sci, Fac Vet Hyg & Ecol, Dept Ecol & Dis Game Fish & Bees, CZ-61242 Brno, Czech Republic	Mendel University in Brno; Brno University of Technology; University of Veterinary Sciences Brno	Kizek, R (corresponding author), Mendel Univ Brno, Dept Chem & Biochem, Zemedelska 1, CZ-61300 Brno, Czech Republic.	kizek@sci.muni.cz	Havelkova, Barbora/AAC-4878-2019; Richtera, Lukas/N-9991-2014; Heger, Zbyněk/D-1973-2013; Němcová, Barbora/GVT-4918-2022; Cernei, Natalia/M-7505-2019; Adam, Vojtech/D-7686-2012; Guran, Roman/C-2610-2016; Cernei, Natalia/K-2578-2016	Havelkova, Barbora/0000-0003-4298-3650; Richtera, Lukas/0000-0002-8288-3999; Heger, Zbyněk/0000-0002-3915-7270; Cernei, Natalia/0000-0002-8259-1566; Adam, Vojtech/0000-0002-8527-286X; Guran, Roman/0000-0002-2912-714X; Cernei, Natalia/0000-0002-8259-1566; Kizek, Rene/0000-0002-0467-6169; Michalek, Petr/0000-0002-0121-0128	Central European Institute of Technology [CEITEC] [CZ.1.05/1.1.00/02.0068]	Central European Institute of Technology [CEITEC]	Financial support was received through a grant (Central European Institute of Technology [CEITEC] CZ.1.05/1.1.00/02.0068).	Asselman J, 2012, AQUAT TOXICOL, V110, P54, DOI 10.1016/j.aquatox.2011.12.010; Benotti MJ, 2009, ENVIRON SCI TECHNOL, V43, P597, DOI 10.1021/es801845a; Bernard E, 2015, ECOTOX ENVIRON SAFE, V114, P273, DOI 10.1016/j.ecoenv.2014.04.024; Bolton JL, 1998, CHEM RES TOXICOL, V11, P1113, DOI 10.1021/tx9801007; Brulle F, 2008, ECOTOX ENVIRON SAFE, V71, P47, DOI 10.1016/j.ecoenv.2007.10.032; Carelli S, 1997, SCIENCE, V277, P1681, DOI 10.1126/science.277.5332.1681; Carr DL, 2011, WATER AIR SOIL POLL, V217, P127, DOI 10.1007/s11270-010-0573-z; Chaki SP, 2006, APOPTOSIS, V11, P1427, DOI 10.1007/s10495-006-8761-4; Colucci MS, 2001, J ENVIRON QUAL, V30, P2070, DOI 10.2134/jeq2001.2070; Demuynck S, 2007, COMP BIOCHEM PHYS C, V145, P658, DOI 10.1016/j.cbpc.2007.03.001; DEVOS CHR, 1992, PLANT PHYSIOL, V98, P853, DOI 10.1104/pp.98.3.853; Finlay-Moore O, 2000, J ENVIRON QUAL, V29, P1604, DOI 10.2134/jeq2000.00472425002900050030x; Gruber C, 2000, EUR J BIOCHEM, V267, P573, DOI 10.1046/j.1432-1327.2000.01035.x; Hanselman TA, 2003, ENVIRON SCI TECHNOL, V37, P5471, DOI 10.1021/es034410+; Heger Z, 2015, ONCOL REP, V33, P921, DOI 10.3892/or.2014.3627; Heger Z, 2013, NEUROENDOCRINOL LETT, V34, P123; Homa J, 2005, ENVIRON POLLUT, V135, P275, DOI 10.1016/j.envpol.2004.10.019; Hughes SL, 2009, J PROTEOME RES, V8, P3512, DOI 10.1021/pr9001806; Jiang WW, 2012, J ENVIRON SCI-CHINA, V24, P320, DOI 10.1016/S1001-0742(11)60746-8; Kadota Y, 2010, EUR J PHARMACOL, V626, P166, DOI 10.1016/j.ejphar.2009.09.060; Kanda N, 2003, J INVEST DERMATOL, V121, P1500, DOI 10.1111/j.1523-1747.2003.12617.x; Kassim R, 2013, J BIOL INORG CHEM, V18, P333, DOI 10.1007/s00775-013-0977-5; Keay J, 2009, ENDOCRINOLOGY, V150, P1731, DOI 10.1210/en.2008-1338; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Kominkova M, 2015, INT J MOL SCI, V16, P7210, DOI 10.3390/ijms16047210; Krajniak KG, 2005, INTEGR COMP BIOL, V45, P88, DOI 10.1093/icb/45.1.88; Krystofova O, 2013, INT J ENV RES PUB HE, V10, P47, DOI 10.3390/ijerph10010047; Liebeke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081271; Liu R, 2004, J CHROMATOGR A, V1022, P179, DOI 10.1016/j.chroma.2003.09.035; Markman S, 2007, CHEMOSPHERE, V70, P119, DOI 10.1016/j.chemosphere.2007.06.045; Muzandu K, 2005, FREE RADICAL RES, V39, P389, DOI 10.1080/10715760400029710; OECD, TEST NO 222 EARTHWOR; Oren I, 2004, BIOPHYS J, V87, P768, DOI 10.1529/biophysj.103.035527; Owen JB, 2010, METHODS MOL BIOL, V648, P269, DOI 10.1007/978-1-60761-756-3_18; PHIPPS GL, 1993, ENVIRON TOXICOL CHEM, V12, P269, DOI 10.1897/1552-8618(1993)12[269:UOTAOL]2.0.CO;2; Sato M, 2002, TOHOKU J EXP MED, V196, P9, DOI 10.1620/tjem.196.9; Segner H, 2003, ECOTOX ENVIRON SAFE, V54, P302, DOI 10.1016/S0147-6513(02)00039-8; Sochor J, 2010, MOLECULES, V15, P8618, DOI 10.3390/molecules15128618; Thomas MP, 2013, J STEROID BIOCHEM, V137, P27, DOI 10.1016/j.jsbmb.2012.12.014; Vasseur P, 2006, CHEMOSPHERE, V62, P1033, DOI 10.1016/j.chemosphere.2005.05.043; Woo S, 2012, MOL CELL TOXICOL, V8, P263, DOI 10.1007/s13273-012-0032-6; Yu ZQ, 2004, ENVIRON TOXICOL CHEM, V23, P531, DOI 10.1897/03-192; Zhang W, 2006, J ENVIRON MONITOR, V8, P963, DOI 10.1039/b605450a	43	12	12	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145426	10.1371/journal.pone.0145426	http://dx.doi.org/10.1371/journal.pone.0145426			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695684	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092500046
J	Kikuchi, K; Mochizuki, O				Kikuchi, Kenji; Mochizuki, Osamu			Diffusive Promotion by Velocity Gradient of Cytoplasmic Streaming (CPS) in Nitella Internodal Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MOTIVE FORCE; ACTIN; MYOSIN; MECHANISM; ALGA	Cytoplasmic streaming (CPS) is well known to assist the movement of nutrients, organelles and genetic material by transporting all of the cytoplasmic contents of a cell. CPS is generated by motility organelles that are driven by motor proteins near a membrane surface, where the CPS has been found to have a flat velocity profile in the flow field according to the sliding theory. There is a consistent mixing of contents inside the cell by CPS if the velocity gradient profile is flattened, which is not assisted by advection diffusion but is only supported by Brownian diffusion. Although the precise flow structure of the cytoplasm has an important role for cellular metabolism, the hydrodynamic mechanism of its convection has not been clarified. We conducted an experiment to visualise the flow of cytoplasm in Nitella cells by injecting tracer fluorescent nanoparticles and using a flow visualisation system in order to understand how the flow profile affects their metabolic system. We determined that the velocity field in the cytosol has an obvious velocity gradient, not a flattened gradient, which suggests that the gradient assists cytosolic mixing by Taylor-Aris dispersion more than by Brownian diffusion.	[Kikuchi, Kenji] Tohoku Univ, Grad Sch Engn, Depertment Bioengn & Robot, Sendai, Miyagi 980, Japan; [Mochizuki, Osamu] Toyo Univ, Depertment Biomed Engn, Kawagoe, Saitama, Japan	Tohoku University; Toyo University	Kikuchi, K (corresponding author), Tohoku Univ, Grad Sch Engn, Depertment Bioengn & Robot, Sendai, Miyagi 980, Japan.	kenji@pfsl.mech.tohoku.ac.jp	Kikuchi, Kenji/T-3160-2019		JSPS KAKENHI [25000008, 25630056]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number, 25000008, 25630056.	ALLEN NS, 1974, J CELL BIOL, V63, P270, DOI 10.1083/jcb.63.1.270; ALLEN NS, 1978, ANNU REV BIOPHYS BIO, V7, P497, DOI 10.1146/annurev.bb.07.060178.002433; Aris R, 1956, DISPERSION SOLUTE FL; Core RW, 2011, NATURE PROTCOLS, V6, P1929; Corti B., 1774, OSSERVAZIONI MICROSC; Ewart AJ, 1903, COMMUNICATION; Goldstein RE, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2015.0030; Hayashi Y, 1980, THEORETICAL STUDY MO, V85, P469; KACHAR B, 1988, J CELL BIOL, V106, P1545, DOI 10.1083/jcb.106.5.1545; KAMIYA N, 1981, ANNU REV PLANT PHYS, V32, P205, DOI 10.1146/annurev.pp.32.060181.001225; Kamiya N., 1956, BOT MAG TOKYO, V69, P544, DOI [10.15281/jplantres1887.69.544, DOI 10.15281/JPLANTRES1887.69.544]; Kaneko T, 2005, PLANT CELL PHYSIOL, V46, P130, DOI 10.1093/pcp/pci004; KATO T, 1977, J BIOCHEM-TOKYO, V82, P777, DOI 10.1093/oxfordjournals.jbchem.a131754; MA YZ, 1989, PLANT PHYSIOL, V89, P586, DOI 10.1104/pp.89.2.586; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; MUSTACICH RV, 1974, PHYS REV LETT, V33, P617, DOI 10.1103/PhysRevLett.33.617; PALEVITZ BA, 1974, P NATL ACAD SCI USA, V71, P363, DOI 10.1073/pnas.71.2.363; Park JS, 2004, EXPT FLUIDS, P37105; Pieuchot L, 2015, DEV CELL, V34, P410, DOI 10.1016/j.devcel.2015.07.017; Shimmen T, 2004, CURR OPIN CELL BIOL, V16, P68, DOI 10.1016/j.ceb.2003.11.009; Shimmen T, 1996, PLANT CELL PHYSIOL, V37, P591, DOI 10.1093/oxfordjournals.pcp.a028986; Shimmen T, 2007, J PLANT RES, V120, P31, DOI 10.1007/s10265-006-0061-0; STAIGER CJ, 1987, PROTOPLASMA, V141, P1, DOI 10.1007/BF01276783; TAZAWA M, 1968, PROTOPLASMA, V65, P207, DOI 10.1007/BF01666379; TSUCHIYA Y, 1991, BIOPHYS J, V59, P249, DOI 10.1016/S0006-3495(91)82215-9; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; van de Meent JW, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.178102; van de Meent JW, 2010, J FLUID MECH, V642, P5, DOI 10.1017/S0022112009992187; Vedel S, 2014, J FLUID MECH, V752, P107, DOI 10.1017/jfm.2014.324; WILLIAMSON RE, 1974, NATURE, V248, P801, DOI 10.1038/248801a0; Wolff K, 2012, J R SOC INTERFACE, V9, P1398, DOI 10.1098/rsif.2011.0868	31	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144938	10.1371/journal.pone.0144938	http://dx.doi.org/10.1371/journal.pone.0144938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694322	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500016
J	Stiles, M; Moiseyev, GP; Budda, ML; Linens, A; Brush, RS; Qi, H; White, GL; Wolf, RF; Ma, JX; Floyd, R; Anderson, RE; Mandal, NA				Stiles, Megan; Moiseyev, Gennadiy P.; Budda, Madeline L.; Linens, Annette; Brush, Richard S.; Qi, Hui; White, Gary L.; Wolf, Roman F.; Ma, Jian-xing; Floyd, Robert; Anderson, Robert E.; Mandal, Nawajes A.			PBN (Phenyl-N-Tert-Butylnitrone)-Derivatives Are Effective in Slowing the Visual Cycle and Rhodopsin Regeneration and in Protecting the Retina from Light-Induced Damage	PLOS ONE			English	Article							TERT-BUTYLNITRONE PROTECTS; FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; ISOMEROHYDROLASE ACTIVITY; CONGENITAL AMAUROSIS; PIGMENT EPITHELIUM; RPE65 MUTATIONS; GLIOMA MODELS; VITAMIN-A; LIPOFUSCIN	A2E and related toxic molecules are part of lipofuscin found in the retinal pigment epithelial (RPE) cells in eyes affected by Stargardt's disease, age-related macular degeneration (AMD), and other retinal degenerations. A novel therapeutic approach for treating such degenerations involves slowing down the visual cycle, which could reduce the amount of A2E in the RPE. This can be accomplished by inhibiting RPE65, which produces 11-cis-retinol from all-trans-retinyl esters. We recently showed that phenyl-N-tert-butylnitrone (PBN) inhibits RPE65 enzyme activity in RPE cells. In this study we show that like PBN, certain PBN-derivatives (PBNDs) such as 4-F-PBN, 4-CF3-PBN, 3,4-di-F-PBN, and 4-CH3-PBN can inhibit RPE65 and synthesis of 11-cis-retinol in in vitro assays using bovine RPE microsomes. We further demonstrate that systemic (intraperitoneal, IP) administration of these PBNDs protect the rat retina from light damage. Electroretinography (ERG) and histological analysis showed that rats treated with PBNDs retained similar to 90% of their photoreceptor cells compared to a complete loss of function and 90% loss of photoreceptors in the central retina in rats treated with vehicle/control injections. Topically applied PBN and PBNDs also significantly slowed the rate of the visual cycle in mouse and baboon eyes. One hour dark adaptation resulted in 75-80% recovery of bleachable rhodopsin in control/vehicle treated mice. Eye drops of 5% 4-CH3-PBN were most effective, inhibiting the regeneration of bleachable rhodopsin significantly (60% compared to vehicle control). In addition, a 10% concentration of PBN and 5% concentration of 4-CH3-PBN in baboon eyes inhibited the visual cycle by 60% and by 30%, respectively. We have identified a group of PBN related nitrones that can reach the target tissue (RPE) by systemic and topical application and slow the rate of rhodopsin regeneration and therefore the visual cycle in mouse and baboon eyes. PBNDs can also protect the rat retina from light damage. There is potential in developing these compounds as preventative therapeutics for the treatment of human retinal degenerations in which the accumulation of lipofuscin may be pathogenic.	[Stiles, Megan; Linens, Annette; Brush, Richard S.; Qi, Hui; Anderson, Robert E.; Mandal, Nawajes A.] OUHSC, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Moiseyev, Gennadiy P.; Ma, Jian-xing] OUHSC, Dept Physiol, Oklahoma City, OK USA; [Budda, Madeline L.; Mandal, Nawajes A.] OUHSC, Dept Cell Biol, Oklahoma City, OK USA; [White, Gary L.; Wolf, Roman F.; Anderson, Robert E.] OUHSC, Dept Pathol, Oklahoma City, OK USA; [Ma, Jian-xing; Mandal, Nawajes A.] OUHSC, Dept Endocrinol & Diabet, Oklahoma City, OK USA; [Mandal, Nawajes A.] OUHSC, Oklahoma Ctr Neurosci, Oklahoma City, OK USA; [Stiles, Megan; Linens, Annette; Brush, Richard S.; Qi, Hui; Anderson, Robert E.; Mandal, Nawajes A.] Dean McGee Eye Inst, Oklahoma City, OK USA; [Floyd, Robert] Oklahoma Med Res Fdn, Expt Therapeut, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Mandal, NA (corresponding author), OUHSC, Dept Ophthalmol, Oklahoma City, OK 73104 USA.	mmandal@ouhsc.edu			Foundation Fighting Blindness (United States); Beckman Initiative for Macular Research; RPB; National Institutes of Health; NATIONAL EYE INSTITUTE [P30EY021725] Funding Source: NIH RePORTER	Foundation Fighting Blindness (United States); Beckman Initiative for Macular Research; RPB(Research to Prevent Blindness (RPB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research is conducted by the fundings from The Foundation Fighting Blindness (United States), Beckman Initiative for Macular Research, RPB and National Institutes of Health fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Chen H, 2013, J LIPID RES, V54, P1616, DOI 10.1194/jlr.M035048; Chen H, 2012, MOL VIS, V18, P1325; Choi CH, 2008, FREE RADICAL BIO MED, V44, P1772, DOI 10.1016/j.freeradbiomed.2008.02.005; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Floyd RA, 2008, FREE RADICAL BIO MED, V45, P1361, DOI 10.1016/j.freeradbiomed.2008.08.017; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gollapalli DR, 2004, P NATL ACAD SCI USA, V101, P10030, DOI 10.1073/pnas.0401936101; Grimm C, 2000, INVEST OPHTH VIS SCI, V41, P3984; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; He T, 2011, FREE RADICAL BIO MED, V51, P490, DOI 10.1016/j.freeradbiomed.2011.04.037; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Mandal MNA, 2011, J BIOL CHEM, V286, P32491, DOI 10.1074/jbc.M111.255877; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; Maples KR, 2004, CNS DRUGS, V18, P1071, DOI 10.2165/00023210-200418150-00003; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Nguyen DH, 2013, DISCOV MED, V15, P343; Noell W K, 1966, Invest Ophthalmol, V5, P450; NOELL WK, 1971, SCIENCE, V172, P76, DOI 10.1126/science.172.3978.76; NOELL WK, 1971, SCIENCE, V172, P72, DOI 10.1126/science.172.3978.72; Palczewski K, 2010, TRENDS PHARMACOL SCI, V31, P284, DOI 10.1016/j.tips.2010.03.001; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Poliakov E, 2011, BIOCHEMISTRY-US, V50, P6739, DOI 10.1021/bi200532m; Ranchon I, 2003, J NEUROSCI, V23, P6050, DOI 10.1523/JNEUROSCI.23-14-06050.2003; Ranchon I, 2001, INVEST OPHTH VIS SCI, V42, P1375; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; SHICHI H, 1969, J BIOL CHEM, V244, P529; Sieving PA, 2001, P NATL ACAD SCI USA, V98, P1835, DOI 10.1073/pnas.041606498; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Suter M, 2000, J BIOL CHEM, V275, P39625, DOI 10.1074/jbc.M007049200; Tanito M, 2009, J LIPID RES, V50, P807, DOI 10.1194/jlr.M800170-JLR200; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Towner RA, 2013, NEURO-ONCOLOGY, V15, P330, DOI 10.1093/neuonc/nos337; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	50	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145305	10.1371/journal.pone.0145305	http://dx.doi.org/10.1371/journal.pone.0145305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694648	gold, Green Submitted, Green Published			2022-12-27	WOS:000367092500038
J	Chapman, DC; Stocki, P; Williams, DB				Chapman, Daniel C.; Stocki, Pawel; Williams, David B.			Cyclophilin C Participates in the US2-Mediated Degradation of Major Histocompatibility Complex Class I Molecules	PLOS ONE			English	Article							SIGNAL PEPTIDE PEPTIDASE; ENDOPLASMIC-RETICULUM CHAPERONES; PROTEIN DISULFIDE-ISOMERASE; MEMBRANE-PROTEIN; ANTIGEN PRESENTATION; MONOCLONAL-ANTIBODIES; MISFOLDED PROTEINS; MASS-SPECTROMETRY; STRUCTURAL BASIS; RIBOPHORIN I	Human cytomegalovirus uses a variety of mechanisms to evade immune recognition through major histocompatibility complex class I molecules. One mechanism mediated by the immunoevasin protein US2 causes rapid disposal of newly synthesized class I molecules by the endoplasmic reticulum-associated degradation pathway. Although several components of this degradation pathway have been identified, there are still questions concerning how US2 targets class I molecules for degradation. In this study we identify cyclophilin C, a peptidyl prolyl isomerase of the endoplasmic reticulum, as a component of US2-mediated immune evasion. Cyclophilin C could be co-isolated with US2 and with the class I molecule HLA-A2. Furthermore, it was required at a particular expression level since depletion or overexpression of cyclophilin C impaired the degradation of class I molecules. To better characterize the involvement of cyclophilin C in class I degradation, we used LC-MS/MS to detect US2-interacting proteins that were influenced by cyclophilin C expression levels. We identified malectin, PDIA6, and TMEM33 as proteins that increased in association with US2 upon cyclophilin C knockdown. In subsequent validation all were shown to play a functional role in US2 degradation of class I molecules. This was specific to US2 rather than general ER-associated degradation since depletion of these proteins did not impede the degradation of a misfolded substrate, the null Hong Kong variant of alpha(1)-antitrypsin.	[Chapman, Daniel C.; Williams, David B.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Stocki, Pawel; Williams, David B.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University of Toronto	Williams, DB (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	david.williams@utoronto.ca			Canadian Cancer Society [018157]; Canadian Institutes of Health Research [MOP-123226]	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grant 018157 from the Canadian Cancer Society to DBW (http://www.cancer.ca) and grant MOP-123226 from the Canadian Institutes of Health Research to DBW (http://www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Bergeron MJ, 2011, J BIOL CHEM, V286, P11242, DOI 10.1074/jbc.M110.171728; Bernasconi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013008; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Boname JM, 2014, J CELL BIOL, V205, P847, DOI 10.1083/jcb.201312009; Carpentier M, 1999, J BIOL CHEM, V274, P10990, DOI 10.1074/jbc.274.16.10990; Chapman DC, 2010, SEMIN CELL DEV BIOL, V21, P512, DOI 10.1016/j.semcdb.2009.12.013; Chen Y, 2011, MOL BIOL CELL, V22, P3559, DOI 10.1091/mbc.E11-03-0201; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Danilczyk UG, 2001, J BIOL CHEM, V276, P25532, DOI 10.1074/jbc.M100270200; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; Furman MH, 2002, J VIROL, V76, P11753, DOI 10.1128/JVI.76.22.11753-11756.2002; Galli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016304; Gewurz BE, 2001, P NATL ACAD SCI USA, V98, P6794, DOI 10.1073/pnas.121172898; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Hegde NR, 2006, J BIOL CHEM, V281, P20910, DOI 10.1074/jbc.M602989200; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Hsu JL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004811; Jansen G, 2012, MOL CELL PROTEOMICS, V11, P710, DOI 10.1074/mcp.M111.016550; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; JONES TR, 1995, J VIROL, V69, P4830, DOI 10.1128/JVI.69.8.4830-4841.1995; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Kim E, 2009, J IMMUNOL, V183, P7379, DOI 10.4049/jimmunol.0901489; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; Kumar P, 2009, J BIOL CHEM, V284, P29784, DOI 10.1074/jbc.M109.038497; Lee SO, 2010, EMBO J, V29, P363, DOI 10.1038/emboj.2009.359; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Niu L, 2013, MOL IMMUNOL, V55, P381, DOI 10.1016/j.molimm.2013.03.015; Noriega V, 2012, IMMUNOL RES, V54, P140, DOI 10.1007/s12026-012-8304-8; Oresic K, 2008, J GEN VIROL, V89, P1122, DOI 10.1099/vir.0.83516-0; Oresic K, 2009, J BIOL CHEM, V284, P5905, DOI 10.1074/jbc.M807568200; Park B, 2010, J EXP MED, V207, P2033, DOI 10.1084/jem.20091793; Qin SY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394288; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Rutkevich LA, 2010, MOL BIOL CELL, V21, P3093, DOI 10.1091/mbc.E10-04-0356; Sakabe I, 2015, BREAST CANCER RES TR, V153, P285, DOI 10.1007/s10549-015-3536-7; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Schallus T, 2008, MOL BIOL CELL, V19, P3404, DOI 10.1091/mbc.E08-04-0354; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seitz C, 1998, MOL IMMUNOL, V35, P819, DOI 10.1016/S0161-5890(98)00077-7; Soetandyo N, 2010, J BIOL CHEM, V285, P32352, DOI 10.1074/jbc.M110.131649; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; STAM NJ, 1986, J IMMUNOL, V137, P2299; Stocki P, 2014, J BIOL CHEM, V289, P23086, DOI 10.1074/jbc.M114.570911; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takeda K, 2014, BIOCHEM BIOPH RES CO, V454, P436, DOI 10.1016/j.bbrc.2014.10.102; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Urade Takeshi, 2014, Kobe J Med Sci, V60, pE57; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van de Weijer ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4832; van den Boomen DJH, 2015, MOL IMMUNOL, V68, P106, DOI 10.1016/j.molimm.2015.07.005; van den Boomen DJH, 2014, P NATL ACAD SCI USA, V111, P11425, DOI 10.1073/pnas.1409099111; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang GH, 2006, J PROTEOME RES, V5, P1214, DOI 10.1021/pr050406g; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yu CC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056667, 10.1371/journal.pone.0054627]	79	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145458	10.1371/journal.pone.0145458	http://dx.doi.org/10.1371/journal.pone.0145458			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691022	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300078
J	Fogliata, A; Nicolini, G; Bourgier, C; Clivio, A; De Rose, F; Fenoglietto, P; Lobefalo, F; Mancosu, P; Tomatis, S; Vanetti, E; Scorsetti, M; Cozzi, L				Fogliata, Antonella; Nicolini, Giorgia; Bourgier, Celine; Clivio, Alessandro; De Rose, Fiorenza; Fenoglietto, Pascal; Lobefalo, Francesca; Mancosu, Pietro; Tomatis, Stefano; Vanetti, Eugenio; Scorsetti, Marta; Cozzi, Luca			Performance of a Knowledge-Based Model for Optimization of Volumetric Modulated Arc Therapy Plans for Single and Bilateral Breast Irradiation	PLOS ONE			English	Article							RADIATION-THERAPY; PROSTATE-CANCER; AT-RISK; IMRT; RADIOTHERAPY; QUALITY; ENGINE; ORGANS; BEAMS	Purpose To evaluate the performance of a model-based optimisation process for volumetric modulated arc therapy, VMAT, applied to whole breast irradiation. Methods and Materials A set of 150 VMAT dose plans with simultaneous integrated boost were selected to train a model for the prediction of dose-volume constraints. The dosimetric validation was done on different groups of patients from three institutes for single (50 cases) and bilateral breast (20 cases). Results Quantitative improvements were observed between the model-based and the reference plans, particularly for heart dose. Of 460 analysed dose-volume objectives, 13% of the clinical plans failed to meet the constraints while the respective model-based plans succeeded. Only in 5 cases did the reference plans pass while the respective model-based failed the criteria. For the bilateral breast analysis, the model-based plans resulted in superior or equivalent dose distributions to the reference plans in 96% of the cases. Conclusions Plans optimised using a knowledge-based model to determine the dose-volume constraints showed dosimetric improvements when compared to earlier approved clinical plans. The model was applicable to patients from different centres for both single and bilateral breast irradiation. The data suggests that the dose-volume constraint optimisation can be effectively automated with the new engine and could encourage its application to clinical practice.	[Fogliata, Antonella; De Rose, Fiorenza; Lobefalo, Francesca; Mancosu, Pietro; Tomatis, Stefano; Scorsetti, Marta; Cozzi, Luca] Humanitas Clin & Res Ctr, Radiotherapy & Radiosurg Dept, Milan, Italy; [Nicolini, Giorgia; Clivio, Alessandro; Vanetti, Eugenio] Oncol Inst Southern Switzerland, Bellinzona, Switzerland; [Bourgier, Celine; Fenoglietto, Pascal] ICM Val dAurelle, Dept Radiotherapy, Montpellier, France	Institute of Oncology Research (IOR); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Fogliata, A (corresponding author), Humanitas Clin & Res Ctr, Radiotherapy & Radiosurg Dept, Milan, Italy.	antonella.fogliata@humanitas.it	De Rose, Fiorenza/AAC-6414-2022; Mancosu, Pietro/AAB-9807-2019; Mancosu, Pietro/HBQ-0722-2022; Scorsetti, Marta/AAB-7024-2019; Bourgier, Celine/Y-8679-2019; Tomatis, Stefano/AAA-6002-2021; nicolini, giorgia/AAZ-3810-2021; cozzi, luca/GZL-4895-2022; nicolini, giorgia/AAA-2633-2019; clivio, alessandro/AAG-5660-2021	De Rose, Fiorenza/0000-0001-7994-495X; Mancosu, Pietro/0000-0002-0165-7931; Mancosu, Pietro/0000-0002-0165-7931; cozzi, luca/0000-0001-7862-898X; nicolini, giorgia/0000-0002-8130-8861; LOBEFALO, FRANCESCA/0000-0003-3634-2582; Scorsetti, Marta/0000-0003-0320-559X; Fogliata, Antonella/0000-0002-2282-9894; Tomatis, Stefano/0000-0002-4791-0373	Varian Medical Systems; Wellcome Trust; National Council of Science, Technology and Innovation (NACOSTI); Kilifi [084538]	Varian Medical Systems; Wellcome Trust(Wellcome TrustEuropean Commission); National Council of Science, Technology and Innovation (NACOSTI); Kilifi	The funder Varian Medical Systems provided support in the form of salaries for author LC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.; We would like to acknowledge financial support from Wellcome Trust programme, Kilifi (strategic award, 084538) and the National Council of Science, Technology and Innovation (NACOSTI). The children of Mukuru/Mbagathi and their parents/guardians who participated in the study. Special thanks to the entire field, clinical and laboratory staff of the Kenya Medical Research Institute, Mukuru clinics and Mbagathi District hospital, involved in collection of all the data used in this project. This article is published with permission from the Director, KEMRI.	Appenzoller LM, 2012, MED PHYS, V39, P7446, DOI 10.1118/1.4761864; Chanyavanich V, 2011, MED PHYS, V38, P2515, DOI 10.1118/1.3574874; Fogliata A, 2014, RADIOTHER ONCOL, V113, P385, DOI 10.1016/j.radonc.2014.11.009; Fogliata A, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0236-0; Good D, 2013, INT J RADIAT ONCOL, V87, P176, DOI 10.1016/j.ijrobp.2013.03.015; Hastie T., 2009, UNSUPERVISED LEARNIN; Johansen S, 2009, ACTA ONCOL, V48, P495, DOI 10.1080/02841860802657227; Lian J, 2013, MED PHYS, V40, DOI 10.1118/1.4828788; Moore KL, 2011, INT J RADIAT ONCOL, V81, P545, DOI 10.1016/j.ijrobp.2010.11.030; Nichols GP, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-66; Nicolini G, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-27; Popescu CC, 2010, INT J RADIAT ONCOL, V76, P287, DOI 10.1016/j.ijrobp.2009.05.038; Qiu JJ, 2010, INT J RADIAT ONCOL, V78, P288, DOI 10.1016/j.ijrobp.2009.10.036; Scorsetti M, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-145; Spruijt KH, 2013, INT J RADIAT ONCOL, V85, P506, DOI 10.1016/j.ijrobp.2012.03.040; Subramaniam S, 2012, STRAHLENTHER ONKOL, V188, P484, DOI 10.1007/s00066-012-0075-6; Tol JP, 2015, INT J RADIAT ONCOL, V91, P612, DOI 10.1016/j.ijrobp.2014.11.014; Toscas JI, 2010, RADIOTHER ONCOL, V96, P192, DOI 10.1016/j.radonc.2010.05.007; Varian Medical Systems, 2014, ECL PHOT EL INSTR US, P183; Yin Y, 2012, MED DOSIM, V37, P287, DOI 10.1016/j.meddos.2011.11.001; Yuan LL, 2012, MED PHYS, V39, P6868, DOI 10.1118/1.4757927; Zhu XF, 2011, MED PHYS, V38, P719, DOI 10.1118/1.3539749	22	54	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145137	10.1371/journal.pone.0145137	http://dx.doi.org/10.1371/journal.pone.0145137			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691687	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092300042
J	Chen, JH; Xia, QH; Jiang, B; Chang, WL; Yuan, WZ; Ma, ZJ; Liu, ZY; Shu, XG				Chen, Jinhuang; Xia, Qinghua; Jiang, Bin; Chang, Weilong; Yuan, Wenzheng; Ma, Zhijun; Liu, Zhengyi; Shu, Xiaogang			Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 1; POOR-PROGNOSIS; BREAST-CANCER; COLON-CANCER; RECTAL-CANCER; RESISTANCE; CD133; FEATURES; IMPACT; EPCAM	Objective Many studies have indicated the prognostic and clinicopathological value of aldehyde dehydrogenase 1 (ALDH1) in colorectal cancer (CRC) patients still remains controversial. Thus we performed this study to clarify the relationship between high ALDH1 expression in CRC and its impact on survival and clinicopathological features. Methods Publications for relevant studies in Pubmed, the Cochrane Library, Embase, and China National Knowledge Infrastructure (CNKI) through April 2015 were identified. Only articles describing ALDH1 antigen with immunohistochemistry in CRC were included. The software RevMan 5.1 was used to analyze the outcomes, including 5-year overall survival (OS), disease- free survival (DFS) and clinicopathological features. Results 9 studies with 1203 patients satisfying the criteria were included. The overall rate of high ALDH1 expression was 46.5% by immunohistochemical staining. High ALDH1 expression as an independent prognostic factor was significantly associated with the 5-year OS and DFS (OR = 0.42, 95% CI: 0.26-0.68, P = 0.0004; OR = 0.38, 95% CI: 0.24-0.59, P < 0.0001, respectively). High ALDH1 expression was highly correlated with the tumor (T) stage (T3 + T4 vs. T1 + T2; OR = 2.16, 95% CI: 1.09-4.28, P = 0.03), lymph node (N) stage (N1 + N2 vs. N0; OR = 1.8; 95% CI: 1.17-2.79, P = 0.008), and tumor differentiation (G3 vs. G1 + G2; OR = 1.88; 95% CI: 1.07-3.30, P = 0.03). However, high ALDH1 expression was not significantly correlated with the patient age (>60 years old vs. <60 years old; OR = 1.11, 95% CI: 0.63-1.94, P = 0.72). Conclusions High ALDH1 expression indicates a poor prognosis in CRC patients. Moreover, high ALDH1 expression correlates with the T stage, N stage, and tumor differentiation, but not with age.	[Chen, Jinhuang; Xia, Qinghua; Jiang, Bin; Chang, Weilong; Yuan, Wenzheng; Ma, Zhijun; Liu, Zhengyi; Shu, Xiaogang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gastrointestinal Surg, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Shu, XG (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gastrointestinal Surg, Wuhan 430074, Peoples R China.	sxg678@yahoo.com			National Nature Science Foundation of China [81470789]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Nature Science Foundation of China (No. 81470789). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avoranta ST, 2013, HUM PATHOL, V44, P966, DOI 10.1016/j.humpath.2012.10.003; Burger PE, 2009, STEM CELLS, V27, P2220, DOI 10.1002/stem.135; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056380; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Deng Y, 2014, BRIT J CANCER, V110, P430, DOI 10.1038/bjc.2013.767; Doherty RE, 2011, BIOCHEM BIOPH RES CO, V414, P801, DOI 10.1016/j.bbrc.2011.10.010; Fitzgerald TL, 2014, J SURG RES, V192, P82, DOI 10.1016/j.jss.2014.05.054; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goossens-Beumer IJ, 2014, BRIT J CANCER, V110, P2935, DOI 10.1038/bjc.2014.226; He SB, 2014, BIOMED PHARMACOTHER, V68, P507, DOI 10.1016/j.biopha.2014.03.016; Hessman CJ, 2012, AM J SURG, V203, P649, DOI 10.1016/j.amjsurg.2012.01.003; Hostettler I, 2010, WORLD J GASTROENTERO, V16, P732, DOI 10.3748/wjg.v16.i6.732; Hou Y, 2013, ASIAN PAC J TROP MED, V6, P574, DOI 10.1016/S1995-7645(13)60099-1; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Kahlert C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-275; Kim YH, 2014, ONCOL REP, V31, P1380, DOI 10.3892/or.2014.2970; Leng ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056082; Liu Y, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-444; Lugli A, 2010, BRIT J CANCER, V103, P382, DOI 10.1038/sj.bjc.6605762; Magni M, 1996, BLOOD, V87, P1097, DOI 10.1182/blood.V87.3.1097.bloodjournal8731097; Moreb JS, 2012, CHEM-BIOL INTERACT, V195, P52, DOI 10.1016/j.cbi.2011.10.007; Nalwoga H, 2010, BRIT J CANCER, V102, P369, DOI 10.1038/sj.bjc.6605488; Ni C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070958; Nishida S, 2012, J UROLOGY, V188, P294, DOI 10.1016/j.juro.2012.02.2555; O'Dwyer D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027718; Oh SY, 2015, J SURG ONCOL, V111, P243, DOI 10.1002/jso.23792; Ohi Y, 2011, HISTOPATHOLOGY, V59, P776, DOI 10.1111/j.1365-2559.2011.03884.x; Pan Z-j, 2009, CHIN ARCH GEN SURG, V3, P19; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Singh S, 2015, ADV EXP MED BIOL, V815, P281, DOI 10.1007/978-3-319-09614-8_16; Singh S, 2013, FREE RADICAL BIO MED, V56, P89, DOI 10.1016/j.freeradbiomed.2012.11.010; Toll AD, 2012, HUM PATHOL, V43, P238, DOI 10.1016/j.humpath.2011.04.026; Ueda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075463; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vogler T, 2010, EXPT MOL PATHOLOGY, V92, P111; Wang K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-573; Zhou CY, 2014, ORAL ONCOL, V50, P1144, DOI 10.1016/j.oraloncology.2014.08.018; Zhou F, 2014, ONCOL LETT, V7, P507, DOI 10.3892/ol.2013.1723	40	13	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145164	10.1371/journal.pone.0145164	http://dx.doi.org/10.1371/journal.pone.0145164			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682730	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800039
J	Gutierrez-Bedmar, M; Maritnez, EV; Garcia-Rodriguez, A; Munoz-Bravo, C; Mariscal, A				Gutierrez-Bedmar, Mario; Villalobos Maritnez, Elena; Garcia-Rodriguez, Antonio; Munoz-Bravo, Carlos; Mariscal, Alberto			Psychiatric Status across Body Mass Index in a Mediterranean Spanish Population	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; PERSONALITY-DISORDERS; MENTAL-HEALTH; PSYCHOLOGICAL DISTRESS; DIETARY PATTERN; WEIGHT-LOSS; OBESITY; DEPRESSION; ASSOCIATIONS; PREVALENCE	Background Mental and body weight disorders are among the major global health challenges, and their comorbidity may play an important role in treatment and prevention of both pathologies. A growing number of studies have examined the relationship between psychiatric status and body weight, but our knowledge is still limited. Objective The present study aims to investigate the cross-sectional relationships of psychiatric status and body mass index (BMI) in Malaga, a Mediterranean city in the South of Spain. Materials and Methods A total of 563 participants were recruited from those who came to his primary care physician, using a systematic random sampling, non-proportional stratified by BMI categories. Structured clinical interviews were used to assess current Axes-I and II mental disorders according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). BMI was calculated as weight (Kg) divided by square of height in meters (m(2)). Logistic regression was used to investigate the association between BMI and the presence of any mental disorder. BMI was introduced in the models using restricted cubic splines. Results We found that high BMI values were directly associated with mood and adjustment disorders, and low BMI values were directly associated with avoidant and dependent personality disorders (PDs). We observed an inverse relationship between low BMI values and cluster A PDs. There were not significant relationships between anxiety or substance-related disorders and BMI. Conclusion Psychiatric status and BMI are related in a Mediterranean Spanish population. A multidisciplinary approach to both pathologies becomes increasingly more necessary.	[Gutierrez-Bedmar, Mario; Garcia-Rodriguez, Antonio; Munoz-Bravo, Carlos; Mariscal, Alberto] Univ Malaga, Dept Publ Hlth & Psychiat, E-29071 Malaga, Spain; [Villalobos Maritnez, Elena] Univ Hosp Virgen Victoria, Community Mental Hlth Serv, Malaga, Spain	Universidad de Malaga	Gutierrez-Bedmar, M (corresponding author), Univ Malaga, Dept Publ Hlth & Psychiat, E-29071 Malaga, Spain.	bedmar@uma.es	Mariscal, Alberto/ABH-5409-2020; Gutierrez-Bedmar, Mario/F-2364-2018	Mariscal, Alberto/0000-0002-4684-2161; Gutierrez-Bedmar, Mario/0000-0003-0898-8212; Garcia Rodriguez, Antonio/0000-0002-7672-3024				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; AssociationAP, 2000, DSM 4 APATF DIAGN ST; Atlantis E, 2008, INT J OBESITY, V32, P881, DOI 10.1038/ijo.2008.54; Barry D, 2008, ANN EPIDEMIOL, V18, P458, DOI 10.1016/j.annepidem.2007.12.009; Berkowitz RI, 2011, PSYCHIAT CLIN N AM, V34, P747, DOI 10.1016/j.psc.2011.08.007; Bornstein RF, 2001, J PSYCHOPATHOL BEHAV, V23, P151, DOI 10.1023/A:1010913203679; Bruffaerts R, 2008, CAN J PSYCHIAT, V53, P679, DOI 10.1177/070674370805301007; Casey P, 2011, WORLD PSYCHIATRY, V10, P11; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015; de Wit LM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-14; Esposito K, 2011, METAB SYNDR RELAT D, V9, P1, DOI 10.1089/met.2010.0031; Fabricatore AN, 2011, INT J OBESITY, V35, P1363, DOI 10.1038/ijo.2011.2; Faith MS, 2011, OBES REV, V12, pe438, DOI 10.1111/j.1467-789X.2010.00843.x; Goldney RD, 2009, AUST NZ J PSYCHIAT, V43, P652, DOI 10.1080/00048670902970825; Hach I, 2007, EUR J PUBLIC HEALTH, V17, P297, DOI 10.1093/eurpub/ckl227; Harding JL, 2014, OBESITY, V22, P277, DOI 10.1002/oby.20423; Harrell FE, 2001, REGRESSION MODELING; Henriksen CA, 2014, J NERV MENT DIS, V202, P379, DOI 10.1097/NMD.0000000000000135; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Beunza JJ, 2010, AM J CLIN NUTR, V92, P1484, DOI 10.3945/ajcn.2010.29764; Kelly SJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-765; Kessler RC, 2013, BIOL PSYCHIAT, V73, P904, DOI 10.1016/j.biopsych.2012.11.020; Lenzenweger MF, 2007, BIOL PSYCHIAT, V62, P553, DOI 10.1016/j.biopsych.2006.09.019; Lopresti AL, 2013, PROG NEURO-PSYCHOPH, V45, P92, DOI 10.1016/j.pnpbp.2013.05.005; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Maclean JC, 2014, ECON HUM BIOL, V12, P153, DOI 10.1016/j.ehb.2013.10.002; Marcus MD, 2014, CURR OPIN PSYCHIATR, V27, P443, DOI 10.1097/YCO.0000000000000103; Marek RJ, 2014, OBES SURG, V24, P631, DOI 10.1007/s11695-013-1149-y; Mather AA, 2009, J PSYCHOSOM RES, V66, P277, DOI 10.1016/j.jpsychores.2008.09.008; Mather AA, 2008, PSYCHOSOM MED, V70, P1012, DOI 10.1097/PSY.0b013e318189a930; McCrea R, 2012, INT J OBESITY, V36, P414, DOI 10.1038/ijo.2011.65; McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634; McLaren L, 2008, SOC PSYCH PSYCH EPID, V43, P63, DOI 10.1007/s00127-007-0269-x; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Orsini N, 2009, 3 NORD BALT COUNTR S; Pan A, 2012, INT J OBESITY, V36, P595, DOI 10.1038/ijo.2011.111; PETRY NM, 2008, OVERWEIGHT OBESITY A, V70, P288, DOI DOI 10.1097/PSY.0B013E3181651651; Pickering RP, 2007, J CLIN PSYCHIAT, V68, P998, DOI 10.4088/JCP.v68n0704; Pickering RP, 2011, J CLIN PSYCHIAT, V72, P1494, DOI 10.4088/JCP.10m06077gry; Revah-Levy A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-649; Rienks J, 2013, EUR J CLIN NUTR, V67, P75, DOI 10.1038/ejcn.2012.193; Roberts RE, 2003, INT J OBESITY, V27, P514, DOI 10.1038/sj.ijo.0802204; Rosmond R, 1999, J ENDOCRINOL INVEST, V22, P279, DOI 10.1007/BF03343557; Rosmond R, 2001, J ENDOCRINOL INVEST, V24, P159, DOI 10.1007/BF03343836; Sanchez-Villegas A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-208; Schneider N, 2009, EAT WEIGHT DISORD-ST, V14, pE205, DOI 10.1007/BF03325118; Scott KM, 2008, INT J OBESITY, V32, P192, DOI 10.1038/sj.ijo.0803701; Scott KA, 2008, J PSYCHOSOM RES, V64, P97, DOI 10.1016/j.jpsychores.2007.09.006; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Stanley SH, 2013, SOC PSYCH PSYCH EPID, V48, P487, DOI 10.1007/s00127-012-0546-1; Martinez EV, 2014, NUTRIENTS, V6, P1662, DOI 10.3390/nu6041662; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; World Health Organization, 1995, WHO TECH REP SER; Zhao G, 2009, INT J OBESITY, V33, P257, DOI 10.1038/ijo.2008.268	57	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145414	10.1371/journal.pone.0145414	http://dx.doi.org/10.1371/journal.pone.0145414			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9KM	26684876	Green Published, gold, Green Submitted			2022-12-27	WOS:000366725800073
J	Jongbloets, BC; van Gassen, KLI; Kan, AA; Engberink, AHOO; de Wit, M; Wolterink-Donselaar, IG; Koerkamp, MJAG; van Nieuwenhuizen, O; Holstege, FCP; de Graan, PNE				Jongbloets, Bart C.; van Gassen, Koen L. I.; Kan, Anne A.; Engberink, Anneke H. O. Olde; de Wit, Marina; Wolterink-Donselaar, Inge G.; Koerkamp, Marian J. A. Groot; van Nieuwenhuizen, Onno; Holstege, Frank C. P.; de Graan, Pierre N. E.			Expression Profiling after Prolonged Experimental Febrile Seizures in Mice Suggests Structural Remodeling in the Hippocampus	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; IMMATURE RAT MODEL; LARGE GENE LISTS; LONG-TERM; STATUS EPILEPTICUS; GLUTAMINE-SYNTHETASE; MICROARRAY DATA; CHANNELS; CELLS; BRAIN	Febrile seizures are the most prevalent type of seizures among children up to 5 years of age (2-4% ofWestern-European children). Complex febrile seizures are associated with an increased risk to develop temporal lobe epilepsy. To investigate short-and long-term effects of experimental febrile seizures (eFS), we induced eFS in highly febrile convulsion-susceptible C57BL/6J mice at post-natal day 10 by exposure to hyperthermia (HT) and compared them to normotherm-exposed (NT) mice. We detected structural re-organization in the hippocampus 14 days after eFS. To identify molecular candidates, which entrain this structural re-organization, we investigated temporal changes in mRNA expression profiles eFS 1 hour to 56 days after eFS. We identified 931 regulated genes and profiled several candidates using in situ hybridization and histology at 3 and 14 days after eFS. This is the first study to report genome-wide transcriptome analysis after eFS in mice. We identify temporal regulation of multiple processes, such as stress-, immune-and inflammatory responses, glia activation, glutamate-glutamine cycle and myelination. Identification of the short-and long-term changes after eFS is important to elucidate the mechanisms contributing to epileptogenesis.	[Jongbloets, Bart C.; van Gassen, Koen L. I.; Kan, Anne A.; Engberink, Anneke H. O. Olde; de Wit, Marina; Wolterink-Donselaar, Inge G.; de Graan, Pierre N. E.] Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Koerkamp, Marian J. A. Groot; Holstege, Frank C. P.] Univ Med Ctr Utrecht, Div Biomed Genet, Mol Canc Res, Utrecht, Netherlands; [van Nieuwenhuizen, Onno] Univ Med Ctr Utrecht, Dept Pediat Neurol, Brain Ctr Rudolf Magnus, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	de Graan, PNE (corresponding author), Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	P.N.E.deGraan@umcutrecht.nl	Holstege, Frank/AAM-9944-2021	van Gassen, Koen/0000-0001-7934-0662; Groot Koerkamp, Marian JA/0000-0002-0867-0821; Olde Engberink, Anneke/0000-0002-0100-4770	National Epilepsy Fund of the Netherlands [NEF 10-17, 03-12]; Epilepsies of Childhood Foundation	National Epilepsy Fund of the Netherlands; Epilepsies of Childhood Foundation	This work was supported by the National Epilepsy Fund of the Netherlands, grant number: NEF 10-17 and 03-12, (https://www.epilepsie.nl), and the Epilepsies of Childhood Foundation, grant number: N/A, website: N/A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica E, 2007, NEUROBIOL DIS, V26, P497, DOI 10.1016/j.nbd.2007.01.015; BABB TL, 1984, EPILEPSIA, V25, P729, DOI 10.1111/j.1528-1157.1984.tb03484.x; Baram TZ, 1997, DEV BRAIN RES, V98, P265, DOI 10.1016/S0165-3806(96)00190-3; Barnes G, 2003, HIPPOCAMPUS, V13, P1, DOI 10.1002/hipo.10041; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; BLACKSTAD T, 1961, J COMP NEUROL, V117, P133, DOI 10.1002/cne.901170202; Boender AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094159; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Chui R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-1; Cross JH, 2012, EPILEPSIA, V53, P3, DOI 10.1111/j.1528-1167.2012.03608.x; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Drojdahl N, 2010, GLIA, V58, P29, DOI 10.1002/glia.20897; Dube C, 2005, ANN NEUROL, V57, P152, DOI 10.1002/ana.20358; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Dube C, 2000, ANN NEUROL, V47, P336, DOI 10.1002/1531-8249(200003)47:3<336::AID-ANA9>3.0.CO;2-W; Dube CM, 2009, BRAIN DEV-JPN, V31, P366, DOI 10.1016/j.braindev.2008.11.010; Eckhaus J, 2013, EPILEPSY RES, V105, P103, DOI 10.1016/j.eplepsyres.2013.02.011; Edgar JM, 2009, GLIA, V57, P1815, DOI 10.1002/glia.20893; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eid T, 2004, LANCET, V363, P28, DOI 10.1016/S0140-6736(03)15166-5; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Fang M, 2010, BRAIN RES, V1324, P14, DOI 10.1016/j.brainres.2010.02.007; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; Gatti S, 2002, MECH FEVER FEBRILE S; Gonzalez P, 2009, J NEUROPATH EXP NEUR, V68, P391, DOI 10.1097/NEN.0b013e31819dca30; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; Hamelin S, 2014, NEUROBIOL DIS, V69, P156, DOI 10.1016/j.nbd.2014.05.025; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Hessel EVS, 2009, GENES BRAIN BEHAV, V8, P248, DOI 10.1111/j.1601-183X.2008.00466.x; Hessel EVS, 2014, ANN CLIN TRANSL NEUR, V1, P239, DOI 10.1002/acn3.48; Holtmaat AJGD, 2003, EXP NEUROL, V182, P142, DOI 10.1016/S0014-4886(03)00035-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ishizaki Y, 2009, EPILEPSIA, V50, P761, DOI 10.1111/j.1528-1167.2008.01861.x; Jansen JFA, 2008, NEUROBIOL DIS, V32, P293, DOI 10.1016/j.nbd.2008.07.010; Jung KH, 2011, EPILEPSIA, V52, P541, DOI 10.1111/j.1528-1167.2010.02916.x; Kamal A, 2006, EUR J NEUROSCI, V23, P2230, DOI 10.1111/j.1460-9568.2006.04732.x; Kan AA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-207; Kohara K, 2014, NAT NEUROSCI, V17, P269, DOI 10.1038/nn.3614; Koyama R, 2012, NAT MED, V18, P1271, DOI 10.1038/nm.2850; Kuijpers M, 2010, J NEUROIMMUNOL, V229, P73, DOI 10.1016/j.jneuroim.2010.07.004; Kwak SE, 2008, BRAIN RES, V1216, P1, DOI 10.1016/j.brainres.2008.04.026; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Levin S G, 2007, Neurosci Behav Physiol, V37, P467, DOI 10.1007/s11055-007-0036-1; Lewis DV, 2014, ANN NEUROL, V75, P178, DOI 10.1002/ana.24081; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Louboutin JP, 2011, FASEB J, V25, P737, DOI 10.1096/fj.10-161851; Malik AR, 2013, J BIOL CHEM, V288, P8544, DOI 10.1074/jbc.M112.411629; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Myllykoski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032336; Mylvaganam S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00172; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Neligan A, 2012, NEUROLOGY, V78, P1166, DOI 10.1212/WNL.0b013e31824f807a; Niisato E, 2012, DEV NEUROBIOL, V72, P1447, DOI 10.1002/dneu.22007; Notenboom RGE, 2010, EUR J NEUROSCI, V32, P749, DOI 10.1111/j.1460-9568.2010.07321.x; Otte WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039078; Parent JM, 2006, HIPPOCAMPUS, V16, P321, DOI 10.1002/hipo.20166; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Proper EA, 2000, BRAIN, V123, P19, DOI 10.1093/brain/123.1.19; Richichi C, 2008, NEUROBIOL DIS, V29, P297, DOI 10.1016/j.nbd.2007.09.003; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schuchmann S, 2006, NAT MED, V12, P817, DOI 10.1038/nm1422; Sharma AK, 2009, TOXICOL PATHOL, V37, P776, DOI 10.1177/0192623309344202; Shinnar S, 2012, NEUROLOGY, V79, P871, DOI 10.1212/WNL.0b013e318266fcc5; Steinhauser C, 2012, GLIA, V60, P1192, DOI 10.1002/glia.22313; Swijsen A, 2012, EPILEPSIA, V53, P1968, DOI 10.1111/j.1528-1167.2012.03694.x; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Theodore WH, 1999, NEUROLOGY, V52, P132, DOI 10.1212/WNL.52.1.132; Toth Z, 1998, J NEUROSCI, V18, P4285; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; van Campen JS, 2014, EPILEPSY BEHAV, V38, P160, DOI 10.1016/j.yebeh.2013.09.029; van der Hel WS, 2005, NEUROLOGY, V64, P326, DOI 10.1212/01.WNL.0000149636.44660.99; van Gassen KLI, 2008, GENES BRAIN BEHAV, V7, P578, DOI 10.1111/j.1601-183X.2008.00393.x; van Gassen KLI, 2009, GENES BRAIN BEHAV, V8, P290, DOI 10.1111/j.1601-183X.2008.00471.x; van Gassen KLI, 2008, EPILEPSIA, V49, P1055, DOI 10.1111/j.1528-1167.2007.01470.x; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Wang ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095237; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Xiong Y, 2014, BRAIN RES; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhou Y, 2011, J NEUROCHEM, V116, P406, DOI 10.1111/j.1471-4159.2010.07121.x	84	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145247	10.1371/journal.pone.0145247	http://dx.doi.org/10.1371/journal.pone.0145247			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684451	gold, Green Published, Green Submitted			2022-12-27	WOS:000366725800051
J	Magni, S; Christofides, N; Johnson, S; Weiner, R				Magni, Sarah; Christofides, Nicola; Johnson, Saul; Weiner, Renay			Alcohol Use and Transactional Sex among Women in South Africa: Results from a Nationally Representative Survey	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; DAR-ES-SALAAM; HIV-INFECTION; CAPE-TOWN; BINGE DRINKING; HIV/AIDS RISK; YOUNG-PEOPLE; UNSAFE SEX; CONDOM USE; MEN	Background Transactional sex is a risk factor for HIV infection. Alcohol use may increase the risk of transactional sex. No nationally-representative studies have examined the relationship between multiple dimensions of alcohol use and transactional sex in women in South Africa. The aim of the study was to examine the relationship between alcohol dependence, binge drinking and frequency of drinking in the past month and transactional sex in adult women in South Africa. Methods A cross-sectional study using multi-stage, cluster sampling collected data from a nationally representative sample of 5,969 women aged 16-55 years in 2012. The analysis conducted for this paper was restricted to women reporting sexual activity in the past 12 months (n = 3,594). Transactional sex was defined as having received money/gifts in exchange for sex with any sex partner in the past year. Alcohol use measures included: alcohol dependence (>= 2 positive responses to the CAGE questionnaire); binge drinking (>= 4 drinks for women on one occasion); and drinking frequency in the previous month. Logistic regression models were built to test the hypotheses that each dimension of alcohol use was associated with transactional sex. Results About 6.3% (n = 225) of sexually active women reported transactional sex. Almost a third (30.6%) of sexually active women had ever drunk alcohol, and 19.2% were current (past month) drinkers. Among lifetime drinkers, 28.0% were alcohol dependent and 56.6% were binge drinkers. Alcohol dependent women were twice as likely to report transactional sex (AOR 2.0, 95% CI 1.1-4.3, p<0.05) than those not alcohol dependent. Binge drinkers were 3.1 times more likely to have had transactional sex (95% CI 1.5-6.6, p<0.01) than non-binge drinkers. There was no significant relationship between frequency of drinking in the past month and transactional sex. Conclusion Alcohol dependency and binge drinking are significantly associated with transactional sex in South African women. HIV prevention programmes need to target these women, and address both their alcohol use, as well as the HIV risks associated with transactional sex.	[Magni, Sarah; Christofides, Nicola; Weiner, Renay] Univ Witwatersrand, Johannesburg, South Africa; [Magni, Sarah; Johnson, Saul] Anansi Hlth Consulting, Johannesburg, South Africa; [Weiner, Renay] Soul City Inst Hlth & Dev Commun, Johannesburg, South Africa	University of Witwatersrand	Magni, S (corresponding author), Univ Witwatersrand, Johannesburg, South Africa.	sarah.e.magni@gmail.com			Anansi Health Consulting	Anansi Health Consulting	The authors received no specific funding for this work. Anansi Health Consulting provided support in the form of salaries for authors SM and SJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2012, UNAIDS REPORT ON THE; [Anonymous], 2011, NAT STRAT PLAN HIV S; [Anonymous], 1998, S AFR DEM HLTH SURV; Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x; Bonita R., 2006, BASIC EPIDEMIOLOGY, V2nd ed.; Braithwaite RS, 2014, ALCOHOL CLIN EXP RES, V38, P1059, DOI 10.1111/acer.12332; Carrasco MA, 2016, AIDS BEHAV, V20, P484, DOI 10.1007/s10461-015-1233-5; Chatterji M, 2005, SOC BIOL, V52, P56; Chavez PR, 2011, AM J PREV MED, V40, P468, DOI 10.1016/j.amepre.2010.12.008; Chersich MF, 2007, INT J STD AIDS, V18, P764, DOI 10.1258/095646207782212342; Chersich MF, 2010, INT J STD AIDS, V21, P2, DOI 10.1258/ijsa.2000.009432; Claassen JN, 1999, S AFR MED J, V89, P976; CLELAND J, 1987, POP STUD-J DEMOG, V41, P5, DOI 10.1080/0032472031000142516; Coldiron ME, 2008, AIDS BEHAV, V12, P594, DOI 10.1007/s10461-007-9304-x; Cook RL, 2005, SEX TRANSM DIS, V32, P156, DOI 10.1097/01.olq.0000151418.03899.97; Courtney KE, 2009, PSYCHOL BULL, V135, P142, DOI 10.1037/a0014414; Dhalla S, 2007, CLIN INVEST MED, V30, P33, DOI 10.25011/cim.v30i1.447; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2007, SOC SCI MED, V65, P1235, DOI 10.1016/j.socscimed.2007.04.029; European Centre for Monitoring Alcohol Marketing, 2008, WOM NEW MARK TRENDS; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Fisher JC, 2008, SEX TRANSM DIS, V35, P537, DOI 10.1097/OLQ.0b013e3181677547; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Fritz K, 2009, PREVENTION ALCOHOL R; Fritz K, 2013, MEASURING ALCOHOL RE; Fritz K. E., 2002, AIDS BEHAV, V6, P221, DOI DOI 10.1023/A:1019887707474; Ghebremichael M, 2009, SEX TRANSM DIS, V36, P102, DOI 10.1097/OLQ.0b013e31818b20e6; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P793, DOI 10.1046/j.1365-3156.2002.00943.x; Harrison L, 1997, NIDA Res Monogr, V167, P1; Hunter Mark., 2002, AFR STUD-UK, V61, P99, DOI [DOI 10.1080/00020180220140091, 10.1080/00020180220140091]; Jernigan DH, 2015, ADDICTION, V110, P551, DOI 10.1111/add.12468; Jewkes R., 2012, Journal of AIDS and Clinical Research, V3, P158; Jewkes R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-325; Johnson S, 2013, 3 NATL HIV COMMUNICA; Kalichman SC, 2007, JAIDS-J ACQ IMM DEF, V44, P594, DOI 10.1097/QAI.0b013e3180415e07; Kalichman SC, 2013, SEX TRANSM INFECT, V89, P231, DOI 10.1136/sextrans-2012-050569; Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009; Kincaid DL, 2000, COMMUN RES, V27, P723, DOI 10.1177/009365000027006003; Lane T, 2008, AIDS BEHAV, V12, pS78, DOI 10.1007/s10461-008-9389-x; LeBeau D, 2009, ALCOHOL CONSUMPTION; Leclerc-Madlala S, 2003, SOC DYNAMICS, V29, P213, DOI 10.1080/02533950308628681; Lewis JJC, 2005, SEX TRANSM DIS, V32, P364, DOI 10.1097/01.olq.0000154506.84492.61; Luke N, 2003, STUD FAMILY PLANN, V34, P67, DOI 10.1111/j.1728-4465.2003.00067.x; MacPhail C, 2001, SOC SCI MED, V52, P1613, DOI 10.1016/S0277-9536(00)00272-0; Maganja RK, 2007, AIDS CARE, V19, P974, DOI 10.1080/09540120701294286; Matasha E, 1998, AIDS CARE, V10, P571, DOI 10.1080/09540129848433; Mbulaiteye SM, 2000, INT J EPIDEMIOL, V29, P911, DOI 10.1093/ije/29.5.911; Morojele NK, 2006, SOC SCI MED, V62, P217, DOI 10.1016/j.socscimed.2005.05.031; Myer L, 2007, EPIDEMIOLOGY RES MAN, P155; Ojo OA, 2010, SAMJ S AFR MED J, V100, P180, DOI 10.7196/SAMJ.3767; Parry CDH, 2005, ADDICTION, V100, P426, DOI 10.1111/j.1360-0443.2005.01015.x; Peltzer K, 2011, AFR J PSYCHIATRY, V14, P30; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Pitpitan EV, 2014, PREV SCI, V15, P296, DOI 10.1007/s11121-013-0381-y; Republic of South Africa, 2019, HLTH ACT 61 2003; Shisana O, 2014, S AFRICAN NATL HIV P; Shuper PA, 2010, ALCOHOL ALCOHOLISM, V45, P159, DOI 10.1093/alcalc/agp091; Stoebenau K, 2015, CLARIFYING MEANING T; Townsend L, 2011, QUAL HEALTH RES, V21, P41, DOI 10.1177/1049732310378296; Townsend L, 2011, AIDS BEHAV, V15, P132, DOI 10.1007/s10461-010-9680-5; Wamoyi J, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-2; Watt MH, 2012, SOC SCI MED, V74, P1005, DOI 10.1016/j.socscimed.2011.12.022; Weiser SD, 2006, PLOS MED, V3, P1940, DOI 10.1371/journal.pmed.0030392; WHO, 2011, PREV HIV SEX WORK SE; Wojcicki JM, 2001, SOC SCI MED, V53, P99, DOI 10.1016/S0277-9536(00)00315-4; Wolff B, 2006, ADDICTION, V101, P1277, DOI 10.1111/j.1360-0443.2006.01516.x; Zablotska IB, 2006, AIDS, V20, P1191, DOI 10.1097/01.aids.0000226960.25589.72; Zembe YZ, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-28	70	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145326	10.1371/journal.pone.0145326	http://dx.doi.org/10.1371/journal.pone.0145326			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9KM	26683812	gold, Green Published			2022-12-27	WOS:000366725800065
J	Marton, G; Orban, G; Kiss, M; Fiath, R; Pongracz, A; Ulbert, I				Marton, Gergely; Orban, Gabor; Kiss, Marcell; Fiath, Richard; Pongracz, Anita; Ulbert, Istvan			A Multimodal, SU-8-Platinum - Polyimide Microelectrode Array for Chronic In Vivo Neurophysiology	PLOS ONE			English	Article							DRUG-DELIVERY; BRAIN-TISSUE; ELECTROCORTICOGRAPHY; OSCILLATIONS; FABRICATION; INTERFACE; DESIGN; SYSTEM; SLEEP; VITRO	Utilization of polymers as insulator and bulk materials of microelectrode arrays (MEAs) makes the realization of flexible, biocompatible sensors possible, which are suitable for various neurophysiological experiments such as in vivo detection of local field potential changes on the surface of the neocortex or unit activities within the brain tissue. In this paper the microfabrication of a novel, all-flexible, polymer-based MEA is presented. The device consists of a three dimensional sensor configuration with an implantable depth electrode array and brain surface electrodes, allowing the recording of electrocorticographic (ECoG) signals with laminar ones, simultaneously. In vivo recordings were performed in anesthetized rat brain to test the functionality of the device under both acute and chronic conditions. The ECoG electrodes recorded slow-wave thalamocortical oscillations, while the implanted component provided high quality depth recordings. The implants remained viable for detecting action potentials of individual neurons for at least 15 weeks.	[Marton, Gergely; Fiath, Richard; Ulbert, Istvan] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, H-1117 Budapest, Hungary; [Marton, Gergely; Kiss, Marcell; Pongracz, Anita] Hungarian Acad Sci, Energy Res Ctr, Inst Tech Phys & Mat Sci, Dept Microtechnol, H-1121 Budapest, Hungary; [Marton, Gergely] Semmelweis Univ, Sch PhD Studies, H-1085 Budapest, Hungary; [Orban, Gabor; Kiss, Marcell] Budapest Univ Technol & Econ, Dept Electron Devices, H-1117 Budapest, Hungary; [Fiath, Richard; Ulbert, Istvan] Pazmany Peter Catholic Univ, Fac Informat Technol & Bion, H-1083 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Energy Research; Hungarian Research Centre for Natural Sciences; Semmelweis University; Budapest University of Technology & Economics	Marton, G (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Magyar Tudosok Korutja 2,Bldg Q2, H-1117 Budapest, Hungary.	marton.gergely@ttk.mta.hu	Ulbert, Istvan/F-2213-2010; Fiath, Richard/V-4360-2019	Fiath, Richard/0000-0001-8732-2691; Kiss, Marcell/0000-0001-5930-1367	Bolyai Janos Grant of the HAS; KTIA [NAP 13-2-2015-0004]; OTKA [K81354]; ANR-TET Multisca; EU FP7 NeuroSeeker grants [600925];  [KTIA_13_NAP-A-IV/1-2-3-6];  [TAMOP-4.2.1.B-11/2/KMR-2011-0002]	Bolyai Janos Grant of the HAS; KTIA; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ANR-TET Multisca(French National Research Agency (ANR)); EU FP7 NeuroSeeker grants; ; 	This work was funded by the Bolyai Janos Grant of the HAS and KTIA NAP 13-2-2015-0004 to Anita Pongracz, and OTKA K81354, KTIA_13_NAP-A-IV/1-2-3-6, ANR-TET Multisca, TAMOP-4.2.1.B-11/2/KMR-2011-0002, EU FP7 Grant No. 600925 NeuroSeeker grants to Istvan Ulbert. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Mrs. Karolyne Payer, Mr. Robert Hodovan and Mr. Andras Lorincz for their support in microfabrication. We also wish to thank Attila Nagy for his help with packaging and Richard Fiath for useful discussions on in vivo measurements. This work was funded by the Bolyai Janos Grant of the HAS and KTIA NAP 13-2-2015-0004 to Anita Pongracz and OTKA K81354, KTIA_13_NAP-A-IV/1-2-3-6, ANR-TET Multisca, TAMOP-4.2.1.B-11/2/KMR-2011-0002, EU FP7 Grant No. 600925 NeuroSeeker grants to Istvan Ulbert. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuna A, 2013, LAB CHIP, V13, P1422, DOI 10.1039/c3lc41364k; Boretius T, 2010, BIOSENS BIOELECTRON, V26, P62, DOI 10.1016/j.bios.2010.05.010; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Chader GJ, 2009, PROG BRAIN RES, V175, P317, DOI 10.1016/S0079-6123(09)17522-2; Chang CW, 2013, SENSORS-BASEL, V13, P4624, DOI 10.3390/s130404624; Chang TY, 2007, LANGMUIR, V23, P11718, DOI 10.1021/la7017049; Chauvette S, 2011, J NEUROSCI, V31, P14998, DOI 10.1523/JNEUROSCI.2339-11.2011; Chauvette S, 2010, CEREB CORTEX, V20, P2660, DOI 10.1093/cercor/bhq009; Chen YY, 2009, J NEUROSCI METH, V182, P6, DOI 10.1016/j.jneumeth.2009.05.010; Cheung KC, 2007, BIOMED MICRODEVICES, V9, P923, DOI 10.1007/s10544-006-9045-z; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; Csercsa R, 2010, BRAIN, V133, P2814, DOI 10.1093/brain/awq169; Dombovari B., 2013, BIOMED TECH, P1; DYMOND AM, 1970, J NEUROSURG, V33, P574, DOI 10.3171/jns.1970.33.5.0574; Ereifej ES, 2013, BIOMED MICRODEVICES, V15, P917, DOI 10.1007/s10544-013-9780-x; Fontanini A, 2003, J NEUROSCI, V23, P7993; Hashiguchi K, 2007, SEIZURE-EUR J EPILEP, V16, P238, DOI 10.1016/j.seizure.2006.12.010; Hassler C, 2011, J POLYM SCI POL PHYS, V49, P18, DOI 10.1002/polb.22169; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Jones MS, 1999, J NEUROPHYSIOL, V82, P1599, DOI 10.1152/jn.1999.82.3.1599; Kelly RC, 2007, J NEUROSCI, V27, P261, DOI 10.1523/JNEUROSCI.4906-06.2007; Kim BJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/045002; Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8; Laszlo G, 2011, SENSOR ACTUAT A-PHYS, V166, P14, DOI 10.1016/j.sna.2010.12.019; Marton G, 2015, MICROSYST TECHNOL, V21, P619, DOI 10.1007/s00542-014-2203-y; Marton G, 2014, J MATER SCI-MATER M, V25, P931, DOI 10.1007/s10856-013-5114-z; Marton G, 2013, IEEE SENS J, V13, P3263, DOI 10.1109/JSEN.2013.2260325; Matsuo T, 2013, NEUROSURGERY, V73, P146, DOI 10.1227/01.neu.0000430327.48387.e1; McKhann GM, 2000, J NEUROSURG, V93, P44, DOI 10.3171/jns.2000.93.1.0044; Mercanzini A, 2008, SENSOR ACTUAT A-PHYS, V143, P90, DOI 10.1016/j.sna.2007.07.027; Metz S, 2004, BIOSENS BIOELECTRON, V19, P1309, DOI 10.1016/j.bios.2003.11.021; Myllymaa S, 2009, BIOSENS BIOELECTRON, V24, P3067, DOI 10.1016/j.bios.2009.03.028; Nemani KV, 2013, MAT SCI ENG C-MATER, V33, P4453, DOI 10.1016/j.msec.2013.07.001; Ochoa M, 2013, BIOMED MICRODEVICES, V15, P437, DOI 10.1007/s10544-013-9743-2; Paxinos G, 2009, RAT BRIAN STEREOTAXI; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Poppendieck W, 2014, BIOMED MICRODEVICES, V16, P837, DOI 10.1007/s10544-014-9887-8; Seymour JP, 2011, BIOMED MICRODEVICES, V13, P441, DOI 10.1007/s10544-011-9512-z; SPENCER DD, 1984, NEUROLOGY, V34, P432, DOI 10.1212/WNL.34.4.432; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stieglitz T, 2002, BIOSENS BIOELECTRON, V17, P685, DOI 10.1016/S0956-5663(02)00019-2; Stieglitz T, 2000, BIOMED MICRODEVICES, V2, P283, DOI 10.1023/A:1009955222114; Sugano H, 2007, SEIZURE-EUR J EPILEP, V16, P120, DOI 10.1016/j.seizure.2006.10.010; Toda H, 2011, NEUROIMAGE, V54, P203, DOI 10.1016/j.neuroimage.2010.08.003; Ulbert I, 2001, J NEUROSCI METH, V106, P69, DOI 10.1016/S0165-0270(01)00330-2; Ulbert T, 2004, EPILEPSIA, V45, P48, DOI 10.1111/j.0013-9580.2004.04011.x; von Metzen RP, 2013, BIOMED MICRODEVICES, V15, P727, DOI 10.1007/s10544-013-9758-8; Ward MP, 2009, BRAIN RES, V1282, P183, DOI 10.1016/j.brainres.2009.05.052; WISE KD, 1970, IEEE T BIO-MED ENG, VBM17, P238, DOI 10.1109/TBME.1970.4502738; Wise KD, 2007, SENSOR ACTUAT A-PHYS, V136, P39, DOI 10.1016/j.sna.2007.02.013	50	24	24	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145307	10.1371/journal.pone.0145307	http://dx.doi.org/10.1371/journal.pone.0145307			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683306	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000366725800061
J	Mullapudi, N; Ye, B; Suzuki, M; Fazzari, M; Han, W; Shi, MK; Marquardt, G; Lin, J; Wang, T; Keller, S; Zhu, CC; Locker, JD; Spivack, SD				Mullapudi, Nandita; Ye, Bin; Suzuki, Masako; Fazzari, Melissa; Han, Weiguo; Shi, Miao K.; Marquardt, Gaby; Lin, Juan; Wang, Tao; Keller, Steven; Zhu, Changcheng; Locker, Joseph D.; Spivack, Simon D.			Genome Wide Methylome Alterations in Lung Cancer	PLOS ONE			English	Article							METHYLATION-SPECIFIC PCR; DNA METHYLATION; PROMOTER METHYLATION; GENE-EXPRESSION; CPG ISLANDS; ADENOCARCINOMA; ASSOCIATION; BIOMARKERS; PHENOTYPE; DIAGNOSIS	Aberrant cytosine 5-methylation underlies many deregulated elements of cancer. Among paired non-small cell lung cancers (NSCLC), we sought to profile DNA 5-methyl-cytosine features which may underlie genome-wide deregulation. In one of the more dense interrogations of the methylome, we sampled 1.2 million CpG sites from twenty-four NSCLC tumor (T)-non-tumor (NT) pairs using a methylation-sensitive restriction enzyme-based HELP-microarray assay. We found 225,350 differentially methylated (DM) sites in adenocarcinomas versus adjacent non-tumor tissue that vary in frequency across genomic compartment, particularly notable in gene bodies (GB; p<2.2E-16). Further, when DM was coupled to differential transcriptome (DE) in the same samples, 37,056 differential loci in adenocarcinoma emerged. Approximately 90% of the DM-DE relationships were non-canonical; for example, promoter DM associated with DE in the same direction. Of the canonical changes noted, promoter (PR) DM loci with reciprocal changes in expression in adenocarcinomas included HBEGF, AGER, PTPRM, DPT, CST1, MELK; DM GB loci with concordant changes in expression included FOXM1, FERMT1, SLC7A5, and FAP genes. IPA analyses showed adenocarcinoma- specific promoter DMxDE overlay identified familiar lung cancer nodes [tP53, Akt] as well as less familiar nodes [HBEGF, NQO1, GRK5, VWF, HPGD, CDH5, CTNNAL1, PTPN13, DACH1, SMAD6, LAMA3, AR]. The unique findings from this study include the discovery of numerous candidate The unique findings from this study include the discovery of numerous candidate methylation sites in both PR and GB regions not previously identified in NSCLC, and many non-canonical relationships to gene expression. These DNA methylation features could potentially be developed as risk or diagnostic biomarkers, or as candidate targets for newer methylation locus-targeted preventive or therapeutic agents.	[Mullapudi, Nandita; Han, Weiguo; Shi, Miao K.; Marquardt, Gaby; Spivack, Simon D.] Albert Einstein Coll Med, Dept Med Pulm, Bronx, NY 10467 USA; [Ye, Bin] Albert Einstein Coll Med, Dept Bioinformat, Bronx, NY 10467 USA; [Suzuki, Masako; Fazzari, Melissa; Spivack, Simon D.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Lin, Juan] Albert Einstein Coll Med, Div Biostat, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Wang, Tao; Spivack, Simon D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Keller, Steven] Montefiore Med Ctr, Dept Cardiovasc & Thorac Surg, Bronx, NY 10467 USA; [Zhu, Changcheng; Locker, Joseph D.] Montefiore Med Ctr, Dept Pathol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Spivack, SD (corresponding author), Albert Einstein Coll Med, Dept Med Pulm, Bronx, NY 10467 USA.	simon.spivack@einstein.yu.edu	Suzuki, Masako/ABF-6497-2020	Suzuki, Masako/0000-0003-0605-9225; Fazzari, Melissa/0000-0002-5674-3589	NCI [1RC1 CA145422-01, 1K24-CA139054-01]; Stony-Wold Herbert Foundation [1R01-CA180126-01, P30 CA013330]; NATIONAL CANCER INSTITUTE [K24CA139054, P30CA013330, R01CA180126, RC1CA145422] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stony-Wold Herbert Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by NCI 1RC1 CA145422-01 (SDS); 1K24-CA139054-01 (SDS); Stony-Wold Herbert Foundation (NM); 1R01-CA180126-01 (SDS Co-PI); P30 CA013330 (Albert Einstein Cancer Center core grant).	Alberg AJ, 2013, CHEST, P143; American Cancer Society, 2014, CANC FACTS FIG; Anglim PP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-81; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cao X, 2015, SCI REP; Carvalho RH, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-9; Chen K, 2013, CANCER RES, V73, P3262, DOI 10.1158/0008-5472.CAN-12-3191; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Fang ZY, 2013, J BIOL CHEM, V288, P7918, DOI 10.1074/jbc.M112.416842; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Fu Y, DNA METHYLATION MEDI, P5; Ganguly R, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0045-y; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Han WG, 2006, ANAL BIOCHEM, V355, P50, DOI 10.1016/j.ab.2006.05.010; Han WG, 2013, EPIGENETICS-US, V8, P1176, DOI 10.4161/epi.26195; Han WG, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-86; Hatada I, 2006, ONCOGENE, V25, P3059, DOI 10.1038/sj.onc.1209331; Heller G, 2013, CARCINOGENESIS, V34, P513, DOI 10.1093/carcin/bgs363; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Jones PA, 2012, FUNCTIONS DNA METHYL, V13, DOI [10.1038/nrg3230, DOI 10.1038/NRG3230]; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Khulan B, 2006, COMP ISOSCHIZOMER PR, P1046; Kim YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040960; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lin J, 2014, AM J PATHOL, V184, P2868, DOI 10.1016/j.ajpath.2014.06.028; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lokk K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039813; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; Micke P, 2014, INT J CANCER, V135, P2206, DOI 10.1002/ijc.28857; Moravcikova E, 2012, INT J ONCOL, V40, P2111, DOI 10.3892/ijo.2012.1397; Nikolaidis G, 2012, CANCER RES, V72, P5692, DOI 10.1158/0008-5472.CAN-12-2309; Oh JE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.130; Ostrow KL, 2010, CLIN CANCER RES, V16, P3463, DOI 10.1158/1078-0432.CCR-09-3304; Palmisano WA, 2000, ADV BRIEF PREDICTING, V1, P5954; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Sandoval J, 2013, J CLIN ONCOL, V31, P4140, DOI 10.1200/JCO.2012.48.5516; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Shinjo K, 2012, SCI TECHNOLOGY; Tan XL, 2009, CLIN CANCER RES, V15, P7562, DOI 10.1158/1078-0432.CCR-09-1694; Tanaka M, 2011, J HISTOCHEM CYTOCHEM, V59, P942, DOI 10.1369/0022155411420569; Thompson RF, 2008, BIOINFORMATICS, V24, P1161, DOI 10.1093/bioinformatics/btn096; Toyooka S, 2003, INT J CANCER, V103, P153, DOI 10.1002/ijc.10787; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Tsou JA, 2002, ONCOGENE, V21, P5450, DOI 10.1038/sj.onc.1205605; Varley KE, 2013, DYNAMIC DNA METHYLAT, P555; Wan J, 2013, NUCLEIC ACIDS RES, V41, P8503, DOI 10.1093/nar/gkt652; Wang HB, 2014, J BIOL CHEM, V289, P19823, DOI 10.1074/jbc.M114.548446; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Wessa P, 2014, OFFIC RES DEV ED, V1, P23; Woenckhaus M, 2006, J PATHOL, V210, P192, DOI 10.1002/path.2039; Yamatoji M, 2012, INT J CANCER, V130, P2903, DOI 10.1002/ijc.26328; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492	62	26	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0143826	10.1371/journal.pone.0143826	http://dx.doi.org/10.1371/journal.pone.0143826			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683690	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800010
J	Simoneau-Buessinger, E; Leteneur, S; Toumi, A; Dessurne, A; Gabrielli, F; Barbier, F; Jakobi, JM				Simoneau-Buessinger, Emilie; Leteneur, Sebastien; Toumi, Anis; Dessurne, Alexandra; Gabrielli, Franois; Barbier, Franck; Jakobi, Jennifer M.			Bilateral Strength Deficit Is Not Neural in Origin; Rather Due to Dynamometer Mechanical Configuration	PLOS ONE			English	Article							ISOKINETIC DYNAMOMETER; POSTURAL ADJUSTMENTS; MUSCLE ACTIVATION; CORTICAL ACTIVITY; CROSS-EDUCATION; FLEXOR MUSCLES; LEG PRESS; CONTRACTIONS; HUMANS; TORQUE	During maximal contractions, the sum of forces exerted by homonymous muscles unilaterally is typically higher than the sum of forces exerted by the same muscles bilaterally. However, the underlying mechanism(s) of this phenomenon, which is known as the bilateral strength deficit, remain equivocal. One potential factor that has received minimal attention is the contribution of body adjustments to bilateral and unilateral force production. The purpose of this study was to evaluate the plantar-flexors in an innovative dynamometer that permitted the influence of torque from body adjustments to be adapted. Participants were identically positioned between two setup configurations where torques generated from body adjustments were included within the net ankle torque (locked-unit) or independent of the ankle (open-unit). Twenty healthy adult males performed unilateral and bilateral maximal voluntary isometric plantar-flexion contractions using the dynamometer in the open and locked-unit mechanical configurations. While there was a significant bilateral strength deficit in the locked-unit (p = 0.01), it was not evident in the open-unit (p = 0.07). In the locked-unit, unilateral torque was greater than in the open-unit (p<0.001) and this was due to an additional torque from the body since the electromyographic activity of the agonist muscles did not differ between the two setups (p>0.05). This study revealed that the mechanical configuration of the dynamometer and then the body adjustments caused the observation of a bilateral strength deficit.	[Simoneau-Buessinger, Emilie; Leteneur, Sebastien; Toumi, Anis; Gabrielli, Franois; Barbier, Franck] UVHC, Lab Automat Mecan & Informat Ind & Humaines LAMIH, CNRS, UMR 8201, Valenciennes, France; [Dessurne, Alexandra] HEPH Condorcet, Lab Effort & Mouvement, Tournai, Belgium; [Jakobi, Jennifer M.] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada	Centre National de la Recherche Scientifique (CNRS); Universite Polytechnique Hauts-de-France; University of British Columbia; University of British Columbia Okanagan	Simoneau-Buessinger, E (corresponding author), UVHC, Lab Automat Mecan & Informat Ind & Humaines LAMIH, CNRS, UMR 8201, Valenciennes, France.	emilie.simoneau@univ-valenciennes.fr	Simoneau, Emilie/ABA-6405-2020	SIMONEAU-BUESSINGER, Emilie/0000-0003-2059-884X; Gabrielli, Francois/0000-0001-5019-1261				Barry BK, 2008, EXP BRAIN RES, V190, P347, DOI 10.1007/s00221-008-1479-5; Buckthorpe MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057549; CHAPMAN JP, 1987, NEUROPSYCHOLOGIA, V25, P579, DOI 10.1016/0028-3932(87)90082-0; Cresswell AG, 2002, J SPORT MED PHYS FIT, V42, P19; Devanne H, 2002, J NEUROPHYSIOL, V87, P3006, DOI 10.1152/jn.2002.87.6.3006; Drouin JM, 2004, EUR J APPL PHYSIOL, V91, P22, DOI 10.1007/s00421-003-0933-0; Ebben WP, 2006, J STRENGTH COND RES, V20, P985; Ebben WP, 2008, MED SCI SPORT EXER, V40, P1805, DOI 10.1249/MSS.0b013e31817dc4ad; Enoka RM, 1997, J BIOMECH, V30, P447, DOI 10.1016/S0021-9290(96)00170-4; Farthing JP, 2007, BRAIN TOPOGR, V20, P77, DOI 10.1007/s10548-007-0033-2; Farthing JP, 2009, EXERC SPORT SCI REV, V37, P179, DOI 10.1097/JES.0b013e3181b7e882; FORSSBERG H, 1994, EXP BRAIN RES, V97, P515; FRIEDLI WG, 1984, J NEUROL NEUROSUR PS, V47, P611, DOI 10.1136/jnnp.47.6.611; Hakkinen K, 1996, J GERONTOL A-BIOL, V51, pB21, DOI 10.1093/gerona/51A.1.B21; Hakkinen K, 1997, Electromyogr Clin Neurophysiol, V37, P131; Hasan Z, 2005, J MOTOR BEHAV, V37, P484, DOI 10.3200/JMBR.37.6.484-493; Hay D, 2006, HUM MOVEMENT SCI, V25, P181, DOI 10.1016/j.humov.2005.11.007; HENRY FM, 1961, RES QUART, V32, P42, DOI 10.1080/10671188.1961.10762069; Herbert RD, 1996, J APPL PHYSIOL, V80, P1351, DOI 10.1152/jappl.1996.80.4.1351; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; HERZOG W, 1988, J BIOMECH, V21, P5, DOI 10.1016/0021-9290(88)90185-6; HOWARD JD, 1991, J APPL PHYSIOL, V70, P306, DOI 10.1152/jappl.1991.70.1.306; Jakobi JM, 2001, CAN J APPL PHYSIOL, V26, P12, DOI 10.1139/h01-002; Jakobi JM, 1998, J APPL PHYSIOL, V84, P200, DOI 10.1152/jappl.1998.84.1.200; Janzen CL, 2006, EUR J APPL PHYSIOL, V97, P253, DOI 10.1007/s00421-006-0165-1; Katz R, 1999, PROG NEUROBIOL, V57, P325, DOI 10.1016/S0301-0082(98)00056-2; KAUFMAN KR, 1995, J BIOMECH, V28, P1243, DOI 10.1016/0021-9290(94)00176-5; Kawakami Y, 1998, EUR J APPL PHYSIOL O, V77, P212, DOI 10.1007/s004210050324; Kuruganti U, 2005, EUR J APPL PHYSIOL, V94, P175, DOI 10.1007/s00421-004-1313-0; Lan N., 2002, IEEE T NEUR SYS REH, V10, P59; LeBozec S, 1997, CR ACAD SCI III-VIE, V320, P715, DOI 10.1016/S0764-4469(97)84819-6; MacDonald MM, 2014, APPL PHYSL NUTR META; Maffiuletti NA, 2002, J APPL PHYSIOL, V92, P1383, DOI 10.1152/japplphysiol.00884.2001; Magnus CRA, 2008, APPL PHYSIOL NUTR ME, V33, P1132, DOI 10.1139/H08-101; Massion J, 2004, PROG BRAIN RES, V143, P13, DOI 10.1016/S0079-6123(03)43002-1; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Mottram CJ, 2005, J NEUROPHYSIOL, V93, P1381, DOI 10.1152/jn.00837.2004; ODA S, 1994, EUR J APPL PHYSIOL O, V69, P240, DOI 10.1007/BF01094795; OHTSUKI T, 1983, BEHAV BRAIN RES, V7, P165, DOI 10.1016/0166-4328(83)90190-0; Post M, 2007, NEUROIMAGE, V35, P16, DOI 10.1016/j.neuroimage.2006.11.050; Simoneau E, 2007, EUR J APPL PHYSIOL, V100, P507, DOI 10.1007/s00421-006-0254-1; SOECHTING JF, 1989, EXP BRAIN RES, V74, P535; Taniguchi Y, 2001, EXP BRAIN RES, V137, P259; Toumi A, 2015, EUR J APPL PHYSIOL, V115, P2303, DOI 10.1007/s00421-015-3210-0; van der Fits IBM, 1998, EXP BRAIN RES, V120, P202, DOI 10.1007/s002210050394; Van Dieen JH, 2003, MED SCI SPORT EXER, V35, P111, DOI 10.1097/00005768-200301000-00018; Webber SC, 2010, PHYS THER, V90, P1165, DOI 10.2522/ptj.20090394	47	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145077	10.1371/journal.pone.0145077	http://dx.doi.org/10.1371/journal.pone.0145077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684828	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800036
J	Zhang, DH; Jasieniecka-Gazarkiewicz, K; Wan, X; Luo, L; Zhang, YB; Banas, A; Jiang, ML; Gong, YM				Zhang, Donghui; Jasieniecka-Gazarkiewicz, Katarzyna; Wan, Xia; Luo, Ling; Zhang, Yinbo; Banas, Antoni; Jiang, Mulan; Gong, Yangmin			Molecular Characterization of Two Lysophospholipid:acyl-CoA Acyltransferases Belonging to the MBOAT Family in Nicotiana benthamiana	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); POLYUNSATURATED FATTY-ACIDS; ACYL-COA; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; LANDS CYCLE; YEAST; IDENTIFICATION; BIOSYNTHESIS; PHOSPHATIDYLCHOLINE; METABOLISM	In the remodeling pathway for the synthesis of phosphatidylcholine (PC), acyl-CoA-dependent lysophosphatidylcholine (lysoPC) acyltransferase (LPCAT) catalyzes the reacylation of lysoPC. A number of genes encoding LPCATs have been cloned and characterized from several plants in recent years. Using Arabidopsis and other plant LPCAT sequences to screen the genome database of Nicotiana benthamiana, we identified two cDNAs encoding the putative tobacco LPCATs (NbLPCAT1 and NbLPCAT2). Both of them were predicted to encode a protein of 463 amino acids with high similarity to LPCATs from other plants. Protein sequence features such as the presence of at least eight putative transmembrane regions, four highly conserved signature motifs and several invariant residues indicate that NbLPCATs belong to the membrane bound O-acyltransferase family. Lysophospholipid acyltransferase activity of NbLPCATs was confirmed by testing lysoplatelet-activating factor (lysoPAF) sensitivity through heterologous expression of each full-length cDNA in a yeast mutant Y02431 (lca1 Delta) disrupted in endogenous LPCAT enzyme activity. Analysis of fatty acid profiles of phospholipids from the NbLPCAT-expressing yeast mutant Y02431 cultures supplemented with polyunsaturated fatty acids suggested more incorporation of linoleic acid (18: 2n6, LA) and alpha-linolenic acid (18: 3n3, ALA) into PC compared to yeast mutant harbouring empty vector. In vitro enzymatic assay demonstrated that NbLPCAT1 had high lysoPC acyltransferase activity with a clear preference for alpha-linolenoyl-CoA (18: 3), while NbLPCAT2 showed a high lysophosphatidic acid (lysoPA) acyltransferase activity towards alpha-linolenoyl-CoA and a weak lysoPC acyltransferase activity. Tissue-specific expression analysis showed a ubiquitous expression of NbLPCAT1 and NbLPCAT2 in roots, stems, leaves, flowers and seeds, and a strong expression in developing flowers. This is the first report on the cloning and characterization of lysophospholipid acyltransferases from N. benthamiana.	[Zhang, Donghui; Wan, Xia; Luo, Ling; Zhang, Yinbo; Jiang, Mulan; Gong, Yangmin] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan 430062, Peoples R China; [Jasieniecka-Gazarkiewicz, Katarzyna; Banas, Antoni] Univ Gdansk, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland; [Jasieniecka-Gazarkiewicz, Katarzyna; Banas, Antoni] Med Univ Gdansk, PL-80822 Gdansk, Poland	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Jiang, ML (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan 430062, Peoples R China.	mljiang@oilcrops.cn; gongyangmin@caas.cn		Jasieniecka-Gazarkiewicz, Katarzyna/0000-0002-7682-188X; Banas, Antoni/0000-0001-9397-7627	National Natural Science Foundation of China [31270346]; National Hi-Tech Program of China [2011AA100904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Program of China	This research was supported by grants from the National Natural Science Foundation of China (31270346) and National Hi-Tech Program of China (2011AA100904).	Abbadi A, 2004, PLANT CELL, V16, P2734, DOI 10.1105/tpc.104.026070; Bao XM, 1998, PLANT PHYSIOL, V118, P183, DOI 10.1104/pp.118.1.183; Cahoon EB, 2007, CURR OPIN PLANT BIOL, V10, P236, DOI 10.1016/j.pbi.2007.04.005; Chen QL, 2007, FEBS LETT, V581, P5511, DOI 10.1016/j.febslet.2007.10.061; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hoffmann M, 2008, J BIOL CHEM, V283, P22352, DOI 10.1074/jbc.M802377200; Kazachkov M, 2008, LIPIDS, V43, P895, DOI 10.1007/s11745-008-3233-y; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Lager I, 2013, J BIOL CHEM, V288, P36902, DOI 10.1074/jbc.M113.521815; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1982, J BIOL CHEM, V257, P4968; LANDS WEM, 1965, ANNU REV BIOCHEM, V34, P313, DOI 10.1146/annurev.bi.34.070165.001525; Arroyo-Caro JM, 2013, LIPIDS, V48, P663, DOI 10.1007/s11745-013-3797-z; MYHER JJ, 1989, LIPIDS, V24, P396, DOI 10.1007/BF02535147; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Petrie JR, 2010, METAB ENG, V12, P233, DOI 10.1016/j.ymben.2009.12.001; Shimizu T, 2006, IUBMB LIFE, V58, P328, DOI 10.1080/15216540600702289; Shindou H, 2000, BIOCHEM BIOPH RES CO, V271, P812, DOI 10.1006/bbrc.2000.2723; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, BIOCHEM BIOPH RES CO, V383, P320, DOI 10.1016/j.bbrc.2009.04.013; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang LP, 2012, PLANT CELL, V24, P4652, DOI 10.1105/tpc.112.104604; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200; Zheng Q, 2012, PHYTOCHEMISTRY, V75, P21, DOI 10.1016/j.phytochem.2011.11.022	34	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144653	10.1371/journal.pone.0144653	http://dx.doi.org/10.1371/journal.pone.0144653			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684752	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800017
J	Jiao, B; Liu, XY; Zhou, L; Wang, MH; Zhou, YF; Xiao, TT; Zhang, WW; Sun, R; Waye, MMY; Tang, BS; Shen, L				Jiao, Bin; Liu, Xiaoyan; Zhou, Lin; Wang, Maggie Haitian; Zhou, Yafang; Xiao, Tingting; Zhang, Weiwei; Sun, Rui; Waye, Mary Miu Yee; Tang, Beisha; Shen, Lu			Polygenic Analysis of Late-Onset Alzheimer's Disease from Mainland China	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; SUSCEPTIBILITY LOCI; COMMON VARIANTS; CLU; POLYMORPHISM; MUTATION; CD2AP; EPHA1	Recently, a number of single nucleotide polymorphisms (SNPs) were identified to be associated with late-onset Alzheimer disease (LOAD) through genome-wide association study data. Identification of SNP-SNP interaction played an important role in better understanding genetic basis of LOAD. In this study, fifty-eight SNPs were screened in a cohort of 229 LOAD cases and 318 controls from mainland China, and their interaction was evaluated by a series of analysis methods. Seven risk SNPs and six protective SNPs were identified to be associated with LOAD. Risk SNPs included rs9331888 (CLU), rs6691117 (CR1), rs4938933 (MS4A), rs9349407 (CD2AP), rs1160985 (TOMM40), rs4945261 (GAB2) and rs5984894 (PCDH11X); Protective SNPs consisted of rs744373 (BIN1), rs1562990 (MS4A), rs597668 (EXOC3L2), rs9271192 (HLA-DRB5/DRB1), rs157581 and rs11556505 (TOMM40). Among positive SNPs presented above, we found the interaction between rs4938933 (risk) and rs1562990 (protective) in MS4A weakened their each effect for LOAD; for three significant SNPs in TOMM40, their cumulative interaction induced the two protective SNPs effects lost and made the risk SNP effect aggravate for LOAD. Finally, we found rs6656401-rs3865444 (CR1-CD33) pairs were significantly associated with decreasing LOAD risk, while rs28834970-rs6656401 (PTK2B-CR1), and rs28834970-rs6656401 (PTK2B-CD33) were associated with increasing LOAD risk. In a word, our study indicates that SNP-SNP interaction existed in the same gene or cross different genes, which could weaken or aggravate their initial single effects for LOAD.	[Jiao, Bin; Liu, Xiaoyan; Zhou, Lin; Zhou, Yafang; Xiao, Tingting; Zhang, Weiwei; Tang, Beisha; Shen, Lu] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Tang, Beisha; Shen, Lu] State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Zhou, Lin; Zhou, Yafang; Tang, Beisha; Shen, Lu] Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha, Hunan, Peoples R China; [Wang, Maggie Haitian; Sun, Rui] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Div Biostat, Shatin, Hong Kong, Peoples R China; [Waye, Mary Miu Yee] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Central South University; Central South University; Chinese University of Hong Kong; Chinese University of Hong Kong	Shen, L (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China.	shenlu2505@126.com	Wang, Maggie Haitian/F-5954-2017; Jiao, Bin/HHZ-6629-2022; 韋妙宜教授, Mary Miu Yee Waye/A-9674-2008	Wang, Maggie Haitian/0000-0003-1223-4595; 韋妙宜教授, Mary Miu Yee Waye/0000-0002-2582-4917	National Natural Science Foundation of China [81471295]; Natural Science Foundation of Hunan Province [14jj7011]; Hunan Provincial Innovation Foundation For Postgraduate [CX2014B113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Hunan Provincial Innovation Foundation For Postgraduate	! This study was supported by the National Natural Science Foundation of China (No. 81471295, sponsored by LS, http://npd.nsfc.gov.cn/); the Natural Science Foundation of Hunan Province (No.14jj7011, sponsored by LZ, http://www.hnst.gov.cn/zxgz/zkjj/); Hunan Provincial Innovation Foundation For Postgraduate (No. CX2014B113, sponsored by BJ, http://wenku.baidu.com/link?url=J1uokswv7ZGiIQ ? boCUWwU8GV9hJTic2aGOP2S3rTW9uT3_fGaFF1neXBII2-l9xLhZFMOBhqD-kBAT3hSMF91WE2bi2OyKU_shtFYDKbtJq).	Balasa M, 2011, NEUROLOGY, V76, P1720, DOI 10.1212/WNL.0b013e31821a44dd; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Beck Tim N, 2014, Oncoscience, V1, P486; BERTRAND P, 1995, MOL BRAIN RES, V33, P174, DOI 10.1016/0169-328X(95)00097-C; Chen H, 2015, MOL NEUROBIOL; Crehan H, 2012, IMMUNOBIOLOGY, V217, P244, DOI 10.1016/j.imbio.2011.07.017; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; De Jager P, 2012, ALZHEIMERS DEMENT, V8, P232; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Jiao B, 2014, NEUROBIOL AGING, V35, pe1951, DOI DOI 10.1016/J.NEUR0BI0LAGING.2014.02.014; Jiao B, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.10.001; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Jun G, 2015, MOL PSYCHIAT; Jun G, 2012, ARCH NEUROL-CHICAGO, V69, P1270, DOI 10.1001/archneurol.2012.2052; Kullo IJ, 2011, AM J HUM GENET, V89, P131, DOI 10.1016/j.ajhg.2011.05.019; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lockhart R, 2014, ANN STAT, V42, P413, DOI 10.1214/13-AOS1175; Ma J, 2014, MOL NEUROBIOL; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Salakhov R R, 2014, Genetika, V50, P222; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shuai P, 2015, NEUROSCI LETT, V591, P160, DOI 10.1016/j.neulet.2015.02.040; Shulman JM, 2013, JAMA NEUROL, V70, P1150, DOI 10.1001/jamaneurol.2013.2815; Tanzi RE, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006296; Wang MH, 2014, META GENE, V2, P384, DOI 10.1016/j.mgene.2014.04.010; Wetzel-Smith MK, 2014, NAT MED, V20, P1452, DOI 10.1038/nm.3736	34	52	53	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144898	10.1371/journal.pone.0144898	http://dx.doi.org/10.1371/journal.pone.0144898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680604	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400033
J	Mayne, SL; Lee, BK; Auchincloss, AH				Mayne, Stephanie L.; Lee, Brian K.; Auchincloss, Amy H.			Evaluating Propensity Score Methods in a Quasi-Experimental Study of the Impact of Menu-Labeling	PLOS ONE			English	Article							NATURAL-EXPERIMENT; RESTAURANTS; PURCHASES; BALANCE; DESIGNS	Background Quasi-experimental studies of menu labeling have found mixed results for improving diet. Differences between experimental groups can hinder interpretation. Propensity scores are an increasingly common method to improve covariate balance, but multiple methods exist and the improvements associated with each method have rarely been compared. In this reanalysis of the impact of menu labeling, we compare multiple propensity score methods to determine which methods optimize balance between experimental groups. Methods Study participants included adult customers who visited full-service restaurants with menu labeling (treatment) and without (control). We compared the balance between treatment groups obtained by four propensity score methods: 1) 1:1 nearest neighbor matching (NN), 2) augmented 1:1 NN (using caliper of 0.2 and an exact match on an imbalanced covariate), 3) full matching, and 4) inverse probability weighting (IPW). We then evaluated the treatment effect on differences in nutrients purchased across the different methods. Results 1:1 NN resulted in worse balance than the original unmatched sample (average standardized absolute mean distance [ASAM]: 0.185 compared to 0.171). Augmented 1: 1 NN improved balance (ASAM: 0.038) but resulted in a large reduction in sample size. Full matching and IPW improved balance over the unmatched sample without a reduction in sample size (ASAM: 0.049 and 0.031, respectively). Menu labeling was associated with decreased calories, fat, sodium and carbohydrates in the unmatched analysis. Results were qualitatively similar in the propensity score matched/weighted models. Conclusions While propensity scores offer an increasingly popular tool to improve causal inference, choosing the correct method can be challenging. Our results emphasize the benefit of examining multiple methods to ensure results are consistent, and considering approaches beyond the most popular method of 1:1 NN matching.	[Mayne, Stephanie L.; Lee, Brian K.; Auchincloss, Amy H.] Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA	Drexel University	Mayne, SL (corresponding author), Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA.	slm387@drexel.edu						Auchincloss AH, 2013, AM J PREV MED, V45, P710, DOI 10.1016/j.amepre.2013.07.014; Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, MED DECIS MAKING, V29, P661, DOI 10.1177/0272989X09341755; Bleich S, 2008, ANNU REV PUBL HEALTH, V29, P273, DOI 10.1146/annurev.publhealth.29.020907.090954; Cerda M, 2012, AM J EPIDEMIOL, V175, P1045, DOI 10.1093/aje/kwr428; Cheng SH, 2012, MED CARE, V50, P109, DOI 10.1097/MLR.0b013e31822d5d36; Cohen DA, 2012, HEALTH PLACE, V18, P39, DOI 10.1016/j.healthplace.2011.09.008; Conniffe D, 2000, ECON SOC REV, V31, P283; Dumanovsky T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4464; Elbel B, 2011, INT J OBESITY, V35, P493, DOI 10.1038/ijo.2011.4; Elbel B, 2013, OBESITY, V21, P2172, DOI 10.1002/oby.20550; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; Finkelstein EA, 2011, AM J PREV MED, V40, P122, DOI 10.1016/j.amepre.2010.10.019; Funk MJ, 2011, AM J EPIDEMIOL, V173, P761, DOI 10.1093/aje/kwq439; Gu XS., 1993, J COMPUT GRAPH STAT, V2, P405, DOI [10.1080/10618600.1993.10474623, DOI 10.1080/10618600.1993.10474623]; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Hansen BB, 2004, J AM STAT ASSOC, V99, P609, DOI 10.1198/016214504000000647; Hansen BB, 2006, J COMPUT GRAPH STAT, V15, P609, DOI 10.1198/106186006X137047; Harder VS, 2010, PSYCHOL METHODS, V15, P234, DOI 10.1037/a0019623; Ho D, 2007, NONPARAMETRIC PREPRO, P2; MacDonald JM, 2010, AM J PREV MED, V39, P105, DOI 10.1016/j.amepre.2010.03.016; R Development Core Team, 2008, LANG ENV STAT COMP; ROSENBAUM PR, 1987, J AM STAT ASSOC, V82, P387, DOI 10.2307/2289440; ROSENBAUM PR, 1985, BIOMETRICS, V41, P103, DOI 10.2307/2530647; ROSENBAUM PR, 1991, J ROY STAT SOC B MET, V53, P597; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Stuart EA, 2008, DEV PSYCHOL, V44, P395, DOI 10.1037/0012-1649.44.2.395; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tandon PS, 2011, AM J PREV MED, V41, P434, DOI 10.1016/j.amepre.2011.06.033; Vadiveloo MK, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-51	35	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144962	10.1371/journal.pone.0144962	http://dx.doi.org/10.1371/journal.pone.0144962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JO	26677849	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400037
J	Meng, RT; Luo, Y; Liu, B; Hu, Y; Yu, CH				Meng, Runtang; Luo, Yi; Liu, Bing; Hu, Ying; Yu, Chuanhua			The Nurses' Well-Being Index and Factors Influencing This Index among Nurses in Central China: A Cross-Sectional Study	PLOS ONE			English	Article							JOB-SATISFACTION; NURSING-STUDENTS; BURNOUT; WORK; HAPPINESS; STRESS; PERFORMANCE; PREVALENCE; WORKPLACE; CONFLICT	Backgrounds/Objectives A discussion and analysis of factors that contribute to nurses' happiness index can be useful in developing effective interventions to improve nurses' enthusiasm, sense of honor and pride and to improve the efficiency and quality of medical services. Methods In this study, 206 registered nurses at the 2011 annual encounter for 12 Hanchuan hospitals completed a questionnaire survey that covered three aspects of the well-being index and thus served as a comprehensive well-being and general information tool. Results Based on their index score, the nurses' overall happiness level was moderate. The dimensions of the happiness index are listed in descending order of their contribution to the nurses' comprehensive happiness levels: health concerns, friendly relationships, self-worth, altruism, vitality, positive emotions, personality development, life satisfaction and negative emotions. Four variables (positive emotion, life satisfaction, negative emotions, and friendly relationships) jointly explained 47.80% of the total variance of the happiness index; positive emotions had the greatest impact on the happiness index. Conclusions Appropriate nursing interventions can improve nurses' happiness index scores, thereby increasing nurses' motivation and promoting the development of their nursing practice.	[Meng, Runtang; Hu, Ying; Yu, Chuanhua] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430071, Hubei, Peoples R China; [Luo, Yi] Ningbo Coll Hlth Sci, Sch Nursing, Ningbo 315100, Zhejiang, Peoples R China; [Liu, Bing] Hubei Univ Med, Ctr Hlth Adm & Dev Studies, Shiyan 442000, Hubei, Peoples R China; [Hu, Ying; Yu, Chuanhua] Wuhan Univ, Global Hlth Inst, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Hubei University of Medicine; Wuhan University	Yu, CH (corresponding author), Wuhan Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430071, Hubei, Peoples R China.	yuchua@163.com	Meng, Runtang/C-6952-2018	Meng, Runtang/0000-0002-5826-5576; Luo, Yi/0000-0001-6442-6607	National Natural Science Foundation of China [81273179]; scientific research project for university student of Hubei University of Medicine [2011XS16]; project of the Institute of Medicine and Nursing; medical institutions of Hanchuan City in the Chinese Province of Hubei	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific research project for university student of Hubei University of Medicine; project of the Institute of Medicine and Nursing; medical institutions of Hanchuan City in the Chinese Province of Hubei	This work was supported by the National Natural Science Foundation of China (Grant No. 81273179) and the scientific research project for university student of Hubei University of Medicine (Grant No. 2011XS16), and as a summer social practice project of the Institute of Medicine and Nursing in 2011.; Project funding: This project was funded by the National Natural Science Foundation of China (Grant No. 81273179) and the scientific research project for university student of Hubei University of Medicine (Grant No. 2011XS16), and as a summer social practice project of the Institute of Medicine and Nursing in 2011. While we were conducting this study, we received warm receptions and support from the medical institutions of Hanchuan City in the Chinese Province of Hubei. We are very grateful to the nurses who participated in this study and to all of the field investigators. We also thank Professor Yuanjiang Miao (Nanchang University) for his survey instrument. We would also like to acknowledge our friends Zhen He and Bing Yang for their valuable assistance in our study.	Abbott D, 2011, J SURG RES, V165, P203; Al-Dubai SAR, 2010, J OCCUP HEALTH, V52, P58, DOI 10.1539/joh.O8030; Ashker VE, 2012, NEPHROL NURS J, V39, P231; Blanchflower DG, 2004, J PUBLIC ECON, V88, P1359, DOI 10.1016/S0047-2727(02)00168-8; Donoso LMB, 2015, INT J NURS STUD, V52, P804, DOI 10.1016/j.ijnurstu.2015.01.002; Bourgault P, 2015, J EMERG NURS, V41, P323, DOI 10.1016/j.jen.2014.10.001; Cao Lili, 2014, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V32, P100; Decramer A, 2015, EVAL PROGRAM PLANN, V49, P98, DOI 10.1016/j.evalprogplan.2014.12.018; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; Gavin JH, 2004, ORGAN DYN, V33, P379, DOI 10.1016/j.orgdyn.2004.09.005; Gong YH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07109; Hammig O, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13577; Hegney Desley, 2003, Int J Nurs Pract, V9, P261, DOI 10.1046/j.1440-172X.2003.00431.x; Hervas G, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-66; HUANG J-h, 2008, BORDER EC CULTURE, V8, P64; Jiao ML, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006719; Karimi L, 2015, ASIA PAC J HUM RESOU, V53, P296, DOI 10.1111/1744-7941.12049; Kobau Rosemarie, 2011, Am J Public Health, V101, pe1, DOI 10.2105/AJPH.2010.300083; Kwok R. P. W., 2006, Hong Kong Medical Journal, V12, P6; Laschinger HKS, 2014, INT J NURS STUD, V51, P1615, DOI 10.1016/j.ijnurstu.2014.04.010; Lee H, 2003, J ADV NURS, V44, P534, DOI 10.1046/j.0309-2402.2003.02837.x; Li-li L, 2010, CHINESE NURSING MANA, V10, P35; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Miao Y., 2003, THESIS; Pedrazza M, 2015, WESTERN J NURS RES, V37, P781, DOI 10.1177/0193945914527356; Por J, 2011, NURS EDUC TODAY, V31, P855, DOI 10.1016/j.nedt.2010.12.023; Sabbah I., 2012, Health, V4, P644; Sliter M, 2014, SEX ROLES, V71, P43, DOI 10.1007/s11199-013-0337-5; Sparks SA, 2005, J APPL SOC PSYCHOL, V35, P922, DOI 10.1111/j.1559-1816.2005.tb02153.x; Stutzer A., 2006, J SOCIO EC, V35, P326, DOI [10.1016/j.socec.2005.11.043, DOI 10.1016/J.SOCEC.2005.11.043, DOI 10.1016/j.socec.2005.11.043]; Wang Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-915; Watson R, 2008, INT J NURS STUD, V45, P1534, DOI 10.1016/j.ijnurstu.2007.11.003; Wu SY, 2007, J ADV NURS, V59, P233, DOI 10.1111/j.1365-2648.2007.04301.x; Zangaro GA, 2007, RES NURS HEALTH, V30, P445, DOI 10.1002/nur.20202; Zencirci AD, 2011, CROAT MED J, V52, P527, DOI 10.3325/cmj.2011.52.527	36	20	21	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144414	10.1371/journal.pone.0144414	http://dx.doi.org/10.1371/journal.pone.0144414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JO	26680594	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400013
J	Zhang, B; Yu, W; Zhou, LQ; He, ZS; Shen, C; He, Q; Li, J; Liu, LB; Wang, C; Chen, XY; Fan, Y; Hu, S; Zhang, L; Han, WK; Jin, J				Zhang, Bo; Yu, Wei; Zhou, Li-Qun; He, Zhi-Song; Shen, Cheng; He, Qun; Li, Jun; Liu, Li-Bo; Wang, Cong; Chen, Xiao-Yu; Fan, Yu; Hu, Shuai; Zhang, Lei; Han, Wen-Ke; Jin, Jie			Prognostic Significance of Preoperative Albumin-Globulin Ratio in Patients with Upper Tract Urothelial Carcinoma	PLOS ONE			English	Article							UPPER URINARY-TRACT; SYSTEMIC INFLAMMATORY RESPONSE; LONG-TERM MORTALITY; C-REACTIVE PROTEIN; CANCER-PATIENTS; RADICAL NEPHROURETERECTOMY; CLINICAL-SIGNIFICANCE; ARISTOLOCHIC ACID; PREDICT SURVIVAL; LYMPHOCYTE RATIO	Background Preoperative albumin-globulin ratio (AGR) reflects both malnutrition and systemic inflammation in cancer patients. In particular, systemic inflammation has been reported to contribute to tumor progression and poor oncological outcome in various malignancies. However, the prognostic value of preoperative AGR in upper tract urothelial carcinoma (UTUC) has not been examined. Methods We retrospectively reviewed medical data of 187 operable UTUC patients in a Chinese cohort with a high incidence of chronic kidney disease (CKD). AGR was calculated as [AGR = albumin/(serum total protein-albumin)]. The associations of preoperative AGR with clinicopathologic characteristics and prognosis were assessed. Multivariate analyses using Cox regression models were performed to determine the independent prognostic factors. Results The median (IQR) preoperative AGR was 1.50 (1.30-1.70), and the optimal cutoff value was determined to be 1.45 according to the receiver operating curve analysis. Low AGR was significantly associated with female gender, high CKD stage and tumor grade (P < 0.05). Eighty-three patients died before the follow-up endpoint. Kaplan-Meier analysis showed that an AGR < 1.45 predicted significantly poorer overall and cancer-specific survivals compared to an AGR >= 1.45 (P < 0.001 and P = 0.008, respectively). Multivariate analyses showed that an AGR < 1.45 was an independent risk factor for poorer overall and cancer-specific survivals (P = 0.002 and P = 0.015, respectively). Conclusions Preoperative AGR can act as an effective biomarker with easy accessibility for evaluating the prognosis of patients with UTUC. AGR should be applied in UTUC patients for risk stratification and determination of optimal therapeutic regimens.	[Zhang, Bo; Yu, Wei; Zhou, Li-Qun; He, Zhi-Song; Shen, Cheng; He, Qun; Li, Jun; Liu, Li-Bo; Fan, Yu; Hu, Shuai; Zhang, Lei; Han, Wen-Ke; Jin, Jie] Peking Univ, Hosp 1, Dept Urol, Beijing 100871, Peoples R China; [Zhang, Bo; Yu, Wei; Zhou, Li-Qun; He, Zhi-Song; Shen, Cheng; He, Qun; Li, Jun; Liu, Li-Bo; Fan, Yu; Hu, Shuai; Zhang, Lei; Han, Wen-Ke; Jin, Jie] Peking Univ, Inst Urol, Beijing 100871, Peoples R China; [Zhang, Bo; Yu, Wei; Zhou, Li-Qun; He, Zhi-Song; Shen, Cheng; He, Qun; Li, Jun; Liu, Li-Bo; Fan, Yu; Hu, Shuai; Zhang, Lei; Han, Wen-Ke; Jin, Jie] Natl Urol Canc Ctr, Beijing, Peoples R China; [Wang, Cong; Chen, Xiao-Yu] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Han, WK (corresponding author), Peking Univ, Hosp 1, Dept Urol, Beijing 100871, Peoples R China.	hanwenke@medmail.com.cn; jinjie@vip.163.com	Zhou, Li/GSE-4531-2022		National Natural Science Foundation of China [81200548]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China to Wei Yu (http://www.nsfc.gov.cn/publish/portal1/) (Grant No. 81200548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absenger G, 2013, BRIT J CANCER, V109, P395, DOI 10.1038/bjc.2013.346; Al-Shaiba R, 2004, BRIT J CANCER, V91, P205, DOI 10.1038/sj.bjc.6601886; Azab B, 2013, INT J COLORECTAL DIS, V28, P1629, DOI 10.1007/s00384-013-1748-z; Azab BN, 2013, AM J SURG, V206, P764, DOI 10.1016/j.amjsurg.2013.03.007; Barber MD, 1999, NUTR CANCER, V35, P106, DOI 10.1207/S15327914NC352_2; CAZADOR AC, 1989, REV ESP ENFERM APAR, V75, P143; Chandra RK, 1999, P NUTR SOC, V58, P681, DOI 10.1017/S0029665199000890; Chen CY, 2007, J FORMOS MED ASSOC, V106, P992, DOI 10.1016/S0929-6646(08)60074-1; COHEN MH, 1981, CANCER TREAT REP, V65, P187; Colin P, 2009, BJU INT, V104, P1436, DOI 10.1111/j.1464-410X.2009.08838.x; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Ding YJ, 2012, TOXICOL APPL PHARM, V261, P59, DOI 10.1016/j.taap.2012.03.011; Du XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094473; Duran AO, 2014, ASIAN PAC J CANCER P, V15, P6449, DOI 10.7314/APJCP.2014.15.15.6449; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Fox P, 2013, BRIT J CANCER, V109, P147, DOI 10.1038/bjc.2013.300; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Hashimoto T, 2013, WORLD J UROL, V31, P953, DOI 10.1007/s00345-012-0942-x; Huang CC, 2007, TOXICOL SCI, V100, P486, DOI 10.1093/toxsci/kfm235; Kaysen GA, 2003, KIDNEY INT, V64, pS92, DOI 10.1046/j.1523-1755.64.s87.14.x; Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549; Ku JH, 2014, INT BRAZ J UROL, V40, P753, DOI 10.1590/S1677-5538.IBJU.2014.06.06; LAURSEN I, 1990, ANTICANCER RES, V10, P343; Lehmann J, 2007, EUR UROL, V51, P1281, DOI 10.1016/j.eururo.2006.11.021; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lughezzani G, 2012, EUR UROL, V62, P100, DOI 10.1016/j.eururo.2012.02.030; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McMillan DC, 2001, NUTR CANCER, V39, P210, DOI 10.1207/S15327914nc392_8; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Muliawati Yanti, 2012, Acta Med Indones, V44, P154; Obata J, 2013, UROL ONCOL-SEMIN ORI, V31, P1725, DOI 10.1016/j.urolonc.2012.05.008; Qayyum Tahir, 2013, Curr Urol, V6, P189, DOI 10.1159/000343537; Raman JD, 2011, BJU INT, V107, P1059, DOI 10.1111/j.1464-410X.2010.09675.x; Saito K, 2007, BJU INT, V100, P269, DOI 10.1111/j.1464-410X.2007.06934.x; Sakano S, 2013, ANN SURG ONCOL, V20, P4389, DOI 10.1245/s10434-013-3259-0; Seaton K, 2001, J NATL MED ASSOC, V93, P490; Sung HH, 2015, BJU INT, V115, P587, DOI 10.1111/bju.12846; Yang MH, 2002, UROLOGY, V59, P681, DOI 10.1016/S0090-4295(02)01529-7; Yeun J Y, 1998, Am J Kidney Dis, V32, pS118, DOI 10.1016/S0272-6386(98)70174-X	39	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144961	10.1371/journal.pone.0144961	http://dx.doi.org/10.1371/journal.pone.0144961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26681341	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400036
J	He, MZ; Yang, Z; Abdellatif, M; Sayed, D				He, Minzhen; Yang, Zhi; Abdellatif, Maha; Sayed, Danish			GTPase Activating Protein (Sh3 Domain) Binding Protein 1 Regulates the Processing of MicroRNA-1 during Cardiac Hypertrophy	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL GENE-REGULATION; ENDORIBONUCLEASE G3BP; MESSENGER-RNA; EXPRESSION; INITIATION; GROWTH; BIOGENESIS; PROMOTES; TARGETS; MUSCLE	Background MicroRNAs (miR) are small, posttranscriptional regulators, expressed as part of a longer primary transcript, following which they undergo nuclear and cytoplasmic processing by Drosha and Dicer, respectively, to form the functional mature similar to 20mer that gets incorporated into the silencing complex. Others and we have shown that mature miR-1 levels decrease with pressure-induced cardiac hypertrophy, however, there is little or no change in the primary transcript encompassing miR-1 stem-loop, suggesting critical regulatory step in microRNA processing. The objective of this study was to investigate the underlying mechanisms regulating miR-1 expression in cardiomyocytes. Results Here we report that GTPase-activating protein (SH3 domain) binding protein 1 (G3bp1), an endoribonuclease regulates miR-1 processing in cardiomyocytes. G3bp1 is upregulated during cardiac hypertrophy and restricts miR-1 processing by binding to its consensus sequence in the pre-miR-1-2 stem-loop. In accordance, exogenous G3bp1 is sufficient to reduce miR-1 levels, along with derepression of miR-1 targets; General transcription factor IIB (Gtf2b), cyclin dependent factor 9 (Cdk9) and eukaryotic initiation factor 4E (Eif4e). While Cdk9 and Gtf2b are essential for transcription, Eif4e is required for translation. Thus, downregulation of miR-1 is necessary for increase in these molecules. Similar to miR-1 knockdown, G3bp1 overexpression is not sufficient for development of cardiac hypertrophy. Conversely, knockdown of G3bp1 in hypertrophying cardiomyocytes inhibited downregulation of miR-1 and upregulation of its targets along with restricted hypertrophy, suggesting that G3bp1 is necessary for development of cardiac hypertrophy. These results indicate that G3bp1-mediated inhibition of miR-1 processing with growth stimulation results in decrease in mature miR-1 and, thereby, an increase of its targets, which play fundamental roles in the development of hypertrophy. Conclusion G3bp1 posttranscriptionally regulates miRNA-1 processing in the heart, and G3bp1 mediated downregulation of mature miRNA-1 levels is required for the derepression of its targets and increase in gene expression during cardiac hypertrophy.	[He, Minzhen; Yang, Zhi; Abdellatif, Maha; Sayed, Danish] Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sayed, D (corresponding author), Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA.	sayeddh@njms.rutgers.edu			American Heart Association [12SDG8820011]; National Heart Lung Blood Institute [1R01 HL-081381-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128799, R01HL081381] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	DS was funded by 12SDG8820011, American Heart Association, http://www.heart.org/HEARTORG/. MA was funded by 1R01 HL-081381-01A1, National Heart Lung Blood Institute, http://www.nhlbi.nih.gov/.	Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Briata P, 2013, BIOCH BIOPHYS ACTA, V22; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chang SH, 2014, CURR OPIN HEMATOL, V21, P235, DOI 10.1097/MOH.0000000000000040; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Creighton CJ, 2008, RNA, V14, P2290, DOI 10.1261/rna.1188208; CUTILLETTA AF, 1978, J MOL CELL CARDIOL, V10, P677, DOI 10.1016/0022-2828(78)90403-0; CUTILLETTA AF, 1979, TEX REP BIOL MED, V39, P95; CUTILLETTA AF, 1980, J MOL CELL CARDIOL, V12, P827, DOI 10.1016/0022-2828(80)90083-8; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Giudice J, 2014, ADV EXP MED BIOL, V825, P389, DOI 10.1007/978-1-4939-1221-6_11; Graham F L, 1991, Methods Mol Biol, V7, P109, DOI 10.1385/0-89603-178-0:109; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Ho JJD, 2014, WIRES RNA, V5, P69, DOI 10.1002/wrna.1197; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Kennedy D, 1996, Biomed Pept Proteins Nucleic Acids, V2, P93; Kennedy Derek, 2001, Journal of Cellular Biochemistry, V84, P173; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; King IN, 2014, J BIOL CHEM, V289, P14263, DOI 10.1074/jbc.M114.561902; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lypowy J, 2005, J BIOL CHEM, V280, P25717, DOI 10.1074/jbc.M414266200; Mahmoud SA, 2013, J PATHOL, V231, P147, DOI 10.1002/path.4234; Makhlouf AA, 1998, AM J PHYSIOL-HEART C, V274, pH2133, DOI 10.1152/ajpheart.1998.274.6.H2133; Martin S, 2013, J NEUROCHEM, V4, P12189; Matsuki H, 2013, GENES CELLS, V18, P135, DOI 10.1111/gtc.12023; MEERSON FZ, 1974, BASIC RES CARDIOL, V69, P484, DOI 10.1007/BF01906981; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Ortega AD, 2010, J CELL SCI, V123, P2685, DOI 10.1242/jcs.065920; Parker F, 1996, MOL CELL BIOL, V16, P2561; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Sayed D, 2015, CIRC-HEART FAIL, V8, P138, DOI 10.1161/CIRCHEARTFAILURE.114.001660; Sayed D, 2013, J BIOL CHEM, V288, P2546, DOI 10.1074/jbc.M112.429449; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; SCHEPER GC, 1992, J BIOL CHEM, V267, P7269; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Wada H, 1996, J BIOL CHEM, V271, P8359, DOI 10.1074/jbc.271.14.8359; Winslow S, 2013, MOL CANCER, V12, P1476; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Zekri L, 2005, MOL CELL BIOL, V25, P8703, DOI 10.1128/MCB.25.19.8703-8716.2005	60	19	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145112	10.1371/journal.pone.0145112	http://dx.doi.org/10.1371/journal.pone.0145112			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675618	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700100
J	Sabariego, C; Coenen, M; Ballert, C; Cabello, M; Leonardi, M; Anczewska, M; Pitkanen, T; Raggi, A; Mellor, B; Covelli, V; Witaj, P; Levola, J; Schiavolin, S; Chrostek, A; Bickenbach, J; Chatterji, S; Cieza, A				Sabariego, Carla; Coenen, Michaela; Ballert, Carolina; Cabello, Maria; Leonardi, Matilde; Anczewska, Marta; Pitkanen, Tuuli; Raggi, Alberto; Mellor, Blanca; Covelli, Venusia; witaj, Piotr; Levola, Jonna; Schiavolin, Silvia; Chrostek, Anna; Bickenbach, Jerome; Chatterji, Somnath; Cieza, Alarcos			Determinants of Psychosocial Difficulties Experienced by Persons with Brain Disorders: Towards a 'Horizontal Epidemiology' Approach	PLOS ONE			English	Article							VARIABLE IMPORTANCE; HEALTH; SCHIZOPHRENIA; DISABILITY; WEATHER; PEOPLE; COHORT	Background Persons with brain disorders experience significant psychosocial difficulties (PSD) in daily life, e.g. problems with managing daily routine or emotional lability, and the level of the PSD depends on social, physical and political environments, and psychologic-personal determinants. Our objective is to determine a brief set of environmental and psychologic-personal factors that are shared determinants of PSD among persons with different brain disorders. Methods Cross-sectional study, convenience sample of persons with either dementia, stroke, multiple sclerosis, epilepsy, migraine, depression, schizophrenia, substance dependence or Parkinson's disease. Random forest regression and classical linear regression were used in the analyses. Results 722 subjects were interviewed in four European countries. The brief set of determinants encompasses presence of comorbidities, health status appraisal, stressful life events, personality changes, adaptation, self-esteem, self-worth, built environment, weather, and health problems in the family. Conclusions The identified brief set of common determinants of PSD can be used to support the implementation of cross-cutting interventions, social actions and policy tools to lower PSD experienced by persons with brain disorders. This set complements a recently proposed reliable and valid direct metric of PSD for brain disorders called PARADISE24.	[Sabariego, Carla; Coenen, Michaela; Cieza, Alarcos] Univ Munich, Inst Med Informat Proc Biometry & Epidemiol IBE, Chair Publ Hlth & Hlth Serv Res, Res Unit Biopsychosocial Hlth, Munich, Germany; [Ballert, Carolina; Bickenbach, Jerome; Cieza, Alarcos] Swiss Parapleg Res, Nottwil, Switzerland; [Cabello, Maria; Mellor, Blanca] Univ Autonoma Madrid, Inst Invest,Hosp Univ Princesa IIS IP, CIBERSAM,Inst Salud Carlos 3, Dept Psychiat,Psychiat Serv, Madrid, Spain; [Cabello, Maria; Mellor, Blanca] Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain; [Leonardi, Matilde; Raggi, Alberto; Covelli, Venusia; Schiavolin, Silvia; Chrostek, Anna] Neurol Inst Carlo Besta IRCCS Fdn, Sci Directorate, Neurol Publ Hlth & Disabil Unit, Milan, Italy; [Anczewska, Marta; witaj, Piotr] Inst Psychiat & Neurol, Dept Psychiat, Warsaw, Poland; [Pitkanen, Tuuli; Levola, Jonna] A Clin Fdn, Helsinki, Finland; [Levola, Jonna] Natl Inst Hlth & Welf, Dept Mental Hlth, Helsinki, Finland; [Levola, Jonna] Natl Inst Hlth & Welf, Subst Abuse Serv, Helsinki, Finland; [Schiavolin, Silvia] Neurol Inst Carlos Besta IRCCS Fdn, Div Neurosurg 2, Milan, Italy; [Chatterji, Somnath] World Hlth Org, Multi Country Studies, Dept Measurement & Hlth Informat Syst, Geneva, Switzerland; [Cieza, Alarcos] Univ Southampton, Sch Psychol, Fac Social & Human Sci, Southampton, Hants, England	University of Munich; Swiss Paraplegic Research; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Autonomous University of Madrid; IRCCS Istituto Neurologico Besta; Institute of Psychiatry & Neurology; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; World Health Organization; University of Southampton	Sabariego, C (corresponding author), Univ Munich, Inst Med Informat Proc Biometry & Epidemiol IBE, Chair Publ Hlth & Hlth Serv Res, Res Unit Biopsychosocial Hlth, Munich, Germany.	carla.sabariego@med.uni-muenchen.de	COVELLI, VENUSIA/AAG-9232-2020; Levola, Jonna/GLV-0401-2022; leonardi, matilde/J-9997-2018; Raggi, Alberto/K-5787-2016; Pitkänen, Tuuli/AAH-2204-2020; Cabello, Maria/R-5665-2019; Schiavolin, Silvia/K-6595-2016; CHATTERJI, Somnath/ABE-6832-2020	COVELLI, VENUSIA/0000-0002-5965-2658; Levola, Jonna/0000-0002-4707-1485; leonardi, matilde/0000-0003-0552-8923; Raggi, Alberto/0000-0002-7433-7779; Cabello, Maria/0000-0003-2362-6092; Schiavolin, Silvia/0000-0002-5391-7539; Switaj, Piotr/0000-0002-0805-6696; Anczewska, Marta/0000-0001-8816-930X; Pitkanen, Tuuli/0000-0002-2381-9436; Coenen, Michaela/0000-0001-7492-7907	Coordination Theme 1 (Health) of the European Community's FP7 [HEALTH-F2-2009-241572]	Coordination Theme 1 (Health) of the European Community's FP7	The PARADISE project is supported by the Coordination Theme 1 (Health) of the European Community's FP7, Grant Agreement No. HEALTH-F2-2009-241572.	Al Nima A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073265; Cabello M, 2012, J AFFECT DISORDERS, V141, P22, DOI 10.1016/j.jad.2011.12.009; Cieza A, 2008, GESUNDHEITSWESEN, V70, P569, DOI 10.1055/s-2008-1080933; Cieza A., UNDERSTANDING UNPUB; Cieza A, PARADISE 24 IN PRESS; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Geyh Szilvia, 2011, Am J Phys Med Rehabil, V90, pS79, DOI 10.1097/PHM.0b013e318230fb68; Habermann Barbara, 2005, J Gerontol Nurs, V31, P49; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hartley S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096890; Hillegers MHJ, 2004, BRIT J PSYCHIAT, V185, P97, DOI 10.1192/bjp.185.2.97; Hojat M, 2010, INT J MED EDUC, V1, P83, DOI 10.5116/ijme.4d00.b701; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hothorn T, 2006, BIOSTATISTICS, V7, P355, DOI 10.1093/biostatistics/kxj011; Khan F, 2012, J REHABIL MED, V44, P570, DOI 10.2340/16501977-0972; Levola J, 2014, DISABIL REHABIL, V36, P1227, DOI 10.3109/09638288.2013.837104; Madden RH, 2013, DISABILITY REHABILIT; McWilliams S, 2014, INT J BIOMETEOROLOGY; Meltzer H., 2003, EUROHIS DEV COMMON I; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Institute for Health and Care Excellence, 2011, 136 NICE; Peter C, 2013, J HLTH PSYCHOL, DOI 10.1177/1359105313475897; Peyrin-Biroulet L, 2012, GUT, V61, P241, DOI 10.1136/gutjnl-2011-300049; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Quintas R, 2012, EPILEPSY BEHAV, V25, P60, DOI 10.1016/j.yebeh.2012.05.016; Raggi A, 2012, J HEADACHE PAIN, V13, P595, DOI 10.1007/s10194-012-0482-1; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Saaroni H, 2010, NEUROEPIDEMIOLOGY, V35, P142, DOI 10.1159/000313446; Sabariego C, DETERMINANTS OF PSYC; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Schwegler U, 2013, INT J REHABILITATION; Shiloh R, 2005, EUR PSYCHIAT, V20, P61, DOI 10.1016/j.eurpsy.2004.09.020; Silverstone Peter H, 2003, Ann Gen Hosp Psychiatry, V2, P2, DOI 10.1186/1475-2832-2-2; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Switaj P, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-193; Weisberg S., 2005, APPL LINEAR REGRESSI, DOI DOI 10.1002/0471704091; Welage N, 2011, DISABIL REHABIL-ASSI, V6, P1, DOI 10.3109/17483107.2010.522680; WHO, 2001, WHO INT CLASS FUNCT; Woodward LJ, 2001, J AM ACAD CHILD PSY, V40, P1086, DOI 10.1097/00004583-200109000-00018; Zebenholzer K, 2011, CEPHALALGIA, V31, P391, DOI 10.1177/0333102410385580	42	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0141322	10.1371/journal.pone.0141322	http://dx.doi.org/10.1371/journal.pone.0141322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JH	26675663	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000366722700002
J	Santulli-Marotto, S; Gervais, A; Fisher, J; Strake, B; Ogden, CA; Riveley, C; Giles-Komar, J				Santulli-Marotto, Sandra; Gervais, Alexis; Fisher, Jamie; Strake, Brandy; Ogden, Carol Anne; Riveley, Chelsea; Giles-Komar, Jill			Discovering Molecules That Regulate Efferocytosis Using Primary Human Macrophages and High Content Imaging	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RECEPTOR TYROSINE KINASES; APOPTOTIC CELL CLEARANCE; ALPHA SIRP-ALPHA; IMPAIRED CLEARANCE; IN-VITRO; FC-GAMMA; PHAGOCYTOSIS; ACTIVATION; INFLAMMATION	Defective clearance of apoptotic cells can result in sustained inflammation and subsequent autoimmunity. Macrophages, the "professional phagocyte" of the body, are responsible for efficient, non-phlogistic, apoptotic cell clearance. Controlling phagocytosis of apoptotic cells by macrophages is an attractive therapeutic opportunity to ameliorate inflammation. Using high content imaging, we have developed a system for evaluating the effects of antibody treatment on apoptotic cell uptake in primary human macrophages by comparing the Phagocytic Index (PI) for each antibody. Herein we demonstrate the feasibility of evaluating a panel of antibodies of unknown specificities obtained by immunization of mice with primary human macrophages and show that they can be distinguished based on individual PI measurements. In this study similar to 50% of antibodies obtained enhance phagocytosis of apoptotic cells while approximately 5% of the antibodies in the panel exhibit some inhibition. Though the specificities of the majority of antibodies are unknown, two of the antibodies that improved apoptotic cell uptake recognize recombinant MerTK; a receptor known to function in this capacity in vivo. The agonistic impact of these antibodies on efferocytosis could be demonstrated without addition of either of the MerTK ligands, Gas6 or ProS. These results validate applying the mechanism of this fundamental biological process as a means for identification of modulators that could potentially serve as therapeutics. This strategy for interrogating macrophages to discover molecules regulating apoptotic cell uptake is not limited by access to purified protein thereby increasing the possibility of finding novel apoptotic cell uptake pathways.	[Santulli-Marotto, Sandra; Gervais, Alexis; Fisher, Jamie; Strake, Brandy; Ogden, Carol Anne; Giles-Komar, Jill] Janssen Res & Dev LLC, Spring House, PA 19477 USA; [Riveley, Chelsea] FlowMetric Inc, Doylestown, PA 18902 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Santulli-Marotto, S (corresponding author), Janssen Res & Dev LLC, 1400 Welsh & McKean Rds, Spring House, PA 19477 USA.	ssantull@its.jnj.com						A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Bottcher A, 2006, ARTHRITIS RHEUM-US, V54, P927, DOI 10.1002/art.21660; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Cohen HB, 2013, J LEUKOCYTE BIOL, V94, P913, DOI 10.1189/jlb.0413236; Cook RS, 2013, J CLIN INVEST, V123, P3231, DOI 10.1172/JCI67655; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; Dialynas DP, 1997, IMMUNOLOGY, V90, P470, DOI 10.1046/j.1365-2567.1997.00185.x; Dialynas DP, 1997, CELL IMMUNOL, V177, P182, DOI 10.1006/cimm.1997.1112; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; Gaipl US, 2007, J AUTOIMMUN, V28, P114, DOI 10.1016/j.jaut.2007.02.005; Gaipl US, 2005, AUTOIMMUN REV, V4, P189, DOI 10.1016/j.autrev.2004.10.007; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Graham DK, 2006, CLIN CANCER RES, V12, P2662, DOI 10.1158/1078-0432.CCR-05-2208; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407, DOI 10.1002/jlb.37.4.407; Hart SP, 1997, J IMMUNOL, V159, P919; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Nguyen KQ, 2013, AUTOIMMUNITY, V46, P294, DOI 10.3109/08916934.2013.794515; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Kim S, 2005, CELL CYCLE, V4, P231; Korns D, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00057; Krysko O, 2010, APOPTOSIS, V15, P1137, DOI 10.1007/s10495-010-0504-x; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mantovani A, 2014, CURR OPIN PHARMACOL, V17, P38, DOI 10.1016/j.coph.2014.07.004; McCubbrey AL, 2012, J IMMUNOL, V189, P112, DOI 10.4049/jimmunol.1200984; McGrath MS, 1999, PATHOBIOLOGY, V67, P277, DOI 10.1159/000028079; Mikolajczyk TP, 2009, IMMUNOLOGY, V128, P103, DOI 10.1111/j.1365-2567.2009.03087.x; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Mor Gil, 2003, Reprod Biol Endocrinol, V1, P119, DOI 10.1186/1477-7827-1-119; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munoz LE, 2005, RHEUMATOLOGY, V44, P1101, DOI 10.1093/rheumatology/keh693; Munoz LE, 2010, AUTOIMMUN REV, V10, P38, DOI 10.1016/j.autrev.2010.08.015; Munoz LE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00139; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Pradhan D, 1997, MOL BIOL CELL, V8, P767, DOI 10.1091/mbc.8.5.767; Reddy SM, 2002, J IMMUNOL, V169, P702, DOI 10.4049/jimmunol.169.2.702; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Richens TR, 2009, AM J RESP CRIT CARE, V179, P1011, DOI 10.1164/rccm.200807-1148OC; Rycyzyn MA, 2008, HYBRIDOMA, V27, P25, DOI 10.1089/hyb.2007.0537; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Scarlett JL, 2000, FEBS LETT, V475, P267, DOI 10.1016/S0014-5793(00)01681-1; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Shao WH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3206; Sheriff A, 2004, RHEUM DIS CLIN N AM, V30, P505, DOI 10.1016/j.rdc.2004.04.006; Stanford JC, 2014, J CLIN INVEST, V124, P4737, DOI 10.1172/JCI76375; Stepczynska A, 2001, ONCOGENE, V20, P1193, DOI 10.1038/sj.onc.1204221; Tominaga T, 1998, TOHOKU J EXP MED, V186, P99, DOI 10.1620/tjem.186.99; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; van den Brand BT, 2013, ARTHRITIS RHEUM-US, V65, P671, DOI 10.1002/art.37786; van der Goes A, 2000, J LEUKOCYTE BIOL, V67, P801, DOI 10.1002/jlb.67.6.801; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vandivier RW, 2002, CHEST, V121, p89S, DOI 10.1378/chest.121.3_suppl.89S; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	73	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145078	10.1371/journal.pone.0145078	http://dx.doi.org/10.1371/journal.pone.0145078			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674639	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700094
J	Shaughnessy, RG; Farrell, D; Riepema, K; Bakker, D; Gordon, SV				Shaughnessy, Ronan G.; Farrell, Damien; Riepema, Karel; Bakker, Douwe; Gordon, Stephen V.			Analysis of Biobanked Serum from a Mycobacterium avium subsp paratuberculosis Bovine Infection Model Confirms the Remarkable Stability of Circulating miRNA Profiles and Defines a Bovine Serum miRNA Repertoire	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; LIPID-METABOLISM; WHOLE-BLOOD; SMALL RNA; EXPRESSION; MICRORNA; BIOMARKERS; DIAGNOSIS; CANCER; DISEASES	Johne's Disease (JD) is a chronic enteritis of ruminants caused by Mycobacterium avium subspecies paratuberculosis (MAP). Current disease control strategies are hampered by the lack of sensitive and specific diagnostic modalities. Therefore, novel diagnostic and prognostic tools are needed, and circulating microRNAs (miRNAs) may hold potential in this area. The aims of this study were twofold: (i) to address the stability of miRNA in bovine sera from biobanked samples, and (ii) to assess the potential of miRNAs as biomarkers for JD disease progression. To address these aims we used bovine sera from an experimental MAP infection model that had been stored at -20 degrees C for over a decade, allowing us to also assess the stability of miRNA profiles in biobanked serum samples through comparison with fresh sera. Approximately 100-200 intact miRNAs were identified in each sample with 83 of these being consistently detected across all 57 samples. The miRNA profile of the biobanked sera stored at -20 degrees C for over 10 years was highly similar to the profile of < 1 year-old sera stored at -80 degrees C, with an overlap of 73 shared miRNAs. IsomiR analysis also indicated a distinct bovine serum-specific isomiR profile as compared to previously reported bovine macrophage miRNA profiles. To explore the prognostic potential of miRNA profiles cattle defined as seropositive for anti-MAP antibodies (n = 5) were compared against seronegative cattle (n = 7). No significant differential expressed miRNAs were detected at either the early (6 months) or late (43, 46 and 49 months) intervals (FDR <= 0.05, fold-change >= 1.5) across seropositive or seronegative animals. However, comparing pre-infection sera to the early and late time-points identified increased miR-29a and miR-92b abundance (2-fold) that may be due to blood-cell population changes over time (P<0.001). In conclusion our study has demonstrated that bovine circulating miRNAs retain their integrity under long-term sub-optimal storage temperatures opening the way for increased miRNA analyses from biobanked samples for a range of infectious and non-infectious diseases.	[Shaughnessy, Ronan G.; Farrell, Damien; Gordon, Stephen V.] Univ Coll Dublin, UCD Sch Vet Med, Dublin 4, Ireland; [Riepema, Karel] Wageningen Univ, Dept Bacteriol, NL-8200 AB Lelystad, Netherlands; [Riepema, Karel] Wageningen Univ, TSEs, Cent Vet Inst, NL-8200 AB Lelystad, Netherlands; [Gordon, Stephen V.] Univ Coll Dublin, UCD Sch Med, Dublin 4, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Sci, Dublin 4, Ireland	University College Dublin; Wageningen University & Research; Wageningen University & Research; University College Dublin; University College Dublin; University College Dublin	Gordon, SV (corresponding author), Univ Coll Dublin, UCD Sch Vet Med, Dublin 4, Ireland.	stephen.gordon@ucd.ie		Farrell, Damien/0000-0003-3020-7945; Gordon, Stephen/0000-0002-4833-5542; Shaughnessy, Ronan/0000-0002-9164-3583	Irish Department of Agriculture Food and the Marine [RSF11/S/141, ERA_NET 11/RD/EMIDA/1]; Irish Research Council Postdoctoral Fellowship [GOIPD/2015/475]; Dutch Department of Economic Affairs	Irish Department of Agriculture Food and the Marine; Irish Research Council Postdoctoral Fellowship(Irish Research Council for Science, Engineering and Technology); Dutch Department of Economic Affairs	This work was supported by the Irish Department of Agriculture Food and the Marine grants RSF11/S/141 (ICONMAP) and ERA_NET 11/RD/EMIDA/1 (MycobactDiagnosis). DF is funded by an Irish Research Council Postdoctoral Fellowship (GOIPD/2015/475). The cattle infections were funded by the Dutch Department of Agriculture, Nature and Fisheries, currently known as the Dutch Department of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Irish Department of Agriculture Food and the Marine grants RSF11/S/141 (ICONMAP) and ERA_NET 11/RD/EMIDA/1 (MycobactDiagnosis). DF is funded by an Irish Research Council Postdoctoral Fellowship (GOIPD/2015/475). The cattle infections were funded by the Dutch Department of Agriculture, Nature and Fisheries, currently known as the Dutch Department of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Dr Jim O'Mahony (Cork Institute of Technology, Ireland) for the gift of M. avium subspecies paratuberculosis CIT003, Dr John Browne (UCD) for advice on RNA-seq library preparation and Dr Kevin Carr (Michigan State University, USA) for advice on small RNA sequencing.	Abd-El-Fattah AA, 2013, CELL BIOCHEM BIOPHYS, V67, P875, DOI 10.1007/s12013-013-9575-y; Afum-Adjei Awuah A, 2014, INT IMMUNOLOGY; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burgos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094839; Chan YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058169; Chase CCL, 2008, VET CLIN N AM-FOOD A, V24, P87, DOI 10.1016/j.cvfa.2007.11.001; Chen JD, 2014, PEDIATR RES, V75, P595, DOI 10.1038/pr.2014.18; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Chevillet JR, 2014, P NATL ACAD SCI USA, V111, P14888, DOI 10.1073/pnas.1408301111; Coussens Paul M., 2001, Animal Health Research Reviews, V2, P141; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; David J, 2014, VET RES, V45, DOI 10.1186/s13567-014-0096-5; David J, 2014, VET IMMUNOL IMMUNOP, V160, P107, DOI 10.1016/j.vetimm.2014.04.006; De Guire V, 2013, CLIN BIOCHEM, V46, P846, DOI 10.1016/j.clinbiochem.2013.03.015; Dhahbi JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-298; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Farrell D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134310; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fu YR, 2011, J CLIN MICROBIOL, V49, P4246, DOI 10.1128/JCM.05459-11; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Guo L, 2014, GENE, V544, P1, DOI 10.1016/j.gene.2014.04.039; Guo L, 2012, MOL BIOL REP, V39, P6699, DOI 10.1007/s11033-012-1493-3; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Herthnek D, 2006, J APPL MICROBIOL, V100, P1095, DOI 10.1111/j.1365-2672.2006.02924.x; Hines ME, 2007, VET MICROBIOL, V122, P197, DOI 10.1016/j.vetmic.2007.03.009; JORGENSEN JB, 1982, ACTA VET SCAND, V23, P325; Jutila Mark A., 2008, Animal Health Research Reviews, V9, P47, DOI 10.1017/S1466252307001363; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim SJ, 2007, CLIN CHEM, V53, P1038, DOI 10.1373/clinchem.2006.078436; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Llorens F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-104; Loher P, 2014, ONCOTARGET, V5, P8790, DOI 10.18632/oncotarget.2405; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; McGahon MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065809; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Muskens J, 2000, VET MICROBIOL, V77, P253, DOI 10.1016/S0378-1135(00)00310-2; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Noren Hooten N, 2013, AGING-US, V5, P725, DOI 10.18632/aging.100603; Olsen I, 2002, VET QUART, V24, P12, DOI 10.1080/01652176.2002.9695120; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Qi YH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-384; REDDI KK, 1976, P NATL ACAD SCI USA, V73, P2308, DOI 10.1073/pnas.73.7.2308; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258; Shin MK, 2015, J MICROBIOL BIOTECHN, V25, P255, DOI 10.4014/jmb.1408.08059; Siddle KJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005064; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Thirunavukkarasu S, 2014, VET IMMUNOL IMMUNOP, V160, P147, DOI 10.1016/j.vetimm.2014.04.002; Tiberio P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/731479; Timms VJ, 2011, J MICROBIOL METH, V85, P1, DOI 10.1016/j.mimet.2011.01.026; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Vegh P, 2013, VET IMMUNOL IMMUNOP, V155, P238, DOI 10.1016/j.vetimm.2013.08.004; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Zhang HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088909; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081076	60	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145089	10.1371/journal.pone.0145089	http://dx.doi.org/10.1371/journal.pone.0145089			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675426	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700099
J	Brohus, M; Gorbunova, V; Faulkes, CG; Overgaard, MT; Conover, CA				Brohus, Malene; Gorbunova, Vera; Faulkes, Chris G.; Overgaard, Michael T.; Conover, Cheryl A.			The Insulin-Like Growth Factor System in the Long-Lived Naked Mole-Rat	PLOS ONE			English	Article							PLASMA-PROTEIN-A; FACTOR RECEPTOR; PAPP-A; BINDING PROTEINS; CLEAVAGE SITE; IGF; EXPRESSION; LONGEVITY; INSIGHTS; CANCER	Naked mole-rats (Heterocephalus glaber) (NMRs) are the longest living rodents known. They show negligible senescence, and are resistant to cancers and certain damaging effects associated with aging. The insulin-like growth factors (IGFs) have pluripotent actions, influencing growth processes in virtually every system of the body. They are established contributors to the aging process, confirmed by the demonstration that decreased IGF signaling results in life-extending effects in a variety of species. The IGFs are likewise involved in progression of cancers by mediating survival signals in malignant cells. This report presents a full characterization of the IGF system in the NMR: ligands, receptors, IGF binding proteins (IGFBPs), and IGFBP proteases. A particular emphasis was placed on the IGFBP protease, pregnancy-associated plasma protein-A (PAPP-A), shown to be an important lifespan modulator in mice. Comparisons of IGF-related genes in the NMR with human and murine sequences indicated no major differences in essential parts of the IGF system, including PAPP-A. The protease was shown to possess an intact active site despite the report of a contradictory genome sequence. Furthermore, PAPP-A was expressed and translated in NMRs cells and retained IGF-dependent proteolytic activity towards IGFBP-4 and IGF-independent activity towards IGFBP-5. However, experimental data suggest differential regulatory mechanisms for PAPP-A expression in NMRs than those described in humans and mice. This overall description of the IGF system in the NMR represents an initial step towards elucidating the complex molecular mechanisms underlying longevity, and how these animals have evolved to ensure a delayed and healthy aging process.	[Brohus, Malene; Conover, Cheryl A.] Mayo Clin, Div Endocrinol, Rochester, MN 55905 USA; [Gorbunova, Vera] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Faulkes, Chris G.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Brohus, Malene; Overgaard, Michael T.] Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg Oe, Denmark	Mayo Clinic; University of Rochester; University of London; Queen Mary University London; Aalborg University	Conover, CA (corresponding author), Mayo Clin, Div Endocrinol, 200 First St SW, Rochester, MN 55905 USA.	Conover.Cheryl@mayo.edu	Overgaard, Michael Toft/E-1354-2011; Faulkes, Chris/O-8101-2019	Overgaard, Michael Toft/0000-0002-1423-2481; Gorbunova, Vera/0000-0001-8979-0333; Faulkes, Christopher/0000-0002-5228-9075	NATIONAL INSTITUTE ON AGING [P01AG047200] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG047200] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Anisimov VN, 2011, CELL CYCLE, V10, P4230, DOI 10.4161/cc.10.24.18486; Austad SN, 2010, J COMP PATHOL, V141, pS10, DOI 10.1016/j.jcpa.2009.10.024; Azpurua J, 2013, AGING-US, V5, P304, DOI 10.18632/aging.100552; Bach LA, 2005, TRENDS ENDOCRIN MET, V16, P228, DOI 10.1016/j.tem.2005.05.005; Baxter RC, 2000, AM J PHYSIOL-ENDOC M, V278, pE967, DOI 10.1152/ajpendo.2000.278.6.E967; Boldt HB, 2004, J BIOL CHEM, V279, P38525, DOI 10.1074/jbc.M405222200; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; Boldt HB, 2007, GROWTH HORM IGF RES, V17, P10, DOI 10.1016/j.ghir.2006.11.003; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; Byun D, 2000, J CLIN ENDOCR METAB, V85, P373, DOI 10.1210/jc.85.1.373; Cohen P, 2006, HORM RES, V65, P3, DOI 10.1159/000090640; Conover CA, 2006, AM J PHYSIOL-CELL PH, V290, pC183, DOI 10.1152/ajpcell.00199.2005; Conover CA, 2004, BONE, V34, P297, DOI 10.1016/j.bone.2003.10.011; CONOVER CA, 1995, J BIOL CHEM, V270, P4395, DOI 10.1074/jbc.270.9.4395; Conover CA, 2010, J GERONTOL A-BIOL, V65, P590, DOI 10.1093/gerona/glq032; Davidge-Pitts C, 2014, J ENDOCRINOL, V222, P87, DOI 10.1530/JOE-13-0610; Davies KTJ, 2014, GENE, V549, P228, DOI 10.1016/j.gene.2014.07.061; Delaney MA, 2013, VET PATHOL, V50, P607, DOI 10.1177/0300985812471543; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; Edrey YH, 2011, ILAR J, V52, P41, DOI 10.1093/ilar.52.1.41; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gorbunova V, 2014, NAT REV GENET, V15, P531, DOI 10.1038/nrg3728; Harstad SL, 2014, EXP GERONTOL, V57, P13, DOI 10.1016/j.exger.2014.04.011; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Katic M, 2005, CELL MOL LIFE SCI, V62, P320, DOI 10.1007/s00018-004-4297-y; Keane M, 2014, BIOINFORMATICS, V30, P3558, DOI 10.1093/bioinformatics/btu579; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Laursen LS, 2001, FEBS LETT, V504, P36, DOI 10.1016/S0014-5793(01)02760-0; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Monget P, 2003, BIOL REPROD, V68, P77, DOI 10.1095/biolreprod.102.007609; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Resch ZT, 2004, ENDOCRINOLOGY, V145, P1124, DOI 10.1210/en.2003-1313; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200	41	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145587	10.1371/journal.pone.0145587	http://dx.doi.org/10.1371/journal.pone.0145587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694858	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092500060
J	Kavaliunas, A; Wiberg, M; Tinghog, P; Glaser, A; Gyllensten, H; Alexanderson, K; Hillert, J				Kavaliunas, Andrius; Wiberg, Michael; Tinghog, Petter; Glaser, Anna; Gyllensten, Hanna; Alexanderson, Kristina; Hillert, Jan			Earnings and Financial Compensation from Social Security Systems Correlate Strongly with Disability for Multiple Sclerosis Patients	PLOS ONE			English	Article							HISTORICAL PROSPECTIVE COHORT; OF-THE-LITERATURE; ECONOMIC BURDEN; CONSEQUENCES; POPULATION; PENSION; COST	Background Multiple sclerosis (MS) patients earn lower incomes and receive higher benefits. However, there is limited knowledge of how this is correlated with their disability. Objective To elucidate sources and levels of income among MS patients with different disability, assessed with the Expanded Disability Status Scale. Methods A total of 7929 MS patients aged 21-64 years and living in Sweden in 2010 were identified for this cross-sectional study. Descriptive statistics, logistic and truncated linear regression models were used to estimate differences between MS patients regarding earnings, disability pension, sickness absence, disability allowance, unemployment compensation, and social assistance. Results The average level of earnings was ten times lower and the average level of health-related benefits was four times higher when comparing MS patients with severe and mild disability. MS patients with severe disability had on average SEK 166,931 less annual income from earnings and SEK 54,534 more income from benefits compared to those with mild disability. The combined average income for MS patients was 35% lower when comparing patients in the same groups. The adjusted risk ratio for having earnings among MS patients with severe disability compared to the patients with mild disability was 0.33 (95% CI 0.29-0.39), while the risk ratio for having benefits was 1.93 (95% CI 1.90-1.94). Conclusions Disease progression affects the financial situation of MS patients considerably. Correlations between higher disability and patient income were observed, suggesting that earnings and benefits could be used as measures of MS progression and proxies of disability.	[Kavaliunas, Andrius; Wiberg, Michael; Tinghog, Petter; Glaser, Anna; Gyllensten, Hanna; Alexanderson, Kristina; Hillert, Jan] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Wiberg, Michael] Swedish Social Insurance Agcy, Dept Anal & Prognosis, Stockholm, Sweden; [Tinghog, Petter] Red Cross Univ Coll, Stockholm, Sweden	Karolinska Institutet	Kavaliunas, A (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	andrius.kavaliunas@ki.se	Kavaliunas, Andrius/GVS-3565-2022; Gyllensten, Hanna/H-7378-2016	Gyllensten, Hanna/0000-0001-6890-5162; Kavaliunas, Andrius/0000-0003-3896-7332	Biogen	Biogen(Biogen)	This study was financially supported by Biogen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman Gabriel, 2013, J Med Econ, V16, P639, DOI 10.3111/13696998.2013.778268; Berg Jenny, 2006, Eur J Health Econ, V7 Suppl 2, pS75; Confavreux C, 2014, HAND CLINIC, V122, P343, DOI 10.1016/B978-0-444-52001-2.00014-5; Dusankova JB, 2012, MULT SCLER J, V18, P662, DOI 10.1177/1352458511424422; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Hillert J, 2015, ACTA NEUROL SCAND, V132, P11, DOI 10.1111/ane.12425; Jennum P, 2012, EUR NEUROPSYCHOPHARM, V22, P36, DOI 10.1016/j.euroneuro.2011.05.001; Julian LJ, 2008, J NEUROL, V255, P1354, DOI 10.1007/s00415-008-0910-y; Kobelt G, 2006, J NEUROL NEUROSUR PS, V77, P918, DOI 10.1136/jnnp.2006.090365; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS24; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lindholm C, 2001, SCAND J PUBLIC HEALT, V29, P63, DOI 10.1177/14034948010290011201; Naci H, 2010, PHARMACOECONOMICS, V28, P363, DOI 10.2165/11532230-000000000-00000; Pfleger CCH, 2010, EUR J NEUROL, V17, P1346, DOI 10.1111/j.1468-1331.2010.03020.x; Pfleger CCH, 2010, MULT SCLER, V16, P121, DOI 10.1177/1352458509352196; Reese JP, 2011, EUR NEUROL, V66, P311, DOI 10.1159/000331043; Sainani KL, 2011, PM&R, V3, P263, DOI 10.1016/j.pmrj.2011.01.009; Tinghog P, 2013, MULT SCLER J, V19, P1923, DOI 10.1177/1352458513488234; Wiberg M, 2015, MULT SCLER J, V21, P1730, DOI 10.1177/1352458515570767; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	20	29	29	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145435	10.1371/journal.pone.0145435	http://dx.doi.org/10.1371/journal.pone.0145435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695832	Green Published, gold			2022-12-27	WOS:000367092500047
J	Kempa, M; Budrejko, S; Piepiorka-Broniecka, M; Rogowski, J; Kozlowski, D; Raczak, G				Kempa, Maciej; Budrejko, Szymon; Piepiorka-Broniecka, Marta; Rogowski, Jan; Kozlowski, Dariusz; Raczak, Grzegorz			One-Year Follow-Up of Patients Undergoing Transvenous Extraction of Pacemaker and Defibrillator Leads	PLOS ONE			English	Article							EXPERIENCE; MORTALITY	Introduction The number of pacemaker and ICD implantations has increased substantially in the recent years. Therefore, complications are also observed in a greater number. In many cases, transvenous extraction of the previously implanted device (pacemaker or ICD) is the only solution. One may find in the literature information about the efficacy and safety of that procedure, but data concerning the results of long-term follow up are still limited. Aim The aim of the study was to assess the one-year mortality in the cohort of patients undergoing transvenous lead extraction procedures in our centre. Methods Records of the patients undergoing transvenous lead removal in the Department of Cardiology and Electrotherapy of the Medical University of Gdansk were analyzed. We collected detailed information about 192 patients that had undergone the procedure from January 2003 until June 2012. Data were collected from medical and surgical records. We analyzed concomitant diseases, indications, and possible complications. Long-term follow-up data were gathered in the follow-up ambulatory records and over-the-phone interviews with patients or families. In several cases, we consulted the database of the Polish National Health Fund. Results During the early post-operative period 5 patients died, although none of those deaths was associated with the procedure itself. No other major complications were observed. During one-year follow-up other 5 patients died, which gave the overall one-year survival rate of 92.7%. Heart failure, renal failure and an infective indication showed significant association with increased mortality. Conclusion Results of transvenous lead extraction, a relatively safe procedure, should be assessed over time extending beyond the sole perioperative period. Some complications may be delayed in their nature, and may be observed only during the long-term follow up.	[Kempa, Maciej; Budrejko, Szymon; Kozlowski, Dariusz; Raczak, Grzegorz] Med Univ Gdansk, Dept Cardiol & Electrotherapy, Gdansk, Poland; [Piepiorka-Broniecka, Marta] St Vincent Paulo Hosp, Dept Cardiol, Gdynia, Poland; [Rogowski, Jan] Med Univ Gdansk, Dept Cardiac Surg, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Kozlowski, D (corresponding author), Med Univ Gdansk, Dept Cardiol & Electrotherapy, Gdansk, Poland.	dkozl@gumed.edu.pl						Byrd CL, 2002, PACE, V25, P804, DOI 10.1046/j.1460-9592.2002.t01-1-00804.x; Hamid S, 2010, PACE, V33, P209, DOI 10.1111/j.1540-8159.2009.02601.x; Hendrikson C, 2011, PACE, V34, P32, DOI [10.1111/j.1540-8159.2010.02941.x, DOI 10.1111/J.1540-8159.2010.02941.X]; Kutarski A, 2010, KARDIOL POL, V68, P736; Kutarski A, 2009, KARDIOL POL, V67, P149; Maytin M, 2012, CIRC-ARRHYTHMIA ELEC, V5, P252, DOI 10.1161/CIRCEP.111.965277; Maytin M, 2010, CIRC-ARRHYTHMIA ELEC, V3, P413, DOI 10.1161/CIRCEP.110.954107; Nielsen JC, 2015, EUR HEART J, V36, P2484, DOI 10.1093/eurheartj/ehv060; SMITH HJ, 1994, PACE, V17, P2016, DOI 10.1111/j.1540-8159.1994.tb03792.x; Wazni O, 2010, J AM COLL CARDIOL, V55, P579, DOI 10.1016/j.jacc.2009.08.070; Wilkoff BL, 2009, HEART RHYTHM, V6, P1085, DOI 10.1016/j.hrthm.2009.05.020	11	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144915	10.1371/journal.pone.0144915	http://dx.doi.org/10.1371/journal.pone.0144915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694032	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092500014
J	Li, XL; Shi, HQ; Xu, WF; Liu, W; Wang, XJ; Hou, LY; Feng, F; Yuan, WP; Li, LH; Xu, H				Li, Xianglan; Shi, Huiqiu; Xu, Wenfang; Liu, Wei; Wang, Xiujun; Hou, Longyu; Feng, Fei; Yuan, Wenping; Li, Linghao; Xu, Hua			Seasonal and Spatial Variations of Bulk Nitrogen Deposition and the Impacts on the Carbon Cycle in the Arid/Semiarid Grassland of Inner Mongolia, China	PLOS ONE			English	Article							TIME-SERIES DATASET; WET DEPOSITION; N DEPOSITION; ECOSYSTEMS; FORESTS; INCREASE; FLUXES; AGROECOSYSTEMS; ENVIRONMENT; LIMITATION	Atmospheric nitrogen (N) deposition is an important component that affects the structure and function of different terrestrial ecosystem worldwide. However, much uncertainty still remains concerning the magnitude of N deposition on grassland ecosystem in China. To study the spatial and temporal patterns of bulk N deposition, the levels of N (NH4+-N and NO3--N) concentration in rainfall were measured at 12 sites across a 1200 km grassland transect in Inner Mongolia, China, and the respective N deposition rates were estimated. The inorganic N deposition rates ranged from 4.53 kg N ha(-1) to 12.21 kg N ha(-1) with a mean value of 8.07 kg N ha(-1) during the entire growing season, decreasing steadily from the eastern to the western regions. Inorganic N deposition occurred mainly in July and August across meadow steppe, typical steppe, and desert steppe, which corresponded to the seasonal distribution of mean annual precipitation. A positive relationship was found between inorganic N deposition and mean annual precipitation (R-2 = 0.54 similar to 0.72, P < 0.0001) across the grassland transect. Annual estimation of inorganic N deposition was 0.67 Pg yr(-1) in Inner Mongolia, China based on the correlation between N deposition rates and precipitation. N deposition was an important factor controlling aboveground biomass and ecosystem respiration, but has no effect on root biomass and soil respiration. We must clarify that we used the bulk deposition samplers during the entire sampling process and estimated the dissolved NH4+-N and NO3--N deposition rates during the entire growing season. Long-term N deposition monitoring networks should be constructed to study the patterns of N deposition and its potential effect on grassland ecosystem, considering various N species, i.e., gaseous N, particle N, and wet N deposition.	[Li, Xianglan; Xu, Hua] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Li, Xianglan; Wang, Xiujun; Feng, Fei] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing 100875, Peoples R China; [Li, Xianglan; Wang, Xiujun; Feng, Fei] Joint Ctr Global Change Studies, Beijing, Peoples R China; [Shi, Huiqiu; Liu, Wei; Hou, Longyu; Li, Linghao] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Shi, Huiqiu; Xu, Wenfang; Liu, Wei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Wenfang] Chinese Acad Sci, State Key Lab Cryospher Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China; [Wang, Xiujun] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [Yuan, Wenping] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Beijing Normal University; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; University System of Maryland; University of Maryland College Park; Beijing Normal University	Yuan, WP (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	yuanwpcn@126.com; llinghao@ibcas.ac.cn; hxu@issas.ac.cn	Wang, Xiujun/F-2641-2010	Wang, Xiujun/0000-0002-2859-8011; Xu, Wenfang/0000-0002-2883-2760; Hou, Longyu/0000-0003-1221-4586	National Sciences Foundation of China [31130008, 41205104]; Ministry of Science and Technology of China [2010CB833502]; Fundamental Research Funds for Central Universities	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	Funding for this work was provided by the National Sciences Foundation of China (Grant No. 31130008 and 41205104) and the Ministry of Science and Technology of China (2010CB833502). This work was also supported by the Fundamental Research Funds for the Central Universities.	Aber JD, 2003, BIOSCIENCE, V53, P375, DOI 10.1641/0006-3568(2003)053[0375:INDATN]2.0.CO;2; Ambus P, 2006, BIOGEOCHEMISTRY, V79, P315, DOI 10.1007/s10533-005-5313-x; Anderson KA, 2006, WATER AIR SOIL POLL, V176, P351, DOI 10.1007/s11270-006-9172-4; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bowden RD, 2000, J ENVIRON QUAL, V29, P268, DOI 10.2134/jeq2000.00472425002900010034x; BRUMME R, 1992, J GEOPHYS RES-ATMOS, V97, P12851, DOI 10.1029/92JD01217; DISE NB, 1995, FOREST ECOL MANAG, V71, P153, DOI 10.1016/0378-1127(94)06092-W; Du E, 2014, ATMOS ENVIRON, V98, P474, DOI 10.1016/j.atmosenv.2014.09.005; Du EZ, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/9/095004; Fang HJ, 2012, PLANT SOIL, V351, P177, DOI 10.1007/s11104-011-0942-4; Fenn ME, 1998, ECOL APPL, V8, P706, DOI 10.1890/1051-0761(1998)008[0706:NEINAE]2.0.CO;2; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; GALLOWAY JN, 1995, GLOBAL BIOGEOCHEM CY, V9, P235, DOI 10.1029/95GB00158; Galy-Lacaux C, 2009, ATMOS CHEM PHYS, V9, P1579, DOI 10.5194/acp-9-1579-2009; He CE, 2007, AGR ECOSYST ENVIRON, V121, P395, DOI 10.1016/j.agee.2006.12.016; Jia Y.L., 2014, SCI REP-UK, V4, P3763, DOI [10.1038/srep03763, DOI 10.1038/srep03763]; Jiang CM, 2010, ATMOS ENVIRON, V44, P2920, DOI 10.1016/j.atmosenv.2010.03.030; Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Li JZ, 2011, PLANT SOIL, V340, P253, DOI 10.1007/s11104-010-0612-y; Liu J, 2010, FIELD CROP RES, V118, P145, DOI 10.1016/j.fcr.2010.05.003; Liu XJ, 2006, AGR ECOSYST ENVIRON, V113, P370, DOI 10.1016/j.agee.2005.11.002; Liu XJ, 2015, SCI TOTAL ENVIRON, V520, P300, DOI 10.1016/j.scitotenv.2015.03.004; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Liu XJ, 2010, J ARID LAND, V2, P137, DOI 10.3724/SP.J.1227.2010.00137; Lu CQ, 2015, ATMOS ENVIRON, V101, P352, DOI 10.1016/j.atmosenv.2014.11.032; Lu CQ, 2014, ATMOS ENVIRON, V97, P68, DOI 10.1016/j.atmosenv.2014.07.061; Lu CQ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007990; Mo JM, 2006, PLANT SOIL, V282, P135, DOI 10.1007/s11104-005-5446-7; Neff JC, 2002, BIOGEOCHEMISTRY, V57, P99, DOI 10.1023/A:1015791622742; Pan YP, 2012, ATMOS CHEM PHYS, V12, P6515, DOI 10.5194/acp-12-6515-2012; Pan YP, 2015, ATMOS ENVIRON, V101, P350, DOI 10.1016/j.atmosenv.2014.10.062; RAM J, 1991, J RANGE MANAGE, V44, P140, DOI 10.2307/4002312; Sheng WP, 2013, ENVIRON MONIT ASSESS, V185, P833, DOI 10.1007/s10661-012-2594-0; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Templer PH, 2012, FRONT ECOL ENVIRON, V10, P547, DOI 10.1890/120055; TILMAN D, 1991, ECOLOGY, V72, P1038, DOI 10.2307/1940604; Townsend AR, 1996, ECOL APPL, V6, P806, DOI 10.2307/2269486; Wei CZ, 2013, GLOBAL CHANGE BIOL, V19, P3688, DOI 10.1111/gcb.12348; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; [张国忠 Zhang Guozhong], 2015, [环境科学研究, Research of Environmental Sciences], V28, P684; Zhang Y, 2008, ATMOS ENVIRON, V42, P1436, DOI 10.1016/j.atmosenv.2007.11.002; Zhang Y, 2012, ATMOS ENVIRON, V46, P195, DOI 10.1016/j.atmosenv.2011.09.080; Zhao X, 2009, WATER AIR SOIL POLL, V203, P277, DOI 10.1007/s11270-009-0011-2; Zhu JX, 2015, SCI TOTAL ENVIRON, V511, P777, DOI 10.1016/j.scitotenv.2014.12.038	47	17	19	3	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144689	10.1371/journal.pone.0144689	http://dx.doi.org/10.1371/journal.pone.0144689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695940	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092500008
J	Alestalo, K; Miettinen, JA; Vuolteenaho, O; Huikuri, H; Lehenkari, P				Alestalo, Kirsi; Miettinen, Johanna A.; Vuolteenaho, Olli; Huikuri, Heikki; Lehenkari, Petri			Bone Marrow Mononuclear Cell Transplantation Restores Inflammatory Balance of Cytokines after ST Segment Elevation Myocardial Infarction	PLOS ONE			English	Article							THROMBOLYTIC THERAPY; INJURY; RECOVERY; REPAIR; INTERLEUKIN-10; MODULATION; MECHANISMS; EXPRESSION; INJECTION; ALPHA	Background Acute myocardial infarction (AMI) launches an inflammatory response and a repair process to compensate cardiac function. During this process, the balance between proinflammatory and anti-inflammatory cytokines is important for optimal cardiac repair. Stem cell transplantation after AMI improves tissue repair and increases the ventricular ejection fraction. Here, we studied in detail the acute effect of bone marrow mononuclear cell (BMMNC) transplantation on proinflammatory and anti-inflammatory cytokines in patients with ST segment elevation myocardial infarction (STEMI). Methods Patients with STEMI treated with thrombolysis followed by percutaneous coronary intervention (PCI) were randomly assigned to receive either BMMNC or saline as an intracoronary injection. Cardiac function was evaluated by left ventricle angiogram during the PCI and again after 6 months. The concentrations of 27 cytokines were measured from plasma samples up to 4 days after the PCI and the intracoronary injection. Results Twenty-six patients (control group, n = 12; BMMNC group, n = 14) from the previously reported FINCELL study (n = 80) were included to this study. At day 2, the change in the proinflammatory cytokines correlated with the change in the anti-inflammatory cytokines in both groups (Kendall's tau, control 0.6; BMMNC 0.7). At day 4, the correlation had completely disappeared in the control group but was preserved in the BMMNC group (Kendall's tau, control 0.3; BMMNC 0.7). Conclusions BMMNC transplantation is associated with preserved balance between pro- and anti-inflammatory cytokines after STEMI in PCI-treated patients. This may partly explain the favorable effect of stem cell transplantation after AMI.	[Alestalo, Kirsi; Lehenkari, Petri] Oulu Univ Hosp, Med Res Ctr, Surg Clin, Oulu, Finland; [Alestalo, Kirsi; Lehenkari, Petri] Univ Oulu, Med Res Ctr, Dept Anat & Cell Biol, Oulu, Finland; [Miettinen, Johanna A.; Huikuri, Heikki] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Miettinen, Johanna A.; Huikuri, Heikki] Univ Oulu, Oulu, Finland; [Vuolteenaho, Olli] Univ Oulu, Dept Physiol, Inst Biomed, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu	Alestalo, K (corresponding author), Oulu Univ Hosp, Med Res Ctr, Surg Clin, Oulu, Finland.	kirsi.alestalo@gmail.com	Lehenkari, Petri/O-3009-2016	Lehenkari, Petri/0000-0002-0055-5183	Finnish Foundation for Cardiovascular Research	Finnish Foundation for Cardiovascular Research	The research project was sponsored by the Finnish Foundation for Cardiovascular Research.	Afzal MR, 2015, CIRC RES, V117, P558, DOI 10.1161/CIRCRESAHA.114.304792; Alestalo K, 2015, SCAND CARDIOVASC J, V49, P82, DOI 10.3109/14017431.2015.1018311; Ben-Mordechai T, 2013, J AM COLL CARDIOL, V62, P1890, DOI 10.1016/j.jacc.2013.07.057; Burchfield JS, 2008, CIRC RES, V103, P203, DOI 10.1161/CIRCRESAHA.108.178475; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; Debrunner M, 2008, CLIN RES CARDIOL, V97, P298, DOI 10.1007/s00392-007-0626-5; Dong F, 2012, CIRCULATION, V126, P314, DOI 10.1161/CIRCULATIONAHA.111.082453; Du YY, 2008, CYTOTHERAPY, V10, P469, DOI 10.1080/14653240802129893; Engel D, 2004, AM J PHYSIOL-HEART C, V287, pH1303, DOI 10.1152/ajpheart.00053.2004; Fan CQ, 2014, INT HEART J, V55, P362, DOI 10.1536/ihj.14-007; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frangogiannis NG, 2000, J IMMUNOL, V165, P2798, DOI 10.4049/jimmunol.165.5.2798; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Guo J, 2007, INFLAMMATION, V30, P97, DOI 10.1007/s10753-007-9025-3; Gyongyosi M, 2015, CIRC RES, V116, P1346, DOI 10.1161/CIRCRESAHA.116.304346; Hofmann U, 2014, CIRC-HEART FAIL, V7, P822, DOI 10.1161/CIRCHEARTFAILURE.113.001020; Huikuri HV, 2008, EUR HEART J, V29, P2723, DOI 10.1093/eurheartj/ehn436; Jaremo P, 2008, EUR J INTERN MED, V19, P330, DOI 10.1016/j.ejim.2007.06.017; Jiang CY, 2008, J ZHEJIANG UNIV-SC B, V9, P630, DOI 10.1631/jzus.B0820004; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Krause K, 2009, HEART, V95, P1145, DOI 10.1136/hrt.2008.155077; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Lee SH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-16; Li JM, 2010, BRAIN RES, V1334, P65, DOI 10.1016/j.brainres.2010.03.080; Makela J, 2007, J THORAC CARDIOV SUR, V134, P565, DOI 10.1016/j.jtcvs.2007.05.004; Makela J, 2009, SCAND CARDIOVASC J, V43, P366, DOI 10.3109/14017430903045350; Mao F, 2010, INFLAMM RES, V59, P219, DOI 10.1007/s00011-009-0090-y; Miettinen JA, 2010, HEART, V96, P362, DOI 10.1136/hrt.2009.171694; Pasqui AL, 2006, CLIN EXP MED, V6, P38, DOI 10.1007/s10238-006-0092-9; Patti G, 2005, CLIN CARDIOL, V28, P193, DOI 10.1002/clc.4960280409; Puhakka M, 2003, J CARD FAIL, V9, P325, DOI 10.1054/jcaf.2003.38; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; Semedo P, 2009, INT IMMUNOPHARMACOL, V9, P677, DOI 10.1016/j.intimp.2008.12.008; Seropian IM, 2014, J AM COLL CARDIOL, V63, P1593, DOI 10.1016/j.jacc.2014.01.014; Shames BD, 2002, SHOCK, V17, P114, DOI 10.1097/00024382-200202000-00006; Sharma AK, 2012, CIRCULATION, V126, pS38, DOI 10.1161/CIRCULATIONAHA.111.083451; Swart JF, 2015, ANN RHEUM DIS, V74, P769, DOI 10.1136/annrheumdis-2013-204147; Swirski FK, 2013, J AM COLL CARDIOL, V62, P1902, DOI 10.1016/j.jacc.2013.07.058; Szkodzinski J, 2011, HEART VESSELS, V26, P399, DOI 10.1007/s00380-010-0076-2; Troidl C, 2009, J CELL MOL MED, V13, P3485, DOI 10.1111/j.1582-4934.2009.00707.x; Tsai PJ, 2014, CELL TRANSPLANT; Udina M, 2014, CNS NEUROL DISORD-DR, V13, P1066, DOI 10.2174/1871527313666140612121921; YLIMAYRY S, 1993, AM J CARDIOL, V72, P1371, DOI 10.1016/0002-9149(93)90182-C; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106	45	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145094	10.1371/journal.pone.0145094	http://dx.doi.org/10.1371/journal.pone.0145094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690350	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300034
J	Alves, JM; Carneiro, M; Afonso, S; Lopes, S; Garreau, H; Boucher, S; Allain, D; Queney, G; Esteves, PJ; Bolet, G; Ferrand, N				Alves, Joel M.; Carneiro, Miguel; Afonso, Sandra; Lopes, Susana; Garreau, Herve; Boucher, Samuel; Allain, Daniel; Queney, Guillaume; Esteves, Pedro J.; Bolet, Gerard; Ferrand, Nuno			Levels and Patterns of Genetic Diversity and Population Structure in Domestic Rabbits	PLOS ONE			English	Article							GENOME-WIDE SURVEY; ORYCTOLAGUS-CUNICULUS; NUCLEOTIDE DIVERSITY; LINKAGE DISEQUILIBRIUM; PRINCIPAL-COMPONENTS; MICROSATELLITE LOCI; CATTLE BREEDS; REVEALS; WILD; PROGRAM	Over thousands of years humans changed the genetic and phenotypic composition of several organisms and in the process transformed wild species into domesticated forms. From this close association, domestic animals emerged as important models in biomedical and fundamental research, in addition to their intrinsic economical and cultural value. The domestic rabbit is no exception but few studies have investigated the impact of domestication on its genetic variability. In order to study patterns of genetic structure in domestic rabbits and to quantify the genetic diversity lost with the domestication process, we genotyped 45 microsatellites for 471 individuals belonging to 16 breeds and 13 wild localities. We found that both the initial domestication and the subsequent process of breed formation, when averaged across breeds, culminated in losses of similar to 20% of genetic diversity present in the ancestral wild population and domestic rabbits as a whole, respectively. Despite the short time elapsed since breed diversification we uncovered a well-defined structure in domestic rabbits where the FST between breeds was 22%. However, we failed to detect deeper levels of structure, probably consequence of a recent and single geographic origin of domestication together with a non-bifurcating process of breed formation, which were often derived from crosses between two or more breeds. Finally, we found evidence for intrabreed stratification that is associated with demographic and selective causes such as formation of strains, colour morphs within the same breed, or country/breeder of origin. These additional layers of population structure within breeds should be taken into account in future mapping studies.	[Alves, Joel M.; Carneiro, Miguel; Afonso, Sandra; Lopes, Susana; Esteves, Pedro J.; Ferrand, Nuno] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal; [Alves, Joel M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Alves, Joel M.; Carneiro, Miguel; Ferrand, Nuno] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Garreau, Herve; Allain, Daniel; Bolet, Gerard] INRA, Genet Physiol & Syst Elevage UMR1388, F-31326 Castanet Tolosan, France; [Boucher, Samuel] Labovet Conseil Reseau Cristal, Les Herbiers, France; [Queney, Guillaume] ANTAGENE, Wildlife Genet Lab, Lyon, France; [Esteves, Pedro J.] CESPU, IPSN, CITS, Gandra, Portugal	Universidade do Porto; University of Cambridge; Universidade do Porto; INRAE	Alves, JM (corresponding author), Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Campus Agr Vairao, Vairao, Portugal.	j.alves@gen.cam.ac.uk	Afonso, Sandra/AAV-9350-2021; Ferrand, Nuno/E-6085-2014; Allain, Daniel/AAT-6658-2020; QUENEY, Guillaume/C-5723-2009; afonso, sandra/M-5702-2013; Carneiro, Miguel/L-7864-2013; Alves, Joel/L-8007-2013; Esteves, Pedro/A-7537-2010	Afonso, Sandra/0000-0001-7212-991X; Ferrand, Nuno/0000-0002-2408-4195; QUENEY, Guillaume/0000-0002-6071-5169; afonso, sandra/0000-0001-7212-991X; Carneiro, Miguel/0000-0001-9882-7775; Alves, Joel/0000-0001-6138-9134; Esteves, Pedro/0000-0002-6055-8298	FEDER funds through the COMPETE program; Portuguese national funds through the FCT Fundacao para a Ciencia e a Tecnologia [POCI/CVT/61590/2004, PTDC/BIA-BDE/72304/2006, PTDC/BIA-BDE/72277/2006, PTDC/CVT/122943/2010]; POPH-QREN funds from the European Social Fund and Portuguese MCTES [IF/00283/2014, SFRH/BPD/72343/2010, SFRH/BD/72381/2010]; Project "Genomics Applied To Genetic Resources"; North Portugal Regional Operational Programme (ON.2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF); Labovet Conseil; ANTAGENE	FEDER funds through the COMPETE program; Portuguese national funds through the FCT Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); POPH-QREN funds from the European Social Fund and Portuguese MCTES; Project "Genomics Applied To Genetic Resources"; North Portugal Regional Operational Programme (ON.2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF); Labovet Conseil; ANTAGENE	This work was partially funded by FEDER funds through the COMPETE program and Portuguese national funds through the FCT Fundacao para a Ciencia e a Tecnologia - (POCI/CVT/61590/2004; PTDC/BIA-BDE/72304/2006; PTDC/BIA-BDE/72277/2006; PTDC/CVT/122943/2010 research projects to N.F. and Wessel van der Loo) and by POPH-QREN funds from the European Social Fund and Portuguese MCTES (FCT Investigator grant to M.C. (IF/00283/2014); FCT, SFRH/BPD/72343/2010 post-doc grant to M.C.; FCT SFRH/BD/72381/2010 PhD grant to J.M.A.) and through the Project "Genomics Applied To Genetic Resources" co-financed by North Portugal Regional Operational Programme 2007/2013 (ON.2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF). FCT website: http://www.fct.pt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Labovet Conseil and ANTAGENE provided support in the form of salaries for authors S.B. and G.Q. respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bjornstad G, 2000, J ANIM BREED GENET, V117, P307, DOI 10.1046/j.1439-0388.2000.00264.x; Bolet G, 1999, EVALUATION CONSERVAT, P281; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Branco M, 2000, HEREDITY, V85, P307, DOI 10.1046/j.1365-2540.2000.00756.x; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Callou C, 2003, GARENNE CLAPIER ETUD; Canon J, 2006, ANIM GENET, V37, P327, DOI 10.1111/j.1365-2052.2006.01461.x; Canon J, 2000, ANIM GENET, V31, P39, DOI 10.1046/j.1365-2052.2000.00591.x; Canon J, 2001, GENET SEL EVOL, V33, P311, DOI 10.1051/gse:2001121; Carneiro M, 2007, GENET SEL EVOL, V39, P341, DOI 10.1051/gse:2007007; Carneiro M, 2014, SCIENCE, V345, P1074, DOI 10.1126/science.1253714; Carneiro M, 2011, MOL BIOL EVOL, V28, P1801, DOI 10.1093/molbev/msr003; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chang ML, 2009, J HERED, V100, pS28, DOI 10.1093/jhered/esp012; Chantry-Darmon C, 2003, CYTOGENET GENOME RES, V103, P192, DOI 10.1159/000076310; Chapman JA, 2008, LAGOMORPH BIOL; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dobney K, 2006, J ZOOL, V269, P261, DOI 10.1111/j.1469-7998.2006.00042.x; Donard E., 1982, RECHERCHES LEPORINES; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Ferrand N, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P207, DOI 10.1007/1-4020-4904-8_7; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; FLUX JEC, 1992, MAMMAL REV, V22, P151, DOI 10.1111/j.1365-2907.1992.tb00129.x; Gao LZ, 2008, GENETICS, V179, P965, DOI 10.1534/genetics.106.068072; Geraldes A, 2005, ANIM GENET, V36, P349, DOI 10.1111/j.1365-2052.2005.01300.x; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Granevitze Z, 2009, ANIM GENET, V40, P686, DOI 10.1111/j.1365-2052.2009.01902.x; Gray MM, 2009, GENETICS, V181, P1493, DOI 10.1534/genetics.108.098830; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; HARDY C, 1995, J MOL EVOL, V40, P227, DOI 10.1007/BF00163228; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Langella O., 1999, POPULATIONS 1 2 32; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Laval G, 2000, GENET SEL EVOL, V32, P187, DOI 10.1051/gse:2000113; Lebas F., 1997, FAO ANIMAL PRODUCTIO, V21; Liu AZ, 2006, GENETICS, V173, P321, DOI 10.1534/genetics.105.051110; Long JR, 2003, ANIM GENET, V34, P82, DOI 10.1046/j.1365-2052.2003.00945.x; Lopez-Martinez N., 1989, REVISION SISTEMATICA; Luetkemeier ES, 2010, MOL PHYLOGENET EVOL, V54, P680, DOI 10.1016/j.ympev.2009.11.004; MacHugh DE, 1998, ANIM GENET, V29, P333, DOI 10.1046/j.1365-2052.1998.295330.x; MONNEROT M, 1994, GENET SEL EVOL, V26, pS167, DOI 10.1051/gse:19940712; Mougel F, 1997, ANIM GENET, V28, P58, DOI 10.1111/j.1365-2052.1997.00047.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Queney G, 2002, J HERED, V93, P205, DOI 10.1093/jhered/93.3.205; Queney G, 2001, MOL BIOL EVOL, V18, P2169, DOI 10.1093/oxfordjournals.molbev.a003763; R Core Team, 2013, R LANG ENV STAT COMP; Rogel-Gaillard Claire, 2009, V3, P165, DOI 10.1007/978-3-540-73835-0_7; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shiomi Masashi, 2009, P49, DOI 10.1007/978-90-481-2227-1_7; Tapio M, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-76; Vallone PM, 2004, BIOTECHNIQUES, V37, P226, DOI 10.2144/04372ST03; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vigouroux Y, 2005, GENETICS, V169, P1617, DOI 10.1534/genetics.104.032086; Vila C, 2005, TRENDS GENET, V21, P214, DOI 10.1016/j.tig.2005.02.004; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitman B.D., 2004, DOMESTIC RABBITS THE	76	27	27	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144687	10.1371/journal.pone.0144687	http://dx.doi.org/10.1371/journal.pone.0144687			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689909	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300012
J	Brouard, MJ; Coulson, T; Newman, C; Macdonald, DW; Buesching, CD				Brouard, Marc J.; Coulson, Tim; Newman, Chris; Macdonald, David W.; Buesching, Christina D.			Analysis on Population Level Reveals Trappability of Wild Rodents Is Determined by Previous Trap Occupant	PLOS ONE			English	Article							SHORT-TAILED VOLE; APODEMUS-SYLVATICUS; MICROTUS-AGRESTIS; PEROMYSCUS-MANICULATUS; CONSPECIFIC ODORS; WOODLAND RODENTS; MUS-MUSCULUS; HOUSE MICE; CAPTURE; GLAREOLUS	Live trapping is central to the study of small mammals. Thus, any bias needs to be understood and accounted for in subsequent analyses to ensure accurate population estimates. One rarely considered bias is the behavioural response of individuals to the trap, in particular the olfactory cues left behind by previous occupants (PO). We used a data set of 8,115 trap nights spanning 17 separate trapping sessions between August 2002 and November 2013 in Wytham Woods, Oxfordshire, UK to examine if the decision to enter a trap was affected by the PO, if this was detectable in traditional Capture-Mark-Recapture trapping data (i.e., individuals not uniquely marked), and if it was possible for this effect to bias the population estimates obtained. Data were collected on Apodemus sylvaticus, Myodes glareolus, and Microtus agrestis. Three Generalised Linear Models revealed a significant tendency for the three species to enter traps with same-species PO. With, for example, A. sylvaticus 9.1 times more likely to enter a same species PO trap compared to one that contained a M. agrestis in the grassland during the nocturnal period. Simulation highlighted that, when all other factors are equal, the species with the highest PO effect will have the highest capture rate and therefore return more accurate population estimates. Despite the large dataset, certain species-, sex-, and/or age-combinations were under-represented, and thus no effects of any additional individual-specific characteristics could be evaluated. Uniquely marking individuals would allow for the PO effect to be disentangled from other biases such as trap-shyness and spatial heterogeneity, but may not be possible in all cases and will depend on the aims of the study and the resources available.	[Brouard, Marc J.; Coulson, Tim] Univ Oxford, Dept Zool, Ecol & Evolutionary Dynam E2D, Oxford, Oxon, England; [Newman, Chris; Macdonald, David W.; Buesching, Christina D.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, Oxon, England	University of Oxford; University of Oxford	Buesching, CD (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, Oxon, England.	christina.buesching@zoo.ox.ac	Coulson, Tim/AAL-8148-2021	Coulson, Tim/0000-0001-9371-9003; Brouard, Marc/0000-0002-6758-2194	Earthwatch Institute Europe; People's Trust for Endangered Species; ERC; Natural Environment Research Council [NE/K014218/1] Funding Source: researchfish; NERC [NE/K014218/1] Funding Source: UKRI	Earthwatch Institute Europe; People's Trust for Endangered Species; ERC(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The different studies which contributed to this data set were made possible by field grants from the Earthwatch Institute Europe and the People's Trust for Endangered Species. Tim Coulson acknowledges support from an ERC grant that has funded data collection from small rodents in Wytham Woods since 2013.	Bailey NT, 1952, THE JOURNAL OF ANIMA, P120, DOI [10.2307/1913, DOI 10.2307/1913]; BAILEY NTJ, 1951, BIOMETRIKA, V38, P293, DOI 10.2307/2332575; BOONSTRA R, 1976, J ZOOL, V180, P467; Buesching CD, 2008, MAMM BIOL, V73, P318, DOI 10.1016/j.mambio.2007.09.009; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Coulson T, 2012, OIKOS, V121, P1337, DOI 10.1111/j.1600-0706.2012.00035.x; Crawley MJ, 2013, R BOOK, P557; Cubaynes S, 2010, CONSERV BIOL, V24, P621, DOI 10.1111/j.1523-1739.2009.01431.x; DALY M, 1980, BEHAV ECOL SOCIOBIOL, V6, P323, DOI 10.1007/BF00292775; DALY M, 1978, BEHAV BIOL, V23, P254, DOI 10.1016/S0091-6773(78)91926-0; DRICKAMER LC, 1995, J CHEM ECOL, V21, P541, DOI 10.1007/BF02033700; Edalgo JA, 2007, J WILDLIFE MANAGE, V71, P246, DOI 10.2193/2006-344; Fisher N, 2010, WYTHAM WOODS: OXFORD'S ECOLOGICAL LABORATORY, P197; Gipps J. H. W., 1985, S ZOOLOGICAL SOC LON, V55, P61; GURNELL J, 1992, ANIM BEHAV, V43, P623, DOI 10.1016/0003-3472(92)90084-M; GURNELL J, 1983, J ZOOL, V200, P289; Gurnell J., 2006, LIVE TRAPPING SMALL, VFourth edition, revised ed.; Hayes RA, 2006, ANIM BEHAV, V71, P1307, DOI 10.1016/j.anbehav.2005.08.017; Herman CS, 2000, OIKOS, V91, P139, DOI 10.1034/j.1600-0706.2000.910113.x; Heth G, 1996, CHEMOECOLOGY, V7, P107, DOI 10.1007/BF01239487; Huggins R, 1991, BIOMETRICS, P725, DOI [10.2307/2532158, DOI 10.2307/2532158]; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; JENSEN TS, 1975, OIKOS, V26, P196, DOI 10.2307/3543709; Jolly G, 1965, BIOMETRIKA, P225, DOI [10.2307/2333826, DOI 10.2307/2333826]; Kikkawa J, 1964, THE JOURNAL OF ANIMA, P259, DOI [10.2307/2631, DOI 10.2307/2631]; Krebs CJ, 2006, ECOLOGICAL CENSUS TECHNIQUES: A HANDBOOK, 2ND EDITION, P351, DOI 10.1017/CBO9780511790508.011; KREBS CJ, 1984, CAN J ZOOL, V62, P2440, DOI 10.1139/z84-360; KREBS CJ, 1966, ECOL MONOGR, V36, P240, DOI 10.2307/1942418; Lincoln F. C., 1930, CALCULATING WATERFOW; Macdonald DW, 1998, PROPOSALS FOR FUTURE; MAZDZER E, 1976, J MAMMAL, V57, P607, DOI 10.2307/1379317; MONTGOMERY WI, 1979, ACTA THERIOL, V24, P35, DOI 10.4098/AT.arch.79-4; MYLLYMAKI A, 1977, OIKOS, V29, P553, DOI 10.2307/3543594; Oracle, 2015, TREEMAP JAVA PLATFOR; Peterson C.G.J, 1896, REPORT DANISH BIOL S, V6, P1; R Core Team, 2014, R A LANGUAGE AND ENV; ROWE FP, 1970, J ZOOL, V162, P517; SHILLITO ELIZABETH E., 1963, BEHAVIOUR, V21, P145, DOI 10.1163/156853963X00149; Simeonovska-Nikolova DM, 2007, J ETHOL, V25, P41, DOI 10.1007/s10164-006-0203-9; SMITH MH, 1968, J MAMMAL, V49, P455, DOI 10.2307/1378203; Stoddart D, 1985, S ZOOL SOC LOND, V55, P117; STODDART DM, 1982, ANIM BEHAV, V30, P293, DOI 10.1016/S0003-3472(82)80266-2; STODDART DM, 1982, J ANIM ECOL, V51, P375, DOI 10.2307/3971; STODDART DM, 1976, OECOLOGIA, V22, P439, DOI 10.1007/BF00345320; STODDART DM, 1986, OIKOS, V46, P194, DOI 10.2307/3565467; Stoddart DM, 1983, CHEM SIGNALS VERTEBR, V3, P223; STODDART DM, 1980, CHEM SIGNALS VERTEBR, P1; Strachan R, 1995, MAMMAL DETECTIVE; SUMMERLIN CT, 1973, ECOLOGY, V54, P1156, DOI 10.2307/1935584; TEW TE, 1994, J MAMMAL, V75, P750, DOI 10.2307/1382526; Villette P, 2015, J MAMMAL; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wolton R.J., 1985, S ZOOL SOC LONDON, V55, P249; WUENSCH KL, 1982, J MAMMAL, V63, P312, DOI 10.2307/1380645; Yalden DW, 2008, MAMMALS OF THE BRITI; Yunger JA, 1999, J MAMMAL, V80, P1336, DOI 10.2307/1383184	56	5	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145006	10.1371/journal.pone.0145006	http://dx.doi.org/10.1371/journal.pone.0145006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689683	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300030
J	Mbae, C; Mulinge, E; Waruru, A; Ngugi, B; Wainaina, J; Kariuki, S				Mbae, Cecilia; Mulinge, Erastus; Waruru, Anthony; Ngugi, Benjamin; Wainaina, James; Kariuki, Samuel			Genetic Diversity of Cryptosporidium in Children in an Urban Informal Settlement of Nairobi, Kenya	PLOS ONE			English	Article							N. SP APICOMPLEXA; CLINICAL-MANIFESTATIONS; MOLECULAR EPIDEMIOLOGY; SEQUENCE-ANALYSIS; MURIS INFECTION; SUBTYPES; IDENTIFICATION; PARVUM; GIARDIA; POPULATION	Introduction Globally Cryptosporidium and Giardia species are the most common non-bacterial causes of diarrhoea in children and HIV infected individuals, yet data on their role in paediatric diarrhoea in Kenya remains scant. This study investigated the occurrence of Cryptosporidium species, genotypes and subtypes in children, both hospitalized and living in an informal settlement in Nairobi. Methods This was a prospective cross-sectional study in which faecal specimen positive for Cryptosporidium spp. by microscopy from HIV infected and uninfected children aged five years and below presenting with diarrhoea at selected outpatient clinics in Mukuru informal settlements, or admitted to the paediatric ward at the Mbagathi District Hospital were characterized. The analysis was done by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) of the 18srRNA gene for species identification and PCR-sequencing of the 60 kDa glycoprotein (GP60) gene for subtyping. Results C. hominis was the most common species of Cryptosporidium identified in125/151(82.8%) of the children. Other species identified were C. parvum 18/151(11.9%), while C. felis and C. meleagridis were identified in 4 and 2 children, respectively. Wide genetic variation was observed within C. hominis, with identification of 5 subtype families; Ia, Ib, Id, Ie and If and 21 subtypes. Only subtype family IIc was identified within C. parvum. There was no association between species and HIV status or patient type. Conclusion C. hominis is the most common species associated with diarrhoea in the study population. There was high genetic variability in the C. hominis isolates with 22 different subtypes identified, whereas genetic diversity was low within C. parvum with only one subtype family IIc identified.	[Mbae, Cecilia; Mulinge, Erastus; Ngugi, Benjamin; Kariuki, Samuel] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Waruru, Anthony] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Wainaina, James] Int Livestock Res Inst, Biosci Eastern & Cent Africa, Nairobi, Kenya	Kenya Medical Research Institute; Kenya Medical Research Institute; CGIAR; International Livestock Research Institute (ILRI)	Mbae, C (corresponding author), Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya.	cmkathure@gmail.com	Waruru, Anthony/U-7217-2019	Waruru, Anthony/0000-0002-4281-6345	Kilifi [084538]; National Council of Science and Technology [L022]; Wellcome Trust; National Council of Science, Technology and Innovation (NACOSTI)	Kilifi; National Council of Science and Technology; Wellcome Trust(Wellcome TrustEuropean Commission); National Council of Science, Technology and Innovation (NACOSTI)	Financial support was recieved from the Wellcome Trust programme, Kilifi (strategic award, 084538) and National Council of Science and Technology, grant no. L022. Financial support was given to CKM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We would like to acknowledge financial support from Wellcome Trust programme, Kilifi (strategic award, 084538) and the National Council of Science, Technology and Innovation (NACOSTI). The children of Mukuru/Mbagathi and their parents/guardians who participated in the study. Special thanks to the entire field, clinical and laboratory staff of the KenyaMedical Research Institute, Mukuru clinics and Mbagathi District hospital, involved in collection of all the data used in this project. This article is published with permission from the Director, KEMRI.	Abu Samra N, 2013, ZOONOSES PUBLIC HLTH, V60, P154, DOI 10.1111/j.1863-2378.2012.01507.x; Ajjampur SSR, 2007, J CLIN MICROBIOL, V45, P915, DOI 10.1128/JCM.01590-06; Ajjampur SSR, 2010, J CLIN MICROBIOL, V48, P2075, DOI 10.1128/JCM.02509-09; Akinbo FO, 2013, AM J TROP MED HYG, V89, P157, DOI 10.4269/ajtmh.12-0635; Akiyoshi DE, 2006, J PARASITOL, V92, P1097, DOI 10.1645/GE-843R.1; Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; Bouzid M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-213; Cama VA, 2008, EMERG INFECT DIS, V14, P1567, DOI 10.3201/eid1410.071273; Cama VA, 2007, J INFECT DIS, V196, P684, DOI 10.1086/519842; Cevallos AM, 2000, INFECT IMMUN, V68, P4108, DOI 10.1128/IAI.68.7.4108-4116.2000; Chalmers RM, 2010, J APPL MICROBIOL, V109, P1487, DOI 10.1111/j.1365-2672.2010.04764.x; Chalmers RM, 2008, EMERG INFECT DIS, V14, P496, DOI 10.3201/eid1403.071320; Cohen S, 2006, J CLIN MICROBIOL, V44, P589, DOI 10.1128/JCM.44.2.589-591.2006; Elwin K, 2012, INT J PARASITOL, V42, P675, DOI 10.1016/j.ijpara.2012.04.016; Fayer R, 2010, VET PARASITOL, V172, P23, DOI 10.1016/j.vetpar.2010.04.028; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Feng XC, 2000, APPL ENVIRON MICROB, V66, P3344, DOI 10.1128/AEM.66.8.3344-3349.2000; Gatei W, 2002, EMERG INFECT DIS, V8, P204, DOI 10.3201/eid0802.010256; Gatei W, 2008, EMERG INFECT DIS, V14, P841, DOI 10.3201/eid1405.071277; Gatei W, 2006, J EUKARYOT MICROBIOL, V53, pS43, DOI 10.1111/j.1550-7408.2006.00169.x; Gatei W, 2006, AM J TROP MED HYG, V75, P78, DOI 10.4269/ajtmh.2006.75.78; Geurden T, 2009, PARASITOLOGY, V136, P1161, DOI 10.1017/S0031182009990436; Giangaspero A, 2009, PARASITOL INT, V58, P12, DOI 10.1016/j.parint.2008.07.003; Glaberman S, 2002, EMERG INFECT DIS, V8, P631, DOI 10.3201/eid0806.010368; Hijjawi N, 2010, EXP PARASITOL, V125, P161, DOI 10.1016/j.exppara.2010.01.011; Hung CC, 2007, J FORMOS MED ASSOC, V106, P31, DOI 10.1016/S0929-6646(09)60213-8; Insulander M, 2013, EPIDEMIOL INFECT, V141, P1009, DOI 10.1017/S0950268812001665; Jex AR, 2010, BIOTECHNOL ADV, V28, P17, DOI 10.1016/j.biotechadv.2009.08.003; Katsumata T, 2000, AM J TROP MED HYG, V62, P70, DOI 10.4269/ajtmh.2000.62.70; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; Leav BA, 2002, INFECT IMMUN, V70, P3881, DOI 10.1128/IAI.70.7.3881-3890.2002; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; Lim YAL, 2011, INFECT GENET EVOL, V11, P968, DOI 10.1016/j.meegid.2011.03.007; Mbae CK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-243; Molloy SF, 2010, AM J TROP MED HYG, V82, P608, DOI 10.4269/ajtmh.2010.09-0624; Morgan-Ryan UM, 2002, J EUKARYOT MICROBIOL, V49, P433, DOI 10.1111/j.1550-7408.2002.tb00224.x; Plutzer J, 2009, VET PARASITOL, V165, P187, DOI 10.1016/j.vetpar.2009.07.003; Power ML, 2009, EXP PARASITOL, V121, P219, DOI 10.1016/j.exppara.2008.10.016; Putignani Lorenza, 2010, Interdiscip Perspect Infect Dis, V2010, DOI 10.1155/2010/753512; Robinson G, 2010, ZOONOSES PUBLIC HLTH, V57, pE1, DOI 10.1111/j.1863-2378.2009.01308.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sharma P, 2013, INT J INFECT DIS; Strong WB, 2000, INFECT IMMUN, V68, P4117, DOI 10.1128/IAI.68.7.4117-4134.2000; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Traversa D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-21; Waldron LS, 2010, EMERG INFECT DIS, V16, P2006, DOI 10.3201/eid1612.100715; Wielinga PR, 2008, INT J PARASITOL, V38, P809, DOI 10.1016/j.ijpara.2007.10.014; Xiao LH, 2001, J INFECT DIS, V183, P492, DOI 10.1086/318090; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578; Xiao LH, 2001, EMERG INFECT DIS, V7, P141, DOI 10.3201/eid0701.010121; Xiao LH, 2008, FEMS IMMUNOL MED MIC, V52, P309, DOI 10.1111/j.1574-695X.2008.00377.x; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Zhu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043682	55	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0142055	10.1371/journal.pone.0142055	http://dx.doi.org/10.1371/journal.pone.0142055			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691531	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300001
J	Hajri, S; Raifman, S; Gerdts, C; Baum, S; Foster, DG				Hajri, Selma; Raifman, Sarah; Gerdts, Caitlin; Baum, Sarah; Foster, Diana Greene			'This Is Real Misery': Experiences of Women Denied Legal Abortion in Tunisia	PLOS ONE			English	Article							MEDICAL ABORTION; POSTABORTION CARE; IMPROVE ACCESS; SAFE; TERMINATION; PREGNANCY; ATTITUDES; AFRICA	Barriers to accessing legal abortion services in Tunisia are increasing, despite a liberal abortion law, and women are often denied wanted legal abortion services. In this paper, we seek to explore the reasons for abortion denial and whether these reasons had a legal or medical basis. We also identify barriers women faced in accessing abortion and make recommendations for improved access to quality abortion care. We recruited women immediately after they had been turned away from legal abortion services at two facilities in Tunis, Tunisia. Thirteen women consented to participate in qualitative interviews two months after they were turned away from the facility. Women were denied abortion care on the day they were recruited due to three main reasons: gestational age, health conditions, and logistical barriers. Nine women ultimately terminated their pregnancies at another facility, and four women carried to term. None of the women attempted illegal abortion services or self-induction. Further research is needed in order to assess abortion denial from the perspective of providers and medical staff.	[Hajri, Selma] Grp Tawhida Ben Cheikh, Tunis, Tunisia; [Raifman, Sarah; Foster, Diana Greene] Univ Calif San Francisco, Bixby Ctr Global Reprod Hlth, Advancing New Stand Reprod Hlth ANSIRH, Oakland, CA USA; [Gerdts, Caitlin; Baum, Sarah] Ibis Reprod Hlth, Oakland, CA USA	University of California System; University of California San Francisco	Hajri, S (corresponding author), Grp Tawhida Ben Cheikh, Tunis, Tunisia.	selmahajri@gmail.com			Society of Family Planning [SFPRF7-8]	Society of Family Planning	Funding for this work was provided by the Society of Family Planning (http://www.societyfp.org/, grant number SFPRF7-8) to DF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee SK, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-227; Bankole AS, 1998, INT FAMILY PLANNING, V24; Ben Farhat E, 2012, INT J GYNECOL OBSTET, V116, P165, DOI 10.1016/j.ijgo.2011.10.010; Berer M, 2000, B WORLD HEALTH ORGAN, V78, P580; Blum J, 2004, CONTRACEPTION, V69, P63, DOI 10.1016/j.contraception.2003.08.019; Boughzala MH, 2014, 17 GLOB EC DEV; Chang J., 2003, MMWR SURVEILL SUMM, V52, P1; Davey A, 2006, CONTRACEPTION, V74, P16, DOI 10.1016/j.contraception.2006.03.003; Drey EA, 2006, OBSTET GYNECOL, V107, P128, DOI 10.1097/01.AOG.0000189095.32382.d0; Gerdts C, 2015, J FAM PLAN REPROD H, V41, P161, DOI 10.1136/jfprhc-2014-100999; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Guiahi M, 2012, CONTRACEPTION, V86, P622, DOI 10.1016/j.contraception.2012.09.001; Hajri S, 2004, CONTRACEPTION, V70, P487, DOI 10.1016/j.contraception.2004.06.012; Harries Jane, 2007, Reprod Health, V4, P7, DOI 10.1186/1742-4755-4-7; Harries J, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0014-y; Harries J, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-16; Henderson JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064775; Ilboudo PGC, 2014, INT J WOMENS HEALTH, V6, P565, DOI 10.2147/IJWH.S60709; Janiak E, 2012, FOSTERING ABORTION R; Jewkes R, 2005, BJOG-INT J OBSTET GY, V112, P355, DOI 10.1111/j.1471-0528.2004.00422.x; Kallner HK, 2015, BJOG-INT J OBSTET GY, V122, P510, DOI 10.1111/1471-0528.12982; Loi UR, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1502-2; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; MOH, 1991, HLTH TMO; Naili H, 2012, TUNISIA LOSES GROUND; Nazer I, 1980, Int J Gynaecol Obstet, V17, P488; Ngoc NTN, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-118; Ohier F, 2014, ABORTION TUNISIA SHI; Paul M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-28; Pew Forum on Religion & Public Life, 2009, MAPP GLOB MUSL POP R; Puri MV, 2015, INT PERSPECTIVES SEX; Rogo K O, 2001, East Afr Med J, V78, P468; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sedgh G, 2012, LANCET, V379, P625, DOI 10.1016/S0140-6736(11)61786-8; Sneeringer RK, 2012, J PUBLIC HEALTH POL, V33, P218, DOI 10.1057/jphp.2012.11; Squires A, 2009, INT J NURS STUD, V46, P277, DOI 10.1016/j.ijnurstu.2008.08.006; Tey NP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052116; Turner KL, 2008, REPROD HEALTH MATTER, V16, P108, DOI 10.1016/S0968-8080(08)31389-5; UN, 1995, INT C POP DEV PROGR; UN, 2002, AB POL GLOB REV; United Nations DoEaSA, 2013, WORLD POP PROSP 2012; van Bogaert Louis-Jacques, 2002, Dev World Bioeth, V2, P131, DOI 10.1111/1471-8847.00046; WHO, 2011, SEX REP HLTH COR COM; World Health Organization, 2008, WHO AIMS REP MENT HL	44	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145338	10.1371/journal.pone.0145338	http://dx.doi.org/10.1371/journal.pone.0145338			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684189	Green Published, gold, Green Submitted			2022-12-27	WOS:000366725800067
J	Walter, BM; Cartman, ST; Minton, NP; Butala, M; Rupnik, M				Walter, Beata M.; Cartman, Stephen T.; Minton, Nigel P.; Butala, Matej; Rupnik, Maja			The SOS Response Master Regulator LexA Is Associated with Sporulation, Motility and Biofilm Formation in Clostridium difficile	PLOS ONE			English	Article							BACILLUS-SUBTILIS; TOXIN PRODUCTION; GENE-EXPRESSION; CELL-DIVISION; PCR RIBOTYPES; CHEO BOX; RESISTANCE; RECA; METRONIDAZOLE; PROTEIN	The LexA regulated SOS network is a bacterial response to DNA damage of metabolic or environmental origin. In Clostridium difficile, a nosocomial pathogen causing a range of intestinal diseases, the in-silico deduced LexA network included the core SOS genes involved in the DNA repair and genes involved in various other biological functions that vary among different ribotypes. Here we describe the construction and characterization of a lexA Clos Tron mutant in C. difficile R20291 strain. The mutation of lexA caused inhibition of cell division resulting in a filamentous phenotype. The lexA mutant also showed decreased sporulation, a reduction in swimming motility, greater sensitivity to metronidazole, and increased biofilm formation. Changes in the regulation of toxin A, but not toxin B, were observed in the lexA mutant in the presence of sub-inhibitory concentrations of levofloxacin. C. difficile LexA is, therefore, not only a regulator of DNA damage but also controls many biological functions associated with virulence.	[Walter, Beata M.; Rupnik, Maja] NLZOH, Natl Lab Hlth Environm & Food, Maribor, Slovenia; [Cartman, Stephen T.; Minton, Nigel P.] Univ Nottingham, Clostridia Res Grp, BBSRC EPSRC Synthet Biol Res Ctr, Sch Life Sci,Ctr Biomol Sci, Nottingham NG7 2RD, England; [Butala, Matej] Univ Ljubljana, Biotechn Fac, Dept Biol, Ljubljana, Slovenia; [Rupnik, Maja] Univ Maribor, Fac Med, SLO-2000 Maribor, Slovenia; [Rupnik, Maja] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Nottingham; University of Ljubljana; University of Maribor	Butala, M (corresponding author), Univ Ljubljana, Biotechn Fac, Dept Biol, Ljubljana, Slovenia.	matej.butala@bf.uni-lj.si	Walter, Beata/AAF-7927-2019	Walter, Beata/0000-0002-7597-9431; Minton, Nigel/0000-0002-9277-1261	European Community's Seventh Framework Programme FP7 [237942]; Javna Agencija za Raziskovalno Dejavnost RS [P1-0207]; MRC [G0601176] Funding Source: UKRI; Medical Research Council [G0601176] Funding Source: researchfish	European Community's Seventh Framework Programme FP7; Javna Agencija za Raziskovalno Dejavnost RS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by European Community's Seventh Framework Programme FP7/2007-2013 (Grant agreement: 237942; Recipients: BMW, STC, NPM, and MR; http://ec.europa.eu/research/fp7/index_en.cfm); and Javna Agencija za Raziskovalno Dejavnost RS (SI), (Award Number: P1-0207; Recipient: MB; https://www.arrs.gov.si/en/novo.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldape MJ, 2013, J MED MICROBIOL, V62, P741, DOI 10.1099/jmm.0.056218-0; Au N, 2005, J BACTERIOL, V187, P7655, DOI 10.1128/JB.187.22.7655-7666.2005; Baharoglu Z, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003421; Bouillaut Laurent, 2011, Curr Protoc Microbiol, VChapter 9, DOI 10.1002/9780471729259.mc09a02s20; Buchholz M, 2013, MICROBIOL-SGM, V159, P1564, DOI 10.1099/mic.0.064766-0; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; Burns DA, 2010, J BACTERIOL, V192, P657, DOI 10.1128/JB.01209-09; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Cartman ST, 2012, APPL ENVIRON MICROB, V78, P4683, DOI 10.1128/AEM.00249-12; Chellappa ST, 2013, RES MICROBIOL, V164, P1019, DOI 10.1016/j.resmic.2013.10.001; Chong PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082622; Cowan AE, 2003, P NATL ACAD SCI USA, V100, P4209, DOI 10.1073/pnas.0636762100; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Da Re S, 2009, EMBO REP, V10, P929, DOI 10.1038/embor.2009.99; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; Deneve C, 2008, J MED MICROBIOL, V57, P732, DOI 10.1099/jmm.0.47676-0; Drummond LJ, 2003, J MED MICROBIOL, V52, P1033, DOI 10.1099/jmm.0.05387-0; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Edwards AN, 2014, FEMS MICROBIOL LETT, V358, P110, DOI 10.1111/1574-6968.12499; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Fang AQ, 2009, P NATL ACAD SCI USA, V106, P13225, DOI 10.1073/pnas.0906425106; Godoy V. G, 2004, ENCY BIOL CHEM, P546; Gotoh H, 2010, Biofouling, V26, P603, DOI 10.1080/08927014.2010.501895; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Hocquet D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002778; Jerman B, 2005, ANTIMICROB AGENTS CH, V49, P3087, DOI 10.1128/AAC.49.7.3087-3090.2005; Johnston JL, 1997, MICROBIOL-UK, V143, P885, DOI 10.1099/00221287-143-3-885; Kawai Y, 2003, MOL MICROBIOL, V47, P1113, DOI 10.1046/j.1365-2958.2003.03360.x; Keessen EC, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-14; Lachowicz D, 2015, ANAEROBE, V31, P37, DOI 10.1016/j.anaerobe.2014.09.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053757; Mani N, 2001, P NATL ACAD SCI USA, V98, P5844, DOI 10.1073/pnas.101126598; Mathur H, 2013, ANTIMICROB AGENTS CH, V57, P2882, DOI 10.1128/AAC.00261-13; Metcalf D, 2010, ANAEROBE, V16, P439, DOI 10.1016/j.anaerobe.2010.06.007; Moura I, 2013, J ANTIMICROB CHEMOTH, V68, P362, DOI 10.1093/jac/dks420; Nuyts S, 2001, APPL ENVIRON MICROB, V67, P4464, DOI 10.1128/AEM.67.10.4464-4470.2001; Pelaez T, 2008, J CLIN MICROBIOL, V46, P3028, DOI 10.1128/JCM.00524-08; Pettit LJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-160; Pultz NJ, 2005, ANTIMICROB AGENTS CH, V49, P3529, DOI 10.1128/AAC.49.8.3529-3532.2005; Quinones M, 2005, MOL CELL, V17, P291, DOI 10.1016/j.molcel.2004.11.046; Redgrave LS, 2014, TRENDS MICROBIOL, V22, P438, DOI 10.1016/j.tim.2014.04.007; Roth V, 2006, DOUBLING TIME ONLINE; Rowland SL, 2004, MOL CELL, V13, P689, DOI 10.1016/S1097-2765(04)00084-X; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sagar S., 2014, INT J PHARM SCI REV, V25, P102; Singh R, 2010, ANTIMICROB AGENTS CH, V54, P4262, DOI 10.1128/AAC.00168-10; Spigaglia P, 2008, J MED MICROBIOL, V57, P784, DOI 10.1099/jmm.0.47738-0; Spigaglia P, 2009, ANTIMICROB AGENTS CH, V53, P2463, DOI 10.1128/AAC.01252-08; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P2929, DOI 10.1128/AAC.00220-12; The European Committee on Antimicrobial Susceptibility Testing, 2015, BREAKP TABL INT MICS; Vlasic I, 2014, NUCLEIC ACIDS RES, V42, P2295, DOI 10.1093/nar/gkt1194; Walter BM, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-88; Zgur-Bertok D, 2012, BIOCHEM SOC T, V40, P1507, DOI 10.1042/BST20120184; Zidaric V, 2012, APPL ENVIRON MICROB, V78, P8515, DOI 10.1128/AEM.02185-12	58	38	39	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144763	10.1371/journal.pone.0144763	http://dx.doi.org/10.1371/journal.pone.0144763			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682547	gold, Green Published, Green Submitted			2022-12-27	WOS:000366725800020
J	Janmaat, CJ; de Rooij, KE; Locher, H; de Groot, SC; de Groot, JCMJ; Frijns, JHM; Huisman, MA				Janmaat, C. J.; de Rooij, K. E.; Locher, H.; de Groot, S. C.; de Groot, J. C. M. J.; Frijns, J. H. M.; Huisman, M. A.			Human Dermal Fibroblasts Demonstrate Positive Immunostaining for Neuron- and Glia-Specific Proteins	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; III BETA-TUBULIN; STEM-CELLS; EXPRESSION; MARKERS; IDENTITY; DISEASE; ENOLASE; MODEL; SOX9	In stem cell cultures from adult human tissue, undesirable contamination with fibroblasts is frequently present. The presence of fibroblasts obscures the actual number of stem cells and may result in extracellular matrix production after transplantation. Identification of fibroblasts is difficult because of the lack of specific fibroblast markers. In our laboratory, we isolate and expand neural-crest-derived stem cells from human hair follicle bulges and investigate their potential to differentiate into neural cells. To establish cellular identities, we perform immunohistochemistry with antibodies specific for glial and neuronal markers, and use fibroblasts as negative control. We frequently observe that human adult dermal fibroblasts also express some glial and neuronal markers. In this study, we have sought to determine whether our observations represent actual expression of these markers or result from cross-reactivity. Immunohistochemistry was performed on human adult dermal fibroblasts using acknowledged glial and neuronal antibodies followed by verification of the data using RT-qPCR. Human adult dermal fibroblasts showed expression of the glia-specific markers SOX9, glial fibrillary acidic protein and EGR2 (KROX20) as well as for the neuron-specific marker class III beta-tubulin, both at the protein and mRNA level. Furthermore, human adult dermal fibroblasts showed false-positive immunostaining for S100 beta and GAP43 and to a lower extent for OCT6. Our results indicate that immunophenotyping as a tool to determine cellular identity is not as reliable as generally assumed, especially since human adult dermal fibroblasts may be mistaken for neural cells, indicating that the ultimate proof of glial or neuronal identity can only be provided by their functionality.	[Janmaat, C. J.; Locher, H.; de Groot, S. C.; de Groot, J. C. M. J.; Frijns, J. H. M.; Huisman, M. A.] Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, Netherlands; [de Rooij, K. E.] Percuros BV, Enschede, Netherlands; [de Rooij, K. E.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Janmaat, CJ (corresponding author), Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, Netherlands.	C.J.Janmaat@lumc.nl	Locher, Heiko/C-8481-2013; Frijns, Johan H.M./H-6249-2011	Locher, Heiko/0000-0002-4174-0270; Frijns, Johan H.M./0000-0002-1180-3314	Stichting Het Heinsius-Houbolt Fonds	Stichting Het Heinsius-Houbolt Fonds	We thank T. Schomann, C. van der Ploeg and C. Out for technical support. H. Locher was supported by Stichting Het Heinsius-Houbolt Fonds.	Azzimonti B, 2009, VIROLOGY, V388, P260, DOI 10.1016/j.virol.2009.03.033; Bainbridge P, 2013, J WOUND CARE, V22, P407; Bianco P, 2013, EMBO J, V32, P1489, DOI 10.1038/emboj.2013.114; CACCAMO DV, 1989, ACTA NEUROPATHOL, V79, P248, DOI 10.1007/BF00294658; Chakravarty G, 2011, EXP BIOL MED, V236, P145, DOI 10.1258/ebm.2010.010086; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Dupin E, 2012, DEV BIOL, V366, P83, DOI 10.1016/j.ydbio.2012.02.035; Fanjul M, 2010, J HISTOCHEM CYTOCHEM, V58, P807, DOI 10.1369/jhc.2010.955807; Gasca S, 2002, P NATL ACAD SCI USA, V99, P11199, DOI 10.1073/pnas.172383099; Goodpaster T, 2008, J HISTOCHEM CYTOCHEM, V56, P347, DOI 10.1369/jhc.7A7287.2007; Grigoriadis N, 2011, EXP NEUROL, V230, P78, DOI 10.1016/j.expneurol.2011.02.021; HAYNES BF, 1984, J EXP MED, V159, P1149, DOI 10.1084/jem.159.4.1149; Hematti P, 2012, CYTOTHERAPY, V14, P516, DOI 10.3109/14653249.2012.677822; Jessen KR, 2002, J ANAT, V200, P367, DOI 10.1046/j.1469-7580.2002.00046.x; Jouhilahti EM, 2008, J HISTOCHEM CYTOCHEM, V56, P1113, DOI 10.1369/jhc.2008.952002; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Kisselbach L, 2009, CYTOTECHNOLOGY, V59, P31, DOI 10.1007/s10616-009-9190-3; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Locher H, 2013, DIFFERENTIATION, V85, P173, DOI 10.1016/j.diff.2013.05.003; Mladinic M, 2014, STEM CELL RES, V12, P815, DOI 10.1016/j.scr.2014.03.006; Nakatani K, 2006, ARCH HISTOL CYTOL, V69, P61, DOI 10.1679/aohc.69.61; Ng Tsz Kin, 2014, World J Stem Cells, V6, P111, DOI 10.4252/wjsc.v6.i2.111; Pereira MCL, 2011, STEM CELL REV REP, V7, P1006, DOI 10.1007/s12015-011-9256-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Plotnikov SV, 2013, CURR OPIN CELL BIOL, V25, P619, DOI 10.1016/j.ceb.2013.06.003; Rehberg S, 2002, MOL CELL BIOL, V22, P5826, DOI 10.1128/MCB.22.16.5826-5834.2002; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; Sensenbrenner M, 1997, J MOL MED-JMM, V75, P653, DOI 10.1007/s001090050149; Shiras A, 2001, IN VITRO CELL DEV-AN, V37, P172; Sieber-Blum Maya, 2004, Birth Defects Res C Embryo Today, V72, P162, DOI 10.1002/bdrc.20008; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Stoll SW, 2012, J INVEST DERMATOL, V132, P2148, DOI 10.1038/jid.2012.78; Takenouchi T, 2010, CELL BIOL INT REP, V17; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vento P, 1999, J HISTOCHEM CYTOCHEM, V47, P1405, DOI 10.1177/002215549904701107; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zimmermann T, 2001, ARTHRITIS RES, V3, P72, DOI 10.1186/ar142	38	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145235	10.1371/journal.pone.0145235	http://dx.doi.org/10.1371/journal.pone.0145235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678612	Green Published, gold, Green Submitted			2022-12-27	WOS:000366723400062
J	Sloka, S; Zhornitsky, S; Silva, C; Metz, LM; Yong, VW				Sloka, Scott; Zhornitsky, Simon; Silva, Claudia; Metz, Luanne M.; Yong, V. Wee			1,25-Dihydroxyvitamin D-3 Protects against Immune-Mediated Killing of Neurons in Culture and in Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							VITAMIN-D HORMONE; MULTIPLE-SCLEROSIS; IN-VIVO; ENVIRONMENTAL-FACTORS; GLATIRAMER ACETATE; RISK-FACTORS; BRAIN; MODEL; MS; NEUROPROTECTION	Several studies have reported that low vitamin D levels are associated with an increased risk of developing multiple sclerosis (MS). As MS is an inflammatory disorder with degeneration of axons and neurons, we examined whether the biologically active form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25D3), could protect against the T cell-mediated killing of human neurons in culture, and the axonal loss seen in mice with experimental autoimmune encephalomyelitis (EAE). Human neurons were exposed to activated human T lymphocytes and the loss of neurons was documented 24 hours later by counting the number of microtubule-associated protein-2 positive cells. Mice with EAE were harvested for counts of axonal profiles in the spinal cord. 1,25D3 was exposed to T cells in culture or administered to mice from peak EAE clinical severity when axonal loss was already evolving. Activated T lymphocytes killed human neurons prominently within 24 hours but toxicity was significantly attenuated when T cells were exposed to 1,25D3 prior to the co-culture. In EAE, 1,25D3 treatment initiated from peak clinical severity reduced the extent of clinical disability and mitigated the progressive loss of axons. The reduction of axonal and neuronal loss by 1,25D3 in the context of an inflammatory assault to the central nervous system is a potential contributor to the putative benefits of vitamin D in MS.	[Sloka, Scott] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada	University of Calgary; University of Calgary	Yong, VW (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	vyong@ucalgary.ca		Yong, V. Wee/0000-0002-2600-3563	NeuroScience Canada Brain Repair program; Multiple Sclerosis Scientific Research Foundation; Canadian Institutes of Health Research; Alberta Innovates [201300669] Funding Source: researchfish	NeuroScience Canada Brain Repair program; Multiple Sclerosis Scientific Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This work was funded by operating grants from the NeuroScience Canada Brain Repair program, the Multiple Sclerosis Scientific Research Foundation, and the Canadian Institutes of Health Research (VWY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by operating grants from the NeuroScience Canada Brain Repair program, the Multiple Sclerosis Scientific Research Foundation, and the Canadian Institutes of Health Research.	ACHESON E. D., 1960, ACTA PSYCHIATR ET NEUROL SCAND SUPPL, V35, P132, DOI 10.1111/j.1600-0447.1960.tb08674.x; Ascherio A, 2008, SEMIN NEUROL, V28, P17, DOI 10.1055/s-2007-1019126; Atif F, 2013, NEUROPHARMACOLOGY, V67, P78, DOI 10.1016/j.neuropharm.2012.10.004; Beretich BD, 2009, MULT SCLER J, V15, P891, DOI 10.1177/1352458509105579; Brewer LD, 2001, J NEUROSCI, V21, P98, DOI 10.1523/JNEUROSCI.21-01-00098.2001; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Duan SR, 2014, NEUROSCI LETT, V570, P108, DOI 10.1016/j.neulet.2014.04.021; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Farias AS, 2013, CNS NEUROSCI THER, V19, P269, DOI 10.1111/cns.12071; GASCONBARRE M, 1983, AM J PHYSIOL, V244, pE266, DOI 10.1152/ajpendo.1983.244.3.E266; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Girolamo F, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0084-z; Giuliani F, 2005, J NEUROIMMUNOL, V158, P213, DOI 10.1016/j.jneuroim.2004.09.006; Giuliani F, 2003, J IMMUNOL, V171, P368, DOI 10.4049/jimmunol.171.1.368; Jang W, 2014, BIOCHEM BIOPH RES CO, V451, P142, DOI 10.1016/j.bbrc.2014.07.081; Koch MW, 2013, J NEUROL SCI, V324, P10, DOI 10.1016/j.jns.2012.10.021; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; Makar TK, 2008, J NEUROL SCI, V270, P70, DOI 10.1016/j.jns.2008.02.011; Marrie RA, 2004, LANCET NEUROL, V3, P709, DOI 10.1016/S1474-4422(04)00933-0; Methner A, 2013, NAT REV NEUROL, V9, P72, DOI 10.1038/nrneurol.2012.277; Mishra MK, 2014, ANN CLIN TRANSL NEUR, V1, P409, DOI 10.1002/acn3.67; Nystad AE, 2014, APMIS, V122, P1178, DOI 10.1111/apm.12281; PARDRIDGE WM, 1985, J NEUROCHEM, V44, P1138, DOI 10.1111/j.1471-4159.1985.tb08735.x; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Shirazi HA, 2015, EXP MOL PATHOL, V98, P240, DOI 10.1016/j.yexmp.2015.02.004; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Skihar V, 2009, P NATL ACAD SCI USA, V106, P17992, DOI 10.1073/pnas.0909607106; Sloka S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-56; Sloka S, 2011, CAN J NEUROL SCI, V38, P98, DOI 10.1017/S0317167100011124; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Wergeland S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026262	33	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144084	10.1371/journal.pone.0144084	http://dx.doi.org/10.1371/journal.pone.0144084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679341	Green Submitted, Green Published, gold			2022-12-27	WOS:000366723400007
J	Martens, J; Daly, D; Deschamps, K; Fernandes, RJP; Staes, F				Martens, Jonas; Daly, Daniel; Deschamps, Kevin; Pinto Fernandes, Ricardo Jorge; Staes, Filip			Intra-Individual Variability of Surface Electromyography in Front Crawl Swimming	PLOS ONE			English	Article							INTERINDIVIDUAL VARIABILITY; NORMALIZATION METHODS; EMG; GAIT; PERFORMANCE; REPEATABILITY; MOVEMENTS; SHOULDER; PATTERNS; CHILDREN	The variability of electromyographic (EMG) recordings between and within participants is a complex problem, rarely studied in swimming. The importance of signal normalization has long been recognized, but the method used might influence variability. The aims of this study were to: (i) assess the intra-individual variability of the EMG signal in highly skilled front crawl swimmers, (ii) determine the influence of two methods of both amplitude and time normalization of the EMG signal on intra-individual variability and of time normalization on muscle activity level and (iii) describe the muscle activity, normalized using MVIC, in relation to upper limb crawl stroke movements. Muscle activity of rectus abdominis and deltoideus medialis was recorded using wireless surface EMG in 15 adult male competitive swimmers during three trials of 12.5 m front crawl at maximal speed without breathing. Two full upper limb cycles were analyzed from each of the swimming trials, resulting in six full cycles used for the intra-individual variability assessment, quantified with the coefficient of variation (CV), coefficient of quartile variation (CQV) and the variance ratio (VR). The results of this study support previous findings on EMG patterns of deltoideus medialis and rectus abdominis as prime mover during the recovery (45% activity relative to MVIC), and stabilizer of the trunk during the pull (14.5% activity) respectively. The intra-individual variability was lower (VR of 0.34-0.47) when compared to other cyclic movements. No meaningful differences were found between variability measures CV or VR when applying either of the amplitude or the time normalization methods. In addition to reporting the mean amplitude and standard deviation, future EMG studies in swimming should also report the intra-individual variability, preferably using VR as it is independent of peak amplitude, provides a good measure of repeatability and is insensitive to mean EMG amplitude and the degree of smoothing applied.	[Martens, Jonas; Daly, Daniel] Katholieke Univ Leuven, Dept Kinesiol, Leuven, Belgium; [Deschamps, Kevin; Staes, Filip] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Pinto Fernandes, Ricardo Jorge] Univ Porto, Ctr Res Educ Innovat & Intervent Sport, Fac Sport, P-4100 Oporto, Portugal	KU Leuven; KU Leuven; Universidade do Porto	Martens, J (corresponding author), Katholieke Univ Leuven, Dept Kinesiol, Leuven, Belgium.	Jonas.Martens@faber.kuleuven.be	Fernandes, Ricardo J./A-1040-2012	Fernandes, Ricardo J./0000-0002-5811-0443; Staes, Filip/0000-0002-1569-6333				Albertus-Kajee Y, 2010, J ELECTROMYOGR KINES, V20, P1036, DOI 10.1016/j.jelekin.2010.07.011; Ball N, 2013, J APPL BIOMECH, V29, P600, DOI 10.1123/jab.29.5.600; Barthels KM, 1971, 1 INT S BIOM SWIMM W, P105; Ben Kibler W, 2006, SPORTS MED, V36, P189, DOI 10.2165/00007256-200636030-00001; Bolgla LA, 2007, J ELECTROMYOGR KINES, V17, P102, DOI 10.1016/j.jelekin.2005.11.007; Bonett DG, 2006, BIOMETRICAL J, V48, P144, DOI 10.1002/bimj.200410148; Burden A, 2010, J ELECTROMYOGR KINES, V20, P1023, DOI 10.1016/j.jelekin.2010.07.004; Burden AM, 2003, J ELECTROMYOGR KINES, V13, P519, DOI 10.1016/S1050-6411(03)00082-8; Clarys Jan Pieter, 1993, Journal of Sports Sciences, V11, P379, DOI 10.1080/02640419308730010; CLARYS JP, 1985, APPL ERGON, V16, P11, DOI 10.1016/0003-6870(85)90143-7; Clarys JP, 2000, ERGONOMICS, V43, P1750, DOI 10.1080/001401300750004159; Clarys JP, 2011, WORLD BOOK SWIMMING, P43; Cram J, 1998, INTRO SURFACE ELECTR; GABEL RH, 1994, ELECTROEN CLIN NEURO, V93, P188, DOI 10.1016/0168-5597(94)90040-X; Granata KP, 2005, GAIT POSTURE, V22, P346, DOI 10.1016/j.gaitpost.2004.11.014; Guidetti L, 1996, J ELECTROMYOGR KINES, V6, P37, DOI 10.1016/1050-6411(95)00015-1; Hermens H.J.M.R.F.B., 1999, SENIAM EUROPEAN RECO; HERSHLER C, 1978, IEEE T BIO-MED ENG, V25, P413, DOI 10.1109/TBME.1978.326338; Hibbs AE, 2008, SPORTS MED, V38, P995, DOI 10.2165/00007256-200838120-00004; Hislop H.J., 2007, DANIELS WORTHINGHAMS; Hug F, 2008, EUR J APPL PHYSIOL, V104, P667, DOI 10.1007/s00421-008-0810-y; Hug F, 2009, J ELECTROMYOGR KINES, V19, P182, DOI 10.1016/j.jelekin.2007.10.010; KADABA MP, 1985, J ORTHOPAED RES, V3, P350, DOI 10.1002/jor.1100030312; Kamen G, 2010, ESSENTIALS ELECTROMY; KNUTSON LM, 1994, J ELECTROMYOGR KINES, V4, P47, DOI 10.1016/1050-6411(94)90026-4; Lewillie L., 1976, P 5 INT C BIOM, P230; Lewillie L, 1974, BIOMECHANICS, P203; Martens J, 2014, OPEN SLEEP J, V7, P1; Martens J, 2015, J ELECTROMYOGR KINES, V25, P273, DOI 10.1016/j.jelekin.2014.12.003; McLeod I., 2010, SWIMMING ANATOMY; Monteil KM, 1992, SWIMMING SCI, VVI, P99; Persyn U, 1974, TECHNISCH HYDRODYNAM; Piette G., 1979, SWIMMING, P153; PINK M, 1991, AM J SPORT MED, V19, P569, DOI 10.1177/036354659101900603; ROUARD AH, 1995, J ELECTROMYOGR KINES, V5, P177, DOI 10.1016/1050-6411(95)00008-N; ROUARD AH, 1990, INT J SPORTS MED, V11, P150, DOI 10.1055/s-2007-1024781; Rouffet DM, 2008, J ELECTROMYOGR KINES, V18, P866, DOI 10.1016/j.jelekin.2007.03.008; Tirosh O, 2013, J ELECTROMYOGR KINES, V23, P1451, DOI 10.1016/j.jelekin.2013.06.002; Winter D., 2009, BIOMECHANICS MOTOR C, V4th	39	25	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144998	10.1371/journal.pone.0144998	http://dx.doi.org/10.1371/journal.pone.0144998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673163	gold, Green Submitted, Green Published			2022-12-27	WOS:000366722700084
J	Perpetuo, IP; Raposeiro, R; Caetano-Lopes, J; Vieira-Sousa, E; Campanilho-Marques, R; Ponte, C; Canhao, H; Ainola, M; Fonseca, JE				Perpetuo, Ines P.; Raposeiro, Rita; Caetano-Lopes, Joana; Vieira-Sousa, Elsa; Campanilho-Marques, Raquel; Ponte, Cristina; Canhao, Helena; Ainola, Mari; Fonseca, Joao E.			Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Ankylosing Spondylitis	PLOS ONE			English	Article							BONE-MINERAL DENSITY; RHEUMATOID-ARTHRITIS; L-SELECTIN; RADIOGRAPHIC PROGRESSION; RECEPTOR ACTIVATOR; UP-REGULATION; DIFFERENTIATION; INFLAMMATION; NEUTROPHIL; BIOMARKERS	Introduction Ankylosing Spondylitis (AS) is characterized by excessive local bone formation and concomitant systemic bone loss. Tumor necrosis factor (TNF) plays a central role in the inflammation of axial skeleton and enthesis of AS patients. Despite reduction of inflammation and systemic bone loss, AS patients treated with TNF inhibitors (TNFi) have ongoing local bone formation. The aim of this study was to assess the effect of TNFi in the differentiation and activity of osteoclasts (OC) in AS patients. Methods 13 AS patients treated with TNFi were analyzed at baseline and after a minimum follow-up period of 6 months. 25 healthy donors were recruited as controls. Blood samples were collected to assess receptor activator of nuclear factor kappa-B ligand (RANKL) surface expression on circulating leukocytes and frequency and phenotype of monocyte subpopulations. Quantification of serum levels of bone turnover markers and cytokines, in vitro OC differentiation assay and qRT-PCR for OC specific genes were performed. Results RANKL(+) circulating lymphocytes (B and T cells) and IL-17A, IL-23 and TGF-beta levels were decreased after TNFi treatment. We found no differences in the frequency of the different monocyte subpopulations, however, we found decreased expression of CCR2 and increased expression of CD62L after TNFi treatment. OC number was reduced in patients at baseline when compared to controls. OC specific gene expression was reduced in circulating OC precursors after TNFi treatment. However, when cultured in OC differentiating conditions, OC precursors from AS TNFi-treated patients showed increased activity as compared to baseline. Conclusion In AS patients, TNFi treatment reduces systemic pro osteoclastogenic stimuli. However, OC precursors from AS patients exposed to TNFi therapy have increased in vitro activity in response to osteoclastogenic stimuli.	[Perpetuo, Ines P.; Raposeiro, Rita; Caetano-Lopes, Joana; Vieira-Sousa, Elsa; Campanilho-Marques, Raquel; Ponte, Cristina; Canhao, Helena; Fonseca, Joao E.] Univ Lisbon, Lisbon Acad Med Ctr, Inst Med Mol, Rheumatol Res Unit,Fac Med, P-1699 Lisbon, Portugal; [Vieira-Sousa, Elsa; Campanilho-Marques, Raquel; Ponte, Cristina; Canhao, Helena; Fonseca, Joao E.] Ctr Hosp Lisboa Norte, Rheumatol & Bone Metab Dis Dept, Lisbon Acad Med Ctr, Hosp Santa Maria,EPE, Lisbon, Portugal; [Ainola, Mari] Univ Helsinki, Musculoskeletal Dis & Inflammat Res Grp, Biomedicum Helsinki, Fac Med,Inst Clin Med, Helsinki, Finland	Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; University of Helsinki	Perpetuo, IP (corresponding author), Univ Lisbon, Lisbon Acad Med Ctr, Inst Med Mol, Rheumatol Res Unit,Fac Med, P-1699 Lisbon, Portugal.	ines.perpetuo@gmail.com	Ponte, Cristina/AEU-0624-2022; Caetano-Lopes, Joana/J-9345-2012; IP, Perpétuo/F-3643-2011; Canhao, Helena/C-9611-2018; Ainola, Mari-Mia/T-8035-2017	Ponte, Cristina/0000-0002-3989-1192; Caetano-Lopes, Joana/0000-0003-0310-4641; IP, Perpétuo/0000-0001-7671-2539; Canhao, Helena/0000-0003-1894-4870; Ainola, Mari-Mia/0000-0003-2853-5851; Vieira de Sousa, Elsa Cristina/0000-0002-7170-8802	Fundacao para a Ciencia e Tecnologia [SFRH/BD/70533/2010]; Investigator-Initiated Studies Program of Merck Sharp Dohme Corp	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Investigator-Initiated Studies Program of Merck Sharp Dohme Corp	This work was supported by Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/index.phtml.en) PhD grant (SFRH/BD/70533/2010) and in part by a research grant from Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp (http://www.merck.com/index.html-Merck_P08574). The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck Sharp & Dohme Corp. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Appel H, 2009, CLIN EXP RHEUMATOL, V27, pS15; ARNETT TR, 1987, ENDOCRINOLOGY, V120, P602, DOI 10.1210/endo-120-2-602; BARBIERI P, 1990, ANN RHEUM DIS, V49, P396, DOI 10.1136/ard.49.6.396; BIASI D, 1995, CLIN EXP RHEUMATOL, V13, P623; Boissy P, 2002, ENDOCRINOLOGY, V143, P1913, DOI 10.1210/en.143.5.1913; Caetano-Lopes J, 2014, CLIN REV ALLERG IMMU, V47, P38, DOI 10.1007/s12016-013-8366-y; CALIN A, 1994, J RHEUMATOL, V21, P2281; Carmona-Fernandes D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3500; Cascao R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3168; Chen CH, 2010, CLIN RHEUMATOL, V29, P1155, DOI 10.1007/s10067-010-1543-y; Corr M, 2014, CLIN RHEUMATOL, V33, P759, DOI 10.1007/s10067-014-2663-6; El Maghraoui A, 2004, JOINT BONE SPINE, V71, P291, DOI 10.1016/j.jbspin.2003.06.002; Faccio R, 2003, J CLIN INVEST, V111, P749, DOI 10.1172/JCI200316924; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Haroon NN, 2014, SEMIN ARTHRITIS RHEU, V44, P155, DOI 10.1016/j.semarthrit.2014.05.008; Husheem M, 2005, CALCIFIED TISSUE INT, V76, P222, DOI 10.1007/s00223-004-0123-z; Hwang ST, 1996, J EXP MED, V184, P1343, DOI 10.1084/jem.184.4.1343; Jung YK, 2012, J BONE MINER RES, V27, P2024, DOI 10.1002/jbmr.1632; Kang KY, 2013, RHEUMATOLOGY, V52, P718, DOI 10.1093/rheumatology/kes364; Kim MS, 2005, J BIOL CHEM, V280, P16163, DOI 10.1074/jbc.M412713200; Klingberg E, 2014, J RHEUMATOL, V41, P1349, DOI 10.3899/jrheum.131199; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; KURIHARA N, 1989, BLOOD, V74, P1295; Lees RL, 1999, J BONE MINER RES, V14, P937, DOI 10.1359/jbmr.1999.14.6.937; Limon-Camacho L, 2012, J RHEUMATOL, V39, P830, DOI 10.3899/jrheum.110862; Machado P, 2011, ANN RHEUM DIS, V70, P47, DOI 10.1136/ard.2010.138594; Mader TL, 2014, CALCIFIED TISSUE INT, V95, P457, DOI 10.1007/s00223-014-9914-z; Maksymowych WP, 2015, ANN RHEUM DIS, V74, P123, DOI 10.1136/annrheumdis-2015-eular.6285; Maxwell LJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005468.pub2; Mei Y, 2011, CLIN RHEUMATOL, V30, P269, DOI 10.1007/s10067-010-1647-4; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; OSIER LK, 1987, BONE MINER, V3, P35; Pedersen SJ, 2011, J RHEUMATOL, V38, P1349, DOI 10.3899/jrheum.100925; Pedersen SJ, 2011, ARTHRITIS RHEUM-US, V63, P3789, DOI 10.1002/art.30627; PIPER K, 1992, ANAT EMBRYOL, V186, P291; Schett G, 2005, NAT CLIN PRACT RHEUM, V1, P47, DOI 10.1038/ncprheum0036; SIMON SI, 1995, J IMMUNOL, V155, P1502; Singh HJ, 2013, J CLIN DIAGN RES, V7, P2832, DOI 10.7860/JCDR/2013/6779.3770; Siu S, 2014, ARTHRITIS CARE RES; Stupphann D, 2008, RHEUMATOL INT, V28, P987, DOI 10.1007/s00296-008-0567-y; Surdacki A, 2014, J RHEUMATOL, V41, P481, DOI 10.3899/jrheum.130803; Taylan A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-191; Ustun N, 2014, ACTA REUMATOL PORT, V39, P146; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Wright C, 2009, ANN RHEUM DIS, V68, P1626, DOI 10.1136/ard.2008.097204; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	49	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144655	10.1371/journal.pone.0144655	http://dx.doi.org/10.1371/journal.pone.0144655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674064	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700051
J	Tveitaras, MK; Skogstrand, T; Leh, S; Helle, F; Iversen, BM; Chatziantoniou, C; Reed, RK; Hultstrom, M				Tveitaras, Maria K.; Skogstrand, Trude; Leh, Sabine; Helle, Frank; Iversen, Bjarne M.; Chatziantoniou, Christos; Reed, Rolf K.; Hultstrom, Michael			Matrix Metalloproteinase-2 Knockout and Heterozygote Mice Are Protected from Hydronephrosis and Kidney Fibrosis after Unilateral Ureteral Obstruction	PLOS ONE			English	Article							RENAL INTERSTITIAL FIBROSIS; GROWTH; STAGE; INJURY; MATRIX-METALLOPROTEINASE-9; INHIBITION; SECRETION; ISCHEMIA; CLEAVAGE; PROTEIN	Matrix Metalloproteinase-2 (Mmp2) is a collagenase known to be important in the development of renal fibrosis. In unilateral ureteral obstruction (UUO) the obstructed kidney (OK) develops fibrosis, while the contralateral (CL) does not. In this study we investigated the effect of UUO on gene expression, fibrosis and pelvic remodeling in the kidneys of Mmp2 deficient mice (Mmp2-/-), heterozygous animals (Mmp2+/-) and wild-type mice (Mmp2+/+). Sham operated animals served as controls (Cntrl). UUO was prepared under isoflurane anaesthesia, and the animals were sacrificed after one week. UUO caused hydronephrosis, dilation of renal tubules, loss of parenchymal thickness, and fibrosis. Damage was most severe in Mmp2+/+ mice, while both Mmp2-/- and Mmp2+/- groups showed considerably milder hydronephrosis, no tubular necrosis, and less tubular dilation. Picrosirius red quantification of fibrous collagen showed 1.63 +/- 0.25% positivity in OK and 0.29 +/- 0.11% in CL (p<0.05) of Mmp2+/+, Mmp2-/- OK and Mmp2-/- CL exhibited only 0.49 +/- 0.09% and 0.23 +/- 0.04% (p<0.05) positivity, respectively. Mmp2+/- OK and Mmp2+/- CL showed 0.43 +/- 0.09% and 0.22 +/- 0.06% (p<0.05) positivity, respectively. Transcriptomic analysis showed that 26 genes (out of 48 examined) were differentially expressed by ANOVA (p<0.05). 25 genes were upregulated in Mmp2+/+ OK compared to Mmp2+/+ CL: Adamts1, -2, Col1a1, -2, -3a1, -4a1, -5a1, -5a2, Dcn, Fbln1, -5, Fmod, Fn1, Itga2, Loxl1, Mgp, Mmp2, -3, Nid1, Pdgfb, Spp1, Tgfb1, Timp2, Trf, Vim. In Mmp2-/- and Mmp2+/- 18 and 12 genes were expressed differentially between OK and CL, respectively. Only Mmp2 was differentially regulated when comparing Mmp2-/- OK and Mmp2+/- OK. Under stress, it appears that Mmp2+/- OK responds with less Mmp2 upregulation than Mmp2+/+ OK, suggesting that there is a threshold level of Mmp2 necessary for damage and fibrosis to occur. In	[Tveitaras, Maria K.; Skogstrand, Trude; Reed, Rolf K.; Hultstrom, Michael] Univ Bergen, Dept Biomed, Bergen, Norway; [Tveitaras, Maria K.; Skogstrand, Trude; Leh, Sabine; Helle, Frank; Iversen, Bjarne M.; Hultstrom, Michael] Univ Bergen, Dept Clin Med, Bergen, Norway; [Skogstrand, Trude] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Leh, Sabine] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Chatziantoniou, Christos] Univ Paris 06, INSERM, UMR 702, Paris, France; [Reed, Rolf K.] Univ Bergen, Ctr Canc Biomarkers, CCBIO, Bergen, Norway; [Hultstrom, Michael] Uppsala Univ, Dept Med Cellbiol, Uppsala, Sweden; [Hultstrom, Michael] Uppsala Univ, Dept Surg Sci, Anaesthesiol & Intens Care Med, Uppsala, Sweden	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Bergen; Uppsala University; Uppsala University	Hultstrom, M (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	michael.hultstrom@mcb.uu.se	Leh, Sabine/E-6053-2011; Hultström, Michael/H-3642-2019; Reed, Rolf K./B-9422-2017; Chatziantoniou, Christos/L-2501-2016	Leh, Sabine/0000-0002-0764-2941; Hultström, Michael/0000-0003-4675-1099; Reed, Rolf K./0000-0002-2633-6595; 	Western Health Authority of Norway (Helse Vest) [911685]; Swedish Society For Medical Research (SSMF); Western Health Authority of Norway (Helse Vest)	Western Health Authority of Norway (Helse Vest); Swedish Society For Medical Research (SSMF); Western Health Authority of Norway (Helse Vest)	The study was supported by the Western Health Authority of Norway (Helse Vest) (project no: 911685) www.helsevest.no, and the Swedish Society For Medical Research (SSMF) www.ssmf.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by the Western Health Authority of Norway (Helse Vest), and the Swedish Society for Medical Research (SSMF).	AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Chade Alejandro R, 2012, F1000 Med Rep, V4, P1, DOI 10.3410/M4-1; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Du TY, 2013, PLOS ONE, V8; Du XY, 2012, LAB INVEST, V92, P1149, DOI 10.1038/labinvest.2012.68; Eitner F, 2008, J AM SOC NEPHROL, V19, P281, DOI 10.1681/ASN.2007030290; Fernandez-Patron C, 1999, CIRC RES, V85, P906; Flamant M, 2007, HYPERTENSION, V50, P212, DOI 10.1161/HYPERTENSIONAHA.107.089631; Goulter AB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-34; Hamdi A, 2012, BJU INT, V110, pE1027, DOI 10.1111/j.1464-410X.2012.11193.x; Heikkila J, 2011, J UROLOGY, V186, P2392, DOI 10.1016/j.juro.2011.07.109; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Hultstrom M, 2008, NEPHROL DIAL TRANSPL, V23, P896, DOI 10.1093/ndt/gfm710; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kaneko T, 2012, NEPHRON EXP NEPHROL, V122, P23, DOI 10.1159/000346569; Kim HS, 2001, J AM SOC NEPHROL, V12, P736, DOI 10.1681/ASN.V124736; Kishioka H, 2001, AM J HYPERTENS, V14, P439, DOI 10.1016/S0895-7061(00)01290-5; Kunugi S, 2011, LAB INVEST, V91, P170, DOI 10.1038/labinvest.2010.174; LeBleu VS, 2013, NAT MED, V19, P227, DOI 10.1038/nm.2989; Ledbetter S, 2000, KIDNEY INT, V58, P2367, DOI 10.1046/j.1523-1755.2000.00420.x; Martin IV, 2013, AM J PATHOL, V182, P107, DOI 10.1016/j.ajpath.2012.09.006; Martinez A, 2004, BIOCHEM J, V383, P413, DOI 10.1042/BJ20040920; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; Nishida M, 2007, BIOCHEM BIOPH RES CO, V354, P133, DOI 10.1016/j.bbrc.2006.12.165; Ohno-Matsui K, 2003, INVEST OPHTH VIS SCI, V44, P5370, DOI 10.1167/iovs.03-0249; Ostendorf T, 2014, KIDNEY INT SUPPL, V4, P65, DOI 10.1038/kisup.2014.12; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Skogstrand T, 2013, J HYPERTENS, V31, P152, DOI 10.1097/HJH.0b013e32835a5d4e; Suofu Y, 2012, NEUROSCIENCE, V212, P180, DOI 10.1016/j.neuroscience.2012.03.036; Takamiya Y, 2013, NEPHROL DIAL TRANSPL, V28, P55, DOI 10.1093/ndt/gfs387; Tan TK, 2013, LAB INVEST, V93, P434, DOI 10.1038/labinvest.2013.3; Tang WW, 1996, AM J PATHOL, V148, P1169; Tveitaras MK S T, 2012, FASEB J, V26, p[868, 812]; Vesey DA, 2002, J LAB CLIN MED, V140, P342, DOI 10.1067/mlc.2002.128468; Wang XH, 2010, AM J PHYSIOL-RENAL, V299, pF973, DOI 10.1152/ajprenal.00216.2010; Wang ZC, 2014, KIDNEY INT, V85, P82, DOI 10.1038/ki.2013.225; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100	39	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143390	10.1371/journal.pone.0143390	http://dx.doi.org/10.1371/journal.pone.0143390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673451	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700009
J	Cumming, TB; Churilov, L; Sena, ES				Cumming, Toby B.; Churilov, Leonid; Sena, Emily S.			The Missing Medians: Exclusion of Ordinal Data from Meta-Analyses	PLOS ONE			English	Article							GENERALIZED ODDS RATIOS; MINI-MENTAL-STATE; EFFECT SIZE; MULTIPLE-SCLEROSIS; CLINICAL-TRIALS; DISEASE; SCALE; STROKE	Background Meta-analyses are considered the gold standard of evidence-based health care, and are used to guide clinical decisions and health policy. A major limitation of current meta-analysis techniques is their inability to pool ordinal data. Our objectives were to determine the extent of this problem in the context of neurological rating scales and to provide a solution. Methods Using an existing database of clinical trials of oral neuroprotective therapies, we identified the 6 most commonly used clinical rating scales and recorded how data from these scales were reported and analysed. We then identified systematic reviews of studies that used these scales (via the Cochrane database) and recorded the meta-analytic techniques used. Finally, we identified a statistical technique for calculating a common language effect size measure for ordinal data. Results We identified 103 studies, with 128 instances of the 6 clinical scales being reported. The majority-80%-reported means alone for central tendency, with only 13% reporting medians. In analysis, 40% of studies used parametric statistics alone, 34% of studies employed non-parametric analysis, and 26% did not include or specify analysis. Of the 60 systematic reviews identified that included meta-analysis, 88% used mean difference and 22% employed difference in proportions; none included rank-based analysis. We propose the use of a rank-based generalised odds ratio (WMW GenOR) as an assumption-free effect size measure that is easy to compute and can be readily combined in meta-analysis. Conclusion There is wide scope for improvement in the reporting and analysis of ordinal data in the literature. We hope that adoption of the WMW GenOR will have the dual effect of improving the reporting of data in individual studies while also increasing the inclusivity (and therefore validity) of meta-analyses.	[Cumming, Toby B.; Churilov, Leonid] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Sena, Emily S.] Univ Edinburgh, Ctr Clin Brain Sci, Sch Clin Sci, Edinburgh, Midlothian, Scotland	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Edinburgh	Sena, ES (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Sch Clin Sci, Edinburgh, Midlothian, Scotland.	emily.sena@ed.ac.uk		Sena, Emily S/0000-0002-3282-8502	UK National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) infrastructure award: ivSyRMAF-the CAMARADES-NC3Rs in vivo systematic review and meta-analysis facility [NC/L000970/1]; Research Councils UK	UK National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) infrastructure award: ivSyRMAF-the CAMARADES-NC3Rs in vivo systematic review and meta-analysis facility; Research Councils UK(UK Research & Innovation (UKRI))	TC and LC received no specific funding for this work. ES was supported by the UK National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) infrastructure award: ivSyRMAF-the CAMARADES-NC3Rs in vivo systematic review and meta-analysis facility, grant number NC/L000970/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Emily Sena is supported by funding from Research Councils UK. We thank Mahsa Keshtkaran for assistance with data extraction and Hayden Johns for development of statistical programming.	Agresti A, 1996, BIOMETRICS, V52, P1103, DOI 10.2307/2533072; AGRESTI A, 1980, BIOMETRICS, V36, P59, DOI 10.2307/2530495; [Anonymous], 2011, **NON-TRADITIONAL**; Bath PMW, 2011, INT J STROKE, V6, P472, DOI 10.1111/j.1747-4949.2011.00614.x; Bland M., 2015, INT J STAT MED RES, V4, P57, DOI [10.6000/1929-6029.2015.04.01.6, DOI 10.6000/1929-6029.2015.04.01.6]; Branscum AJ, 2008, BIOMETRICS, V64, P825, DOI 10.1111/j.1541-0420.2007.00946.x; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Churilov L, 2014, INT J STROKE, V9, P999, DOI 10.1111/ijs.12364; Coe R, 2002, ANN C BRIT ED RES AS; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; Cumming TB, 2013, ACTA NEUROL SCAND, V128, P122, DOI 10.1111/ane.12084; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guttman M, 1997, NEUROLOGY, V49, P1060, DOI 10.1212/WNL.49.4.1060; HEDGES LV, 1984, PSYCHOL BULL, V96, P573, DOI 10.1037/0033-2909.96.3.573; HOHOL MJ, 1995, NEUROLOGY, V45, P251, DOI 10.1212/WNL.45.2.251; Hong KS, 2009, STROKE, V40, P3828, DOI 10.1161/STROKEAHA.109.561365; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Kaul S, 2011, ROBUST METAANALYSIS; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; KRAEMER HC, 1982, PSYCHOL BULL, V91, P404, DOI 10.1037/0033-2909.91.2.404; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Mas V, 2008, BMC GENOMICS, V9; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; Mioshi E, 2012, J CLIN NEUROSCI, V19, P552, DOI 10.1016/j.jocn.2011.07.042; Mohs RC, 1997, ALZ DIS ASSOC DIS, V11, pS13; OBrien RG, 2006, 31 ANN SAS US GROUP; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Vesterinen HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117705; WHITEHEAD A, 1994, STAT MED, V13, P2503, DOI 10.1002/sim.4780132313	31	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145580	10.1371/journal.pone.0145580	http://dx.doi.org/10.1371/journal.pone.0145580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26697876	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600100
J	Palem, PPC; Kuriakose, GC; Jayabaskaran, C				Palem, Padmini P. C.; Kuriakose, Gini C.; Jayabaskaran, Chelliah			An Endophytic Fungus, Talaromyces radicus, Isolated from Catharanthus roseus, Produces Vincristine and Vinblastine, Which Induce Apoptotic Cell Death	PLOS ONE			English	Article							ALKALOIDS; TAXOL	Endophytic fungi isolated from Catharanthus roseus were screened for the production of vincristine and vinblastine. Twenty-two endophytic fungi isolated from various tissues of C. roseus were characterized taxonomically by sequence analysis of the internal transcribed spacer (ITS) region of rDNA and grouped into 10 genera: Alternaria, Aspergillus, Chaetomium, Colletotrichum, Dothideomycetes, Eutypella, Eutypa, Flavodon, Fusarium and Talaromyces. The antiproliferative activity of these fungi was assayed in HeLa cells using the MTT assay. The fungal isolates Eutypella sp-CrP14, obtained from stem tissues, and Talaromyces radicus-CrP20, obtained from leaf tissues, showed the strongest antiproliferative activity, with IC50 values of 13.5 mu g/ml and 20 mu g/ml, respectively. All 22 endophytic fungi were screened for the presence of the gene encoding tryptophan decarboxylase (TDC), the key enzyme in the terpenoid indole alkaloid biosynthetic pathway, though this gene could only be amplified from T. radicus-CrP20 (NCBI GenBank accession number KC920846). The production of vincristine and vinblastine by T. radicus-CrP20 was confirmed and optimized in nine different liquid media. Good yields of vincristine (670 mu g/l) in modified M2 medium and of vinblastine (70 mu g/l) in potato dextrose broth medium were obtained. The cytotoxic activity of partially purified fungal vincristine was evaluated in different human cancer cell lines, with HeLa cells showing maximum susceptibility. The apoptosis-inducing activity of vincristine derived from this fungus was established through cell cycle analysis, loss of mitochondrial membrane potential and DNA fragmentation patterns.	[Palem, Padmini P. C.; Kuriakose, Gini C.; Jayabaskaran, Chelliah] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Jayabaskaran, C (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	jbc.biochem.iisc@gmail.com	Anantharaman, Perumal/AAI-4015-2020	Anantharaman, Perumal/0000-0001-6396-9845	Department of Science and Technology (DST), New Delhi, India [SR/WOS-A/LS-407/2011]; Department of Biotechnology (DBT), New Delhi, India; University Grants Commission (UGC), New Delhi, India	Department of Science and Technology (DST), New Delhi, India(Department of Science & Technology (India)); Department of Biotechnology (DBT), New Delhi, India(Department of Biotechnology (DBT) India); University Grants Commission (UGC), New Delhi, India(University Grants Commission, India)	PPCP thanks the Department of Science and Technology (DST), New Delhi, India for providing the grant under Women Scientist Scheme (SR/WOS-A/LS-407/2011). CJB thanks Department of Biotechnology (DBT), New Delhi, India for the financial support under IISc-DBT partnership program. GCK thanks University Grants Commission (UGC), New Delhi, India for the award of Kothari fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aslam J, 2011, ACTA PHYSIOL PLANT, V33, P473, DOI 10.1007/s11738-010-0569-8; Chakravarthi BVSK, 2008, J BIOSCIENCES, V33, P259, DOI 10.1007/s12038-008-0043-6; Chandra S, 2012, APPL MICROBIOL BIOT, V95, P47, DOI 10.1007/s00253-012-4128-7; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; DELUCA V, 1989, P NATL ACAD SCI USA, V86, P2582; DEMAIN AL, 1981, SCIENCE, V214, P987, DOI 10.1126/science.6946560; Eyberger AL, 2006, J NAT PROD, V69, P1121, DOI 10.1021/np060174f; FRAKER PJ, 1995, METHOD CELL BIOL, V46, P57; Gangadevi V., 2008, MYCOL BALC, V5, P1, DOI DOI 10.5281/zenodo.2548403; Gini CK, 2014, PHARM ANAL ACTA, V5, P4; Goklany S, 2009, BIOTECHNOL PROGR, V25, P1289, DOI 10.1002/btpr.204; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; Groninger E, 2002, INT J ONCOL, V21, P1339; HASHIMOTO T, 1994, ANNU REV PLANT PHYS, V45, P257, DOI 10.1146/annurev.pp.45.060194.001353; Ishikawa H, 2009, J AM CHEM SOC, V131, P4904, DOI 10.1021/ja809842b; Jayabaskaran C, 2008, J MOL SIGNAL, V3, P1; Ji YuBin, 2014, Journal of Chemical and Pharmaceutical Research, V6, P338; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Kharwar RN, 2008, CURR SCI INDIA, V95, P228; Kumar A., 2013, INT J BOT, V3, P1; Kumar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064364; Kumaran RS, 2008, ENG LIFE SCI, V8, P438, DOI 10.1002/elsc.200800019; Kusari S, 2011, J NAT PROD, V74, P764, DOI 10.1021/np1008398; Kusari S, 2009, J NAT PROD, V72, P2, DOI 10.1021/np800455b; Lee SB, 1990, PCR PROTOCOLS GUIDE, P280; Momsia T, 2013, INT J LIFE SCI BIOTE, V2, P82; NOBLE RL, 1990, BIOCHEM CELL BIOL, V68, P1344, DOI 10.1139/o90-197; OKAMI Y, 1986, MICROBIAL ECOL, V12, P65, DOI 10.1007/BF02153223; Qui M, 2010, ANN MICROBIOL, V60, P143; Ramani S., 2013, NATURAL PRODUCTS, P575, DOI DOI 10.1007/978-3-642-22144-6_21; Saxton GE, 1994, MONOTERPENOID INDOLE, P715; Shams KA, 2009, AFR J TRADIT COMPLEM, V6, P118; STROBEL G, 1993, MYCOTAXON, V47, P71; Strobel G, 1996, MICROBIOL-UK, V142, P435, DOI 10.1099/13500872-142-2-435; Tanaka Y., 1992, SEARCH BIOACTIVE COM, P303; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Visagie CM, 2012, PERSOONIA, V28, P14, DOI 10.3767/003158512X632455; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wilson D, 2000, BOOK SOIL P, P389; [杨昱志 Yang Yuzhi], 2004, [中草药, Chinese Traditional and Herbal Drugs], V35, P79; Zhang LQ, 2000, CHIN TRADIT HERB DRU, V31, P805; Zhao J, 2011, MINI-REV MED CHEM, V11, P159, DOI 10.2174/138955711794519492	43	47	49	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144476	10.1371/journal.pone.0144476	http://dx.doi.org/10.1371/journal.pone.0144476			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26697875	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000367092600020
J	Chandrasekara, CHWMRB; Wijesundera, WSS; Perera, HN; Chong, SS; Rajan-Babu, IS				Chandrasekara, C. H. W. M. R. Bhagya; Wijesundera, W. S. Sulochana; Perera, Hemamali N.; Chong, Samuel S.; Rajan-Babu, Indhu-Shree			Cascade Screening for Fragile X Syndrome/CGG Repeat Expansions in Children Attending Special Education in Sri Lanka	PLOS ONE			English	Article							CGG REPEAT; FMR1 GENE; MENTAL-RETARDATION; HIGH-RISK; DIAGNOSIS; METHYLATION; MUTATION; DNA; PREVALENCE; FREQUENCY	Fragile X syndrome (FXS) is the commonest cause of inherited mental retardation and clinically presents with learning, emotional and behaviour problems. FXS is caused by expansion of cytosine-guanine-guanine (CGG) repeats present in the 5' untranslated region of the FMR1 gene. The aim of this study was to screen children attending special education institutions in Sri Lanka to estimate the prevalence of CGG repeat expansions. The study population comprised a representative national sample of 850 children (540 males, 310 females) with 5 to 18 years of age from moderate to severe mental retardation of wide ranging aetiology. Screening for CGG repeat expansion was carried out on DNA extracted from buccal cells using 3' direct triplet primed PCR followed by melting curve analysis. To identify the expanded status of screened positive samples, capillary electrophoresis, methylation specific PCR and Southern hybridization were carried out using venous blood samples. Prevalence of CGG repeat expansions was 2.2%. Further classification of the positive samples into FXS full mutation, pre-mutation and grey zone gave prevalence of 1.3%, 0.8% and 0.1% respectively. All positive cases were male. No females with FXS were detected in our study may have been due to the small sample size.	[Chandrasekara, C. H. W. M. R. Bhagya; Wijesundera, W. S. Sulochana] Univ Colombo, Fac Med, Dept Biochem & Mol Biol, Colombo 08, Sri Lanka; [Perera, Hemamali N.] Univ Colombo, Fac Med, Dept Psychol Med, Colombo 08, Sri Lanka; [Chong, Samuel S.; Rajan-Babu, Indhu-Shree] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 119074, Singapore; [Chong, Samuel S.] Natl Univ Hlth Syst, Childrens Med Inst, Khoo Teck Puat Natl Univ, Singapore 119228, Singapore; [Chong, Samuel S.] Natl Univ Singapore Hosp, Dept Lab Med, Singapore 119074, Singapore	University of Colombo; University of Colombo; National University of Singapore; National University of Singapore; National University of Singapore	Chandrasekara, CHWMRB (corresponding author), Univ Colombo, Fac Med, Dept Biochem & Mol Biol, Kynsey Rd, Colombo 08, Sri Lanka.	chmbhagya@gmail.com	Chong, Samuel S./D-8098-2015	Chong, Samuel S./0000-0002-1872-5937; Rajan Babu, Indhu Shree/0000-0002-5614-5212	National Research Council Sri Lanka [12-068]; University of Colombo Sri Lanka [AP/3/2012/CG/11]	National Research Council Sri Lanka; University of Colombo Sri Lanka	This work was supported by the National Research Council Sri Lanka, 12-068, www.nrc.gov.lk/; and the University of Colombo Sri Lanka AP/3/2012/CG/11, www.cmb.ac.lk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalaf M, 2001, MED PRIN PRACT, V10, P73, DOI 10.1159/000050344; Behery AK, 2008, J EGYPT PUBLIC HEAL, V83, P273; Bhagya C H W M R Chandrasekara, 2013, Indian J Hum Genet, V19, P78, DOI 10.4103/0971-6866.112898; Bilgen T, 2005, Indian J Med Sci, V59, P150; Chandrasekara B, 2016, SLJCH IN PRESS, V45; Crawford DC, 1999, AM J HUM GENET, V64, P495, DOI 10.1086/302260; Demirhan O, 2003, YONSEI MED J, V44, P583, DOI 10.3349/ymj.2003.44.4.583; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; FalikZaccai TC, 1997, AM J HUM GENET, V60, P103; Fatima T, 2014, AM J MED GENET A, V164, P1151, DOI 10.1002/ajmg.a.36423; Fernandez-Carvajal I, 2009, J MOL DIAGN, V11, P306, DOI 10.2353/jmoldx.2009.080174; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Godler DE, 2013, HUM MOL GENET, V22, P1516, DOI 10.1093/hmg/ddt002; Godler DE, 2010, HUM MOL GENET, V19, P1618, DOI 10.1093/hmg/ddq037; Grasso M, 2014, J MOL DIAGN, V16, P23, DOI 10.1016/j.jmoldx.2013.09.004; Greydanus Donald E., 2005, Indian Journal of Pediatrics, V72, P859, DOI 10.1007/BF02731116; Hagerman R, 2011, J NEURODEV DISORD, V3, P211, DOI 10.1007/s11689-011-9084-5; Hagerman RJ, 2008, CLIN INTERV AGING, V3, P251, DOI 10.2147/CIA.S1794; HAGERMAN RJ, 1994, AM J MED GENET, V51, P474, DOI 10.1002/ajmg.1320510436; HAGERMAN RJ, 1994, AM J MED GENET, V51, P298, DOI 10.1002/ajmg.1320510404; Handel CM, 2006, WILDLIFE SOC B, V34, P1094, DOI 10.2193/0091-7648(2006)34[1094:UOBSFS]2.0.CO;2; HOFSTEE Y, 1994, AM J MED GENET, V51, P466, DOI 10.1002/ajmg.1320510434; Iqbal MA, 2000, ANN SAUDI MED, V20, P214, DOI 10.5144/0256-4947.2000.214; Kanwal M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122213; Lim GXY, 2015, J MOL DIAGN, V17, P302, DOI 10.1016/j.jmoldx.2014.12.005; Lyons JI, 2015, J MOL DIAGN, V17, P463, DOI 10.1016/j.jmoldx.2015.04.006; Maddalena Anne, 2001, Genetics in Medicine, V3, P200, DOI 10.1097/00125817-200105000-00010; Major T, 2003, J NEUROGENET, V17, P223, DOI 10.1080/714049415; MAVROU A, 1988, AM J MED GENET, V31, P735, DOI 10.1002/ajmg.1320310403; McConkie-Rosell Allyn, 2005, J Genet Couns, V14, P249, DOI 10.1007/s10897-005-4802-x; Merenstein SA, 1996, AM J MED GENET, V64, P388, DOI 10.1002/(SICI)1096-8628(19960809)64:2<388::AID-AJMG31>3.3.CO;2-S; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monaghan KG, 2013, GENET MED, V15, P575, DOI 10.1038/gim.2013.61; NANBA E, 1995, BRAIN DEV-JPN, V17, P317, DOI 10.1016/0387-7604(95)00031-6; Paul R, 2010, NEUROTOXICOLOGY, V31, P399, DOI 10.1016/j.neuro.2010.04.002; Pietrobono R, 2005, HUM MOL GENET, V14, P267, DOI 10.1093/hmg/ddi024; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Seltzer MM, 2012, AM J MED GENET B, V159B, P589, DOI 10.1002/ajmg.b.32065; Sharma D, 2001, GENET EPIDEMIOL, V20, P129, DOI 10.1002/1098-2272(200101)20:1<129::AID-GEPI11>3.0.CO;2-2; Sofocleous C, 2008, IN VIVO, V22, P451; Sullivan SD, 2011, SEMIN REPROD MED, V29, P299, DOI 10.1055/s-0031-1280915; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Teo CRL, 2012, CLIN CHEM, V58, P568, DOI 10.1373/clinchem.2011.174615; Tuncbilek E, 1999, AM J MED GENET, V84, P202, DOI 10.1002/(SICI)1096-8628(19990528)84:3<202::AID-AJMG6>3.0.CO;2-O; Winarni TI, 2012, GENET TEST MOL BIOMA, V16, P162, DOI 10.1089/gtmb.2011.0089; Youings SA, 2000, J MED GENET, V37, P415, DOI 10.1136/jmg.37.6.415; Zhou Y, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012716; Zhou YY, 2006, CLIN CHEM, V52, P1492, DOI 10.1373/clinchem.2006.068593	48	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145537	10.1371/journal.pone.0145537	http://dx.doi.org/10.1371/journal.pone.0145537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694146	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500055
J	Kuessel, L; Husslein, H; Marschalek, J; Brunner, J; Ristl, R; Popow-Kraupp, T; Kiss, H				Kuessel, Lorenz; Husslein, Heinrich; Marschalek, Julian; Brunner, Julia; Ristl, Robin; Popow-Kraupp, Theresia; Kiss, Herbert			Prediction of Maternal Cytomegalovirus Serostatus in Early Pregnancy: A Retrospective Analysis in Western Europe	PLOS ONE			English	Article							TO-MOTHER TRANSMISSION; CONGENITAL-CYTOMEGALOVIRUS; SEXUAL-ACTIVITY; UNITED-STATES; RISK-FACTORS; INFECTION; SEROPREVALENCE; PREVENTION; BIRTH; WOMEN	Background Cytomegalovirus (CMV) is the most prevalent congenital viral infection and thus places an enormous disease burden on newborn infants. Seroprevalence of maternal antibodies to CMV due to CMV exposure prior to pregnancy is currently the most important protective factor against congenital CMV disease. The aim of this study was to identify potential predictors, and to develop and evaluate a risk-predicting model for the maternal CMV serostatus in early pregnancy. Methods Maternal and paternal background information, as well as maternal CMV serostatus in early pregnancy from 882 pregnant women were analyzed. Women were divided into two groups based on their CMV serostatus, and were compared using univariate analysis. To predict serostatus based on epidemiological baseline characteristics, a multiple logistic regression model was calculated using stepwise model selection. Sensitivity and specificity were analyzed using ROC curves. A nomogram based on the model was developed. Results 646 women were CMV seropositive (73.2%), and 236 were seronegative (26.8%). The groups differed significantly with respect to maternal age (p = 0.006), gravidity (p<0.001), parity (p<0.001), use of assisted reproduction techniques (p = 0.018), maternal and paternal migration background (p<0.001), and maternal and paternal education level (p<0.001). ROC evaluation of the selected prediction model revealed an area under the curve of 0.83 (95% CI: 0.8-0.86), yielding sensitivity and specificity values of 0.69 and 0.86, respectively. Conclusion We identified predictors of maternal CMV serostatus in early pregnancy and developed a risk-predicting model based on baseline epidemiological characteristics. Our findings provide easy accessible information that can influence the counseling of pregnant woman in terms of their CMV-associated risk.	[Kuessel, Lorenz; Husslein, Heinrich; Marschalek, Julian; Brunner, Julia; Kiss, Herbert] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Ristl, Robin] Med Univ Vienna, Sect Med Stat, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Popow-Kraupp, Theresia] Med Univ Vienna, Dept Virol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Kiss, H (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria.	herbert.kiss@meduniwien.ac.at		Husslein, Heinrich/0000-0003-0585-7444; Ristl, Robin/0000-0002-4163-9236				Adler SP, 1996, PEDIATR INFECT DIS J, V15, P240, DOI 10.1097/00006454-199603000-00013; Adler SP, 2005, PEDIATR INFECT DIS J, V24, P1105, DOI 10.1097/00006454-200512000-00016; Adler SP, 2004, J PEDIATR-US, V145, P485, DOI 10.1016/j.jpeds.2004.05.041; Adler SP, 2013, CLIN INFECT DIS, V57, pS189, DOI 10.1093/cid/cit585; Bodeus M, 2010, J CLIN VIROL, V47, P201, DOI 10.1016/j.jcv.2009.11.009; Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; Feigin RD., 2009, FEIGIN CHERRYS TXB P, V6th ed.; Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000; Fowler KB, 2006, PEDIATRICS, V118, pE286, DOI 10.1542/peds.2005-1142; Fowler KB, 2003, JAMA-J AM MED ASSOC, V289, P1008, DOI 10.1001/jama.289.8.1008; Fowler KB, 1992, NEW ENGL J MED, V327, P495; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Gratacap-Cavallier B, 1998, EUR J EPIDEMIOL, V14, P147, DOI 10.1023/A:1007450729633; Hecker M, 2004, VOX SANG, V86, P41, DOI 10.1111/j.0042-9007.2004.00388.x; ISTAS AS, 1995, CLIN INFECT DIS, V20, P665, DOI 10.1093/clinids/20.3.665; Kadambari S, 2011, EARLY HUM DEV, V87, P723, DOI 10.1016/j.earlhumdev.2011.08.021; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882; Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337; Ornoy A, 2006, REPROD TOXICOL, V21, P399, DOI 10.1016/j.reprotox.2005.02.002; Pembrey L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081881; Plosa EJ, 2012, AM ACAD PEDIAT, V33, P156, DOI [10.1542/pir.33-4-156, DOI 10.1542/PIR.33-4-156]; Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214; Sheffield JS, 2015, CYTOMEGALOVIRUS INFE; Staras SAS, 2008, SEX TRANSM DIS, V35, P472, DOI 10.1097/OLQ.0b013e3181644b70; Staras SAS, 2008, J CLIN VIROL, V43, P266, DOI 10.1016/j.jcv.2008.07.012; Townsend CL, 2013, CLIN INFECT DIS, V56, P1232, DOI 10.1093/cid/cit018; van der Sande MAB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000492; Vauloup-Fellous C, 2009, J CLIN VIROL, V46, pS49, DOI 10.1016/j.jcv.2009.09.003	33	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145470	10.1371/journal.pone.0145470	http://dx.doi.org/10.1371/journal.pone.0145470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26693714	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092500052
J	Schuldt, NJ; Auger, JL; Hogquist, KA; Binstadt, BA				Schuldt, Nathaniel J.; Auger, Jennifer L.; Hogquist, Kristin A.; Binstadt, Bryce A.			Bi-Allelic TCR alpha or beta Recombination Enhances T Cell Development but Is Dispensable for Antigen Responses and Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							EXPRESSION; MICE; REPERTOIRE; EXCLUSION; SELECTION; ACTIVATION; FREQUENCY; DELETION; CHAINS; LOCUS	Dual TCR alpha-expressing T cells outnumber dual TCR beta-expressing cells by similar to 10:1. As a result, efforts to understand how dual TCR T cells impact immunity have focused on dual TCR alpha expression; dual TCR beta expression remains understudied. We recently demonstrated, however, that dual TCR beta expression accelerated disease in a TCR transgenic model of autoimmune arthritis through enhanced positive selection efficiency, indicating that dual TCR beta expression, though rare, can impact thymic selection. Here we generated mice hemizygous for TCR alpha, TCR beta, or both on the C57BL/6 background to investigate the impact bi-allelic TCR chain recombination has on T cell development, repertoire diversity, and autoimmunity. Lack of bi-allelic TCR alpha or TCR beta recombination reduced alpha beta thymocyte development efficiency, and the absence of bi-allelic TCR beta recombination promotedd T cell development. However, we observed no differences in the numbers of naive and expanded antigen-specific T cells between TCR alpha(+/-)beta(+/-) and wildtype mice, and TCR repertoire analysis revealed only subtle differences in V beta gene usage. Finally, the absence of dual TCR T cells did not impact induced experimental autoimmune encephalomyelitis pathogenesis. Thus, despite more stringent allelic exclusion of TCR beta relative to TCR alpha, bi-allelic TCR beta expression can measurably impact thymocyte development and is necessary for maintaining normal alpha beta/gamma delta T cell proportions.	[Schuldt, Nathaniel J.; Auger, Jennifer L.; Hogquist, Kristin A.; Binstadt, Bryce A.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Hogquist, Kristin A.] Univ Minnesota, Lab Med & Pathol, Minneapolis, MN 55455 USA; [Schuldt, Nathaniel J.; Auger, Jennifer L.; Hogquist, Kristin A.; Binstadt, Bryce A.] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Binstadt, BA (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	binstadt@umn.edu	Binstadt, Bryce/N-1305-2013	Binstadt, Bryce/0000-0003-3127-3856; Schuldt, Nathan/0000-0001-7692-4814	National Institutes of Health/National Institute of Allergy and Infectious Diseases; American Association of Immunologists; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035296, R21AI101540] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Association of Immunologists; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov) and American Association of Immunologists (aai.org).	Akue AD, 2012, J IMMUNOL, V188, P2516, DOI 10.4049/jimmunol.1102213; Auger JL, 2012, EUR J IMMUNOL, V42, P2354, DOI 10.1002/eji.201242520; Blink SE, 2009, CURR MOL MED, V9, P15, DOI 10.2174/156652409787314516; Bolotin DA, 2012, EUR J IMMUNOL, V42, P3073, DOI 10.1002/eji.201242517; Brady BL, 2010, J IMMUNOL, V185, P3801, DOI 10.4049/jimmunol.1001158; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Corthay A, 2001, J AUTOIMMUN, V16, P423, DOI 10.1006/jaut.2001.0504; Delarasse C, 2003, J CLIN INVEST, V112, P544, DOI 10.1172/JCI200315861; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; ELLIOTT JI, 1995, J EXP MED, V182, P953, DOI 10.1084/jem.182.4.953; Elliott JI, 1996, EUR J IMMUNOL, V26, P953, DOI 10.1002/eji.1830260436; Enouz S, 2012, J EXP MED, V209, P1769, DOI 10.1084/jem.20120905; Frommer F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015372; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; He X, 2002, NAT IMMUNOL, V3, P127, DOI 10.1038/ni751; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Ji QY, 2010, NAT IMMUNOL, V11, P628, DOI 10.1038/ni.1888; Mendel I, 1996, EUR J IMMUNOL, V26, P2470, DOI 10.1002/eji.1830261030; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1991, P NATL ACAD SCI USA, V88, P3084, DOI 10.1073/pnas.88.8.3084; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Morris GP, 2009, J IMMUNOL, V182, P6639, DOI 10.4049/jimmunol.0900638; Ni PP, 2014, J IMMUNOL, V193, P1778, DOI 10.4049/jimmunol.1400532; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; Sarukhan A, 1998, IMMUNITY, V8, P563, DOI 10.1016/S1074-7613(00)80561-0; Spahn TW, 1999, EUR J IMMUNOL, V29, P4060, DOI 10.1002/(SICI)1521-4141(199912)29:12<4060::AID-IMMU4060>3.0.CO;2-S; Su DL, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/985753; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Zal T, 1996, P NATL ACAD SCI USA, V93, P9102, DOI 10.1073/pnas.93.17.9102; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	34	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145762	10.1371/journal.pone.0145762	http://dx.doi.org/10.1371/journal.pone.0145762			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26693713	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500072
J	Chen, H; Li, LM; Ren, J; Wang, Y; Zhao, YM; Wang, X; Wang, S; Xu, SZ				Chen, Huan; Li, Lemin; Ren, Jing; Wang, Yang; Zhao, Yangming; Wang, Xiong; Wang, Sheng; Xu, Shizhong			A Scheme to Optimize Flow Routing and Polling Switch Selection of Software Defined Networks	PLOS ONE			English	Article								This paper aims at minimizing the communication cost for collecting flow information in Software Defined Networks (SDN). Since flow-based information collecting method requires too much communication cost, and switch-based method proposed recently cannot benefit from controlling flow routing, jointly optimize flow routing and polling switch selection is proposed to reduce the communication cost. To this end, joint optimization problem is formulated as an Integer Linear Programming (ILP) model firstly. Since the ILP model is intractable in large size network, we also design an optimal algorithm for the multi-rooted tree topology and an efficient heuristic algorithm for general topology. According to extensive simulations, it is found that our method can save up to 55.76% communication cost compared with the state-of-the-art switch-based scheme.	[Chen, Huan; Li, Lemin; Ren, Jing; Wang, Yang; Zhao, Yangming; Wang, Xiong; Wang, Sheng; Xu, Shizhong] Univ Elect Sci & Technol China, Key Lab Opt Fiber Sensing & Commun, Educ Minist China, Chengdu 610054, Sichuan, Peoples R China	University of Electronic Science & Technology of China	Ren, J (corresponding author), Univ Elect Sci & Technol China, Key Lab Opt Fiber Sensing & Commun, Educ Minist China, Chengdu 610054, Sichuan, Peoples R China.	renjing@uestc.edu.cn			973 Program [2013CB329103]; NSFC Fund [61271165, 61301153, 61401070]; Program for Changjiang Scholars and Innovative Research Team (PCSIRT) in University; 111 Project [B14039]	973 Program(National Basic Research Program of China); NSFC Fund(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team (PCSIRT) in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project)	This work is partially supported by 973 Program (2013CB329103), NSFC Fund (61271165, 61301153, 61401070), Program for Changjiang Scholars and Innovative Research Team (PCSIRT) in University and the 111 Project B14039.	Al-Fares M, 2008, ACM SIGCOMM COMP COM, V38, P63, DOI 10.1145/1402946.1402967; Banerjee S, 2013, COMPACT TCAM FLOW EN; Chowdhury SR., 2014, IEEE NETW OP MAN S N, P1, DOI [10.1109/NOMS.2014.6838227, DOI 10.1109/NOMS.2014.6838227]; Claise Benoit, 2004, REQUEST FOR COMMENTS, DOI DOI 10.17487/RFC3954; Curtis AR, 2011, ACM SIGCOMM COMP COM, V41, P254, DOI 10.1145/2043164.2018466; Estan C, 2002, ACM SIGCOMM COMP COM, V32, P323, DOI 10.1145/964725.633056; Flagberg A, 2013, NETWORKX; Greenberg A, 2009, ACM SIGCOMM COMP COM, V39, P51, DOI 10.1145/1594977.1592576; ibm, CPLEX OPT; Jose L., 2011, PROC HOT ICE, P1; Kanizo Y, 2013, INFOCOM 2013 P IEEE, V1, P515; Medina A, 2002, ACM SIGCOMM COMP COM, V32, P161, DOI 10.1145/964725.633041; Mills D. L., 1987, Computer Communication Review, V17, P191, DOI 10.1145/55483.55502; Moshref M, 2013, P 2 ACM SIGCOMM WORK, V1, P73, DOI DOI 10.1145/2491185.2491196; Open Flow Consoritum, 2009, OPENFLOW SWITCH SPEC; Sekar V., 2010, PROC 10 ANN C INTERN, P328; Su ZY, 2014, IEEE GLOB COMM CONF, P1956, DOI 10.1109/GLOCOM.2014.7037094; Wang M, 2004, INT CON DISTR COMP S, P628, DOI 10.1109/ICDCS.2004.1281630; White S., 2003, P 9 ACM SIGKDD INT C, P266, DOI [DOI 10.1145/956750.956782, 10.1145/956750.956782]; Wu B, 2009, J LIGHTWAVE TECHNOL, V27, P4175, DOI 10.1109/JLT.2009.2022769; Yu M., 2011, COMPUT COMMUN REV, V41, P351, DOI DOI 10.1145/1851182.1851224; Yu M., 2009, PROC ACM C EMERG NET, P313; Yu MJ, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00677-13; Zhang Y, 2013, J MATER CHEM B, V1, P132, DOI 10.1039/c2tb00071g	24	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145437	10.1371/journal.pone.0145437	http://dx.doi.org/10.1371/journal.pone.0145437			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690571	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300075
J	Gallotti, R; Mussi, M				Gallotti, Rosalia; Mussi, Margherita			The Unknown Oldowan: similar to 1.7-Million-Year-Old Standardized Obsidian Small Tools from Garba IV, Melka Kunture, Ethiopia	PLOS ONE			English	Article							LANDSCAPE-SCALE VARIATION; LAKE NATRON; UPPER AWASH; SITE; ASSEMBLAGES; TECHNOLOGY; PENINJ; SKILLS; BASIN; GONA	The Oldowan Industrial Complex has long been thought to have been static, with limited internal variability, embracing techno-complexes essentially focused on small-to-medium flake production. The flakes were rarely modified by retouch to produce small tools, which do not show any standardized pattern. Usually, the manufacture of small standardized tools has been interpreted as a more complex behavior emerging with the Acheulean technology. Here we report on the similar to 1.7 Ma Oldowan assemblages from Garba IVE-F at Melka Kunture in the Ethiopian highland. This industry is structured by technical criteria shared by the other East African Oldowan assemblages. However, there is also evidence of a specific technical process never recorded before, i.e. the systematic production of standardized small pointed tools strictly linked to the obsidian exploitation. Standardization and raw material selection in the manufacture of small tools disappear at Melka Kunture during the Lower Pleistocene Acheulean. This proves that 1) the emergence of a certain degree of standardization in toolkits does not reflect in itself a major step in cultural evolution; and that 2) the Oldowan knappers, when driven by functional needs and supported by a highly suitable raw material, were occasionally able to develop specific technical solutions. The small tool production at similar to 1.7 Ma, at a time when the Acheulean was already emerging elsewhere in East Africa, adds to the growing amount of evidence of Oldowan techno-economic variability and flexibility, further challenging the view that early stone knapping was static over hundreds of thousands of years.	[Gallotti, Rosalia; Mussi, Margherita] Univ Roma La Sapienza, Dipartimento Sci Antichita, I-00185 Rome, Italy; [Gallotti, Rosalia; Mussi, Margherita] Italian Archaeol Mission Melka Kunture & Balchit, Rome, Italy; [Gallotti, Rosalia] Univ Bordeaux 1, PACEA PPP UMR5199, F-33615 Pessac, France	Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux	Gallotti, R (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Antichita, Via Volsci 122, I-00185 Rome, Italy.	rosalia.gallotti@uniroma1.it	Mussi, Margherita/L-7162-2014; Gallotti, Rosalia/AAP-4599-2020	Gallotti, Rosalia/0000-0001-7308-7715; MUSSI, Margherita/0000-0001-9393-9591	La Sapienza University of Rome ("Grandi scavi archeologici"); Italian Foreign Ministry	La Sapienza University of Rome ("Grandi scavi archeologici"); Italian Foreign Ministry	The research was supported by grants in 2014 from La Sapienza University of Rome ("Grandi scavi archeologici") and from the Italian Foreign Ministry.	[Anonymous], 1984, AFR ARCHAEOL REV, DOI DOI 10.1007/BF01117229; Barsky D, 2013, QUATERN INT, V316, P140, DOI 10.1016/j.quaint.2013.05.024; Barsky D, 2011, J AFR ARCHAEOL, V9, P207, DOI 10.3213/2191-5784-10196; Barsky D, 2009, VERTEBR PALEOBIOL PA, P39, DOI 10.1007/978-1-4020-9060-8_4; Beyene Y, 2013, P NATL ACAD SCI USA, V110, P1584, DOI 10.1073/pnas.1221285110; Blumenschine RJ, 2008, J ARCHAEOL SCI, V35, P76, DOI 10.1016/j.jas.2007.02.009; Braun DR, 2009, J ARCHAEOL SCI, V36, P1605, DOI 10.1016/j.jas.2009.03.025; Braun DR, 2008, J HUM EVOL, V55, P1053, DOI 10.1016/j.jhevol.2008.05.020; Carbonell E, 2009, VERTEBR PALEOBIOL PA, P25, DOI 10.1007/978-1-4020-9060-8_3; Chavaillon J., 2004, STUDIES EARLY PALEOL, P253; Chavaillon J., 2004, J SCI EXPLOR; Chernet T, 1998, J VOLCANOL GEOTH RES, V80, P267, DOI 10.1016/S0377-0273(97)00035-8; Condemi S., 2004, STUDIES EARLY PALEOL, P687; de la Torre I, 2004, CURR ANTHROPOL, V45, P439, DOI 10.1086/422079; de la Torre I, 2005, TECHNOLOGICAL STRATE; de la Torre I, 2008, J ANTHROPOL ARCHAEOL, V27, P244, DOI 10.1016/j.jaa.2007.12.001; de la Torre I, 2011, J HUM EVOL, V60, P768, DOI 10.1016/j.jhevol.2011.01.009; de la Torre I, 2011, PHILOS T R SOC B, V366, P1028, DOI 10.1098/rstb.2010.0350; de Lumley H, 2005, ANTHROPOLOGIE, V109, P1, DOI 10.1016/j.anthro.2005.02.011; Delagnes A, 2005, J HUM EVOL, V48, P435, DOI 10.1016/j.jhevol.2004.12.005; Dominguez-Rodrigo M, 2002, J ARCHAEOL SCI, V29, P639, DOI 10.1006/jasc.2001.0768; Gallotti R, 2014, QUATERN INT, V343, P17, DOI 10.1016/j.quaint.2014.04.039; Gallotti R, 2013, J HUM EVOL, V65, P594, DOI 10.1016/j.jhevol.2013.07.001; Gallotti R, 2010, AFR ARCHAEOL REV, V27, P291, DOI 10.1007/s10437-010-9083-z; Geneste J.M., 1991, TECHNIQUES CULTURE, V17-18, P1, DOI DOI 10.4000/TC.5013; Geneste J.M., 1989, LHOMME NEANDERTAL, V6, P75; Goldman-Neuman T, 2012, J HUM EVOL, V62, P353, DOI 10.1016/j.jhevol.2011.05.006; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; HOVERS E, 2003, OLDOWAN RATHER MORE, P145; Hovers E, 2012, DEV QUATER SCI, V16, P51, DOI 10.1016/B978-0-444-53821-5.00005-1; Inizan Marie -Louise, 1999, PRE HIST PIERRE TAIL; Kieffer G, 2004, STUDIES EARLY PALEOL, P93; Kimura Y, 2002, J HUM EVOL, V43, P291, DOI 10.1006/jhev.2002.0576; Lapedes DN, 1978, MCGRAW HILL DICT SCI; Le Bourdonnec F.-X, 2007, THESIS; Leakey M., 1971, EXCAVATIONS BED 1 2, V3; Leakey MD., 1975, AUSTRALOPITHECINES, P477, DOI [10.1515/9783110878837.477, DOI 10.1515/9783110878837.477]; Lepre CJ, 2011, NATURE, V477, P82, DOI 10.1038/nature10372; Leroi-Gourhan A., 1964, TECHNIQUE LANGAGE; Leroi-Gourhan A., 1971, HOMME MATIERE; Merrick H.V., 1994, SOC CULTURE TECHNOLO, P29; Mohr P, 1999, COMMENT HOMME DECOUV, P231; Morgan LE, 2012, J HUM EVOL, V62, P104, DOI 10.1016/j.jhevol.2011.10.007; Mussi M, 2014, QUATERN INT, V343, P28, DOI 10.1016/j.quaint.2013.08.028; Negash A, 2006, J ARCHAEOL SCI, V33, P1647, DOI 10.1016/j.jas.2005.11.001; Pelegrin J., 1985, STUDIA PRAEHISTORICA, V4, P72; Perles C., 1991, 11 RENCONTRES INTERN, P35; Piperno M, 1975, QUATERNARIA, V18, P347; Piperno M., 2004, STUDIES EARLY PALEOL, P581; Piperno M., 2004, STUDIES EARLY PALEOL, P449; Piperno M, 2009, VERTEBR PALEOBIOL PA, P111, DOI 10.1007/978-1-4020-9060-8_10; Poupeau G., 2004, STUDIES EARLY PALEOL, P103; Quade J, 2004, GEOL SOC AM BULL, V116, P1529, DOI 10.1130/B25358.1; Quade J, 2008, GEOL SOC AM SPEC PAP, V446, P1, DOI 10.1130/2008.2446(01); Raynal J-P., 2004, STUDIES EARLY PALEOL, P137; Schick K., 2006, STONE AGE I PUBLICAT, P3; Semaw S., 2006, OLDOWAN CASE STUDIES, P43; Semaw S., 2005, PALEOLITHIQUE AFRIQU, P13; Stout D, 2011, PHILOS T R SOC B, V366, P1050, DOI 10.1098/rstb.2010.0369; Tactikos JC., 2005, PHD THESIS; Tamrat E, 2014, QUATERN INT, V343, P5, DOI 10.1016/j.quaint.2013.11.030; TEXIER PJ, 1995, CR ACAD SCI II, V320, P647; Zaidner Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066851; Zilberman U, 2004, J HUM EVOL, V46, P647, DOI 10.1016/j.jhevol.2004.02.005; Zilberman U., 2004, STUDIES EARLY PALEOL, P703	65	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145101	10.1371/journal.pone.0145101	http://dx.doi.org/10.1371/journal.pone.0145101			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690569	gold, Green Submitted, Green Published			2022-12-27	WOS:000367092300035
J	Westbom, C; Thompson, JK; Leggett, A; MacPherson, M; Beuschel, S; Pass, H; Vacek, P; Shukla, A				Westbom, Catherine; Thompson, Joyce K.; Leggett, Alan; MacPherson, Maximilian; Beuschel, Stacie; Pass, Harvey; Vacek, Pamela; Shukla, Arti			Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma	PLOS ONE			English	Article							NLRP3 INFLAMMASOME; PROSTATE-CANCER; CELLS; CASPASE-1; PROMOTES; IL-1-BETA; RELEASE; GROWTH; DOXORUBICIN; RESISTANCE	Malignant mesothelioma (MM) is a fatal disease in dire need of therapy. The role of inflammasomes in cancer is not very well studied, however, literature supports both pro- and antitumorigenic effects of inflammasomes on cancer depending upon the type of cancer. Asbestos is a causative agent for MM and we have shown before that it causes inflammasome priming and activation in mesothelial cells. MM tumor cells/tissues showed decreased levels of inflammasome components like NLRP3 and caspase-1 as compared to human mesothelial cells or normal tissue counterpart of tumor. Based on our preliminary findings we hypothesized that treatment of MMs with chemotherapeutic drugs may elevate the levels of NLRP3 and caspase-1 resulting in increased cell death by pyroptosis while increasing the levels of IL-1 beta and other pro-inflammatory molecules. Therefore, a combined strategy of chemotherapeutic drug and IL-1R antagonist may play a beneficial role in MM therapy. To test our hypothesis we used two human MM tumor cell lines (Hmeso, H2373) and two chemotherapeutic drugs (doxorubicin, cisplatin). Through a series of experiments we showed that both chemotherapeutic drugs caused increases in NLRP3 levels, caspase-1 activation, pyroptosis and pro-inflammatory molecules released from MM cells. In vivo studies using SCID mice and Hmeso cells showed that tumors were smaller in combined treatment group of cisplatin and IL-1R antagonist (Anakinra) as compared to cisplatin alone or untreated control groups. Taken together our study suggests that chemotherapeutic drugs in combination with IL-1R antagonist may have a beneficial role in MM treatment.	[Westbom, Catherine; Thompson, Joyce K.; Leggett, Alan; MacPherson, Maximilian; Beuschel, Stacie; Shukla, Arti] Univ Vermont, Coll Med, Dept Pathol & Lab Med, Burlington, VT 05405 USA; [Vacek, Pamela] Univ Vermont, Coll Med, Dept Med Biostat, Burlington, VT USA; [Pass, Harvey] NYU, Hosp Joint Dis, Dept Cardiothorac Surg, New York, NY USA	University of Vermont; University of Vermont; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC	Shukla, A (corresponding author), Univ Vermont, Coll Med, Dept Pathol & Lab Med, Burlington, VT 05405 USA.	Arti.Shukla@med.uvm.edu		Thompson, Joyce/0000-0001-7898-0078; Pass, Harvey/0000-0003-3222-3471	NIH [RO1 ES021110]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021110] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by NIH RO1 ES021110.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Antonopoulos C, 2015, J BIOL CHEM, V290, P20167, DOI 10.1074/jbc.M115.652321; Antonopoulos C, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27499; Antonopoulos C, 2013, J IMMUNOL, V191, P4789, DOI 10.4049/jimmunol.1300645; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bruchard M, 2014, B CANCER, V101, P605, DOI 10.1684/bdc.2014.1936; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Creagh EM, 2014, TRENDS IMMUNOL, V35, P631, DOI 10.1016/j.it.2014.10.004; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Hillegass JM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-39; Hillegass JM, 2011, INT J CANCER, V129, P233, DOI 10.1002/ijc.25666; Hillegass JM, 2010, ANN NY ACAD SCI, V1203, P7, DOI 10.1111/j.1749-6632.2010.05554.x; Hillegass JM, 2010, WIRES NANOMED NANOBI, V2, P219, DOI 10.1002/wnan.54; Huang J, 2012, CANCER RES, V72, P230, DOI 10.1158/0008-5472.CAN-11-2001; Idris Adi, 2015, Biomark Cancer, V7, P25, DOI 10.4137/BIC.S25375; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Lee DW, 2015, RENAL FAILURE, V37, P144, DOI 10.3109/0886022X.2014.970194; Newick K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039404; Palomo J, 2015, CYTOKINE, V76, P25, DOI 10.1016/j.cyto.2015.06.017; Pan BZ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-165; Park MS, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134858; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; REALE FR, 1987, CANCER RES, V47, P3199; Schwarznau A, 2009, J CELL PHYSIOL, V220, P341, DOI 10.1002/jcp.21770; Shukla A, 2006, FASEB J, V20, P997, DOI 10.1096/fj.05-4554fje; Shukla A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-314; Shukla A, 2013, CLIN CANCER RES, V19, P2071, DOI 10.1158/1078-0432.CCR-12-3202; Shukla A, 2011, INT J CANCER, V129, P1075, DOI 10.1002/ijc.25763; Shukla A, 2009, AM J PATHOL, V175, P2197, DOI 10.2353/ajpath.2009.090400; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Smythe W Roy, 2002, Curr Oncol Rep, V4, P305, DOI 10.1007/s11912-002-0006-2; Wang YH, 2004, INT J ONCOL, V25, P173; Westbom CM, 2014, AM J PATHOL, V184, P2816, DOI 10.1016/j.ajpath.2014.06.008; Winter RN, 2004, ANTICANCER RES, V24, P1377; Winter RN, 2001, CANCER RES, V61, P1227; Wong J, 2014, CANCER BIOL THER, V15, P1395, DOI 10.4161/cbt.29922; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zhang YY, 2014, TOXICOL APPL PHARM, V281, P1, DOI 10.1016/j.taap.2014.09.016	41	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145404	10.1371/journal.pone.0145404	http://dx.doi.org/10.1371/journal.pone.0145404			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689911	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092300072
J	Wibberg, D; Rupp, O; Blom, J; Jelonek, L; Krober, M; Verwaaijen, B; Goesmann, A; Albaum, S; Grosch, R; Puhler, A; Schluter, A				Wibberg, Daniel; Rupp, Oliver; Blom, Jochen; Jelonek, Lukas; Kroeber, Magdalena; Verwaaijen, Bart; Goesmann, Alexander; Albaum, Stefan; Grosch, Rita; Puehler, Alfred; Schlueter, Andreas			Development of a Rhizoctonia solani AG1-IB Specific Gene Model Enables Comparative Genome Analyses between Phytopathogenic R-solani AG1-IA, AG1-IB, AG3 and AG8 Isolates	PLOS ONE			English	Article							SOFTWARE; SEQUENCE; INSIGHTS; FUNGUS; ANNOTATION; PREDICTION; EVOLUTION; ALIGNMENT; RNA	Rhizoctonia solani, a soil-born plant pathogenic basidiomycetous fungus, affects various economically important agricultural and horticultural crops. The draft genome sequence for the R. solani AG1-IB isolate 7/3/14 as well as a corresponding transcriptome dataset (Expressed Sequence Tags-ESTs) were established previously. Development of a specific R. solani AG1-IB gene model based on GMAP transcript mapping within the eukaryotic gene prediction platform AUGUSTUS allowed detection of new genes and provided insights into the gene structure of this fungus. In total, 12,616 genes were recognized in the genome of the AG1-IB isolate. Analysis of predicted genes by means of different bioinformatics tools revealed new genes whose products potentially are involved in degradation of plant cell wall components, melanin formation and synthesis of secondary metabolites. Comparative genome analyses between members of different R. solani anastomosis groups, namely AG1-IA, AG3 and AG8 and the newly annotated R. solani AG1-IB genome were performed within the comparative genomics platform EDGAR. It appeared that only 21 to 28% of all genes encoded in the draft genomes of the different strains were identified as core genes. Based on Average Nucleotide Identity (ANI) and Average Amino-acid Identity (AAI) analyses, considerable sequence differences between isolates representing different anastomosis groups were identified. However, R. solani isolates form a distinct cluster in relation to other fungi of the phylum Basidiomycota. The isolate representing AG1-IB encodes significant more genes featuring predictable functions in secondary metabolite production compared to other completely sequenced R. solani strains. The newly established R. solani AG1-IB 7/3/14 gene layout now provides a reliable basis for post-genomics studies.	[Wibberg, Daniel; Jelonek, Lukas; Kroeber, Magdalena; Verwaaijen, Bart; Albaum, Stefan; Puehler, Alfred; Schlueter, Andreas] Univ Bielefeld, CeBiTec, Inst Genome Res & Syst Biol, D-33615 Bielefeld, Germany; [Rupp, Oliver; Blom, Jochen; Jelonek, Lukas; Goesmann, Alexander] Univ Giessen, Bioinformat & Syst Biol, D-35390 Giessen, Germany; [Grosch, Rita] Leibniz Inst Vegetables & Ornamental Crops, Grossbeeren, Germany	University of Bielefeld; Justus Liebig University Giessen; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	Schluter, A (corresponding author), Univ Bielefeld, CeBiTec, Inst Genome Res & Syst Biol, D-33615 Bielefeld, Germany.	aschluet@CeBiTec.Uni-Bielefeld.de	Grosch, Rita/HHM-5490-2022	Goesmann, Alexander/0000-0002-7086-2568; Rupp, Oliver/0000-0003-2755-6458; Puhler, Alfred/0000-0003-4723-2960; Schluter, Andreas/0000-0003-4830-310X; Jelonek, Lukas/0000-0002-9973-0374; Grosch, Rita/0000-0002-7179-5715	Federal Ministry of Education and Research (Germany) [0315654B, 031A533, 031A560D]; CLIB Graduate Cluster Industrial Biotechnology at Bielefeld University (Germany) - Federal Ministry of Innovation, Science and Research (MIWF) of the federal state North Rhine-Westphalia, Germany; Article Processing Charge by the Deutsche Forschungsgemeinschaft; Open Access Publication Fund of Bielefeld University	Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); CLIB Graduate Cluster Industrial Biotechnology at Bielefeld University (Germany) - Federal Ministry of Innovation, Science and Research (MIWF) of the federal state North Rhine-Westphalia, Germany; Article Processing Charge by the Deutsche Forschungsgemeinschaft; Open Access Publication Fund of Bielefeld University	The work was funded by the Federal Ministry of Education and Research (Germany): Grant numbers: 0315654B, 031A533 and 031A560D. LJ and BV acknowledge their scholarships from the CLIB Graduate Cluster Industrial Biotechnology at Bielefeld University (Germany) granted by the Federal Ministry of Innovation, Science and Research (MIWF) of the federal state North Rhine-Westphalia, Germany. Moreover, the authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bekel T, 2009, J BIOTECHNOL, V140, P3, DOI 10.1016/j.jbiotec.2009.01.006; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Carling DE, 2002, PHYTOPATHOLOGY, V92, P893, DOI 10.1094/PHYTO.2002.92.8.893; Cubeta MA, 2014, GENOME ANNOUNC, V2; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Foissac S, 2007, NUCLEIC ACIDS RES, V35, pW297, DOI 10.1093/nar/gkm311; Ghosh S, 2014, CURR GENET, V60, P327, DOI 10.1007/s00294-014-0438-x; Garcia VG, 2006, SPAN J AGRIC RES, V4, P55; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Hane JK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004281; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Losada L, 2014, FEMS MICROBIOL LETT, V352, P165, DOI 10.1111/1574-6968.12387; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; McGuire AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r50; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Morgenstern B, 2005, NUCL ACIDS RES, V33; Muszewska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029425; Reid I, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-229; Rupp O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085568; Satou Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r152; Schaefer Wilhelm, 1993, Trends in Microbiology, V1, P69, DOI 10.1016/0966-842X(93)90037-R; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Steinbiss S, 2009, NUCLEIC ACIDS RES, V37, P7002, DOI 10.1093/nar/gkp759; Wibberg D, 2015, J BIOTECHNOL, V203, P19, DOI 10.1016/j.jbiotec.2015.03.005; Wibberg D, 2014, FUNGAL BIOL-UK, V118, P800, DOI 10.1016/j.funbio.2014.06.007; Wibberg D, 2013, J BIOTECHNOL, V167, P142, DOI 10.1016/j.jbiotec.2012.12.010; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Zheng AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2427; Zuccaro A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002290	36	26	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144769	10.1371/journal.pone.0144769	http://dx.doi.org/10.1371/journal.pone.0144769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690577	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300015
J	Xu, XJ; Xie, SP; Shi, XM; Lv, J; Tang, XW; Wang, XL; Lu, SP; Wang, MZ; Zhang, XB; Sun, J; Yao, H				Xu, Xijia; Xie, Shiping; Shi, Xiaomeng; Lv, Jie; Tang, Xiaowei; Wang, Xiaolan; Lu, Shuiping; Wang, Mingzhong; Zhang, Xiaobing; Sun, Jing; Yao, Hui			Hexanucleotide Repeat Expansion in C9ORF72 Is Not Detected in the Treatment-Resistant Schizophrenia Patients of Chinese Han	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; GENE; ALS	Hexanucleotide (GGGGCC) repeat expansion in C9ORF72 (HRE) causes frontotemporal lobar degeneration, frontotemporal dementia-amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. HRE was also seen in the genomes of patients suffering from several other degenerative diseases. However, whether it is present in the treatment-resistant schizophrenia patients remains unknown. Genotyping 386 patients suffering from treatment-resistant schizophrenia using the method of Repeat-Primed PCR, we reported here that no HRE was detected in the patients of Chinese Han.	[Xu, Xijia; Xie, Shiping; Shi, Xiaomeng; Wang, Xiaolan; Lu, Shuiping; Sun, Jing; Yao, Hui] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Psychiat, Nanjing 210029, Jiangsu, Peoples R China; [Xu, Xijia; Xie, Shiping] Nanjing Univ, Nanjing Brain Hosp, Sch Med, Nanjing 210093, Jiangsu, Peoples R China; [Lv, Jie; Wang, Mingzhong] Nanjing Qinglongshan Mental Hosp, Dept Psychiat, Nanjing 211123, Jiangsu, Peoples R China; [Tang, Xiaowei; Zhang, Xiaobing] Yangzhou Univ, Coll Med, Affiliated Wutaishan Hosp, Dept Psychiat, Yangzhou 225003, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University; Yangzhou University	Xie, SP (corresponding author), Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Psychiat, Nanjing 210029, Jiangsu, Peoples R China.	xieshiping@medmail.com.cn			Nanjing Medical Science and Technique Development Foundation, Nanjing Commission of Health and Family Planning [QRX11121, ZKX08034]; Jiangsu Provincial Commission of Health and Family Planning [H200875]; National Health and Family Planning Commission of the People's Republic of China [2011-873]; Jiangsu Provincial Commission of Health and Family Planning	Nanjing Medical Science and Technique Development Foundation, Nanjing Commission of Health and Family Planning; Jiangsu Provincial Commission of Health and Family Planning; National Health and Family Planning Commission of the People's Republic of China; Jiangsu Provincial Commission of Health and Family Planning	This work was funded by Nanjing Medical Science and Technique Development Foundation, Nanjing Commission of Health and Family Planning (grant numbers: QRX11121, ZKX08034; http://www.njjsw.gov.cn/; recipient: XX); Jiangsu Provincial Commission of Health and Family Planning (grant number: H200875; http://www.jswst.gov.cn; recipient: XX); National Health and Family Planning Commission of the People's Republic of China (grant number: State Key Clinical Specialty [Psychiatry, 2011-873]; http://www.nhfpc.gov.cn/; recipients: XX SX); and Jiangsu Provincial Commission of Health and Family Planning (grant number: Provincial Medical Key Discipline [Psychiatry, 2011-12]; http://www.jswst.gov.cn; recipients: XX SX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck J, 2013, AM J HUM GENET, V92, P345, DOI 10.1016/j.ajhg.2013.01.011; Bieniek KF, 2014, JAMA NEUROL, V71, P775, DOI 10.1001/jamaneurol.2013.6368; Daoud H, 2014, CAN J NEUROL SCI, V41, P759, DOI 10.1017/cjn.2014.39; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Frank J, 2015, MOL PSYCHIATR, V20, P150, DOI 10.1038/mp.2014.56; Galimberti D, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.004; Galimberti D, 2013, BIOL PSYCHIAT, V74, P384, DOI 10.1016/j.biopsych.2013.01.031; Garcia-Redondo A, 2013, HUM MUTAT, V34, P79, DOI 10.1002/humu.22211; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Goldman JS, 2014, JAMA NEUROL, V71, P771, DOI 10.1001/jamaneurol.2013.5762; He J, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.06.002; Kohli MA, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.003; Koutsis G, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.08.020; Liu R, 2013, AMYOTROPH LAT SCL FR, V14, P630, DOI 10.3109/21678421.2013.817588; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Ogaki K, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.05.011; Pliner HA, 2014, ACTA NEUROPATHOL, V127, P391, DOI 10.1007/s00401-014-1250-x; Rademakers R, 2012, LANCET NEUROL, V11, P297, DOI 10.1016/S1474-4422(12)70046-7; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Yoshino Y, 2015, J NEURAL TRANSM, V122, P731, DOI 10.1007/s00702-014-1295-y	21	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145347	10.1371/journal.pone.0145347	http://dx.doi.org/10.1371/journal.pone.0145347			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691640	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300061
J	Houle, D; Paquette, A; Cote, B; Logan, T; Power, H; Charron, I; Duchesne, L				Houle, Daniel; Paquette, Alain; Cote, Benoit; Logan, Travis; Power, Hugues; Charron, Isabelle; Duchesne, Louis			Impacts of Climate Change on the Timing of the Production Season of Maple Syrup in Eastern Canada	PLOS ONE			English	Article							SAP; FLOW	Maple syrup production is an important economic activity in north-eastern North-America. The beginning and length of the production season is linked to daily variation in temperature. There are increasing concerns about the potential impact of climatic change on this industry. Here, we used weekly data of syrup yield for the 1999-2011 period from 121 maple stands in 11 regions of Quebec (Canada) to predict how the period of production may be impacted by climate warming. The date at which the production begins is highly variable between years with an average range of 36 days among the regions. However, the average start date for a given region, which ranged from Julian day 65 to 83, was highly predictable (r(2) = 0.88) using the average temperature from January to April (TJ-A). A logistic model predicting the weekly presence or absence of production was also developed. Using the inputs of 77 future climate scenarios issued from global models, projections of future production timing were made based on average TJ-A and on the logistic model. The projections of both approaches were in very good agreement and suggest that the sap season will be displaced to occur 15-19 days earlier on average in the 2080-2100 period. The data also show that the displacement in time will not be accompanied by a greater between years variability in the beginning of the season. However, in the southern part of Quebec, very short periods of syrup production due to unfavourable conditions in the spring will occur more frequently in the future although their absolute frequencies will remain low.	[Houle, Daniel; Power, Hugues; Duchesne, Louis] Minist Forets Faune & Parcs Quebec, Direct Rech Forestiere, Quebec City, PQ G1P 3W8, Canada; [Houle, Daniel; Logan, Travis; Charron, Isabelle] Consortium Climatol Reg & Adaptat Changements Cli, Montreal, PQ H3A 1B9, Canada; [Paquette, Alain] Univ Quebec, Ctr Forest Res, Ctr Ville Stn, Montreal, PQ H3C 3P8, Canada; [Cote, Benoit] McGill Univ, Dep Nat Resource Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada	Ouranos Consortium; University of Quebec; University of Quebec Montreal; McGill University	Houle, D (corresponding author), Minist Forets Faune & Parcs Quebec, Direct Rech Forestiere, 2700 Einstein, Quebec City, PQ G1P 3W8, Canada.	daniel.houle@mffp.gouv.qc.ca		Duchesne, Louis/0000-0001-6784-445X	Ministere des Forets, de la Faune et des Parcs du Quebec; Le Fond Vert du Ministere du Developpement Durable, Environnement, et Parc du Quebec; Natural Resources Canada	Ministere des Forets, de la Faune et des Parcs du Quebec; Le Fond Vert du Ministere du Developpement Durable, Environnement, et Parc du Quebec; Natural Resources Canada(Natural Resources CanadaCanadian Forest Service)	The costs associated with this research were covered by the "Ministere des Forets, de la Faune et des Parcs du Quebec" (DH) and "Le Fond Vert du Ministere du Developpement Durable, Environnement, et Parc du Quebec" within the framework of the Action Plan 2006-2012 on climate change in association with Natural Resources Canada (DH and BC) (http://www.mffp.gouv.qc.ca/accueil.jsp), (http://www.mddelcc.gouv.qc.ca/ministere/fonds-vert/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 2000, SPECIAL REPORT EMISS; Bradley E, 1983, AM STAT, V37, P36; Duchesne L, 2014, PEERJ, V2, DOI 10.7717/peerj.428; Duchesne L, 2009, FOREST ECOL MANAG, V258, P2683, DOI 10.1016/j.foreco.2009.09.035; Gabriel WJ, 1972, PHENOTYPIC SELECTION; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Hopkinson RF, 2011, J APPL METEOROL CLIM, V50, P1654, DOI 10.1175/2011JAMC2684.1; Hutchinson MF, 2009, J APPL METEOROL CLIM, V48, P725, DOI 10.1175/2008JAMC1979.1; KIM YT, 1985, FOREST CHRON, V61, P303, DOI 10.5558/tfc61303-4; Logan T, 2011, ATLAS SCENARIOS CLIM; MARVIN JW, 1956, PLANT PHYSIOL, V31, P57, DOI 10.1104/pp.31.1.57; Marvin JW, 1957, INVESTIGATION SUGAR; Marvin JW, 1958, PHYSL MAPLE SAPFLOW; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Mpelasoka FS, 2009, J HYDROMETEOROL, V10, P1168, DOI 10.1175/2009JHM1045.1; Murphy BL, 2012, J RURAL COMMUNITY D, V7, P42; Norby RJ, 2003, GLOBAL CHANGE BIOL, V9, P1792, DOI 10.1111/j.1365-2486.2003.00714.x; Perkins TD, 2009, ADV FOOD NUTR RES, V56, P101, DOI 10.1016/S1043-4526(08)00604-9; PLAMONDON A P, 1977, Naturaliste Canadien (Quebec), V104, P127; PLAMONDON AP, 1980, CAN J FOREST RES, V10, P152, DOI 10.1139/x80-027; POTHIER D, 1995, CAN J FOREST RES, V25, P1815, DOI 10.1139/x95-196; Skinner CB, 2010, CLIMATIC CHANGE, V100, P685, DOI 10.1007/s10584-009-9685-0; Tyminski WPJ, 2011, UTILITY USING SUGAR; USDA NASS, 2012, MAPL SYR 2012 2012 M	26	18	19	2	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144844	10.1371/journal.pone.0144844	http://dx.doi.org/10.1371/journal.pone.0144844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682889	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800022
J	Morita, C; Tsuji, H; Hata, T; Gondo, M; Takakura, S; Kawai, K; Yoshihara, K; Ogata, K; Nomoto, K; Miyazaki, K; Sudo, N				Morita, Chihiro; Tsuji, Hirokazu; Hata, Tomokazu; Gondo, Motoharu; Takakura, Shu; Kawai, Keisuke; Yoshihara, Kazufumi; Ogata, Kiyohito; Nomoto, Koji; Miyazaki, Kouji; Sudo, Nobuyuki			Gut Dysbiosis in Patients with Anorexia Nervosa	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE; MICROBIOTA; INCREASE; DIARRHEA; SYSTEM; RISK; ENVIRONMENT; INFECTION; COMMUNITY; OUTBREAK	Anorexia nervosa (AN) is a psychological illness with devastating physical consequences; however, its pathophysiological mechanism remains unclear. Because numerous reports have indicated the importance of gut microbiota in the regulation of weight gain, it is reasonable to speculate that AN patients might have a microbial imbalance, i.e. dysbiosis, in their gut. In this study, we compared the fecal microbiota of female patients with AN (n = 25), including restrictive (ANR, n = 14) and binge-eating (ANBP, n = 11) subtypes, with those of age-matched healthy female controls (n = 21) using the Yakult Intestinal Flora-SCAN based on 16S or 23S rRNA-targeted RT-quantitative PCR technology. AN patients had significantly lower amounts of total bacteria and obligate anaerobes including those from the Clostridium coccoides group, Clostridium leptum subgroup, and Bacteroides fragilis group than the age-matched healthy women. Lower numbers of Streptococcus were also found in the AN group than in the control group. In the analysis based on AN subtypes, the counts of the Bacteroides fragilis group in the ANR and ANBP groups and the counts of the Clostridium coccoides group in the ANR group were significantly lower than those in the control group. The detection rate of the Lactobacillus plantarum subgroup was significantly lower in the AN group than in the control group. The AN group had significantly lower acetic and propionic acid concentrations in the feces than the control group. Moreover, the subtype analysis showed that the fecal concentrations of acetic acid were lower in the ANR group than in the control group. Principal component analysis confirmed a clear difference in the bacterial components between the AN patients and healthy women. Collectively, these results clearly indicate the existence of dysbiosis in the gut of AN patients.	[Morita, Chihiro; Hata, Tomokazu; Gondo, Motoharu; Takakura, Shu; Kawai, Keisuke; Yoshihara, Kazufumi; Sudo, Nobuyuki] Kyushu Univ, Grad Sch Med Sci, Dept Psychosomat Med, Fukuoka 812, Japan; [Tsuji, Hirokazu; Ogata, Kiyohito; Nomoto, Koji; Miyazaki, Kouji] Yakult Cent Inst, Tokyo, Japan	Kyushu University; Yakult Honsha Company, Limited	Sudo, N (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Psychosomat Med, Fukuoka 812, Japan.	nobuyuki@med.kyushu-u.ac.jp		Sudo, Nobuyuki/0000-0002-7935-878X; Hirokazu, Tsuji/0000-0003-2856-6447	Ministry of Education, Culture, Sports, Science, and Technology in Japan [22659144, 25293167]	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by Grants-in-Aid for General Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (22659144, https://kaken.nii.ac.jp/d/p/22659144.ja.html; 25293167, https://kaken.nii.ac.jp/d/p/25293167.ja.html: NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; COATES ME, 1963, BRIT J NUTR, V17, P141, DOI 10.1079/BJN19630015; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Corder GW, 2009, COMP 2 UNRELATED SAM, P57; DEMPSEY DT, 1984, AM J CLIN NUTR, V39, P236, DOI 10.1093/ajcn/39.2.236; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gareau MG, 2011, GUT, V60, P307, DOI 10.1136/gut.2009.202515; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; KAYE WH, 1988, AM J CLIN NUTR, V47, P989, DOI 10.1093/ajcn/47.6.989; Kurakawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126226; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Marzola E, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-290; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; MOORE PR, 1946, J BIOL CHEM, V165, P437; Moukaddem M, 1997, AM J CLIN NUTR, V66, P133; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Nishino R, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12110; Ohigashi S, 2013, DIGEST DIS SCI, V58, P1717, DOI 10.1007/s10620-012-2526-4; Pepin J, 2005, CLIN INFECT DIS, V40, P1591, DOI 10.1086/430315; Sakaguchi S, 2010, J CLIN MICROBIOL, V48, P1624, DOI 10.1128/JCM.01724-09; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Shah S, 2000, QJM-MON J ASSOC PHYS, V93, P175, DOI 10.1093/qjmed/93.3.175; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sudo N, 1997, J IMMUNOL, V159, P1739; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Van Wymelbeke V, 2004, AM J CLIN NUTR, V80, P1469, DOI 10.1093/ajcn/80.6.1469	37	115	119	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145274	10.1371/journal.pone.0145274	http://dx.doi.org/10.1371/journal.pone.0145274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682545	gold, Green Published, Green Submitted			2022-12-27	WOS:000366725800056
J	Lima-Costa, MF; Macinko, J; Mambrini, JVD; Cesar, CC; Peixoto, SV; Magalhaes, WCS; Horta, BL; Barreto, M; Castro-Costa, E; Firmo, JOA; Proietti, FA; Leal, TP; Rodrigues, MR; Pereira, A; Tarazona-Santos, E				Lima-Costa, M. Fernanda; Macinko, James; de Melo Mambrini, Juliana Vaz; Cesar, Cibele C.; Peixoto, Sergio V.; Magalhaes, Wagner C. S.; Horta, Bernardo L.; Barreto, Mauricio; Castro-Costa, Erico; Firmo, Joselia O. A.; Proietti, Fernando A.; Leal, Thiago Peixoto; Rodrigues, Maira R.; Pereira, Alexandre; Tarazona-Santos, Eduardo			Genomic Ancestry, Self-Rated Health and Its Association with Mortality in an Admixed Population: 10 Year Follow-Up of the Bambui-Epigen (Brazil) Cohort Study of Ageing	PLOS ONE			English	Article							OLDER-ADULTS; SOCIOECONOMIC-STATUS; LATIN-AMERICA; COMMUNITY; COLOR; SURVIVAL; POSITION; MODELS; US	Background Self-rated health (SRH) has strong predictive value for mortality in different contexts and cultures, but there is inconsistent evidence on ethnoracial disparities in SRH in Latin America, possibly due to the complexity surrounding ethnoracial self-classification. Materials/Methods We used 370,539 Single Nucleotide Polymorphisms (SNPs) to examine the association between individual genomic proportions of African, European and Native American ancestry, and ethnoracial self-classification, with baseline and 10-year SRH trajectories in 1,311 community dwelling older Brazilians. We also examined whether genomic ancestry and ethnoracial self-classification affect the predictive value of SRH for subsequent mortality. Results European ancestry predominated among participants, followed by African and Native American (median = 84.0%, 9.6% and 5.3%, respectively); the prevalence of Non-White (Mixed and Black) was 39.8%. Persons at higher levels of African and Native American genomic ancestry, and those self-identified as Non-White, were more likely to report poor health than other groups, even after controlling for socioeconomic conditions and an array of self-reported and objective physical health measures. Increased risks for mortality associated with worse SRH trajectories were strong and remarkably similar (hazard ratio similar to 3) across all genomic ancestry and ethno-racial groups. Conclusions Our results demonstrated for the first time that higher levels of African and Native American genomic ancestry-and the inverse for European ancestry-were strongly correlated with worse SRH in a Latin American admixed population. Both genomic ancestry and ethnoracial self-classification did not modify the strong association between baseline SRH or SRH trajectory, and subsequent mortality.	[Lima-Costa, M. Fernanda; de Melo Mambrini, Juliana Vaz; Peixoto, Sergio V.; Castro-Costa, Erico; Firmo, Joselia O. A.; Proietti, Fernando A.] Fundacao Oswaldo Cruz, Inst Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Macinko, James] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA; [Macinko, James] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA USA; [Cesar, Cibele C.] Univ Fed Minas Gerais, Dept Estat, Belo Horizonte, MG, Brazil; [Magalhaes, Wagner C. S.; Leal, Thiago Peixoto; Rodrigues, Maira R.; Tarazona-Santos, Eduardo] Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Horta, Bernardo L.] Univ Fed Pelotas, Dept Social Med, Pelotas, RS, Brazil; [Barreto, Mauricio] Fundacao Oswaldo Cruz, Inst Pesquisas Goncalo Muniz, Salvador, BA, Brazil; [Pereira, Alexandre] Univ Sao Paulo, Inst Coracao, Sao Paulo, Brazil	Fundacao Oswaldo Cruz; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Pelotas; Fundacao Oswaldo Cruz; Universidade de Sao Paulo	Lima-Costa, MF (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	lima-costa@cpqrr.fiocruz.br	de Melo Mambrini, Juliana Vaz/AAO-9462-2021; Pereira, Alexandre/HHN-1038-2022; Firmo, Josélia Oliveira Araújo/AAD-6553-2022; Peixoto, SÃ©rgio/AAK-7335-2021; Tarazona-Santos, Eduardo/AAF-1110-2019; Horta, Bernardo/A-7604-2008; Costa, Maria Fernanda Furtado de Lima e/ABE-3779-2021; Magalhaes, Wagner CS/D-8822-2015; Barreto, Mauricio L/B-1752-2008; Peixoto, Sergio/K-3230-2016; de Castro e Costa, Erico/G-1684-2014	Firmo, Josélia Oliveira Araújo/0000-0001-5330-476X; Horta, Bernardo/0000-0001-9843-412X; Costa, Maria Fernanda Furtado de Lima e/0000-0002-3474-2980; Barreto, Mauricio L/0000-0002-0215-4930; Tarazona, Eduardo/0000-0003-3508-3160; Peixoto, Sergio/0000-0001-9431-2280; Macinko, James/0000-0001-8055-5441; Peixoto Leal, Thiago/0000-0002-5829-6452; de Castro e Costa, Erico/0000-0003-0792-5439	Department of Science and Technology (DECIT, Ministry of Health); National Fund for Scientific and Technological Development (FNDCT, Ministry of Science and Technology); Funding of Studies and Projects (FINEP, Ministry of Science and Technology, Brazil); Coordination of Improvement of Higher Education Personnel (CAPES, Ministry of Education, Brazil)	Department of Science and Technology (DECIT, Ministry of Health); National Fund for Scientific and Technological Development (FNDCT, Ministry of Science and Technology); Funding of Studies and Projects (FINEP, Ministry of Science and Technology, Brazil); Coordination of Improvement of Higher Education Personnel (CAPES, Ministry of Education, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Department of Science and Technology (DECIT, Ministry of Health) and National Fund for Scientific and Technological Development (FNDCT, Ministry of Science and Technology), Funding of Studies and Projects (FINEP, Ministry of Science and Technology, Brazil), Coordination of Improvement of Higher Education Personnel (CAPES, Ministry of Education, Brazil). MFLC, SVP, JOAF, FAP, CCC and ETS are fellow researchers of the National Council for Research and Technological Development (CNPq).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Beleigoli AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075809; Beleigoli AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052111; Benyamini Y, 2003, GERONTOLOGIST, V43, P396, DOI 10.1093/geront/43.3.396; de Oliveira BLCA, 2014, CAD SAUDE PUBLICA, V30, P1438, DOI 10.1590/0102-311X00071413; Chor D, 2004, INT J EPIDEMIOL, V33, P100, DOI 10.1093/ije/dyg277; Costa E, 2006, INT PSYCHOGERIATR, V18, P493, DOI 10.1017/S1041610205002954; COX DR, 1972, J R STAT SOC B, V34, P187; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Diggle P. J., 2002, ANALYSIS OF LONGITUD; Lima-Costa MF, 2012, ANN EPIDEMIOL, V22, P644, DOI 10.1016/j.annepidem.2012.06.101; Fernandes F., 1972, NEGRO MUNDO BRANCOS; Fitzmaurice GM, 2011, APPLIED LONGITUDINAL; Franks P, 2003, SOC SCI MED, V56, P2505, DOI 10.1016/S0277-9536(02)00281-2; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2013, ATLAS DO CENSO DEMOG; Ismail K, 2008, EVID-BASED MENT HEAL, V11, P99, DOI 10.1136/ebmh.11.4.99; Jurges H, 2007, HEALTH ECON, V16, P163, DOI 10.1002/hec.1134; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kwate NOA, 2014, SOC SCI MED, V116, P150, DOI 10.1016/j.socscimed.2014.05.041; Lee SJ, 2007, J AM GERIATR SOC, V55, P1624, DOI 10.1111/j.1532-5415.2007.01360.x; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lima-Costa MF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09812; Lima-Costa MF, 2012, AM J EPIDEMIOL, V175, P228, DOI 10.1093/aje/kwr290; Lima-Costa MF, 2011, INT J EPIDEMIOL, V40, P862, DOI 10.1093/ije/dyq143; Lima-Costa MF, 2010, STROKE, V41, P2477, DOI 10.1161/STROKEAHA.110.588061; Lima-Costa MF, 2010, AM J EPIDEMIOL, V172, P190, DOI 10.1093/aje/kwq106; Lopez R, 2004, SOC SCI MED, V59, P2409, DOI 10.1016/j.socscimed.2004.03.033; Meyer OL, 2014, AM J PUBLIC HEALTH, V104, P1734, DOI 10.2105/AJPH.2014.302003; Montenegro RA, 2006, LANCET, V367, P1859, DOI 10.1016/S0140-6736(06)68808-9; Perreira KM, 2014, SOC SCI MED, V116, P241, DOI 10.1016/j.socscimed.2014.05.054; Prefeitura Municipal de Bambui, 2015, HISTORIA DA CIDADE; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Silva Clarice Lima Alvares da, 2013, Cad Saude Publica, V29, P2241; Telles E. E., 2004, RACE IN ANOTHER AMER; Telles E, 2013, HAHR-HISP AM HIST R, V93, P411, DOI 10.1215/00182168-2210858; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; Travassos C, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-35; Viruell-Fuentes EA, 2011, AM J PUBLIC HEALTH, V101, P1306, DOI 10.2105/AJPH.2009.175455	41	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144456	10.1371/journal.pone.0144456	http://dx.doi.org/10.1371/journal.pone.0144456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680774	gold, Green Submitted, Green Published			2022-12-27	WOS:000366723400014
J	Ayo, CM; Camargo, AVD; Frederico, FB; Siqueira, RC; Previato, M; Murata, FHA; Silveira-Carvalho, AP; Barbosa, AP; de Mattos, CDB; de Mattos, LC				Ayo, Christiane Maria; da Silveira Camargo, Ana Vitoria; Frederico, Fabio Batista; Siqueira, Rubens Camargo; Previato, Mariana; Antunes Murata, Fernando Henrique; Silveira-Carvalho, Aparecida Perpetuo; Barbosa, Amanda Pires; Brandao de Mattos, Cinara de Cassia; de Mattos, Luiz Carlos			MHC Class I Chain-Related Gene A Polymorphisms and Linkage Disequilibrium with HLA-B and HLA-C Alleles in Ocular Toxoplasmosis	PLOS ONE			English	Article							CONGENITAL TOXOPLASMOSIS; NK CELLS; GLOBAL REASSESSMENT; MICA POLYMORPHISM; MEMORIAL-LECTURE; SOUTHERN BRAZIL; EYE LESIONS; T-CELLS; GONDII; DISEASE	This study investigated whether polymorphisms of the MICA (major histocompatibility complex class I chain-related gene A) gene are associated with eye lesions due to Toxoplasma gondii infection in a group of immunocompetent patients from southeastern Brazil. The study enrolled 297 patients with serological diagnosis of toxoplasmosis. Participants were classified into two distinct groups after conducting fundoscopic exams according to the presence (n = 148) or absence (n = 149) of ocular scars/lesions due to toxoplasmosis. The group of patients with scars/lesions was further subdivided into two groups according to the type of the ocular manifestation observed: primary (n = 120) or recurrent (n = 28). Genotyping of the MICA and HLA alleles was performed by the polymerase chain reaction-sequence specific oligonucleotide technique (PCR-SSO; One Lambda (R)) and the MICA-129 polymorphism (rs1051792) was identified by nested polymerase chain reaction (PCR-RFLP). Significant associations involving MICA polymorphisms were not found. Although the MICA*002 similar to HLA-B*35 haplotype was associated with increased risk of developing ocular toxoplasmosis (P-value = 0.04; OR = 2.20; 95% CI = 1.05-4.60), and the MICA*008 similar to HLA-C*07 haplotype was associated with protection against the development of manifestations of ocular toxoplasmosis (P-value = 0.009; OR: 0.44; 95% CI: 0.22-0.76), these associations were not statistically significant after adjusting for multiple comparisons. MICA polymorphisms do not appear to influence the development of ocular lesions in patients diagnosed with toxoplasmosis in this study population.	[Ayo, Christiane Maria; da Silveira Camargo, Ana Vitoria; Siqueira, Rubens Camargo; Previato, Mariana; Antunes Murata, Fernando Henrique; Silveira-Carvalho, Aparecida Perpetuo; Brandao de Mattos, Cinara de Cassia; de Mattos, Luiz Carlos] Fac Med Sao Jose Rio Preto Sao Jose Rio Preto, Dept Mol Biol, Immunogenet Lab, Sao Jose Do Rio Preto, SP, Brazil; [Frederico, Fabio Batista; Barbosa, Amanda Pires] Hosp Base Sao Jose Rio Preto, Ophthalmol Outpatient Clin, Fundacao Fac Reg Med Sao Jose Rio Preto, Sao Jose Do Rio Preto, SP, Brazil; [Ayo, Christiane Maria; da Silveira Camargo, Ana Vitoria; Frederico, Fabio Batista; Previato, Mariana; Antunes Murata, Fernando Henrique; Barbosa, Amanda Pires; Brandao de Mattos, Cinara de Cassia; de Mattos, Luiz Carlos] Fundacao Fac Reg Med Sao Jose Do Rio Preto, FAMERP Toxoplasma Res Grp, Sao Jose Do Rio Preto, SP, Brazil	Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)	de Mattos, LC (corresponding author), Fac Med Sao Jose Rio Preto Sao Jose Rio Preto, Dept Mol Biol, Immunogenet Lab, Sao Jose Do Rio Preto, SP, Brazil.	luiz.demattos@outlook.com	Frederico, Fábio Batista/AAE-2118-2019; BRANDÃO, CINARA/B-3650-2008; Murata, Fernando/AFV-2409-2022; ayo, christiane/B-5448-2017; Ayo, Christiane/AAE-2356-2019; PREVIATO, MARIANA/O-6122-2018; Murata, Fernando Henrique Antunes/AAD-5840-2020; de Mattos, Luiz Carlos/P-3574-2019; DE MATTOS, LUIZ CARLOS/F-6739-2010; de Mattos, Luiz Carlos/P-4005-2019	Frederico, Fábio Batista/0000-0002-0993-7938; BRANDÃO, CINARA/0000-0002-4836-3113; Ayo, Christiane/0000-0003-3983-0119; Murata, Fernando Henrique Antunes/0000-0002-4642-9553; DE MATTOS, LUIZ CARLOS/0000-0002-8572-8177; de Mattos, Luiz Carlos/0000-0002-8572-8177; Siqueira, Rubens/0000-0003-4563-1570	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/06580-9, 2013/10050-5, 2013/15879-8, 2015/13723-6, 2013/25650-8, 2009/17540-2]; Fundacao de Apoio a Pesquisa e Extensao de Sao Jose do Rio Preto (FAPERP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Faculdade de Medicina de Sao Jose do Rio Preto (BAP-FAMERP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473579/2009-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Apoio a Pesquisa e Extensao de Sao Jose do Rio Preto (FAPERP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Faculdade de Medicina de Sao Jose do Rio Preto (BAP-FAMERP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grants: 2013/06580-9 to CMA; 2013/10050-5 to MP; 2013/15879-8 to FHAM; 2015/13723-6 to CCBM; 2013/25650-8 and 2009/17540-2 to LCM); by Fundacao de Apoio a Pesquisa e Extensao de Sao Jose do Rio Preto (FAPERP) to FHAM. AVSC was supported by scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). CCBM was supported by grant from Faculdade de Medicina de Sao Jose do Rio Preto (BAP-FAMERP). LCM was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (grant: 473579/2009-0). FBF RCS APB APSC were not supported by grants. The opinions, assumptions, and conclusions or recommendations expressed in this material are the responsibility of the authors and do not necessarily reflect the views of FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour Y, 2014, INT J IMMUNOGENET, V41, P486, DOI 10.1111/iji.12146; Carneiro ACAV, 2013, J CLIN MICROBIOL, V51, P901, DOI 10.1128/JCM.02502-12; Amroun H, 2005, HUM IMMUNOL, V66, P1057, DOI 10.1016/j.humimm.2005.09.004; Andrade GMQ, 2009, J PEDIAT, V86, P85; Arantes TEF, 2015, AM J OPHTHALMOL, V159, P1002, DOI 10.1016/j.ajo.2015.02.015; Aspinall TV, 2003, INT J PARASITOL, V33, P97, DOI 10.1016/S0020-7519(02)00230-8; Ayo CM, 2015, CLIN INFECT DIS; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Berrebi A, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.002; Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Bosch-Driessen LEH, 2002, OPHTHALMOLOGY, V109, P869, DOI 10.1016/S0161-6420(02)00990-9; Bustillo JL, 2015, BRIT J OPHTHALMOL, V99, P382, DOI 10.1136/bjophthalmol-2014-305843; Caspi RR, 2006, IMMUNOL REV, V213, P23, DOI 10.1111/j.1600-065X.2006.00439.x; Collins RWM, 2004, EUR J IMMUNOGENET, V31, P105, DOI 10.1111/j.1365-2370.2004.00457.x; Combe CL, 2005, INFECT IMMUN, V73, P4913, DOI 10.1128/IAI.73.8.4913-4921.2005; Crane IJ, 2008, SEMIN IMMUNOPATHOL, V30, P165, DOI 10.1007/s00281-008-0106-7; de-la-Torre A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002541; DEBOER JH, 1994, INVEST OPHTH VIS SCI, V35, P3702; del Puerto F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001587; DESMONTS G, 1974, NEW ENGL J MED, V290, P1110, DOI 10.1056/NEJM197405162902003; Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765; Dutra MS, 2013, J INFECT DIS, V207, P152, DOI 10.1093/infdis/jis640; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Ferreira AIC, 2014, EPIDEMIOL INFECT, V142, P142, DOI 10.1017/S0950268813000526; Furtado JM, 2013, CLIN EXP OPHTHALMOL, V41, P82, DOI 10.1111/j.1442-9071.2012.02821.x; Garcia G, 2011, HUM IMMUNOL, V72, P904, DOI 10.1016/j.humimm.2011.06.010; GAZZINELLI RT, 1994, EXP PARASITOL, V78, P217, DOI 10.1006/expr.1994.1022; Gilbert RE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000277; Gong Z, 2012, BRAZ J MED BIOL RES, V45, P222, DOI 10.1590/S0100-879X2012007500024; Grigg ME, 2015, AM J OPHTHALMOL, V159, P999, DOI 10.1016/j.ajo.2015.04.005; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Holland GN, 2004, AM J OPHTHALMOL, V137, P1, DOI 10.1016/j.ajo.2003.10.032; Holland GN, 2003, AM J OPHTHALMOL, V136, P973, DOI 10.1016/j.ajo.2003.09.040; Hong JX, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-6; Hunter CA, 1996, CURR TOP MICROBIOL, V219, P113; Imanish T, 1992, HLA 1991, V1, P1065; Jones JL, 2014, AM J TROP MED HYG, V90, P794, DOI 10.4269/ajtmh.13-0722; Khan A, 2006, EMERG INFECT DIS, V12, P942, DOI 10.3201/eid1206.060025; Klaren VNA, 2001, J IMMUNOL, V167, P6263, DOI 10.4049/jimmunol.167.11.6263; Lemaitre C, 2001, INVEST OPHTH VIS SCI, V42, P2022; Lopez-Hernandez R, 2010, HUM IMMUNOL, V71, P512, DOI 10.1016/j.humimm.2010.02.003; Lu FL, 2004, INFECT IMMUN, V72, P4966, DOI 10.1128/IAI.72.9.4966-4972.2004; Maenz M, 2014, PROG RETIN EYE RES, V39, P77, DOI 10.1016/j.preteyeres.2013.12.005; Marin MLC, 2004, EUR J IMMUNOGENET, V31, P63, DOI 10.1111/j.1365-2370.2004.00446.x; Meerburg BG, 2009, PARASITOL RES, V105, P17, DOI 10.1007/s00436-009-1447-4; Mendes NHD, 2014, T ROY SOC TROP MED H, V108, P656, DOI 10.1093/trstmh/tru113; Miller CM, 2009, INT J PARASITOL, V39, P23, DOI 10.1016/j.ijpara.2008.08.002; Nagineni CN, 2002, CLIN EXP IMMUNOL, V128, P372, DOI 10.1046/j.1365-2249.2002.01815.x; Pardoll DM, 2001, SCIENCE, V294, P534, DOI 10.1126/science.1066284; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Phan L, 2008, AM J OPHTHALMOL, V146, P375, DOI 10.1016/j.ajo.2008.04.033; Phan L, 2008, OPHTHALMOLOGY, V115, P553, DOI 10.1016/j.ophtha.2007.06.022; Pleyer U, 2014, OPHTHALMIC RES, V52, P116, DOI 10.1159/000363141; Pollock RA, 2013, TISSUE ANTIGENS, V82, P43, DOI 10.1111/tan.12126; Ribas F, 2008, TISSUE ANTIGENS, V72, P532, DOI 10.1111/j.1399-0039.2008.01142.x; Ferreira IMR, 2011, EXP PARASITOL, V129, P190, DOI 10.1016/j.exppara.2011.06.002; Roberts F, 1999, PARASITOL TODAY, V15, P51, DOI 10.1016/S0169-4758(98)01377-5; Rosenberg EA, 2008, AM FAM PHYSICIAN, V77, P1431; Rothova Aniki, 2003, Curr Opin Ophthalmol, V14, P384, DOI 10.1097/00055735-200312000-00011; Sáfadi Marco A. P., 2003, Braz J Infect Dis, V7, P325, DOI 10.1590/S1413-86702003000500007; Sauer A, 2012, J INFECT DIS, V206, P1319, DOI 10.1093/infdis/jis486; do Sacramento WS, 2012, INT J IMMUNOGENET, V39, P210, DOI 10.1111/j.1744-313X.2011.01074.x; Solana R, 2012, SEMIN IMMUNOL, V24, P331, DOI 10.1016/j.smim.2012.04.008; Souza CF, 2012, TISSUE ANTIGENS, V79, P58, DOI 10.1111/j.1399-0039.2011.01789.x; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Stephens HAF, 2001, TRENDS IMMUNOL, V22, P378, DOI 10.1016/S1471-4906(01)01960-3; Streilein JW, 1999, PROG RETIN EYE RES, V18, P357, DOI 10.1016/S1350-9462(98)00022-6; Vasconcelos-Santos DV, 2012, CURR OPIN OPHTHALMOL, V23, P543, DOI 10.1097/ICU.0b013e328358bae5; Yoshida K, 2011, ARTHRITIS RHEUM-US, V63, P3058, DOI 10.1002/art.30501; Zwirner NW, 2006, INMUNOLOGIA, V25, P25	72	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144534	10.1371/journal.pone.0144534	http://dx.doi.org/10.1371/journal.pone.0144534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672749	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700043
J	Chen, YM; Hou, YS; Guo, ZX; Wang, WQ; Zhong, CR; Zhou, RC; Shi, SH				Chen, Yongmei; Hou, Yansong; Guo, Zixiao; Wang, Wenqing; Zhong, Cairong; Zhou, Renchao; Shi, Suhua			Applications of Multiple Nuclear Genes to the Molecular Phylogeny, Population Genetics and Hybrid Identification in the Mangrove Genus Rhizophora	PLOS ONE			English	Article							ADAPTIVE INTROGRESSION; NATURAL HYBRIDIZATION; CHLOROPLAST DNA; RIBOSOMAL DNA; R. MUCRONATA; SOFTWARE; PATTERNS; TRAITS	The genus Rhizophora is one of the most important components of mangrove forests. It is an ideal system for studying biogeography, molecular evolution, population genetics, hybridization and conservation genetics of mangroves. However, there are no sufficient molecular markers to address these topics. Here, we developed 77 pairs of nuclear gene primers, which showed successful PCR amplifications across all five Rhizophora species and sequencing in R. apiculata. Here, we present three tentative applications using a subset of the developed nuclear genes to (I) reconstruct the phylogeny, (II) examine the genetic structure and (III) identify natural hybridization in Rhizophora. Phylogenetic analyses support the hypothesis that Rhizophora had disappeared in the Atlantic-East Pacific (AEP) region and was re-colonized from the IWP region approximately 12.7 Mya. Population genetics analyses in four natural populations of R. apiculata in Hainan, China, revealed extremely low genetic diversity, strong population differentiation and extensive admixture, suggesting that the Pleistocene glaciations, particularly the last glacial maximum, greatly influenced the population dynamics of R. apiculata in Hainan. We also verified the hybrid status of a morphologically intermediate individual between R. apiculata and R. stylosa in Hainan. Based on the sequences of five nuclear genes and one chloroplast intergenic spacer, this individual is likely to be an F1 hybrid, with R. stylosa as its maternal parent. The nuclear gene markers developed in this study should be of great value for characterizing the hybridization and introgression patterns in other cases of this genus and testing the role of natural selection using population genomics approaches.	[Chen, Yongmei; Hou, Yansong; Guo, Zixiao; Zhou, Renchao; Shi, Suhua] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Yongmei; Hou, Yansong; Guo, Zixiao; Zhou, Renchao; Shi, Suhua] Sun Yat Sen Univ, Guangdong Prov Key Lab Plant Resources, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Wenqing] Xiamen Univ, Sch Life Sci, Xiamen, Fujian, Peoples R China; [Zhong, Cairong] Hainan Dongzhai Harbor Natl Nat Reserve, Haikou, Hainan, Peoples R China; [Chen, Yongmei] Univ Sichuan Sci & Engn, Sch Chem & Pharmaceut Engn, Zigong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Xiamen University	Zhou, RC (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	zhrench@mail.sysu.edu.cn; lssssh@mail.sysu.edu.cn		Guo, Zixiao/0000-0003-4820-4056	National Natural Science Foundation of China [41130208, 91331202, 31170213, 91231106]; State Key Laboratory of Biocontrol [SKLBC14A03]; Chang Hungta Science Foundation of Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Biocontrol; Chang Hungta Science Foundation of Sun Yat-sen University	This project was supported by grants from the National Natural Science Foundation of China (http://npd.nsfc.gov.cn/fundingProjectSearchAction.action, Nos. 41130208 and 91331202 (SS received the funding), 31170213 and 91231106 (RZ received the funding)), the State Key Laboratory of Biocontrol (http://sklbc.sysu.edu.cn/Ky_work/Project/index.aspx?typeid=273, Nos. SKLBC14A03 (SS received the funding)) and the Chang Hungta Science Foundation of Sun Yat-sen University. All funders supported the study design. The data collection and analysis were supported by grants from the National Natural Science Foundation of China (Nos. 41130208 and 91331202) and the State Key Laboratory of Biocontrol (Nos. SKLBC14A03). The preparation of the manuscript and decision to publish were supported by grants from the National Natural Science Foundation of China (Nos. 31170213 and 91231106).	Arnold Michael L., 2009, Journal of Biology (London), V8, P82, DOI 10.1186/jbiol176; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Cannon CH, 2009, P NATL ACAD SCI USA, V106, P11188, DOI 10.1073/pnas.0809865106; CARNEY SE, 1994, AM J BOT, V81, P1169, DOI 10.2307/2445479; Ceron-Souza I, 2010, AM J BOT, V97, P945, DOI 10.3732/ajb.0900172; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drexler Judy Z., 2001, Pacific Science, V55, P17, DOI 10.1353/psc.2001.0004; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duke NC, 2010, BLUMEA, V55, P171, DOI 10.3767/000651910X527293; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; Duke NC, 2002, TREES-STRUCT FUNCT, V16, P65, DOI 10.1007/s00468-001-0141-7; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Graham A, 2006, ANN MO BOT GARD, V93, P325, DOI 10.3417/0026-6493(2006)93[325:PEAMDI]2.0.CO;2; Guo MM, 2011, AQUAT BOT, V95, P59, DOI 10.1016/j.aquabot.2011.03.001; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Inomata N, 2009, GENES GENET SYST, V84, P277, DOI 10.1266/ggs.84.277; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lo EYY, 2010, J EVOLUTION BIOL, V23, P2249, DOI 10.1111/j.1420-9101.2010.02087.x; Lo EYY, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-83; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Miyama M, 2006, PLANT SCI, V171, P234, DOI 10.1016/j.plantsci.2006.03.015; Ng W, 2015, CONSERV GENET, V16, P137, DOI 10.1007/s10592-014-0647-3; Ng WL, 2015, AQUAT BOT, V120, P222, DOI 10.1016/j.aquabot.2014.07.006; Ng WL, 2013, TREE GENET GENOMES, V9, P1151, DOI 10.1007/s11295-013-0619-7; Park KR, 2003, BOT B ACAD SINICA, P44; Parks DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069885; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RABINOWITZ D, 1978, J BIOGEOGR, V5, P113, DOI 10.2307/3038167; Rambaut A., 2003, TRACER; Ricklefs RE, 2006, AM NAT, V168, P805, DOI 10.1086/508711; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sandoval-Castro E, 2012, AQUAT BOT, V99, P20, DOI 10.1016/j.aquabot.2012.01.002; Schwarzbach AE, 2000, AM J BOT, V87, P547, DOI 10.2307/2656599; Schwarzbach Andrea E., 2001, Wetlands Ecology and Management, V9, P195, DOI 10.1023/A:1011104706251; Shi SH, 2002, BIOCHEM SYST ECOL, V30, P309, DOI 10.1016/S0305-1978(01)00102-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomlinson PB, 1986, THE BOTANY OF MANGRO; Triest L, 2008, AQUAT BOT, V89, P138, DOI 10.1016/j.aquabot.2007.12.013; Vaillancourt RE, 2000, THEOR APPL GENET, V101, P473, DOI 10.1007/s001220051505; Vergeer P, 2013, NEW PHYTOL, V197, P989, DOI 10.1111/nph.12060; Wee AKS, 2014, J BIOGEOGR, V41, P954, DOI 10.1111/jbi.12263; Whitney KD, 2006, AM NAT, V167, P794, DOI 10.1086/504606; Whitney KD, 2010, NEW PHYTOL, V187, P230, DOI 10.1111/j.1469-8137.2010.03234.x; Woodruff DS, 2010, BIODIVERS CONSERV, V19, P919, DOI 10.1007/s10531-010-9783-3; Zhang RS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-74; Zhou RC, 2005, MOL PHYLOGENET EVOL, V35, P595, DOI 10.1016/j.ympev.2005.03.012; Zhou RC, 2011, MOL BIOL EVOL, V28, P2833, DOI 10.1093/molbev/msr102	51	10	10	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145058	10.1371/journal.pone.0145058	http://dx.doi.org/10.1371/journal.pone.0145058			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674070	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700090
J	Yamada, T; Yamada, M; Tsukagoshi, M				Yamada, Toshihiro; Yamada, Mariko; Tsukagoshi, Minoru			Taxonomic Revision of Pinus fujiii (Yasui) Miki (Pinaceae) and Its Implications for the Phytogeography of the Section Trifoliae in East Asia	PLOS ONE			English	Article							FOSSIL; MIOCENE; WASHINGTON; PHYLOGENY; JAPAN; CONES; MA	Pinus trifolia Miki 1939 (Pinaceae) was originally proposed based on seed cones from the upper Miocene of Aichi and Gifu Prefectures, central Japan. However, before the publication of P. trifolia, a different name (Pinus fujiii (Yasui) Miki) was given to a female cone with the same morphology. On the other hand, P. fujiii auct. non (Yasui) Miki has been used for seed cones with different morphologies from Yasui's holotype, i.e., apophyses arranged in 5:8 parastichies and a perexcentromucronate slightly-pointed umbo. As a result of re-examination on the Miki and Yasui specimens, we concluded that P. trifolia was a synonym for P. fujiii and proposed here Pinus mikii sp. nov. for cones assigned to P. fujiii auct. non (Yasui) Miki. We also emended the diagnosis of P. fujiii based on these specimens. Pinus fujiii is characterized by a large female cone in which the apophyses with a centromucronate prickle-like umbo are arranged in 8:13 parastichies, and deciduous seed wings. These characters suggest that P. fujiii belongs to the section Trifoliae of the subgenus Pinus, which is now restricted to North and Central America and the Caribbean islands. Fossil data suggest that the P. fujiii lineage firstly appeared in Japan around the Eocene/Oligocene boundary. We speculate that the P. fujiii lineage might have moved southward to Japan from a refugium located elsewhere in high-latitude areas in response to the late Eocene cooling event, as occurred with other Trifoliae species in North America.	[Yamada, Toshihiro; Yamada, Mariko] Kanazawa Univ, Coll Sci & Engn, Sch Nat Syst, Kanazawa, Ishikawa, Japan; [Tsukagoshi, Minoru] Osaka Museum Nat Hist, Osaka, Japan	Kanazawa University	Yamada, T (corresponding author), Kanazawa Univ, Coll Sci & Engn, Sch Nat Syst, Kanazawa, Ishikawa, Japan.	ptilo@mb.infoweb.ne.jp	Yamada, Mariko/GQY-4891-2022; Yamada, Toshihiro/L-3594-2015	Yamada, Toshihiro/0000-0002-9064-7048	Ministry of Education, Culture, Sports, Science and Technology [26304010]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by KAKENHI (Grant-in-Aid for Scientific Research) 26304010 from the Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp) to TY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 1999, B GIFU PREF MUS, V20, P17; AXELROD D., 1967, P S BIOL CALIFORNIA, P93; AXELROD D I, 1984, Transactions of the San Diego Society of Natural History, V20, P277; AXELROD DI, 1986, ANN MO BOT GARD, V73, P565, DOI 10.2307/2399194; Axelrod DI, 1937, PUBL CARNEGIE I WASH, V476, P125; Axelrod DI, 1950, PUBL CARNEGIE I WASH, V590, P119; Condit C, 1944, PUBL CARNEGIE I WASH, V553, P57; Debreczy Z, 2011, CONIFERS WORLD, V2; Debreczy Z, 2011, CONIFERS WORLD, V1-2; Dorf E., 1930, PUBL CARNEGIE I WASH, V412, P1; Duhamel du Monceau M., 1755, TRAITE ARBRES ARBUST, V2; Eckert AJ, 2006, MOL PHYLOGENET EVOL, V40, P166, DOI 10.1016/j.ympev.2006.03.009; FARJON A, 1997, FLORA NEOTROPICA MON, V75; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Gorozhankin I.N., 1904, LEKCII MORFOLOGII SI; Hernandez-Leon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070501; Ina H, 1981, MONOGRAPH MIZUNAMI F, V2, P1; Kimura T., 1981, T P PALAEONOLOGICAL, V122, P87; Kvacek Z, 2014, PALAEONTOGR ABT B, V291, P131; Lindley J, 1832, FOSSIL FLORA GREAT B, V1; Linnaeus C., 1753, SPECIES PLANTARUM, P1000; Little EL, 1969, USDA FOREST SERVICE, V1144; Loudon JC, 1838, ARBORETUM FRUCTICETU, V4, P2152; Maarten JM, 2011, PHYTOTAXA, V19, P55; MAI D H, 1986, Feddes Repertorium, V97, P571; Maruyama S, 1997, ISL ARC, V6, P121, DOI 10.1111/j.1440-1738.1997.tb00043.x; MATSUO H., 1963, TERTIARY FLORAS JAPA, P219; Miki S, 1972, GEOGR REP KUMAMOTO U, V2, P72; MIKI S, 1948, MINERAL GEOL, V2, P105; MIKI SHIGERU, 1941, JAPANESE JOUR BOT, V11, P237; MIKI SHIGERU, 1939, BOT MAG [TOKYO], V53, P239; Mili S., 1957, Journal of the Institute of Polytechnics, Osaka City University, Osaka Ser. D., P221; Millar Constance L., 1998, P69; MILLER CN, 1992, AM J BOT, V79, P754, DOI 10.2307/2444940; MILLER CN, 1978, B TORREY BOT CLUB, V105, P93, DOI 10.2307/2484425; Mirov N. T., 1967, GENUS PINUS; Muller K, 2004, MOL PHYLOGENET EVOL, V31, P780, DOI 10.1016/j.ympev.2003.12.006; Nakayama K, 1989, EARTH SCI, V43, P40; Nakayama K, 1999, EARTH SCI, V53, P173; Nirei T, 2011, B SAITAMA MUS NAT HI, V5, P101; Oga Y, 1960, J SOC EARTHSCIENTIST, V11, P228; Omori M, 1965, J GEOL SOC JAPAN, V842, P467; Ozaki Masanori, 1996, Journal of the Geological Society of Japan, V102, P73; Pilger R., 1926, NATURL PFLANZ, VXIII, P331; Price Robert A., 1998, P49; Rossler R, 2014, TAXON, V63, P177, DOI 10.12705/631.7; Saneyoshi M, 2000, EARTH SCI, V54, P127; Sawada K, 2013, INT J COAL GEOL, V107, P78, DOI 10.1016/j.coal.2012.10.013; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanai T., 1961, J FS HOKKAIDO U, V11, P119; Teodoridis V, 2008, NEUES JAHRB GEOL P-A, V250, P287, DOI 10.1127/0077-7749/2008/0250-0287; Thiers B., INDEX HERBARIORUM GL; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; TSUKAGOSHI M, 1998, J GEOL SOC JAPAN, V104, P495; UNDERWOOD JC, 1980, AM J BOT, V67, P1132, DOI 10.2307/2442205; WIGGINS IL, 1951, AM J BOT, V38, P211, DOI 10.2307/2438071; Willyard A, 2007, MOL BIOL EVOL, V24, P620, DOI 10.1093/molbev/msl207; Yamada M., 2014, J PHYTOGEOGRAPHY TAX, V62, P29; Yamada T, 2014, J PLANT RES, V127, P193, DOI 10.1007/s10265-013-0621-z; Yasui K., 1928, J FS IMPERIAL U TOKY, V1, P381; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	62	5	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143512	10.1371/journal.pone.0143512	http://dx.doi.org/10.1371/journal.pone.0143512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673795	Green Published, gold			2022-12-27	WOS:000366722700011
J	Zhou, XX; Wang, Q; Zhang, XL; Chen, YS; Peng, XC; Mao, YQ; Yang, Y; Fu, BG; Wang, XH; Tang, TT				Zhou, Xiaoxiao; Wang, Qi; Zhang, Xianlong; Chen, Yunsu; Peng, Xiaochun; Mao, Yuanqing; Yang, Yang; Fu, Beigang; Wang, Xiuhui; Tang, Tingting			Severe Pelvic Obliquity Affects Femoral Offset in Patients with Total Hip Arthroplasty but Not Leg-Length Inequality	PLOS ONE			English	Article							DISCREPANCY; MOTION; GAIT	Leg-length inequality is an extensively studied complication of total hip arthroplasty in normal patients. However, few studies have focused on the pelvic obliquity of coronal pelvic malrotation. We hypothesized that pelvic obliquity with a fixed abduction/adduction contracture deformity of the hip may intraoperatively affect the release of soft tissues, ultimately resulting in a leg-length inequality. This study also investigated whether the femoral and vertical offsets of total hip arthroplasty were correlated with pelvic obliquity. This prospective study divided 98 patients into six groups based on the inclination of pelvic obliquity before total hip arthroplasty. Leg-length inequality, variation of pelvic obliquity, offset, and vertical offset were measured after total hip arthroplasty. Leg-length inequality and vertical offset were not significantly different among groups, whereas the variation of pelvic obliquity was significantly higher in type IIC pelvic obliquity than in other groups. Type IC pelvic obliquity had a significantly shorter offset than did the other groups, which may have been an important factor leading to type IC pelvic obliquity. Pelvic obliquity exhibited no significant effect on leg-length inequality in patients with total hip arthroplasty. A shorter offset may be caused by the higher tension of the abductor in the operated hip, which may result in the formation of type IC pelvic obliquity. Releasing the abductor contracture and restoring femoral offset are important for increasing hip stability and maintaining pelvic balance following total hip arthroplasty.	[Zhou, Xiaoxiao; Fu, Beigang; Wang, Xiuhui] Shanghai Univ Med & Hlth Sci, Dept Orthoped, Zhoupu Hosp Pudong Dist, Shanghai, Peoples R China; [Wang, Qi; Zhang, Xianlong; Chen, Yunsu; Peng, Xiaochun] Shanghai Jiao Tong Univ, Dept Orthopaed, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China; [Mao, Yuanqing; Tang, Tingting] Shanghai Jiao Tong Univ, Dept Orthopaed, Peoples Hosp 9, Shanghai 200030, Peoples R China; [Yang, Yang] Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China	Shanghai University of Medicine & Health Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Wenzhou Medical University	Wang, Q (corresponding author), Shanghai Univ Med & Hlth Sci, Dept Orthoped, Zhoupu Hosp Pudong Dist, Shanghai, Peoples R China.	wongqi2010@126.com	Tang, Tingting/B-1361-2013; zhang, xian/GYA-0290-2022	Tang, Tingting/0000-0002-1670-7452; 				Bouffard V, 2011, REHABIL RES PRACT, V2011, DOI 10.1155/2011/586412; Brinckmann P, 2002, MUSCULOSKELETAL BIOM, P69; Charnley J., 1979, LOW FRICTION ARTHROP, P3; Dastane M, 2011, CLIN ORTHOP RELAT R, V469, P429, DOI 10.1007/s11999-010-1554-7; Dolhain P, 2002, Acta Orthop Belg, V68, P490; DUBOUSSET J, 1990, ORTHOPADE, V19, P300; FACKLER CD, 1980, CLIN ORTHOP RELAT R, P169; Feng Zongquan, 2000, CHIN J ORTHOP, V20, P649; Free SA, 1996, J ORTHOP RES, V14, P245, DOI 10.1002/jor.1100140212; GOODMAN SB, 1988, CLIN ORTHOP RELAT R, P199; Jasty M, 1996, CLIN ORTHOP RELAT R, P165; JOHNSTON RC, 1979, J BONE JOINT SURG AM, V61, P639, DOI 10.2106/00004623-197961050-00001; Kakushima M, 2003, SPINE, V28, P2472, DOI 10.1097/01.BRS.0000090829.82231.4A; Laupacis A, 2002, J BONE JOINT SURG AM, V84A, P1823, DOI 10.2106/00004623-200210000-00013; Lee DY, 1997, J BONE JOINT SURG BR, V79B, P190, DOI 10.1302/0301-620X.79B2.7052; Little NJ, 2009, CLIN ORTHOP RELAT R, V467, P2895, DOI 10.1007/s11999-009-0845-3; LOIZEAU J, 1995, ARCH PHYS MED REHAB, V76, P552, DOI 10.1016/S0003-9993(95)80510-9; Madsen MS, 2004, J ORTHOP RES, V22, P44, DOI 10.1016/S0736-0266(03)00151-7; Maloney WJ, 2004, J ARTHROPLASTY, V19, P108, DOI 10.1016/j.arth.2004.02.018; MCGRORY BJ, 1995, J BONE JOINT SURG BR, V77B, P865, DOI 10.1302/0301-620X.77B6.7593096; Nordin M, 2001, BASIC BIOMECHANICS M, P203; Polkowski GG, 2010, SPORTS MED ARTHROSC, V18, P56, DOI 10.1097/JSA.0b013e3181dc5774; Ranawat CS, 2001, J ARTHROPLASTY, V16, P715, DOI 10.1054/arth.2001.24442; Ranawat CS, 1997, J ARTHROPLASTY, V12, P359, DOI 10.1016/S0883-5403(97)90190-X; Restrepo C, 2011, CLIN ORTHOP RELAT R, V469, P476, DOI 10.1007/s11999-010-1561-8; Sathappan SS, 2008, J ARTHROPLASTY, V23, P203, DOI 10.1016/j.arth.2007.01.022; VASAVADA AN, 1994, CLIN ORTHOP RELAT R, P121; Visuri T, 1993, Ital J Orthop Traumatol, V19, P107; Zhao Hongwu, 2013, J PRACTICAL ORTHOPAE, V19, P1023; Zhou XX, 2012, J ARTHROPLASTY, V27, P299, DOI 10.1016/j.arth.2011.09.022	30	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144863	10.1371/journal.pone.0144863	http://dx.doi.org/10.1371/journal.pone.0144863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673427	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700067
J	Kingston, D; Austin, MP; McDonald, SW; Vermeyden, L; Heaman, M; Hegadoren, K; Lasiuk, G; Kingston, J; Sword, W; Jarema, K; van Zanten, SV; McDonald, SD; Biringer, A				Kingston, Dawn; Austin, Marie-Paule; McDonald, Sheila W.; Vermeyden, Lydia; Heaman, Maureen; Hegadoren, Kathleen; Lasiuk, Gerri; Kingston, Joshua; Sword, Wendy; Jarema, Karly; van Zanten, Sander Veldhuyzen; McDonald, Sarah D.; Biringer, Anne			Pregnant Women's Perceptions of Harms and Benefits of Mental Health Screening	PLOS ONE			English	Article							POSTNATAL DEPRESSION; ACCEPTABILITY; PREECLAMPSIA	Background A widely held concern of screening is that its psychological harms may outweigh the benefits of early detection and treatment. This study describes pregnant women's perceptions of possible harms and benefits of mental health screening and factors associated with identifying screening as harmful or beneficial. Methods This study analyzed a subgroup of women who had undergone formal or informal mental health screening from our larger multi-site, cross-sectional study. Pregnant women > 16 years of age who spoke/read English were recruited (May-December 2013) from prenatal classes and maternity clinics in Alberta, Canada. Descriptive statistics were generated to summarize harms and benefits of screening and multivariable logistic regression identified factors associated with reporting at least one harm or affirming screening as a positive experience (January-December 2014). Results Overall study participation rate was 92% (N = 460/500). Among women screened for mental health concerns (n = 238), 63% viewed screening as positive, 69% were glad to be asked, and 87% took it as evidence their provider cared about them. Only one woman identified screening as a negative experience. Of the 6 harms, none was endorsed by >7% of women, with embarrassment being most cited. Women who were very comfortable (vs somewhat/not comfortable) with screening were more likely to report it as a positive experience. Limitations Women were largely Caucasian, well-educated, partnered women; thus, findings may not be generalizable to women with socioeconomic risk. Conclusions Most women perceived prenatal mental health screening as having high benefit and low harm. These findings dispel popular concerns that mental health screening is psychologically harmful.	[Kingston, Dawn] Univ Alberta, Dept Obstet & Gynecol, Fac Nursing, Edmonton, AB, Canada; [Austin, Marie-Paule] Univ New S Wales, Sch Psychiat, St John God Chair Perinatal & Womens Mental Hlth, Sydney, NSW, Australia; [McDonald, Sheila W.] Alberta Hlth Serv, Populat Publ & Aboriginal Hlth, Calgary, AB, Canada; [Vermeyden, Lydia; Hegadoren, Kathleen; Jarema, Karly] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Heaman, Maureen] Univ Manitoba, Fac Hlth Sci, Coll Nursing, Winnipeg, MB, Canada; [Lasiuk, Gerri] Univ Saskatchewan, Fac Nursing, Regina, SK, Canada; [Kingston, Joshua] MacEwan Univ, Fac Sci Comp Sci, Edmonton, AB, Canada; [Sword, Wendy] Univ Ottawa, Fac Hlth Sci, Sch Nursing, Ottawa, ON, Canada; [van Zanten, Sander Veldhuyzen] Univ Alberta, Div Gastroenterol, Edmonton, AB, Canada; [McDonald, Sarah D.] McMaster Univ, Div Maternal Fetal Med, Dept Obstet & Gynecol, Hamilton, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Dept Radiol, Div Maternal Fetal Med, Hamilton, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Dept Clin Epidemiol & Biostat, Div Maternal Fetal Med, Hamilton, ON, Canada; [Biringer, Anne] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Biringer, Anne] Mt Sinai Hosp, Ray D Wolfe Dept Family Med, Matern Care, Toronto, ON M5G 1X5, Canada	University of Alberta; St John of God Health Care; University of New South Wales Sydney; Alberta Health Services (AHS); University of Calgary; University of Alberta; University of Manitoba; University of Saskatchewan; University of Ottawa; University of Alberta; McMaster University; McMaster University; McMaster University; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Kingston, D (corresponding author), Univ Alberta, Dept Obstet & Gynecol, Fac Nursing, Edmonton, AB, Canada.	dawn.kingston@ualberta.ca		Hegadoren, Kathy/0000-0001-5494-9658; Heaman, Maureen/0000-0002-8775-714X	Women's and Children's Health Research Institute (WCHRI, University of Alberta); Early Career Transition Award through Alberta Centre for Child, Family, and Community Research; Canadian Institutes of Health Research New Investigator Award; Tier 2 Canada Research Chair; Ada and Slaight Family Directorship in Maternity Care, Mount Sinai Hospital	Women's and Children's Health Research Institute (WCHRI, University of Alberta); Early Career Transition Award through Alberta Centre for Child, Family, and Community Research; Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Tier 2 Canada Research Chair(Canada Research Chairs); Ada and Slaight Family Directorship in Maternity Care, Mount Sinai Hospital	This study was funded by the Women's and Children's Health Research Institute (WCHRI, University of Alberta). The funder had no role in study design, data collection, analysis or interpretation of data, writing of the report, or decision where to submit for publication. Dr. Kingston is supported by an Early Career Transition Award through the Alberta Centre for Child, Family, and Community Research and a Canadian Institutes of Health Research New Investigator Award. Dr. Sarah McDonald is supported by a Tier 2 Canada Research Chair. Dr. Biringer is supported by the Ada and Slaight Family Directorship in Maternity Care, Mount Sinai Hospital.	Amir E, 2012, JNCI-J NATL CANCER I, V104, P1542, DOI 10.1093/jnci/djs394; [Anonymous], 2015, OBSTET GYNECOL, V125, P1268; Austin M-P., 2011, CLIN PRACTICE GUIDEL; Austin MP, 2014, BEST PRACT RES CL OB, V28, P179, DOI 10.1016/j.bpobgyn.2013.08.016; Austin MP, 2013, WOMEN BIRTH, V26, P17, DOI 10.1016/j.wombi.2011.06.002; Bond M, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17130; Bowen A, 2012, CAN J PSYCHIAT, V57, P161, DOI 10.1177/070674371205700305; Buist A, 2006, J AFFECT DISORDERS, V93, P233, DOI 10.1016/j.jad.2006.02.019; Chew-Graham CA, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-7; Clatworthy J, 2012, J AFFECT DISORDERS, V137, P25, DOI 10.1016/j.jad.2011.02.029; Gemmill AW, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-211; Giallo R, 2015, EUR CHILD ADOLESC PS; Green Sb, 1991, MULTIVARIATE BEHAV R; Holman LL, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.022; Hooper DE, 1996, J REPROD MED, V41, P885; Joffres M, 2013, CAN MED ASSOC J, V185, P775, DOI 10.1503/cmaj.130403; Kapadia MZ, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0535-y; Kingston D, 2015, AM J PREV M IN PRESS; Kingston D, 2015, J AFFECT DI IN PRESS; LaRocco-Cockburn A, 2003, OBSTET GYNECOL, V101, P892, DOI 10.1016/S0029-7844(03)00171-6; Leddy M, 2011, J PSYCHOSOM OBST GYN, V32, P27, DOI 10.3109/0167482X.2010.547639; Leigh B, 2007, AUST J ADV NURS, V24, P14; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Matthey S, 2005, ARCH WOMEN MENT HLTH, V8, P171, DOI 10.1007/s00737-005-0076-x; Mayo K, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.027; Milgrom J, 2014, EVID BASED NURS; NICE, 2014, ANT POSTN MENT HLTH, P192; Pare E, 2014, OBSTET GYNECOL, V124, P763, DOI 10.1097/AOG.0000000000000451; Pel A. J., 2015, PSYCHOL MED, P1, DOI [DOI 10.1080/14719037.2015.1045020, 10.3997/2214-4609.201412939]; Reid AJ, 1998, CAN MED ASSOC J, V159, P677; Rollans M, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-18; Shakespeare J, 2003, BRIT J GEN PRACT, V53, P614; Van den Bruel A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h980	33	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145189	10.1371/journal.pone.0145189	http://dx.doi.org/10.1371/journal.pone.0145189			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SH	26696004	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092500028
J	Nyikuri, M; Tsofa, B; Barasa, E; Okoth, P; Molyneux, S				Nyikuri, Mary; Tsofa, Benjamin; Barasa, Edwine; Okoth, Philip; Molyneux, Sassy			Crises and Resilience at the Frontline-Public Health Facility Managers under Devolution in a Sub-County on the Kenyan Coast	PLOS ONE			English	Article							SERVICE DELIVERY; HUMAN-RESOURCES; SYSTEMS; DECENTRALIZATION; ACCESS; LEVEL	Background Public primary health care (PHC) facilities are for many individuals the first point of contact with the formal health care system. These facilities are managed by professional nurses or clinical officers who are recognised to play a key role in implementing health sector reforms and facilitating initiatives aimed at strengthening community involvement. Little in-depth research exists about the dimensions and challenges of these managers' jobs, or on the impact of decentralisation on their roles and responsibilities. In this paper, we describe the roles and responsibilities of PHC managers-or 'in-charges' in Kenya, and their challenges and coping strategies, under accelerated devolution. Methods The data presented in this paper is part of a wider set of activities aimed at understanding governance changes under devolution in Kenya, under the umbrella of a 'learning site'. A learning site is a long term process of collaboration between health managers and researchers deciding together on key health system questions and interventions. Data were collected through seven formal in depth interviews and observations at four PHC facilities as well as eight in depth interviews and informal interactions with sub-county managers from June 2013 to July 2014. Drawing on the Aragon framework of organisation capacity we discuss the multiple accountabilities, daily routines, challenges and coping strategies among PHC facility managers. Results PHC in-charges perform complex and diverse roles in a difficult environment with relatively little formal preparation. Their key concerns are lack of job clarity and preparedness, the difficulty of balancing multidirectional accountability responsibilities amidst significant resource shortages, and remuneration anxieties. We show that day-to-day management in an environment of resource constraints and uncertainty requires PHC in-charges who are resilient, reflective, and continuously able to learn and adapt. We highlight the importance of leadership development including the building of critical soft skills such as relationship building.	[Nyikuri, Mary; Tsofa, Benjamin; Barasa, Edwine; Okoth, Philip; Molyneux, Sassy] KEMRI Wellcome Trust Res Programme KWTRP, Dept Hlth Syst & Res Eth, Kilifi, Kenya; [Barasa, Edwine] Univ Cape Town, Hlth Econ Unit, ZA-7975 Cape Town, South Africa; [Molyneux, Sassy] Univ Oxford, Dept Publ Hlth, Ethox Ctr, Oxford OX3 7LF, England; [Molyneux, Sassy] Univ Oxford, Nuffield Dept Med, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LF, England	University of Cape Town; University of Oxford; University of Oxford	Nyikuri, M (corresponding author), KEMRI Wellcome Trust Res Programme KWTRP, Dept Hlth Syst & Res Eth, POB 230-80108, Kilifi, Kenya.	mnyikuri@kemri-wellcome.org	Molyneux, Catherine/HGB-8464-2022	Molyneux, Catherine/0000-0001-9522-416X; Barasa, Edwine/0000-0001-5793-7177	KEMRI-Wellcome Trust Research Programme in Kenya [077092]; Wellcome Trust [085418]; UK Department for International Development as part of Consortium for Research on Resilient and Responsive Health Systems (RESYST.); Department for International Development (DFID) [201889] Funding Source: researchfish	KEMRI-Wellcome Trust Research Programme in Kenya; Wellcome Trust(Wellcome TrustEuropean Commission); UK Department for International Development as part of Consortium for Research on Resilient and Responsive Health Systems (RESYST.); Department for International Development (DFID)	M.N, B.T., E.B., P.O., and S.M. are members of the KEMRI-Wellcome Trust Research Programme in Kenya (core grant number #077092). S.M. was supported over the course of much of this work by a fellowship from the Wellcome Trust (grant number #085418). This work was supported by the UK Department for International Development as part of the Consortium for Research on Resilient and Responsive Health Systems (RESYST.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberese-Ako M, 2014, HEALTH POLICY PLANN, V29, P15, DOI 10.1093/heapol/czu068; Bardhan P, 2002, J ECON PERSPECT, V16, P185, DOI 10.1257/089533002320951037; Bossert TJ, 2002, HEALTH POLICY PLANN, V17, P14, DOI 10.1093/heapol/17.1.14; Cleary SM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-320; Conyers D, 2007, IDS BULL-I DEV STUD, V38, P18, DOI 10.1111/j.1759-5436.2007.tb00334.x; Daire J., 2014, DEV LEADERSHIP MANAG; Daire J, 2014, HEALTH POLICY PLANN, V29, P82, DOI 10.1093/heapol/czu075; Elloker S, 2012, S AFRICAN HLTH REV, V2012, P161; Gilson L, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-30; Gormley W, 2011, JAIDS-J ACQ IMM DEF, V57, pS113, DOI 10.1097/QAI.0b013e31821e9320; Kenya Go. Ministry of Health, 2007, PUBL EXP TRACK SURV; KNBoS, 2010, KEN DEM HLTH SURV 20; Mills A, 1990, HLTH SYSTEM DECENTRA; Mo Health, 2013, GUID COMM NURS SERV; Mogensen H. O., 2001, Urban Anthropology, V30, P71; Opwora A, 2010, HLTH POLICY PLANNING; Phillps-Howard PA, 2003, AM J TROP MED HYG, V68, P44, DOI 10.4269/ajtmh.2003.68.44; Ranson MK, 2003, J INT DEV J DEV STUD, V15, P15, DOI DOI 10.1002/JID.964; Rene Loewenson T, 2004, ASSESSING IMPACT HLT; Ritchie J., 2013, QUALITATIVE RES PRAC; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Schneider H, 2006, REPROD HEALTH MATTER, V14, P12, DOI 10.1016/S0968-8080(06)27232-X; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Scott V, 2014, HEALTH POLICY PLANN, V29, P59, DOI 10.1093/heapol/czu073; Sheikh K, 2014, HEALTH POLICY PLANN, V29, P1, DOI 10.1093/heapol/czu082; Sheikh K, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-19; Topp SM, 2015, HEALTH POLICY PLANN, V30, P485, DOI 10.1093/heapol/czu029; Tsofa B., 2015, INT J HLTH PLANNING; Walker L, 2004, SOC SCI MED, V59, P1251, DOI 10.1016/j.socscimed.2003.12.020; Waweru E, 2013, REV HLTH SECTO UNPUB; Waweru E, 2016, HEALTH POLICY PLANN, V31, P137, DOI 10.1093/heapol/czv030	31	43	45	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144768	10.1371/journal.pone.0144768	http://dx.doi.org/10.1371/journal.pone.0144768			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SH	26696096	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092500009
J	Zang, YF; Wei, XR; Hao, MD				Zang, Yifei; Wei, Xiaorong; Hao, Mingde			Long-Term Effect of Crop Rotation and Fertilisation on Bioavailability and Fractionation of Copper in Soil on the Loess Plateau in Northwest China	PLOS ONE			English	Article							SOLID-WASTE COMPOST; MICRONUTRIENT AVAILABILITY; ORGANIC-MATTER; SEWAGE-SLUDGE; HEAVY-METALS; HUMIC-ACID; ZINC; PHOSPHATE; SORPTION; ACCUMULATION	The bioavailability and fractionation of Cu reflect its deliverability in soil. Little research has investigated Cu supply to crops in soil under long-term rotation and fertilisation on the Loess Plateau. A field experiment was conducted in randomized complete block design to determine the bioavailability and distribution of Cu fractions in a Heilu soil (Calcaric Regosol) after 18 years of rotation and fertilisation. The experiment started in 1984, including five cropping systems (fallow control, alfalfa cropping, maize cropping, winter wheat cropping, and grain-legume rotation of pea/winter wheat/winter wheat + millet) and five fertiliser treatments (unfertilised control, N, P, N + P, and N + P + manure). Soil samples were collected in 2002 for chemical analysis. Available Cu was assessed by diethylene triamine pentaacetic acid (DTPA) extraction, and Cu was fractionated by sequential extraction. Results showed that DTPA-Cu was lower in cropping systems compared with fallow control. Application of fertilisers resulted in no remarkable changes in DTPA-Cu compared with unfertilised control. Correlation and path analyses revealed that soil pH and CaCO3 directly affected Cu bioavailability, whereas available P indirectly affected Cu bioavailability. The concentrations of Cu fractions (carbonate and Fe/Al oxides) in the plough layer were lower in cropping systems, while the values in the plough sole were higher under grain-legume rotation relative to fallow control. Manure with NP fertiliser increased Cu fractions bound to organic matter and minerals in the plough layer, and its effects in the plough sole varied with cropping systems. The direct sources (organic-matter-bound fraction and carbonate-bound fraction) of available Cu contributed much to Cu bioavailability. The mineral-bound fraction of Cu acted as an indicator of Cu supply potential in the soil.	[Zang, Yifei; Hao, Mingde] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China; [Wei, Xiaorong; Hao, Mingde] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Wei, Xiaorong; Hao, Mingde] Minist Water Resources, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources	Hao, MD (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China.	mdhao@ms.iswc.ac.cn	Hao, Ming/GXI-0243-2022		National Science and Technology Support Program [2011BAD31B01]	National Science and Technology Support Program	Funding provided by National Science and Technology Support Program (2011BAD31B01), http://program.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrochemistry Commission Soil Science Society of China, 1983, ROUT METH SOIL AGR A; Ahumada I, 2009, J ENVIRON MANAGE, V90, P2665, DOI 10.1016/j.jenvman.2009.02.004; [Anonymous], 1954, ESTIMATION AVAILABLE; BARROW NJ, 1987, J SOIL SCI, V38, P453, DOI 10.1111/j.1365-2389.1987.tb02280.x; Bhattacharyya P, 2006, ENVIRON GEOL, V49, P1064, DOI 10.1007/s00254-005-0150-8; Bradl HB, 2004, J COLLOID INTERF SCI, V277, P1, DOI 10.1016/j.jcis.2004.04.005; Cao J, 2004, CHEMOSPHERE, V54, P507, DOI 10.1016/j.chemosphere.2003.08.027; CLARK CJ, 1985, SOIL SCI, V139, P412, DOI 10.1097/00010694-198505000-00006; Fan JL, 2012, ENVIRON SCI POLLUT R, V19, P2745, DOI 10.1007/s11356-012-0774-7; FAO, 1988, SOIL MAP WORLD; Feng XY, 2007, POLL CONTROL TECHNOL, V20, P28; Fu HuiLan, 1997, Soybean Science, V16, P156; Gao M, 2000, PLANT NUTR FERTIL SC, V6, P11; Guan TX, 2011, CHEMOSPHERE, V82, P215, DOI 10.1016/j.chemosphere.2010.10.018; Gustafson GM, 2003, EUR J AGRON, V20, P89, DOI 10.1016/S1161-0301(03)00077-7; He MM, 2009, J HAZARD MATER, V163, P671, DOI 10.1016/j.jhazmat.2008.07.013; HOGG DS, 1993, SOIL SCI SOC AM J, V57, P361, DOI 10.2136/sssaj1993.03615995005700020013x; JOHNSTON AE, 1986, SOIL USE MANAGE, V2, P97, DOI 10.1111/j.1475-2743.1986.tb00690.x; Kabala C, 2001, J ENVIRON QUAL, V30, P485, DOI 10.2134/jeq2001.302485x; Kabata-Pendias A., 2011, TRACE ELEMENTS SOILS, DOI [10.1201/9781420039900, 10.1201/b10158-25, DOI 10.1201/B10158-25]; Kalavrouziotis IK, 2008, WATER AIR SOIL POLL, V190, P309, DOI 10.1007/s11270-007-9602-y; Kidd PS, 2007, CHEMOSPHERE, V66, P1458, DOI 10.1016/j.chemosphere.2006.09.007; KNOKE D, 1994, STAT SOCIAL DATA ANA; Li BY, 2007, SOIL TILL RES, V96, P166, DOI 10.1016/j.still.2007.05.005; [李志军 Li Zhijun], 2010, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V16, P1456; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Lu HF, 2010, J ENVIRON MANAGE, V91, P2727, DOI 10.1016/j.jenvman.2010.07.025; Mackowiak CL, 2001, SOIL SCI SOC AM J, V65, P1744, DOI 10.2136/sssaj2001.1744; Maiz I, 2000, ENVIRON POLLUT, V110, P3, DOI 10.1016/S0269-7491(99)00287-0; Mo RC, 1997, TROPICAL SUBTROPICAL, V6, P171; Nemati K, 2009, MICROCHEM J, V92, P165, DOI 10.1016/j.microc.2009.03.002; Pan WeiBin, 2000, Fujian Journal of Agricultural Sciences, V15, P45; Perez-Novo C, 2011, J HAZARD MATER, V185, P220, DOI 10.1016/j.jhazmat.2010.09.021; Perez-Novo C, 2009, GEODERMA, V150, P166, DOI 10.1016/j.geoderma.2009.02.001; [任顺荣 REN Shunrong], 2005, [生态环境, Ecology and Environment], V14, P921; Rodd AV, 2002, CAN J SOIL SCI, V82, P33, DOI 10.4141/S00-055; Rodriguez-Rubio P, 2003, EUR J SOIL SCI, V54, P401, DOI 10.1046/j.1365-2389.2003.00529.x; *SAS I INC, 2000, SAS PROC GUID VERS 8; Shao YuTing, 1995, Acta Pedologica Sinica, V32, P423; SHUMAN LM, 1985, SOIL SCI, V140, P11, DOI 10.1097/00010694-198507000-00003; Spark KM, 1997, AUST J SOIL RES, V35, P103, DOI 10.1071/S96009; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Thakur SK, 2006, GEODERMA, V130, P240, DOI 10.1016/j.geoderma.2005.01.026; [田秀平 Tian Xiuping], 2003, [植物营养与肥料学报, Plant nutrition and fertitizer science], V9, P253; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; [王存龙 Wang Cunlong], 2012, [岩矿测试, Rock and Mineral Analysis], V31, P361; [王美 Wang Mei], 2014, [农业环境科学学报, Journal of Agro-Environment Science], V33, P1500; Wei XR, 2007, GEODERMA, V138, P213, DOI 10.1016/j.geoderma.2006.11.012; Wei XR, 2006, SOIL TILL RES, V91, P120, DOI 10.1016/j.still.2005.11.009; Wei XR, 2010, SOIL SCI PLANT NUTR, V56, P617, DOI 10.1111/j.1747-0765.2010.00497.x; Wu X, 2015, MICROB ECOL, V70, P1; Xing GX, 2003, SOIL CHEM TRACE ELEM; Xu J., 1995, HEAVY METAL TERRESTR; Xu Li, 2009, Acta Pedologica Sinica, V46, P1013; YU C, 1991, Acta Pedologica Sinica, V28, P317; [张维碟 Zhang Weidie], 2003, [环境科学学报, Acta Scientiae Circumstantiae], V23, P376; Zhu XianJin, 2009, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V17, P1063, DOI 10.3724/SP.J.1011.2009.01063	57	6	6	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145370	10.1371/journal.pone.0145370	http://dx.doi.org/10.1371/journal.pone.0145370			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694965	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092500041
J	Jia, H; Shao, MQ; He, YJ; Guan, RZ; Chu, P; Jiang, HD				Jia, Huan; Shao, Mingquan; He, Yongjun; Guan, Rongzhan; Chu, Pu; Jiang, Haidong			Proteome Dynamics and Physiological Responses to Short-Term Salt Stress in Brassica napus Leaves	PLOS ONE			English	Article							CINNAMYL ALCOHOL-DEHYDROGENASE; QUANTITATIVE PROTEOMICS; ARABIDOPSIS-THALIANA; PLANT; PHOTOSYNTHESIS; EXPRESSION; PROTEINS; SALINITY; WHEAT; MECHANISMS	Salt stress limits plant growth and crop productivity and is an increasing threat to agriculture worldwide. In this study, proteomic and physiological responses of Brassica napus leaves under salt stress were investigated. Seedlings under salt treatment showed growth inhibition and photosynthesis reduction. A comparative proteomic analysis of seedling leaves exposed to 200 mM NaCl for 24 h, 48 h and 72 h was conducted. Forty-four protein spots were differentially accumulated upon NaCl treatment and 42 of them were identified, including several novel salt-responsive proteins. To determine the functional roles of these proteins in salt adaptation, their dynamic changes in abundance were analyzed. The results suggested that the up-accumulated proteins, which were associated with protein metabolism, damage repair and defense response, might contribute to the alleviation of the deleterious effect of salt stress on chlorophyll biosynthesis, photosynthesis, energy synthesis and respiration in Brassica napus leaves. This study will lead to a better understanding of the molecular basis of salt stress adaptation in Brassica napus and provides a basis for genetic engineering of plants with improved salt tolerance in the future.	[Jia, Huan; Shao, Mingquan; He, Yongjun; Guan, Rongzhan; Chu, Pu; Jiang, Haidong] Nanjing Agr Univ, Coll Agr, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Guan, Rongzhan] Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Chu, P (corresponding author), Nanjing Agr Univ, Coll Agr, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	chupu@njau.edu.cn; hdjiang@njau.edu.cn		Guan, Rongzhan/0000-0001-9177-6610	National Natural Science Foundation of China [31270386, 31301352]; Fundamental Research Funds for the Central Universities of China [KYZ201202-7, KJQN201423]; National Basic Research Program of China (973 Program) [2011CB109300]; Jiangsu Agricultural Science and Technology Innovation Fund (JASTIF) [CX (14) 2003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Jiangsu Agricultural Science and Technology Innovation Fund (JASTIF)	This work was supported by the National Natural Science Foundation of China (No. 31270386 and 31301352), the Fundamental Research Funds for the Central Universities of China (KYZ201202-7 and KJQN201423), the National Basic Research Program of China (973 Program) (No. 2011CB109300), and the Jiangsu Agricultural Science and Technology Innovation Fund (JASTIF) (CX (14) 2003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NU, 2012, PLANT PHYSIOL BIOCH, V58, P106, DOI 10.1016/j.plaphy.2012.06.015; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Bandehagh A., 2013, Annals of Biological Research, V4, P212; Bandehagh A, 2011, PROTEOMICS, V11, P1965, DOI 10.1002/pmic.201000564; Barkla BJ, 2013, PROTEOMICS, V13, P1885, DOI 10.1002/pmic.201200399; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BOLLER T, 1983, PLANTA, V157, P22, DOI 10.1007/BF00394536; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; de Abreu CEB, 2014, PLANT CELL REP, V33, P1289, DOI 10.1007/s00299-014-1616-5; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen AP, 2007, J PLANT RES, V120, P337, DOI 10.1007/s10265-006-0058-8; Chu P, 2015, J PROTEOMICS, V113, P244, DOI 10.1016/j.jprot.2014.10.005; Deng WW, 2013, J PLANT PHYSIOL, V170, P272, DOI 10.1016/j.jplph.2012.10.010; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El-Shintinawy F, 2001, BIOL PLANTARUM, V44, P541, DOI 10.1023/A:1013738603020; Fatehi F, 2012, MOL BIOL REP, V39, P6387, DOI 10.1007/s11033-012-1460-z; Fernandez-Garcia N, 2011, PLANT CELL ENVIRON, V34, P821, DOI 10.1111/j.1365-3040.2011.02285.x; Gao L, 2011, PHYTOCHEMISTRY, V72, P1180, DOI 10.1016/j.phytochem.2010.12.008; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; GRIMM B, 1990, P NATL ACAD SCI USA, V87, P4169, DOI 10.1073/pnas.87.11.4169; Hartel H, 1997, PLANT PHYSIOL, V113, P1113, DOI 10.1104/pp.113.4.1113; Ismail A, 2014, J EXP BOT, V65, P2963, DOI 10.1093/jxb/eru159; Li B, 2013, PLANT PHYSIOL BIOCH, V67, P7, DOI 10.1016/j.plaphy.2013.02.016; Liu CW, 2014, PROTEOMICS, V14, P1759, DOI 10.1002/pmic.201300276; Lyon BR, 2011, PLANT PHYSIOL, V157, P1926, DOI 10.1104/pp.111.185025; Ma HY, 2012, J PROTEOMICS, V75, P1529, DOI 10.1016/j.jprot.2011.11.026; Machado CR, 1997, J MOL BIOL, V273, P114, DOI 10.1006/jmbi.1997.1302; Machado CR, 1996, PLANT MOL BIOL, V31, P585, DOI 10.1007/BF00042231; Manaa A, 2014, COMPARATIVE PROTEOMI, V15, P21803; McCarty RE, 2005, J BIOENERG BIOMEMBR, V37, P289, DOI 10.1007/s10863-005-8640-7; Moradi F, 2007, ANN BOT-LONDON, V99, P1161, DOI 10.1093/aob/mcm052; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Parker R, 2006, J EXP BOT, V57, P1109, DOI 10.1093/jxb/erj134; Podda A, 2013, J PLANT PHYSIOL, V170, P1101, DOI 10.1016/j.jplph.2013.03.006; Purty Ram Singh, 2008, Physiology and Molecular Biology of Plants, V14, P39, DOI 10.1007/s12298-008-0004-4; Qureshi MI, 2007, J PLANT PHYSIOL, V164, P1239, DOI 10.1016/j.jplph.2007.01.013; Rai S, 2014, J PROTEOMICS, V98, P254, DOI 10.1016/j.jprot.2013.12.020; Razavizadeh R, 2009, PEPTIDES, V30, P1651, DOI 10.1016/j.peptides.2009.06.023; Ribeiro DT, 2005, J EXP BOT, V56, P1797, DOI 10.1093/jxb/eri168; Rossignol M, 2006, PROTEOMICS, V6, P5529, DOI 10.1002/pmic.200600260; Saha P, 2012, PLANT PHYSIOL BIOCH, V60, P214, DOI 10.1016/j.plaphy.2012.08.008; Sanchez-Aguayo I, 2004, PLANTA, V220, P278, DOI 10.1007/s00425-004-1350-2; Shavrukov Y, 2013, J EXP BOT, V64, P119, DOI 10.1093/jxb/ers316; Shi SS, 2011, PROTEOMICS, V11, P4712, DOI 10.1002/pmic.201100042; Sobhanian H, 2011, J PROTEOMICS, V74, P1323, DOI 10.1016/j.jprot.2011.03.018; Sobhanian H, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-19; Stepien P, 2009, PLANT PHYSIOL, V149, P1154, DOI 10.1104/pp.108.132407; Steppuhn H, 2001, CROP SCI, V41, P1827, DOI 10.2135/cropsci2001.1827; Subramanian B, 2005, J AGR FOOD CHEM, V53, P313, DOI 10.1021/jf048922z; Sudhir P, 2004, PHOTOSYNTHETICA, V42, P481, DOI 10.1007/S11099-005-0001-6; Tahir, 2013, SALT STRESS PLANTS S, P47; Tang XL, 2015, CRIT REV BIOTECHNOL, V35, P425, DOI 10.3109/07388551.2014.889080; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Tsang EWT, 2003, PLANT MOL BIOL, V51, P191, DOI 10.1023/A:1021102118801; Turan S, 2015, PHYSIOL PLANTARUM, V153, P477, DOI 10.1111/ppl.12250; Wang HL, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-6; Wang JC, 2015, PLANT CELL ENVIRON, V38, P655, DOI 10.1111/pce.12428; Wang L., 2014, DISCRETE DYN NAT SOC, V2014, P1, DOI DOI 10.1002/ASL2.454; Wang MY, 2011, METHOD ENZYMOL, V489, P319, DOI 10.1016/B978-0-12-385116-1.00018-2; Wang ZM, 2013, INT J MOL SCI, V14, P20299, DOI 10.3390/ijms141020299; Xu CP, 2010, PLANT CELL REP, V29, P595, DOI 10.1007/s00299-010-0847-3; Yadav S, 2011, J ENVIRON BIOL, V32, P667; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; Yang L, 2012, J PLANT PHYSIOL, V169, P839, DOI 10.1016/j.jplph.2012.01.023; Yi XP, 2014, J PROTEOMICS, V99, P84, DOI 10.1016/j.jprot.2014.01.017; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhang X, 2008, J EXP BOT, V59, P839, DOI 10.1093/jxb/erm364; Zhao Q, 2013, P NATL ACAD SCI USA, V110, P13660, DOI 10.1073/pnas.1312234110; Zhou YL, 2012, PLANTA, V235, P523, DOI 10.1007/s00425-011-1527-4; Zou J, 2011, PLANT CELL REP, V30, P2155, DOI 10.1007/s00299-011-1122-y	70	24	25	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144808	10.1371/journal.pone.0144808	http://dx.doi.org/10.1371/journal.pone.0144808			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691228	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300019
J	Kondo, K; Kubo, T; Kunieda, T				Kondo, Koyuki; Kubo, Takeo; Kunieda, Takekazu			Suggested Involvement of PP1/PP2A Activity and De Novo Gene Expression in Anhydrobiotic Survival in a Tardigrade, Hypsibius dujardini, by Chemical Genetic Approach	PLOS ONE			English	Article							OXIDATIVE STRESS; WATER-LOSS; PROTEIN; DESICCATION; INHIBITION; TREHALOSE; TRANSCRIPTION; SUBUNIT; PHOSPHORYLATION; DEHYDRATION	Upon desiccation, some tardigrades enter an ametabolic dehydrated state called anhydrobiosis and can survive a desiccated environment in this state. For successful transition to anhydrobiosis, some anhydrobiotic tardigrades require pre-incubation under high humidity conditions, a process called preconditioning, prior to exposure to severe desiccation. Although tardigrades are thought to prepare for transition to anhydrobiosis during preconditioning, the molecular mechanisms governing such processes remain unknown. In this study, we used chemical genetic approaches to elucidate the regulatory mechanisms of anhydrobiosis in the anhydrobiotic tardigrade, Hypsibius dujardini. We first demonstrated that inhibition of transcription or translation drastically impaired anhydrobiotic survival, suggesting that de novo gene expression is required for successful transition to anhydrobiosis in this tardigrade. We then screened 81 chemicals and identified 5 chemicals that significantly impaired anhydrobiotic survival after severe desiccation, in contrast to little or no effect on survival after high humidity exposure only. In particular, cantharidic acid, a selective inhibitor of protein phosphatase (PP) 1 and PP2A, exhibited the most profound inhibitory effects. Another PP1/PP2A inhibitor, okadaic acid, also significantly and specifically impaired anhydrobiotic survival, suggesting that PP1/PP2A activity plays an important role for anhydrobiosis in this species. This is, to our knowledge, the first report of the required activities of signaling molecules for desiccation tolerance in tardigrades. The identified inhibitory chemicals could provide novel clues to elucidate the regulatory mechanisms underlying anhydrobiosis in tardigrades.	[Kondo, Koyuki; Kubo, Takeo; Kunieda, Takekazu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Kunieda, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	kunieda@bs.s.u-tokyo.ac.jp	Kunieda, Takekazu/G-4946-2014; KUBO, TAKEO/G-4951-2014	Kubo, Takeo/0000-0002-5914-5269; Kunieda, Takekazu/0000-0002-6256-1335	Japan Society for the Promotion of Science [26660288, 25281016, 15J11297]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for challenging Exploratory Research (No. 26660288) and Grants-in-Aid for Scientific Research (No. 25281016) from the Japan Society for the Promotion of Science. KK received a Grant-in-Aid for JSPS Fellows (No. 15J11297) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; AHN HS, 1989, BIOCHEM PHARMACOL, V38, P3331; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Banton MC, 2012, J EXP BIOL, V215, P4288, DOI 10.1242/jeb.074799; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Contreras-Porcia L, 2011, J EXP BOT, V62, P1815, DOI 10.1093/jxb/erq364; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; CROWE J H, 1975, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V32, P37; Crowe LM, 2002, COMP BIOCHEM PHYS A, V131, P505, DOI 10.1016/S1095-6433(01)00503-7; Degma P, 2015, ACTUAL CHECKLIST TAR, P40; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Ding JY, 2000, J BIOL CHEM, V275, P30873, DOI 10.1074/jbc.M004813200; Dingle H., 1996, BIOL LIFE MOVE, P474; Erkut C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082473; Erkut C, 2011, CURR BIOL, V21, P1331, DOI 10.1016/j.cub.2011.06.064; Gabriel WN, 2007, DEV BIOL, V312, P545, DOI 10.1016/j.ydbio.2007.09.055; Gusev O, 2011, CELL STRESS CHAPERON, V16, P81, DOI 10.1007/s12192-010-0223-9; Halberg KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085091; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Harper JL, 2003, BIOCHEM PHARMACOL, V65, P329, DOI 10.1016/S0006-2952(02)01488-0; HASHIMOTO Y, 1991, BIOCHEM BIOPH RES CO, V181, P423, DOI 10.1016/S0006-291X(05)81436-6; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HIGA LM, 1993, J EXP ZOOL, V267, P120, DOI 10.1002/jez.1402670205; Ito S, 2004, EUR J PHARMACOL, V486, P325, DOI 10.1016/j.ejphar.2004.01.013; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Johnson CG, 1940, ANN APPL BIOL, V27, P295, DOI 10.1111/j.1744-7348.1940.tb07499.x; Jonsson KI, 2007, COMP BIOCHEM PHYS B, V146, P456, DOI 10.1016/j.cbpb.2006.10.111; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lapinski J, 2003, FEBS LETT, V553, P387, DOI 10.1016/S0014-5793(03)01062-7; Leuenroth JS, 2007, PNAS, V104, P4389, DOI [10.1073/pnas.0700499104, DOI 10.1073/PNAS.0700499104]; LI YM, 1993, BIOCHEM PHARMACOL, V46, P1435, DOI 10.1016/0006-2952(93)90109-A; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Liu QY, 2011, INT IMMUNOPHARMACOL, V11, P377, DOI 10.1016/j.intimp.2011.01.012; MACHIN J, 1967, J ZOOL, V152, P55; MACNEIL S, 1988, BIOCHEM PHARMACOL, V37, P1717, DOI 10.1016/0006-2952(88)90434-0; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; McCallum C, 2007, IMMUNOBIOLOGY, V212, P549, DOI 10.1016/j.imbio.2007.02.002; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; Narasimhan SD, 2009, CELL CYCLE, V8, P3878, DOI 10.4161/cc.8.23.10072; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Pal R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5425; Pereira ED, 2003, CELL STRESS CHAPERON, V8, P120; Qin SF, 1997, J BIOL CHEM, V272, P17994, DOI 10.1074/jbc.272.29.17994; Raman CS, 2001, BIOCHEMISTRY-US, V40, P13448, DOI 10.1021/bi010957u; Reiter W, 2013, MOL CELL BIOL, V33, P1057, DOI 10.1128/MCB.00834-12; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shannon AJ, 2005, J EXP BIOL, V208, P2433, DOI 10.1242/jeb.01629; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Soundararajan R, 2009, CANCER BIOL THER, V8, P2054, DOI 10.4161/cbt.8.21.9803; Stateva SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128783; Tanaka S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118272; Tenlen JR, 2013, DEV GENES EVOL, V223, P171, DOI 10.1007/s00427-012-0432-6; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vereshchagina N, 2008, J CELL SCI, V121, P3383, DOI 10.1242/jcs.035220; Wang WY, 2006, MOL PHARMACOL, V70, P1380, DOI 10.1124/mol.106.023986; Watanabe M, 2006, APPL ENTOMOL ZOOL, V41, P15, DOI 10.1303/aez.2006.15; Watanabe M, 2002, J EXP BIOL, V205, P2799; Waters V, 2005, AM J RESP CELL MOL, V33, P138, DOI 10.1165/rcmb.2005-0005OC; WESTH P, 1991, J EXP ZOOL, V258, P303, DOI 10.1002/jez.1402580305; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; WINSTON PW, 1960, ECOLOGY, V41, P232, DOI 10.2307/1931961; WRIGHT JC, 1989, J EXP BIOL, V142, P267; Yamaguchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044209; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200	68	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144803	10.1371/journal.pone.0144803	http://dx.doi.org/10.1371/journal.pone.0144803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690982	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300018
J	Macreadie, PI; Rolph, TC; Boyd, R; Schroder-Adams, CJ; Skilbeck, CG				Macreadie, Peter I.; Rolph, Timothy C.; Boyd, Ron; Schroeder-Adams, Claudia J.; Skilbeck, Charles G.			Do ENSO and Coastal Development Enhance Coastal Burial of Terrestrial Carbon?	PLOS ONE			English	Article							EL-NINO; MARINE-SEDIMENTS; ORGANIC-MATTER; PRECIPITATION; ACCUMULATION; EVOLUTION	Carbon cycling on the east coast of Australia has the potential to be strongly affected by El Nino-Southern Oscillation (ENSO) intensification and coastal development (industrialization and urbanization). We performed paleoreconstructions of estuarine sediments from a seagrass-dominated estuary on the east coast of Australia (Tuggerah Lake, New South Wales) to test the hypothesis that millennial-scale ENSO intensification and European settlement in Australia have increased the transfer of organic carbon from land into coastal waters. Our data show that carbon accumulation rates within coastal sediments increased significantly during periods of maximum millennial-scale ENSO intensity ("super-ENSO") and coastal development. We suggest that ENSO and coastal development destabilize and liberate terrestrial soil carbon, which, during rainfall events (e.g., La Nina), washes into estuaries and becomes trapped and buried by coastal vegetation (seagrass in this case). Indeed, periods of high carbon burial were generally characterized as having rapid sedimentation rates, higher content of fine-grained sediments, and increased content of wood and charcoal fragments. These results, though preliminary, suggest that coastal development and ENSO intensification-both of which are predicted to increase over the coming century-can enhance capture and burial of terrestrial carbon by coastal ecosystems. These findings have important relevance for current efforts to build an understanding of terrestrial-marine carbon connectivity into global carbon budgets.	[Macreadie, Peter I.] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Broadway, NSW 2007, Australia; [Macreadie, Peter I.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic 3125, Australia; [Rolph, Timothy C.; Boyd, Ron] Univ Newcastle, Sch Geosci, Callaghan, NSW 2308, Australia; [Schroeder-Adams, Claudia J.] Carleton Univ, Dept Earth Sci, Ottawa, ON K1S 5B6, Canada; [Skilbeck, Charles G.] Univ Technol Sydney, Sch Environm, Broadway, NSW 2007, Australia	University of Technology Sydney; Deakin University; University of Newcastle; Carleton University; University of Technology Sydney	Macreadie, PI (corresponding author), Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Broadway, NSW 2007, Australia.	petermacreadie@gmail.com		Schroder-Adams, Claudia/0000-0002-0245-2559; Boyd, Ronald/0000-0002-2374-7567	Australian Research Council DECRA [DE130101084]; Australian Institute of Nuclear Science and Engineering AINSE [ALNGRA 14031, 04-140]; ARC [DP0209388]; NSERC	Australian Research Council DECRA(Australian Research Council); Australian Institute of Nuclear Science and Engineering AINSE; ARC(Australian Research Council); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by an Australian Research Council DECRA Fellowship (DE130101084 to P.I.M.), an Australian Institute of Nuclear Science and Engineering AINSE Grants (ALNGRA 14031 and 04-140 to P.I.M., T.C.R.and C.G.S.), an ARC Discovery Project DP0209388 (to T.C.R., C.G.S., and R.B.), and a NSERC Discovery Grant (to C.J.S.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto R, 2003, NATURE, V425, P493, DOI 10.1038/nature02002; Bauer JE, 2013, NATURE, V504, P61, DOI 10.1038/nature12857; Berkeley A, 2007, EARTH-SCI REV, V83, P205, DOI 10.1016/j.earscirev.2007.04.003; Bianchi TS, 2013, GEOPHYS RES LETT, V40, P116, DOI 10.1029/2012GL054145; Burdige DJ, 2007, CHEM REV, V107, P467, DOI 10.1021/cr050347q; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Cane MA, 2005, EARTH PLANET SC LETT, V230, P227, DOI 10.1016/j.epsl.2004.12.003; Eusterhues K, 2003, ORG GEOCHEM, V34, P1591, DOI 10.1016/j.orggeochem.2003.08.007; Fissore C, 2010, FRONT ECOL ENVIRON, V8, P409, DOI 10.1890/090059; FOLEY JA, 2002, GLOBAL BIOGEOCHEM CY, V16, P1, DOI DOI 10.1029/2002GB001872; Gagan MK, 2004, QUATERN INT, V118, P127, DOI 10.1016/S1040-6182(03)00134-4; Hilton RG, 2008, NAT GEOSCI, V1, P759, DOI 10.1038/ngeo333; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Kirwan ML, 2011, GEOLOGY, V39, P507, DOI 10.1130/G31789.1; Lynch AH, 2007, ANNU REV EARTH PL SC, V35, P215, DOI 10.1146/annurev.earth.35.092006.145055; Macreadie P. I., 2015, GEORESJ, V5, P57, DOI DOI 10.1016/J.GRJ.2015.01.002; Macreadie PI, 2012, GLOBAL CHANGE BIOL, V18, P891, DOI 10.1111/j.1365-2486.2011.02582.x; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Micevski T, 2006, J HYDROL, V327, P219, DOI 10.1016/j.jhydrol.2005.11.017; NADELHOFFER KF, 1988, SOIL SCI SOC AM J, V52, P1633, DOI 10.2136/sssaj1988.03615995005200060024x; Nyberg J, 2001, QUATERNARY RES, V56, P87, DOI 10.1006/qres.2001.2249; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Power S, 2013, NATURE, V502, P541, DOI 10.1038/nature12580; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/ngeo1830, 10.1038/NGEO1830]; ROY PS, 1981, J GEOL SOC AUST, V28, P471, DOI 10.1080/00167618108729182; Saintilan N, 2013, ESTUAR COAST SHELF S, V128, P84, DOI 10.1016/j.ecss.2013.05.010; Schroder-Adams CJ, 2014, ESTUAR COAST SHELF S, V139, P78, DOI 10.1016/j.ecss.2013.12.006	29	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145136	10.1371/journal.pone.0145136	http://dx.doi.org/10.1371/journal.pone.0145136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691557	Green Published, gold			2022-12-27	WOS:000367092300041
J	Marcelino, I; Ventosa, M; Pires, E; Muller, M; Lisacek, F; Lefrancois, T; Vachiery, N; Coelho, AV				Marcelino, Isabel; Ventosa, Miguel; Pires, Elisabete; Mueller, Markus; Lisacek, Frederique; Lefrancois, Thierry; Vachiery, Nathalie; Coelho, Ana Varela			Comparative Proteomic Profiling of Ehrlichia ruminantium Pathogenic Strain and Its High-Passaged Attenuated Strain Reveals Virulence and Attenuation-Associated Proteins	PLOS ONE			English	Article							IV SECRETION SYSTEM; TICK-BORNE DISEASES; ANAPLASMA-PHAGOCYTOPHILUM; GENE-EXPRESSION; COWDRIA-RUMINANTIUM; INACTIVATED VACCINE; CHROMOSOME SEGREGATION; RICKETTSIA-PROWAZEKII; COG DATABASE; IN-VITRO	The obligate intracellular bacterium Ehrlichia ruminantium (ER) causes heartwater, a fatal tick-borne disease in livestock. In the field, ER strains present different levels of virulence, limiting vaccine efficacy, for which the molecular basis remains unknown. Moreover, there are no genetic tools currently available for ER manipulation, thus limiting the knowledge of the genes/proteins that are essential for ER pathogenesis and biology. As such, to identify proteins and/or mechanisms involved in ER virulence, we performed the first exhaustive comparative proteomic analysis between a virulent strain (ERGvir) and its high-passaged attenuated strain (ERGatt). Despite their different behaviors in vivo and in vitro, our results from 1DE-nanoLC-MS/MS showed that ERGvir and ERGatt share 80% of their proteins; this core proteome includes chaperones, proteins involved in metabolism, protein-DNA-RNA biosynthesis and processing, and bacterial effectors. Conventional 2DE revealed that 85% of the identified proteins are proteoforms, suggesting that post-translational modifications (namely glycosylation) are important in ER biology. Strain-specific proteins were also identified: while ERGatt has an increased number and overexpression of proteins involved in cell division, metabolism, transport and protein processing, ERGvir shows an overexpression of proteins and proteoforms (DIGE experiments) involved in pathogenesis such as Lpd, AnkA, VirB9 and B10, providing molecular evidence for its increased virulence in vivo and in vitro. Overall, our work reveals that ERGvir and ERGatt proteomes are streamlined to fulfill their biological function (maximum virulence for ERGvir and replicative capacity for ERGatt), and we provide both pioneering data and novel insights into the pathogenesis of this obligate intracellular bacterium.	[Marcelino, Isabel; Ventosa, Miguel] Inst Biol Expt & Tecnol iBET, Oeiras, Portugal; [Marcelino, Isabel; Ventosa, Miguel; Pires, Elisabete; Coelho, Ana Varela] Univ Nova Lisboa ITQB UNL, Inst Tecnol & Quim Biol Antonio Xavier, Oeiras, Portugal; [Marcelino, Isabel; Vachiery, Nathalie] CIRAD, UMR, CMAEE, F-97170 Petit Bourg, Guadeloupe, France; [Marcelino, Isabel; Vachiery, Nathalie] INRA, CMAEE, UMR1309, F-34398 Montpellier, France; [Mueller, Markus; Lisacek, Frederique] SIB, Proteome Informat, Geneva, Switzerland; [Lefrancois, Thierry] CIRAD, UMR, CMAEE, F-34398 Montpellier, France	Universidade Nova de Lisboa; CIRAD; INRAE; Swiss Institute of Bioinformatics; CIRAD	Marcelino, I (corresponding author), Inst Biol Expt & Tecnol iBET, Oeiras, Portugal.	Isabel.Marcelino@cirad.fr	lefrancois, thierry/C-5070-2011; Marcelino, Isabel/D-6503-2017; Coelho, Ana V/H-8885-2012; Coelho, Ana V Varela/O-3977-2014	lefrancois, thierry/0000-0001-8793-5228; Marcelino, Isabel/0000-0001-5454-8811; Coelho, Ana V/0000-0002-6143-4203; Coelho, Ana V Varela/0000-0002-6143-4203; Muller, Markus/0000-0003-0907-3583; LISACEK, Frederique/0000-0002-0948-4537; Pires, Elisabete/0000-0001-8646-062X	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/CVT/114118/2009, Pest-OE/EQB/LA0004/2011]; National Reequipment Program for "Rede Nacional de Espectrometria de Massa - RNEM" [REDE/1504/RNEM/2005]; EU projects COST action [FA-1002]; FEDER project [FED 1/1.4-30305]; FCT (Portugal) [SFRH/BPD/45978/2008]; EPIGENESIS RegPot European project [315988]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); National Reequipment Program for "Rede Nacional de Espectrometria de Massa - RNEM"; EU projects COST action; FEDER project(European Commission); FCT (Portugal)(Portuguese Foundation for Science and TechnologyEuropean Commission); EPIGENESIS RegPot European project	This work was supported by the Fundacao para a Ciencia e Tecnologia (FCT) through the PTDC/CVT/114118/2009 research project, grant #Pest-OE/EQB/LA0004/2011 and the National Reequipment Program for "Rede Nacional de Espectrometria de Massa - RNEM" (REDE/1504/RNEM/2005). The authors MV and IM also acknowledge funding from the EU projects COST action FA-1002 (for networking opportunities) and FEDER 2007-2013 project (FED 1/1.4-30305). IM acknowledges financial support from Post-doc grant SFRH/BPD/45978/2008 from FCT (Portugal) and from EPIGENESIS RegPot European project (no 315988). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeykoon A, 2014, J BIOL CHEM, V289, P7691, DOI 10.1074/jbc.M113.535567; Ahrne E, 2011, J PROTEOME RES, V10, P2913, DOI 10.1021/pr200152g; Ahrne E, 2010, PROTEOMICS, V10, P671, DOI 10.1002/pmic.200900502; Allsopp BA, 2009, ONDERSTEPOORT J VET, V76, P81; Beceiro A, 2013, CLIN MICROBIOL REV, V26, P185, DOI 10.1128/CMR.00059-12; Bechah Y, 2010, GENOME RES, V20, P655, DOI 10.1101/gr.103564.109; Bekker CPJ, 2002, GENE, V285, P193, DOI 10.1016/S0378-1119(02)00408-0; Beyer AR, 2015, CELL MICROBIOL, V17, P504, DOI 10.1111/cmi.12380; Caina JA, 2014, J PROTEOMICS, V97, P265, DOI 10.1016/j.jprot.2013.08.012; Chao CC, 2007, BBA-PROTEINS PROTEOM, V1774, P373, DOI 10.1016/j.bbapap.2007.01.001; Chen G, 2012, INFECT IMMUN, V80, P3194, DOI 10.1128/IAI.00532-12; Cheng ZH, 2006, CELL MICROBIOL, V8, P1241, DOI 10.1111/j.1462-5822.2006.00704.x; Collins NE, 2005, P NATL ACAD SCI USA, V102, P838, DOI 10.1073/pnas.0406633102; Dettman JR, 2015, GENOME BIOL EVOL, V7, P18, DOI 10.1093/gbe/evu260; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Dunphy PS, 2014, INFECT IMMUN, V82, P4154, DOI 10.1128/IAI.01984-14; DUPLESSIS JL, 1989, ONDERSTEPOORT J VET, V56, P195; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; Emboule L, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-111; Felek S, 2003, INFECT IMMUN, V71, P6063, DOI 10.1128/IAI.71.10.6063-6067.2003; Felsheim RF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008361; Fournier PE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-166; Frutos R, 2006, J BACTERIOL, V188, P2533, DOI 10.1128/JB.188.7.2533-2542.2006; Frutos R, 2006, ANN NY ACAD SCI, V1081, P417, DOI 10.1196/annals.1373.061; Garcia-Garcia JC, 2009, INFECT IMMUN, V77, P2385, DOI 10.1128/IAI.00023-09; Ge H, 2003, ANN NY ACAD SCI, V990, P671, DOI 10.1111/j.1749-6632.2003.tb07442.x; Gillespie JJ, 2014, FEMS MICROBIOL REV; Gillespie JJ, 2010, INFECT IMMUN, V78, P1809, DOI 10.1128/IAI.01384-09; GOEBEL W, 1988, A VAN LEEUW J MICROB, V54, P453, DOI 10.1007/BF00461864; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Hajem N, 2009, APMIS, V117, P253, DOI 10.1111/j.1600-0463.2009.02435.x; Hallstrom T, 2012, J IMMUNOL, V189, P4939, DOI 10.4049/jimmunol.1200386; Hudson P, 2006, INFECT IMMUN, V74, P931, DOI 10.1128/IAI.74.2.931-939.2006; JONGEJAN F, 1991, RES VET SCI, V51, P24, DOI 10.1016/0034-5288(91)90025-J; Jongejan F, 1993, Rev Elev Med Vet Pays Trop, V46, P223; JONGEJAN F, 1988, RES VET SCI, V44, P186, DOI 10.1016/S0034-5288(18)30836-1; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lasocki K, 2007, J BACTERIOL, V189, P5762, DOI 10.1128/JB.00371-07; Lin MQ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00024; Lopez JE, 2007, INFECT IMMUN, V75, P2333, DOI 10.1128/IAI.00061-07; Madinez D., 1997, THESIS; Mansueto P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/967852; Marcelino I, 2006, VACCINE, V24, P1716, DOI 10.1016/j.vaccine.2005.08.109; Marcelino I, 2005, VET MICROBIOL, V110, P87, DOI 10.1016/j.vetmic.2005.07.012; Marcelino I, 2014, P 5 MAN COMM M 3 M W, P112; Marcelino I, 2007, VACCINE, V25, P4903, DOI 10.1016/j.vaccine.2007.04.055; Marcelino I, 2015, VACCINE, V33, P678, DOI 10.1016/j.vaccine.2014.11.059; Marcelino I, 2012, J PROTEOMICS, V75, P4232, DOI 10.1016/j.jprot.2012.03.026; Marcelino I, 2012, VET MICROBIOL, V156, P305, DOI 10.1016/j.vetmic.2011.11.022; Martinez D, 2004, ANN NY ACAD SCI, V1026, P106, DOI 10.1196/annals.1307.014; MARTINEZ D, 1994, VET IMMUNOL IMMUNOP, V41, P153, DOI 10.1016/0165-2427(94)90064-7; Martinez E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004013; Meyer DF, 2013, NUCLEIC ACIDS RES, V41, P9218, DOI 10.1093/nar/gkt718; Mierzejewska J, 2012, PLASMID, V67, P1, DOI 10.1016/j.plasmid.2011.08.003; Moumene A, 2014, OM PROTEOME; Moumene A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116758; Munderloh UG, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00086; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Niu H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000774; Ojogun N, 2012, INFECT IMMUN, V80, P3748, DOI 10.1128/IAI.00654-12; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Perez JM, 1998, PARASITE IMMUNOL, V20, P613, DOI 10.1046/j.1365-3024.1998.00193.x; Pevzner PA, 2000, J COMPUT BIOL, V7, P777, DOI 10.1089/10665270050514927; Pinto PM, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-45; Postigo M, 2008, VET MICROBIOL, V128, P136, DOI 10.1016/j.vetmic.2007.09.023; Pretorius A, 2010, VACCINE, V28, P3531, DOI 10.1016/j.vaccine.2010.03.017; Pruneau L, 2012, FEMS IMMUNOL MED MIC, V64, P66, DOI 10.1111/j.1574-695X.2011.00901.x; Renesto P, 2005, ANN NY ACAD SCI, V1063, P90, DOI 10.1196/annals.1355.014; Rikihisa Y, 2010, CURR OPIN MICROBIOL, V13, P59, DOI 10.1016/j.mib.2009.12.008; Rikihisa Y, 2009, ANN NY ACAD SCI, V1166, P106, DOI 10.1111/j.1749-6632.2009.04527.x; Sebatjane SI, 2010, VET IMMUNOL IMMUNOP, V137, P217, DOI 10.1016/j.vetimm.2010.05.011; Sinclair SH, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00274; Smith LM, 2013, NAT METHODS, V10, P186, DOI 10.1038/nmeth.2369; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thomas S, 2009, PARASITE IMMUNOL, V31, P296, DOI 10.1111/j.1365-3024.2009.01099.x; UILENBERG G, 1993, VET QUART, V15, P48, DOI 10.1080/01652176.1993.9694371; Vachiery N, 2013, DEV BIOLOGICALS, V135, P191, DOI 10.1159/000190050; Vachiery N, 2006, VACCINE, V24, P4747, DOI 10.1016/j.vaccine.2006.03.031; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; Wang RZ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00144; Wang XQ, 2007, J BACTERIOL, V189, P4880, DOI 10.1128/JB.00318-07; Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004; Zweygarth E, 2005, VACCINE, V23, P1695, DOI 10.1016/j.vaccine.2004.09.030	89	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145328	10.1371/journal.pone.0145328	http://dx.doi.org/10.1371/journal.pone.0145328			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691135	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300058
J	Bonsang-Kitzis, H; Chaltier, L; Belin, L; Savignoni, A; Rouzier, R; Sablin, MP; Lerebours, F; Bidard, FC; Cottu, P; Sastre-Garau, X; Lae, M; Pierga, JY; Reyal, F				Bonsang-Kitzis, Helene; Chaltier, Leonor; Belin, Lisa; Savignoni, Alexia; Rouzier, Roman; Sablin, Marie-Paule; Lerebours, Florence; Bidard, Francois-Clement; Cottu, Paul; Sastre-Garau, Xavier; Lae, Marick; Pierga, Jean-Yves; Reyal, Fabien			Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; PREOPERATIVE CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; MOLECULAR SUBTYPES; DOSE INTENSITY; OBESE-PATIENTS; TUMOR SIZE; EXPRESSION; SURVIVAL	Background Triple-negative breast cancers (TNBC) are a specific subtype of breast cancers with a particularly poor prognosis. However, it is a very heterogeneous subgroup in terms of clinical behavior and sensitivity to systemic treatments. Thus, the identification of risk factors specifically associated with those tumors still represents a major challenge. A therapeutic strategy increasingly used for TNBC patients is neoadjuvant chemotherapy (NAC). Only a subset of patients achieves a pathologic complete response (pCR) after NAC and have a better outcome than patients with residual disease. Purpose The aim of this study is to identify clinical factors associated with the metastatic-free survival in TNBC patients who received NAC. Methods We analyzed 326 cT1-3N1-3M0 patients with ductal infiltrating TNBC treated by NAC. The survival analysis was performed using a Cox proportional hazard model to determine clinical features associated with prognosis on the whole TNBC dataset. In addition, we built a recursive partitioning tree in order to identify additional clinical features associated with prognosis in specific subgroups of TNBC patients. Results We identified the lymph node involvement after NAC as the only clinical feature significantly associated with a poor prognosis using a Cox multivariate model (HR = 3.89 [2.42-6.25], p<0.0001). Using our recursive partitioning tree, we were able to distinguish 5 subgroups of TNBC patients with different prognosis. For patients without lymph node involvement after NAC, obesity was significantly associated with a poor prognosis (HR = 2.64 [1.28-5.55]). As for patients with lymph node involvement after NAC, the pre-menopausal status in grade III tumors was associated with poor prognosis (HR = 9.68 [5.71-18.31]). Conclusion This study demonstrates that axillary lymph node status after NAC is the major prognostic factor for triple-negative breast cancers. Moreover, we identified body mass index and menopausal status as two other promising prognostic factors in this breast cancer subgroup. Using these clinical factors, we were able to classify TNBC patients in 5 subgroups, for which pre-menopausal patients with grade III tumors and lymph node involvement after NAC have the worse prognosis.	[Bonsang-Kitzis, Helene; Rouzier, Roman; Reyal, Fabien] Inst Curie, Dept Surg, Paris, France; [Chaltier, Leonor; Belin, Lisa; Savignoni, Alexia] Inst Curie, Dept Biostat, Paris, France; [Sablin, Marie-Paule; Lerebours, Florence; Bidard, Francois-Clement; Cottu, Paul; Pierga, Jean-Yves] Inst Curie, Dept Med Oncol, Paris, France; [Sastre-Garau, Xavier; Lae, Marick] Inst Curie, Dept Tumor Biol, Paris, France; [Pierga, Jean-Yves] Paris Descartes Univ, Paris, France; [Bonsang-Kitzis, Helene; Reyal, Fabien] Inst Curie, Translat Res Dept, Residual Tumor & Response Treatment Lab, Paris, France; [Bonsang-Kitzis, Helene; Reyal, Fabien] INSERM, Immun & Canc UMR932, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Reyal, F (corresponding author), Inst Curie, Dept Surg, Paris, France.	fabien.reyal@curie.fr	Cottu, Paul/ABC-8595-2020; Rouzier, Roman/G-2953-2018	Sastre-Garau, Xavier/0000-0001-5992-2083; Rouzier, Roman/0000-0002-8167-6808; Belin, Lisa/0000-0002-7628-6629; Bidard, Francois-Clement/0000-0001-5932-8949				Aurilio G, 2014, EUR J CANCER, V50, P277, DOI 10.1016/j.ejca.2013.10.004; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Blows FM, 2010, SUBTYPING BREAST CAN, P7, DOI [10.1371/journal.pmed.1000279, DOI 10.1371/JOURNAL.PMED.1000279]; BRENTANI MM, 1986, INT J CANCER, V38, P637, DOI 10.1002/ijc.2910380504; Buchholz TA, 2008, J CLIN ONCOL, V26, P791, DOI 10.1200/JCO.2007.15.0326; Budman DR, 1998, J NATL CANCER I, V90, P1205, DOI 10.1093/jnci/90.16.1205; Bulun SE, 2012, TRENDS ENDOCRIN MET, V23, P83, DOI 10.1016/j.tem.2011.10.003; Carey LA, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2011-S1-71; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dent R, 2009, CANCER-AM CANCER SOC, V115, P4917, DOI 10.1002/cncr.24573; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Fisher CS, 2012, ANN SURG ONCOL, V19, P253, DOI 10.1245/s10434-011-1877-y; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Foulkes WD, 2009, BREAST CANCER RES TR, V117, P199, DOI 10.1007/s10549-008-0102-6; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Fulford LG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1636; Gaudet MM, 2011, BREAST CANCER RES TR, V130, P587, DOI 10.1007/s10549-011-1616-x; Greenman CG, 2008, CANCER-AM CANCER SOC, V112, P2159, DOI 10.1002/cncr.23416; Griggs JJ, 2005, ARCH INTERN MED, V165, P1267, DOI 10.1001/archinte.165.11.1267; He JH, 2012, MED ONCOL, V29, P406, DOI 10.1007/s12032-011-9832-0; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Loibl S, 2011, BREAST CANCER RES TR, V130, P477, DOI 10.1007/s10549-011-1715-8; Lorincz AM, 2006, ENDOCR-RELAT CANCER, V13, P279, DOI 10.1677/erc.1.00729; Lyman GH, 2011, J ONCOL PRACT, V7, P17, DOI 10.1200/JOP.2010.000200; Lyman GH, 2009, J NATL COMPR CANC NE, V7, P99, DOI 10.6004/jnccn.2009.0009; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Phipps AI, 2011, CANCER EPIDEM BIOMAR, V20, P454, DOI 10.1158/1055-9965.EPI-10-0974; Pierga JY, 2000, BRIT J CANCER, V83, P1480, DOI 10.1054/bjoc.2000.1461; Rakha EA, 2006, PROGNOSTIC MARKERS T, V2, P4, DOI [10.1002/cncr.22381, DOI 10.1002/CNCR.22381]; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Sorlie Therese, 2007, Methods Mol Biol, V360, P91; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stephenson GD, 2003, NUTR CANCER, V45, P1, DOI 10.1207/S15327914NC4501_1; Symmans WF, 2007, J CLIN ONCOL, V25, P4414, DOI 10.1200/JCO.2007.10.6823; Tang DB, 2012, MED ONCOL, V29, P526, DOI 10.1007/s12032-011-9948-2; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Tutt ANJ, 2008, TRIPLE NEGATIVE TUMO, P108, DOI [10.1111/j.1365-2559.2007.02889.x, DOI 10.1111/J.1365-2559.2007.02889.X]; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806	42	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144359	10.1371/journal.pone.0144359	http://dx.doi.org/10.1371/journal.pone.0144359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684197	gold, Green Published, Green Submitted			2022-12-27	WOS:000366725800013
J	Chu, KH; Unger, JB; Allem, JP; Pattarroyo, M; Soto, D; Cruz, TB; Yang, HD; Jiang, L; Yang, CC				Chu, Kar-Hai; Unger, Jennifer B.; Allem, Jon-Patrick; Pattarroyo, Monica; Soto, Daniel; Cruz, Tess Boley; Yang, Haodong; Jiang, Ling; Yang, Christopher C.			Diffusion of Messages from an Electronic Cigarette Brand to Potential Users through Twitter	PLOS ONE			English	Article								Objective This study explores the presence and actions of an electronic cigarette (e-cigarette) brand, Blu, on Twitter to observe how marketing messages are sent and diffused through the retweet (i.e., message forwarding) functionality. Retweet networks enable messages to reach additional Twitter users beyond the sender's local network. We follow messages from their origin through multiple retweets to identify which messages have more reach, and the different users who are exposed. Methods We collected three months of publicly available data from Twitter. A combination of techniques in social network analysis and content analysis were applied to determine the various networks of users who are exposed to e-cigarette messages and how the retweet network can affect which messages spread. Results The Blu retweet network expanded during the study period. Analysis of user profiles combined with network cluster analysis showed that messages of certain topics were only circulated within a community of e-cigarette supporters, while other topics spread further, reaching more general Twitter users who may not support or use e-cigarettes. Conclusions Retweet networks can serve as proxy filters for marketing messages, as Twitter users decide which messages they will continue to diffuse among their followers. As certain e-cigarette messages extend beyond their point of origin, the audience being exposed expands beyond the e-cigarette community. Potential implications for health education campaigns include utilizing Twitter and targeting important gatekeepers or hubs that would maximize message diffusion.	[Chu, Kar-Hai; Unger, Jennifer B.; Allem, Jon-Patrick; Pattarroyo, Monica; Soto, Daniel; Cruz, Tess Boley] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Yang, Haodong; Jiang, Ling; Yang, Christopher C.] Drexel Univ, Coll Comp & Informat, Philadelphia, PA 19104 USA	University of Southern California; Drexel University	Chu, KH (corresponding author), Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA.	karhaich@usc.edu		Unger, Jennifer/0000-0001-9064-6603; Cruz, Tess Boley/0000-0002-5894-1802	National Cancer Institute [P50CA180905]; FDA Center for Tobacco Products (CTP); NATIONAL CANCER INSTITUTE [P50CA180905] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FDA Center for Tobacco Products (CTP)(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by grant number P50CA180905 from the National Cancer Institute and FDA Center for Tobacco Products (CTP).	[Anonymous], [No title captured]; Barbera P, 2015, POLIT ANAL, V23, P76, DOI 10.1093/pan/mpu011; Barrington-Trimis JL, 2014, JAMA-J AM MED ASSOC, V312, P2493, DOI 10.1001/jama.2014.14830; Bhatnagar A, 2014, CIRCULATION, V130, P1418, DOI 10.1161/CIR.0000000000000107; Caponnetto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066317; Chu Kar-Hai, 2015, Tob Regul Sci, V1, P36; Cole-Lewis H, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4392; Colleoni E, 2014, J COMMUN, V64, P317, DOI 10.1111/jcom.12084; Conover M. D., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P192, DOI 10.1109/PASSAT/SocialCom.2011.34; Durmowicz EL, 2014, TOB CONTROL, V23, P41, DOI 10.1136/tobaccocontrol-2013-051468; Giovenco DP, 2015, NICOTINE TOB RES, V17, P1279, DOI 10.1093/ntr/ntu282; Hajek P, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0225-z; Hale SA, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P833, DOI 10.1145/2556288.2557203; Harris JK, 2014, J MED INTERNET RES, V16, DOI [10.2196/jmir.2972, 10.2196/jmir.3622]; Huang JD, 2014, TOB CONTROL, V23, P26, DOI 10.1136/tobaccocontrol-2014-051551; Kim AE, 2014, AM J PREV MED, V46, P409, DOI 10.1016/j.amepre.2013.11.003; Mangold WG, 2009, BUS HORIZONS, V52, P357, DOI 10.1016/j.bushor.2009.03.002; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Nguyen D., 2013, 7 INT AAAI C WEBL SO; Pearson JL, 2012, AM J PUBLIC HEALTH, V102, P1758, DOI 10.2105/AJPH.2011.300526; Rao Delip, 2010, P 2 INT WORKSH SEARC, P37, DOI DOI 10.1145/1871985.1871993; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; van Liere D., 2010, P INT WORKSH MOD SOC, DOI 10.1145/1835980.1835986; Vardavas CI, 2012, CHEST, V141, P1400, DOI 10.1378/chest.11-2443; Yang J., 2010, P INT AAAI C WEB SOC, V4	26	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145387	10.1371/journal.pone.0145387	http://dx.doi.org/10.1371/journal.pone.0145387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9KM	26684746	Green Published, gold			2022-12-27	WOS:000366725800071
J	Denecke, S; Nowell, CJ; Fournier-Level, A; Perry, T; Batterham, P				Denecke, Shane; Nowell, Cameron J.; Fournier-Level, Alexandre; Perry, Trent; Batterham, Phil			The Wiggle Index: An Open Source Bioassay to Assess Sub-Lethal Insecticide Response in Drosophila melanogaster	PLOS ONE			English	Article							TARGET-SITE RESISTANCE; NEONICOTINOID INSECTICIDES; ENVIRONMENTAL FATE; DEGRADATION; PESTICIDES; SPINOSAD; STRAIN; METABOLISM; RESOURCE; ACID	Toxicological assays measuring mortality are routinely used to describe insecticide response, but sub-lethal exposures to insecticides can select for resistance and yield additional biological information describing the ways in which an insecticide impacts the insect. Here we present the Wiggle Index (WI), a high-throughput method to quantify insecticide response by measuring the reduction in motility during sub-lethal exposures in larvae of the vinegar fly Drosophila melanogaster. A susceptible wild type strain was exposed to the insecticides chlorantraniliprole, imidacloprid, spinosad, and ivermectin. Each insecticide reduced larval motility, but response times and profiles differed among insecticides. Two sets of target site mutants previously identified in mortality studies on the basis of imidacloprid or spinosad resistance phenotypes were tested. In each case the resistant mutant responded significantly less than the control. The WI was also able to detect a spinosad response in the absence of the primary spinosad target site. This response was not detected in mortality assays suggesting that spinosad, like many other insecticides, may have secondary targets affecting behaviour. The ability of the WI to detect changes in insecticide metabolism was confirmed by overexpressing the imidacloprid metabolizing Cyp6g1 gene in digestive tissues or the central nervous system. The data presented here validate the WI as an inexpensive, generic, sub-lethal assay that can complement information gained from mortality assays, extending our understanding of the genetic basis of insecticide response in D. melanogaster.	[Denecke, Shane; Fournier-Level, Alexandre; Perry, Trent; Batterham, Phil] Univ Melbourne, Sch BioSci, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Nowell, Cameron J.] Monash Univ, Fac Pharm & Pharmaceut Sci, Parkville, Vic 3052, Australia	University of Melbourne; Monash University	Batterham, P (corresponding author), Univ Melbourne, Sch BioSci, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.	p.batterham@unimelb.edu.au	Denecke, Shane/AAO-6540-2020; Perry, Trent/ABB-9462-2021; Batterham, Philip/G-5914-2012; Perry, Trent/A-7206-2012	Denecke, Shane/0000-0002-7291-1394; Perry, Trent/0000-0002-8045-0487; Batterham, Philip/0000-0001-9840-9119; Perry, Trent/0000-0002-8045-0487; Nowell, Cameron/0000-0002-8662-9840; FOURNIER-LEVEL, ALEXANDRE/0000-0002-6047-7164	Australian Research Council [DP130102414]	Australian Research Council(Australian Research Council)	This research was supported by the Australian Research Council (Discovery Project Grant DP130102414), http://www.arc.gov.au/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to thank the Basler lab, the Bloomington stock centre and the Drosophila Genome Resource Center for the provision of D. melanogaster stocks and the Australian Drosophila Biomedical Research Support Facility for handling the quarantine of imported flies. This research was supported by funding from the Australian Research Council (Discovery Project Grant DP130102414) awarded to PB.	Bai D, 1991, ACTIONS IMIDACLOPRID, P197; Banks WA, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-S1-S3; Bass C, 2013, P NATL ACAD SCI USA, V110, P19460, DOI 10.1073/pnas.1314122110; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000802; Begley DJ, 2004, CURR PHARM DESIGN, V10, P1295, DOI 10.2174/1381612043384844; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bloomquist J, 1992, REDUCED NEURONAL SEN, V25, P17; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Cameron R, 2013, J ECON ENTOMOL, V106, P597, DOI 10.1603/EC12370; Cleveland CB, 2002, J AGR FOOD CHEM, V50, P3244, DOI 10.1021/jf011663i; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daborn PJ, 2012, INSECT BIOCHEM MOLEC, V42, P918, DOI 10.1016/j.ibmb.2012.09.003; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; Feyereisen R, 2015, PESTIC BIOCHEM PHYS, V121, P61, DOI 10.1016/j.pestbp.2015.01.004; Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895; Flood J, 2010, FOOD SECUR, V2, P215, DOI 10.1007/s12571-010-0072-5; Gao JR, 2007, INSECT MOL BIOL, V16, P325, DOI 10.1111/j.1365-2583.2007.00730.x; Garlapow ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138129; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Hellou J, 2011, ENVIRON SCI POLLUT R, V18, P1, DOI 10.1007/s11356-010-0367-2; Hoi KK, 2014, ANAL CHEM, V86, P3525, DOI 10.1021/ac404188g; Hsu JC, 2012, INSECT BIOCHEM MOLEC, V42, P806, DOI 10.1016/j.ibmb.2012.07.010; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; IRAC [Insecticide Resistance Action Committee], 2015, TEST METH; Ivanov DK, 2015, J GERONTOL A-BIOL, V70, P1470, DOI 10.1093/gerona/glv047; Joussen N, 2008, METABOLISM IMIDACLOP, V73, P65, DOI [10.1002/ps, DOI 10.1002/PS]; Kane NS, 2000, P NATL ACAD SCI USA, V97, P13949, DOI 10.1073/pnas.240464697; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Lahm GP, 2009, BIOORGAN MED CHEM, V17, P4127, DOI 10.1016/j.bmc.2009.01.018; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu ZH, 2011, PEST MANAG SCI, V67, P1245, DOI 10.1002/ps.2174; Liu ZW, 2005, P NATL ACAD SCI USA, V102, P8420, DOI 10.1073/pnas.0502901102; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Marriage TN, 2014, GENETICS, V198, P45, DOI 10.1534/genetics.114.162107; McKenzie J a, 1994, GENETICA, P9; McKenzie JA, 1998, PREDICTING INSECTICI, P1729; Nichols CD, 2012, JOVE-J VIS EXP, DOI 10.3791/3795; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Perry T, 2008, INSECT BIOCHEM MOLEC, V38, P520, DOI 10.1016/j.ibmb.2007.12.007; Perry T, 2007, INSECT BIOCHEM MOLEC, V37, P184, DOI 10.1016/j.ibmb.2006.11.009; Perry T, 2015, INSECT BIOCHEM MOLEC, V64, P106, DOI 10.1016/j.ibmb.2015.01.017; Perry T, 2012, PESTIC BIOCHEM PHYS, V102, P56, DOI 10.1016/j.pestbp.2011.10.010; Preston S, 2015, INT J PARASITOL, V45, P333, DOI 10.1016/j.ijpara.2015.01.007; Puinean AM, 2013, J NEUROCHEM, V124, P590, DOI 10.1111/jnc.12029; Remucal CK, 2014, ENVIRON SCI-PROC IMP, V16, P628, DOI 10.1039/c3em00549f; Roote J, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-3-149, 10.1186/gb4010]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Strycharz JP, 2013, PESTIC BIOCHEM PHYS, V107, P207, DOI 10.1016/j.pestbp.2013.06.010; Tome HW, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-195; Tooming E, 2014, PEST MANAG SCI, V70, P959, DOI 10.1002/ps.3636; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Watson GB, 2001, PESTIC BIOCHEM PHYS, V71, P20, DOI 10.1006/pest.2001.2559; Watson GB, 2010, INSECT BIOCHEM MOLEC, V40, P376, DOI 10.1016/j.ibmb.2009.11.004; Wei H, 2010, AGR SCI CHINA, V9, P1612, DOI 10.1016/S1671-2927(09)60258-3; Wolf FW, 2002, J NEUROSCI, V22, P11035; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107	62	15	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145051	10.1371/journal.pone.0145051	http://dx.doi.org/10.1371/journal.pone.0145051			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684454	Green Published, gold			2022-12-27	WOS:000366725800033
J	Mettler, R; Segelbacher, G; Schaefer, HM				Mettler, Raeann; Segelbacher, Gernot; Schaefer, H. Martin			Interactions between a Candidate Gene for Migration (ADCYAP1), Morphology and Sex Predict Spring Arrival in Blackcap Populations	PLOS ONE			English	Article							SYLVIA-ATRICAPILLA; BIRD POPULATION; MIGRANT BIRDS; WING-LENGTH; CLOCK GENES; BEHAVIOR; HETEROZYGOSITY; ADAPTATIONS; EVOLUTION; COMMON	Avian research has begun to reveal associations between candidate genes and migratory behaviors of captive birds, yet few studies utilize genotypic, morphometric, and phenological data from wild individuals. Previous studies have identified an association between ADCYAP1 polymorphism and autumn migratory behavior (restlessness, or zugunruhe), but little is known about the relationship between ADCYAP1 and spring migratory behavior. The timing of spring migration and arrival to the breeding ground are phenological traits which could be particularly favorable for establishing territories and acquiring mates, thus important to fitness and reproductive success. Here, we investigated how individual genotypic ADCYAP1 variation and phenotypic variation (wing length and shape) of blackcaps (Sylvia atricapilla) affect spring arrival date across nine natural populations in Europe. We hypothesized that longer alleles should be associated with earlier spring arrival dates and expected the effect on arrival date to be stronger for males as they arrive earlier. However, we found that longer wings were associated with earlier spring arrival to the breeding grounds for females, but not for males. Another female-specific effect indicated an interaction between ADCYAP1 allele size and wing pointedness on the response of spring arrival: greater allele size had a positive effect on spring arrival date for females with rounder wings, while a negative effect was apparent for females with more pointed wings. Also, female heterozygotes with pointed wing tips arrived significantly earlier than both homozygotes with pointed wings and heterozygotes with round wings. Stable isotope ratios (delta H-2) of a subset of blackcaps captured in Freiburg in 2011 allowed us also to assign individuals to their main overwintering areas in northwest (NW) and southwest (SW) Europe. NW males arrived significantly earlier to the Freiburg breeding site than both SW males and females in 2011. NW females had more pointed wing tips compared to SW females, but no difference in ADCYAP1 allele size was found between the different migration routes.	[Mettler, Raeann; Schaefer, H. Martin] Univ Freiburg, Dept Evolutionary Biol & Anim Ecol, D-79106 Freiburg, Germany; [Mettler, Raeann; Schaefer, H. Martin] Black Hills State Univ, Sch Nat Sci, Spearfish, SD 57799 USA; [Segelbacher, Gernot] Univ Freiburg, Wildlife Ecol & Management, D-79106 Freiburg, Germany	University of Freiburg; Black Hills State University; University of Freiburg	Mettler, R (corresponding author), Black Hills State Univ, Sch Nat Sci, Spearfish, SD 57799 USA.	raeann.mettler@gmail.com	Segelbacher, Gernot/F-3633-2011	Segelbacher, Gernot/0000-0002-8024-7008	Deutsche Forschungsgemeinschaft (DE) grant [Scha 1008/6-1]; Deutsche Forschungsgemeinschaft (DFG) [Scha 1008/6-1]	Deutsche Forschungsgemeinschaft (DE) grant; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	RM, HMS, and GS were funded through a Deutsche Forschungsgemeinschaft (DE) grant (Scha 1008/6-1).; The authors thank Heidi Kurz, Hans Winkler, Diego Santiago-Alarcon, Gregor Rolshausen, Michael W. Stracco, and several students at Universitat Freiburg for field assistance and analysis advice. We also thank the staff at Universitat Freiburg Institute fur Rechtsmedizin for technical laboratory assistance and the Universitat Freiburg Open-Access-Publikationsfonds for publication assistance. This research was funded by a grant (Scha 1008/6-1) of the Deutsche Forschungsgemeinschaft (DFG).	Alho JS, 2010, MOL ECOL RESOUR, V10, P720, DOI 10.1111/j.1755-0998.2010.02830.x; [Anonymous], 1992, HDB BIRDS EUROPE MID; Baldwin MW, 2010, J EVOLUTION BIOL, V23, P1050, DOI 10.1111/j.1420-9101.2010.01975.x; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Bourret A, 2015, ECOL EVOL, V5, P3628, DOI 10.1002/ece3.1630; Caro SP, 2009, FUNCT ECOL, V23, P172, DOI 10.1111/j.1365-2435.2008.01486.x; Cassone VM, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00032; Chakarov N, 2013, MOL ECOL, V22, P5430, DOI 10.1111/mec.12493; Coppack T, 2011, J ORNITHOL, V152, P67, DOI 10.1007/s10336-011-0708-z; Delmore KE, 2015, MOL ECOL, V24, P1873, DOI 10.1111/mec.13150; Desrochers A, 2010, ECOLOGY, V91, P1577, DOI 10.1890/09-2202.1; Dierschke V, 2005, BEHAV ECOL SOCIOBIOL, V57, P470, DOI 10.1007/s00265-004-0872-8; Dingle H, 2006, J ORNITHOL, V147, P212, DOI 10.1007/s10336-005-0052-2; Fiedler W, 2005, ANN NY ACAD SCI, V1046, P253, DOI 10.1196/annals.1343.022; Forschler MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018732; Forstmeier W, 2012, MOL ECOL, V21, P3237, DOI 10.1111/j.1365-294X.2012.05593.x; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; HELBIG AJ, 1991, BEHAV ECOL SOCIOBIOL, V28, P9; Hermes C, PLOS ONE IN PRESS; JENNI L, 1989, BIRD STUDY, V36, P1, DOI 10.1080/00063658909476996; Johnsen A, 2007, MOL ECOL, V16, P4867, DOI 10.1111/j.1365-294X.2007.03552.x; Kopiec K, 2012, ORNIS FENNICA, V89, P254; Kwak E, 2006, J BIOL CHEM, V281, P19100, DOI 10.1074/jbc.M511927200; Liedvogel M, 2011, TRENDS ECOL EVOL, V26, P561, DOI 10.1016/j.tree.2011.07.009; Liedvogel M, 2009, MOL ECOL, V18, P2444, DOI 10.1111/j.1365-294X.2009.04204.x; Lo Valvo F, 1998, RINGING MIGR, V9, P51; Lockwood R, 1998, J AVIAN BIOL, V29, P273, DOI 10.2307/3677110; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; Mettler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081365; Miller JM, 2014, HEREDITY, V112, P240, DOI 10.1038/hdy.2013.99; MONKKONEN M, 1995, EVOL ECOL, V9, P520, DOI 10.1007/BF01237833; Mueller JC, 2013, MOL ECOL, V22, P3629, DOI 10.1111/mec.12288; Mueller JC, 2011, P ROY SOC B-BIOL SCI, V278, P2848, DOI 10.1098/rspb.2010.2567; Nagy AD, 2007, PEPTIDES, V28, P1767, DOI 10.1016/j.peptides.2007.07.013; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nosil P, 2012, OX ECOL EV, P3; Nowak JZ, 2003, CURR PHARM DESIGN, V9, P467, DOI 10.2174/1381612033391586; Petering M.E.H., 2013, FLEX SERV MANUF J, P1, DOI 10.12688/f1000research.2-115.v1; Piersma T, 2005, ANN NY ACAD SCI, V1046, P282, DOI 10.1196/annals.1343.026; Pulido F, 2003, AVIAN MIGRATION, P53; Pulido F, 2001, P ROY SOC B-BIOL SCI, V268, P953, DOI 10.1098/rspb.2001.1602; Pulido F, 2007, BIOSCIENCE, V57, P165, DOI 10.1641/B570211; Pulido F, 2010, P NATL ACAD SCI USA, V107, P7341, DOI 10.1073/pnas.0910361107; R Core Team, 2013, R LANG ENV STAT COMP; Rappole J., 2013, AVIAN MIGRANT BIOL B; Rolshausen G, 2013, ECOL EVOL, V3, P4278, DOI 10.1002/ece3.825; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Rolshausen G, 2010, OECOLOGIA, V162, P175, DOI 10.1007/s00442-009-1445-3; Ruegg K, 2014, MOL ECOL, V23, P4757, DOI 10.1111/mec.12842; Saino N, 2015, MOL ECOL, V24, P1758, DOI 10.1111/mec.13159; Santiago-Alarcon D, 2013, J AVIAN BIOL, V44, P521, DOI 10.1111/j.1600-048X.2013.00181.x; Schwartz C, 2013, CURR TOP DEV BIOL, V105, P247, DOI 10.1016/B978-0-12-396968-2.00009-9; Steinmeyer C, 2009, GENETICA, V136, P109, DOI 10.1007/s10709-008-9318-y; Tarka M, 2014, AM NAT, V183, P62, DOI 10.1086/674072; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Venables WN., 2002, MODERN APPL STAT S 4; Wang G, 2012, J BIOL RHYTHM, V27, P145, DOI 10.1177/0748730411435965; WINKLER H, 1992, IBIS, V134, P21	60	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144587	10.1371/journal.pone.0144587	http://dx.doi.org/10.1371/journal.pone.0144587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684459	Green Published, gold, Green Submitted			2022-12-27	WOS:000366725800015
J	Pintar, KDM; Christidis, T; Thomas, MK; Anderson, M; Nesbitt, A; Keithlin, J; Marshall, B; Pollari, F				Pintar, Katarina D. M.; Christidis, Tanya; Thomas, M. Kate; Anderson, Maureen; Nesbitt, Andrea; Keithlin, Jessica; Marshall, Barbara; Pollari, Frank			A Systematic Review and Meta-Analysis of the Campylobacter spp. Prevalence and Concentration in Household Pets and Petting Zoo Animals for Use in Exposure Assessments	PLOS ONE			English	Review							ESCHERICHIA-COLI O157; CRYPTOSPORIDIUM-PARVUM OOCYSTS; RISK-FACTORS; UNITED-STATES; ZOONOTIC AGENTS; NEW-ZEALAND; OUTBREAK DATA; GASTROINTESTINAL-DISEASE; CLOSTRIDIUM-PERFRINGENS; SPATIAL-DISTRIBUTION	Animal contact is a potential transmission route for campylobacteriosis, and both domestic household pet and petting zoo exposures have been identified as potential sources of exposure. Research has typically focussed on the prevalence, concentration, and transmission of zoonoses from farm animals to humans, yet there are gaps in our understanding of these factors among animals in contact with the public who don't live on or visit farms. This study aims to quantify, through a systematic review and meta-analysis, the prevalence and concentration of Campylobacter carriage in household pets and petting zoo animals. Four databases were accessed for the systematic review (PubMed, CAB direct, ProQuest, and Web of Science) for papers published in English from 1992-2012, and studies were included if they examined the animal population of interest, assessed prevalence or concentration with fecal, hair coat, oral, or urine exposure routes (although only articles that examined fecal routes were found), and if the research was based in Canada, USA, Europe, Australia, and New Zealand. Studies were reviewed for qualitative synthesis and meta-analysis by two reviewers, compiled into a database, and relevant studies were used to create a weighted mean prevalence value. There were insufficient data to run a meta-analysis of concentration values, a noted study limitation. The mean prevalence of Campylobacter in petting zoo animals is 6.5% based on 7 studies, and in household pets the mean is 24.7% based on 34 studies. Our estimated concentration values were: 7.65x10(3)cfu/g for petting zoo animals, and 2.9x10(5)cfu/g for household pets. These results indicate that Campylobacter prevalence and concentration are lower in petting zoo animals compared with household pets and that both of these animal sources have a lower prevalence compared with farm animals that do not come into contact with the public. There is a lack of studies on Campylobacter in petting zoos and/or fair animals in Canada and abroad. Within this literature, knowledge gaps were identified, and include: a lack of concentration data reported in the literature for Campylobacter spp. in animal feces, a distinction between ill and diarrheic pets in the reported studies, noted differences in shedding and concentrations for various subtypes of Campylobacter, and consistent reporting between studies.	[Pintar, Katarina D. M.; Christidis, Tanya; Thomas, M. Kate; Nesbitt, Andrea; Marshall, Barbara; Pollari, Frank] Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, Ottawa, ON, Canada; [Anderson, Maureen] Ontario Minist Agr Food & Rural Affairs, Guelph, ON, Canada; [Keithlin, Jessica] Univ Guelph, Ctr Publ Hlth & Zoonoses, Guelph, ON N1G 2W1, Canada	Public Health Agency of Canada; University of Guelph	Pintar, KDM (corresponding author), Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, Ottawa, ON, Canada.	katarina.pintar@phac-aspc.gc.ca						Acke E, 2006, VET REC, V158, P51, DOI 10.1136/vr.158.2.51; Aktan I, 2007, VET REC, V161, P386, DOI 10.1136/vr.161.11.386; [Anonymous], 1997, Commun Dis Rep CDR Wkly, V7, P266; [Anonymous], 2011, MMWR MORB MORTAL WKL, V60, p1; Arsenault J, 2010, EPIDEMIOLOGIE SPATIA; Asensio L, 2008, FOOD CONTROL, V19, P1, DOI 10.1016/j.foodcont.2007.02.010; Atwill ER, 1999, AM J VET RES, V60, P420; Atwill ER, 2000, EQUINE VET J, V32, P247, DOI 10.2746/042516400776563545; Baker J, 1999, AUST VET J, V77, P662, DOI 10.1111/j.1751-0813.1999.tb13159.x; Ballweber LR, 2009, VET PARASITOL, V160, P306, DOI 10.1016/j.vetpar.2008.11.018; Batchelor DJ, 2008, TRANSBOUND EMERG DIS, V55, P99, DOI 10.1111/j.1865-1682.2007.01005.x; Bell JA, 1997, COMP CONT ED PRACT, V16, P617; Bender JB, 2005, JAVMA-J AM VET MED A, V226, P544, DOI 10.2460/javma.2005.226.544; Bessell PR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-423; Blagburn BL, 1996, PREVALENCE CANINE PA; Blagburn Byron L, 2008, Vet Ther, V9, P169; Borenstein M, 2009, INTRO META ANAL; Bryan HM, 2011, CAN J VET RES, V75, P11; BURNENS AP, 1992, AM J VET RES, V53, P48; Butler AJ, 2015, FOODBORNE PATHOG DIS, V12, P335, DOI 10.1089/fpd.2014.1856; Bybee SN, 2011, J VET INTERN MED, V25, P856, DOI 10.1111/j.1939-1676.2011.0738.x; Carbonero A, 2012, COMP IMMUNOL MICROB, V35, P505, DOI 10.1016/j.cimid.2012.05.002; Carlin EP, 2006, VET THER, V7, P199; Cave NJ, 2002, J AM VET MED ASSOC, V221, P52, DOI 10.2460/javma.2002.221.52; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V60, P1745; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P293; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P426; Chaban B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-73; Chapman PA, 2000, EPIDEMIOL INFECT, V125, P531, DOI 10.1017/S0950268800004775; Cho S, 2006, VET MICROBIOL, V118, P289, DOI 10.1016/j.vetmic.2006.07.021; Cole DJ, 1998, J AM VET MED ASSOC, V213, P1296; Crump JA, 2002, NEW ENGL J MED, V347, P555, DOI 10.1056/NEJMoa020524; David S T, 2004, Can Commun Dis Rep, V30, P173; Davies M, 2006, JAMA-J AM MED ASSOC, V295, P378; de la Paz Manuel Posada, 2010, RARE DIS EPIDEMIOLOG; De Santis-Kerr AC, 2006, J FELINE MED SURG, V8, P292, DOI 10.1016/j.jfms.2006.02.005; DebRoy C, 2006, J VET DIAGN INVEST, V18, P597, DOI 10.1177/104063870601800614; Derlet RW, 2002, WILD ENVIRON MED, V13, P113, DOI 10.1580/1080-6032(2002)013[0113:AAOHPF]2.0.CO;2; Eberhart-Phillips J, 1997, J EPIDEMIOL COMMUN H, V51, P686, DOI 10.1136/jech.51.6.686; Elwin K, 2001, APPL ENVIRON MICROB, V67, P5581, DOI 10.1128/AEM.67.12.5581-5584.2001; Engvall EO, 2003, SCAND J INFECT DIS, V35, P713, DOI 10.1080/00365540310014558; Epe C, 2010, VET PARASITOL, V173, P32, DOI 10.1016/j.vetpar.2010.06.015; Ethelberg S, 2005, AM J EPIDEMIOL, V162, P1008, DOI 10.1093/aje/kwi316; Evans MR, 1996, EPIDEMIOL INFECT, V117, P457, DOI 10.1017/S0950268800059112; Evans MR, 2003, EMERG INFECT DIS, V9, P1219; Evers E. G., 2008, International Journal of Risk Assessment & Management, V8, P174, DOI 10.1504/IJRAM.2008.016151; Forde KN, 1998, J EQUINE VET SCI, V18, P38, DOI 10.1016/S0737-0806(98)80183-4; Frederick J, 2009, J VET INTERN MED, V23, P1254, DOI 10.1111/j.1939-1676.2009.0383.x; Friedman CR, 1998, J PEDIATR-US, V132, P802, DOI 10.1016/S0022-3476(98)70307-5; Gabriel E, 2010, EPIDEMIOL INFECT, V138, P1384, DOI 10.1017/S0950268810000488; Galanis E, 2014, EPIDEMIOL INFECT, V142, P2075, DOI 10.1017/S095026881400123X; Gates MC, 2009, VET PARASITOL, V166, P153, DOI 10.1016/j.vetpar.2009.07.041; Gaunt MC, 2011, CAN VET J, V52, P497; Gonzalez AE, 2006, PARASITOL INT, V55, pS131, DOI 10.1016/j.parint.2005.11.021; Gookin JL, 2004, J CLIN MICROBIOL, V42, P2707, DOI 10.1128/JCM.42.6.2707-2710.2004; GOOSSENS H, 1991, LANCET, V337, P1486, DOI 10.1016/0140-6736(91)93182-9; Gow AG, 2009, J FELINE MED SURG, V11, P655, DOI 10.1016/j.jfms.2008.12.007; Green CG, 2006, INT J HLTH GEOGR, V5; Greig JD, 2009, INT J FOOD MICROBIOL, V130, P77, DOI 10.1016/j.ijfoodmicro.2008.12.031; Guest CM, 2007, J SMALL ANIM PRACT, V48, P631, DOI 10.1111/j.1748-5827.2007.00367.x; Guevremont E, 2014, FOODBORNE PATHOG DIS, V11, P388, DOI 10.1089/fpd.2013.1706; Hackett T, 2003, J AM ANIM HOSP ASSOC, V39, P52, DOI 10.5326/0390052; Hald B, 2004, J CLIN MICROBIOL, V42, P2003, DOI 10.1128/JCM.42.5.2003-2012.2004; Hald B, 1997, J CLIN MICROBIOL, V35, P3351, DOI 10.1128/JCM.35.12.3351-3352.1997; Hale CR, 2012, CLIN INFECT DIS, V54, pS472, DOI 10.1093/cid/cis051; Hemsworth S, 2006, EUR J ONCOL NURS, V10, P117, DOI 10.1016/j.ejon.2005.08.001; Heuvelink AE, 2007, EPIDEMIOL INFECT, V135, P1174, DOI 10.1017/S0950268807008072; Heuvelink AE, 2002, EPIDEMIOL INFECT, V129, P295, DOI 10.1017/S095026880200732X; Heuvelink AE, 2009, INT J FOOD MICROBIOL, V134, P70, DOI 10.1016/j.ijfoodmicro.2008.12.026; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hill SL, 2000, J AM VET MED ASSOC, V216, P687, DOI 10.2460/javma.2000.216.687; Himsworth CG, 2010, AM J TROP MED HYG, V83, P338, DOI 10.4269/ajtmh.2010.10-0137; Inglis GD, 2004, APPL ENVIRON MICROB, V70, P2296, DOI 10.1128/AEM.70.4.2296-2306.2004; Jacobs SR, 2001, CAN VET J, V42, P45; Jepsen MR, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-11; Keen JE, 2006, EMERG INFECT DIS, V12, P780; Keithlin J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1203; Kemp R, 2005, APPL ENVIRON MICROB, V71, P1876, DOI 10.1128/AEM.71.4.1876-1882.2005; Kiang KM, 2006, EPIDEMIOL INFECT, V134, P878, DOI 10.1017/S0950268805005649; Kingsbury DD, 2010, NEW ZEAL VET J, V58, P6, DOI 10.1080/00480169.2010.65054; Koricheva J., 2013, HDB META ANAL ECOLOG; Kovats RS, 2005, INT J BIOMETEOROL, V49, P207, DOI 10.1007/s00484-004-0241-3; Labarca JA, 2002, CLIN INFECT DIS, V34, pE59, DOI 10.1086/340266; Lee Michelle K, 2004, Foodborne Pathog Dis, V1, P223, DOI 10.1089/fpd.2004.1.223; Lefebvre SL, 2006, J HOSP INFECT, V62, P458, DOI 10.1016/j.jhin.2005.09.025; LeJeune JT, 2004, JAVMA-J AM VET MED A, V224, P1440, DOI 10.2460/javma.2004.224.1440; Leonard EK, 2011, EPIDEMIOL INFECT, V139, P1531, DOI 10.1017/S0950268810002906; Line J, 2008, POULTRY SCI, V87, P1700, DOI 10.3382/ps.2008-00027; Majewska AC, 2004, PARASITOL RES, V93, P274, DOI 10.1007/s00436-004-1111-y; McDowall RM, 2011, CAN VET J, V52, P1329; McGlade TR, 2003, VET PARASITOL, V110, P197, DOI 10.1016/S0304-4017(02)00322-9; Milne L M, 1999, Commun Dis Public Health, V2, P22; MORENO GS, 1993, J APPL BACTERIOL, V75, P49, DOI 10.1111/j.1365-2672.1993.tb03406.x; Moser I, 2001, J CLIN MICROBIOL, V39, P2548, DOI 10.1128/JCM.39.7.2548-2557.2001; Moyaert H, 2008, VLAAMS DIERGEN TIJDS, V77, P92; Mueller-Doblies D, 2008, VET PARASITOL, V154, P214, DOI 10.1016/j.vetpar.2008.03.021; Netherwood T, 1996, EPIDEMIOL INFECT, V117, P375, DOI 10.1017/S0950268800001564; Nylen G, 2002, EPIDEMIOL INFECT, V128, P383, DOI 10.1017/S0950268802006830; Ogden ID, 2009, FOODBORNE PATHOG DIS, V6, P1161, DOI 10.1089/fpd.2009.0327; Olson ME, 2010, CAN VET J, V51, P640; Paiba GA, 2003, VET REC, V153, P347, DOI 10.1136/vr.153.12.347; PARRY SM, 1995, LANCET, V346, P572, DOI 10.1016/S0140-6736(95)91407-2; Parsons BN, 2010, VET J, V184, P66, DOI 10.1016/j.tvjl.2009.01.009; Payne CJI, 2003, EMERG INFECT DIS, V9, P526, DOI 10.3201/eid0905.020237; Pintar K, COMP EXPOSURE ASSESS; Pires SM, 2010, FOODBORNE PATHOG DIS, V7, P1351, DOI 10.1089/fpd.2010.0564; Pritchard GC, 2007, VET REC, V161, P11, DOI 10.1136/vr.161.1.11; Pritchard GC, 2009, VET REC, V164, P545, DOI 10.1136/vr.164.18.545; Pritchard GC, 2000, VET REC, V147, P259, DOI 10.1136/vr.147.10.259; Proquest LLC, 2013, REFW; Public Health Agency of Canada, 2014, SHORT REPORT FOODNET; Public Health Agency of Canada, 2014, CAN NOT DIS SURV SYS; Queen EV, 2012, J VET INTERN MED, V26, P54, DOI 10.1111/j.1939-1676.2011.00843.x; Ravel A, 2009, J FOOD PROTECT, V72, P1963, DOI 10.4315/0362-028X-72.9.1963; Rechel B, 2011, EUROSURVEILLANCE, V16, P18; Richter B, 2011, J VET DIAGN INVEST, V23, P430, DOI 10.1177/1040638711403415; Rind E, 2010, EPIDEMIOL INFECT, V138, P1359, DOI 10.1017/S095026881000018X; Rosef O, 2001, INT J ENVIRON HEAL R, V11, P321, DOI 10.1080/09603120120081791; Rossi M, 2008, VET MICROBIOL, V129, P304, DOI 10.1016/j.vetmic.2007.11.014; Sandberg M, 2002, PREV VET MED, V55, P241, DOI 10.1016/S0167-5877(02)00095-8; Schilling AK, 2012, APPL ENVIRON MICROB, V78, P3785, DOI 10.1128/AEM.07802-11; Shukla R, 1995, Commun Dis Rep CDR Rev, V5, pR86; Shukla R, 2006, CAN VET J, V47, P1179; Small A, 2002, J FOOD PROTECT, V65, P931, DOI 10.4315/0362-028X-65.6.931; Smith A., 2012, HOUSEHOLD PETS ZOONO; Sockett P N, 2001, Paediatr Child Health, V6, P203; Sokolow SH, 2005, AM J VET RES, V66, P1018, DOI 10.2460/ajvr.2005.66.1018; Spain CV, 2001, J VET INTERN MED, V15, P33, DOI 10.1892/0891-6640(2001)015&lt;0033:POEZAI&gt;2.3.CO;2; Stanley K, 2003, J APPL MICROBIOL, V94, p104S, DOI 10.1046/j.1365-2672.94.s1.12.x; Stavisky J, 2011, PREV VET MED, V99, P185, DOI 10.1016/j.prevetmed.2011.02.009; Steinmuller N, 2006, CLIN INFECT DIS, V43, P1596, DOI 10.1086/509576; Stirling J, 2008, ZOONOSES PUBLIC HLTH, V55, P166, DOI 10.1111/j.1863-2378.2007.01099.x; Stull JW, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-520; Stull JW, 2015, CANADIAN MED ASS J; Thomas MK, 2013, FOODBORNE PATHOG DIS, V10, P639, DOI 10.1089/fpd.2012.1389; Thompson RCA, 2004, VET PARASITOL, V126, P15, DOI 10.1016/j.vetpar.2004.09.008; Trevena W B, 1999, Commun Dis Public Health, V2, P263; Tzannes S, 2008, J FELINE MED SURG, V10, P1, DOI 10.1016/j.jfms.2007.05.006; Warshawsky Bryna, 2002, Can J Infect Dis, V13, P175; Weese JS, 2007, CLIN INFECT DIS, V45, P10, DOI 10.1086/518572; Weese JS, 2011, VET CLIN N AM-SMALL, V41, P287, DOI 10.1016/j.cvsm.2010.12.005; Weese JS, 2001, CAN VET J, V42, P292; Wells DL, 2003, VET REC, V153, P51, DOI 10.1136/vr.153.2.51; Westgarth C, 2009, VET REC, V165, P526, DOI 10.1136/vr.165.18.526; Whitfield Y, 2014, ENTERIC ZOONOSES PET; Willshaw GA, 2003, VET REC, V152, P365, DOI 10.1136/vr.152.12.365	146	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144976	10.1371/journal.pone.0144976	http://dx.doi.org/10.1371/journal.pone.0144976			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683667	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800028
J	Wang, Y; Li, GH; Yang, SY; Gu, XY; Li, XY; Liu, MY; Wu, XJ; Guan, Y; Press, R; Zhu, J; Zhang, HL				Wang, Ying; Li, Guihong; Yang, Siyu; Gu, Xiaoyi; Li, Xinyu; Liu, Mingyang; Wu, Xiujuan; Guan, Yun; Press, Rayomand; Zhu, Jie; Zhang, Hong-Liang			Fasting Glucose Levels Correlate with Disease Severity of Guillain-Barre Syndrome	PLOS ONE			English	Article							DIABETIC-NEUROPATHY	Objective A potential association between diabetes and Guillain-Barre syndrome (GBS) has been indicated by a few case studies. We retrospectively analyzed the clinical features of a large cohort of GBS patients to explore the relationship between the level of fasting plasma glucose (FPG) obtained in the acute phase at admission and the severity of GBS. Methods Three hundred and four GBS patients were divided into two groups, one with normal FPG and the other with high FPG levels according to the international standards of FPG. Results The GBS disability scale score was positively, the Medical Research Council (MRC) sum score was negatively correlated to the level of FPG, but not to blood HBA1c or CSF glucose concentrations. A relatively higher FPG level was observed in older and younger GBS patients, and more often in those with cranial nerve involvement, autonomic deficit, dyspnea and ventilator dependence than in patients without these clinical characteristics. Importantly, higher levels of FPG at admission were associated with poorer short-term prognosis measured by the MRC sum score and the GBS disability scale at discharge. Conclusions Our data demonstrates that FPG in the acute phase of GBS correlates with the severity of GBS and may predict the short-term prognosis of GBS.	[Wang, Ying; Wu, Xiujuan; Zhu, Jie; Zhang, Hong-Liang] Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Peoples R China; [Li, Guihong; Yang, Siyu; Gu, Xiaoyi; Li, Xinyu; Liu, Mingyang] Jilin Univ, Norman Bethune Hlth Sci Ctr, Changchun 130023, Peoples R China; [Guan, Yun] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Press, Rayomand] Karolinska Inst, Div Neurol, Dept Clin Neurosci, Stockholm, Sweden; [Zhu, Jie; Zhang, Hong-Liang] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden	Jilin University; Jilin University; Fudan University; Karolinska Institutet; Karolinska Institutet	Zhang, HL (corresponding author), Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Peoples R China.	drzhl@hotmail.com	Zhang, Hongliang/AAN-3077-2020; Press, Rayomand/AAW-8142-2020; Li, Lambert LL/F-7146-2015; li, xin/HHS-9461-2022; Li, Guihong/GSI-5154-2022	Zhang, Hongliang/0000-0001-9205-5559; liu, mingyang/0000-0003-4101-716X				Chamberlain JL, 2010, J AUTOIMMUN, V34, P469, DOI 10.1016/j.jaut.2009.12.004; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; FLAX H, 1990, DIABETES RES CLIN EX, V14, P47; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; Kanemasa Y, 2011, INTERNAL MED, V50, P2201, DOI 10.2169/internalmedicine.50.5553; KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111; Lu MO, 2011, J NEUROL, V258, P533, DOI 10.1007/s00415-010-5836-5; MASER RE, 1989, DIABETES, V38, P1456, DOI 10.2337/diabetes.38.11.1456; Misasi R, 1997, DIABETES METAB REV, V13, P163, DOI 10.1002/(SICI)1099-0895(199709)13:3<163::AID-DMR189>3.0.CO;2-Z; Roodbol J, 2011, NEUROLOGY, V76, P807, DOI 10.1212/WNL.0b013e31820e7b62; Rouanet-Larriviere M, 2000, J PERIPHER NERV SYST, V5, P27, DOI 10.1046/j.1529-8027.2000.00122.x; Tishler M, 2004, ISR MED ASSOC J, V6, P430; Vaishnavi C, 2014, INDIAN J PATHOL MICR, V57, P51, DOI 10.4103/0377-4929.130897; Zhang HL, 2014, EXPERT OPIN THER TAR, V18, P355, DOI 10.1517/14728222.2014.882899; Zhang HL, 2013, CYTOKINE GROWTH F R, V24, P443, DOI 10.1016/j.cytogfr.2013.05.005; Zychowska M, 2013, PHARMACOL REP, V65, P1601, DOI 10.1016/S1734-1140(13)71521-4	16	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145075	10.1371/journal.pone.0145075	http://dx.doi.org/10.1371/journal.pone.0145075			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684748	gold, Green Published, Green Submitted			2022-12-27	WOS:000366725800035
J	White, ME; Hayward, JJ; Stokol, T; Boyko, AR				White, Michelle E.; Hayward, Jessica J.; Stokol, Tracy; Boyko, Adam R.			Genetic Mapping of Novel Loci Affecting Canine Blood Phenotypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DOG DOMESTICATION; ACTIVATION; MONOCYTES; REVEALS; DISEASE; TRAITS; BIM	Since the publication of the dog genome and the construction of high-quality genome-wide SNP arrays, thousands of dogs have been genotyped for disease studies. For many of these dogs, additional clinical phenotypes are available, such as hematological and clinical chemistry results collected during routine veterinary care. Little is known about the genetic basis of variation in blood phenotypes, but this variation may play an important role in the etiology and progression of many diseases. From a cohort of dogs that had been previously genotyped on a semi-custom Illumina CanineHD array for various genome-wide association studies (GWAS) at Cornell University Hospital for Animals, we chose 353 clinically healthy, adult dogs for our analysis of clinical pathologic test results (14 hematological tests and 25 clinical chemistry tests). After correcting for age, body weight and sex, genetic associations were identified for amylase, segmented neutrophils, urea nitrogen, glucose, and mean corpuscular hemoglobin. Additionally, a strong genetic association (P = 8.1x10(-13)) was evident between a region of canine chromosome 13 (CFA13) and alanine aminotransferase (ALT), explaining 23% of the variation in ALT levels. This region of CFA13 encompasses the GPT gene that encodes the transferase. Dogs homozygous for the derived allele exhibit lower ALT activity, making increased ALT activity a less useful marker of hepatic injury in these individuals. Overall, these associations provide a roadmap for identifying causal variants that could improve interpretation of clinical blood tests and understanding of genetic risk factors associated with diseases such as canine diabetes and anemia, and demonstrate the utility of holistic phenotyping of dogs genotyped for disease mapping studies.	[White, Michelle E.; Hayward, Jessica J.; Boyko, Adam R.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Stokol, Tracy] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	White, ME (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	mew248@cornell.edu; boyko@cornell.edu	Hayward, Jessica/AGW-0493-2022	White, Michelle E./0000-0002-9079-0880	Zoetis Animal Health; Cornell University Center for Advanced Technology in Life Science Enterprise; NIH [R24 GM082910-A1, R24 GM082910-S1, R01 12-PAF-04410]; Office Of the Director, National Institutes Of Health of the National Institutions of Health [T32ODO011000]; Stanton Foundation Next Generation Canine Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103961, R24GM082910] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011000] Funding Source: NIH RePORTER	Zoetis Animal Health; Cornell University Center for Advanced Technology in Life Science Enterprise; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office Of the Director, National Institutes Of Health of the National Institutions of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanton Foundation Next Generation Canine Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was made possible by funding support from Zoetis Animal Health (ARB), the Cornell University Center for Advanced Technology in Life Science Enterprise (ARB), NIH R24 GM082910-A1 (ARB), R24 GM082910-S1 (ARB), and R01 12-PAF-04410 (ARB). https://www.zoetis.com/, https://smallbizdev.cornell.edu/organizations/cat, http://grants.nih.gov/grants/oer.htm. MEW was supported by the Office Of the Director, National Institutes Of Health of the National Institutions of Health under Award Number T32ODO011000, http://grants.nih.gov/grants/oer.htm. JJH was supported by a Stanton Foundation Next Generation Canine Research Fellowship. http://thestantonfoundation.org/canine/next-gen-research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andina N, 2009, CELL DEATH DIFFER, V16, P1248, DOI 10.1038/cdd.2009.50; Arendt M, 2014, ANIM GENET, V45, P716, DOI 10.1111/age.12179; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Bates D., 2015, LINEAR MIXED EFFECTS; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Behrend EN, 1997, VET CLIN N AM-SMALL, V27, P187, DOI 10.1016/S0195-5616(97)50027-1; Castelhano MGP, 2009, JAVMA-J AM VET MED A, V234, P75, DOI 10.2460/javma.234.1.75; Center SA, 2007, VET CLIN N AM-SMALL, V37, P297, DOI 10.1016/j.cvsm.2006.11.009; Conklin KA, 2000, NUTR CANCER, V37, P1, DOI 10.1207/S15327914NC3701_1; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Davis RC, 2013, MAMM GENOME, V24, P105, DOI 10.1007/s00335-013-9448-0; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEVRIES JE, 1979, J IMMUNOL, V122, P1099; Faldyna M, 2001, VET IMMUNOL IMMUNOP, V82, P23, DOI 10.1016/S0165-2427(01)00337-3; Gabriele L, 2004, BLOOD, V103, P980, DOI 10.1182/blood-2003-03-0981; Hayward J, NAT COMMUN IN PRESS; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Lavoue R, 2014, VET CLIN PATH, V43, P352, DOI 10.1111/vcp.12151; Lawrence J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081288; Lidell ME, 2011, DIABETES, V60, P427, DOI 10.2337/db10-0409; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Nakajima Kei, 2011, BMC Res Notes, V4, P419, DOI 10.1186/1756-0500-4-419; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Raviv Z, 2013, CANCER CHEMOTH PHARM, V71, P275, DOI 10.1007/s00280-012-2039-z; Schoenebeck JJ, 2014, ANNU REV CELL DEV BI, V30, P535, DOI 10.1146/annurev-cellbio-100913-012927; Shannon LM, 2015, P NATL ACAD SCI USA, V112, P13639, DOI 10.1073/pnas.1516215112; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Takemoto Y, 1999, INT IMMUNOL, V11, P1957, DOI 10.1093/intimm/11.12.1957; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Ziegler A, 2012, HUM GENET, V131, P1627, DOI 10.1007/s00439-012-1188-9	35	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145199	10.1371/journal.pone.0145199	http://dx.doi.org/10.1371/journal.pone.0145199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683458	gold, Green Submitted, Green Published			2022-12-27	WOS:000366725800044
J	Aoun, SM; Deas, K; Howting, D; Lee, G				Aoun, Samar M.; Deas, Kathleen; Howting, Denise; Lee, Gabriel			Exploring the Support Needs of Family Caregivers of Patients with Brain Cancer Using the CSNAT: A Comparative Study with Other Cancer Groups	PLOS ONE			English	Article							HIGH-GRADE GLIOMA; ASSESSMENT TOOL CSNAT; OF-LIFE CARE; PALLIATIVE CARE; HOME; BEREAVEMENT; VALIDATION; THERAPY; TUMOR; END	A substantial burden is placed on family caregivers of patients diagnosed with brain cancers. Despite this, the support needs of the caregivers are often under-recognised and not addressed adequately in current routine and patient centred clinical care. The Care Support Needs Assessment Tool (CSNAT) is a validated instrument designed to systematically identify and address caregiver needs. It has been trialled in an Australian palliative care community setting using a stepped wedge cluster design involving 322 family carers of terminally ill patients. The current article reports on a subset from this trial, 29 caregivers of patients with primary brain cancer, and compares their profile and outcomes to those of other cancer groups. Caregiver strain was assessed using the Family Appraisal of Caregiving Questionnaire, caregiver physical and mental wellbeing using SF12 and caregiver workload using a questionnaire on support with activities of daily living (ADL). In comparison to caregivers of patients with all other cancers, the primary brain cancer group had significantly higher levels of caregiver strain, lower levels of mental wellbeing and a higher level of ADL workload. Their physical wellness also deteriorated significantly over time. An action plan approach led to practical solutions for addressing highlighted concerns. Four themes evolved from the family caregivers' feedback interviews: The extremely challenging caregiver experience with brain cancer; the systematic and practical approach of the CSNAT during rapid changes; connection with health professionals, feeling acknowledged and empowered; and timely advice and assurance of support during the caregiving journey. This preliminary study has demonstrated that the CSNAT provides a practical and useful tool for assessing the support needs of family caregivers of patients with brain cancer and has provided the basis for a larger scale, longitudinal study that allows a more detailed characterisation of the evolving caregiver needs at different stages of the disease.	[Aoun, Samar M.; Deas, Kathleen; Howting, Denise] Curtin Univ, Sch Nursing Midwifery & Paramed, Perth, WA, Australia; [Lee, Gabriel] St John Of God Hosp, Subiaco, WA, Australia; [Lee, Gabriel] Univ Western Australia, Sch Surg, Nedlands, WA 6009, Australia	Curtin University; St John of God Health Care; University of Western Australia	Aoun, SM (corresponding author), Curtin Univ, Sch Nursing Midwifery & Paramed, Perth, WA, Australia.	s.aoun@curtin.edu.au	Howting, Denise Ann/GWU-5045-2022	Howting, Denise Ann/0000-0001-8753-5849; Aoun, Samar/0000-0002-4073-4805	Australian Research Council linkage grant; Silver Chain [LP110100622]	Australian Research Council linkage grant(Australian Research Council); Silver Chain	This research was financially supported by an Australian Research Council linkage grant and Silver Chain (LP110100622).; This research was financially supported by an Australian Research Council linkage grant and Silver Chain (LP110100622). The authors gratefully acknowledge the contribution of the Silver Chain Hospice Care Service nurses in recruitment, data collection and valuable advice and the contribution of family caregivers to enriching the project with their feedback considering their difficult circumstances.	Aoun S, 2015, PALLIAT MED; Aoun S, 2015, PALLIATIVE MED, P1; Aoun S, 2015, PLOS ONE, P10; Aoun SM, 2015, J PALLIAT MED, V18, P31, DOI 10.1089/jpm.2014.0213; Aoun SM, 2005, PALLIATIVE MED, V19, P551, DOI 10.1191/0269216305pm1053oa; Arber A., 2010, BR J NEUROSCI NURS, V6, P329, DOI [10.12968/bjnn.2010.6.7.79227, DOI 10.12968/BJNN.2010.6.7.79227]; Arber A, 2013, EUR J ONCOL NURS, V17, P52, DOI 10.1016/j.ejon.2012.01.008; Catt S, 2008, LANCET ONCOL, V9, P884, DOI 10.1016/S1470-2045(08)70230-4; Collins A, 2014, BMJ SUPPORT PALLIAT, V4, P68, DOI 10.1136/bmjspcare-2012-000419; Cooper B, 2006, PSYCHO-ONCOLOGY, V15, P613, DOI 10.1002/pon.1001; Damodaran O, 2014, J CLIN NEUROSCI, V21, P478, DOI 10.1016/j.jocn.2013.07.042; Ewing G, 2013, J PAIN SYMPTOM MANAG, V46, P395, DOI 10.1016/j.jpainsymman.2012.09.008; Ewing G, 2013, PALLIATIVE MED, V27, P244, DOI 10.1177/0269216312440607; Fabi A, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-10; Ferrario SR, 2004, PALLIATIVE MED, V18, P129, DOI 10.1191/0269216304pm870oa; Grande G, 2009, PALLIATIVE MED, V23, P339, DOI 10.1177/0269216309104875; Grande GE, 2004, J PALLIATIVE CARE, V20, P69, DOI 10.1177/082585970402000202; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hudson PL, 2010, PALLIATIVE MED, V24, P656, DOI 10.1177/0269216310373167; Janda M, 2008, PATIENT EDUC COUNS, V71, P251, DOI 10.1016/j.pec.2008.01.020; Kissane DW, 2006, AM J PSYCHIAT, V163, P1208, DOI 10.1176/appi.ajp.163.7.1208; Madsen K, 2011, EUR J CANCER CARE, V20, P33, DOI 10.1111/j.1365-2354.2010.01184.x; McConigley R, 2010, PALLIAT MED; Moore G, 2013, PATIENT EDUC COUNS, V91, P141, DOI 10.1016/j.pec.2012.11.002; Northouse LL, 2010, CA-CANCER J CLIN, V60, P317, DOI 10.3322/caac.20081; Parvataneni R, 2011, J NEURO-ONCOL, V104, P737, DOI 10.1007/s11060-011-0534-4; Payne S., 2013, SUPPORTING FAMILY CA; Sanderson K, 2002, AUST NZ J PUBL HEAL, V26, P343, DOI 10.1111/j.1467-842X.2002.tb00182.x; Schubart JR, 2008, NEURO-ONCOLOGY, V10, P61, DOI 10.1215/15228517-2007-040; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Sherwood Paula R, 2004, Int J Palliat Nurs, V10, P67; Stajduhar KI, 2010, PALLIATIVE MED, V24, P573, DOI 10.1177/0269216310371412; Sterckx W, 2013, EUR J ONCOL NURS, V17, P107, DOI 10.1016/j.ejon.2012.04.006	34	21	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145106	10.1371/journal.pone.0145106	http://dx.doi.org/10.1371/journal.pone.0145106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JO	26679505	Green Published, gold			2022-12-27	WOS:000366723400048
J	Ding, XD; Jiang, W; Zhou, PP; Liu, LL; Wan, XL; Yuan, XJ; Wang, XZ; Chen, M; Chen, J; Yang, J; Kong, C; Li, B; Peng, C; Wong, CCL; Hou, FJ; Zhang, Y				Ding, Xiaodan; Jiang, Wei; Zhou, Peipei; Liu, Lulu; Wan, Xiaoling; Yuan, Xiujie; Wang, Xizi; Chen, Miao; Chen, Jun; Yang, Jing; Kong, Chao; Li, Bin; Peng, Chao; Wong, Catherine C. L.; Hou, Fajian; Zhang, Yan			Mixed Lineage Leukemia 5 (MLL5) Protein Stability Is Cooperatively Regulated by O-GlcNac Transferase (OGT) and Ubiquitin Specific Protease 7 (USP7)	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINE TRANSFERASE; CELL-CYCLE PROGRESSION; PROSTATE-CANCER CELLS; EMBRYONIC STEM-CELLS; BREAST-CANCER; SUBSTRATE-SPECIFICITY; GENOMIC STABILITY; MYELOID-LEUKEMIA; X-CHROMOSOME; KAPPA-B	Mixed lineage leukemia 5 (MLL5) protein is a trithorax family histone 3 lysine 4 (H3K4) methyltransferase that regulates diverse biological processes, including cell cycle progression, hematopoiesis and cancer. The mechanisms by which MLL5 protein stability is regulated have remained unclear to date. Here, we showed that MLL5 protein stability is cooperatively regulated by O-GlcNAc transferase (OGT) and ubiquitin-specific protease 7 (USP7). Depletion of OGT in cells led to a decrease in the MLL5 protein level through ubiquitin/proteasome-dependent proteolytic degradation, whereas ectopic expression of OGT protein suppressed MLL5 ubiquitylation. We further identified deubiquitinase USP7 as a novel MLL5-associated protein using mass spectrometry. USP7 stabilized the MLL5 protein through direct binding and deubiquitylation. Loss of USP7 induced degradation of MLL5 protein. Conversely, overexpression of USP7, but not a catalytically inactive USP7 mutant, led to decreased ubiquitylation and increased MLL5 stability. Co-immunoprecipitation and co-immunostaining assays revealed that MLL5, OGT and USP7 interact with each other to form a stable ternary complex that is predominantly located in the nucleus. In addition, upregulation of MLL5 expression was correlated with increased expression of OGT and USP7 in human primary cervical adenocarcinomas. Our results collectively reveal a novel molecular mechanism underlying regulation of MLL5 protein stability and provide new insights into the functional interplay among O-GlcNAc transferase, deubiquitinase and histone methyltransferase.	[Ding, Xiaodan] Nanjing Med Univ, Dept Immunol, Nanjing, Jiangsu, Peoples R China; [Ding, Xiaodan; Zhou, Peipei; Liu, Lulu; Wan, Xiaoling; Yuan, Xiujie; Chen, Miao; Yang, Jing; Kong, Chao; Li, Bin; Zhang, Yan] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Jiang, Wei] Fudan Univ, Shanghai Red House Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Liu, Lulu] Soochow Univ, Inst Biol & Med Sci, Suzhou, Jiangsu, Peoples R China; [Wang, Xizi] Sun Yet Sen Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Chen, Miao; Chen, Jun] Shanghai Normal Univ, Coll Life Sci, Shanghai, Peoples R China; [Peng, Chao; Wong, Catherine C. L.; Hou, Fajian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai, Shanghai, Peoples R China	Nanjing Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Fudan University; Soochow University - China; Sun Yat Sen University; Shanghai Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jiang, W (corresponding author), Fudan Univ, Shanghai Red House Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China.	jw52317@126.com; yan_zhang@sibs.ac.cn	Wan, Xiaoling/T-1813-2019; lI, Bin/AAR-4966-2021	lI, Bin/0000-0002-7640-8884; Wong, Catherine CL/0000-0001-7270-980X	National Basic Research Program of China [2015CB964901]; National Natural Science Foundation of China [31471207, 81270618]; Medicine Guide Project of the Science and Technology Commission of Shanghai Municipality [114119a233]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medicine Guide Project of the Science and Technology Commission of Shanghai Municipality	This work is supported by National Basic Research Program of China Grants (2015CB964901, http://www.most.gov.cn), National Natural Science Foundation of China Grants (31471207 and 81270618, http://www.nsfc.gov.cn) to YZ, and the Medicine Guide Project of the Science and Technology Commission of Shanghai Municipality (114119a233, http://www.stcsm.gov.cn/) to WJ.	Baychelier F, 2013, BLOOD, V122, P2935, DOI 10.1182/blood-2013-03-489054; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Champattanachai V, 2013, PROTEOMICS, V13, P2088, DOI 10.1002/pmic.201200126; Chang F, 2008, INT J BIOCHEM CELL B, V40, P2472, DOI 10.1016/j.biocel.2008.04.012; Cheon KW, 2006, INT J ONCOL, V28, P1209; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; de Bie P, 2010, BIOCHEM BIOPH RES CO, V400, P389, DOI 10.1016/j.bbrc.2010.08.082; Deng LW, 2004, P NATL ACAD SCI USA, V101, P757, DOI 10.1073/pnas.2036345100; Ding F, 2013, AMINO ACIDS, V45, P339, DOI 10.1007/s00726-013-1504-2; Dong S, 2014, CELL REP, V9, P16, DOI 10.1016/j.celrep.2014.08.068; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Faesen AC, 2012, BIOCHEM SOC T, V40, P539, DOI 10.1042/BST20120004; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Giovinazzi S, 2014, ONCOTARGET, V5, P3728, DOI 10.18632/oncotarget.1989; Golks A, 2007, EMBO J, V26, P4368, DOI 10.1038/sj.emboj.7601845; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; He JS, 2014, J BIOL CHEM, V289, P27278, DOI 10.1074/jbc.M114.589812; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; Huang X, 2013, J BIOL CHEM, V288, P36418, DOI 10.1074/jbc.M113.495713; Huang Z, 2011, NAT CELL BIOL, V13, P142, DOI 10.1038/ncb2153; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Jagannathan M, 2014, MOL CELL BIOL, V34, P132, DOI 10.1128/MCB.00639-13; Jin FZ, 2013, EXP CELL RES, V319, P1482, DOI 10.1016/j.yexcr.2013.03.013; Kamigaito T, 2014, PROSTATE CANCER P D, V17, P18, DOI 10.1038/pcan.2013.56; Keembiyehetty C, 2015, J BIOL CHEM; Khoronenkova SV, 2011, NUCLEIC ACIDS RES, V39, P2604, DOI 10.1093/nar/gkq1210; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kumar A, 2014, J BIOL CHEM, V289, P13543, DOI 10.1074/jbc.M114.553321; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Lucena-Araujo AR, 2014, BRIT J HAEMATOL, V166, P540, DOI 10.1111/bjh.12921; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Ma JF, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-8; Ma ZY, 2014, J BIOL CHEM, V289, P34457, DOI 10.1074/jbc.R114.577718; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Maertens GN, 2010, EMBO J, V29, P2553, DOI 10.1038/emboj.2010.129; Marz P, 2006, J BIOL CHEM, V281, P20263, DOI 10.1074/jbc.M601563200; Milne TA, 2014, HAEMATOLOGICA, V99, P1405, DOI 10.3324/haematol.2014.113357; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Nagel AK, 2014, AMINO ACIDS, V46, P2305, DOI 10.1007/s00726-014-1827-7; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Park JJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.32; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Qian J., 2014, ONCOGENE; Qiao Z, 2012, J BIOMED RES, V26, P268, DOI 10.7555/JBR.26.20110121; Qin WH, 2011, J CELL BIOCHEM, V112, P439, DOI 10.1002/jcb.22998; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shi DD, 2010, CANCER BIOL THER, V10, P737, DOI 10.4161/cbt.10.8.13417; Sodi VL, 2015, MOL CANC RES; Starska K, 2014, CLIN EXP MED; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tan EP, 2014, J BIOL CHEM, V289, P14719, DOI 10.1074/jbc.M113.525790; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Vocadlo DJ, 2012, CURR OPIN CHEM BIOL, V16, P488, DOI 10.1016/j.cbpa.2012.10.021; Wan XL, 2014, STEM CELL REV REP, V10, P643, DOI 10.1007/s12015-014-9527-y; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yap DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027127; Yew CW, 2011, CANCER RES, V71, P6696, DOI 10.1158/0008-5472.CAN-11-1271; Yun HY, 2014, HAEMATOLOGICA, V99, P1456, DOI 10.3324/haematol.2013.101386; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905; Zhou PP, 2013, J BIOL CHEM, V288, P17532, DOI 10.1074/jbc.M112.439729	78	39	42	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145023	10.1371/journal.pone.0145023	http://dx.doi.org/10.1371/journal.pone.0145023			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678539	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400042
J	Duke, JC; Alexander, TN; Zhao, XQ; Delahanty, JC; Allen, JA; MacMonegle, AJ; Farrelly, MC				Duke, Jennifer C.; Alexander, Tesfa N.; Zhao, Xiaoquan; Delahanty, Janine C.; Allen, Jane A.; MacMonegle, Anna J.; Farrelly, Matthew C.			Youth's Awareness of and Reactions to The Real Cost National Tobacco Public Education Campaign	PLOS ONE			English	Article							ESTABLISHED SMOKING; MEDIA CAMPAIGN; ANTISMOKING; PROGRESSION; VALIDATION; INTENTIONS; SMOKERS; IMPACT; TRUTH	In 2014, the Food and Drug Administration (FDA) launched its first tobacco-focused public education campaign, The Real Cost, aimed at reducing tobacco use among 12- to 17-year-olds in the United States. This study describes The Real Cost message strategy, implementation, and initial evaluation findings. The campaign was designed to encourage youth who had never smoked but are susceptible to trying cigarettes (susceptible nonsmokers) and youth who have previously experimented with smoking (experimenters) to reassess what they know about the "costs" of tobacco use to their body and mind. The Real Cost aired on national television, online, radio, and other media channels, resulting in high awareness levels. Overall, 89.0% of U.S. youth were aware of at least one advertisement 6 to 8 months after campaign launch, and high levels of awareness were attained within the campaign's two targeted audiences: susceptible nonsmokers (90.5%) and experimenters (94.6%). Most youth consider The Real Cost advertising to be effective, based on assessments of ad perceived effectiveness (mean = 4.0 on a scale from 1.0 to 5.0). High levels of awareness and positive ad reactions are requisite proximal indicators of health behavioral change. Additional research is being conducted to assess whether potential shifts in population-level cognitions and/or behaviors are attributable to this campaign. Current findings demonstrate that The Real Cost has attained high levels of ad awareness which is a critical first step in achieving positive changes in tobacco-related attitudes and behaviors. These data can also be used to inform ongoing message and media strategies for The Real Cost and other U.S. youth tobacco prevention campaigns.	[Duke, Jennifer C.; Allen, Jane A.; MacMonegle, Anna J.; Farrelly, Matthew C.] RTI Int, Res Triangle Pk, NC 27709 USA; [Alexander, Tesfa N.; Zhao, Xiaoquan; Delahanty, Janine C.] US FDA, Ctr Tobacco Prod, Silver Spring, MD USA; [Zhao, Xiaoquan] George Mason Univ, Dept Commun, Fairfax, VA 22030 USA	Research Triangle Institute; US Food & Drug Administration (FDA); FDA Center for Tobacco Products (CTP); George Mason University	Duke, JC (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	jduke@rti.org		Delahanty, Janine/0000-0002-4714-6774; duke, jennifer/0000-0002-4643-2429; Farrelly, Matthew/0000-0002-6035-1596; MacMonegle, Anna/0000-0001-9729-8015; Appleyard Allen, Jane/0000-0001-7914-1866	US Food and Drug Administration (FDA) [HHSF223201310001B]	US Food and Drug Administration (FDA)	The study was funded by the US Food and Drug Administration (FDA) contract HHSF223201310001B. JCD, JAA, AJM, and MCF are all employees of the company receiving the funding (RTI International)., Co-authors TNA and JCD (2) are FDA employees and contributed to the writing and preparation of the manuscript.	Arrozola RA, 2015, MMWR-MORBID MORTAL W, V64, P381; Bandura A, 1998, PSYCHOL HEALTH, V13, P623, DOI 10.1080/08870449808407422; Bauer UE, 2000, JAMA-J AM MED ASSOC, V284, P723, DOI 10.1001/jama.284.6.723; Brennan E, 2013, CECCR WORKING PAPER; Brinn MP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001006.pub2; Center for Disease Control and Prevention, 2014, BEST PRACT COMPR TOB; Davis KC, 2013, HEALTH COMMUN, V28, P461, DOI 10.1080/10410236.2012.696535; Davis KC, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110102; Davis KC, 2011, TOB CONTROL, V20, P26, DOI 10.1136/tc.2009.035568; Duke JC, 2014, AM J HEALTH PROMOT, V28, P242, DOI 10.4278/ajhp.120920-QUAN-452; Farrelly MC, 2009, AM J PREV MED, V36, P379, DOI 10.1016/j.amepre.2009.01.019; Farrelly MC, 2002, AM J PUBLIC HEALTH, V92, P901, DOI 10.2105/AJPH.92.6.901; Farrelly MC, 2005, AM J PUBLIC HEALTH, V95, P425, DOI 10.2105/AJPH.2004.049692; Fishbein M, 2008, MED DECIS MAKING, V28, P834, DOI 10.1177/0272989X08326092; Hornik R. C., 2002, PUBLIC HLTH COMMUNIC, P1; McAfee T, 2013, LANCET, V382, P2003, DOI 10.1016/S0140-6736(13)61686-4; Mowery PD, 2004, AM J PUBLIC HEALTH, V94, P331, DOI 10.2105/AJPH.94.2.331; NCI, 2008, ROL MED PROM RED TOB; Niederdeppe J, 2011, SOC SCI MED, V72, P773, DOI 10.1016/j.socscimed.2010.12.025; Petty R. E., 1986, ELABORATION LIKELIHO; Pierce JP, 1996, HEALTH PSYCHOL, V15, P355, DOI 10.1037/0278-6133.15.5.355; SAMHSA, 2015, RES 2014 NAT SURV DR; Siegel M, 2000, AM J PUBLIC HEALTH, V90, P380, DOI 10.2105/AJPH.90.3.380; Southwell BG, 2002, J HEALTH COMMUN, V7, P445, DOI 10.1080/10810730290001800; US Department of Health and Human Services (USD-HHS), 2014, HLTH CONSMOK 50 YE; US Department of Health and Human Services (USD-HHS), 2012, PREV TOB UYOUTH YO; Wakefield M, 2003, J HEALTH COMMUN, V8, P229, DOI 10.1080/10810730305686; Wilson LM, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/961724; Wong NCH, 2009, J APPL COMMUN RES, V37, P1, DOI 10.1080/00909880802593928	29	79	79	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144827	10.1371/journal.pone.0144827	http://dx.doi.org/10.1371/journal.pone.0144827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JO	26679504	gold, Green Submitted, Green Published			2022-12-27	WOS:000366723400028
J	Curry, CJ; White, PA; Derr, JN				Curry, Caitlin J.; White, Paula A.; Derr, James N.			Mitochondrial Haplotype Diversity in Zambian Lions: Bridging a Gap in the Biogeography of an Iconic Species	PLOS ONE			English	Article							PANTHERA-LEO; CONSERVATION; POPULATION; INFERENCE; EVOLUTION; SOUTHERN; MRBAYES; HISTORY; EASTERN; PARK	Analysis of DNA sequence diversity at the 12S to 16S mitochondrial genes of 165 African lions (Panthera leo) from five main areas in Zambia has uncovered haplotypes which link Southern Africa with East Africa. Phylogenetic analysis suggests Zambia may serve as a bridge connecting the lion populations in southern Africa to eastern Africa, supporting earlier hypotheses that eastern-southern Africa may represent the evolutionary cradle for the species. Overall gene diversity throughout the Zambian lion population was 0.7319 +/-0.0174 with eight haplotypes found; three haplotypes previously described and the remaining five novel. The addition of these five novel haplotypes, so far only found within Zambia, nearly doubles the number of haplotypes previously reported for any given geographic location of wild lions. However, based on an AMOVA analysis of these haplotypes, there is little to no matrilineal gene flow (FST = 0.47) when the eastern and western regions of Zambia are considered as two regional sub-populations. Crossover haplotypes (H9, H11, and Z1) appear in both populations as rare in one but common in the other. This pattern is a possible result of the lion mating system in which predominately males disperse, as all individuals with crossover haplotypes were male. The determination and characterization of lion sub-populations, such as done in this study for Zambia, represent a higher-resolution of knowledge regarding both the genetic health and connectivity of lion populations, which can serve to inform conservation and management of this iconic species.	[Curry, Caitlin J.; Derr, James N.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, Interdisciplinary Program Genet, College Stn, TX 77845 USA; [White, Paula A.] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California Los Angeles	Derr, JN (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, Interdisciplinary Program Genet, College Stn, TX 77845 USA.	jderr@cvm.tamu.edu		Curry, Caitlin/0000-0002-3853-7191	Zambia Wildlife Authority; Professional Hunters Association of Zambia; Safari Hunters and Outfitters Association of Zambia; Boore Family Foundation; Dallas Safari Club; Safari Club International Foundation; Texas AM Foundation	Zambia Wildlife Authority; Professional Hunters Association of Zambia; Safari Hunters and Outfitters Association of Zambia; Boore Family Foundation; Dallas Safari Club; Safari Club International Foundation; Texas AM Foundation	This research has been funded in part by the Zambia Wildlife Authority, Professional Hunters Association of Zambia (www.phazambia.com), Safari Hunters and Outfitters Association of Zambia, the Boore Family Foundation, Dallas Safari Club (biggame.org), Safari Club International Foundation (www.safariclub.org) and the Texas A&M Foundation (txamfoundation.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], AFR LION PANTH LEO S; [Anonymous], SEQ VERS 5 3 SEQ AN; [Anonymous], AS LION PANTH LEO PE; Antunes A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000251; Arif I. A., 2009, Animal Biodiversity and Conservation, V32, P9; Avise JC, 1995, MITOCHONDRIAL DNA PO, V9, P686; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barnett R, 2006, P ROY SOC B-BIOL SCI, V273, P2119, DOI 10.1098/rspb.2006.3555; Barnett R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-70; Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; Bauer H, 2012, PANTHERA LEO IUCN RE; Becker MS, 2013, J WILDLIFE MANAGE, V77, P128, DOI 10.1002/jwmg.446; Bertola LD, 2011, J BIOGEOGR, V38, P1356, DOI 10.1111/j.1365-2699.2011.02500.x; Bertola LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137975; Bertola LD, 2012, GENETIC DIVERSITY NE, P61; Dolrenry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088081; Dubach J, 2005, CONSERV GENET, V6, P15, DOI 10.1007/s10592-004-7729-6; Dubach JM, 2013, CONSERV GENET, V14, P741, DOI 10.1007/s10592-013-0453-3; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, 2006, CONS STRAT LION PATH; Kim JH, 2006, GENE, V366, P292, DOI 10.1016/j.gene.2005.08.023; Midlane N, 2014, BIOL CONSERV, V172, P101, DOI 10.1016/j.biocon.2014.02.006; Midlane N, 2015, BIODIVERS CONSERV; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nowell K., 1996, WILD CATS STATUS SUR; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; Rambaut A, 2009, FIGTREE V1 3 1; Rambaut A, TRACER V1 2014; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenblatt E, 2014, BIOL CONSERV, V180, P176, DOI 10.1016/j.biocon.2014.10.006; Spong G, 2002, J EVOLUTION BIOL, V15, P945, DOI 10.1046/j.1420-9101.2002.00473.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tende T, 2014, ECOL EVOL, V4, P2668, DOI 10.1002/ece3.1116; Tende T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084288; Triant DA, 2011, ANIM BEHAV, V82, P601, DOI 10.1016/j.anbehav.2011.06.011; Trinkel M, 2008, ANIM CONSERV, V11, P138, DOI 10.1111/j.1469-1795.2008.00163.x; Wan QH, 2004, ELECTROPHORESIS, V25, P2165, DOI 10.1002/elps.200305922; Zwickl DJ, 2006, PHILOSOPHY	42	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143827	10.1371/journal.pone.0143827	http://dx.doi.org/10.1371/journal.pone.0143827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674533	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700016
J	Kim, WS; Kim, JS; Bin Cha, S; Han, SJ; Kim, H; Kwon, KW; Kim, SJ; Eum, SY; Cho, SN; Shin, SJ				Kim, Woo Sik; Kim, Jong-Seok; Bin Cha, Seung; Han, Seung Jung; Kim, HongMin; Kwon, Kee Woong; Kim, So Jeong; Eum, Seok-Yong; Cho, Sang-Nae; Shin, Sung Jae			Virulence-Dependent Alterations in the Kinetics of Immune Cells during Pulmonary Infection by Mycobacterium tuberculosis	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELLS; STRAIN; HOST; TH1; MICE; PATHOGENESIS; MACROPHAGES; VACCINATION; NECROSIS	A better understanding of the kinetics of accumulated immune cells that are involved in pathophysiology during Mycobacterium tuberculosis (Mtb) infection may help to facilitate the development of vaccines and immunological interventions. However, the kinetics of innate and adaptive cells that are associated with pathogenesis during Mtb infection and their relationship to Mtb virulence are not clearly understood. In this study, we used a mouse model to compare the bacterial burden, inflammation and kinetics of immune cells during aerogenic infection in the lung between laboratory-adapted strains (Mtb H37Rv and H37Ra) and Mtb K strain, a hyper-virulent W-Beijing lineage strain. The Mtb K strain multiplied more than 10- and 3.54-fold more rapidly than H37Ra and H37Rv, respectively, during the early stage of infection (at 28 days post-infection) and resulted in exacerbated lung pathology at 56 to 112 days post-infection. Similar numbers of innate immune cells had infiltrated, regardless of the strain, by 14 days post-infection. High, time-dependent frequencies of F4/80(-)CD11c(+)CD11b(-)Siglec-H(+)PDCA-1(+) plasmacytoid DCs and CD11c(-)CD11b(+)Gr-1(int) cells were observed in the lungs of mice that were infected with the Mtb K strain. Regarding adaptive immunity, Th1 and Th17 T cells that express T-bet and ROR gamma t, respectively, significantly increased in the lungs that were infected with the laboratory-adapted strains, and the population of CD4(+)CD25(+)Foxp3(+) regulatory T cells was remarkably increased at 112 days post-infection in the lungs of mice that were infected with the K strain. Collectively, our findings indicate that the highly virulent Mtb K strain may trigger the accumulation of pDCs and Gr1(int)CD11b(+) cells with the concomitant down-regulation of the Th1 response and the maintenance of an up-regulated Th2 response without inducing a Th17 response during chronic infection. These results will help to determine which immune system components must be considered for the development of tuberculosis (TB) vaccines and immunological interventions.	[Kim, Woo Sik; Kim, Jong-Seok; Bin Cha, Seung; Han, Seung Jung; Kim, HongMin; Kwon, Kee Woong; Kim, So Jeong; Cho, Sang-Nae; Shin, Sung Jae] Yonsei Univ, Dept Microbiol, Inst Immunol & Immunol Dis, Coll Med, Seoul 120749, South Korea; [Kim, HongMin; Kwon, Kee Woong; Kim, So Jeong; Cho, Sang-Nae; Shin, Sung Jae] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea; [Eum, Seok-Yong] Int TB Res Ctr, Div Immunopathol & Cellular Immunol, Chang Won, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Shin, SJ (corresponding author), Yonsei Univ, Dept Microbiol, Inst Immunol & Immunol Dis, Coll Med, Seoul 120749, South Korea.	sjshin@yuhs.ac		Shin, Sung Jae/0000-0003-0854-4582	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of the Ministry of science, ICT & Future Planning [NRF-2013R1A2A1A01009932]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of the Ministry of science, ICT & Future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of the Ministry of science, ICT & Future Planning (NRF-2013R1A2A1A01009932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/814943; Ali A., 2014, JOURNAL OF MICROBIOL, V4, P25, DOI [10.5923/s.microbiology.201401.04, DOI 10.5923/S.MICROBIOLOGY.201401.04]; Amaral EP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004188; Ancelet LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045888; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Beisiegel M, 2009, EUR J IMMUNOL, V39, P3369, DOI 10.1002/eji.200939615; Buu TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042323; Byun EH, 2012, FASEB J, V26, P2695, DOI 10.1096/fj.11-199588; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Chakraborty P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062966; Ehlers S, 2003, ANN RHEUM DIS, V62, P37, DOI 10.1136/ard.62.suppl_2.ii37; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Guidry TV, 2007, MICROBIOL-SGM, V153, P3360, DOI 10.1099/mic.0.2007/010850-0; Gupta V, 2010, HUM IMMUNOL, V71, P682, DOI 10.1016/j.humimm.2010.03.010; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Hunter RL, 2014, ANN CLIN LAB SCI, V44, P365; Jeon BY, 2012, J MED MICROBIOL, V61, P1373, DOI 10.1099/jmm.0.047027-0; Kamath AB, 2003, INFECT IMMUN, V71, P4112, DOI 10.1128/IAI.71.7.4112-4118.2003; Kim SJ, 2001, INT J TUBERC LUNG D, V5, P824; Kipnis A, 2005, INFECT IMMUN, V73, P7759, DOI 10.1128/IAI.73.11.7759-7764.2005; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Leung AN, 1999, RADIOLOGY, V210, P307, DOI 10.1148/radiology.210.2.r99ja34307; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Meraviglia S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/587315; Mihret A, 2012, VIRULENCE, V3, P654, DOI 10.4161/viru.22586; Obregon-Henao A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080669; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003; Peters W, 2001, P NATL ACAD SCI USA, V98, P7958, DOI 10.1073/pnas.131207398; Reiling N, 2013, MBIO, V4, DOI 10.1128/mBio.00250-13; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Satchidanandam V, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004176; Semple PL, 2013, AM J RESP CRIT CARE, V187, P1249, DOI 10.1164/rccm.201210-1934OC; Shin AR, 2008, CLIN VACCINE IMMUNOL, V15, P1788, DOI 10.1128/CVI.00231-08; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Sreejit G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004446; Tsiganov EN, 2014, J IMMUNOL, V192, P4718, DOI 10.4049/jimmunol.1301365; Tundup S, 2014, FEBS OPEN BIO, V4, P822, DOI 10.1016/j.fob.2014.09.001; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Verwaerde C, 2014, VACCINE, V32, P6240, DOI 10.1016/j.vaccine.2014.09.024; Vilaplana C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100830; Weiser JN, 2015, J INFECT DIS, V212, P1677, DOI 10.1093/infdis/jiv262; WHO, 2014, GLOBAL TUBERCULOSIS; Zhang L, 2012, DNA CELL BIOL, V31, P171, DOI 10.1089/dna.2011.1290	49	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145234	10.1371/journal.pone.0145234	http://dx.doi.org/10.1371/journal.pone.0145234			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675186	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700117
J	Zhang, Y; Feng, YM; Ahmad, M; Ming, X; Zhou, L; Deng, J				Zhang, Ying; Feng, Yuanming; Ahmad, Munir; Ming, Xin; Zhou, Li; Deng, Jun			Intermediate Megavoltage Photon Beams for Improved Lung Cancer Treatments	PLOS ONE			English	Article							BODY RADIATION-THERAPY; DOSE CALCULATION TOOL; BREAST-CANCER; RADIOTHERAPY; ENERGY; MV; TARGETS; PLANAR; IMRT	The goal of this study is to evaluate the effects of intermediate megavoltage (3-MV) photon beams on SBRT lung cancer treatments. To start with, a 3-MV virtual beam was commissioned on a commercial treatment planning system based on Monte Carlo simulations. Three optimized plans (6-MV, 3-MV and dual energy of 3-and 6-MV) were generated for 31 lung cancer patients with identical beam configuration and optimization constraints for each patient. Dosimetric metrics were evaluated and compared among the three plans. Overall, planned dose conformity was comparable among three plans for all 31 patients. For 21 thin patients with average short effective path length (< 10 cm), the 3-MV plans showed better target coverage and homogeneity with dose spillage index R-50% = 4.68 +/- 0.83 and homogeneity index = 1.26 +/- 0.06, as compared to 4.95 +/- 1.01 and 1.31 +/- 0.08 in the 6-MV plans (p < 0.001). Correspondingly, the average/maximum reductions of lung volumes receiving 20 Gy (V-20Gy), 5 Gy (V-5Gy), and mean lung dose (MLD) were 7%/20%, 9%/30% and 5%/10%, respectively in the 3-MV plans (p < 0.05). The doses to 5% volumes of the cord, esophagus, trachea and heart were reduced by 9.0%, 10.6%, 11.4% and 7.4%, respectively (p < 0.05). For 10 thick patients, dual energy plans can bring dosimetric benefits with comparable target coverage, integral dose and reduced dose to the critical structures, as compared to the 6-MV plans. In conclusion, our study indicated that 3-MV photon beams have potential dosimetric benefits in treating lung tumors in terms of improved tumor coverage and reduced doses to the adjacent critical structures, in comparison to 6-MV photon beams. Intermediate megavoltage photon beams (< 6-MV) may be considered and added into current treatment approaches to reduce the adjacent normal tissue doses while maintaining sufficient tumor dose coverage in lung cancer radiotherapy.	[Zhang, Ying; Feng, Yuanming; Ming, Xin] Tianjin Univ, Dept Biomed Engn, Tianjin 300072, Peoples R China; [Zhang, Ying; Ming, Xin; Deng, Jun] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Ahmad, Munir] William W Backus Hosp, Dept Radiat Oncol, Norwich, CT USA; [Zhou, Li] Sichuan Univ, West China Hosp, Ctr Radiat Phys & Technol, Ctr Canc, Chengdu 610064, Peoples R China	Tianjin University; Yale University; Sichuan University	Deng, J (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA.	jun.deng@yale.edu			China Scholarship Council [201206250087]	China Scholarship Council(China Scholarship Council)	YZ was supported by China Scholarship Council (no. 201206250087). There was no other funding support for YZ or any co-author of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNESJO A, 1989, MED PHYS, V16, P577, DOI 10.1118/1.596360; Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; Bjorn Hardemark A L, 2004, P3IMRT DIRECT MACHIN; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; Deng J, 2000, PHYS MED BIOL, V45, P411, DOI 10.1088/0031-9155/45/2/311; Dong P, 2014, MED PHYS, V41, DOI [10.1118/1.4868464, 10.1118/1.4888003]; Doyle JJ, 2007, INT J RADIAT ONCOL, V68, P82, DOI 10.1016/j.ijrobp.2006.12.019; Fox C, 2008, PHYS MED BIOL, V53, P3175, DOI 10.1088/0031-9155/53/12/007; Gong YL, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-11; Guckenberger M, 2007, RADIOTHER ONCOL, V85, P435, DOI 10.1016/j.radonc.2007.10.044; HALPERIN E, 2005, PEDIAT RAD ONCOLOGY; Kataria T, 2012, J MED PHYS, V37, P207, DOI 10.4103/0971-6203.103606; Keller BM, 2007, MED PHYS, V34, P3996, DOI 10.1118/1.2775666; Li JS, 2000, PHYS MED BIOL, V45, P2969, DOI 10.1088/0031-9155/45/10/316; Lu XQ, 2000, FEASIBILITY STUDY US, V441, P449; Ma C.-M., 1995, 509D NRC PIRS; Ma CM, 1998, RADIAT PHYS CHEM, V53, P329, DOI 10.1016/S0969-806X(98)00113-3; Ma CM, 2002, PHYS MED BIOL, V47, P1671, DOI 10.1088/0031-9155/47/10/305; Madani I, 2007, RADIOTHER ONCOL, V82, P63, DOI 10.1016/j.radonc.2006.11.016; Meeks SL, 2005, MED PHYS, V32, P2673, DOI 10.1118/1.1990289; Nelson W. R., 1985, EGS4 CODE SYSTEM; Organization W.H., 2014, GLOBOCAN 2012 EST CA; Park JM, 2012, MED PHYS, V39, P1265, DOI 10.1118/1.3682172; Park JM, 2011, J APPL CLIN MED PHYS, V12, P147, DOI 10.1120/jacmp.v12i4.3563; Parsons D, 2012, MED PHYS, V39, P4568, DOI 10.1118/1.4730503; Robar JL, 2009, MED PHYS, V36, P3955, DOI 10.1118/1.3183499; ROGERS DWO, 1995, MED PHYS, V22, P503, DOI 10.1118/1.597552; Seco J, 2013, MONTE CARLO TECHNIQU; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; St-Hilaire J, 2009, J APPL CLIN MED PHYS, V10, P36, DOI 10.1120/jacmp.v10i4.3012; Stevens SW, 2011, PHYS MED BIOL, V56, P3809, DOI 10.1088/0031-9155/56/13/005; Timmerman RD, 2005, CURRENT PROBLEMS CAN; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Yartsev S, 2007, Biomed Imaging Interv J, V3, pe17, DOI 10.2349/biij.3.1.e17; Zhang Ying, 2015, British Journal of Medicine and Medical Research, V6, P661, DOI 10.9734/BJMMR/2015/15040	35	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145117	10.1371/journal.pone.0145117	http://dx.doi.org/10.1371/journal.pone.0145117			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672752	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700102
J	Burtin, C; Langer, D; van Remoortel, H; Demeyer, H; Gosselink, R; Decramer, M; Dobbels, F; Janssens, W; Troosters, T				Burtin, Chris; Langer, Daniel; van Remoortel, Hans; Demeyer, Heleen; Gosselink, Rik; Decramer, Marc; Dobbels, Fabienne; Janssens, Wim; Troosters, Thierry			Physical Activity Counselling during Pulmonary Rehabilitation in Patients with COPD: A Randomised Controlled Trial	PLOS ONE			English	Article							LIFE; BEHAVIOR; DISEASE; HEALTH; STYLE; PEDOMETER; STEPS/DAY; EFFICACY; PROGRAM; PEOPLE	Background Pulmonary rehabilitation programs only modestly enhance daily physical activity levels in patients with chronic obstructive pulmonary disease (COPD). This randomised controlled trial investigates the additional effect of an individual activity counselling program during pulmonary rehabilitation on physical activity levels in patients with moderate to very severe COPD. Methods Eighty patients (66 +/- 7 years, 81% male, forced expiratory volume in 1 second 45 +/- 16% of predicted) referred for a six-month multidisciplinary pulmonary rehabilitation program were randomised. The intervention group was offered an additional eight-session activity counselling program. The primary outcomes were daily walking time and time spent in at least moderate intense activities. Results Baseline daily walking time was similar in the intervention and control group (median 33 [interquartile range 16-47] vs 29 [17-44]) whereas daily time spent in at least moderate intensity was somewhat higher in the intervention group (17[4-50] vs 12[2-26] min). No significant intervention*time interaction effects were observed in daily physical activity levels. In the whole group, daily walking time and time spent in at least moderate intense activities did not significantly change over time. Conclusions The present study identified no additional effect of eight individual activity counselling sessions during pulmonary rehabilitation to enhance physical activity levels in patients with COPD.	[Burtin, Chris; Langer, Daniel; van Remoortel, Hans; Demeyer, Heleen; Gosselink, Rik; Troosters, Thierry] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Leuven, Belgium; [Burtin, Chris; Langer, Daniel; van Remoortel, Hans; Demeyer, Heleen; Gosselink, Rik; Decramer, Marc; Janssens, Wim; Troosters, Thierry] Katholieke Univ Leuven, Resp Rehabil & Resp Div, Univ Hosp, Leuven, Belgium; [Burtin, Chris] Hasselt Univ, Fac Med & Life Sci, Rehabil Res Ctr, Biomed Res Inst, Diepenbeek, Belgium; [Dobbels, Fabienne] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium	KU Leuven; KU Leuven; Hasselt University; KU Leuven	Troosters, T (corresponding author), Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Leuven, Belgium.	thierry.troosters@med.kuleuven.be	Van Remoortel, Hans/AAH-2425-2019; Gosselink, Rik/AAK-4655-2020; burtin, chris/B-3343-2015; Langer, Daniel/B-7307-2014	Langer, Daniel/0000-0001-8738-9482; Janssens, Wim/0000-0003-1830-2982; Dobbels, Fabienne/0000-0002-9502-7374; Demeyer, Heleen/0000-0001-8925-0564; Gosselink, Rik/0000-0003-0444-8606				Altenburg WA, 2015, RESP MED, V109, P112, DOI 10.1016/j.rmed.2014.10.020; Avery L, 2012, DIABETES CARE, V35, P2681, DOI 10.2337/dc11-2452; Bennett JA, 2007, NURS RES, V56, P18, DOI 10.1097/00006199-200701000-00003; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Brodie DA, 2005, J ADV NURS, V50, P518, DOI 10.1111/j.1365-2648.2005.03422.x; Brug J, 2007, J NUTR EDUC BEHAV, V39, P8, DOI 10.1016/j.jneb.2006.08.010; Carels RA, 2007, HEALTH PSYCHOL, V26, P369, DOI 10.1037/0278-6133.26.3.369; de Blok BMJ, 2006, PATIENT EDUC COUNS, V61, P48, DOI 10.1016/j.pec.2005.02.005; Decramer M, 2005, RESP MED, V99, pS3, DOI 10.1016/j.rmed.2005.09.010; DECRAMER M, 1994, AM J RESP CRIT CARE, V150, P11, DOI 10.1164/ajrccm.150.1.8025735; Demeyer H, 2014, CHEST, V146, P318, DOI 10.1378/chest.13-1968; Doig GS, 2005, J CRIT CARE, V20, P187, DOI 10.1016/j.jcrc.2005.04.005; Garcia-Aymerich J, 2006, THORAX, V61, P772, DOI 10.1136/thx.2006.060145; Groeneveld IF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-836; GUYATT GH, 1987, THORAX, V42, P773, DOI 10.1136/thx.42.10.773; GUYATT GH, 1984, THORAX, V39, P818, DOI 10.1136/thx.39.11.818; Hardcastle SJ, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-40; Harland J, 1999, BRIT MED J, V319, P828, DOI 10.1136/bmj.319.7213.828; Heckman CJ, 2010, TOB CONTROL, V19, P410, DOI 10.1136/tc.2009.033175; Hill K, 2015, INTERN MED J, V45, P474, DOI 10.1111/imj.12570; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Kang M, 2009, RES Q EXERCISE SPORT, V80, P131, DOI 10.1080/02701367.2009.10599546; KAPLAN RM, 1994, HEALTH PSYCHOL, V13, P366, DOI 10.1037/0278-6133.13.4.366; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; Langer D, 2009, THORAX, V64, P641, DOI 10.1136/thx.2008.112102; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Michie S, 2011, ADDICT BEHAV, V36, P315, DOI 10.1016/j.addbeh.2010.11.016; Miller William R, 2005, J Cardiopulm Rehabil, V25, P207, DOI 10.1097/00008483-200507000-00005; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Ng LWC, 2012, CHRON RESP DIS, V9, P17, DOI 10.1177/1479972311430335; O'Halloran PD, 2014, CLIN REHABIL, V28, P1159, DOI 10.1177/0269215514536210; Patel Sanjay A, 2007, COPD, V4, P107, DOI 10.1080/15412550701246658; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; Pitta F, 2008, CHEST, V134, P273, DOI 10.1378/chest.07-2655; Puhan MA, 2008, EUR RESPIR J, V32, P637, DOI 10.1183/09031936.00140507; Puhan MA, 2011, EUR RESPIR J, V37, P784, DOI 10.1183/09031936.00063810; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Sjoling Mats, 2011, BMC Res Notes, V4, P352, DOI 10.1186/1756-0500-4-352; Smedslund G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008063.pub2; Thorpe O, 2012, J CARDIOPULM REHABIL, V32, P359, DOI 10.1097/HCR.0b013e318262d7df; Troosters T, 2005, AM J RESP CRIT CARE, V172, P19, DOI 10.1164/rccm.200408-1109SO; Troosters T, 2010, EUR RESPIR REV, V19, P24, DOI 10.1183/09059180.00007809; Troosters T, 2000, AM J MED, V109, P207, DOI 10.1016/S0002-9343(00)00472-1; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-80; Tudor-Locke C, 2009, PREV MED, V49, P3, DOI 10.1016/j.ypmed.2009.04.012; van Keulen HM, 2011, ANN BEHAV MED, V41, P104, DOI 10.1007/s12160-010-9231-3; Van Remoortel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039198; Vorrink SNW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-33; Watz H, 2014, EUR RESPIR J, V44, P1521, DOI 10.1183/09031936.00046814	50	34	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144989	10.1371/journal.pone.0144989	http://dx.doi.org/10.1371/journal.pone.0144989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26697853	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600040
J	Wang, YL; Mao, YH; Xu, XD; Tao, SH; Chen, HY				Wang, Yalan; Mao, Yuanhui; Xu, Xiaodong; Tao, Shiheng; Chen, Hongying			Codon Usage in Signal Sequences Affects Protein Expression and Secretion Using Baculovirus/Insect Cell Expression System	PLOS ONE			English	Article							WHOLE GENOME ANALYSIS; ESCHERICHIA-COLI; NONOPTIMAL CODONS; DROSOPHILA-MELANOGASTER; RESPECTIVE CODONS; TRANSFER-RNAS; TRANSLATION; ABUNDANCE; PATTERNS; CHOICE	By introducing synonymous mutations into the coding sequences of GP64sp and FibHsp signal peptides, the influences of mRNA secondary structure and codon usage of signal sequences on protein expression and secretion were investigated using baculovirus/insect cell expression system. The results showed that mRNA structural stability of the signal sequences was not correlated with the protein production and secretion levels, and FibHsp was more tolerable to codon changes than GP64sp. Codon bias analyses revealed that codons for GP64sp were well de-optimized and contained more non-optimal codons than FibHsp. Synonymous mutations in GP64sp sufficiently increased its average codon usage frequency and resulted in dramatic reduction of the activity and secretion of luciferase. Protein degradation inhibition assay with MG-132 showed that higher codon usage frequency in the signal sequence increased the production as well as the degradation of luciferase protein, indicating that the synonymous codon substitutions in the signal sequence caused misfolding of luciferase instead of slowing down the protein production. Meanwhile, we found that introduction of more non-optimal codons into FibHsp could increase the production and secretion levels of luciferase, which suggested a new strategy to improve the production of secretory proteins in insect cells.	[Wang, Yalan; Mao, Yuanhui; Xu, Xiaodong; Tao, Shiheng; Chen, Hongying] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Mao, Yuanhui; Tao, Shiheng] Northwest A&F Univ, State key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Tao, SH (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.	shihengt@nwsuaf.edu.cn; chenhy@nwsuaf.edu.cn	Xu, Xiaodong/Q-8429-2017	Xu, Xiaodong/0000-0001-6452-8419; Chen, Hongying/0000-0001-8258-0683	Program for New Century Excellent Talents in University [NCET-090652]; Fundamental Research Funds for the Central Universities [QN2011065]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	HC is supported by the Program for New Century Excellent Talents in University (NCET-090652) and the Fundamental Research Funds for the Central Universities (QN2011065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HC is supported by Program for New Century Excellent Talents in University (NCET-09-0652) and the Fundamental Research Funds for the Central Universities (QN2011065).	AKASHI H, 1994, GENETICS, V136, P927; Cortazzo P, 2002, BIOCHEM BIOPH RES CO, V293, P537, DOI 10.1016/S0006-291X(02)00226-7; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Fedyunin I, 2012, FEBS LETT, V586, P3336, DOI 10.1016/j.febslet.2012.07.012; Fluman N, 2014, ELIFE, P3; Futatsumori-Sugai M, 2010, BIOCHEM BIOPH RES CO, V391, P931, DOI 10.1016/j.bbrc.2009.11.167; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lakey DL, 2000, INFECT IMMUN, V68, P233, DOI 10.1128/IAI.68.1.233-238.2000; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li YD, 2006, BIOSYSTEMS, V85, P225, DOI 10.1016/j.biosystems.2006.02.006; Mao YH, 2013, GENE, V517, P230, DOI 10.1016/j.gene.2012.12.062; Ng DTW, 2013, APPL ENVIRON MICROB, V79, P347, DOI 10.1128/AEM.02667-12; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Power PM, 2004, BIOCHEM BIOPH RES CO, V322, P1038, DOI 10.1016/j.bbrc.2004.08.022; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Tsuchiya Y, 2003, NUCL ACIDS S SERIES; Tsuchiya Y, 2004, NUCL ACIDS S SERIES; Tsuchiya Y, 2005, NUCL ACIDS S SERIES; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Xu XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054631; Zalucki YM, 2008, BIOCHEM BIOPH RES CO, V366, P135, DOI 10.1016/j.bbrc.2007.11.093; Zalucki YM, 2010, BBA-BIOMEMBRANES, V1798, P1244, DOI 10.1016/j.bbamem.2010.03.010; Zhao YG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng006; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	32	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145887	10.1371/journal.pone.0145887	http://dx.doi.org/10.1371/journal.pone.0145887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26697848	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600140
J	Florek, M; Schneidawind, D; Pierini, A; Baker, J; Armstrong, R; Pan, YQ; Leveson-Gower, D; Negrin, R; Meyer, E				Florek, Mareike; Schneidawind, Dominik; Pierini, Antonio; Baker, Jeanette; Armstrong, Randall; Pan, Yuqiong; Leveson-Gower, Dennis; Negrin, Robert; Meyer, Everett			Freeze and Thaw of CD4(+) CD25(+) Foxp3(+) Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease	PLOS ONE			English	Article							L-SELECTIN EXPRESSION; CD34(+) CELLS; BONE-MARROW; CRYOPRESERVATION; IMPACT; TRANSPLANTATION; ENGRAFTMENT; RECOVERY; GVHD	The adoptive transfer of CD4(+) CD25(+) Foxp3(+) regulatory T cells (Tregs) in murine models of allogeneic hematopoietic cell transplantation (HCT) has been shown to protect recipient mice from lethal acute graft-versus-host disease (GVHD) and this approach is being actively investigated in human clinical trials. Here, we examined the effects of cryopreservation on Tregs. We found that freeze and thaw of murine and human Tregs is associated with reduced expression of L-selectin (CD62L), which was previously established to be an important factor that contributes to the in vivo protective effects of Tregs. Frozen and thawed murine Tregs showed a reduced capacity to bind to the CD62L binding partner MADCAM1 in vitro as well as an impaired homing to secondary lymphoid organs in vivo. Upon adoptive transfer frozen and thawed Tregs failed to protect against lethal GVHD compared with fresh Tregs in a murine model of allogeneic HCT across major histocompatibility barriers. In summary, the direct administration of adoptively transferred frozen and thawed Tregs adversely affects their immunosuppressive potential which is an important factor to consider in the clinical implementation of Treg immunotherapies.	[Florek, Mareike; Schneidawind, Dominik; Pierini, Antonio; Baker, Jeanette; Armstrong, Randall; Pan, Yuqiong; Leveson-Gower, Dennis; Negrin, Robert; Meyer, Everett] Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Schneidawind, Dominik] Univ Tubingen, Dept Med 2, Tubingen, Germany; [Pierini, Antonio] Univ Perugia, Dept Med, Hematol & Clin Immunol, I-06100 Perugia, Italy	Stanford University; Eberhard Karls University of Tubingen; University of Perugia	Schneidawind, D (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA.	dominik.schneidawind@med.uni-tuebingen.de	Pierini, Antonio/K-6650-2016; Schneidawind, Dominik/AAR-4509-2020		SPARK program at Stanford University; Dr. Mildred Scheel Postdoctoral Fellowship from the German Cancer Aid; Stanford Institute for Immunity, Transplantation and Infection; American Society for Blood and Marrow Transplantation; Fondazione Italiana per la Ricerca sul Cancro (FIRC); Societa Italiana di Ematologia Sperimentale (SIES); Associazione Italiana contro le Leucemie-Linfomi e Mieloma (AIL); New Investigator Award from the American Society for Blood and Marrow Transplantation; Amy Manesevit Award from the National Marrow Donor Program; NIH [5 K08 HL119590]; NATIONAL CANCER INSTITUTE [R01CA231582, P01CA049605] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL119590, R01HL114591] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	SPARK program at Stanford University; Dr. Mildred Scheel Postdoctoral Fellowship from the German Cancer Aid; Stanford Institute for Immunity, Transplantation and Infection; American Society for Blood and Marrow Transplantation; Fondazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Societa Italiana di Ematologia Sperimentale (SIES); Associazione Italiana contro le Leucemie-Linfomi e Mieloma (AIL); New Investigator Award from the American Society for Blood and Marrow Transplantation; Amy Manesevit Award from the National Marrow Donor Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This study was supported by the SPARK program at Stanford University. DS was supported by a Dr. Mildred Scheel Postdoctoral Fellowship from the German Cancer Aid, a Young Investigator Award from the Stanford Institute for Immunity, Transplantation and Infection, and a New Investigator Award from the American Society for Blood and Marrow Transplantation. AP was supported by Fondazione Italiana per la Ricerca sul Cancro (FIRC), Societa Italiana di Ematologia Sperimentale (SIES), Associazione Italiana contro le Leucemie-Linfomi e Mieloma (AIL) and a New Investigator Award from the American Society for Blood and Marrow Transplantation. EM was supported by the Amy Manesevit Award from the National Marrow Donor Program and NIH Grant Number 5 K08 HL119590.	Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; Connor EM, 1999, J LEUKOCYTE BIOL, V65, P349, DOI 10.1002/jlb.65.3.349; De Boer F, 1998, BONE MARROW TRANSPL, V22, P1103, DOI 10.1038/sj.bmt.1701495; Deneys V, 1999, J IMMUNOL METHODS, V228, P13, DOI 10.1016/S0022-1759(99)00089-7; Di Ianni M, 2011, BLOOD, V117, P3921, DOI 10.1182/blood-2010-10-311894; Edinger M, 2003, BLOOD, V101, P640, DOI 10.1182/blood-2002-06-1751; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Fu S, 2004, AM J TRANSPLANT, V4, P65, DOI 10.1046/j.1600-6143.2003.00293.x; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Hattori Y, 2001, EXP HEMATOL, V29, P114, DOI 10.1016/S0301-472X(00)00615-9; Koenigsmann MP, 1998, BONE MARROW TRANSPL, V22, P1077, DOI 10.1038/sj.bmt.1701484; KORBLING M, 1995, BLOOD, V86, P2842; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; Medd P, 2013, BONE MARROW TRANSPL, V48, P243, DOI 10.1038/bmt.2012.118; Nguyen VH, 2007, BLOOD, V109, P2649, DOI 10.1182/blood-2006-08-044529; Ochando JC, 2005, J IMMUNOL, V174, P6993, DOI 10.4049/jimmunol.174.11.6993; Oelschlaegel U, 2007, ANN HEMATOL, V86, P569, DOI 10.1007/s00277-007-0286-6; Parody R, 2013, EUR J HAEMATOL, V91, P448, DOI 10.1111/ejh.12140; Peters JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003161; ROSILLO MC, 1995, VOX SANG, V68, P210, DOI 10.1111/j.1423-0410.1995.tb02574.x; ROWLEY SD, 1994, BLOOD, V83, P2731; Sattui S, 2012, CYTOM PART B-CLIN CY, V82B, P54, DOI 10.1002/cyto.b.20621; Schneidawind D, 2015, BLOOD, V125, P3491, DOI 10.1182/blood-2014-11-612762; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; Taylor PA, 2004, BLOOD, V104, P3804, DOI 10.1182/blood-2004-05-1850; Timeus F, 2003, HAEMATOLOGICA, V88, P74; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482; Zhao XY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0507-z	28	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145763	10.1371/journal.pone.0145763	http://dx.doi.org/10.1371/journal.pone.0145763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26693907	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092500073
J	Lee, SM; Kim, SE; Kim, EB; Jeong, HJ; Son, YK; An, WS				Lee, Su Mi; Kim, Seong Eun; Kim, Eun Bin; Jeong, Hyo Jin; Son, Young Ki; An, Won Suk			Lactate Clearance and Vasopressor Seem to Be Predictors for Mortality in Severe Sepsis Patients with Lactic Acidosis Supplementing Sodium Bicarbonate: A Retrospective Analysis	PLOS ONE			English	Article							SERUM LACTATE; MILD HYPERLACTATEMIA; BLOOD LACTATE; ORGAN FAILURE; MULTICENTER; THERAPY; DISEASE	Introduction Initial lactate level, lactate clearance, C-reactive protein, and procalcitonin in critically ill patients with sepsis are associated with hospital mortality. However, no study has yet discovered which factor is most important for mortality in severe sepsis patients with lactic acidosis. We sought to clarify this issue in patients with lactic acidosis who were supplementing with sodium bicarbonate. Materials and Methods Data were collected from a single center between May 2011 and April 2014. One hundred nine patients with severe sepsis and lactic acidosis who were supplementing with sodium bicarbonate were included. Results The 7-day mortality rate was 71.6%. The survivors had higher albumin levels and lower SOFA, APACHE II scores, vasopressor use, and follow-up lactate levels at an elapsed time after their initial lactate levels were checked. In particular, a decrement in lactate clearance of at least 10% for the first 6 hours, 24 hours, and 48 hours of treatment was more dominant among survivors than non-survivors. Although the patients who were treated with broad-spectrum antibiotics showed higher illness severity than those who received conventional antibiotics, there was no significant mortality difference. 6-hour, 24-hour, and 48-hour lactate clearance (HR: 4.000, 95% CI: 1.309-12.219, P = 0.015) and vasopressor use (HR: 4.156, 95% CI: 1.461-11.824, P = 0.008) were significantly associated with mortality after adjusting for confounding variables. Conclusions Lactate clearance at a discrete time point seems to be a more reliable prognostic index than initial lactate value in severe sepsis patients with lactic acidosis who were supplementing with sodium bicarbonate. Careful consideration of vasopressor use and the initial application of broad-spectrum antibiotics within the first 48 hours may be helpful for improving survival, and further study is warranted.	[Lee, Su Mi; Kim, Seong Eun; Kim, Eun Bin; Jeong, Hyo Jin; Son, Young Ki; An, Won Suk] Dong A Univ, Dept Internal Med, Busan, South Korea; [An, Won Suk] Dong A Univ, Coll Med, Inst Med Sci, Busan, South Korea	Dong A University; Dong A University	An, WS (corresponding author), Dong A Univ, Dept Internal Med, Busan, South Korea.	anws@dau.ac.kr			Dong-A University	Dong-A University	This study was supported by research funds from Dong-A University.	ADUEN J, 1994, JAMA-J AM MED ASSOC, V272, P1678, DOI 10.1001/jama.272.21.1678; Arnold RC, 2009, SHOCK, V32, P35, DOI 10.1097/SHK.0b013e3181971d47; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Castelli GP, 2004, CRIT CARE, V8, pR234, DOI 10.1186/cc2877; De Backer D, 2003, INTENS CARE MED, V29, P699, DOI 10.1007/s00134-003-1746-7; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Gaieski DF, 2005, ANN EMERG MED, V46, P561, DOI 10.1016/j.annemergmed.2005.07.021; Garcia-Alvarez M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0503-3; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; Kim HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065283; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kraut JA, 2014, NEW ENGL J MED, V371, P2309, DOI 10.1056/NEJMra1309483; Kruse O, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-74; Levraut J, 1998, AM J RESP CRIT CARE, V157, P1021, DOI 10.1164/ajrccm.157.4.9705037; Levy B, 2008, SHOCK, V30, P417, DOI 10.1097/SHK.0b013e318167378f; Luft FC, 2001, J AM SOC NEPHROL, V12, pS15; MADIAS NE, 1986, KIDNEY INT, V29, P752, DOI 10.1038/ki.1986.62; Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68; Mitaka C, 2005, CLIN CHIM ACTA, V351, P17, DOI 10.1016/j.cccn.2004.08.018; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A7; Rachoin JS, 2011, J HOSP MED, V6, pE1, DOI 10.1002/jhm.703; Rishu AH, 2013, CRIT CARE, V17, DOI 10.1186/cc12891; Susantitaphong P, 2012, AM J NEPHROL, V35, P540, DOI 10.1159/000339329; Trzeciak S, 2007, INTENS CARE MED, V33, P970, DOI 10.1007/s00134-007-0563-9; Valenza F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046035; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	29	20	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145181	10.1371/journal.pone.0145181	http://dx.doi.org/10.1371/journal.pone.0145181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692209	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092300045
J	Mitsi, M; Schulz, MMP; Gousopoulos, E; Ochsenbein, AM; Detmar, M; Vogel, V				Mitsi, Maria; Schulz, Martin Michael Peter; Gousopoulos, Epameinondas; Ochsenbein, Alexandra Michaela; Detmar, Michael; Vogel, Viola			Walking the Line: A Fibronectin Fiber-Guided Assay to Probe Early Steps of (Lymph) angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR LUMEN FORMATION; VEGF-A; EXTRACELLULAR-MATRIX; CELL-MIGRATION; MECHANICAL FORCES; NETWORK FORMATION; VESSEL FORMATION; LYMPHANGIOGENESIS; DISEASE	Angiogenesis and lymphangiogenesis are highly complex morphogenetic processes, central to many physiological and pathological conditions, including development, cancer metastasis, inflammation and wound healing. While it is described that extracellular matrix (ECM) fibers are involved in the spatiotemporal regulation of angiogenesis, current angiogenesis assays are not specifically designed to dissect and quantify the underlying molecular mechanisms of how the fibrillar nature of ECM regulates vessel sprouting. Even less is known about the role of the fibrillar ECM during the early stages of lymphangiogenesis. To address such questions, we introduced here an in vitro (lymph) angiogenesis assay, where we used microbeads coated with endothelial cells as simple sprouting sources and deposited them on single Fn fibers used as substrates to mimic fibrillar ECM. The fibers were deposited on a transparent substrate, suitable for live microscopic observation of the ensuing cell outgrowth events at the single cell level. Our proof-of-concept studies revealed that fibrillar Fn, compared to Fn-coated surfaces, provides far stronger sprouting and guidance cues to endothelial cells, independent of the tested mechanical strains of the Fn fibers. Additionally, we found that VEGF-A, but not VEGF-C, stimulates the collective outgrowth of lymphatic endothelial cells (LEC), while the collective outgrowth of blood vascular endothelial cells (HUVEC) was prominent even in the absence of these angiogenic factors. In addition to the findings presented here, the modularity of our assay allows for the use of different ECM or synthetic fibers as substrates, as well as of other cell types, thus expanding the range of applications in vascular biology and beyond.	[Mitsi, Maria; Vogel, Viola] ETH, Lab Appl Mech, Zurich, Switzerland; [Schulz, Martin Michael Peter; Gousopoulos, Epameinondas; Ochsenbein, Alexandra Michaela; Detmar, Michael] ETH, Inst Pharmaceut Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Vogel, V (corresponding author), ETH, Lab Appl Mech, Zurich, Switzerland.	viola.vogel@hest.ethz.ch	Vogel, Viola/O-8025-2015; Mitsi, Maria/S-2519-2017	Vogel, Viola/0000-0003-2898-7671; Mitsi, Maria/0000-0001-8983-1983	European Research Council [233157, 268968]; National Institute of Health [CA69184]; Swiss National Science Foundation [31003A-130627, 310030B-147087]; Competence Centre for Materials Science and Technology; Oncosuisse and Krebsliga Zurich; NATIONAL CANCER INSTITUTE [R01CA069184] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Competence Centre for Materials Science and Technology; Oncosuisse and Krebsliga Zurich; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge financial support from the European Research Council: 233157, VV and 268968, MD (http://erc.europa.eu/advanced-grants); National Institute of Health: CA69184, MD (http://grants.nih.gov/grants/oer.htm); Swiss National Science Foundation: 31003A-130627 and 310030B-147087, both to MD; Competence Centre for Materials Science and Technology: Grant title: 'Fibroblast growth factor-2 delivery for tissue repair: from natural concepts to engineered systems' to both VV and MD (http://www.ccmx.ch/academia/benefits-for-academia/funding-of-projects/); Oncosuisse and Krebsliga Zurich (both to MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima S, 2011, DEVELOPMENT, V138, P4763, DOI 10.1242/dev.068023; Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Axnick J, 2012, CURR OPIN HEMATOL, V19, P192, DOI 10.1097/MOH.0b013e3283523ebc; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Benest AV, 2008, CARDIOVASC RES, V78, P315, DOI 10.1093/cvr/cvm094; Bentley K, 2014, NAT CELL BIOL, V16, P309, DOI 10.1038/ncb2926; BROWN RA, 1994, BIOMATERIALS, V15, P457, DOI 10.1016/0142-9612(94)90225-9; Bruce D, 2011, CELL COMMUN ADHES, V18, P85, DOI 10.3109/15419061.2011.619673; Caussinus E, 2008, CURR BIOL, V18, P1727, DOI 10.1016/j.cub.2008.10.062; Chabria M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1135; Chen Daniel, 2015, DEV BIOL, P1; Chen L, 2011, J SURG ONCOL, V103, P475, DOI 10.1002/jso.21794; Childs S, 2002, DEVELOPMENT, V129, P973; Chiu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043040; CLARK RAF, 1982, J INVEST DERMATOL, V79, P269, DOI 10.1111/1523-1747.ep12500076; CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075; CLARK RAF, 1982, J EXP MED, V156, P646, DOI 10.1084/jem.156.2.646; Cueni Leah N., 2008, Lymphatic Research and Biology, V6, P109, DOI 10.1089/lrb.2008.1008; EJIM OS, 1993, BIOMATERIALS, V14, P743, DOI 10.1016/0142-9612(93)90038-4; Farhadian F, 1996, CARDIOVASC RES, V32, P433, DOI 10.1016/S0008-6363(96)00119-8; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Hagerling R, 2013, EMBO J, V32, P629, DOI 10.1038/emboj.2012.340; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Hamada K, 2000, BLOOD, V96, P3793, DOI 10.1182/blood.V96.12.3793.h8003793_3793_3800; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Hong YK, 2004, FASEB J, V18, P1111, DOI 10.1096/fj.03-1179fje; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jansen KA, 2013, BIOPHYS J, V105, P2240, DOI 10.1016/j.bpj.2013.10.008; Korff T, 1999, J CELL SCI, V112, P3249; Kubow KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9026; Kubow KE, 2009, INTEGR BIOL-UK, V1, P635, DOI 10.1039/b914996a; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Little WC, 2008, MATRIX BIOL, V27, P451, DOI 10.1016/j.matbio.2008.02.003; Little WC, 2009, NANO LETT, V9, P4158, DOI 10.1021/nl902365z; Malinda Katherine M., 2009, V467, P287, DOI 10.1007/978-1-59745-241-0_17; Mallory BP, 2006, MICROVASC RES, V72, P62, DOI 10.1016/j.mvr.2006.05.002; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; NEHLS V, 1995, MICROVASC RES, V50, P311, DOI 10.1006/mvre.1995.1061; Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639; Planas-Paz L, 2013, CELL MOL LIFE SCI, V70, P4341, DOI 10.1007/s00018-013-1358-5; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Sacharidou A, 2012, CELLS TISSUES ORGANS, V195, P122, DOI 10.1159/000331410; SANDERS EJ, 1994, INT J DEV BIOL, V38, P701; Schulz MMP, 2012, P NATL ACAD SCI USA, V109, pE2665, DOI 10.1073/pnas.1206036109; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Stenzel D, 2011, DEVELOPMENT, V138, P4451, DOI 10.1242/dev.071381; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Van Obberghen-Schilling E, 2011, INT J DEV BIOL, V55, P511, DOI 10.1387/ijdb.103243eo; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; Wuest TR, 2010, J EXP MED, V207, P101, DOI 10.1084/jem.20091385; Yang L, 2013, J THEOR BIOL, V332, P228, DOI 10.1016/j.jtbi.2013.03.013; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zheng W, 2011, BLOOD, V118, P1154, DOI 10.1182/blood-2010-11-317800; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	68	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145210	10.1371/journal.pone.0145210	http://dx.doi.org/10.1371/journal.pone.0145210			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689200	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300047
J	Wang, JT; Hsu, LY; Lauderdale, TL; Fan, WC; Wang, FD				Wang, Jann-Tay; Hsu, Le-Yin; Lauderdale, Tsai-Ling; Fan, Wen-Chien; Wang, Fu-Der			Comparison of Outcomes among Adult Patients with Nosocomial Bacteremia Caused by Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus: A Retrospective Cohort Study	PLOS ONE			English	Article							MINIMUM INHIBITORY CONCENTRATION; METICILLIN-RESISTANT; MRSA BACTEREMIA; MORTALITY; VANCOMYCIN; INFECTIONS; IMPACT; SURVEILLANCE; GUIDELINES	Several studies have shown that patients with bacteremia caused by methicillin-resistant Staphylococcus aureus (MRSA) have worse outcomes than those with bacteremia caused by methicillin-susceptible S. aureus (MSSA). However, only a limited number of studies have stratified the MRSA isolates into healthcare-associated (HA-) and community-associated (CA-) MRSA strains in such a comparison. This three-year retrospective cohort study, enrolling adult patients with nosocomial S. aureus bacteremia (SAB), was designed to investigate whether CA-MRSA and/or HA-MRSA strains were associated with different outcomes in comparison to MSSA in such a setting. The drug susceptibilities and staphylococcal cassette chromosome mec (SCCmec) types were determined for all of the causative isolates available. The MRSA bacteremia was further categorized into those caused by CAMRSA strains (CA-MRSA-S bacteremia) when the causative isolates carried the type IV or V SCCmec element, those caused by HA-MRSA strains (HA-MRSA-S bacteremia) when the isolates carried the type I, II, or III SCCmec element, or unclassified MRSA bacteremia when the isolates were not available. The relevant demographic, clinical, and laboratory data were collected by reviewing the patients' charts. The primary outcome was all-cause in-hospital mortality. A total of 353 patients were studied. The overall in-hospital mortality rate was 32.6%, with 23.3% in MSSA, 30.5% in CA-MRSA-S, 47.5% in HA-MRSA-S, and 35.3% in unclassified MRSA bacteremia, respectively. The multivariate analysis showed that HA-MRSA-S, but not CA-MRSA-S, bacteremia was associated with a significantly worse outcome compared with MSSA. The other risk factors independently associated with all-cause in-hospital mortality included the Charlson co-morbidity index, septic shock, thrombocytopenia, and persistent bacteremia. Resistance to linezolid and daptomycin was found among the MRSA isolates. The present study showed that bacteremia caused by HA-MRSA-S, but not CA-MRSA-S, was an independent risk factor for all-cause in-hospital mortality in patients with nosocomial SAB. Continuous monitoring regarding the susceptibilities of MRSA to linezolid and daptomycin is necessary.	[Wang, Jann-Tay] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Hsu, Le-Yin] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lauderdale, Tsai-Ling] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan; [Fan, Wen-Chien; Wang, Fu-Der] Taipei Vet Gen Hosp, Dept Internal Med, Taipei, Taiwan; [Wang, Fu-Der] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Wang, FD (corresponding author), Taipei Vet Gen Hosp, Dept Internal Med, Taipei, Taiwan.	fdwang@vghtpe.gov.tw		WANG, JANN-TAY/0000-0002-0924-3469	Ministry of Science and Technology, Taiwan [NSC 101-2314-B-002-087-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was granted by Ministry of Science and Technology, Taiwan (NSC 101-2314-B-002-087-MY3). The sponsor has no role in study design, data collection, data interpretation, and preparation of the manuscript.; This study was granted by Ministry of Science and Technology, Taiwan (NSC 101- 2314-B002-087-MY3). The sponsor has no role in study design, data collection, data interpretation, and preparation of the manuscript.	Blot SI, 2002, ARCH INTERN MED, V162, P2229, DOI 10.1001/archinte.162.19.2229; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chang SC, 1997, INT J ANTIMICROB AG, V8, P109, DOI 10.1016/S0924-8579(96)00360-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen SY, 2012, CLIN INFECT DIS, V55, P1329, DOI 10.1093/cid/cis717; Chen SY, 2010, MEDICINE, V89, P285, DOI 10.1097/MD.0b013e3181f1851e; Clinical and Laboratory Standards Institute (CLSI), 2009, CLSI PUBL, VM07-A8; CLSI, 2013, PERF STAND ANT SUS S; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Ganga R, 2009, J CLIN MICROBIOL, V47, P590, DOI 10.1128/JCM.00397-08; Greenland S., 2008, MEASURES EFFECT MEAS, P51; Holmes NE, 2011, J INFECT DIS, V204, P340, DOI 10.1093/infdis/jir270; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jensen AG, 2002, ARCH INTERN MED, V162, P25, DOI 10.1001/archinte.162.1.25; Kalil AC, 2014, JAMA-J AM MED ASSOC, V312, P1552, DOI 10.1001/jama.2014.6364; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lalueza A, 2010, J INFECT DIS, V201, P311, DOI 10.1086/649572; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Liu QZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037005; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Neuner EA, 2010, DIAGN MICR INFEC DIS, V67, P228, DOI 10.1016/j.diagmicrobio.2010.02.026; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; Rieg S, 2009, J INFECTION, V59, P232, DOI 10.1016/j.jinf.2009.07.015; Roghmann MC, 2000, ARCH INTERN MED, V160, P1001, DOI 10.1001/archinte.160.7.1001; Schweizer ML, 2011, ANTIMICROB AGENTS CH, V55, P1082, DOI 10.1128/AAC.00918-10; Soriano A, 2008, CLIN INFECT DIS, V46, P193, DOI 10.1086/524667; Tseng YC, 2007, DIAGN MICR INFEC DIS, V59, P181, DOI 10.1016/j.diagmicrobio.2007.04.024; Turnidge JD, 2009, MED J AUSTRALIA, V191, P368, DOI 10.5694/j.1326-5377.2009.tb02841.x; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; Wang FD, 2008, AM J INFECT CONTROL, V36, P118, DOI 10.1016/j.ajic.2007.02.005; Wang JT, 2008, J ANTIMICROB CHEMOTH, V62, P514, DOI 10.1093/jac/dkn208; Wang JT, 2010, J INFECTION, V61, P449, DOI 10.1016/j.jinf.2010.09.029; Wang JT, 2010, J FORMOS MED ASSOC, V109, P258, DOI 10.1016/S0929-6646(10)60051-4; Wang JL, 2008, CLIN INFECT DIS, V46, P799, DOI 10.1086/527389; Wang JL, 2013, INT J ANTIMICROB AG, V42, P390, DOI 10.1016/j.ijantimicag.2013.07.010; Wang JL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-159; Wang JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009489; Weber JT, 2005, CLIN INFECT DIS, V41, pS269, DOI 10.1086/430788; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F; Yaw LK, 2014, LANCET INFECT DIS, V14, P967, DOI 10.1016/S1473-3099(14)70876-X	41	13	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144710	10.1371/journal.pone.0144710	http://dx.doi.org/10.1371/journal.pone.0144710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690351	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092300014
J	Daianu, M; Jacobs, RE; Weitz, TM; Town, TC; Thompson, PM				Daianu, Madelaine; Jacobs, Russell E.; Weitz, Tara M.; Town, Terrence C.; Thompson, Paul M.			Multi-Shell Hybrid Diffusion Imaging (HYDI) at 7 Tesla in TgF344-AD Transgenic Alzheimer Rats	PLOS ONE			English	Article							MRI TRACTOGRAPHY; AXON DIAMETER; BRAIN; DENSITY; DISEASE; HARDI	Diffusion weighted imaging (DWI) is widely used to study microstructural characteristics of the brain. Diffusion tensor imaging (DTI) and high-angular resolution imaging (HARDI) are frequently used in radiology and neuroscience research but can be limited in describing the signal behavior in composite nerve fiber structures. Here, we developed and assessed the benefit of a comprehensive diffusion encoding scheme, known as hybrid diffusion imaging (HYDI), composed of 300 DWI volumes acquired at 7-Tesla with diffusion weightings at b = 1000, 3000, 4000, 8000 and 12000 s/mm(2) and applied it in transgenic Alzheimer rats (line TgF344-AD) that model the full clinico-pathological spectrum of the human disease. We studied and visualized the effects of the multiple concentric "shells" when computing three distinct anisotropy maps-fractional anisotropy (FA), generalized fractional anisotropy (GFA) and normalized quantitative anisotropy (NQA). We tested the added value of the multi-shell q-space sampling scheme, when reconstructing neural pathways using mathematical frameworks from DTI and q-ball imaging (QBI). We show a range of properties of HYDI, including lower apparent anisotropy when using high b-value shells in DTI-based reconstructions, and increases in apparent anisotropy in QBI-based reconstructions. Regardless of the reconstruction scheme, HYDI improves FA-, GFA- and NQA-aided tractography. HYDI may be valuable in human connectome projects and clinical research, as well as magnetic resonance research in experimental animals.	[Daianu, Madelaine; Thompson, Paul M.] Univ So Calif, Mark & Mary Stevens Neuroimaging & Informat Inst, Imaging Genet Ctr, Marina Del Rey, CA 90292 USA; [Daianu, Madelaine; Thompson, Paul M.] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA; [Jacobs, Russell E.] CALTECH, Beckman Inst, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Weitz, Tara M.; Town, Terrence C.] Univ So Calif, Zilkha Neurogenet Inst, Dept Physiol & Biophys, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Neurol, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Psychiat, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Radiol, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Engn, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Thompson, Paul M.] Univ So Calif, Dept Ophthalmol, Los Angeles, CA 90089 USA	University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Institute of Technology; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Thompson, PM (corresponding author), Univ So Calif, Mark & Mary Stevens Neuroimaging & Informat Inst, Imaging Genet Ctr, Marina Del Rey, CA 90292 USA.	pthomp@usc.edu	Thompson, Paul M/C-4194-2018; Jacobs, Russell/H-1087-2011	Thompson, Paul M/0000-0002-4720-8867; Jacobs, Russell/0000-0002-1382-8486	NIBIB [R01 EB008281, R01 EB008432]; NIA; National Library of Medicine [AG016570, AG040060, EB01651, MH097268, LM05639]; NINDS [R01 NS076794]; NIH [R01 AG034499-05]; NIH Institutes [R01 EB008432, U54 EB020403]; NIH/NINDS [5R01NS076794-05]; NIMH; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000993, U54EB020403, R01EB008281, P41EB015922, R01EB008432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016570, R01AG040060, RF1AG041915, R01AG034499] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM005639] Funding Source: NIH RePORTER	NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Algorithm development and image analysis for this study were funded, in part, by grants to PT from the NIBIB (R01 EB008281, R01 EB008432) and by the NIA, NIBIB, NIMH, and the National Library of Medicine (AG016570, AG040060, EB01651, MH097268, LM05639 to PT) and by an NINDS grant to TT (R01 NS076794). Data collection and sharing for this project was funded by NIH Grant R01 AG034499-05. NIBIB & the Beckman Institute at Caltech provided essential support for the scanner & personnel (NIBIB EB000993). This work was also supported in part by a Consortium grant (U54 EB020403) from the NIH Institutes contributing to the Big Data to Knowledge (BD2K) Initiative and R01 EB008432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Algorithm development and image analysis for this study were funded, in part, by grants to PT from the NIBIB (R01 EB008281, R01 EB008432) and by the NIA, NIBIB, NIMH, and the National Library of Medicine (AG016570, AG040060, EB01651, MH097268, LM05639 to PT) and by an NINDS grant to TT (R01 NS076794). Data collection and sharing for this project was funded by NIH Grant R01 AG034499-05. NIBIB & the Beckman Institute at Caltech provided essential support for the scanner & personnel (NIBIB EB000993). TT and TMW were supported by an NIH/NINDS grant (5R01NS076794-05). This work was also supported in part by a Consortium grant (U54 EB020403) from the NIH Institutes contributing to the Big Data to Knowledge (BD2K) Initiative and R01 EB008432.	Aganj I, 2011, MED IMAGE ANAL, V15, P414, DOI 10.1016/j.media.2011.01.003; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Alomair OI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130133; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benveniste H, 2000, NEUROIMAGE, V11, P601, DOI 10.1006/nimg.2000.0567; Caruyer Emmanuel, 2013, Magn Reson Med, V69, P1534, DOI 10.1002/mrm.24736; Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013; Daianu M, 2016, INT SOC OPT IN PRESS; Daianu M., 2015, LECT NOTES IN PRESS; Daianu M, 2015, INT SOC OPTICS PHOTO, V9413; Daianu M., 2015, BRAIN IMAGI IN PRESS; Daianu M, 2015, HUM BRAIN MAPP, V36, P3087, DOI 10.1002/hbm.22830; Daianu M, 2013, BRAIN CONNECT, V3, P407, DOI 10.1089/brain.2012.0137; Davoodi-Bojd E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095921; DeLano MC, 2000, AM J NEURORADIOL, V21, P1830; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Descoteaux M, 2011, MED IMAGE ANAL, V15, P603, DOI 10.1016/j.media.2010.07.001; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Duarte-Carvajalino JM, 2014, MAGN RESON MED, V72, P1471, DOI 10.1002/mrm.25046; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Khachaturian MH, 2007, MAGN RESON MED, V57, P289, DOI 10.1002/mrm.21090; Leow A, 2005, LECT NOTES COMPUT SC, V3565, P493; Nir T. M., 2015, MED IMAGE C IN PRESS; Nir TM, 2013, NEUROIMAGE-CLIN, V3, P180, DOI 10.1016/j.nicl.2013.07.006; Setsompop K, 2013, NEUROIMAGE, V80, P220, DOI 10.1016/j.neuroimage.2013.05.078; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Villalon-Reina JE, 2015, MED IMAGE C IN PRESS; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Weiner HL, 2002, NATURE, V420, P879, DOI 10.1038/nature01325; Wu YC, 2008, IEEE T MED IMAGING, V27, P858, DOI 10.1109/TMI.2008.922696; Wu YC, 2007, NEUROIMAGE, V36, P617, DOI 10.1016/j.neuroimage.2007.02.050; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2011, NEUROIMAGE, V55, P1054, DOI 10.1016/j.neuroimage.2010.11.087; Zhan L, 2011, I S BIOMED IMAGING, P305, DOI 10.1109/ISBI.2011.5872411	41	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145205	10.1371/journal.pone.0145205	http://dx.doi.org/10.1371/journal.pone.0145205			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683657	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000366725800046
J	Griffin, RH; Yapuncich, GS				Griffin, Randi H.; Yapuncich, Gabriel S.			The Independent Evolution Method Is Not a Viable Phylogenetic Comparative Method	PLOS ONE			English	Article							ORNSTEIN-UHLENBECK MODELS; STABILIZING SELECTION; ADAPTIVE EVOLUTION; PLANUM TEMPORALE; SIZE DIMORPHISM; FOOD HABITS; ASYMMETRY; TREES; CHARACTERS; MORPHOLOGY	Phylogenetic comparative methods (PCMs) use data on species traits and phylogenetic relationships to shed light on evolutionary questions. Recently, Smaers and Vinicius suggested a new PCM, Independent Evolution (IE), which purportedly employs a novel model of evolution based on Felsenstein's Adaptive Peak Model. The authors found that IE improves upon previous PCMs by producing more accurate estimates of ancestral states, as well as separate estimates of evolutionary rates for each branch of a phylogenetic tree. Here, we document substantial theoretical and computational issues with IE. When data are simulated under a simple Brownian motion model of evolution, IE produces severely biased estimates of ancestral states and changes along individual branches. We show that these branch-specific changes are essentially ancestor-descendant or "directional" contrasts, and draw parallels between IE and previous PCMs such as "minimum evolution". Additionally, while comparisons of branch-specific changes between variables have been interpreted as reflecting the relative strength of selection on those traits, we demonstrate through simulations that regressing IE estimated branch-specific changes against one another gives a biased estimate of the scaling relationship between these variables, and provides no advantages or insights beyond established PCMs such as phylogenetically independent contrasts. In light of our findings, we discuss the results of previous papers that employed IE. We conclude that Independent Evolution is not a viable PCM, and should not be used in comparative analyses.	[Griffin, Randi H.; Yapuncich, Gabriel S.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA	Duke University	Griffin, RH (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA.	randi.griffin@duke.edu; gabriel.yapuncich@duke.edu	Yapuncich, Gabriel/AAC-8197-2019	Yapuncich, Gabriel/0000-0001-7371-5857				[Anonymous], 2014, R LANG ENV STAT COMP; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Beaulieu JM, 2012, EVOLUTION, V66, P2369, DOI 10.1111/j.1558-5646.2012.01619.x; BURTON AM, 1994, J ZOOL, V232, P525, DOI 10.1111/j.1469-7998.1994.tb00001.x; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Carrano MT, 2000, PALEOBIOLOGY, V26, P489, DOI 10.1666/0094-8373(2000)026<0489:HATEOD>2.0.CO;2; Cavalli-Sforza LL, 1964, EVOLUTION, V22, P550; EARHART CM, 1970, CONDOR, V72, P251, DOI 10.2307/1366002; Eastman JM, 2011, EVOLUTION, V65, P3578, DOI 10.1111/j.1558-5646.2011.01401.x; FARRIS JS, 1970, SYST ZOOL, V19, P83, DOI 10.2307/2412028; FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802; FELSENSTEIN J, 1988, ANNU REV ECOL SYST, V19, P445, DOI 10.1146/annurev.es.19.110188.002305; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; GALABURDA AM, 1987, NEUROPSYCHOLOGIA, V25, P853, DOI 10.1016/0028-3932(87)90091-1; Garamszegi, 2014, MODERN PHYLOGENETIC, P553; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GARLAND T, 1991, EVOLUTION, V45, P1969, DOI 10.1111/j.1558-5646.1991.tb02703.x; Gingerich PD, 2000, J THEOR BIOL, V204, P201, DOI 10.1006/jtbi.2000.2008; Goswami A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0254; GOULD SJ, 1971, AM NAT, V105, P113, DOI 10.1086/282710; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Griffin RH, 2015, EVALUATING LEGITIMAC; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Hansen TF, 2008, EVOLUTION, V62, P1965, DOI 10.1111/j.1558-5646.2008.00412.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Ho LST, 2014, METHODS ECOL EVOL, V5, P1133, DOI 10.1111/2041-210X.12285; HUEY RB, 1987, EVOLUTION, V41, P1098, DOI 10.1111/j.1558-5646.1987.tb05879.x; Ingram T, 2013, METHODS ECOL EVOL, V4, P416, DOI 10.1111/2041-210X.12034; Jombart T., 2008, ADEPHYLO EXPLORATORY; Jones KE, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0285-5; Kivell TL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-229; Laurin M, 2010, SYST BIOL, V59, P689, DOI 10.1093/sysbio/syq059; LOSOS JB, 1990, ANIM BEHAV, V39, P879, DOI 10.1016/S0003-3472(05)80952-2; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; MARTINS EP, 1991, EVOLUTION, V45, P534, DOI [10.2307/2409910, 10.1111/j.1558-5646.1991.tb04328.x]; Mays S, 1999, INT J OSTEOARCHAEOL, V9, P18, DOI 10.1002/(SICI)1099-1212(199901/02)9:1<18::AID-OA455>3.0.CO;2-A; Nunn C. L., 2011, COMP APPROACH EVOLUT; O'Meara BC, 2012, ANNU REV ECOL EVOL S, V43, P267, DOI 10.1146/annurev-ecolsys-110411-160331; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; PAGEL M, 1993, J THEOR BIOL, V164, P191, DOI 10.1006/jtbi.1993.1148; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Plochocki JH, 2002, INT J OSTEOARCHAEOL, V12, P349, DOI 10.1002/oa.633; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rabosky DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089543; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rezende EL, 2012, COMPR PHYSIOL, V2, P639, DOI 10.1002/cphy.c100079; Royer-Carenzi M, 2013, MATH BIOSCI, V242, P95, DOI 10.1016/j.mbs.2012.12.003; Smaers JB, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0269; Smaers JB, 2013, ANN NY ACAD SCI, V1822, P59; Smaers JB, 2015, EVOMAP R PACKAGE EVO; Smaers JB, 2012, P NATL ACAD SCI USA, V109, P18006, DOI 10.1073/pnas.1212181109; Smaers JB, 2011, ANN NY ACAD SCI, V1225, P176, DOI 10.1111/j.1749-6632.2011.06003.x; Smaers JB, 2009, EVOL ECOL RES, V11, P991; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; Sokal RR, 1995, BIOMETRY; Steinmetz H, 1996, NEUROSCI BIOBEHAV R, V20, P587, DOI 10.1016/0149-7634(95)00071-2; STORER RW, 1966, AUK, V83, P423, DOI 10.2307/4083053; Thomas G.H., 2014, BIAS MEASUREMENT ERR, DOI [10.1101/004036, DOI 10.1101/004036]; Thomas GH, 2012, METHODS ECOL EVOL, V3, P145, DOI 10.1111/j.2041-210X.2011.00132.x; Tsegai ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078781; Uyeda JC, 2014, SYST BIOL, V63, P902, DOI 10.1093/sysbio/syu057; VANVALEN L, 1962, EVOLUTION, V16, P125; Webster AJ, 2004, J EVOLUTION BIOL, V17, P396, DOI 10.1046/j.1420-9101.2003.00664.x; WHEELER WC, 1993, MOL BIOL EVOL, V10, P707; Yapuncich GS, 2015, AM J PHYS ANTHROPOL, V157, P472, DOI 10.1002/ajpa.22735	66	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144147	10.1371/journal.pone.0144147	http://dx.doi.org/10.1371/journal.pone.0144147			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683838	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800011
J	Wallrabenstein, I; Singer, M; Panten, J; Hatt, H; Gisselmann, G				Wallrabenstein, Ivonne; Singer, Marco; Panten, Johannes; Hatt, Hanns; Gisselmann, Guenter			Timberol (R) Inhibits TAAR5-Mediated Responses to Trimethylamine and Influences the Olfactory Threshold in Humans	PLOS ONE			English	Article							AMINE-ASSOCIATED RECEPTORS; MAMMALIAN ODORANT RECEPTORS; FUNCTIONAL EXPRESSION; GENETIC-VARIATION; MENSTRUATION; ACTIVATION; SUBSYSTEM; CELLS	In mice, trace amine-associated receptors (TAARs) are interspersed in the olfactory epithelium and constitute a chemosensory subsystem that is highly specific for detecting volatile amines. Humans possess six putative functional TAAR genes. Human TAAR5 (hTAAR5) is highly expressed in the olfactory mucosa and was shown to be specifically activated by trimethylamine. In this study, we were challenged to uncover an effective blocker substance for trimethylamine-induced hTAAR5 activation. To monitor blocking effects, we recombinantly expressed hTAAR5 and employed a commonly used Cre-luciferase reporter gene assay. Among all tested potential blocker substances, Timberol (R), an amber-woody fragrance, is able to inhibit the trimethylamine-induced hTAAR5 activation up to 96%. Moreover, human psychophysical data showed that the presence of Timberol (R) increases the olfactory detection threshold for the characteristic fishy odor of trimethylamine by almost one order of magnitude. In conclusion, our results show that among tested receptors Timberol (R) is a specific and potent antagonist for the hTAAR5-mediated response to trimethylamine in a heterologous system. Furthermore, our data concerning the observed shift of the olfactory detection threshold in vivo implicate that hTAAR5 or other receptors that may be inhibited by Timberol (R) could be involved in the high affinity olfactory perception of trimethylamine in humans.	[Wallrabenstein, Ivonne; Hatt, Hanns; Gisselmann, Guenter] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Singer, Marco; Panten, Johannes] Symrise AG, Holzminden, Germany	Ruhr University Bochum; Symrise	Gisselmann, G (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, Bochum, Germany.	Guenter.Gisselmann@rub.de			Deutsche Forschungsgemeinschaft [SFB642, SPP1932]; Symrise AG	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Symrise AG	Supported by the grants SFB642 and SPP1932 by Deutsche Forschungsgemeinschaft (www.dfg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Symrise AG provided support in the form of salaries for authors MS and JP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amoore JE, 1976, J CHEM ECOL, V2, P49, DOI 10.1007/BF00988023; Carnicelli V, 2010, CHEMOSENS PERCEPT, V3, P99, DOI 10.1007/s12078-010-9075-z; Ferrero DM, 2012, ACS CHEM BIOL, V7, P1184, DOI 10.1021/cb300111e; Gram L, 2002, CURR OPIN BIOTECH, V13, P262, DOI 10.1016/S0958-1669(02)00309-9; Horowitz LF, 2014, J NEUROSCI, V34, P12241, DOI 10.1523/JNEUROSCI.1779-14.2014; Hukkanen J, 2005, BRIT J CLIN PHARMACO, V60, P224, DOI 10.1111/j.1365-2125.2005.02406.x; Jacquier V, 2006, J NEUROCHEM, V97, P537, DOI 10.1111/j.1471-4159.2006.03771.x; Jaeger SR, 2013, CURR BIOL, V23, P1601, DOI 10.1016/j.cub.2013.07.030; Johnson MA, 2012, P NATL ACAD SCI USA, V109, P13410, DOI 10.1073/pnas.1206724109; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Li Q, 2013, CURR BIOL, V23, P11, DOI 10.1016/j.cub.2012.10.047; Li YR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001230; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, ANN NY ACAD SCI, V1170, P168, DOI 10.1111/j.1749-6632.2009.04014.x; Lindemann L, 2005, GENOMICS, V85, P372, DOI 10.1016/j.ygeno.2004.11.010; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mcrae JF, 2012, CHEM SENSES, V37, P585, DOI 10.1093/chemse/bjs049; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; Mitchell SC, 2001, DRUG METAB DISPOS, V29, P517; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; Pacifico R, 2012, CELL REP, V2, P76, DOI 10.1016/j.celrep.2012.06.006; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Shimizu M, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-2; Shirasu M, 2011, J BIOCHEM, V150, P257, DOI 10.1093/jb/mvr090; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Treacy EP, 1998, HUM MOL GENET, V7, P839, DOI 10.1093/hmg/7.5.839; Vallender EJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-51; Wallrabenstein I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054950; Wolrath H, 2002, APMIS, V110, P819, DOI 10.1034/j.1600-0463.2002.1101108.x; Zhang AQ, 1996, LANCET, V348, P1740, DOI 10.1016/S0140-6736(05)65872-2; Zhang JJ, 2013, J NEUROSCI, V33, P3228, DOI 10.1523/JNEUROSCI.4299-12.2013; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200; Zschocke J, 1999, LANCET, V354, P834	35	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144704	10.1371/journal.pone.0144704	http://dx.doi.org/10.1371/journal.pone.0144704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684881	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800019
J	Moreno, E; Perez-Gonzalez, J; Carranza, J; Moya-Larano, J				Moreno, Eulalia; Perez-Gonzalez, Javier; Carranza, Juan; Moya-Larano, Jordi			Better Fitness in Captive Cuvier's Gazelle despite Inbreeding Increase: Evidence of Purging?	PLOS ONE			English	Article							GENETIC LOAD; DELETERIOUS MUTATIONS; SPECIES CONSERVATION; ENDANGERED UNGULATE; DEPRESSION; MICROSATELLITES; POPULATIONS; SIZE; PROGRAMS; SURVIVAL	Captive breeding of endangered species often aims at preserving genetic diversity and to avoid the harmful effects of inbreeding. However, deleterious alleles causing inbreeding depression can be purged when inbreeding persists over several generations. Despite its great importance both for evolutionary biology and for captive breeding programmes, few studies have addressed whether and to which extent purging may occur. Here we undertake a longitudinal study with the largest captive population of Cuvier's gazelle managed under a European Endangered Species Programme since 1975. Previous results in this population have shown that highly inbred mothers tend to produce more daughters, and this fact was used in 2006 to reach a more appropriate sex-ratio in this polygynous species by changing the pairing strategy (i.e., pairing some inbred females instead of keeping them as surplus individuals in the population). Here, by using studbook data we explore whether purging has occurred in the population by investigating whether after the change in pairing strategy a) inbreeding and homozygosity increased at the population level, b) fitness (survival) increased, and c) the relationship between inbreeding and juvenile survival, was positive. Consistent with the existence of purging, we found an increase in inbreeding coefficients, homozygosity and juvenile survival. In addition, we showed that in the course of the breeding programme the relationship between inbreeding and juvenile survival was not uniform but rather changed over time: it was negative in the early years, flat in the middle years and positive after the change in pairing strategy. We highlight that by allowing inbred individuals to mate in captive stocks we may favour sex-ratio bias towards females, a desirable managing strategy to reduce the surplus of males that force most zoos to use ethical culling and euthanizing management tools. We discuss these possibilities but also acknowledge that many other effects should be considered before implementing inbreeding and purging as elements in management decisions.	[Moreno, Eulalia; Moya-Larano, Jordi] Estn Expt Zonas Aridas CSIC, Dept Ecol Func & Evolut, Ctra Sacramento S-N, E-04120 La Canada De San Urbano, Almeria, Spain; [Perez-Gonzalez, Javier; Carranza, Juan] Univ Cordoba, Ungulate Res Unit, Catedra Recursos Cineget & Piscicolas, E-14071 Cordoba, Spain; [Perez-Gonzalez, Javier] Mancomunidad Integral Municipios Ctr, Guarderia Rural, E-06810 Badajoz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Universidad de Cordoba	Moreno, E (corresponding author), Estn Expt Zonas Aridas CSIC, Dept Ecol Func & Evolut, Ctra Sacramento S-N, E-04120 La Canada De San Urbano, Almeria, Spain.	emoreno@eeza.csic.es	Moreno, Eulalia/D-4230-2014; Carranza, Juan/E-4472-2010; Pérez-González, Javier/AAF-6106-2020; Moya-Laraño, Jordi/K-8596-2014	Moreno, Eulalia/0000-0002-7197-5679; Moya-Laraño, Jordi/0000-0001-7141-3206; Perez-Gonzalez, Javier/0000-0003-0624-835X	Spanish Ministry of Science and Innovation [GCL 2008-00562/BOS, CGL2010-17163]; European Regional Development Fund	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission)	This work was partly funded by the Spanish Ministry of Science and Innovation under Projects GCL 2008-00562/BOS to EM and CGL2010-17163 to JC, and by the European Regional Development Fund.	ALADOS CL, 1991, J ZOOL, V223, P307, DOI 10.1111/j.1469-7998.1991.tb04767.x; BARRETT SCH, 1991, NATURE, V352, P522, DOI 10.1038/352522a0; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Beudels RC, 2005, SAHELO SAHARAN ANTEL, P57; Bijlsma R, 1999, J EVOLUTION BIOL, V12, P1125, DOI 10.1046/j.1420-9101.1999.00113.x; BISHOP MD, 1994, GENETICS, V136, P619; Boakes EH, 2007, HEREDITY, V98, P172, DOI 10.1038/sj.hdy.6800923; Buchanan F. C., 1993, Animal Genetics, V24, P145, DOI 10.1111/j.1365-2052.1993.tb00269.x; Cassinello J, 2005, BIOL CONSERV, V122, P453, DOI 10.1016/j.biocon.2004.09.006; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; CHARLESWORTH D, 1990, EVOLUTION, V44, P1469, DOI 10.1111/j.1558-5646.1990.tb03839.x; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Crow James F., 1993, Oxford Surveys in Evolutionary Biology, V9, P3; Darwin CR, 1876, EFFECTS CROSS SELF F; EDE AJ, 1995, ANIM GENET, V26, P129, DOI 10.1111/j.1365-2052.1995.tb02655.x; Espeso G, 2012, INT CUVIERS GAZELLE; Fair MD, 2012, S AFR J ANIM SCI, V42, P114, DOI 10.4314/sajas.v42i2.3; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fox CW, 2008, EVOLUTION, V62, P2236, DOI 10.1111/j.1558-5646.2008.00441.x; Fox CW, 2011, EVOLUTION, V65, P246, DOI 10.1111/j.1558-5646.2010.01108.x; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; Fredrickson R, 2002, ANIM CONSERV, V5, P39, DOI 10.1017/S1367943002001051; Glemin S, 2003, EVOLUTION, V57, P2678; Gonzalez-Recio O, 2007, J DAIRY SCI, V90, P5744, DOI 10.3168/jds.2007-0203; GROSSE WM, 1995, ANIM GENET, V26, P126, DOI 10.1111/j.1365-2052.1995.tb02652.x; Gutierrez JP, 2008, GENET SEL EVOL, V40, P359, DOI 10.1051/gse:2008008; Hedrick PW, 2002, EVOLUTION, V56, P654; Hedrick PW, 1997, ZOO BIOL, V16, P47, DOI 10.1002/(SICI)1098-2361(1997)16:1<47::AID-ZOO7>3.0.CO;2-B; HEDRICK PW, 1994, HEREDITY, V73, P363, DOI 10.1038/hdy.1994.183; Ibanez B, 2013, ANIM CONSERV, V16, P108, DOI 10.1111/j.1469-1795.2012.00580.x; Ibanez B, 2014, ECOL EVOL, V4, P4117, DOI 10.1002/ece3.1280; Ibanez B, 2011, MAMM BIOL, V76, P748, DOI 10.1016/j.mambio.2011.04.002; ISIS, 2004, INT SPEC INF SYST SP; Jamieson IG, 2006, CONSERV BIOL, V20, P38, DOI 10.1111/j.1523-1739.2005.00282.x; Johnstone-Yellin TL, 2009, J MAMMAL, V90, P453, DOI 10.1644/08-MAMM-A-030.1; Joron M, 2003, NATURE, V424, P191, DOI 10.1038/nature01713; Ruiz-Lopez MJ, 2010, P ROY SOC B-BIOL SCI, V277, P2541, DOI 10.1098/rspb.2010.0333; Kalinowski ST, 1999, CONSERV BIOL, V13, P1371, DOI 10.1046/j.1523-1739.1999.98346.x; Lacy Robert, 1995, P187; Lacy RC, 2012, METHODS ECOL EVOL, V3, P433, DOI 10.1111/j.2041-210X.2011.00148.x; Larsen LK, 2011, J EVOLUTION BIOL, V24, P823, DOI 10.1111/j.1420-9101.2010.02224.x; Leberg PL, 2008, MOL ECOL, V17, P334, DOI 10.1111/j.1365-294X.2007.03433.x; Legendre P., 2012, NUMERICAL ECOLOGY; MITTON JB, 1993, HEREDITY, V71, P59, DOI 10.1038/hdy.1993.107; MOMMENS G, 1994, ANIM GENET, V25, P368, DOI 10.1111/j.1365-2052.1994.tb00381.x; MOORE SS, 1994, MAMM GENOME, V5, P84, DOI 10.1007/BF00292333; Moreno E, 2006, P 23 EAZA ANN C MADR; Moreno E, 2008, INT STUDBOOK CUVIER; Moreno E, 2011, J NAT CONSERV, V19, P148, DOI 10.1016/j.jnc.2010.10.004; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Ogilby WM, 1841, P ZOOL SOC, V1836-1840, P34; OHTA T, 1974, GENET RES, V23, P191, DOI 10.1017/S0016672300014816; Pekkala N, 2012, ECOL EVOL, V2, P1791, DOI 10.1002/ece3.293; Pelletier F, 2009, TRENDS ECOL EVOL, V24, P263, DOI 10.1016/j.tree.2008.11.013; Penfold LM, 2014, ZOO BIOL, V33, P20, DOI 10.1002/zoo.21104; R Core Team, 2013, R LANG ENV STAT COMP; Ralls K, 1983, GENETICS CONSERVATIO, P164; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2000, ANIM CONSERV, V3, P7, DOI 10.1017/S136794300000069X; Reid JM, 2006, AM NAT, V168, P1, DOI 10.1086/504852; Robert A, 2009, BIOL CONSERV, V142, P2915, DOI 10.1016/j.biocon.2009.07.016; Robertson BC, 2006, BIOL LETTERS, V2, P229, DOI 10.1098/rsbl.2005.0430; Roff DA, 2002, EVOLUTION, V56, P768, DOI 10.1111/j.0014-3820.2002.tb01387.x; Roldan ERS, 1998, P ROY SOC B-BIOL SCI, V265, P243, DOI 10.1098/rspb.1998.0288; Steck B, 2014, LESSER KUDU EUROPEAN; STEFFEN P, 1993, ANIM GENET, V24, P121, DOI 10.1111/j.1365-2052.1993.tb00252.x; Tella JL, 2001, TRENDS ECOL EVOL, V16, P76, DOI 10.1016/S0169-5347(00)02075-9; TEMPLETON AR, 1984, ZOO BIOL, V3, P177, DOI 10.1002/zoo.1430030302; TEMPLETON AR, 1987, ZOO BIOL, V6, P305, DOI 10.1002/zoo.1430060405; Templeton AR, 1983, GENETICS CONSERVATIO, P241; van Oosterhout C, 2003, J EVOLUTION BIOL, V16, P273, DOI 10.1046/j.1420-9101.2003.00511.x; Wang JL, 2000, GENET RES, V76, P75, DOI 10.1017/S0016672399004450; Wilcken J, 1998, MANAGING ZOO POPULAT; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Xue YL, 2015, SCIENCE, V348, P242, DOI 10.1126/science.aaa3952; Zschokke S, 2002, CAN J ZOOL, V80, P2014, DOI [10.1139/z02-183, 10.1139/Z02-183]	82	13	13	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145111	10.1371/journal.pone.0145111	http://dx.doi.org/10.1371/journal.pone.0145111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679703	Green Submitted, Green Published, gold			2022-12-27	WOS:000366723400049
J	Nusinovici, S; Madouasse, A; Hoch, T; Guatteo, R; Beaudeau, F				Nusinovici, Simon; Madouasse, Aurelien; Hoch, Thierry; Guatteo, Raphael; Beaudeau, Francois			Evaluation of Two PCR Tests for Coxiella burnetii Detection in Dairy Cattle Farms Using Latent Class Analysis	PLOS ONE			English	Article							Q-FEVER; CONDITIONAL DEPENDENCE; BAYESIAN-ANALYSIS; GOAT FARMS; ABSENCE; SAMPLES	Different tests performed on bulk tank milk samples (BTM) are available to determine the C. burnetii status of herds. However, these tests, which are based on the detection of either antibodies directed against C. burnetii (ELISA) or bacterial DNA (PCR), have limitations. A currently disease-free herd infected in the past may continue to test positive with ELISA due to the persistence of antibodies in animals that were infected and that subsequently cleared the infection. Infectious herds can also be misclassified using PCR because of the absence of bacteria in the BTM when the test is performed. Recently, PCR has been used for bacterial DNA detection in the farm environment, which constitutes the main reservoir of C. burnetii. The objectives of this study were to assess and compare the sensitivities and specificities of one commonly used PCR test in BTM (PCR BTM) and of a PCR applied to environmental samples (PCR DUST) in dairy cattle farms. BTM and dust samples were collected (using environmental swabs) in 95 herds. The evaluation of the performance of the 2 tests was conducted using latent class models accounting for within herd disease dynamics. Parameter estimation was carried out using MCMC, within a Bayesian framework. Two types of priors were used for the specificity of PCR DUST. A model with a uniform prior on 0-1 fitted the data better than a model with a uniform prior on 0.95-1. With the best model PCR DUST had a lower sensitivity than PCR BTM (0.75 versus 0.83) and a specificity of 0.72. The moderately low value for the specificity of PCR DUST suggests that the presence of bacteria on farm is not always associated with persistent infections and shedding of bacteria in milk.	[Nusinovici, Simon; Madouasse, Aurelien; Hoch, Thierry; Guatteo, Raphael; Beaudeau, Francois] INRA, Biol Epidemiol & Risk Anal Anim Hlth UMR1300, CS 40706, F-44307 Nantes, France; [Nusinovici, Simon; Madouasse, Aurelien; Hoch, Thierry; Guatteo, Raphael; Beaudeau, Francois] LUNAM Univ, Oniris, UMR BioEpAR, CS 40706, F-44307 Nantes, France	INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Madouasse, A (corresponding author), INRA, Biol Epidemiol & Risk Anal Anim Hlth UMR1300, CS 40706, F-44307 Nantes, France.	aurelien.madouasse@oniris-nantes.fr	Hoch, Thierry/P-6980-2019; Hoch, Thierry/ACK-3000-2022; Madouasse, Aurélien/AAC-2814-2019	Madouasse, Aurélien/0000-0002-9254-5707; Hoch, Thierry/0000-0002-7916-1936	French Research Agency, program Investments for the future [ANR-10-BINF-07 (MIHMES)]; European fund for the regional development FEDER; Groupement de Defense Sanitaire de Bretagne	French Research Agency, program Investments for the future(French National Research Agency (ANR)); European fund for the regional development FEDER; Groupement de Defense Sanitaire de Bretagne	This work was supported by the French Research Agency, program Investments for the future, project ANR-10-BINF-07 (MIHMES), by the European fund for the regional development FEDER, and by the Groupement de Defense Sanitaire de Bretagne.; This work was supported by the French Research Agency, program Investments for the future, project ANR-10-BINF-07 (MIHMES), by the European fund for the regional development FEDER, and by the Groupement de Defense Sanitaire de Bretagne. The authors thank Jean-Yves Audiart for his outstanding contribution to the data collection process.	Agerholm JS, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-13; Arricau-Bouvery N, 2005, VET RES, V36, P327, DOI 10.1051/vetres:2005010; Berri M, 2000, VET MICROBIOL, V72, P285, DOI 10.1016/S0378-1135(99)00178-9; Botner A, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1595; Collins J, 2014, STAT MED, V33, P4141, DOI 10.1002/sim.6218; de Bruin A, 2011, APPL ENVIRON MICROB, V77, P6516, DOI 10.1128/AEM.05097-11; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; Engel B, 2010, J AGR BIOL ENVIR ST, V15, P83, DOI 10.1007/s13253-009-0013-y; Gelman A, 2004, BIOMETRICS, V60, P407, DOI 10.1111/j.0006-341X.2004.00185.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Guatteo R, 2007, VET RES, V38, P849, DOI 10.1051/vetres:2007038; Guatteo R, 2006, VET RES, V37, P827, DOI 10.1051/vetres:2006038; Hogerwerf L, 2012, APPL ENVIRON MICROB, V78, P5410, DOI 10.1128/AEM.00677-12; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Jones G, 2010, BIOMETRICS, V66, P855, DOI 10.1111/j.1541-0420.2009.01330.x; Kersh GJ, 2013, APPL ENVIRON MICROB, V79, P1697, DOI 10.1128/AEM.03472-12; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Norris M, 2009, STAT INTERFACE, V2, P171; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Toft N, 2007, VET MICROBIOL, V120, P77, DOI 10.1016/j.vetmic.2006.10.025; VACEK PM, 1985, BIOMETRICS, V41, P959, DOI 10.2307/2530967; Wang C, 2011, J DAIRY SCI, V94, P2320, DOI 10.3168/jds.2010-3675	22	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144608	10.1371/journal.pone.0144608	http://dx.doi.org/10.1371/journal.pone.0144608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673419	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700047
J	Lugnani, F; Zanconati, F; Marcuzzo, T; Bottin, C; Mikus, P; Guenther, E; Klein, N; Rubinsky, L; Stehling, MK; Rubinsky, B				Lugnani, Franco; Zanconati, Fabrizio; Marcuzzo, Thomas; Bottin, Cristina; Mikus, Paul; Guenther, Enric; Klein, Nina; Rubinsky, Liel; Stehling, Michael K.; Rubinsky, Boris			A Vivens Ex Vivo Study on the Synergistic Effect of Electrolysis and Freezing on the Cell Nucleus	PLOS ONE			English	Article							CRYOSURGERY; MECHANISMS; CANCER; TISSUE; TUMORS; LIVER	Freezing-cryosurgery, and electrolysis-electrochemical therapy (EChT), are two important minimally invasive surgery tissue ablation technologies. Despite major advantages they also have some disadvantages. Cryosurgery cannot induce cell death at high subzero freezing temperatures and requires multiple freeze thaw cycles, while EChT requires high concentrations of electrolytic products-which makes it a lengthy procedure. Based on the observation that freezing increases the concentration of solutes (including products of electrolysis) in the frozen region and permeabilizes the cell membrane to these products, this study examines the hypothesis that there could be a synergistic effect between freezing and electrolysis in their use together for tissue ablation. Using an animal model we refer to as vivens ex vivo, which may be of value in reducing the use of animals for experiments, combined with a Hematoxylin stain of the nucleus, we show that there are clinically relevant protocols in which the cell nucleus appears intact when electrolysis and freezing are used separately but is affected by certain combinations of electrolysis and freezing.	[Lugnani, Franco] Franco Lugnani MD, Trieste, Italy; [Zanconati, Fabrizio; Marcuzzo, Thomas; Bottin, Cristina] Univ Trieste, UCO Anat & Istol Patolog, Trieste, Italy; [Mikus, Paul; Guenther, Enric; Rubinsky, Liel; Stehling, Michael K.; Rubinsky, Boris] Inter Sci GmbH, Biophys, Luzern, Switzerland; [Guenther, Enric; Klein, Nina; Stehling, Michael K.] Inst Bildgebende Diagnost, R&D, Offenbach, Hessen, Germany	University of Trieste	Guenther, E (corresponding author), Inter Sci GmbH, Biophys, Luzern, Switzerland.	enric@interscience.ch		ZANCONATI, FABRIZIO/0000-0001-5357-9579				Amory R, 1886, TREATISE ELECT ITS T; Arnott J., 1851, TREATEMENT CANC REGU; Baust JG, 2014, CRYOBIOLOGY, V68, P1, DOI 10.1016/j.cryobiol.2013.11.001; Baust J. G., 1997, Cryobiology, V35, P322; Baust JG, 2005, BJU INT, V95, P1187, DOI 10.1111/j.1464-410X.2005.05502.x; Baust JG, 2009, CURR OPIN UROL, V19, P127, DOI 10.1097/MOU.0b013e328323f654; Fosh BG, 2002, BRIT J SURG, V89, P999, DOI 10.1046/j.1365-2168.2002.02134.x; Gage AA, 2009, CRYOBIOLOGY, V59, P229, DOI 10.1016/j.cryobiol.2009.10.001; Gage AA, 1998, CRYOBIOLOGY, V37, P171, DOI 10.1006/cryo.1998.2115; Gage AA, 2007, J AM COLL SURGEONS, V205, P342, DOI 10.1016/j.jamcollsurg.2007.03.007; GILBERT JC, 1984, IEEE T BIO-MED ENG, V31, P565; Hollister WR, 1998, MOL UROL, V2, P13; Mir LM, 2002, BRIT J CANCER, V86, P1658, DOI 10.1038/sj.bjc.6600306; Nilsson E, 2000, BIOELECTROCHEMISTRY, V51, P1, DOI 10.1016/S0302-4598(99)00073-2; NORDENSTROM B, 1978, IRCS (International Research Communications System) Medical Science Library Compendium, V6, P537; NORDENSTROM BEW, 1994, EUR J SURG S, V574, P93; ONIK G, 1984, CRYOBIOLOGY, V21, P321, DOI 10.1016/0011-2240(84)90327-4; Rubinsky B, 2000, ANNU REV BIOMED ENG, V2, P157, DOI 10.1146/annurev.bioeng.2.1.157; RUBINSKY B, 1988, PROC R SOC SER B-BIO, V234, P343, DOI 10.1098/rspb.1988.0053; RUBINSKY B, 1979, J HEAT TRANS-T ASME, V101, P326, DOI 10.1115/1.3450968; Russell WMS., 1959, MED J AUSTRALIA; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3	22	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145133	10.1371/journal.pone.0145133	http://dx.doi.org/10.1371/journal.pone.0145133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695185	gold, Green Published			2022-12-27	WOS:000367092500023
J	Romero, L; Jimenez, M; Espinosa, MD; Dominguez, M				Romero, Luis; Jimenez, Mariano; del Mar Espinosa, Maria; Dominguez, Manuel			New Design for Rapid Prototyping of Digital Master Casts for Multiple Dental Implant Restorations	PLOS ONE			English	Article							TECHNOLOGY; DENTISTRY	Aim This study proposes the replacement of all the physical devices used in the manufacturing of conventional prostheses through the use of digital tools, such as 3D scanners, CAD design software, 3D implants files, rapid prototyping machines or reverse engineering software, in order to develop laboratory work models from which to finish coatings for dental prostheses. Different types of dental prosthetic structures are used, which were adjusted by a non-rotatory threaded fixing system. Method From a digital process, the relative positions of dental implants, soft tissue and adjacent teeth of edentulous or partially edentulous patients has been captured, and a maser working model which accurately replicates data relating to the patients oral cavity has been through treatment of three-dimensional digital data. Results Compared with the conventional master cast, the results show a significant cost savings in attachments, as well as an increase in the quality of reproduction and accuracy of the master cast, with the consequent reduction in the number of patient consultation visits. The combination of software and hardware three-dimensional tools allows the optimization of the planning of dental implant-supported rehabilitations protocol, improving the predictability of clinical treatments and the production cost savings of master casts for restorations upon implants.	[Romero, Luis; del Mar Espinosa, Maria; Dominguez, Manuel] Natl Distance Educ Univ UNED, Dept Construct & Fabricat Engn, Madrid, Spain; [Jimenez, Mariano] Comillas Univ, Dept Mech Engn, Tech Sch Engn ICAI, Madrid, Spain	Universidad Nacional de Educacion a Distancia (UNED); Comillas Pontifical University	Romero, L (corresponding author), Natl Distance Educ Univ UNED, Dept Construct & Fabricat Engn, Madrid, Spain.	lromero@ind.uned.es	Somonte, Manuel Domínguez/P-2514-2015; Espinosa, María del Mar/ABF-5928-2021; Romero, Luis/D-7850-2016; Domínguez, Manuel/AAE-4412-2022; del Mar Espinosa, Maria/I-1363-2016	Somonte, Manuel Domínguez/0000-0003-1037-0542; Espinosa, María del Mar/0000-0002-2812-7041; Romero, Luis/0000-0002-8597-3084; Domínguez, Manuel/0000-0003-1037-0542; del Mar Espinosa, Maria/0000-0002-2812-7041	Industrial Engineering School of UNED [2016-ICF06]	Industrial Engineering School of UNED	The work presented was carried out within the cooperation agreement established between the following entities: Universidad Nacional de Educacion a Distancia (UNED), Pontifical University Comillas of Madrid and IDITEC NORTH WEST S.L. The manuscript has been copyedited for language usage, spelling, and grammar by "Traducciones TRIDIOM". Thanks to the Industrial Engineering School of UNED for the support that they provided with the Project '2016-ICF06'.	ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776; Azari A, 2009, RAPID PROTOTYPING J, V15, P216, DOI 10.1108/13552540910961946; Bibb R, 2006, RAPID PROTOTYPING J, V12, P95, DOI 10.1108/13552540610652438; Bjorn TD, 2012, LABOR DENT, V15, P197; Chang CC, 2006, INT J ADV MANUF TECH, V31, P41, DOI 10.1007/s00170-005-0181-z; Goshtasby AA, 1997, IEEE T MED IMAGING, V16; Gutierrez ME, 2010, APLICACION ARTICULAD; Jimenez M, 2015, RAPID PROTOTYPING J, V21, P56, DOI 10.1108/RPJ-11-2012-0101; Kuhmstedt P, 2007, SPIE P, V6762; Liu QB, 2006, INT J ADV MANUF TECH, V29, P317, DOI 10.1007/s00170-005-2523-2; Mayordomo C., 2013, UTILIZACION RESTAURA; Pedrola F., 2008, IMPLANTOLOGIA ORAL A; Penarrocha M, 2001, IMPLANTOLOGIA ORAL; Petzold R, 1999, COMPUT MED IMAG GRAP, V23, P277, DOI 10.1016/S0895-6111(99)00025-7; Rosati R, 2010, AM J ORTHOD DENTOFAC, V138, P84, DOI 10.1016/j.ajodo.2009.10.035; Sanchez H, 2007, REV FACULTAD ODONTOL, V19, P49; Sinescu C, 2008, LASERS DENT; Sutter F, 1993, INT J PERIODONTICS R, V13, P409; Velasco Ortega E, 2008, REV ESP ODONTOESTOMA, V16, P211; Velasco Ortega E, 2011, AV PERIODONC IMPLANT, V23, P11; Wirz J, 1998, QUITESSENCE, V11, P112	21	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145253	10.1371/journal.pone.0145253	http://dx.doi.org/10.1371/journal.pone.0145253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696528	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092500031
J	Xu, XM; Cai, GY; Bu, R; Wang, WJ; Bai, XY; Sun, XF; Chen, XM				Xu, Xiao-meng; Cai, Guang-yan; Bu, Ru; Wang, Wen-juan; Bai, Xue-yuan; Sun, Xue-feng; Chen, Xiang-mei			Beneficial Effects of Caloric Restriction on Chronic Kidney Disease in Rodent Models: A Meta-Analysis and Systematic Review	PLOS ONE			English	Article							DIETARY RESTRICTION; LIFE-SPAN; RENAL-DISEASE; PROTEIN; RATS	Background Numerous studies have demonstrated the life-extending effect of caloric restriction. It is generally accepted that caloric restriction has health benefits, such as prolonging lifespan and delaying the onset and progression of CKD in various species, especially in rodent models. Although many studies have tested the efficacy of caloric restriction, no complete quantitative analysis of the potential beneficial effects of reducing caloric intake on the development and progression of CKD has been published. Methods All studies regarding the relationship between caloric restriction and chronic kidney diseases were searched in electronic databases, including PubMed/MEDLINE, EMBASE, Science Citation Index (SCI), OVID evidence-based medicine, Chinese Bio-medical Literature and Chinese science and technology periodicals (CNKI, VIP, and Wan Fang). The pooled odds ratios (OR) and 95% confidence intervals (95% CI) were calculated by using fixed- or random-effects models. Results The data from 27 of all the studies mentioned above was used in the Meta analysis. Through the meta-analysis, we found that the parameter of blood urea nitrogen, serum creatinine and urinary protein levels of the AL group was significant higher than that of the CR group, which are 4.11 mg/dl, 0.08mg/dl and 33.20mg/kg/24h, respectively. The incidence of the nephropathy in the caloric restriction (CR) group was significantly lower than that in the ad libitum-fed (AL) group. We further introduced the subgroup analysis and found that the effect of caloric restriction on the occurrence of kidney disease was only significant with prolonged intervention; the beneficial effects of CR on the 60%-caloric-restriction group were greater than on the less-than-60%-caloric-restriction group, and caloric restriction did not show obvious protective effects in genetically modified strains. Moreover, survival rate of the caloric restriction group is much higher than that of the ad libitum-fed (AL) group. Conclusions Our findings demonstrate for the first time that compared with the AL group, the caloric restriction indeed decreased urea nitrogen, creatinine, urine protein, incidence of kidney diseases and increased the survival rate on 700 similar to 800 days.	[Xu, Xiao-meng; Cai, Guang-yan; Bu, Ru; Wang, Wen-juan; Bai, Xue-yuan; Sun, Xue-feng; Chen, Xiang-mei] Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Kidney Dis, Chinese PLA Inst Nephrol, Dept Nephrol,State Key Lab Kidney Dis, Beijing 100853, Peoples R China; [Xu, Xiao-meng; Wang, Wen-juan] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China	Chinese People's Liberation Army General Hospital; Nankai University	Cai, GY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Kidney Dis, Chinese PLA Inst Nephrol, Dept Nephrol,State Key Lab Kidney Dis, Beijing 100853, Peoples R China.	caiguangyan@sina.com			Aging Biology of Individual and Organs and Risk Evaluation System of Geriatric Diseases; National Key Basic Research Program of China (973 Program) [2013CB530805]; Beijing Municipal Natural Science Foundation (CN) [81171645]	Aging Biology of Individual and Organs and Risk Evaluation System of Geriatric Diseases; National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Beijing Municipal Natural Science Foundation (CN)	This work was funded by Aging Biology of Individual and Organs and Risk Evaluation System of Geriatric Diseases, National Key Basic Research Program of China (973 Program), No. 2013CB530805 (to Prof. Cai Guangyan), and Beijing Municipal Natural Science Foundation (CN) 81171645. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2008, HORMONES ATHENS; [Anonymous], 2009, AGING CELL, V8, P514, DOI [10.1111/j.1474-9726.2009.00497.x, DOI 10.1111/J.1474-9726.2009.00497.X]; [Anonymous], 2010, PHILOS T ROYAL SOC B, V365, P147; [Anonymous], 2009, AM J KIDNEY DIS, V53, P208, DOI [10.1053/j.ajkd.2008.08.009, DOI 10.1053/J.AJKD.2008.08.009]; [Anonymous], 1997, FASEB J, V11, P573; [Anonymous], 2003, AM J KIDNEY DIS OFFI, V41, P319; [Anonymous], 1995, J GERONTOL A, V50, pB337; [Anonymous], 2014, TRANSLATIONAL RES J, V164, P302; [Anonymous], 2004, STROKE, V35, P1203; [Anonymous], 2012, AGING CELL, V11, P401; [Anonymous], 2010, SCIENCE, V328, P321, DOI [10.1126/science.1172539, DOI 10.1126/SCIENCE.1172539]; [Anonymous], 2014, DIABETES METABOLISM, V40, P158; Bourg EL, 2010, AGEING RES REV, V9, P289, DOI [10.1016/j.arr.2010.01.001, DOI 10.1016/J.ARR.2010.01.001]; DAVIS TA, 1983, EXP GERONTOL, V18, P427, DOI 10.1016/0531-5565(83)90021-9; FD L M., 2009, COCHRANE DATABASE SY, V6; GUMPRECHT LA, 1993, TOXICOL PATHOL, V21, P528, DOI 10.1177/019262339302100602; Hong-mei A, 2008, J PRACTICAL MED TECH; Kilkenny C, 2010, VET CLIN PATHOL, V1, P27; LETO S, 1976, J GERONTOL, V31, P144, DOI 10.1093/geronj/31.2.144; LG H, 2004, J AM SOC NEPHROLOGY, V15, P1363; MASORO EJ, 1989, AM J CLIN NUTR, V49, P1217; Masoro EJ, 2005, MECH AGEING DEV, P126; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Mulder W J., 2001, Eur J Intern Med, V12, P86, DOI 10.1016/S0953-6205(01)00121-2; Partridge L, 2005, MECH AGEING DEV, V126, P911, DOI 10.1016/j.mad.2005.04.003; Phelan J, 2005, AGEING RES REV; Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013; Rigaud M, 2008, PAIN, V136, P188, DOI 10.1016/j.pain.2008.01.016; Soare A, 2014, DIABETES-METAB RES, V30, P41, DOI 10.1002/dmrr.2517; WE H, 2003, KIDNEY INT, V63, pS31	31	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144442	10.1371/journal.pone.0144442	http://dx.doi.org/10.1371/journal.pone.0144442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695411	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092500004
J	Kerherve, HA; Millet, GY; Solomon, C				Kerherve, Hugo A.; Millet, Guillaume Y.; Solomon, Colin			The Dynamics of Speed Selection and Psycho-Physiological Load during a Mountain Ultramarathon	PLOS ONE			English	Article							ULTRA-MARATHON RACE; ENERGY-COST; PACING STRATEGIES; PERCEIVED EXERTION; EXERCISE; PERFORMANCE; WALKING; UPHILL; LEVEL; MODEL	Background Exercise intensity during ultramarathons (UM) is expected to be regulated as a result of the development of psycho-physiological strain and in anticipation of perceived difficulties (duration, topography). The aim of this study was to investigate the dynamics of speed, heart rate and perceived exertion during a long trail UM in a mountainous setting. Methods Fifteen participants were recruited from competitors in a 106 km trail mountain UM with a total elevation gain and loss of 5870 m. Speed and gradient, heart rate (HR) and ratings of perceived exertion (dissociated between the general [RPEGEN] and knee extensor fatigue [RPEKE] and collected using a voice recorder) were measured during the UM. Self-selected speed at three gradients (level, negative, positive), HR, RPEGEN and RPEKE were determined for each 10% section of total event duration (TED). Results The participants completed the event in 18.3 +/- 3.0 h, for a total calculated distance of 105.6 +/- 1.8 km. Speed at all gradients decreased, and HR at all gradients significantly decreased from 10% to 70%, 80% and 90%, but not 100% of TED. RPEGEN and RPEKE increased throughout the event. Speed increased from 90% to 100% of TED at all gradients. Average speed was significantly correlated with total time stopped (r = -.772; p = .001; 95% confidence interval [CI] = -1.15, -0.39) and the magnitude of speed loss (r = .540; p = .038; 95% CI = -1.04, -0.03), but not with the variability of speed (r = -.475; p = .073; 95% CI = -1.00, 0.05). Conclusions Participants in a mountain UM event combined positive pacing strategies (speed decreased until 70-90% of TED), an increased speed in the last 10% of the event, a decrease in HR at 70-90% of TED, and an increase in RPEGEN and RPEKE in the last 30% of the event. A greater speed loss and less total time stopped were the factors associated with increased total performance. These results could be explained by theoretical perspectives of a complex regulatory system modulating motor drive in anticipation of perceived difficulties such as elevation changes.	[Kerherve, Hugo A.; Solomon, Colin] Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld 4556, Australia; [Kerherve, Hugo A.] Univ Savoie Mt Blanc, Lab Physiol Exercice, EA 4338, Le Bourget Du Lac, France; [Millet, Guillaume Y.] Univ Calgary, Human Performance Lab, Calgary, AB, Canada; [Millet, Guillaume Y.] Univ Lyon, Lab Physiol Exercice, F-42023 St Etienne, France	University of the Sunshine Coast; University of Calgary	Kerherve, HA (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld 4556, Australia.	hugo-alain.kerherve@univ-smb.fr	Millet, Guillaume/AAO-6520-2020	Millet, Guillaume/0000-0002-6395-0762	USC; Queensland Education and Training	USC; Queensland Education and Training	No specific funding was used for this study. The first author was supported by university research funds and scholarship (USC and Queensland Education and Training).	Abbiss CR, 2008, SPORTS MED, V38, P239, DOI 10.2165/00007256-200838030-00004; Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Angus SD, 2011, MED SCI SPORT EXER, V43, P2405, DOI 10.1249/MSS.0b013e3182245367; Ansley L, 2004, MED SCI SPORT EXER, V36, P1819, DOI 10.1249/01.MSS.0000142409.70181.9D; Ansley L, 2004, MED SCI SPORT EXER, V36, P309, DOI 10.1249/01.MSS.0000113474.31529.C6; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; DAVIES CTM, 1986, J APPL PHYSIOL, V61, P611, DOI 10.1152/jappl.1986.61.2.611; de Koning JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015863; Gimenez P, 2013, MED SCI SPORT EXER, V45, P1807, DOI 10.1249/MSS.0b013e318292c0ec; Hoffman MD, 2014, INT J SPORT PHYSIOL, V9, P1054, DOI 10.1123/ijspp.2013-0556; Clemente-Suarez VJ, 2015, APPL PHYSIOL NUTR ME, V40, P269, DOI 10.1139/apnm-2014-0263; Knechtle B, 2012, CHINESE J PHYSIOL, V55, P125, DOI [10.4077/CJP.2012.BAA022, 10.4077/CJP.2011.AMM050]; Lambert MI, 2004, J SPORT SCI MED, V3, P167; Martin V, 2005, J SPORT MED PHYS FIT, V45, P143; Martin V, 2010, J APPL PHYSIOL, V108, P1224, DOI 10.1152/japplphysiol.01202.2009; Micklewright D, 2009, S AFRICAN J SPORTS M, V21; Millet GY, 2011, SPORTS MED, V41, P489, DOI 10.2165/11588760-000000000-00000; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; MINETTI AE, 1994, J EXP BIOL, V195, P211; Minetti AE, 2002, J APPL PHYSIOL, V93, P1039, DOI 10.1152/japplphysiol.01177.2001; Morin JB, 2011, J BIOMECH, V44, P1104, DOI 10.1016/j.jbiomech.2011.01.028; Morin JB, 2011, MED SCI SPORT EXER, V43, P829, DOI 10.1249/MSS.0b013e3181fec518; Noakes TD, 2009, BRIT J SPORT MED, V43, P760, DOI 10.1136/bjsm.2008.046763; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; Swart J, 2009, BRIT J SPORT MED, V43, P782, DOI 10.1136/bjsm.2008.055889; Townshend AD, 2008, MED SCI SPORT EXER, V40, P124, DOI 10.1249/mss.0b013e3181590bc2; Townshend AD, 2010, MED SCI SPORT EXER, V42, P160, DOI 10.1249/MSS.0b013e3181af21e2; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; Tucker R, 2009, BRIT J SPORT MED, V43, DOI 10.1136/bjsm.2009.057562; Utter AC, 2003, PERCEPT MOTOR SKILL, V97, P175, DOI 10.2466/PMS.97.5.175-184; Vernillo G, 2015, J SPORT SCI, V33, P1998, DOI 10.1080/02640414.2015.1022870; Vincenty T., 1975, SURVEY REV, V23, P88, DOI [10.1179/sre.1975.23.176.88, DOI 10.1179/SRE.1975.23.176.88]; Waldron M, 2011, J SPORT SCI, V29, P1613, DOI 10.1080/02640414.2011.608703	34	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145482	10.1371/journal.pone.0145482	http://dx.doi.org/10.1371/journal.pone.0145482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691599	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092300081
J	Koenig-Robert, R; VanRullen, R; Tsuchiya, N				Koenig-Robert, Roger; VanRullen, Rufin; Tsuchiya, Naotsugu			Semantic Wavelet-Induced Frequency-Tagging (SWIFT) Periodically Activates Category Selective Areas While Steadily Activating Early Visual Areas	PLOS ONE			English	Article							TOP-DOWN FACILITATION; FUSIFORM FACE AREA; PARAHIPPOCAMPAL PLACE AREA; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; OBJECT RECOGNITION; FUNCTIONAL LOCALIZERS; EXTRASTRIATE CORTEX; EVOKED-POTENTIALS; NEURAL RESPONSES	Primate visual systems process natural images in a hierarchical manner: at the early stage, neurons are tuned to local image features, while neurons in high-level areas are tuned to abstract object categories. Standard models of visual processing assume that the transition of tuning from image features to object categories emerges gradually along the visual hierarchy. Direct tests of such models remain difficult due to confounding alteration in low-level image properties when contrasting distinct object categories. When such contrast is performed in a classic functional localizer method, the desired activation in high-level visual areas is typically accompanied with activation in early visual areas. Here we used a novel image-modulation method called SWIFT (semantic wavelet-induced frequency-tagging), a variant of frequency-tagging techniques. Natural images modulated by SWIFT reveal object semantics periodically while keeping low-level properties constant. Using functional magnetic resonance imaging (fMRI), we indeed found that faces and scenes modulated with SWIFT periodically activated the prototypical category-selective areas while they elicited sustained and constant responses in early visual areas. SWIFT and the localizer were selective and specific to a similar extent in activating category-selective areas. Only SWIFT progressively activated the visual pathway from low-to high-level areas, consistent with predictions from standard hierarchical models. We confirmed these results with criterion-free methods, generalizing the validity of our approach and show that it is possible to dissociate neural activation in early and category-selective areas. Our results provide direct evidence for the hierarchical nature of the representation of visual objects along the visual stream and open up future applications of frequency-tagging methods in fMRI.	[Koenig-Robert, Roger; Tsuchiya, Naotsugu] Monash Univ, Fac Biomed & Psychol Sci, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [VanRullen, Rufin] Fac Med Purpan, CNRS, UMR5549, Ctr Rech Cerveau & Cognit, F-31052 Toulouse, France; [VanRullen, Rufin] Univ Toulouse 3, Univ Toulouse, Ctr Rech Cerveau & Cognit, F-31052 Toulouse, France; [Tsuchiya, Naotsugu] Japan Sci & Technol Agcy, Decoding & Controlling Brain Informat, Chiyoda Ku, Tokyo 1028266, Japan	Monash University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Japan Science & Technology Agency (JST)	Koenig-Robert, R (corresponding author), Univ New S Wales, Fac Sci, Sch Psychol, Sydney, NSW, Australia.	rogkoenig@gmail.com; naotsugu.tsuchiya@monash.edu	VanRullen, Rufin/B-2150-2008; Tsuchiya, Naotsugu/N-8153-2014	VanRullen, Rufin/0000-0002-3611-7716; Tsuchiya, Naotsugu/0000-0003-4216-8701	Monash Biomedical Imaging-Psychology Grant; Scientific Mobility Program - Australian Academy of Science/French Embassy; JST PRESTO fellowship (Japan); ARC (Australia)	Monash Biomedical Imaging-Psychology Grant; Scientific Mobility Program - Australian Academy of Science/French Embassy; JST PRESTO fellowship (Japan); ARC (Australia)(Australian Research Council)	This research was supported by Monash Biomedical Imaging-Psychology Grant (to NT, RK, RV), Scientific Mobility Program - Australian Academy of Science/French Embassy (to RK), JST PRESTO fellowship (Japan, to NT), ARC Future Fellowship and Discovery Project (Australia, to NT).	Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Aissani C, 2011, BRAIN RES, V1408, P27, DOI 10.1016/j.brainres.2011.05.051; Andrews TJ, 2010, NEUROIMAGE, V49, P703, DOI 10.1016/j.neuroimage.2009.08.046; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Bayram A, 2011, CLIN EEG NEUROSCI, V42, P98, DOI 10.1177/155005941104200210; Berman MG, 2010, NEUROIMAGE, V50, P56, DOI 10.1016/j.neuroimage.2009.12.024; Bianciardi M, 2009, CLIN NEUROPHYSIOL, V120, P738, DOI 10.1016/j.clinph.2009.01.009; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Boremanse A, 2014, EUR J NEUROSCI, V40, P2987, DOI 10.1111/ejn.12663; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Cant JS, 2011, J NEUROSCI, V31, P8248, DOI 10.1523/JNEUROSCI.6113-10.2011; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DiCarlo JJ, 2007, TRENDS COGN SCI, V11, P333, DOI 10.1016/j.tics.2007.06.010; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Dilks DD, 2013, J NEUROSCI, V33, P1331, DOI 10.1523/JNEUROSCI.4081-12.2013; Eger E, 2007, CEREB CORTEX, V17, P2123, DOI 10.1093/cercor/bhl119; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Esterman M, 2010, CEREB CORTEX, V20, P1245, DOI 10.1093/cercor/bhp188; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Fenske MJ, 2006, PROG BRAIN RES, V155, P3, DOI 10.1016/S0079-6123(06)55001-0; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Frackowiak RSJ., 2003, HUMAN BRAIN FUNCTION; Freeman J, 2013, NAT NEUROSCI, V16, P974, DOI 10.1038/nn.3402; Freiwald WA, 2009, NAT NEUROSCI, V12, P1187, DOI 10.1038/nn.2363; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Gonzalez-Castillo J, 2012, P NATL ACAD SCI USA, V109, P5487, DOI 10.1073/pnas.1121049109; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Gruter T, 2008, J NEUROPSYCHOL, V2, P79, DOI 10.1348/174866407X231001; Hinrichs H, 1997, HUM BRAIN, V292, P287, DOI DOI 10.1002/(SICI)1097-0193(1997)5:4%; Hubel BYDH, 1962, NEUR LAB DEP PHARM C, P106; Im CH, 2006, J NEUROSCI METH, V157, P118, DOI 10.1016/j.jneumeth.2006.03.015; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Janz C, 2001, MAGN RESON MED, V46, P482, DOI 10.1002/mrm.1217; Jehna M, 2011, BRAIN RES, V1393, P73, DOI 10.1016/j.brainres.2011.04.007; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kleinhans NM, 2011, NEUROIMAGE, V54, P697, DOI 10.1016/j.neuroimage.2010.07.037; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Koenig-Robert R, 2013, NEUROIMAGE, V81, P273, DOI 10.1016/j.neuroimage.2013.04.116; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Marsman JBC, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00109; NOWAK LG, 1995, VISUAL NEUROSCI, V12, P371, DOI 10.1017/S095252380000804X; Ohayon S, 2012, NEURON, V74, P567, DOI 10.1016/j.neuron.2012.03.024; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; Parvizi J, 2012, J NEUROSCI, V32, P14915, DOI 10.1523/JNEUROSCI.2609-12.2012; Perlstein WM, 2003, NEUROSCI LETT, V342, P191, DOI 10.1016/S0304-3940(03)00226-X; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; Pollen DA, 2003, CEREB CORTEX, V13, P807, DOI 10.1093/cercor/13.8.807; Rajimehr R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000608; REGAN MP, 1988, J THEOR BIOL, V133, P293, DOI 10.1016/S0022-5193(88)80323-0; Rice GE, 2014, J NEUROSCI, V34, P8837, DOI 10.1523/JNEUROSCI.5265-13.2014; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Rossion B, 2012, BRAIN COGNITION, V79, P138, DOI 10.1016/j.bandc.2012.01.001; Rust NC, 2010, J NEUROSCI, V30, P12978, DOI 10.1523/JNEUROSCI.0179-10.2010; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Sadr J, 2004, COGNITIVE SCI, V28, P259, DOI 10.1016/j.cogsci.2004.09.003; Sammer G, 2005, NEUROIMAGE, V24, P1012, DOI 10.1016/j.neuroimage.2004.10.026; Saxe R, 2006, NEUROIMAGE, V30, P1088, DOI 10.1016/j.neuroimage.2005.12.062; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Seth AK, 2013, NEUROIMAGE, V65, P540, DOI 10.1016/j.neuroimage.2012.09.049; Srinivasan R, 1999, J NEUROSCI, V19, P5435; Stephan KE, 2010, WIRES COGN SCI, V1, P446, DOI 10.1002/wcs.58; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Sutoyo D, 2009, BRAIN RES, V1251, P245, DOI 10.1016/j.brainres.2008.09.086; SWETS D, 1966, SIGNAL DETECTION THE; Tanaka K, 1997, CURR OPIN NEUROBIOL, V7, P523, DOI 10.1016/S0959-4388(97)80032-3; Tsai JJ, 2012, J NEUROSCI, V32, P2783, DOI 10.1523/JNEUROSCI.4485-11.2012; Warnking J, 2002, NEUROIMAGE, V17, P1665, DOI 10.1006/nimg.2002.1304; Yamins DLK, 2014, P NATL ACAD SCI USA, V111, P8619, DOI 10.1073/pnas.1403112111; Yue XM, 2011, CEREB CORTEX, V21, P35, DOI 10.1093/cercor/bhq050	79	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144858	10.1371/journal.pone.0144858	http://dx.doi.org/10.1371/journal.pone.0144858			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691722	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092300022
J	Patel, R; Ladusingh, L				Patel, Rachana; Ladusingh, Laishram			Do Physical Proximity and Availability of Adequate Infrastructure at Public Health Facility Increase Institutional Delivery? A Three Level Hierarchical Model Approach	PLOS ONE			English	Article							CARE SERVICES; CONTEXTUAL INFLUENCES; QUALITY	This study aims to examine the inter-district and inter-village variation of utilization of health services for institutional births in EAG states in presence of rural health program and availability of infrastructures. District Level Household Survey-III (2007-08) data on delivery care and facility information was used for the purpose. Bivariate results examined the utilization pattern by states in presence of correlates of women related while a three-level hierarchical multilevel model illustrates the effect of accessibility, availability of health facility and community health program variables on the utilization of health services for institutional births. The study found a satisfactory improvement in state Rajasthan, Madhya Pradesh and Orissa, importantly, in Bihar and Uttaranchal. The study showed that increasing distance from health facility discouraged institutional births and there was a rapid decline of more than 50% for institutional delivery as the distance to public health facility exceeded 10 km. Additionally, skilled female health worker (ANM) and observed improved public health facility led to significantly increase the probability of utilization as compared to non-skilled ANM and not-improved health centers. Adequacy of essential equipment/laboratory services required for maternal care significantly encouraged deliveries at public health facility. District/village variables neighborhood poverty was negatively related to institutional delivery while higher education levels in the village and women's residing in more urbanized districts increased the utilization. "Inter-district" variation was 14 percent whereas "between-villages" variation for the utilization was 11 percent variation once controlled for all the three-level variables in the model. This study suggests that the mere availability of health facilities is necessary but not sufficient condition to promote utilization until the quality of service is inadequate and inaccessible considering the inter-districts variation for the program implementation.	[Patel, Rachana] IIPS, Bombay, Maharashtra, India; [Ladusingh, Laishram] IIPS, Dept Math Demog & Stat, Bombay, Maharashtra, India	International Institute for Population Sciences; International Institute for Population Sciences	Patel, R (corresponding author), IIPS, Bombay, Maharashtra, India.	contact.rachi@gmail.com						Amooti-Kaguna B, 2000, SOC SCI MED, V50, P203, DOI 10.1016/S0277-9536(99)00275-0; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Baltussen RMPM, 2002, HEALTH POLICY PLANN, V17, P42, DOI 10.1093/heapol/17.1.42; Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1; Collins J. W. Jr., 2003, Neighborhoods and health, P223; Dholakia RA, 2004, MDG NEEDS ASSESSMENT; Gage AL, 2006, POP STUD-J DEMOG, V60, P271, DOI 10.1080/00324720600895934; Glei DA, 2003, SOC SCI MED, V57, P2447, DOI 10.1016/S0277-9536(03)00140-0; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Haddad S, 1998, INT J QUAL HEALTH C, V10, P93, DOI 10.1093/intqhc/10.2.93; Hermaline Al, 1987, ORG EFFECTIVE FAMILY, P583; Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS SURV; International Institute for Population Sciences (IIPS), 2006, DISTR LEV HOUS SURV; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jacobi J, 2004, AFRICAN J REPROD HLT, V3, P66; Kandel DB, 2004, AM J PUBLIC HEALTH, V94, P128, DOI 10.2105/AJPH.94.1.128; Lopez-Cevallos DF, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-64; Magadi MA, 2003, POP STUD-J DEMOG, V57, P347, DOI 10.1080/0032472032000137853; Marmot MG, 1998, MILBANK Q, V76, P403, DOI 10.1111/1468-0009.00097; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; PAHO, 2002, HLTH AM, V1; Pearl M, 2001, AM J PUBLIC HEALTH, V91, P1808, DOI 10.2105/AJPH.91.11.1808; Rasbash J., 2004, USERS GUIDE MLWIN VE; Sample Registration System, 2003, SPEC B MAT MORT IND; Sample Registration System, 2006, SPEC B MAT MORT IND; Stephenson R, 2003, AM J PUBLIC HEALTH, V93, P1820, DOI 10.2105/AJPH.93.11.1820; Stephenson R, 2002, STUD FAMILY PLANN, V33, P309, DOI 10.1111/j.1728-4465.2002.00309.x; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; United Nations, 2012, UN MILL DEV GOALS; van Duong D, 2004, INT J QUAL HEALTH C, V16, P447, DOI 10.1093/intqhc/mzh073; Vissandjee B, 1997, PUBLIC HEALTH, V111, P135, DOI 10.1016/S0033-3506(97)00572-6; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R	32	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144352	10.1371/journal.pone.0144352	http://dx.doi.org/10.1371/journal.pone.0144352			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SF	26689199	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092300007
J	Hyun, SH; Lee, KH; Choi, JY; Kim, BT; Kim, J; Zo, JI; Kim, H; Kwon, OJ; Ahn, HK				Hyun, Seung Hyup; Lee, Kyung-Han; Choi, Joon Young; Kim, Byung-Tae; Kim, Jhingook; Zo, Jae Ill; Kim, Hojoong; Kwon, O. Jung; Ahn, Hee Kyung			Influence of Body Mass Index on the Prognostic Value of Tumor F-18-FDG Uptake in Stage I Non-Small Cell Lung Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; METABOLIC SYNDROME; OBESITY; SURVIVAL; MORTALITY; ASSOCIATION; COHORT; RISK	Background The impact of host energy balance status on outcome of lung cancer has not been fully explored. It is also unknown if there is a potential modifying effect of body mass index (BMI) on tumor cell behavior in patients with early-stage non-small cell lung cancer (NSCLC). We therefore investigated the interactive effects of tumor [F-18]-fluorodeoxyglucose (FDG) avidity and BMI. Methods We investigated 1,197 patients with stage I NSCLC who underwent preoperative FDG positron emission tomography followed by curative resection. The primary outcome measure was disease-free survival (DFS). A multivariable Cox proportional hazards model was used to assess the potential independent effects of the prognostic variables. A stratified Cox regression analysis was also performed to assess the potential modifying effects of BMI on the relationship between tumor FDG uptake and patient survival. Results There were 145 tumor recurrences and 19 deaths during a median follow-up of 30 months. Tumor-related variables, including tumor size, maximum standardized uptake value (SUVmax), histologic cell type, differentiation, lymphovascular invasion, and visceral pleural invasion, did not differ significantly according to BMI status. In multivariable Cox regression analysis, overweight or obesity [hazard ratio (HR), 0.59; 95% CI, 0.43-0.81; P = 0.001] and tumor SUVmax (HR, 1.72; 95% CI, 1.43-2.07; P < 0.001) were significantly associated with DFS. There was a significant modifying effect of BMI (P for interaction < 0.001 in multivariable analysis). High tumor SUVmax was more strongly associated with worse DFS in normal weight patients (HR, 4.72; 95% CI, 2.77-8.06; P < 0.001) than in overweight or obese patients (HR, 2.61; 95% CI, 1.58-4.31; P < 0.001). Conclusions Tumor FDG avidity is an independent predictor of DFS in patients with early-stage NSCLC and this prognostic value was strengthened in normal weight patients than in overweight or obese patients. These results suggest that the host-tumor interaction between host energy balance status and tumor glucose metabolism plays an important role in the outcome of early-stage NSCLC.	[Hyun, Seung Hyup; Lee, Kyung-Han; Choi, Joon Young; Kim, Byung-Tae] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Nucl Med, Seoul, South Korea; [Kim, Jhingook; Zo, Jae Ill] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea; [Kim, Hojoong; Kwon, O. Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Ahn, Hee Kyung] Gachon Univ, Div Hematol Oncol, Dept Internal Med, Gil Med Ctr, Incheon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Gachon University	Lee, KH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Nucl Med, Seoul, South Korea.	khnm.lee@samsung.com	Choi, Joon Young/D-6140-2017		Samsung Medical Center	Samsung Medical Center(Samsung)	The authors received no specific funding for this work. Co-authors Seung Hyup Hyun, Kyung-Han Lee, Joon Young Choi, Byung-Tae Kim, Jhingook Kim, Jae Ill Zo, Hojoong Kim, and O Jung Kwon are employed by Samsung Medical Center, which is administratively separate from the Samsung Corporation. Samsung Medical Center provided support in the form of salaries for authors SHH, K-HL, JYC, B-TK, JK, JIZ, HK and OJK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Attaran S, 2012, EUR J CARDIO-THORAC, V42, P653, DOI 10.1093/ejcts/ezs135; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Braun S, 2011, INT J BIOL SCI, V7, P1003, DOI 10.7150/ijbs.7.1003; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cavazos DA, 2014, NUTR CANCER, V66, P1179, DOI 10.1080/01635581.2014.951738; Choi Y, 2013, INT J CANCER, V132, P625, DOI 10.1002/ijc.27639; Dahlberg SE, 2013, J THORAC ONCOL, V8, P1121, DOI 10.1097/JTO.0b013e31829cf942; Dooms C, 2009, J THORAC ONCOL, V4, P822, DOI 10.1097/JTO.0b013e3181a97df7; Downey RJ, 2004, J CLIN ONCOL, V22, P3255, DOI 10.1200/JCO.2004.11.109; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Graham MM, 2000, NUCL MED BIOL, V27, P647, DOI 10.1016/S0969-8051(00)00143-8; Hakimi AA, 2013, JNCI-J NATL CANCER I, V105, P1862, DOI 10.1093/jnci/djt310; Hursting SD, 2012, ARTERIOSCL THROM VAS, V32, P1766, DOI 10.1161/ATVBAHA.111.241927; Kollarova H, 2008, NEOPLASMA, V55, P71; LAUSEN B, 1992, BIOMETRICS, V48, P73, DOI 10.2307/2532740; Leung CC, 2011, INT J EPIDEMIOL, V40, P174, DOI 10.1093/ije/dyq134; Lynam-Lennon N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-907; Paesmans M, 2010, J THORAC ONCOL, V5, P612, DOI 10.1097/JTO.0b013e3181d0a4f5; Park SY, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-151; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Vesselle H, 2008, J THORAC ONCOL, V3, P971, DOI 10.1097/JTO.0b013e31818307a7; Vucenik I, 2012, ANN NY ACAD SCI, V1271, P37, DOI 10.1111/j.1749-6632.2012.06750.x; Yang L, 2009, INT J CANCER, V125, P2136, DOI 10.1002/ijc.24527; Yang Y, 2013, INT J CANCER, V132, P1162, DOI 10.1002/ijc.27719; Yoon HH, 2011, J CLIN ONCOL, V29, P4561, DOI 10.1200/JCO.2011.37.1260; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151	27	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145020	10.1371/journal.pone.0145020	http://dx.doi.org/10.1371/journal.pone.0145020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684001	Green Submitted, gold, Green Published			2022-12-27	WOS:000366725800030
J	Izac, M; Garnier, D; Speck, D; Lindley, ND				Izac, Marie; Garnier, Dominique; Speck, Denis; Lindley, Nic D.			A Functional Tricarboxylic Acid Cycle Operates during Growth of Bordetella pertussis on Amino Acid Mixtures as Sole Carbon Substrates	PLOS ONE			English	Article							ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; TOXIN PRODUCTION; GENOMIC CONTENT; FERMENTATION; CULTIVATION; METABOLISM; PROTEIN	It has been claimed that citrate synthase, aconitase and isocitrate dehydrogenase activities are non-functional in Bordetella pertussis and that this might explain why this bacterium's growth is sometimes associated with accumulation of polyhydroxybutyrate (PHB) and/or free fatty acids. However, the sequenced genome includes the entire citric acid pathway genes. Furthermore, these genes were expressed and the corresponding enzyme activities detected at high levels for the pathway when grown on a defined medium imitating the amino acid content of complex media often used for growth of this pathogenic micro-organism. In addition, no significant PHB or fatty acids could be detected. Analysis of the carbon balance and stoichiometric flux analysis based on specific rates of amino acid consumption, and estimated biomass requirements coherent with the observed growth rate, clearly indicate that a fully functional tricarboxylic acid cycle operates in contrast to previous reports.	[Izac, Marie; Lindley, Nic D.] Univ Toulouse, INSA, UPSr, INP,LISBP, Toulouse, France; [Izac, Marie; Lindley, Nic D.] INRA, Ingn Syst Biol & Proc UMR792, F-31931 Toulouse, France; [Izac, Marie; Lindley, Nic D.] CNRS, UMR5504, Toulouse, France; [Garnier, Dominique; Speck, Denis] Sanofi Pasteur, Marcy Letoile, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse	Lindley, ND (corresponding author), Univ Toulouse, INSA, UPSr, INP,LISBP, Toulouse, France.	lindley@insa-toulouse.fr		Lindley, Nic D/0000-0002-9538-1306	Sanofi-Pasteur	Sanofi-Pasteur	This project was funded by a direct grant (MI) from Sanofi-Pasteur who were involved in the study design and the decision to publish the data.; The authors would like to thank Sanofi-Pasteur for financial support and the GeT platform (http://get.genotoul.fr/) for help in qPCR experiments and primer design.	Ampe F, 1997, APPL ENVIRON MICROB, V63, P2765, DOI 10.1128/AEM.63.7.2765-2770.1997; [Anonymous], 2013, VACCINES 6; Antoine R, 2005, J MOL BIOL, V351, P799, DOI 10.1016/j.jmb.2005.05.071; Antoine R, 2003, J BACTERIOL, V185, P1470, DOI 10.1128/JB.185.4.1470-1474.2003; Bart MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01074-14; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bogdan JA, 2001, INFECT IMMUN, V69, P6823, DOI 10.1128/IAI.69.11.6823-6830.2001; Bouchez V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002437; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Budman H, 2013, BIOTECHNOL PROGR, V29, P520, DOI 10.1002/btpr.1675; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Esquerre T, 2014, NUCLEIC ACIDS RES, V42, P2460, DOI 10.1093/nar/gkt1150; Frohlich BT, 1996, J BIOTECHNOL, V45, P137, DOI 10.1016/0168-1656(95)00155-7; FROHLICH BT, 1995, J BIOTECHNOL, V39, P205, DOI 10.1016/0168-1656(95)00013-G; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; HOZBOR D, 1994, FEMS IMMUNOL MED MIC, V9, P117; IMAIZUMI A, 1983, J CLIN MICROBIOL, V17, P781, DOI 10.1128/JCM.17.5.781-786.1983; JEBB WHH, 1951, J GEN MICROBIOL, V5, P951, DOI 10.1099/00221287-5-5-951; King AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-64; Lambert LC, 2014, J INFECT DIS, V209, pS4, DOI 10.1093/infdis/jit592; Lapujade P, 1998, APPL ENVIRON MICROB, V64, P2485; Maharjan RP, 2008, RES MICROBIOL, V159, P602, DOI 10.1016/j.resmic.2008.08.004; NIKOLAJEWSKI HE, 1990, BIOLOGICALS, V18, P305, DOI 10.1016/1045-1056(90)90034-W; Nouaille S, 2009, APPL ENVIRON MICROB, V75, P4473, DOI 10.1128/AEM.02653-08; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; ROWATT E, 1957, J GEN MICROBIOL, V17, P297, DOI 10.1099/00221287-17-2-297; Scheu PD, 2012, J BACTERIOL, V194, P636, DOI 10.1128/JB.06345-11; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; Thalen M, 2006, BIOLOGICALS, V34, P289, DOI 10.1016/j.biologicals.2005.12.001; Ulloa-Gutierrez R, 2009, EXPERT REV VACCINES, V8, P153, DOI 10.1586/14760584.8.2.153; Weitzman PDJ., 1969, METHOD ENZYMOL, P22; Yamamoto K, 2009, BIOSCI BIOTECH BIOCH, V73, P346, DOI 10.1271/bbb.80586	33	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145251	10.1371/journal.pone.0145251	http://dx.doi.org/10.1371/journal.pone.0145251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684737	Green Submitted, gold, Green Published			2022-12-27	WOS:000366725800053
J	Kristmundsson, A; Erlingsdottir, A; Freeman, MA				Kristmundsson, Arni; Erlingsdottir, Asthildur; Freeman, Mark A.			Is an Apicomplexan Parasite Responsible for the Collapse of the Iceland Scallop (Chlamys islandica) Stock?	PLOS ONE			English	Article							PECTEN-MAXIMUS L; PLACOPECTEN-MAGELLANICUS; PROTOTHACA-STAMINEA; MASS MORTALITY; SEA SCALLOP; MULLER; INFECTION; POPULATIONS; ATLANTIC; WATERS	Due to the total and unexpected collapse of the Iceland scallop, Chlamys islandica, stocks around Iceland during the 2000s, a commercial fishing ban has been imposed on this valuable resource since 2003. Following the initial identification of an apicomplexan parasite in the scallops, a long-term surveillance program was established to evaluate the effect of the parasite on the population. The infections were highly prevalent in all shell sizes throughout the study. However, the parasite only impacts mature scallops where they cause severe macroscopic changes, characterized by an extensively diminished and abnormally coloured adductor muscle. A highly significant relationship was observed between infection intensity and gonad and adductor muscle indices. The first four years of the study, were characterized by high infection intensity and very poor condition of the adductor muscle and gonads, whilst during subsequent years, infections gradually decreased and the condition of the scallops improved. Histopathological changes were restricted to the presence of apicomplexan zoites which were widely distributed, causing varying degrees of pathology in all organs. In heavy infections, muscular and connective tissues were totally necrotized, destroying significant parts of numerous organs, especially the adductor muscle, digestive gland and gonads. The progression of the disease was in good synchrony with the mortality rates and the subsequent decline observed in the scallop stock and recruitment indices. Our findings strongly suggest that the apicomplexan parasite played a major role in the collapse of the Iceland scallop stock in Breidafjordur. In addition to causing mortality, the infections significantly impact gonad development which contributes further to the collapse of the stock in the form of lower larval recruitment. Furthermore, compelling evidence exists that this apicomplexan pathogen is causing serious disease outbreaks in other scallop populations. Similar abnormal adductor muscles and the parasite itself have been identified or observed in association with other mass mortality events in several different scallop species and commercial stocks in the northern hemisphere.	[Kristmundsson, Arni; Erlingsdottir, Asthildur; Freeman, Mark A.] Univ Iceland, Fish Dis Lab, Inst Expt Pathol Keldur, Reykjavik, Iceland; [Freeman, Mark A.] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Freeman, Mark A.] Ross Univ, Sch Vet Med, Basseterre, St Kitts & Nevi	University of Iceland; Universiti Malaya	Kristmundsson, A (corresponding author), Univ Iceland, Fish Dis Lab, Inst Expt Pathol Keldur, Reykjavik, Iceland.	arnik@hi.is	Freeman, Mark A/B-7777-2010	Kristmundsson, Arni/0000-0001-7387-8584	Ministry of Industries and Innovation in Iceland [IEP-H.diskur-69935]; University of Malaya, Malaysia [RP001L-13SUS]	Ministry of Industries and Innovation in Iceland; University of Malaya, Malaysia(Universiti Malaya)	This work was supported by the Ministry of Industries and Innovation in Iceland; http://eng.atvinnuvegaruduneyti.is [grant no. IEP-H.diskur-69935] and University of Malaya, Malaysia [grant number RP001L-13SUS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnfinnsson J, 2015, 20 INT PECT WORKSH G, P7; Brenner K, 2012, J SHELLFISH RES, V31, P1123, DOI 10.2983/035.031.0423; Brokordt KB, 2004, J SHELLFISH RES, V23, P25; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Carballal MJ, 2001, J INVERTEBR PATHOL, V78, P87, DOI 10.1006/jipa.2001.5049; Desser SS, 1997, FOLIA PARASIT, V44, P241; DICKIE LM, 1963, J FISH RES BOARD CAN, V20, P451, DOI 10.1139/f63-035; Eiriksson H, 1986, HAFRANNSOKNIR, V35, P5; Eiriksson H, 2000, ICES ANN SCI C NANT; Freeman MA, 2008, J FISH DIS, V31, P921, DOI 10.1111/j.1365-2761.2008.00965.x; Garcia EG, 2006, ADV MAR BIOL, V51, P1, DOI 10.1016/S0065-2881(06)51001-6; Giguere M., 1995, CAN TECH REP FISH AQ, V2033, P26; Gudfinnsson HG, 2001, SJOR SJAVARNYTJAR HE, P20; GULKA G, 1983, J FISH DIS, V6, P355, DOI 10.1111/j.1365-2761.1983.tb00087.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Haynes E. B., 1966, Research Bulletin International Commission NW Atlantic Fisheries, V3, P32; Hine PM, 2002, DIS AQUAT ORGAN, V51, P49, DOI 10.3354/dao051049; Howard DW, 2004, 5 NOAA NOS NCCOS; ICES, 2006, CM2006MCC01 ICES ACF; Inglis S, 2015, 20 INT PECT WORKSH G, P96; Jonasson JP, 2007, ICES J MAR SCI, V64, P298, DOI 10.1093/icesjms/fsl028; Jonasson JP, 2004, AQUAC RES, V35, P1405, DOI 10.1111/j.1365-2109.2004.01159.x; Karlsson JD, 1991, WORLD AQUACULTURE WO, V1, P180; Kristmundsson A, 2014, P 7 INT S AQ AN HLTH, P155; Kristmundsson A, 2005, P 12 INT C EUR ASS F; Kristmundsson A, 2011, J INVERTEBR PATHOL, V108, P147, DOI 10.1016/j.jip.2011.08.003; Kristmundsson A, 2011, J INVERTEBR PATHOL, V108, P139, DOI 10.1016/j.jip.2011.08.001; Leibovitz L., 1984, Journal of the World Mariculture Society, V15, P269; LESTER RJG, 1984, HELGOLANDER MEERESUN, V37, P53, DOI 10.1007/BF01989295; MASON J, 1958, J MAR BIOL ASSOC UK, V37, P653, DOI 10.1017/S0025315400005701; Mayo-Hernandez E, 2013, J SEA RES, V83, P195, DOI 10.1016/j.seares.2013.04.001; MCDONALD V, 1987, J PARASITOL, V73, P617, DOI 10.2307/3282145; Medcof J. C., 1965, Studies from the Stations of the Fisheries Research Board of Canada, P33; Medcof J.C., 1949, PROG REP ATLANTIC CO, V45, P3; MORADO JF, 1984, J INVERTEBR PATHOL, V43, P207, DOI 10.1016/0022-2011(84)90139-3; MRI, 2007, STAT MAR STOCKS IC W; MRI, 2002, STAT MAR STOCKS IC W; MRI, 2009, STAT MAR STOCKS IC W; MRI, 2015, 2015 STAT MAR STOCKS; MRI, 2003, STAT MAR STOCKS IC W; Naidu K.S., 1987, J NW ATL FISH SCI, V7, P131, DOI [10.2960/J.v7.a15, DOI 10.2960/J.V7.A15]; Rubach S, 1987, RESSURSKARTLEGGING A; Samuelsen OB, 2006, DIS AQUAT ORGAN, V71, P239, DOI 10.3354/dao071239; Steinhagen D, 1998, FOLIA PARASIT, V45, P326; Stevenson, 1936, THESIS; Stokesbury KDE, 2007, MAR ECOL PROG SER, V349, P151, DOI 10.3354/meps07113; Sundet JH, ARE THERE POTE UNPUB, V43, P12; TAYLOR AC, 1978, J MAR BIOL ASSOC UK, V58, P687, DOI 10.1017/S0025315400041333; THORARINSDOTTIR GG, 1993, AQUACULTURE, V110, P87, DOI 10.1016/0044-8486(93)90436-3; VAHL O, 1981, J EXP MAR BIOL ECOL, V53, P281, DOI 10.1016/0022-0981(81)90026-5; Webb S, 2008, 1334 CAWTHR, P28; WHYTE SK, 1994, DIS AQUAT ORGAN, V18, P53, DOI 10.3354/dao018053; WIBORG KRISTIAN FREDRIK, 1963, FISKERIDIREKT SKRIFTER SER HAVUNDERS, V13, P38; [No title captured]	54	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144685	10.1371/journal.pone.0144685	http://dx.doi.org/10.1371/journal.pone.0144685			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684810	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800018
J	Biyikli, E; To, AC				Biyikli, Emre; To, Albert C.			Proportional Topology Optimization: A New Non-Sensitivity Method for Solving Stress Constrained and Minimum Compliance Problems and Its Implementation in MATLAB	PLOS ONE			English	Article							STRUCTURAL OPTIMIZATION; CONTINUUM STRUCTURES; OPTIMALITY CRITERIA; CODE WRITTEN	A new topology optimization method called the Proportional Topology Optimization ( PTO) is presented. As a non-sensitivity method, PTO is simple to understand, easy to implement, and is also efficient and accurate at the same time. It is implemented into two MATLAB programs to solve the stress constrained and minimum compliance problems. Descriptions of the algorithm and computer programs are provided in detail. The method is applied to solve three numerical examples for both types of problems. The method shows comparable efficiency and accuracy with an existing optimality criteria method which computes sensitivities. Also, the PTO stress constrained algorithm and minimum compliance algorithm are compared by feeding output from one algorithm to the other in an alternative manner, where the former yields lower maximum stress and volume fraction but higher compliance compared to the latter. Advantages and disadvantages of the proposed method and future works are discussed. The computer programs are self-contained and publicly shared in the website www.ptomethod.org.	[To, Albert C.] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Simulat & Modeling, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	To, AC (corresponding author), Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15260 USA.	albertto@pitt.edu		To, Albert/0000-0003-2893-8378	Mascaro Center for Sustainable Innovations (MCSI) at University of Pittsburgh	Mascaro Center for Sustainable Innovations (MCSI) at University of Pittsburgh	The financial support from Mascaro Center for Sustainable Innovations (MCSI) at University of Pittsburgh is gratefully acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen E, 2011, STRUCT MULTIDISCIP O, V43, P1, DOI 10.1007/s00158-010-0594-7; Back T., 1996, EVOLUTIONARY ALGORIT; Bendsoe M.P., 1995, OPTIMIZATION STRUCTU; BENDSOE MP, 1988, COMPUT METHOD APPL M, V71, P197, DOI 10.1016/0045-7825(88)90086-2; Bendsoe MP., 1989, STRUCT OPTIMIZATION, V1, P193, DOI 10.1007/BF01650949; Bruggi M, 2008, STRUCT MULTIDISCIP O, V36, P125, DOI 10.1007/s00158-007-0203-6; Bruns TE, 2001, COMPUT METHOD APPL M, V190, P3443, DOI 10.1016/S0045-7825(00)00278-4; Challis VJ, 2010, STRUCT MULTIDISCIP O, V41, P453, DOI 10.1007/s00158-009-0430-0; Christensen P.W, 2009, INTRO STRUCTURAL OPT; Dantzig G. B., 1963, LINEAR PROGRAMMING I; Dorigo M, 1996, IEEE T SYST MAN CY B, V26, P29, DOI 10.1109/3477.484436; Duysinx P, 1998, INT J NUMER METH ENG, V43, P1453; FLEURY C, 1986, INT J NUMER METH ENG, V23, P409, DOI 10.1002/nme.1620230307; Glover F., 1977, DECISION SCI, V8, P156, DOI [10.1111/j.1540-5915.1977.tb01074.x, DOI 10.1111/J.1540-5915.1977.TB01074.X]; Haftka R.T., 1992, ELEMENTS STRUCTURAL; Holmberg E, 2013, STRUCT MULTIDISCIP O, V48, P33, DOI 10.1007/s00158-012-0880-7; Huang x, 2010, EVOLUTIONARY TOPOLOG; Le C, 2010, STRUCT MULTIDISCIP O, V41, P605, DOI 10.1007/s00158-009-0440-y; Lee E, 2012, STRUCT MULTIDISCIP O, V46, P647, DOI 10.1007/s00158-012-0780-x; Lee KS, 2005, COMPUT METHOD APPL M, V194, P3902, DOI 10.1016/j.cma.2004.09.007; Lee KS, 2004, COMPUT STRUCT, V82, P781, DOI 10.1016/j.compstruc.2004.01.002; Liu K, 2014, STRUCT MULTIDISCIP O, V50, P1175, DOI 10.1007/s00158-014-1107-x; Luh GC, 2004, COMPUT METHOD APPL M, V193, P4035, DOI 10.1016/j.cma.2004.02.013; Michell AGM, 1904, PHILOS MAG, V8, P589, DOI 10.1080/14786440409463229; Nandy AK, 2012, STRUCT MULTIDISCIP O, V45, P717, DOI 10.1007/s00158-011-0737-5; Paris J, 2010, COMPUT METHOD APPL M, V199, P2110, DOI 10.1016/j.cma.2010.03.010; Paris J, 2009, STRUCT MULTIDISCIP O, V39, P419, DOI 10.1007/s00158-008-0336-2; Patel NM, 2008, AIAA J, V46, P1963, DOI 10.2514/1.31053; Pereira JT, 2004, STRUCT MULTIDISCIP O, V26, P50, DOI 10.1007/s00158-003-0301-z; PRAGER W, 1968, P NATL ACAD SCI USA, V61, P794, DOI 10.1073/pnas.61.3.794; Rozvany GIN, 2009, STRUCT MULTIDISCIP O, V37, P217, DOI 10.1007/s00158-007-0217-0; Russell DM, 1989, ADV DESIGN AUTOMATIO, V2, P217; Shim PY, 1997, INT J NUMER METH ENG, V40, P1053, DOI 10.1002/(SICI)1097-0207(19970330)40:6<1053::AID-NME97>3.0.CO;2-I; Sigmund O, 2001, STRUCT MULTIDISCIP O, V21, P120, DOI 10.1007/s001580050176; Sigmund O, 2007, STRUCT MULTIDISCIP O, V33, P401, DOI 10.1007/s00158-006-0087-x; Sigmund O, 2011, STRUCT MULTIDISCIP O, V43, P589, DOI 10.1007/s00158-011-0638-7; Stolpe M, 2001, STRUCT MULTIDISCIP O, V22, P116, DOI 10.1007/s001580100129; SVANBERG K, 1987, INT J NUMER METH ENG, V24, P359, DOI 10.1002/nme.1620240207; Svanberg K, 2007, STRUCT MULTIDISCIP O, V34, P277, DOI 10.1007/s00158-007-0118-2; Talischi C, 2012, STRUCT MULTIDISCIP O, V45, P329, DOI 10.1007/s00158-011-0696-x; Talischi C, 2012, STRUCT MULTIDISCIP O, V45, P309, DOI 10.1007/s00158-011-0706-z; Vemaganti K, 2005, COMPUT METHOD APPL M, V194, P3637, DOI 10.1016/j.cma.2004.08.008; Wu CY, 2010, STRUCT MULTIDISCIP O, V42, P939, DOI 10.1007/s00158-010-0523-9; Xie Y. M., 1992, P INT C COMP ENG SCI; Yang DQ, 2000, APPL MATH MECH-ENGL, V21, P19; Yang RZ, 2013, STRUCT MULTIDISCIP O, V47, P191, DOI 10.1007/s00158-012-0838-9; Zhang P, 2014, J MANUFACTURING SCI, P137	48	41	45	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145041	10.1371/journal.pone.0145041	http://dx.doi.org/10.1371/journal.pone.0145041			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678849	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000366723400044
J	Salzberger, W; Garcia-Beltran, WF; Dugan, H; Gubbala, S; Simoneau, C; Gressens, SB; Jost, S; Altfeld, M				Salzberger, Wilhelm; Garcia-Beltran, Wilfredo F.; Dugan, Haley; Gubbala, Supreetha; Simoneau, Camille; Gressens, Simon B.; Jost, Stephanie; Altfeld, Marcus			Influence of Glycosylation Inhibition on the Binding of KIR3DL1 to HLA-B*57:01	PLOS ONE			English	Article							CELL-SURFACE EXPRESSION; LINKED OLIGOSACCHARIDES; RECOGNITION; MOLECULES; LYMPHOCYTES; ACTIVATION; PATTERNS; SITE	Viral infections can affect the glycosylation pattern of glycoproteins involved in antiviral immunity. Given the importance of protein glycosylation for immune function, we investigated the effect that modulation of the highly conserved HLA class I N-glycan has on KIR: HLA interactions and NK cell function. We focused on HLA-B*57:01 and its interaction with KIR3DL1, which has been shown to play a critical role in determining the progression of a number of human diseases, including human immunodeficiency virus-1 infection. 721.221 cells stably expressing HLA-B*57:01 were treated with a panel of glycosylation enzyme inhibitors, and HLA class I expression and KIR3DL1 binding was quantified. In addition, the functional outcomes of HLA-B*57:01 N-glycan disruption/modulation on KIR3DL1 zeta(+) Jurkat reporter cells and primary human KIR3DL1+NK cells was assessed. Different glycosylation enzyme inhibitors had varying effects on HLA-B*57:01 expression and KIR3DL1-Fc binding. Themost remarkable effect was that of tunicamycin, an inhibitor of the first step of N-glycosylation, which resulted in significantly reduced KIR3DL1-Fc binding despite sustained expression of HLA-B*57:01 on 721.221 cells. This effect was paralleled by decreased activation of KIR3DL1 zeta(+) Jurkat reporter cells, as well as increased degranulation of primary human KIR3DL1(+) NK cell clones when encountering HLA-B*57:01-expressing 721.221 cells that were pre-treated with tunicamycin. Overall, these results demonstrate that N-glycosylation of HLA class I is important for KIR:HLA binding and has an impact on NK cell function.	[Salzberger, Wilhelm; Altfeld, Marcus] Leibniz Inst Expt Virol, Heinrich Pette Inst, Dept Virus Immunol, Hamburg, Germany; [Garcia-Beltran, Wilfredo F.; Dugan, Haley; Gubbala, Supreetha; Simoneau, Camille; Gressens, Simon B.; Jost, Stephanie; Altfeld, Marcus] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA	Heinrich Pette Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Altfeld, M (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Dept Virus Immunol, Hamburg, Germany.	marcus.altfeld@hpi.uni-hamburg.de	Altfeld, Marcus/AAE-7306-2019	Altfeld, Marcus/0000-0001-5972-2997	Deutsche Gesellschaft fur Infektiologische Forschung (WFS); Heinrich-Pette-Institut (WFS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI116366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Deutsche Gesellschaft fur Infektiologische Forschung (WFS); Heinrich-Pette-Institut (WFS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Deutsche Gesellschaft fur Infektiologische Forschung (WFS), http://www.dzif.de/, and the Heinrich-Pette-Institut (WFS), http://www.hpi-hamburg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman ME, 2013, J CLIN INVEST, V123, P2183, DOI 10.1172/JCI65708; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Alter G, 2009, J VIROL, V83, P6798, DOI 10.1128/JVI.00256-09; Altfeld M, 2015, NAT IMMUNOL, V16, P554, DOI 10.1038/ni.3157; Bagriacik EU, 1996, GLYCOBIOLOGY, V6, P413, DOI 10.1093/glycob/6.4.413; Barber LD, 1996, J IMMUNOL, V156, P3275; BARBOSA JA, 1987, J EXP MED, V166, P1329, DOI 10.1084/jem.166.5.1329; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Bieberich Erhard, 2014, Adv Neurobiol, V9, P47, DOI 10.1007/978-1-4939-1154-7_3; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Campbell KS, 2013, J ALLERGY CLIN IMMUN, V132, P536, DOI 10.1016/j.jaci.2013.07.006; Cella M, 2000, METH MOL B, V121, P1; Chung AW, 2014, AIDS, V28, P2523, DOI 10.1097/QAD.0000000000000444; Esko JD, 2009, CHEM TOOLS INHIBITIN; Fadda L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002805; Fadda L, 2011, J VIROL, V85, P5970, DOI 10.1128/JVI.00412-11; GLASSY MC, 1981, AM J PATHOL, V103, P1; GOLDSTEIN SAN, 1985, J EXP MED, V162, P1381, DOI 10.1084/jem.162.4.1381; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HART GW, 1982, J BIOL CHEM, V257, P151; Kamya P, 2011, J VIROL, V85, P5949, DOI 10.1128/JVI.02652-10; Korner C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00326; Lanteri M, 2003, GLYCOBIOLOGY, V13, P909, DOI 10.1093/glycob/cwg110; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; MIYAZAKI J, 1986, J EXP MED, V163, P856, DOI 10.1084/jem.163.4.856; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nagae M, 2012, INT J MOL SCI, V13, P8398, DOI 10.3390/ijms13078398; Orange JS, 2006, CURR OPIN ALLERGY CL, V6, P399, DOI 10.1097/ACI.0b013e3280106b65; PAABO S, 1986, P NATL ACAD SCI USA, V83, P9665, DOI 10.1073/pnas.83.24.9665; PARHAM P, 1977, J BIOL CHEM, V252, P7555; PLOEGH HL, 1981, J IMMUNOL, V126, P270; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; STORKUS WJ, 1989, J IMMUNOL, V143, P3853; Tardif KD, 2003, J VIROL, V77, P11644, DOI 10.1128/JVI.77.21.11644-11650.2003; van Teijlingen NH, 2014, AIDS, V28, P1399, DOI 10.1097/QAD.0000000000000284; VANKEMENADE FJ, 1994, J LEUKOCYTE BIOL, V56, P159, DOI 10.1002/jlb.56.2.159; Vestrheim AC, 2014, IMMUN INFLAMM DIS, V2, P76, DOI 10.1002/iid3.22; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Wu J, 2003, ADV CANCER RES, V90, P127, DOI 10.1016/S0065-230X(03)90004-2	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145324	10.1371/journal.pone.0145324	http://dx.doi.org/10.1371/journal.pone.0145324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680341	gold, Green Published, Green Submitted			2022-12-27	WOS:000366723400071
J	Tehrani, F; Reiner, L; Bavarian, B				Tehrani, Farshad; Reiner, Lisa; Bavarian, Behzad			Rapid Prototyping of a High Sensitivity Graphene Based Glucose Sensor Strip	PLOS ONE			English	Article							COPPER; NANOWIRES; HYBRID; NANOPARTICLES; NANOCUBES; SHEETS	A rapid prototyping of an inexpensive, disposable graphene and copper nanocomposite sensor strip using polymeric flexible substrate for highly sensitive and selective nonenzymatic glucose detection has been developed and tested for direct oxidization of glucose. The CuNPs were electrochemically deposited on to the graphene sheets to improve electron transfer rates and to enhance electrocatalytic activity toward glucose. The graphene based electrode with CuNPs demonstrated a high degree of sensitivity (1101.3 +/- 56 mu A/mM. cm(2)), excellent selectivity (without an interference with Ascorbic Acid, Uric Acid, Dopamine, and Acetaminophen), good stability with a linear response to glucose ranging from 0.1 mM to 0.6 mM concentration, and detection limits of 0.025 mM to 0.9 mM. Characterization of the electrodes was performed by scanning electron microscopy (FESEM and SEM). The electrochemical properties of the modified graphene electrodes were inspected by cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), and amperometry.	[Tehrani, Farshad; Reiner, Lisa; Bavarian, Behzad] Calif State Univ Northridge, Mfg Syst Engn & Management, Kecks Adv Mat Lab, Northridge, CA 91330 USA; [Tehrani, Farshad; Reiner, Lisa; Bavarian, Behzad] Calif State Univ Northridge, Mfg Syst Engn & Management, Corros Res Lab, Northridge, CA 91330 USA	California State University System; California State University Northridge; California State University System; California State University Northridge	Tehrani, F (corresponding author), Calif State Univ Northridge, Mfg Syst Engn & Management, Kecks Adv Mat Lab, Northridge, CA 91330 USA.	farshad.tehrani.703@my.csun.edu						Claussen JC, 2012, ADV FUNCT MATER, V22, P3399, DOI 10.1002/adfm.201200551; Fan ZJ, 2013, ELECTROCHIM ACTA, V109, P602, DOI 10.1016/j.electacta.2013.07.153; Gan T, 2011, MICROCHIM ACTA, V175, P1, DOI 10.1007/s00604-011-0639-7; Gao HC, 2011, ACS APPL MATER INTER, V3, P3049, DOI 10.1021/am200563f; Grujicic D, 2002, ELECTROCHIM ACTA, V47, P2901, DOI 10.1016/S0013-4686(02)00161-5; He P, 2012, ANAL CHIM ACTA, V739, P25, DOI 10.1016/j.aca.2012.06.004; Hecht DS, 2011, ADV MATER, V23, P1482, DOI 10.1002/adma.201003188; Huang JW, 2013, SENSOR ACTUAT B-CHEM, V182, P618, DOI 10.1016/j.snb.2013.03.065; Kang XH, 2007, ANAL BIOCHEM, V363, P143, DOI 10.1016/j.ab.2007.01.003; Kang XH, 2009, BIOSENS BIOELECTRON, V25, P901, DOI 10.1016/j.bios.2009.09.004; Luo J, 2012, ANAL CHIM ACTA, V709, P47, DOI 10.1016/j.aca.2011.10.025; Luo LQ, 2012, BIOELECTROCHEMISTRY, V88, P156, DOI 10.1016/j.bioelechem.2012.03.006; Mallesha M, 2012, J SOLID STATE ELECTR, V16, P2675, DOI 10.1007/s10008-012-1674-y; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Pumera M., 2010, TRENDS ANAL CHEM, V29; Shao YY, 2010, ELECTROANAL, V22, P1027, DOI 10.1002/elan.200900571; Song HY, 2013, ANAL CHIM ACTA, V788, P24, DOI 10.1016/j.aca.2013.06.016; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Wang J, 2011, ELECTROCHIM ACTA, V56, P7510, DOI 10.1016/j.electacta.2011.06.102; Wang LS, 2013, SENSOR ACTUAT B-CHEM, V176, P9, DOI 10.1016/j.snb.2012.08.077; Wu HX, 2010, ELECTROCHIM ACTA, V55, P3734, DOI 10.1016/j.electacta.2010.02.017; Yang JA, 2010, BIOSENS BIOELECTRON, V26, P279, DOI 10.1016/j.bios.2010.06.014; Zhang S, 2011, CHEM MATER, V23, P1079, DOI 10.1021/cm101568z; Zhang YC, 2012, BIOSENS BIOELECTRON, V31, P426, DOI 10.1016/j.bios.2011.11.006; Zhao Y, 2012, COLLOID SURFACE A, V409, P105, DOI 10.1016/j.colsurfa.2012.05.045; Zhu Z, 2012, SENSORS, P12	26	18	18	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145036	10.1371/journal.pone.0145036	http://dx.doi.org/10.1371/journal.pone.0145036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678700	Green Submitted, Green Published, gold			2022-12-27	WOS:000366723400043
J	Zhang, XY; Zhao, L; Cui, Z; Wang, YG				Zhang, Xinyu; Zhao, Lin; Cui, Zhuang; Wang, Yaogang			Study on Equity and Efficiency of Health Resources and Services Based on Key Indicators in China	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; DECISION-MAKING; ALLOCATION; CARE; INEQUITY; QUALITY	Background This study aims to evaluate the dialectical relationship between equity and efficiency of health resource allocation and health service utilization in China. Methods We analyzed the inequity of health resource allocation and health service utilization based on concentration index (CI) and Gini coefficient. Data envelopment analysis (DEA) was used to evaluate the inefficiency of resource allocation and service utilization. Factor Analysis (FA) was used to determine input/output indicators. Results The CI of Health Institutions, Beds in Health Institutions, Health Professionals and Outpatient Visits were -0.116, -0.012, 0.038, and 0.111, respectively. Gini coefficient for the 31 provinces varied between 0.05 and 0.43; out of these 23 (742%) were observed to be technically efficient constituting the "best practice frontier". The other 8 (25.8%) provinces were technically inefficient. Conclusions Health professionals and outpatient services are focused on higher income levels, while the Health Institutions and Beds in Health Institutions were concentrated on lower income levels. In China, a few provinces attained a basic balance in both equity and efficiency in terms of current health resource and service utilization, thus serving as a reference standard for other provinces.	[Zhang, Xinyu; Zhao, Lin; Wang, Yaogang] Tianjin Med Univ, Sch Publ Hlth, Dept Hlth Serv Management, Tianjin, Peoples R China; [Cui, Zhuang] Tianjin Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Wang, YG (corresponding author), Tianjin Med Univ, Sch Publ Hlth, Dept Hlth Serv Management, Tianjin, Peoples R China.	wangyg@tmu.edu.cn			National Natural Science Foundation of China [71273187, 71473175]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China [no. 71273187] and National Natural Science Foundation of China [no. 71473175]	[Anonymous], 2000, WHO LAB MAN EX HUM S, P4; BANKER RD, 1984, MANAGE SCI, V30, P1078, DOI 10.1287/mnsc.30.9.1078; Caballer-Tarazona M, 2010, MATH COMPUT MODEL, V52, P1095, DOI 10.1016/j.mcm.2010.03.006; Cao H, 2012, MED DECIS MAKING, V32, P470, DOI 10.1177/0272989X12437247; Cattell R.B, 1988, HDB MULTIVARIATE EXP; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Chen MS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-466; Chu JH, 2010, CHINESE HLTH EC, V6, P15; Cooper WW., 2007, DATA ENVELOPMENT ANA, V2nd; Elwell-Sutton TM, 2013, HEALTH POLICY PLANN, V28, P467, DOI 10.1093/heapol/czs077; FORD JK, 1986, PERS PSYCHOL, V39, P291, DOI 10.1111/j.1744-6570.1986.tb00583.x; Gai RY, 2010, BIOSCI TRENDS, V4, P218; Jat TR, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21742; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Kreng V, 2013, CHINESE MED J-PEKING, V126, P2900, DOI 10.3760/cma.j.issn.0366-6999.20123455; Liu S, 2011, PUBLIC HEALTH, V125, P669, DOI 10.1016/j.puhe.2011.08.004; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Nuti S, 2011, INT J QUAL HEALTH C, V23, P324, DOI 10.1093/intqhc/mzr005; Opuni M, 2011, HEALTH ECON, V20, P1298, DOI 10.1002/hec.1671; Poveda AC, 2012, SOC INDIC RES, V105, P343, DOI 10.1007/s11205-010-9772-7; Saronga HP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-96; Shrestha S, 2007, ENVIRON MODELL SOFTW, V22, P464, DOI 10.1016/j.envsoft.2006.02.001; Tao Y, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0010-x; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; WAGSTAFF A, 1991, J HEALTH ECON, V10, P169, DOI 10.1016/0167-6296(91)90003-6; Walsh B, 2012, HEALTH ECON, V21, P1250, DOI 10.1002/hec.1784; Wang Yande, 2010, J HENAN U TECHNOLOGY, P36; WHO, 2014, LIF EXP LIF EXP DAT; Zere E, 2007, INT J EQUITY HEALTH, V6, P1; Zhang YH, 2011, MED DECIS MAKING, V31, P245, DOI 10.1177/0272989X10375990; Zhou Z, 2011, BMC HEALTH SERV RES, V11, P697	31	42	44	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144809	10.1371/journal.pone.0144809	http://dx.doi.org/10.1371/journal.pone.0144809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JO	26679187	gold, Green Published, Green Submitted			2022-12-27	WOS:000366723400026
J	Brahma, B; Patra, MC; Karri, S; Chopra, M; Mishra, P; De, BC; Kumar, S; Mahanty, S; Thakur, K; Poluri, KM; Datta, TK; De, S				Brahma, Biswajit; Patra, Mahesh Chandra; Karri, Satyanagalakshmi; Chopra, Meenu; Mishra, Purusottam; De, Bidhan Chandra; Kumar, Sushil; Mahanty, Sourav; Thakur, Kiran; Poluri, Krishna Mohan; Datta, Tirtha Kumar; De, Sachinandan			Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins	PLOS ONE			English	Article							BUBALUS-BUBALIS; MEMBRANE CURVATURE; OUTER-MEMBRANE; PEPTIDES; RESISTANCE; PROTEINS; CELLS; INDOLICIDIN; DEFENSINS; GEOMETRY	Cathelicidins are an ancient class of antimicrobial peptides (AMPs) with broad spectrum bactericidal activities. In this study, we investigated the diversity and biological activity of cathelicidins of buffalo, a species known for its disease resistance. A series of new homologs of cathelicidin4 (CATHL4), which were structurally diverse in their antimicrobial domain, was identified in buffalo. AMPs of newly identified buffalo CATHL4s (buCATHL4s) displayed potent antimicrobial activity against selected Gram positive (G+) and Gram negative (G-) bacteria. These peptides were prompt to disrupt the membrane integrity of bacteria and induced specific changes such as blebing, budding, and pore like structure formation on bacterial membrane. The peptides assumed different secondary structure conformations in aqueous and membrane-mimicking environments. Simulation studies suggested that the amphipathic design of buCATHL4 was crucial for water permeation following membrane disruption. A great diversity, broad-spectrum antimicrobial action, and ability to induce an inflammatory response indicated the pleiotropic role of cathelicidins in innate immunity of buffalo. This study suggests short buffalo cathelicidin peptides with potent bactericidal properties and low cytotoxicity have potential translational applications for the development of novel antibiotics and antimicrobial peptidomimetics.	[Brahma, Biswajit; Patra, Mahesh Chandra; Karri, Satyanagalakshmi; Chopra, Meenu; Mishra, Purusottam; De, Bidhan Chandra; Kumar, Sushil; Mahanty, Sourav; Thakur, Kiran; Datta, Tirtha Kumar; De, Sachinandan] Natl Dairy Res Inst, Anim Biotechnol Ctr, Anim Genom Lab, Karnal 132001, Haryana, India; [Poluri, Krishna Mohan] Indian Inst Technol, Dept Biotechnol, Roorkee, Uttarakhand, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee	De, S (corresponding author), Natl Dairy Res Inst, Anim Biotechnol Ctr, Anim Genom Lab, Karnal 132001, Haryana, India.	sachinandan@ndri.res.in	Poluri, Krishna Mohan/H-6083-2013; Patra, Mahesh/I-9746-2014	Poluri, Krishna Mohan/0000-0003-3801-7134; De, Sachinandan/0000-0002-3182-0904; Brahma, Biswajit/0000-0003-0052-5029; Patra, Mahesh/0000-0003-0471-6236; De, Bidhan Chandra/0000-0002-9379-8909	Department of Biotechnology, Govt. of India [BT/PR3111/AAQ/1/474/2011]; IYBA fellowship from DBT, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); IYBA fellowship from DBT, Govt. of India	The study was supported by funding from Department of Biotechnology, Govt. of India (Grant No.: BT/PR3111/AAQ/1/474/2011). KMP acknowledge the support of IYBA fellowship from DBT, Govt. of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express our sincere thanks to Dr Jasvir Singh (IARI, New Delhi) for taking TEM images. We thank Dr SK Tomar, and Mr. Babbar (NDRI, India) for their help in SEM analysis. We are thankful to Dr AK Srivastava (Director, NDRI) for providing research facilities and his valuable comments on this study. The study was supported by funding from Department of Biotechnology (DBT), Govt. of India (Grant No.: BT/PR3111/AAQ/1/474/2011). KMP acknowledges the support of IYBA fellowship from DBT, Govt. of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; BARBER J, 1989, NATURE, V340, P601, DOI 10.1038/340601a0; BASSAM BJ, 1993, APPL BIOCHEM BIOTECH, V42, P181, DOI 10.1007/BF02788051; Berney M, 2007, APPL ENVIRON MICROB, V73, P3283, DOI 10.1128/AEM.02750-06; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000; Borriello G, 2006, INFECT IMMUN, V74, P2115, DOI 10.1128/IAI.74.4.2115-2120.2006; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Das H, 2008, DNA SEQUENCE, V19, P347, DOI 10.1080/10425170701606219; Das H, 2006, DNA SEQUENCE, V17, P407, DOI 10.1080/10425170600760125; FAO, 2000, WAT BUFF ASS UND, P1; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Hancock REW, 1997, TRENDS MICROBIOL, V5, P37, DOI 10.1016/S0966-842X(97)81773-8; HEIN WR, 1991, IMMUNOL TODAY, V12, P30, DOI 10.1016/0167-5699(91)90109-7; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Hsu CH, 2005, NUCLEIC ACIDS RES, V33, P4053, DOI 10.1093/nar/gki725; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Limia A, 2001, FEMS MICROBIOL LETT, V197, P151, DOI 10.1111/j.1574-6968.2001.tb10597.x; Liu GY, 2009, PEDIATR RES, V65, p71R, DOI 10.1203/PDR.0b013e31819dc44d; Moser B, 2011, CELL MOL LIFE SCI, V68, P2443, DOI 10.1007/s00018-011-0706-6; Mukherjee A, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-15; Nagpal S, 1999, J BIOL CHEM, V274, P23296, DOI 10.1074/jbc.274.33.23296; NRC, 1981, WAT BUFF NEW PROSP U; Panicker VP, 2013, INDIAN J BIOCHEM BIO, V50, P273; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Pulido D, 2012, ANTIMICROB AGENTS CH, V56, P2378, DOI 10.1128/AAC.06107-11; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Schmidt NW, 2013, CURR OPIN SOLID ST M, V17, P151, DOI 10.1016/j.cossms.2013.09.004; Schmidt NW, 2013, J AM CHEM SOC, V135, P13710, DOI 10.1021/ja400146z; Schmidt NW, 2012, J BIOL CHEM, V287, P21866, DOI 10.1074/jbc.M112.358721; Schmidt NW, 2011, J AM CHEM SOC, V133, P6720, DOI 10.1021/ja200079a; Siegel DP, 2004, BIOPHYS J, V87, P366, DOI 10.1529/biophysj.104.040782; Singh MK., 2013, J TEXT, V2013, P1, DOI [10.1155/2013/579129, DOI 10.1155/2013/579129]; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Subbalakshmi C, 1998, FEMS MICROBIOL LETT, V160, P91, DOI 10.1016/S0378-1097(98)00008-1; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Torrent M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003005; Walsh AG, 2000, MOL MICROBIOL, V35, P718, DOI 10.1046/j.1365-2958.2000.01741.x; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024030; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhu SY, 2012, P NATL ACAD SCI USA, V109, P8495, DOI 10.1073/pnas.1201263109; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	51	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144741	10.1371/journal.pone.0144741	http://dx.doi.org/10.1371/journal.pone.0144741			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675301	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700059
J	Hopkinson, RJ; Leung, IKH; Smart, TJ; Rose, NR; Henry, L; Claridge, TDW; Schofield, CJ				Hopkinson, Richard J.; Leung, Ivanhoe K. H.; Smart, Tristan J.; Rose, Nathan R.; Henry, Luc; Claridge, Timothy D. W.; Schofield, Christopher J.			Studies on the Glutathione-Dependent Formaldehyde-Activating Enzyme from Paracoccus denitrificans	PLOS ONE			English	Article							NMR-SPECTROSCOPY; ESCHERICHIA-COLI; HISTONE DEMETHYLASES; 2-DIMENSIONAL NMR; EXCHANGE; REPAIR; DNA; METABOLISM; PATHWAY; BINDING	Formaldehyde is a toxin and carcinogen that is both an environmental pollutant and an endogenous metabolite. Formaldehyde metabolism, which is probably essential for all aerobic cells, likely proceeds via multiple mechanisms, including via a glutathione-dependent pathway that is widely conserved in bacteria, plants and animals. However, it is unclear whether the first step in the glutathione-dependent pathway (i.e. formation of S-hydroxymethylglutathione (HMG)) is enzyme-catalysed. We report studies on glutathione-dependent formaldehyde-activating enzyme (GFA) from Paracoccus denitrificans, which has been proposed to catalyse HMG formation from glutathione and formaldehyde on the basis of studies using NMR exchange spectroscopy (EXSY). Although we were able to replicate the EXSY results, time course experiments unexpectedly imply that GFA does not catalyse HMG formation under standard conditions. However, GFA was observed to bind glutathione using NMR and mass spectrometry. Overall, the results reveal that GFA binds glutathione but does not directly catalyse HMG formation under standard conditions. Thus, it is possible that GFA acts as a glutathione carrier that acts to co-localise glutathione and formaldehyde in a cellular context.	[Hopkinson, Richard J.; Leung, Ivanhoe K. H.; Smart, Tristan J.; Rose, Nathan R.; Henry, Luc; Claridge, Timothy D. W.; Schofield, Christopher J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Leung, Ivanhoe K. H.] Univ Auckland, Sch Chem Sci, Auckland, New Zealand	University of Oxford; University of Auckland	Hopkinson, RJ (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England.	richard.hopkinson@chem.ox.ac.uk; christopher.schofield@chem.ox.ac.uk	Hopkinson, Richard J/K-8372-2013; Leung, Ivanhoe/G-6168-2010; Claridge, Tim/A-8324-2018	Hopkinson, Richard J/0000-0001-7610-8163; Leung, Ivanhoe/0000-0003-0633-6771; Claridge, Tim/0000-0001-5583-6460; Schofield, Christopher/0000-0002-0290-6565; Henry, Luc/0000-0001-9653-7299	Wellcome Trust [086482/Z/08/Z]; British Heart Foundation [PG/12/33/29546]; University of Auckland [FRDF/3708277]; Biotechnology and Biological Sciences Research Council [BB/E527620/1]; St. Edmund Hall, University of Oxford; St. John's College, University of Oxford	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); University of Auckland; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); St. Edmund Hall, University of Oxford; St. John's College, University of Oxford	The authors thank the Wellcome Trust (086482/Z/08/Z, www.wellcome.ac.uk), the British Heart Foundation (PG/12/33/29546, www.bhf.org.uk), the University of Auckland (IKHL, FRDF/3708277, www.auckland.ac.nz) and the Biotechnology and Biological Sciences Research Council (studentship to RJH, BB/E527620/1, www.bbsrc.ac.uk) for funding the work. RJH acknowledges a William R. Miller Junior Research Fellowship from St. Edmund Hall, University of Oxford. LH acknowledges a Berrow Foundation Scholarship, Lincoln College, University of Oxford. NRR acknowledges a Commonwealth Scholarship and a Junior Research Fellowship from St. John's College, University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or publication of the manuscript.	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; Bachand AM, 2010, CRIT REV TOXICOL, V40, P85, DOI 10.3109/10408440903341696; Bateman R, 2007, ORG BIOMOL CHEM, V5, P3363, DOI 10.1039/b707602a; Bosetti C, 2008, ANN ONCOL, V19, P29, DOI 10.1093/annonc/mdm202; Dalvit C, 2000, J BIOMOL NMR, V18, P65, DOI 10.1023/A:1008354229396; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; ELBING K, 2001, CURRENT PROTOCOLS MO; Goenrich M, 2002, J BIOL CHEM, V277, P3069, DOI 10.1074/jbc.C100579200; Gutheil WG, 1997, BIOCHEM BIOPH RES CO, V238, P693, DOI 10.1016/S0006-291X(00)90000-7; Harms N, 1996, J BACTERIOL, V178, P6296, DOI 10.1128/jb.178.21.6296-6299.1996; Hopkinson RJ, 2010, ORG BIOMOL CHEM, V8, P4915, DOI 10.1039/c0ob00208a; Hopkinson RJ, 2010, CHEMBIOCHEM, V11, P506, DOI 10.1002/cbic.200900713; HUNTER BK, 1984, BIOCHEMISTRY-US, V23, P508, DOI 10.1021/bi00298a017; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Kong XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025444; Leung IKH, 2010, CHEM BIOL, V17, P1316, DOI 10.1016/j.chembiol.2010.09.016; MASON RP, 1986, BIOCHEMISTRY-US, V25, P4504, DOI 10.1021/bi00364a008; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; NAYLOR S, 1988, BIOCHEM J, V249, P573, DOI 10.1042/bj2490573; Neculai AM, 2005, J BIOL CHEM, V280, P2826, DOI 10.1074/jbc.C400517200; PAIK WK, 1973, BIOCHEM BIOPH RES CO, V51, P781, DOI 10.1016/0006-291X(73)91383-1; PERRIN CL, 1990, CHEM REV, V90, P935, DOI 10.1021/cr00104a002; Pontel Lucas B, 2015, MOL CELL, V60, P177, DOI [10.1016/j.molcel.2015.08.020, DOI 10.1016/J.MOLCEL.2015.08.020]; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Sanchez-Pedregal VM, 2005, ANGEW CHEM INT EDIT, V44, P4172, DOI 10.1002/anie.200500503; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Seidman CE, 2001, CURRENT PROTOCOLS MO; Tabor S., 2001, CURRENT PROTOCOLS MO; Tadeu AMB, 2008, EMBO J, V27, P2510, DOI 10.1038/emboj.2008.175; Walport LJ, 2014, J BIOL CHEM, V289, P18302, DOI 10.1074/jbc.M114.555052; Walport LJ, 2012, CURR OPIN CHEM BIOL, V16, P525, DOI 10.1016/j.cbpa.2012.09.015; Yi CQ, 2010, NATURE, V468, P330, DOI 10.1038/nature09497	33	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145085	10.1371/journal.pone.0145085	http://dx.doi.org/10.1371/journal.pone.0145085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675168	Green Published, gold			2022-12-27	WOS:000366722700097
J	Sato, T				Sato, Tatsuhiko			Analytical Model for Estimating Terrestrial Cosmic Ray Fluxes Nearly Anytime and Anywhere in the World: Extension of PARMA/EXPACS	PLOS ONE			English	Article							MOUNTAIN ALTITUDE; FLIGHT ALTITUDES; RADIATION-EXPOSURE; NEUTRON-SPECTRA; GROUND-LEVEL; SEA-LEVEL; ATMOSPHERE; JAPAN; PARTICLES; FIELD	By extending our previously established model, here we present a new model called "PHITS-based Analytical Radiation Model in the Atmosphere (PARMA) version 3.0," which can instantaneously estimate terrestrial cosmic ray fluxes of neutrons, protons, ions with charge up to 28 (Ni), muons, electrons, positrons, and photons nearly anytime and anywhere in the Earth's atmosphere. The model comprises numerous analytical functions with parameters whose numerical values were fitted to reproduce the results of the extensive air shower (EAS) simulation performed by Particle and Heavy Ion Transport code System (PHITS). The accuracy of the EAS simulation was well verified using various experimental data, while that of PARMA3.0 was confirmed by the high R-2 values of the fit. The models to be used for estimating radiation doses due to cosmic ray exposure, cosmic ray induced ionization rates, and count rates of neutron monitors were validated by investigating their capability to reproduce those quantities measured under various conditions. PARMA3.0 is available freely and is easy to use, as implemented in an open-access software program EXcel-based Program for Calculating Atmospheric Cosmic ray Spectrum (EXPACS). Because of these features, the new version of PARMA/EXPACS can be an important tool in various research fields such as geosciences, cosmic ray physics, and radiation research.	[Sato, Tatsuhiko] Japan Atom Energy Agcy JAEA, Res Grp Radiat Transport Anal, Tokai, Ibaraki 3191195, Japan	Japan Atomic Energy Agency	Sato, T (corresponding author), Japan Atom Energy Agcy JAEA, Res Grp Radiat Transport Anal, Shirakata 2-4, Tokai, Ibaraki 3191195, Japan.	sato.tatsuhiko@jaea.go.jp	Sato, Tatsuhiko/G-5964-2012	Sato, Tatsuhiko/0000-0001-9902-7083				Abe S, 2011, J PHYS CONF SER, V312, DOI 10.1088/1742-6596/312/6/062004; [Anonymous], 2015, SPAC PHYS DAT SYST; Argento DC, 2013, NUCL INSTRUM METH B, V294, P464, DOI 10.1016/j.nimb.2012.05.022; BARBER HB, 1980, PHYS REV D, V22, P2667, DOI 10.1103/PhysRevD.22.2667; Boudard A, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.014606; Burda O, 2013, J RADIOL PROT, V33, P339, DOI 10.1088/0952-4746/33/2/339; Caballero-Lopez RA, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010098; Cecchini S, 2005, ALTITUDE DEPENDENCE, V2, P349; Cheminet A, 2013, J GEOPHYS RES-SPACE, V118, P7488, DOI 10.1002/2013JA019166; Chen J, 2009, RADIAT ENVIRON BIOPH, V48, P317, DOI 10.1007/s00411-009-0226-z; Clem JM, 2004, RADIAT PROT DOSIM, V110, P423, DOI 10.1093/rpd/nch175; DIGGORY IS, 1974, J PHYS A-MATH GEN, V7, P741, DOI 10.1088/0305-4470/7/6/010; Ebisuzaki T, 2011, GONDWANA RES, V19, P1054, DOI 10.1016/j.gr.2010.11.004; Forschungszentrum Karlsruhe Heck D, 1998, FZKA6097; GOLDEN RL, 1995, J GEOPHYS RES-SPACE, V100, P23515, DOI 10.1029/95JA02449; Goldhagen P, 2004, RADIAT PROT DOSIM, V110, P387, DOI 10.1093/rpd/nch216; Haino S, 2004, PHYS LETT B, V594, P35, DOI 10.1016/j.physletb.2004.05.019; International Commission on Radiological Protection, 2013, ICRP PUBL, V123; International Commission on Radiological Protection, 2010, ICRP PUBL, V116; International Commission on Radiological Protection, 2007, ICRP PUBL; Karapetyan GG, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.093005; Kataoka R, 2014, GONDWANA RES, V25, P1153, DOI 10.1016/j.gr.2013.05.003; Kikuchi S, 2009, J ENVIRON RADIOACTIV, V100, P515, DOI 10.1016/j.jenvrad.2009.03.017; Kirkby J, 2011, NATURE, V476, P429, DOI 10.1038/nature10343; Kocharian NM, 1959, SOV PHYS JETP, V35, P933; Kowatari M, 2007, J NUCL SCI TECHNOL, V44, P114, DOI 10.3327/jnst.44.114; Kremer J, 1999, PHYS REV LETT, V83, P4241, DOI 10.1103/PhysRevLett.83.4241; Latocha M, 2007, RADIAT PROT DOSIM, V125, P412, DOI 10.1093/rpd/ncl123; Lifton N, 2014, EARTH PLANET SC LETT, V386, P149, DOI 10.1016/j.epsl.2013.10.052; LIPARI P, 1991, PHYS REV D, V44, P3543, DOI 10.1103/PhysRevD.44.3543; Mares V, 2010, RADIAT MEAS, V45, P1553, DOI 10.1016/j.radmeas.2010.06.015; Masarik J, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010557; Matthia D, 2014, SPACE WEATHER, V12, P161, DOI 10.1002/2013SW001022; Matthia D, 2013, ADV SPACE RES, V51, P329, DOI 10.1016/j.asr.2012.09.022; Mertens CJ, 2010, SPACE WEATHER, V8, DOI 10.1029/2009SW000487; Mishev A, 2015, J SPACE WEATHER SPAC, V5, DOI 10.1051/swsc/2015011; Mochiutti E., 2003, THESIS; Nakamura T, 2005, J NUCL SCI TECHNOL, V42, P843, DOI 10.3327/jnst.42.843; NEHER HV, 1967, J GEOPHYS RES, V72, P1527, DOI 10.1029/JZ072i005p01527; NEHER HV, 1971, J GEOPHYS RES, V76, P1637, DOI 10.1029/JA076i007p01637; Nesterenok A, 2013, NUCL INSTRUM METH B, V295, P99, DOI 10.1016/j.nimb.2012.11.005; O'Brien K, 2003, ADV SPACE RES, V31, P835, DOI 10.1016/S0273-1177(02)00882-7; O'Brien K, 1998, ADV SPACE RES, V21, P1739, DOI 10.1016/S0273-1177(98)00060-X; Ogawa T, 2014, NUCL INSTRUM METH A, V763, P575, DOI 10.1016/j.nima.2014.06.088; Pierce JR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037946; Roesler S, 1998, RADIAT RES, V149, P87, DOI 10.2307/3579685; Ruhm W, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017524; Sanuki T, 2003, PHYS LETT B, V577, P10, DOI 10.1016/j.physletb.2003.10.021; Sanuki T, 2002, PHYS LETT B, V541, P234, DOI 10.1016/S0370-2693(02)02265-7; Sato T, 2014, RADIAT PROT DOSIM, V161, P274, DOI 10.1093/rpd/nct332; Sato T, 2008, RADIAT RES, V170, P244, DOI 10.1667/RR1094.1; Sato T, 2006, RADIAT RES, V166, P544, DOI 10.1667/RR0610.1; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; Sierawski BD, 2010, IEEE T NUCL SCI, V57, P3273, DOI 10.1109/TNS.2010.2080689; Sloan T, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/2/024001; Stone EC, 1998, SPACE SCI REV, V86, P1, DOI 10.1023/A:1005082526237; Svensmark H, 2007, ASTRON GEOPHYS, V48, P18; University of Delaware Bartol Research Institute Neutron Monitor Program, 2015, NEUTR MON PROGR; Usoskin IG, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2002JA009343; Usoskin IG, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007150; Wissmann F, 2010, RADIAT PROT DOSIM, V140, P319, DOI 10.1093/rpd/ncq128; Yasuda H, 2011, RADIAT PROT DOSIM, V146, P123, DOI [10.1093/rpd/ncr133, 10.1093/rpd/ncr.133]; Ziegler JF, 1998, IBM J RES DEV, V42, P117, DOI 10.1147/rd.421.0117	64	77	78	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144679	10.1371/journal.pone.0144679	http://dx.doi.org/10.1371/journal.pone.0144679			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674183	Green Submitted, gold, Green Published			2022-12-27	WOS:000366722700052
J	Vasiliadis, HS; Nikolakopoulou, A; Shrier, I; Lunn, MP; Brassington, R; Scholten, RJP; Salanti, G				Vasiliadis, Haris S.; Nikolakopoulou, Adriani; Shrier, Ian; Lunn, Michael P.; Brassington, Ruth; Scholten, Rob J. P.; Salanti, Georgia			Endoscopic and Open Release Similarly Safe for the Treatment of Carpal Tunnel Syndrome. A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COMPLICATIONS; RISK	Background The Endoscopic Release of Carpal Tunnel Syndrome (ECTR) is a minimal invasive approach for the treatment of Carpal Tunnel Syndrome. There is scepticism regarding the safety of this technique, based on the assumption that this is a rather "blind" procedure and on the high number of severe complications that have been reported in the literature. Purpose To evaluate whether there is evidence supporting a higher risk after ECTR in comparison to the conventional open release. Methods We searched MEDLINE (January 1966 to November 2013), EMBASE (January 1980 to November 2013), the Cochrane Neuromuscular Disease Group Specialized Register ( November 2013) and CENTRAL (2013, issue 11 in The Cochrane Library). We hand-searched reference lists of included studies. We included all randomized or quasi-randomized controlled trials (e.g. study using alternation, date of birth, or case record number) that compare any ECTR with any OCTR technique. Safety was assessed by the incidence of major, minor and total number of complications, recurrences, and re-operations. The total time needed before return to work or to return to daily activities was also assessed. We synthesized data using a random- effects meta-analysis in STATA. We conducted a sensitivity analysis for rare events using binomial likelihood. We judged the conclusiveness of meta-analysis calculating the conditional power of meta-analysis. Conclusions ECTR is associated with less time off work or with daily activities. The assessment of major complications, reoperations and recurrence of symptoms does not favor either of the interventions. There is an uncertain advantage of ECTR with respect to total minor complications (more transient paresthesia but fewer skin-related complications). Future studies are unlikely to alter these findings because of the rarity of the outcome. The effect of a learning curve might be responsible for reduced recurrences and reoperations with ECTR in studies that are more recent, although formal statistical analysis failed to provide evidence for such an association. Level of evidence: I.	[Vasiliadis, Haris S.] Orthopaedie Sonnenhof, Bern, Switzerland; [Nikolakopoulou, Adriani] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Shrier, Ian] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Lunn, Michael P.; Brassington, Ruth] Natl Hosp Neurol & Neurosurg, Ctr Neuromuscular Dis, London WC1N 3BG, England; [Scholten, Rob J. P.] Univ Med Ctr Utrecht, Dutch Cochrane Ctr, Utrecht, Netherlands; [Scholten, Rob J. P.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Salanti, Georgia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Salanti, Georgia] Univ Bern, Berner Inst Hausarztmed BIHAM, Bern, Switzerland	University of Ioannina; Lady Davis Institute; McGill University; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Bern; University of Bern	Vasiliadis, HS (corresponding author), Orthopaedie Sonnenhof, Bern, Switzerland.	charilaosvasileiadis@sonnenhof.ch	Shrier, Ian/AAI-6502-2020	Shrier, Ian/0000-0001-9914-3498; Salanti, Georgia/0000-0002-3830-8508; Lunn, Michael/0000-0003-3174-6027	European Research Council (IMMA) [260559]	European Research Council (IMMA)(European Research Council (ERC))	GS, AC and HV received funding from the European Research Council (IMMA, grant no. 260559). HV received travel support from the manufacturer of instrumentation (Stryker) for miniopen and endoscopic release to attend an orthopedic conference. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGEE JM, 1992, J HAND SURG-AM, V17A, P987, DOI 10.1016/S0363-5023(09)91044-9; Aslani HR, 2012, CLIN NEUROL NEUROSUR, V114, P965, DOI 10.1016/j.clineuro.2012.02.017; Atroshi I, 2006, BRIT MED J, V332, P1473, DOI 10.1136/bmj.38863.632789.1F; Atroshi I, 2009, J HAND SURG-AM, V34A, P266, DOI 10.1016/j.jhsa.2008.10.026; Beck JD, 2011, J HAND SURG-AM, V36A, P61, DOI 10.1016/j.jhsa.2010.10.017; Benedetti V R, 1996, Handchir Mikrochir Plast Chir, V28, P151; Benson LS, 2006, ARTHROSCOPY, V22, P919, DOI 10.1016/j.arthro.2006.05.008; Boeckstyns MEH, 1999, J HAND SURG-BRIT EUR, V24B, P9, DOI 10.1016/S0266-7681(99)90009-8; Borenstein M., 2011, INTRO META ANAL, V17, P58; BOZENTKA DJ, 1995, HAND CLIN, V11, P91; Braga S J, 1996, REV BRAS ORTOP, V31, P355; BROWN RA, 1993, J BONE JOINT SURG AM, V75A, P1265, DOI 10.2106/00004623-199309000-00002; Chen L, 2014, ARCH ORTHOP TRAUM SU, V134, P585, DOI 10.1007/s00402-013-1898-z; CHOW J C Y, 1989, Arthroscopy, V5, P19, DOI 10.1016/0749-8063(89)90085-6; COBB TK, 1994, J HAND SURG-BRIT EUR, V19B, P283, DOI 10.1016/0266-7681(94)90070-1; Concannon MJ, 2000, PLAST RECONSTR SURG, V105, P1662, DOI 10.1097/00006534-200004050-00010; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DUMONTIER C, 1995, J HAND SURG-BRIT EUR, V20B, P658, DOI 10.1016/S0266-7681(05)80130-5; Eichhorn J D, 2003, CHIR PRAX, P61; Ejiri Soichi, 2012, Fukushima J Med Sci, V58, P49; ERDMANN MWH, 1994, J HAND SURG-BRIT EUR, V19B, P5, DOI 10.1016/0266-7681(94)90038-8; Ferdinand RD, 2002, J BONE JOINT SURG BR, V84B, P375, DOI 10.1302/0301-620X.84B3.12224; Forman DL, 1998, J HAND SURG-AM, V23A, P1010, DOI 10.1016/S0363-5023(98)80008-7; Foucher G, 1993, Chirurgie, V119, P80; Foucher G, 1994, PROSPECTIVE RANDOMIZ; Giele H, 2000, BILATERAL SIMULTANEO, P28; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Higgins JPT, 2008, COCHRANE HANDB SYST; Hoefnagels W A, 1997, Ned Tijdschr Geneeskd, V141, P878; Hulsizer DL, 1998, J HAND SURG-AM, V23A, P865, DOI 10.1016/S0363-5023(98)80164-0; Incoll I W, 2004, ENDOSCOPIC VS OPEN C, P478; Jacobsen MB, 1996, J HAND SURG-BRIT EUR, V21B, P202, DOI 10.1016/S0266-7681(96)80097-0; Koskella K R, 1996, COMP OPEN ENDOSCOPIC, P1102; Langan D, 2012, J CLIN EPIDEMIOL, V65, P511, DOI 10.1016/j.jclinepi.2011.10.009; Larsen MB, 2013, J HAND SURG-EUR VOL, V38, P646, DOI 10.1177/1753193412475247; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacDermid JC, 2003, J HAND SURG-AM, V28A, P475, DOI 10.1053/jhsu.2003.50080; Makowiec RL, 2002, ARTHROSCOPY, V18, P27, DOI 10.1053/jars.2002.29903; Malhotra R, 2007, Indian J Orthop, V41, P57, DOI 10.4103/0019-5413.30527; Muller LP, 2000, KNEE SURG SPORT TR A, V8, P166, DOI 10.1007/s001670050209; OKUTSU I, 1989, Arthroscopy, V5, P11, DOI 10.1016/0749-8063(89)90084-4; Papageorgiou C D, 1998, Knee Surg Sports Traumatol Arthrosc, V6, P189, DOI 10.1007/s001670050097; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Roloff V, 2013, STAT MED, V32, P11, DOI 10.1002/sim.5524; Sanati KA, 2011, J OCCUP REHABIL, V21, P474, DOI 10.1007/s10926-011-9310-8; Saw NLB, 2003, J HAND SURG-BRIT EUR, V28B, P444, DOI 10.1016/S0266-7681(03)00097-4; Schafer W, 1996, Handchir Mikrochir Plast Chir, V28, P143; Sennwald G R, 1995, Knee Surg Sports Traumatol Arthrosc, V3, P113, DOI 10.1007/BF01552386; SHINYA K, 1995, J HAND SURG-BRIT EUR, V20B, P222, DOI 10.1016/S0266-7681(05)80056-7; Sorensen A I, 1997, CARPAL TUNNEL RELEAS, P24; Stark B, 1996, Handchir Mikrochir Plast Chir, V28, P128; STATA, 2014, STAT STAT SOFTW REL; Sutton AJ, 2007, STAT MED, V26, P2479, DOI 10.1002/sim.2704; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Tian Ye, 2007, Chinese Medical Sciences Journal, V22, P104; Trumble TE, 2002, J BONE JOINT SURG AM, V84A, P1107, DOI 10.2106/00004623-200207000-00003; Tuzuner S, 2008, J HAND SURG-AM, V33A, P1063, DOI 10.1016/j.jhsa.2008.03.007; Uchiyama S, 2013, ARTHROSCOPY, V29, P860, DOI 10.1016/j.arthro.2013.01.027; Urbaniak JR, 1996, HAND CLIN, V12, P325; Vasiliadis HS, 2006, ARTHROSCOPY, V22, P807, DOI 10.1016/j.arthro.2006.03.021; Vasiliadis HS, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008265.pub2; Vasiliadis HS, 2010, ARTHROSCOPY, V26, P26, DOI 10.1016/j.arthro.2009.06.027; Werber K D, 1996, ENDOSCOPIC CARPAL TU, P11; Westphal KP, 2000, LYMPH FORSCH, V4, P69; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013	66	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143683	10.1371/journal.pone.0143683	http://dx.doi.org/10.1371/journal.pone.0143683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674211	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700014
J	Zhang, XY; Crippen, TL; Coates, CJ; Wood, TK; Tomberlin, JK				Zhang, Xinyang; Crippen, Tawni L.; Coates, Craig J.; Wood, Thomas K.; Tomberlin, Jeffery K.			Effect of Quorum Sensing by Staphylococcus epidermidis on the Attraction Response of Female Adult Yellow Fever Mosquitoes, Aedes aegypti aegypti (Linnaeus) (Diptera: Culicidae), to a Blood-Feeding Source	PLOS ONE			English	Article							TO-CELL COMMUNICATION; HUMAN SKIN; MALARIA MOSQUITO; CARBON-DIOXIDE; HOST-SEEKING; MICROBIOTA; BACTERIA; CALLIPHORIDAE; ODOR; IDENTIFICATION	Aedes aegypti, the principal vector of yellow fever and dengue fever, is responsible for more than 30,000 deaths annually. Compounds such as carbon dioxide, amino acids, fatty acids and other volatile organic compounds (VOCs) have been widely studied for their role in attracting Ae. aegypti to hosts. Many VOCs from humans are produced by associated skin microbiota. Staphyloccocus epidermidis, although not the most abundant bacteria according to surveys of relative 16S ribosomal RNA abundance, commonly occurs on human skin. Bacteria demonstrate population level decision-making through quorum sensing. Many quorum sensing molecules, such as indole, volatilize and become part of the host odor plum. To date, no one has directly demonstrated the link between quorum sensing (i.e., decision-making) by bacteria associated with a host as a factor regulating arthropod vector attraction. This study examined this specific question with regards to S. epidermidis and Ae. aegypti. Pairwise tests were conducted to examine the response of female Ae. aegypti to combinations of tryptic soy broth (TSB) and S. epidermidis wildtype and agr-strains. The agr gene expresses an accessory gene regulator for quorum sensing; therefore, removing this gene inhibits quorum sensing of the bacteria. Differential attractiveness of mosquitoes to the wildtype and agr-strains was observed. Both wildtype and the agr-strain of S. epidermidis with TSB were marginally more attractive to Ae. aegypti than the TSB alone. Most interestingly, the blood-feeder treated with wildtype S. epidermidis/TSB attracted 74% of Ae. aegypti compared to the agr-strain of S. epidermidis/TSB (P <= 0.0001). This study is the first to suggest a role for interkingdom communication between host symbiotic bacteria and mosquitoes. This may have implications for mosquito decision-making with regards to host detection, location and acceptance. We speculate that mosquitoes "eavesdrop" on the chemical discussions occurring between host-associated microbes to determine suitability for blood feeding. We believe these data suggest that manipulating quorum sensing by bacteria could serve as a novel approach for reducing mosquito attraction to hosts, or possibly enhancing the trapping of adults at favored oviposition sites.	[Zhang, Xinyang; Coates, Craig J.; Tomberlin, Jeffery K.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Zhang, Xinyang] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Crippen, Tawni L.] Texas A&M Univ, USDA ARS, Southern Plains Agr Res Ctr, College Stn, TX 77843 USA; [Wood, Thomas K.] Penn State Univ, Dept Chem Engn, State Coll, PA 16802 USA	Texas A&M University System; Texas A&M University College Station; University of Cambridge; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Zhang, XY (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	zxy1385@gmail.com; jktomberlin@tamu.edu	Wood, Thomas/GWZ-2481-2022	Wood, Thomas/0000-0001-8962-8571; Crippen, Tawni/0000-0001-5129-2371	Department of Entomology and AgriLife Research, Texas AM University	Department of Entomology and AgriLife Research, Texas AM University	The authors wish to thank the support from Department of Entomology and AgriLife Research, Texas A&M University for this research. This work was completed in partial fulfillment of a MS degree to XZ.	Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chaudhury MF, 2010, J MED ENTOMOL, V47, P349, DOI 10.1603/ME09235; Chaudhury MF, 2002, J MED ENTOMOL, V39, P130, DOI 10.1603/0022-2585-39.1.130; Clements A, 1995, AM J TROP MED HYG, V52, P579; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Cork A, 1996, OLF MOSQ HOST INT CI; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DAVIS EE, 1975, J COMP PHYSIOL, V96, P223, DOI 10.1007/BF00612696; De Jong R, 1996, CIB FUND S; DEJONG R, 1995, EXPERIENTIA, V51, P80, DOI 10.1007/BF01964925; Dekker T, 2001, PHYSIOL ENTOMOL, V26, P124, DOI 10.1046/j.1365-3032.2001.00225.x; Eldridge B.F., 2003, MED ENTOMOLOGY TXB P; Eldridge BF, 2000, MEDICAL ENTOMOLOGY, P1; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; Geier M, 1999, CHEM SENSES, V24, P647, DOI 10.1093/chemse/24.6.647; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; James A G, 2004, Int J Cosmet Sci, V26, P149, DOI 10.1111/j.1467-2494.2004.00214.x; Joint I, 2002, SCIENCE, V298, P1207, DOI 10.1126/science.1077075; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; KLOWDEN MJ, 1988, J AM MOSQUITO CONTR, V4, P73; Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042; Lee J, 2008, ISME J, V2, P1007, DOI 10.1038/ismej.2008.54; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; LEYDEN JJ, 1987, J INVEST DERMATOL, V88, pS65, DOI 10.1111/1523-1747.ep12468965; Lowery CA, 2008, CHEM SOC REV, V37, P1337, DOI 10.1039/b702781h; Ma Q, 2012, ISME J, V6, P1356, DOI 10.1038/ismej.2011.210; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; McCLELLAND G. A. H., 1959, BULL ENT RES, V50, P227, DOI 10.1017/S0007485300054547; Microbiology ASF., 2008, HUM HAV 10 TIM MOR B; Moreira CG, 2012, INFECT IMMUN, V80, P4344, DOI 10.1128/IAI.00803-12; Morris MC, 2005, NEW ZEAL J AGR RES, V48, P151, DOI 10.1080/00288233.2005.9513645; Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105; PRICE GD, 1979, J CHEM ECOL, V5, P383, DOI 10.1007/BF00987924; Qiu YT, 2004, MED VET ENTOMOL, V18, P429, DOI 10.1111/j.0269-283X.2004.00534.x; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; SCHLEIFER KH, 1975, INT J SYST BACTERIOL, V25, P50, DOI 10.1099/00207713-25-1-50; SHELLEY WB, 1953, AMA ARCH DERM SYPH, V68, P430, DOI 10.1001/archderm.1953.01540100070012; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Smallegange RC, 2011, TRENDS PARASITOL, V27, P143, DOI 10.1016/j.pt.2010.12.009; Sturgill G, 2004, MOL MICROBIOL, V51, P437, DOI 10.1046/j.1365-2958.2003.03835.x; Sumba Leunita A., 2004, International Journal of Tropical Insect Science, V24, P260, DOI 10.1079/IJT200433; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816; THOMAS DL, 1990, J WILDLIFE MANAGE, V54, P322, DOI 10.2307/3809050; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Verhulst NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015829; Verhulst NO, 2010, FEMS MICROBIOL ECOL, V74, P1, DOI 10.1111/j.1574-6941.2010.00908.x; Verhulst NO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-302; Vuong C, 2000, INFECT IMMUN, V68, P1048, DOI 10.1128/IAI.68.3.1048-1053.2000; Wang YL, 2010, P NATL ACAD SCI USA, V107, P8375, DOI 10.1073/pnas.1003571107; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319	61	11	11	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143950	10.1371/journal.pone.0143950	http://dx.doi.org/10.1371/journal.pone.0143950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674802	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700018
J	Colchero, MA; Salgado, JC; Unar-Munguia, M; Molina, M; Ng, SW; Rivera-Dommarco, JA				Arantxa Colchero, M.; Carlos Salgado, Juan; Unar-Munguia, Mishel; Molina, Mariana; Ng, Shuwen; Angel Rivera-Dommarco, Juan			Changes in Prices After an Excise Tax to Sweetened Sugar Beverages Was Implemented in Mexico: Evidence from Urban Areas	PLOS ONE			English	Article								In 2014 an excise tax to non-alcoholic sweetened beverages (SSB) was implemented in Mexico. The objective of this paper is to study whether and to what degree these taxes passed-through onto SSB prices in urban areas overall and by region, type of beverage and package size. Prices were obtained from the National Institute of Statistics and Geography from 2011 to 2014. We applied a pre-post quasi-experimental approach using fixed effects models. In sensitivity analysis we applied other model specifications to test the robustness of the findings and we also present weighted estimations based on household purchases. The dependent variables are real prices of a specific beverage category; the main independent variables are dummies for each month of 2014, and the models adjust for time trends and seasonality. Results suggest that the SSB tax passed along to consumers for all SSBs and we found overshifting for the carbonated SSBs. A greater effect is seen among the small package sizes, and we see heterogeneous effects by region. Estimating the effect of the tax on prices is important to understand the potential effect on consumption.	[Arantxa Colchero, M.; Carlos Salgado, Juan; Molina, Mariana] Inst Nacl Salud Publ, Ctr Hlth Syst Res CISS, Cuernavaca, Morelos, Mexico; [Unar-Munguia, Mishel; Angel Rivera-Dommarco, Juan] Inst Nacl Salud Publ, Nutr & Hlth Res Ctr CINyS, Cuernavaca, Morelos, Mexico; [Ng, Shuwen] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Ng, Shuwen] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Colchero, MA (corresponding author), Inst Nacl Salud Publ, Ctr Hlth Syst Res CISS, Cuernavaca, Morelos, Mexico.	acolchero@insp.mx	Munguia, Mishel Unar/P-7134-2019	Munguia, Mishel Unar/0000-0002-1156-9337	Bloomberg Foundation	Bloomberg Foundation	Funded by Bloomberg Foundation, project "Fighting obesity in Mexico: Supporting the design and evaluation of effective social actions and public policies". The sponsor did not have any role in the study design, analysis, and preparation of the manuscript or decision to publish.	Barquera S, 2013, SALUD PUBLICA MEXICO, V55, pS151, DOI 10.21149/spm.v55s2.5111; Berardi N., 2012, IMPACT SODA TAX PRIC, DOI 10.2139/ssrn.2192470; Bergman UM, 2012, ARE EXCISE TAXES BEV; Besley T, 1998, 6667 NAT BUR EC RES; Besley TJ, 1999, NATL TAX J, V52, P157; Bonnet C, 2013, J PUBLIC ECON, V106, P77, DOI 10.1016/j.jpubeco.2013.06.010; Cahuana H L, 2012, OBSEIDAD MEXICO RECO, P331; Colchero MA, 2015, ECON HUM BIOL, V19, P129, DOI 10.1016/j.ehb.2015.08.007; Consejo Nacional de Poblacion, 2012, PROYECC POBL NAC 201; Delipalla S, 1999, ESTIMATING TAX INCID, V9901; Euromonitor, 2011, EUR INT PASS GLOB MA; Harris J, 1987, TAX POLICY EC; Hernandez-Avila M, 2013, SALUD PUBLICA MEXICO, V55, pS129, DOI 10.21149/spm.v55s2.5108; Instituto Nacional de Estadistica y Geografia, 2013, MONTHL SURV MAN IND; Instituto Nacional de Estadistica y Geografia, 2011, SIST CUENT NAC MEX; Instituto Nacional de Estadistica y Geografia, 2013, IND NAC PREC CONS DO; Instituto Nacional de Estadustica y Geografia, 2014, IND PREC; Instituto Nacional de Salud Publica, 2012, EST NUTR AN SEQ AL P; Kenkel D, 2005, AM EC REV, V95; Konrad KA, 2014, CAN J ECON, V47, P173, DOI 10.1111/caje.12067; Ma ZQ, 2013, PREV CHRONIC DIS, V10, DOI [10.5888/pcd10.120268, 10.5888/pcd10.130143]; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Mccorriston S, 2005, INT TAX PUBLIC FINAN, V12, P627, DOI 10.1007/s10797-005-0476-x; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; OECD, 2011, HLTH GLANC 2011 IND; Roodman D, 2009, STATA J, V9, P86, DOI 10.1177/1536867X0900900106; Sanchez-Pimienta T, 2015, 16 C INV SAL PUBL; Seade J, 1985, 260 U WARW DEP EC WA; Secretaria de Salud, 2013, ESTR NAC PREV CONTR; Stata Corp, 2014, STATA STAT SOFTW REL; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Willett WC, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8077; Young DJ, 2002, NATL TAX J, V55, P57, DOI 10.17310/ntj.2002.1.04	34	110	113	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144408	10.1371/journal.pone.0144408	http://dx.doi.org/10.1371/journal.pone.0144408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26675166	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900044
J	Michoux, N; Guillet, A; Rommel, D; Mazzamuto, G; Sindic, C; Duprez, T				Michoux, Nicolas; Guillet, Alain; Rommel, Denis; Mazzamuto, Giosue; Sindic, Christian; Duprez, Thierry			Texture Analysis of T2-Weighted MR Images to Assess Acute Inflammation in Brain MS Lesions	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; DIFFUSION; CLASSIFICATION; HETEROGENEITY; PATTERNS	Brain blood barrier breakdown as assessed by contrast-enhanced (CE) T1-weighted MR imaging is currently the standard radiological marker of inflammatory activity in multiple sclerosis (MS) patients. Our objective was to evaluate the performance of an alternative model assessing the inflammatory activity of MS lesions by texture analysis of T2-weighted MR images. Twenty-one patients with definite MS were examined on the same 3.0T MR system by T2-weighted, FLAIR, diffusion-weighted and CE-T1 sequences. Lesions and mirrored contralateral areas within the normal appearing white matter (NAWM) were characterized by texture parameters computed from the gray level co-occurrence and run length matrices, and by the apparent diffusion coefficient (ADC). Statistical differences between MS lesions and NAWM were analyzed. ROC analysis and leave-one-out cross-validation were performed to evaluate the performance of individual parameters, and multi-parametric models using linear discriminant analysis (LDA), partial least squares (PLS) and logistic regression (LR) in the identification of CE lesions. ADC and all but one texture parameter were significantly different within white matter lesions compared to within NAWM(p < 0.0167). Using LDA, an 8-texture parameter model identified CE lesions with a sensitivity Se = 70% and a specificity Sp = 76%. Using LR, a 10-texture parameter model performed better with Se = 86%/Sp = 84%. Using PLS, a 6-texture parameter model achieved the highest accuracy with Se = 88%/Sp = 81%. Texture parameter from T2-weighted images can assess brain inflammatory activity with sufficient accuracy to be considered as a potential alternative to enhancement on CE T1-weighted images.	[Michoux, Nicolas] Catholic Univ Louvain, IREC Inst Expt & Clin Res, B-1200 Brussels, Belgium; [Guillet, Alain] Catholic Univ Louvain, Dept Stat, B-1200 Brussels, Belgium; [Rommel, Denis; Mazzamuto, Giosue; Duprez, Thierry] Catholic Univ Louvain, Dept Radiol, Clin Univ St Luc, B-1200 Brussels, Belgium; [Sindic, Christian] Catholic Univ Louvain, Dept Neurol, Clin Univ St Luc, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Michoux, N (corresponding author), Catholic Univ Louvain, IREC Inst Expt & Clin Res, B-1200 Brussels, Belgium.	nicolas.michoux@uclouvain.be		Duprez, Thierry/0000-0002-1579-0100; Guillet, Alain/0000-0002-2938-1498				Anik Y, 2011, CLIN NEURORADIOL, V21, P207, DOI 10.1007/s00062-011-0091-4; Bammer R, 2000, MAGNET RESON MED, V44, P583, DOI 10.1002/1522-2594(200010)44:4<583::AID-MRM12>3.0.CO;2-O; Baumann K, 2003, TRAC-TREND ANAL CHEM, V22, P395, DOI 10.1016/S0165-9936(03)00607-1; Bonzano L, 2009, MULT SCLER J, V15, P1043, DOI 10.1177/1352458509106610; Collewet G, 2004, MAGN RESON IMAGING, V22, P81, DOI 10.1016/j.mri.2003.09.001; CROSS GR, 1983, IEEE T PATTERN ANAL, V5, P25, DOI 10.1109/TPAMI.1983.4767341; Depeursinge A, 2012, LECT NOTES COMPUTER; Drabycz S, 2008, INT J COMPUT ASS RAD, V3, P465, DOI 10.1007/s11548-008-0219-4; Farber RS, 2009, J MAGN RESON IMAGING, V30, P732, DOI 10.1002/jmri.21922; Faro A, P MEDICON IFMBE 2010, V20, P272; Filippi M, 2000, ARCH NEUROL-CHICAGO, V57, P1017, DOI 10.1001/archneur.57.7.1017; Filippi M, 2011, ARCH NEUROL-CHICAGO, V68, P1514, DOI 10.1001/archneurol.2011.914; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; GARTHWAITE PH, 1994, J AM STAT ASSOC, V89, P122, DOI 10.2307/2291207; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Harrison LCV, 2010, ACAD RADIOL, V17, P696, DOI 10.1016/j.acra.2010.01.005; Henning J, 2011, HIGH FIELD MR IMAGIN, P81; Inglese M, 2010, NMR BIOMED, V23, P865, DOI 10.1002/nbm.1515; Karimaghaloo Z, 2013, LECT NOTES COMPUT SC, V8151, P543, DOI 10.1007/978-3-642-40760-4_68; Loizou CP, 2011, IEEE T INF TECHNOL B, V15, P119, DOI 10.1109/TITB.2010.2091279; Loizou CP, 2011, IFIP ADV INF COMM TE, V364, P400; Loizou CP, 2014, J NEURORADIOL, V23; Niall A, 2004, METHODS MODELS STAT; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Pagani E, 2007, AM J NEURORADIOL, V28, P411; Pampel F, 2000, SAGE U PAPERS SERIES, P07; Plumat J, 2009, INSIGHT J; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Poonawalla AH, 2008, RADIOLOGY, V246, P880, DOI 10.1148/radiol.2463070486; Savio S, 2014, ACTA RADIOL, V14; Tang XO, 1998, IEEE T IMAGE PROCESS, V7, P1602, DOI 10.1109/83.725367; Theocharakis P, 2009, MAGN RESON IMAGING, V27, P417, DOI 10.1016/j.mri.2008.07.014; Tozer DJ, 2009, J MAGN RESON IMAGING, V30, P506, DOI 10.1002/jmri.21885; Verma RK, 2013, PLOS ONE, V16; Yu O, 2004, MAGN RESON IMAGING, V22, P1139, DOI 10.1016/j.mri.2004.08.017; Yu O, 1999, MAGN RESON IMAGING, V17, P1261, DOI 10.1016/S0730-725X(99)00062-4; Yurtsever I, 2008, EUR J RADIOL, V65, P421, DOI 10.1016/j.ejrad.2007.05.002; Zhang J, 2008, MAGN RESON IMAGING, V26, P1160, DOI 10.1016/j.mri.2008.01.016; Zhang YY, 2014, MAGN RESON IMAGING, V32, P168, DOI 10.1016/j.mri.2013.10.006; Zhang YY, 2013, ANN NEUROL, V74, P91, DOI 10.1002/ana.23867; Zhang YY, 2009, NEUROIMAGE, V47, P107, DOI 10.1016/j.neuroimage.2009.03.075; Zhu H, 2003, P 11 INT SOC MAGN RE, P277	42	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145497	10.1371/journal.pone.0145497	http://dx.doi.org/10.1371/journal.pone.0145497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26693908	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092500053
J	Geue, C; Wu, O; Xin, YQ; Heggie, R; Hutchinson, S; Martin, NK; Fenwick, E; Goldberg, D				Geue, Claudia; Wu, Olivia; Xin, Yiqiao; Heggie, Robert; Hutchinson, Sharon; Martin, Natasha K.; Fenwick, Elisabeth; Goldberg, David		Consortium; ECDC	Cost-Effectiveness of HBV and HCV Screening Strategies - A Systematic Review of Existing Modelling Techniques	PLOS ONE			English	Article							HEPATITIS-C VIRUS; UTILITY ANALYSIS; VACCINATION STRATEGIES; B VIRUS; GENERAL-POPULATION; UNITED-STATES; PRIMARY-CARE; DRUG-USERS; INFECTION; PROGRAM	Introduction Studies evaluating the cost-effectiveness of screening for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) are generally heterogeneous in terms of risk groups, settings, screening intervention, outcomes and the economic modelling framework. It is therefore difficult to compare cost-effectiveness results between studies. This systematic review aims to summarise and critically assess existing economic models for HBV and HCV in order to identify the main methodological differences in modelling approaches. Methods A structured search strategy was developed and a systematic review carried out. A critical assessment of the decision-analytic models was carried out according to the guidelines and framework developed for assessment of decision-analytic models in Health Technology Assessment of health care interventions. Results The overall approach to analysing the cost-effectiveness of screening strategies was found to be broadly consistent for HBV and HCV. However, modelling parameters and related structure differed between models, producing different results. More recent publications performed better against a performance matrix, evaluating model components and methodology. Conclusion When assessing screening strategies for HBV and HCV infection, the focus should be on more recent studies, which applied the latest treatment regimes, test methods and had better and more complete data on which to base their models. In addition to parameter selection and associated assumptions, careful consideration of dynamic versus static modelling is recommended. Future research may want to focus on these methodological issues. In addition, the ability to evaluate screening strategies for multiple infectious diseases, (HCV and HIV at the same time) might prove important for decision makers.	[Geue, Claudia; Wu, Olivia; Xin, Yiqiao; Heggie, Robert] Univ Glasgow, Hlth Econ & Hlth Technol Assessment, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Hutchinson, Sharon] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Martin, Natasha K.] Univ Calif San Diego, Div Global Publ Hlth, San Diego, CA 92103 USA; [Martin, Natasha K.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Fenwick, Elisabeth] ICON Hlth Econ & Epidemiol, Dublin, Ireland; [Goldberg, David] NHS Hlth Scotland, Hlth Protect Scotland, Glasgow, Lanark, Scotland	University of Glasgow; Glasgow Caledonian University; University of California System; University of California San Diego; University of Bristol; ICON plc	Geue, C (corresponding author), Univ Glasgow, Hlth Econ & Hlth Technol Assessment, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	Claudia.Geue@glasgow.ac.uk	Wu, Olivia/A-5011-2010; Wu, Olivia/AAH-4621-2019; Hutchinson, Sharon/Y-3949-2019	Wu, Olivia/0000-0002-0570-6016; Wu, Olivia/0000-0002-0570-6016; Hutchinson, Sharon/0000-0002-6891-6758; Xin, Yiqiao/0000-0001-5856-3103; Martin, Natasha/0000-0001-8344-1810	European Centre for Disease Prevention and Control [OJ/27/05/2011-PROC/2011/040]; National Institute for Drug Abuse [R01 DA037773-01A1]; UCSD Centre for AIDS Research; National Institute for Health Research [PDF-2011-04-049] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037773] Funding Source: NIH RePORTER	European Centre for Disease Prevention and Control; National Institute for Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); UCSD Centre for AIDS Research; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the European Centre for Disease Prevention and Control (OJ/27/05/2011-PROC/2011/040). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of the above mentioned grant, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the "author contribution" section. EF is currently affiliated with a commercial company (icon plc) however at the time the study was undertaken EF was not affiliated with a commercial company, so that commercial affiliation did not play a role within the study. NKM acknowledges research funding from the National Institute for Drug Abuse R01 DA037773-01A1 and the UCSD Centre for AIDS Research. This funding does not play a role within the study.	ANTONANZAS F, 1995, PHARMACOECONOMICS, V7, P428, DOI 10.2165/00019053-199507050-00007; AREVALO JA, 1988, JAMA-J AM MED ASSOC, V259, P365, DOI 10.1001/jama.259.3.365; BLOOM BS, 1993, ANN INTERN MED, V118, P298, DOI 10.7326/0003-4819-118-4-199302150-00009; Castelnuovo E, 2006, HEALTH TECHNOL ASSES, V10, P1; Cipriano LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045176; Coffin PO, 2012, CLIN INFECT DIS, V54, P1259, DOI 10.1093/cid/cis011; Coon JT, 2006, FAM PRACT, V23, P393, DOI 10.1093/fampra/cml032; Deuffic-Burban S, 2009, GUT, V58, P105, DOI 10.1136/gut.2007.145516; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Eckman MH, 2013, CLIN INFECT DIS, V56, P1382, DOI 10.1093/cid/cit069; Eckman MH, 2011, CLIN INFECT DIS, V52, P1294, DOI 10.1093/cid/cir199; Glanville J, 2009, INT J TECHNOL ASSESS, V25, P522, DOI 10.1017/S0266462309990523; Hahne SJM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-181; Honeycutt AA, 2007, PUBLIC HEALTH REP, V122, P55, DOI 10.1177/00333549071220S211; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; Josset V, 2004, GASTROEN CLIN BIOL, V28, P351, DOI 10.1016/S0399-8320(04)94935-4; Jusot JF, 2001, EUR J PUBLIC HEALTH, V11, P373, DOI 10.1093/eurpub/11.4.373; Kim SY, 2006, AM J PREV MED, V30, P498, DOI 10.1016/j.amepre.2006.01.017; KWANGETT TSC, 1994, ARCH PEDIAT ADOL MED, V148, P915, DOI 10.1001/archpedi.1994.02170090029003; Lapane KL, 1998, AM J GASTROENTEROL, V93, P591, DOI 10.1111/j.1572-0241.1998.170_b.x; Leal P, 1999, J MED SCREEN, V6, P124, DOI 10.1136/jms.6.3.124; Linas BP, 2012, CLIN INFECT DIS, V55, P279, DOI 10.1093/cid/cis382; Liu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058975; Loubiere S, 2003, INT J TECHNOL ASSESS, V19, P632, DOI 10.1017/S026646230300059X; Loubiere S, JOURNAL; McGarry LJ, 2012, HEPATOLOGY, V55, P1344, DOI 10.1002/hep.25510; Miners AH, 2014, J VIRAL HEPATITIS, V21, P616, DOI 10.1111/jvh.12190; MULLEY AG, 1982, NEW ENGL J MED, V307, P644, DOI 10.1056/NEJM198209093071103; Nakamura J, 2008, TOHOKU J EXP MED, V215, P33, DOI 10.1620/tjem.215.33; National Institute for Health and Clinical Excellence, 2012, FIN APPR DET BOC TRE; Philips Z, 2006, PHARMACOECONOMICS, V24, P355, DOI 10.2165/00019053-200624040-00006; Plunkett BA, 2005, AM J OBSTET GYNECOL, V192, P1153, DOI 10.1016/j.ajog.2004.10.600; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Rein DB, 2011, PUBLIC HEALTH REP, V126, P560, DOI 10.1177/003335491112600412; Rossi C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073548, DOI 10.1371/JOURNAL.PONE.0073548]; Ruggeri M, HLTH POLICY, V102, P72, DOI [10.1016/j.healthpal.2010.09.012, DOI 10.1016/J.HEALTHP0L.2010.09.012]; Ruggeri M, 2013, VALUE HEALTH, V16, P965, DOI 10.1016/j.jval.2013.07.005; Schackman BR, 2015, ADDICTION, V110, P129, DOI 10.1111/add.12754; Singer ME, 2001, AM J MED, V111, P614, DOI 10.1016/S0002-9343(01)00951-2; Sroczynski G, 2009, EUR J PUBLIC HEALTH, V19, P245, DOI 10.1093/eurpub/ckp001; Stein K, 2004, J PUBLIC HEALTH-UK, V26, P61, DOI 10.1093/pubmed/fdh109; Stein K, 2003, J HEPATOL, V39, P814, DOI 10.1016/S0168-8278(03)00392-1; Sutton AJ, 2008, J VIRAL HEPATITIS, V15, P797, DOI 10.1111/j.1365-2893.2008.01008.x; Sutton AJ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-170; THOMAS IL, 1990, AUST NZ J OBSTET GYN, V30, P331, DOI 10.1111/j.1479-828X.1990.tb02022.x; TORMANS G, 1993, SOC SCI MED, V37, P173, DOI 10.1016/0277-9536(93)90453-B; Tramarin A, 2008, CURR PHARM DESIGN, V14, P1655, DOI 10.2174/138161208784746833; Urbanus AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070319; Veldhuijzen IK, 2010, GASTROENTEROLOGY, V138, P522, DOI 10.1053/j.gastro.2009.10.039; Walensky RP, 2007, CLIN INFECT DIS, V45, pS248, DOI 10.1086/522546; Wong WWL, 2015, CAN MED ASSOC J, V187, pE110, DOI 10.1503/cmaj.140711; Wong WWL, JOURNAL; Zurn P, 1998, SOZ PRAVENTIV MED, V43, pS61, DOI 10.1007/BF02042178	53	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145022	10.1371/journal.pone.0145022	http://dx.doi.org/10.1371/journal.pone.0145022			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SF	26689908	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000367092300032
J	Forbi, JC; Layden, JE; Phillips, RO; Mora, N; Xia, GL; Campo, DS; Purdy, MA; Dimitrova, ZE; Owusu, DO; Punkova, LT; Skums, P; Owusu-Ofori, S; Sarfo, FS; Vaughan, G; Roh, H; Opare-Sem, OK; Cooper, RS; Khudyakov, YE				Forbi, Joseph C.; Layden, Jennifer E.; Phillips, Richard O.; Mora, Nallely; Xia, Guo-liang; Campo, David S.; Purdy, Michael A.; Dimitrova, Zoya E.; Owusu, Dorcas O.; Punkova, Lili T.; Skums, Pavel; Owusu-Ofori, Shirley; Sarfo, Fred Stephen; Vaughan, Gilberto; Roh, Hajung; Opare-Sem, Ohene K.; Cooper, Richard S.; Khudyakov, Yury E.			Next-Generation Sequencing Reveals Frequent Opportunities for Exposure to Hepatitis C Virus in Ghana	PLOS ONE			English	Article							BLOOD-DONORS; WEST-AFRICA; INFECTION; EPIDEMIOLOGY; POPULATION; GENOTYPE; EFFICACY; PREVALENCE; SOFOSBUVIR; EVOLUTION	Globally, hepatitis C Virus (HCV) infection is responsible for a large proportion of persons with liver disease, including cancer. The infection is highly prevalent in sub-Saharan Africa. West Africa was identified as a geographic origin of two HCV genotypes. However, little is known about the genetic composition of HCV populations in many countries of the region. Using conventional and next-generation sequencing (NGS), we identified and genetically characterized 65 HCV strains circulating among HCV-positive blood donors in Kumasi, Ghana. Phylogenetic analysis using consensus sequences derived from 3 genomic regions of the HCV genome, 5'-untranslated region, hypervariable region 1 (HVR1) and NS5B gene, consistently classified the HCV variants (n = 65) into genotypes 1 (HCV-1, 15%) and genotype 2 (HCV-2, 85%). The Ghanaian and West African HCV-2 NS5B sequences were found completely intermixed in the phylogenetic tree, indicating a substantial genetic heterogeneity of HCV-2 in Ghana. Analysis of HVR1 sequences from intra-host HCV variants obtained by NGS showed that three donors were infected with >1 HCV strain, including infections with 2 genotypes. Two other donors share an HCV strain, indicating HCV transmission between them. The HCV-2 strain sampled from one donor was replaced with another HCV-2 strain after only 2 months of observation, indicating rapid strain switching. Bayesian analysis estimated that the HCV-2 strains in Ghana were expanding since the 16th century. The blood donors in Kumasi, Ghana, are infected with a very heterogeneous HCV population of HCV-1 and HCV-2, with HCV-2 being prevalent. The detection of three cases of co- or super-infections and transmission linkage between 2 cases suggests frequent opportunities for HCV exposure among the blood donors and is consistent with the reported high HCV prevalence. The conditions for effective HCV-2 transmission existed for similar to 3-4 centuries, indicating a long epidemic history of HCV-2 in Ghana.	[Forbi, Joseph C.; Xia, Guo-liang; Campo, David S.; Purdy, Michael A.; Dimitrova, Zoya E.; Punkova, Lili T.; Skums, Pavel; Vaughan, Gilberto; Roh, Hajung; Khudyakov, Yury E.] Ctr Dis Control & Prevent, Mol Epidemiol & Bioinformat Lab, Div Viral Hepatitis, Atlanta, GA 30333 USA; [Layden, Jennifer E.; Mora, Nallely; Cooper, Richard S.] Loyola Univ Chicago, Dept Publ Hlth Sci, Maywood, IL USA; [Layden, Jennifer E.] Loyola Univ Chicago, Stritch Sch Med, Dept Med, Maywood, IL USA; [Phillips, Richard O.; Owusu, Dorcas O.; Owusu-Ofori, Shirley; Sarfo, Fred Stephen; Opare-Sem, Ohene K.] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Phillips, Richard O.; Sarfo, Fred Stephen] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana	Centers for Disease Control & Prevention - USA; Loyola University Chicago; Loyola University Chicago; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Forbi, JC (corresponding author), Ctr Dis Control & Prevent, Mol Epidemiol & Bioinformat Lab, Div Viral Hepatitis, Atlanta, GA 30333 USA.	JForbi@cdc.gov	OWUSU, Dorcas Ohui/O-9491-2014; Phillips, Richard Odame/ABD-5394-2021; Roh, Ha-Jung/N-1365-2016	OWUSU, Dorcas Ohui/0000-0003-4299-5870; Phillips, Richard Odame/0000-0001-8992-0222; Roh, Ha-Jung/0000-0003-1523-6844	Loyola University, Chicago, USA; Laboratory Branch, Division of Viral Hepatitis, CDC, Atlanta, USA; MRC [MR/J01477X/1] Funding Source: UKRI	Loyola University, Chicago, USA; Laboratory Branch, Division of Viral Hepatitis, CDC, Atlanta, USA; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Internal funding was provided to JEL by Loyola University, Chicago, USA. This work was supported by the Laboratory Branch, Division of Viral Hepatitis, CDC, Atlanta, USA.	Alfonso V, 2005, J GEN VIROL, V86, P2781, DOI 10.1099/vir.0.81084-0; Allain JP, 2009, TRANSFUSION, V49, P669, DOI 10.1111/j.1537-2995.2008.02055.x; Ampofo W, 2002, J CLIN MICROBIOL, V40, P3523, DOI 10.1128/JCM.40.9.3523-3525.2002; [Anonymous], 1999, J Hepatol, V31 Suppl 1, P3; Averhoff FM, 2012, CLIN INFECT DIS, V55, pS10, DOI 10.1093/cid/cis361; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Campo D. S., 2015, J INFECT DIS; Campo DS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00267; Candotti D, 2003, J VIROL, V77, P7914, DOI 10.1128/JVI.77.14.7914-7923.2003; Chen CM, 2004, P NATL ACAD SCI USA, V101, P5303, DOI 10.1073/pnas.0307513100; Cuevas JM, 2009, J VIROL, V83, P5760, DOI 10.1128/JVI.00201-09; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Farci P, 2011, SEMIN LIVER DIS, V31, P356, DOI 10.1055/s-0031-1297925; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Forbi JC, 2014, J MED VIROL, V86, P765, DOI 10.1002/jmv.23897; Forbi JC, 2012, J GEN VIROL, V93, P1410, DOI 10.1099/vir.0.042184-0; Forbi JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011615; Ghana-HealthNest, 2013, GHAN NEEDS 250000 UN; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Itskowitz Marc S., 2007, Comprehensive Therapy, V33, P87, DOI 10.1007/s12019-007-8005-8; Koff RS, 2014, ALIMENT PHARM THER, V39, P478, DOI 10.1111/apt.12601; Layden JE, 2014, CLIN INFECT DIS; Layden JE, 2015, CLIN INFECT DIS, V60, P1033, DOI 10.1093/cid/ciu965; Li H S, 2010, ACTA ECOLOGICA SINIC, V1, P1, DOI DOI 10.1371/J0URNAL.PPAT.1000890; Li H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002880; Madhava V, 2002, LANCET INFECT DIS, V2, P293, DOI 10.1016/S1473-3099(02)00264-5; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Mathworks, 2010, MATLAB; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nkrumah B, 2011, Ghana Med J, V45, P97; Owusu-Ofori S, 2005, TRANSFUSION, V45, P133, DOI 10.1111/j.1537-2995.2004.04279.x; Pouillot R, 2008, INFECT GENET EVOL, V8, P676, DOI 10.1016/j.meegid.2008.06.001; Purdy MA, 2015, J GEN VIROL; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Ramachandran S, 2011, J VIROL, V85, P6369, DOI 10.1128/JVI.02204-10; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Schmidt-Martin D, 2015, J GEN VIROL; Schvaneveldt R. W., 1989, PSYCHOL LEARN MOTIV, V24, P249, DOI DOI 10.1016/S0079-7421(08)60539-3; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Skums P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S6; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tejada-Strop A, 2015, J VIROL METHODS, V212, P66, DOI 10.1016/j.jviromet.2014.10.018; Wansbrough-Jones MH, 1998, T ROY SOC TROP MED H, V92, P496, DOI 10.1016/S0035-9203(98)90887-2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yusim K, 2010, J GEN VIROL, V91, P1194, DOI 10.1099/vir.0.017491-0	48	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145530	10.1371/journal.pone.0145530	http://dx.doi.org/10.1371/journal.pone.0145530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683463	Green Published, Green Submitted, gold			2022-12-27	WOS:000366725800080
J	Forman, OP; Pettitt, L; Komaromy, AM; Bedford, P; Mellersh, C				Forman, Oliver P.; Pettitt, Louise; Komaromy, Andrs M.; Bedford, Peter; Mellersh, Cathryn			A Novel Genome-Wide Association Study Approach Using Genotyping by Exome Sequencing Leads to the Identification of a Primary Open Angle Glaucoma Associated Inversion Disrupting ADAMTS17	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; PRIMARY LENS LUXATION; MUTATION; BREEDS; DOG; DELETION; LINKAGE	Closed breeding populations in the dog in conjunction with advances in gene mapping and sequencing techniques facilitate mapping of autosomal recessive diseases and identification of novel disease-causing variants, often using unorthodox experimental designs. In our investigation we demonstrate successful mapping of the locus for primary open angle glaucoma in the Petit Basset Griffon Venden dog breed with 12 cases and 12 controls, using a novel genotyping by exome sequencing approach. The resulting genome-wide association signal was followed up by genome sequencing of an individual case, leading to the identification of an inversion with a breakpoint disrupting the ADAMTS17 gene. Genotyping of additional controls and expression analysis provide strong evidence that the inversion is disease causing. Evidence of cryptic splicing resulting in novel exon transcription as a consequence of the inversion in ADAMTS17 is identified through RNAseq experiments. This investigation demonstrates how a novel genotyping by exome sequencing approach can be used to map an autosomal recessive disorder in the dog, with the use of genome sequencing to facilitate identification of a disease-associated variant.	[Forman, Oliver P.; Pettitt, Louise; Mellersh, Cathryn] Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket Suffolk CB8 7UU, England; [Bedford, Peter] Univ London, Univ London Royal Vet Coll, Dept Clin Sci & Serv, Hatfield AL9 7TA, Herts, England; [Komaromy, Andrs M.] Michigan State Univ, Ctr Vet Med, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA	Animal Health Trust; University of London; University of London Royal Veterinary College; Michigan State University	Forman, OP (corresponding author), Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket Suffolk CB8 7UU, England.	oliver.forman@aht.org.uk			Waltham Foundation	Waltham Foundation	The study into primary open angle glaucoma was funded by the Waltham Foundation (www.waltham.com/waltham-research/funding-opportunities/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111941; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Farias FHG, 2010, INVEST OPHTH VIS SCI, V51, P4716, DOI 10.1167/iovs.09-5142; Gilliam D, 2014, J VET INTERN MED, V28, P871, DOI 10.1111/jvim.12355; Gould D, 2011, VET OPHTHALMOL, V14, P378, DOI 10.1111/j.1463-5224.2011.00892.x; Guo JY, 2015, BMC VET RES, V10, DOI 10.1186/s12917-014-0181-z; Guo J, 2014, MOL GENET METAB, V112, P302, DOI 10.1016/j.ymgme.2014.05.014; Hubmacher D, 2011, CELL MOL LIFE SCI, V68, P3137, DOI 10.1007/s00018-011-0780-9; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kuchtey J, 2014, J OCUL PHARMACOL TH, V30, P170, DOI 10.1089/jop.2013.0184; Kuchtey J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001306; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim G, 2011, LEUKEMIA RES, V35, pE106, DOI 10.1016/j.leukres.2011.03.020; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Mosyak L, 2008, PROTEIN SCI, V17, P16, DOI 10.1110/ps.073287008; Parker HG, 2007, GENOME RES, V17, P1562, DOI 10.1101/gr.6772807; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Safra N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003646; Siva N, 2015, LANCET, V385, P103, DOI 10.1016/S0140-6736(14)62453-3	22	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0143546	10.1371/journal.pone.0143546	http://dx.doi.org/10.1371/journal.pone.0143546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683476	Green Submitted, Green Published, gold			2022-12-27	WOS:000366725800008
J	Gueguen, N; Desquiret-Dumas, V; Leman, G; Chupin, S; Baron, S; Nivet-Antoine, V; Vessieres, E; Ayer, A; Henrion, D; Lenaers, G; Reynier, P; Procaccio, V				Gueguen, Naig; Desquiret-Dumas, Valerie; Leman, Geraldine; Chupin, Stephanie; Baron, Stephanie; Nivet-Antoine, Valerie; Vessieres, Emilie; Ayer, Audrey; Henrion, Daniel; Lenaers, Guy; Reynier, Pascal; Procaccio, Vincent			Resveratrol Directly Binds to Mitochondrial Complex I and Increases Oxidative Stress in Brain Mitochondria of Aged Mice	PLOS ONE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; RESPIRATORY-CHAIN; CYTOCHROME-C; DIETARY RESVERATROL; YARROWIA-LIPOLYTICA; TRANS-RESVERATROL; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; RAT-LIVER	Resveratrol is often described as a promising therapeutic molecule for numerous diseases, especially in metabolic and neurodegenerative disorders. While the mechanism of action is still debated, an increasing literature reports that resveratrol regulates the mitochondrial respiratory chain function. In a recent study we have identified mitochondrial complex I as a direct target of this molecule. Nevertheless, the mechanisms and consequences of such an interaction still require further investigation. In this study, we identified in silico by docking study a binding site for resveratrol at the nucleotide pocket of complex I. In vitro, using solubilized complex I, we demonstrated a competition between NAD+ and resveratrol. At low doses (<5 mu M), resveratrol stimulated complex I activity, whereas at high dose (50 mu M) it rather decreased it. In vivo, in brain mitochondria from resveratrol treated young mice, we showed that complex I activity was increased, whereas the respiration rate was not improved. Moreover, in old mice with low antioxidant defenses, we demonstrated that complex I activation by resveratrol led to oxidative stress. These results bring new insights into the mechanism of action of resveratrol on mitochondria and highlight the importance of the balance between pro- and antioxidant effects of resveratrol depending on its dose and age. These parameters should be taken into account when clinical trials using resveratrol or analogues have to be designed.	[Gueguen, Naig; Desquiret-Dumas, Valerie; Leman, Geraldine; Chupin, Stephanie; Vessieres, Emilie; Ayer, Audrey; Henrion, Daniel; Lenaers, Guy; Reynier, Pascal; Procaccio, Vincent] Univ Angers, F-49000 Angers, France; [Gueguen, Naig; Desquiret-Dumas, Valerie; Chupin, Stephanie; Reynier, Pascal; Procaccio, Vincent] CHU Angers, Dept Biochim & Genet, F-49000 Angers, France; [Gueguen, Naig; Desquiret-Dumas, Valerie; Leman, Geraldine; Chupin, Stephanie; Vessieres, Emilie; Ayer, Audrey; Henrion, Daniel; Lenaers, Guy; Reynier, Pascal; Procaccio, Vincent] CNRS, INSERM, U1083, UMR 6214, F-49000 Angers, France; [Baron, Stephanie; Nivet-Antoine, Valerie] Univ Paris 05, Fac Pharm, EA 4466, F-75270 Paris, France	Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; UDICE-French Research Universities; Universite Paris Cite	Gueguen, N (corresponding author), Univ Angers, F-49000 Angers, France.	NaGueguen@chu-angers.fr	Henrion, Daniel/N-7023-2015; Baron, Stephanie/AAY-5703-2020; Lenaers, guy/X-4727-2019; Nivet-Antoine, Valerie/R-1981-2017; Henrion, Daniel/J-8141-2015; Henrion, Daniel/AAK-1995-2021; Naig, Gueguen/K-2699-2015; lenaers, guy/K-2421-2015	Henrion, Daniel/0000-0003-1094-0285; Baron, Stephanie/0000-0002-0375-6968; Nivet-Antoine, Valerie/0000-0003-2490-0428; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Naig, Gueguen/0000-0002-3094-8121; procaccio, Vincent/0000-0002-1537-4684; Reynier, Pascal/0000-0003-0802-4608; lenaers, guy/0000-0003-2736-3349; Desquiret-Dumas, Valerie/0000-0001-9551-9400	Region Pays de la Loire; Fondation pour la Recherche Medicale [DRM20101220457]; Union Nationale des Aveugles et Deficients Visuels; Retina France; Ouvrir les Yeux; Association contre les Maladies Mitochondriales	Region Pays de la Loire(Region Pays de la Loire); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Union Nationale des Aveugles et Deficients Visuels; Retina France; Ouvrir les Yeux; Association contre les Maladies Mitochondriales	Funding provided by Region Pays de la Loire (VP, PR), Fondation pour la Recherche Medicale (VP) grant no DRM20101220457, Union Nationale des Aveugles et Deficients Visuels www.unadev.com (VP, PR), Retina France www.retina.fr (PR), Ouvrir les Yeux www.ouvrirlesyeux.org (PR) and Association contre les Maladies Mitochondriales www.association-ammi.org (VP, PR).	Agarwal B, 2013, INT J CARDIOL, V166, P246, DOI 10.1016/j.ijcard.2012.09.027; de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Baron S, 2014, J GERONTOL A-BIOL, V69, P260, DOI 10.1093/gerona/glt081; Bastin J, 2011, HUM MOL GENET, V20, P2048, DOI 10.1093/hmg/ddr089; Batandier C, 2006, J BIOENERG BIOMEMBR, V38, P33, DOI 10.1007/s10863-006-9003-8; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; BENZI G, 1992, NEUROBIOL AGING, V13, P361, DOI 10.1016/0197-4580(92)90109-B; Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003; Bikadi Z, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-15; Birrell JA, 2013, BIOCHEM J, V456, P139, DOI 10.1042/BJ20130606; Birrell JA, 2011, FEBS LETT, V585, P2318, DOI 10.1016/j.febslet.2011.05.065; Bosutti A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08093; Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46; Boyer JZ, 2012, J PHOTOCH PHOTOBIO B, V113, P42, DOI 10.1016/j.jphotobiol.2012.04.013; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P1034, DOI 10.1177/0960327110383641; Chakrabarti S, 2011, AGING DIS, V2, P242; Chan SHH, 2009, HYPERTENSION, V53, P217, DOI 10.1161/HYPERTENSIONAHA.108.116905; Chen CZ, 2013, FOOD CHEM TOXICOL, V59, P8, DOI 10.1016/j.fct.2013.05.030; Crowell JA, 2004, TOXICOL SCI, V82, P614, DOI 10.1093/toxsci/kfh263; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; Desquiret-Dumas V, 2013, J BIOL CHEM, V288, P36662, DOI 10.1074/jbc.M113.466490; Djafarzadeh R, 2000, BBA-BIOENERGETICS, V1459, P230, DOI 10.1016/S0005-2728(00)00154-7; Flamment M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1162, DOI 10.1152/ajpendo.00169.2009; Friedman J, 2011, OXID STRESS APPL BAS, P19, DOI 10.1007/978-1-60327-514-9_2; Fu S, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00022; Fukuhara K, 2006, BIOORGAN MED CHEM, V14, P1437, DOI 10.1016/j.bmc.2005.09.070; Fukui M, 2010, FREE RADICAL BIO MED, V49, P800, DOI 10.1016/j.freeradbiomed.2010.06.002; Fusser M, 2011, CARCINOGENESIS, V32, P80, DOI 10.1093/carcin/bgq196; Galati G, 2002, TOXICOLOGY, V177, P91, DOI 10.1016/S0300-483X(02)00198-1; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Gertz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049761; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Gliemann L, 2013, J PHYSIOL-LONDON, V591, P5047, DOI 10.1113/jphysiol.2013.258061; Guillet V, 2011, FASEB J, V25, P1618, DOI 10.1096/fj.10-173609; Guillet V, 2010, MITOCHONDRION, V10, P115, DOI 10.1016/j.mito.2009.11.004; Hadi SM, 2007, SEMIN CANCER BIOL, V17, P370, DOI 10.1016/j.semcancer.2007.04.002; Han YS, 2004, BRIT J PHARMACOL, V141, P997, DOI 10.1038/sj.bjp.0705688; Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Jackson JR, 2011, J GERONTOL A-BIOL, V66, P751, DOI 10.1093/gerona/glr047; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kipp JL, 2001, ENDOCRINE, V15, P165, DOI 10.1385/ENDO:15:2:165; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Kudin AP, 2008, BBA-BIOENERGETICS, V1777, P689, DOI 10.1016/j.bbabio.2008.05.010; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Leifert WR, 2008, NUTR RES, V28, P729, DOI 10.1016/j.nutres.2008.09.001; Lelfert WR, 2008, NUTR RES, V28, P842, DOI 10.1016/j.nutres.2008.09.001; LEQUOC D, 1976, BIOCHEM BIOPH RES CO, V68, P106, DOI 10.1016/0006-291X(76)90016-4; Lu KT, 2006, J AGR FOOD CHEM, V54, P3126, DOI [10.1021/jf053011q, 10.1021/JF053011Q]; Manczak M, 2005, J NEUROCHEM, V92, P494, DOI 10.1111/j.1471-4159.2004.02884.x; Lopez-Nicolas JM, 2008, J AGR FOOD CHEM, V56, P7600, DOI 10.1021/jf800843e; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Menet MC, 2013, ANAL CHIM ACTA, V761, P128, DOI 10.1016/j.aca.2012.11.048; Moreira AC, 2013, FOOD CHEM TOXICOL, V53, P18, DOI 10.1016/j.fct.2012.11.031; Mourier A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001129; Nemekaite-Ceniene A, 2005, ARCH BIOCHEM BIOPHYS, V441, P182, DOI 10.1016/j.abb.2005.07.002; Nulton-Persson AC, 2004, J CARDIOVASC PHARM, V44, P591, DOI 10.1097/00005344-200411000-00012; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pereverzev MO, 2003, BIOCHEM SOC T, V31, P1312; Pshenichnyuk Stanislav A, 2015, Methods Mol Biol, V1265, P285, DOI 10.1007/978-1-4939-2288-8_20; Ray PS, 1999, FREE RADICAL BIO MED, V27, P160, DOI 10.1016/S0891-5849(99)00063-5; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Robb EL, 2008, BIOCHEM BIOPH RES CO, V372, P254, DOI 10.1016/j.bbrc.2008.05.028; Robb EL, 2010, MOLECULES, V15, P1196, DOI 10.3390/molecules15031196; Rocha KKR, 2009, FOOD CHEM TOXICOL, V47, P1362, DOI 10.1016/j.fct.2009.03.010; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sakai K, 2014, SUBCELL BIOCHEM, V77, P61, DOI 10.1007/978-94-007-7920-4_5; Salvador Gabriela A, 2010, Int J Alzheimers Dis, V2011, P720658, DOI 10.4061/2011/720658; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Sassi N, 2014, BBA-BIOENERGETICS, V1837, P1781, DOI 10.1016/j.bbabio.2014.06.010; Sassi N, 2014, CURR PHARM DESIGN, V20, P172, DOI 10.2174/13816128113199990034; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schirmer H, 2012, MOL BIOL REP, V39, P3281, DOI 10.1007/s11033-011-1096-4; Srividhya R, 2009, INT J DEV NEUROSCI, V27, P223, DOI 10.1016/j.ijdevneu.2009.01.003; Stojanovic S, 2001, ARCH BIOCHEM BIOPHYS, V391, P79, DOI 10.1006/abbi.2001.2388; Tan GY, 2010, POULTRY SCI, V89, P115, DOI 10.3382/ps.2009-00318; Vingtdeux V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S6; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Wilson T, 1996, LIFE SCI, V59, pPL15, DOI 10.1016/0024-3205(96)00260-3; Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397; Zhou X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.530; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859; Zini R, 1999, DRUG EXP CLIN RES, V25, P87	90	55	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144290	10.1371/journal.pone.0144290	http://dx.doi.org/10.1371/journal.pone.0144290			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684010	gold, Green Submitted, Green Published			2022-12-27	WOS:000366725800012
J	Jetsu, L; Porceddu, S				Jetsu, Lauri; Porceddu, Sebastian			Shifting Milestones of Natural Sciences: The Ancient Egyptian Discovery of Algol's Period Confirmed	PLOS ONE			English	Article							TRIPLE SYSTEM	The Ancient Egyptians wrote Calendars of Lucky and Unlucky Days that assigned astronomically influenced prognoses for each day of the year. The best preserved of these calendars is the Cairo Calendar (hereafter CC) dated to 1244-1163 B.C. We have presented evidence that the 2.85 days period in the lucky prognoses of CC is equal to that of the eclipsing binary Algol during this historical era. We wanted to find out the vocabulary that represents Algol in the mythological texts of CC. Here we show that Algol was represented as Horus and thus signified both divinity and kingship. The texts describing the actions of Horus are consistent with the course of events witnessed by any naked eye observer of Algol. These descriptions support our claim that CC is the oldest preserved historical document of the discovery of a variable star. The period of the Moon, 29.6 days, has also been discovered in CC. We show that the actions of Seth were connected to this period, which also strongly regulated the times described as lucky for Heaven and for Earth. Now, for the first time, periodicity is discovered in the descriptions of the days in CC. Unlike many previous attempts to uncover the reasoning behind the myths of individual days, we discover the actual rules in the appearance and behaviour of deities during the whole year.	[Jetsu, Lauri; Porceddu, Sebastian] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland	University of Helsinki	Jetsu, L (corresponding author), Univ Helsinki, Dept Phys, POB 64, FI-00014 Helsinki, Finland.	lauri.jetsu@helsinki.fi		Porceddu, Sebastian/0000-0002-7361-2644; Jetsu, Lauri/0000-0001-6418-5137				Adams WB, 2011, ASTRONOMICAL SOC PAC, V441, P311; Bakir A. el-M., 1966, CAIRO CALENDAR 86637; Baron F, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/20; Brunner-Traut E., 1970, ANTAIOS, V12, P332; Clagett Marshall, 1995, ANCIENT EGYPTIAN SCI, V2; Goodricke J., 1783, ROYAL SOC LONDON P 1, V73, P474; Hardy PA, 2002, ARCH, V17, P48; Jetsu L, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/1; Krauss R., 2002, EYE HORUS PLANET VEN, P297; Leitz, 1989, STUDIEN AGYPTISCHEN, V49; Leitz C., 1994, TAGEWAHLEREI BUCH VE; Lichtheim M., 1976, ANCIENT EGYPTIAN LIT; Porceddu S, 2008, CAMB ARCHAEOL J, V18, P327, DOI 10.1017/S0959774308000395; Smith DG, 2012, EGYPTOLOGICAL J  OCT, P6; Troy L., 1989, UPPSALA STUDIES ANCI, V20, P127; Wells R. A., 2001, OXFORD ENCY ANCIENT, V2; Wells RA, 1994, REVOLUTION TIME STUD; Winnecke A., 1878, MNRAS, V39, P146, DOI [10.1093/mnras/39.2.146, DOI 10.1093/MNRAS/39.2.146]; Zavala RT, 2010, ASTROPHYS J LETT, V715, pL44, DOI 10.1088/2041-8205/715/1/L44	19	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144140	10.1371/journal.pone.0144140	http://dx.doi.org/10.1371/journal.pone.0144140			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679699	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400009
J	Logan, SL; Spriet, LL				Logan, Samantha L.; Spriet, Lawrence L.			Omega-3 Fatty Acid Supplementation for 12 Weeks Increases Resting and Exercise Metabolic Rate in Healthy Community-Dwelling Older Females	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DIETARY FISH-OIL; RANDOMIZED CONTROLLED-TRIALS; SKELETAL-MUSCLE METABOLISM; OMEGA-3 SUPPLEMENTATION; ENERGY-EXPENDITURE; PHYSICAL-ACTIVITY; BODY-COMPOSITION; DISEASE RISK; ADULTS	Critical among the changes that occur with aging are decreases in muscle mass and metabolic rate and an increase in fat mass. These changes may predispose older adults to chronic disease and functional impairment; ultimately resulting in a decrease in the quality of life. Research has suggested that long chain omega-3 fatty acids, found predominantly in fatty fish, may assist in reducing these changes. The objective of this study was to evaluate the effect of fish oil (FO) supplementation in a cohort of healthy, community-dwelling older females on 1) metabolic rate and substrate oxidation at rest and during exercise; 2) resting blood pressure and resting and exercise heart rates; 3) body composition; 4) strength and physical function, and; 5) blood measures of insulin, glucose, c-reactive protein, and triglycerides. Twenty-four females (66 +/- 1 yr) were recruited and randomly assigned to receive either 3g/d of EPA and DHA or a placebo (PL, olive oil) for 12 wk. Exercise measurements were taken before and after 12 wk of supplementation and resting metabolic measures were made before and at 6 and 12 wk of supplementation. The results demonstrated that FO supplementation significantly increased resting metabolic rate by 14%, energy expenditure during exercise by 10%, and the rate of fat oxidation during rest by 19% and during exercise by 27%. In addition, FO consumption lowered triglyceride levels by 29% and increased lean mass by 4% and functional capacity by 7%, while no changes occurred in the PL group. In conclusion, FO may be a strategy to improve age-related physical and metabolic changes in healthy older females.	[Logan, Samantha L.; Spriet, Lawrence L.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Logan, SL (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	samanthell@gmail.com			Natural Sciences and Engineering Research Council of Canada Discovery grant [NCT01734538]	Natural Sciences and Engineering Research Council of Canada Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was a registered Clinical Trial (NCT01734538) and was supported by a Natural Sciences and Engineering Research Council of Canada Discovery grant to LLS.	Abe Y, 1998, ARTERIOSCL THROM VAS, V18, P723, DOI 10.1161/01.ATV.18.5.723; [Anonymous], [No title captured]; Baillie RA, 1999, PROSTAG LEUKOTR ESS, V60, P351, DOI 10.1016/S0952-3278(99)80011-8; Balk EM, 2006, ATHEROSCLEROSIS, V189, P19, DOI 10.1016/j.atherosclerosis.2006.02.012; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bryan Shirley, 2010, Health Rep, V21, P71; Buckley JD, 2010, NUTRIENTS, V2, P1212, DOI 10.3390/nu2121212; Campbell WW, 2001, J GERONTOL A-BIOL, V56, pM373, DOI 10.1093/gerona/56.6.M373; Canadian Society for Exercise Physiology, 2003, CAN PHYS ACT FITN LI; Clavel S, 2002, EUR J APPL PHYSIOL, V87, P193, DOI 10.1007/s00421-002-0612-6; Couet C, 1997, INT J OBESITY, V21, P637, DOI 10.1038/sj.ijo.0800451; Deslypere J P, 1992, Verh K Acad Geneeskd Belg, V54, P189; Drewnowski A, 2001, J GERONTOL A-BIOL, V56, P89, DOI 10.1093/gerona/56.suppl_2.89; Elia M, 1999, ORGAN TISSUE CONTRIB, P61; Eritsland J, 1996, AM J CARDIOL, V77, P31, DOI 10.1016/S0002-9149(97)89130-8; EVANS WJ, 1993, J NUTR, V123, P465, DOI 10.1093/jn/123.suppl_2.465; Farooqui AA, 2006, PHOSPHOLIPASE A2 GEN, P115; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geleijnse JM, 2002, J HYPERTENS, V20, P1493, DOI 10.1097/00004872-200208000-00010; Gerling CJ, 2014, APPL PHYSIOL NUTR ME, V39, P1083, DOI 10.1139/apnm-2014-0049; Gladman SJ, 2012, J NEUROSCI, V32, P563, DOI 10.1523/JNEUROSCI.3371-11.2012; Harris WS, 2008, ATHEROSCLEROSIS, V197, P12, DOI 10.1016/j.atherosclerosis.2007.11.008; Harris WS, 2009, J NUTR, V139, p804S, DOI 10.3945/jn.108.101329; Health Canada, 2014, CONS ADV MAK INF CHO; Health Canada, 2014, DIET REF VAL MACR; Health Canada, 2014, FOOD NUTR EST EN REQ; Herbst EAF, 2014, J PHYSIOL-LONDON, V592, P1341, DOI 10.1113/jphysiol.2013.267336; Hulbert AJ, 2007, LIPIDS, V42, P811, DOI 10.1007/s11745-007-3058-0; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; Hutchins-Wiese HL, 2013, J NUTR HEALTH AGING, V17, P76, DOI 10.1007/s12603-012-0415-3; Janssen I, 2000, J APPL PHYSIOL, V89, P81; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Kota BP, 2005, PHARMACOL RES, V51, P85, DOI 10.1016/j.phrs.2004.07.012; LAKATTA EG, 1987, J AM COLL CARDIOL, V10, pA42, DOI 10.1016/S0735-1097(87)80447-3; Leaf A, 1999, J MEMBRANE BIOL, V172, P1, DOI 10.1007/s002329900578; Leonard WR, 2010, J ANTHROPOL SCI, V88, P221; Lin QO, 1999, BIOCHEMISTRY-US, V38, P185, DOI 10.1021/bi9816094; Logan SL, 2013, J HUM NUTR FOOD SCI, V1, P1; Mozaffarian D, 2005, CIRCULATION, V112, P1945, DOI 10.1161/CIRCULATIONAHA.105.556886; Muskiet FAJ, 2004, J NUTR, V134, P183, DOI 10.1093/jn/134.1.183; Noreen EE, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-31; Olesen J, 2010, PFLUG ARCH EUR J PHY, V460, P153, DOI 10.1007/s00424-010-0834-0; Patten GS, 2002, J NUTR, V132, P2506, DOI 10.1093/jn/132.9.2506; PEPE S, 1993, J PHARMACOL TOXICOL, V29, P203, DOI 10.1016/1056-8719(93)90026-B; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Poprzecki S, 2009, INT J FOOD SCI NUTR, V60, P67, DOI 10.1080/09637480802406161; Power GW, 1997, J NUTR, V127, P2142, DOI 10.1093/jn/127.11.2142; Rodacki CLN, 2012, AM J CLIN NUTR, V95, P428, DOI 10.3945/ajcn.111.021915; Rosa M. L. de, 2012, Pharmacology and Pharmacy, V3, P234, DOI 10.4236/pp.2012.32031; Schutz Y, 2002, INT J OBESITY, V26, P953, DOI 10.1038/sj.ijo.0802037; Seo T, 2005, CURR OPIN LIPIDOL, V16, P11, DOI 10.1097/00041433-200502000-00004; Shields M, 2010, HEALTH REP, V21; Smith GI, 2015, AM J CLIN NUTR, V102, P115, DOI 10.3945/ajcn.114.105833; Smith GI, 2011, AM J CLIN NUTR, V93, P402, DOI 10.3945/ajcn.110.005611; Statistics Canada, 2014, PORTR SEN CAN; Visser M., 2012, SARCOPENIA, P1; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Williams KN, 2010, J PSYCHOSOC NURS MEN, V48, P42, DOI 10.3928/02793695-20100331-03; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	62	88	90	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144828	10.1371/journal.pone.0144828	http://dx.doi.org/10.1371/journal.pone.0144828			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679702	Green Published, Green Submitted, gold			2022-12-27	WOS:000366723400029
J	Brun, J; Lutz, KA; Neumayer, KMH; Klein, G; Seeger, T; Uynuk-Ool, T; Worgotter, K; Schmid, S; Kraushaar, U; Guenther, E; Rolauffs, B; Aicher, WK; Hart, ML				Brun, Juliane; Lutz, Katrin A.; Neumayer, Katharina M. H.; Klein, Gerd; Seeger, Tanja; Uynuk-Ool, Tatiana; Woergoetter, Katharina; Schmid, Sandra; Kraushaar, Udo; Guenther, Elke; Rolauffs, Bernd; Aicher, Wilhelm K.; Hart, Melanie L.			Smooth Muscle-Like Cells Generated from Human Mesenchymal Stromal Cells Display Marker Gene Expression and Electrophysiological Competence Comparable to Bladder Smooth Muscle Cells	PLOS ONE			English	Article							STRESS URINARY-INCONTINENCE; GATED SODIUM-CHANNELS; STEM-CELLS; T-TYPE; CA2+ CHANNELS; PERIURETHRAL INJECTION; PHENOTYPIC MODULATION; MOLECULAR REGULATION; REGENERATIVE CELLS; VASCULAR-DISEASE	The use of mesenchymal stromal cells (MSCs) differentiated toward a smooth muscle cell (SMC) phenotype may provide an alternative for investigators interested in regenerating urinary tract organs such as the bladder where autologous smooth muscle cells cannot be used or are unavailable. In this study we measured the effects of good manufacturing practice (GMP)-compliant expansion followed by myogenic differentiation of human MSCs on the expression of a range of contractile (from early to late) myogenic markers in relation to the electrophysiological parameters to assess the functional role of the differentiated MSCs and found that differentiation of MSCs associated with electrophysiological competence comparable to bladder SMCs. Within 1-2 weeks of myogenic differentiation, differentiating MSCs significantly expressed alpha smooth muscle actin (alpha SMA; ACTA2), transgelin (TAGLN), calponin (CNN1), and smooth muscle myosin heavy chain (SM-MHC; MYH11) according to qRT-PCR and/or immunofluorescence and Western blot. Voltage-gated Na+ current levels also increased within the same time period following myogenic differentiation. In contrast to undifferentiated MSCs, differentiated MSCs and bladder SMCs exhibited elevated cytosolic Ca2+ transients in response to K+-induced depolarization and contracted in response to K+ indicating functional maturation of differentiated MSCs. Depolarization was suppressed by Cd2+, an inhibitor of voltage-gated Ca2+-channels. The expression of Na+-channels was pharmacologically identified as the Na(v)1.4 subtype, while the K+ and Ca2+ ion channels were identified by gene expression of KCNMA1, CACNA1C and CACNA1H which encode for the large conductance Ca2+-activated K+ channel BKCa channels, Cav1.2 L-type Ca2+ channels and Cav3.2 T-type Ca2+ channels, respectively. This protocol may be used to differentiate adult MSCs into smooth muscle-like cells with an intermediate-to-late SMC contractile phenotype exhibiting voltage-gated ion channel activity comparable to bladder SMCs which may be important for urological regenerative medicine applications.	[Brun, Juliane; Lutz, Katrin A.; Neumayer, Katharina M. H.; Aicher, Wilhelm K.; Hart, Melanie L.] Univ Tubingen, Dept Urol, Clin Res Grp KFO 273, Tubingen, Germany; [Klein, Gerd; Seeger, Tanja] Univ Tubingen, Med Res Ctr, Univ Med Clin, Dept 2, Tubingen, Germany; [Uynuk-Ool, Tatiana; Woergoetter, Katharina; Rolauffs, Bernd; Hart, Melanie L.] Univ Tubingen, Siegfried Weller Inst Trauma Res, Lab Mol Biomech, Tubingen, Germany; [Schmid, Sandra; Kraushaar, Udo; Guenther, Elke] Univ Tubingen, NMI Nat & Med Sci Inst, Dept Electrophysiol, Reutlingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Hart, ML (corresponding author), Univ Tubingen, Dept Urol, Clin Res Grp KFO 273, Tubingen, Germany.	melaniehar@gmail.com	Klein, Gerd/C-8499-2013	Kraushaar, Udo/0000-0002-4660-1093; Rolauffs, Bernd/0000-0002-3275-8196; Brun, Juliane/0000-0002-0964-3681; Aicher, Wilhelm K/0000-0003-2210-6773; Dr. Guenther, Elke/0000-0002-8758-1607	German Research Foundation (DFG); Kathe und Josef Klinz-Stiftung	German Research Foundation (DFG)(German Research Foundation (DFG)); Kathe und Josef Klinz-Stiftung	This study was funded by the German Research Foundation (DFG) for the KFO 273 (http://www.kfo273.org), the Kathe und Josef Klinz-Stiftung and institutional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Tanja Abruzzese and Jan Maerz for their excellent technical support and expert training of the students involved in this project. We would also like to thank Dr. Hans-Jorg Buhring and Dr. Kavitha Sivasubramanian for helping with the flow cytometry experiments, as well as Sandra Buckenmaier for helping with the patch clamp data. This study was funded by the German Research Foundation (DFG) for the KFO 273 (http://www.kfo273.org), the Kathe und Josef Klinz-Stiftung and institutional funding.	Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Antoon R, 2012, J BIOMED MATER RES A, V100A, P72, DOI 10.1002/jbm.a.33230; Archer SL, 1996, CIRC RES, V78, P431, DOI 10.1161/01.RES.78.3.431; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Babu GJ, 2000, MICROSC RES TECHNIQ, V50, P532, DOI 10.1002/1097-0029(20000915)50:6<532::AID-JEMT10>3.0.CO;2-E; Bajpai VK, 2012, STEM CELL RES, V8, P74, DOI 10.1016/j.scr.2011.07.003; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Bharadwaj S, 2011, TISSUE ENG PT A, V17, P2123, DOI [10.1089/ten.TEA.2010.0637, 10.1089/ten.tea.2010.0637]; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Bieback K, 2013, TRANSFUS MED HEMOTH, V40, P326, DOI 10.1159/000354061; Buhring HJ, 2007, ANN NY ACAD SCI, V1106, P262, DOI 10.1196/annals.1392.000; Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0; Campbell JH, 2012, ARTERIOSCL THROM VAS, V32, P1784, DOI 10.1161/ATVBAHA.111.243212; Cheong A, 2006, CELL CYCLE, V5, P129, DOI 10.4161/cc.5.2.2310; Cox RH, 1998, J VASC RES, V35, P310, DOI 10.1159/000025600; Doughty D., 2005, URINARY FECAL INCONT, V3rd; Felka T, 2010, CYTOTHERAPY, V12, P143, DOI 10.3109/14653240903470647; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Fry CH, 2006, CELL CALCIUM, V40, P231, DOI 10.1016/j.ceca.2006.04.027; Fry CH, 2014, PFLUG ARCH EUR J PHY, V466, P781, DOI 10.1007/s00424-014-1446-x; Gong Z, 2009, TISSUE ENG PT A, V15, P319, DOI 10.1089/ten.tea.2008.0161; Gotoh M, 2014, INT J UROL, V21, P294, DOI 10.1111/iju.12266; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harris LJ, 2011, J SURG RES, V168, P306, DOI 10.1016/j.jss.2009.08.001; Hart ML, 2015, TISSUE ENG PART B-RE, V21, P365, DOI [10.1089/ten.teb.2014.0627, 10.1089/ten.TEB.2014.0627]; Hart ML, 2015, TISSUE EN B IN PRESS; Herman IM, 1993, CURR OPIN CELL BIOL, V5, P48, DOI 10.1016/S0955-0674(05)80007-9; Herrera GM, 2001, AM J PHYSIOL-CELL PH, V280, pC481, DOI 10.1152/ajpcell.2001.280.3.C481; Herrera-Imbroda B, 2015, ADV DRUG DELIVER REV, V82-83, P106, DOI 10.1016/j.addr.2014.10.018; Hill-Eubanks DC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004549; Hollywood MA, 2003, J PHYSIOL-LONDON, V550, P753, DOI 10.1113/jphysiol.2003.043695; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035; Kajioka S, 2002, EUR J PHARMACOL, V443, P19, DOI 10.1016/S0014-2999(02)01593-5; Kanematsu A, 2005, AM J PATHOL, V166, P565, DOI 10.1016/S0002-9440(10)62278-X; Kim JH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/930713; Klein G, 2015, ADV DRUG DELIVER REV, V82-83, P123, DOI 10.1016/j.addr.2014.10.026; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Lee CN, 2010, J KOREAN MED SCI, V25, P813, DOI 10.3346/jkms.2010.25.6.813; MURAKI K, 1991, J PHYSIOL-LONDON, V442, P351, DOI 10.1113/jphysiol.1991.sp018797; Narita Y, 2008, CELL TISSUE RES, V333, P449, DOI 10.1007/s00441-008-0654-0; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Park WS, 2013, AM J PHYSIOL-CELL PH, V305, pC377, DOI 10.1152/ajpcell.00404.2012; Petkov GV, 2014, AM J PHYSIOL-REG I, V307, pR571, DOI 10.1152/ajpregu.00142.2014; Pilz GA, 2011, STEM CELLS DEV, V20, P635, DOI 10.1089/scd.2010.0308; Platoshyn O, 2004, AM J PHYSIOL-LUNG C, V287, pL226, DOI 10.1152/ajplung.00438.2003; Raghavan AM, 2009, KIDNEY INT, V76, P236, DOI 10.1038/ki.2009.81; Ratz PH, 2005, AM J PHYSIOL-CELL PH, V288, pC769, DOI 10.1152/ajpcell.00529.2004; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rodman DM, 2005, CIRC RES, V96, P864, DOI 10.1161/01.RES.0000163066.07472.ff; Saleh S, 2005, J PHYSIOL-LONDON, V568, P155, DOI 10.1113/jphysiol.2005.090951; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Seeger T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137419; SHINJOH M, 1991, EUR J PHARMACOL, V205, P199; Sobue K, 1999, MOL CELL BIOCHEM, V190, P105, DOI 10.1023/A:1006941621170; Sui GP, 2004, PROSTATE, V59, P275, DOI 10.1002/pros.20007; Sui GP, 2003, BJU INT, V92, P476, DOI 10.1046/j.1464-410X.2003.04356.x; Tian H, 2010, BIOMATERIALS, V31, P870, DOI 10.1016/j.biomaterials.2009.10.001; Ulrich C, 2015, STEM CELLS DEV, V24, P1558, DOI 10.1089/scd.2014.0465; Ulrich C, 2013, STEM CELLS DEV, V22, P2859, DOI 10.1089/scd.2012.0693; Wang GK, 2008, MOL PHARMACOL, V73, P940, DOI 10.1124/mol.107.041541; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; Williams C, 2012, TISSUE ENG PT A, V18, P986, DOI [10.1089/ten.tea.2011.0172, 10.1089/ten.TEA.2011.0172]; WINDER SJ, 1993, CELL SIGNAL, V5, P677, DOI 10.1016/0898-6568(93)90029-L; Yamamoto T, 2012, INT J UROL, V19, P652, DOI 10.1111/j.1442-2042.2012.02999.x	67	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145153	10.1371/journal.pone.0145153	http://dx.doi.org/10.1371/journal.pone.0145153			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673782	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700108
J	Evans, BJ; Carter, TF; Greenbaum, E; Gvozdik, V; Kelley, DB; McLaughlin, PJ; Pauwels, OSG; Portik, DM; Stanley, EL; Tinsley, RC; Tobias, ML; Blackburn, DC				Evans, Ben J.; Carter, Timothy F.; Greenbaum, Eli; Gvozdik, Vaclav; Kelley, Darcy B.; McLaughlin, Patrick J.; Pauwels, Olivier S. G.; Portik, Daniel M.; Stanley, Edward L.; Tinsley, Richard C.; Tobias, Martha L.; Blackburn, David C.			Genetics, Morphology, Advertisement Calls, and Historical Records Distinguish Six New Polyploid Species of African Clawed Frog (Xenopus, Pipidae) from West and Central Africa	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; LAEVIS-LAEVIS ANURA; GENUS XENOPUS; SKIN SECRETIONS; CAPE PROVINCE; EVOLUTION; PHYLOGENY; GENOME; SOUTH; GILLI	African clawed frogs, genus Xenopus, are extraordinary among vertebrates in the diversity of their polyploid species and the high number of independent polyploidization events that occurred during their diversification. Here we update current understanding of the evolutionary history of this group and describe six new species from west and central sub-Saharan Africa, including four tetraploids and two dodecaploids. We provide information on molecular variation, morphology, karyotypes, vocalizations, and estimated geographic ranges, which support the distinctiveness of these new species. We resurrect Xenopus calcaratus from synonymy of Xenopus tropicalis and refer populations from Bioko Island and coastal Cameroon (near Mt. Cameroon) to this species. To facilitate comparisons to the new species, we also provide comments on the type specimens, morphology, and distributions of X. epitropicalis, X. tropicalis, and X. fraseri. This includes significantly restricted application of the names X. fraseri and X. epitropicalis, the first of which we argue is known definitively only from type specimens and possibly one other specimen. Inferring the evolutionary histories of these new species allows refinement of species groups within Xenopus and leads to our recognition of two subgenera (Xenopus and Silurana) and three species groups within the subgenus Xenopus (amieti, laevis, and muelleri species groups).	[Evans, Ben J.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Carter, Timothy F.] Univ Guelph, Ontario Vet Coll, Biomed Sci, Guelph, ON N1G 2W1, Canada; [Greenbaum, Eli] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Gvozdik, Vaclav] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Gvozdik, Vaclav; Tobias, Martha L.] Natl Museum, Dept Zool, Prague, Czech Republic; [Kelley, Darcy B.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [McLaughlin, Patrick J.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Pauwels, Olivier S. G.] Inst Royal Sci Nat Belgique, Dept Vertebres Recents, B-1040 Brussels, Belgium; [Portik, Daniel M.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Stanley, Edward L.; Blackburn, David C.] Calif Acad Sci, San Francisco, CA 94118 USA; [Tinsley, Richard C.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	McMaster University; University of Guelph; University of Texas System; University of Texas El Paso; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; National Museum; Columbia University; Drexel University; University of California System; University of California Berkeley; California Academy of Sciences; University of Bristol	Evans, BJ (corresponding author), McMaster Univ, Dept Biol, Life Sci Bldg,Room 328, Hamilton, ON, Canada.	evansb@mcmaster.ca	Gvozdik, Vaclav/E-4043-2010; Blackburn, David/L-3812-2019	Blackburn, David/0000-0002-1810-9886; Evans, Ben/0000-0002-9512-8845	NSERC [RGPIN/283102-2012]; NSF [DEB1202609]; Museum of Comparative Zoology; Czech Science Foundation (GACR) [15-13415Y]; IVB institutional support [RVO: 68081766]; Ministry of Culture of the Czech Republic [DKRVO 2015/15, 00023272]; Centre National de la Recherche Scientifique et Technologique (CENAREST); Direct For Biological Sciences [1145459] Funding Source: National Science Foundation; Division Of Environmental Biology [1560667] Funding Source: National Science Foundation	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); Museum of Comparative Zoology; Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); IVB institutional support; Ministry of Culture of the Czech Republic; Centre National de la Recherche Scientifique et Technologique (CENAREST)(Centre National de la Recherche Scientifique (CNRS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support for components of this work come from NSERC RGPIN/283102-2012 BJE), NSF DEB1202609 (DCB), and the Museum of Comparative Zoology. VG was supported by the Czech Science Foundation (GACR, project number 15-13415Y), IVB institutional support (RVO: 68081766), and Ministry of Culture of the Czech Republic (DKRVO 2015/15, National Museum, 00023272). The material collected in Gabon was supported by a National Geographic Young Explorer's Grant with permission from the Centre National de la Recherche Scientifique et Technologique (CENAREST) and logistical support of the Wildlife Conservation Society, Gabon Program.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AmphibiaWeb, 2015, INF AMPH BIOL CONS; Bauer Aaron M., 1996, Mitteilungen aus dem Zoologischen Museum in Berlin, V72, P259; Bewick AJ, 2013, GENOME BIOL EVOL, V5, P1087, DOI 10.1093/gbe/evt073; Bewick AJ, 2012, SYST BIOL, V61, P913, DOI 10.1093/sysbio/sys039; Bewick AJ, 2011, EVOLUTION, V65, P698, DOI 10.1111/j.1558-5646.2010.01163.x; Blackburn DC, 2011, ZOOTAXA, P57, DOI 10.11646/zootaxa.3035.1.2; Boulenger G.A., 1882, CATALOGUE BATRACHIA, VSecond; Boulenger GA, 1905, P ZOOL SOC LOND, V1905, P248; Bowes JB, 2008, NUCLEIC ACIDS RES, V36, pD761, DOI 10.1093/nar/gkm826; Brown R.W., 1956, COMPOSITION SCI WORD; Cannatella D, 2015, CYTOGENET GENOME RES, V145, P283, DOI 10.1159/000438910; CANNATELLA DC, 1993, SYST BIOL, V42, P476, DOI 10.2307/2992485; CANNATELLA DC, 1988, ZOOL J LINN SOC-LOND, V94, P1, DOI 10.1111/j.1096-3642.1988.tb00880.x; Conlon JM, 2015, PEPTIDES, V63, P118, DOI 10.1016/j.peptides.2014.11.005; Conlon JM, 2014, COMP BIOCHEM PHYS D, V12, P45, DOI 10.1016/j.cbd.2014.10.001; Conlon JM, 2012, PEPTIDES, V37, P113, DOI 10.1016/j.peptides.2012.07.005; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Oliveira FB, 2006, S AM PRIMATES COMP P, P55; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Du Preez LH, 2009, AQUAT TOXICOL, V95, P10, DOI 10.1016/j.aquatox.2009.07.018; Dupont LM, 2000, PALAEOGEOGR PALAEOCL, V155, P95, DOI 10.1016/S0031-0182(99)00095-4; Ernst R, 2015, SALAMANDRA, V51, P147; ESTES R, 1977, Annals of the South African Museum, V73, P49; Evans BJ, 2011, J ZOOL, V283, P276, DOI 10.1111/j.1469-7998.2010.00769.x; Evans B. J., 2012, POLYPLOIDY GENOME EV, P385, DOI DOI 10.1007/978-3-642-31442-1_18; Evans BJ, 2008, FRONT BIOSCI-LANDMRK, V13, P4687, DOI 10.2741/3033; Evans BJ, 2008, ZOOTAXA, P55; Evans BJ, 2007, GENETICS, V176, P1119, DOI 10.1534/genetics.106.069690; Evans BJ, 2011, MOL ECOL, V20, P4216, DOI 10.1111/j.1365-294X.2011.05262.x; Evans BJ, 2005, MOL BIOL EVOL, V22, P1193, DOI 10.1093/molbev/msi104; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Evans BJ, 1998, COPEIA, P504; Evans BJ, 1997, MOL ECOL, V6, P333, DOI 10.1046/j.1365-294X.1997.00198.x; Fischberg M., 1982, Alytes (Paris), V1, P53; Fischer WJ, 2000, J ZOOL, V252, P99, DOI 10.1017/S0952836900009110; Fisher CT, 2013, OXFORD DICT NATL BIO; FLAJNIK MF, 1993, EMBO J, V12, P4385, DOI 10.1002/j.1460-2075.1993.tb06123.x; Fogell DJ, 2013, PEERJ, V1, DOI 10.7717/peerj.166; Furman BLS, 2015, MOL ECOL, V24, P909, DOI 10.1111/mec.13076; GRAF JD, 1986, BIOCHEM GENET, V24, P821, DOI 10.1007/BF00554522; Gray J.E., 1864, ANN MAG NAT HIST, V14, P315; GREENBAUM E, 2010, HERPETOLOGICAL REV, V41, P376; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunther A, 1858, CATALOGUE BATRACHIA; Haramoto Y, 2015, MITOCHONDRI IN PRESS; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; Hedtke SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067908; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Henrici AC, 2001, J PALEONTOL, V75, P870, DOI 10.1666/0022-3360(2001)075<0870:FOOXAP>2.0.CO;2; Herrmann H.-J., 1989, Veroeffentlichungen Naturhistorisches Museum Schloss Bertholdsburg Schleusingen, V4, P13; Herrmann H-J, 1994, AMPHIBIEN AQUARIUM; Irisarri I, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-114; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jackson JA, 2006, INT J PARASITOL, V36, P1341, DOI 10.1016/j.ijpara.2006.07.003; Jackson JA, 2003, INT J PARASITOL, V33, P137, DOI 10.1016/S0020-7519(02)00255-2; JACKSON JA, 1995, SYST PARASITOL, V32, P1, DOI 10.1007/BF00009463; Jackson JA, 2001, J ZOOL, V254, P405, DOI 10.1017/S0952836901000905; Jackson JA, 1998, INT J PARASITOL, V28, P1195, DOI 10.1016/S0020-7519(98)00065-4; Jackson K, 2010, HERPETOL CONSERV BIO, V5, P414; Kobel H.R., 1996, Symposia of the Zoological Society of London, V68, P9; KOBEL HR, 1981, J ZOOL, V194, P317, DOI 10.1111/j.1469-7998.1981.tb04584.x; Kobel HR, 1998, HERPETOL J, V8, P13; Lillo F, 2013, ITAL J ZOOL, V80, P566, DOI 10.1080/11250003.2013.847502; Mable BK, 2011, J ZOOL, V284, P151, DOI 10.1111/j.1469-7998.2011.00829.x; Maley J, 1996, P ROYAL SOC EDINBURG, V104B, P31, DOI 10.1017/S0269727000006114; Mechkarska M, 2011, PEPTIDES, V32, P1502, DOI 10.1016/j.peptides.2011.05.025; Mechkarska M, 2011, COMP BIOCHEM PHYS D, V6, P206, DOI 10.1016/j.cbd.2011.03.003; Mohneke M., 2010, Traffic Bulletin, V22, P117; MULLER L, 1910, ABHANDLUNGEN KONI MP, V24, P544; Nichol JE, 1999, GEOGR J, V165, P79, DOI 10.2307/3060512; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ouidah Law R., 2004, SOCIAL HIST W AFRICA; Peters W.C.H., 1875, MONATSBERICHTE KONIG, V1875, P196; Picker M. D., 1996, BIOL XENOPUS, P61; Pokorna M, 2014, CYTOGENET GENOME RES, V142, P190, DOI 10.1159/000358847; Rambaut A., 2007, TRACER V1 5; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Rungger D, 2002, INT J DEV BIOL, V46, P49; Sabaj Perez M. H., 2014, STANDARD SYMBOLIC CO; Salamone L, 2006, HERMINE B SOC ZOOLOG, V147, P2; Salamone L, 2006, BIOL C 16 17 FEBR 20, P11; SATO K, 1993, J IMMUNOL, V150, P2831; Schmid M, 2015, CYTOGENET GENOME RES, V145, P315, DOI 10.1159/000431388; Schmid M, 2015, CYTOGENET GENOME RES, V145, P201, DOI 10.1159/000433481; Shapiro HA, 1934, NATURE, V133, P762, DOI 10.1038/133762a0; SHELTON PMJ, 1970, J EMBRYOL EXP MORPH, V24, P511; SHUM BP, 1993, J IMMUNOL, V151, P5376; Tinsley R.C., 1996, Symposia of the Zoological Society of London, V68, P35; Tinsley R.C., 1996, Symposia of the Zoological Society of London, V68, P403; Tinsley R.C., 1996, Symposia of the Zoological Society of London, V68, P233; Tinsley R. C., 1995, Amphibia-Reptilia, V16, P375, DOI 10.1163/156853895X00451; Tinsley RC, 1998, INT J PARASITOL, V28, P1573, DOI 10.1016/S0020-7519(98)00085-X; Tinsley RC, 1998, SYST PARASITOL, V40, P93, DOI 10.1023/B:SYPA.0000004047.41228.a6; TINSLEY RC, 1973, J ZOOL, V169, P1, DOI 10.1111/j.1469-7998.1973.tb04650.x; TINSLEY RC, 1979, J ZOOL, V188, P69; Tobias ML, 2014, BEHAVIOUR, V151, P1313, DOI 10.1163/1568539X-00003186; Tobias ML, 2011, BEHAVIOUR, V148, P519, DOI 10.1163/000579511X569435; Trueb Linda, 1996, Symposia of the Zoological Society of London, V68, P349; Tymowska J., 1991, P259; VIGNY C, 1979, REV SUISSE ZOOL, V86, P877, DOI 10.5962/bhl.part.82345; Wagler J., 1827, ISIS OKEN, V20, P726; Wagner P, 2013, SALAMANDRA, V49, P206; Yager David D., 1996, Symposia of the Zoological Society of London, V68, P121; Zhang P, 2013, MOL BIOL EVOL, V30, P1899, DOI 10.1093/molbev/mst091; Zimkus BM, 2013, ZOOL SCR, V42, P591, DOI 10.1111/zsc.12029; Zimkus Breda M., 2012, Herpetological Review, V43, P99	107	42	44	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0142823	10.1371/journal.pone.0142823	http://dx.doi.org/10.1371/journal.pone.0142823			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672747	gold, Green Published, Green Submitted			2022-12-27	WOS:000366722700005
J	Fusco, N; Guerini-Rocco, E; Del Gobbo, A; Franco, R; Zito-Marino, F; Vaira, V; Bulfamante, G; Ercoli, G; Nosotti, M; Palleschi, A; Bosari, S; Ferrero, S				Fusco, Nicola; Guerini-Rocco, Elena; Del Gobbo, Alessandro; Franco, Renato; Zito-Marino, Federica; Vaira, Valentina; Bulfamante, Gaetano; Ercoli, Giulia; Nosotti, Mario; Palleschi, Alessandro; Bosari, Silvano; Ferrero, Stefano			The Contrasting Role of p16(Ink4A) Patterns of Expression in Neuroendocrine and Non-Neuroendocrine Lung Tumors: A Comprehensive Analysis with Clinicopathologic and Molecular Correlations	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROGNOSTIC IMPLICATIONS; CANCER PATIENTS; IMAGE-ANALYSIS; P16; P53; IMMUNOHISTOCHEMISTRY; ADENOCARCINOMAS; LOCALIZATION; INHIBITORS	Lung cancer encompasses a constellation of malignancies with no validated prognostic markers. p16(Ink4A) expression has been reported in different subtypes of lung cancers; however, its prognostic value is controversial. Here, we sought to investigate the clinical significance of p16(Ink4A) immunoexpression according to specific staining patterns and its operational implications. A total of 502 tumors, including 277 adenocarcinomas, 84 squamous cell carcinomas, 22 large cell carcinomas, 47 typical carcinoids, 12 atypical carcinoids, 28 large cell neuroendocrine carcinomas, and 32 small cell carcinomas were reviewed and subjected to immunohistochemical analysis for p16Ink4A and Ki67. The spectrum of p16Ink4A expression was annotated for each case as negative, sporadic, focal, or diffuse. Expression at immunohistochemical level showed intra-tumor homogeneity, regardless tumor histo-type. Enrichments in cells expressing p16(Ink4A) were observed from lower- to higher-grade neuroendocrine malignancies, whereas a decrease was seen in poorly and undifferentiated non-neuroendocrine carcinomas. Tumor proliferation indices were higher in neuroendocrine tumors expressing p16(Ink4A) while non-neuroendocrine malignancies immunoreactive for p16(Ink4A) showed a decrease in Ki67-positive cells. Quantitative statistical analyses including each histotype and the p16(Ink4A) status confirmed the independent prognostic role of p16(Ink4A) expression, being a high-risk indicator in neuroendocrine tumors and a marker of good prognosis in non-neuroendocrine lung malignancies. In this study, we provide circumstantial evidence to suggest that the routinary assessment of p16(Ink4A) expression using a three-tiered scoring algorithm, even in a small biopsy, may constitute a reliable, reproducible, and cost-effective substrate for a more accurate risk stratification of each individual patient.	[Fusco, Nicola; Guerini-Rocco, Elena; Del Gobbo, Alessandro; Ercoli, Giulia; Bosari, Silvano; Ferrero, Stefano] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Div Pathol, Milan, Italy; [Franco, Renato; Zito-Marino, Federica] IRCCS Fdn Pascale, Ist Nazl Tumori, Dept Pathol, Naples, Italy; [Vaira, Valentina] Ist Nazl Genet Mol Romeo & Enrica Invernizzi, Milan, Italy; [Vaira, Valentina; Bosari, Silvano] Univ Milan, Dept Pathophysiol & Organ Transplantat, Milan, Italy; [Bulfamante, Gaetano] Univ Milan, Div Pathol, San Paolo Hosp, Dept Hlth Sci, Milan, Italy; [Nosotti, Mario; Palleschi, Alessandro] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Div Thorac Surg, Milan, Italy; [Ferrero, Stefano] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; University of Milan; San Paolo-Polo Universitaria Hospital; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Ferrero, S (corresponding author), Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Div Pathol, Milan, Italy.	stefano.ferrero@unimi.it	Palleschi, Alessandro/J-6416-2015; Marino, Federica ZMF Zito/K-8634-2016; Nosotti, Mario/K-7389-2016; Fusco, Nicola/D-6264-2016; Vaira, Valentina/K-6499-2016; Nosotti, Mario/AAA-5976-2022; Bosari, Silvano/K-7744-2016	Palleschi, Alessandro/0000-0003-4510-5167; Nosotti, Mario/0000-0002-8571-121X; Fusco, Nicola/0000-0002-9101-9131; Vaira, Valentina/0000-0003-4416-6216; Nosotti, Mario/0000-0002-8571-121X; Franco, Renato/0000-0002-8340-3184; Bosari, Silvano/0000-0002-9744-6951; GUERINI ROCCO, ELENA/0000-0003-2001-7582				[Anonymous], 2015, SURV EP END RES STAT; Arcaro A, 2015, CRIT REV ONCOL HEMAT, V95, P154, DOI 10.1016/j.critrevonc.2015.03.001; Cortes AA, 2015, TRANSL LUNG CANCER R, V4, P191, DOI 10.3978/j.issn.2218-6751.2014.06.01; Beasley MB, 2003, HUM PATHOL, V34, P136, DOI 10.1053/hupa.2003.8; Bian CA, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0502-0; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chan JKC, 2013, INT J SURG PATHOL, V21, P455, DOI 10.1177/1066896913502529; Chen LY, 2015, BREAST CANCER RES TR, V149, P631, DOI 10.1007/s10549-015-3288-4; Chen M, 2010, INT J ONCOL, V37, P963, DOI 10.3892/ijo_00000747; Cheng YL, 2003, EUR J CARDIO-THORAC, V23, P221, DOI 10.1016/S1010-7940(02)00749-2; Compton C. C., 2012, AJCC CANC STAGING AT; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Derenzini M, 2009, J PATHOL, V219, P373, DOI 10.1002/path.2612; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Evangelou K, 2004, BIOTECH HISTOCHEM, V79, P5, DOI 10.1080/10520290310001659466; Fan XH, 2015, TUMOR BIOL, V36, P3043, DOI 10.1007/s13277-014-2940-7; Fusco N, 2016, HISTOPATHOLOGY, V68, P262, DOI 10.1111/his.12735; Fusco N, 2013, MODERN PATHOL, V26, P816, DOI 10.1038/modpathol.2012.228; Gazzeri S, 1998, ONCOGENE, V16, P497, DOI 10.1038/sj.onc.1201559; Georgiadou D, 2014, APMIS, V122, P1230, DOI 10.1111/apm.12289; Gessner C, 2002, EUR RESPIR J, V19, P134, DOI 10.1183/09031936.02.00219402; Han CP, 2009, MODERN PATHOL, V22, P797, DOI 10.1038/modpathol.2009.31; Inoue R, 2004, GENE THER, V11, P1195, DOI 10.1038/sj.gt.3302284; Kawahara A, 2012, LUNG CANCER, V78, P39, DOI 10.1016/j.lungcan.2012.07.002; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Lade-Keller J, 2014, J CLIN PATHOL, V67, P520, DOI 10.1136/jclinpath-2013-202127; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; Lou-Qian Zhang, 2013, PLoS One, V8, pe54970, DOI 10.1371/journal.pone.0054970; Marchetti A, 2014, J THORAC ONCOL, V9, P1470, DOI 10.1097/JTO.0000000000000280; McCalmont TH, 2012, J CUTAN PATHOL, V39, P1060, DOI 10.1111/cup.12059; Nilsson K, 2006, INT J CANCER, V118, P1120, DOI 10.1002/ijc.21466; Pan QL, 2005, J MOL DIAGN, V7, P396, DOI 10.1016/S1525-1578(10)60569-7; Piscuoglio S, 2015, HISTOPATHOLOGY, V67, P719, DOI 10.1111/his.12712; Remo A, 2016, APPL IMMUNOHISTO M M, V24, P201, DOI 10.1097/PAI.0000000000000171; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shoushtari A, 2010, CANCER-AM CANCER SOC, V116, P2645, DOI 10.1002/cncr.25040; Singhal S, 2005, CLIN CANCER RES, V11, P3974, DOI 10.1158/1078-0432.CCR-04-2661; Souza-Rodrigues E, 2007, PROTEOMICS, V7, P4102, DOI 10.1002/pmic.200700133; Subhawong AP, 2009, AM J SURG PATHOL, V33, P163, DOI 10.1097/PAS.0b013e31817f9790; Tong JL, 2011, LUNG CANCER, V74, P155, DOI 10.1016/j.lungcan.2011.04.019; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; Vaira V, 2015, LIVER INT, V35, P1077, DOI 10.1111/liv.12636; Zhu CQ, 2006, J CLIN PATHOL, V59, P790, DOI 10.1136/jcp.2005.031351; Zhu CQ, 2014, TRANSL LUNG CANCER R, V3, P149, DOI 10.3978/j.issn.2218-6751.2014.06.09	44	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144923	10.1371/journal.pone.0144923	http://dx.doi.org/10.1371/journal.pone.0144923			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674347	Green Submitted, Green Published, gold			2022-12-27	WOS:000366722700073
J	Liu, Q; Ren, J; Song, JN; Li, JY				Liu, Qian; Ren, Jing; Song, Jiangning; Li, Jinyan			Co-Occurring Atomic Contacts for the Characterization of Protein Binding Hot Spots	PLOS ONE			English	Article							FREE-ENERGY; PREDICTION; INTERFACES; AFFINITY; DATABASE; IDENTIFICATION; MUTATIONS; SERVER; MODEL	A binding hot spot is a small area at a protein-protein interface that can make significant contribution to binding free energy. This work investigates the substantial contribution made by some special co-occurring atomic contacts at a binding hot spot. A co-occurring atomic contact is a pair of atomic contacts that are close to each other with no more than three covalent-bond steps. We found that two kinds of co-occurring atomic contacts can play an important part in the accurate prediction of binding hot spot residues. One is the co-occurrence of two nearby hydrogen bonds. For example, mutations of any residue in a hydrogen bond network consisting of multiple co-occurring hydrogen bonds could disrupt the interaction considerably. The other kind of co-occurring atomic contact is the co-occurrence of a hydrophobic carbon contact and a contact between a hydrophobic carbon atom and a pi ring. In fact, this co-occurrence signifies the collective effect of hydrophobic contacts. We also found that the B-factor measurements of several specific groups of amino acids are useful for the prediction of hot spots. Taking the B-factor, individual atomic contacts and the co-occurring contacts as features, we developed a new prediction method and thoroughly assessed its performance via cross-validation and independent dataset test. The results show that our method achieves higher prediction performance than well-known methods such as Robetta, FoldX and Hotpoint. We conclude that these contact descriptors, in particular the novel co-occurring atomic contacts, can be used to facilitate accurate and interpretable characterization of protein binding hot spots.	[Liu, Qian; Ren, Jing; Li, Jinyan] Univ Technol Sydney, Adv Analyt Inst, Broadway, NSW 2007, Australia; [Song, Jiangning] Monash Univ, Fac Med, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Song, Jiangning] Monash Univ, Fac Informat Technol, Ctr Res Intelligent Syst, Melbourne, Vic 3800, Australia; [Li, Jinyan] Univ Technol Sydney, Ctr Hlth Technol, Broadway, NSW 2007, Australia	University of Technology Sydney; Monash University; Monash University; University of Technology Sydney	Li, JY (corresponding author), Univ Technol Sydney, Adv Analyt Inst, Broadway, NSW 2007, Australia.	jinyan.li@uts.edu.au	Song, Jiangning/F-9787-2010	Song, Jiangning/0000-0001-8031-9086; Li, Jinyan/0000-0003-1833-7413	Australian Research Council Discovery Project grant [ARC DP130102124]	Australian Research Council Discovery Project grant(Australian Research Council)	This work was partly supported by an Australian Research Council Discovery Project grant (ARC DP130102124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partly supported by an Australian Research Council Discovery Project grant (ARC DP130102124). We thank Professors Geoffrey I. Webb and Robert Pike for their comments and proofreading work on some parts of this manuscript.	Assi SA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1158; Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen P, 2013, PROTEINS, V81, P1351, DOI 10.1002/prot.24278; Cho KI, 2009, NUCLEIC ACIDS RES, V37, P2672, DOI 10.1093/nar/gkp132; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Darnell SJ, 2008, NUCLEIC ACIDS RES, V36, pW265, DOI 10.1093/nar/gkn346; Dehouck Y, 2013, NUCLEIC ACIDS RES, V41, pW333, DOI 10.1093/nar/gkt450; Fischer TB, 2003, BIOINFORMATICS, V19, P1453, DOI 10.1093/bioinformatics/btg163; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guney E, 2008, NUCLEIC ACIDS RES, V36, pD662, DOI 10.1093/nar/gkm813; Halperin I, 2004, STRUCTURE, V12, P1027, DOI 10.1016/j.str.2004.04.009; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Kastritis PL, 2014, J MOL BIOL, V426, P2632, DOI 10.1016/j.jmb.2014.04.017; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T, 2004, SCI STKE, V2004; Lei Deng, 2013, Research in Computational Molecular Biology. 17th Annual International Conference (RECOMB 2013). Proceedings, P333, DOI 10.1007/978-3-642-37195-0_32; Liu Q, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-57; Liu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059737; Liu QY, 2013, ANAL CHEM, V85, P9630, DOI 10.1021/ac401921z; Moretti R, 2013, PROTEINS, V81, P1980, DOI 10.1002/prot.24356; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Pallara C, 2013, PROTEINS, V81, P2192, DOI 10.1002/prot.24387; Parthasarathy S, 1997, PROTEIN SCI, V6, P2561, DOI 10.1002/pro.5560061208; Schymkowitz J, 2005, NUCL ACIDS RES, V33; Shingate P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-303; Thorn KS, 2001, BIOINFORMATICS, V17, P284, DOI 10.1093/bioinformatics/17.3.284; Tuncbag N, 2010, NUCLEIC ACIDS RES, V38, pW402, DOI 10.1093/nar/gkq323; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Wang L, 2012, PROTEIN ENG DES SEL, V25, P119, DOI 10.1093/protein/gzr066; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Xia JF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-174; Yuan Z, 2005, PROTEINS, V58, P905, DOI 10.1002/prot.20375; Yuan Z, 2003, PROTEIN ENG, V16, P109, DOI 10.1093/proeng/gzg014; Zhu XL, 2013, PROTEINS, V81, P2221, DOI 10.1002/prot.24405	40	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144486	10.1371/journal.pone.0144486	http://dx.doi.org/10.1371/journal.pone.0144486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675422	Green Published, Green Submitted, gold			2022-12-27	WOS:000366722700040
J	Hasebe, Y; Yamamoto, H; Fukuda, K; Nishimiya, K; Hanawa, K; Shindo, T; Kondo, M; Nakano, M; Wakayama, Y; Takayama, K; Shimokawa, H				Hasebe, Yuhi; Yamamoto, Hiroaki; Fukuda, Koji; Nishimiya, Kensuke; Hanawa, Kenichiro; Shindo, Tomohiko; Kondo, Masateru; Nakano, Makoto; Wakayama, Yuji; Takayama, Kazuyoshi; Shimokawa, Hiroaki			Development of a Novel Shock Wave Catheter Ablation System - The First Feasibility Study in Pigs	PLOS ONE			English	Article							RECURRENT VENTRICULAR-TACHYCARDIA; RADIOFREQUENCY ABLATION; ATRIAL-FIBRILLATION; NONISCHEMIC CARDIOMYOPATHY; LESION FORMATION; THERAPY; RISK; DEFIBRILLATOR; COMPLICATIONS; TEMPERATURE	Introduction Radio-frequency catheter ablation (RFCA) using Joule heat has two fundamental weaknesses: the limited depth of treatment and the risk of thrombus formation. In contrast, focused shock wave (SW) therapy could damage tissues at arbitrary depths without heat generation. Thus, we aimed to develop a SWcatheter ablation (SWCA) system that could compensate for the weaknesses of RFCA therapy. Methods and Results We developed a SWCA system where the SW generated by a Q-switched Holmium: yttrium aluminum garnet (YAG) laser beam was reflected by a reflector attached to 14-Fr catheter tip and then was converged onto the focus. We examined the feasibility of our system on pigs in vivo. When applied using the epicardial approach, the SWCA caused persistent spheroidal lesions with mild superficial injury than the RFCA. The lesions were created to a depth based on the focal length (2.0 mm) [2.36 +/- 0.45 (SD) mm immediately after procedure, n = 16]. When applied to the atrioventricular (AV) node using the endocardial approach, the SWCA caused junctional escape rhythms in 2 pigs and AV block in 12 pigs (complete AV block in 9) in acute phase (n = 14). Nine of the 14 pigs survived with pacemakers for the long-term study, and the AV block persisted for 12.6 +/- 3.9 (SD) days in all surviving pigs. Histological examination showed AV nodal cell body atrophy in the acute phase and fibrotic lesions in the chronic phase. Importantly, no acute or chronic fatal complications were noted. Conclusions Our novel SWCA system could be a promising modality as a non-thermal ablation method to compensate for the weaknesses of RFCA therapy. However, further research and development will be necessary as the current prototype still exhibited the presence of micro-thrombus formation in the animal studies.	[Hasebe, Yuhi; Fukuda, Koji; Nishimiya, Kensuke; Hanawa, Kenichiro; Shindo, Tomohiko; Kondo, Masateru; Nakano, Makoto; Wakayama, Yuji; Takayama, Kazuyoshi; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan; [Yamamoto, Hiroaki; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Adv Cardiovasc Med, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Shimokawa, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan.	shimo@cardio.med.tohoku.ac.jp	Santos-Gomes, G/J-2367-2019; Lago, Joao/W-5238-2019; Fukuda, Koji/AAP-5927-2021; Passero, Luiz Felipe D/B-9549-2012; Laurenti, Marcia Dalastra/C-4734-2012; Santos-Gomes, Gabriela/I-2391-2012; Levy, Debora/G-8208-2014	Lago, Joao/0000-0002-1193-8374; Passero, Luiz Felipe D/0000-0002-5986-6381; FUKUDA, KOJI/0000-0001-7209-8420; Levy, Debora/0000-0001-7492-997X; Santos-Gomes, Gabriela/0000-0001-9264-3887; Yamamoto, Eduardo/0000-0003-2375-6081; Kallas, Esper/0000-0003-2026-6925; Shimokawa, Hiroaki/0000-0001-7534-4826; Rafael-Fernandes, Mariana/0000-0002-5214-7667; Silva, Marcelo/0000-0002-1000-0149; Laurenti, Marcia Dalastra/0000-0002-1080-2440	Japanese Ministry of Health, Labour and Welfare, Tokyo, Japan; Japan Science and Technology Agency, Tokyo, Japan [AS2313010F]	Japanese Ministry of Health, Labour and Welfare, Tokyo, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency, Tokyo, Japan(Japan Science & Technology Agency (JST))	The authors had no disclosure for this work. This work was supported in part by the grants-in- aid for Medical Equipment Development and Promotion Research Project (H20-Activity-General-002) from the Japanese Ministry of Health, Labour and Welfare, Tokyo, Japan and the grants- in- aid for Adaptable and Seamless Technology transfer Program (A- STEP) through target-driven R& D (AS2313010F) from Japan Science and Technology Agency, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; DELIUS M, 1987, ULTRASOUND MED BIOL, V13, P61, DOI 10.1016/0301-5629(87)90075-5; Dukkipati SR, 2011, CIRC-ARRHYTHMIA ELEC, V4, P185, DOI 10.1161/CIRCEP.110.957290; EVAN AP, 1991, AM J KIDNEY DIS, V17, P445, DOI 10.1016/S0272-6386(12)80639-1; Evan AP, 1998, NEPHRON, V78, P1, DOI 10.1159/000044874; Fenelon G, 2006, J INTERV CARD ELECTR, V15, P57, DOI 10.1007/s10840-006-7620-0; Gaita F, 2010, CIRCULATION, V122, P1667, DOI 10.1161/CIRCULATIONAHA.110.937953; Haqqani HM, 2011, HEART RHYTHM, V8, P1169, DOI 10.1016/j.hrthm.2011.03.008; Hohnloser SH, 2006, EUR HEART J, V27, P3027, DOI 10.1093/eurheartj/ehl276; Hsia HH, 2003, CIRCULATION, V108, P704, DOI 10.1161/01.CIR.0000083725.72693.EA; JACKMAN WM, 1992, NEW ENGL J MED, V327, P313, DOI 10.1056/NEJM199207303270504; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Keane D, 2005, J CARDIOVASC ELECTR, V16, P1025, DOI 10.1111/j.1540-8167.2005.00270.x; Khairy P, 2003, CIRCULATION, V107, P2045, DOI 10.1161/01.CIR.0000058706.82623.A1; Kikuchi Y, 2010, CIRC J, V74, P589, DOI 10.1253/circj.CJ-09-1028; Koruth JS, 2012, HEART RHYTHM, V9, P1932, DOI 10.1016/j.hrthm.2012.08.001; KUWAHARA MA, 1987, J UROLOGY, V137, P837, DOI 10.1016/S0022-5347(17)44268-6; Matlaga BR, 2008, J ENDOUROL, V22, P121, DOI 10.1089/end.2007.9852; MAYER R, 1990, J UROLOGY, V144, P1505, DOI 10.1016/S0022-5347(17)39787-2; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; NAKAGAWA H, 1995, CIRCULATION, V91, P2264, DOI 10.1161/01.CIR.91.8.2264; Nakahara S, 2010, J AM COLL CARDIOL, V55, P2355, DOI 10.1016/j.jacc.2010.01.041; NATH S, 1995, PROG CARDIOVASC DIS, V37, P185, DOI 10.1016/S0033-0620(05)80006-4; Nishida T, 2004, CIRCULATION, V110, P3055, DOI 10.1161/01.CIR.0000148849.51177.97; Rassweiler JJ, 2011, EUR UROL, V59, P784, DOI 10.1016/j.eururo.2011.02.033; Raum K, 1997, IEEE T ULTRASON FERR, V44, P810, DOI 10.1109/58.655196; Sacher F, 2010, J AM COLL CARDIOL, V55, P2366, DOI 10.1016/j.jacc.2009.10.084; Sinelnikov YD, 2009, ACOUST PHYS+, V55, P647, DOI 10.1134/S1063771009040216; Soejima K, 2001, CIRCULATION, V103, P1858; Sosa E, 2000, J AM COLL CARDIOL, V35, P1442, DOI 10.1016/S0735-1097(00)00606-9; STRICKBERGER SA, 1995, AM HEART J, V130, P1026, DOI 10.1016/0002-8703(95)90204-X; TAKAYAMA K, 1989, P INT WORKSH SHOCK W, P217; TANNO K, 1994, JPN CIRC J, V58, P123, DOI 10.1253/jcj.58.123; Tokuda M, 2011, CIRC-ARRHYTHMIA ELEC, V4, P889, DOI 10.1161/CIRCEP.111.966283; Zhou L, 1999, J CARDIOVASC ELECTR, V10, P611, DOI 10.1111/j.1540-8167.1999.tb00719.x	35	50	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116017	10.1371/journal.pone.0116017	http://dx.doi.org/10.1371/journal.pone.0116017			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	26674781	Green Published, Green Submitted, gold			2022-12-27	WOS:000348609800005
J	Yamamoto, ES; Campos, BLS; Jesus, JA; Laurenti, MD; Ribeiro, SP; Kallas, EG; Rafael-Fernandes, M; Santos-Gomes, G; Silva, MS; Sessa, DP; Lago, JHG; Levy, D; Passero, LFD				Yamamoto, Eduardo S.; Campos, Bruno L. S.; Jesus, Jessica A.; Laurenti, Marcia D.; Ribeiro, Susan P.; Kallas, Esper G.; Rafael-Fernandes, Mariana; Santos-Gomes, Gabriela; Silva, Marcelo S.; Sessa, Deborah P.; Lago, Joao H. G.; Levy, Debora; Passero, Luiz F. D.			The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis	PLOS ONE			English	Article							OLEANOLIC ACID; AMPHOTERICIN-B; IN-VITRO; ANTILEISHMANIAL ACTIVITY; VISCERAL LEISHMANIASIS; SECONDARY METABOLITES; TRADITIONAL MEDICINE; APOPTOSIS; DONOVANI; MECHANISM	Among neglected tropical diseases, leishmaniasis is one of the most important ones, affecting more than 12 million people worldwide. The available treatments are not well tolerated, and present diverse side effects, justifying the search for new therapeutic compounds. In the present study, the activity of ursolic acid (UA) and oleanolic acid (OA) were assayed in experimental cutaneous leishmaniasis (in vitro and in vivo). Promastigote forms of L. amazonensis were incubated with OA and UA for 24h, and effective concentration 50% (EC50) was estimated. Ultraestructural alterations in Leishmania amazonensis promastigotes after UA treatment were evaluated by transmission electron microscopy, and the possible mode of action was assayed through Annexin V and propidium iodide staining, caspase 3/7 activity, DNA fragmentation and transmembrane mitochondrial potential. The UA potential was evaluated in intracellular amastigotes, and its therapeutic potential was evaluated in L. amazonensis infected BALB/c mice. UA eliminated L. amazonensis promastigotes with an EC50 of 6.4 mu g/mL, comparable with miltefosine, while OA presented only a marginal effect on promastigote forms at 100 mu g/mL. The possible mechanism by which promastigotes were eliminated by UA was programmed cell death, independent of caspase 3/7, but it was highly dependent on mitochondria activity. UA was not toxic for peritoneal macrophages from BALB/c mice, and it was able to eliminate intracellular amastigotes, associated with nitric oxide (NO) production. OA did not eliminate amastigotes nor trigger NO. L. amazonensis infected BALB/c mice submitted to UA treatment presented lesser lesion size and parasitism compared to control. This study showed, for the first time, that UA eliminate promastigote forms through a mechanism associated with programed cell death, and importantly, was effective in vivo. Therefore, UA can be considered an interesting candidate for future tests as a prototype drug for the treatment of cutaneous leishmaniasis.	[Yamamoto, Eduardo S.; Campos, Bruno L. S.; Jesus, Jessica A.; Laurenti, Marcia D.; Passero, Luiz F. D.] Univ Sao Paulo, Lab Pathol Infect Dis LIM50, Dept Pathol, Sch Med, BR-01246903 Sao Paulo, SP, Brazil; [Ribeiro, Susan P.; Kallas, Esper G.] Univ Sao Paulo, Lab Clin Immunol & Allergy LIM60, Sch Med, BR-01246903 Sao Paulo, SP, Brazil; [Rafael-Fernandes, Mariana; Santos-Gomes, Gabriela; Silva, Marcelo S.] Univ Nova Lisboa, Global Hlth & Trop Med, IHMT, P-1349008 Lisbon, Portugal; [Sessa, Deborah P.; Lago, Joao H. G.] Univ Fed Sao Paulo, Inst Environm Chem & Pharmaceut Sci, BR-09920000 Diadema, SP, Brazil; [Levy, Debora] Univ Sao Paulo, Lab Genet & Mol Hematol LIM31, Sch Med, BR-01246903 Sao Paulo, SP, Brazil; [Ribeiro, Susan P.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Case Western Reserve University	Passero, LFD (corresponding author), Univ Sao Paulo, Lab Pathol Infect Dis LIM50, Dept Pathol, Sch Med, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.	felipepassero@yahoo.com.br	Santos-Gomes, G/J-2367-2019; Lago, Joao/W-5238-2019; Fukuda, Koji/AAP-5927-2021; Passero, Luiz Felipe D/B-9549-2012; Laurenti, Marcia Dalastra/C-4734-2012; Santos-Gomes, Gabriela/I-2391-2012; Levy, Debora/G-8208-2014	Lago, Joao/0000-0002-1193-8374; Passero, Luiz Felipe D/0000-0002-5986-6381; FUKUDA, KOJI/0000-0001-7209-8420; Levy, Debora/0000-0001-7492-997X; Santos-Gomes, Gabriela/0000-0001-9264-3887; Yamamoto, Eduardo/0000-0003-2375-6081; Kallas, Esper/0000-0003-2026-6925; Shimokawa, Hiroaki/0000-0001-7534-4826; Rafael-Fernandes, Mariana/0000-0002-5214-7667; Silva, Marcelo/0000-0002-1000-0149; Laurenti, Marcia Dalastra/0000-0002-1080-2440	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/03903-9, 2013/16297-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grants: 2012/03903-9 and 2013/16297-2. URL: http://fapesp.br/en/.	Alvarado HL, 2015, COLLOID SURFACE B, V130, P40, DOI 10.1016/j.colsurfb.2015.03.062; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002; Begum S, 2014, CHEM BIODIVERS, V11, P709, DOI 10.1002/cbdv.201300151; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Bero J, 2011, J ETHNOPHARMACOL, V137, P998, DOI 10.1016/j.jep.2011.07.022; Both DM, 2002, ARCH DERMATOL RES, V293, P569, DOI 10.1007/s00403-001-0272-0; Camargos HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104429; Campos BLS, 2015, PARASITE IMMUNOL, V37, P407, DOI 10.1111/pim.12206; Carneiro MB, 2015, IFN GAMMA DEPENDENT; Chattopadhyay A, 2011, BIOCHEM BIOPH RES CO, V416, P7, DOI 10.1016/j.bbrc.2011.11.023; da Luz RAI, 2011, J ANTIMICROB CHEMOTH, V66, P350, DOI 10.1093/jac/dkq444; da Silva AA, 2009, FITOTERAPIA, V80, P478, DOI 10.1016/j.fitote.2009.06.007; Das M, 2001, J CELL SCI, V114, P2461; Das R, 2008, APOPTOSIS, V13, P867, DOI 10.1007/s10495-008-0224-7; Decuypere S, 2005, ANTIMICROB AGENTS CH, V49, P4616, DOI 10.1128/AAC.49.11.4616-4621.2005; Demicheli C, 2008, CHEM COMMUN, P4828, DOI 10.1039/b809186b; Passero LFD, 2014, CURR CLIN PHARMACOL, V9, P187, DOI 10.2174/1574884709999140606161413; Passero LFD, 2010, APMIS, V118, P973, DOI 10.1111/j.1600-0463.2010.02679.x; Dutta A, 2007, J MED MICROBIOL, V56, P1196, DOI 10.1099/jmm.0.47114-0; Serna ME, 2015, PARASITOL INT, V64, P295, DOI 10.1016/j.parint.2015.03.005; Franca F, 1996, Rev Soc Bras Med Trop, V29, P229, DOI 10.1590/S0037-86821996000300002; Freitas-Junior LH, 2012, INT J PARASITOL-DRUG, V2, P11, DOI 10.1016/j.ijpddr.2012.01.003; Gachet MS, 2010, J ETHNOPHARMACOL, V128, P184, DOI 10.1016/j.jep.2010.01.007; Germonprez N, 2005, J MED CHEM, V48, P32, DOI 10.1021/jm031150y; Giovannini C, 2002, FEBS LETT, V523, P200, DOI 10.1016/S0014-5793(02)02972-1; Gnoatto SCB, 2008, J ENZYM INHIB MED CH, V23, P604, DOI [10.1080/14756360802204870, 10.1080/14756360802204870 ]; Hill RA, 2012, NAT PROD REP, V29, P780, DOI 10.1039/c2np20027a; Jesus JA, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/620472; Johann S, 2012, MED MYCOL, V50, P843, DOI 10.3109/13693786.2012.678903; Kontogianni VG, 2009, ANAL CHIM ACTA, V635, P188, DOI 10.1016/j.aca.2009.01.021; Laniado-Laborin R, 2009, REV IBEROAM MICOL, V26, P223, DOI 10.1016/j.riam.2009.06.003; Laurenti MD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/134236; Lin XR, 2014, FOOD FUNCT, V5, P1175, DOI 10.1039/c3fo60720h; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Machado M, 2012, EXP PARASITOL, V130, P223, DOI 10.1016/j.exppara.2011.12.012; Maes L, 2004, ANTIMICROB AGENTS CH, V48, P2056, DOI 10.1128/AAC.48.6.2056-2060.2004; Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200; Neto RLM, 2011, EXP PARASITOL, V127, P215, DOI 10.1016/j.exppara.2010.07.020; Nam H, 2013, FOOD CHEM TOXICOL, V62, P579, DOI 10.1016/j.fct.2013.09.024; Oldfield E, 2012, ANGEW CHEM INT EDIT, V51, P1124, DOI 10.1002/anie.201103110; Ovesna Z, 2006, MUTAT RES-FUND MOL M, V600, P131, DOI 10.1016/j.mrfmmm.2006.03.008; Passero LFD, 2015, PARASITOL INT, V64, P32, DOI 10.1016/j.parint.2015.01.006; Passero LFD, 2011, PARASITOL RES, V108, P529, DOI 10.1007/s00436-010-2091-8; Rath S, 2003, QUIM NOVA, V26, P550, DOI 10.1590/S0100-40422003000400018; Rego FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122038; Rittig MG, 2000, PARASITOL TODAY, V16, P292, DOI 10.1016/S0169-4758(00)01692-6; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Santos DO, 2008, PARASITOL RES, V103, P1, DOI 10.1007/s00436-008-0943-2; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Seebacher W, 2003, MAGN RESON CHEM, V41, P636, DOI 10.1002/mrc.1214; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Tan N, 2002, PHYTOCHEMISTRY, V61, P881, DOI 10.1016/S0031-9422(02)00361-8; Thakur CP, 1999, T ROY SOC TROP MED H, V93, P319, DOI 10.1016/S0035-9203(99)90037-8; Torrado JJ, 2008, J PHARM SCI-US, V97, P2405, DOI 10.1002/jps.21179; Torres-Santos EC, 2004, PHYTOMEDICINE, V11, P114, DOI 10.1078/0944-7113-00381; Wang X, 2013, CARCINOGENESIS, V34, P1323, DOI 10.1093/carcin/bgt058; Yamamoto ES, 2014, PARASITOL RES, V113, P333, DOI 10.1007/s00436-013-3659-x; Yang L, 2010, CANCER LETT, V298, P128, DOI 10.1016/j.canlet.2010.06.010; You HJ, 2001, FEBS LETT, V509, P156, DOI 10.1016/S0014-5793(01)03161-1; Zeng JW, 2015, MOL MED REP, V12, P1997, DOI 10.3892/mmr.2015.3666	62	50	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144946	10.1371/journal.pone.0144946	http://dx.doi.org/10.1371/journal.pone.0144946			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674781	Green Submitted, gold, Green Published			2022-12-27	WOS:000366722700076
